PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, JJ; Corona, AL; Dunn, BP; Cai, EM; Prakken, JN; Blobe, GC				Huang, Jennifer J.; Corona, Armando L.; Dunn, Brian P.; Cai, Elise M.; Prakken, Jesse N.; Blobe, Gerard C.			Increased type III TGF-beta receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition	ONCOGENE			English	Article							SIGNALING PATHWAY; PEPTIDE INHIBITORS; CANCER; BETAGLYCAN; ACTIVATION; METASTASIS; MECHANISMS; APOPTOSIS; RIII; ERK	The type III TGF-beta receptor (T beta RIII) is a TGF-beta co-receptor that presents ligand to the type II TGF-beta receptor to initiate signaling. T beta RIII also undergoes ectodomain shedding to release a soluble form (sT beta RIII) that can bind ligand, sequestering it away from cell surface receptors. We have previously identified a T beta RIII extracellular mutant that has enhanced ectodomain shedding ("super shedding (SS)"-T beta RIII-SS). Here, we utilize T beta RIII-SS to study the balance of cell surface and soluble T beta RIII in the context of lung cancer. We demonstrate that expressing T beta RIII-SS in lung cancer cell models induces epithelial-to-mesenchymal transition (EMT) and that these T beta RIII-SS (EMT) cells are less migratory, invasive and adhesive and more resistant to gemcitabine. Moreover, T beta RIII-SS (EMT) cells exhibit decreased tumorigenicity but increased growth rate in vitro and in vivo. These studies suggest that the balance of cell surface and soluble T beta RIII may regulate a dichotomous role for T beta RIII during cancer progression.	[Huang, Jennifer J.; Corona, Armando L.; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Dunn, Brian P.; Cai, Elise M.; Prakken, Jesse N.; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA	Duke University; Duke University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA.	gerard.blobe@duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Cai, Elise/0000-0002-6650-8208	National Institutes of Health/National Cancer Institute [F30CA196162, T32-GM007171, R01CA135006]; NATIONAL CANCER INSTITUTE [F30CA196162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the National Institutes of Health/National Cancer Institute: F30CA196162 (J.J.H.), T32-GM007171 (Medical Scientist Training Program; J.J.H), and R01CA135006 (G.C.B).	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dotor J, 2007, CYTOKINE, V39, P106, DOI 10.1016/j.cyto.2007.06.004; Elderbroom JL, 2014, MOL BIOL CELL, V25, P2320, DOI 10.1091/mbc.E13-09-0524; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gallo-Oller G, 2016, CANCER LETT, V381, P67, DOI 10.1016/j.canlet.2016.07.029; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Huang JJ, 2016, BIOCHEM SOC T, V44, P1441, DOI 10.1042/BST20160065; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Jurisic D, 2015, GROWTH FACTORS, V33, P200, DOI 10.3109/08977194.2015.1055740; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Llopiz D, 2009, INT J CANCER, V125, P2614, DOI 10.1002/ijc.24656; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Treffers LW, 2016, IMMUNOL REV, V273, P312, DOI 10.1111/imr.12444; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Vilchis-Landeros MM, 2001, BIOCHEM J, V355, P215, DOI 10.1042/0264-6021:3550215; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	40	8	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3402	3414		10.1038/s41388-018-0672-7	http://dx.doi.org/10.1038/s41388-018-0672-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30643193	Green Accepted			2022-12-26	WOS:000466610000006
J	Ajith, A; Portik-Dobos, V; Nguyen-Lefebvre, AT; Callaway, C; Horuzsko, DD; Kapoor, R; Zayas, C; Maenaka, K; Mulloy, LL; Horuzsko, A				Ajith, Ashwin; Portik-Dobos, Vera; Anh Thu Nguyen-Lefebvre; Callaway, Christine; Horuzsko, Daniel D.; Kapoor, Rajan; Zayas, Carlos; Maenaka, Katsumi; Mulloy, Laura L.; Horuzsko, Anatolij			HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival	FASEB JOURNAL			English	Article						HLA-G; human kidney transplantation; humanized mouse	CLASS-I MOLECULES; CD8(+) T-CELLS; GENE-EXPRESSION; LILR FAMILY; PERFORIN; RECEPTOR; MECHANISMS; TRANSPLANTATION; INDUCE; IMPACT	Human leukocyte antigen G (HLA-G), a nonclassic HLA class Ib molecule involved in the maintenance of maternal tolerance to semiallogeneic fetal tissues during pregnancy, has emerged as a potential therapeutic target to control allograft rejection. We demonstrate here that the level of soluble HLA-G dimer was higher in a group of 90 patients with a functioning renal allograft compared with 40 patients who rejected (RJ) their transplants. The HLA-G dimer level was not affected by demographic status. One of the potential mechanisms in tissue-organ allograft rejection involves the induction of granzymes and perforin, which are the main effector molecules expressed by CD8(+) cytotoxic T lymphocytes and function to destroy allogeneic transplants. Using genomics and molecular and cellular analyses of cells from T-cell-mediated RJ and nonrejected kidney transplant patients, cells from leukocyte Ig-like receptor B1 (LILRB1) transgenic mice, humanized mice, and genetically engineered HLA-G dimer, we demonstrated a novel mechanism by which HLA-G dimer inhibits activation and cytotoxic capabilities of human CD8(+) T cells. This mechanism implicated the down-regulation of Granzyme B expression and the essential involvement of LILRB1. Thus, HLA-G dimer has the potential to be a specific and effective therapy for prevention of allograft rejection and prolongation of graft survival.	[Ajith, Ashwin; Portik-Dobos, Vera; Anh Thu Nguyen-Lefebvre; Horuzsko, Daniel D.; Horuzsko, Anatolij] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3154, Augusta, GA 30912 USA; [Callaway, Christine; Kapoor, Rajan; Zayas, Carlos; Mulloy, Laura L.] Augusta Univ, Med Coll Georgia, Div Nephrol, Dept Med, Augusta, GA USA; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Hokkaido University	Horuzsko, A (corresponding author), Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3154, Augusta, GA 30912 USA.	ahoruzsko@augusta.edu			Department of Medicine; Georgia Cancer Center at the Augusta University community; Carlos and Marguerite Mason Trust; U.S. National Institutes of Health, National Cancer Institute [CA 172230]; NATIONAL CANCER INSTITUTE [R01CA172230] Funding Source: NIH RePORTER	Department of Medicine; Georgia Cancer Center at the Augusta University community; Carlos and Marguerite Mason Trust; U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. R. B. Markowitz (Georgia Cancer Center, Augusta University) for critically reading the manuscript. The authors thank Peggy Best, Walidah Walker, Joan Holloway, and physicians at the Medical College of Georgia for support of collection materials from kidney transplant recipients. The authors thank Eiko Kitamura (Georgia Cancer Center Integrated Genomics Shared Resource) for technical support. The authors are grateful to the Department of Medicine and the Georgia Cancer Center at the Augusta University community for fruitful discussion and support. These research results were supported by the Carlos and Marguerite Mason Trust, and by U.S. National Institutes of Health, National Cancer Institute Grant CA 172230 (to A.H.). The authors declare no conflicts of interest.	Altimari A, 2008, TRANSPLANTATION, V85, P1778, DOI 10.1097/TP.0b013e318177dfe4; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Carosella ED, 2007, SEMIN CANCER BIOL, V17, P411, DOI 10.1016/j.semcancer.2007.06.014; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Chapman JR, 2017, AM J KIDNEY DIS, V69, P287, DOI 10.1053/j.ajkd.2016.08.024; Choy JC, 2010, CELL DEATH DIFFER, V17, P567, DOI 10.1038/cdd.2009.161; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Desgrandchamps Francois, 2018, Oncotarget, V9, P33160, DOI 10.18632/oncotarget.26036; Esensten JH, 2017, ANNU REV PATHOL-MECH, V12, P305, DOI 10.1146/annurev-pathol-052016-100304; Ezeakile M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/153981; Favier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021011; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Halloran P. F, 2010, AM J TRANSPLANT, V10, P1496; Halloran Philip F, 2010, Am J Transplant, V10, P1111, DOI 10.1111/j.1600-6143.2010.03121.x; Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; KUMMER JA, 1995, CLIN EXP IMMUNOL, V100, P164; Kuroki K, 2013, HUM IMMUNOL, V74, P433, DOI 10.1016/j.humimm.2012.11.060; Leblanc J., 2018, CAN J KIDNEY HLTH DI, V5; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; LeMaoult J, 2013, FASEB J, V27, P3643, DOI 10.1096/fj.13-228247; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2006, EUR J IMMUNOL, V36, P2457, DOI 10.1002/eji.200636031; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; LIU CC, 1989, J EXP MED, V170, P2105, DOI 10.1084/jem.170.6.2105; Lopez-Alvarez MR, 2014, IMMUNOGENETICS, V66, P73, DOI 10.1007/s00251-013-0742-5; Matas AJ, 2015, AM J TRANSPLANT, V15, DOI 10.1111/ajt.13195; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Qiu J, 2006, AM J TRANSPLANT, V6, P2152, DOI 10.1111/j.1600-6143.2006.01417.x; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riella LV, 2017, TRANSPLANT REV-ORLAN, V31, P1, DOI 10.1016/j.trre.2016.10.005; Ristich V, 2007, HUM IMMUNOL, V68, P264, DOI 10.1016/j.humimm.2006.11.008; Rouas-Freiss N, 2007, TRANSPLANTATION, V84, pS21, DOI 10.1097/01.tp.0000269117.32179.1c; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Sanchez-Fueyo A, 2011, GASTROENTEROLOGY, V140, P51, DOI 10.1053/j.gastro.2010.10.059; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069; Wensink AC, 2015, J IMMUNOL, V194, P491, DOI 10.4049/jimmunol.1401214; Wensink AC, 2014, P NATL ACAD SCI USA, V111, P5974, DOI 10.1073/pnas.1317347111; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Yu CR, 1999, J IMMUNOL, V162, P2785; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297; Zhang WJ, 2008, IEEE INT SYM BROADB, P1	53	12	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5220	5236		10.1096/fj.201802017R	http://dx.doi.org/10.1096/fj.201802017R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30620626	Green Published, Bronze			2022-12-26	WOS:000462888500048
J	Snyder, NA; Palmer, MV; Reinhardt, TA; Cunningham, KW				Snyder, Nathan A.; Palmer, Mitchell V.; Reinhardt, Timothy A.; Cunningham, Kyle W.			Milk biosynthesis requires the Golgi cation exchanger TMEM165	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						galactosyltransferase; Golgi; calcium transport; mammary gland; manganese; pH regulation	SECRETORY PATHWAY CA2+; MAMMARY-GLAND; GLYCOSYLATION; PROTEIN; DEFICIENCY; EXPRESSION; MUTATIONS; MANGANESE; CELLS; YEAST	Milk is a hallmark of mammals that is critical for normal growth and development of offspring. During biosynthesis of lactose in the Golgi complex, H+ is produced as a by-product, and there is no known mechanism for maintaining luminal pH within the physiological range. Here, using conditional, tissue-specific knockout mice, immunostaining, and biochemical assays, we test whether the putative H+/Ca2+/Mn2+ exchanger known as TMEM165 (transmembrane protein 165) participates in normal milk production. We find TMEM165 is crucial in the lactating mammary gland for normal biosynthesis of lactose and for normal growth rates of nursing pups. The milk of TMEM165-deficient mice contained elevated concentrations of fat, protein, iron, and zinc, which are likely caused by decreased osmosis-mediated dilution of the milk caused by the decreased biosynthesis of lactose. When normalized to total protein levels, only calcium and manganese levels were significantly lower in the milk from TMEM165-deficient dams than control dams. These findings suggest that TMEM165 supplies Ca2+ and Mn2+ to the Golgi complex in exchange for H+ to sustain the functions of lactose synthase and potentially other glycosyl-transferases. Our findings highlight the importance of cation and pH homeostasis in the Golgi complex of professional secretory cells and the critical role of TMEM165 in this process.	[Snyder, Nathan A.; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA; [Reinhardt, Timothy A.] USDA ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA; [Palmer, Mitchell V.] USDA ARS, Bacterial Dis Livestock, Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA	Johns Hopkins University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.; Reinhardt, TA (corresponding author), USDA ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA.	tim.reinhardt@ars.usda.gov; kwc@jhu.edu	; Reinhardt, Timothy/A-7536-2009	Snyder, Nathan/0000-0001-9204-8420; Reinhardt, Timothy/0000-0001-5552-2509; Cunningham, Kyle/0000-0001-6877-6321	National Institutes of Health from the NICHD [R21HD080102]; NIAID [R21AI115016]; NIGMS [T32GM007231]; United States Department of Agriculture [5030-32000-115-00-D]; Johns Hopkins University	National Institutes of Health from the NICHD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Johns Hopkins University(Johns Hopkins University)	This work was supported by grants from the National Institutes of Health Grants R21HD080102 from the NICHD, R21AI115016 from the NIAID, and T32GM007231 from the NIGMS, by United States Department of Agriculture Project 5030-32000-115-00-D, and by funds from Johns Hopkins University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AOKI T, 1987, BIOCHIM BIOPHYS ACTA, V911, P238, DOI 10.1016/0167-4838(87)90013-6; Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Bammens R, 2015, GLYCOBIOLOGY, V25, P669, DOI 10.1093/glycob/cwv009; BERLINER LJ, 1982, BIOCHEMISTRY-US, V21, P6340, DOI 10.1021/bi00268a003; Colinet AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24282; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Dulary E, 2017, TISSUE CELL, V49, P150, DOI 10.1016/j.tice.2016.06.006; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; FRASER IH, 1976, BIOCHEM J, V156, P347, DOI 10.1042/bj1560347; HOLT C, 1983, J THEOR BIOL, V101, P247, DOI 10.1016/0022-5193(83)90339-9; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Ng BG, 2018, TRENDS GENET, V34, P466, DOI 10.1016/j.tig.2018.03.002; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; POWELL JT, 1976, J BIOL CHEM, V251, P3645; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 2014, BIOCHEM BIOPH RES CO, V445, P417, DOI 10.1016/j.bbrc.2014.02.020; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; Sheehan D.C., 1980, THEORY PRACTICE HIST; Snyder NA, 2017, G3-GENES GENOM GENET, V7, P3913, DOI 10.1534/g3.117.300339; STACEY A, 1995, P NATL ACAD SCI USA, V92, P2835, DOI 10.1073/pnas.92.7.2835; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; STINNAKRE MG, 1994, P NATL ACAD SCI USA, V91, P6544, DOI 10.1073/pnas.91.14.6544; Thines L, 2018, J BIOL CHEM, V293, P8048, DOI 10.1074/jbc.RA118.002324; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200	33	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3181	3191		10.1074/jbc.RA118.006270	http://dx.doi.org/10.1074/jbc.RA118.006270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30622138	hybrid, Green Published			2022-12-26	WOS:000464980100017
J	Donkor, GY; Dontoh, E; Owusu-Ofori, A				Donkor, Gracious Yoofi; Dontoh, Ebenezer; Owusu-Ofori, Alex			A cross-sectional study on the prevalence of antibiotic use prior to laboratory tests at two Ghanaian hospitals	PLOS ONE			English	Article							SELF-MEDICATION; BACTEREMIA; RESISTANCE; CULTURE	There has been a significant rise in global antibiotic use in recent years. Development of resistance has been linked to easy accessibility, lack of regulation of sale, increased tendency to self-medicate and the lack of public knowledge. The increase in antibiotic misuse, including self-medication, has not been well documented in developing countries. Antibiotic use prior to visiting health facilities has been found to be prevalent in developing countries. It has been identified by some studies to increase the likelihood of missed diagnoses and influence the outcome of bacteriological tests. This study is aimed at determining the prevalence of prior antibiotic use through a cross-sectional survey of patients undergoing laboratory tests at two health facilities in Ghana. Face-to-face questionnaires were used to interview 261 individuals chosen by random sampling of patients visiting the bacteriology laboratory of the hospitals within a two-month period. The questionnaire investigated participant demographic characteristics, knowledge about antibiotics and the nature of antibiotic use. Antibiotic property detection bioassay was performed on patient's urine sample using a disk diffusion method to accurately determine antibiotic use within 72 hours. Culture results were used as an index to evaluate the effect of prior antibiotic use on bacteriological tests. Out of a 261 participants enrolled, 19.9% (95% CI, 14.9-24.9) acknowledged using antibiotics prior to their visit to the laboratory during the study period. On the contrary, 31.4% (95% CI, 25.7-37.5) of participants' urine samples were positive for antimicrobial activity. Participants within the age ranges of 20-30, 31-40 and 41-50 years had significantly lower odds of urine antimicrobial activity. Participants who had urine antimicrobial activity were more likely to have no growth on their culture plates than participants who had no urine antimicrobial activity [OR 2.39(1.37-4.18), p = 0.002]. The most commonly used antibiotics were the penicillins, fluoroquinolones and metronidazole. Although, majority of the participant (54.8%) had knowledge of antibiotics, most of them had inadequate information on their proper use. The commonest indications for antibiotic use were aches and pains (30.3%), diarrhoea (43.3%) and urinary tract infections (28.0%). Prior antibiotic use was found to increase the likelihood of obtaining a culture negative result and can affect the outcome of bacteriological tests.	[Donkor, Gracious Yoofi; Dontoh, Ebenezer] Kwame Nkrumah Univ Sci & Technol, Dept Med Lab Technol, Kumasi, Ghana; [Owusu-Ofori, Alex] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Clin Microbiol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Donkor, GY (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Med Lab Technol, Kumasi, Ghana.	roknod19@hotmail.com	Dontoh, Ebenezer/AAC-5980-2021; Owusu-Ofori, Alex/AAU-9071-2020	Dontoh, Ebenezer/0000-0001-9047-3570; Donkor, Gracious/0000-0001-8871-8970; Owusu-Ofori, Alex Kwame/0000-0002-2172-8645				AduSarkodie YA, 1997, INT J STD AIDS, V8, P456, DOI 10.1258/0956462971920343; Ahiabu MA, 2016, HEALTH POLICY PLANN, V31, P250, DOI 10.1093/heapol/czv048; [Anonymous], 2016, J ANTIMICROB AGENTS, V2, P1; Arya SC, 2011, J INFECT DEV COUNTR, V5, P677, DOI 10.3855/jidc.2100; Behzadi Payam, 2010, Maedica (Bucur), V5, P111; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Center for Disease Dynamics and Policy, 2015, STAT WORLDS ANT 2015; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Dougherty TJ, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P1, DOI 10.1007/978-1-4614-1400-1; Driscoll AJ, 2012, CLIN INFECT DIS, V54, pS159, DOI 10.1093/cid/cir1061; European Centre for Disease Prevention and Control (ECDC), 2012, SUMM LAT DAT ANT RES, P1; Khennavong M, 2011, AM J TROP MED HYG, V85, P295, DOI 10.4269/ajtmh.2011.11-0076; Kimanga AN, 2012, ETHIOP J HEALTH SCI, V22, P135; Kotwani A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-99; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1567; Lerbech A., 2014, PLOS ONE, V9, P1; Liu YC, 1999, LANCET, V354, P1360, DOI 10.1016/S0140-6736(99)07446-2; Micek S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-56; Newman MJ, 2011, RESISTANCE ANTIMICRO, P215; Ocan M, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0027-8; Ocan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092323; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Opintan JA, 2015, INFECT DRUG RESIST, V8, P379, DOI 10.2147/IDR.S88725; Paz Z, 2015, THE IMPACT OF PRIOR, P5; Radyowijati A, IMPROVING ANTIBIOTIC; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Seiter A, 2009, POLICY NOTE PHARM SE, V2009, P1; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Vila J., 2010, J OPEN INFECT DIS, V4, P38, DOI [10.2174/1874279301004020 038, DOI 10.2174/1874279301004020038]; Yevutsey SK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4910-7	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210716	10.1371/journal.pone.0210716	http://dx.doi.org/10.1371/journal.pone.0210716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645626	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200047
J	Karger, A; Bettin, B; Gethmann, JM; Klaus, C				Karger, Axel; Bettin, Barbara; Gethmann, Joern M.; Klaus, Christine			Whole animal matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry of ticks - Are spectra of Ixodes ricinus nymphs influenced by environmental, spatial, and temporal factors?	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; IDENTIFICATION	In the recent years matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) has become a useful tool to characterize arthropod species and their different stages of development. It was reported for sand flies and mosquitoes at immature stages and also assumed for ticks that geographic location can have a subtle influence on MALDI-TOF mass spectra which allows the discrimination of animals with specific local variations of the MALDI-TOF MS phenotype. It is so far uncertain, however, if these mass-spectrometric differences are based on genetic variation or on spectral features which depend on environmental or temporal features. The aim of this study was to analyze the influence of the geographic location, environmental factors and the season of the year on the MALDI-TOF mass spectra of Ixodes (I.) ricinus nymphs and if spectral variation would allow to draw conclusions with respect to the tick's provenience or conditions that influence the tick life cycle. Application of multivariate statistical models on spectra of ticks collected in different seasons and different habitats and locations within Germany showed that the impact of the location seemed to be small while season and habitat seemed to have stronger impact on the MALDI-TOF mass spectra. Possibilities and limitations of MALDI-TOF mass spectra to draw conclusions on the tick life cycle are discussed.	[Karger, Axel; Bettin, Barbara] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Gethmann, Joern M.] Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Klaus, Christine] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Klaus, C (corresponding author), Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany.	christine.klaus@fli.de	Karger, Axel/AAA-9102-2020	Karger, Axel/0000-0002-0054-7394; Gethmann, Jorn/0000-0001-7455-803X	German Federal Environmental Agency [UFOPLAN 3708 49 400]	German Federal Environmental Agency	The authors wish to thank the German Federal Environmental Agency for travel expenses (connected with UFOPLAN 3708 49 400) that allowed us to collect ticks at different places and at different seasons. Besides travel expenses no further funding for this study occurred, neither from the German Federal Environmental Agency nor from any other intern or extern funders. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOB BRIEF VECT BORN; Beati L, 2012, VECTOR-BORNE ZOONOT, V12, P514, DOI 10.1089/vbz.2011.0859; Brown RN, 2005, TICK-BORNE DISEASES OF HUMANS, P363; Dieme C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0544-0; Dvorak V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-21; Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016; Estrada-Pena A, 2009, FRONT BIOSCI-LANDMRK, V14, P2674, DOI 10.2741/3405; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Karger A, 2016, PROTEOMICS CLIN APPL; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kumsa B, 2016, PARASITOL RES, V115, P4199, DOI 10.1007/s00436-016-5197-9; Pineda FJ, 2003, ANAL CHEM, V75, P3817, DOI 10.1021/ac034069b; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Swei A, 2017, ISME J, V11, P813, DOI 10.1038/ismej.2016.152; Yssouf A, 2015, TICKS TICK-BORNE DIS, V6, P579, DOI 10.1016/j.ttbdis.2015.04.013; Yssouf A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003473; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	17	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210590	10.1371/journal.pone.0210590	http://dx.doi.org/10.1371/journal.pone.0210590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645604	Green Published, gold, Green Submitted			2022-12-26	WOS:000455810200038
J	Aguilera, VM; Escribano, R; Vargas, CA; Gonzalez, MT				Aguilera, Victor M.; Escribano, Ruben; Vargas, Cristian A.; Teresa Gonzalez, M.			Upwelling modulation of functional traits of a dominant planktonic grazer during "warm-acid" El Nino 2015 in a year-round upwelling area of Humboldt Current	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CALANUS-CHILENSIS; HATCHING SUCCESS; NORTHERN CHILE; EGG-PRODUCTION; ACARTIA-TONSA; CO2-INDUCED ACIDIFICATION; SPATIAL-DISTRIBUTION; SECONDARY PRODUCTION; CLIMATE-CHANGE	Climate change is expected to exacerbate upwelling intensity and natural acidification in Eastern Boundaries Upwelling Systems (EBUS). Conducted between January-September 2015 in a nearshore site of the northern Humboldt Current System directly exposed to year-round upwelling episodes, this study was aimed at assessing the relationship between upwelling mediated pH-changes and functional traits of the numerically dominant planktonic copepod-grazer Acartia tonsa (Copepoda). Environmental temperature, salinity, oxygen, pH, alkalinity, chlorophyll-a (Chl), copepod adult size, egg production (EP), and egg size and growth were assessed through 28 random oceanographic surveys. Agglomerative clustering and multidimensional scaling identified three main di-similitude nodes within temporal variability of abiotic and biotic variables: A) "upwelling", B) "non-upwelling", and C) "warm-acid" conditions. Nodes A and B represented typical features within the upwelling phenology, characterized by the transition from low temperature, oxygen, pH and Chl during upwelling to higher levels during non-upwelling conditions. However, well-oxygenated, saline and "warm-acid" node C seemed to be atypical for local climatology, suggesting the occurrence of a low frequency oceanographic perturbation. Multivariate (LDA and ANCOVA) analyses revealed upwelling through temperature, oxygen and pH were the main factors affecting variations in adult size and EP, and highlighted growth rates were significantly lower under node C. Likely buffering upwelling pH-reductions, phytoplankton biomass maintained copepod reproduction despite prevailing low temperature, oxygen and pH levels in the upwelling setting. Helping to better explain why this species is among the most recurrent ones in these variable yet productive upwelling areas, current findings also provide opportune cues on plankton responses under warm-acid conditions, which are expected to occur in productive EBUS as a consequence of climate perturbations.	[Aguilera, Victor M.] CEAZA, Coquimbo, Chile; [Aguilera, Victor M.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile; [Aguilera, Victor M.; Escribano, Ruben; Vargas, Cristian A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Inst Milenio Oceanog, Concepcion, Chile; [Aguilera, Victor M.; Escribano, Ruben; Vargas, Cristian A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile; [Vargas, Cristian A.] Univ Concepcion, Fac Environm Sci, Dept Aquat Syst, Aquat Ecosyst Functioning Lab LAFE, Concepcion, Chile; [Vargas, Cristian A.] Univ Concepcion, Environm Sci Ctr EULA Chile, Concepcion, Chile; [Vargas, Cristian A.] Univ Concepcion, Ctr Study Multiple Drivers Marine Socioecol Syst, Concepcion, Chile; [Teresa Gonzalez, M.] Univ Antofagasta, Inst Ciencias Nat Alexander von Humboldt, Antofagasta, Chile	Universidad Catolica del Norte; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Universidad de Antofagasta	Aguilera, VM (corresponding author), CEAZA, Coquimbo, Chile.; Aguilera, VM (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile.; Aguilera, VM (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Inst Milenio Oceanog, Concepcion, Chile.; Aguilera, VM (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile.	victor.aguilera@ceaza.cl	Aguilera, Victor M/AAH-4460-2020	Aguilera, Victor M/0000-0001-5791-5250; Vargas, Cristian A./0000-0002-1486-3611; Escribano, Ruben/0000-0002-9843-7723	VAR - FONDECYT [11130495 VAR]; Millennium Scientific Initiative [IC120019]	VAR - FONDECYT; Millennium Scientific Initiative	This work was supported by VAR was funding by FONDECYT Grant No. 11130495 VAR, RE & CVG were funded by Millennium Scientific Initiative Grant IC120019.	Aguilera VM, 2013, ESTUAR COAST, V36, P1084, DOI 10.1007/s12237-013-9615-2; Aguilera VM, 2011, MAR BIOL RES, V7, P235, DOI 10.1080/17451000.2010.499437; Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Auel H, 2007, J EXP MAR BIOL ECOL, V352, P234, DOI 10.1016/j.jembe.2007.07.020; Bailey A, 2017, ICES J MAR SCI, V74, P996, DOI 10.1093/icesjms/fsw066; Bednarsek N, 2015, MAR ECOL PROG SER, V523, P93, DOI 10.3354/meps11199; Blanco JL, 2001, J GEOPHYS RES-OCEANS, V106, P11451, DOI 10.1029/2000JC000540; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; DAGG M, 1977, LIMNOL OCEANOGR, V22, P99, DOI 10.4319/lo.1977.22.1.0099; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Dickson A., 2007, PICES SPEC PUBL; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Escribano R, 2000, J MAR BIOL ASSOC UK, V80, P283, DOI 10.1017/S002531549900185X; Escribano R, 1999, MAR ECOL PROG SER, V177, P147, DOI 10.3354/meps177147; Escribano R, 2012, PROG OCEANOGR, V97, P174, DOI 10.1016/j.pocean.2011.11.006; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Giraldo A, 2002, MAR ECOL PROG SER, V230, P225, DOI 10.3354/meps230225; Harris KE, 2013, GEOPHYS RES LETT, V40, P2720, DOI 10.1002/grl.50460; Hauri C, 2013, BIOGEOSCIENCES, V10, P193, DOI 10.5194/bg-10-193-2013; Hidalgo P, 2012, PROG OCEANOGR, V92-95, P134, DOI 10.1016/j.pocean.2011.07.012; Hidalgo P, 2010, DEEP-SEA RES PT II, V57, P2089, DOI 10.1016/j.dsr2.2010.09.012; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hirst AG, 1998, MAR BIOL, V132, P247, DOI 10.1007/s002270050390; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jacox MG, 2016, GEOPHYS RES LETT, V43, P7072, DOI 10.1002/2016GL069716; Kapsenberg L, 2016, LIMNOL OCEANOGR, V61, P953, DOI 10.1002/lno.10264; KIORBOE T, 1994, LIMNOL OCEANOGR, V39, P493, DOI 10.4319/lo.1994.39.3.0493; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lefevre N, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000395; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Marin VH, 2003, INVEST           MAR, P31; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McElhany P, 2017, ICES J MAR SCI, V74, P926, DOI 10.1093/icesjms/fsw085; MCLAREN IA, 1966, BIOL BULL, V131, P457, DOI 10.2307/1539985; PARRISH KK, 1978, MAR BIOL, V46, P65, DOI 10.1007/BF00393822; Peterson W, 1998, J MARINE SYST, V15, P313, DOI 10.1016/S0924-7963(97)00082-1; PETERSON WT, 1988, PROG OCEANOGR, V20, P1, DOI 10.1016/0079-6611(88)90052-3; POULET SA, 1995, ICES J MAR SCI, V52, P359, DOI 10.1016/1054-3139(95)80051-4; Reum JCP, 2016, ICES J MAR SCI, V73, P582, DOI 10.1093/icesjms/fsu231; Ruz PM, 2015, J MARINE SYST, V148, P200, DOI 10.1016/j.jmarsys.2015.03.007; Sobarzo M, DEEPSEA RES 1, V48, P2699; Strickland JD, 1962, B FISH RES BD CAN, P167; Strub P, 1998, COASTAL OCEAN CIRCUL, V11; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Takeshita Y, 2015, BIOGEOSCIENCES, V12, P5853, DOI 10.5194/bg-12-5853-2015; TESTER PA, 1990, J EXP MAR BIOL ECOL, V141, P169, DOI 10.1016/0022-0981(90)90222-X; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Torres R, 2002, DEEP-SEA RES PT I, V49, P1413, DOI 10.1016/S0967-0637(02)00034-1; Torres R, 1997, J GEOPHYS RES OCEANS, V108; Ulloa O, 2001, GEOPHYS RES LETT, V28, P1591, DOI 10.1029/2000GL011548; UYE S-I, 1982, Journal of the Oceanographical Society of Japan, V38, P149, DOI 10.1007/BF02110286; Vargas CA, 2004, AQUAT MICROB ECOL, V34, P151, DOI 10.3354/ame034151; Vargas CA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0084; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9	63	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209823	10.1371/journal.pone.0209823	http://dx.doi.org/10.1371/journal.pone.0209823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640913	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000014
J	Holldobler, B; Kwapich, CL				Holldobler, Bert; Kwapich, Christina L.			Behavior and exocrine glands in the myrmecophilous beetle Dinarda dentata (Gravenhorst, 1806) (Coleoptera: Staphylinidae: Aleocharinae)	PLOS ONE			English	Article							CHEMICAL MIMICRY; LOMECHUSA; ATEMELES; BIOLOGY; HOST; ANTS	The nests of advanced eusocial ant species can be considered ecological islands with a diversity of ecological niches inhabited by not only the ants and their brood, but also a multitude of other organisms adapted to particular niches. In the current paper, we describe the myrmecophilous behavior and the exocrine glands that enable the staphylinid beetle Dinarda dentata to live closely with its host ants Formica sanguinea. We confirm previous anecdotal descriptions of the beetle's ability to snatch regurgitated food from ants that arrive with a full crop in the peripheral nest chambers, and describe how the beetle is able to appease its host ants and dull initial aggression in the ants.	[Holldobler, Bert; Kwapich, Christina L.] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85281 USA; [Holldobler, Bert] Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B; Kwapich, CL (corresponding author), Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85281 USA.; Holldobler, B (corresponding author), Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany.	bert.hoelldobler@asu.edu; ckwapich@asu.edu		Kwapich, Christina/0000-0001-5141-7605	Arizona State University	Arizona State University	This work was funded by B.H. and Arizona State University. The funders had no role in study design, data collection, decision to publish or preparation on the manuscript.	Akino Toshiharu, 2008, Myrmecological News, V11, P173; Bernhauer M., 1917, STAPHILINIDEN MADAGA; BLACKWELDER RICHARD E., 1936, SMITHSONIAN MISC COLL, V94, P1; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Donisthorpe H, 1927, GUESTS BRIT ANTS; HENDERSON G, 1986, J KANSAS ENTOMOL SOC, V59, P454; Hlavac P, 2011, ZOOTAXA, P1; Holldobler B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200309; HOLLDOBL.B, 1967, Z VERGL PHYSIOL, V56, P1, DOI 10.1007/BF00333561; HOLLDOBLER B, 1970, Z VERGL PHYSIOL, V66, P215, DOI 10.1007/BF00297780; Holldobler B., 1990, pi; HOLLDOBLER B, 1971, SCI AM, V224, P86; HOLLDOLBER B, 1981, Psyche (Cambridge), V88, P347, DOI 10.1155/1981/75317; HOWARD RW, 1980, SCIENCE, V210, P431, DOI 10.1126/science.210.4468.431; Jordan KHC, 1913, Z WISS ZOOL ABT A, V107, P346; Kloft W., 1960, ZOOL BEITR, V5, P519; Lenoir Alain, 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/840860; Lobl D, 2015, CATALOGUE PALAEARCTI; Mizuno T, 2018, CHEMOECOLOGY, P1; Paivinen J, 2003, OECOLOGIA, V134, P587, DOI 10.1007/s00442-002-1141-z; Parker J, 2016, MYRMECOL NEWS, V22, P65; Parmentier T, 2017, J CHEM ECOL, V43, P644, DOI 10.1007/s10886-017-0868-2; Parmentier T, 2016, OIKOS, V125, P1182, DOI 10.1111/oik.02991; Parmentier T, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0583-6; PASTEELS J M, 1968, Archives de Biologie, V79, P381; Phillips ZI, 2017, INSECT SOC, V64, P277, DOI 10.1007/s00040-016-0535-6; RATHMAYER W, 1962, EXPERIENTIA, V18, P47, DOI 10.1007/BF02136658; ROMEIS B, 1948, MIKROSKOPISCHE TECHN; Stoeffler M, 2007, J CHEM ECOL, V33, P1382, DOI 10.1007/s10886-007-9315-0; Stoeffler M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1605, DOI 10.1007/s00265-011-1171-9; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; TRANIELLO JFA, 1980, NATURWISSENSCHAFTEN, V67, P361, DOI 10.1007/BF01106597; Tschinkel WR, 2006, FIRE ANTS; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806; von Beeren Christoph, 2011, BMC Ecology, V11, P30, DOI 10.1186/1472-6785-11-30; Wasmann E., 1889, Wiener Entomologische Zeitung, Vviii, P153; Wasmann E., 1920, GASTPFLEGE AMEISEN; Wheeler W. M, 1910, ANTS	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210524	10.1371/journal.pone.0210524	http://dx.doi.org/10.1371/journal.pone.0210524			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633774	Green Submitted, gold, Green Published			2022-12-26	WOS:000455485100027
J	Lin, JP; Lin, PW; Lai, IC; Tsai, JC				Lin, Jih-Pin; Lin, Pei-Wen; Lai, Ing-Chou; Tsai, Jen-Chia			Segmental inner macular layer analysis with spectral-domain optical coherence tomography for early detection of normal tension glaucoma	PLOS ONE			English	Article							RETINAL NERVE-FIBER; OPEN-ANGLE GLAUCOMA; GANGLION-CELL COMPLEX; DIAGNOSTIC-ACCURACY; PLEXIFORM LAYER; THICKNESS; PARAMETERS; ABILITY; ONSET; OCT	Purpose To segment the inner macular layers (IML) and compare the discriminating abilities of the macular and peripapillary retinal nerve fiber layer (mRNFL and pRNFL, respectively) thicknesses in patients with early-stage normal tension glaucoma (NTG). Design Cross-sectional study Methods Forty-nine normal subjects and 69 preperimetric glaucoma (PPG) and 60 NTG patients were enrolled. Spectral-domain optical coherence tomography (SD-OCT) was used to obtain pRNFL and macular thickness parameters and segment the IML in all subjects. Area under the receiver operating characteristic (AUROC) curves were used to compare the diagnostic capabilities of different parameters. Results The pRNFL, total macular layer (TML), mRNFL, and macular ganglion cell layer (mGCL) were significantly thinner in the NTG group than in the PPG and normal groups. The global and superotemporal pRNFL and the mGCL in the superior outer area were the three best parameters for detecting early NTG. The discriminating capabilities of the superior and inferior mGCL were comparable to those of the corresponding pRNFL (p = 0.573, 0.841). Concerning location, the mGCL had higher AUROCs in the outer sectors (0.863, 0.837) than in the inner sectors (0.747, 0.747). Pearson's correlation coefficients also revealed significant correlations between the mGCL and pRNFL (superior: r = 0.499, inferior: r = 0.624). The strongest correlation was between the mGCL and mean deviation (MD) (superior: r = 0.434 and inferior: r = 0.402). Conclusions The diagnostic value of mGCL thickness is comparable to that of pRNFL thickness. IMLs in the outer sectors had better diagnostic capabilities than those in the inner sector for detecting early NTG.	[Lin, Jih-Pin; Lin, Pei-Wen; Lai, Ing-Chou; Tsai, Jen-Chia] Kaohsiung Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lin, Pei-Wen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lin, PW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.; Lin, PW (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	lpw324@gmail.com		Lin, Jih-Pin/0000-0002-4085-9392				Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Edlinger FSM, 2018, GRAEF ARCH CLIN EXP, V256, P1245, DOI 10.1007/s00417-018-3944-6; Fan N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/308505; Firat PG, 2013, GRAEF ARCH CLIN EXP, V251, P831, DOI 10.1007/s00417-012-2114-5; Greenfield DS, 2003, ARCH OPHTHALMOL-CHIC, V121, P41; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182404; Kim HJ, 2017, JPN J OPHTHALMOL, V61, P324, DOI 10.1007/s10384-017-0511-3; Kim HJ, 2016, INVEST OPHTH VIS SCI, V57, P4799, DOI 10.1167/iovs.16-19214; Kim NR, 2013, J GLAUCOMA, V22, P133, DOI 10.1097/IJG.0b013e3182254cde; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kiriyama N, 2003, GRAEF ARCH CLIN EXP, V241, P541, DOI 10.1007/s00417-003-0702-0; Martinez-De-La-Casa JM, 2014, INVEST OPHTH VIS SCI, V55, P8343, DOI 10.1167/iovs.14-15501; Michelessi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008803.pub2; Munemasa Y, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00060; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Oddone F, 2016, OPHTHALMOLOGY, V123, P939, DOI 10.1016/j.ophtha.2015.12.041; Pazos M, 2017, OPHTHALMOLOGY, V124, P1218, DOI 10.1016/j.ophtha.2017.03.044; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Thonginnetra O, 2010, J GLAUCOMA, V19, P151, DOI 10.1097/IJG.0b013e318193c45c; Van Ginderdeuren R, 2016, J GLAUCOMA, V25, pE546, DOI 10.1097/IJG.0000000000000388; Yamada H, 2014, AM J OPHTHALMOL, V158, P1318, DOI 10.1016/j.ajo.2014.08.040; Zangalli CS, 2016, J GLAUCOMA, V25, pE401, DOI 10.1097/IJG.0000000000000336	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210215	10.1371/journal.pone.0210215	http://dx.doi.org/10.1371/journal.pone.0210215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629663	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000062
J	Minakova, E; Lang, J; Medel-Matus, JS; Gould, GG; Reynolds, A; Shin, D; Mazarati, A; Sankar, R				Minakova, Elena; Lang, Jordan; Medel-Matus, Jesus-Servando; Gould, Georgianna G.; Reynolds, Ashley; Shin, Don; Mazarati, Andrey; Sankar, Raman			Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; SOCIAL-BEHAVIOR; OXYTOCIN TREATMENT; RECEPTOR 4; MICE; PREFERENCE; DEFICITS; AGONIST; FEMALE; RATS	Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by impaired social interactions, difficulty with communication, and repetitive behavior patterns. In humans affected by ASD, there is a male pre-disposition towards the condition with a male to female ratio of 4:1. In part due to the complex etiology of ASD including genetic and environmental interplay, there are currently no available medical therapies to improve the social deficits of ASD. Studies in rodent models and humans have shown promising therapeutic effects of oxytocin in modulating social adaptation. One pharmacological approach to stimulating oxytocinergic activity is the melanocortin receptor 4 agonist Melanotan-II (MT-II). Notably the effects of oxytocin on environmental rodent autism models has not been investigated to date. We used a maternal immune activation (MIA) mouse model of autism to assess the therapeutic potential of MT-II on autism-like features in adult male mice. The male MIA mice exhibited autism-like features including impaired social behavioral metrics, diminished vocal communication, and increased repetitive behaviors. Continuous administration of MT-II to male MIA mice over a seven-day course resulted in rescue of social behavioral metrics. Normal background C57 male mice treated with MT-II showed no significant alteration in social behavioral metrics. Additionally, there was no change in anxiety-like or repetitive behaviors following MT-II treatment of normal C57 mice, though there was significant weight loss following subacute treatment. These data demonstrate MT-II as an effective agent for improving autism-like behavioral deficits in the adult male MIA mouse model of autism.	[Minakova, Elena] UCLA, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA; [Lang, Jordan] Huntington Mem Hosp, Dept Internal Med, Pasadena, CA USA; [Medel-Matus, Jesus-Servando; Reynolds, Ashley; Shin, Don; Mazarati, Andrey; Sankar, Raman] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Gould, Georgianna G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Mazarati, Andrey; Sankar, Raman] UCLA, Childrens Discovery & Innovat Inst, Los Angeles, CA USA; [Minakova, Elena] Washington Univ, Sch Med, Dept Pediat, Div Neonatol, St Louis, MO 63110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Huntington Memorial Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Los Angeles; Washington University (WUSTL)	Minakova, E (corresponding author), UCLA, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA.; Minakova, E (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Neonatol, St Louis, MO 63110 USA.	eminakova@email.wustl.edu		Medel-Matus, Jesus Servando/0000-0003-1103-468X; Sankar, Raman/0000-0002-5609-0362	UCLA Children's Discovery and innovation Institute William F. Friedman Fellowship Grant	UCLA Children's Discovery and innovation Institute William F. Friedman Fellowship Grant	EM received funding from the UCLA Children's Discovery and innovation Institute William F. Friedman Fellowship Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altadottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI [10.1007/s10803-010-1006-y, DOI 10.1007/S10803-010-1006-Y]; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; ARTYMYSHYN R, 1990, J NEUROSCI METH, V32, P185, DOI 10.1016/0165-0270(90)90139-7; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Barrett CE, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.73; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Campbell-Smith EJ, 2015, LEARN MEMORY, V22, P247, DOI 10.1101/lm.036962.114; Canetta S, 2016, MOL PSYCHIATR, V21, P956, DOI 10.1038/mp.2015.222; Caruso V, 2014, NAT REV NEUROSCI, V15, P98, DOI 10.1038/nrn3657; Chen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V63, P88, DOI 10.1016/j.bbi.2016.09.028; Douglas LA, 2004, DEV PSYCHOBIOL, V45, P153, DOI 10.1002/dev.20025; Giuliano F, 2006, NEUROSCIENCE, V138, P293, DOI 10.1016/j.neuroscience.2005.11.008; Grabrucker S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00037; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Hagen E, 2015, NEUROTHERAPEUTICS, V12, P657, DOI 10.1007/s13311-015-0357-7; Harony-Nicolas H, 2017, ELIFE, V6, DOI 10.7554/eLife.18904; INSEL TR, 1990, J NEUROENDOCRINOL, V2, P539, DOI 10.1111/j.1365-2826.1990.tb00445.x; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; Kim Gilbert W, 2011, Expert Rev Clin Pharmacol, V4, P243, DOI 10.1586/ecp.11.3; Klenerova V, 2008, NEUROSCI LETT, V432, P202, DOI 10.1016/j.neulet.2007.12.020; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Li K, 2016, CELL, V167, P60, DOI 10.1016/j.cell.2016.08.067; Li Y, 2018, J NEUROSCI, V38, P3358, DOI 10.1523/JNEUROSCI.3642-17.2018; Liu J, 2013, INT J NEUROPSYCHOPH, V16, P105, DOI 10.1017/S146114571100174X; Lu XY, 2003, J NEUROSCI, V23, P7863; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Meltzer A, 2017, NEUROPSYCHOPHARMACOL, V42, P284, DOI 10.1038/npp.2016.158; Meyer-Lindenberg A, 2012, NATURE REV, P524; Meziane H, 2015, BIOL PSYCHIAT, V78, P85, DOI 10.1016/j.biopsych.2014.11.010; Miller JL, 2017, AM J MED GENET A, V173, P1243, DOI 10.1002/ajmg.a.38160; Modi ME, 2015, NEUROPSYCHOPHARMACOL, V40, P1856, DOI 10.1038/npp.2015.35; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Neunuebel JP, 2015, ELIFE, V4, DOI 10.7554/eLife.06203; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Pineda E, 2013, ANN NEUROL, V74, P11, DOI 10.1002/ana.23898; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Prager EM, 2016, J NEUROSCI RES, V94, P548, DOI 10.1002/jnr.23690; Rauk PN, 2001, AM J REPROD IMMUNOL, V45, P148, DOI 10.1111/j.8755-8920.2001.450305.x; Sabihi S, 2014, PSYCHONEUROENDOCRINO, V45, P31, DOI 10.1016/j.psyneuen.2014.03.009; Sala M, 2013, J NEUROENDOCRINOL, V25, P107, DOI 10.1111/j.1365-2826.2012.02385.x; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Schmid B, 2001, ENDOCRINOLOGY, V142, P1380, DOI 10.1210/en.142.4.1380; Serova LI, 2014, J NEUROCHEM, V131, P825, DOI 10.1111/jnc.12847; Shamay-Tsoory SG, 2016, BIOL PSYCHIAT, V79, P194, DOI 10.1016/j.biopsych.2015.07.020; Smith CJW, 2017, BRAIN STRUCT FUNCT, V222, P981, DOI 10.1007/s00429-016-1260-7; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Walum H, 2016, BIOL PSYCHIAT, V79, P251, DOI 10.1016/j.biopsych.2015.06.016; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x	61	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210389	10.1371/journal.pone.0210389	http://dx.doi.org/10.1371/journal.pone.0210389			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629642	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000078
J	Bonsuid, AB; Ncama, BP				Bonsuid, Adwoa Bemah; Ncama, Busisiwe Purity			Recognizing and appraising symptoms of breast cancer as a reason for delayed presentation in Ghanaian women: A qualitative study	PLOS ONE			English	Article							HELP-SEEKING; PATIENT; MODEL; DIAGNOSIS; FRAMEWORK; BELIEFS; AFRICA	Background The burden of late presentation is well established in women presenting with advanced breast cancer in Africa. This paper aims to explore the reasons for delayed presentation in Ghanaian women with breast cancer. Method Eleven (11) women diagnosed with advanced breast cancer were purposively sampled within three years of diagnosis at the palliative care clinic of the Komfo Anokye Teaching Hospital, Ghana. Participation was voluntary. Data was collected through in-depth interviews using a self-devised semi-structured interview guide. The interviews were conducted in "Twi" (local language), audio-tape recorded and covered the women's journey from symptom discovery to their intention to seek help. All audio-taped interviews were transcribed based on the meaning of the respondents' comments. The data was managed using Nvivo version 11 qualitative software. Data was analyzed concurrently with data collection applying the principles of thematic analysis. Key findings All the women delayed presentation due to overlapping reasons. Symptom appraisal among the women occurred in two main stages: individual understanding of breast symptom and interactive understanding of the breast symptom. These stages were based on cognitive, psycho-cultural and social factors. The five main themes generated from the data were: symptom experience, knowledge of breast cancer, role of social life and network, coping with a breast symptom and lastly intent to seeking health care. A conceptual model was developed to illustrate the relationships among the key factors and concepts emanated from this study. Conclusion Recognition and appraisal of breast cancer symptom in the eleven (11) Ghanaian women interviewed in this study was poor. For instance, a painless breast lump was considered not serious until a sensory symptom appears. This led women to experience appraisal and time point intervals. To minimize the incidence of late presentation of breast cancer cases in Ghana, adequate educational intervention should be provided for Ghanaian women and their social network, and other stakeholders.	[Bonsuid, Adwoa Bemah; Ncama, Busisiwe Purity] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Nursing, Durban, South Africa; [Bonsuid, Adwoa Bemah] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana	University of Kwazulu Natal; Kwame Nkrumah University Science & Technology	Bonsuid, AB (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Nursing, Durban, South Africa.; Bonsuid, AB (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana.	bbemahc2000@gmail.com		Boamah Mensah, ADWOA Bemah/0000-0002-1114-702X	University of KwaZulu-Natal College of Health Sciences Scholarship	University of KwaZulu-Natal College of Health Sciences Scholarship	Research reported in this publication was supported by the University of KwaZulu-Natal College of Health Sciences Scholarship to ABB. The content is solely the responsibility of the authors and does not represent the official view of the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Andersen RS, 2010, SOC SCI MED, V71, P378, DOI 10.1016/j.socscimed.2010.03.044; Asobayire A, 2015, HEALTH PROMOT INT, V30, P647, DOI 10.1093/heapro/dat087; Aziato L, 2015, HEALTH CARE WOMEN IN, V36, P543, DOI 10.1080/07399332.2014.911299; Bonsu AB, 2014, INT J PALLIATIVE CAR, V2014; Bosu W K, 2012, Ghana Med J, V46, P69; Caplan L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00087; Clegg-Lamptey J, 2009, GHANA MED J, V43; Clegg-Lamptey J N A, 2009, West Afr J Med, V28, P114; Cohen M, 2006, PSYCHO-ONCOLOGY, V15, P873, DOI 10.1002/pon.1018; Creswell J. W., 2017, QUAL INQ; de Nooijer J, 2001, PATIENT EDUC COUNS, V42, P145, DOI 10.1016/S0738-3991(00)00104-X; Doody Owen, 2013, Nurse Res, V20, P28; Dye TD, 2011, GLOB PUBLIC HEALTH, V6, P719, DOI 10.1080/17441692.2010.510479; Ezeome E., 2010, NIGERIAN J CLIN PRAC, V13; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; Feller A, 2017, INT J CANCER, V141, P1529, DOI 10.1002/ijc.30856; Guba E., 1989, 4 GENERATION EVALUAT; Jones CEL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006944; Khakbazan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110262; Khakbazan Z, 2014, ASIAN PAC J CANCER P, V15, P8135, DOI 10.7314/APJCP.2014.15.19.8135; Kohler RE, 2017, PATIENT EDUC COUNS, V100, P167, DOI 10.1016/j.pec.2016.08.012; Lam WWT, 2009, J PUBLIC HEALTH-UK, V31, P59, DOI 10.1093/pubmed/fdn088; Laryea DO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-362; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th; Majaj L, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-26; Mensah AC, 2016, OPEN ACCESS LIB J, V3, P1, DOI DOI 10.4236/oalib.1102145; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Moodley J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009905; Obrist M, 2014, BREAST, V23, P821, DOI 10.1016/j.breast.2014.08.014; Ohene-Yeboah M, 2012, GHANA MED J, V46; Opoku SY, 2012, PAN AFR MED J, V11; Pang J, 2012, BREAST CANCER RES TR, V135, P59, DOI 10.1007/s10549-012-2055-z; Polit D. F., 2012, NURSING RES GENERATI; Punch K. F., 2013, INTRO SOCIAL RES QUA, V3rd; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Stark A, 2010, CANCER-AM CANCER SOC, V116, P4926, DOI 10.1002/cncr.25276; Stefan DC, 2013, LANCET ONCOL, V14, pE189, DOI 10.1016/S1470-2045(13)70100-1; Taha H, 2012, VOICES FEAR SAFETY; Taib NA, 2014, WORLD J SURG, V38, P1676, DOI 10.1007/s00268-013-2339-4; Taib NA, 2011, ASIAN PAC J CANCER P, V12, P1601; Ukwenya A, 2008, S AFRICAN J SURG, V46; Unger-Saldana K, 2011, SOC SCI MED, V72, P1096, DOI 10.1016/j.socscimed.2011.01.022; Vanderpool Robin C, 2013, Glob Adv Health Med, V2, P75, DOI 10.7453/gahmj.2013.046; World Health Organization, BREAST CANC PREV CON; Zelle SG, 2012, TROP MED INT HEALTH, V17, P1031, DOI 10.1111/j.1365-3156.2012.03021.x	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208773	10.1371/journal.pone.0208773	http://dx.doi.org/10.1371/journal.pone.0208773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625156	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400017
J	Carvelli, A; Sala, M; Autorino, GL; Scicluna, MT; Iacoponi, F; Rombola, P; Scaramozzino, P				Carvelli, Andrea; Sala, Marcello; Autorino, Gian Luca; Scicluna, Maria Teresa; Iacoponi, Francesca; Rombola, Pasquale; Scaramozzino, Paola			A cross-sectional serosurvey in a sheep population in central Italy following a bluetongue epidemic	PLOS ONE			English	Article							CULICOIDES-IMICOLA; DOMESTIC RUMINANTS; VIRUS SEROTYPES; ABUNDANCE; DURATION; VIREMIA	Bluetongue (BT) is a viral disease that affects ruminants and is transmitted by midges of the genus Culicoides spp. The seroprevalence, the clinical form and the occurrence rates significantly differ in relation to several factors such as bluetongue virus (BTV) serotype, host species, breed susceptibility, specific previous exposure, vector ecology, husbandry and health status. Following the 2001-2006 BTV2 and BTV16 epidemics in central Italy, a new epidemic caused by BTV1 occurred in 2013-2015 causing 398 outbreaks in a susceptible population of about 1 million ruminants. The present study assessed the BTV1 seroprevalence in the sheep population of central Italy by conducting two cross-sectional surveys, in the proximity of and within BT outbreak farms. A total of 2,984 sheep from 437 farms were sampled. The animal-level prevalence was 19% (95% CI: 17-21%), the between-herd prevalence was 46% (95% CI: 41-51%) and the within-herd prevalence was 21% (95% CI: 16-26%). Risk factors were investigated by logistic regression models. Living on a farm where an outbreak occurred and the number of outbreaks in proximity of the farm were identified as risk factors, while herd size was identified as a protective factor. This study represents the first BT survey in southern Europe and reports valuable findings on BTV epidemiology. Despite intensive virus circulation, the estimated seroprevalences were low. The assessment of the population immunity level is crucial for defining an efficient vaccination strategy and for predicting the impact of future virus circulation. In view of the low seroprevalence detected albeit an extensive BTV1 circulation, the population immunity was likely to be inadequate in preventing new BTV1 epidemics. Moreover, considering the recurrent introduction of new serotypes from North Africa and the Balkans, the control of multi-serotype BTV infections will continue to present a challenge in the near future.	[Carvelli, Andrea; Sala, Marcello; Iacoponi, Francesca; Rombola, Pasquale; Scaramozzino, Paola] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Epidemiol Unit, Rome, Italy; [Autorino, Gian Luca; Scicluna, Maria Teresa] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Virol Unit, Rome, Italy	IZS Lazio e Toscana; IZS Lazio e Toscana	Carvelli, A (corresponding author), Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Epidemiol Unit, Rome, Italy.	andrea.carvelli@izslt.it	Scaramozzino, Paola/AAS-8717-2020; carvelli, andrea/P-2246-2019; Scaramozzino, Paola/P-6860-2016	Scaramozzino, Paola/0000-0002-7871-8915; carvelli, andrea/0000-0003-1320-9682; Iacoponi, Francesca/0000-0001-6298-0700; Sala, Marcello Giovanni/0000-0003-4876-2656; ROMBOLA', Pasquale/0000-0001-9699-713X				Andriamandimby SF, 2015, VET MICROBIOL, V176, P268, DOI 10.1016/j.vetmic.2015.02.009; Arenas-Montes A, 2016, TRANSBOUND EMERG DIS, V63, pE339, DOI 10.1111/tbed.12309; Arun S, 2014, TROP BIOMED, V31, P26; Blaker H, 2000, CAN J STAT, V28, P783, DOI 10.2307/3315916; Bonneau KR, 2002, VET MICROBIOL, V88, P115, DOI 10.1016/S0378-1135(02)00106-2; Calistri P, 2004, VETER ITAL SER, V40, P243; Calvo-Pinilla E, 2014, VIRUS RES, V182, P78, DOI 10.1016/j.virusres.2013.11.013; Cappai S, 2018, PREV VET MED, V155, P75, DOI 10.1016/j.prevetmed.2018.04.004; Carpenter S., 2011, PLOS ONE, V6; Carvelli A, 2015, P 9 ANN M EP 2015 AU; Corine Land Cover (CLC), 2017, COORD INF ENV; De Liberato C, 2003, MED VET ENTOMOL, V17, P388, DOI 10.1111/j.1365-2915.2003.00456.x; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; Dohoo I, 2009, VET EPIDEMIOLOGY RES, P95; EFSA AHAW Panel (EFSA Panel on Animal Health and Welfare), 2017, EFSA J, V15, P4698, DOI [10.2903/j.efsa.2017.4698, DOI 10.2903/J.EFSA.2017.4698]; Eschbaumer M, 2012, VACCINE, V30, P7142, DOI 10.1016/j.vaccine.2012.08.030; European Food Safety Authority Panel on Animal Health and Welfare, 2017, EFSA J, V15, P4957, DOI [10.2903/j.efsa.2017.4957, DOI 10.2903/J.EFSA.2017.4957]; European Union Animal Health Regulatory Committee, 2016, BLUET VACC; Ferrari G., 2016, FOOT MOUTH DIS VACCI; Giovannini A, 2004, VETER ITAL SER, V40, P369; HOSMER DW, 2000, WILEY PS TX, P1; Jacquot M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0919; Lelli R., 2003, Veterinaria Italiana, V39, P5; Lorusso A, 2013, INFECT GENET EVOL, V19, P81, DOI 10.1016/j.meegid.2013.06.028; MacLachlan N J, 2004, Vet Ital, V40, P462; Mahmoud MAF, 2017, VET WORLD, V10, P1161, DOI 10.14202/vetworld.2017.1161-1166; Mayo C, 2017, VET MICROBIOL, V206, P84, DOI 10.1016/j.vetmic.2017.03.015; Pascual-Linaza AV, 2014, PREV VET MED, V116, P279, DOI 10.1016/j.prevetmed.2014.05.009; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; ROY P, 1994, VACCINE, V12, P805, DOI 10.1016/0264-410X(94)90289-5; Rushton J, 2015, VET ITAL, V51, P401, DOI 10.12834/VetIt.646.3183.1; Sanders CJ, 2017, J APPL ECOL, V54, P1429, DOI 10.1111/1365-2664.12875; Scavia G, 2004, VETER ITAL SER, V40, P274; Sergeant ESG, 2018, EPITOOLS EPIDEMIOLOG; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; Vannier P, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2189; Viarouge C, 2014, VET MICROBIOL, V174, P78, DOI 10.1016/j.vetmic.2014.09.006; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; 2009, BLUETONGUE, P1	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208074	10.1371/journal.pone.0208074	http://dx.doi.org/10.1371/journal.pone.0208074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625135	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400011
J	Neto, JMR; Tebexreni, AS; Novakoski, A; Alves, F; Smanio, PEP; de Abreu, FB; Thomazi, MC; Nishio, PA; Cuninghant, IA				Rossi Neto, Joao Manoel; Tebexreni, Antonio Sergio; Novakoski, Alexandre; Alves, Ferreira; Poggio Smanio, Paola Emanuela; de Abreu, Floriana Bertini; Thomazi, Mauricio Cruz; Nishio, Priscilla Ayumi; Cuninghant, Ivana Antelmi			Cardiorespiratory fitness data from 18,189 participants who underwent treadmill cardiopulmonary exercise testing in a Brazilian population	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; SCIENTIFIC STATEMENT; REFERENCE-STANDARDS; REFERENCE VALUES; ALL-CAUSE; REGISTRY; MORTALITY; MEN	Purpose Cardiorespiratory fitness is inversely associated with a high risk of cardiovascular disease, all-cause mortality, and mortality attributable to various cancers. It is often estimated indirectly using mathematical formulas for estimating oxygen uptake. Cardiopulmonary exercise testing, especially oxygen uptake, represents the "gold standard" for assessing exercise capacity. The purpose of this report was to develop reference standards for exercise capacity by establishing cardiorespiratory fitness values derived from cardiopulmonary exercise testing in a Brazilian population. We focused on oxygen uptake standards and compared the maximal oxygen uptake [mLO(2).kg(-1).min(-1)] values with those in the existing literature. Methods A database was constructed using reports from cardiopulmonary exercise testing performed at Fleury laboratory. The final cohort included 18,189 individuals considered to be free of structural heart disease. Percentiles of maximal oxygen uptake for men and women were determined for six age groups between 7 and 84 years. We compared the values with existing reference data from patients from Norway and the United States. Results There were significant differences in maximal oxygen uptake between sexes and across the age groups. In our cohort, the 50th percentile maximal oxygen uptake values for men and women decreased from 44.7 and 36.3 mLO(2).kg(-1).min(-1) to 28.4 and 22.3 mLO(2).kg(-1).min(-1) for patients aged 20-29 years to patients aged 60-69 years, respectively. For each age group, both Norwegian men and women had greater cardiorespiratory fitness than cohorts in the United States and Brazil. Conclusion To our knowledge, our analysis represents the largest reference data for cardiorespiratory fitness based on treadmill cardiopulmonary exercise testing. Our findings provide reference values of maximal oxygen uptake measurements from treadmill tests in Brazilian populations that are more accurate than previous standard values based on workload-derived estimations. This data may also add information to the global data used for the interpretation of cardiorespiratory fitness.	[Rossi Neto, Joao Manoel; Tebexreni, Antonio Sergio; Novakoski, Alexandre; Alves, Ferreira; Poggio Smanio, Paola Emanuela; de Abreu, Floriana Bertini; Thomazi, Mauricio Cruz; Nishio, Priscilla Ayumi; Cuninghant, Ivana Antelmi] Fleury Med & Saude, Sao Paulo, SP, Brazil		Neto, JMR (corresponding author), Fleury Med & Saude, Sao Paulo, SP, Brazil.	joao.rossi@grupofleury.com.br		Rossi Neto, Joao M/0000-0002-5959-9359				ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Silva CGDE, 2018, EUR J PREV CARDIOL, V25, P742, DOI 10.1177/2047487318763958; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Farrell SW, 2013, CIRC-HEART FAIL, V6, P898, DOI 10.1161/CIRCHEARTFAILURE.112.000088; Franklin BA, 2000, ACSMS GUIDELINES EXE; Herdy AH, 2016, ARQ BRAS CARDIOL, V106, P389, DOI 10.5935/abc.20160070; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Kaminsky LA, 2017, MAYO CLIN PROC, V92, P228, DOI 10.1016/j.mayocp.2016.10.003; Kaminsky LA, 2015, MAYO CLIN PROC, V90, P1515, DOI 10.1016/j.mayocp.2015.07.026; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kokkinos P, 2017, AM J CARDIOL, V120, P688, DOI 10.1016/j.amjcard.2017.05.037; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; MIYAMURA M, 1972, J APPL PHYSIOL, V32, P185, DOI 10.1152/jappl.1972.32.2.185; Myers J, 2014, CIRCULATION, V130, P1014, DOI 10.1161/CIR.0000000000000101; Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520; Riebe D, 2018, ACSMS GUIDELINES EXE, P111; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461	21	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209897	10.1371/journal.pone.0209897	http://dx.doi.org/10.1371/journal.pone.0209897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625200	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400061
J	Tetteh, EN; Abunyewa, AA; Tuffour, HO; Berchie, JN; Acheampong, PP; Twum-Ampofo, K; Dawoe, E; Logah, V; Agbenyega, O; Ennin, SA; Nunoo, I; Melenya, C; Danquah, EO; Barnes, VR; Partey, ST				Tetteh, Erasmus Narteh; Abunyewa, Akwasi Adutwum; Tuffour, Henry Oppong; Berchie, Joseph Nketiah; Acheampong, Patricia Pinamang; Twum-Ampofo, Kwame; Dawoe, Evans; Logah, Vincent; Agbenyega, Olivia; Ennin, Stella Ama; Nunoo, Isaac; Melenya, Caleb; Danquah, Eric Owusu; Barnes, Victor Rex; Partey, Samuel Tetteh			Rubber and plantain intercropping: Effects of different planting densities on soil characteristics	PLOS ONE			English	Article							MICROBIAL BIOMASS CARBON; FOREST SOILS; RAIN-FOREST; LAND-USE; NITROGEN; SYSTEMS; MANAGEMENT	Two field experiments were conducted at Ellembelle and Jomoro districts in the Western region of Ghana where rubber cultivation is a predominant farming activity. The objective of the study was to assess the effect of rubber and plantain intercropping systems on selected soil properties. The experiment was arranged in a randomized complete block design (RCBD) with 3 replications. The treatments were the sole crop rubber (R), sole crop plantain (P) and three intercrop systems comprising an additive series of plantain: one row of plantain to one row of rubber (PR), two rows of plantain to one row of rubber (PPR) and three rows of plantain to one row of rubber (PPPR). Generally, agroforestry systems improved the soil hydraulic properties considerably, with the highest cumulative infiltration rates of 5.16 and 8.68 cm/min observed under the PPPR systems at the Ellembelle and Jomoro sites, respectively. Microbial biomass C (C-mic), N (N-mic) and P (P-mic) was significantly improved (P < 0.05) under the agroforestry than the monocrop systems. The C-mic, N-mic and P-mic values were highest under the PPPR system at both Ellembelle (C-mic, = 139.9 mg/kg; N-mic = 36.26 mg/kg and P-mic = 87.6 mg/kg) and Jomoro (C-mic = 78.7 mg/kg; N-mic = 80.3 mg/kg and P-mic = 3.45 mg/kg) sites.	[Tetteh, Erasmus Narteh; Berchie, Joseph Nketiah; Acheampong, Patricia Pinamang; Ennin, Stella Ama] CSIR, Crops Res Inst, Kumasi, Ghana; [Abunyewa, Akwasi Adutwum; Twum-Ampofo, Kwame; Dawoe, Evans; Agbenyega, Olivia; Nunoo, Isaac; Danquah, Eric Owusu; Barnes, Victor Rex] Kwame Nkrumah Univ Sci & Technol, Dept Agroforestry, Kumasi, Ghana; [Tuffour, Henry Oppong; Logah, Vincent; Melenya, Caleb] Kwame Nkrumah Univ Sci & Technol, Dept Crop & Soil Sci, Kumasi, Ghana; [Partey, Samuel Tetteh] Int Crops Res Inst Semi Arid Trop, CGIAR Res Program Climate Change Agr & Food Secur, Bamako, Mali	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Tetteh, EN (corresponding author), CSIR, Crops Res Inst, Kumasi, Ghana.	buawolor2000@yahoo.com	Acheampong, Patricia Pinamang/AAB-1182-2019; Owusu Danquah, Eric/AHD-5101-2022; Danquah, Eric Owusu/AAV-9556-2020; Owusu Danquah, Eric/AAW-2104-2020	Owusu Danquah, Eric/0000-0003-1101-9690; Narteh Tetteh, Erasmus/0000-0003-4221-4018				Abdul Razak M. A., 2001, Unasylva (English ed.), V52, P9; Abraham P.D., 1980, SIARAN PEKEBUN, V78, P25; Agboola A. A., 1994, ALTERNATIVES SLASH A, P107; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; Anderson TH, 2003, AGR ECOSYST ENVIRON, V98, P285, DOI 10.1016/S0167-8809(03)00088-4; Araujo ASF, 2008, EUR J SOIL BIOL, V44, P225, DOI 10.1016/j.ejsobi.2007.06.001; Barua SK, 2013, LAND DEGRAD DEV, V24, P63, DOI 10.1002/ldr.1107; Bautista-Cruz A, 2005, SOIL SCI SOC AM J, V69, P906, DOI 10.2136/sssaj2004.0130; Berg B., 2003, DECOMPOSITION PROCES; Bouyoucos G. J., 1962, SOIL SCI SOC AM P, V26, P464; Bowden GD, 1985, ATTRIBUTES TREES CRO; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Charles R., 2013, INT J ENV PROT, V3, P29; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Djagbletey E. D., 2017, THESIS; Esekhade T. U., 2014, WUDPECKER J AGR RES, V3, P150; FAO (Food and Agriculture Organization of the United Nations), 1990, GUID PROF DESCR; Ferreira MM, 2010, PHYS 303 SOIL; FISHER RF, 1995, SOIL SCI SOC AM J, V59, P544, DOI 10.2136/sssaj1995.03615995005900020039x; FRANZLEUBBERS AJ, 1994, SOIL BIOL BIOCHEM, V26, P1469, DOI 10.1016/0038-0717(94)90086-8; Fu BJ, 2003, CATENA, V54, P197, DOI 10.1016/S0341-8162(03)00065-1; Ghana Statistical Service (GSS), 2014, POP HOUS CENS 2010 J; Ghana Statistical Service (GSS), 2013, POP HOUS CENS 2010 R; Gindaba J, 2005, BIOL FERT SOILS, V42, P66, DOI 10.1007/s00374-005-0859-2; Hajabbasi MA, 1997, PLANT SOIL, V190, P301, DOI 10.1023/A:1004243702208; Jenkinson D.S., 1981, SOIL BIOCH; Joergensen R. G., 1995, GOTTINGER BODENKUNDL, V104, P1; Juo ASR, 1996, AGR ECOSYST ENVIRON, V58, P49, DOI 10.1016/0167-8809(95)00656-7; Kumar B. M., 2006, Journal of Tropical Agriculture, V44, P1; LADD JN, 1989, SOIL BIOL BIOCHEM, V21, P457, DOI 10.1016/0038-0717(89)90160-0; Landon J.R., 1991, HDB SOIL SURVEY AGR; Liao JD, 2008, SOIL BIOL BIOCHEM, V40, P1207, DOI 10.1016/j.soilbio.2007.12.018; LLOYD D, 1995, TRENDS ECOL EVOL, V10, P476, DOI 10.1016/S0169-5347(00)89192-2; Logah V., 2013, Journal of Tropical Agriculture, V51, P98; LUIZAO RCC, 1992, SOIL BIOL BIOCHEM, V24, P805, DOI 10.1016/0038-0717(92)90256-W; Makova J, 2011, J CENT EUR AGRIC, V12, P752, DOI 10.5513/JCEA01/12.4.986; Marfo KA, 2009, KWAME ASIEDU MARFOS; Masea A., 1995, PLANT SOIL INTERACTI; Masebo N., 2014, DIRECT RES J AGR FOO, V2, P141; Mbow C, 2014, CURR OPIN ENV SUST, V6, P8, DOI 10.1016/j.cosust.2013.09.002; Meyer K, 1997, APPL SOIL ECOL, V5, P71, DOI 10.1016/S0929-1393(96)00123-0; Michael U, 2006, KEYNOTE ADDRESS PRES; Mishra V.K., 2003, SOIL HYDROLOGICAL BE; Nair P.K.R., 1993, CLASSIFICATION AGROF, DOI [10.1007/978-3-030-75358-0, DOI 10.1007/978-3-030-75358-0]; Olayemi J.K., 1980, NIGERIA SMALL FARMER; Pattanayak S, 1996, 59 FPEI RES TRIANGL; POWLSON DS, 1987, SOIL BIOL BIOCHEM, V19, P159, DOI 10.1016/0038-0717(87)90076-9; Rivest D, 2013, SCI TOTAL ENVIRON, V463, P51, DOI 10.1016/j.scitotenv.2013.05.071; Seneviratne HTJ, 2015, NBRO S INN RES ENV; Seobi T, 2005, SOIL SCI SOC AM J, V69, P893, DOI 10.2136/sssaj2004.0280; SILVA D. C., 2011, REV ESTUDOS AMBIENTA, V13, P77, DOI DOI 10.7867/1983-1501.2011V13N1P77-86; Soils Laboratory Staff, 1984, METH SOIL AN; Spohn M, 2015, BIOGEOSCIENCES, V12, P817, DOI 10.5194/bg-12-817-2015; Sternberg RJ, 2002, EVOLUTION OF INTELLIGENCE, P1; Templer PH, 2001, THESIS; Tornquist CG, 1999, AGR ECOSYST ENVIRON, V73, P19, DOI 10.1016/S0167-8809(99)00004-3; Tuffour H., 2013, INDIAN J APPL AGR RE, V1, P69; Tuffour HO., 2016, INT RES J ENG TECHNO, V3, P149; Udofia KJW, 2006, REPORT PRESIDENTIAL; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P697, DOI 10.1016/0038-0717(87)90051-4; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Wilding L. P., 1985, Soil spatial variability, P166; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029; Yan TM, 2003, GEODERMA, V115, P129, DOI 10.1016/S0016-7061(03)00082-X; Zainol E.A., 1993, NAT RUBBER RES, V8920, P124; Zhu J, 2010, 19 WORLD C SOIL SCI	67	9	9	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209260	10.1371/journal.pone.0209260	http://dx.doi.org/10.1371/journal.pone.0209260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625193	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000455359400032
J	Vaisanen, T; Markkanen, J; Penttila, A; Muinonen, K				Vaisanen, Timo; Markkanen, Johannes; Penttila, Antti; Muinonen, Karri			Radiative transfer with reciprocal transactions: Numerical method and its implementation	PLOS ONE			English	Article							DISCRETE RANDOM-MEDIA; MULTIPLE-SCATTERING; EM WAVES; T-MATRIX; SPHERES; LIGHT; EQUATIONS	We present a numerical method for solving electromagnetic scattering by dense discrete random media entitled radiative transfer with reciprocal transactions ((RT2)-T-2). The (RT2)-T-2 is a combination of the Monte Carlo radiative-transfer, coherent-backscattering, and superposition T-matrix methods. The applicability of the radiative transfer is extended to dense random media by incorporating incoherent volume elements containing multiple particles. We analyze the (RT2)-T-2 by comparing the results with the asymptotically exact superposition T-matrix method, and show that the (RT2)-T-2 removes the caveats of radiative-transfer methods by comparing it to the RT-CB. We study various implementation choices that result in an accurate and efficient numerical algorithm. In particular, we focus on the properties of the incoherent volume elements and their effects on the final solution.	[Vaisanen, Timo; Markkanen, Johannes; Penttila, Antti; Muinonen, Karri] Univ Helsinki, Dept Phys, Helsinki, Finland; [Markkanen, Johannes] Max Planck Inst Solar Syst Res, Gottingen, Germany; [Muinonen, Karri] Natl Land Survey Finland, Finnish Geospatial Res Inst FGI, Helsinki, Finland	University of Helsinki; Max Planck Society; The National Land Survey of Finland	Vaisanen, T (corresponding author), Univ Helsinki, Dept Phys, Helsinki, Finland.	timo.h.vaisanen@helsinki.fi	Penttilä, Antti/C-4886-2012	Penttilä, Antti/0000-0001-7403-1721; Markkanen, Henri Johannes/0000-0001-5989-3630; Muinonen, Karri/0000-0001-8058-2642; Vaisanen, Timo Henrik/0000-0003-3815-0293	FP7 Ideas: European Research Council, SAEMPL [320733]	FP7 Ideas: European Research Council, SAEMPL	Funding was provided by FP7 Ideas: European Research Council, SAEMPL, Project ID: 320733 to KM (https.//cordis.europa.eu/prolect/rcn/107666_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohren C.F., 2008, ABSORPTION SCATTERIN; BRUNING JH, 1971, IEEE T ANTENN PROPAG, VAP19, P378, DOI 10.1109/TAP.1971.1139944; BRUNING JH, 1971, IEEE T ANTENN PROPAG, VAP19, P391, DOI 10.1109/TAP.1971.1139925; Chandrasekhar S., 1960, RAD TRANSFER; Choi CH, 1999, J CHEM PHYS, V111, P8825, DOI 10.1063/1.480229; FRADEN S, 1990, PHYS REV LETT, V65, P512, DOI 10.1103/PhysRevLett.65.512; Gumerov NA, 2003, SIAM J SCI COMPUT, V25, P1344, DOI 10.1137/S1064827501399705; Haapanala P, 2017, ATMOS CHEM PHYS, V17, P6865, DOI 10.5194/acp-17-6865-2017; Haramoto H, 2008, LECT NOTES COMPUT SC, V5203, P290, DOI 10.1007/978-3-540-85912-3_26; ISHIMARU A, 1982, J OPT SOC AM, V72, P1317, DOI 10.1364/JOSA.72.001317; Juvela M, 1997, ASTRON ASTROPHYS, V322, P943; Lord Rayleigh F.R.S., 1899, PHIL, V47, P375, DOI [10.1080/14786449908621276, DOI 10.1080/14786449908621276, 10.1017/cbo9780511703997.052, DOI 10.1017/CBO9780511703997.052]; Markkanen J, 2018, OPT LETT, V43, P2925, DOI 10.1364/OL.43.002925; Markkanen J, 2018, ASTROPHYS J LETT, V868, DOI 10.3847/2041-8213/aaee10; Markkanen J, 2017, J QUANT SPECTROSC RA, V189, P181, DOI 10.1016/j.jqsrt.2016.11.004; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Mishchenko M. I., 2006, MULTIPLE SCATTERING; Muinonen K, 2017, RADIO SCI, V52, P1419, DOI 10.1002/2017RS006419; Muinonen K, 2004, WAVE RANDOM MEDIA, V14, P365, DOI 10.1088/0959-7174/14/3/010; Muinonen K, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/118; Muinonen K, 2018, OPT LETT, V43, P683, DOI 10.1364/OL.43.000683; PETERSON B, 1973, PHYS REV D, V8, P3661, DOI 10.1103/PhysRevD.8.3661; Saito M, 2008, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2006, P607, DOI 10.1007/978-3-540-74496-2_36; SAULNIER PM, 1990, PHYS REV B, V42, P2621, DOI 10.1103/PhysRevB.42.2621; Shoemake K, 1992, GRAPHICS GEMS, P124, DOI DOI 10.1016/B978-0-08-050755-2.50036-1; TSANG L, 1987, J ELECTROMAGNET WAVE, V1, P59; Vaisanen T, 2016, URSI INT SYM ELECT, P396, DOI 10.1109/URSI-EMTS.2016.7571408; WATERMAN PC, 1965, PR INST ELECTR ELECT, V53, P805, DOI 10.1109/PROC.1965.4058; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; YUSEFZADEH F, 1984, ASTROPHYS J, V278, P186, DOI 10.1086/161780; ZURK LM, 1995, J OPT SOC AM A, V12, P1772, DOI 10.1364/JOSAA.12.001772	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210155	10.1371/journal.pone.0210155	http://dx.doi.org/10.1371/journal.pone.0210155			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620746	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300017
J	Bansal, M; He, J; Peyton, M; Kustagi, M; Iyer, A; Comb, M; White, M; Minna, JD; Califano, A				Bansal, Mukesh; He, Jing; Peyton, Michael; Kustagi, Manjunath; Iyer, Archana; Comb, Michael; White, Michael; Minna, John D.; Califano, Andrea			Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling network analysis	PLOS ONE			English	Article							EML4-ALK FUSION GENE; COMBINATION THERAPY; BREAST-CANCER; SYSTEMATIC DISCOVERY; REGULATORY NETWORK; SOMATIC MUTATIONS; PROSTATE-CANCER; PLUS DOCETAXEL; PHASE-III; EGFR	To understand drug combination effect, it is necessary to decipher the interactions between drug targets many of which are signaling molecules. Previously, such signaling pathway models are largely based on the compilation of literature data from heterogeneous cellular contexts. Indeed, de novo reconstruction of signaling interactions from large-scale molecular profiling is still lagging, compared to similar efforts in transcriptional and protein-protein interaction networks. To address this challenge, we introduce a novel algorithm for the systematic inference of protein kinase pathways, and applied it to published mass spectrometry -based phosphotyrosine profile data from 250 lung adenocarcinoma (LUAD) samples. The resulting network includes 43 TKs and 415 inferred, LUAD-specific substrates, which were validated at >60% accuracy by SILAC assays, including "novel' substrates of the EGFR and c-MET TKs, which play a critical oncogenic role in lung cancer. This systematic, data-driven model supported drug response prediction on an individual sample basis, including accurate prediction and validation of synergistic EGFR and c-MET inhibitor activity in cells lacking mutations in either gene, thus contributing to current precision oncology efforts.	[Bansal, Mukesh] Psychogenics Inc, Paramus, NJ 07652 USA; [Bansal, Mukesh] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [He, Jing; Kustagi, Manjunath; Iyer, Archana; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [He, Jing; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY 10027 USA; [He, Jing; Califano, Andrea] Columbia Univ, Dept Biomed Informat DBMI, New York, NY 10027 USA; [Peyton, Michael; White, Michael] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Comb, Michael] Cell Signaling Technol, 3 Trask Lane, Danvers, MA USA; [Minna, John D.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Simmons Comprehens Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; [Minna, John D.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Simmons Comprehens Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Columbia University; Columbia University	Bansal, M (corresponding author), Psychogenics Inc, Paramus, NJ 07652 USA.; Bansal, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biomed Informat DBMI, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	mukesh.bansal@psychogenics.com; ac2248@cumc.columbia.edu		Kustagi, Manjunath/0000-0002-8218-1778; Califano, Andrea/0000-0003-4742-3679	National Cancer Institute (NCI) Cancer Target Discovery and Development program [U01CA217858, U01CA176284]; NCI Cancer Systems Biology Consortium [U54CA209997]; NCI Outstanding Investigator Award [R35CA197745]; NIH, Office of the Director, Shared Instrumentation Grants [S10OD012351, S10OD021764]; NCI SPORE in Lung Cancer [P50CA70907]; CPRIT [RP110708]; Cell Signaling Technologies; Psychogenics; NATIONAL CANCER INSTITUTE [U01CA217858, U54CA209997, R35CA197745, U01CA176284, P50CA070907] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Cancer Target Discovery and Development program; NCI Cancer Systems Biology Consortium; NCI Outstanding Investigator Award; NIH, Office of the Director, Shared Instrumentation Grants; NCI SPORE in Lung Cancer; CPRIT; Cell Signaling Technologies; Psychogenics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute (NCI) Cancer Target Discovery and Development program (U01CA217858 to A.C., and U01CA176284 to JDM), NCI Cancer Systems Biology Consortium (U54CA209997 to A.C.), NCI Outstanding Investigator Award (R35CA197745 to A.C.), NIH, Office of the Director, Shared Instrumentation Grants (S10OD012351 and S10OD021764) to AC, NCI SPORE in Lung Cancer (P50CA70907 to JDM), and CPRIT (Award RP110708 to JDM). Dr. Bansal performed this work when he was employed at Columbia. His role since joining Psychogenics has been only related to editing the manuscript for submission and revision. Dr. Comb was an author on the original study that was published in Cell where the dataset we used was published. He provided relevant information on how to best use the data and the genomic/clinical annotation of the samples. Neither company provided any funding or material support toward this study. The funders Cell Signaling Technologies and Psychogenics provided support in the form of salaries for authors MB and MC, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Darwin Health provided no salary support for any authors and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Dr. Califano's commercial affiliations did not provide any funding nor does it support the salary. It is provided only because the Dr. Califano is required by Columbia University to state his conflict of interest on all of publications.; We thank George Rosenberger for manuscript advice. This work was supported by the National Cancer Institute (NCI) Cancer Target Discovery and Development program (U01CA217858 to A.C., and U01CA176284 to JDM), NCI Cancer Systems Biology Consortium (U54CA209997 to A.C.), NCI Outstanding Investigator Award (R35CA197745 to A.C.), NIH, Office of the Director, Shared Instrumentation Grants (S10OD012351 and S10OD021764) to AC, NCI SPORE in Lung Cancer (P50CA70907 to JDM), and CPRIT (Award RP110708 to JDM).	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Amato KR, 2016, CANCER RES, V76, P305, DOI 10.1158/0008-5472.CAN-15-0717; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Bender C, 2010, BIOINFORMATICS, V26, pi596, DOI 10.1093/bioinformatics/btq385; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Bisikirska B, 2016, CANCER RES, V76, P664, DOI 10.1158/0008-5472.CAN-15-0828; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Budak G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00730; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Crystal AS, 2012, CLIN CANCER RES, V18, P4479, DOI 10.1158/1078-0432.CCR-12-1952; Davoli A, 2010, CANCER CHEMOTH PHARM, V65, P611, DOI 10.1007/s00280-009-1208-1; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Giansanti P, 2015, CELL REP, V11, P1834, DOI 10.1016/j.celrep.2015.05.029; Gillet LC, 2016, ANNU REV ANAL CHEM, V9, P449, DOI 10.1146/annurev-anchem-071015-041535; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Hashemikhabir S, 2012, IEEE ACM T COMPUT BI, V9, P1696, DOI 10.1109/TCBB.2012.128; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Karasaki T, 2016, J THORAC ONCOL, V11, P324, DOI 10.1016/j.jtho.2015.11.006; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landi L, 2013, CURR OPIN ONCOL, V25, P130, DOI 10.1097/CCO.0b013e32835daf37; Laurent C, 2009, J CLIN ONCOL, V27, P4211, DOI 10.1200/JCO.2008.21.5020; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mak KS, 2014, NEUROONCOL; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Metro G, 2012, TRANSL LUNG CANCER R, V1, P5, DOI 10.3978/j.issn.2218-6751.2011.12.01; Mitrofanova A, 2015, CELL REP, V12, P2060, DOI 10.1016/j.celrep.2015.08.051; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; Okamoto I, 2010, FEBS J, V277, P309, DOI 10.1111/j.1742-4658.2009.07449.x; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pegram MD, 1999, SEMIN ONCOL, V26, P89; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Putcha P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0658-0; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shi TJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0891; Shimoni Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000828; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sokai A, 2014, JPN J CLIN ONCOL, V44, P93, DOI 10.1093/jjco/hyt173; Sonabend AM, 2014, CANCER RES, V74, P1440, DOI 10.1158/0008-5472.CAN-13-2150; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Sun MGF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002411; Talos F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14662; Tsvetkova E, 2012, CURR ONCOL, V19, pS45, DOI 10.3747/co.19.1113; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vendrell JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12679-8; Voena C, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.7; Walsh LA, 2017, CELL REP, V20, P1623, DOI 10.1016/j.celrep.2017.07.052; Wang S, 2012, J MED CHEM, V55, P2427, DOI 10.1021/jm201743s; Wilson FH, 2015, CANCER CELL, V27, P397, DOI 10.1016/j.ccell.2015.02.005; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Ying CY, 2013, NAT IMMUNOL, V14, P1084, DOI 10.1038/ni.2688; Zhang GL, 2011, J PROTEOME RES, V10, P305, DOI 10.1021/pr1006203; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	83	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0208646	10.1371/journal.pone.0208646	http://dx.doi.org/10.1371/journal.pone.0208646			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615629	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900011
J	Price, MA; Cruz, R; Baxter, S; Escalettes, F; Rosser, SJ				Price, Marcus A.; Cruz, Rita; Baxter, Scott; Escalettes, Franck; Rosser, Susan J.			CRISPR-Cas9 In Situ engineering of subtilisin E in Bacillus subtilis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEASE; GENOME; TOOL	CRISPR-Cas systems have become widely used across all fields of biology as a genome engineering tool. With its recent demonstration in the Gram positive industrial workhorse Bacillus subtilis, this tool has become an attractive option for rapid, markerless strain engineering of industrial production hosts. Previously described strategies for CRISPR-Cas9 genome editing in B. subtilis have involved chromosomal integrations of Cas9 and single guide RNA expression cassettes, or construction of large plasmids for simultaneous transformation of both single guide RNA and donor DNA. Here we use a flexible, co-transformation approach where the single guide RNA is inserted in a plasmid for Cas9 co-expression, and the donor DNA is supplied as a linear PCR product observing an editing efficiency of 76%. This allowed multiple, rapid rounds of in situ editing of the subtilisin E gene to incorporate a salt bridge triad present in the Bacillus clausii thermotolerant homolog, M-protease. A novel subtilisin E variant was obtained with increased thermotolerance and activity.	[Price, Marcus A.; Rosser, Susan J.] Univ Edinburgh, Dept Quantitat Biol Biochem & Biotechnol, Edinburgh, Midlothian, Scotland; [Price, Marcus A.; Cruz, Rita; Baxter, Scott; Escalettes, Franck] Ingenza Ltd, Roslin Innovat Ctr, Roslin, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Price, MA; Rosser, SJ (corresponding author), Univ Edinburgh, Dept Quantitat Biol Biochem & Biotechnol, Edinburgh, Midlothian, Scotland.; Price, MA (corresponding author), Ingenza Ltd, Roslin Innovat Ctr, Roslin, Midlothian, Scotland.	M.A.Price-4@sms.ed.ac.uk; Susan.Rosser@ed.ac.uk		Price, Marcus/0000-0002-7435-873X; Cruz, Rita/0000-0002-6176-7892; Rosser, Susan/0000-0002-2560-6485	Industrial Biotechnology Innovation Centre (IBiolC); lngenza limited	Industrial Biotechnology Innovation Centre (IBiolC); lngenza limited	This work was supported by the Industrial Biotechnology Innovation Centre (IBiolC: www.ibloic.com) and lngenza limited (www.ingenza.com) as part of M.A.P PhD studentship. lngenza Ltd. provided support in the form of salaries for authors (R.C., S.B. and F.E.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Bryan PN, 2000, BBA-PROTEIN STRUCT M, V1543, P203, DOI 10.1016/S0167-4838(00)00235-1; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Burby PE, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00682-16; Che A., 2015, United States Patent, Patent No. [US 8,999,679 B2, 8999679]; Cupp-Enyard C., 2008, JOVE, V19, P899, DOI [DOI 10.3791/899, 10.3791/899]; ERWIN CR, 1990, PROTEIN ENG, V4, P87, DOI 10.1093/protein/4.1.87; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jakutyte-Giraitiene L, 2016, J IND MICROBIOL BIOT, V43, P1183, DOI 10.1007/s10295-016-1784-0; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kobayashi T, 2005, WORLD J MICROB BIOT, V21, P961, DOI 10.1007/s11274-004-7162-5; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sambrook J., 2001, MOL CLONING LAB MANU; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Westbrook AW, 2016, APPL ENVIRON MICROB, V82, P4876, DOI 10.1128/AEM.01159-16; Zhang KJ, 2016, SCI CHINA PHYS MECH, V59, DOI 10.1007/s11433-016-0021-5; Zhang XZ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl358	24	15	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210121	10.1371/journal.pone.0210121	http://dx.doi.org/10.1371/journal.pone.0210121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615645	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900041
J	Graber, TG; Fry, CS; Brightwell, CR; Moro, T; Maroto, R; Bhattarai, N; Porter, C; Wakamiya, M; Rasmussen, BB				Graber, Ted G.; Fry, Christopher S.; Brightwell, Camille R.; Moro, Tatiana; Maroto, Rosario; Bhattarai, Nisha; Porter, Craig; Wakamiya, Maki; Rasmussen, Blake B.			Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling, muscle cell hypertrophy, and mitochondrial respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GATOR1 (GTPase-activating protein (GAP) activity toward Rags-1); gene knockout; muscle; muscle hypertrophy; translation control; transgenic mice; mTOR complex (mTORC); amino acid sensing; muscle contractility	ACTIVATION; COMPLEX; CAPACITY; STRENGTH; EXERCISE; MODEL; MICE	mTORC1 regulates protein synthesis and in turn is regulated by growth factors, energy status, and amino acid availability. In kidney cell (HEK293-T) culture, the GAP activity toward RAG (GATOR1) protein complex suppresses activation of the RAG A/B-RAG C/D heterodimer when amino acids are insufficient. During amino acid sufficiency, the RAG heterodimer recruits mTORC1 to the lysosomal membrane where its interaction with Ras homolog enriched in brain (Rheb) stimulates mTORC1's kinase activity. The DEP domain containing 5 (DEPDC5) protein, a GATOR1 subunit, causes familial focal epilepsy when mutated, and global knockout of the Depdc5 gene is embryonically lethal. To study the function of DEPDC5 in skeletal muscle, we generated a muscle-specific inducible Depdc5 knockout mouse, hypothesizing that knocking out Depdc5 in muscle would make mTORC1 constitutively active, causing hypertrophy and improving muscle function. Examining mTORC1 signaling, morphology, mitochondrial respiratory capacity, contractile function, and applied physical function (e.g. rotarod, treadmill, grip test, and wheel running), we observed that mTORC1 activity was significantly higher in knockout (KO) mice, indicated by the increased phosphorylation of mTOR and its downstream effectors (by 118% for p-mTOR/mTOR, 114% for p-S6K1/S6K1, and 35% for p-4E-BP1/4E-BP1). The KO animals also exhibited soleus muscle cell hypertrophy and a 2.5-fold increase in mitochondrial respiratory capacity. However, contrary to our hypothesis, neither physical nor contractile function improved. In conclusion, DEPDC5 depletion in adult skeletal muscle removes GATOR1 inhibition of mTORC1, resulting in muscle hypertrophy and increased mitochondrial respiration, but does not improve overall muscle quality and function.	[Graber, Ted G.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Graber, Ted G.; Fry, Christopher S.; Moro, Tatiana; Maroto, Rosario; Rasmussen, Blake B.] Univ Texas Med Branch, Dept Nutr & Metab, 301 Univ Blvd, Galveston, TX 77555 USA; [Brightwell, Camille R.] Univ Texas Med Branch, Program Cell Biol, Galveston, TX 77555 USA; [Bhattarai, Nisha; Porter, Craig] Univ Texas Med Branch, Dept Surg Burn Metab, Galveston, TX 77555 USA; [Wakamiya, Maki] Univ Texas Med Branch, Transgen Core Facil, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rasmussen, BB (corresponding author), Univ Texas Med Branch, Dept Nutr & Metab, 301 Univ Blvd, Galveston, TX 77555 USA.	blrasmus@utmb.edu	Fry, Christopher/U-2216-2019; Brightwell, Camille R./X-8718-2019; Moro, Tatiana/N-6669-2019	Brightwell, Camille R./0000-0001-6334-3789; Moro, Tatiana/0000-0002-1404-1511; Rasmussen, Blake/0000-0001-7854-5375; Graber, Ted/0000-0002-5332-7838	National Institutes of Health NCATS CTSA [TL1TR001440 NSRA]; NIA [P30 AG024832, R56 AG051267, T32 AG000270]; NIAMS [R01 AR072061]; Shriners Hospitals for Children Grant [84090]; NCATSS CTSA KL2 scholar award [KL2TR001441]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001440, KL2TR001441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, T32AG000270] Funding Source: NIH RePORTER	National Institutes of Health NCATS CTSA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Shriners Hospitals for Children Grant; NCATSS CTSA KL2 scholar award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health NCATS CTSA TL1TR001440 NSRA Fellowship and NIA P30 AG024832 Pilot/Developmental grants (to T. G. G.), NIA R56 AG051267 (to B. B. R.), NIAMS R01 AR072061 (to C. S. F.), NIA T32 AG000270 (to C. R. B.), and NCATSS CTSA KL2 scholar award KL2TR001441 (to C. P.) and by Shriners Hospitals for Children Grant 84090 (to C. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrigo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2063179; ALNAQEEB MA, 1984, J ANAT, V139, P677; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chen CNJ, 2014, J MUSCLE RES CELL M, V35, P191, DOI 10.1007/s10974-014-9385-x; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dutchak PA, 2018, CELL REP, V23, P1907, DOI 10.1016/j.celrep.2018.04.058; Dutchak PA, 2015, CELL REP, V12, P371, DOI 10.1016/j.celrep.2015.06.042; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Graber TG, 2018, EXP GERONTOL, V106, P88, DOI 10.1016/j.exger.2018.02.002; Graber TG, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0187-1; Graber TG, 2015, AGE, V37, DOI 10.1007/s11357-015-9773-1; Graber TG, 2013, J GERONTOL A-BIOL, V68, P1326, DOI 10.1093/gerona/glt032; Guridi M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0084-8; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Hughes J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12574-2; Kappel S, 2017, ANIMALS, V7, DOI 10.3390/ani7120088; Kimball SR, 2014, AM J CLIN NUTR, V99, p237S, DOI 10.3945/ajcn.113.068387; Kowalczyk MS, 2012, MAMM GENOME, V23, P404, DOI 10.1007/s00335-012-9398-y; Marsan E, 2016, NEUROBIOL DIS, V89, P180, DOI 10.1016/j.nbd.2016.02.010; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; MAUGHAN RJ, 1984, SPORTS MED, V1, P263, DOI 10.2165/00007256-198401040-00002; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Porter C, 2016, CELL METAB, V24, P246, DOI 10.1016/j.cmet.2016.07.004; Porter C, 2015, AM J PHYSIOL-ENDOC M, V309, pE224, DOI 10.1152/ajpendo.00125.2015; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SALE DG, 1992, EUR J APPL PHYSIOL O, V64, P51, DOI 10.1007/BF00376440; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; Webers EM, 2017, LAB ANIMAL, V46, P157, DOI 10.1038/laban.1219; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010	38	15	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4091	4102		10.1074/jbc.RA118.005970	http://dx.doi.org/10.1074/jbc.RA118.005970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30635399	hybrid, Green Published			2022-12-26	WOS:000461854400022
J	Pietrocola, G; Nobile, G; Alfeo, MJ; Foster, TJ; Geoghegan, JA; De Filippis, V; Speziale, P				Pietrocola, Giampiero; Nobile, Giulia; Alfeo, Mariangela J.; Foster, Timothy J.; Geoghegan, Joan A.; De Filippis, Vincenzo; Speziale, Pietro			Fibronectin-binding protein B (FnBPB) from Staphylococcus aureus protects against the antimicrobial activity of histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); histone; plasminogen; innate immunity; cell surface protein; virulence factor; methicillin-resistant Staphylococcus aureus (MRSA); adhesin; extracellular trap; fibronectin-binding protein B	COMMUNITY-ASSOCIATED MRSA; EXTRACELLULAR HISTONES; BIOFILM FORMATION; CLUMPING FACTOR; FIBRINOGEN; MSCRAMM; RESISTANCE; DOMAIN; MODEL; PLASMINOGEN	Staphylococcus aureus is a Gram-positive bacterium that can cause both superficial and deep-seated infections. Histones released by neutrophils kill bacteria by binding to the bacterial cell surface and causing membrane damage. We postulated that cell wall-anchored proteins protect S. aureus from the bactericidal effects of histones by binding to and sequestering histones away from the cell envelope. Here, we focused on S. aureus strain LAC and by using an array of biochemical assays, including surface plasmon resonance and ELISA, discovered that fibronectin-binding protein B (FnBPB) is the main histone receptor. FnBPB bound all types of histones, but histone H3 displayed the highest affinity and bactericidal activity and was therefore investigated further. H3 bound specifically to the A domain of recombinant FnBPB with a K-D of 86 nm, approximate to 20-fold lower than that for fibrinogen. Binding apparently occurred by the same mechanism by which FnBPB binds to fibrinogen, because FnBPB variants defective in fibrinogen binding also did not bind H3. An FnBPB-deletion mutant of S. aureus LAC bound less H3 and was more susceptible to its bactericidal activity and to neutrophil extracellular traps, whereas an FnBPB-overexpressing mutant bound more H3 and was more resistant than the WT. FnBPB bound simultaneously to H3 and plasminogen, which after activation by tissue plasminogen activator cleaved the bound histone. We conclude that FnBPB provides a dual immune-evasion function that captures histones and prevents them from reaching the bacterial membrane and simultaneously binds plasminogen, thereby promoting its conversion to plasmin to destroy the bound histone.	[Pietrocola, Giampiero; Nobile, Giulia; Alfeo, Mariangela J.; Speziale, Pietro] Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy; [Foster, Timothy J.] Trinity Coll Dublin, Dept Microbiol, Dublin 2, Ireland; [Geoghegan, Joan A.] Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Sch Genet & Microbiol, Dublin 2, Ireland; [De Filippis, Vincenzo] Univ Padua, Lab Prot Chem & Mol Hematol, Dept Pharmaceut & Pharmacol Sci, I-36131 Padua, Italy; [Speziale, Pietro] Univ Pavia, Dept Ind & Informat Engn, I-27100 Pavia, Italy	University of Pavia; Trinity College Dublin; Trinity College Dublin; University of Padua; University of Pavia	Pietrocola, G; Speziale, P (corresponding author), Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy.	giampiero.pietrocola@unipv.it; pspeziale@unipv.it		Alfeo, Mariangela Jessica/0000-0002-4600-1901; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155	Fondazione CARIPLO Grant Vaccines [2009-3546]; PRAT-2015 Grant	Fondazione CARIPLO Grant Vaccines(Fondazione Cariplo); PRAT-2015 Grant	This work was supported by Fondazione CARIPLO Grant Vaccines 2009-3546 (to P. S.) and in part by PRAT-2015 Grant (to V. D. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Burke FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-160; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chaput C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071097; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DELANGE RJ, 1971, ANNU REV BIOCHEM, V40, P279, DOI 10.1146/annurev.bi.40.070171.001431; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dohrmann S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43039; Eisenbeis J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00235; Foster TJ, 2019, TRENDS MICROBIOL, V27, P26, DOI 10.1016/j.tim.2018.06.005; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; Loughman A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-74; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McCourt J, 2014, FEMS MICROBIOL LETT, V353, P157, DOI 10.1111/1574-6968.12424; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Morita S, 2013, PEPTIDES, V48, P75, DOI 10.1016/j.peptides.2013.07.025; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Murphy EC, 2014, J INNATE IMMUN, V6, P394, DOI 10.1159/000356432; Nitzsche R, 2016, J INNATE IMMUN, V8, P589, DOI 10.1159/000448039; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Pietrocola G, 2016, J BIOL CHEM, V291, P18148, DOI 10.1074/jbc.M116.731125; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Rose-Martel M, 2014, INT J ANTIMICROB AG, V44, P470, DOI 10.1016/j.ijantimicag.2014.07.008; Schorn C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00277; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Sollberger G, 2018, DEV CELL, V44, P542, DOI 10.1016/j.devcel.2018.01.019; Stapels DAC, 2014, P NATL ACAD SCI USA, V111, P13187, DOI 10.1073/pnas.1407616111; Ueki S, 2013, BLOOD, V121, P2074, DOI 10.1182/blood-2012-05-432088; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Westman J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00236; Westman J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005319; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	57	18	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3588	3602		10.1074/jbc.RA118.005707	http://dx.doi.org/10.1074/jbc.RA118.005707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622139	Green Published, hybrid			2022-12-26	WOS:000461853900023
J	Hwang, JK; Gwag, HB; Park, KM; On, YK; Kim, JS; Park, SJ				Hwang, Jin Kyung; Gwag, Hye Bin; Park, Kyoung-min; On, Young Keun; Kim, June Soo; Park, Seung-Jung			Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response	PLOS ONE			English	Article							PACED HEART-RATE; FAILURE; MORTALITY; INCREASE; RHYTHM	It remains unclear as to whether cardiac resynchronization therapy (CRT) would be as effective in patients with atrial fibrillation (AF) accompanied by slow ventricular response (AFSVR, < 60 beats/min) as in those with sinus rhythm (SR). Echocardiographic reverse remodeling was compared between AF-SVR patients (n = 17) and those with SR (n = 88) at six months and 12 months after CRT treatment. We also evaluated the changes in QRS duration; New York Heart Association (NYHA) functional class; and long-term composite clinical outcomes including cardiac death, heart transplantation, and heart failure (HF)-related hospitalization. Left ventricular pacing sites and biventricular pacing percentages were not significantly different between the AF-SVR and SR groups. However, heart rate increase after CRT was significantly greater in the AF-SVR group than in the SR group (P < 0.001). At six and 12 months postoperation, both groups showed a comparable improvement in NYHA class; QRS narrowing; and echocardiographic variables including left ventricular end-systolic volume, left ventricular ejection fraction, and left atrial volume index. Over the median follow-up duration of 1.6 (interquartile range: 0.8-2.2) years, no significant between-group differences were observed regarding the rates of long-term composite clinical events (35% versus 24%; hazard ratio: 1.71; 95% confidence interval: 0.23-12.48; P = 0.60). CRT implantation provided comparable beneficial effects for patients with AF-SVR as compared with those with SR, by correcting electrical dyssynchrony and increasing biventricular pacing rate, in terms of QRS narrowing, symptom improvement, ventricular reverse remodeling, and long-term clinical outcomes.	[Hwang, Jin Kyung] Vet Hlth Serv Med Ctr, Div Cardiol, Dept Med, Seoul, South Korea; [Gwag, Hye Bin; Park, Kyoung-min; On, Young Keun; Kim, June Soo; Park, Seung-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea	Veterans Health Service Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.	orthovics@skku.edu		Park, Seung-Jung/0000-0003-3288-0594				Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Delnoy PPHM, 2007, AM J CARDIOL, V99, P1252, DOI 10.1016/j.amjcard.2006.12.040; Gasparini M, 2006, J AM COLL CARDIOL, V48, P734, DOI 10.1016/j.jacc.2006.03.056; Gasparini M, 2013, JACC-HEART FAIL, V1, P500, DOI 10.1016/j.jchf.2013.06.003; Gwag HB, 2017, YONSEI MED J, V58, P703, DOI 10.3349/ymj.2017.58.4.703; Jeon DS, 2017, KOREAN CIRC J, V47, P523, DOI 10.4070/kcj.2016.0361; Khand AU, 2000, EUR HEART J, V21, P614, DOI 10.1053/euhj.1999.1767; Lim K, 2017, KOREAN CIRC J, V47, P132, DOI 10.4070/kcj.2016.0176; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; MUKHARJI J, 1990, CLIN CARDIOL, V13, P639, DOI 10.1002/clc.4960130910; NISHIMURA RA, 1995, J AM COLL CARDIOL, V25, P281, DOI 10.1016/0735-1097(94)00419-Q; Stahlberg M, 2015, EUROPACE, V17, P439, DOI 10.1093/europace/euu289; Stahlberg M, 2011, EUROPACE, V13, P237, DOI 10.1093/europace/euq354; Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wilton SB, 2011, HEART RHYTHM, V8, P1088, DOI 10.1016/j.hrthm.2011.02.014	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210603	10.1371/journal.pone.0210603	http://dx.doi.org/10.1371/journal.pone.0210603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633768	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100031
J	Cheng, G; Zhou, SH; Zhang, J; Huang, XY; Bai, XJ; Xie, TL; Guo, RR; Liu, JB; Yu, H; Xie, LJ				Cheng, Guo; Zhou, Sihong; Zhang, Jin; Huang, Xiaoyun; Bai, Xianjin; Xie, Taili; Guo, Rongrong; Liu, Jinbiao; Yu, Huan; Xie, Linjun			Comparison of transcriptional expression patterns of phenols and carotenoids in 'Kyoho' grapes under a two-crop-a-year cultivation system	PLOS ONE			English	Article							CABERNET-SAUVIGNON GRAPES; VITIS-VINIFERA; BERRY SKIN; BIOSYNTHESIS; L.; ANTHOCYANINS; ACCUMULATION; PARAMETERS; IMPACTS; CLIMATE	To fully utilize the characteristic climatic conditions in the southern region of China, a two-crop-a-year cultivation system technique for 'Kyoho' grape was developed during the past decade. After summer harvest in June, appropriate pruning and chemical treatments promote flowering and fruiting, which enables a second harvest in late December. Due to climatic differences between the two crop growing seasons, grape phenol and carotenoid metabolism differ greatly. The reported study analyzed the transcriptome of the carotenoid and phenylpropanoid/flavonoid pathways in grapes at four different stages during the two growing seasons. Compared with those in summer grapes, expression levels of the majority of genes involved in the carotenoid metabolic pathway in winter grapes were generally upregulated. This result was associated with lower rainfall and much more abundant sunlight during the second growing season. On the other hand, summer cropping strongly triggered the expression of upstream genes in the phenylpropanoid/flavonoid pathway at E-L33 and E-L35. Transcript levels of flavonoid 3',5'-hydroxylase (F3'5'H), flavonoid 3'-hydroxylase (F3'H), flavonoid 3-hydroxylase (F3H) and glutathione S-transferase (GST) were upregulated in winter grapes at the mature stage. Together, these results might indicate that more flavonoids would be synthesized in ripe winter grapes during the mature stage of the second crop under much drier conditions, longer sunlight hours and lower temperature. These data provide a theoretical foundation for the secondary metabolism of berries grown under two-crop-a-year cultivation systems.	[Cheng, Guo; Zhou, Sihong; Zhang, Jin; Huang, Xiaoyun; Bai, Xianjin; Xie, Taili; Guo, Rongrong; Liu, Jinbiao; Yu, Huan; Xie, Linjun] Guangxi Acad Agr Sci, Grape & Wine Res Inst, Nanning, Guangxi, Peoples R China; [Zhou, Sihong] Guangxi Crop Genet Improvement & Biotechnol Lab, Nanning, Peoples R China	Guangxi Academy of Agricultural Sciences	Zhou, SH; Xie, TL (corresponding author), Guangxi Acad Agr Sci, Grape & Wine Res Inst, Nanning, Guangxi, Peoples R China.; Zhou, SH (corresponding author), Guangxi Crop Genet Improvement & Biotechnol Lab, Nanning, Peoples R China.	bear824@126.com; xietaili@gxaas.net			Basal Research Fund of Guangxi Academy of Agricultural Sciences [2015YT82, 2015YT85]; Natural Science Foundation of Guangxi [2017GXNSFBA198156]; Guinongke Grant [2015YT82, 2015YT85, 2017GXNSFBA198156]	Basal Research Fund of Guangxi Academy of Agricultural Sciences; Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Guinongke Grant	This work was supported by the Basal Research Fund of Guangxi Academy of Agricultural Sciences (Guinongke Grant Nos. 2015YT82 and 2015YT85), and the Natural Science Foundation of Guangxi (Grant No. 2017GXNSFBA198156). Guinongke Grant Nos. 2015YT82 and 2015YT85 have roles in data collection and analysis; Grant No. 2017GXNSFBA198156 has a role in the study design and preparation of the manuscript.	Bai XianJin, 2008, Southwest China Journal of Agricultural Sciences, V21, P953; Bai XJ, 2015, S CHINA FRUITS, V45, P167; Balic I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190087; Bindon KA, 2007, J AGR FOOD CHEM, V55, P4493, DOI 10.1021/jf063331p; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Brantley P. M., 2013, MOL BIOL BIOCH FRUIT, P76; Cao XiongJun, 2014, Southwest China Journal of Agricultural Sciences, V27, P1228; Carvalho LC, 2011, MOL PLANT, V4, P1038, DOI 10.1093/mp/ssr027; Carvalho LJCB, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0826-0; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen WK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01912; Chen WK, 2017, J PLANT PHYSIOL, V213, P75, DOI 10.1016/j.jplph.2017.03.001; Cheng Guo, 2017, Journal of Fruit Science, V34, P1125; Cheng G, 2014, MOLECULES, V19, P13683, DOI 10.3390/molecules190913683; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Crupi P, 2010, J AGR FOOD CHEM, V58, P9647, DOI 10.1021/jf100564v; de Rosas I, 2017, PLANT SCI, V258, P137, DOI 10.1016/j.plantsci.2017.01.015; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Dunlevy J. D., 2009, GRAPEVINE MOL PHYSL, P293, DOI DOI 10.1007/978-90-481-2305-6_11; Fraga H, 2012, FOOD ENERGY SECUR, V1, P94, DOI 10.1002/fes3.14; Goto-Yamamoto N, 2009, J INT SCI VIGNE VIN, P75; Guan L, 2016, PLANTA, V243, P23, DOI 10.1007/s00425-015-2391-4; Jeandet P, 1995, INT J BIOCHEM CELL B, V26, P165; Li Q, 2014, PLANT PHYSIOL BIOCH, V84, P45, DOI 10.1016/j.plaphy.2014.08.026; Liang ZC, 2008, FOOD CHEM, V111, P837, DOI 10.1016/j.foodchem.2008.04.069; Liu XM, 2016, SINOOVERSEAS GRAPEVI, V05, P131; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; Montealegre RR, 2006, J FOOD COMPOS ANAL, V19, P687, DOI 10.1016/j.jfca.2005.05.003; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Oliveira C, 2004, J AGR FOOD CHEM, V52, P4178, DOI 10.1021/jf0498766; Pan QH, 2009, PLANT SCI, V176, P360, DOI 10.1016/j.plantsci.2008.12.004; Poni S, 2009, AUST J GRAPE WINE R, V15, P185, DOI 10.1111/j.1755-0238.2008.00044.x; Savoi S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0760-1; Storchi P, 2005, ACTA HORTIC, P333, DOI 10.17660/ActaHortic.2005.689.39; Sun LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-257; Sun RZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00547; Sun RZ, 2015, J PLANT PHYSIOL, V178, P43, DOI 10.1016/j.jplph.2015.01.012; Waffo-Teguo P., 2008, P25, DOI 10.1007/978-3-540-74603-4_2; Wang B, 2012, SCI HORTIC-AMSTERDAM, V137, P20, DOI 10.1016/j.scienta.2011.10.006; Xu CM, 2011, J AGR FOOD CHEM, V59, P1078, DOI 10.1021/jf104157z; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243; Zhou YM, 2015, SO HORTIC, V26, P22	45	4	4	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210322	10.1371/journal.pone.0210322	http://dx.doi.org/10.1371/journal.pone.0210322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629640	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000074
J	Toro-Sazo, M; Brea, J; Loza, MI; Cimadevila, M; Cassels, BK				Toro-Sazo, Miguel; Brea, Jose; Loza, Maria I.; Cimadevila, Marta; Cassels, Bruce K.			5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines	PLOS ONE			English	Article							INTERACTION PROFILES; STRUCTURAL BASIS; SEROTONIN; AGONISTS; DERIVATIVES; PHENETHYLAMINES; LORCASERIN; EFFICACY; SERIES	The last fifteen years have seen the emergence and overflow into the drug scene of "super-potent" N-benzylated phenethylamines belonging to the "NBOMe" series, accompanied by numerous research articles. Although N-benzyl substitution of 5-methoxytryptamine is known to increase its affinity and potency at 5-HT2 receptors associated with psychedelic activity, N-benzylated tryptamines have been studied much less than their phenethylamine analogs. To further our knowledge of the activity of N-benzyltryptamines, we have synthesized a family of tryptamine derivatives and, for comparison, a few 5-methoxytryptamine analogs with many different substitution patterns on the benzyl moiety, and subjected them to in vitro affinity and functional activity assays vs. the human 5-HT2 receptor subtypes. In the binding (radioligand displacement) studies some of these compounds exhibited only modest selectivity for either 5-HT2A or 5-HT2C receptors suggesting that a few of them, with affinities in the 10-100 nanomolar range for 5-HT2A receptors, might presumably be psychedelic. Unexpectedly, their functional (calcium mobilization) assays reflected very different trends. All of these compounds proved to be 5-HT2C receptor full agonists while most of them showed low efficacy at the 5-HT2A subtype. Furthermore, several showed moderateto-strong preferences for activation of the 5-HT2C subtype at nanomolar concentrations. Thus, although some N-benzyltryptamines might be abuse-liable, others might represent new leads for the development of therapeutics for weight loss, erectile dysfunction, drug abuse, or schizophrenia.	[Toro-Sazo, Miguel; Cassels, Bruce K.] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile; [Brea, Jose; Loza, Maria I.; Cimadevila, Marta] Univ Santiago De Compostela, CIMUS, BioFarma Res Grp, Santiago De Compostela, Spain	Universidad de Chile; Universidade de Santiago de Compostela	Cassels, BK (corresponding author), Univ Chile, Fac Sci, Dept Chem, Santiago, Chile.	bcassels@uchile.cl	Brea, Jose/ABH-3260-2020; Cassels Niven, Bruce Kennedy/H-6937-2013	Loza Garcia, Maria Isabel/0000-0003-4730-0863; Cassels Niven, Bruce Kennedy/0000-0002-0082-0661; Cimadevila, Marta/0000-0002-5090-8311; Brea, Jose/0000-0002-5523-1979	FONDECYT (Chile) [1110146, 1150868]; CONICYT [21140358]	FONDECYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT (Chile) regular research grants 1110146 and 1150868 to BKC and CONICYT doctoral grant 21140358 to MT-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Castillo C, 2002, BRIT J PHARMACOL, V136, P510, DOI 10.1038/sj.bjp.0704747; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Eshleman AJ, 2018, BIOCHEM PHARMACOL, V158, P27, DOI 10.1016/j.bcp.2018.09.024; Garcia-Carceles J, 2017, J MED CHEM, V60, P9575, DOI 10.1021/acs.jmedchem.7b00994; Glennon RA, J MED CHEM; Halberstadt AL, 2017, CURR TOP BEHAV NEURO, V32, P283, DOI 10.1007/7854_2016_64; Hansen M, 2015, BIOORGAN MED CHEM, V23, P3933, DOI 10.1016/j.bmc.2014.12.011; Hansen M, 2014, ACS CHEM NEUROSCI, V5, P243, DOI 10.1021/cn400216u; Heim R., 2003, THESIS; Higgins GA, 2015, ACS CHEM NEUROSCI, V6, P1071, DOI 10.1021/acschemneuro.5b00025; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hutcheson JD, 2011, PHARMACOL THERAPEUT, V132, P146, DOI 10.1016/j.pharmthera.2011.03.008; Jensen N., 2004, THESIS; Juncosa JI, 2013, ACS CHEM NEUROSCI, V4, P96, DOI 10.1021/cn3000668; Luethi D, 2018, INT J NEUROPSYCHOPH, V21, P926, DOI 10.1093/ijnp/pyy047; Marti-Solano M, 2015, MOL PHARMACOL, V87, P740, DOI 10.1124/mol.114.097022; Moya PR, 2007, J PHARMACOL EXP THER, V321, P1054, DOI 10.1124/jpet.106.117507; Nichols DE, 2016, PHARMACOL REV, V68, P264, DOI 10.1124/pr.115.011478; Nichols DE, 2015, ACS CHEM NEUROSCI, V6, P1165, DOI 10.1021/cn500292d; Peng Y, 2018, CELL, V172, P719, DOI 10.1016/j.cell.2018.01.001; Pogorelov VM, 2017, NEUROPSYCHOPHARMACOL, V42, P2163, DOI 10.1038/npp.2017.52; Preller KH, 2017, CURR BIOL, V27, P451, DOI 10.1016/j.cub.2016.12.030; Rickli A, 2016, EUR NEUROPSYCHOPHARM, V26, P1327, DOI 10.1016/j.euroneuro.2016.05.001; Rickli A, 2015, NEUROPHARMACOLOGY, V99, P546, DOI 10.1016/j.neuropharm.2015.08.034; Roth BL, 1997, J PHARMACOL EXP THER, V280, P576; Shimada I, 2008, BIOORGAN MED CHEM, V16, P3309, DOI 10.1016/j.bmc.2007.12.009; Silva ME, 2011, J COMPUT AID MOL DES, V25, P51, DOI 10.1007/s10822-010-9400-2; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Tan L, 2018, J MED CHEM, V61, P9841, DOI 10.1021/acs.jmedchem.8b00435; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Tirapegui C, 2014, J CHIL CHEM SOC, V59, P2625, DOI 10.4067/S0717-97072014000300022; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807	34	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209804	10.1371/journal.pone.0209804	http://dx.doi.org/10.1371/journal.pone.0209804			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629611	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000033
J	Hamamoto, Y; Honda, D				Hamamoto, Yoko; Honda, Daiske			Nutritional intake of Aplanochytrium (Labyrinthulea, Stramenopiles) from living diatoms revealed by culture experiments suggesting the new prey-predator interactions in the grazing food web of the marine ecosystem	PLOS ONE			English	Article							GENE PHYLOGENY THRAUSTOCHYTRIACEAE; POLYUNSATURATED FATTY-ACIDS; TAXONOMIC REARRANGEMENT; DOCOSAHEXAENOIC ACID; ECTOPLASMIC NETS; SLIME-MOLD; FUNGI; SCHIZOCHYTRIUM; MORPHOLOGY; DIVERSITY	Labyrinthuleans (Labyrinthulea, Stramenopiles) are recognized as decomposers in marine ecosystems but their nutrient sources are not fully understood. We conducted two-membered culture experiments with labyrinthuleans and diatoms to discover where labyrinthuleans obtain their nutrients from. The results showed that Aplanochytrium strains obtained nutrients by consuming living diatoms. Aplanochytrium cells did not release digestive enzymes into the medium, but adhered to diatom cells via the tip of their characteristic ectoplasmic net system to obtain nutrients from them. The chloroplast and cell contents of the diatoms shrank and were absorbed, and then the number of Aplanochytrium cells rapidly increased as multiple aplanospores were released. To estimate the effect of labyrinthulean organisms including Aplanochytrium on marine ecosystem, we explored the dataset generated by the Tara Oceans Project from a wide range of oceanic regions. The average proportion of all labyrinthulean sequences to diatom sequences at each station was about 10%, and labyrinthulids, oblongichytrids, and aplanochytrids were the major constituent genera, accounting for more than 80% of labyrinthuleans. Therefore, these groups are suggested to greatly affect the marine ecosystem. There were positive correlations between aplanochytrids and phototrophs, green algae, and diatoms. At many stations, relatively large proportions of aplanochytrid sequences were detected in the size fraction larger than their cell size. This implied that Aplanochytrium cells increased their particle size by adhering to each other and forming aggregates with diatoms that are captured by larger zooplankton in the environment, thereby bypassing the food web pathway via aplanochytrids to higher predators. The intake of nutrients from diatoms by aplanochytrids represents a newly recognized pathway in the grazing food chain in the marine ecosystem.	[Hamamoto, Yoko] Konan Univ, Grad Sch Nat Sci, Higashinada Ku, Kobe, Hyogo, Japan; [Hamamoto, Yoko; Honda, Daiske] Konan Univ, Inst Integrat Neurobiol, Higashinada Ku, Kobe, Hyogo, Japan; [Honda, Daiske] Konan Univ, Dept Biol, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo, Japan	Konan University; Konan University; Konan University	Honda, D (corresponding author), Konan Univ, Inst Integrat Neurobiol, Higashinada Ku, Kobe, Hyogo, Japan.; Honda, D (corresponding author), Konan Univ, Dept Biol, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo, Japan.	dhonda@konan-u.ac.jp		Honda, Daiske/0000-0002-3436-4561	Japan Society for the Promotion of Science (KAKENHI) [JP17H03855]; Sasakawa Scientific Research Grant from The Japanese Science Society [2018-7046]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant from The Japanese Science Society	This study was financially supported by a grant-in-aid from Japan Society for the Promotion of Science (KAKENHI Grant Number JP17H03855) to D. Honda, and a Sasakawa Scientific Research Grant (2018-7046) from The Japanese Science Society to Y. Hamamoto.; We are grateful to Ayako Gotoh, PhD, Konan University, Hyogo, Japan, who kindly provided valuable suggestions for statistical analyses. We thank members of JEOL Ltd. for material treatments and assistance with the SEM observations. We thank Jennifer Smith, PhD, from Edanz Group (www.edanzediting.com/ac) for editing the English text of drafts of this manuscript. This study was financially supported by a grant-in-aid from Japan Society for the Promotion of Science (KAKENHI Grant Number JP17H03855) to D. Honda, and a Sasakawa Scientific Research Grant (2018-7046) from The Japanese Science Society to Y. Hamamoto.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Anderson OR, 2012, ACTA PROTOZOOL, V51, P291, DOI 10.4467/16890027AP.12.023.0783; BAHNWEG G, 1972, ARCH MIKROBIOL, V81, P45, DOI 10.1007/BF00715023; Bai MH, 2019, MICROB ECOL, V77, P394, DOI 10.1007/s00248-018-1235-8; Bennett R.M., 2017, HDB PROTISTS, P1, DOI DOI 10.1007/978-3-319-32669-6_25-1; Bochdansky AB, 2017, ISME J, V11, P362, DOI 10.1038/ismej.2016.113; Bongiorni L, 2005, AQUAT MICROB ECOL, V41, P299, DOI 10.3354/ame041299; BREMER GB, 1995, BOT MAR, V38, P37, DOI 10.1515/botm.1995.38.1-6.37; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; COLEMAN NK, 1987, CAN J MICROBIOL, V33, P841, DOI 10.1139/m87-147; Collado-Mercado E, 2010, AQUAT MICROB ECOL, V58, P215, DOI 10.3354/ame01361; Damare V, 2006, INDIAN J MAR SCI, V35, P326; Damare V, 2010, MAR ECOL PROG SER, V399, P53, DOI 10.3354/meps08277; Damare VS, 2013, MICROB ECOL, V65, P955, DOI 10.1007/s00248-012-0149-0; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dietz C, 1999, PROTOPLASMA, V206, P97, DOI 10.1007/BF01279256; Doi K, 2017, PHYCOL RES, V65, P188, DOI 10.1111/pre.12175; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; Estudillo-del Castillo C, 2009, AQUACULTURE, V293, P57, DOI 10.1016/j.aquaculture.2009.04.008; Fan K. W., 2000, Fungal Diversity, V5, P185; Fenchel T., 1987, BROCK SPRINGER SERIE, P32, DOI [10.1007/978-3-662-25981-8_3, DOI 10.1007/978-3-662-25981-8_3]; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Furuita H, 1996, FISHERIES SCI, V62, P372, DOI 10.2331/fishsci.62.372; GAERTNER A, 1979, Veroeffentlichungen des Instituts fuer Meeresforschung in Bremerhaven, V18, P29; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hirai J, 2018, PLANKTON BENTHOS RES, V13, P75, DOI 10.3800/pbr.13.75; Honda D, 1999, J EUKARYOT MICROBIOL, V46, P637, DOI 10.1111/j.1550-7408.1999.tb05141.x; Huang JZ, 2003, MAR BIOTECHNOL, V5, P450, DOI 10.1007/s10126-002-0110-1; Hulsemann Kuni, 1994, Invertebrate Taxonomy, V8, P1461, DOI 10.1071/IT9941461; Iwata I, 2018, PROTIST, V169, P727, DOI 10.1016/j.protis.2018.06.002; Iwata I, 2017, PROTIST, V168, P206, DOI 10.1016/j.protis.2016.12.002; IZQUIERDO MS, 1989, NIPPON SUISAN GAKK, V55, P859; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Kaya K, 2011, BIOSCI BIOTECH BIOCH, V75, P2246, DOI 10.1271/bbb.110430; Kimura H, 2001, AQUAT MICROB ECOL, V25, P293, DOI 10.3354/ame025293; Kimura H., 2001, AQUAT ECOSYST HEALTH, V4, P13, DOI DOI 10.1080/146349801753569243; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leander CA, 2004, EUR J PROTISTOL, V40, P317, DOI 10.1016/j.ejop.2004.07.003; Leander CA, 2001, MYCOLOGIA, V93, P459, DOI 10.2307/3761732; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Lewis TE, 1999, MAR BIOTECHNOL, V1, P580, DOI 10.1007/PL00011813; Li Q, 2013, MICROB ECOL, V66, P823, DOI 10.1007/s00248-013-0275-3; Liu Y, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix070; Mansour MP, 1999, J PHYCOL, V35, P710, DOI 10.1046/j.1529-8817.1999.3540710.x; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Moro I, 2003, PROTIST, V154, P331, DOI 10.1078/143446103322454103; MOSS ST, 1985, BOT J LINN SOC, V91, P329, DOI 10.1111/j.1095-8339.1985.tb01154.x; Nagano N, 2011, MAR BIOTECHNOL, V13, P133, DOI 10.1007/s10126-010-9297-8; Naganuma T, 1998, MAR ECOL PROG SER, V162, P105, DOI 10.3354/meps162105; Nakahara T, 1996, J AM OIL CHEM SOC, V73, P1421, DOI 10.1007/BF02523506; Nakai R., 2015, MARINE PROTISTS, P331; Nakai R, 2013, MAR ECOL PROG SER, V486, P1, DOI 10.3354/meps10412; Nakazawa A, 2014, J APPL PHYCOL, V26, P29, DOI 10.1007/s10811-013-0080-x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Ohno M, 1999, BIOSCI BIOTECH BIOCH, V63, P1083, DOI 10.1271/bbb.63.1083; Pan JW, 2017, J EUKARYOT MICROBIOL, V64, P88, DOI 10.1111/jeu.12342; PATTERSON DJ, 1989, SYST ASSOC SPEC VOL, V38, P357; PERKINS FO, 1972, ARCH MIKROBIOL, V84, P95, DOI 10.1007/BF00412431; PERKINS FO, 1973, CAN J BOT, V51, P485, DOI 10.1139/b73-057; PORTER D, 1969, PROTOPLASMA, V67, P1, DOI 10.1007/BF01256763; Porter D., 1990, P388; PORTER D, 1972, PROTOPLASMA, V74, P427, DOI 10.1007/BF01281960; Preston TM, 2005, J EUKARYOT MICROBIOL, V52, P461, DOI 10.1111/j.1550-7408.2005.00064.x; QUICK JA, 1974, T AM MICROSC SOC, V93, P344, DOI 10.2307/3225435; RAGHUKUMAR C, 1986, INDIAN J MAR SCI, V15, P121; RAGHUKUMAR C, 1992, MYCOL RES, V96, P542, DOI 10.1016/S0953-7562(09)80978-7; Raghukumar S, 2001, AQUAT MICROB ECOL, V24, P175, DOI 10.3354/ame024175; RAGHUKUMAR S, 1994, J EXP MAR BIOL ECOL, V183, P113, DOI 10.1016/0022-0981(94)90160-0; Raghukumar S, 1999, MAR ECOL PROG SER, V190, P133, DOI 10.3354/meps190133; Raghukumar S., 2017, FUNGI COASTAL OCEANI, DOI DOI 10.1007/978-3-319-54304-8; Raghukumar S., 1985, MAHASAGAR, V18, P457; Russell NJ, 1999, MICROBIOL-UK, V145, P767, DOI 10.1099/13500872-145-4-767; SHORT FT, 1993, DIS AQUAT ORGAN, V16, P73, DOI 10.3354/dao016073; Song XJ, 2007, FISHERIES SCI, V73, P565, DOI 10.1111/j.1444-2906.2007.01369.x; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; Ueda M, 2015, AQUAT MICROB ECOL, V74, P187, DOI 10.3354/ame01736; ULKEN A, 1985, MAR BIOL, V85, P89, DOI 10.1007/BF00396419; WHYTE SK, 1994, DIS AQUAT ORGAN, V19, P129, DOI 10.3354/dao019129; Yamasaki T, 2007, J BIOSCI BIOENG, V104, P200, DOI 10.1263/jbb.104.200; Yang EJ, 2009, J PLANKTON RES, V31, P647, DOI 10.1093/plankt/fbp014; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0; Yokoyama Rinka, 2007, Mycoscience, V48, P329, DOI 10.1007/s10267-007-0377-1; Yoshimatsu T, 1997, HYDROBIOLOGIA, V358, P153, DOI 10.1023/A:1003161214088; ZHUKOVA NV, 1995, PHYTOCHEMISTRY, V39, P351, DOI 10.1016/0031-9422(94)00913-E; Zuendorf A, 2006, FEMS MICROBIOL ECOL, V58, P476, DOI 10.1111/j.1574-6941.2006.00171.x	92	15	16	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208941	10.1371/journal.pone.0208941	http://dx.doi.org/10.1371/journal.pone.0208941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625142	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400022
J	Yu, X; Dobrikov, M; Keir, ST; Gromeier, M; Pastan, IH; Reisfeld, R; Bigner, DD; Chandramohan, V				Yu, Xin; Dobrikov, Mikhail; Keir, Stephen T.; Gromeier, Matthias; Pastan, Ira H.; Reisfeld, Ralph; Bigner, Darell D.; Chandramohan, Vidyalakshmi			Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors	PLOS ONE			English	Article							IMMUNOTOXIN THERAPY; MELANOMA; PROTEOGLYCAN; ACTIVATION; INHIBITOR; PROMOTES; CELLS; BEVACIZUMAB; EXPRESSION; APOPTOSIS	Standard treatment, unfortunately, yields a poor prognosis for patients with primary or metastatic cancers in the central nervous system, indicating a necessity for novel therapeutic agents. Immunotoxins (ITs) are a class of promising therapeutic candidates produced by fusing antibody fragments with toxin moieties. In this study, we investigated if inherent resistance to IT cytotoxicity can be overcome by rational combination with pro-apoptotic enhancers. Therefore, we combined ITs (9.2.27-PE38KDEL or Mel-14-PE38KDEL) targeting chondroitin sulfate proteoglycan 4 (CSPG4) with a panel of Bcl-2 family inhibitors (ABT-737, ABT-263, ABT-199 [Venetoclax], A-1155463, and S63845) against patient-derived glioblastoma, melanoma, and breast cancer cells/cell lines. In vitro cytotoxicity assays demonstrated that the addition of the ABT compounds, specifically ABT-737, sensitized the different tumors to IT treatment, and improved the IC50 values of 9.2.27-PE38KDEL up to > 1,000-fold. Mechanistic studies using 9.2.27-PE38KDEL and ABT-737 revealed that increased levels of intracellular IT, processed (active) exotoxin, and PARP cleavage correlated with the enhanced sensitivity to the combination treatment. Furthermore, we confirmed the synergistic effect of 9.2.27-PE38KDEL and ABT-737 combination therapy in orthotopic GBM xenograft and cerebral melanoma metastasis models in nude mice. Our study defines strategies for overcoming IT resistance and enhancing specific antitumor cytotoxicity in primary and metastatic brain tumors.	[Yu, Xin; Bigner, Darell D.; Chandramohan, Vidyalakshmi] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Dobrikov, Mikhail; Keir, Stephen T.; Gromeier, Matthias; Bigner, Darell D.; Chandramohan, Vidyalakshmi] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA; [Pastan, Ira H.] NCI, Lab Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Reisfeld, Ralph] Scripps Inst, Dept Immunol & Microbiol, La Jolla, CA USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Scripps Research Institute	Chandramohan, V (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; Chandramohan, V (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA.	vidyalakshmi.chandramohan@duke.edu	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Chandramohan, Vidyalakshmi/0000-0002-0653-3014	National Institutes of Health (NIH) of the United States [P01-5P01CA154291, 1R35CA197264]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Silvian Foundation; NATIONAL CANCER INSTITUTE [P01CA154291, ZIABC008753, R35CA197264] Funding Source: NIH RePORTER	National Institutes of Health (NIH) of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Silvian Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants from the National Institutes of Health (NIH) of the United States: P01-5P01CA154291 (D.D. Bigner) and the Outstanding Investigator Award 1R35CA197264 (D.D. Bigner), Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (I.H. Pastan), and funding from the Silvian Foundation (V.Chandramohan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2018, CELL DEATH DIFFER, V25, P27, DOI 10.1038/cdd.2017.161; Antignani A, 2014, MOL CANCER THER, V13, P1655, DOI 10.1158/1535-7163.MCT-13-0998; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; CARREL S, 1982, HYBRIDOMA, V1, P387, DOI 10.1089/hyb.1.1982.1.387; Chandramohan V, 2013, CLIN CANCER RES, V19, P4717, DOI 10.1158/1078-0432.CCR-12-3891; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; COLAPINTO EV, 1990, CANCER RES, V50, P1822; Giedt RJ, 2014, BIOCONJUGATE CHEM, V25, P2081, DOI 10.1021/bc500433k; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hollevoet K, 2014, J IMMUNOTHER, V37, P8, DOI 10.1097/CJI.0000000000000010; Hsu NC, 2013, BIOCHEM BIOPH RES CO, V441, P514, DOI 10.1016/j.bbrc.2013.10.093; Ira Pastan RH, 2016, NAT REV CANCER, V6, P559; Jane EP, 2013, MOL CANCER THER, V12, P326, DOI 10.1158/1535-7163.MCT-12-0901; Karpel-Massler G, 2017, EXPERT OPIN DRUG DIS, V12, P1031, DOI 10.1080/17460441.2017.1356286; Knechtle SJ, 2001, PHILOS T R SOC B, V356, P681, DOI 10.1098/rstb.2001.0839; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; KURPAD SN, 1995, GLIA, V15, P244, DOI 10.1002/glia.440150306; Leone JP, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0028-8; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; Mattoo AR, 2013, INT J CANCER, V132, P978, DOI 10.1002/ijc.27732; MORGAN AC, 1981, HYBRIDOMA, V1, P27, DOI 10.1089/hyb.1.1981.1.27; Nelson ER, 2016, ONCOTARGET, V7, P84030, DOI 10.18632/oncotarget.12767; PAI LH, 1993, JAMA-J AM MED ASSOC, V269, P78, DOI 10.1001/jama.269.1.78; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Schepisi G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122627; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Tazi K, 2015, CANCER MED-US, V4, P1, DOI 10.1002/cam4.315; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Vogler M, 2010, CLIN CANCER RES, V16, P4217, DOI 10.1158/1078-0432.CCR-10-0777; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Zipfel PA, 2010, ONCOGENE, V29, P4859, DOI 10.1038/onc.2010.224	36	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210608	10.1371/journal.pone.0210608	http://dx.doi.org/10.1371/journal.pone.0210608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625226	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400098
J	Ganan, M; Lorentzen, SB; Agger, JW; Heyward, CA; Bakke, O; Knutsen, SH; Aam, BB; Eijsink, VGH; Gaustad, P; Sorlie, M				Ganan, Monica; Lorentzen, Silje B.; Agger, Jane W.; Heyward, Catherine A.; Bakke, Oddmund; Knutsen, Svein H.; Aam, Berit B.; Eijsink, Vincent G. H.; Gaustad, Peter; Sorlie, Morten			Antifungal activity of well-defined chito-oligosaccharide preparations against medically relevant yeasts	PLOS ONE			English	Article							MOLECULAR-WEIGHT; CANDIDA-ALBICANS; CHITOOLIGOSACCHARIDES; EPIDEMIOLOGY; THERAPY; TARGETS; AGENTS; MODE	Due to their antifungal activity, chitosan and its derivatives have potential to be used for treating yeast infections in humans. However, to be considered for use in human medicine, it is necessary to control and know the chemical composition of the compound, which is not always the case for polymeric chitosans. Here, we analyze the antifungal activity of a soluble and well-defined chito-oligosaccharide (CHOS) with an average polymerization degree (DPn) of 32 and fraction of acetylation (F-A) of 0.15 (C32) on 52 medically relevant yeast strains. Minimal inhibitory concentrations (MIC) varied widely among yeast species, strains and isolates (from > 5000 to < 9.77 mu g mL(-1)) and inhibition patterns showed a time- and dose-dependencies. The antifungal activity was predominantly fungicidal and was inversely proportional to the pH, being maximal at pH 4.5, the lowest tested pH. Furthermore, antifungal effects of CHOS fractions with varying average molecular weight indicated that those fractions with an intermediate degree of polymerization, i.e. DP 31 and 54, had the strongest inhibitory effects. Confocal imaging showed that C32 adsorbs to the cell surface, with subsequent cell disruption and accumulation of C32 in the cytoplasm. Thus, C32 has potential to be used as a therapy for fungal infections.	[Ganan, Monica; Lorentzen, Silje B.; Agger, Jane W.; Aam, Berit B.; Eijsink, Vincent G. H.; Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Ganan, Monica; Gaustad, Peter] Univ Oslo, Inst Clin Med, Dept Microbiol, Oslo, Norway; [Heyward, Catherine A.; Bakke, Oddmund] Univ Oslo, Dept Biosci, Oslo, Norway; [Knutsen, Svein H.] Norwegian Inst Food Fisheries & Aquaculture Res, Nofima, As, Norway	Norwegian University of Life Sciences; University of Oslo; University of Oslo; Nofima	Sorlie, M (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	morten.sorlie@nmbu.no	Agger, Jane Wittrup/G-6783-2017; Agger, Jane Wittrup/AAF-8701-2020	Agger, Jane Wittrup/0000-0002-7796-3089; Agger, Jane Wittrup/0000-0002-7796-3089; Bakke, Oddmund/0000-0003-4843-7626; Ganan, Monica/0000-0001-7277-0029; Sorlie, Morten/0000-0001-7259-6710; Knutsen, Svein Halvor/0000-0002-7012-2965	Research Council of Norway [226280]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway through grant 226280 to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Alburquenque C, 2010, MED MYCOL, V48, P1018, DOI 10.3109/13693786.2010.486412; Bahrke S, 2002, BIOMACROMOLECULES, V3, P696, DOI 10.1021/bm020010n; Bergan T, 1997, SCAND J INFECT DIS, P1; Cederkvist FH, 2008, CARBOHYD POLYM, V74, P41, DOI 10.1016/j.carbpol.2008.01.020; Danby CS, 2012, ANTIMICROB AGENTS CH, V56, P1403, DOI 10.1128/AAC.05025-11; Fostel JM, 2000, DRUG DISCOV TODAY, V5, P25, DOI 10.1016/S1359-6446(99)01430-0; Georgopapadakou NH, 1996, ANTIMICROB AGENTS CH, V40, P279, DOI 10.1128/AAC.40.2.279; Graybill JR, 1997, EUR J CLIN MICROBIOL, V16, P42, DOI 10.1007/BF01575120; Hazen KC, 1998, J AM ACAD DERMATOL, V38, pS37, DOI 10.1016/S0190-9622(98)70482-7; Heilmann CJ, 2013, EUKARYOT CELL, V12, P254, DOI 10.1128/EC.00278-12; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Kasaai MR, 2010, CARBOHYD POLYM, V79, P801, DOI 10.1016/j.carbpol.2009.10.051; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Knaul JZ, 1998, CAN J CHEM, V76, P1699, DOI 10.1139/cjc-76-11-1699; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5; Kyle AA, 2004, AM J CLIN DERMATOL, V5, P443, DOI 10.2165/00128071-200405060-00009; LAMPS CA, 1995, CURR EYE RES, V14, P637, DOI 10.3109/02713689508998490; Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Hernandez-Lauzardo AN, 2011, AFR J MICROBIOL RES, V5, P4243, DOI 10.5897/AJMR11.104; Palma-Guerrero J, 2010, MOL MICROBIOL, V75, P1021, DOI 10.1111/j.1365-2958.2009.07039.x; Palmeira-de-Oliveira A, 2010, GYNECOL OBSTET INVES, V70, P322, DOI 10.1159/000314023; Pena A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/527549; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Rahman MH, 2015, EUR J PLANT PATHOL, V141, P147, DOI 10.1007/s10658-014-0533-3; Rahman MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093192; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Ruhnke M, 2006, CURR DRUG TARGETS, V7, P495, DOI 10.2174/138945006776359421; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Somashekar D, 1996, BIORESOURCE TECHNOL, V55, P35, DOI 10.1016/0960-8524(95)00144-1; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Tayel AA, 2010, INT J BIOL MACROMOL, V47, P454, DOI 10.1016/j.ijbiomac.2010.06.011; Wang QZ, 2006, CARBOHYD POLYM, V65, P194, DOI 10.1016/j.carbpol.2006.01.001; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005	39	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210208	10.1371/journal.pone.0210208	http://dx.doi.org/10.1371/journal.pone.0210208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620751	Green Submitted, Green Published, gold			2022-12-26	WOS:000455161300021
J	Mattingly, TJ; Meninger, S; Heil, EL				Mattingly, T. Joseph, II; Meninger, Stephen; Heil, Emily L.			Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis	PLOS ONE			English	Article							ALLERGY; VANCOMYCIN; HEALTH; RESISTANT; OUTCOMES; VACCINE; IMPACT	Background Beta-lactams are the mainstay for treating methicillin-susceptible Staphylococcus aureus (MSSA) infections complicated by bacteremia due to superior outcomes compared with vancomycin. With approximately 11% of inpatients reporting a penicillin (PCN) allergy, many patients receive suboptimal treatment for MSSA bacteremia. Objective Evaluate the cost-effectiveness of penicillin skin testing (PST) in adult patients with self-reported PCN allergy in an inpatient setting undergoing treatment for MSSA bacteremia. Methods A decision analytic model was developed comparing an acute care PST intervention to a scenario with no confirmatory allergy testing. The primary outcome was the incremental cost-effectiveness ratio (ICER) from the health-sector perspective over a 1-year time horizon using quality-adjusted life years (QALYs) as the measure for effectiveness. One-way and probabilistic sensitivity analyses were conducted to assess the uncertainty of the ICER estimation. Results Over a 1-year time horizon, PST services applied to all MSSA bacteremia patients reporting a PCN-allergy would result in a cost per patient of $12,559 and 0.73 QALYs while no PST services would have a higher cost per patient of $13,219 and 0.66 QALYs per patient. This resulted in a cost-effectiveness estimate of -$9,429 per QALY gained. Varying the cost of implementing PST services determined a break-even point of $959.98 where any PST cost less than this amount would actually be cost saving. Conclusions Patients reporting a PCN allergy on admission may receive sub-optimal alternative therapies to beta-lactams, such as vancomycin, for MSSA bacteremia. This economic analysis demonstrates that inpatient PST services confirming PCN allergy are cost-effective for patients with MSSA bacteremia.	[Mattingly, T. Joseph, II; Meninger, Stephen; Heil, Emily L.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Mattingly, TJ (corresponding author), Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA.	jmattingly@rx.umaryland.edu	Mattingly, T. Joseph/C-9368-2014	Mattingly, T. Joseph/0000-0001-7786-5780	ALK, Inc.	ALK, Inc.	This study was supported by an unrestricted educational grant by ALK, Inc. The funding source had no role in the design and conduct of the study; collection, management, and analysis of the data; or preparation, review, and approval of the manuscript.	Abbo LM, 2013, JAMA INTERN MED, V173, P1376, DOI 10.1001/jamainternmed.2013.6480; Bennett JE, 2000, ARCH PEDIAT ADOL MED, V154, P43; Blumenthal KG, 2015, CLIN INFECT DIS, V61, P741, DOI 10.1093/cid/civ394; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094; Flabbee J, 2008, ALLERGY, V63, P360, DOI 10.1111/j.1398-9995.2007.01513.x; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; Heil EL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw155; Jones BM, 2017, AM J HEALTH-SYST PH, V74, P232, DOI 10.2146/ajhp160233; Kamiya H, 2016, VACCINE, V34, P1832, DOI 10.1016/j.vaccine.2016.02.027; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; King EA, 2016, ANN ALLERG ASTHMA IM, V117, P67, DOI 10.1016/j.anai.2016.04.021; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Li M, 2014, J CLIN PATHOL, V67, P1088, DOI 10.1136/jclinpath-2014-202438; Macy E, 1998, J ALLERGY CLIN IMMUN, V102, P281, DOI 10.1016/S0091-6749(98)70097-1; Macy E, 2015, CURR OPIN ALLERGY CL, V15, P308, DOI 10.1097/ACI.0000000000000173; Mattingly TJ, 2018, J ALLER CL IMM-PRACT, V6, P1649, DOI 10.1016/j.jaip.2017.12.033; McComb MN, 2014, PHARMACOTHERAPY, V34, P537, DOI 10.1002/phar.1393; McDanel JS, 2015, CLIN INFECT DIS, V61, P361, DOI 10.1093/cid/civ308; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mostofsky E, 2011, J ANTIMICROB CHEMOTH, V66, P2199, DOI 10.1093/jac/dkr278; Narayanan PP, 2017, ANN PHARMACOTHER, V51, P504, DOI 10.1177/1060028017690854; Neumann PJ, 2018, VALUE HEALTH, V21, P119, DOI 10.1016/j.jval.2017.12.012; Sade K, 2003, CLIN EXP ALLERGY, V33, P501, DOI 10.1046/j.1365-2222.2003.01638.x; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Satta Giovanni, 2013, Clin Mol Allergy, V11, P2, DOI 10.1186/1476-7961-11-2; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Shiragami M, 2015, INFECT DIS THER, V4, P93, DOI 10.1007/s40121-014-0053-7; Slover JD, 2015, J ARTHROPLASTY, V30, P543, DOI 10.1016/j.arth.2014.11.001; SOGN DD, 1992, ARCH INTERN MED, V152, P1025, DOI 10.1001/archinte.152.5.1025; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386; Tice AD, 2004, CLIN INFECT DIS, V38, P1651, DOI 10.1086/420939; Wall GC, 2004, AM J HEALTH-SYST PH, V61, P1271, DOI 10.1093/ajhp/61.12.1271; Wong D, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0143-3	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210271	10.1371/journal.pone.0210271	http://dx.doi.org/10.1371/journal.pone.0210271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615655	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900056
J	O'Neill, B; Kalia, S; Aliarzadeh, B; Moineddin, R; Fung, WLA; Sullivan, F; Maloul, A; Bernard, S; Greiver, M				O'Neill, Braden; Kalia, Sumeet; Aliarzadeh, Babak; Moineddin, Rahim; Fung, Wai Lun Alan; Sullivan, Frank; Maloul, Asmaa; Bernard, Steven; Greiver, Michelle			Agreement between primary care and hospital diagnosis of schizophrenia and bipolar disorder: A cross-sectional, observational study using record linkage	PLOS ONE			English	Article							SURVEILLANCE; MORTALITY; ILLNESS; COHORT	People with serious mental illness die 10-25 years sooner than people without these conditions. Multiple challenges to accessing and benefitting from healthcare have been identified amongst this population, including a lack of coordination between mental health services and general health services. It has been identified in other conditions such as diabetes that accurate documentation of diagnosis in the primary care chart is associated with better quality of care. It is suspected that if a patient admitted to the hospital with serious mental illness is then discharged without adequate identification of their diagnosis in the primary care setting, follow up (such as medication management and care coordination) may be more difficult. We identified cohorts of patients with schizophrenia and bipolar disorder who accessed care through the North York Family Health Team (a group of 77 family physicians in Toronto, Canada) and North York General Hospital (a large community hospital) between January 1, 2012 and December 31, 2014. We identified whether labeling for these conditions was concordant between the two settings and explored predictors of concordant labeling. This was a retrospective cross-sectional study using de-identified data from the Health Databank Collaborative, a linked primary care-hospital database. We identified 168 patients with schizophrenia and 370 patients with bipolar disorder. Overall diagnostic concordance between primary care and hospital records was 23.2% for schizophrenia and 15.7% for bipolar disorder. Concordance was higher for those with multiple (2+) inpatient visits (for schizophrenia: OR 2.42; 95% CI 0.64-9.20 and for bipolar disorder: OR 8.38; 95% CI 3.16-22.22). Capture-recapture modeling estimated that 37.4% of patients with schizophrenia (95% CI 20.7-54.1) and 39.6% with bipolar disorder (95% CI 25.7-53.6) had missing labels in both settings when adjusting for patients' age, sex, income quintiles and co-morbidities. In this sample of patients accessing care at a large family health team and community hospital, concordance of diagnostic information about serious mental illness was low. Interventions should be developed to improve diagnosis and continuity of care across multiple settings.	[O'Neill, Braden; Sullivan, Frank; Greiver, Michelle] North York Gen Hosp, Dept Family & Community Med, Toronto, ON, Canada; [O'Neill, Braden; Moineddin, Rahim; Greiver, Michelle] Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada; [O'Neill, Braden; Kalia, Sumeet; Aliarzadeh, Babak; Sullivan, Frank; Greiver, Michelle] Univ Toronto, Practice Based Res Network, Toronto, ON, Canada; [Kalia, Sumeet; Aliarzadeh, Babak] North York Gen Hosp, Res & Innovat, Toronto, ON, Canada; [Fung, Wai Lun Alan] North York Gen Hosp, Dept Psychiat, Toronto, ON, Canada; [Fung, Wai Lun Alan] Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada; [Sullivan, Frank] Univ St Andrews, Sch Med, St Andrews, Scotland; [Maloul, Asmaa; Bernard, Steven] North York Gen Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of St Andrews; University of Toronto; University Toronto Affiliates; North York General Hospital	O'Neill, B (corresponding author), North York Gen Hosp, Dept Family & Community Med, Toronto, ON, Canada.; O'Neill, B (corresponding author), Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada.; O'Neill, B (corresponding author), Univ Toronto, Practice Based Res Network, Toronto, ON, Canada.	braden.oneill@nygh.on.ca	Sullivan, Frank/L-8286-2019	Sullivan, Frank/0000-0002-6623-4964	North York General Hospital; North York General Hospital, as part of the development and implementation of the Health Databank Collaborative; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto	North York General Hospital(University of Toronto); North York General Hospital, as part of the development and implementation of the Health Databank Collaborative; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto	Support for this project was provided by North York General Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was reviewed and approved by the Research Ethics Board of North York General Hospital, Toronto, Ontario. It was funded by North York General Hospital, as part of the development and implementation of the Health Databank Collaborative. Drs. O'Neill and Greiver hold Investigator awards from the Department of Family and Community Medicine, Faculty of Medicine, University of Toronto. Dr. Greiver is supported by a research stipend from North York General Hospital. All authors declare that they have no conflicts of interest to disclose with respect to this study.	Agency for Healthcare Research and Quality, 2014, TOOLK IMPL CHRON CAR; An J, 2015, STUD HEALTH TECHNOL, V208, P45, DOI 10.3233/978-1-61499-488-6-45; Birtwhistle R, 2009, J AM BOARD FAM MED, V22, P412, DOI 10.3122/jabfm.2009.04.090081; Birtwhistle RV, 2011, CAN FAM PHYSICIAN, V57, P1219; Canadian Institute for Health Information, 2017, NAT AMB CAR REP SYST; Canadian Institute for Health Information, 2017, ONT MENT HLTH REP SY; College of Physicians and Surgeons of Ontario, 2012, MED REC POL STAT 4 1, P4; Davydow DS, 2016, MED CARE, V54, P90, DOI 10.1097/MLR.0000000000000448; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Gatov E, 2017, CAN MED ASSOC J, V189, pE1177, DOI 10.1503/cmaj.161351; Greiver M, 2018, NPJ PRIM CARE RESP M, V28, DOI 10.1038/s41533-018-0076-8; Hayes JF, 2017, BRIT J PSYCHIAT, V211, P175, DOI 10.1192/bjp.bp.117.202606; Health Canada, 2012, SCHIZ REP MENT ILLN; Health Canada, 2012, REPORT MENTAL ILLNES; Healthcare Information and Management Systems Society, 2016, NON TRADITIONAL REF; Jacobs R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1107-6; Kurdyak P, 2015, CAN J PSYCHIAT, V60, P362, DOI 10.1177/070674371506000805; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Molina-Ortiz EI, 2012, MT SINAI J MED, V79, P475, DOI 10.1002/msj.21328; Pampalon R, 2009, CHRONIC DIS CAN, V29, P178; Payne RA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000723; Queenan JA, 2016, CMAJ OPEN, V4, pE2; Revilla-Lopez C, 2016, ATEN PRIM, V48, P244, DOI 10.1016/j.aprim.2015.06.002; Rhodes A, 2006, PRIMARY CARE ONTARIO; Schoepf D, 2014, EUR ARCH PSY CLIN N, V264, P3, DOI 10.1007/s00406-013-0436-x; Slomp M, 2009, CAN J PSYCHIAT, V54, P199, DOI 10.1177/070674370905400308; Stukel Therese A, 2013, Open Med, V7, pe40; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wilkins R, 1993, Health Rep, V5, P157; Williamson T, 2014, ANN FAM MED, V12, P367, DOI 10.1370/afm.1644	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210214	10.1371/journal.pone.0210214	http://dx.doi.org/10.1371/journal.pone.0210214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615653	Green Published, gold			2022-12-26	WOS:000455045900053
J	Yoo, S; Lee, Y; Park, J; Cho, SY; Cho, MC; Jeong, H; Son, H				Yoo, Sangjun; Lee, Youkyung; Park, Juhyun; Cho, Sung Yong; Cho, Min Chul; Jeong, Hyeon; Son, Hwancheol			Voided volume < 150 mL on initial uroflowmetry in men with storage symptoms: Is it an unreliable test result or a sign of severe storage symptoms?	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; BLADDER OUTLET OBSTRUCTION; RESIDUAL URINE; MANAGEMENT; VALUES	Purpose To assess the utility of voided volume on initial uroflowmetry in predicting symptom severity in men with storage symptoms. In addition, we assessed the probability that men would show a voided volume of >= 150 mL on uroflowmetry if the examination is repeated. Methods Between 2016 and 2017, 352 men with storage symptoms were enrolled in the study. The patients completed the frequency-volume chart and were divided into four groups based on the voided volume. A multivariate analysis was performed to determine the variables affecting voided volume. Results The VV was < 68.8 mL in 88 patients (25.0%), 68.9-150 in 89 (25.3%), 150-250 in 87 (24.7%), and >= 250 in 88 (25.0%) patients. Although the International Prostate Symptom Score did not differ among the groups, the storage subscore was significantly higher in patients with decreased voided volume (p = 0.010). The total number of voids was greater in patients with decreased voided volume (p < 0.001), as was the number of nocturnal voids (p = 0.007). The maximum voided volume (p < 0.001) and 24-h urine output (p = 0.003) decreased as voided volume decreased. The proportions of patients with a mean daytime urine output >= 150 mL were 30.1%, 43.0%, 64.7%, and 66.7% in each group, respectively (p < 0.001). Older age and decreased maximum voided volume significantly affected the voided volume on initial uroflowmetry. Conclusions A decreased voided volume on initial uroflowmetry may be a sign of severe storage symptoms in men. This finding is related to older age and decreased functional capacity. In these patients, it is better to perform a careful clinical assessment to diagnose and treat overactive bladder.	[Yoo, Sangjun; Lee, Youkyung; Park, Juhyun; Cho, Sung Yong; Cho, Min Chul; Jeong, Hyeon; Son, Hwancheol] Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea; [Jeong, Hyeon; Son, Hwancheol] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Son, H (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea.; Son, H (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	volley@snu.ac.kr	CHO, MIN CHUL/R-7835-2019; Yoo, Sangjun/AAQ-5385-2021	Yoo, Sangjun/0000-0003-4992-7053				Abrams P, 2013, J UROLOGY, V189, pS93, DOI 10.1016/j.juro.2012.11.021; Abrams P, 1999, BJU INT, V84, P14; BARRY MJ, 1995, J UROLOGY, V153, P99, DOI 10.1097/00005392-199501000-00036; Blake-James BT, 2007, BJU INT, V99, P85, DOI 10.1111/j.1464-410X.2006.06574.x; Blanker MH, 2001, UROLOGY, V57, P1093, DOI 10.1016/S0090-4295(01)00988-8; Blanker MH, 2001, UROLOGY, V57; Bradley CS, 2017, J UROLOGY, V198, P1010, DOI 10.1016/j.juro.2017.04.097; Chrzan R, 2005, EUR J PEDIATR SURG, V15, P26, DOI 10.1055/s-2004-830551; Dani H, 2016, NAT REV UROL, V13, P573, DOI 10.1038/nrurol.2016.134; DRACH GW, 1979, J UROLOGY, V122, P210, DOI 10.1016/S0022-5347(17)56333-8; Herschorn S, 2017, UROLOGY, V106, P55, DOI 10.1016/j.urology.2017.04.016; JORGENSEN JB, 1986, BRIT J UROL, V58, P390, DOI 10.1111/j.1464-410X.1986.tb09092.x; Kaplan SA, 2008, J UROLOGY, V180, P47, DOI 10.1016/j.juro.2008.03.027; Kaplan SA, 2016, J UROLOGY, V196, P1713, DOI 10.1016/j.juro.2016.09.019; McNeill SA, 2001, UROLOGY, V57, P459, DOI 10.1016/S0090-4295(00)01021-9; Oelke M, 2008, EUR UROL, V54, P419, DOI 10.1016/j.eururo.2008.02.017; Oh CY, 2010, YONSEI MED J, V51, P248, DOI 10.3349/ymj.2010.51.2.248; Ojewola RW, 2016, WORLD J MENS HEALTH, V34, P200, DOI 10.5534/wjmh.2016.34.3.200; Ozgur BC, 2014, J PAK MED ASSOC, V64, P252; Tong YC, 2006, NEUROUROL URODYNAM, V25, P8, DOI 10.1002/nau.20163; van Haarst EP, 2004, BJU INT, V93, P1257, DOI 10.1111/j.1464-4096.2004.04821.x; van Haarst EP, 2014, NEUROUROL URODYNAM, V33, P296, DOI 10.1002/nau.22410	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0207208	10.1371/journal.pone.0207208	http://dx.doi.org/10.1371/journal.pone.0207208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615618	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900005
J	Traore, K; Konate, S; Thera, MA; Niangaly, A; Ba, A; Niare, A; Arama, C; Di Cristofaro, J; Baby, M; Picot, S; Chiaroni, J; Boetsch, G; Doumbo, OK				Traore, Karim; Konate, Salimata; Thera, Mahamadou A.; Niangaly, Amadou; Ba, Alhassane; Niare, Alassane; Arama, Charles; Di Cristofaro, Julie; Baby, Mounirou; Picot, Stephane; Chiaroni, Jacques; Boetsch, Gilles; Doumbo, Ogobara K.			Genetic polymorphisms with erythrocyte traits in malaria endemic areas of Mali	PLOS ONE			English	Article							ETHNIC-GROUPS; DIVERSITY; RH; TRANSFUSION; INFECTIONS; HISTORY; FULANI	African populations are characterized by high degree of genetic diversity. This high genetic diversity could result from the natural selection pressure. Several studies have described an association between some genetic diversities and difference of susceptibility to infectious diseases like malaria. It seems therefore important to consider genetic diversity impact when interpreting results of clinical trials in malaria endemic areas. This study aimed to determine the genetic polymorphism with erythrocyte traits in different populations of malaria endemic area in Mali. The cross-sectional surveys were carried out in different ethnic groups living in malaria endemic areas in Mali. Six milliliters of whole blood were collected in EDTA vials from each participant after informed consent has been obtained. The ABO, RH, Kell, MNSs, Kidd and Duffy systems phenotypes were assessed by the technique of gel filtration. A total of 231 subjects were included from six villages. The blood groups phenotypes O (40.7%) and A (31.2%) were more frequent with respective allele frequencies of 0.65 and 0.21. In the RH system the haplotypes R0 (0.55), r (0.20) and R1 (0.13) were the most frequent. Seven percent (7%) of Duffy positive and 4% of Glycophorin B deficiency (S-s-) were observed among participants. All participants were Kell negative. ABO and RH systems were polymorphic in these ethnic groups in Mali. Their implication in susceptibility to malaria should be taken into account in clinical trials interpretation, and for prevention of blood transfusion risks during anemia frequently caused by malaria in children.	[Traore, Karim; Konate, Salimata; Thera, Mahamadou A.; Niangaly, Amadou; Niare, Alassane; Arama, Charles; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, UMI3189, DEAP FMPOS, Malaria Res & Training Ctr, Bamako, Mali; [Traore, Karim; Picot, Stephane] Univ Lyon, Univ Claude Bernard Lyon 1, Inst Chim & Biochim Mol & Supramol, UMR 5246 CNRS INSA CPE,Malaria Res Unit, Lyon, France; [Traore, Karim; Thera, Mahamadou A.; Boetsch, Gilles; Doumbo, Ogobara K.] Univ Cheikh Anta Diop, CNRST UGB UCAD, CNRS USTTB, Unite Mixte Int UMI 3189 Environm Sante Soc, Dakar, Senegal; [Ba, Alhassane; Baby, Mounirou] Ctr Natl Transfus Sanguine, Bamako, Mali; [Di Cristofaro, Julie; Chiaroni, Jacques] Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); University of Science & Technology of Bamako; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University Cheikh Anta Diop Dakar; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Traore, K (corresponding author), Univ Sci Tech & Technol Bamako, UMI3189, DEAP FMPOS, Malaria Res & Training Ctr, Bamako, Mali.; Traore, K (corresponding author), Univ Lyon, Univ Claude Bernard Lyon 1, Inst Chim & Biochim Mol & Supramol, UMR 5246 CNRS INSA CPE,Malaria Res Unit, Lyon, France.; Traore, K (corresponding author), Univ Cheikh Anta Diop, CNRST UGB UCAD, CNRS USTTB, Unite Mixte Int UMI 3189 Environm Sante Soc, Dakar, Senegal.	karim@icermali.org	picot, stephane/F-5973-2014; Chiaroni, Jacques/ABA-2944-2021	picot, stephane/0000-0002-5735-6759; Chiaroni, Jacques/0000-0002-3133-8990; Thera, Mahamadou A/0000-0002-2679-035X; Di Cristofaro, Julie/0000-0001-7867-6455; Traore, Karim/0000-0002-9553-6611	Etablissement Francais du Sang EFS-Marseille; Malaria Research and Training Center [UMI 3189]	Etablissement Francais du Sang EFS-Marseille; Malaria Research and Training Center	This work was supported by Etablissement Francais du Sang EFS-Marseille and Malaria Research and Training Center (UMI 3189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Arama C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018319; Band G, 2015, NATURE, V526, P253, DOI 10.1038/nature15390; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Chiaroni J, 2005, GROUPES SANGUINS ERY; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Crubezy E, 2008, ANTHOPOBIOLOGIE, V7; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Diarra AB, 2013, TRANSFUS CLIN BIOL, V20, P476, DOI 10.1016/j.tracli.2013.04.111; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393; Israelsson E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-136; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lokki AI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-9; Mellal PDB, 2008, LEBAN SCI J, V9, P17; Niangaly A, 2017, AM J TROP MED HYG, V97, P744, DOI 10.4269/ajtmh.17-0254; Noizat-Pirenne F, 2011, TRANSFUS CLIN BIOL, V18, P527, DOI 10.1016/j.tracli.2011.09.001; PASVOL G, 1983, CIBA F SYMP, V94, P174; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2009, CURR OPIN HEMATOL, V16, P480, DOI 10.1097/MOH.0b013e3283313de0; Santovito A, 2009, INT J IMMUNOGENET, V36, P189, DOI 10.1111/j.1744-313X.2009.00842.x; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wagner FF, 2002, BLOOD, V99, P2272, DOI 10.1182/blood-2001-12-0153	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209966	10.1371/journal.pone.0209966	http://dx.doi.org/10.1371/journal.pone.0209966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608964	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800033
J	Wang, CY; Zhu, GM; He, WY; Yin, HB; Lin, F; Gou, X; Li, XY				Wang, Chenyang; Zhu, Gongmin; He, Weiyang; Yin, Hubin; Lin, Fan; Gou, Xin; Li, Xinyuan			BMSCs protect against renal ischemia-reperfusion injury by secreting exosomes loaded with miR-199a-5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages	FASEB JOURNAL			English	Article						miRNA; I/R injury; time dependence	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; EXTRACELLULAR VESICLES; LIVER ISCHEMIA; ER STRESS; KIDNEY; ACTIVATION; TRANSPLANTATION; COMBINATION; APOPTOSIS	Bone marrow-derived mesenchymal stem cells (BMSCs) have been recently reported to play a variety of vital roles in organ and tissue damage repair, mainly via potent paracrine activity, including secreting extracellular vesicles, such as exosomes, that serve as mediators facilitating intercellular communication and reprogramming recipient cells by delivering their contents to target cells. However, the underlying mechanisms are diverse and complex, and the influencing characteristics have rarely been studied. Accordingly, we designed this study to explore the time dependence of the effects of exosomes derived from BMSCs (BMexos) on renal ischemia-reperfusion (I/R) injury and the underlying mechanisms associated with the reperfusion time. Impressively, our study is the first to find that BMexos protected against renal I/R injury in vitro and in vivo at the very early reperfusion stages, especially 4-8 h after reperfusion in vitro and 8-16 h after reperfusion in vivo. Interestingly, we simultaneously found that endoplasmic reticulum (ER) stress was significantly suppressed following the administration of BMexos in vitro and in vivo with a similar time dependence. Additionally, we discovered that miR-199a-5p, which was abundant in the BMSCs, was transferred into renal tubular epithelial cells (NRK-52E) in a time-dependent manner and significantly inhibited I/R-induced ER stress by targeting binding immunoglobulin protein (BIP). Cocultivation with miR-199a-5p-overexpressing BMSCs amplified the suppression of ER stress and further protected against I/R injury. However, coculture with miR-199a-5p-knockdown BMSCs obviously increased ER stress and reversed the BMexos-induced protection, and silencing BIP by small interfering RNA-1098 in NRK-52E inhibited these effects. This study provides evidence that administering BMexos at the very early reperfusion stages significantly protects against renal I/R injury, and ER stress is closely linked to this protection. These results suggest a novel therapeutic strategy during the very early reperfusion stages of renal I/R injury.	[Wang, Chenyang; Zhu, Gongmin; He, Weiyang; Yin, Hubin; Lin, Fan; Gou, Xin; Li, Xinyuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Wang, Chenyang; Zhu, Gongmin; Yin, Hubin; Lin, Fan; Li, Xinyuan] Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China; [Wang, Chenyang] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China	Chongqing Medical University; Sun Yat Sen University	Gou, X; Li, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, 1 Youyi Rd, Chongqing 400016, Peoples R China.	gouxincq@163.com; urologyxinyuan@163.com		Wang, Chenyang/0000-0003-3345-5725	Natural Science Foundation of Chongqing [cstc2015shmszx10014, cstc2016jcyjA0042]	Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	The authors thank Professors Xin Gou, Weiyang He, and Jie Li of The First Affiliated Hospital of Chongqing Medical University for providing technical support. This study was funded by the Natural Science Foundation of Chongqing (Grants cstc2015shmszx10014 and cstc2016jcyjA0042). The authors declare no conflicts of interest.	Amarnath S, 2015, STEM CELLS, V33, P1200, DOI 10.1002/stem.1934; Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Bao CF, 2015, CELL PHYSIOL BIOCHEM, V37, P901, DOI 10.1159/000430217; Beiral HJV, 2014, CELL TRANSPLANT, V23, P207, DOI 10.3727/096368912X659862; Bi LY, 2015, EXP THER MED, V10, P851, DOI 10.3892/etm.2015.2592; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chung YS, 2011, CHINESE J PHYSIOL, V54, P205, DOI 10.4077/CJP.2011.AMM078; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; Dai Y, 2017, BEHAV BRAIN RES, V332, P99, DOI 10.1016/j.bbr.2017.05.055; Deng MY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00205; Galluzzi L, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0020; Gu D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2093940; Guzel E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040792; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hu JQ, 2017, AM J TRANSL RES, V9, P79; Leng SL, 2008, NEUROSCI LETT, V448, P282, DOI 10.1016/j.neulet.2008.10.016; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lin KC, 2016, INT J CARDIOL, V216, P173, DOI 10.1016/j.ijcard.2016.04.061; Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618; Liu DX, 2017, MOL NEUROBIOL, V54, P5440, DOI 10.1007/s12035-016-0079-9; Liu L, 2012, CONTEMPORARY INNOVATION AND DEVELOPMENT IN STATISTICAL SCIENCE, P92; Mann MI, 2006, CANCER BIOL THER, V5, P736, DOI 10.4161/cbt.5.7.2969; MCDOUGAL WS, 1988, J UROLOGY, V140, P1325, DOI 10.1016/S0022-5347(17)42037-4; Mead B, 2017, STEM CELL TRANSL MED, V6, P1273, DOI 10.1002/sctm.16-0428; Minasyan L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1675230; Parra C, 2010, TRANSPL P, V42, P245, DOI 10.1016/j.transproceed.2009.11.018; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Shi DY, 2017, GUT, V66, P955, DOI 10.1136/gutjnl-2015-311146; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Takahashi Y, 2017, METHODS MOL BIOL, V1660, P245, DOI 10.1007/978-1-4939-7253-1_20; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Taniguchi M, 2015, CURR OPIN NEPHROL HY, V24, P345, DOI 10.1097/MNH.0000000000000141; Umezu T, 2017, BLOOD ADV, V1, P812, DOI 10.1182/bloodadvances.2016003251; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Wang JH, 2015, ONCOTARGET, V6, P43992, DOI 10.18632/oncotarget.6083; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wang Rulin, 2014, Zhonghua Yi Xue Za Zhi, V94, P3298; Wu H, 2016, INT J CARDIOL, V208, P65, DOI 10.1016/j.ijcard.2016.01.119; Zhang C, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00029; Zhu J, 2015, TRANSPL P, V47, P1646, DOI 10.1016/j.transproceed.2015.05.013	46	50	50	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5440	5456		10.1096/fj.201801821R	http://dx.doi.org/10.1096/fj.201801821R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640521	Bronze			2022-12-26	WOS:000462888500065
J	Wang, XH; Chen, QQ; Yi, S; Liu, QY; Zhang, RR; Wang, P; Qian, TM; Li, SY				Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying			The microRNAs let-7 and miR-9 down-regulate the axon-guidance genes Ntn1 and Dcc during peripheral nerve regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; microRNA (miRNA); regeneration; Schwann cells; neuron; translation regulation; deleted in colorectal carcinoma; let-7; miR-9; Netrin-1; peripheral nerve regeneration	SCIATIC-NERVE; EXPRESSION; NETRIN-1; DEADENYLATION; MIRNA; MIGRATION; GROWTH; CANCER; UNC5	Axon guidance helps growing neural axons to follow precise paths to reach their target locations. It is a critical step for both the formation and regeneration of neuronal circuitry. Netrin-1 (Ntn1) and its receptor, deleted in colorectal carcinoma (Dcc) are essential factors for axon guidance, but their regulation in this process is incompletely understood. In this study, using quantitative real-time RT-PCR (qRT-PCR) and biochemical and reporter gene assays, we found that the Ntn1 and Dcc genes are both robustly up-regulated in the sciatic nerve stump after peripheral nerve injury. Moreover, we found that the microRNA (miR) let-7 directly targets the Ntn1 transcript by binding to its 3-untranslated region (3-UTR), represses Ntn1 expression, and reduces the secretion of Ntn1 protein in Schwann cells. We also identified miR-9 as the regulatory miRNA that directly targets Dcc and found that miR-9 down-regulates Dcc expression and suppresses the migration ability of Schwann cells by regulating Dcc abundance. Functional examination in dorsal root ganglion neurons disclosed that let-7 and miR-9 decrease the protein levels of Ntn1 and Dcc in these neurons, respectively, and reduce axon outgrowth. Moreover, we identified a potential regulatory network comprising let-7, miR-9, Ntn1, Dcc, and related molecules, including the RNA-binding protein Lin-28 homolog A (Lin28), SRC proto-oncogene nonreceptor tyrosine kinase (Src), and the transcription factor NF-B. In summary, our findings reveal that the miRs let-7 and miR-9 are involved in regulating neuron pathfinding and extend our understanding of the regulatory pathways active during peripheral nerve regeneration.	[Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nanjing 226001, Jiangsu, Peoples R China; [Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying] Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Nanjing 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Li, SY (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nanjing 226001, Jiangsu, Peoples R China.	lisy0379@ntu.edu.cn	Yi, Sheng/AAA-6017-2020	Yi, Sheng/0000-0003-1316-3370; Liu, Qianyan/0000-0003-2818-8511	National Key RAMP;D Program of China [2017YFA0104703]; National Key Research and Development Program of China [31730031]; Collegiate Natural Science Fund of Jiangsu Province [16KJA310005]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Nantong Grant [MS12017015-2]; Postgraduate Research AMP; Practice Innovation Program of Jiangsu Province [KYCX18-2398]	National Key RAMP;D Program of China; National Key Research and Development Program of China; Collegiate Natural Science Fund of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Nantong Grant; Postgraduate Research AMP; Practice Innovation Program of Jiangsu Province	This work was supported by National Key R&D Program of China Grant 2017YFA0104703, National Key Research and Development Program of China Grant 31730031, Collegiate Natural Science Fund of Jiangsu Province Grant 16KJA310005, the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Natural Science Foundation of Nantong Grant MS12017015-2, and Postgraduate Research & Practice Innovation Program of Jiangsu Province Grant KYCX18-2398. The authors declare that they have no conflicts of interest with the contents of this article.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basu A, 2017, P NATL ACAD SCI USA, V114, pE10206, DOI 10.1073/pnas.1704372114; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; Cai Yan, 2011, Chinese Medical Sciences Journal, V26, P175; Cheng XL, 2015, NEURAL REGEN RES, V10, P1663, DOI 10.4103/1673-5374.167767; da Silva TF, 2014, J CLIN INVEST, V124, P2560, DOI 10.1172/JCI72063; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Faria AM, 2015, CLIN ENDOCRINOL, V82, P481, DOI 10.1111/cen.12607; Flamand MN, 2016, NUCLEIC ACIDS RES, V44, P5924, DOI 10.1093/nar/gkw276; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Han L, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-40; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Iyer AN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00078; Jiang JJ, 2017, MOL PAIN, V13, DOI 10.1177/1744806917711612; Kefeli U, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698388; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Li SY, 2017, MOL NEUROBIOL, V54, P4379, DOI 10.1007/s12035-016-9965-4; Li SY, 2017, ENGINEERING-PRC, V3, P3, DOI 10.1016/J.ENG.2017.01.005; Li SY, 2015, MOL THER, V23, P423, DOI 10.1038/mt.2014.220; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Li SY, 2011, SCI CHINA LIFE SCI, V54, P806, DOI 10.1007/s11427-011-4213-7; Liu S, 2014, J CELL BIOCHEM, V115, P1368, DOI 10.1002/jcb.24786; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; Mediero A, 2016, FASEB J, V30, P3835, DOI 10.1096/fj.201600615R; Moon C, 2006, J NEUROIMMUNOL, V172, P66, DOI 10.1016/j.jneuroim.2005.11.002; Namgung U, 2014, CELLS TISSUES ORGANS, V200, P6, DOI 10.1159/000370324; O'Donnell MP, 2013, J NEUROSCI, V33, P305, DOI 10.1523/JNEUROSCI.2756-12.2013; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Poliak S, 2015, ELIFE, V4, DOI 10.7554/eLife.10841; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Wang XD, 2013, NEURAL REGEN RES, V8, P64, DOI 10.3969/j.issn.1673-5374.2013.01.008; Wu D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00055; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; Yi S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00022; Yi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29121; Yi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143491; Zhou SL, 2014, J CELL SCI, V127, P967, DOI 10.1242/jcs.131672	46	31	31	3	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3489	3500		10.1074/jbc.RA119.007389	http://dx.doi.org/10.1074/jbc.RA119.007389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30626732	hybrid, Green Published			2022-12-26	WOS:000461853900016
J	Platten, JD; Cobb, JN; Zantua, RE				Damien Platten, John; Nathaniel Cobb, Joshua; Zantua, Rochelle E.			Criteria for evaluating molecular markers: Comprehensive quality metrics to improve marker-assisted selection	PLOS ONE			English	Article							BLAST RESISTANCE GENES; GRAIN-YIELD; MICROSATELLITE MARKERS; RICE; QTL; DROUGHT	Despite strong interest over many years, the usage of quantitative trait loci in plant breeding has often failed to live up to expectations. A key weak point in the utilisation of QTLs is the "quality" of markers used during marker-assisted selection (MAS): unreliable markers result in variable outcomes, leading to a perception that MAS products fail to achieve reliable improvement. Most reports of markers used for MAS focus on markers derived from the mapping population. There are very few studies that examine the reliability of these markers in other genetic backgrounds, and critically, no metrics exist to describe and quantify this reliability. To improve the MAS process, this work proposes five core metrics that fully describe the reliability of a marker. These metrics give a comprehensive and quantitative measure of the ability of a marker to correctly classify germplasm as QTL[+]/[-], particularly against a background of high allelic diversity. Markers that score well on these metrics will have far higher reliability in breeding, and deficiencies in specific metrics give information on circumstances under which a marker may not be reliable. The metrics are applicable across different marker types and platforms, allowing an objective comparison of the performance of different markers irrespective of the platform. Evaluating markers using these metrics demonstrates that trait-specific markers consistently out-perform markers designed for other purposes. These metrics also provide a superb set of criteria for designing superior marker systems for a target QTL, enabling the selection of an optimal marker set before committing to design.	[Damien Platten, John; Nathaniel Cobb, Joshua; Zantua, Rochelle E.] Int Rice Res Inst, Los Banos, Philippines	CGIAR; International Rice Research Institute (IRRI)	Platten, JD (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	j.platten@irri.org		Platten, John/0000-0001-6137-5955	Transforming Rice Breeding grant [OPP1076488]; Bill and Melinda Gates Foundation	Transforming Rice Breeding grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	JNC and JDP were funded in part by the Transforming Rice Breeding grant (OPP1076488) of the Bill and Melinda Gates Foundation, www.gatesfoundation.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Babu R, 2004, CURR SCI INDIA, V87, P607; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Bernardo R, 2013, THEOR APPL GENET, V126, P999, DOI 10.1007/s00122-012-2032-2; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Platten JD, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-32; Dixit S, 2012, THEOR APPL GENET, V125, P155, DOI 10.1007/s00122-012-1823-9; Ghimire KH, 2012, FIELD CROP RES, V131, P88, DOI 10.1016/j.fcr.2012.02.028; Haq TU, 2010, FUNCT PLANT BIOL, V37, P634, DOI 10.1071/FP09247; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miah G, 2013, INT J MOL SCI, V14, P22499, DOI 10.3390/ijms141122499; Mohammadi-Nejad G, 2008, AFR J BIOTECHNOL, V7, P730; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Scheuermann KK, 2016, PHYTOPATHOLOGY, V106, P871, DOI 10.1094/PHYTO-02-16-0091-R; Singh AK, 2015, PLANT PATHOLOGY J, V31, P12, DOI 10.5423/PPJ.OA.06.2014.0054; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; Swamy BPM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062795; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thomson M. J., 2014, Plant Breeding and Biotechnology, V2, P195, DOI 10.9787/PBB.2014.2.3.195; Tian DG, 2016, RICE, V9, DOI 10.1186/s12284-016-0091-8; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Yadaw RB, 2013, FIELD CROP RES, V144, P281, DOI 10.1016/j.fcr.2013.01.019; Yang TF, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0520-9; 조영찬, 2007, Journal of Crop Science and Biotechnology, V10, P265	32	35	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210529	10.1371/journal.pone.0210529	http://dx.doi.org/10.1371/journal.pone.0210529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645632	gold, Green Submitted, Green Published			2022-12-26	WOS:000455810200033
J	Delgado, R; Nunez-Gonzalez, JD				Delgado, Rosario; David Nunez-Gonzalez, J.			Enhancing Confusion Entropy (CEN) for binary and multiclass classification	PLOS ONE			English	Article								Different performance measures are used to assess the behaviour, and to carry out the comparison, of classifiers in Machine Learning. Many measures have been defined on the literature, and among them, a measure inspired by Shannon's entropy named the Confusion Entropy (CEN). In this work we introduce a new measure, MCEN, by modifying CEN to avoid its unwanted behaviour in the binary case, that disables it as a suitable performance measure in classification. We compare MCEN with CEN and other performance measures, presenting analytical results in some particularly interesting cases, as well as some heuristic computational experimentation.	[Delgado, Rosario] Univ Autonoma Barcelona, Dept Math, Campus UAB, Cerdanyola Del Valles, Spain; [David Nunez-Gonzalez, J.] Univ Basque Country, UPV EHU, Dept Math, Leioa, Spain	Autonomous University of Barcelona; University of Basque Country	Nunez-Gonzalez, JD (corresponding author), Univ Basque Country, UPV EHU, Dept Math, Leioa, Spain.	josedavid.nunez@ehu.eus		Nunez Gonzalez, Jose David/0000-0002-5047-1033; Delgado, Rosario/0000-0003-1208-9236	Ministerio de Economia y Competitividad, Gobierno de Espana [MTM2015 67802-P]	Ministerio de Economia y Competitividad, Gobierno de Espana	This work was supported by Ministerio de Economia y Competitividad, Gobierno de Espana, MTM2015 67802-P to R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work have been supported by Ministerio de Economia y Competitividad, Gobierno de Espana, project ref. MTM2015 67802-P.	[Anonymous], [No title captured]; Antunes F, 2017, APPL SOFT COMPUT, V60, P831, DOI 10.1016/j.asoc.2017.06.043; Gonzalez D, 2019, ADV INTELLIGENT SYST, V771; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Jin H., 2013, P 2013 INT C MACH LE; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036540; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Roumani YF, 2018, ANN OPER RES, V263, P429, DOI 10.1007/s10479-016-2350-x; Roumani YF, 2013, HEALTH CARE MANAG SC, V16, P119, DOI 10.1007/s10729-012-9216-9; Sigdel Madhav, 2013, Machine Learning and Data Mining in Pattern Recognition. 9th International Conference, MLDM 2013. Proceedings: LNCS 7988, P281, DOI 10.1007/978-3-642-39712-7_22; Sublime J., 2016, INT J HYBRID INTELLI, V12, P245, DOI [DOI 10.3233/HIS-160219, 10.3233/HIS-160219]; Sublime J, 2017, PATTERN RECOGN, V72, P144, DOI 10.1016/j.patcog.2017.07.014; Sublime J, 2017, IEEE IJCNN, P4126, DOI 10.1109/IJCNN.2017.7966377; Valverde-Albacete FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084217; Wang XN, 2013, ENTROPY-SWITZ, V15, P4969, DOI 10.3390/e15114969; Wei JM, 2010, EXPERT SYST APPL, V37, P3799, DOI 10.1016/j.eswa.2009.11.040	16	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210264	10.1371/journal.pone.0210264	http://dx.doi.org/10.1371/journal.pone.0210264			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640948	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000021
J	Hugdahl, E; Bachmann, IM; Schuster, C; Ladstein, RG; Akslen, LA				Hugdahl, Emilia; Bachmann, Ingeborg M.; Schuster, Cornelia; Ladstein, Rita G.; Akslen, Lars A.			Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AGGRESSIVE TUMOR FEATURES; VASCULAR PROLIFERATION; NECROSIS; HYPOXIA; CANCER; UROKINASE; INVASION; INHIBITION; LYMPHANGIOGENESIS	Angiogenesis is important for the progression of cutaneous melanoma. Here, we analyzed the prognostic impact of the angiogenic factor urokinase plasminogen activator resecptor (uPAR), vascular proliferation index (VPI) and tumor necrosis as a measure of hypoxia in a patient series of nodular melanomas (n = 255) and matched loco-regional metastases (n = 78). Expression of uPAR was determined by immunohistochemistry and VPI was assessed by dual immunohistochemistry using Factor-VIII/Ki67 staining. Necrosis was recorded based on HE-slides. As novel findings, high uPAR expression and high VPI were associated with each other, and with increased tumor thickness, presence of tumor necrosis, tumor ulceration, increased mitotic count and reduced cancer specific survival in primary melanoma. In matched cases, VPI was decreased in metastases, whereas the frequency of necrosis was increased. Our findings demonstrate for the first time the impact on melanoma specific survival of uPAR expression and VPI in primary tumors, and of increased necrosis as an indicator of tumor hypoxia in loco-regional metastases. These findings support the importance of tumor angiogenesis in melanoma aggressiveness, and suggest uPAR as an indicator of vascular proliferation and a potential biomarker in melanoma.	[Hugdahl, Emilia; Bachmann, Ingeborg M.; Ladstein, Rita G.; Akslen, Lars A.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Hugdahl, Emilia; Bachmann, Ingeborg M.; Ladstein, Rita G.] Haukeland Hosp, Dept Dermatol, Bergen, Norway; [Schuster, Cornelia] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Schuster, Cornelia] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, Bergen, Norway.; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	Lars.Akslen@k1.uib.no	Schuster, Cornelia/AAX-9719-2021; Akslen, Lars A/C-1202-2017; Akslen, Lars A./AAG-6097-2021	Schuster, Cornelia/0000-0003-2665-9527; Akslen, Lars A/0000-0003-2710-9543; Akslen, Lars A./0000-0003-2710-9543	Research Council of Norway through its Centres of Excellence funding scheme [223250]; University of Bergen; Research Council of Norway [802630]; Norwegian Cancer Society [803149]; Helse Vest Research Fund [911873]	Research Council of Norway through its Centres of Excellence funding scheme; University of Bergen; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Helse Vest Research Fund	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223250. Other funding sources were University of Bergen, Research Council of Norway (grant #802630), Norwegian Cancer Society (grant #803149) and Helse Vest Research Fund (grant #911873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gerd Lillian Hallseth, Bendik Nordanger and Randi Hope Lavik for excellent technical assistance. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, Project Number 223250.	Alexander RA, 2012, CARDIOVASC RES, V94, P125, DOI 10.1093/cvr/cvs017; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Arnes JB, 2012, BREAST CANCER RES TR, V133, P501, DOI 10.1007/s10549-011-1785-7; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bredholt G, 2015, ONCOTARGET, V6, P39676, DOI 10.18632/oncotarget.5344; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243; CLARK WH, 1969, CANCER RES, V29, P705; de Geus SWL, 2017, BIOMARK INSIGHTS, V12, P1, DOI 10.1177/1177271917715443; DEVRIES TJ, 1994, AM J PATHOL, V144, P70; Dohn L.H., 2015, UROL ONCOL, V33, pe15, DOI DOI 10.1016/J.UR0L0NC.2014.12.001; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Edwards JG, 2003, CHEST, V124, P1916, DOI 10.1378/chest.124.5.1916; Erhard H, 1997, MELANOMA RES, V7, pS19; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hillen F, 2006, MELANOMA RES, V16, P453, DOI 10.1097/01.cmr.0000232291.68666.4c; Hoyer-Hansen G, 2012, J CLIN ONCOL S, V30, P35; Hugdahl E, 2017, BR J CANC; Hugdahl E, 2016, BRIT J CANCER, V114, P801, DOI 10.1038/bjc.2016.44; Kashani-Sabet M, 2002, J CLIN ONCOL, V20, P1826, DOI 10.1200/JCO.2002.07.082; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kriegbaum MC, 2015, J HISTOCHEM CYTOCHEM, V63, P142, DOI 10.1369/0022155414563107; Ladstein RG, 2012, J INVEST DERMATOL, V132, P1247, DOI 10.1038/jid.2011.464; Ladstein RG, 2012, AM J SURG PATHOL, V36, P1477, DOI 10.1097/PAS.0b013e31825a5b45; Laerum OD, 2012, INT J CANCER, V131, P558, DOI 10.1002/ijc.26382; Laurenzana A, 2015, J MOL MED, V93, P783, DOI 10.1007/s00109-015-1266-2; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Li YL, 2014, INT J CLIN EXP PATHO, V7, P3771; Marconi C, 2008, CLIN EXP METASTAS, V25, P225, DOI 10.1007/s10585-007-9136-0; Matheis F, 2016, J INVEST DERMATOL, V136, P2475, DOI 10.1016/j.jid.2016.07.026; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Pastushenko I, 2016, AM J DERMATOPATH, V38, P338, DOI 10.1097/DAD.0000000000000488; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Ramnefjell M, 2017, J PATHOL CLIN RES, V3, P249, DOI 10.1002/cjp2.78; Ria R, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/185687; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Schuster C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155242; Shi H, 2015, MELANOMA RES, V25, P15, DOI 10.1097/CMR.0000000000000124; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; STAHL A, 1994, CANCER RES, V54, P3066; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Stefansson IM, 2004, HISTOPATHOLOGY, V44, P472, DOI 10.1111/j.1365-2559.2004.01882.x; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Straume O, 1999, INT J ONCOL, V15, P595; Straume O, 1997, INT J CANCER, V74, P535, DOI 10.1002/(SICI)1097-0215(19971021)74:5<535::AID-IJC10>3.0.CO;2-5; Straume O, 2002, AM J PATHOL, V160, P1009, DOI 10.1016/S0002-9440(10)64922-X; Streit M, 2003, ONCOGENE, V22, P3172, DOI 10.1038/sj.onc.1206457; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vinay K., 2007, ROBBINS BASIC PATHOL; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	57	12	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210399	10.1371/journal.pone.0210399	http://dx.doi.org/10.1371/journal.pone.0210399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640942	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000027
J	Nemtseva, EV; Gerasimova, MA; Melnik, TN; Melnik, BS				Nemtseva, Elena V.; Gerasimova, Marina A.; Melnik, Tatiana N.; Melnik, Bogdan S.			Experimental approach to study the effect of mutations on the protein folding pathway	PLOS ONE			English	Article							FLUORESCENCE LIFETIMES ORIGIN; TRANSITION-STATE; EXCHANGE; TRYPTOPHAN; STABILITY; ELEMENTS	Is it possible to compare the physicochemical properties of a wild-type protein and its mutant form under the same conditions? Provided the mutation has destabilized the protein, it may be more correct to compare the mutant protein under native conditions to the wild-type protein destabilized with a small amount of the denaturant. In general, is it appropriate to compare the properties of proteins destabilized by different treatments: mutations, pH, temperature, and denaturants like urea? These issues have compelled us to search for methods and ways of presentation of experimental results that would allow a comparison of mutant forms of proteins under different conditions and lead to conclusions on the effect of mutations on the protein folding/unfolding pathway. We have studied equilibrium unfolding of wild-type bovine carbonic anhydrase II (BCA II) and its six mutant forms using different urea concentrations. BCA II has been already studied in detail and is a good model object for validating new techniques. In this case, time-resolved fluorescence spectroscopy was chosen as the basic research method. The main features of this experimental method allowed us to compare different stages of unfolding of studied proteins and prove experimentally that a single substitution of the amino acid in three mutant forms of BCA II affected the native state of the protein but did not change its unfolding pathway. On the contrary, the inserted disulfide bridge in three other mutant forms of BCA II affected the protein unfolding pathway. An important result of this research is that we have validated the new approach allowing investigation of the effect of mutations on the folding of globular proteins, because in this way it is possible to compare proteins in the same structural states rather than under identical conditions.	[Nemtseva, Elena V.; Gerasimova, Marina A.] Siberian Fed Univ, Krasnoyarsk, Russia; [Nemtseva, Elena V.] Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk, Russia; [Melnik, Tatiana N.; Melnik, Bogdan S.] Russian Acad Sci, Inst Prot Res, Pushchino, Moscow Region, Russia	Siberian Federal University; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Russian Academy of Sciences	Melnik, BS (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino, Moscow Region, Russia.	bmelnik@phys.protres.ru	Gerasimova, Marina A/L-5569-2017; Nemtseva, Elena/M-5056-2016; Melnik, Bogdan/U-1988-2017	Gerasimova, Marina A/0000-0001-8445-2714; Nemtseva, Elena/0000-0003-1725-8625; Melnik, Bogdan/0000-0002-9176-6452	Ministry of Science and Education of the Russian Federation [6.7734.2017]; Russian Science Foundation [N14-24-00157]	Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF))	The study of time-resolved protein fluorescence was supported by the Ministry of Science and Education of the Russian Federation (Projects 6.7734.2017). The investigation of protein fluorescence and genetic engineering studies of bovine carbonic anhydrase II were supported by grant N14-24-00157 from the Russian Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study of time-resolved protein fluorescence was supported by the Ministry of Science and Education of the Russian Federation (Project 6.7734.2017). The investigation of protein fluorescence and genetic engineering studies of bovine carbonic anhydrase II were supported by grant N14-24-00157 from the Russian Science Foundation.	Albani JR, 2014, J FLUORESC, V24, P93, DOI 10.1007/s10895-013-1277-8; Albani JR, 2014, J FLUORESC, V24, P105, DOI 10.1007/s10895-013-1274-y; ARMSTRONG JM, 1966, J BIOL CHEM, V241, P5137; Beechem J M, TOPICS FLUORESCENCE, P241; Beechem JM, 1997, METHOD ENZYMOL, V278, P24; Berberan-Santos, 2013, MOL FLUORESCENCE PRI; BREMS DN, 1985, BIOCHEMISTRY-US, V24, P1689, DOI 10.1021/bi00328a018; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Choe SE, 2000, J MOL BIOL, V304, P99, DOI 10.1006/jmbi.2000.4190; DOLGIKH DA, 1984, FEBS LETT, V165, P88, DOI 10.1016/0014-5793(84)80020-4; Dyson HJ, 1996, ANNU REV PHYS CHEM, V47, P369, DOI 10.1146/annurev.physchem.47.1.369; Englander SW, 2017, P NATL ACAD SCI USA, V114, P8253, DOI 10.1073/pnas.1706196114; FERSHT AR, 1992, FARADAY DISCUSS, V93, P183, DOI 10.1039/fd9929300183; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Krishnamoorthy G, 2018, J BIOSCIENCES, V43, P555, DOI 10.1007/s12038-018-9763-4; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027; Melnik BS, 2008, BIOCHEM BIOPH RES CO, V369, P701, DOI 10.1016/j.bbrc.2008.02.096; Melnik B. S., 2016, Biophysics, V61, P860, DOI 10.1134/S0006350916060178; Melnik BS, 2016, BBA-PROTEINS PROTEOM, V1864, P1809, DOI 10.1016/j.bbapap.2016.09.006; Melnik TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098645; Melnik TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048604; Nemtseva E. V., 2016, Biophysics, V61, P193, DOI 10.1134/S0006350916020111; Nemtseva EV, 2018, METHODS APPL FLUORES, V6, DOI 10.1088/2050-6120/aa994a; Pilipczuk J, 2017, J BIOL CHEM, V292, P16136, DOI 10.1074/jbc.M117.785477; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; SEMISOTNOV GV, 1990, J MOL BIOL, V213, P561, DOI 10.1016/S0022-2836(05)80215-3; Tran DT, 2012, ANAL CHEM, V84, P1653, DOI 10.1021/ac202927p; Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45; VIGUERA AR, 1995, J MOL BIOL, V247, P670, DOI 10.1016/S0022-2836(05)80146-9; Yang HJ, 1997, BIOCHEMISTRY-US, V36, P14992, DOI 10.1021/bi9717183; ZAHLER WL, 1968, J BIOL CHEM, V243, P716	38	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210361	10.1371/journal.pone.0210361	http://dx.doi.org/10.1371/journal.pone.0210361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640946	gold, Green Submitted, Green Published			2022-12-26	WOS:000455808000023
J	Lee, H; Bang, J; Kim, S; Yang, H				Lee, HyeYeon; Bang, JongHo; Kim, SooJung; Yang, HeeJun			The axillary vein and its tributaries are not in the mirror image of the axillary artery and its branches	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; VASCULAR ACCESS; CEPHALIC ARCH; COMPLICATIONS; IMPLANTATION; INSERTION; LEADS; SAFE	Introduction The axillary and cephalic veins are used for various clinical purposes but their anatomy is not fully understood. Increased knowledge and information about them as well as superficial veins in the upper arm would be useful. Objective The aim of this study is to contribute to the literature regarding the anatomy of the venous drainage of the upper extremity. Methods The veins of forty upper extremities from twenty one adult cadavers were injected and their axillary regions dissected. The course and pattern of drainage of the venous tributaries in the axillary region were identified and recorded. Results The basilic, brachial, subscapular, lateral thoracic and superior thoracic veins drained mainly into the axillary vein, in common with most textbook descriptions. However, the thoracoacromial veins were observed to drain into the cephalic vein in 70.0% of upper limbs. In addition, a venous channel connecting the distal part and proximal part of the axilla was found along the posterolateral wall of the axilla in 77.5% of the upper limbs. In 95.0% of upper limbs, we discovered a superficial vein which ran from the axillary base and drained directly into the axillary vein. Conclusion The veins from the inferomedial part of the axilla drain into the axillary vein, whereas the veins from the superolateral part of the axilla drain into the cephalic vein. The venous drainage of the axilla is variable and in common with venous drainage elsewhere, does not necessarily follow the pattern of the arterial supply.	[Lee, HyeYeon; Bang, JongHo; Kim, SooJung] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Yang, HeeJun] Gachon Univ, Coll Med, Dept Anat, Incheon, South Korea	Yonsei University; Yonsei University Health System; Gachon University	Yang, H (corresponding author), Gachon Univ, Coll Med, Dept Anat, Incheon, South Korea.	yangmdphd@gmail.com		Yang, Hee-Jun/0000-0002-4983-6365; Lee, Hye-Yeon/0000-0001-6945-1967	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2055742]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2055742), http://english.moe.go.kr/main.do?s=english.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2015, INT J CARDIOL, V199, P277, DOI 10.1016/j.ijcard.2015.07.055; Al Fagih A, 2015, J INVASIVE CARDIOL, V27, P341; Andel H, 1999, BURNS, V25, P753, DOI 10.1016/S0305-4179(99)00090-X; Askegard-Giesmann JR, 2009, SEMIN PEDIATR SURG, V18, P73, DOI 10.1053/j.sempedsurg.2009.02.003; Bennett S, 2015, J VASC ACCESS, V16, P13, DOI 10.5301/jva.5000291; Bertoglio S, 2017, J VASC ACCESS, V18, P89, DOI 10.5301/jva.5000668; Birch R, 2016, GRAYS ANATOMY ANATOM, P779; Dolister M, 2013, J VASC ACCESS, V14, P216, DOI 10.5301/jva.5000130; Grimm JC, 2014, J VASC SURG, V59, P1651, DOI 10.1016/j.jvs.2013.12.042; Hadimani S, 2013, Kathmandu Univ Med J (KUMJ), V11, P162; Hadjis A, 2017, EUROPACE, V19, P1514, DOI 10.1093/europace/euw276; Kim SY, 2015, KOREAN CIRC J, V45, P428, DOI 10.4070/kcj.2015.45.5.428; Kusztal M, 2014, J VASC ACCESS, V15, pS70, DOI 10.5301/jva.5000257; Landin L, 2015, ANN PLAS SURG, V74, P52, DOI 10.1097/SAP.0b013e31828d9983; Lewis FT, 1905, AM J ANAT, V5, P113, DOI 10.1002/aja.1000050108; Liechty JM, 2015, ANN VASC SURG, V29, P690, DOI 10.1016/j.avsg.2014.11.014; Mehrotra S, 2015, Indian Heart J, V67, P136, DOI 10.1016/j.ihj.2015.04.007; Migliore F, 2016, J CARDIOVASC MED, V17, P309, DOI 10.2459/JCM.0000000000000154; Nayak BS, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/9396.5113; Neri R, 2003, PACE, V26, P2313, DOI 10.1111/j.1540-8159.2003.00365.x; Panagiotounakou P, 2014, J PERINATOL, V34, P461, DOI 10.1038/jp.2014.36; Povoski SP, 2000, ANN SURG ONCOL, V7, P496, DOI 10.1007/s10434-000-0496-9; Seo TS, 2014, J VASC INTERV RADIOL, V25, P1439, DOI 10.1016/j.jvir.2013.12.571; Sigala F, 2014, J VASC ACCESS, V15, P272, DOI 10.5301/jva.5000195; Spahos T, 2012, EUR J VASC ENDOVASC, V43, P457, DOI 10.1016/j.ejvs.2012.01.002; Su TW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000728; SVENSSON WE, 1994, EUR J CANCER, V30A, P657, DOI 10.1016/0959-8049(94)90539-8; Takano A, 2017, J ARRYTHM, V33, P12, DOI 10.1016/j.joa.2016.04.008; Tickle C., 2016, GRAYS ANATOMY ANATOM, P795	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210464	10.1371/journal.pone.0210464	http://dx.doi.org/10.1371/journal.pone.0210464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629680	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000093
J	Nakamura, A; Morise, J; Yabuno-Nakagawa, K; Hashimoto, Y; Takematsu, H; Oka, S				Nakamura, Ayasa; Morise, Jyoji; Yabuno-Nakagawa, Keiko; Hashimoto, Yuki; Takematsu, Hiromu; Oka, Shogo			Site-specific HNK-1 epitope on alternatively spliced fibronectin type-III repeats in tenascin-C promotes neurite outgrowth of hippocampal neurons through contactin-1	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; EXPRESSION; CLONING; MICE; BIOSYNTHESIS; DEFICIENT; PROTEIN; F3/CONTACTIN; L2/HNK-1; DOMAINS	The human natural killer-1 (HNK-1) carbohydrate epitope, composed of a unique sulfated trisaccharide (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-R), is highly expressed during brain development and regulates higher brain function. However, it remains unclear which glycoprotein carries the HNK-1 epitope in the embryonic brain and the functional role it plays. Here, we showed that one of the major HNK-1 carrier proteins in the embryonic brain is tenascin-C (TNC), an extracellular matrix protein that regulates neurite outgrowth by interacting with the GPI-anchored protein contactin-1 (CNTN). Because the alternatively spliced fibronectin type-III (FNIII) repeats in TNC give rise to many isoforms and affect neuronal function, we evaluated neurite outgrowth of primary hippocampal neurons on purified recombinant FNIII repeats with or without the HNK-1 epitope as a substrate. We found that the presence of the HNK-1 epitope on the C domain of TNC promoted neurite outgrowth, and that this signal was mediated by CNTN, which is an HNK-1-expressing neuronal receptor. The neurite-promoting activity of the HNK-1 epitope on TNC required neuronal HNK-1 expression, which was defective in neurons lacking the glucuronyltransferases GlcAT-P and GlcAT-S. These results suggest that the HNK-1 epitope is a key modifier of TNC and CNTN in the regulation of embryonic brain development.	[Nakamura, Ayasa; Morise, Jyoji; Yabuno-Nakagawa, Keiko; Hashimoto, Yuki; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto, Japan	Kyoto University	Oka, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto, Japan.	shogo@hs.med.kyoto-u.ac.jp		Takematsu, Hiromu/0000-0003-1689-9500	Japan Society for the Promotion of Science [16K14695, 17K15090]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Challenging Exploratory Research (No. 16K14695 to S.O.) and Young Scientists (B) (No. 17K15090 to J.M.) from the Japan Society for the Promotion of Science.	Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Forsberg E, 1996, P NATL ACAD SCI USA, V93, P6594, DOI 10.1073/pnas.93.13.6594; Fukamauchi F, 1998, NEUROPEPTIDES, V32, P461, DOI 10.1016/S0143-4179(98)90072-5; Gallego RG, 2001, J BIOL CHEM, V276, P30834, DOI 10.1074/jbc.M101013200; GENNARINI G, 1989, J NEUROSCI RES, V22, P1, DOI 10.1002/jnr.490220102; Gennarini G, 2017, MOL CELL NEUROSCI, V81, P49, DOI 10.1016/j.mcn.2016.11.006; Giblin SP, 2015, CELL ADHES MIGR, V9, P48, DOI 10.4161/19336918.2014.987587; Gurevicius K, 2009, HIPPOCAMPUS, V19, P1232, DOI 10.1002/hipo.20585; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2012, CELL MOL LIFE SCI, V69, P4135, DOI 10.1007/s00018-012-1036-z; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Meiners S, 1999, J NEUROSCI, V19, P8443; Michele M, 2009, MOL CELL NEUROSCI, V41, P397, DOI 10.1016/j.mcn.2009.04.004; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Morellini F, 2006, EUR J NEUROSCI, V23, P1255, DOI 10.1111/j.1460-9568.2006.04657.x; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Nakic M, 1998, J NEUROBIOL, V37, P393; Nakic M, 1996, J NEUROSCI RES, V44, P355; Nishio T, 2003, BRAIN RES, V990, P129, DOI 10.1016/S0006-8993(03)03448-6; Puzzo D, 2013, HIPPOCAMPUS, V23, P1367, DOI 10.1002/hipo.22186; Rigato F, 2002, J NEUROSCI, V22, P6596; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Siddiqui S, 2008, NEURON GLIA BIOL, V4, P271, DOI 10.1017/S1740925X09990020; Sogawa Y, 2000, BRAIN RES, V881, P165, DOI 10.1016/S0006-8993(00)02838-9; Stamenkovic V, 2017, BEHAV BRAIN RES, V331, P241, DOI 10.1016/j.bbr.2017.05.047; Stamenkovic V, 2017, BRAIN STRUCT FUNCT, V222, P393, DOI 10.1007/s00429-016-1224-y; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Yabuno K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144560; Yagi H, 2010, J BIOL CHEM, V285, P37293, DOI 10.1074/jbc.M110.157081; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	44	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210193	10.1371/journal.pone.0210193	http://dx.doi.org/10.1371/journal.pone.0210193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629639	Green Published, gold			2022-12-26	WOS:000455483000060
J	Rendon, D; Taylor, PW; Wilder, SM; Whitehouse, MEA				Rendon, Dalila; Taylor, Phillip W.; Wilder, Shawn M.; Whitehouse, Mary E. A.			Does prey encounter and nutrient content affect prey selection in wolf spiders inhabiting Bt cotton fields?	PLOS ONE			English	Article							LIMITATION PROMOTE OMNIVORY; ACTIVE PREDATOR CHOICE; NITROGEN LIMITATION; SIZE SELECTION; INTRAGUILD PREDATION; AUSTRALIAN COTTON; HELICOVERPA SPP.; CONSUMPTION; ARANEAE; APHID	Wolf spiders are abundant and voracious predators at the soil-plant interface in cotton crops. Among other prey, they attack late-instar larvae of the cotton bollworm Helicoverpa spp., an economically important pest. Consequently, wolf spiders in transgenic Bt cotton could provide significant biological control of Bt-resistant Helicoverpa larvae that descend to the soil to pupate. The predator-prey interactions between wolf spiders and Helicoverpa could, however, be constrained by the presence of alternative prey and intraguild predators. This study used laboratory enclosures to analyse the effect of alternative prey on predatory selection of the wolf spider Tasmanicosa leuckartii Thorell. The prey included another wolf spider Hogna crispipes Koch (potential intraguild predator), the ground cricket Teleogryllus commodus Walker (minor pest), and Helicoverpa armigera larvae (major pest). We tested if encounter rates, prey vulnerability, and prey nutritional content influenced the likelihood that a prey was attacked. In three-way food webs, Tasmanicosa encountered and attacked Teleogryllus and Helicoverpa in similar frequencies. However, in the presence of a competing intraguild predator and potential prey (Hogna) in a four-way food web, Tasmanicosa did not always attack Teleogryllus at first encounter, but still attacked Helicoverpa at each encounter. Helicoverpa (protein-poor) and Hogna (protein-rich) were consumed by Tasmanicosa in similar proportions, suggesting that Tasmanicosa might benefit from nutrient balance as an outcome of diverse prey in this food web. As Teleogryllus (protein rich) escapes quicker than Helicoverpa and Hogna, Hogna may be an easier protein-rich option than Teleogryllus. Field surveys showed that while Teleogryllus was the most common prey, wolf spiders feed on diverse insect taxa, as well as other spiders. That Tasmanicosa readily attacked Helicoverpa larvae in the presence of alternative prey is an encouraging result that supports the potential of Tasmanicosa predation to assist in the control of Bt-resistant Helicoverpa larvae and thereby inhibit the proliferation and spread of resistance.	[Rendon, Dalila; Whitehouse, Mary E. A.] CSIRO Agr & Food, Australian Cotton Res Inst, Narrabri, NSW, Australia; [Rendon, Dalila; Taylor, Phillip W.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Wilder, Shawn M.] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Macquarie University; Oklahoma State University System; Oklahoma State University - Stillwater	Rendon, D (corresponding author), CSIRO Agr & Food, Australian Cotton Res Inst, Narrabri, NSW, Australia.; Rendon, D (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	dalila.rendon@oregonstate.edu	Taylor, Phillip W/E-4620-2011	Taylor, Phillip W/0000-0002-7574-7737; Wilder, Shawn/0000-0003-0359-7220; Whitehouse, Mary/0000-0001-9911-8356	Macquarie University Post-graduate Research fund; Endeavour Postgraduate scholarship (Australia Awards)	Macquarie University Post-graduate Research fund; Endeavour Postgraduate scholarship (Australia Awards)	This project was funded by a Macquarie University Post-graduate Research fund. D. Rendon was supported by an Endeavour Postgraduate scholarship (Australia Awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell CJ, 1996, ENVIRON ENTOMOL, V25, P1083, DOI 10.1093/ee/25.5.1083; Barry KL, 2013, OIKOS, V122, P1058, DOI 10.1111/j.1600-0706.2012.00164.x; BENCE JR, 1986, ECOLOGY, V67, P324, DOI 10.2307/1938576; Brechbuehl R, 2011, ECOSPHERE, V2, DOI [10.1007/s00442-010-1811-1, DOI 10.1007/S00442-010-1811-1]; Constable GA, 1988, AGFACT; Dangles O, 2006, ANIM BEHAV, V72, P603, DOI 10.1016/j.anbehav.2005.11.018; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Downes S, 2009, J ECON ENTOMOL, V102, P733, DOI 10.1603/029.102.0234; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Downes SJ, 2002, BEHAV ECOL, V13, P551, DOI 10.1093/beheco/13.4.551; EDGAR WD, 1969, J ZOOL, V159, P405, DOI 10.1111/j.1469-7998.1969.tb03897.x; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Fagan WF, 2004, ECOL LETT, V7, P876, DOI 10.1111/j.1461-0248.2004.00641.x; Fitt Gary, 2009, P507, DOI 10.1007/978-1-4020-8990-9_17; Gavish-Regev E, 2009, BIOCONTROL, V54, P341, DOI 10.1007/s10526-008-9170-0; GREENSTONE MH, 1979, NATURE, V282, P501, DOI 10.1038/282501a0; Hagler JR, 2013, ECOL ENTOMOL, V38, P258, DOI 10.1111/een.12014; Hagler JR, 2011, BIOL CONTROL, V58, P337, DOI 10.1016/j.biocontrol.2011.05.015; Harwood JD, 2009, BIOL CONTROL, V51, P499, DOI 10.1016/j.biocontrol.2009.09.007; Harwood JD, 2004, MOL ECOL, V13, P3549, DOI 10.1111/j.1365-294X.2004.02331.x; Hawley J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099165; HAYES JL, 1990, ENVIRON ENTOMOL, V19, P1512, DOI 10.1093/ee/19.5.1512; Hodge MA, 1999, J ARACHNOL, V27, P351; IBM, 2011, SPSS STAT WIND 20 0; Jensen K, 2011, OECOLOGIA, V165, P577, DOI 10.1007/s00442-010-1811-1; Johnson M-L, 2000, REV BENEFICIALS COTT; Krebs J.R., 1978, P23; Kuusk AK, 2010, BIOL CONTROL, V55, P20, DOI 10.1016/j.biocontrol.2010.06.009; Lang A, 2001, J APPL ENTOMOL, V125, P53, DOI 10.1046/j.1439-0418.2001.00511.x; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Liu X, 2014, PLOS ONE, V9; Madsen M, 2004, BIOCONTROL, V49, P483, DOI 10.1023/B:BICO.0000036442.70171.66; Matsumura M, 2004, ECOLOGY, V85, P2601, DOI 10.1890/03-0629; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; MOLLES MC, 1987, OECOLOGIA, V72, P473, DOI 10.1007/BF00377582; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; NENTWIG W, 1986, OECOLOGIA, V69, P571, DOI 10.1007/BF00410365; Oelbermann K, 2002, BASIC APPL ECOL, V3, P285, DOI 10.1078/1439-1791-00094; Okuyama Toshinori, 2008, Acta Arachnologica, V57, P47, DOI 10.2476/asjaa.57.47; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Persons MH, 1997, J INSECT BEHAV, V10, P737, DOI 10.1007/BF02765390; Provost C, 2006, BIOL CONTROL, V37, P148, DOI 10.1016/j.biocontrol.2006.01.005; Rendon D, 2018, BIOL CONTROL, V122, P51, DOI 10.1016/j.biocontrol.2018.03.019; Rendon D, 2016, ENTOMOL EXP APPL, V158, P170, DOI 10.1111/eea.12390; Rendon D, 2015, ENVIRON ENTOMOL, V44, P174, DOI 10.1093/ee/nvu025; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Storm JJ, 2008, CAN J ZOOL, V86, P1259, DOI 10.1139/Z08-114; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Teakle R.E., 1985, P313; Toft S, 1999, J ARACHNOL, V27, P301; Toft S, 2010, PHYSIOL ENTOMOL, V35, P317, DOI 10.1111/j.1365-3032.2010.00746.x; Turesson H, 2002, ECOL FRESHW FISH, V11, P223, DOI 10.1034/j.1600-0633.2002.00019.x; UETZ GW, 1992, J ARACHNOL, V20, P207; Vandervoet TF, 2018, J ECON ENTOMOL, V111, P1056, DOI 10.1093/jee/toy049; Welch KD, 2016, B ENTOMOL RES, V106, P91, DOI 10.1017/S0007485315000875; Whitehouse MEA, 2014, ENVIRON ENTOMOL, V43, P218, DOI 10.1603/EN13167; Whitehouse MEA, 2005, ENVIRON ENTOMOL, V34, P1224, DOI 10.1603/0046-225X(2005)034[1224:ACOACI]2.0.CO;2; Whitehouse MEA, 2009, 3 INT S BIOL CONTR A; Whitney TD, 2018, MOL ECOL, V27, P1739, DOI 10.1111/mec.14554; Wilder SM, 2013, ECOL LETT, V16, P895, DOI 10.1111/ele.12116; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2010, ECOLOGY, V91, P3114, DOI 10.1890/09-2080.1; Wilson LJ, 2018, ANNU REV ENTOMOL, V63, P215, DOI 10.1146/annurev-ento-020117-043432; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; Xia JY, 2018, ECOL COMPLEX, V33, P11, DOI 10.1016/j.ecocom.2017.09.003	69	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210296	10.1371/journal.pone.0210296	http://dx.doi.org/10.1371/journal.pone.0210296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629650	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000070
J	Yokoyama, A; Yokoyama, T; Omori, T; Maesato, H; Takimura, T; Iwahara, C; Kimura, M; Matsui, T; Mizukami, T; Maruyama, K				Yokoyama, Akira; Yokoyama, Tetsuji; Omori, Tai; Maesato, Hitoshi; Takimura, Tsuyoshi; Iwahara, Chie; Kimura, Mitsuru; Matsui, Toshifumi; Mizukami, Takeshi; Maruyama, Katsuya			Endoscopic screening using esophageal iodine staining and genotypes of ADH1B and ALDH2 in Japanese alcohol-dependent women	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; ALDEHYDE DEHYDROGENASE GENOTYPES; SALIVARY ACETALDEHYDE-LEVELS; LUGOL-VOIDING LESIONS; GENETIC POLYMORPHISMS; NECK-CANCER; RISK; MEN; CONSUMPTION	Background The presence of large or multiple esophageal distinct iodine-unstained lesions (DIULs) is a strong predictor of field cancerization in the upper aerodigestive tract. Several risk factors for DIULs, including genetic polymorphisms of alcohol and aldehyde dehydrogenases (ADH1B, rs1229984; ALDH2, rs671), have been demonstrated in Japanese alcohol-dependent men. However, few evaluations of alcohol-dependent women have been conducted in this field. Methods Using multiple logistic regression models, we investigated the results of screening using esophageal iodine staining and the identification of determinants for esophageal DIULs in 472 Japanese alcohol-dependent women. Results DIULs >= 5 mm, multiple DILUs, and both characteristics were observed in 35 (7.4%), 31 (6.6%), and 16 (3.4%) patients, respectively. DIULs >= 5 mm were histologically diagnosed as low-grade intraepithelial neoplasia in 26 patients and superficial squamous cell carcinoma in 9 patients. Although the inactive heterozygous ALDH2(*) 1/(*)2 genotype was more common (33.3% vs. 11.4%, p = 0.002) in the group with DIULs >= 5 mm than in the group without DIULs. 5 mm, no significant differences in the results of a questionnaire asking about current and past facial flushing after a glass of beer were seen between the groups with and without DIULs >= 5 mm. When individuals with current or former flushing were assumed to have inactive ALDH2, the sensitivity and specificity of current or former flushing to identify the presence of inactive ALDH2 were 50.0% and 93.5%, respectively; these values were previously reported to be 88% and 92%, respectively, in a Japanese general female population. The low sensitivity in the present study suggests that a lack of alcohol flushing may play a crucial role in the development of alcohol dependence in women with inactive ALDH2. No significant differences in age, usual alcohol consumption, or smoking habits were observed according to ADH1B and ALDH2 genotypes. Multiple logistic regression analyses showed that the slow-metabolizing ADH1B(*)1/(*)1 genotype (odds ratio [95% confidence interval], 12.5 [4.82-32.4] and 9.89 [3.50-27.9]), the inactive heterozygous ALDH2(*)1/(*)2 genotype (2.94 [1.18-7.38] and 3.79 [1.40-10.3]), a lower body mass index per -1 kg/m2 (1.17 [1.02-1.35] and 1.38 [1.14-1.67]), and a mean corpuscular volume > 106 fl (3.70 [1.56-8.81] and 3.27 [1.24-8.64]) increased the risk of DIULs >= 5 mm and multiple DIULs, respectively. The combination of ADH1B(*) 1/(*) 1 and ALDH2(*)1/(*)2 markedly increased the risk of esophageal DIULs >= 5 mm (39.3 [10.6-146]). Conclusions Japanese alcohol-dependent women shared several common risk factors for esophageal squamous cell neoplasia with alcohol-dependent men, but with considerably different magnitudes.	[Yokoyama, Akira; Maesato, Hitoshi; Takimura, Tsuyoshi; Iwahara, Chie; Kimura, Mitsuru; Matsui, Toshifumi; Mizukami, Takeshi; Maruyama, Katsuya] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama, Japan; [Omori, Tai] Kawasaki Municipal Ida Hosp, Endoscopy Ctr, Kawasaki, Kanagawa, Japan	National Institute of Public Health - Japan	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan.	a_yokoyama@kurihama1.hosp.go.jp		Matsui, Toshifumi/0000-0002-8478-2809				Abiko S, 2018, J GASTROENTEROL, V53, P1120, DOI 10.1007/s00535-018-1441-7; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Brooks PJ, 2014, ENVIRON MOL MUTAGEN, V55, P77, DOI 10.1002/em.21824; Chiang CP, 2016, PHARMACOGENET GENOM, V26, P184, DOI 10.1097/FPC.0000000000000205; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Garaycoechea JI, 2018, NATURE, V553, P171, DOI 10.1038/nature25154; GARRO AJ, 1986, ALCOHOL CLIN EXP RES, V10, pS73, DOI 10.1111/j.1530-0277.1986.tb05184.x; Health and Welfare Statistics Association, 2015, KOKUMIN EISEI DOKO 2, V61; Homann N, 2000, CARCINOGENESIS, V21, P663, DOI 10.1093/carcin/21.4.663; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, ALC CONS ETH CARB; International Agency for Research on Cancer World Health Organization, 2010, IARC MON EV CARC RIS, V96; Japanese Society for Esophageal Disease, 2001, GUID CLIN PATH STUD; Katada C, 2014, DIS ESOPHAGUS, V27, P457, DOI 10.1111/j.1442-2050.2012.01429.x; Katada C, 2016, GASTROENTEROLOGY, V15, pe7; Katada C, 2016, GASTROENTEROLOGY, V151, P860, DOI 10.1053/j.gastro.2016.07.040; Kimura M, 2011, ALCOHOL CLIN EXP RES, V35, P1923, DOI 10.1111/j.1530-0277.2011.01543.x; Lee CH, 2009, INT J CANCER, V125, P1134, DOI 10.1002/ijc.24357; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Matejcic M, 2017, CARCINOGENESIS, V38, P859, DOI 10.1093/carcin/bgx067; Ministry of Health Labor and Welfare, 2014, KOK EIYO GENJ 2014; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Onochi K, 2019, J CLIN GASTROENTEROL, V53, pE164, DOI 10.1097/MCG.0000000000001019; Osaki Y, 2016, ALCOHOL ALCOHOLISM, V51, P465, DOI 10.1093/alcalc/agw002; Polimanti R, 2018, AM J MED GENET B, V177, P113, DOI 10.1002/ajmg.b.32523; Polimanti R, 2016, NEUROPSYCHOPHARMACOL, V41, P2688, DOI 10.1038/npp.2016.72; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; Shimizu Y, 2001, GASTROINTEST ENDOSC, V54, P190, DOI 10.1067/mge.2001.116877; Shimizu Y, 2003, ENDOSCOPY, V35, P322, DOI 10.1055/s-2003-38151; Song H, 2017, BRIT J CANCER, V117, P1715, DOI 10.1038/bjc.2017.332; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Urabe Y, 2009, ENDOSCOPY, V41, P304, DOI 10.1055/s-0029-1214477; Wang YL, 2011, ASIAN PAC J CANCER P, V12, P2065; World Health Organization, 1992, INT STAT CLASS DIS R; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; Yokoyama A, 2006, ALCOHOL CLIN EXP RES, V30, P491, DOI 10.1111/j.1530-0277.2006.00053.x; Yokoyama A, 2003, CARCINOGENESIS, V24, P1773, DOI 10.1093/carcin/bgg142; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 2002, CANCER EPIDEM BIOMAR, V11, P895; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Yokoyama A, 2008, CANCER SCI, V99, P1164, DOI 10.1111/j.1349-7006.2008.00807.x; Yokoyama A, 2007, INT J CANCER, V121, P1047, DOI 10.1002/ijc.22792; Yokoyama A, 2006, CANCER EPIDEM BIOMAR, V15, P2209, DOI 10.1158/1055-9965.EPI-06-0435; Yokoyama A, 2016, ALCOHOL CLIN EXP RES, V40, P1241, DOI 10.1111/acer.13073; Yokoyama A, 2014, ALCOHOL CLIN EXP RES, V38, P1237, DOI 10.1111/acer.12372; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1123, DOI 10.1111/acer.12069; Yokoyama A, 2013, ALCOHOL ALCOHOLISM, V48, P146, DOI 10.1093/alcalc/ags135; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2010, CANCER SCI, V101, P2497, DOI 10.1111/j.1349-7006.2010.01709.x; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227; Zhao TT, 2015, ONCOTARGETS THER, V8, P649, DOI 10.2147/OTT.S76526	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210546	10.1371/journal.pone.0210546	http://dx.doi.org/10.1371/journal.pone.0210546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629674	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000106
J	Carrillo-de-Albornoz, J; Aker, A; Kurtic, E; Plaza, L				Carrillo-de-Albornoz, Jorge; Aker, Ahmet; Kurtic, Emina; Plaza, Laura			Beyond opinion classification: Extracting facts, opinions and experiences from health forums	PLOS ONE			English	Article							SENTIMENT; UMLS; MANAGEMENT; TEXT	Introduction Surveys indicate that patients, particularly those suffering from chronic conditions, strongly benefit from the information found in social networks and online forums. One challenge in accessing online health information is to differentiate between factual and more subjective information. In this work, we evaluate the feasibility of exploiting lexical, syntactic, semantic, network-based and emotional properties of texts to automatically classify patient-generated contents into three types: "experiences", "facts" and "opinions", using machine learning algorithms. In this context, our goal is to develop automatic methods that will make online health information more easily accessible and useful for patients, professionals and researchers. Material and methods We work with a set of 3000 posts to online health forums in breast cancer, morbus crohn and different allergies. Each sentence in a post is manually labeled as "experience", "fact" or "opinion". Using this data, we train a support vector machine algorithm to perform classification. The results are evaluated in a 10-fold cross validation procedure. Results Overall, we find that it is possible to predict the type of information contained in a forum post with a very high accuracy (over 80 percent) using simple text representations such as word embeddings and bags of words. We also analyze more complex features such as those based on the network properties, the polarity of words and the verbal tense of the sentences and show that, when combined with the previous ones, they can boost the results.	[Carrillo-de-Albornoz, Jorge; Plaza, Laura] UNED IR & NLP Grp, Madrid, Spain; [Aker, Ahmet] Univ Duisburg Essen, Duisburg, Germany; [Kurtic, Emina] Univ Sheffield, Dept Human Commun Sci, Sheffield, S Yorkshire, England	Universidad Nacional de Educacion a Distancia (UNED); University of Duisburg Essen; University of Sheffield	Carrillo-de-Albornoz, J (corresponding author), UNED IR & NLP Grp, Madrid, Spain.	jcalbornoz@lsi.uned.es	; Plaza, Laura/H-9995-2015	Carrillo-de-Albornoz, Jorge/0000-0002-1449-1547; Plaza, Laura/0000-0001-5144-8014	Spanish Ministry of Science and Innovation [TIN2015-71785-R]; UNED [2014V/PUNED/001]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); UNED	This research was supported by the Spanish Ministry of Science and Innovation (Vemodalen Project, TIN2015-71785-R) and UNED (project 2014V/PUNED/001). There was no additional external funding received for this study.; This research was supported by the Spanish Ministry of Science and Innovation (Vemodalen Project, TIN2015-71785-R) and UNED (project 2014V/PUNED/001).	Agarwal S, 2009, BIOINFORMATICS, V25, P3174, DOI 10.1093/bioinformatics/btp548; Ali T, 2013, P 6 INT JOINT C NAT, P667; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Baroni M, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P238; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Carrillo-de Albornoz J, 2012, P 8 INT C LANG RES E; Carrillo-de-Albornoz J, 2013, J AM SOC INF SCI TEC, V64, P1618, DOI 10.1002/asi.22859; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Denecke K., 2015, HLTH WEB SCI, P83; Denecke K, 2015, ARTIF INTELL MED, V64, P17, DOI 10.1016/j.artmed.2015.03.006; Fox S, 2011, PEER TO PEER HLTH CA; Fox S, 2013, DIAGNOSIS DIFFERENCE; Girju CR, 2017, P 11 INT C SEM COMP; Gupta S, 2014, J AM MED INFORM ASSN, V21, P902, DOI 10.1136/amiajnl-2014-002669; Hatzivassiloglou V, 2000, P INT C COMP LING CO; Herskovic JR, 2011, INT J MED INFORM, V80, P431, DOI 10.1016/j.ijmedinf.2011.02.008; Iftikhar R, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5989; Jimeno Yepes A, 2013, P BIOASQ WORKSH; Jimeno-Yepes Antonio, 2012, Journal of Computing Science and Engineering, V6, P151, DOI 10.5626/JCSE.2012.6.2.151; Kouramajian V, 1995, Proc Annu Symp Comput Appl Med Care, P878; LEWIS DD, 1992, SIGIR 92 : PROCEEDINGS OF THE FIFTEENTH ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P37; Lorig K, 2013, HEALTH EDUC BEHAV, V40, P67, DOI 10.1177/1090198112436969; McCray AT, 2001, STUD HEALTH TECHNOL, V84, P216; Merolli M, 2013, J BIOMED INFORM, V46, P957, DOI 10.1016/j.jbi.2013.04.010; Plaza-del-Arco F, 2016, PROCES LENG NAT, P83; Pang B, 2004, PROCEEDINGS OF THE A; Plaza L, 2011, ARTIF INTELL MED, V53, P1, DOI 10.1016/j.artmed.2011.06.005; Riloff E, 2006, P C EMP METH NAT LAN; Ruch P, 2006, BIOINFORMATICS, V22, P658, DOI 10.1093/bioinformatics/bti783; Scott S, 1999, MACHINE LEARNING, PROCEEDINGS, P379; Smith L, 2004, BIOINFORMATICS, V20, P2320, DOI 10.1093/bioinformatics/bth227; Sohn S, 2008, J AM MED INFORM ASSN, V15, P546, DOI 10.1197/jamia.M2431; Sokolova M, 2015, RANLP, P604; Spolaor N, 2013, P BIOASQ WORKSH; Stone P.J., 1966, GEN INQUIRER COMPUTE; Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Wiebe J, 2005, LANG RESOUR EVAL, V39, P165, DOI 10.1007/s10579-005-7880-9; Wiebe J, 2004, COMPUT LINGUIST, V30, P277, DOI 10.1162/0891201041850885; Yepes AJJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0539-7; Yetisgen-Yildiz M, 2005, P AMIA ANN S; Zhang S, 2017, P 26 INT C WORLD WID, P1073; Zwerink M, 2014, SELF MANAGEMENT PATI	43	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209961	10.1371/journal.pone.0209961	http://dx.doi.org/10.1371/journal.pone.0209961			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625206	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400067
J	Clarke, TA; Reuter, KE; LaFleur, M; Schaefer, MS				Clarke, Tara A.; Reuter, Kim E.; LaFleur, Marni; Schaefer, Melissa S.			A viral video and pet lemurs on Twitter	PLOS ONE			English	Article							CAPTIVE LEMURS; MEDIA; MADAGASCAR; CONSERVATION; OWNERSHIP; IMPACT; TRUST; TRADE	Content shared on social media platforms can impact public perceptions of wildlife. These perceptions, which are in part shaped by context (e.g. non-naturalistic setting, presence of a human), can influence people's desires to interact with or acquire wild animals as pets. However, few studies have examined whether this holds true for wild animals featured in viral videos. This study reports on opportunistic data collected on Twitter before, during, and after a video that featured a habituated ring-tailed lemur (Lemur catta), called "Sefo", in southern Madagascar went 'viral' (i.e. circulated rapidly on the internet). Our dataset of 13,953 tweets (from an 18.5-week time period in early 2016) referencing lemurs was collected using targeted keywords on the Twitonomy Service. We identified 613 individual tweets about people wanting a lemur as a pet. In addition, 744 tweets that were captured in our dataset linked to the Sefo viral video. We found that as the number of tweets about the viral video increased, so did the number of tweets where an individual wanted to have a lemur as a pet. Most tweets (91%) did not make reference to a specific species of lemur, but when they did, they often (82%) referenced ring-tailed lemurs (L. catta), ruffed lemurs (Varecia spp.), and mouse lemurs (Microcebus spp.). This study serves as a case study to consider how viral content can impact how wild animals are perceived. We close by noting that social media sites like Twitter, which are increasingly providing their users with news and information, should carefully consider how information about wild animals is shared on their platforms, as it may impact animal welfare.	[Clarke, Tara A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Clarke, Tara A.; Reuter, Kim E.; LaFleur, Marni; Schaefer, Melissa S.] Univ Utah, Pet Lemur Survey Initiat, Salt Lake City, UT 84112 USA; [Reuter, Kim E.; Schaefer, Melissa S.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [LaFleur, Marni] Lemur Love Inc, San Diego, CA USA; [LaFleur, Marni] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; [Schaefer, Melissa S.] Salt Lake City Community Coll, Anthropol Program, Salt Lake City, UT USA	Duke University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego	Clarke, TA (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.; Clarke, TA (corresponding author), Univ Utah, Pet Lemur Survey Initiat, Salt Lake City, UT 84112 USA.	lemurgirl.clarke@gmail.com						Andriantsaralaza S., 2016, LEMUR CONSERVATION C; [Anonymous], 2017, CHECKLIST OF CITES S; [Anonymous], 2016, ICT FACTS AND FIGURE; [Anonymous], 2014, **DROPPED REF**; Balk EM., 2012, ACCURACY DATA EXTRAC; Box Office Mojo, 2017, MAD; Brewer-Hay R., 2008, EBAY I GLOBAL BAN IV; Christy B., 2008, LIZARD KING TRUE CRI, V1; Dwoskin E, 2017, WASHINGTON POST; Eckler P., 2011, J INTERACT ADVERT, V11, P1, DOI [DOI 10.1080/15252019.2011.10722180, 10.1080/1525019.2011.10722180, DOI 10.1080/1525019.2011.10722180]; El-Harrad A, 2013, AFRICAN PRIMATES, V8, P67; Fletcher R, 2017, DIGIT JOURNAL, V5, P1281, DOI 10.1080/21670811.2017.1279979; Gallo-Cajiao E, 2018, CONSERV BIOL, P1; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Herzog HA, 2004, P ROY SOC B-BIOL SCI, V271, pS353, DOI 10.1098/rsbl.2004.0185; Jackson J., 2016, A LITTLE HIGHER WATC; Leighty KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118487; Mason Robin, 2007, Internet and Higher Education, V10, P196, DOI 10.1016/j.iheduc.2007.06.003; Megias DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182368; Militz TA, 2017, FISH FISH, V18, P596, DOI 10.1111/faf.12202; Nekaris KAI, 2012, ORYX, V46, P169, DOI 10.1017/S0030605312000427; Nekaris KAI, 2015, FOLIA PRIMATOL, V86, P534, DOI 10.1159/000444231; Nekaris KAI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069215; Nelson-Field K, 2013, AUSTRALAS MARK J, V21, P205, DOI 10.1016/j.ausmj.2013.07.003; Newkey-Burden C., 2017, GUARDIAN; Nijman V, 2017, GLOB ECOL CONSERV, V11, P84, DOI 10.1016/j.gecco.2017.04.004; Patil S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7392; Pepitone J., 2010, TWITTER USERS NOT SO; Pew Research Center, 2017, NEWS USE ACROSS SOCI; Pew Research Center, 2017, ATTITUDES ABOUT THE; Pew Research Center, 2018, WESTERN EUROPE PUBLI; Pew Research Center, 2017, SCIENCE NEWS AND INF; Pew Research Center, 2010, GLOBAL ATTITUDES PRO; Reuter K, 2014, PRIMATE CONSERV, V28, P37, DOI [10.1896/052.028.0111, DOI 10.1896/052.028.0111]; Reuter KE, CONFERENCE JOINT MEE; Reuter KE, 2018, FOLIA PRIMATOL, V89, P81, DOI 10.1159/000477400; Reuter KE, 2017, ANTHROZOOS, V30, P33, DOI 10.1080/08927936.2017.1270589; Reuter KE, 2016, FOLIA PRIMATOL, V87, P48, DOI 10.1159/000444582; Reuter KE, 2016, ORYX, V50, P344, DOI 10.1017/S003060531400074X; Roberts DL, 2017, ORYX, V51, P393, DOI 10.1017/S0030605317000679; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; Rushby K., 2016, GUARDIAN; Schroepfer KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026048; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Trip Advisor, 2018, US; Tsfati Y, 2010, AM BEHAV SCI, V54, P22, DOI 10.1177/0002764210376309; Turcotte J, 2014, J COMPUT-MEDIAT COMM, V20, P520; Vieilledent G, 2018, BIOL CONSERV, V222, P189, DOI 10.1016/j.biocon.2018.04.008; Westerman D, 2014, J COMPUT-MEDIAT COMM, V19, P171, DOI 10.1111/jcc4.12041	50	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208577	10.1371/journal.pone.0208577	http://dx.doi.org/10.1371/journal.pone.0208577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625137	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400014
J	Doubek, JP; Carey, CC; Lavender, M; Winegardner, AK; Beaulieu, M; Kelly, PT; Pollard, AI; Straile, D; Stockwell, JD				Doubek, Jonathan P.; Carey, Cayelan C.; Lavender, Michael; Winegardner, Amanda K.; Beaulieu, Marieke; Kelly, Patrick T.; Pollard, Amina I.; Straile, Dietmar; Stockwell, Jason D.			Calanoid copepod zooplankton density is positively associated with water residence time across the continental United States	PLOS ONE			English	Article							CRUSTACEAN ZOOPLANKTON; LAND-USE; PRIMARY PRODUCTIVITY; TERRESTRIAL SUPPORT; SIZE DISTRIBUTION; REGRESSION TREES; TOTAL PHOSPHORUS; TROPHIC STATE; LAKES; FISH	Inherent differences between naturally-formed lakes and human-made reservoirs may play an important role in shaping zooplankton community structure. For example, because many reservoirs are created by impounding and managing lotic systems for specific human purposes, zooplankton communities may be affected by factors that are unique to reservoirs, such as shorter water residence times and a reservoir's management regime, compared to natural lakes. However, the environmental factors that structure zooplankton communities in natural lakes vs. reservoirs may vary at the continental scale and remain largely unknown. We analyzed data from the 2007 U.S. Environmental Protection Agency's National Lakes Assessment and the U.S. Army Corps of Engineers' National Inventory of Dams to compare large-bodied crustacean zooplankton communities (defined here as individuals retained by 0.243 mm mesh size) in natural lakes and reservoirs across the continental U.S. using multiple linear regressions and regression tree analyses. We found that large-bodied crustacean zooplankton density was overall higher in natural lakes compared to reservoirs when the effect of latitude was controlled. The difference between waterbody types was driven by calanoid copepods, which were also more likely to be dominant in the >0.243 mm zooplankton community in natural lakes than in reservoirs. Regression tree analyses revealed that water residence time was not a major driver of calanoid copepod density in natural lakes but was one of the most important drivers of calanoid copepod density in reservoirs, which had on average 0.5-year shorter water residence times than natural lakes. Reservoirs managed for purposes that resulted in shorter residence times (e.g., hydroelectric power) had lower zooplankton densities than reservoirs managed for purposes that resulted in longer residence times (e.g., irrigation). Consequently, our results indicate that water residence time may be an important characteristic driving differing large-bodied zooplankton dynamics between reservoirs and natural lakes.	[Doubek, Jonathan P.; Carey, Cayelan C.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Lavender, Michael] Queens Univ, Biol Dept, Biosci Complex, Kingston, ON, Canada; [Winegardner, Amanda K.] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Beaulieu, Marieke] Univ Sherbrooke, Dept Genie Civil, Sherbrooke, PQ, Canada; [Kelly, Patrick T.] Miami Univ, Biol Dept, Oxford, OH 45056 USA; [Pollard, Amina I.] US EPA, Off Water, Washington, DC 20460 USA; [Straile, Dietmar] Univ Konstanz, Limnol Inst, Constance, Germany; [Stockwell, Jason D.] Univ Vermont, Rubenstein Ecosyst Sci Lab, Burlington, VT USA	Virginia Polytechnic Institute & State University; Queens University - Canada; McGill University; University of Sherbrooke; University System of Ohio; Miami University; United States Environmental Protection Agency; University of Konstanz; University of Vermont	Doubek, JP (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jpdoubek@vt.edu	Straile, Dietmar/A-4065-2008; Lavender, Mike/K-8551-2019	Straile, Dietmar/0000-0002-7441-8552; Lavender, Mike/0000-0003-1541-3388; Doubek, Jonathan/0000-0003-2651-4715	National Science Foundation [DEB-1601061, EF-1137353, EF-1137327, ICER-1517823, EF-1702506]; Global Lake Ecological Observatory Network (GLEON), Virginia Tech Fralin Life Sciences Institute; Global Change Center	National Science Foundation(National Science Foundation (NSF)); Global Lake Ecological Observatory Network (GLEON), Virginia Tech Fralin Life Sciences Institute; Global Change Center	This work was supported by the National Science Foundation DEB-1601061, EF-1137353, EF-1137327, ICER-1517823, EF-1702506, Global Lake Ecological Observatory Network (GLEON), Virginia Tech Fralin Life Sciences Institute, and the Global Change Center.	Abell JM, 2012, FUND APPL LIMNOL, V181, P1, DOI 10.1127/1863-9135/2012/0272; ALLAN JD, 1976, AM NAT, V110, P165, DOI 10.1086/283056; Amsinck SL, 2006, FRESHWATER BIOL, V51, P2124, DOI 10.1111/j.1365-2427.2006.01627.x; ANDERSSON G, 1978, HYDROBIOLOGIA, V59, P9, DOI 10.1007/BF00017602; Andradottir HO, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012069; Balcer M. D., 1984, ZOOPLANKTON GREAT LA; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Basu BK, 1996, LIMNOL OCEANOGR, V41, P1572; Beaulieu M, 2013, LIMNOL OCEANOGR, V58, P1736, DOI 10.4319/lo.2013.58.5.1736; Beaver JR, 2014, HARMFUL ALGAE, V36, P57, DOI 10.1016/j.hal.2014.03.005; Beaver JR, 2014, FRESHWATER BIOL, V59, P1173, DOI 10.1111/fwb.12338; Beaver JR, 2013, HYDROBIOLOGIA, V705, P173, DOI 10.1007/s10750-012-1397-1; Bernot RJ, 2004, HYDROBIOLOGIA, V525, P101, DOI 10.1023/B:HYDR.0000038857.19342.fd; BLANCHER EC, 1984, HYDROBIOLOGIA, V109, P251, DOI 10.1007/BF00007743; Brooks JR, 2014, LIMNOL OCEANOGR, V59, P2150, DOI 10.4319/lo.2014.59.6.2150; Campbell CE, 1998, CAN J FISH AQUAT SCI, V55, P230, DOI 10.1139/cjfas-55-1-230; CANFIELD DE, 1981, CAN J FISH AQUAT SCI, V38, P414, DOI 10.1139/f81-058; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Chase JM, 2004, ECOL LETT, V7, P676, DOI 10.1111/j.1461-0248.2004.00622.x; Chou FNF, 2015, J HYDROL, V521, P245, DOI 10.1016/j.jhydrol.2014.11.073; COLE GA, 1961, LIMNOL OCEANOGR, V6, P432, DOI 10.4319/lo.1961.6.4.0432; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; CONFER JL, 1983, CAN J FISH AQUAT SCI, V40, P36, DOI 10.1139/f83-006; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DODSON S, 1992, LIMNOL OCEANOGR, V37, P848, DOI 10.4319/lo.1992.37.4.0848; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Dodson SI, 2007, HYDROBIOLOGIA, V579, P393, DOI 10.1007/s10750-006-0392-9; Doubek JP, 2017, INLAND WATERS, V7, P171, DOI 10.1080/20442041.2017.1293317; Doubek JP, 2015, AQUAT SCI, V77, P681, DOI 10.1007/s00027-015-0411-x; Doubek JP, 2011, J GREAT LAKES RES, V37, P159, DOI 10.1016/j.jglr.2010.11.012; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Gillooly JF, 2000, LIMNOL OCEANOGR, V45, P22, DOI 10.4319/lo.2000.45.1.0022; Griffith MB, 2001, ECOL APPL, V11, P489, DOI 10.1890/1051-0761(2001)011[0489:AOMAIR]2.0.CO;2; Hall SR, 2003, J GREAT LAKES RES, V29, P54, DOI 10.1016/S0380-1330(03)70415-8; Havens KE, 2011, HYDROBIOLOGIA, V668, P49, DOI 10.1007/s10750-010-0386-5; HAVENS KE, 1993, ENVIRON SCI TECHNOL, V27, P1621, DOI 10.1021/es00045a019; Helland IP, 2007, OECOLOGIA, V151, P322, DOI 10.1007/s00442-006-0541-x; Hoffmann MD, 2005, ECOLOGY, V86, P255, DOI 10.1890/03-0833; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1616, DOI 10.1111/j.1365-2427.2005.01413.x; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1030; Jeppesen E, 2011, HYDROBIOLOGIA, V676, P279, DOI 10.1007/s10750-011-0831-0; Jeziorski A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2449; JOHNSON RK, 1989, FRESHWATER BIOL, V21, P375, DOI 10.1111/j.1365-2427.1989.tb01370.x; JONES JR, 1978, HYDROBIOLOGIA, V57, P267, DOI 10.1007/BF00014580; Jones RI, 1999, OIKOS, V86, P97, DOI 10.2307/3546573; Karlsson J, 2005, GLOBAL CHANGE BIOL, V11, P710, DOI 10.1111/j.1365-2486.2005.00945.x; Kelly PT, 2014, ECOLOGY, V95, P1236, DOI 10.1890/13-1586.1; Kramer AM, 2008, ECOLOGY, V89, P2760, DOI 10.1890/07-1505.1; Kutner M., 2005, APPL LINEAR STAT MOD; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; Larsen J, 1996, HYDROBIOLOGIA, V328, P57, DOI 10.1007/BF00016900; Lehman JT, 2007, FRESHWATER BIOL, V52, P1773, DOI 10.1111/j.1365-2427.2007.01808.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Merrix-Jones FL, 2013, J LIMNOL, V72, P140, DOI 10.4081/jlimnol.2013.e12; Moore MV, 1996, ARCH HYDROBIOL, V135, P289; O'Brien WJ, 2004, LIMNOL OCEANOGR, V49, P1250, DOI 10.4319/lo.2004.49.4_part_2.1250; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Obertegger U, 2007, AQUAT SCI, V69, P575, DOI 10.1007/s00027-007-0924-z; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Peck DV, 2013, FRESHW SCI, V32, P1231, DOI 10.1899/11-075.1; Pinto-Coelho R, 2005, CAN J FISH AQUAT SCI, V62, P348, DOI 10.1139/F04-178; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2016, R LANG ENV STAT COMP; Ray MR, 2011, J HYDRO-ENVIRON RES, V5, P177, DOI 10.1016/j.jher.2010.12.001; RICHMAN S, 1983, LIMNOL OCEANOGR, V28, P948, DOI 10.4319/lo.1983.28.5.0948; Rigler FH, 1984, MANUAL METHODS ASSES, V17, ppp19; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Romare P, 1999, LIMNOL OCEANOGR, V44, P1655, DOI 10.4319/lo.1999.44.7.1655; Rosenberg DM, 2000, BIOSCIENCE, V50, P746, DOI 10.1641/0006-3568(2000)050[0746:GSEEOH]2.0.CO;2; Silva LHS, 2014, LIMNOLOGICA, V48, P1, DOI 10.1016/j.limno.2014.04.004; Simoes NR, 2015, HYDROBIOLOGIA, V758, P3, DOI 10.1007/s10750-015-2260-y; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sondergaard M, 2005, J APPL ECOL, V42, P616, DOI 10.1111/j.1365-2664.2005.01040.x; SPRULES WG, 1975, J FISH RES BOARD CAN, V32, P389, DOI 10.1139/f75-045; Straile D, 2015, FRESHWATER BIOL, V60, P174, DOI 10.1111/fwb.12484; Thornton K. W., 1981, P S SURF WAT IMP AM, V1, P654; Thornton K. W, 1990, RESERVOIR LIMNOLOGY; US Environmental Protection Agency, 2009, 841R09001 EPA; Vanderploeg HA, 2009, J EXP MAR BIOL ECOL, V381, pS92, DOI 10.1016/j.jembe.2009.07.027; Vanderploeg HA, 2009, J EXP MAR BIOL ECOL, V381, pS108, DOI 10.1016/j.jembe.2009.07.015; VANNI MJ, 1986, ECOLOGY, V67, P337, DOI 10.2307/1938577; VANNI MJ, 1990, ECOLOGY, V71, P921, DOI 10.2307/1937363; Vanni MJ, 1997, ECOLOGY, V78, P21; Waervagen SB, 2002, FRESHWATER BIOL, V47, P1866, DOI 10.1046/j.1365-2427.2002.00934.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wetzel R.G., 1990, P227; Whittier TR, 2002, HYDROBIOLOGIA, V470, P157, DOI 10.1023/A:1015688407915; Williamson CE, 2002, LIMNOL OCEANOGR, V47, P1844, DOI 10.4319/lo.2002.47.6.1844; Winslow LA, 2014, FRESHWATER BIOL, V59, P213, DOI 10.1111/fwb.12258; Yan ND, 2002, ECOL LETT, V5, P481, DOI 10.1046/j.1461-0248.2002.00348.x; Yuan LL, 2014, FRESHW SCI, V33, P1184, DOI 10.1086/678465; Yuan LL, 2014, FRESHWATER BIOL, V59, P1970, DOI 10.1111/fwb.12400; Zhang W, 2016, WATER RESOUR MANAG, V30, P523, DOI 10.1007/s11269-015-1175-8	95	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209567	10.1371/journal.pone.0209567	http://dx.doi.org/10.1371/journal.pone.0209567			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625172	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400045
J	Lee, YY; Wang, ZX				Lee, Ying Ying; Wang, Zixin			Facilitators and barriers for healthcare providers to recommend HPV vaccination to attendees of public sexually transmitted diseases clinics in Hong Kong, China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; GYNECOLOGISTS KNOWLEDGE; GENERAL-PRACTITIONERS; ADOLESCENT FEMALES; ATTITUDES; INFECTION; ACCEPTABILITY; BEHAVIORS; NEOPLASIA; PARENTS	Background Attendees of sexually transmitted diseases (STD) clinics could also benefit from HPV vaccination. Healthcare providers' recommendation is the most effective published method in motivating HPV vaccination initiation. This study was to investigate practice of recommending HPV vaccination to attendees among healthcare providers (doctors and nurses) working in public STD clinics in Hong Kong, China. Method Participants were medical doctors, registered nurses and enrolled nurses working in all eight public STD clinics in Hong Kong. All of them (29 doctors and 82 nurses) were approached by telephone. A self-administered questionnaire was mailed to them. A total of 98 completed questionnaires were received (28 doctors and 70 nurses). The study was conducted during January to May, 2018. Using recommendation of HPV vaccination to any attendees in the last year as the dependent variable, univariate and multiple logistic regression models were fitted. Results In the last 12 months, 16.3% and 36.7% of the participants had recommended HPV vaccination to any male attendees and to any female attendees of their clinics; 41.8% had recommended it to either male or female attendees. Adjusting for significant background variables (professions and years of working experience in the clinic), three constructs of the Theory of Planned Behavior were significantly associated with the dependent variable in expected directions. They were: 1) the Positive Attitude Scale (adjusted odds ratios, AOR: 1.20, 95% CI: 1.02, 1.41), 2) the Negative Attitude Scale (AOR: 0.85, 95% CI: 0.77, 0.94), and 3) the Perceived Behavioral Control Scale (AOR: 1.37, 95% CI: 1.08, 1.75). Conclusion STD clinics are ideal settings that allow healthcare providers to access individuals who are at high-risk of HPV infection and promote HPV vaccination. Health promotion targeting these healthcare providers is warranted to enhance their perceived importance of recommending HPV vaccination. Such promotion should modify their attitudes and perceived behavioral control related to recommending HPV vaccination to attendees.	[Lee, Ying Ying] Dept Hlth, Hong Kong, Peoples R China; [Wang, Zixin] Chinese Univ Hong Kong, Ctr Hlth Behav Res, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China	Chinese University of Hong Kong	Wang, ZX (corresponding author), Chinese Univ Hong Kong, Ctr Hlth Behav Res, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.	wangzx@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022					AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bartlett JA, 2011, J SCH NURS, V27, P434, DOI 10.1177/1059840511415861; Bianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614; Centers for Disease Control and Prevention, 2016, HPV VACC REC; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705; Centre for Health Protection, 2017, HONG KONG STD AIDS U; Chawla PC, 2016, INDIAN J MED RES, V144, P740, DOI 10.4103/ijmr.IJMR_1106_14; Cheung T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198615; Choi HCW, 2013, VACCINE, V32, P78, DOI 10.1016/j.vaccine.2013.10.068; Collange F, 2016, VACCINE, V34, P762, DOI 10.1016/j.vaccine.2015.12.054; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Department of Health, 2017, HONG KONG STD AIDS U; Duval B, 2007, VACCINE, V25, P7841, DOI 10.1016/j.vaccine.2007.08.041; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Hill M, 2014, HUM VACC IMMUNOTHER, V10, P2551, DOI 10.4161/21645515.2014.970933; JOURA EA, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E1401; Kahn JA, 2007, AMBUL PEDIATR, V7, P367, DOI 10.1016/j.ambp.2007.05.010; Landis K, 2018, VACCINE, V36, P3498, DOI 10.1016/j.vaccine.2018.04.075; Lataifeh I, 2014, EUR J GYNAECOL ONCOL, V35, P429; Lau JTF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057204; Lau M, 2012, VACCINE, V30, P3112, DOI 10.1016/j.vaccine.2012.02.034; McGinley L.., 2016, WASH POST; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Moss JL, 2015, PREV MED, V78, P65, DOI 10.1016/j.ypmed.2015.07.002; Napolitano F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194920; Napolitano F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2138-2; Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271; Nilsen K, 2017, SCAND J PRIM HEALTH, V35, P387, DOI 10.1080/02813432.2017.1358433; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perkins RB, 2012, AM J MENS HEALTH, V6, P320, DOI 10.1177/1557988312438911; Ragan KR, 2018, VACCINE, V36, P331, DOI 10.1016/j.vaccine.2017.07.041; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Schoeb V, 2016, CHINA PERSPECT, P51; Siu JYM, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-73; Songthap A, 2009, SE ASIAN J TROP MED, V40, P1048; Stamenkovic Z, 2017, J LOW GENIT TRACT DI, V21, P9, DOI 10.1097/LGT.0000000000000262; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; Wang ZX, 2018, VACCINE, V36, P2657, DOI 10.1016/j.vaccine.2018.03.057; Wong MCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071827; Ylitalo KR, 2013, AM J PUBLIC HEALTH, V103, P164, DOI 10.2105/AJPH.2011.300600	41	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209942	10.1371/journal.pone.0209942	http://dx.doi.org/10.1371/journal.pone.0209942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625211	gold, Green Submitted, Green Published			2022-12-26	WOS:000455359400066
J	Moity, N; Delgado, B; Salinas-de-Leon, P				Moity, Nicolas; Delgado, Byron; Salinas-de-Leon, Pelayo			Mangroves in the Galapagos islands: Distribution and dynamics	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; GOOGLE EARTH; POSITIONAL ACCURACY; FORESTS; CLASSIFICATION; BIOMASS; IMAGERY; WORLD; ICESAT/GLAS; EXTINCTION	Mangrove forests provide valuable coastal protection from erosion, habitat for terrestrial and marine species, nursery grounds for commercial fisheries and are economically important for tourism. Galapagos' mangroves usually grow directly on solid lava and fragmented rocky shores, thereby stabilizing the sediment and facilitating colonisation by other plants and many animals. However, until very recently, only inaccurate data described mangrove coverage and its distribution. We mapped mangroves using freely available Google Earth Very High Resolution images based on on-screen classification and compared this method to three semi-automatic classification algorithms. We also analysed mangrove change for the period 2004-2014. We obtained an area of 3657.1 ha of fringing mangrove that covers 35% of the coastline. Eighty percent of mangrove cover is found in Isabela island, and 90% in the western and central south-eastern bioregions. The overall accuracy of mangrove classification was 99.1% with a Kappa coefficient of 0.97 when validated with field data. On-screen digitization was significantly more accurate than other tested methods. From the semi-automated methods, Maximum Likelihood Classification with prior land-sea segmentation yielded the best results. During the 2004-2014 period, mangrove coverage increased 24% mainly by expansion of existing mangroves patches as opposed to generation of new patches. We estimate that mangrove cover and growth are inversely proportional to the geological age of the islands. However, many other factors like nutrients, currents or wave exposure protection might explain this pattern. The precise localization of mangrove cover across the Galapagos islands now enables documenting whether it is changing over time.	[Moity, Nicolas; Delgado, Byron; Salinas-de-Leon, Pelayo] Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador; [Salinas-de-Leon, Pelayo] Natl Geog Soc, Pristine Seas, Washington, DC USA	National Geographic Society	Moity, N (corresponding author), Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador.	nicolas.moity@fcdarwin.org.ec	Moity, Nicolas/F-5312-2017	Moity, Nicolas/0000-0002-4021-9782; Delgado, Byron/0000-0002-5250-0213	Leona M. and Harry B. Helmsley Charitable Trust	Leona M. and Harry B. Helmsley Charitable Trust	This research was supported by grants to the Charles Darwin Research Station by The Leona M. and Harry B. Helmsley Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10030646; Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Aguaiza C, 2016, THESIS; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 1974, ANN REV ECOL SYST, DOI DOI 10.1146/ANNUREV.ES.05.110174.000351; Asian A, 2016, REMOTE SENS ENVIRON, V183, P65, DOI 10.1016/j.rse.2016.04.026; BALL MC, 1995, FUNCT ECOL, V9, P77, DOI 10.2307/2390093; Banks S, 2002, RESERVA MARINA GALAP, P18; Becek K, 2011, FIG WORK WEEK 2011 B; Benker SC, 2011, GEOCARTO INT, V26, P291, DOI 10.1080/10106049.2011.568125; Blasco F, 1996, CATENA, V27, P167, DOI 10.1016/0341-8162(96)00013-6; Brinkhoff T., 1995, ACMGIS109; Briones EE, 1997, INVENTARIO HUMEDALES; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Carvajal Y., 1979, ZONIFICACION ESTRUCT; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Collin A, 2014, ISPRS INT J GEO-INF, V3, P1157, DOI 10.3390/ijgi3041157; CONALGODON, 2022, CONF COL ALG; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh-Guebas F, 2008, AQUAT BOT, V89, P80, DOI 10.1016/j.aquabot.2008.03.012; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Dodd Richard S., 2008, P172, DOI 10.1017/CBO9780511751790.017; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Dvorak M, 2004, ORYX, V38, P171, DOI 10.1017/S0030605304000316; Edgar GJ, 2004, J BIOGEOGR, V31, P1107, DOI 10.1111/j.1365-2699.2004.01055.x; Salinas-Castillo WE, 2014, GEOCARTO INT, V29, P625, DOI 10.1080/10106049.2013.821176; Epler B., 2007, TOURISM EC POPULATIO, P68; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; Fatoyinbo TE, 2013, INT J REMOTE SENS, V34, P668, DOI 10.1080/01431161.2012.712224; Fessl B, 2010, PHILOS T R SOC B, V365, P1019, DOI 10.1098/rstb.2009.0288; Fierro D, 2017, THESIS; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Geist D., 1996, NOTICIAS GALAPAGOS, V56, P5; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Giri C, 2016, OBSERVATION MONITORI; Giri C, 2000, GLOBAL MANGROVE FORE; Giri C, 2015, J ENVIRON MANAGE, V148, P101, DOI 10.1016/j.jenvman.2014.01.020; Giri C, 2011, J COASTAL RES, V27, P1059, DOI 10.2112/JCOASTRES-D-11-00028.1; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Goldberg Walter M., 2016, Atoll Research Bulletin, P1; Guo MR, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17051140; Hamilton S, 2013, B MAR SCI, V89, P585, DOI 10.5343/bms.2012.1069; Hay GJ, 2005, INT J APPL EARTH OBS, V7, P339, DOI 10.1016/j.jag.2005.06.005; Heumann BW, 2011, REMOTE SENS-BASEL, V3, P2440, DOI 10.3390/rs3112440; Hogarth PJ, 2015, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198716549.001.0001; Hossain MS, 2016, MAR POLICY, V72, P176, DOI 10.1016/j.marpol.2016.07.003; Hu Q, 2013, REMOTE SENS-BASEL, V5, P6026, DOI 10.3390/rs5116026; Hunt ER, 2013, INT J APPL EARTH OBS, V21, P103, DOI 10.1016/j.jag.2012.07.020; Ibharim NA, 2015, OCEAN COAST MANAGE, V114, P64, DOI 10.1016/j.ocecoaman.2015.06.005; INEC, 2015, AN LISIS RESULTADOS; INGALA PRONAREG ORSTOM, 1989, INV CART REC NAT GEO; Itow S., 1992, ALTITUDINAL CHANGE P; Itow S., 2003, GLOBAL ENV RES, V7, P39; Jacobson A, 2015, ENVIRON MODELL SOFTW, V72, P1, DOI 10.1016/j.envsoft.2015.06.011; Jaenig M., 2010, THESIS; JARA V, 2012, ACTA OCEANOGR PAC, V17, P1; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Krauss KW, 2013, TREES-STRUCT FUNCT, V27, P7, DOI 10.1007/s00468-012-0767-7; Kuenzer C, 2011, REMOTE SENS-BASEL, V3, P878, DOI 10.3390/rs3050878; Kurz MD, 1999, GEOCHIM COSMOCHIM AC, V63, P4139, DOI 10.1016/S0016-7037(99)00314-2; Liew T-S, 2016, BIORXIV; Liu YX, 2006, CHINESE GEOGR SCI, V16, P282, DOI 10.1007/s11769-006-0282-0; Llerena Y, 2010, IDENTIFICATION REARI; Llerena Y, 2012, P 3 COL WORKSH CONDR; Long J, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.c01; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Lucas RM, 2007, AQUAT CONSERV, V17, P245, DOI 10.1002/aqc.833; Lugendo BR, 2007, B MAR SCI, V80, P497; Lynett P, 2013, PURE APPL GEOPHYS, V170, P1189, DOI 10.1007/s00024-012-0568-3; Lynham J, 2015, EC VALUATION MARIN A, P44; Mackenzie JR, 2016, MAR POLLUT BULL, V109, P751, DOI 10.1016/j.marpolbul.2016.05.069; McCarthy MJ, 2015, INT J APPL EARTH OBS, V40, P11, DOI 10.1016/j.jag.2015.03.011; Millennium Ecosystem Assessment, 2005, EC HUM WELL BE WETL; Moity N, 2017, 1 FUND CHARL DARW, P45; Mukherjee N, 2014, PLOS ONE, P9; Nabhan GP, 1973, CHARACTERIZATION GAL, P38; Son NT, 2016, WETLANDS, V36, P565, DOI 10.1007/s13157-016-0767-2; Nolan M, 2015, CRYOSPHERE, DOI [10.1.1.668.3895&rep=rep1&type=pdf, DOI 10.1.1.668.3895&REP=REP1&TYPE=PDF]; Palacios DM, 2004, DEEP-SEA RES PT II, V51, P43, DOI 10.1016/j.dsr2.2003.08.001; Palma C, 2018, REV BIOL TROP, V66, P674, DOI [10.15517/rbt.v66i2.33400, DOI 10.15517/RBT.V66I2.33400]; Penas Merino A., 2011, GLOBAL GEOBOTANY, V1, P1, DOI [DOI 10.5616/GG110001, 10.5616/gg110001]; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Potere D, 2008, SENSORS-BASEL, V8, P7973, DOI 10.3390/s8127973; Pulighe G, 2016, INT J DIGIT EARTH, V9, P342, DOI 10.1080/17538947.2015.1031716; QGIS Development Team, 2018, QGIS DEV TEAM V 3 2; Quisthoudt K, 2012, TREES-STRUCT FUNCT, V26, P1919, DOI 10.1007/s00468-012-0760-1; R Core Team, 2018, R LANG ENV STAT COMP; Ramdani F., 2015, Journal of Geographic Information System, V7, P43, DOI 10.4236/jgis.2015.71004; Rivas-Torres GF, 2018, PROG PHYS GEOG, V42, P83, DOI 10.1177/0309133317752278; Roelfsema C, 2018, REMOTE SENS ENVIRON, V208, P27, DOI 10.1016/j.rse.2018.02.005; Schmid MO, 2015, CRYOSPHERE, V9, P2089, DOI 10.5194/tc-9-2089-2015; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Shahzad N, 2017, INT J REMOTE SENS, V38, P1579, DOI 10.1080/01431161.2016.1278311; Simard M., 2011, J GEOPHYS RES-BIOGEO, P116; Simard M, 2008, REMOTE SENS ENVIRON, V112, P2131, DOI 10.1016/j.rse.2007.10.012; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Sun GQ, 2011, REMOTE SENS ENVIRON, V115, P2906, DOI 10.1016/j.rse.2011.03.021; Teas H. J., 1983, BIOL ECOLOGY MANGROV; Thi VT, 2014, BIOGEOSCIENCES, V11, P3781, DOI 10.5194/bg-11-3781-2014; TNC-CLIRSEN, 2006, CART GAL 2006 CONS O; Paredes-Hernandez CU, 2013, B CIENC GEOD, V19, P588, DOI 10.1590/S1982-21702013000400005; Valderrama-Landeros L, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-017-6399-z; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Verheyden Anouk, 2002, Environment Development and Sustainability, V4, P113, DOI 10.1023/A:1020887510357; Waltham NJ, 2015, MAR POLICY, V57, P78, DOI 10.1016/j.marpol.2015.03.030; Wang WQ, 2011, TREES-STRUCT FUNCT, V25, P953, DOI 10.1007/s00468-011-0570-x; Wells A.G., 1982, MANGROVE ECOSYSTEMS, P57; Wiggins IL, 1971, FLORA GALAPAGOS ISLA; Wium-Andersen S., 1986, I GEOGR FICO MIL REV, V23, P101; Yanyun Liu, 2014, International Journal of Oceanography, DOI 10.1155/2014/198686; Yu L, 2012, INT J REMOTE SENS, V33, P3966, DOI 10.1080/01431161.2011.636081	118	15	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209313	10.1371/journal.pone.0209313	http://dx.doi.org/10.1371/journal.pone.0209313			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625180	Green Published, gold			2022-12-26	WOS:000455359400034
J	Price, RL; Bugeon, L; Mostowy, S; Makendi, C; Wren, BW; Williams, HD; Willcocks, SJ				Price, R. L.; Bugeon, L.; Mostowy, S.; Makendi, C.; Wren, B. W.; Williams, H. D.; Willcocks, S. J.			In vitro and in vivo properties of the bovine antimicrobial peptide, Bactenecin 5	PLOS ONE			English	Article							MYCOBACTERIUM-MARINUM INFECTION; GROWTH-FACTOR-BETA; HOST-DEFENSE; TNF-ALPHA; MACROPHAGE ACTIVATION; MEDIATES RESISTANCE; ADULT ZEBRAFISH; PROTECTIVE ROLE; IMMUNE-SYSTEM; TUBERCULOSIS	Antimicrobial peptides (AMP), part of the innate immune system, are well studied for their ability to kill pathogenic microorganisms. However, many also possess important immunomodulatory effects, and this area has potential for the development of novel therapies to supplement traditional methods such as the use of antibiotics. Here, we characterise the microbicidal and immunomodulatory potential of the proline-rich bovine AMP, Bactenecin 5 (Bac5). We demonstrate broad antimicrobial activity, including against some mycobacterial species, which are important pathogens of fish, cattle and humans. Bac5 is able to activate macrophage-like THP-1 cells and can synergistically trigger the upregulation of tnf-alpha when co-stimulated with M. marinum. Furthermore, Bac5 sensitises A549 epithelial cells to stimulation with TNF-alpha. For the first time, we characterise the activity of Bac5 in vivo, and show it to be a potent chemokine for macrophages in the zebrafish (Danio rerio) embryo model of infection. Bac5 also supports the early recruitment of neutrophils in the presence of M. marinum. In the absence of host adaptive immunity, exogenous injected Bac5 is able to slow, although not prevent, infection of zebrafish with M. marinum.	[Price, R. L.; Bugeon, L.; Williams, H. D.] Imperial Coll London, Dept Life Sci, London, England; [Mostowy, S.] Imperial Coll London, Dept Med, London, England; [Makendi, C.; Wren, B. W.; Willcocks, S. J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England	Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Willcocks, SJ (corresponding author), London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.	sam.willcocks@lshtm.ac.uk		Mostowy, Serge/0000-0002-7286-6503; Bugeon, Laurence/0000-0002-6978-2878	BBSRC [BB/N004590/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 2001, IMMUNOBIOLOGY IMMUNE; [Anonymous], 2007, J ALLERGY CLIN IMMUN, V119, pS260; Bednarska N. G., 2017, DRUG DISCOV TODAY; BETHEA JR, 1992, J NEUROIMMUNOL, V36, P179, DOI 10.1016/0165-5728(92)90049-Q; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Bourigault ML, 2013, IMMUN INFLAMM DIS, V1, P47, DOI 10.1002/iid3.9; Brandenburg LO, 2012, POLYMERS-BASEL, V4, P539, DOI 10.3390/polym4010539; Brunetti J, 2016, J BIOL CHEM, V291, P25742, DOI 10.1074/jbc.M116.750257; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Castro-Garza J, 2012, CAN J MICROBIOL, V58, P909, DOI [10.1139/w2012-067, 10.1139/W2012-067]; Cheah FSH, 2005, DEV DYNAM, V232, P1021, DOI 10.1002/dvdy.20282; Choi HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164458; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Corleis B, 2012, CELL MICROBIOL, V14, P1109, DOI 10.1111/j.1462-5822.2012.01783.x; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Cronan MR, 2014, DIS MODEL MECH, V7, P777, DOI 10.1242/dmm.016089; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Freer E, 1999, INFECT IMMUN, V67, P6181, DOI 10.1128/IAI.67.11.6181-6186.1999; Freitas C. G., 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/IAI.00887-06, DOI 10.1128/IAI.00887-06]; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gallego C, 2011, INFECT IMMUN, V79, P2871, DOI 10.1128/IAI.01388-10; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; IKEJIMA T, 1990, J INFECT DIS, V162, P215, DOI 10.1093/infdis/162.1.215; Jarczak J, 2014, ANIM SCI PAP REP, V32, P41; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Ledesma E, 2004, CYTOKINE, V26, P66, DOI 10.1016/j.cyto.2003.12.009; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Madhongsa K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002267; Mansour SC, 2015, J PEPT SCI, V21, P323, DOI 10.1002/psc.2708; Marin ND, 2012, CLIN VACCINE IMMUNOL, V19, P1667, DOI 10.1128/CVI.00390-12; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mishra B, 2017, CURR OPIN CHEM BIOL, V38, P87, DOI 10.1016/j.cbpa.2017.03.014; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Mudaliar M, 2016, MOL BIOSYST, V12, P2748, DOI 10.1039/c6mb00290k; Niyonsaba F, 2013, J LEUKOCYTE BIOL, V94, P159, DOI 10.1189/jlb.1012497; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Paulsen V. S., 2016, MICROBIOLOGY, V1; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Raj PA, 1996, BIOCHEMISTRY-US, V35, P4314, DOI 10.1021/bi951681r; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rivas-Santiago B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059119; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Salim T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153289; Schaal JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051337; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; SCOCCHI M, 1992, EUR J BIOCHEM, V209, P589, DOI 10.1111/j.1432-1033.1992.tb17324.x; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Suzuki Y, 2011, BURNS, V37, P109, DOI 10.1016/j.burns.2010.08.004; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Tokunaga Y, 2001, J PEPT SCI, V7, P297, DOI 10.1002/psc.317; Tomasinsig L, 2002, J LEUKOCYTE BIOL, V72, P1003; Tomasinsig L, 2012, J PEPT SCI, V18, P105, DOI 10.1002/psc.1422; Tomasinsig L, 2010, INFECT IMMUN, V78, P1781, DOI 10.1128/IAI.01090-09; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P613; van der Vaart Michiel, 2012, Adv Hematol, V2012, P159807, DOI 10.1155/2012/159807; van Dijk A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147919; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; VERBANAC D, 1993, FEBS LETT, V317, P255, DOI 10.1016/0014-5793(93)81287-A; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Young-Speirs M, 2018, INT J ANTIMICROB AG, V51, P813, DOI 10.1016/j.ijantimicag.2018.02.006; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; ZANETTI M, 1991, J IMMUNOL, V146, P4295; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x	88	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210508	10.1371/journal.pone.0210508	http://dx.doi.org/10.1371/journal.pone.0210508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625198	Green Accepted, Green Published, gold			2022-12-26	WOS:000455359400091
J	Shayo, FK; Bintabara, D				Shayo, Festo K.; Bintabara, Deogratius			Are Tanzanian health facilities ready to provide management of chronic respiratory diseases? An analysis of national survey for policy implications	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DEVELOPING-COUNTRIES; AVAILABILITY; READINESS; COPD; CARE	Introduction Chronic respiratory diseases in Tanzania are prevalent and a silent burden to the affected population, and healthcare system. We aimed to explore the availability of services and level of health facilities readiness to provide management of chronic respiratory diseases and its associated factors. Methods The current study is a secondary analysis of the 2014-2015 Tanzania Service Provision Assessment Survey data. Facilities were considered to have a high readiness to provide management of chronic respiratory diseases if they scored at least half (>50%) of the indicators listed in each of the three domains (staff training and guideline, equipment, and basic medicines) as identified by World Health Organization-Service Availability and Readiness Assessment manual. Descriptive, unadjusted and adjusted logistic regression analyses were performed. A Pvalue < 0.05 was taken to indicate statistical significance. Results Out of 723 facilities included in this analysis, approximately one-tenth had a high readiness to provide management of chronic respiratory diseases. Less than 10% of the facilities had at least one staff who received training for management of chronic respiratory diseases. In an adjusted model, privately owned facilities [AOR = 3.3; 95% CI, 1.5-7.5], hospitals [AOR = 11.6; 95% CI, 5.0-27.2], health centres [AOR = 5.0; 95% CI, 2.4-10.7], and performance of routine management meeting [AOR = 3.3; 95% CI, 1.4-7.8] were significantly associated with high readiness to provide management for chronic respiratory diseases. Conclusion Majority of Tanzanian health facilities have low readiness to provide management for chronic respiratory diseases. There is a need for the Tanzanian government to increase the availability of diagnostic equipment, medication, and to provide refresher training specifically in the lower-level and public health facilities for better management of chronic respiratory diseases and other non-communicable diseases.	[Shayo, Festo K.; Bintabara, Deogratius] Tokyo Med & Dent Univ, Dept Global Hlth Entrepreneurship, Div Publ Hlth, Grad Sch, Tokyo, Japan; [Shayo, Festo K.] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Bintabara, Deogratius] Univ Dodoma, Dept Publ Hlth, Coll Hlth Sci, Dodoma, Tanzania	Tokyo Medical & Dental University (TMDU); Muhimbili University of Health & Allied Sciences	Bintabara, D (corresponding author), Tokyo Med & Dent Univ, Dept Global Hlth Entrepreneurship, Div Publ Hlth, Grad Sch, Tokyo, Japan.; Bintabara, D (corresponding author), Univ Dodoma, Dept Publ Hlth, Coll Hlth Sci, Dodoma, Tanzania.	bintabaradeo@gmail.com		Bintabara, Deogratius/0000-0001-7877-870X				Agwanda Alfred, 2009, KENYA WORKING PAPERS, V4; Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; Basu S, 2012, PLOS MED, V9, P19, DOI DOI 10.1371/J0URNAL.PMED.1001244; Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Bousquet J, 2003, ALLERGY, V58, P265, DOI 10.1034/j.1398-9995.2003.02005.x; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Checkley W, 2014, GLOB HEART, V9, P431, DOI 10.1016/j.gheart.2014.11.003; Global Asthma Network, 2014, GLOB ASTHM REP 2014, V5, P14, DOI DOI 10.3740/MRSK.2003.13.10.645; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, ASTHM COPD OV SYNDR; Hancock C, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-23; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kebede A, 2017, ETHIOPIA SERVICE AVA, P1; Lusambo L.P., 2016, J ECOSYSTEM ECOGRAPH, V5, P007, DOI [https://doi.org/10.4172/2157-7625.S5-007, DOI 10.4172/2157-7625.S5-007]; Magitta F., 2018, EPIDEMIOLOGY CHALLEN, V2, P17; Magitta NF, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00182-2017; Mayige M., 2013, TANZANIA STEPS SURVE; Mehrotra A, 2018, TROP MED INT HEALTH, V23, pE1, DOI 10.1111/tmi.13045; Ministry of Health, 2016, TANZ DEM HLTH SURV M; Ministry of Health and Welfare, 2016, TANZ DEM HLTH SURV M, P172, DOI DOI 10.1017/CBO9781107415324.004; Ministry of Health Community Development Gender Elderly and Children, 2016, STRATEGIC ACTION PLA; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) [Tanzania Mainland] Ministry of Health (MoH) [Zanzibar] National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2015, TANZ 2015 16 DEM HLT; Mortimer Kevin, 2015, BMC Proc, V9, pS3, DOI 10.1186/1753-6561-9-S10-S3; Patel ARC, 2011, EXPERT REV RESP MED, V5, P647, DOI [10.1586/ERS.11.62, 10.1586/ers.11.62]; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Salvi S, 2015, LANCET GLOB HEALTH, V3, pE6, DOI 10.1016/S2214-109X(14)70359-6; Schroth RJ., 2016, SAUDI J DENT RES, V7, P118, DOI DOI 10.1016/J.SJDR.2016.04.006; Shayo FK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0694-5; Shimwela M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-387; Sikika, 2011, MED MED SUPPL AV REP; The International Union Against Tuberculosis and Lung Disease, 2011, GLOB ASTHM REP 2011; van Gemert F, 2015, LANCET GLOB HEALTH, V3, pE44, DOI 10.1016/S2214-109X(14)70337-7; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; Wang WJ, 2017, GLOB HEALTH-SCI PRAC, V5, P244, DOI 10.9745/GHSP-D-16-00311; World Health Organisation (WHO), 2013, PREV CHRON RESP DIES; World Health Organization, 2012, MAN SEV MAL PRACT HD, P1; World Health Organization (WHO), 2008, WORLD HLTH STAT, P112, DOI [10.1061/(ASCE)HY.1943-7900.0000746, DOI 10.1061/(ASCE)HY.1943-7900.0000746]	38	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210350	10.1371/journal.pone.0210350	http://dx.doi.org/10.1371/journal.pone.0210350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615663	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900066
J	Tamma, A; Bjelic-Radisic, V; Holbfer, S; Trutnovsky, G; Tamussino, K; Aigmuller, T; Ulrich, D				Tamma, Ayman; Bjelic-Radisic, Vesna; Hoelbfer, Susanne; Trutnovsky, Gerda; Tamussino, Karl; Aigmueller, Thomas; Ulrich, Daniela			Sonographic sling position and cure rate 10-years after TVT-O procedure	PLOS ONE			English	Article							FREE VAGINAL TAPE; STRESS URINARY-INCONTINENCE; TENSION; WOMEN; LOCATION; QUESTIONNAIRE; VALIDATION; ULTRASOUND; BLADDER; SURGERY	Aim To examine the position of the TVT-O sling 10 years postoperatively and its association with outcome. Methods A total of 124 patients who received a TVT-O sling at two centers in 2004 and 2007 were invited for follow-up. The position of the sling on perineal ultrasound was described relative to the bladder neck and the lower margin of the pubic symphysis at rest and on Valsalva. Objective cure was defined as a negative cough stress test at 300 ml. Subjective cure was evaluated with the Kings' Health Questionnaire (KHQ), Incontinence Outcome Questionnaire (IOQ), Female Sexual Function Index Questionnaire (FSFI) and the Patient Global Impression of Improvement score (PGII). Results 78 of 124 patients (57%) were available for follow-up 10 years after surgery. I Eleven (14%) had undergone reoperation and were excluded. Tapes were visualized in the remaining 67 (54%) women. The subjective and objective cure rates in this sub-cohort were 67% (45/67) and 77% (52/67), respectively. In these 67 women the mean distances from the bladder neck to the proximal edge of the tape (BNTD) during Valsalva maneuver were significantly higher in cured women compared to the not-cured women (11.2 vs. 9.4mm). The distance between tape and urethra (TUD) was significantly lower in cured vs. not cured patients (2.6 vs. 4.1 mm). All women with a TUD of >5mm (n = 5) were incontinent. Tape position was not associated with overactive bladder symptoms. Conclusions Tape position near the bladder neck and large distance to the urethra is associated with incontinence 10 years after TVT-O.	[Tamma, Ayman; Bjelic-Radisic, Vesna; Trutnovsky, Gerda; Tamussino, Karl; Aigmueller, Thomas; Ulrich, Daniela] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Tamma, Ayman; Hoelbfer, Susanne] Wilhelminen Hosp, Dept Obstet & Gynecol, Vienna, Austria; [Bjelic-Radisic, Vesna] Univ Witten Herdecke, Helios Univ Hosp, Dept Obstet & Gynecol, Wuppertal, Germany	Medical University of Graz; Wilhelminenspital; Witten Herdecke University	Bjelic-Radisic, V (corresponding author), Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria.; Bjelic-Radisic, V (corresponding author), Univ Witten Herdecke, Helios Univ Hosp, Dept Obstet & Gynecol, Wuppertal, Germany.	vesna.bjelic-radisic@helios-gesundheit.de	Gold, Daniela/ABE-4818-2020	Gold, Daniela/0000-0002-7196-454X; Trutnovsky, Gerda/0000-0001-6445-2418				Aigmuller T, 2014, INT UROGYNECOL J, V25, P1023, DOI 10.1007/s00192-014-2384-z; Aigmueller T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.010; Berner MM, 2004, GEBURTSH FRAUENHEILK, V64, P465, DOI [10.1002/uog.10086, DOI 10.1002/UOG.10086]; Bjelic-Radisic V, 2005, NEUROUROL URODYNAM, V24, P63, DOI 10.1002/nau.20092; Bjelic-Radisic V, 2006, AM J OBSTET GYNECOL, V195, P1784, DOI 10.1016/j.ajog.2006.07.014; Bjelic-Radisic V, 2007, INT UROGYNECOL J, V18, P1139, DOI 10.1007/s00192-007-0302-3; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; de Leval J, 1984, Acta Urol Belg, V52, P286; de Leval J, 2003, EUR UROL, V44, P724, DOI 10.1016/j.eururo.2003.09.003; Dietz HP, 2005, ULTRASOUND OBST GYN, V26, P175, DOI 10.1002/uog.1945; Ford AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub4; Gilchrist AS, 2012, UROLOGY, V79, P76, DOI 10.1016/j.urology.2011.08.009; Jiang YH, 2013, J ULTRAS MED, V32, P239, DOI 10.7863/jum.2013.32.2.239; Kociszewski J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538391; Kociszewski J, 2012, ULTRASOUND OBST GYN, V39, P210, DOI 10.1002/uog.10050; Kociszewski J, 2008, NEUROUROL URODYNAM, V27, P485, DOI 10.1002/nau.20556; Kociszewski J, 2017, INT J UROL, V24, P144, DOI 10.1111/iju.13262; Kociszewski J, 2010, INT UROGYNECOL J, V21, P795, DOI 10.1007/s00192-010-1119-z; Labrie J, 2013, NEW ENGL J MED, V369, P1124, DOI 10.1056/NEJMoa1210627; Novara G, 2010, EUR UROL, V58, P218, DOI 10.1016/j.eururo.2010.04.022; Oliphant SS, 2010, OBSTET GYNECOL, V116, P926, DOI 10.1097/AOG.0b013e3181f38599; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P7, DOI 10.1111/j.1600-0412.1990.tb08027.x; Schuettoff S, 2006, ULTRASOUND OBST GYN, V27, P687, DOI 10.1002/uog.2781; Shek KL, 2010, J UROLOGY, V183, P1450, DOI 10.1016/j.juro.2009.12.028; Srikrishna S, 2010, INT UROGYNECOL J, V21, P523, DOI 10.1007/s00192-009-1069-5; Tammaa A, 2017, NEUROUROL URODYN; Tamussino K, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.08.018; Tamussino KF, 2001, OBSTET GYNECOL, V98, P732, DOI 10.1016/S0029-7844(01)01565-4; Tunn R, 2014, GEBURTSH FRAUENHEILK, V74, P1093, DOI 10.1055/s-0034-1383044; Ulrich D, 2016, J UROLOGY, V196, P1201, DOI 10.1016/j.juro.2016.05.036; Viereck V, 2015, NEUROUROL URODYNAM, V34, P741, DOI 10.1002/nau.22658; WESTBY M, 1982, AM J OBSTET GYNECOL, V144, P408, DOI 10.1016/0002-9378(82)90245-9; Wlazlak E, 2017, NEUROUROL URODYNAM, V36, P1910, DOI 10.1002/nau.23211; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Yang JM, 2012, ULTRASOUND OBST GYN, V39, P458, DOI 10.1002/uog.10086	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209668	10.1371/journal.pone.0209668	http://dx.doi.org/10.1371/journal.pone.0209668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615677	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900023
J	Jang, D; Kwon, H; Choi, M; Lee, J; Pak, Y				Jang, Donghwan; Kwon, Hayeong; Choi, Moonjeong; Lee, Jaewoong; Pak, Yunbae			Sumoylation of Flotillin-1 promotes EMT in metastatic prostate cancer by suppressing Snail degradation	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; BREAST-CANCER; UP-REGULATION; ACTIVATION; KINASE; CAVEOLIN-2; PROTEIN; MEMBRANE	Flotillin-1 (Flot-1) has been shown to regulate cancer progression, but the regulatory role of post-translational modifications of Flot-1 on cancers remains elusive. Herein, we show that up-regulated E2 conjugating enzyme UBC9 sumoylates Flot-1 at Lys-51 and Lys-195 with small ubiquitin-like modifier (SUMO)-2/3 modification in metastatic prostate cancer. Mitogen induced the sumoylation and nuclear translocation of Flot-1. The nuclear-targeted Flot-1 physically interacted with Snail, and inhibited Snail degradation through the proteasome in a sumoylation-dependent manner, thereby promoting epithelial-to-mesenchymal transition (EMT). Sumoylation of Flot-1 by up-regulated UBC9 in human metastatic prostate cancer tissues and prostate cancer cells with high metastatic potential positively correlated with the stabilization of Snail and the induction of Snail-mediated EMT genes in the metastatic prostate cancer. Our study reveals a new mechanism of sumoylated Flot-1-mediating Snail stabilization, and identifies a novel sumoylated Flot-1-Snail signaling axis in EMT of metastatic prostate cancer.	[Jang, Donghwan; Kwon, Hayeong; Choi, Moonjeong; Lee, Jaewoong; Pak, Yunbae] Gyeongsang Natl Univ, BK21 Plus Program, Div Life Sci, Grad Sch Appl Life Sci,PMBBRC, Jinju 52828, South Korea	Gyeongsang National University	Pak, Y (corresponding author), Gyeongsang Natl Univ, BK21 Plus Program, Div Life Sci, Grad Sch Appl Life Sci,PMBBRC, Jinju 52828, South Korea.	ybpak@gnu.ac.kr	Pak, Yunbae/Q-5783-2019	Pak, Yunbae/0000-0002-8594-5673; Kwon, Hayeong/0000-0002-8828-6060; Jang, Donghwan/0000-0002-4639-1102	National Research Foundation of Korea [NRF-2015R1D1A3A01016537, NRF-2018R1D1A1B07045995, NRF-2015R1D1A4A01017437, NRF-2018R1C1B6006816]; National R&D Program for Cancer Control of Korea [1631090]; Next-Generation BioGreen 21 Program of Korea SSAC [PJ01317301]; Global Ph.D. Fellowship Program [NRF-2013H1A2A1034489]; the BK21 Plus Program	National Research Foundation of Korea(National Research Foundation of Korea); National R&D Program for Cancer Control of Korea; Next-Generation BioGreen 21 Program of Korea SSAC; Global Ph.D. Fellowship Program; the BK21 Plus Program	This work was supported by grants from the National Research Foundation of Korea (NRF-2015R1D1A3A01016537 and NRF-2018R1D1A1B07045995 to YP and NRF-2015R1D1A4A01017437 and NRF-2018R1C1B6006816 to HK), the National R&D Program for Cancer Control of Korea (1631090 to HK), and the Next-Generation BioGreen 21 Program of Korea SSAC, Project No. PJ01317301 to HK. DJ is a recipient of the Global Ph.D. Fellowship Program (NRF-2013H1A2A1034489). MC was supported by a scholarship from the BK21 Plus Program.	Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Baulida J, 2015, BBA-REV CANCER, V1856, P55, DOI 10.1016/j.bbcan.2015.05.005; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Garbis SD, 2008, J PROTEOME RES, V7, P3146, DOI 10.1021/pr800060r; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gomez V, 2010, J BIOL CHEM, V285, P20683, DOI 10.1074/jbc.M110.130591; Green J. R, 2006, CAN MED BIOL ENG C, DOI [10.13140/2.1.1621.3446, DOI 10.13140/2.1.1621.3446]; Guillaume E, 2013, J CELL SCI, V126, P5293, DOI 10.1242/jcs.133975; Jang D, 2015, J CELL SCI, V128, P2179, DOI 10.1242/jcs.169409; Jeong K, 2012, TRAFFIC, V13, P1218, DOI 10.1111/j.1600-0854.2012.01378.x; Kaufhold S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0062-0; Koh M, 2016, INT J CANCER, V138, P1232, DOI 10.1002/ijc.29869; Kuhne S, 2015, INT J MOL SCI, V16, P6447, DOI 10.3390/ijms16036447; Kwon H, 2015, BBA-MOL CELL RES, V1853, P1022, DOI 10.1016/j.bbamcr.2015.02.002; Kwon H, 2013, BBA-MOL CELL RES, V1833, P2176, DOI 10.1016/j.bbamcr.2013.05.003; Kwon H, 2011, J CELL MOL MED, V15, P888, DOI 10.1111/j.1582-4934.2010.01079.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Meister M, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.47; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Osorio LA, 2016, MOL MED REP, V13, P778, DOI 10.3892/mmr.2015.4585; Poblete CE, 2014, INT J ONCOL, V44, P647, DOI 10.3892/ijo.2014.2254; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Randle DD, 2013, ONCOL LETT, V6, P1767, DOI 10.3892/ol.2013.1635; Ren ZX, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150070; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Song LB, 2012, GASTROENTEROLOGY, V143, P995, DOI 10.1053/j.gastro.2012.06.033; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Yan Y, 2014, TUMOR BIOL, V35, P10479, DOI 10.1007/s13277-014-2343-9; Zhang YY, 2014, MOL MED REP, V10, P860, DOI 10.3892/mmr.2014.2310; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	23	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3248	3260		10.1038/s41388-018-0641-1	http://dx.doi.org/10.1038/s41388-018-0641-1			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30631151	hybrid, Green Published			2022-12-26	WOS:000465557200010
J	Tripathi, V; Shin, JH; Stuelten, CH; Zhang, YE				Tripathi, Veenu; Shin, Jee-Hye; Stuelten, Christina H.; Zhang, Ying E.			TGF-beta-induced alternative splicing of TAK1 promotes EMT and drug resistance	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; TO-MESENCHYMAL TRANSITION; CANCER; MAPKKK; TRAF6; P38; PHOSPHORYLATION; METASTASIS; REGULATOR	Transforming growth factor-beta (TGF-beta) is major inducer of epithelial-to-mesenchymal transition (EMT), which associates with cancer cell metastasis and resistance to chemotherapy and targeted drugs, through both transcriptional and non-transcriptional mechanisms. We previously reported that, in cancer cells, heightened mitogenic signaling allows TGF-beta-activated Smad3 to interact with poly(RC) binding protein 1 (PCBP1) and together they regulate many alternative splicing events that favors expression of protein isoforms essential for EMT, cytoskeletal rearrangement, and adherens junction signaling. Here we show that the exclusion of TGF-beta-activated kinase 1 (TAK1) variable exon 12 requires another RNA-binding protein, Fox-1 homolog 2 (Rbfox2), which binds intronic sequences in front of exon 12 independently of the Smad3-PCBP1 complex. Functionally, exon 12-excluded TAK1 Delta E12 and full-length TAK1FL are distinct. The short isoform TAK1 Delta E12 is constitutively active and supports TGF-beta-induced EMT and nuclear factor kappa B (NF-kappa B) signaling, whereas the full-length isoform TAK1FL promotes TGF-beta-induced apoptosis. These observations offer a harmonious explanation for how a single TAK1 kinase can mediate the opposing responses of cell survival and apoptosis in response to TGF-beta. They also reveal a propensity of the alternatively spliced TAK1 isoform TAK1 Delta E12 to cause drug resistance due to its activity in supporting EMT and NF-kappa B survival signaling.	[Tripathi, Veenu; Shin, Jee-Hye; Stuelten, Christina H.; Zhang, Ying E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhang, YE (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601	NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. K. Matsumoto for providing HATAK1 (Delta E12) plasmids; Dr. ZG Liu for NF kappa B-Luc reporter construct; Dr. K Hunter, Dr. L. Yang, and Dr. T. Misteli for Met-1, 4T1, and hMSC cells, respectively. This research was supported by the intramural research program of the NIH, National Cancer Institute, Center for Cancer Research.	Akhurst RJ, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022301; Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bakin AV, 2002, J CELL SCI, V115, P3193; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Brown M, 2008, EXPERT OPIN THER TAR, V12, P1109, DOI 10.1517/14728222.12.9.1109 ; Dempsey CE, 2000, BBA-GENE STRUCT EXPR, V1517, P46, DOI 10.1016/S0167-4781(00)00258-X; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Disterer P, 2014, HUM GENE THER, V25, P587, DOI 10.1089/hum.2013.234; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Hirata Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010205; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Ouyang C, 2014, J BIOL CHEM, V289, P24226, DOI 10.1074/jbc.M114.559963; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Seoane J, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022277; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Tripathi V, 2016, MOL CELL, V64, P549, DOI 10.1016/j.molcel.2016.09.013; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; Venables JP, 2012, MOL BIOL EVOL, V29, P260, DOI 10.1093/molbev/msr193; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhou DH, 2018, BIOCHEM BIOPH RES CO, V497, P1018, DOI 10.1016/j.bbrc.2018.02.160	43	42	46	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3185	3200		10.1038/s41388-018-0655-8	http://dx.doi.org/10.1038/s41388-018-0655-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30626936	Green Accepted			2022-12-26	WOS:000465557200006
J	Amior, L; Srivastava, R; Nano, R; Bertuzzi, F; Melloul, D				Amior, Livnat; Srivastava, Rohit; Nano, Rita; Bertuzzi, Federico; Melloul, Danielle			The role of Cox-2 and prostaglandin E-2 receptor EP3 in pancreatic beta-cell death	FASEB JOURNAL			English	Article						islet; palmitate; apoptosis; cyclooxygenase-2; diabetes mellitus	FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; HIGH GLUCOSE; PGE2 INHIBITION; HUMAN ISLETS; APOPTOSIS; EXPRESSION; CYCLOOXYGENASE-2; DYSFUNCTION; MECHANISMS	Elevated levels of lipids, in particular saturated fatty acids, are known to be associated with type 2 diabetes (T2D) and to have a negative effect on beta-cell function and survival. We bring new evidence indicating that palmitate up-regulates cyclooxygenase-2 (COX-2) expression levels in human islets and in MIN6 beta cells, and that it is elevated in islets isolated from T2D donors. Both small interfering specific cyclooxygenase-2 small interfering RNA (siRNA) or the COX-2 inhibitor celecoxib significantly inhibited apoptosis induced by palmitate. Prostaglandin E-2 (PGE(2)), the predominant product of COX-2 enzymatic activity, activates membrane receptors, which are members of the GPCR-family (EP1-EP4). In the present study, elevated expression of the PGE(2) receptor subtype 3 (EP3) receptor was observed in cells exposed to palmitate and in islets from individuals with T2D. Down-regulation of the pathway using EP3 siRNA or the specific L-798,106 antagonist markedly decreased the levels of palmitate-induced apoptosis. Altogether, our data put forward the COX-2-PGE(2)-EP3 pathway as one of the mediators of palmitate-induced apoptosis in beta-cells.	[Amior, Livnat; Srivastava, Rohit; Melloul, Danielle] Hadassah Univ Hosp, Dept Endocrinol, POB 12000, IL-91120 Jerusalem, Israel; [Nano, Rita; Bertuzzi, Federico] Ist Sci San Raffaele, IRCCS, Diabet Res Inst, Milan, Italy; [Bertuzzi, Federico] Osped Niguarda Ca Granda, Milan, Italy	Hebrew University of Jerusalem; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Melloul, D (corresponding author), Hadassah Univ Hosp, Dept Endocrinol, POB 12000, IL-91120 Jerusalem, Israel.	daniellem@ekmd.huji.ac.il	Nano, Rita/AAC-1934-2019	Nano, Rita/0000-0003-4520-8481; Srivastava, Rohit/0000-0002-6703-9642	Israel Science Foundation [ISF 1370/15]	Israel Science Foundation(Israel Science Foundation)	The authors are grateful to Gerard Elberg and Ronit Sionov (both from The Hebrew University of Jerusalem-Hadassah Medical School, Jerusalem, Israel), for technical help and helpful discussions. This work was supported by a grant from the Israel Science Foundation (ISF 1370/15). The authors declare no conflicts of interest.	Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carboneau BA, 2017, MOL METAB, V6, P548, DOI 10.1016/j.molmet.2017.04.002; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; HUGHES JH, 1989, DIABETES, V38, P1251, DOI 10.2337/diabetes.38.10.1251; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Keanei DC, 2011, CLIN SCI, V120, P195, DOI 10.1042/CS20100282; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Luo C, 2002, CELL TISSUE RES, V310, P169, DOI 10.1007/s00441-002-0628-6; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Oshima H, 2006, J BIOL CHEM, V281, P29330, DOI 10.1074/jbc.M602424200; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Papadimitriou A, 2007, CELL PHYSIOL BIOCHEM, V20, P607, DOI 10.1159/000107544; Persaud Shanta J., 2007, Archives of Physiology and Biochemistry, V113, P104, DOI 10.1080/13813450701531177; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; ROBERTSON RP, 1988, DIABETES, V37, P367, DOI 10.2337/diabetes.37.4.367; ROBERTSON RP, 1987, DIABETES, V36, P1047, DOI 10.2337/diabetes.36.9.1047; Salgin B, 2012, J CLIN ENDOCR METAB, V97, P3302, DOI 10.1210/jc.2012-1428; Sargsyan E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-115; SEAQUIST ER, 1989, DIABETES, V38, P1439, DOI 10.2337/diabetes.38.11.1439; Shanmugam N, 2006, DIABETOLOGIA, V49, P100, DOI 10.1007/s00125-005-0065-7; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shridas P, 2014, J BIOL CHEM, V289, P27410, DOI 10.1074/jbc.M114.591735; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Wormser U, 2004, TOXICOL APPL PHARM, V200, P40, DOI 10.1016/j.taap.2004.03.013; Zawalich WS, 2007, METABOLISM, V56, P12, DOI 10.1016/j.metabol.2006.08.016	52	15	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4975	4986		10.1096/fj.201801823R	http://dx.doi.org/10.1096/fj.201801823R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629897	Bronze			2022-12-26	WOS:000462888500027
J	van der Veen, JN; Lingrell, S; McCloskey, N; LeBlond, ND; Galleguillos, D; Zhao, YY; Curtis, JM; Sipione, S; Fullerton, MD; Vance, DE; Jacobs, RL				van der Veen, Jelske N.; Lingrell, Susanne; McCloskey, Nicholas; LeBlond, Nicholas D.; Galleguillos, Danny; Zhao, Yuan Y.; Curtis, Jonathan M.; Sipione, Simonetta; Fullerton, Morgan D.; Vance, Dennis E.; Jacobs, Rene L.			A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling	FASEB JOURNAL			English	Article						phospholipid; insulin resistance; PEMT; fatty liver disease; lipids	DIET-INDUCED OBESITY; N-METHYLTRANSFERASE; CGI-58 KNOCKDOWN; LIPID-METABOLISM; RESISTANCE; MICE; SENSITIVITY; INHIBITION; STEATOSIS; PREVENTS	Phosphatidylethanolamine N-methyltransferase (PEMT) is an important enzyme in hepatic phosphatidylcholine (PC) biosynthesis. Pemt(-/-) mice fed a high-fat diet are protected from obesity and whole-body insulin resistance. However, Pemt(-/-) mice develop severe nonalcoholic steatohepatitis (NASH). Because NASH is often associated with hepatic insulin resistance, we investigated whether the increased insulin sensitivity in Pemt(-/-) mice was restricted to nonhepatic tissues or whether the liver was also insulin sensitive. Strikingly, the livers of Pemt(-/-) mice compared with those of Pemt(+/+) mice were not insulin resistant, despite elevated levels of hepatic triacylglycerols and diacylglycerols, as well as increased hepatic inflammation and fibrosis. Endogenous glucose production was lower in Pemt(-/-) mice under both basal and hyperinsulinemic conditions. Experiments in primary hepatocytes and hepatoma cells revealed improved insulin signaling in the absence of PEMT, which was not due to changes in diacylglycerols, ceramides, or gangliosides. On the other hand, the phospholipid composition in hepatocytes seems critically important for insulin signaling such that lowering the PC:phosphatidylethanolamine (PE) ratio improves insulin signaling. Thus, treatments to reduce the PC:PE ratio in liver may protect against the development of hepatic insulin resistance.	[van der Veen, Jelske N.; Lingrell, Susanne; Galleguillos, Danny; Sipione, Simonetta; Vance, Dennis E.; Jacobs, Rene L.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada; [van der Veen, Jelske N.; Lingrell, Susanne; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Galleguillos, Danny; Sipione, Simonetta] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Zhao, Yuan Y.; Curtis, Jonathan M.; Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, 4-002E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada; [McCloskey, Nicholas; LeBlond, Nicholas D.; Fullerton, Morgan D.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Ottawa	Jacobs, RL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, 4-002E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	rjacobs@ualberta.ca			Canadian Institutes of Health Research [OCN143065, MSH141981, MOP 5182]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Canadian Institutes of Health Research [Bridge Funding OCN143065 and New Investigator MSH141981 (to M.D.F.), and MOP 5182 (to J.N.V.D.V., D.E.V., and R.L.J.)]. The authors declare no conflicts of interest.	Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farese RV, 2010, AM J PHYSIOL-ENDOC M, V298, pE385, DOI 10.1152/ajpendo.00608.2009; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gao X, 2015, J LIPID RES, V56, P1701, DOI 10.1194/jlr.M059287; Gao X, 2015, BBA-MOL CELL BIOL L, V1851, P152, DOI 10.1016/j.bbalip.2014.11.006; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; Maglione V, 2010, J NEUROSCI, V30, P4072, DOI 10.1523/JNEUROSCI.6348-09.2010; Mi S, 2016, J CHROMATOGR B, V1031, P50, DOI 10.1016/j.jchromb.2016.07.028; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Salinas M, 2000, MOL CELL NEUROSCI, V15, P156, DOI 10.1006/mcne.1999.0813; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sasaki N, 2015, J BIOL CHEM, V290, P25475, DOI 10.1074/jbc.M115.684274; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van der Veen JN, 2016, AM J PHYSIOL-GASTR L, V310, pG526, DOI 10.1152/ajpgi.00243.2015; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; ZHOU X, 1992, J LIPID RES, V33, P1233	51	21	21	2	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5045	5057		10.1096/fj.201802117R	http://dx.doi.org/10.1096/fj.201802117R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30615497	Bronze			2022-12-26	WOS:000462888500033
J	Ziegler, CS; Bouchab, L; Tramier, M; Durand, D; Fieschi, F; Dupre-Crochet, S; Merola, F; Nusse, O; Erard, M				Ziegler, Cornelia S.; Bouchab, Leila; Tramier, Marc; Durand, Dominique; Fieschi, Franck; Dupre-Crochet, Sophie; Merola, Fabienne; Nusse, Oliver; Erard, Marie			Quantitative live-cell imaging and 3D modeling reveal critical functional features in the cytosolic complex of phagocyte NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); fluorescence correlation spectroscopy (FCS); protein complex; NADPH oxidase; structural model; FCCS; fluorescent protein; FRET-FLIM; intrinsically disordered proteins; protein-protein interaction	PROTEIN-PROTEIN INTERACTIONS; X-RAY-SCATTERING; FLUORESCENT PROTEIN; P47(PHOX); CYAN; P67(PHOX); BINDING; DOMAIN; MACROMOLECULES; SPECTROSCOPY	Phagocyte NADPH oxidase produces superoxide anions, a precursor of reactive oxygen species (ROS) critical for host responses to microbial infections. However, uncontrolled ROS production contributes to inflammation, making NADPH oxidase a major drug target. It consists of two membranous (Nox2 and p22(phox)) and three cytosolic subunits (p40(phox), p47(phox), and p67(phox)) that undergo structural changes during enzyme activation. Unraveling the interactions between these subunits and the resulting conformation of the complex could shed light on NADPH oxidase regulation and help identify inhibition sites. However, the structures and the interactions of flexible proteins comprising several well-structured domains connected by intrinsically disordered protein segments are difficult to investigate by conventional techniques such as X-ray crystallography, NMR, or cryo-EM. Here, we developed an analytical strategy based on FRET-fluorescence lifetime imaging (FLIM) and fluorescence cross-correlation spectroscopy (FCCS) to structurally and quantitatively characterize NADPH oxidase in live cells. We characterized the inter- and intramolecular interactions of its cytosolic subunits by elucidating their conformation, stoichiometry, interacting fraction, and affinities in live cells. Our results revealed that the three subunits have a 1:1:1 stoichiometry and that nearly 100% of them are present in complexes in living cells. Furthermore, combining FRET data with small-angle X-ray scattering (SAXS) models and published crystal structures of isolated domains and subunits, we built a 3D model of the entire cytosolic complex. The model disclosed an elongated complex containing a flexible hinge separating two domains ideally positioned at one end of the complex and critical for oxidase activation and interactions with membrane components.	[Ziegler, Cornelia S.; Bouchab, Leila; Dupre-Crochet, Sophie; Merola, Fabienne; Nusse, Oliver; Erard, Marie] Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Chim Phys, F-91405 Orsay, France; [Tramier, Marc] Univ Rennes, CNRS, Inst Genet & Dev Rennes, UMR 6290,BIOSIT UMS 3480, F-35000 Rennes, France; [Durand, Dominique] Univ Paris Saclay, Univ Paris Sud, CNRS UMR 9198, Inst Integrat Biol Cell,CEA, F-91190 Gif Sur Yvette, France; [Fieschi, Franck] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38044 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nusse, O; Erard, M (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Chim Phys, F-91405 Orsay, France.	oliver.nusse@u-psud.fr; marie.erard@u-psud.fr	ERARD, Marie/L-9089-2019; Erard, Marie/G-7478-2012; Nüsse, Oliver/J-8645-2013; Dupré-Crochet, Sophie/J-8607-2013; Fieschi, Franck/W-2748-2019	ERARD, Marie/0000-0002-4063-365X; Erard, Marie/0000-0002-4063-365X; Nüsse, Oliver/0000-0003-0068-8346; Dupré-Crochet, Sophie/0000-0002-6405-3748; FIESCHI, Franck/0000-0003-1194-8107; Tramier, Marc/0000-0001-8200-6446	Foundation for Medical Research Grant [DCM20121225747]; IDEX Paris Saclay (IRS BioProbe); IDEX Paris-Saclay; Region Ile-de-France (DIM Malinf); LabExPALMGrant [ANR-10-LABX-0039-PALM]	Foundation for Medical Research Grant; IDEX Paris Saclay (IRS BioProbe); IDEX Paris-Saclay; Region Ile-de-France (DIM Malinf)(Region Ile-de-France); LabExPALMGrant	This work was supported by "The Foundation for Medical Research Grant DCM20121225747," by LabExPALMGrant ANR-10-LABX-0039-PALM, and by the IDEX Paris Saclay (IRS BioProbe). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral grant from IDEX Paris-Saclay.; Supported by a doctoral grant from Region Ile-de-France (DIM Malinf).	Betolngar DB, 2015, ANAL BIOANAL CHEM, V407, P4183, DOI 10.1007/s00216-015-8636-z; Bohmer M, 2002, CHEM PHYS LETT, V353, P439, DOI 10.1016/S0009-2614(02)00044-1; Boura E, 2011, P NATL ACAD SCI USA, V108, P9437, DOI 10.1073/pnas.1101763108; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Cifuentes-Pagano ME, 2015, CURR PHARM DESIGN, V21, P6023, DOI 10.2174/1381612821666151029112013; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; Demeautis C, 2017, SCI REP-UK, V7, DOI 10.1038/srep41026; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Erard M, 2013, MOL BIOSYST, V9, P258, DOI 10.1039/c2mb25303h; Espagne A, 2011, BIOCHEMISTRY-US, V50, P437, DOI 10.1021/bi1015875; Faure MC, 2013, BIOL CELL, V105, P501, DOI 10.1111/boc.201300010; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Fuertes G, 2017, P NATL ACAD SCI USA, V114, pE6342, DOI 10.1073/pnas.1704692114; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; Greife A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36792; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Herbomel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45058; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Karimi G, 2014, BBA-GEN SUBJECTS, V1840, P3277, DOI 10.1016/j.bbagen.2014.07.022; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kofoed EM, 2010, J BIOL CHEM, V285, P2428, DOI 10.1074/jbc.M109.045203; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Laraia L, 2015, CHEM BIOL, V22, P689, DOI 10.1016/j.chembiol.2015.04.019; Marcoux J, 2010, J BIOL CHEM, V285, P28980, DOI 10.1074/jbc.M110.139824; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Merola F, 2016, METHODS APPL FLUORES, V4, DOI 10.1088/2050-6120/4/1/012001; Moore BL, 2013, J COMPUT CHEM, V34, P1881, DOI 10.1002/jcc.23330; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Padilla-Parra S, 2014, METHODS MOL BIOL, V1076, P683, DOI 10.1007/978-1-62703-649-8_31; Padilla-Parra S, 2011, MICROSC RES TECHNIQ, V74, P788, DOI 10.1002/jemt.21015; Pauwels K, 2017, CELL MOL LIFE SCI, V74, P3185, DOI 10.1007/s00018-017-2561-6; Peti W, 2018, METHODS MOL BIOL, V1688, P375, DOI 10.1007/978-1-4939-7386-6_17; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Poea-Guyon S, 2013, ANAL BIOANAL CHEM, V405, P3983, DOI 10.1007/s00216-013-6860-y; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Song ZM, 2017, J LEUKOCYTE BIOL, V101, P1155, DOI 10.1189/jlb.1A0716-305R; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; STEINBERG IZ, 1968, J CHEM PHYS, V48, P2411, DOI 10.1063/1.1669461; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uversky VN, 2016, J BIOL CHEM, V291, P6681, DOI 10.1074/jbc.R115.685859; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Valeur B., 2006, MOL FLUORESCENCE PRI; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Vogel SS, 2014, METHODS, V66, P131, DOI 10.1016/j.ymeth.2013.06.021; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yuzawa S, 2009, J INNATE IMMUN, V1, P543, DOI 10.1159/000235656; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zachariassen LG, 2016, P NATL ACAD SCI USA, V113, pE3950, DOI 10.1073/pnas.1601747113	62	16	16	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3824	3836		10.1074/jbc.RA118.006864	http://dx.doi.org/10.1074/jbc.RA118.006864			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30630949	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000461854400003
J	Byun, J; Del Re, DP; Zhai, PY; Ikeda, S; Shirakabe, A; Mizushima, W; Miyamoto, S; Brown, JH; Sadoshima, J				Byun, Jaemin; Del Re, Dominic P.; Zhai, Peiyong; Ikeda, Shohei; Shirakabe, Akihiro; Mizushima, Wataru; Miyamoto, Shigeki; Brown, Joan H.; Sadoshima, Junichi			Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; signal transduction; cardiomyocyte; cardiovascular disease; heart failure; YAP	HIPPO PATHWAY; TISSUE HOMEOSTASIS; MOUSE HEART; PROMOTES; GROWTH; ACTIVATION; SURVIVAL; MYOCYTES; YAP/TAZ; KINASE	Cardiovascular disease (CVD) remains the leading cause of death globally, and heart failure is a major component of CVD-related morbidity and mortality. The development of cardiac hypertrophy in response to hemodynamic overload is initially considered to be beneficial; however, this adaptive response is limited and, in the presence of prolonged stress, will transition to heart failure. Yes-associated protein (YAP), the central downstream effector of the Hippo signaling pathway, regulates proliferation and survival in mammalian cells. Our previous work demonstrated that cardiac-specific loss of YAP leads to increased cardiomyocyte (CM) apoptosis and impaired CM hypertrophy during chronic myocardial infarction (MI) in the mouse heart. Because of its documented cardioprotective effects, we sought to determine the importance of YAP in response to acute pressure overload (PO). Our results indicate that endogenous YAP is activated in the heart during acute PO. YAP activation that depended upon RhoA was also observed in CMs subjected to cyclic stretch. To examine the function of endogenous YAP during acute PO, Yap(+/flox);Cre(-MHC) (YAP-CHKO) and Yap(+/flox) mice were subjected to transverse aortic constriction (TAC). We found that YAP-CHKO mice had attenuated cardiac hypertrophy and significant increases in CM apoptosis and fibrosis that correlated with worsened cardiac function after 1 week of TAC. Loss of CM YAP also impaired activation of the cardioprotective kinase Akt, which may underlie the YAP-CHKO phenotype. Together, these data indicate a prohypertrophic, prosurvival function of endogenous YAP and suggest a critical role for CM YAP in the adaptive response to acute PO.	[Byun, Jaemin; Del Re, Dominic P.; Zhai, Peiyong; Ikeda, Shohei; Shirakabe, Akihiro; Mizushima, Wataru; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Miyamoto, Shigeki; Brown, Joan H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Diego	Sadoshima, J (corresponding author), Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA.	sadoshju@njms.rutgers.edu		Del Re, Dominic/0000-0002-5504-9114	National Institutes of Health [HL127339, HL135726, HL097037, HL080101, HL105242, HL028143, HL067724, HL091469, HL112330, HL138720, AG023039]; Tobacco-related Disease Research Program (TRDRP) [26IP-0040]; Foundation Leducq Transatlantic Network of Excellence [15CBD04]; American Heart Association [11SDG7240067, 15GRNTZ297009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138720, R15HL135726, R01HL127339, R01HL145459, R01HL067724, R01HL091469, R37HL028143, R01HL112330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program (TRDRP)(University of California System); Foundation Leducq Transatlantic Network of Excellence; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants HL127339 and HL135726 (to D. P. D.), HL097037 (to S. M.), HL080101, HL105242, and HL028143 (to J. H. B.), and HL067724, HL091469, HL112330, HL138720, and AG023039 (to J. S.), Tobacco-related Disease Research Program (TRDRP) Grant 26IP-0040 (to J. H. B.), the Foundation Leducq Transatlantic Network of Excellence 15CBD04 (to J. S.), and American Heart Association Grant 11SDG7240067 (to D. P. D.) and 15GRNTZ297009 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Astone M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27657-x; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; He MJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0013-6; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Ikeda S, 2019, CIRC RES, V124, P292, DOI 10.1161/CIRCRESAHA.118.314048; Lauriol J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005262; Li CZ, 2013, BIOCHEM BIOPH RES CO, V438, P607, DOI 10.1016/j.bbrc.2013.08.008; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Lorell BH, 2000, CIRCULATION, V102, P470; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Morikawa Y, 2017, NATURE, V547, P227, DOI 10.1038/nature22979; Nakamura M, 2018, NAT REV CARDIOL, V15, P387, DOI 10.1038/s41569-018-0007-y; Ohgushi M, 2015, CELL STEM CELL, V17, P448, DOI 10.1016/j.stem.2015.07.009; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Tsika RW, 2010, J BIOL CHEM, V285, P13721, DOI 10.1074/jbc.M109.063057; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wackerhage H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005096; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang XH, 2018, CELL DEATH DIFFER, V25, P966, DOI 10.1038/s41418-017-0036-9; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yang YF, 2015, CIRC RES, V117, P891, DOI 10.1161/CIRCRESAHA.115.306624; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	52	42	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3603	3617		10.1074/jbc.RA118.006123	http://dx.doi.org/10.1074/jbc.RA118.006123			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635403	Green Published, hybrid			2022-12-26	WOS:000461853900024
J	Li, ZK; Qi, DL; Singh, HP; Zou, Y; Shen, BH; Cobrinik, D				Li, Zhengke; Qi, Dong-Lai; Singh, Hardeep P.; Zou, Yue; Shen, Binghui; Cobrinik, David			A novel thyroid hormone receptor isoform, TR beta 2-46, promotes SKP2 expression and retinoblastoma cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor cell biology; retina; translation initiation; cell cycle; proliferation; retinoblastoma; thyroid hormone receptor beta 2	DEPENDENT REGULATION; S-PHASE; BETA-2; RB; PHOSPHORYLATION; LOCALIZATION; IDENTIFICATION; DEGRADATION; MECHANISM; BINDING	Retinoblastoma is a childhood retinal tumor that develops from cone photoreceptor precursors in response to inactivating RB1 mutations and loss of functional RB protein. The cone precursor's response to RB loss involves cell type-specific signaling circuitry that helps to drive tumorigenesis. One component of the cone precursor circuitry, the thyroid hormone receptor beta 2 (TR beta 2), enables the aberrant proliferation of diverse RB-deficient cells in part by opposing the down-regulation of S-phase kinase-associated protein 2 (SKP2) by the more widely expressed and tumor-suppressive TR beta 1. However, it is unclear how TR beta 2 opposes TR beta 1 to enable SKP2 expression and cell proliferation. Here, we show that in human retinoblastoma cells TR beta 2 mRNA encodes two TR beta 2 protein isoforms: a predominantly cytoplasmic 54-kDa protein (TR beta 2-54) corresponding to the well-characterized full-length murine Tr beta 2 and an N-terminally truncated and exclusively cytoplasmic 46-kDa protein (TR beta 2-46) that starts at Met-79. Whereas TR beta 2 knockdown decreased SKP2 expression and impaired retinoblastoma cell cycle progression, re-expression of TR beta 2-46 but not TR beta 2-54 stabilized SKP2 and restored proliferation to an extent similar to that of ectopic SKP2 restoration. We conclude that TR beta 2-46 is an oncogenic thyroid hormone receptor isoform that promotes SKP2 expression and SKP2-dependent retinoblastoma cell proliferation.	[Li, Zhengke; Qi, Dong-Lai; Singh, Hardeep P.; Cobrinik, David] Childrens Hosp Los Angeles, Vis Ctr, Los Angeles, CA 90027 USA; [Li, Zhengke; Qi, Dong-Lai; Singh, Hardeep P.; Cobrinik, David] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Li, Zhengke; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA; [Li, Zhengke; Zou, Yue] East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA; [Cobrinik, David] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, Los Angeles, CA 90033 USA; [Cobrinik, David] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; City of Hope; Beckman Research Institute of City of Hope; East Tennessee State University; University of Southern California; University of Southern California	Li, ZK (corresponding author), East Tennessee State Univ, Quillen Coll Med, Johnson City, TN 37614 USA.; Cobrinik, D (corresponding author), Childrens Hosp Los Angeles, 4650 Sunset Blvd,MS 163, Los Angeles, CA 90027 USA.	LIZ01@mail.etsu.edu; dcobrinik@chla.usc.edu	Li, Zhengke/J-8527-2016; Zou, Yue/ABA-8429-2020	Li, Zhengke/0000-0001-5560-343X; Singh, Hardeep/0000-0002-9586-8544; Shen, Binghui/0000-0002-4408-407X	Larry and Celia Moh Foundation; Neonatal Blindness Research Fund; Research to Prevent Blindness; Saban Research Institute research career development fellowship; National Institutes of Health [R01CA085344, P30CA014089, R01EY026661, R01CA137124]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA137124, R01CA219342, R01CA085344] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY026661] Funding Source: NIH RePORTER	Larry and Celia Moh Foundation; Neonatal Blindness Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Saban Research Institute research career development fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Larry and Celia Moh Foundation, the Neonatal Blindness Research Fund, an unrestricted grant from Research to Prevent Blindness (to the University of Southern California Department of Ophthalmology), a Saban Research Institute research career development fellowship (to D.-L. Q.), and National Institutes of Health Grants R01CA085344 (to B. H. S.), P30CA014089, R01EY026661, and R01CA137124 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anyetei-Anum CS, 2018, J ENDOCRINOL, V237, pR19, DOI 10.1530/JOE-17-0708; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Clement E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao3810; Davis PJ, 2008, STEROIDS, V73, P1013, DOI 10.1016/j.steroids.2007.12.030; Dimaras H, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.21; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hahm JB, 2013, MOL ENDOCRINOL, V27, P840, DOI 10.1210/me.2012-1117; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; Hones GS, 2017, P NATL ACAD SCI USA, V114, pE11323, DOI 10.1073/pnas.1706801115; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lee TC, 2006, INVEST OPHTH VIS SCI, V47, P5590, DOI 10.1167/iovs.06-0063; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; Martin NP, 2014, ENDOCRINOLOGY, V155, P3713, DOI 10.1210/en.2013-2058; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Maruvada P, 2004, MOL BIOL CELL, V15, P1895, DOI 10.1091/mbc.e03-09-0636; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Oberste-Berghaus C, 2000, J BIOL CHEM, V275, P1787, DOI 10.1074/jbc.275.3.1787; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; Privalsky ML, 2009, J BIOL CHEM, V284, P19554, DOI 10.1074/jbc.M109.007542; Qi DL, 2017, ONCOGENE, V36, P1760, DOI 10.1038/onc.2016.350; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Singh HP, 2018, P NATL ACAD SCI USA, V115, pE9391, DOI 10.1073/pnas.1808903115; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Song GJ, 2015, J BIOL CHEM, V290, P2879, DOI 10.1074/jbc.M114.609768; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tamarkin-Ben-Harush A, 2017, ELIFE, V6, DOI 10.7554/eLife.21907; Wan W, 2005, MOL ENDOCRINOL, V19, P1529, DOI 10.1210/me.2005-0014; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wang X, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166941; WOOD WM, 1994, MOL ENDOCRINOL, V8, P1605, DOI 10.1210/me.8.12.1605; Xu XLL, 2017, CANCER RES, V77, P6838, DOI 10.1158/0008-5472.CAN-16-3299; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang SH, 2017, CANCER CELL, V31, P669, DOI 10.1016/j.ccell.2017.04.004	45	4	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2961	2969		10.1074/jbc.AC118.006041	http://dx.doi.org/10.1074/jbc.AC118.006041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30643022	Green Published, hybrid			2022-12-26	WOS:000459601600034
J	Sanchez-Gonzalez, MC; Perez-Cabezas, V; Gutierrez-Sanchez, E; Ruiz-Molinero, C; Rebollo-Salas, M; Jimenez-Rejano, JJ				Carmen Sanchez-Gonzalez, Maria; Perez-Cabezas, Veronica; Gutierrez-Sanchez, Estanislao; Ruiz-Molinero, Carmen; Rebollo-Salas, Manuel; Jesus Jimenez-Rejano, Jose			Nonstrabismic binocular dysfunctions and cervical complaints: The possibility of a cross-dysfunction	PLOS ONE			English	Article							CILIARY MUSCLE-CONTRACTION; NECK PAIN; HEAD; EYE; ADAPTATION; VISION; MUSCULOSKELETAL; STABILIZATION; ACCOMMODATION; REPEATABILITY	The aim of this study is to establish a relationship between non-strabismic binocular dysfunction and neck pain. One hundred twelve participants underwent binocular vision assessment by evaluating horizontal heterophoria, horizontal and vertical fusional vergence ranges and vergence facility. The subjects were classified into two groups: binocular anomalies and normal binocular function. Neck complaints were measured with the Neck Disability Index, visual analogue scale, cervical range of motion, deep-flexor muscle activation score (AS) and performance index (PI). Our results showed that participants with low AS had significantly altered values of lateral phoria (near) (mean = -6.99 SD +/- 6.96 PD) and PFV (near) blur (mean = 9.49 SD +/- 5.45 PD) against those who presented normal AS (lateral phoria (near) mean = -3.64 SD +/- 6.37 PD; PFV (near) blur mean = 12.84 SD +/- 6.20 PD). In addition, participants with NFV (near) recovery outside the norm had a significantly lower right side-bending (mean = 35.63 SD +/- 8.35 PD) than those within the standard (mean = 39.64 SD +/- 9 PD). The subjects with binocular vision impairment showed a diminished response to the deep cervical musculature, with low AS and PI, as well as a tendency to suffer from cervicalgia of more than three months' evolution and a lower range of motion.	[Carmen Sanchez-Gonzalez, Maria] Univ Seville, Opt Area, Dept Condensed Matter Phys, Seville, Spain; [Perez-Cabezas, Veronica; Ruiz-Molinero, Carmen] Univ Cadiz, Dept Nursing & Physiotherapy, Cadiz, Spain; [Gutierrez-Sanchez, Estanislao] Univ Seville, Dept Surg, Ophthalmol Area, Seville, Spain; [Rebollo-Salas, Manuel; Jesus Jimenez-Rejano, Jose] Univ Seville, Dept Physiotherapy, Seville, Spain	University of Sevilla; Universidad de Cadiz; University of Sevilla; University of Sevilla	Ruiz-Molinero, C (corresponding author), Univ Cadiz, Dept Nursing & Physiotherapy, Cadiz, Spain.	carmen.ruizmolinero@uca.es	Sanchez, Estanislao Gutierrez/P-7776-2018; del Carmen Sánchez, María/AAR-9887-2020; Jiménez-Rejano, José-Jesús/E-4955-2018; Rebollo Salas, M./N-4288-2018; Perez-Cabezas, Veronica/AAB-4137-2020	Sanchez, Estanislao Gutierrez/0000-0003-4851-680X; Jiménez-Rejano, José-Jesús/0000-0003-3358-3305; Rebollo Salas, M./0000-0003-2788-0725; Sanchez-Gonzalez, Maria Carmen/0000-0002-9453-8615; Ruiz Molinero, Maria del Carmen/0000-0002-6208-0208; Perez-Cabezas, Veronica/0000-0002-3896-357X				Antona B, 2008, OPHTHAL PHYSL OPT, V28, P475, DOI 10.1111/j.1475-1313.2008.00583.x; Bade A, 2013, OPTOMETRY VISION SCI, V90, P988, DOI 10.1097/OPX.0000000000000012; Cacho-Mart inez P, 2010, J OPTOM, V3, P185, DOI [DOI 10.1016/S1888-4296(10)70028-5, 10.1016/s1888-4296(10)70028-5]; Cacho-Martinez P, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/895803; Cacho-Martinez Pilar, 2014, J Optom, V7, P2, DOI 10.1016/j.optom.2013.01.004; Cacho-Martinez P, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/549435; Charman WN, 2008, CLIN EXP OPTOM, V91, P207, DOI 10.1111/j.1444-0938.2008.00256.x; Chiu TTW, 2005, J ORTHOP SPORT PHYS, V35, P567; Cooper Jeffrey, 2012, Optometry, V83, P137; Dagi LR, 2017, J PEDIAT OPHTH STRAB, V54, P134, DOI 10.3928/01913913-20170417-01; Domkin D, 2016, J ELECTROMYOGR KINES, V28, P193, DOI 10.1016/j.jelekin.2015.11.008; Fu T, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/987048; Gall R, 1998, OPTOMETRY VISION SCI, V75, P731, DOI 10.1097/00006324-199810000-00018; Gall Ronald, 2003, Optometry, V74, P309; Garcia-munoz A, 2016, CLIN EXP OPTOM, V99, P313, DOI 10.1111/cxo.12376; GRISSOM RJ, 1994, J CONSULT CLIN PSYCH, V62, P281, DOI 10.1037/0022-006X.62.2.281; Grissom RJ, 2001, PSYCHOL METHODS, V6, P135, DOI 10.1037//1082-989X.6.2.135; GRISSOM RJ, 1994, J APPL PSYCHOL, V79, P314, DOI 10.1037/0021-9010.79.2.314; Hrynchak PK, 2010, OPHTHAL PHYSL OPT, V30, P304, DOI 10.1111/j.1475-1313.2010.00723.x; Hussaindeen JR, 2018, J OPTOM, V11, P40, DOI 10.1016/j.optom.2017.02.002; Irsch K, 2013, INVEST OPHTH VIS SCI, V54, P3108, DOI 10.1167/iovs.12-11368; Jang Jung Un, 2016, Taiwan J Ophthalmol, V6, P187, DOI 10.1016/j.tjo.2016.07.001; Jimenez R, 2004, OPHTHAL PHYSL OPT, V24, P528, DOI 10.1111/j.1475-1313.2004.00234.x; Johns HA, 2004, OPTOMETRY VISION SCI, V81, P939; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Lanca CC, 2016, STRABISMUS, V24, P63, DOI 10.3109/09273972.2016.1159234; Lim Z, 2011, J AAPOS, V15, P468, DOI 10.1016/j.jaapos.2011.05.011; Lundqvist LO, 2016, OPTOMETRY VISION SCI, V93, P1147, DOI 10.1097/OPX.0000000000000902; Maducdoc MM, 2017, INT OPHTHALMOL, V37, P433, DOI 10.1007/s10792-016-0281-9; Maxwell JS, 1997, VISION RES, V37, P441, DOI 10.1016/S0042-6989(96)00115-0; Maxwell JS, 1996, VISION RES, V36, P1195, DOI 10.1016/0042-6989(95)00222-7; Montfoort I, 2006, INVEST OPHTH VIS SCI, V47, P2881, DOI 10.1167/iovs.05-1561; Mowatt L, 2018, INT J CLIN PRACT, V72, DOI 10.1111/ijcp.13035; Nucci P, 2005, AM J OPHTHALMOL, V140, P65; Ortega JAA, 2008, MED CLIN-BARCELONA, V130, P85; Ostadimoghaddam H, 2017, CLIN EXP OPTOM, V100, P255, DOI 10.1111/cxo.12471; Parihar J K S, 2016, Med J Armed Forces India, V72, P270, DOI 10.1016/j.mjafi.2016.03.016; Radulovic B, 2012, ARH HIG RADA TOKSIKO, V63, P215, DOI 10.2478/10004-1254-63-2012-2197; Randolph SA, 2017, WORKPLACE HEALTH SAF, V65, P328, DOI 10.1177/2165079917712727; Richter HO, 2015, EUR J APPL PHYSIOL, V115, P1501, DOI 10.1007/s00421-015-3125-9; Richter HO, 2011, EUR J APPL PHYSIOL, V111, P29, DOI 10.1007/s00421-010-1629-x; Richter HO, 2010, VISION RES, V50, P2559, DOI 10.1016/j.visres.2010.08.021; Richter HO, 2014, WORK, V47, P413, DOI 10.3233/WOR-131776; Roper-Hall G, 2009, STRABISMUS, V17, P3, DOI 10.1080/09273970802678784; Rowe FJ, 2010, STRABISMUS, V18, P48, DOI 10.3109/09273971003758412; Sheard C., 1930, AM J OPTOM, V7, P9, DOI [10.1097/00006324-193001000-00001, DOI 10.1097/00006324-193001000-00001]; Taimela S, 2000, SPINE, V25, P1021, DOI 10.1097/00007632-200004150-00018; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2014, MANUAL THER, V19, P203, DOI 10.1016/j.math.2014.01.005; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zetterberg C, 2013, J ELECTROMYOGR KINES, V23, P1190, DOI 10.1016/j.jelekin.2013.06.003; Zetterberg C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182439; Zetterberg C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126578; Zhang D, 2016, INT J OPHTHALMOL-CHI, V9, P746, DOI 10.18240/ijo.2016.05.20	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209710	10.1371/journal.pone.0209710	http://dx.doi.org/10.1371/journal.pone.0209710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645581	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200012
J	Lee, YH; Kung, PT; Wang, YH; Kuo, WY; Kao, SL; Tsai, WC				Lee, Yung-Heng; Kung, Pei-Tseng; Wang, Yueh-Hsin; Kuo, Wei-Yin; Kao, Su-Ling; Tsai, Wen-Chen			Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study	PLOS ONE			English	Article							THERAPEUTIC DELAY; BREAST-CANCER; RECTAL-CANCER; YOUNGER; SURGERY; PATIENT; STAGE; SYMPTOMS; VOLUME; COLON	Evidence is limited regarding the effect of diagnosis-to-treatment interval (DTI) on the survival of colorectal cancer (CRC) patients. In addition, previous studies on treatment delay and CRC survival have largely grouped patients from all stages (I-IV) into one cohort. Our study provides analysis on each stage individually. We conducted a retrospective cohort study with 39,000 newly diagnosed CRC patients obtained from the Taiwan Cancer Registry Database from 2004-2010 to examine the effect of DTIs on overall survival. DTIs were divided into 3 groups: <= 30 days (36,115 patients, 90.5% of study patients), 31-150 days (2,533, 6.4%), and >= 151 days (1,252, 3.15%). Risk of death was increased for DTI 31-150 days (hazard ratio 1.51; 95% confidence interval 1.43-1.59) and DTI >= 151 days (1.64; 1.54-1.76) compared to DTI <= 30. This risk was consistent across all cancer stages. Additional factors that increased risk of death include male gender, age > 75, Charlson Comorbidity Index >= 7, other catastrophic illnesses, lack of multidisciplinary team involvement, and treatment in a low volume center. From these results, we advise that the DTI for all CRC patients, regardless of cancer staging, should be 30 days or less.	[Lee, Yung-Heng; Wang, Yueh-Hsin; Kuo, Wei-Yin; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Lee, Yung-Heng] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lee, Yung-Heng] Miaoli Gen Hosp, Dept Orthoped, Miaoli, Taiwan; [Lee, Yung-Heng; Kao, Su-Ling] Jen Teh Jr Coll Med Nursing & Management, Dept Nursing Adm, Miaoli, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Kung, Pei-Tseng] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kao, Su-Ling] Cishan Gen Hosp, Dept Human Resource, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789; Wang, Yueh-Hsin/0000-0002-1282-5945	Ministry of Science and Technology [MOST 104-2410-H-039 -002, ASIA104-CMUH-17]; China Medical University; Asia University, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University(China Medical University); Asia University, Taiwan	This study was supported by grants (MOST 104-2410-H-039 -002 to WCT; ASIA104-CMUH-17 to PTK) from the Ministry of Science and Technology (https://www.most.gov.tw/) and China Medical University (http://www.cmu.edu.tw/) and Asia University (http://www.asia.edu.tw/EN/), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MJ, 2010, EUR J CANCER, V46, P2681, DOI 10.1016/j.ejca.2010.04.026; Abu-Helalah Munir Ahmad, 2016, J Gastrointest Cancer, V47, P36, DOI 10.1007/s12029-015-9783-3; AFZELIUS P, 1994, ACTA ONCOL, V33, P345, DOI 10.3109/02841869409098427; Alok Kumar D., 2012, HEALTH, V4, DOI [10.4236/health.2012.42012, DOI 10.4236/HEALTH.2012.42012]; [Anonymous], 2000, NHS CANC PLAN PLAN I; Bhandari A, 2017, J INVEST MED, V65, P311, DOI 10.1136/jim-2016-000229; Bilimoria KY, 2011, ANN SURG, V253, P779, DOI 10.1097/SLA.0b013e318211cc0f; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Chiang JM, 2003, DIS COLON RECTUM, V46, P904, DOI 10.1007/s10350-004-6683-1; Chou CL, 2011, AM J SURG, V202, P574, DOI 10.1016/j.amjsurg.2010.10.014; Chu YT, 2010, TAIWAN J PUBLIC HLTH, V29, P8; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; FISHER ER, 1977, CANCER-AM CANCER SOC, V40, P3160, DOI 10.1002/1097-0142(197712)40:6<3160::AID-CNCR2820400661>3.0.CO;2-P; Helewa RM, 2013, J SURG ONCOL, V108, P378, DOI 10.1002/jso.23412; Hsu YH, 2016, HEALTH POLICY, V120, P674, DOI 10.1016/j.healthpol.2016.04.001; Huang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101731; Iversen LH, 2009, BRIT J SURG, V96, P1183, DOI 10.1002/bjs.6700; Keating J, 2006, NZ MED J, V119, P2238; Liu CY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-446; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lordan JT, 2009, EJSO-EUR J SURG ONC, V35, P302, DOI 10.1016/j.ejso.2008.01.028; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Ministry of Health and Welfare and Statistics Department, TAIW LEAD CAUS DEATH; Montella M, 2002, CANCER, V95, P2254, DOI 10.1002/cncr.10961; Murchie P, 2014, BRIT J CANCER, V111, P461, DOI 10.1038/bjc.2014.352; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Parikh-Patel A, 2006, CANCER-AM CANCER SOC, V107, P1189, DOI 10.1002/cncr.22016; Pruitt SL, 2013, CANCER CAUSE CONTROL, V24, P961, DOI 10.1007/s10552-013-0172-6; Ramos M, 2007, EUR J CANCER, V43, P2467, DOI 10.1016/j.ejca.2007.08.023; Sarfati D, 2016, CA-CANCER J CLIN, V66, P338, DOI 10.3322/caac.21342; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Taiwan Health Promotion Administration, 2008, TAIW CANC REG CANC S; van de Velde CJH, 2014, EJSO-EUR J SURG ONC, V40, P454, DOI 10.1016/j.ejso.2013.10.013; Visser MRM, 2006, J SURG ONCOL, V93, P571, DOI 10.1002/jso.20552; Wattacheril J, 2008, ALIMENT PHARM THER, V28, P1166, DOI 10.1111/j.1365-2036.2008.03826.x; Yun YH, 2012, ANN ONCOL, V23, P2731, DOI 10.1093/annonc/mds101; Zarcos-Pedrinaci I, 2017, ONCOTARGET, V8, P36728, DOI 10.18632/oncotarget.13574	40	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210465	10.1371/journal.pone.0210465	http://dx.doi.org/10.1371/journal.pone.0210465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640932	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000030
J	Li, YJ; Wu, HH; Liu, SH; Tu, KH; Lee, CC; Hsu, HH; Chang, MY; Yu, KH; Chen, W; Tian, YC				Li, Yi-Jung; Wu, Hsin-Hsu; Liu, Shou-Hsuan; Tu, Kun-Hua; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Yu, Kuang-Hui; Chen, Wei; Tian, Ya-Chung			Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-ANTIGEN; INFECTION; ERYTHEMATOSUS; REPLICATION; JC; PREVALENCE; EXPRESSION; ANTIBODIES; RECIPIENTS	Objective Lupus nephritis (LN) frequently progresses to end-stage renal disease. Finding a biomarker for LN and a predictor for the development of chronic kidney disease (CKD) is important for patients with systemic lupus erythematosus (SLE). Methods Ninety patients with SLE were divided into biopsy-proven LN (n = 54) and no kidney involvement (non-LN) (n = 36) groups and followed up for 54 months. Results Of 36 patients with LN, 3 (5.6%) had class II disease, 3 (5.6%) had class III, 35 (64.8%) had class IV, 10 (18.5%) had class V, and 3 (5.6%) had class VI (advanced sclerosis). Compared to the non-LN group, patients in the LN group had higher autoimmunity evidenced by a higher proportion of low C3 and C4 levels, positive anti-double-stranded DNA antibody levels, and lower estimated glomerular filtration rates (eGFR). Urinary neutrophil gelatinaseassociated lipocalin (uNGAL) levels were significantly higher in the LN group (LN vs nonLN, 670 vs 33 ng/mL, respectively). The patients with LN had a higher urinary polyomavirus BK (BKV) load (3.6 vs 3.0 log copies/mL) and a lower urinary BKV miRNA (miR-B1) 5p level (0.29 vs 0.55 log copies/mL, p = 0.025), while there was no significant difference in the level of miR-B1-3p. Urinary miR-B1-5p level but not urinary BKV load was negatively correlated with uNGAL level (r =-0.22, p = 0.004). At the cutoff value of 80 ng/mL, the receiver operating characteristic curve analysis showed that uNGAL level as a predictor of the presence of LN had a high sensitivity (98%) and specificity (100%) (area under the curve [AUC], 0.997; p < 0.001). During the 54-month follow-up period, 14 (7%) patients with LN and none of the non-LN patients developed CKD. Multivariate Cox regression analysis revealed that baseline uNGAL level was the only predictive factor for CKD development, while baseline serum creatinine level and eGFR were not. Conclusion An elevated urinary BKV viral load with a decreased level of miR-B1 implies the presence of LN. In addition, an increased uNGAL level is a good biomarker not only in predicting the presence of LN but also for prediction of CKD development in patients with SLE.	[Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Tian, Ya-Chung] Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan; [Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Tian, Ya-Chung] Linkou Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan; [Li, Yi-Jung; Wu, Hsin-Hsu; Liu, Shou-Hsuan; Tu, Kun-Hua; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Tian, Ya-Chung] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Liu, Shou-Hsuan; Tu, Kun-Hua; Lee, Cheng-Chia] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Yu, Kuang-Hui] Linkou Chang Gung Mem Hosp, Dept Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Chen, Wei] Xiamen Chang Gung Hosp, Dept Nephrol, Xiamen, Fujian, Peoples R China	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Tian, YC (corresponding author), Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan.; Tian, YC (corresponding author), Linkou Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan.; Tian, YC (corresponding author), Chang Gung Univ, Dept Med, Taoyuan, Taiwan.	dryctian@cgmh.org.tw	Chang, Ming-Yang/AGH-5397-2022; Tu, Kun-Hua/ABD-1751-2021	Chang, Ming-Yang/0000-0001-8899-0376; Tu, Kun-Hua/0000-0002-7146-4481; Lee, Cheng-Chia/0000-0002-6973-5908; Tian, Ya-Chung/0000-0002-0314-5876; Wu, Hsin Hsu/0000-0002-0028-7836	Chung Gang Medical Research Project [CORPG3F0191, CMRPG3A1201-1similar to3, CMRP3E1581-2]	Chung Gang Medical Research Project	This study was supported by grants from the Chung Gang Medical Research Project to Ya-Chung Tian and Yi-Jung Li (CORPG3F0191, CMRPG3A1201-1 similar to 3, CMRPG3E1581-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Deepa Tolani for English editing. This study was supported by grants from the Chung Gang Medical Research Project to Ya-Chung Tian and Yi-Jung Li (CORPG3F0191, CMRPG3A1201-1 similar to 3, CMRP3E1581-2).	ARTHUR RR, 1986, NEW ENGL J MED, V315, P230, DOI 10.1056/NEJM198607243150405; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Colla L, 2007, LUPUS, V16, P881, DOI 10.1177/0961203307084169; Cubukcu-Dimopulo O, 2000, AM J SURG PATHOL, V24, P145, DOI 10.1097/00000478-200001000-00019; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Faurschou M, 2010, ARTHRIT CARE RES, V62, P873, DOI 10.1002/acr.20116; Fenton KA, 2008, MOL IMMUNOL, V45, P3117, DOI 10.1016/j.molimm.2008.03.001; Flodstrom-Tullberg M, 2003, MICROBES INFECT, V5, P911, DOI 10.1016/S1286-4579(03)00161-8; Fogazzi GB, 2001, NEPHROL DIAL TRANSPL, V16, P1496, DOI 10.1093/ndt/16.7.1496; FREDRIKSEN K, 1993, SCAND J IMMUNOL, V38, P401, DOI 10.1111/j.1365-3083.1993.tb01744.x; GARDNER SD, 1971, LANCET, V1, P1253; Hinze CH, 2009, ARTHRITIS RHEUM-US, V60, P2772, DOI 10.1002/art.24751; Kawano Y, 2013, J INFECT DIS, V208, P771, DOI 10.1093/infdis/jit222; Li JYZ, 2014, AM J TRANSPLANT, V14, P1183, DOI 10.1111/ajt.12694; Li YJ, 2009, CLIN TRANSPLANT, V23, P505, DOI 10.1111/j.1399-0012.2009.00982.x; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701; Lu MC, 2009, AUTOIMMUNITY, V42, P216, DOI 10.1080/08916930802709125; Martelli F, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1927; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nukuzuma S, 2014, J MED VIROL, V86, P2026, DOI 10.1002/jmv.23886; Pawar RD, 2012, ARTHRITIS RHEUM-US, V64, P1620, DOI 10.1002/art.33485; Perez-Mercado AE, 2010, JCR-J CLIN RHEUMATOL, V16, P335, DOI 10.1097/RHU.0b013e3181f4cf52; Rekvig OP, 2006, ADV EXP MED BIOL, V577, P117; Rekvig OP, 1997, J CLIN INVEST, V99, P2045, DOI 10.1172/JCI119373; Rubinstein T, 2010, RHEUMATOLOGY, V49, P960, DOI 10.1093/rheumatology/kep468; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Torres-Salido MT, 2014, NEPHROL DIAL TRANSPL, V29, P1740, DOI 10.1093/ndt/gfu062; Tesar V, 2011, NAT REV NEPHROL, V7, P96, DOI 10.1038/nrneph.2010.170; Tian YC, 2014, BIOCHEM BIOPH RES CO, V447, P543, DOI 10.1016/j.bbrc.2014.04.030; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; Yen CL, 2016, J FORMOS MED ASSOC, V115, P539, DOI 10.1016/j.jfma.2016.01.008	36	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210633	10.1371/journal.pone.0210633	http://dx.doi.org/10.1371/journal.pone.0210633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640964	gold, Green Submitted, Green Published			2022-12-26	WOS:000455808000036
J	Pardo, FOC; Wayne, S; Culhane, MR; Perez, A; Allerson, M; Torremorell, M				Pardo, Fabian Orlando Chamba; Wayne, Spencer; Culhane, Marie Rene; Perez, Andres; Allerson, Matthew; Torremorell, Montserrat			Effect of strain-specific maternally-derived antibodies on influenza A virus infection dynamics in nursery pigs	PLOS ONE			English	Article							SWINE-INFLUENZA; UNITED-STATES; ANTIGENIC SITES; POPULATION-DYNAMICS; IMMUNE-RESPONSES; H3N2 VIRUSES; TRANSMISSION; EVOLUTION; VACCINES; PIGLETS	Reducing the number of influenza A virus (IAV) infected pigs at weaning is critical to minimize IAV spread to other farms. Sow vaccination is a common measure to reduce influenza levels at weaning. However, the impact of maternally-derived antibodies on IAV infection dynamics in growing pigs is poorly understood. We evaluated the effect of maternallyderived antibodies at weaning on IAV prevalence at weaning, time of influenza infection, number of weeks that pigs tested IAV positive, and estimated quantity of IAV in nursery pigs. We evaluated 301 pigs within 10 cohorts for their influenza serological (seroprevalence estimated by hemagglutination inhibition (HI) test) and virological (prevalence) status. Nasal swabs were collected weekly and pigs were bled 3 times throughout the nursery period. There was significant variability in influenza seroprevalence, HI titers and influenza prevalence after weaning. Increase in influenza seroprevalence at weaning was associated with low influenza prevalence at weaning and delayed time to IAV infection throughout the nursery. Piglets with IAV HI titers of 40 or higher at weaning were also less likely to test IAV positive at weaning, took longer to become infected, tested IAV RT-PCR positive for fewer weeks, and had higher IAV RT-PCR cycle threshold values compared to piglets with HI titers less than 40. Our findings suggest that sow vaccination or infection status that results in high levels of IAV strain-specific maternally-derived antibodies may help to reduce IAV circulation in both suckling and nursery pigs.	[Pardo, Fabian Orlando Chamba; Culhane, Marie Rene; Perez, Andres; Torremorell, Montserrat] Univ Minnesota, Vet Populat Med Dept, St Paul, MN 55108 USA; [Wayne, Spencer] Pipestone Vet Serv, Hlth Serv, Pipestone, MN USA; [Allerson, Matthew] Holden Farms Inc, Hlth & Res Div, Northfield, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Vet Populat Med Dept, St Paul, MN 55108 USA.	torr0033@umn.edu	Chamba Pardo, Fabian O/A-8202-2015; Perez, Andres/HGD-8377-2022	Chamba Pardo, Fabian O/0000-0002-3093-9719; Culhane, Marie/0000-0002-3547-7576	National Pork Board [15-026]	National Pork Board	The author(s) received funding for this work from the National Pork Board (grant number: 15-026 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2017, VIROLOGY, V511, P56, DOI 10.1016/j.virol.2017.08.021; Allerson MW, 2014, TRANSBOUND EMERG DIS, V61, P490, DOI 10.1111/tbed.12053; Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; Allerson MW, 2013, THESIS; Alvarez J, 2015, PREV VET MED, V121, P240, DOI 10.1016/j.prevetmed.2015.07.003; Anderson TK, 2015, VIRUS RES, V201, P24, DOI 10.1016/j.virusres.2015.02.009; Anderson TK, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12193; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bao Y, 2007, NUCLEIC ACIDS RES, V35, pW280, DOI 10.1093/nar/gkm354; BLASKOVIC D, 1970, B WORLD HEALTH ORGAN, V42, P767; Bolton MJ, 2019, INFLUENZA OTHER RESP, V13, P83, DOI 10.1111/irv.12610; Brown VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088817; Cador C, 2016, VET RES, V47, DOI 10.1186/s13567-016-0365-6; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Choi YK, 2004, AM J VET RES, V65, P303, DOI 10.2460/ajvr.2004.65.303; Ciacci Zanella Janice R, 2012, Influenza Res Treat, V2012, P329029, DOI 10.1155/2012/329029; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Corzo CA, 2012, J SWINE HEALTH PROD, V20, P283; Deblanc C, 2018, VET MICROBIOL, V216, P142, DOI 10.1016/j.vetmic.2018.01.019; Diaz A, 2017, J VIROL, V91, DOI 10.1128/JVI.00745-17; Diaz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129213; Er C, 2016, J ANIM SCI, V94, P751, DOI 10.2527/jas.2015-9251; Er C, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0284-6; Ferreira JB, 2018, TRANSBOUND EMERG DIS, V65, pe145, DOI 10.1111/tbed.12701; Ferreira JB, 2017, VET RES, V48, DOI 10.1186/s13567-017-0466-x; Gao SB, 2017, J GEN VIROL, V98, P2001, DOI 10.1099/jgv.0.000885; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Gracia JCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175267; Harris KA, 2017, ECOHEALTH, V14, P342, DOI 10.1007/s10393-017-1244-y; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Kaplan BS, 2015, EMERG INFECT DIS, V21, P1834, DOI 10.3201/eid2110.140633; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Kitikoon P, 2014, METHODS MOL BIOL, V1161, P295, DOI 10.1007/978-1-4939-0758-8_24; Kitikoon P, 2013, J GEN VIROL, V94, P1236, DOI [10.1099/vir.0.51839-0, 10.1099/vir.0.051839-0]; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Kyriakis CS, 2013, VET MICROBIOL, V162, P543, DOI 10.1016/j.vetmic.2012.11.014; Kyriakis CS, 2017, VET MICROBIOL, V211, P174, DOI 10.1016/j.vetmic.2017.10.016; Laurie KL, 2015, J INFECT DIS, V212, P1701, DOI 10.1093/infdis/jiv260; Lewis NS, 2016, ELIFE, V5, DOI 10.7554/eLife.12217; Lewis NS, 2014, J VIROL, V88, P4752, DOI 10.1128/JVI.03805-13; Loeffen WLA, 2009, VET MICROBIOL, V137, P45, DOI 10.1016/j.vetmic.2009.01.004; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Loeffen WLA, 2003, VET MICROBIOL, V91, P295, DOI 10.1016/S0378-1135(02)00306-1; Lorusso A, 2014, J GEN VIROL, V95, P2618, DOI 10.1099/vir.0.067926-0; Lorusso A, 2013, CURR TOP MICROBIOL, V370, P113, DOI 10.1007/82_2011_196; LUBECK MD, 1981, VIROLOGY, V113, P64, DOI 10.1016/0042-6822(81)90136-7; Lugar DW, 2017, J SWINE HEALTH PROD, V25, P303; Mughini-Gras Lapo, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.4211b8d6cedd8c870db723455409c0f8; Na W, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0343-z; Nelson MI, 2015, J VIROL, V89, P6218, DOI 10.1128/JVI.00459-15; Nelson MI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7696; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Obadan AO, 2015, J GEN VIROL, V96, P2511, DOI 10.1099/vir.0.000190; Pardo FOC, 2018, PREV VET MED, V161, P33, DOI 10.1016/j.prevetmed.2018.10.008; Pileri E, 2017, PREV VET MED, V138, P147, DOI 10.1016/j.prevetmed.2017.01.008; R Core Team, 2020, R LANG ENV STAT COMP; Rajao DS, 2018, VIROLOGY, V518, P45, DOI 10.1016/j.virol.2018.02.006; Rajao DS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00123; Rajao DS, 2017, J VIROL, V91, DOI 10.1128/JVI.01763-16; Rajao DS, 2015, J VIROL, V89, P11213, DOI 10.1128/JVI.01675-15; Reeth VK, 2012, DIS SWINE, V10th, P557; RENSHAW HW, 1975, AM J VET RES, V36, P5; Rose N, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-72; Rutvisuttinunt W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/j.jviromet.2013.07.001; Sandbulte MR, 2015, VACCINES-BASEL, V3, P22, DOI 10.3390/vaccines3010022; Sandbulte MR, 2014, VIROLOGY, V464, P45, DOI 10.1016/j.virol.2014.06.027; Shahmoradian SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05587-4; Simon-Grife M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-24; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Sriwilaijaroen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016302; United States Department of Agriculture, 2017, INFLUENZA A VIRUS IN; USDA, 2015, REF SWIN HLTH HLTH 2; Vincent AL, 2017, VET MICROBIOL, V206, P35, DOI 10.1016/j.vetmic.2016.11.026; Walia RR, 2019, INFLUENZA OTHER RESP, V13, P262, DOI 10.1111/irv.12559; Xu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20239; Zhang JQ, 2014, METHODS MOL BIOL, V1161, P277, DOI 10.1007/978-1-4939-0758-8_23; Zhang JQ, 2014, METHODS MOL BIOL, V1161, P265, DOI 10.1007/978-1-4939-0758-8_22; Zhang Y, 2017, NUCLEIC ACIDS RES, V45, pD466, DOI 10.1093/nar/gkw857	83	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210700	10.1371/journal.pone.0210700	http://dx.doi.org/10.1371/journal.pone.0210700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640929	gold, Green Submitted, Green Published			2022-12-26	WOS:000455808000040
J	Taskova, K; Fontaine, JF; Mrowka, R; Andrade-Navarro, MA				Taskova, Katerina; Fontaine, Jean-Fred; Mrowka, Ralf; Andrade-Navarro, Miguel A.			Literature optimized integration of gene expression for organ-specific evaluation of toxicogenomics datasets	PLOS ONE			English	Article							IN-VITRO; RANK AGGREGATION; INDUCED LIVER; DRUG; MECHANISMS; OVEREXPRESSION; IDENTIFICATION; TOXICOLOGY; DISCOVERY; DATABASE	The study of drug toxicity in human organs is complicated by their complex inter-relations and by the obvious difficulty to testing drug effects on biologically relevant material. Animal models and human cell cultures offer alternatives for systematic and large-scale profiling of drug effects on gene expression level, as typically found in the so-called toxicogenomics datasets. However, the complexity of these data, which includes variable drug doses, time points, and experimental setups, makes it difficult to choose and integrate the data, and to evaluate the appropriateness of one or another model system to study drug toxicity (of particular drugs) of particular human organs. Here, we define a protocol to integrate drug-wise rankings of gene expression changes in toxicogenomics data, which we apply to the TG-GATEs dataset, to prioritize genes for association to drug toxicity in liver or kidney. Contrast of the results with sets of known human genes associated to drug toxicity in the literature allows to compare different rank aggregation approaches for the task at hand. Collectively, ranks from multiple models point to genes not previously associated to toxicity, notably, the PCNA clamp associated factor (PCLAF), and genes regulated by the master regulator of the antioxidant response NFE2L2, such as NQO1 and SRXN1. In addition, comparing gene ranks from different models allowed us to evaluate striking differences in terms of toxicity-associated genes between human and rat hepatocytes or between rat liver and rat hepatocytes. We interpret these results to point to the different molecular functions associated to organ toxicity that are best described by each model. We conclude that the expected production of toxicogenomics panels with larger numbers of drugs and models, in combination with the ongoing increase of the experimental literature in organ toxicity, will lead to increasingly better associations of genes for organism toxicity.	[Taskova, Katerina; Fontaine, Jean-Fred; Andrade-Navarro, Miguel A.] Biozentrum I, Fac Biol, Mainz, Germany; [Mrowka, Ralf] KIM III, Univ Klinikum Jena, Expt Nephrol, Jena, Germany	Friedrich Schiller University of Jena	Andrade-Navarro, MA (corresponding author), Biozentrum I, Fac Biol, Mainz, Germany.	andrade@uni-mainz.de	Fontaine, Jean-Fred/GNP-2904-2022; Mrowka, Ralf/AAW-1480-2021; Andrade, Miguel/B-6565-2008	Fontaine, Jean-Fred/0000-0002-1101-4091; Mrowka, Ralf/0000-0002-0991-3418; Taskova, Katerina/0000-0002-3217-7877; Andrade, Miguel/0000-0001-6650-1711	BMBF grant program SysToxChip [FKZ 031A303A, FKZ 031A303E]; Bundesministerium fur Bildung und Forschung	BMBF grant program SysToxChip; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	KT, JF, RM and MAA received funds from BMBF grant program SysToxChip (FKZ 031A303A and FKZ 031A303E), Bundesministerium fur Bildung und Forschung, https://www.bmbf.de/.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Andrade-Navarro M.A., 2016, GENOMICS COMPUTATION, V2, pe33; Attia SM, 2010, OXID MED CELL LONGEV, V3, P238, DOI 10.4161/oxim.3.4.13246; Aubrecht J, 2013, GENOME MED, V5, DOI 10.1186/gm489; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Badgeley MA, 2015, BIOINFORMATICS, V31, P209, DOI 10.1093/bioinformatics/btu518; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boullata JI, 2013, J CLIN PHARM THER, V38, P269, DOI 10.1111/jcpt.12075; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Cheng Y, 2013, LAB INVEST, V93, P1276, DOI 10.1038/labinvest.2013.124; Chikina M D, 2014, R IMPLEMENTATION BIR; Clarke JI, 2016, EXPERT OPIN DRUG SAF, V15, P625, DOI 10.1517/14740338.2016.1160057; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; De Biasio A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7439; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; El-Hachem N, 2016, ENVIRON HEALTH PERSP, V124, P313, DOI 10.1289/ehp.1409157; Fisher RA, STAT METHODS RES WOR, P1925; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Griffith O, 2012, R HEATMAP FUNCTION; Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106; Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Johansson I, 2011, TOXICOL SCI, V120, P1, DOI 10.1093/toxsci/kfq374; Kato T, 2012, LUNG CANCER, V75, P110, DOI 10.1016/j.lungcan.2011.05.024; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136698; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lin SL, 2010, WILEY INTERDISCIP RE, V2, P555, DOI 10.1002/wics.111; Liu ZC, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00074; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nueda MJ, 2012, BIOSTATISTICS, V13, P553, DOI 10.1093/biostatistics/kxr042; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rueda-Zarate HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176284; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suter L, 2011, TOXICOL APPL PHARM, V252, P73, DOI 10.1016/j.taap.2010.10.008; Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230; Te JA, 2016, J APPL TOXICOL, V36, P1137, DOI 10.1002/jat.3278; Team RC, 2015, R LANG ENV STAT COMP; Tiong HY, 2014, MOL PHARMACEUT, V11, P1933, DOI 10.1021/mp400720w; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang JD, 2014, PHARMACOGENOMICS J, V14, P208, DOI 10.1038/tpj.2013.39; Zhu K, 2013, CANCER SCI, V104, P353, DOI 10.1111/cas.12083; Zou JL, 2015, CHEM RES TOXICOL, V28, P373, DOI 10.1021/tx500333q	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210467	10.1371/journal.pone.0210467	http://dx.doi.org/10.1371/journal.pone.0210467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640953	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000031
J	Kline, JA; Fisher, MA; Pettit, KL; Linville, CT; Beck, AM				Kline, Jeffrey A.; Fisher, Michelle A.; Pettit, Katherine L.; Linville, Courtney T.; Beck, Alan M.			Controlled clinical trial of canine therapy versus usual care to reduce patient anxiety in the emergency department	PLOS ONE			English	Article							ANIMAL-ASSISTED THERAPY; PAIN; STRESS; DOGS	Objective Test if therapy dogs reduce anxiety in emergency department (ED) patients. Methods In this controlled clinical trial (NCT03471429), medically stable, adult patients were approached if the physician believed that the patient had "moderate or greater anxiety." Patients were allocated on a 1: 1 ratio to either 15 min exposure to a certified therapy dog and handler (dog), or usual care (control). Patient reported anxiety, pain and depression were assessed using a 0-10 scale (10 = worst). Primary outcome was change in anxiety from baseline (T0) to 30 min and 90 min after exposure to dog or control (T1 and T2 respectively); secondary outcomes were pain, depression and frequency of pain medication. Results Among 93 patients willing to participate in research, 7 had aversions to dogs, leaving 86 (92%) were willing to see a dog six others met exclusion criteria, leaving 40 patients allocated to each group (dog or control). Median and mean baseline anxiety, pain and depression scores were similar between groups. With dog exposure, median anxiety decreased significantly from T0 to T1: 6 (IQR 4-9.75) to T1: 2 (0-6) compared with 6 (4-8) to 6 (2.5-8) in controls (P<0.001, for T1, Mann-Whitney U and unpaired t-test). Dog exposure was associated with significantly lower anxiety at T2 and a significant overall treatment effect on two-way repeated measures ANOVA for anxiety, pain and depression. After exposure, 1/40 in the dog group needed pain medication, versus 7/40 in controls (P = 0.056, Fisher's exact test). Conclusions Exposure to therapy dogs plus handlers significantly reduced anxiety in ED patients.	[Kline, Jeffrey A.; Pettit, Katherine L.; Linville, Courtney T.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Fisher, Michelle A.] Eskenazi Hlth, Indianapolis, IN USA; [Beck, Alan M.] Purdue Univ, Dept Comparat Pathobiol, Lafayette, IN USA	Indiana University System; Indiana University Bloomington; Eskenazi Health; Purdue University System; Purdue University	Kline, JA (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.	jefkline@iupui.edu		Beck, Alan/0000-0002-0661-7672	Lilly Physician Scientist Initiative	Lilly Physician Scientist Initiative	This work was supported by the Lilly Physician Scientist Initiative to JAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, BIOPHILIA HUMAN BOND; Antonioli C, 2005, BMJ-BRIT MED J, V331, P1231, DOI 10.1136/bmj.331.7527.1231; Barker SB, 1998, PSYCHIATR SERV, V49, P797, DOI 10.1176/ps.49.6.797; Beck A. M., 2014, Animal Frontiers, V4, P32, DOI 10.2527/af.2014-0019; Braun Carie, 2009, Complement Ther Clin Pract, V15, P105, DOI 10.1016/j.ctcp.2009.02.008; Brucker K, 2018, ACAD EMERG MED, V28; Burt RS, 2005, BROKERAGE CLOSURE IN; Epstein RM, 2007, J GEN INTERN MED, V22, P1731, DOI 10.1007/s11606-007-0416-9; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Havener L, 2001, Issues Compr Pediatr Nurs, V24, P137, DOI 10.1080/01460860118472; Havey J, 2014, ANTHROZOOS, V27, P361, DOI 10.2752/175303714X13903827487962; Kertes DA, 2017, SOC DEV, V26, P382, DOI 10.1111/sode.12203; Lin MP, 2017, PATIENT ED COUNS; Marcus DA, 2013, PAIN MED, V14, P43, DOI 10.1111/j.1526-4637.2012.01522.x; McCullough A, 2018, J PEDIATR ONCOL NURS, V35, P159, DOI 10.1177/1043454217748586; McKinley S, 2004, AM J CRIT CARE, V13, P146, DOI 10.4037/ajcc2004.13.2.146; McKinley S, 2008, J PSYCHOSOM RES, V64, P503, DOI 10.1016/j.jpsychores.2008.02.002; Lasa SM, 2015, NEUROLOGIA, V30, P1, DOI 10.1016/j.nrl.2013.01.012; Musey P, 2018, AM J CARDIOL; Musey PI, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0161-x; Musey PI, 2017, J EMERG MED, V52, P273, DOI 10.1016/j.jemermed.2016.11.022; Nahm N, 2012, WEST J EMERG MED, V13, P363, DOI 10.5811/westjem.2011.5.6574; Patel R, 2014, ACAD EMERG MED, V21, P1478, DOI 10.1111/acem.12543; Perpina-Galvan J, 2009, AM J CRIT CARE, V18, P571, DOI 10.4037/ajcc2009682; POULIN PA, 2016, PAIN RES MANAG, pNIL1, DOI DOI 10.1155/2016/3092391; Sobo EJ, 2006, J HOLIST NURS, V24, P51, DOI 10.1177/0898010105280112; Tanabe P, 2008, ANN EMERG MED, V51, P221, DOI 10.1016/j.annemergmed.2007.10.017; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402	28	18	18	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209232	10.1371/journal.pone.0209232	http://dx.doi.org/10.1371/journal.pone.0209232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625184	Green Submitted, gold, Green Published			2022-12-26	WOS:000455359400030
J	Sommers, JA; Kulikowicz, T; Croteau, DL; Dexheimer, T; Dorjsuren, D; Jadhav, A; Maloney, DJ; Simeonov, A; Bohr, VA; Brosh, RM				Sommers, Joshua A.; Kulikowicz, Tomasz; Croteau, Deborah L.; Dexheimer, Thomas; Dorjsuren, Dorjbal; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton; Bohr, Vilhelm A.; Brosh, Robert M., Jr.			A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN)	PLOS ONE			English	Article							SYNDROME PROTEIN; DNA HELICASE; FUNCTIONAL INTERACTION; CELLULAR-RESPONSE; CANCER; REPAIR; BINDING; DAMAGE; ROLES	Werner syndrome (WS), an autosomal recessive genetic disorder, displays accelerated clinical symptoms of aging leading to a mean lifespan less than 50 years. The WS helicase-nuclease (WRN) is involved in many important pathways including DNA replication, recombination and repair. Replicating cells are dependent on helicase activity, leading to the pursuit of human helicases as potential therapeutic targets for cancer treatment. Small molecule inhibitors of DNA helicases can be used to induce synthetic lethality, which attempts to target helicase-dependent compensatory DNA repair pathways in tumor cells that are already genetically deficient in a specific pathway of DNA repair. Alternatively, helicase inhibitors may be useful as tools to study the specialized roles of helicases in replication and DNA repair. In this study, approximately 350,000 small molecules were screened based on their ability to inhibit duplex DNA unwinding by a catalytically active WRN helicase domain fragment in a high-throughput fluorometric assay to discover new non-covalent small molecule inhibitors of the WRN helicase. Select compounds were screened to exclude ones that inhibited DNA unwinding by other helicases in the screen, bound non-specifically to DNA, acted as irreversible inhibitors, or possessed unfavorable chemical properties. Several compounds were tested for their ability to impair proliferation of cultured tumor cells. We observed that two of the newly identified WRN helicase inhibitors inhibited proliferation of cancer cells in a lineage-dependent manner. These studies represent the first high-throughput screen for WRN helicase inhibitors and the results have implications for anti-cancer strategies targeting WRN in different cancer cells and genetic backgrounds.	[Sommers, Joshua A.; Kulikowicz, Tomasz; Croteau, Deborah L.; Bohr, Vilhelm A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Dexheimer, Thomas; Dorjsuren, Dorjbal; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Croteau, Deb/AAP-5933-2020; Bohr, Vilhelm/AAP-5931-2020; Brosh, Robert/AAR-6124-2020	Croteau, Deborah/0000-0002-6094-4084	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000721] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Programs of the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) and the National Institute on Aging, NIH.	Aggarwal M, 2013, CELL CYCLE, V12, P3329, DOI 10.4161/cc.26320; Aggarwal M, 2013, CANCER RES, V73, P5497, DOI 10.1158/0008-5472.CAN-12-2975; Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; Banerjee T, 2016, METHODS, V108, P130, DOI 10.1016/j.ymeth.2016.04.007; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2001, EMBO J, V20, P5791; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Coussens NP, 2017, PHARMACOL REV, V69, P479, DOI 10.1124/pr.117.013755; Datta A, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00059; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Nguyen GH, 2013, CHEM BIOL, V20, P55, DOI 10.1016/j.chembiol.2012.10.016; Gillette WK, 2011, PROTEIN EXPRES PURIF, V76, P238, DOI 10.1016/j.pep.2010.12.003; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Ishibashi T, 1998, P NATL ACAD SCI USA, V95, P4219, DOI 10.1073/pnas.95.8.4219; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Lauper JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059709; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Moles R, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0352-4; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Rosenthal AS, 2013, BIOORG MED CHEM LETT, V23, P5660, DOI 10.1016/j.bmcl.2013.08.025; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sarkar J, 2015, NUCLEIC ACIDS RES, V43, P5912, DOI 10.1093/nar/gkv522; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Shamanna Raghavendra A, 2017, F1000Res, V6, P1779, DOI 10.12688/f1000research.12110.1; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	34	15	15	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210525	10.1371/journal.pone.0210525	http://dx.doi.org/10.1371/journal.pone.0210525			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625228	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400094
J	Coucha, M; Barrett, AC; Elgebaly, M; Ergul, A; Abdelsaid, M				Coucha, Maha; Barrett, Amy C.; Elgebaly, Mostafa; Ergul, Adviye; Abdelsaid, Mohammed			Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats	PLOS ONE			English	Article							ENDOTHELIAL-CELL; ANGIOGENESIS; MECHANISMS; RECEPTORS; TARGET; REPAIR; MODEL; VEGF	We have previously shown that diabetes causes dysfunctional cerebral neovascularization that increases the risk for cerebrovascular disorders such as stroke and cognitive impairment. Pericytes (PCs) play a pivotal role in the angiogenic process through their interaction with the endothelial cells (EC). Yet, the role of PCs in dysfunctional cerebral neovascularization in diabetes is unclear. In the present study, we tested the hypothesis that the increased proangiogenic Ephrin-B2 signaling in PCs contributes to the dysfunctional cerebral neovascularization in diabetes. Type-II diabetes was induced by a combination of high fat diet and low dose streptozotocin injection in male Wistar rats. Selective in vivo Ephrin-B2 silencing in brain PCs was achieved using the stereotactic injection of adeno-associated virus (AAV) with NG2-promoter that expresses Ephrin-B2 shRNA. Neovascularization was assessed using vascular fluorescent dye stain. Novel object recognition (NOR) test was used to determine cognitive functions. Human brain microvascular pericytes HBMVPCs were grown in high glucose 25 mM and palmitate 200 uM (HG/Pal) to mimic diabetic conditions. Scratch migration and tube formation assays were conducted to evaluate PC/EC interaction and angiogenic functions in PC/EC co-culture. Diabetes increased the expression of Ephrin-B2 in the cerebrovasculature and pericytes. Concomitant increases in cerebral neovascularization parameters including vascular density, tortuosity and branching density in diabetic rats were accompanied by deterioration of cognitive function. Inhibition of Ephrin-B2 expression in PCs significantly restored cerebral vascularization and improved cognitive functions. HG/Pal increased PC/EC angiogenic properties in co-culture. Silencing Ephrin-B2 in PCs significantly reduced PC migration and PC/EC co-culture angiogenic properties. This study emphasizes the significant contribution of PCs to the pathological neovascularization in diabetes. Our findings introduce Ephrin-B2 signaling as a promising therapeutic target to improve cerebrovascular integrity in diabetes.	[Coucha, Maha] South Univ, Sch Pharm, Dept Pharmaceut Sci, Savannah, GA USA; [Barrett, Amy C.; Abdelsaid, Mohammed] Mercer Univ, Sch Med, Biomed Sci Dept, Savannah, GA 31404 USA; [Elgebaly, Mostafa] Larkin Univ, Coll Pharm, Dept Pharmaceut Sci, Miami, FL USA; [Ergul, Adviye] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Ergul, Adviye] Augusta Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA	Mercer University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University	Abdelsaid, M (corresponding author), Mercer Univ, Sch Med, Biomed Sci Dept, Savannah, GA 31404 USA.	Abdelsaid_ma@mercer.edu	Coucha, Maha/AAC-9947-2022	Abdelsaid, Mohammed/0000-0001-9846-6623	Veterans Affairs (VA) Merit Award [BX000347]; VA Research Career Scientist Award; National Institutes of Health (NIH) [R01NS083559, 16SDG30270013]; Mercer University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083559] Funding Source: NIH RePORTER	Veterans Affairs (VA) Merit Award(US Department of Veterans Affairs); VA Research Career Scientist Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mercer University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AE is a Research Career Scientist at the Charlie Norwood Veterans Affairs Medical Center in Augusta, Georgia. This work was supported in part by a Veterans Affairs (VA) Merit Award (BX000347) to AE, VA Research Career Scientist Award and National Institutes of Health (NIH) award (R01NS083559) to AE. Scientist Development Grant (16SDG30270013) to MA, Mercer University seed grant to MA. The contents do not represent the views of the Department of Veterans Affairs or the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsaid M, 2017, DIABETOLOGIA, V60, P740, DOI 10.1007/s00125-017-4214-6; Abdelsaid M, 2015, DIABETES, V64, P1804, DOI 10.2337/db14-1423; Abdelsaid M, 2014, LIFE SCI, V118, P268, DOI 10.1016/j.lfs.2014.01.008; Abdelsaid M, 2014, TRANSL RES, V164, P424, DOI 10.1016/j.trsl.2014.06.003; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P147, DOI 10.1111/1523-1747.ep12477903; Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; Eilken HM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01738-3; Ejaz S, 2008, DIABETES OBES METAB, V10, P53, DOI 10.1111/j.1463-1326.2007.00795.x; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Ghori A, 2017, ARTERIOSCL THROM VAS, V37, P867, DOI 10.1161/ATVBAHA.116.308620; Herman WH, 1997, ENDOCRIN METAB CLIN, V26, P679, DOI 10.1016/S0889-8529(05)70274-7; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lv JH, 2016, EXP MOL PATHOL, V100, P402, DOI 10.1016/j.yexmp.2016.03.011; Neng LL, 2013, JARO-J ASSOC RES OTO, V14, P175, DOI 10.1007/s10162-012-0365-9; Pitulescu ME, 2014, CELL ADHES MIGR, V8, P366, DOI 10.4161/19336918.2014.970010; Prakash R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056264; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Qu Z, 2014, STROKE, V45, pA169; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Thomas HM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061129; Umeda N, 2004, AM J OPHTHALMOL, V138, P270, DOI 10.1016/j.ajo.2004.04.006; Winkler EA, 2018, J NEUROSURG, V129, P1464, DOI 10.3171/2017.6.JNS17860; Yang D, 2016, ANGIOGENESIS, V19, P297, DOI 10.1007/s10456-016-9514-9; Zhang NN, 2017, J INT MED RES, V45, P594, DOI 10.1177/0300060517693178	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210523	10.1371/journal.pone.0210523	http://dx.doi.org/10.1371/journal.pone.0210523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620753	Green Submitted, Green Published, gold			2022-12-26	WOS:000455161300040
J	Hsieh, CJ; Jin, SC; Chen, JC; Kuo, CW; Wang, RT; Chu, WC				Hsieh, Chia-Jui; Jin, Shih-Chun; Chen, Jyh-Cheng; Kuo, Chih-Wei; Wang, Ruei-Teng; Chu, Woei-Chyn			Performance of sparse-view CT reconstruction with multi-directional gradient operators	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; COMPUTED-TOMOGRAPHY; PROJECTION	To further reduce the noise and artifacts in the reconstructed image of sparse-view CT, we have modified the traditional total variation (TV) methods, which only calculate the gradient variations in xand ydirections, and have proposed 8- and 26-directional (the multi-directional) gradient operators for TV calculation to improve the quality of reconstructed images. Different from traditional TV methods, the proposed 8- and 26-directional gradient operators additionally consider the diagonal directions in TV calculation. The proposed method preserves more information from original tomographic data in the step of gradient transform to obtain better reconstruction image qualities. Our algorithms were tested using two-dimensional Shepp-Logan phantom and three-dimensional clinical CT images. Results were evaluated using the root-mean-square error (RMSE), peak signal-to-noise ratio (PSNR), and universal quality index (UQI). All the experiment results show that the sparse-view CT images reconstructed using the proposed 8- and 26-directional gradient operators are superior to those reconstructed by traditional TV methods. Qualitative and quantitative analyses indicate that the more number of directions that the gradient operator has, the better images can be reconstructed. The 8- and 26-directional gradient operators we proposed have better capability to reduce noise and artifacts than traditional TV methods, and they are applicable to be applied to and combined with existing CT reconstruction algorithms derived from CS theory to produce better image quality in sparse-view reconstruction.	[Hsieh, Chia-Jui; Chu, Woei-Chyn] Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan; [Hsieh, Chia-Jui; Jin, Shih-Chun; Chen, Jyh-Cheng] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Kuo, Chih-Wei; Wang, Ruei-Teng] Natl Chung Shan Inst Sci & Technol, Mat & Electroopt Res Div, Taoyuan, Taiwan; [Kuo, Chih-Wei] Natl United Univ, Dept Electroopt Engn, Miaoli, Miaoli County, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National United University	Chu, WC (corresponding author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan.; Chen, JC (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.	jcchen@ym.edu.tw; woeichyn@gmail.com		Chu, Woei-Chyn/0000-0002-9407-0741	National Chung-Shan Institute of Science Technology [NCSIST-164-V101(105)]; Ministry of Sciences and Technology [MOST 106-2218-E-010-003, MOST 106-2221-E-010-012]	National Chung-Shan Institute of Science Technology; Ministry of Sciences and Technology	This work was supported by the National Chung-Shan Institute of Science & Technology [grant number NCSIST-164-V101(105)]; and the Ministry of Sciences and Technology [grant numbers MOST 106-2218-E-010-003, MOST 106-2221-E-010-012].	Ahn D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184633; Aubertin G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183523; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Chen CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192002; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Chen MY, 2015, J MED IMAG HEALTH IN, V5, P309, DOI 10.1166/jmihi.2015.1392; Clark DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180324; Deans S.R., 2007, RADON TRANSFORM SOME; Dehairs M, 2017, PHYS MED BIOL, V62, P6610, DOI 10.1088/1361-6560/aa7a9d; den Harder AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175714; Deng LZ, 2015, BIO-MED MATER ENG, V26, pS1685, DOI 10.3233/BME-151468; Dettmer S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191457; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Durand P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173751; Giacomini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190770; Gong CF, 2017, PHYS MED BIOL, V62, P2612, DOI 10.1088/1361-6560/aa5d40; Han H, 2017, PHYS MED BIOL, V62, P6408, DOI 10.1088/1361-6560/aa7733; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Huang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079709; Kak A. C., 2001, PRINCIPLES COMPUTERI; Li S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191569; Liu L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172938; Liu Y, PHYS MED BIOL; Liu Y, 2012, PHYS MED BIOL, V57, P7923, DOI 10.1088/0031-9155/57/23/7923; Malusek A, 2017, MED PHYS, V44, P2345, DOI 10.1002/mp.12238; Miranda GE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196770; Niu SZ, 2014, PHYS MED BIOL, V59, P2997, DOI 10.1088/0031-9155/59/12/2997; Nowik P, 2017, PHYS MED BIOL, V62, pN538, DOI 10.1088/1361-6560/aa9259; Park HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170713; Ramirez-Giraldo JC, 2011, MED PHYS, V38, P2157, DOI 10.1118/1.3560878; Saltybaeva N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155722; Sauter A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162716; Seong KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171777; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Tian Z, 2011, PHYS MED BIOL, V56, P5949, DOI 10.1088/0031-9155/56/18/011; Tschauner S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178747; Weiss J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180671; Yamamoto T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189493; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109345; Zhang H, 2014, MED PHYS, V41, DOI 10.1118/1.4901265; Zhang Y, 2017, MED PHYS	46	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209674	10.1371/journal.pone.0209674	http://dx.doi.org/10.1371/journal.pone.0209674			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615635	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900025
J	Semba, M; Lumpkin, R; Kimirei, I; Shaghude, Y; Nyandwi, N				Semba, Masumbuko; Lumpkin, Rick; Kimirei, Ismael; Shaghude, Yohanna; Nyandwi, Ntahondi			Seasonal and spatial variation of surface current in the Pemba Channel, Tanzania	PLOS ONE			English	Article							INDIAN-OCEAN; SATELLITE ALTIMETRY; GLOBAL OCEAN; CIRCULATION	The surface current speeds within the Pemba channel were examined using 24 years of drifter data received from the Global Drifter Program. This study aimed to uncover varying surface current in the Pemba Channel in different seasons. The results revealed the Pemba Channel experiences relatively higher median surface current speeds during the southeast (SE) monsoon season compared to the northeast (NE) and inter-monsoon (IN) periods. The strongest current speeds were confined in waters deeper than 200 meters between similar to 39.4 degrees E and 39.7 degrees E. These results prove that surface currents from the drifters can be used to uncover the patterns of surface circulation even in areas where in-situ measurements are scarce.	[Semba, Masumbuko; Shaghude, Yohanna; Nyandwi, Ntahondi] Inst Marine Sci, Zanzibar, Tanzania; [Semba, Masumbuko] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Lumpkin, Rick] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Kimirei, Ismael] Tanzania Fisheries Res Inst TAFIRI, Kigoma, Tanzania	Nelson Mandela African Institution of Science & Technology; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Semba, M (corresponding author), Inst Marine Sci, Zanzibar, Tanzania.; Semba, M (corresponding author), Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania.	masumbuko.semba@nm-aist.ac.tz	Kimirei, Ismael Aaron/F-7385-2012; Lumpkin, Rick/C-9615-2009	Kimirei, Ismael Aaron/0000-0002-1101-5262; Lumpkin, Rick/0000-0002-6690-1704; Semba, Masumbuko/0000-0002-5002-9747	Office of Naval Research; NERC [NE/P021050/1] Funding Source: UKRI	Office of Naval Research(Office of Naval Research); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Office of Naval Research provided a financial support for author Masumbuko Semba for a fellowship at at the Atlantic Oceanographic and Meteorological Laboratory of the National Oceanic and Atmospheric Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FIELD GUIDE SEASHORE; Barlow R, 2011, AFR J MAR SCI, V33, P283, DOI 10.2989/1814232X.2011.600430; Benny NP, 2014, TERR ATMOS OCEAN SCI, V25, P91, DOI 10.3319/TAO.2013.08.05.01(Oc); Bosire J., 2015, REGIONAL STATE COAST, P213; Fu LL, 2006, CR GEOSCI, V338, P1063, DOI 10.1016/j.crte.2006.05.015; Grolemond G, 2011, J STAT SOFTW, V40, P1; Halo I, 2015, REGIONAL STATE COAST, P187; Kobayashi DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103701; KOCH SE, 1983, J CLIM APPL METEOROL, V22, P1487, DOI 10.1175/1520-0450(1983)022<1487:AIBOMA>2.0.CO;2; Lacasce JH, 2000, J MAR RES, V58, P61; Laurindo LC, 2017, DEEP-SEA RES PT I, V124, P73, DOI 10.1016/j.dsr.2017.04.009; Levine A, 2016, REG ENVIRON CHANGE, V16, P1279, DOI 10.1007/s10113-015-0856-4; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; Lumpkin R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017519; Lumpkin R, 2007, LAGRANGIAN ANALYSIS AND PREDICTION OF COASTAL AND OCEAN DYNAMICS, P39, DOI 10.1017/CBO9780511535901.003; Lumpkin R, 2013, J GEOPHYS RES-OCEANS, V118, P2992, DOI 10.1002/jgrc.20210; Lumpkin R, 2012, J ATMOS OCEAN TECH, V29, P300, DOI 10.1175/JTECH-D-11-00100.1; Lumpkin R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006285; Mahongo S, 2015, REGIONAL STATE COAST, P3; Mahongo S. B., 2011, Western Indian Ocean Journal of Marine Science, V10, P107; Mahongo S.B., 2014, J OCEANOGRAPHY MARIN, V5, P1, DOI DOI 10.5897/JOMS2013.0100; Manyilizu M, 2014, AFR J MAR SCI, V36, P233, DOI 10.2989/1814232X.2014.928651; Mayorga-Adame CG, 2016, J GEOPHYS RES-OCEANS, V121, P1377, DOI 10.1002/2015JC010860; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; McKight P.E., 2010, CORSINI ENCY PSYCHOL, P1, DOI DOI 10.1002/9780470479216.CORPSYO491; MOLINARI RL, 1990, J GEOPHYS RES-OCEANS, V95, P7217, DOI 10.1029/JC095iC05p07217; Nyandwi N., 2013, J OCEAN TECHNOL, V8 (, P65; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Peng SQ, 2015, J PHYS OCEANOGR, V45, P441, DOI 10.1175/JPO-D-14-0050.1; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts M., 2015, W INDIAN OCEAN UPWEL; Shaghude YW, 1998, AMBIO, V27, P729; Shaghude YW, 2000, ESTUAR COAST SHELF S, V51, P477, DOI 10.1006/ecss.2000.0686; Shenoi SSC, 1999, J MAR RES, V57, P885, DOI 10.1357/002224099321514088; SVERDRUP HU, 1947, P NATL ACAD SCI USA, V33, P318, DOI 10.1073/pnas.33.11.318; SWALLOW JC, 1991, J GEOPHYS RES-OCEANS, V96, P22245, DOI 10.1029/91JC01942; Wihsgott Juliane, MONSOON FORCED UNPUB; Wyrtki K, 1973, Science, V181, P262, DOI 10.1126/science.181.4096.262; Zavala-Garay J, 2015, J GEOPHYS RES-OCEANS, V120, P6091, DOI 10.1002/2015JC010879; Zheng SJ, 2012, ATMOS OCEAN SCI LETT, V5, P329, DOI 10.1080/16742834.2012.11447015	40	15	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210303	10.1371/journal.pone.0210303	http://dx.doi.org/10.1371/journal.pone.0210303			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615686	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900062
J	Smith, RJ; Yi, T; Nasiri, B; Breuer, CK; Andreadis, ST				Smith, Randall J., Jr.; Yi, Tai; Nasiri, Bita; Breuer, Christopher K.; Andreadis, Stelios T.			Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response	FASEB JOURNAL			English	Article						monocytes; endothelialization; immunoengineering; inflammation	ENDOTHELIAL PROGENITOR CELLS; SMALL-INTESTINAL SUBMUCOSA; SMALL-DIAMETER; HUMAN MONOCYTES; ARTERIAL GRAFT; BLOOD-VESSELS; IN-VIVO; TISSUE; DIFFERENTIATION; MACROPHAGES	Recently, our group demonstrated that immobilized VEGF can capture flowing endothelial cells (ECs) from the blood in vitro and promote endothelialization and patency of acellular tissue-engineered vessels (A-TEVs) into the arterial system of an ovine animal model. Here, we demonstrate implantability of submillimeter diameter heparin and VEGF-decorated A-TEVs in a mouse model and discuss the cellular and immunologic response. At 1 mo postimplantation, the graft lumen was fully endothelialized, as shown by expression of EC markers such as CD144, eNOS, CD31, and VEGFR2. Interestingly, the same cells coexpressed leukocyte/macrophage (M phi) markers CD14, CD16, VEGFR1, CD38, and EGR2. Notably, there was a stark difference in the cellular makeup between grafts containing VEGF and those containing heparin alone. In VEGF-containing grafts, infiltrating monocytes (MCs) converted into anti-inflammatory M2-M phi s, and the grafts developed well-demarcated luminal and medial layers resembling those of native arteries. In contrast, in grafts containing only heparin, MCs converted primarily into M1-M phi s, and the endothelial and smooth muscle layers were not well defined. Our results indicate that VEGF may play an important role in regulating A-TEV patency and regeneration, possibly by regulating the inflammatory response to the implants.	[Smith, Randall J., Jr.; Andreadis, Stelios T.] SUNY Buffalo, Dept Biomed Engn, Amherst, NY USA; [Nasiri, Bita; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Amherst, NY USA; [Andreadis, Stelios T.] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Amherst, NY USA; [Yi, Tai; Breuer, Christopher K.] Nationwide Childrens Hosp, Columbus, OH USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Andreadis, ST (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall,North Campus, Amherst, NY 14260 USA.	sandread@buffalo.edu		Smith, Randall/0000-0001-8114-3086	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL086582, F31 HL134323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086582, F31HL134323, R01HL139796, R01HL128847] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute to S.T.A. (R01 HL086582) and to R.J.S. (F31 HL134323 Fellowship). The authors declare no conflicts of interest.	Aubin H, 2016, TISSUE ENG PART C-ME, V22, P496, DOI [10.1089/ten.tec.2015.0556, 10.1089/ten.TEC.2015.0556]; Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690; Baer C, 2013, EXP CELL RES, V319, P1626, DOI 10.1016/j.yexcr.2013.03.026; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Chambers SEJ, 2013, IMMUNOBIOLOGY, V218, P1370, DOI 10.1016/j.imbio.2013.06.010; Dahan N, 2017, TISSUE ENG PT A, V23, P69, DOI [10.1089/ten.tea.2016.0126, 10.1089/ten.TEA.2016.0126]; Dahan N, 2012, TISSUE ENG PT A, V18, P411, DOI [10.1089/ten.tea.2011.0173, 10.1089/ten.TEA.2011.0173]; De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016; Digiacomo G, 2017, CELL ADHES MIGR, V11, P327, DOI 10.1080/19336918.2016.1221566; Dimitrievska S, 2015, ACTA BIOMATER, V13, P177, DOI 10.1016/j.actbio.2014.11.015; Gabriel M, 2016, JOVE-J VIS EXP, DOI 10.3791/54272; Gao YH, 2016, ADV HEALTHC MATER, V5, P2427, DOI 10.1002/adhm.201600400; Harrington JK, 2011, FASEB J, V25, P4150, DOI 10.1096/fj.11-185140; Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549; Hibino N, 2015, FASEB J, V29, P2431, DOI 10.1096/fj.14-268334; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Jang JH, 2007, ACTA PHARMACOL SIN, V28, P367, DOI 10.1111/j.1745-7254.2007.00519.x; Janis AD, 2012, J BIOMATER APPL, V26, P1013, DOI 10.1177/0885328210391688; Kang J, 2014, J MOL CELL CARDIOL, V75, P64, DOI 10.1016/j.yjmcc.2014.06.019; Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z; Khosravi R, 2016, ANN BIOMED ENG, V44, P2402, DOI 10.1007/s10439-015-1545-7; Koobatian MT, 2016, BIOMATERIALS, V76, P344, DOI 10.1016/j.biomaterials.2015.10.020; Koobatian MT, 2015, JOVE-J VIS EXP, DOI 10.3791/52354; Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017; Kristofik NJ, 2017, BIOMATERIALS, V141, P63, DOI 10.1016/j.biomaterials.2017.06.025; Kruger A, 2014, CLIN HEMORHEOL MICRO, V58, P229, DOI 10.3233/CH-141875; Lanuti P, 2016, CYTOM PART A, V89A, P259, DOI 10.1002/cyto.a.22730; Lee KW, 2013, BIOMATERIALS, V34, P9877, DOI 10.1016/j.biomaterials.2013.08.082; Li B, 2011, MOL CANCER RES, V9, P702, DOI 10.1158/1541-7786.MCR-10-0484; Ma X, 2017, J CARDIOTHORAC SURG, V12, DOI 10.1186/s13019-017-0661-x; Mahara A, 2015, BIOMATERIALS, V58, P54, DOI 10.1016/j.biomaterials.2015.04.031; Malm CJ, 2012, SCAND CARDIOVASC J, V46, P57, DOI 10.3109/14017431.2011.623788; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Matsuda T, 2013, J BIOMED MATER RES B, V101B, P50, DOI 10.1002/jbm.b.32812; Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011; Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Nakul-Aquaronne D, 2003, CARDIOVASC RES, V57, P816, DOI 10.1016/S0008-6363(02)00776-9; Onwuka E, 2017, REGEN MED, V12, P249, DOI 10.2217/rme-2016-0141; Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002; Pavcnik D, 2009, CARDIOVASC INTER RAD, V32, P106, DOI 10.1007/s00270-008-9449-7; Pelosi E, 2014, BLOOD CELL MOL DIS, V52, P186, DOI 10.1016/j.bcmd.2013.11.004; Peng HF, 2011, TISSUE ENG PT A, V17, P981, DOI [10.1089/ten.tea.2010.0109, 10.1089/ten.TEA.2010.0109]; Peng HF, 2012, CELLS TISSUES ORGANS, V195, P108, DOI 10.1159/000331415; Pennel T, 2014, BIOMATERIALS, V35, P6311, DOI 10.1016/j.biomaterials.2014.04.062; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; Putzu M, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045009; Qiu XF, 2017, ACTA BIOMATER, V51, P138, DOI 10.1016/j.actbio.2017.01.012; Quint C, 2012, J VASC SURG, V55, P790, DOI 10.1016/j.jvs.2011.07.098; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rambol MH, 2018, EBIOMEDICINE, V32, P215, DOI 10.1016/j.ebiom.2018.05.012; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0; Row S, 2015, BIOMATERIALS, V50, P115, DOI 10.1016/j.biomaterials.2015.01.045; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Shi CC, 2015, ACS APPL MATER INTER, V7, P20389, DOI 10.1021/acsami.5b06286; Smith RJ, 2015, BIOMATERIALS, V51, P303, DOI 10.1016/j.biomaterials.2015.02.025; Song L, 2016, CELL MOL BIOL, V62, P31, DOI 10.14715/cmb/2016.62.3.7; Sopova K, 2012, CURR VASC PHARMACOL, V10, P555, DOI 10.2174/157016112801784486; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Swartz DD, 2013, CURR OPIN BIOTECH, V24, P916, DOI 10.1016/j.copbio.2013.05.005; Syedain ZH, 2014, TISSUE ENG PT A, V20, P1726, DOI [10.1089/ten.tea.2013.0550, 10.1089/ten.TEA.2013.0550]; Tara S, 2015, J VASC SURG, V62, P734, DOI 10.1016/j.jvs.2014.03.011; Tchaikovski V, 2008, ARTERIOSCL THROM VAS, V28, P322, DOI 10.1161/ATVBAHA.107.158022; Teixeira TM, 2017, J NUTR, V147, P506, DOI 10.3945/jn.116.239475; Thomas GD, 2017, ARTERIOSCL THROM VAS, V37, P1548, DOI 10.1161/ATVBAHA.117.309145; Usui T, 2004, INVEST OPHTH VIS SCI, V45, P368, DOI 10.1167/iovs.03-0106; Wragg A, 2008, J MOL MED, V86, P1221, DOI 10.1007/s00109-008-0390-7; Wu HK, 2005, J SURG RES, V126, P193, DOI 10.1016/j.jss.2005.01.016; Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821; Wystrychowski W, 2011, J VASC ACCESS, V12, P67, DOI 10.5301/JVA.2011.6360; Xiang P, 2011, INT J BIOL MACROMOL, V49, P281, DOI 10.1016/j.ijbiomac.2011.05.004; Xu SY, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0344-9; Zhang RX, 2005, EXP HEMATOL, V33, P1554, DOI 10.1016/j.exphem.2005.08.011; Zhao YL, 2010, BIOMATERIALS, V31, P296, DOI 10.1016/j.biomaterials.2009.09.049; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	81	23	26	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5089	5100		10.1096/fj.201801856R	http://dx.doi.org/10.1096/fj.201801856R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629890	Green Published, Bronze			2022-12-26	WOS:000462888500038
J	Peshenko, IV; Cideciyan, AV; Sumaroka, A; Olshevskaya, EV; Scholten, A; Abbas, S; Koch, KW; Jacobson, SG; Dizhoor, AM				Peshenko, Igor V.; Cideciyan, Artur V.; Sumaroka, Alexander; Olshevskaya, Elena V.; Scholten, Alexander; Abbas, Seher; Koch, Karl-Wilhelm; Jacobson, Samuel G.; Dizhoor, Alexander M.			A G86R mutation in the calcium-sensor protein GCAP1 alters regulation of retinal guanylyl cyclase and causes dominant cone-rod degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium-binding protein; eye; cyclic GMP (cGMP); phototransduction; photoreceptor; retinal degeneration; guanylate cyclase (guanylyl cyclase); calcium sensor; GUCA1A; RetGC; retinopathy	LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEIN-1; PHOTORECEPTOR DEGENERATION; CONFORMATIONAL-CHANGES; PROGRESSIVE CONE; TARGET ENZYME; GENE; BINDING; GUCA1A; CA2+	The guanylyl cyclase-activating protein, GCAP1, activates photoreceptor membrane guanylyl cyclase (RetGC) in the light, when free Ca2+ concentrations decline, and decelerates the cyclase in the dark, when Ca2+ concentrations rise. Here, we report a novel mutation, G86R, in the GCAP1 (GUCA1A) gene in a family with a dominant retinopathy. The G86R substitution in a hinge region connecting EF-hand domains 2 and 3 in GCAP1 strongly interfered with its Ca2+-dependent activator-to-inhibitor conformational transition. The G86R-GCAP1 variant activated RetGC at low Ca2+ concentrations with higher affinity than did the WT GCAP1, but failed to decelerate the cyclase at the Ca2+ concentrations characteristic of dark-adapted photoreceptors. Ca2+-dependent increase in Trp(94) fluorescence, indicative of the GCAP1 transition to its RetGC inhibiting state, was suppressed and shifted to a higher Ca2+ range. Conformational changes in G86R GCAP1 detectable by isothermal titration calorimetry (ITC) also became less sensitive to Ca2+, and the dose dependence of the G86R GCAP1-RetGC1 complex inhibition by retinal degeneration 3 (RD3) protein was shifted toward higher than normal concentrations. Our results indicate that the flexibility of the hinge region between EF-hands 2 and 3 is required for placing GCAP1-regulated Ca2+ sensitivity of the cyclase within the physiological range of intracellular Ca2+ at the expense of reducing GCAP1 affinity for the target enzyme. The disease-linked mutation of the hinge Gly(86), leading to abnormally high affinity for the target enzyme and reduced Ca2+ sensitivity of GCAP1, is predicted to abnormally elevate cGMP production and Ca2+ influx in photoreceptors in the dark.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Cideciyan, Artur V.; Sumaroka, Alexander; Jacobson, Samuel G.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Scholten, Alexander; Abbas, Seher; Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, D-26129 Oldenburg, Germany	University of Pennsylvania; Carl von Ossietzky Universitat Oldenburg	Jacobson, SG (corresponding author), Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA.; Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	jacobsos@pennmedicine.upenn.edu; adizhoor@salus.edu	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY11522]; Macula Vision Research Foundation; Pennsylvania Department of Health; Deutsche Forschungsgemeinschaft [GRK1885]; German Academic Exchange Program; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Pennsylvania Department of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Program(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY11522 (to A. M. D.), grants from the Macula Vision Research Foundation (to S. G. J., A. V. C.), Pennsylvania Department of Health (to A. M. D.), Deutsche Forschungsgemeinschaft Grant GRK1885 (to S. A., K. W. K., A. S.), and a fellowship from the German Academic Exchange Program (to S. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Cideciyan AV, 2007, J OPT SOC AM A, V24, P1457, DOI 10.1364/JOSAA.24.001457; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P3393, DOI 10.1167/iovs.15-16726; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Kamenarova K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/517570; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Lopez-Begines S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20893-1; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Marino V, 2015, HUM MOL GENET, V24, P6653, DOI 10.1093/hmg/ddv370; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1442, DOI 10.1016/j.ophtha.2005.02.024; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Nong E, 2014, DOC OPHTHALMOL, V128, P59, DOI 10.1007/s10633-013-9420-z; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Robin J, 2015, ACS CHEM BIOL, V10, P2344, DOI 10.1021/acschembio.5b00278; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato M, 2005, GRAEF ARCH CLIN EXP, V243, P235, DOI 10.1007/s00417-004-1015-7; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Sharon D, 2018, PROG RETIN EYE RES, V63, P69, DOI 10.1016/j.preteyeres.2017.10.003; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Sokal I, 1999, J BIOL CHEM, V274, P19829, DOI 10.1074/jbc.274.28.19829; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Stunkel ML, 2018, AM J OPHTHALMOL, V190, P58, DOI 10.1016/j.ajo.2018.03.021; Sulmann S, 2014, CHEM-EUR J, V20, P6756, DOI 10.1002/chem.201402146; To K, 1998, AM J OPHTHALMOL, V126, P140, DOI 10.1016/S0002-9394(98)00085-3; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Vinberg F, 2018, J BIOL CHEM, V293, P7457, DOI 10.1074/jbc.RA117.001574; Vocke F, 2017, HUM MOL GENET, V26, P133, DOI 10.1093/hmg/ddw374; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	80	24	24	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3476	3488		10.1074/jbc.RA118.006180	http://dx.doi.org/10.1074/jbc.RA118.006180			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622141	Green Published, hybrid			2022-12-26	WOS:000461853900015
J	Kokesova, A; Coufal, S; Frybova, B; Kverka, M; Rygl, M				Kokesova, Alena; Coufal, Stepan; Frybova, Barbora; Kverka, Miloslav; Rygl, Michal			The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis	PLOS ONE			English	Article							POSTNATAL COURSE; I-FABP; ISCHEMIA; DISEASE	Background/Purpose We analyzed the capacity of urinary Intestinal fatty acid-binding protein (I-FABP) to quantify the degree of mucosal injury in neonates with gastroschisis (GS) and to predict the speed of their clinical recovery after surgery. Methods In this prospective study, we collected urine during the first 48h after surgery from neonates operated between 2012 and 2015 for GS. Neonates with surgery that did not include gut mucosa served as controls for simple GS and neonates with surgery for intestinal atresia served as control for complex GS patients. The I-FABP levels were analyzed by ELISA. Results Urinary I-FABP after the surgery is significantly higher in GS newborns than in control group; I-FABP in complex GS is higher than in simple GS. I-FABP can predict subsequent operation for ileus in patients with complex GS. Both ways of abdominal wall closure (i.e. primary closure and stepwise reconstruction) led to similar levels of I-FABP. None of the static I-FABP values was useful for the outcome prediction. The steep decrease in I-FABP after the surgery is associated with faster recovery, but it cannot predict early start of minimal enteral feeding, full enteral feeding or length of hospitalization. Conclusion Urinary I-FABP reflects the mucosal damage in gastroschisis but it has only a limited predictive value for patients' outcome.	[Kokesova, Alena; Frybova, Barbora; Rygl, Michal] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic; [Kokesova, Alena; Coufal, Stepan; Kverka, Miloslav] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic; [Kverka, Miloslav] Czech Acad Sci, Inst Expt Med, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Kokesova, A (corresponding author), Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic.; Kokesova, A (corresponding author), Czech Acad Sci, Inst Microbiol, Prague, Czech Republic.	alenakokes@yahoo.com	Coufal, Stepan/S-6152-2017; Frybova, Barbora/AAW-2792-2020; Kverka, Miloslav/H-2507-2014	Coufal, Stepan/0000-0001-6950-1813; Kverka, Miloslav/0000-0002-1335-5252	Charles University Grant Agency [159115, 326815]; Ministry of Health of the Czech Republic [15-28064A]; Institutional Research Concept (Inst. Microbiol. Academy of Sciences) [RVO: 61388971]	Charles University Grant Agency; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Institutional Research Concept (Inst. Microbiol. Academy of Sciences)	This project was supported by The Charles University Grant Agency: Grant No. 159115 (BF), and Grant No. 326815 (SC), Ministry of Health of the Czech Republic: Grant No 15-28064A (MK) and by Institutional Research Concept RVO: 61388971 (Inst. Microbiol. Academy of Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MPM, 2013, ALIMENT PHARM THER, V37, P482, DOI 10.1111/apt.12194; Aina-Mumuney AJ, 2004, AM J OBSTET GYNECOL, V190, P1326, DOI 10.1016/j.ajog.2003.11.003; Bingold TM, 2015, SURG INFECT, V16, P247, DOI 10.1089/sur.2014.073; Caglar M, 2014, J PEDIATR SURG, V49, P1577, DOI 10.1016/j.jpedsurg.2014.06.019; Christison-Lagay ER, 2011, SEMIN FETAL NEONAT M, V16, P164, DOI 10.1016/j.siny.2011.02.003; Coufal S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5727312; Derikx JPM, 2007, GUT, V56, P1473, DOI 10.1136/gut.2007.128934; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; Frybova B, 2015, PEDIATR SURG INT, V31, P381, DOI 10.1007/s00383-015-3675-2; GOLLIN G, 1993, J PEDIATR SURG, V28, P367, DOI 10.1016/0022-3468(93)90233-B; Gollin G, 1993, J PEDIATR SURG, V28, P70; Grootjans J, 2016, WORLD J GASTROENTERO, V22, P2760, DOI 10.3748/wjg.v22.i9.2760; Huh NG, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.888; Janoo Jabin, 2013, W V Med J, V109, P22; Jones AM, 2016, MMWR-MORBID MORTAL W, V65, P23, DOI 10.15585/mmwr.mm6502a2; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Kuleva M, 2012, BJOG-INT J OBSTET GY, V119, P102, DOI 10.1111/j.1471-0528.2011.03183.x; Kunz SN, 2013, J PEDIATR SURG, V48, P845, DOI 10.1016/j.jpedsurg.2013.01.020; LANGER JC, 1989, J PEDIATR SURG, V24, P992, DOI 10.1016/S0022-3468(89)80200-3; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Molik KA, 2001, J PEDIATR SURG, V36, P51, DOI 10.1053/jpsu.2001.20004; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Olesevich M, 2005, J PEDIATR SURG, V40, P789, DOI 10.1016/j.jpedsurg.2005.01.043; Sarikaya M, 2015, CLIN LAB, V61, P87, DOI 10.7754/Clin.Lab.2014.140518; Skarsgard ED, 2016, CURR OPIN PEDIATR, V28, P363, DOI 10.1097/MOP.0000000000000336; Stuber TN, 2016, ARCH GYNECOL OBSTET, V293, P1001, DOI 10.1007/s00404-015-3936-2; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210797	10.1371/journal.pone.0210797	http://dx.doi.org/10.1371/journal.pone.0210797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640955	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000049
J	Zhu, YB; Liu, S; Chen, W; Liu, B; Zhang, F; Lv, HZ; Ji, CN; Zhang, XL; Zhang, YZ				Zhu, Yanbin; Liu, Song; Chen, Wei; Liu, Bo; Zhang, Fei; Lv, Hongzhi; Ji, Chenni; Zhang, Xiaolin; Zhang, Yingze			Epidemiology of low-energy lower extremity fracture in Chinese populations aged 50 years and above	PLOS ONE			English	Article							DISTAL RADIUS FRACTURE; HIP FRACTURE; OSTEOPOROTIC FRACTURES; ULTRAVIOLET-RADIATION; RISK; METAANALYSIS; ASSOCIATION; WOMEN; INDEX; OLDER	This study aimed to investigate the epidemiology of low-energy lower-extremity fracture in Chinese men and women aged 50 years and above. This study was a part of Chinese National Fracture Survey (CNFS), which used the stratified multistage cluster random sampling method to recruit subjects between January and May 2015. A total of 512187 individuals participated in the CNFS and of them there were 154099 men and women aged 50 years and above included in this study for data analysis. Low-energy fracture was defined as a fracture caused by slip, trip or fall from standing height. Univariate analyses and gender-based multivariate logistic regression models were constructed to identify the independent risk factors. A total of 215 patients had sustained low-energy lower extremity fractures in 2014, indicating the overall incidence was 139.5 (120.9 to 158.2) per 100000 persons, with 127.8 (102.5 to 153.1) and 151.1 (123.8 to 178.5) per 100000 person-year in men and women. Over 80% of fractures occurred at home and on the common road. In men, alcohol consumption (OR, 2.00; 95% CI, 1.29 to 3.08), sleep duration <7h/d (OR, 2.60; 95% CI, 1.68 to 4.03) and history of past fracture (OR, 2.57; 95% CI, 1.33 to 4.95) were identified as significant risk factors associated with low-energy fractures. In women, advanced age (80+ years) (OR, 3.22; 95% CI, 1.80 to 5.75), alcohol consumption(OR, 1.72; 95% CI, 1.00 to 2.98), sleep duration <7h/d (OR, 2.11; 95% CI, 1.40 to 3.18), and history of past fracture (OR, 3.46; 95% CI, 1.97 to 6.09) were identified as significant risk factors and living in western region (OR, 0.60; 95% CI, 0.38 to 0.94) and current weight of 50 to 59.9 kg (OR, 0.17; 95% CI, 0.04 to 0.73) were identified as protective factors for fractures. Accordingly, awareness on the importance of sleep and alcohol consumption on fragility fracture should be improved, and health policies that focus on decreasing alcohol consumption and encouraging individuals to improve their sleep quality and duration should be considered. Maintaining a healthy bodyweight for women should be specifically emphasized to prevent low-energy fractures.	[Zhu, Yanbin; Liu, Song; Chen, Wei; Liu, Bo; Zhang, Fei; Lv, Hongzhi; Ji, Chenni; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China; [Zhu, Yanbin; Liu, Song; Chen, Wei; Liu, Bo; Zhang, Fei; Lv, Hongzhi; Ji, Chenni; Zhang, Yingze] Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Zhang, Xiaolin] Hebei Med Univ, Dept Stat & Epidemiol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yingze] Chinese Acad Engn, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Chinese Acad Engn, Beijing, Peoples R China.	drzhang2013@126.com	Chen, Wei/GRX-2231-2022	Zhu, Yanbin/0000-0002-7822-9329; Zhang, YIngze/0000-0001-8042-6105	Hebei Province Medical Science Special Major Projects Research Fund	Hebei Province Medical Science Special Major Projects Research Fund	This study was funded by the Hebei Province Medical Science Special Major Projects Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JD, 2003, OSTEOPOROSIS INT, V14, P895, DOI 10.1007/s00198-003-1483-3; Adams AL, 2013, OSTEOPOROSIS INT, V24, P373, DOI 10.1007/s00198-012-1938-5; Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6; Arakaki H, 2011, J BONE MINER METAB, V29, P309, DOI 10.1007/s00774-010-0218-8; Chen CW, 2013, J TRAUMA ACUTE CARE, V74, P317, DOI 10.1097/TA.0b013e31824bb325; Chen W, 2017, LANCET GLOB HEALTH, V5, pE807, DOI 10.1016/S2214-109X(17)30222-X; Chevalley T, 2007, BONE, V40, P1284, DOI 10.1016/j.bone.2006.12.063; Clark MK, 2003, OSTEOPOROSIS INT, V14, P396, DOI 10.1007/s00198-003-1387-2; Cooper C, 2005, RHEUMATOLOGY, V44, P36, DOI 10.1093/rheumatology/kei060; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; Durvasula S, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0197-9; Foote JE, 2012, J HAND SURG-AM, V37A, P165, DOI 10.1016/j.jhsa.2011.09.025; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Horii M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-304; Ikpeze TC, 2016, GERIATR ORTHOP SURG, V7, P202, DOI 10.1177/2151458516669202; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Johnell O, 2006, HORM RES, V16, P1; Jpw B, 2016, OSTEOPOROSIS INT, V27, P1; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kannus P, 2002, BONE, V31, P430, DOI 10.1016/S8756-3282(02)00832-3; Kaye JA, 2004, INJURY PREV, V10, P368, DOI 10.1136/ip.2004.005843; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Koski AM, 2014, SCAND J SURG, V103, P215, DOI 10.1177/1457496914525554; Ling X, 1996, AM J EPIDEMIOL, V144, P901; Lofman O, 2002, OSTEOPOROSIS INT, V13, P18; Lonnroos E, 2006, BONE, V39, P623, DOI 10.1016/j.bone.2006.03.001; Lubbeke A, 2005, AGING CLIN EXP RES, V17, P276; Maharlouei N, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-013-0165-9; Mann Eva, 2008, BMC Geriatr, V8, P35, DOI 10.1186/1471-2318-8-35; Piirtola M, 2007, AGING CLIN EXP RES, V19, P269; Rice SA, 2015, BRIT J DERMATOL, V172, P652, DOI 10.1111/bjd.13575; Saraiva GL, 2005, OSTEOPOROSIS INT, V16, P1649, DOI 10.1007/s00198-005-1895-3; Scholes S, 2014, AGE AGEING, V43, P234, DOI 10.1093/ageing/aft167; Shen RG, 2004, MATERNAL CHILD HLTH; Statement NC, 2001, J A M A., V17, P1; Stone KL, 2008, ARCH INTERN MED, V168, P1768, DOI 10.1001/archinte.168.16.1768; Weiss RJ, 2009, INJURY, V40, P304, DOI 10.1016/j.injury.2008.07.017; Yoon BH, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0157-9; Zhu YB, 2017, INT WOUND J, V14, P982, DOI 10.1111/iwj.12743	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209203	10.1371/journal.pone.0209203	http://dx.doi.org/10.1371/journal.pone.0209203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640907	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000011
J	Asigbaase, M; Sjogersten, S; Lomax, BH; Dawoe, E				Asigbaase, Michael; Sjogersten, Sofie; Lomax, Barry H.; Dawoe, Evans			Tree diversity and its ecological importance value in organic and conventional cocoa agroforests in Ghana	PLOS ONE			English	Article							SYSTEMS; AGRICULTURE; MANAGEMENT; LANDSCAPE; SERVICES; COVER; LAND	Cocoa agroforestry systems have the potential to conserve biodiversity and provide environmental or ecological benefits at various nested scales ranging from the plot to ecoregion. While integrating organic practices into cocoa agroforestry may further enhance these potentials, empirical and robust data to support this claim is lacking, and mechanisms for biodiversity conservation and the provision of environmental and ecological benefits are poorly understood. A field study was conducted in the Eastern Region of Ghana to evaluate the potential of organic cocoa agroforests to conserve native floristic diversity in comparison with conventional cocoa agroforests. Shade tree species richness, Shannon, Simpson's reciprocal and Margalef diversity indices were estimated from 84 organic and conventional cocoa agroforestry plots. Species importance value index, a measure of how dominant a species is in a given ecosystem, and conservation status were used to evaluate the conservation potential of shade trees on studied cocoa farms. Organic farms recorded higher mean shade tree species richness (5.10 +/- 0.38) compared to conventional farms (3.48 +/- 0.39). Similarly, mean Shannon diversity index, Simpson's reciprocal diversity index and Margalef diversity index were significantly higher on organic farms compared to conventional farms. According to the importance value index, fruit and native shade tree species were the most important on both organic and conventional farms for all the cocoa age groups but more so on organic farms. Organic farms maintained 14 native tree species facing a conservation issue compared to 10 on conventional cocoa farms. The results suggest that diversified organic cocoa farms can serve as reservoirs of native tree species, including those currently facing conservation concerns thereby providing support and contributing to the conservation of tree species in the landscape.	[Asigbaase, Michael; Sjogersten, Sofie; Lomax, Barry H.] Univ Nottingham, Sch Biosci, Dept Agr & Environm Sci, Nottingham, England; [Dawoe, Evans] Kwame Nkrumah Univ Sci & Technol, Fac Renewable Nat Resources, Dept Agroforestry, Kumasi, Ghana	University of Nottingham; Kwame Nkrumah University Science & Technology	Asigbaase, M (corresponding author), Univ Nottingham, Sch Biosci, Dept Agr & Environm Sci, Nottingham, England.	mbxma18@nottingham.ac.uk	Asigbaase, Michael/AAX-2322-2021; Lomax, Barry/P-5609-2019	Asigbaase, Michael/0000-0002-9162-1149; Lomax, Barry/0000-0003-0475-7839	Ghana Education Trust Fund (GET Fund)	Ghana Education Trust Fund (GET Fund)	The study was fully funded by Ghana Education Trust Fund (GET Fund, http://www.getfund.gov.gh/) as part of a doctoral program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Rajab Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149949; African Cocoa Initiative, 2012, ASS AGR INP DEL COC; Alemagi D., 2014, INT J AGR SUSTAIN, V183, P19; Altieri M.A., 2012, SUSTAINABLE AGR REV, DOI [10.1007/978-94-007-5449-2_1, DOI 10.1007/978-94-007-5449-2_1]; Anglaaere LCN, 2011, AGROFOREST SYST, V81, P249, DOI 10.1007/s10457-010-9366-z; Anim-Kwapong GJ, 2009, AGROFOREST SYST, V76, P533, DOI 10.1007/s10457-008-9196-4; Asare R, 2014, AGROFOREST SYST, V88, P1143, DOI 10.1007/s10457-014-9688-3; Asase A, 2010, AFR J ECOL, V48, P338, DOI 10.1111/j.1365-2028.2009.01112.x; Bandanaa J, 2014, AGR FOOD SECURITY, V5, P29, DOI [10.1186/s40066-016-0077-1, DOI 10.1186/S40066-016-0077-1]; Barrientos S., 2008, MAPPING SUSTAINABLE; Barrios E., 2015, P FAO INT S 18 19 SE; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; CHAO A, 1984, SCAND J STAT, V11, P265; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dawoe E, 2016, CARBON BAL MANAGE, V11, DOI 10.1186/s13021-016-0061-x; FAO, 1991, 66 FAO; FAO, 2011, ORG AGR CLIM CHANG M; Gbetoho AJ, 2017, BOIS FOR TROP, P43; Ghana Statistical Services, 2014, 2010 POP HOUS CENS D; Gockowski J, 2013, INT J AGR SUSTAIN, V11, P331, DOI 10.1080/14735903.2013.772714; Gockowski J, 2011, ENVIRON MANAGE, V48, P307, DOI 10.1007/s00267-010-9602-3; Haggar J., 2015, BIODIVERS CONSERV, DOI [10.1007/s10531-015-0859-y, DOI 10.1007/S10531-015-0859-Y]; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hawthorne WD, 1995, FOREST PROTECTION GH; Hooper E, 2005, J APPL ECOL, V42, P1165, DOI 10.1111/j.1365-2664.2005.01106.x; HUNTER JM, 1963, T I BRIT GEOGR, V33, P61; ICCO, 2014, WORLD COC EC CURR ST; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jacobi J, 2015, AGROECOL SUST FOOD, V39, P798, DOI 10.1080/21683565.2015.1039158; Jastrzebska Magdalena, 2013, Acta Agrobotanica, V66, P113, DOI 10.5586/aa.2013.045; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kremen C., 2015, REFRAMING LAND SPARI, V1355, P52; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mbolo MMA, 2016, AGROFOREST SYST, V90, P577, DOI 10.1007/s10457-016-9945-8; Niggli U., 2008, ORGANIC FARMING CLIM; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Philpott SM, 2007, CONSERV BIOL, V21, P975, DOI 10.1111/j.1523-1739.2007.00728.x; Richard A, 2016, NEW FOREST, V47, P287, DOI 10.1007/s11056-015-9515-3; Saj S, 2017, INT J AGR SUSTAIN, V15, P282, DOI 10.1080/14735903.2017.1311764; Scialabba NEH, 2010, RENEW AGR FOOD SYST, V25, P158, DOI 10.1017/S1742170510000116; Snowdon P, 2002, 31 AUSTR GREENH OFF, P66; Solomou AD, 2013, COMMUN SOIL SCI PLAN, V44, P312, DOI 10.1080/00103624.2013.741914; Tondoh JE, 2015, GLOB ECOL CONSERV, V3, P575, DOI 10.1016/j.gecco.2015.02.007; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Vaast P, 2014, AGROFOREST SYST, V88, P947, DOI 10.1007/s10457-014-9762-x; Vanhove W, 2016, AGR ECOSYST ENVIRON, V219, P14, DOI 10.1016/j.agee.2015.12.005; Wade ASI, 2010, AGR ECOSYST ENVIRON, V138, P324, DOI 10.1016/j.agee.2010.06.007; Wessel M, 2015, NJAS-WAGEN J LIFE SC, V74-75, P1, DOI 10.1016/j.njas.2015.09.001	48	25	26	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210557	10.1371/journal.pone.0210557	http://dx.doi.org/10.1371/journal.pone.0210557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633763	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100030
J	Barnaud, ML; Schwartz, JL; Bessiere, P; Diard, J				Barnaud, Marie-Lou; Schwartz, Jean-Luc; Bessiere, Pierre; Diard, Julien			Computer simulations of coupled idiosyncrasies in speech perception and speech production with COSMO, a perceptuo-motor Bayesian model of speech communication	PLOS ONE			English	Article							MOTOR SYSTEM; SELF-ORGANIZATION; VOICE; FAMILIAR; LANGUAGE; COMPENSATION; ACQUISITION; EMERGENCE; ROLES; AREAS	The existence of a functional relationship between speech perception and production systems is now widely accepted, but the exact nature and role of this relationship remains quite unclear. The existence of idiosyncrasies in production and in perception sheds interesting light on the nature of the link. Indeed, a number of studies explore inter-individual variability in auditory and motor prototypes within a given language, and provide evidence for a link between both sets. In this paper, we attempt to simulate one study on coupled idiosyncrasies in the perception and production of French oral vowels, within COSMO, a Bayesian computational model of speech communication. First, we show that if the learning process in COSMO includes a communicative mechanism between a Learning Agent and a Master Agent, vowel production does display idiosyncrasies. Second, we implement within COSMO three models for speech perception that are, respectively, auditory, motor and perceptuo-motor. We show that no idiosyncrasy in perception can be obtained in the auditory model, since it is optimally tuned to the learning environment, which does not include the motor variability of the Learning Agent. On the contrary, motor and perceptuo-motor models provide perception idiosyncrasies correlated with idiosyncrasies in production. We draw conclusions about the role and importance of motor processes in speech perception, and propose a perceptuo-motor model in which auditory processing would enable optimal processing of learned sounds and motor processing would be helpful in unlearned adverse conditions.	[Barnaud, Marie-Lou; Schwartz, Jean-Luc] Univ Grenoble Alpes, Gipsa Lab, Grenoble, France; [Barnaud, Marie-Lou; Schwartz, Jean-Luc] CNRS, Gipsa Lab, Grenoble, France; [Barnaud, Marie-Lou; Diard, Julien] Univ Grenoble Alpes, LPNC, Grenoble, France; [Barnaud, Marie-Lou; Diard, Julien] CNRS, LPNC, Grenoble, France; [Bessiere, Pierre] Sorbonne Univ, CNRS, ISIR, Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Schwartz, JL (corresponding author), Univ Grenoble Alpes, Gipsa Lab, Grenoble, France.; Schwartz, JL (corresponding author), CNRS, Gipsa Lab, Grenoble, France.	Jean-Luc.Schwartz@gipsa-lab.grenoble-inp.fr		Diard, Julien/0000-0003-0673-477X; Bessiere, Pierre/0000-0002-8620-2505	European Research Council [339152]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a grant from the European Research Council (FP7/2007-2013 Grant Agreement no. 339152 to JLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly G, 1997, SPEECH COMMUN, V22, P251, DOI 10.1016/S0167-6393(97)00025-3; Barnaud  M.-L., 2017, BRAIN LANGUAGE; Barnaud ML, 2015, 5TH INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING AND ON EPIGENETIC ROBOTICS (ICDL-EPIROB), P248, DOI 10.1109/DEVLRN.2015.7346149; Barnaud ML, 2016, INTERSPEECH 2016; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BELLBERTI F, 1979, PHONETICA, V36, P373, DOI 10.1159/000259974; Bessiere P, 2013, BAYESIAN PROGRAMMING; Browman C., 1990, PAPERS LAB PHONOLOGY, P340, DOI [10.1017/CBO9780511627736.019, DOI 10.1017/CBO9780511627736.019]; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Canevari C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00364; Castellini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024055; Cristia A, 2019, CHILD DEV, V90, P759, DOI 10.1111/cdev.12974; D'Ausilio A, 2012, CORTEX, V48, P882, DOI 10.1016/j.cortex.2011.05.017; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; de Boer B, 2000, J PHONETICS, V28, P441, DOI 10.1006/jpho.2000.0125; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; FOWLER CA, 1986, J PHONETICS, V14, P3, DOI 10.1016/S0095-4470(19)30607-2; Fowler CA, 2016, SPEECH MOTOR CONTROL; FOX RA, 1982, PHONETICA, V39, P1, DOI 10.1159/000261647; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Goldstein L., 2003, PHONETICS PHONOLOGY, P159; Graux J, 2015, SOC COGN AFFECT NEUR, V10, P101, DOI 10.1093/scan/nsu031; Graux J, 2013, BRAIN TOPOGR, V26, P72, DOI 10.1007/s10548-012-0233-2; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; Holt LL, 2008, CURR DIR PSYCHOL SCI, V17, P42, DOI 10.1111/j.1467-8721.2008.00545.x; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Kaplan JT, 2008, SOC COGN AFFECT NEUR, V3, P218, DOI 10.1093/scan/nsn014; Kerzel D, 2000, J EXP PSYCHOL HUMAN, V26, P634, DOI 10.1037//0096-1523.26.2.634; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Krakauer J., 2006, PLOS BIOL, V4, P1; Kroeger BJ, 2015, J PHONETICS, V53, P88, DOI 10.1016/j.wocn.2015.09.006; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lametti DR, 2014, J NEUROSCI, V34, P10339, DOI 10.1523/JNEUROSCI.0108-14.2014; Laurent R, 2017, PSYCHOL REV, V124, P572, DOI 10.1037/rev0000069; Laurent R, 2013, INTERSPEECH, P2796; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Loakes D., 2006, FORENSIC PHONETIC IN; MAEDA S, 1990, NATO ADV SCI I D-BEH, V55, P131; Massaro DW, 1987, CATEGORICAL PARTITIO; McGettigan C, 2017, OXFORD HDB PSYCHOLIN, DOI [10.1523/JNEUROSCI.0108-14.2014, DOI 10.1523/JNEUROSCI.0108-14.2014]; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Menard L, 2014, ACTA ACUST UNITED AC, V100, P676, DOI 10.3813/AAA.918747; Meunier C., 2007, DYSARTHRIES, P164; Mottonen R, 2012, APHASIOLOGY, V26, P1103, DOI 10.1080/02687038.2011.619515; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Moulin-Frier C, 2012, LANG COGNITIVE PROC, V27, P1240, DOI 10.1080/01690965.2011.645313; Moulin-Frier C, 2015, J PHONETICS, V53, P5, DOI 10.1016/j.wocn.2015.06.001; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nearey TM, 1997, J ACOUST SOC AM, V101, P3241, DOI 10.1121/1.418290; Newman R., 1997, J ACOUST SOC AM, V102, P3114, DOI [10.1121/1, DOI 10.1121/1]; Nolan F., 2013, FORENSIC LINGUIST, V3, P39, DOI [10.1558/ijsll.v3i1.39, DOI 10.1558/IJSLL.V3I1.39]; Oudeyer PY, 2005, CONNECT SCI, V17, P325, DOI 10.1080/09540090500217145; Oudeyer PY, 2001, LECT NOTES COMPUT SC, V2130, P1171; Patri JF, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005942; Patri JF, 2015, PROGR MOTOR CONTROL; Perkell J.S., 1986, INVARIANCE VARIABILI; Perkell JS, 2012, J NEUROLINGUIST, V25, P382, DOI 10.1016/j.jneuroling.2010.02.011; Perrier P., 2005, ZAS PAPERS LINGUISTI, V40, P109; Poeppel D, 2011, LANG COGNITIVE PROC, V26, P935, DOI 10.1080/01690965.2010.493301; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Rapin L, 2017, J ACOUST SOC AM, V141, P3582, DOI [10.1121/1.4987639, DOI 10.1121/1.4987639]; Rogers JC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00754; Roon KD, 2015, PSYCHON B REV, V22, P242, DOI 10.3758/s13423-014-0666-6; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Sato M, 2011, CORTEX, V47, P1001, DOI 10.1016/j.cortex.2011.03.009; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; SAVARIAUX C, 1995, J ACOUST SOC AM, V98, P2428, DOI 10.1121/1.413277; Scarbel L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00568; Schroeder M.R., 1979, FRONTIERS SPEECH COM, P217; Schwartz J.-L., 2002, PHONETICS PHONOLOGY, P244; Schwartz JL, 2012, J NEUROLINGUIST, V25, P336, DOI 10.1016/j.jneuroling.2009.12.004; Schwartz JL, 1997, J PHONETICS, V25, P255, DOI 10.1006/jpho.1997.0043; Schwartz JL, EXPT APPROACHES PHON, DOI [10.1016/j.jneuroling.2009.12.004, DOI 10.1016/J.JNEUROLING.2009.12.004]; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2017, BRAIN LANG, V164, P77, DOI 10.1016/j.bandl.2016.10.004; Steels L, 1998, ARTIF INTELL, V103, P133, DOI 10.1016/S0004-3702(98)00066-6; Stevens KN, 1967, MODELS PERCEPTION SP, P88; Treille A., 2017, PERCEVOIR AGIR NATUR; Tye-Murray N, 2014, J SPEECH LANG HEAR R, V57, P556, DOI 10.1044/2013_JSLHR-H-12-0273; Tye-Murray N, 2013, PSYCHON B REV, V20, P115, DOI 10.3758/s13423-012-0328-5; Weiping Cai, 2010, Proceedings of the 2010 International Conference on Electrical and Control Engineering (ICECE 2010), P1246, DOI 10.1109/iCECE.2010.310; Weirich M, 2013, J ACOUST SOC AM, V134, P3766, DOI 10.1121/1.4822480; Wilson SM, 2006, NEUROIMAGING STUDIES	93	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210302	10.1371/journal.pone.0210302	http://dx.doi.org/10.1371/journal.pone.0210302			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633745	Green Submitted, Green Published, gold			2022-12-26	WOS:000455485100016
J	Boutigny, AL; Gautier, A; Basler, R; Dauthieux, F; Leite, S; Valade, R; Aguayo, J; Ioos, R; Laval, V				Boutigny, Anne-Laure; Gautier, Angelique; Basler, Ryan; Dauthieux, Florian; Leite, Stephen; Valade, Romain; Aguayo, Jaime; Ioos, Renaud; Laval, Valerie			Metabarcoding targeting the EF1 alpha region to assess Fusarium diversity on cereals	PLOS ONE			English	Article							REAL-TIME PCR; GRAMINEARUM SPECIES COMPLEX; SMALL-GRAIN CEREALS; FUNGAL COMMUNITIES; HEAD BLIGHT; MICRODOCHIUM-NIVALE; EAR BLIGHT; SP-NOV; WHEAT; SEQUENCE	Fusarium head blight (FHB) is a major cereal disease caused by a complex of Fusarium species. These species vary in importance depending on climatic conditions, agronomic factors or host genotype. In addition, Fusarium species can release toxic secondary metabolites. These mycotoxins constitute a significant food safety concern as they have health implications in both humans and animals. The Fusarium species involved in FHB differ in their pathogenicity, ability to produce mycotoxins, and fungicide sensitivity. Accurate and exhaustive identification of Fusarium species in planta is therefore of great importance. In this study, using a new set of primers targeting the EF1 alpha gene, the diversity of Fusarium species on cereals was evaluated using Illumina high-throughput sequencing. The PCR amplification parameters and bioinformatic pipeline were optimized with mock and artificially infected grain communities and further tested on 65 field samples. Fusarium species were retrieved from mock communities and good reproducibility between different runs or PCR cycle numbers was be observed. The method enabled the detection of as few as one single Fusarium-infected grain in 10,000. Up to 17 different Fusarium species were detected in field samples of barley, durum and soft wheat harvested in France. This new set of primers enables the assessment of Fusarium diversity by high-throughput sequencing on cereal samples. It provides a more exhaustive picture of the Fusarium community than the currently used techniques based on isolation or species-specific PCR detection. This new experimental approach may be used to show changes in the composition of the Fusarium complex or to detect the emergence of new Fusarium species as far as the EF1 alpha sequence of these species show a sufficient amount of polymorphism in the portion of sequence analyzed. Information on the distribution and prevalence of the different Fusarium species in a given geographical area, and in response to various environmental factors, is of great interest for managing the disease and predicting mycotoxin contamination risks.	[Boutigny, Anne-Laure; Aguayo, Jaime; Ioos, Renaud] ANSES Lab Sante Vegetaux, Unite Mycol, Malzeville, France; [Gautier, Angelique; Basler, Ryan; Dauthieux, Florian; Leite, Stephen; Laval, Valerie] INRA, BIOGER CPP UMR1290, Thiverval Grignon, France; [Valade, Romain] ARVALIS Inst Vegetal, Thiverval Grignon, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Laval, V (corresponding author), INRA, BIOGER CPP UMR1290, Thiverval Grignon, France.	valerie.laval@inra.fr		Ioos, Renaud/0000-0001-9359-5098; Laval, Valerie/0000-0002-3667-3878; Boutigny, Anne-Laure/0000-0001-8999-2314; Aguayo, Jaime/0000-0002-7552-0655	AAP PSPE 2012 (Appel a proposition Pour et Sur le Plan Ecophytro de Juin 2012)	AAP PSPE 2012 (Appel a proposition Pour et Sur le Plan Ecophytro de Juin 2012)	This work was supported by AAP PSPE 2012 (Appel a proposition Pour et Sur le Plan Ecophytro de Juin 2012) www.onema.fr.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andrews S., 2010, FASTQC QUALITY CONTR; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Audenaert K, 2009, EUR J PLANT PATHOL, V125, P445, DOI 10.1007/s10658-009-9494-3; Bluhm BH, 2004, J FOOD PROTECT, V67, P536, DOI 10.4315/0362-028X-67.3.536; Bottalico A., 1998, Journal of Plant Pathology, V80, P85; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Boutigny AL, 2014, EUR J PLANT PATHOL, V138, P133, DOI 10.1007/s10658-013-0312-6; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chandelier A, 2011, EUR J PLANT PATHOL, V130, P403, DOI 10.1007/s10658-011-9762-x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crous PW, 2004, STUD MYCOL, P19; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doohan FM, 1998, PLANT PATHOL, V47, P197, DOI 10.1046/j.1365-3059.1998.00218.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elbelt S, BIORIX, DOI [10.1101/272534, DOI 10.1101/272534]; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Hietaniemi V, 2016, FOOD ADDIT CONTAM A, V33, P831, DOI 10.1080/19440049.2016.1162112; Ioos R, 2005, CROP PROT, V24, P894, DOI 10.1016/j.cropro.2005.01.014; Ioos R, 2004, MYCOPATHOLOGIA, V158, P351, DOI 10.1007/s11046-004-2228-3; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Karlsson I, 2016, APPL ENVIRON MICROB, V82, P491, DOI 10.1128/AEM.02748-15; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LeBlanc N, 2015, MICROB ECOL, V70, P188, DOI 10.1007/s00248-014-0531-1; Liu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086610, 10.1371/journal.pone.0087996]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nicolaisen M, 2009, J MICROBIOL METH, V76, P234, DOI 10.1016/j.mimet.2008.10.016; Nielsen LK, 2011, PHYTOPATHOLOGY, V101, P960, DOI 10.1094/PHYTO-07-10-0188; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sapkota R, 2015, NEW PHYTOL, V207, P1134, DOI 10.1111/nph.13418; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Taylor DL, 2016, APPL ENVIRON MICROB, V82, P7217, DOI 10.1128/AEM.02576-16; Tedersoo L, 2015, MYCOKEYS, P1, DOI 10.3897/mycokeys.10.4852; Torp M, 2004, INT J FOOD MICROBIOL, V95, P247, DOI 10.1016/j.ijfoodmicro.2003.12.014; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Waalwijk C, 2003, EUR J PLANT PATHOL, V109, P743, DOI 10.1023/A:1026086510156; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xu XM, 2008, PHYTOPATHOLOGY, V98, P69, DOI 10.1094/PHYTO-98-1-0069; Xu XM, 2005, EUR J PLANT PATHOL, V112, P143, DOI 10.1007/s10658-005-2446-7; Yli-Mattila T., 2008, Archives of Phytopathology and Plant Protection, V41, P243, DOI 10.1080/03235400600680659; Yli-Mattila T, 2011, INT J FOOD MICROBIOL, V147, P58, DOI 10.1016/j.ijfoodmicro.2011.03.007	50	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0207988	10.1371/journal.pone.0207988	http://dx.doi.org/10.1371/journal.pone.0207988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633747	Green Published, Green Submitted, gold			2022-12-26	WOS:000455485100002
J	Hsieh, WY; Chang, TH; Chang, HF; Chuang, WH; Lu, LC; Yang, CW; Lin, CS; Chang, CC				Hsieh, Wen-Yeh; Chang, Teng-Hsiang; Chang, Hui-Fang; Chuang, Wan-Hsuan; Lu, Li-Che; Yang, Chung-Wei; Lin, Chih-Sheng; Chang, Chia-Chu			Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy	PLOS ONE			English	Article							MAPK SIGNALING PATHWAYS; OXIDATIVE STRESS; ACTIVATION; FIBROSIS; INHIBITION; PROGRESSION; DISEASE; CELLS; INFLAMMATION; EXPRESSION	Angiotensin-converting enzyme (ACE) is the primary enzyme that converts angiotensin I (Ang I) to angiotensin II (Ang II) in the renin-angiotensin system (RAS). However, chymase hydrates Ang I to Ang II independently of ACE in some kidney diseases, and it may play an important role. The present study investigated whether chymase played a crucial role in aristolochic acid I (AAI)-induced nephropathy. C57BL/6 mice were treated with AAI via intraperitoneal injection for an accumulated AAI dosage of 45 mg/kg body weight (BW) (15 mg/kg BW per day for 3 days). The animals were sacrificed after acute kidney injury development, and blood, urine and kidneys were harvested for biochemical and molecular assays. Mice exhibited increased serum creatinine, BUN and urinary protein after the AAI challenge. Significant infiltrating inflammatory cells and tubular atrophy were observed in the kidneys, and high immunocytokine levels were detected. Renal RAS-related enzyme activities were measured, and a significantly increased chymase activity and slightly decreased ACE activity were observed in the AAI-treated mice. The renal Ang II level reflected the altered profile of RAS enzymes and was significantly increased in AAI-treated mice. Treatment of AAI-induced nephropathic mice with an ACE inhibitor (ACEI) or chymase inhibitor (CI; chymostatin) reduced renal Ang II levels. The combination of ACEI and CI (ACEI+CI) treatment significantly reversed the AAI-induced changes of Ang II levels and kidney inflammation and injuries. AAI treatment significantly increased renal p-MEK without increasing p-STAT3 and p-Smad3 levels, and p-MEK/p-ERK1/2 signalling pathway was significantly activated. CI and ACEI+CI treatments reduced this AAI-activated signaling pathway. AAI-induced nephropathy progression was significantly mitigated with CI and ACEI+CI treatment. This study elucidates the role of RAS in the pathogenesis of AAI-induced nephropathy.	[Hsieh, Wen-Yeh] Hsinchu Mackay Mem Hosp, Div Pulm Med, Dept Internal Med, Hsinchu, Taiwan; [Chang, Teng-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Chang, Hui-Fang; Chuang, Wan-Hsuan; Lin, Chih-Sheng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chang, Hui-Fang] Hsinchu Mackay Mem Hosp, Div Endocrinol, Dept Internal Med, Hsinchu, Taiwan; [Lu, Li-Che] Shin Kong Wu Ho Su Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Yang, Chung-Wei] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Hsinchu Branch, Hsinchu, Taiwan; [Lin, Chih-Sheng] Natl Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices IDS2, Hsinchu, Taiwan; [Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Environm & Precis Med Lab, Changhua, Taiwan; [Chang, Chia-Chu] Hungkuang Univ, Dept Nutr, Taichung, Taiwan; [Chang, Chia-Chu] Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan	Mackay Memorial Hospital; Changhua Christian Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Changhua Christian Hospital; Hungkuang University	Chang, CC (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Lin, CS (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Lin, CS (corresponding author), Natl Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices IDS2, Hsinchu, Taiwan.; Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Dept Environm & Precis Med Lab, Changhua, Taiwan.; Chang, CC (corresponding author), Hungkuang Univ, Dept Nutr, Taichung, Taiwan.; Chang, CC (corresponding author), Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan.	lincs@mail.nctu.edu.tw; chiachuchang0312@gmail.com		YANG, CHUNG-WEI/0000-0002-8613-3597	Ministry of Science and Technology (MOST), Taiwan [MOST 104-2313-B-009-001-MY3, MOST 107-2313-B-009-002-MY3]; "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program; Ministry of Education (MOE), Taiwan	Ministry of Science and Technology (MOST), Taiwan; "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program; Ministry of Education (MOE), Taiwan	This work was supported by the grants of MOST 104-2313-B-009-001-MY3 and MOST 107-2313-B-009-002-MY3 from the Ministry of Science and Technology (MOST), Taiwan. This work was also financially supported by the "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project of the National Chiao Tung University and Ministry of Education (MOE), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the grants of MOST 104-2313-B-009-001-MY3 and MOST 107-2313-B-009-002-MY3 from the Ministry of Science and Technology (MOST), Taiwan. This work was also financially supported by the "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project of the National Chiao Tung University and Ministry of Education (MOE), Taiwan.	Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chang HF, 2018, RSC ADV, V8, P29013, DOI 10.1039/c8ra04322a; Cheungpasitporn W, 2015, NEPHROL DIAL TRANSPL, V30, P978, DOI 10.1093/ndt/gfv023; Cristovam PC, 2012, EXP BIOL MED, V237, P985, DOI 10.1258/ebm.2012.011356; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Fan YY, 2009, J PHARMACOL SCI, V111, P82, DOI 10.1254/jphs.09152FP; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Hollenberg NK, 1998, HYPERTENSION, V32, P387, DOI 10.1161/01.HYP.32.3.387; Huang LH, 2013, NEPHRON EXTRA, V3, P12, DOI 10.1159/000346180; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Hung YH, 2016, INT J BIOL SCI, V12, P454, DOI 10.7150/ijbs.13379; Jadot I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020297; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Lim Beom Jin, 2014, Drug Discov Today Dis Models, V11, P45; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; Liu XC, 2015, MOL MED REP, V12, P4340, DOI 10.3892/mmr.2015.3911; Matsumoto T, 2003, CIRCULATION, V107, P2555, DOI 10.1161/01.CIR.0000074041.81728.79; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; MENGS U, 1987, ARCH TOXICOL, V59, P328, DOI 10.1007/BF00295084; Mezzano S, 2003, KIDNEY INT, V64, pS64, DOI 10.1046/j.1523-1755.64.s86.12.x; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Michl J, 2014, NAT PROD REP, V31, P676, DOI 10.1039/c3np70114j; Murphy AM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0023-z; Nanayakkara Shanika, 2012, Environmental Health and Preventive Medicine, V17, P213, DOI 10.1007/s12199-011-0243-9; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Pailer M., 1955, MH CHEM, V86, P676; Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Qin J, 2015, KIDNEY BLOOD PRESS R, V40, P89, DOI 10.1159/000368485; Quiroga B, 2014, NEW ENGL J MED, V370, P777, DOI 10.1056/NEJMc1315504; Rabe M, 2016, NEPHRON, V133, P53, DOI 10.1159/000445171; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P1626, DOI 10.1046/j.1523-1755.2001.0590051626.x; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Solez K, 2001, AM J KIDNEY DIS, V38, P1141, DOI 10.1053/ajkd.2001.29661; Suzuki Hiromichi, 2015, World J Nephrol, V4, P118, DOI 10.5527/wjn.v4.i1.118; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Wasse H, 2012, CURR HYPERTENS REV, V8, P15, DOI 10.2174/157340212800505007; Wilmer WA, 1997, J BIOL CHEM, V272, P10877; Wu Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20556; Xiao Y, 2008, KIDNEY INT, V73, P1231, DOI 10.1038/ki.2008.103; Yang CW, 2017, RENAL FAILURE, V39, P719, DOI 10.1080/0886022X.2017.1398665; Yeh FY, 2014, RSC ADV, V4, P22266, DOI 10.1039/c4ra00258j; Zhang M, 2016, MOL MED REP, V14, P121, DOI 10.3892/mmr.2016.5234	50	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210656	10.1371/journal.pone.0210656	http://dx.doi.org/10.1371/journal.pone.0210656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633770	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100034
J	Lopez, MEJ; Palacios, DM; Legorreta, AJ; Urban, J; Mate, BR				Jimenez Lopez, M. Esther; Palacios, Daniel M.; Jaramillo Legorreta, Armando; Urban R, Jorge; Mate, Bruce R.			Fin whale movements in the Gulf of California, Mexico, from satellite telemetry	PLOS ONE			English	Article							DEVIANCE INFORMATION CRITERION; BALAENOPTERA-PHYSALUS; ANIMAL MOVEMENT; BEHAVIOR; POPULATION; SEA; VARIABILITY; MANAGEMENT; QUESTIONS; DYNAMICS	Fin whales (Balaenoptera physalus) have a global distribution, but the population inhabiting the Gulf of California (GoC) is thought to be geographically and genetically isolated. However, their distribution and movements are poorly known. The goal of this study was to describe fin whale movements for the first time from 11 Argos satellite tags deployed in the southwest GoC in March 2001. A Bayesian Switching State-Space Model was applied to obtain improved locations and to characterize movement behavior as either "area-restricted searching" (indicative of patch residence, ARS) or "transiting" (indicative of moving between patches). Model performance was assessed with convergence diagnostics and by examining the distribution of the deviance and the behavioral parameters from Markov Chain Monte Carlo models. ARS was the predominant mode behavior 83% of the time during both the cool (December-May) and warm seasons (June-November), with slower travel speeds (mean = 0.84 km/h) than during transiting mode (mean = 3.38 km/h). We suggest ARS mode indicates either foraging activities (year around) or reproductive activities during the winter (cool season). We tagged during the cool season, when the whales were located in the Loreto-La Paz Corridor in the southwestern GoC, close to the shoreline. As the season progressed, individuals moved northward to the Midriff Islands and the upper gulf for the warm season, much farther from shore. One tag lasted long enough to document a whale's return to Loreto the following cool season. One whale that was originally of undetermined sex, was tagged in the Bay of La Paz and was photographed 10 years later with a calf in the nearby San Jose Channel, suggesting seasonal site fidelity. The tagged whales moved along the western GoC to the upper gulf seasonally and did not transit to the eastern GoC south of the Midriff Islands. No tagged whales left the GoC, providing supporting evidence that these fin whales are a resident population.	[Jimenez Lopez, M. Esther; Urban R, Jorge] Univ Autonoma Baja California Sur, Programa Invest Mamiferos Marinos, Dept Acad Ciencias Marinas & Costeras, La Paz, Mexico; [Palacios, Daniel M.; Mate, Bruce R.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Palacios, Daniel M.; Mate, Bruce R.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Jaramillo Legorreta, Armando] Natl Inst Ecol, Marine Mammals Program, Camper 6, Ensenada, Baja California, Mexico	Universidad Autonoma de Baja California; Oregon State University; Oregon State University; Instituto de Ecologia - Mexico	Lopez, MEJ (corresponding author), Univ Autonoma Baja California Sur, Programa Invest Mamiferos Marinos, Dept Acad Ciencias Marinas & Costeras, La Paz, Mexico.	estherjim@yahoo.com	R., Jorge Urbán/J-8126-2019; Palacios, Daniel M./B-9180-2008; Lopez, Maria Esther Jimenez/AAR-2826-2021; Jaramillo-Legorreta, Armando/ADL-1282-2022	R., Jorge Urbán/0000-0003-1423-8573; Palacios, Daniel M./0000-0001-7069-7913; Lopez, Maria Esther Jimenez/0000-0002-9932-5184; 	Consejo Nacional de Ciencia y Tecnologia (CONACYT) from Mexico; Marina Mammals Institute at Oregon State University [199425, 001507]	Consejo Nacional de Ciencia y Tecnologia (CONACYT) from Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marina Mammals Institute at Oregon State University	This study was funded by private donors to Oregon State University's Endowed Marine Mammal Program. This work was also funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT) from Mexico. The institution gave the scholarship No. 199425 for Doctorate Program and Scholarship No. 001507 for internship at Marina Mammals Institute at Oregon State University.	Aguilar A., 2002, ENCY MARINE MAMMALS, P435; Alvarez-Borrego S., 1991, GULF CALIFORNIA PROV, V1st ed., P555, DOI DOI 10.1007/978-1-60327-017-5; Alvarez-Borrego S., 1979, CIENC MAR, V6, P43, DOI [DOI 10.7773/CM.V6I1.350, 10.7773/cm.v6i1.350]; Alvarez-Salgado XA, 2002, DEEP-SEA RES PT I, V49, P1725, DOI 10.1016/S0967-0637(02)00094-8; Antezana J. T., 1970, REV BIOL MAR, V14, P19; ARGOS, 2016, ARG US MAN, P1; ARGOTE ML, 1995, J GEOPHYS RES-OCEANS, V100, P16103, DOI 10.1029/95JC01500; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Beier E, 1997, J PHYS OCEANOGR, V27, P615, DOI 10.1175/1520-0485(1997)027<0615:ANIOTA>2.0.CO;2; Berg A, 2004, J BUS ECON STAT, V22, P107, DOI 10.1198/073500103288619430; Berga AS, 2015, MAR MAMMAL SCI, V31, P756, DOI 10.1111/mms.12179; Berube M, 2002, CONSERV GENET, V3, P183, DOI 10.1023/A:1015224730394; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; BREESE D, 1993, MAR MAMMAL SCI, V9, P319, DOI 10.1111/j.1748-7692.1993.tb00460.x; Brinton E., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P211; BRINTON E, 1986, California Cooperative Oceanic Fisheries Investigations Reports, V27, P228; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Castro-Aguirre J. L., 1995, HIDROBIOLOGICA, V5, P57; Chan JCC, 2016, COMPUT STAT DATA AN, V100, P847, DOI 10.1016/j.csda.2014.07.018; CisnerosMata MA, 1996, CAL COOP OCEAN FISH, V37, P201; Clapham P, 2001, MAR MAMMAL SCI, V17, P432, DOI 10.1111/j.1748-7692.2001.tb01289.x; Cohn JP, 1999, BIOSCIENCE, V49, P12, DOI 10.2307/1313488; Croll DA, 1998, DEEP-SEA RES PT II, V45, P1353, DOI 10.1016/S0967-0645(98)00031-9; Cubero-Pardo P, 2011, AQUAT CONSERV, V21, P433, DOI 10.1002/aqc.1205; Cummings WC, 1985, HDB MARINE MAMMALS, P137; Dempster AP, 1997, STAT COMPUT, V7, P247, DOI 10.1023/A:1018598421607; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Edwards EF, 2015, MAMMAL REV, V45, P197, DOI 10.1111/mam.12048; ESRI, 2015, ESRI ARCGIS DESKT SP; Fancy S. G., 1988, US FISH WILDLIFE SER, V172; Geijer CKA, 2016, MAMMAL REV, V46, P284, DOI 10.1111/mam.12069; Gendron D., 2001, Journal of Cetacean Research and Management, V3, P41; GENDRON D, 1992, MAR ECOL PROG SER, V87, P1, DOI 10.3354/meps087001; Gendron D., 2002, THESIS; Gomez-Gutierrez J, 2012, MAR ECOL PROG SER, V455, P173, DOI 10.3354/meps09631; Guerrero Ruiz M., 2006, BALLENAS GOLFO CALIF; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Heide-Jorgensen MP, 2001, MAR MAMMAL SCI, V17, P949, DOI 10.1111/j.1748-7692.2001.tb01309.x; Hidalgo-Gonzalez RM, 2004, DEEP-SEA RES PT II, V51, P739, DOI 10.1016/j.dsr2.2004.05.006; Hill Roger D., 1994, P227; Hoel K, 2013, RISK ASSESSMENT WELF; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Jahoda M, 2003, MAR MAMMAL SCI, V19, P96, DOI 10.1111/j.1748-7692.2003.tb01095.x; Jaume Schinkel MS, 2004, THESIS; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Leatherwood S, 1988, WHALES DOLPHINS PORP; Leos-Barajas V, 2017, J AGR BIOL ENVIR ST, V22, P232, DOI 10.1007/s13253-017-0282-9; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Marinone SG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001720; Mate B, 2007, DEEP-SEA RES PT II, V54, P224, DOI 10.1016/j.dsr2.2006.11.021; McDonald BI, 2013, J EXP BIOL, V216, P3332, DOI 10.1242/jeb.085985; Mikhalev YA, 1997, MAR ECOL PROG SER, V149, P13, DOI 10.3354/meps149013; Mizroch SA, 2009, MAMMAL REV, V39, P193, DOI 10.1111/j.1365-2907.2009.00147.x; Montgomery S., 1987, WORKSH ASS POSS SYST; Morgan L, 2005, COM COOP AMBIENT MAR, V136; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Navarro-Olache LF, 2004, DEEP-SEA RES PT II, V51, P673, DOI 10.1016/j.dsr2.2004.05.014; Okubo A., 2001, INTERD APPL, P10, DOI 10.1007/978-1-4757-4978-6; Patterson TA, 2017, ASTA-ADV STAT ANAL, V101, P399, DOI 10.1007/s10182-017-0302-7; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Python Software Foundation, PYTH LANG REF; Reilly SB, 2013, IUCN RED LIST THREAT; Rojas B L., 1984, PRESENCIA DISTRIBUCI; Rosas Cota A., 1976, CAL COOP OCEAN FISH, V19, P89; SANTAMARIADELANGEL E, 1994, J GEOPHYS RES-OCEANS, V99, P7411, DOI 10.1029/93JC02154; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; SILBER GK, 1994, MAR MAMMAL SCI, V10, P283, DOI 10.1111/j.1748-7692.1994.tb00483.x; Sirovic A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09979-4; Soto-Mardones L, 1999, CIENC MAR, V25, P1; Spiegelhalter D, 2003, WINBUGS USER MANUAL, DOI [10.1023/A:1018598421607, DOI 10.1023/A:1018598421607]; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Team RC, 2016, R LANG ENV STAT COMP; Tershy B.R., 1993, REV INVESTIGACION CI, V1, P31; TERSHY BR, 1992, J MAMMAL, V73, P477, DOI 10.2307/1382013; Tershy BR, REPT INT WHAL COMMN, P369; Tershy BR., 1993, REV INVEST CIENT U A, V1, P69; Tershy BR, 1990, REPORTS INT WHALING, V12, P369; Thomisch Karolin, 2017, Berichte zur Polar- und Meeresforschung, V707, P3, DOI 10.2312/BzPM_0707_2017; THOMPSON PO, 1992, J ACOUST SOC AM, V92, P3051, DOI 10.1121/1.404201; Tomilin A.G, 1957, MAMMALS SSSR ADJACEN; Turchin Peter, 1998; Urban J., 2012, CABOS PROSPECTIVA PA, P101; Urban R. Jorge, 2005, P276; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Walker KA, 2012, WILDLIFE RES, V39, P15, DOI 10.1071/WR10177; Watkins WA, 1996, MAR MAMMAL SCI, V12, P564	92	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209324	10.1371/journal.pone.0209324	http://dx.doi.org/10.1371/journal.pone.0209324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629597	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000022
J	Gentry, KE; Roche, DP; Mugel, SG; Lancaster, ND; Sieving, KE; Freeberg, TM; Lucas, JR				Gentry, Katherine E.; Roche, Daniel P.; Mugel, Stephen G.; Lancaster, Nolan D.; Sieving, Kathryn E.; Freeberg, Todd M.; Lucas, Jeffrey R.			Flocking propensity by satellites, but not core members of mixed-species flocks, increases when individuals experience energetic deficits in a poor-quality foraging habitat	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; DECIDUOUS WOODLAND BIRDS; TIT PARUS-MONTANUS; CAROLINA-CHICKADEES; BODY-MASS; FOREST FRAGMENT; BREEDING BIRDS; SURVIVAL RATE; FOOD ACCESS; FAT	Mixed-species bird flocks are complex social systems comprising core and satellite members. Flocking species are sensitive to habitat disturbance, but we are only beginning to understand how species-specific responses to habitat disturbance affect interspecific associations in these flocks. Here we demonstrate the effects of human-induced habitat disturbance on flocking species' behavior, demography, and individual condition within a remnant network of temperate deciduous forest patches in Indiana, USA. Specifically, we characterized the following properties of two core species, Carolina chickadees (Poecile carolinensis) and tufted titmice (Baeolophus bicolor), across a secondary-forest disturbance gradient: foraging time budgets, home range size, fat scores, fledgling counts, survival rates, and abundance. We also report fat scores for two satellite species that flock with the core study species: white-breasted nuthatches (Sitta carolinensis) and downy woodpeckers (Dryobates pubescens). Finally, we assess mixed-species flock sizes and composition, in addition to avian predator call rates, across the disturbance gradient. Foraging time budgets and home range size were highest and fat scores were lowest for core species in the most-disturbed site. Fat scores of two satellite species followed the same pattern. Additionally, the number of tufted titmice fledglings and winter survival rate of Carolina chickadees were lowest at the most-disturbed site. These results suggest that core species in the most-disturbed site experienced energetic deficits. Moreover, cumulative calling rate of raptors was lowest at the most-disturbed site, and none of the individual raptor species call rates were higher at the most-disturbed site-suggesting that perception of predation risk does not contribute to these patterns. Surprisingly, the satellites continued associating with mixed species flocks through the breeding season at the most-disturbed site. Total flock size and interspecific association patterns were otherwise consistent across the gradient. The fact that satellites continued to flock with core species during the breeding season suggests foraging niche expansion resulting from mixed-species flocking is important in disturbed sites even beyond the winter season. Our study reveals mechanisms underlying flock composition of birds surviving in remnant forest and links the mechanisms to degradation of foraging habitat. These findings offer important insight into the relative impact potential of forest disturbance on mixed-species flocks in the North Temperate Zone.	[Gentry, Katherine E.; Roche, Daniel P.; Mugel, Stephen G.; Lancaster, Nolan D.; Lucas, Jeffrey R.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Sieving, Kathryn E.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Freeberg, Todd M.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA; [Freeberg, Todd M.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Roche, Daniel P.] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE USA; [Mugel, Stephen G.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Lancaster, Nolan D.] Conservat Volunteers Australia, Morningside, Qld, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Delaware; Colorado State University	Gentry, KE (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	gentry.ke@gmail.com	Sieving, Kathyrn E/I-6058-2013	Sieving, Kathyrn E/0000-0002-0849-8101; Mugel, Stephen/0000-0003-1078-5078; Gentry, Katherine/0000-0002-0006-7403	National Science Foundation, Division of Integrative Organismal Systems [NSF1353326-ios, NSF1353308-ios, NSF1353327-ios]	National Science Foundation, Division of Integrative Organismal Systems(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Division of Integrative Organismal Systems (https://www.nsf.gov/div/index.jsp?div=IOS; [NSF1353326-ios, 2014; NSF1353308-ios, 2014; and NSF1353327-ios, 2014]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1987, ECOLOGY, V68, P284, DOI 10.2307/1939259; Amininasab SM, 2016, ACTA OECOL, V70, P37, DOI 10.1016/j.actao.2015.11.006; ANDERSON SH, 1974, ECOLOGY, V55, P828, DOI 10.2307/1934418; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bent AC, 1946, LIFE HIST N AM JAY 2; BERNER TO, 1985, ECOLOGY, V66, P1229, DOI 10.2307/1939176; BLEM CR, 1976, AM ZOOL, V16, P671; Borah B, 2018, J APPL ECOL, V55, P1637, DOI 10.1111/1365-2664.13097; BREWER RICHARD, 1963, AUK, V80, P9; Brittain RA, 2009, J RAPTOR RES, V43, P199, DOI 10.3356/JRR-08-51.1; Brodin A, 2000, BEHAV ECOL, V11, P27, DOI 10.1093/beheco/11.1.27; Brown J. L., 1964, Wilson Bulletin, V76, P160; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cannings RJ, 1993, NO SAW WHET OWL AEGO, DOI [10.1126/science.1057487, DOI 10.1126/SCIENCE.1057487]; CHAPLIN SB, 1974, J COMP PHYSIOL, V89, P321, DOI 10.1007/BF00695350; CIMPRICH DA, 1994, ECOLOGY, V75, P1615, DOI 10.2307/1939622; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; CLOBERT J, 1988, J ANIM ECOL, V57, P287, DOI 10.2307/4779; Cooper SJ, 2007, WILSON J ORNITHOL, V119, P720, DOI 10.1676/06-183.1; CRAWFORD HS, 1981, J WILDLIFE MANAGE, V45, P680, DOI 10.2307/3808701; Curry JR, 1970, THESIS; Dawo B, 2013, ANN ZOOL FENN, V50, P356, DOI 10.5735/086.050.0601; Dhondt AA, 1990, ECOL STUD, P39; Dolby AS, 1998, ANIM BEHAV, V56, P501, DOI 10.1006/anbe.1998.0808; Dolby AS, 2000, BEHAV ECOL, V11, P110, DOI 10.1093/beheco/11.1.110; Dolby AS, 1999, AUK, V116, P557, DOI 10.2307/4089392; Donati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019807; EKMAN J, 1989, WILSON BULL, V101, P263; EKMAN JB, 1993, BEHAV ECOL, V4, P232, DOI 10.1093/beheco/4.3.232; Ficken MS, 1996, AUK, V113, P370, DOI 10.2307/4088904; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fort KT, 2004, ANIM BEHAV, V68, P407, DOI 10.1016/j.anbehav.2003.08.023; Fox J., 2012, REV JAVER, V16; Golawski A, 2015, J ETHOL, V33, P205, DOI 10.1007/s10164-015-0433-9; Goodale E, 2017, MIXED-SPECIES GROUPS OF ANIMALS: BEHAVIOR, COMMUNITY STRUCTURE, AND CONSERVATION, P1; Goodale E, 2015, AVIAN RES, V6, DOI 10.1186/s40657-015-0023-0; Goodale E, 2014, ETHOLOGY, V120, P266, DOI 10.1111/eth.12202; Goodale E, 2010, J AVIAN BIOL, V41, P99, DOI 10.1111/j.1600-048X.2009.04828.x; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Greenberg R, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P521; Grubb TC, 1999, AUK, V116, P618, DOI 10.2307/4089323; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Harrap S., 1995, CHICKADEES TITS NUTH; Harrison NM, 2011, ANIM BEHAV, V81, P675, DOI 10.1016/j.anbehav.2011.01.013; Hartung SC, 2005, CONDOR, V107, P879, DOI 10.1650/7601.1; Hennenlan C, 2007, J WILDLIFE MANAGE, V71, P526, DOI 10.2193/2006-013; Hinsley SA, 2008, LANDSCAPE ECOL, V23, P615, DOI 10.1007/s10980-008-9225-8; Hothorn T., 2013, MULTCOMP SIMULTANEOU; Houston AI, 2012, OIKOS, V121, P597, DOI 10.1111/j.1600-0706.2011.19594.x; Howell S. N, 1997, IDENTIFICATION GUIDE; Hua FY, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0762; Hurd CR, 1996, BEHAV ECOL SOCIOBIOL, V38, P287, DOI 10.1007/s002650050244; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; JOHNSTON DW, 1956, ECOLOGY, V37, P50, DOI 10.2307/1929668; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Knowlton JL, 2011, ECOL APPL, V21, P2974, DOI 10.1890/10-1886.1; Kumara HN, 2014, PRIMATES, V55, P543, DOI 10.1007/s10329-014-0437-z; Laake J., 2011, RMARK PACKAGE FOR R; Lack D., 1954, P343; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lee TM, 2005, BIOL CONSERV, V122, P193, DOI 10.1016/j.biocon.2004.07.005; Loery G, 1997, AUK, V114, P431, DOI 10.2307/4089244; Lopez-Sepulcre A, 2005, AM NAT, V166, P317, DOI 10.1086/432560; Lucas JR, 2006, HORM BEHAV, V49, P634, DOI 10.1016/j.yhbeh.2005.12.012; LUCAS JR, 1994, BEHAV ECOL, V5, P171, DOI 10.1093/beheco/5.2.171; LUCAS JR, 1991, ANIM BEHAV, V41, P579, DOI 10.1016/S0003-3472(05)80898-X; Lundborg K, 2003, IBIS, V145, P78, DOI 10.1046/j.1474-919X.2003.00124.x; Mackenzie JA, 2014, IBIS, V156, P591, DOI 10.1111/ibi.12166; Maldonado-Coelho M, 2004, BIOL CONSERV, V116, P19, DOI 10.1016/S0006-3207(03)00169-1; Mammides C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1118; Marshall HH, 2012, ANIM BEHAV, V84, P1295, DOI 10.1016/j.anbehav.2012.09.030; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Masters RE, 2002, P ROLE FIRE NONGAME, V288; Matthysen E, 2008, ORNITOL NEOTROP, V19, P403; Maute KL, 2013, J COMP PHYSIOL B, V183, P1023, DOI 10.1007/s00360-013-0775-y; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; McDermott ME, 2015, AGROFOREST SYST, V89, P383, DOI 10.1007/s10457-014-9777-3; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; Menon S, 1996, INT J PRIMATOL, V17, P969, DOI 10.1007/BF02735297; Meyers JM, 1978, SE14 USDA FOR SERV, P50; Mitchell K, 2010, QUANTITATIVE ANAL PO; Mokross K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2599; Morosinotto C, 2017, OIKOS, V126, P863, DOI 10.1111/oik.03476; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Mostrom AM, 2002, BIRDS N AM 2 0; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; Orell M, 1999, IBIS, V141, P460, DOI 10.1111/j.1474-919X.1999.tb04415.x; Otter K.A., 2007, ECOLOGY BEHAV CHICKA; PETIT DR, 1989, CONDOR, V91, P766, DOI 10.2307/1368059; Pierce AR, 2006, NAT AREA J, V26, P351, DOI 10.3375/0885-8608(2006)26[351:FSIAOD]2.0.CO;2; Pravosudov VV, 2001, BEHAV ECOL, V12, P207, DOI 10.1093/beheco/12.2.207; Ratikainen II, 2013, ANIM BEHAV, V85, P427, DOI 10.1016/j.anbehav.2012.12.002; Ripley B, 2021, PACKAGE MASS VERSION; RITCHISON G, 1988, CONDOR, V90, P648, DOI 10.2307/1368354; Ritchison G, 2015, BIRDS N AM 2 0; Braga ACR, 2009, ARDEA, V97, P395, DOI 10.5253/078.097.0401; Rocha PLE, 2001, J RAPTOR RES, V35, P107; Sieving KE, 2004, AUK, V121, P738, DOI 10.1642/0004-8038(2004)121[0738:HFOFCB]2.0.CO;2; Sigel BJ, 2006, CONSERV BIOL, V20, P111, DOI 10.1111/j.1523-1739.2005.00293.x; Smith CC, 1991, ANNU REV ECOL SYST, V15, P329; Smits JEG, 2013, COMP IMMUNOL MICROB, V36, P333, DOI 10.1016/j.cimid.2012.11.007; Soard CM, 2009, ANIM BEHAV, V78, P1447, DOI 10.1016/j.anbehav.2009.09.026; Sridhar H, 2008, J TROP ECOL, V24, P135, DOI 10.1017/S0266467408004823; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; SUHONEN J, 1993, ANIM BEHAV, V45, P1193, DOI 10.1006/anbe.1993.1141; SULLIVAN KA, 1984, BEHAVIOUR, V91, P294, DOI 10.1163/156853984X00128; Telleria JL, 2001, OIKOS, V95, P253, DOI 10.1034/j.1600-0706.2001.950207.x; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; TERBORGH J, 1990, AM J PRIMATOL, V21, P87, DOI 10.1002/ajp.1350210203; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Tremblay I, 2005, IBIS, V147, P17, DOI 10.1111/j.1474-919x.2004.00312.x; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Van Houtan KS, 2006, EVOL ECOL RES, V8, P129; VANBALEN JH, 1967, ARDEA, V55, P1; Veit RR, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00121; WAITE TA, 1988, CONDOR, V90, P132, DOI 10.2307/1368442; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS JB, 1979, CONDOR, V81, P122, DOI 10.2307/1367277; WILSON CW, 1995, J WILDLIFE MANAGE, V59, P56, DOI 10.2307/3809116; Wingert AK, 2018, J RAPTOR RES, V52, P361, DOI 10.3356/JRR-17-36.1; WOODREY MS, 1991, ORNIS SCAND, V22, P160, DOI 10.2307/3676547; Wordley CFR, 2015, BIOL CONSERV, V191, P529, DOI 10.1016/j.biocon.2015.08.005; Zachau CE, 2012, BEHAV ECOL SOCIOBIOL, V66, P683, DOI 10.1007/s00265-012-1316-5; Zou F, 2018, BIOL CONSERV	124	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209680	10.1371/journal.pone.0209680	http://dx.doi.org/10.1371/journal.pone.0209680			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625186	gold, Green Submitted, Green Published			2022-12-26	WOS:000455359400052
J	Chauvet-Gelinier, JC; Roussot, A; Cottenet, J; Brindisi, MC; Petit, JM; Bonin, B; Verges, B; Quantin, C				Chauvet-Gelinier, Jean-Christophe; Roussot, Adrien; Cottenet, Jonathan; Brindisi, Marie-Claude; Petit, Jean-Michel; Bonin, Bernard; Verges, Bruno; Quantin, Catherine			Depression and obesity, data from a national administrative database study: Geographic evidence for an epidemiological overlap	PLOS ONE			English	Article							OBESOGENIC ENVIRONMENTS; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; SPATIAL-PATTERNS; MENTAL-DISORDERS; URBAN SPRAWL; RISK-FACTORS; HEALTH; ASSOCIATION; PREVALENCE	Background Depression and obesity are two major conditions with both psychological and somatic burdens. Some data suggest strong connections between depression and obesity and more particularly associated prevalence of both disorders. However, little is known about the geographical distribution of these two diseases. This study aimed to determine if there is spatial overlap between obesity and depression using data from the entire French territory. Methods Data for 5,627 geographic codes for metropolitan France were collected from the two national hospital databases (PMSI-MCO and RIM-P) for the year 2016. We identified people who were depressed, obese or both registered in the two public medico-administrative databases, and we assessed their location. In addition, a multivariable analysis was performed in order to determine geographic interactions between obesity and depression after controlling for age, sex, environmental and socio-economic factors (social/material deprivation, urbanicity/rurality). Results 1,045,682 people aged 18 years and older were identified. The mapping analysis showed several cold and hot regional clusters of coinciding obesity and depression. The multivariable analysis demonstrated significant geographic interactions, with an increasing probability of finding a high prevalence of obesity in regions with major depression (OR 1.29 95% CI 1.13-1.49, p = 0.0002) and an increased probability of finding a high prevalence of depression in regions with a high ration of obesity (OR 1.32, 95% CI 1.15-1.52, p<0.0001). Conclusion Our study confirms the significant bidirectional relationships between obesity and depression at a group level. French geographic patterns reveal a partial overlap between obesity and depression, suggesting these two diseases can be included in a common approach. Further studies should be done to increase the understanding of this complex comorbidity.	[Chauvet-Gelinier, Jean-Christophe] Dijon Univ Hosp, Dept Neurosci, Psychiat Unit, Dijon, France; [Chauvet-Gelinier, Jean-Christophe; Brindisi, Marie-Claude; Petit, Jean-Michel; Bonin, Bernard] INSERM, Res Ctr 866, Dijon, France; [Roussot, Adrien; Cottenet, Jonathan; Quantin, Catherine] Univ Burgundy Franche Comte, Dijon Univ Hosp, Biostat & Bioinformat DIM, Dijon, France; [Cottenet, Jonathan; Quantin, Catherine] Dijon Univ Hosp, Clin Invest Ctr, INSERM, Clin Epidemiol Clin Trials Unit,CIC 1432, Dijon, France; [Brindisi, Marie-Claude; Petit, Jean-Michel; Verges, Bruno] Dijon Univ Hosp, Dept Endocrinol & Metab Dis, Dijon, France; [Bonin, Bernard] Univ Burgundy Franche Comte, Psy DREPI Lab, EA7458, Dijon, France; [Quantin, Catherine] Univ Paris Saclay, UVSQ, Inst Pasteur, INSERM,Biostat Biomath Pharmacoepidemiol & Infect, Paris, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay	Chauvet-Gelinier, JC (corresponding author), Dijon Univ Hosp, Dept Neurosci, Psychiat Unit, Dijon, France.; Chauvet-Gelinier, JC (corresponding author), INSERM, Res Ctr 866, Dijon, France.	jean-christophe.chauvet-gelinier@chu-dijon.fr						Abdulmalak C, 2015, EUR RESPIR J, V46, P503, DOI 10.1183/09031936.00218214; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Amare AT, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.261; Ambrosio G, 2018, PSYCHONEUROENDOCRINO, V91, P132, DOI 10.1016/j.psyneuen.2018.03.005; Archibald D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008372; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Breslau J, 2014, J PSYCHIATR RES, V56, P50, DOI 10.1016/j.jpsychires.2014.05.004; Briffault X, 2010, ENCEPHALE, V36, pD124, DOI 10.1016/j.encep.2009.05.005; Chee CC, 2017, REV EPIDEMIOL SANTE, V65, P349, DOI 10.1016/j.respe.2017.05.006; Combier E, 2013, HEALTH PLACE, V24, P225, DOI 10.1016/j.healthplace.2013.09.006; Crane MM, 2017, AM J MENS HEALTH, V11, P369, DOI 10.1177/1557988316681221; Daray FM, 2017, J AFFECT DISORDERS, V220, P15, DOI 10.1016/j.jad.2017.05.031; de Wit LM, 2010, DEPRESS ANXIETY, V27, P1057, DOI 10.1002/da.20738; Delgado I, 2018, PSYCHONEUROENDOCRINO, V91, P55, DOI 10.1016/j.psyneuen.2018.02.030; Drewnowski A, 2014, INT J OBESITY, V38, P306, DOI 10.1038/ijo.2013.97; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Elinder LS, 2009, PUBLIC HEALTH NUTR, V12, P307, DOI 10.1017/S1368980008002450; Ewing R, 2014, HEALTH PLACE, V26, P118, DOI 10.1016/j.healthplace.2013.12.008; Filipovic-Pierucci A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1163-4; French general direction of public finances, 2014, INCOME TAX PER MUNIC; Garden FL, 2009, J URBAN HEALTH, V86, P19, DOI 10.1007/s11524-008-9332-5; Gibson-Smith D, 2016, J CLIN PSYCHIAT, V77, pE144, DOI 10.4088/JCP.14m09658; Goodnick P J, 2000, Expert Opin Pharmacother, V1, P903, DOI 10.1517/14656566.1.5.903; Gregory CO, 2008, OBESITY, V16, P979, DOI 10.1038/oby.2008.22; Gur E, 2018, ISR J PSYCHIATR REL, V55, P3; Gusmano M, 2015, J HEALTH SERV RES PO, V20, P18, DOI 10.1177/1355819614551849; Hegerl U, 2008, WORLD J BIOL PSYCHIA, V9, P51, DOI 10.1080/15622970701216681; Husky MM, 2018, J WOMENS HEALTH, V27, P183, DOI 10.1089/jwh.2016.6248; INSEE, 2017, RECENSEMENT 2013 RE; InVS, 2008, NON TRADITIONAL REF; Jantaratnotai N, 2017, OBES RES CLIN PRACT, V11, P1, DOI 10.1016/j.orcp.2016.07.003; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; Kochkodan J, 2018, SURG ENDOSC, V32, P1382, DOI 10.1007/s00464-017-5819-z; Kovess-Masfety V, 2005, CAN J PSYCHIAT, V50, P926, DOI 10.1177/070674370505001407; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lojko D, 2017, NEUROPSYCH DIS TREAT, V13, P2447, DOI 10.2147/NDT.S147317; Luck-Sikorski C, 2018, J PSYCHOSOM RES, V106, P29, DOI 10.1016/j.jpsychores.2018.01.003; Matta J, 2018, PRESSE MED, V47, P434, DOI 10.1016/j.lpm.2018.03.023; Michimi A, 2010, AM J PREV MED, V39, pE1, DOI 10.1016/j.amepre.2010.04.008; Middleton N, 2006, J EPIDEMIOL COMMUN H, V60, P1040, DOI 10.1136/jech.2005.045302; Milaneschi Yuri, 2019, Mol Psychiatry, V24, P18, DOI 10.1038/s41380-018-0017-5; Milaneschi Y, 2017, JAMA PSYCHIAT, V74, P1214, DOI 10.1001/jamapsychiatry.2017.3016; Myers CA, 2017, OBESITY, V25, P452, DOI 10.1002/oby.21725; Newton S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177151; Nuemi G, 2013, CANCER EPIDEMIOL, V37, P688, DOI 10.1016/j.canep.2013.06.007; Ouakinin SRS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00431; Pampalon R, 2003, SANTE SOLIDARITE SOC, V2, P191, DOI [10.3406/oss.2003.932, DOI 10.3406/OSS.2003.932]; Patist CM, 2018, COGN AFFECT BEHAV NE, V18, P1121, DOI 10.3758/s13415-018-0626-0; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Penninx BWJH, 2018, DIALOGUES CLIN NEURO, V20, P63; Petit O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156333; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Quantin C, 2016, REV FR AFF SOC, P201; Quteineh L, 2016, J AFFECT DISORDERS, V198, P43, DOI 10.1016/j.jad.2016.03.031; Reeves WC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-414; Romain AJ, 2018, J AFFECT DISORDERS, V225, P381, DOI 10.1016/j.jad.2017.08.065; Roussot A, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-015-0028-2; Ruiz-Grosso P, 2016, ANN EPIDEMIOL, V26, P93, DOI 10.1016/j.annepidem.2015.11.002; Salari-Moghaddam A, 2019, CLIN NUTR, V38, P2360, DOI 10.1016/j.clnu.2018.10.015; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Stone AA, 2018, SOC INDIC RES, V136, P359, DOI 10.1007/s11205-016-1532-x; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Tyrrell J, 2019, INT J EPIDEMIOL, V48, P834, DOI 10.1093/ije/dyy223; Verges B, 2019, DIABETES METAB, V45, P79, DOI 10.1016/j.diabet.2017.05.012; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Voutilainen A, 2015, SCAND J PUBLIC HEALT, V43, P356, DOI 10.1177/1403494815572721; Wen M, 2018, AM J HEALTH PROMOT, V32, P400, DOI 10.1177/0890117116689488; WHO, 2017, DEPR OTH COMM MENT D; Wurtman J, 2018, CURR OBES REP, V7, P1, DOI 10.1007/s13679-017-0291-6	70	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210507	10.1371/journal.pone.0210507	http://dx.doi.org/10.1371/journal.pone.0210507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG7HM	30620759	Green Submitted, Green Published, gold			2022-12-26	WOS:000455161300039
J	Huang, JF; Jiang, HY; Cai, H; Liu, Y; Zhu, YQ; Lin, SS; Hu, TT; Wang, TT; Yang, WJ; Xiao, B; Sun, SH; Ma, LY; Yin, HR; Wang, F				Huang, Jin-Feng; Jiang, Hong-Yue; Cai, Hui; Liu, Yan; Zhu, Yi-Qing; Lin, Sha-Sha; Hu, Ting-Ting; Wang, Tian-Tian; Yang, Wen-Jun; Xiao, Bang; Sun, Shu-Han; Ma, Li-Ye; Yin, Hui-Rong; Wang, Fang			Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor	ONCOGENE			English	Article							LONG NONCODING RNA; ANAPLASTIC LYMPHOMA KINASE; MESSENGER-RNA; FETAL LIVER; PROTEIN HUR; CANCER; PLEIOTROPHIN; EXPRESSION; GROWTH; BETA	Oncofetal genes are genes that express abundantly in both fetal and tumor tissues yet downregulated or undetected in adult tissues, and can be used as tumor markers for cancer diagnosis and treatment. Meanwhile, long noncoding RNAs (lncRNAs) are known to play crucial roles in the pathogenesis of hepatocellular carcinoma (HCC), including tumor growth, proliferation, metastasis, invasion, and recurrence. We performed a genome-wide screening using microarrays to detect the lncRNA expression profiles in fetal livers, adult livers, and liver cancer tissues from mice to identify oncofetal lncRNAs in HCC. From the microarray data analysis, we identified lncRNA Ptn-dt as a possible oncofetal gene. Both in vitro and in vivo experiments results confirmed that overexpression of Ptn-dt significantly promoted the proliferation of mouse HCC cells. RNA pulldown assay showed that Ptn-dt could interact with the HuR protein. Interestingly, miR-96 binds with HuR to maintain its stability as well. Overexpression of lncRNA Ptn-dt led to the downregulation of miR-96, which might be due to the interaction between Ptn-dt and HuR. Meanwhile, previous studies have reported that Ptn can promote tumor growth and vascular abnormalization via anaplastic lymphoma kinase (Alk) signaling. In our study, we found that overexpression of Ptn-dt could promote the expression of Alk through repressing miR-96 via interacting with HuR, thus enhancing the biologic function of Ptn. In summary, a new oncofetal lncRNA Ptn-dt is identified, and it can promote the proliferation of HCC cells by regulating the HuR/miR-96/Alk pathway and Ptn-Alk axis.	[Huang, Jin-Feng; Liu, Yan; Zhu, Yi-Qing; Wang, Tian-Tian; Yang, Wen-Jun; Xiao, Bang; Sun, Shu-Han; Wang, Fang] Second Mil Med Univ, Dept Med Genet, Shanghai 200433, Peoples R China; [Huang, Jin-Feng; Wang, Tian-Tian; Sun, Shu-Han; Wang, Fang] Second Mil Med Univ, Changhai Hosp, Dept Clin Genet, Shanghai 200433, Peoples R China; [Jiang, Hong-Yue] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200032, Peoples R China; [Cai, Hui; Ma, Li-Ye] Second Mil Med Univ, Changhai Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Lin, Sha-Sha; Hu, Ting-Ting; Yin, Hui-Rong] Second Mil Med Univ, Changhai Hosp, Ctr Reprod Med, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fudan University; Naval Medical University; Naval Medical University	Wang, F (corresponding author), Second Mil Med Univ, Dept Med Genet, Shanghai 200433, Peoples R China.; Wang, F (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Clin Genet, Shanghai 200433, Peoples R China.; Ma, LY (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.; Yin, HR (corresponding author), Second Mil Med Univ, Changhai Hosp, Ctr Reprod Med, Shanghai 200433, Peoples R China.	malydr@163.com; topyin@126.com; wfsjz@163.com		, Jin-Feng/0000-0002-4757-3418; Jiang, Hongyue/0000-0001-8783-7759	National Key Basic Research Program (973 project) from the Ministry of Science and Technology of China [2015CB554004]; National Natural Science Foundation of China [81672775, 81330037]; Natural Science Foundation of Shanghai [15XD1504500]	National Key Basic Research Program (973 project) from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	We thank Dr. Li Su for the help in flow cytometry technique, and the Institutional Animal Care and Use Committee (the Second Military Medical University, Shanghai, China) for the ethics approval of animal studies. Some elements of Fig. 6 are from LES LABORATOIRES SERVIER. This work was supported by grants from the National Key Basic Research Program (973 project) (2015CB554004) from the Ministry of Science and Technology of China, the National Natural Science Foundation of China (81672775 and 81330037) and the Natural Science Foundation of Shanghai (15XD1504500).	BECKER D, 2012, MOL CANCER, V11; BERGSTRAND CG, 1956, SCAND J CLIN LAB INV, V8, P174, DOI 10.3109/00365515609049266; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441; Coulouarn C, 2005, J HEPATOL, V42, P860, DOI 10.1016/j.jhep.2005.01.027; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Grzelinski M, 2009, NEOPLASIA, V11, P145, DOI 10.1593/neo.81040; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Iavarone M, 2015, HEPATOLOGY, V62, P784, DOI 10.1002/hep.27729; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaur K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175471; Kong DS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm121; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Koutsioumpa M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0287-3; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Michelotti GA, 2016, GUT, V65, P683, DOI 10.1136/gutjnl-2014-308176; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Park TJ, 2008, MOL CARCINOGEN, V47, P784, DOI 10.1002/mc.20438; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Rosenfield SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047876; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Vishwamitra D, 2012, AM J PATHOL, V180, P1772, DOI 10.1016/j.ajpath.2012.01.008; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang SB, 2016, FEBS LETT, V590, P559, DOI 10.1002/1873-3468.12078; Wilusz CJ, 2012, MOL CELL, V47, P495, DOI 10.1016/j.molcel.2012.08.005; Xu D, 2013, HEPATOLOGY, V58, P739, DOI 10.1002/hep.26361; Xu F, 2010, J CELL BIOCHEM, V111, P727, DOI 10.1002/jcb.22762; Yamauchi N, 2005, MODERN PATHOL, V18, P1591, DOI 10.1038/modpathol.3800436; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1141087; Zhang YM, 2015, INT J CLIN EXP MED, V8, P11683; Zheng L, 2014, TUMOR BIOL, V35, P4095, DOI 10.1007/s13277-013-1535-z	51	17	17	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3428	3445		10.1038/s41388-018-0643-z	http://dx.doi.org/10.1038/s41388-018-0643-z			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30643194				2022-12-26	WOS:000466610000008
J	Cohen-Sharir, Y; Kuperman, Y; Apelblat, D; den Hertog, J; Spiegel, I; Knobler, H; Elson, A				Cohen-Sharir, Yael; Kuperman, Yael; Apelblat, Daniella; den Hertog, Jeroen; Spiegel, Ivo; Knobler, Hilla; Elson, Ari			Protein tyrosine phosphatase alpha inhibits hypothalamic leptin receptor signaling and regulates body weight in vivo	FASEB JOURNAL			English	Article						obesity; leptin resistance; JAK2; PTPRA	PTP-ALPHA; RPTP-ALPHA; MEDIATED PHOSPHORYLATION; INSULIN SENSITIVITY; KINASE ACTIVATION; MICE LACKING; SRC; EPSILON; CONTRIBUTES; RESISTANCE	Understanding how body weight is regulated at the molecular level is essential for treating obesity. We show that female mice genetically lacking protein tyrosine phosphatase (PTP) receptor type (PTPRA) exhibit reduced weight and adiposity and increased energy expenditure, and are more resistant to diet-induced obesity than matched wild-type control mice. These mice also exhibit reduced levels of circulating leptin and are leptin hypersensitive, suggesting that PTPRA inhibits leptin signaling in the hypothalamus. Male and female PTPRA-deficient mice fed a high-fat diet were leaner and displayed increased metabolic rates and lower circulating leptin levels, indicating that the effects of loss of PTPRA persist in the obese state. Molecularly, PTPRA down-regulates leptin receptor signaling by dephosphorylating the receptor-associated kinase JAK2, with which the phosphatase associates constitutively. In contrast to the closely related tyrosine phosphatase epsilon, leptin induces only weak phosphorylation of PTPRA at its C-terminal regulatory site Y789, and this does not affect the activity of PTPRA toward JAK2. PTPRA is therefore an inhibitor of hypothalamic leptin signaling in vivo and may prevent premature activation of leptin signaling, as well as return signaling to baseline after exposure to leptin.	[Cohen-Sharir, Yael; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, 234 Herzl St, IL-76100 Rehovot, Israel; [Kuperman, Yael] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel; [Apelblat, Daniella; Spiegel, Ivo] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [den Hertog, Jeroen] Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol Leiden, Leiden, Netherlands; [Knobler, Hilla] Kaplan Med Ctr, Diabet Endocrinol & Metab Inst, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Hebrew University of Jerusalem; Kaplan Medical Center	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, 234 Herzl St, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135	Kekst Family Institute for Medical Genetics of The Weizmann Institute of Science; David and Fela Shapell Family Center for Genetic Disorders Research of The Weizmann Institute of Science	Kekst Family Institute for Medical Genetics of The Weizmann Institute of Science; David and Fela Shapell Family Center for Genetic Disorders Research of The Weizmann Institute of Science	The authors thank Prof. Michel Tremblay (McGill University) for reagents, and Prof. Alon Chen (Weizmann Institute) for discussions. The authors also thank Dr. Maayan Barnea, Dr. Ron Rotkopf, and Dr. Michael Tsoory for assistance with statistical analyses; and Ofira Higfa and Neriah Sharabi (all from the Weizmann Institute) for expert animal care. This study was supported by the Kekst Family Institute for Medical Genetics and the David and Fela Shapell Family Center for Genetic Disorders Research, both of The Weizmann Institute of Science (to A.E.). A.E. is the incumbent of the Marshall and Renette Ezralow Professorial Chair. Y.K. is the incumbent of the Sarah and Rolando Uziel Research Associate Chair. The authors declare no conflicts of interest.	Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cheng SYS, 2014, MOL CELL BIOL, V34, P348, DOI 10.1128/MCB.00825-13; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Finkelshtein E, 2014, MOL BIOL CELL, V25, P1808, DOI 10.1091/mbc.E14-03-0788; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Huang J, 2011, EMBO J, V30, P3200, DOI 10.1038/emboj.2011.212; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Krajewska M, 2008, AM J PATHOL, V172, P1312, DOI 10.2353/ajpath.2008.070594; Levy-Apter E, 2014, J BIOL CHEM, V289, P36048, DOI 10.1074/jbc.M114.603548; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Maksumova L, 2007, J BIOL CHEM, V282, P20925, DOI 10.1074/jbc.M703157200; Meyer DS, 2014, ONCOGENE, V33, P398, DOI 10.1038/onc.2012.585; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shintani T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12070-7; Sines T, 2007, MOL CELL BIOL, V27, P7102, DOI 10.1128/MCB.02096-06; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Truffi M, 2014, J CELL SCI, V127, P2420, DOI 10.1242/jcs.134379; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wauman J, 2011, FRONT BIOSCI-LANDMRK, V16, P2771, DOI 10.2741/3885; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	51	2	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5101	5111		10.1096/fj.201800860RR	http://dx.doi.org/10.1096/fj.201800860RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30615487	Bronze			2022-12-26	WOS:000462888500039
J	Yoneshiro, T; Shin, W; Machida, K; Fukano, K; Tsubota, A; Chen, Y; Yasui, H; Inanami, O; Okamatsu-Ogura, Y; Kimura, K				Yoneshiro, Takeshi; Shin, Woongchul; Machida, Ken; Fukano, Keigo; Tsubota, Ayumi; Chen, Yong; Yasui, Hironobu; Inanami, Osamu; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro			Differentiation of bone marrow-derived cells toward thermogenic adipocytes in white adipose tissue induced by the beta 3 adrenergic stimulation	FASEB JOURNAL			English	Article						brown adipocytes; beige adipocytes; bone marrow cells; beta 3 adrenergic receptor	ALTERNATIVELY ACTIVATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; BROWN ADIPOCYTES; BEIGE FAT; CATECHOLAMINES; CONTRIBUTE	Bone marrow provides progenitors of several types of cells, including muscle and white adipocytes, ensuring peripheral tissue homeostasis. However, the role of bone marrow-derived cells (BMCs) in induction of thermogenic adipocytes is unresolved. The purpose of this study is to examine whether BMCs are involved in the emergence of thermogenic adipocytes through adrenergic activation. Irradiation of mice with 8 Gy of X-ray-depleted BMCs and peripheral blood mononucleated cells (PBMCs), which in turn impaired induction of uncoupling protein 1 (UCP1) through administration of beta 3 adrenergic receptor agonist, CL 316,243 (CL), in inguinal white adipose tissue (iWAT). In contrast, CL-induced UCP1 induction in brown adipose tissue was unaffected by BMC depletion. Transplantation of normal BMCs into mice depleted of BMCs recovered PBMC levels and rescued the ability of iWAT browning by CL. Furthermore, analyses of mice transplanted with green fluorescent protein (GFP)-labeled BMCs revealed that the number of GFP-positive BMCs and PBMCs were significantly decreased by CL and that GFP-positive stromal cells and GFP-positive UCP1-expressing multilocular adipocytes appeared in iWAT after CL administration, demonstrating differentiation of BMC-derived preadipocytes into UCP1-expressing thermogenic adipocytes. These results unveiled a crucial role of the BMC as a nonresident origin for a subset of thermogenic adipocytes, contributing to browning of white adipose tissue.	[Yoneshiro, Takeshi; Shin, Woongchul; Machida, Ken; Fukano, Keigo; Tsubota, Ayumi; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Lab Biochem, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Yasui, Hironobu; Inanami, Osamu] Hokkaido Univ, Grad Sch Vet Med, Lab Radiat Biol, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan; [Chen, Yong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Hokkaido University; Hokkaido University; Huazhong University of Science & Technology	Yoneshiro, T (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Lab Biochem,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	yoneshiro@vetmed.hokudai.ac.jp	Inanami, Osamu/A-5197-2012; Yasui, Hironobu/E-3794-2010; Yoneshiro, Takeshi/V-3856-2019; Okamatsu-Ogura, Yuko/AAI-5602-2020	Inanami, Osamu/0000-0001-7895-3918; Yasui, Hironobu/0000-0002-6757-1110; Yoneshiro, Takeshi/0000-0001-5298-5831; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [2610103, 26860703]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Momoko Yoneshiro (University of California-San Francisco, San Francisco, CA, USA) for technical support. This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (2610103, 26860703). The authors declare no conflicts of interest.	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; Bukowska J, 2018, CURR OSTEOPOROS REP, V16, P312, DOI 10.1007/s11914-018-0442-z; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Dannheim K, 2016, AM J HEMATOL, V91, P545, DOI 10.1002/ajh.24330; de Jong JMA, 2017, AM J PHYSIOL-ENDOC M, V312, pE508, DOI 10.1152/ajpendo.00437.2016; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fukano K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166579; Gavin KM, 2016, FASEB J, V30, P1096, DOI 10.1096/fj.15-278994; Hepler C, 2017, GENE DEV, V31, P127, DOI 10.1101/gad.293704.116; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Lee MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21173; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Nagaya K., 2018, J PHYSL SCI; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Okamatsu-Ogura Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07206-8; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; Scheller EL, 2016, TRENDS ENDOCRIN MET, V27, P392, DOI 10.1016/j.tem.2016.03.016; Shin W, 2017, OBESITY, V25, P417, DOI 10.1002/oby.21727; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Takahashi M, 2008, J RADIAT RES, V49, P153, DOI 10.1269/jrr.07082; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	36	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5196	5207		10.1096/fj.201801757RR	http://dx.doi.org/10.1096/fj.201801757RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624970				2022-12-26	WOS:000462888500046
J	Chen, YJ; Cohen, TJ				Chen, Youjun; Cohen, Todd J.			Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43) (TARDBP); stress granule; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); post-translational modification (PTM); histone deacetylase 6 (HDAC6); neurodegeneration; amyloid; protein aggregation; amyloid; motor neuron disease; neurodegeneration; oxidative stress; protein aggregation	MENTAL-RETARDATION PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; DEACETYLASE HDAC6; PHASE-TRANSITION; RNA TRANSLATION; MESSENGER-RNA; MUTATIONS; FUS; ACETYLATION	TAR DNA-binding protein 43 (TDP-43) is a nucleic acid-binding protein, and its aggregation represents the defining pathology in amyotrophic lateral sclerosis (ALS) and related proteinopathies. Recent studies implicate cytoplasmic stress granules (SGs) as hubs that may facilitate TDP-43 aggregation. Here, using cellular fractionation, biochemical analyses, and histological assays, we show that TDP-43 targeted to the cytoplasm has multiple fates. Whereas a TDP-43 subpopulation is indeed recruited to SGs, mature aggregated TDP-43, produced with aggregate-prone TDP-43 variants or exposure to oxidative stress, generates distinct TDP-43 inclusions that are surprisingly devoid of SGs. Consistent with this observation, we found that SG components are predominantly excluded from TDP-43 pathology in motor neurons from individuals with ALS. We generated de novo SGs by expressing the fragile X protein (FMRP) and found that rather than directly engaging TDP-43 aggregates, SGs can sequester the proteostasis factor histone deacetylase 6 (HDAC6) and thereby impede TDP-43 clearance from cells. These findings indicate that SGs form distinct cytoplasmic structures that can indirectly enhance TDP-43 aggregation. Therapeutic approaches that inhibit SG formation may therefore be effective at suppressing TDP-43-mediated toxicity in patients with ALS and related TDP-43 proteinopathies.	[Chen, Youjun; Cohen, Todd J.] Univ N Carolina, Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA.	toddcohen@neurology.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; , Pathology Services Core/CEZ-2246-2022		National Institutes of Health [R00 NS080985, R01NS105981]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105981, R00NS080985, P30NS045892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R00 NS080985 (to T. J. C.) and R01NS105981 (to T. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00423, 10.3339/fncel.2015.00423]; Bhandare VV, 2018, J BIOMOL STRUCT DYN, V36, P1075, DOI 10.1080/07391102.2017.1310670; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Coyne AN, 2015, HUM MOL GENET, V24, P6886, DOI 10.1093/hmg/ddv389; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; DEWEY CM, 2011, J BACTERIOL, V193, P1098, DOI DOI 10.1128/MCB.01279-10; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gal J, 2013, J BIOL CHEM, V288, P15035, DOI 10.1074/jbc.M112.431957; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guo WT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00911-y; Hirsch-Reinshagen V, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0493-x; Hwang AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168913; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Majumder P, 2016, ACTA NEUROPATHOL, V132, P721, DOI 10.1007/s00401-016-1603-8; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2016, BRAIN RES, V1649, P189, DOI 10.1016/j.brainres.2016.05.022; Moreno F, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0190-6; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P5211, DOI 10.1093/hmg/ddu243; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Valle C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00005; Wang P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00088-4; Yu ZP, 2012, J BIOL CHEM, V287, P22560, DOI 10.1074/jbc.M112.357582; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	55	47	47	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3696	3706		10.1074/jbc.RA118.006351	http://dx.doi.org/10.1074/jbc.RA118.006351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30630951	Green Published, hybrid			2022-12-26	WOS:000461853900031
J	Witkowski, A; Carta, S; Lu, R; Yokoyama, S; Rubartelli, A; Cavigiolio, G				Witkowski, Andrzej; Carta, Sonia; Lu, Rui; Yokoyama, Shinji; Rubartelli, Anna; Cavigiolio, Giorgio			Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; amyloid; atherosclerosis; cytokine induction; inflammation; interleukin; macrophage; oxidation-reduction (redox); Toll-like receptor (TLR); methionine oxidation; apolipoprotein A-I; cytokines; DAMP; inflammation; methionine oxidation	HIGH-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTORS; NLRP3 INFLAMMASOME; STERILE INFLAMMATION; ALZHEIMERS-DISEASE; CHOLESTEROL EFFLUX; INTERLEUKIN-1-BETA; ACTIVATION; PROTEIN; ATHEROSCLEROSIS	Amyloid deposits of apolipoprotein A-I (apoA-I) and inflammation are common in atherosclerotic arteries. In this study, we investigated the interplay between oxidation of apoA-I methionine residues (Met(O)-ApoA-I), a known amyloidogenic modification of apoA-I, and the inflammatory response of immune cells. Soluble pre-fibrillar Met(O)-ApoA-I, but not apoA-I, induced intracellular accumulation of pro-interleukin (IL)-1 and secretion of the pro-inflammatory cytokines tumor necrosis factor (TNF) and IL-6 in mouse bone marrow-derived macrophages (BMDMs) and human primary monocytes. Additionally, secretion of mature IL-1 was also activated in human monocytes. The pro-inflammatory activity of Met(O)-ApoA-I was Toll-like receptor 4 (TLR4)-dependent and CD36-independent and was solely determined by oxidation of apoA-I methionine residues, in particular Met-86 and Met-148. In contrast, amyloid fibrils or reconstituted high-density lipoproteins (HDLs) generated from Met(O)-ApoA-I did not induce cytokine production in BMDMs. Although lipid-free Met(O)-ApoA-I remained functional in extracting lipids from cells and generating HDL, it gained strong pro-inflammatory properties that may aggravate local inflammation in the arteries and atherosclerosis. Our study indicates that oxidation of apoA-I methionine residues produces a potent danger-associated molecular pattern capable of stimulating pro-inflammatory cytokine secretion at levels similar to those induced by known pathogen-associated molecular patterns, such as lipopolysaccharide.	[Witkowski, Andrzej; Cavigiolio, Giorgio] UCSF Benioff Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Carta, Sonia; Rubartelli, Anna] Osped Policlin San Martino, Cell Biol Unit, I-16132 Genoa, Italy; [Lu, Rui; Yokoyama, Shinji] Chubu Univ, Food & Nutr Sci, Kasugai, Aichi 4878501, Japan	Chubu University	Cavigiolio, G (corresponding author), UCSF Benioff Childrens Hosp Oakland UCSF BCHO Res, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org	Rubartelli, Anna/AAA-1259-2021; carta, sonia/AAB-3799-2020	carta, sonia/0000-0002-1278-9761; Cavigiolio, Giorgio/0000-0002-1622-0628; Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [R01 HL113059]; Japan Society for the Promotion of Science's Invitation Fellowship Program for Research in Japan [L-14559]; Associazione Italiana per la Ricerca sul Cancro [IG 2016-15434]; Fondazione Telethon [GGP14144]; Italian Ministry of Health "Young Investigators" Grant [GR-2016-02363630]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1201007]; MEXT Japan [24614018, 26461370, 15H02903]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science's Invitation Fellowship Program for Research in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health "Young Investigators" Grant; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or part by National Institutes of Health Grant R01 HL113059 (to G. C.); Japan Society for the Promotion of Science's Invitation Fellowship Program for Research in Japan (L-14559) (to G. C. and S. Y.); Associazione Italiana per la Ricerca sul Cancro (IG 2016-15434) and Fondazione Telethon (GGP14144) (to A. R.); Italian Ministry of Health "Young Investigators" Grant GR-2016-02363630 (to S. C.); MEXT-Supported Program for the Strategic Research Foundation at Private Universities Grant S1201007; and MEXT Japan Grants-in-Aid 24614018, 26461370, and 15H02903 (to S. Y. and R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Audet A, 2012, HISTOPATHOLOGY, V61, P610, DOI 10.1111/j.1365-2559.2012.04265.x; Balducci C, 2017, BRAIN BEHAV IMMUN, V60, P188, DOI 10.1016/j.bbi.2016.10.012; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Clark IA, 2015, BRIT J PHARMACOL, V172, P3714, DOI 10.1111/bph.13181; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Eren E, 2015, CLIN CHIM ACTA, V439, P18, DOI 10.1016/j.cca.2014.09.024; Estruch M, 2015, BBA-MOL CELL BIOL L, V1851, P1442, DOI 10.1016/j.bbalip.2015.08.009; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Goulopoulou S, 2016, PHARMACOL REV, V68, P142, DOI 10.1124/pr.114.010090; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Hoshino K, 1999, J IMMUNOL, V162, P3749; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kee P, 2002, ARTERIOSCL THROM VAS, V22, P1912, DOI 10.1161/01.ATV.0000038485.94020.7F; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kristen AV, 2010, CARDIOVASC PATHOL, V19, P228, DOI 10.1016/j.carpath.2009.04.005; Kusters PJH, 2015, METHODS MOL BIOL, V1339, P17, DOI 10.1007/978-1-4939-2929-0_2; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; LIANG HQ, 1994, J LIPID RES, V35, P1187; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; MUCCHIANO G, 1992, AM J PATHOL, V140, P871; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Navab Mohamad, 2007, Curr Atheroscler Rep, V9, P244, DOI 10.1007/s11883-007-0026-3; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Ryan J., 2008, CORNING TECHNICAL B, VTC-305; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Semino C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1121-9; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; Witkowski A, 2018, FASEB J, V32, P3149, DOI 10.1096/fj.201701127R; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200	80	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3634	3646		10.1074/jbc.RA118.005663	http://dx.doi.org/10.1074/jbc.RA118.005663			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635405	Green Published, hybrid			2022-12-26	WOS:000461853900026
J	Campderrich, I; Nazar, FN; Wichman, A; Marin, RH; Estevez, I; Keeling, LJ				Campderrich, Irene; Nicolas Nazar, Franco; Wichman, Anette; Hector Marin, Raul; Estevez, Inma; Keeling, Linda J.			Environmental complexity: A buffer against stress in the domestic chick	PLOS ONE			English	Article							TONIC IMMOBILITY DURATION; TO-LYMPHOCYTE RATIO; LAYING HENS; FLUCTUATING ASYMMETRY; PERCHING BEHAVIOR; IMMUNE-RESPONSE; HEAT-STRESS; GROUP-SIZE; PHENOTYPIC APPEARANCE; COLD STRESS	Birds kept in commercial production systems can be exposed to multiple stressors from early life and this alters the development of different morphological, immunological and behavioural indicators. We explore the hypothesis that provision of a complex environment during early life, better prepares birds to cope with stressful events as well as buffers them against future unpredictable stressful episodes. In this study, 96 one day old pullets were randomly distributed in eight pens (12 birds/pen). Half of the chicks (N = 48) were assigned to a Complex Environment (CENV: with perches, a dark brooder etc.) the others to a Simple Environment (SENV: without enrichment features). Half of the birds from each of these treatments were assigned to a No Stress (NSTR, 33 degrees C) or to an acute Cold Stress (CSTR, 18-20 degrees C) treatment during six hours on their second day of life. At four weeks of age, chicks with these four different backgrounds were exposed to an Intermittent Stressful Challenges Protocol (ISCP). In an immunological test indicative of pro-inflammatory status Phytohemagglutinin-P (PHA-P), the response of CSTR birds was ameliorated by rearing chicks in a CENV as they had a similar response to NSTR chicks and a significantly better pro-inflammatory response than those CSTR birds reared in a SENV (five days after the CSTR treatment was applied). A similar better response when coping with new challenges (the ISCP) was observed in birds reared in a CENV compared to those from a SENV. Birds reared in the CENV had a lower heterophil/lymphocyte ratio after the ISCP than birds reared in SENV, independently of whether or not they had been exposed to CSTR early in life. No effects of stress on general behaviour were detected, however, the provision of a CENV increased resting behaviour, which may have favoured stress recover. Additionally, we found that exposure to cold stress at an early age might have rendered birds more vulnerable to future stressful events. CSTR birds had lower humoral immune responses (sheep red blood cells induced antibodies) after the ISCP and started using elevated structures in the CENV later compared to their NSTR conspecifics. Our study reflects the importance of the early provision of a CENV in commercial conditions to reduce negative stress-related effects. Within the context of the theory of adaptive plasticity, our results suggest that the early experience of the birds had long lasting effects on the modulation of their phenotypes.	[Campderrich, Irene; Estevez, Inma] Neiker Tecnalia Basque Inst Agr Res & Dev, Dept Anim Hlth, Vitoria, Spain; [Campderrich, Irene; Wichman, Anette; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden; [Nicolas Nazar, Franco; Hector Marin, Raul] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Inst Invest Biol & Tecnol, Cordoba, Argentina; [Nicolas Nazar, Franco; Hector Marin, Raul] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Inst Ciencia & Tecnol Alimentos, Cordoba, Argentina; [Estevez, Inma] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Swedish University of Agricultural Sciences; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Basque Foundation for Science	Keeling, LJ (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	linda.keeling@slu.se	Nazar, Franco Nicolas/I-5464-2019; Keeling, Linda/K-6542-2012	Nazar, Franco Nicolas/0000-0002-5282-5931; Marin, Raul/0000-0001-8161-4044; Keeling, Linda/0000-0003-2629-0117	Swedish Research Council Formas [Dnr 221-2010-35]; Ministry of Science and Innovation, Spain [AGL2010-18276, BES-2011-050055, EEBB-I-14-08368, EEBB-I-15-10297]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The Swedish Research Council Formas (grant to LJK, Dnr 221-2010-35) provided the financial support for the experiment. The Ministry of Science and Innovation, Spain also contributed to this research (AGL2010-18276, MODELAY), by a PhD Scholarship for I.C. (BES-2011-050055) and a grant from their program for promoting mobility of pre-doctoral students (2014 and 2015) to fund IC's stay in Sweden (EEBB-I-14-08368, EEBB-I-15-10297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen-Tennekes R, 2009, POULTRY SCI, V88, P1879, DOI 10.3382/ps.2009-00150; [Anonymous], 2006, SAS MIXED MODELS; APPLEBY MC, 1989, BIOL BEHAV, V14, P157; Appleby MC, 1992, POULTRY PRODUCTION S; Arnould U, 2003, APPL ANIM BEHAV SCI, V84, P281, DOI 10.1016/j.applanim.2003.07.003; Baarendse PJJ, 2007, WORLD POULTRY SCI J, V63, P267, DOI 10.1017/S0043933907001456; Bailie CL, 2013, ANIMAL, V7, P618, DOI 10.1017/S1751731112002108; Bateson P, 2014, J PHYSIOL-LONDON, V592, P2357, DOI 10.1113/jphysiol.2014.271460; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P289, DOI 10.1016/0168-1591(84)90121-7; BRAKE J, 1994, POULTRY SCI, V73, P1470, DOI 10.3382/ps.0731470; Campo JL, 2008, POULTRY SCI, V87, P621, DOI 10.3382/ps.2007-00466; Campo JL, 2007, POULTRY SCI, V86, P37, DOI 10.1093/ps/86.1.37; Campo JL, 2010, ARCH GEFLUGELKD, V74, P126; Campo JL, 2005, APPL ANIM BEHAV SCI, V91, P75, DOI 10.1016/j.applanim.2004.08.028; Carere C, 2010, CURRENT ZOOLOGY, V56; Cheng HW, 2004, POULTRY SCI, V83, P707, DOI 10.1093/ps/83.5.707; Cichon M, 2002, P ROY SOC B-BIOL SCI, V269, P1493, DOI 10.1098/rspb.2002.2054; COLLIAS NE, 1967, CONDOR, V69, P360, DOI 10.2307/1366199; Cornetto T, 2002, APPL ANIM BEHAV SCI, V75, P325, DOI 10.1016/S0168-1591(01)00195-2; Cornetto T, 2001, APPL ANIM BEHAV SCI, V71, P141, DOI 10.1016/S0168-1591(00)00171-4; Cornetto T, 2001, POULTRY SCI, V80, P1455, DOI 10.1093/ps/80.10.1455; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Ericsson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153879; Fraser A.F., 1997, FARM ANIMAL BEHAV WE, V3rd; Garcia-Navas V, 2013, ECOSCIENCE, V20, P9, DOI 10.2980/20-1-3545; Ghazi S, 2012, BIOL TRACE ELEM RES, V146, P309, DOI 10.1007/s12011-011-9260-1; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; Gunnarsson S, 2000, APPL ANIM BEHAV SCI, V67, P217, DOI 10.1016/S0168-1591(99)00125-2; Huff GR, 2005, POULTRY SCI, V84, P709, DOI 10.1093/ps/84.5.709; JONES RB, 1989, PHYSIOL BEHAV, V46, P439, DOI 10.1016/0031-9384(89)90017-6; Keeling LJ, 1997, P 31 INT C ISAE RES, P83; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Lechner O, 2001, INT IMMUNOL, V13, P769, DOI 10.1093/intimm/13.6.769; Leone EH, 2007, APPL ANIM BEHAV SCI, V102, P39, DOI 10.1016/j.applanim.2006.03.004; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Liste G, 2015, APPL ANIM BEHAV SCI, V163, P144, DOI 10.1016/j.applanim.2014.11.013; Malleau AE, 2007, APPL ANIM BEHAV SCI, V106, P52, DOI 10.1016/j.applanim.2006.06.017; Marin RH, 2001, APPL ANIM BEHAV SCI, V71, P57, DOI 10.1016/S0168-1591(00)00167-2; MOLLER AP, 1995, POULTRY SCI, V74, P1761, DOI 10.3382/ps.0741761; Mujahid A, 2009, POULTRY SCI, V88, P917, DOI 10.3382/ps.2008-00472; Munoz-Abellan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021426; Nazar FN, 2015, STRESS, V18, P710, DOI 10.3109/10253890.2015.1078306; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Nelson JR, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8100173; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, P23, DOI 10.1098/rspb.2015.1005; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Newberry RC, 1997, ANIM BEHAV, V54, P387, DOI 10.1006/anbe.1996.0421; Newberry RC, 2001, APPL ANIM BEHAV SCI, V73, P117, DOI 10.1016/S0168-1591(01)00135-6; Newberry RC, 2007, APPL ANIM BEHAV SCI, V107, P262, DOI 10.1016/j.applanim.2006.10.010; Oden K, 2002, BRIT POULTRY SCI, V43, P169, DOI 10.1080/00071660120121364; Olfati A, 2018, SPAN J AGRIC RES, V16, DOI 10.5424/sjar/2018162-12753; Quinteiro WM, 2012, J ANIM SCI, V90, P1986, DOI 10.2527/jas.2011-3949; Roberts ML, 2009, J EXP BIOL, V212, P3125, DOI 10.1242/jeb.030726; Rodriguez S, 2016, ECOL EVOL, V6, P4458, DOI 10.1002/ece3.2192; Rygula R, 2013, NEUROPSYCHOPHARMACOL, V38, P2188, DOI 10.1038/npp.2013.116; Schrader L, 2009, APPL ANIM BEHAV SCI, V121, P179, DOI 10.1016/j.applanim.2009.09.010; Server JL, 1961, J IMMUNOL, V88, P320; Shinder D, 2002, J THERM BIOL, V27, P517, DOI 10.1016/S0306-4565(02)00025-6; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Smits JE, 1999, ECOTOXICOLOGY ENV SA, V44, P324; Smits JEG, 2005, DEV COMP IMMUNOL, V29, P161, DOI 10.1016/j.dci.2004.06.007; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Struelens E, 2008, BRIT POULTRY SCI, V49, P381, DOI 10.1080/00071660802158332; SUK YO, 1995, POULTRY SCI, V74, P285, DOI 10.3382/ps.0740285; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Ventura BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029826; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wichman A, 2007, APPL ANIM BEHAV SCI, V105, P165, DOI 10.1016/j.applanim.2006.05.009; Widowski T, 2010, ANIM WELFARE SER, V9, P137, DOI 10.1007/978-90-481-3650-6_6; WOODGUSH DGM, 1959, POULTRY SCI, V38, P321, DOI 10.3382/ps.0380321; Yahav S, 1996, BRIT POULTRY SCI, V37, P43, DOI 10.1080/00071669608417835; Yngvesson J, 2001, ANIM BEHAV, V61, P609, DOI 10.1006/anbe.2000.1616; Yunianto VD, 1997, BRIT J NUTR, V77, P897, DOI 10.1079/BJN19970088; Zidar J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23545-6	81	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210270	10.1371/journal.pone.0210270	http://dx.doi.org/10.1371/journal.pone.0210270			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640921	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000022
J	Ferreira, JE; Ferreira, SC; Almeida-Neto, C; Nishiya, AS; Alencar, CS; Gouveia, GR; Caiaffa, H; Gomes, H; Santosid, RTD; Witkin, SS; Mendrone, A; Sabino, EC				Ferreira, Jerenice E.; Ferreira, Suzete C.; Almeida-Neto, Cesar; Nishiya, Anna S.; Alencar, Cecilia S.; Gouveia, Gisele R.; Caiaffa-Filho, Helio; Gomes, Helio; de Macedo Santosid, Raimunda Telma; Witkin, Steven S.; Mendrone-Junior, Alfredo; Sabino, Ester C.			Molecular characterization of viruses associated with encephalitis in Sao Paulo, Brazil	PLOS ONE			English	Article							ZIKA VIRUS; PCR ASSAYS; DENGUE; INFECTIONS; EPIDEMIOLOGY; ENTEROVIRUS; DISEASES	The objective of this study was to characterize the prevalence of viral encephalitis due to arbovirus infection of the Togaviridae and Flaviviridae families in Sao Paulo, Brazil. A total of 500 cerebrospinal fluid (CSF) samples collected between August 2012 and January 2013, from patients with symptoms of acute encephalitis were analyzed. Findings suggestive of viral encephalitis-elevations in cell concentration, glucose and total protein-were observed in 234 (46.8%) samples, designated as Group 1. The remaining 266 samples comprised Group 2. All samples were tested for Flaviviruses (dengue virus 1, 2, 3 and 4, yellow fever virus and West Nile virus), Alphavirus (NS5 region) and enterovirus by RT-PCR and for herpesviruses and enteroviruses using CLART(-)Entherpex. A presumptive viral etiological agent was detected in 26 samples (5.2%), 18 (8.0%) in Group 1 and 8 (3.0%) in Group 2. In Group 1 human herpesviruses were detected in 9 cases, enteroviruses in 7 cases, dengue viruses (DENV) in 2 CSFs and St. Louis encephalitis virus (SLEV) in one case. In Group 2 there were 3 CSFs positive for human herpesviruses, 2 for enteroviruses, 2 for DENV and 1 for SLEV. Detection of arboviruses, even though present in a minority of infected patients, identifies these viruses as a probable etiological agent of encephalitis. This is of special concern in regions where this class of viruses is endemic and has been linked to other recent epidemics.	[Ferreira, Jerenice E.; Sabino, Ester C.] Univ Sao Paulo, Med Sch, Inst Trop Med IMT, LIM 46 Lab Med Parasitol, Sao Paulo, Brazil; [Ferreira, Jerenice E.; Caiaffa-Filho, Helio; de Macedo Santosid, Raimunda Telma] Adolf Lutz Inst IAL, Pathol Ctr, Sao Paulo, Brazil; [Ferreira, Suzete C.; Almeida-Neto, Cesar; Nishiya, Anna S.; Mendrone-Junior, Alfredo] FPS HSP, Sao Paulo, Brazil; [Almeida-Neto, Cesar] Univ Sao Paulo, Fac Med, Disciplina Ciencias Med, Sao Paulo, Brazil; [Alencar, Cecilia S.; Caiaffa-Filho, Helio; Gomes, Helio] HCSP, DLC, Cent Lab Div, Sao Paulo, Brazil; [Alencar, Cecilia S.; Gomes, Helio] Univ Sao Paulo, Med Sch, Dept Clin Hosp, Clin Lab, Sao Paulo, Brazil; [Alencar, Cecilia S.; Gomes, Helio] Univ Sao Paulo, Med Sch, Dept Clin Hosp, LIM 03, Sao Paulo, Brazil; [Gouveia, Gisele R.] Univ Sao Paulo, Fac Med, FMUSP, Sao Paulo, Brazil; [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Cornell University	Ferreira, JE (corresponding author), Univ Sao Paulo, Med Sch, Inst Trop Med IMT, LIM 46 Lab Med Parasitol, Sao Paulo, Brazil.; Ferreira, JE (corresponding author), Adolf Lutz Inst IAL, Pathol Ctr, Sao Paulo, Brazil.	jerenice.ferreira@gmail.com	Witkin, Steven/AAF-3812-2019; Witkin, Steven/AAW-8602-2021; Sabino, Ester C/F-7750-2010; Nishiya, Anna/Q-8156-2016; Gouveia, Gisele/T-6376-2019; de Almeida-Neto, Cesar/O-9224-2014	Witkin, Steven/0000-0002-3502-3929; Sabino, Ester C/0000-0003-2623-5126; Gouveia, Gisele/0000-0002-1627-4490; de Almeida-Neto, Cesar/0000-0002-8490-4634; Ferreira, Jerenice/0000-0002-9729-9154	Foundation for Research Support of the State of Sao Paulo (FAPESP) [2011/52094-3]	Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Foundation for Research Support of the State of Sao Paulo for the Financial Assistance (FAPESP) (Process Number: 2011/52094-3). Principal Investigator: Ester C. Sabino.; We thank the Foundation for Research Support of the State of Sao Paulo for financial assistance (Process 2011/52094-3). The funders had no role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIR ASS PROT ENC; Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013; Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285; Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953; Briese T, 2000, LANCET, V355, P1614, DOI 10.1016/S0140-6736(00)02220-0; Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cerri GG., 2014, HOSP CLIN FACULDADE; Collucci C, 2016, HC FAZ ANIVERSARIO M; Vieira MACES, 2015, REV INST MED TROP SP, V57, P276, DOI 10.1590/S0036-46652015000300017; da Silva ANM, 2006, MEM I OSWALDO CRUZ, V101, P547, DOI 10.1590/S0074-02762006000500011; Faria JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44949; Ferreira MLB, 2005, ARQ NEURO-PSIQUIAT, V63, P488, DOI 10.1590/S0004-282X2005000300023; Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4; Fujita DM, 2018, J TRAVEL MED, V25; Gendelman HE, 2005, LANCET NEUROL, V4, P12, DOI 10.1016/S1474-4422(04)00951-2; Gilden DH, 2008, ACP MED, P1, DOI [10.1016/S1474-4422(04)00951-2, DOI 10.1016/S1474-4422(04)00951-2]; Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; Jaijakul S, 2017, INT J INFECT DIS, V59, P77, DOI 10.1016/j.ijid.2017.04.010; Johnson BW, 2004, AM J TROP MED HYG, V70, P89, DOI 10.4269/ajtmh.2004.70.89; Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6; Kennedy PGE, 2005, J NEUROL, V252, P268, DOI 10.1007/s00415-005-0770-7; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]; Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x; LOPES ODS, 1979, AM J TROP MED HYG, V28, P583, DOI 10.4269/ajtmh.1979.28.583; Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026; Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007; Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905; Pinheiro FP, 1997, DOENCAS INFECCIOSAS, P208; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008; Rodrigues SG, 2010, PAN AMAZ SAUDE, V1, P81; Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537; Silva MTT, 2013, ARQ NEURO-PSIQUIAT, V71, P703, DOI 10.1590/0004-282X20130155; Teixeira M.G., 1999, INF EPIDEMIOLOGICO S, V8, P5, DOI [10.5123/S0104-16731999000400002, DOI 10.5123/S0104-16731999000400002]; Vasconcelos PFC, 2015, REV PANAMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001; Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170; Volle R, 2012, J VIROL METHODS, V185, P142, DOI 10.1016/j.jviromet.2012.06.019; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209993	10.1371/journal.pone.0209993	http://dx.doi.org/10.1371/journal.pone.0209993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640927	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000017
J	Nielsen, T; Kristensen, SR; Gregersen, H; Teodorescu, EM; Christiansen, G; Pedersen, S				Nielsen, Thoger; Kristensen, Soren Risom; Gregersen, Henrik; Teodorescu, Elena Manuela; Christiansen, Gunna; Pedersen, Shona			Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; THROMBIN GENERATION; CIRCULATING MICROPARTICLES; COAGULATION ACTIVATION; ROUTINE TEST; CANCER; THALIDOMIDE; RISK	Multiple myeloma (MM) patients have increased risk of developing venous thromboembolism, but the underlying mechanisms and the effect on the coagulation system of the disease and the current cancer therapies are not known. It is possible that cancer-associated extracellular vesicles (EV), carrying tissue factor (TF) and procoagulant phospholipids (PPL) may play a role in thrombogenesis. The aim of this study was to perform an in-depth analysis of procoagulant activity of small and large EVs isolated from 20 MM patients at diagnosis and after receiving first-line treatment compared with 20 healthy control subjects. Differential ultracentrifugation at 20,000 x g and 100,000 x g were used to isolate EVs for quantitative and phenotypical analysis through nanoparticle tracking analysis, Western blotting and transmission electron microscopy. The isolated EVs were analyzed for procoagulant activity using the calibrated automated thrombogram technique, a factor Xa-based activity assay, and the STA Procoag-PPL assay. In general, MM patients contained more EVs, and immunoelectron microscopy confirmed the presence of CD9- and CD38-positive EVs. EVs in the 20,000 x g pellets from MM patients exerted procoagulant activity visualized by increased thrombin generation and both TF and PPL activity. This effect diminished during treatment, with the most prominent effect observed in the high-dose chemotherapy eligible patients after induction therapy with bortezomib, cyclophosphamide, and dexamethasone. In conclusion, the EVs in patients with MM carrying TF and PPL are thus capable of exerting procoagulant activity.	[Nielsen, Thoger; Kristensen, Soren Risom; Pedersen, Shona] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Nielsen, Thoger; Kristensen, Soren Risom; Gregersen, Henrik; Teodorescu, Elena Manuela; Pedersen, Shona] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Nielsen, Thoger; Kristensen, Soren Risom; Gregersen, Henrik; Teodorescu, Elena Manuela; Pedersen, Shona] Aalborg Univ Hosp, Fac Med, Aalborg, Denmark; [Gregersen, Henrik; Teodorescu, Elena Manuela] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University	Pedersen, S (corresponding author), Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark.; Pedersen, S (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.; Pedersen, S (corresponding author), Aalborg Univ Hosp, Fac Med, Aalborg, Denmark.	shp@rn.dk		Nielsen, Thoger/0000-0003-1698-2099; Pedersen, Shona/0000-0001-6636-0293	Danish Research Council for Independent Research [4183-00268]; Obel Family Foundation [26145]	Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Obel Family Foundation	This work was funded by grants from the Danish Research Council for Independent Research, https://ufm.dk/en/research-and-innovation/councils-and-commissions/independent-research-fund-Denmark (grant no. 4183-00268), and the Obel Family Foundation, http://obel.com/english (grant no. 26145), awarded to Soren Risom Kristensen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerda JJA, 2011, THROMB HAEMOSTASIS, V105, P14, DOI 10.1160/TH10-03-0187; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Bharthuar A, 2013, THROMB RES, V132, P180, DOI 10.1016/j.thromres.2013.06.026; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Boknas N, 2014, J THROMB HAEMOST, V12, P515, DOI 10.1111/jth.12503; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; Caivano A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061183; Campello E, 2014, BLOOD COAGUL FIBRIN, V25, P534, DOI 10.1097/MBC.0000000000000068; CATOVSKY D, 1970, BRIT MED J, V3, P438, DOI 10.1136/bmj.3.5720.438; Elyamany G, 2014, CLIN MED INSIGHTS-ON, V8, P129, DOI 10.4137/CMO.S18991; Esmon CT, 1999, BEST PRACT RES CL HA, V12, P343, DOI 10.1053/beha.1999.0029; Gardiner C, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26901; Gerotziafas GT, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-16; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hisada Y, 2016, THROMB RES, V139, P90, DOI 10.1016/j.thromres.2016.01.011; Johnsen KB, 2016, CYTOTECHNOLOGY, V68, P2125, DOI 10.1007/s10616-016-9952-7; Judicone C., 2013, J. Thromb. Haemost, V150, P137, DOI 10.1111/jth.12207; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Katsuda T, 2014, PROTEOMICS, V14, P412, DOI 10.1002/pmic.201300389; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Leebeek FWG, 2012, THROMB RES, V129, pS88, DOI 10.1016/S0049-3848(12)70024-5; Leiba M, 2017, BLOOD CELL MOL DIS, V65, P1, DOI 10.1016/j.bcmd.2017.03.010; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Marchetti M, 2014, AM J HEMATOL, V89, P68, DOI 10.1002/ajh.23590; Minnema MC, 2003, J THROMB HAEMOST, V1, P445, DOI 10.1046/j.1538-7836.2003.00083.x; Nielsen T, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1454777; Pap E, 2011, CRIT REV ONCOL HEMAT, V79, P213, DOI 10.1016/j.critrevonc.2010.07.015; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Thaler J, 2012, J THROMB HAEMOST, V10, P1363, DOI 10.1111/j.1538-7836.2012.04754.x; Tilley RE, 2008, THROMB RES, V122, P604, DOI 10.1016/j.thromres.2007.12.023; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tripisciano C, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; van Doormaal FF, 2012, THROMB HAEMOSTASIS, V108, P160, DOI 10.1160/TH12-02-0099; Vogel R, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31242; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zangari M, 2003, CLIN LYMPHOMA, V4, P32, DOI 10.3816/CLM.2003.n.011; Zangari M, 2001, BLOOD, V98, P1614, DOI 10.1182/blood.V98.5.1614	44	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210835	10.1371/journal.pone.0210835	http://dx.doi.org/10.1371/journal.pone.0210835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640949	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000051
J	Waschbusch, D; Hubel, N; Ossendorf, E; Lobbestael, E; Baekelandt, V; Lindsay, AJ; McCaffrey, MW; Khan, AR; Barnekow, A				Waschbuesch, Dieter; Huebel, Nicole; Ossendorf, Edith; Lobbestael, Evy; Baekelandt, Veerle; Lindsay, Andrew J.; McCaffrey, Mary W.; Khan, Amir R.; Barnekow, Angelika			Rab32 interacts with SNX6 and affects retromer-dependent Golgi trafficking	PLOS ONE			English	Article							EARLY/RECYCLING ENDOSOMES; EMERGING ROLE; PROTEIN; TRANSPORT; COMPLEX; GTPASES; IDENTIFICATION; RECOGNITION; SUBUNIT; LRRK2	The Rab family of small GTPases regulate various aspects of cellular dynamics in eukaryotic cells. Membrane trafficking has emerged as central to the functions of leucine-rich repeat kinase 2 (LRRK2), which is associated with inherited and sporadic forms of Parkinson's disease (PD). Rabs act as both regulators of the catalytic activity and targets for serine/threonine phosphorylation by LRRK2. Rab32, Rab38 and Rab29 have been shown to regulate LRRK2 sub-cellular localization through direct interactions. Recently, Rab29 was shown to escort LRRK2 to the Golgi apparatus and activate the phosphorylation of Rab8 and Rab10. Rab32 is linked to multiple cellular functions including endosomal trafficking, mitochondrial dynamics, and melanosome biogenesis. A missense mutation in Rab32 has also recently been linked to PD. Here, we demonstrate that Rab32 directly interacts with sorting nexin 6 (SNX6). SNX6 is a transient subunit of the retromer, an endosome-Golgi retrieval complex whose Vps35 subunit is strongly associated with PD. We could further show that localization of cation-independent mannose-6-phosphate receptors, which are recycled to the trans-Golgi network (TGN) by the retromer, was affected by both Rab32 and SNX6. These data imply that Rab32 is linked to SNX6/retromer trafficking at the Golgi, and also suggests a possible connection between the retromer and Rab32 in the trafficking and biological functions of LRRK2.	[Waschbuesch, Dieter; Huebel, Nicole; Ossendorf, Edith; Barnekow, Angelika] Westfalische Wilhelms Univ Muenster, Dept Expt Tumorbiol, Munster, Germany; [Waschbuesch, Dieter; Khan, Amir R.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Lobbestael, Evy; Baekelandt, Veerle] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Leuven, Belgium; [Lindsay, Andrew J.; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Sch Biochem & Cell Biol, Cork, Ireland	Trinity College Dublin; KU Leuven; University College Cork	Barnekow, A (corresponding author), Westfalische Wilhelms Univ Muenster, Dept Expt Tumorbiol, Munster, Germany.; Khan, AR (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	Amir.Khan@tcd.ie; barneko@uni-muenster.de	Baekelandt, Veerle/ABB-9736-2020; Lindsay, Andrew J/P-9778-2017; Lobbestael, Evy/H-7537-2018	Baekelandt, Veerle/0000-0001-8966-2921; Lindsay, Andrew J/0000-0001-9693-7022; Lobbestael, Evy/0000-0002-6417-4670; Waschbusch, Dieter/0000-0002-8953-2585; Khan, Amir/0000-0003-1176-6952	Science Foundation Ireland [12/IA/1239]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland grant no. 12/IA/1239 to ARK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bultema Jarred J, 2013, Small GTPases, V4, P16, DOI 10.4161/sgtp.22349; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Gao YJ, 2018, MOVEMENT DISORD, V33, P196, DOI 10.1002/mds.27270; Gustavsson E, 2017, INTERNATIONAL CONGRE; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Kail Mark, 2008, V440, P111, DOI 10.1007/978-1-59745-178-9_9; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; McMillan KJ, 2017, CURR OPIN CELL BIOL, V47, P72, DOI 10.1016/j.ceb.2017.02.004; Mir R, 2018, BIOCHEM J, V475, P1861, DOI 10.1042/BCJ20180248; Ortiz-Sandoval C. G., 2014, CELL LOGIST, P2799, DOI [10.4161/21592799.2014.986399, DOI 10.4161/21592799.2014.986399]; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Purlyte E., 2017, EMBO J; Reyniers L, 2014, J NEUROCHEM, V131, P239, DOI 10.1111/jnc.12798; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Simonetti B, 2017, J CELL BIOL, V216, P3695, DOI 10.1083/jcb.201703015; Solano-Collado Virtu, 2018, Small GTPases, V9, P216, DOI 10.1080/21541248.2016.1219207; Spano S, 2014, CELL MICROBIOL, V16, P1321, DOI 10.1111/cmi.12327; Steger M, 2017, ELIFE, V6, DOI 10.7554/eLife.31012; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; SU GF, 1992, INFECT IMMUN, V60, P3345, DOI 10.1128/IAI.60.8.3345-3359.1992; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; Wang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096242; Waschbusch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111632; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Weide T, 2003, BIOCHEM BIOPH RES CO, V306, P79, DOI 10.1016/S0006-291X(03)00918-5; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	34	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208889	10.1371/journal.pone.0208889	http://dx.doi.org/10.1371/journal.pone.0208889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640902	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000008
J	Matthews, TE; Witek, MAG; Heggli, OA; Penhune, VB; Vuust, P				Matthews, Tomas E.; Witek, Maria A. G.; Heggli, Ole A.; Penhune, Virginia B.; Vuust, Peter			The sensation of groove is affected by the interaction of rhythmic and harmonic complexity	PLOS ONE			English	Article							MUSIC; ENTRAINMENT; PERCEPTION; MOVEMENT; INDUCE; CHORDS	The pleasurable desire to move to music, also known as groove, is modulated by rhythmic complexity. How the sensation of groove is influenced by other musical features, such as the harmonic complexity of individual chords, is less clear. To address this, we asked people with a range of musical experience to rate stimuli that varied in both rhythmic and harmonic complexity. Rhythm showed an inverted U-shaped relationship with ratings of pleasure and wanting to move, whereas medium and low complexity chords were rated similarly. Pleasure mediated the effect of harmony on wanting to move and high complexity chords attenuated the effect of rhythm on pleasure. We suggest that while rhythmic complexity is the primary driver, harmony, by altering emotional valence, modulates the attentional and temporal prediction processes that underlie rhythm perception. Investigation of the effects of musical training with both regression and group comparison showed that training increased the inverted U effect for harmony and rhythm, respectively. Taken together, this work provides important new information about how the prediction and entrainment processes involved in rhythm perception interact with musical pleasure.	[Matthews, Tomas E.; Penhune, Virginia B.] Concordia Univ, Lab Motor Learning & Neural Plast, Montreal, PQ, Canada; [Witek, Maria A. G.; Heggli, Ole A.; Vuust, Peter] Aarhus Univ, Ctr Mus Brain, Aarhus, Denmark; [Witek, Maria A. G.; Heggli, Ole A.; Vuust, Peter] Royal Acad Mus, Aarhus, Denmark; [Witek, Maria A. G.] Univ Birmingham, Dept Mus, Birmingham, W Midlands, England	Concordia University - Canada; Aarhus University; University of Birmingham	Matthews, TE (corresponding author), Concordia Univ, Lab Motor Learning & Neural Plast, Montreal, PQ, Canada.	tomas_ma@live.concordia.ca		Matthews, Tomas/0000-0003-4538-0898; Witek, Maria/0000-0002-4369-4570; Heggli, Ole Adrian/0000-0002-7461-0309	Fonds de Recherche du Quebec - Nature et technologies; Erasmus Mundus Student Exchange Network in Auditory Cognitive Neuroscience; Natural Sciences and Engineering Research Council of Canada (NSERC) [2015-04225]; Danish National Research Foundation [DNRF 117]	Fonds de Recherche du Quebec - Nature et technologies; Erasmus Mundus Student Exchange Network in Auditory Cognitive Neuroscience; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Danish National Research Foundation(Danmarks Grundforskningsfond)	TM was supported by Fonds de Recherche du Quebec - Nature et technologies [http://www.frqnt.gouv.qc.ca/en/accueil] and Erasmus Mundus Student Exchange Network in Auditory Cognitive Neuroscience [http://research.uni-leipzig.de/acn/]. VBP was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; 2015-04225) [http://www.nserc-crsng.gc.ca/index_eng.asp]. Center for Music in the Brain is funded by the Danish National Research Foundation (DNRF 117)[https://dg.dk/en/]. The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri V., 2015, PSYCHOMUSICOLOGY MUS, V25, P443, DOI [10.1037/pmu0000124, DOI 10.1037/PMU0000124]; Alluri V, 2017, HUM BRAIN MAPP, V38, P2955, DOI 10.1002/hbm.23565; Arthurs Y, 2017, PSYCHOL MUSIC, V26, P1; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Burger B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00183; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Christensen R.H.B., 2015, REGRESSION MODELS OR, P1; Daly HR, 2018, BRAIN, V28, P117, DOI DOI 10.1037/pmu0000213; Danielsen A., 2006, FUNK GROOVES J BROWN; Doelling KB, 2015, P NATL ACAD SCI USA, P1; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Freeman B., 1989, ARRANGING 2 WORKBOOK; Greenwald J, 2002, BLACK MUSIC RES J, V22, P259, DOI 10.2307/1519959; Hurley BK, 2014, J EXP PSYCHOL HUMAN, V40, P1679, DOI 10.1037/a0037154; HURON D, 1994, MUSIC PERCEPT, V11, P289; Huron David, 2006, SWEET ANTICIPATION M; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; Keller Peter E, 2011, Adv Cogn Psychol, V7, P142, DOI 10.2478/v10053-008-0094-0; Kizach J., 2014, POSTER PRESENT LINGU; Komeilipoor N, 2015, EXP BRAIN RES, V233, P1585, DOI 10.1007/s00221-015-4233-9; Labbe C, 2014, MUSIC PERCEPT, V32, P170, DOI 10.1525/MP.2014.32.2.170; Lahdelma I, 2016, I-PERCEPTION, V7, DOI 10.1177/2041669516655812; Lahdelma I, 2016, PSYCHOL MUSIC, V44, P37, DOI 10.1177/0305735614552006; Large E. W., 1994, Connection Science, V6, P177, DOI 10.1080/09540099408915723; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lartillot O, 2008, ST CLASS DAT ANAL, P261, DOI 10.1007/978-3-540-78246-9_31; Lenth R, 2018, PACKAGE EMMEANS, V34; Levine M., 2011, THE JAZZ THEORY BOOK; London J., 2012, HEARING IN TIME; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; Madison G, 2009, P SMC 2009 6 SOUND M, P239; Madison G, 2006, MUSIC PERCEPT, V24, P201, DOI 10.1525/mp.2006.24.2.201; Madison G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00894; Madison G, 2011, J EXP PSYCHOL HUMAN, V37, P1578, DOI 10.1037/a0024323; Meyer L., 1956, EMOTION MEANING MUSI; Morillon B, 2017, P NATL ACAD SCI USA, V114, pE8913, DOI 10.1073/pnas.1705373114; Nettles B, 1987, HARMONY, V1-4, P33; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Orr MG, 2005, MUSIC PERCEPT, V22, P583, DOI 10.1525/mp.2005.22.4.583; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Pressing J, 2002, MUSIC PERCEPT, V19, P285, DOI 10.1525/mp.2002.19.3.285; Putkinen V, 2017, SOC COGN AFFECT NEUR, V12, P1159, DOI 10.1093/scan/nsx038; Salimpoor VN, 2014, TRENDS COGN SCI, P1; Senn O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199604; Sethares WA, 2004, TUNING TIMBRE SPECTR, P1, DOI DOI 10.1007/978-1-4471-4177-8; Stupacher J, 2016, MUSIC PERCEPT, V33, P571, DOI 10.1525/MP.2016.33.5.571; Stupacher J, 2013, BRAIN COGNITION, V82, P127, DOI 10.1016/j.bandc.2013.03.003; Tingley D, 2014, J STAT SOFTW, V59; Trost WJ, 2017, NEUROPSYCHOLOGIA, V96, P96, DOI 10.1016/j.neuropsychologia.2017.01.004; Trost W, 2014, NEUROIMAGE, V103, P55, DOI 10.1016/j.neuroimage.2014.09.009; Vuust P, 2018, ANN NY ACAD SCI, P1; Vuust P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01111; Vuust P, 2009, CORTEX, V45, P80, DOI 10.1016/j.cortex.2008.05.014; Witek MAG, 2009, P 7 TRIENN C EUR SOC, P573; Witek MAG, 2017, MUSIC ANAL, V36, P138, DOI 10.1111/musa.12082; Witek MAG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094446	65	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0204539	10.1371/journal.pone.0204539	http://dx.doi.org/10.1371/journal.pone.0204539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629596	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000005
J	Monsey, L; Best, LG; Zhu, JH; DeCroo, S; Anderson, MZ				Monsey, Laine; Best, Lyle G.; Zhu, Jianhui; DeCroo, Susan; Anderson, Matthew Z.			The association of mannose binding lectin genotype and immune response to Chlamydia pneumoniae: The Strong Heart Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIOVASCULAR-DISEASE; PROTEIN-LEVELS; RISK-FACTOR; AMERICAN-INDIANS; SERUM-LEVELS; MBL2; GENE; POLYMORPHISMS	Cardiovascular disease (CVD) is an important contributor to morbidity and mortality in American Indian communities. The Strong Heart Study (SHS) was initiated in response to the need for population based estimates of cardiovascular disease in American Indians. Previous studies within SHS have identified correlations between heart disease and deficiencies in mannose binding lectin (MBL), a motif recognition molecule of the innate immune system. MBL mediates the immune response to invading pathogens including Chlamydia pneumoniae (Cp), which has also been associated with the development and progression of CVD. However, a link between MBL2 genotype and Cp in contributing to heart disease has not been established. To address this, SHS collected baseline Cp antibody titers (IgA and IgG) and MBL2 genotypes for common functional variants from 553 individuals among twelve participating tribes. A single nucleotide polymorphism (SNP) in the promoter, designated X/Y, correlated significantly with increased Cp IgG titer levels, whereas another promoter SNP (H/L) did not significantly influence antibody levels to Cp. Two variants within exon 1 of MBL2, the A and B alleles, also displayed significant association with Cp antibody titers. Some MBL2 genotypes were absent from the population, suggesting linkage disequilibrium may be operating within the SHS cohort. Additional factors, such as increasing age and socioeconomic status, were also associated with increased Cp IgG antibody titers. This study demonstrates that MBL2 genotype associates with immune reactivity to C. pneumoniae in the SHS cohort. Thus, MBL2 may contribute to the progression of cardiovascular disease (CVD) among American Indians indirectly through pathogen interactions in addition to its previously defined roles.	[Monsey, Laine; Anderson, Matthew Z.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Best, Lyle G.] Missouri Breaks Ind Res Inc, Timber Lakes, SD USA; [Zhu, Jianhui; DeCroo, Susan] Medstar Res Inst, Washington, DC USA; [Anderson, Matthew Z.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Anderson, MZ (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.; Anderson, MZ (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	anderson.3196@osu.edu	Anderson, Matthew/R-4842-2019	Anderson, Matthew/0000-0003-1683-2170	National Heart, Lung, and Blood Institute, Bethesda, MD [U01-HL65520, U01-HL41642, U01-HL41652, U01-HL41654, U01-HL65521, R01HL62233]; ASC Undergraduate Research Scholarship from The Ohio State University; Missouri Breaks Industries Research, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109319] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ASC Undergraduate Research Scholarship from The Ohio State University; Missouri Breaks Industries Research, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by cooperative agreement grants U01-HL65520, U01-HL41642, U01-HL41652, U01-HL41654, U01-HL65521, and R01HL62233 from the National Heart, Lung, and Blood Institute, Bethesda, MD (https://www.nhlbi.nih.gov/).LM was supported by an ASC Undergraduate Research Scholarship from The Ohio State University (https://aschonors.osu.edu/opportunities/scholarships/undergrad). Missouri Breaks Industries Research, Inc, provided support in the form of salaries for author LGB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Asner SA, 2014, CLIN MICROBIOL INFEC, V20, P1246, DOI 10.1111/1469-0691.12806; Assar Omid, 2015, Glob J Health Sci, V8, P260, DOI 10.5539/gjhs.v8n4p260; Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P134, DOI 10.1016/S1081-1206(10)62586-0; Bernig T, 2005, HUM GENET, V118, P404, DOI 10.1007/s00439-005-0053-5; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Best LG, 2004, CIRCULATION, V109, P471, DOI 10.1161/01.CIR.0000109757.95461.10; Blasi F., 1998, Clin Microbiol Infect, V4 Suppl 4, pS1; Branden E, 2005, RESP MED, V99, P20, DOI 10.1016/j.rmed.2004.04.014; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Crosdale DJ, 2000, EUR J IMMUNOGENET, V27, P111, DOI 10.1046/j.1365-2370.2000.00211.x; de Waure C, 2013, AM J PREV MED, V45, P207, DOI 10.1016/j.amepre.2013.03.020; Fong IW, 2009, CURR CARDIOL REV, V5, P87, DOI 10.2174/157340309788166679; Fong IW, 1999, INFECT IMMUN, V67, P6048, DOI 10.1128/IAI.67.11.6048-6055.1999; Fong IW, 2002, J INFECT DIS, V186, P1469, DOI 10.1086/344730; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; Hegele RA, 1999, CLIN CHEM, V45, P1283; Heron Melonie, 2016, NCHS Data Brief, P1; Jakab L, 2007, CLIN IMMUNOL, V125, P230, DOI 10.1016/j.clim.2007.08.020; Keller TT, 2006, ARTERIOSCL THROM VAS, V26, P2345, DOI 10.1161/01.ATV.0000240517.69201.77; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Lee SG, 2005, MOL IMMUNOL, V42, P969, DOI 10.1016/j.molimm.2004.09.036; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Madsen HO, 1998, LANCET, V352, P959, DOI 10.1016/S0140-6736(05)61513-9; Moazed TC, 1999, J INFECT DIS, V180, P238, DOI 10.1086/314855; Nagy A, 2003, J ALLERGY CLIN IMMUN, V112, P729, DOI 10.1016/S0091-6749(03)02010-4; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paldanius M, 2005, CLIN DIAGN LAB IMMUN, V12, P654, DOI 10.1128/CDLI.12.5.654-659.2005; Pesonen E, 2009, ANN MED, V41, P591, DOI 10.1080/07853890903110994; Phoon MC, 2001, CELL BIOL INT, V25, P777, DOI 10.1006/cbir.2001.0733; Rantala A, 2011, INNATE IMMUN-LONDON, V17, P35, DOI 10.1177/1753425909349759; Rugonfalvi-Kiss S, 2002, CIRCULATION, V106, P1071, DOI 10.1161/01.CIR.0000027137.96791.6A; Sasaki K, 2000, SCAND J GASTROENTERO, V35, P960, DOI 10.1080/003655200750023039; Speletas M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/478412; Stevenson HL, 2013, TRANSPL IMMUNOL, V28, P73, DOI 10.1016/j.trim.2013.02.002; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Su CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32147; Triant VA, 2013, CURR HIV-AIDS REP, V10, P199, DOI 10.1007/s11904-013-0168-6; Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744; Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x	46	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210640	10.1371/journal.pone.0210640	http://dx.doi.org/10.1371/journal.pone.0210640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629683	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000118
J	Gouraguine, A; Moranta, J; Ruiz-Frau, A; Hinz, H; Renones, O; Ferse, SCA; Jompa, J; Smith, DJ				Gouraguine, Adam; Moranta, Joan; Ruiz-Frau, Ana; Hinz, Hilmar; Renones, Olga; Ferse, Sebastian C. A.; Jompa, Jamaluddin; Smith, David J.			Citizen science in data and resource-limited areas: A tool to detect long-term ecosystem changes	PLOS ONE			English	Article							VOLUNTEER TOURISM; TEMPORAL PATTERNS; FISH ASSEMBLAGE; REEF FISH; CORAL; CONSERVATION; MANAGEMENT	Coral reefs are threatened by numerous global and local stressors. In the face of predicted large-scale coral degradation over the coming decades, the importance of long-term monitoring of stress-induced ecosystem changes has been widely recognised. In areas where sustained funding is unavailable, citizen science monitoring has the potential to be a powerful alternative to conventional monitoring programmes. In this study we used data collected by volunteers in Southeast Sulawesi (Indonesia), to demonstrate the potential of marine citizen science programmes to provide scientifically sound information necessary for detecting ecosystem changes in areas where no alternative data are available. Data were collected annually between 2002 and 2012 and consisted of percent benthic biotic and abiotic cover and fish counts. Analyses revealed long-term coral reef ecosystem change. We observed a continuous decline of hard coral, which in turn had a significant effect on the associated fishes, at community, family and species levels. We provide evidence of the importance of marine citizen science programmes in detecting long-term ecosystem change as an effective way of delivering conservation data to local government and national agencies. This is particularly true for areas where funding for monitoring is unavailable, resulting in an absence of ecological data. For citizen science data to contribute to ecological monitoring and local decision-making, the data collection protocols need to adhere to sound scientific standards, and protocols for data evaluation need to be available to local stakeholders. Here, we describe the monitoring design, data treatment and statistical analyses to be used as potential guidelines in future marine citizen science projects.	[Gouraguine, Adam; Smith, David J.] Univ Essex, Sch Biol Sci, Colchester, Essex, England; [Moranta, Joan; Renones, Olga] Ctr Oceanog Balears Ecosyst Oceanog Grp GECO, IEO, Moll De Ponent Sn, Palma, Spain; [Ruiz-Frau, Ana; Hinz, Hilmar] UIB, CSIC, Inst Mediterraneo Estudios Avanzados IMEDEA, Dept Ecol & Marine Resources, Esporles, Spain; [Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Res ZMT, Ecol Dept, Bremen, Germany; [Ferse, Sebastian C. A.] Univ Bremen, Fac Biol & Chem FB2, Bremen, Germany; [Jompa, Jamaluddin] Hasanuddin Univ, Ctr Coral Reef Res, Makassar, Indonesia	University of Essex; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; Universitas Hasanuddin	Gouraguine, A (corresponding author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.	adamgouraguine@gmail.com	Jompa, Jamaluddin/AAD-9280-2021; Hinz, Hilmar/AAH-7148-2019; Ruiz-Frau, Ana/O-5063-2019; Moranta, Joan/B-5522-2008; Ferse, Sebastian/AAH-8048-2021	Jompa, Jamaluddin/0000-0001-9740-333X; Hinz, Hilmar/0000-0003-4909-0089; Ruiz-Frau, Ana/0000-0002-1317-2827; Moranta, Joan/0000-0002-9814-0735; Ferse, Sebastian/0000-0003-0930-5356; Gouraguine, Adam/0000-0001-8670-2676				Anderson LG, 2017, MANAG BIOL INVASION, V8, P589, DOI 10.3391/mbi.2017.8.4.14; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Brooks M. E., 2017, BIORXIV; Burke L, 2012, REEFS RISK REVISITED; Burke Lauretta, 2011, REEFS AT RISK; Callanan M., 2005, NICHE TOURISM CONT I, P183; CHABANET P, 1995, HYDROBIOLOGIA, V300, P299, DOI 10.1007/BF00024470; Clifton J, 2010, ENVIRON SCI ENG TECH, P1; COLTON DE, 1981, ENVIRON BIOL FISH, V6, P341, DOI 10.1007/BF00005762; Connolly J, 2013, J ECOL, V101, P344, DOI 10.1111/1365-2745.12052; Dickinson JL, 2010, ANN REV ECOL EVOL SY; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; English S., 1997, SURVEY MANUAL TROPIC; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P39, DOI 10.3354/meps064039; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gray NJ, 2017, TOUR RECREAT RES, V42, P199, DOI 10.1080/02508281.2017.1300398; Guttentag DA, 2009, INT J TOUR RES, V11, P537, DOI 10.1002/jtr.727; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Hart AM, 1996, MAR ECOL PROG SER, V136, P25, DOI 10.3354/meps136025; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Johnson MF, 2014, GLOBAL ENVIRON CHANG, V29, P235, DOI 10.1016/j.gloenvcha.2014.10.006; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Krone R, 2008, CORAL REEFS, V27, P619, DOI 10.1007/s00338-008-0365-8; Lyons K, 2012, ANN TOURISM RES, V39, P361, DOI 10.1016/j.annals.2011.04.016; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; McGehee NG, 2014, J SUSTAIN TOUR, V22, P847, DOI 10.1080/09669582.2014.907299; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; Mieszkowska N., 2014, PHIL T R SOC A, V372, P1; Pecl G.T., 2017, SCIENCE, P355; Pocock MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172579; R Core Team, 2017, R FOUND STAT COMP; ROBERTS CM, 1992, J BIOGEOGR, V19, P239, DOI 10.2307/2845449; Russell BC, 1990, FAO FISH SYNOPSIS, V12; Sano M, 2004, FISHERIES SCI, V70, P41, DOI 10.1111/j.1444-2906.2003.00768.x; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Sweatman H, 2008, LONG TERM MONITORING; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021	43	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210007	10.1371/journal.pone.0210007	http://dx.doi.org/10.1371/journal.pone.0210007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625207	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400070
J	Lobo, AS; de Assis, MAA; Leal, DB; Borgatto, AF; Vieira, FK; Di Pietro, PF; Kupek, E				Lobo, Adriana Soares; Altenburg de Assis, Maria Alice; Leal, Danielle Biazzi; Borgatto, Adriano Ferreti; Vieira, Francilene Kunradi; Di Pietro, Patricia Faria; Kupek, Emil			Empirically derived dietary patterns through latent profile analysis among Brazilian children and adolescents from Southern Brazil, 2013-2015	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EUROPEAN CHILDREN; SCHOOLCHILDREN; OBESITY; CHILDHOOD; OVERWEIGHT; QUESTIONNAIRE; FLORIANOPOLIS; VALIDATION; ADIPOSITY	The aims of this study were to identify dietary patterns (DPs) of children and adolescents participating in three cross-sectional surveys (2013-2015) and to test their associations with sociodemographic variables, physical activity (PAS), screen-based sedentary activity (SA), and weight status. One-day data were obtained from 5,364 schoolchildren (7-12 years) from public schools of Florianopolis (South of Brazil), using the validated questionnaire Web-CAAFE (Food Intake and Physical Activity of Schoolchildren). DPs were derived from the frequency of daily consumption of 32 foods/beverages by latent profile analysis. Multinomial logistic regression analysis was used to estimate the association of the DPs with sociodemographic variables, physical activity, screen activity and weight status. 'Traditional', 'Monotonous', and 'Mixed' DPs were identified. The percentages of children and adolescents within these profiles were 41.3, 36.3, and 22.4%, respectively. Children and adolescents in the highest tertiles of both PAS and daily frequency of SA had a higher probability to present a 'Mixed' DP compared to peers with less PAS and SA. Children and adolescents who reported having a school meal were significantly more likely to present the 'Traditional'DP, while boys who did not report having a school meal had a higher probability to present the 'Monotonous' DP. The DPs were not associated with the year of survey, age, family income, or weight status.	[Lobo, Adriana Soares; Altenburg de Assis, Maria Alice; Leal, Danielle Biazzi; Vieira, Francilene Kunradi; Di Pietro, Patricia Faria] Univ Fed Santa Catarina, Ctr Hlth Sci, Postgrad Program Nutr, Florianopolis, SC, Brazil; [Altenburg de Assis, Maria Alice; Leal, Danielle Biazzi; Borgatto, Adriano Ferreti] Univ Fed Santa Catarina, Sports Ctr, Postgrad Program Phys Educ, Florianopolis, SC, Brazil; [Borgatto, Adriano Ferreti] Univ Fed Santa Catarina, Technol Ctr, Dept Informat & Stat, Florianopolis, SC, Brazil; [Kupek, Emil] Univ Fed Santa Catarina, Ctr Hlth Sci, Dept Publ Hlth, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Lobo, AS (corresponding author), Univ Fed Santa Catarina, Ctr Hlth Sci, Postgrad Program Nutr, Florianopolis, SC, Brazil.	adri_lobo@outlook.com	Borgatto, Adriano/AAF-9796-2021; Di Pietro, Patricia F/G-6101-2015; de Assis, Maria Alice A/B-8125-2009; Assis, Maria Alice A/L-8489-2015	de Assis, Maria Alice A/0000-0002-5383-3714; Assis, Maria Alice A/0000-0002-5383-3714	Brazilian Ministry of Health (Departamento de Ciencia, Tecnologia e Insumos Estrategicos-DECIT); Brazilian National Council for Scientific and Technological Development - CNPq [300436/2010-6, 305148/2011-7, 308352/2016-5]; Santa Catarina State Research Foundation (FAPESC); Brazilian Federal Agency for the Improvement of Higher Education (CAPES)	Brazilian Ministry of Health (Departamento de Ciencia, Tecnologia e Insumos Estrategicos-DECIT); Brazilian National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Santa Catarina State Research Foundation (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Brazilian Federal Agency for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Brazilian Ministry of Health (Departamento de Ciencia, Tecnologia e Insumos Estrategicos-DECIT); Brazilian National Council for Scientific and Technological Development - CNPq (E. K., grant 300436/2010-6), (M.A.A.A., grant 305148/2011-7 and 308352/2016-5). AS Lobo and DB Leal received a fellowship from the Santa Catarina State Research Foundation (FAPESC) and the Brazilian Federal Agency for the Improvement of Higher Education, respectively (CAPES). The study funders had no role in the design, analysis or writing of this article.	Ambrosini GL, 2014, OBESITY, V22, P458, DOI 10.1002/oby.20542; Ambrosini GL, 2009, PUBLIC HEALTH NUTR, V12, P1807, DOI 10.1017/S1368980008004618; Baranowski T, 2002, J AM DIET ASSOC, V102, P380, DOI 10.1016/S0002-8223(02)90088-X; Baxter SD, 2009, EUR J CLIN NUTR, V63, pS19, DOI 10.1038/ejcn.2008.61; BEATON GH, 1994, AM J CLIN NUTR, V59, p253S, DOI 10.1093/ajcn/59.1.253S; Borges CA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010057; Borges CA, 2018, APPETITE, V123, P402, DOI 10.1016/j.appet.2018.01.001; Brasil Ministerio da Saude, 2014, GUIA ALIMENTAR POPUL; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; da Costa FF, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2646; da Costa FF, 2012, REV SAUDE PUBL, V46, P117, DOI 10.1590/S0034-89102012005000058; Davies VF, 2015, J HUM NUTR DIET, V28, P93, DOI 10.1111/jhn.12262; de Carvalho CA, 2016, CIENC SAUDE COLETIVA, V21, P143, DOI 10.1590/1413-81232015211.18962014; de Jesus GM, 2016, REV BRAS MED ESPORTE, V22, P261, DOI 10.1590/1517-869220162204157067; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; Diep CS, 2015, J ACAD NUTR DIET, V115, P1591, DOI 10.1016/j.jand.2015.02.021; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Fernandez-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78; Gama SR, 2007, CAD SAUDE PUBLICA, V23, P2239, DOI 10.1590/S0102-311X2007000900032; Gatica G, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-43; Gibson RS, 2017, ADV NUTR, V8, P980, DOI 10.3945/an.117.016980; Instituto Brasileiro de Geografia e Estatistica, 2011, BAS INF CENS DEM 201; Instituto Brasileiro de Geografia e Estatistica, 2016, PESQ NAC SAUD ESC PE; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM ANTR ES; Kupek E, 2016, BRIT J NUTR, V116, P1954, DOI 10.1017/S0007114516004128; Kupek E, 2016, PUBLIC HEALTH NUTR, V19, P2347, DOI 10.1017/S1368980016000732; Leal DB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101098; Leal DB, 2014, ANN HUM BIOL, V41, P255, DOI 10.3109/03014460.2013.854832; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Lobstein T, 2015, LANCET, V385, P2510, DOI 10.1016/S0140-6736(14)61746-3; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P267, DOI 10.1590/1809-4503201400050021; Massarani FA, 2015, CAD SAUDE PUBLICA, V31, P2535, DOI 10.1590/0102-311X00090314; McCarthy S, 2014, PHYSIOL BEHAV, V134, P55, DOI 10.1016/j.physbeh.2014.02.046; Mikkila V, 2015, Int J Obes Suppl, V5, pS17, DOI 10.1038/ijosup.2015.14; Ministerio da Saude, 2008, GUIA ALIMENTAR PARA; Ministerio da Saude (BR), 2011, PLAN AC ESTR ENFR DO; Motter AF, 2015, CAD SAUDE PUBLICA, V31, P620, DOI 10.1590/0102-311X00097814; Nascimento Sileia, 2011, Nutr J, V10, P79, DOI 10.1186/1475-2891-10-79; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Nielsen SB, 2008, ARCH DIS CHILD, V93, P971, DOI [10.1136/adc.2007.136119, 10.1136/adc.2007.134486]; Nobre LN, 2012, J PEDIAT-BRAZIL, V88, P129, DOI 10.2223/JPED.2169; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Oberski D, 2016, HUM-COMPUT INT-SPRIN, P275, DOI 10.1007/978-3-319-26633-6_12; Ocke MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013; Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145; Patterson BH, 2002, J AM STAT ASSOC, V97, P721, DOI 10.1198/016214502388618465; Pereira S, 2015, NUTRIENTS, V7, P4345, DOI 10.3390/nu7064345; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Silva RDR, 2012, REV NUTR, V25, P451, DOI 10.1590/S1415-52732012000400003; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Rodrigues Paulo Rogério Melo, 2012, Rev. bras. epidemiol., V15, P662, DOI 10.1590/S1415-790X2012000300019; Rothausen BW, 2013, BRIT J NUTR, V109, P1704, DOI 10.1017/S0007114512003662; Schneider BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149299; Song Y, 2010, INT J OBESITY, V34, P48, DOI 10.1038/ijo.2009.203; Svensson A, 2014, EUR J CLIN NUTR, V68, P822, DOI 10.1038/ejcn.2014.87; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P2679, DOI 10.1590/0102-311X00016814; Thompson FE, 2015, J ACAD NUTR DIET, V115, P1986, DOI 10.1016/j.jand.2015.08.016; Unidas para o Desenvolvimento, ATL DES HUM BRAS 201; Villa Julia Khéde Dourado, 2015, Rev. paul. pediatr., V33, P302, DOI 10.1016/j.rpped.2015.05.001; Wijnhoven TMA, 2015, PUBLIC HEALTH NUTR, V18, P3108, DOI 10.1017/S1368980015001937; World Health Organization, 2013, GLOB ACT PLAN PREV C	64	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210425	10.1371/journal.pone.0210425	http://dx.doi.org/10.1371/journal.pone.0210425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620755	Green Published, gold, Green Submitted			2022-12-26	WOS:000455161300033
J	Vongthilath, R; Thiriez, BR; Dehillotte, C; Lemonnier, L; Guillien, A; Degano, B; Dalphin, ML; Dalphin, JC; Plesiat, P				Vongthilath, Rechana; Thiriez, Benedicte Richaud; Dehillotte, Clemence; Lemonnier, Lydie; Guillien, Alicia; Degano, Bruno; Dalphin, Marie-Laure; Dalphin, Jean-Charles; Plesiat, Patrick			Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry	PLOS ONE			English	Article							RISK-FACTORS; STENOTROPHOMONAS-MALTOPHILIA; INFECTION; DISEASE; ASPERGILLUS; ADOLESCENTS; CHILDREN; DECLINE	Pseudomonas aeruginosa is the main cause of chronic airway infection in cystic fibrosis (CF). However, for unclear reasons some patients are never colonized by P. aeruginosa. The objectives of this study were to better define the clinical, genetic, and microbiological characteristics of such a subpopulation and to identify predictive factors of non-colonization with P. aeruginosa. The French CF patient registry 2013-2014 was used to identify CF patients aged >= 20 years. The clinical outcomes, CF Transmembrane conductance Regulator (CFTR) genotypes, and microbiological data of patients reported positive at least once for P. aeruginosa ("Pyo" group, n = 1,827) were compared to those of patients with no history of P. aeruginosa isolation ("Never" group, n = 303). Predictive factors of non-colonization by P. aeruginosa were identified by multivariate logistic regression model with backward selection. Absence of aspergillosis (odds ratio (OR) [95% CI] = 1.64 [1.01-2.66]), absence of diabetes (2.25 [1.21-4.18]), pancreatic sufficiency (1.81 [1.30-2.52]), forced expiratory volume 1 (FEV1) >= 80% (3.03 [2.28-4.03]), older age at CF diagnosis (1.03 [1.02-1.04]), and absence of F508del/F508del genotype (2.17 [1.48-3.19]) were predictive clinical factors associated with absence of infection ("Never" group). Microbiologically, this same group was associated with more frequent detection of Haemophilus influenzae and lower rates of Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Aspergillus spp. (all p<0.01) in sputum. This study strongly suggests that the absence of pulmonary colonization by P. aeruginosa in a minority of CF adults (14.2%) is associated with a milder form of the disease. Recent progress in the development of drugs to correct CFTR deficiency thus may be decisive in the control of P. aeruginosa lung infection.	[Vongthilath, Rechana; Thiriez, Benedicte Richaud; Dalphin, Jean-Charles] Univ Hosp Jean Minjoz, Dept Resp Med, Besancon, France; [Dehillotte, Clemence; Lemonnier, Lydie] Med Dept Vaincre La Mucoviscidose, Paris, France; [Guillien, Alicia; Degano, Bruno] Univ Hosp Jean Minjoz, Dept Physiol, Besancon, France; [Degano, Bruno] Univ Franche Comte, EA3920, Besancon, France; [Dalphin, Marie-Laure] Univ Hosp Jean Minjoz, Dept Pediat Med, Besancon, France; [Dalphin, Jean-Charles; Plesiat, Patrick] Univ Franche Comte, Chronoenvironm, CNRS, UMR 6249, Besancon, France; [Plesiat, Patrick] Univ Hosp Jean Minjoz, Dept Bacteriol, Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Plesiat, P (corresponding author), Univ Hosp Jean Minjoz, Dept Bacteriol, Besancon, France.	patrick.plesiat@univ-fcomte.fr	Guillien, Alicia/T-5982-2019	Guillien, Alicia/0000-0003-0586-3449; Degano, Bruno/0000-0003-1644-7264				Baxter CG, 2013, THORAX, V68, P652, DOI 10.1136/thoraxjnl-2012-202412; Bendiak GN, 2009, SEMIN RESP CRIT CARE, V30, P587, DOI 10.1055/s-0029-1238917; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Gaspar MC, 2013, EUR J CLIN MICROBIOL, V32, P1231, DOI 10.1007/s10096-013-1876-y; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; Hector A, 2016, J CYST FIBROS, V15, P340, DOI 10.1016/j.jcf.2016.01.004; Hussain R, 2015, EXP LUNG RES, V41, P383, DOI 10.3109/01902148.2015.1046199; Jennings MT, 2017, ANN AM THORAC SOC, V14, P1662, DOI 10.1513/AnnalsATS.201701-058OC; KEREM E, 1990, PEDIATR INFECT DIS J, V9, P494, DOI 10.1097/00006454-199007000-00008; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; KUBESCH P, 1993, LANCET, V341, P189, DOI 10.1016/0140-6736(93)90062-L; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Mohan K, 2008, RESPIRATION, V76, P181, DOI 10.1159/000110206; MucoMicrobes Cystic Fibrosis Consensus Group, 2014, SOC FRANC MICR; Nick JA, 2010, AM J RESP CRIT CARE, V182, P614, DOI 10.1164/rccm.201001-0092OC; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Ritz N, 2005, EUR J PEDIATR, V164, P577, DOI 10.1007/s00431-005-1701-4; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; Spicuzza L, 2009, EUR J CLIN MICROBIOL, V28, P191, DOI 10.1007/s10096-008-0605-4; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC; ZAR H, 1995, J PEDIATR-US, V126, P230, DOI 10.1016/S0022-3476(95)70549-X	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210201	10.1371/journal.pone.0210201	http://dx.doi.org/10.1371/journal.pone.0210201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620748	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300019
J	Chen, MS; Xu, R; Rai, A; Suwakulsiri, W; Izumikawa, K; Ishikawa, H; Greening, DW; Takahashi, N; Simpson, RJ				Chen, Maoshan; Xu, Rong; Rai, Alin; Suwakulsiri, Wittaya; Izumikawa, Keiichi; Ishikawa, Hideaki; Greening, David W.; Takahashi, Nobuhiro; Simpson, Richard J.			Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; PROTEOMIC INSIGHTS; CELL-LINES; METASTASIS; MIRNAS; BIOMARKERS; LIM1863; GROWTH; SERUM; PROFILES	Extracellular vesicle (EV) microRNAs are of major interest as potential diagnostic biomarkers in all cancer types. This study aims to identify miRNA profiles of shed microvesicles (sMVs) and exosomes (Exos) secreted from the isogenic colorectal cancer (CRC) cell lines SW480 and SW620 and evaluate their ability to predict CRC. Deep sequencing of miRNAs in parental cell lysates (CLs) and highly-purified sMVs and Exos was performed. We focused on miRNAs enriched in EVs and dysregulated miRNAs in metastatic cells (SW620) relative to primary cancer cells (SW480). We investigated the ability of EV miRNA signatures to predict CRC tumours using 594 tumours (representing different pathological stages) and 11 normal samples obtained from TCGA. In SW480 and SW620 cells we identified 345 miRNAs, of which 61 and 73 were upregulated and downregulated in SW620-CLs compared to SW480-CLs, respectively. Selective distribution of cellular miRNAs into EVs results in distinct miRNA signatures for sMVs and Exos in each cell line. Cross cell line comparisons of EV miRNA profiles reveal a subset of miRNAs critical in CRC progression from primary carcinoma to metastasis. Many miRNAs non-detectable (<5 TPM) in CLs were significantly enriched (>1000 TPM) in secreted EVs. Strikingly, miR-7641 which is non-detectable in SW480-CL but upregulated in SW620-CL is highly enriched in EVs secreted from both cell lines. Pearson correlation analysis demonstrated that EV miRNA profiles can be used to predict CRC tumours with similar to 96% accuracy. Our findings suggest that EV miRNA profiles from CRC cell lines may allow prediction of CRC tumours, and that miR-7641 may serve as an attractive candidate for the specific, non-invasive diagnosis and prognosis of CRC.	[Chen, Maoshan; Xu, Rong; Rai, Alin; Suwakulsiri, Wittaya; Greening, David W.; Simpson, Richard J.] La Trobe Univ, La Trobe Inst Mol Sci LIMS, Dept Biochem & Genet, Melbourne, Vic, Australia; [Izumikawa, Keiichi; Ishikawa, Hideaki; Takahashi, Nobuhiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Tokyo, Japan; [Izumikawa, Keiichi; Ishikawa, Hideaki; Takahashi, Nobuhiro] Tokyo Univ Agr & Technol, Global Innovat Res Org, Tokyo, Japan	La Trobe University; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Chen, MS; Simpson, RJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci LIMS, Dept Biochem & Genet, Melbourne, Vic, Australia.	m.chen@latrobe.edu.au; Richard.simpson@latrobe.edu.au	Greening, David/E-9138-2016; Rai, Alin/ABC-7474-2020; Xu, Rong/V-7084-2019; TAKAHASHI, Nobuhiro/G-1129-2013; Izumikawa, Keiichi/H-4156-2016	Greening, David/0000-0001-7516-485X; Xu, Rong/0000-0002-5510-3678; Izumikawa, Keiichi/0000-0001-7262-5403; Simpson, Richard/0000-0002-9834-0796; CHEN, MAOSHAN/0000-0002-3827-4969; Rai, Alin/0000-0001-7994-5151; Suwakulsiri, Wittaya/0000-0001-8423-1014	La Trobe University Post-Graduate Research Scholarships; La Trobe University; Australian National Health and Medical Research Council [1139489, 1141946]; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)	La Trobe University Post-Graduate Research Scholarships; La Trobe University; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	MC, RX, AR, WS were supported by La Trobe University Post-Graduate Research Scholarships. RS is supported by a Distinguished Professorship (La Trobe University) and DG, a Stone Molecular Biology Fellowship (La Trobe University) and Australian National Health and Medical Research Council (Project: 1139489 and 1141946). NT, KI, HI were supported by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An QL, 2007, PLANT SIGNAL BEHAV, V2, P4, DOI 10.4161/psb.2.1.3596; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Cellura D, 2015, MOL CANCER RES, V13, P1095, DOI 10.1158/1541-7786.MCR-14-0466; Chen MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38397; Chen WD, 2012, EXP THER MED, V3, P351, DOI 10.3892/etm.2011.411; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Deng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep28301; Deng GR, 2011, ONCOL LETT, V2, P175, DOI 10.3892/ol.2010.222; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Feng L, 2016, EXP THER MED, V12, P3405, DOI 10.3892/etm.2016.3751; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Greening DW, 2018, EXPERT REV PROTEOMIC, V15, P887, DOI 10.1080/14789450.2018.1537788; Greening DW, 2017, EXPERT REV PROTEOMIC, V14, P69, DOI 10.1080/14789450.2017.1260450; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; Hofsli E, 2013, BRIT J CANCER, V108, P1712, DOI 10.1038/bjc.2013.121; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ji DB, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-86; Ji H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110314; Ji H, 2013, PROTEOMICS, V13, P1672, DOI 10.1002/pmic.201200562; Jiang GL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2911-z; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Le MTN, 2014, J CLIN INVEST, V124, P5109, DOI 10.1172/JCI75695; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Machida T, 2015, INT J MOL SCI, V16, P21294, DOI 10.3390/ijms160921294; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsumura T, 2015, BRIT J CANCER, V113, P275, DOI 10.1038/bjc.2015.201; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peng H, 2014, ONCOL REP, V31, P2055, DOI 10.3892/or.2014.3075; Preitner N, 2014, CELL, V158, P368, DOI 10.1016/j.cell.2014.05.042; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shi D, 2015, INDIAN J CANCER, V52, pE47, DOI 10.4103/0019-509X.172513; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P2148, DOI 10.1074/mcp.M112.027086; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Tominaga N, 2015, ADV DRUG DELIVER REV, V95, P50, DOI 10.1016/j.addr.2015.10.002; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04386-1; Wang S, 2016, MOL MED REP, V13, P273, DOI 10.3892/mmr.2015.4557; Wang SY, 2015, INT J CANCER, V136, P152, DOI 10.1002/ijc.28136; Xu R, NATURE REVIEWS CLINI; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Xu R, 2016, J CLIN INVEST, V126, P1152, DOI 10.1172/JCI81129; Xu R, 2015, METHODS, V87, P11, DOI 10.1016/j.ymeth.2015.04.008; Yang Z, 2017, NUCLEIC ACIDS RES, V45, pD812, DOI 10.1093/nar/gkw1079; Yoo JK, 2013, ARCH PHARM RES, V36, P353, DOI 10.1007/s12272-013-0067-9; Yuan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19413; Zhou T, 2013, INT J COLORECTAL DIS, V28, P19, DOI 10.1007/s00384-012-1528-1; ZIRVI KA, 1991, CANCER LETT, V60, P85, DOI 10.1016/0304-3835(91)90052-J	66	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210003	10.1371/journal.pone.0210003	http://dx.doi.org/10.1371/journal.pone.0210003			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608951	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800036
J	Szep, T; Dobranszky, J; Moller, AP; Dyke, G; Lendvai, AZ				Szep, Tibor; Dobranszky, Janos; Moller, Anders Pape; Dyke, Gareth; Lendvai, Adam Z.			Older birds have better feathers: A longitudinal study on the long-distance migratory Sand Martin, Riparia riparia	PLOS ONE			English	Article							FLIGHT FEATHERS; GROWTH-RATE; MECHANICAL-PROPERTIES; FLEXURAL STIFFNESS; TELOMERE LENGTH; MOLT; QUALITY; FITNESS; MASS	Feather quality is of critical importance to long-distance migratory birds. Here, we report a series of analyses of a unique data set encompassing known-age individuals of the long-distance migratory Sand Martin (Riparia riparia). Sampling over 17 years along the Tisza River, eastern Hungary, has resulted in the recapture of numerous individuals enabling longitudinal and cross-sectional investigation of the role of adaptation to variable environmental conditions on feather morphology. We show that older individuals tend to possess better quality feathers, measured using bending stiffness, feather length and thickness as proxies. Bending stiffness and feather thickness do not change with individual age, in contrast with increases in feather length and declines in daily feather growth versus age of individual alongside moult duration. Individuals who live to older ages tend to have similar, or higher, feather growth rates and better feather quality than individuals captured at younger ages. Thus, on the basis of strong selection against individuals with slow feather growth, as seen in other species of swallows and martins, which causes a delay in moult completion, the results of this analysis highlight the potential cost of producing better quality feathers when this depends on moult duration. Feather length also does change during the lifetime of the individual and thus enabled us to further investigate influence of individual and environmental conditions during the moult. The results of this analysis provide important insights on the adaptive significance of these traits, and the potential use of physical characteristics in unravelling the reasons why long distance migratory bird populations are in global decline.	[Szep, Tibor] Univ Nyiregyhaza, Inst Environm Sci, Nyiregyhaza, Hungary; [Dobranszky, Janos] Budapest Univ Technol & Econ, Dept Mat Sci & Engn, Budapest, Hungary; [Moller, Anders Pape] Univ Paris Sud XI, Lab Ecol Systemat & Evolut, AgroParisTech, CNRS,UMR 8079, Orsay, France; [Dyke, Gareth; Lendvai, Adam Z.] Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary; [Dyke, Gareth; Lendvai, Adam Z.] Babes Bolyai Univ, Dept Geol, Cluj Napoca, Romania	Budapest University of Technology & Economics; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Debrecen; Babes Bolyai University from Cluj	Szep, T (corresponding author), Univ Nyiregyhaza, Inst Environm Sci, Nyiregyhaza, Hungary.	szep.tibor@nye.hu	Dyke, Gareth/AAJ-9320-2020; Lendvai, Adam Z/B-8546-2008	Dyke, Gareth/0000-0002-8390-7817; Lendvai, Adam Z/0000-0002-8953-920X	Hungarian Research Council [OTKA K69068]; National Research, Development and Innovation Fund of Hungary [NKFI K 120348]; Romanian Government [PN-III-P4-ID-PCE-2016-0572];  [OTKA K113108]	Hungarian Research Council; National Research, Development and Innovation Fund of Hungary; Romanian Government(Romanian Government); 	We acknowledge funding for fieldwork and analyses from the Hungarian Research Council (OTKA K69068) and from the National Research, Development and Innovation Fund of Hungary (NKFI K 120348). AZL was supported by OTKA K113108 grant during the preparation of this manuscript, and GD and AZL acknowledge support from the Romanian Government (PN-III-P4-ID-PCE-2016-0572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bachmann T, 2012, J EXP BIOL, V215, P405, DOI 10.1242/jeb.059451; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; BONSER RHC, 1995, J EXP BIOL, V198, P1029; Bonser RHC, 1996, J ZOOL, V239, P477, DOI 10.1111/j.1469-7998.1996.tb05937.x; Borgudd J, 2003, TVSM5121 LUND TECHN; Cramp S, 1998, COMPLETE BIRDS W PAL; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; de la Hera I, 2014, IBIS, V156, P209, DOI 10.1111/ibi.12112; de la Hera I, 2013, EVOL ECOL, V27, P1199, DOI 10.1007/s10682-013-9639-x; de la Hera I, 2011, AUK, V128, P321, DOI 10.1525/auk.2011.10181; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; De La Hera I, 2009, ACTA ORNITHOL, V44, P95, DOI 10.3161/000164509X464939; Flinks H, 2012, J ORNITHOL, V153, P1053, DOI 10.1007/s10336-012-0834-2; Gienapp P, 2010, J EVOLUTION BIOL, V23, P715, DOI 10.1111/j.1420-9101.2010.01949.x; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; Hall KSS, 2000, J AVIAN BIOL, V31, P583, DOI 10.1034/j.1600-048X.2000.310419.x; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Jenni L., 1994, BIOL MOULT BIRDS; Kiat Y, 2018, BIOL J LINN SOC, V125, P613, DOI 10.1093/biolinnean/bly135; Kiat Y, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01609; Kiat Y, 2016, EVOL ECOL, V30, P783, DOI 10.1007/s10682-016-9838-3; Laurent CM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0961; Le Tortorec E, 2012, ECOL INDIC, V15, P72, DOI 10.1016/j.ecolind.2011.09.013; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lucas A.M., 1972, AGR HDB, V362; Telleria JL, 2013, ARDEOLA, V60, P191, DOI 10.13157/arla.60.2.2013.191; Marzal A, 2013, J AVIAN BIOL, V44, P437, DOI 10.1111/j.1600-048X.2013.00178.x; Moller AP, 2018, J ORNITHOL, V159, P165, DOI 10.1007/s10336-017-1483-2; Moller AP., 1994, SEXUAL SELECTION BAR; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Norberg UML, 1990, VERTEBRATE FLIGHT; Pap PL, 2015, FUNCT ECOL, V29, P746, DOI 10.1111/1365-2435.12419; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Podlaszczuk P, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0179-4; R Core Team, 2021, R LANGUAGE ENV STAT; Saino N, 2013, J ORNITHOL, V154, P537, DOI 10.1007/s10336-012-0924-1; Saino N, 2012, J AVIAN BIOL, V43, P513, DOI 10.1111/j.1600-048X.2012.05622.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Smith S, 2016, ACTA ORNITHOL, V51, P131, DOI 10.3161/00016454AO2016.51.1.011; Szep T., 2003, Ornis Hungarica, V12-13, P169; SZEP T, 1995, IBIS, V137, P162, DOI 10.1111/j.1474-919X.1995.tb03235.x; Szep T, 2017, J AVIAN BIOL, V48, P114, DOI 10.1111/jav.01339; Tubaro PL, 2003, J AVIAN BIOL, V34, P243, DOI 10.1034/j.1600-048X.2003.03084.x; Vagasi CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040651; Vagasi CI, 2011, ARDEA, V99, P53, DOI 10.5253/078.099.0107; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Weber TP, 2010, J ZOOL, V280, P163, DOI 10.1111/j.1469-7998.2009.00644.x; Weber TP, 2005, BIOL LETT-UK, V1, P27, DOI 10.1098/rsbl.2004.0244; Zuur Alain F., 2009, P1; [No title captured]	56	6	6	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209737	10.1371/journal.pone.0209737	http://dx.doi.org/10.1371/journal.pone.0209737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608973	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800025
J	Huang, CC; Cheng, SH; Wu, CH; Li, WY; Wang, JS; Kung, ML; Chu, TH; Huang, ST; Feng, CT; Huang, SC; Tai, MH				Huang, Chao-Cheng; Cheng, Shih-Hsuan; Wu, Chen-Hsuan; Li, Wen-Yuan; Wang, Jiang-Shiang; Kung, Mei-Lang; Chu, Tian-Huei; Huang, Shih-Tsung; Feng, Chien-Ting; Huang, Shih-Chung; Tai, Ming-Hong			Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling	ONCOGENE			English	Article							STEM-CELLS; GROWTH-FACTOR; DLK1; EXPRESSION; CANCER; GENE; PROTEIN; INHIBITOR; PATHWAY; PREF-1	Ovarian carcinoma is the most lethal type of gynecologic malignancies. Alterations of Notch pathway are prevalent in ovarian carcinogenesis. This study investigated the expression profile and function of delta-like 1 homolog (DLK1), a non-canonical Notch ligand, during ovarian carcinogenesis. Tissue microarray (TMA) consisting of surgically resected samples from 221 patients with ovarian carcinoma was constructed for DLK1 expression. DLK1 overexpression or knockdown was achieved by adenovirus gene delivery to evaluate the effect of DLK1 on the oncogenic behaviors in ovarian cancer cells and in xenografted tumors. TMA analysis revealed that elevated DLK1 expression was correlated with stages, lymph node metastasis and E-cadherin downregulation. Despite no influence on survival among ovarian carcinoma patients, DLK1 overexpression was specially associated with overall survival and progression free survival in high-grade serous carcinoma (HGSC) patients, constituting an independent prognostic factor for these patients. By adenovirus gene delivery, it was found modulation of cellular DLK1 level regulated the tumorigenic behaviors and epithelial-mesenchymal transition (EMT) in vitro and in vivo. Immunohistochemical analysis further showed that DLK1 overexpression resulted in escalated proliferation, angiogenesis, EMT and Notch activities. Application of recombinant DLK1 extracellular domain (rDLK1-EC) recapitulated the tumorigenic behaviors of DLK1 in ovarian cancer cells. By using neutralizing antibody or pharmaceutical inhibitor, blockade of Notch signaling attenuated the tumorigenic behaviors evoked by DLK1 overexpression. The present study indicates that DLK1 overexpression participates in ovarian carcinogenesis through Notch activation and EMT induction. Moreover, DLK1 may constitute a novel diagnostic biomarker and therapeutic target for HGSC.	[Huang, Chao-Cheng; Cheng, Shih-Hsuan; Wang, Jiang-Shiang] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Cheng, Shih-Hsuan; Wu, Chen-Hsuan; Wang, Jiang-Shiang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wang, Jiang-Shiang] Kaohsiung Chang Gung Mem Hosp, Biobank & Tissue Bank, Kaohsiung, Taiwan; [Cheng, Shih-Hsuan; Chu, Tian-Huei; Feng, Chien-Ting; Huang, Shih-Chung; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Wu, Chen-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Wu, Chen-Hsuan] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Li, Wen-Yuan] Fooyin Univ Hosp, Dept Pathol, Pingtung, Taiwan; [Li, Wen-Yuan; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Kung, Mei-Lang] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung, Taiwan; [Chu, Tian-Huei; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung, Taiwan; [Huang, Shih-Tsung] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Huang, Shih-Tsung] Acad Sinica, Doctoral Degree Program Marine Biotechnol, Taipei, Taiwan; [Huang, Shih-Chung] Kaohsiung Armed Forces Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tai, Ming-Hong] Kaohsiung Med Univ, Grad Inst Clin Sci, Kaohsiung 807, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; Academia Sinica - Taiwan; Kaohsiung Medical University	Huang, CC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan.; Huang, CC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Huang, CC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Biobank & Tissue Bank, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Sci, Kaohsiung 807, Taiwan.	huangcc@cgmh.org.tw; minghongtai@gmail.com		Chu, Tian-Huei/0000-0003-1197-5754	Ministry of Science and Technology, Taiwan [NSC101-2320-B-182-009, NSC102-2320-B-182-011, MOST103-2320-B-182-005-MY3, MOST105-2325-B-110-001]; Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital Tissue Bank [CLRPG8E0161, CLRPG8F1701]; Kaohsiung Armed Forces General Hospital, Taiwan [107-10]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital Tissue Bank; Kaohsiung Armed Forces General Hospital, Taiwan	This work was supported by grants from the Ministry of Science and Technology, Taiwan (NSC101-2320-B-182-009, NSC102-2320-B-182-011, MOST103-2320-B-182-005-MY3 to C.C.H., and MOST105-2325-B-110-001 to M.H.T.). We thank Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital Tissue Bank (CLRPG8E0161 and CLRPG8F1701), and the Kaohsiung Armed Forces General Hospital, Taiwan (107-10) for technical support.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Baladron V, 2001, FRONT BIOSCI-LANDMRK, V6, pA25, DOI 10.2741/baladron; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Ceder JA, 2008, EUR UROL, V54, P1344, DOI 10.1016/j.eururo.2008.03.006; Chen X, 2012, CANCER RES, V72, P2294, DOI 10.1158/0008-5472.CAN-11-2181; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Deng JL, 2016, ONCOTARGET, V7, P55771, DOI 10.18632/oncotarget.9908; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Hu W, 2014, CANCER RES, V74, P3282, DOI 10.1158/0008-5472.CAN-13-2066; Huang CC, 2018, ANGIOGENESIS, V21, P901, DOI 10.1007/s10456-018-9615-8; Huang CC, 2018, ANGIOGENESIS, V21, P299, DOI 10.1007/s10456-018-9596-7; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Jung JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004751; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Kim YS, 2016, BIOCHEM BIOPH RES CO, V480, P254, DOI 10.1016/j.bbrc.2016.10.041; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Klymenko Y, 2017, CANCERS, V9, P1; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095912; Liu GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142680; Liu Yu, 2010, Zhongguo Fei Ai Za Zhi, V13, P923, DOI 10.3779/j.issn.1009-3419.2010.10.12; Ma Z, 2017, BIOCHEM BIOPH RES CO, V490, P309, DOI 10.1016/j.bbrc.2017.06.041; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2017, FASEB J, V31, P3484, DOI 10.1096/fj.201601341RRR; Nueda ML, 2014, BBA-MOL CELL RES, V1843, P2674, DOI 10.1016/j.bbamcr.2014.07.015; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wu JC, 2016, PROSTATE, V76, P1469, DOI 10.1002/pros.23230; Xu J, 2016, AM J CANCER RES, V6, P2700; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang S S, 2016, Zhonghua Zhong Liu Za Zhi, V38, P510, DOI 10.3760/cma.j.issn.0253-3766.2016.07.006	54	26	26	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3201	3215		10.1038/s41388-018-0658-5	http://dx.doi.org/10.1038/s41388-018-0658-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30626939				2022-12-26	WOS:000465557200007
J	Yoshino, Y; Qi, HC; Kanazawa, R; Sugamata, M; Suzuki, K; Kobayashi, A; Shindo, K; Matsuzawa, A; Shibata, S; Endo, S; Miyanishi, Y; Shimaoka, T; Ishioka, C; Kanno, S; Yasui, A; Chiba, N				Yoshino, Yuki; Qi, Huicheng; Kanazawa, Ryo; Sugamata, Mami; Suzuki, Kenta; Kobayashi, Akihiro; Shindo, Kazuha; Matsuzawa, Ayako; Shibata, Shun; Endo, Shino; Miyanishi, Yutaro; Shimaoka, Tatsuro; Ishioka, Chikashi; Kanno, Shin-ichiro; Yasui, Akira; Chiba, Natsuko			RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells	ONCOGENE			English	Article							PROTEIN; IDENTIFICATION; ASSOCIATION; INHIBITION; DOMAIN; CYCLE; OLA1	Breast cancer gene 1 (BRCA1) is a tumor suppressor that is associated with hereditary breast and ovarian cancer. BRCA1 functions in DNA repair and centrosome regulation together with BRCA1-associated RING domain protein (BARD1), a heterodimer partner of BRCA1. Obg-like ATPase 1 (OLA1) was identified as a protein that interacts with BARD1. OLA1 regulates the centrosome by binding to and collaborating with BRCA1 and BARD1. We identified receptor for activated C kinase (RACK1) as a protein that interacts with OLA1. RACK1 directly bound to OLA1, the N-terminal region of BRCA1, and gamma-tubulin, associated with BARD1, and localized the centrosomes throughout the cell cycle. Knockdown of RACK1 caused abnormal centrosomal localization of BRCA1 and abrogated centriole duplication. Overexpression of RACK1 increased the centrosomal localization of BRCA1 and caused centrosome amplification due to centriole overduplication. The number of centrioles in cells with two gamma-tubulin spots was higher in cell lines derived from mammary tissue compared to those derived from other tissues. The effects of aberrant RACK1 expression level on centriole duplication were observed in cell lines derived from mammary tissue, but not in those derived from other tissues. Two BRCA1 variants, R133H and E143K, and a RACK1 variant, K280E, associated with cancer, which weakened the BRCA1-RACK1 interaction, interfered with the centrosomal localization of BRCA1 and reduced centrosome amplification induced by overexpression of RACK1. These results suggest that RACK1 regulates centriole duplication by controlling the centrosomal localization of BRCA1 in mammary tissue-derived cells and that this is dependent on the BRCA1-RACK1 interaction.	[Yoshino, Yuki; Qi, Huicheng; Kanazawa, Ryo; Sugamata, Mami; Suzuki, Kenta; Kobayashi, Akihiro; Shindo, Kazuha; Endo, Shino; Miyanishi, Yutaro; Chiba, Natsuko] Tohoku Univ, IDAC, Dept Canc Biol, Sendai, Miyagi, Japan; [Matsuzawa, Ayako; Shibata, Shun] Tohoku Univ, IDAC, Dept Mol Immunol, Sendai, Miyagi, Japan; [Shimaoka, Tatsuro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba, Japan; [Ishioka, Chikashi] Tohoku Univ, IDAC, Dept Clin Oncol, Sendai, Miyagi, Japan; [Kanno, Shin-ichiro; Yasui, Akira] Tohoku Univ, IDAC, Div Dynam Proteome Aging & Canc, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tokyo University of Science; Tohoku University; Tohoku University	Chiba, N (corresponding author), Tohoku Univ, IDAC, Dept Canc Biol, Sendai, Miyagi, Japan.	natsuko.chiba.c7@tohoku.ac.jp	Kanno, Shin-ichiro/AAE-4549-2019; Yoshino, Yuki/AAQ-9620-2021	Shibata, Shun/0000-0002-9081-1370; Ishioka, Chikashi/0000-0002-3023-1227	JSPS KAKENHI [JP24300327, JP16H04690, JP16K18409]; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Program for Interdisciplinary Research in Frontier Research Institute for Interdisciplinary Sciences (FRIS), Tohoku University; Astellas Foundation for Research on Metabolic Disorders; Yasuda Medical Foundation; Princess Takamatsu Cancer Research Fund [1424621]; Daiwa Securities Health Foundation; Kobayashi Foundation for Cancer Research; Kobayashi International Scholarship Foundation; Friends of Leukemia Research Fund; Research Program of the Smart-Aging Research Center, Tohoku University; Foundation for Promotion of Cancer Research in Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Program for Interdisciplinary Research in Frontier Research Institute for Interdisciplinary Sciences (FRIS), Tohoku University; Astellas Foundation for Research on Metabolic Disorders; Yasuda Medical Foundation; Princess Takamatsu Cancer Research Fund; Daiwa Securities Health Foundation; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Kobayashi International Scholarship Foundation; Friends of Leukemia Research Fund; Research Program of the Smart-Aging Research Center, Tohoku University; Foundation for Promotion of Cancer Research in Japan	We thank Satoko Aoki for technical assistance. This study was supported by grants-in-aid from JSPS KAKENHI Grant numbers JP24300327 (to N.C.), JP16H04690 (to N.C and Y.Y.), JP16K18409 (to Y.Y.), Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) (to C.I. and N.C.), Program for Interdisciplinary Research in Frontier Research Institute for Interdisciplinary Sciences (FRIS), Tohoku University, Astellas Foundation for Research on Metabolic Disorders, the Yasuda Medical Foundation, the Princess Takamatsu Cancer Research Fund (1424621), Daiwa Securities Health Foundation, Kobayashi Foundation for Cancer Research, Kobayashi International Scholarship Foundation, Friends of Leukemia Research Fund, Research Program of the Smart-Aging Research Center, Tohoku University (to N.C.), and Foundation for Promotion of Cancer Research in Japan (to Y.Y.).	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Ai E, 2009, MOL BIOL CELL, V20, P1629, DOI 10.1091/mbc.E08-09-0917; Al-Reefy S, 2010, BREAST CANCER RES TR, V123, P911, DOI 10.1007/s10549-010-1020-y; Bai L, 2016, ONCOTARGET, V7, P10402, DOI 10.18632/oncotarget.7224; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Brodie KM, 2012, J BIOL CHEM, V287, P7701, DOI 10.1074/jbc.M111.327296; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cao XX, 2010, BREAST CANCER RES TR, V123, P375, DOI 10.1007/s10549-009-0657-x; Cao XX, 2010, INT J CANCER, V127, P1172, DOI 10.1002/ijc.25120; Clark SL, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204005; Ding ZH, 2016, MOL CELL BIOL, V36, P2568, DOI 10.1128/MCB.00137-16; Duff D, 2017, CELL SIGNAL, V35, P250, DOI 10.1016/j.cellsig.2017.03.005; Fujita H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1075643; Gandin Valentina, 2013, Genes Cancer, V4, P369, DOI 10.1177/1947601913486348; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Guichard P, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700241; Hsu LC, 2001, CANCER RES, V61, P7713; Kais Z, 2012, ONCOGENE, V31, P799, DOI 10.1038/onc.2011.271; Kershner L, 2017, NEURAL REGEN RES, V12, P1036, DOI 10.4103/1673-5374.211175; Ko MJ, 2006, ONCOGENE, V25, P298, DOI 10.1038/sj.onc.1209028; Lacombe J, 2013, INT J CANCER, V132, P1105, DOI 10.1002/ijc.27766; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; Matsuzawa A, 2014, MOL CELL, V53, P101, DOI 10.1016/j.molcel.2013.10.028; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Shimomura A, 2009, J CANCER RES CLIN, V135, P421, DOI 10.1007/s00432-008-0472-5; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Sun H, 2010, MOL CANCER RES, V8, P57, DOI 10.1158/1541-7786.MCR-09-0278; Takaoka M, 2018, INT J CLIN ONCOL, V23, P36, DOI 10.1007/s10147-017-1182-2; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Watanabe G, 2018, CANCER SCI, V109, P2027, DOI 10.1111/cas.13595; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yoshino Y, 2018, MOL CANCER RES, V16, P1499, DOI 10.1158/1541-7786.MCR-18-0269	40	19	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3077	3092		10.1038/s41388-018-0647-8	http://dx.doi.org/10.1038/s41388-018-0647-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IB2GE	30617304				2022-12-26	WOS:000470086900001
J	Feltrin, AS; Tahira, AC; Simoes, SN; Brentani, H; Martins, DC				Feltrin, Arthur Sant'Anna; Tahira, Ana Carolina; Simoes, Sergio Nery; Brentani, Helena; Martins, David Correa, Jr.			Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders	PLOS ONE			English	Article							NETWORK BIOLOGY; GENE NETWORKS; NEUROGENESIS; PATHWAYS; SLC6A3; EEF2	Psychiatric disorders involve both changes in multiple genes as well different types of variations. As such, gene co-expression networks allowed the comparison of different stages and parts of the brain contributing to an integrated view of genetic variation. Two methods based on co-expression networks presents appealing results: Weighted Gene Correlation Network Analysis (WGCNA) and Network-Medicine Relative Importance (NERI). By selecting two different gene expression databases related to schizophrenia, we evaluated the biological modules selected by both WGCNA and NERI along these databases as well combining both WGCNA and NERI results (WGCNA-NERI). Also we conducted a enrichment analysis for the identification of partial biological function of each result (as well a replication analysis). To appraise the accuracy of whether both algorithms (as well our approach, WGCNA-NERI) were pointing to genes related to schizophrenia and its complex genetic architecture we conducted the MSET analysis, based on a reference gene list of schizophrenia database (SZDB) related to DNA Methylation, Exome, GWAS as well as copy number variation mutation studies. The WGCNA results were more associated with inflammatory pathways and immune system response; NERI obtained genes related with cellular regulation, embryological pathways e cellular growth factors. Only NERI were able to provide a statistical meaningful results to the MSET analysis (for Methylation and de novo mutations data). However, combining WGCNA and NERI provided a much more larger overlap in these two categories and additionally on Transcriptome database. Our study suggests that using both methods in combination is better for establishing a group of modules and pathways related to a complex disease than using each method individually. NERI is available at: https://bitbucket.org/sergionery/neri.	[Feltrin, Arthur Sant'Anna; Martins, David Correa, Jr.] Fed Univ ABC UFABC, Ctr Math Computat & Cognit, Santo Andre, SP, Brazil; [Tahira, Ana Carolina; Brentani, Helena] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, LIM23,Inst Psiquiatria, Sao Paulo, SP, Brazil; [Simoes, Sergio Nery] Fed Inst Educ Sci & Technol Espirito Santo, Serra, ES, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Psiquiatria, Sao Paulo, SP, Brazil; [Brentani, Helena] Natl Inst Dev Psychiat Children & Adolescents INP, Sao Paulo, SP, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Instituto Federal do Espirito Santo (IFES); Universidade de Sao Paulo	Feltrin, AS; Martins, DC (corresponding author), Fed Univ ABC UFABC, Ctr Math Computat & Cognit, Santo Andre, SP, Brazil.	s.feltrin@ufabc.edu.br; david.martins@ufabc.edu.br	Brentani, Helena/G-6839-2011; TAHIRA, ANA C/H-7936-2016; Feltrin, Arthur/GON-5818-2022; Tahira, Ana/AAD-4196-2020; Martins-Jr, David/G-2271-2012	Brentani, Helena/0000-0001-5192-4682; TAHIRA, ANA C/0000-0002-7036-7305; Feltrin, Arthur/0000-0002-1810-2203; Tahira, Ana/0000-0002-7036-7305; Martins-Jr, David/0000-0003-0398-8328	FAPESP - Sao Paulo Research Foundation [2014/10488-3, 2011/50761-2, 2015/01587-0, 2014/00041-1, 2011/04956-6]; CNPq - National Council for Scientific and Technological Development [304955/2014-0]; CAPES - Coordination for the Improvement of Higher Education Personnel [1750212, 88881.187975/2018-01]; NAP eScience -PRP- USP; UFABC - Federal University of ABC	FAPESP - Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NAP eScience -PRP- USP; UFABC - Federal University of ABC	This work was supported by FAPESP - Sao Paulo Research Foundation (http://www.fapesp.br/en/): grant numbers 2014/10488-3 (received by ASF); 2011/50761-2 (received by DCMJ); 2015/01587-0 (received by DCMJ); 2014/00041-1 (received by ACT); 2011/04956-6 received by HB); CNPq - National Council for Scientific and Technological Development (http://www.cnpq.br/): grant 304955/2014-0 (received by DCMJ); CAPES - Coordination for the Improvement of Higher Education Personnel (http://www.capes.gov.br/) grant numbers 1750212 and 88881.187975/2018-01 (received by ASF); NAP eScience -PRP- USP and UFABC - Federal University of ABC. The funders had no other role in the project.	Alamowitch S, 2009, NEUROLOGY, V73, P1873, DOI 10.1212/WNL.0b013e3181c3fd12; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Arpon A, 2018, EPIGENOMICS-UK, V10, P91, DOI 10.2217/epi-2017-0082; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Carroll LS, 2010, MOL PSYCHIATR, V15, P1101, DOI 10.1038/mp.2009.96; Chaste P, 2015, BIOL PSYCHIAT, V77, P775, DOI 10.1016/j.biopsych.2014.09.017; Chinese Marketing, 2019, P 3 INT ICWSM C; Damiani D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13509; Dresler T, 2010, NEUROPSYCHOPHARMACOL, V35, P2193, DOI 10.1038/npp.2010.91; Eisinger BE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-147; Fillman SG, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.8; Flint J, 2014, NATURE, V511, P412, DOI 10.1038/nature13645; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hirt L., 2018, CLIN TRANSLATIONAL N, P1, DOI [10.1177/2514183X17752902, DOI 10.1177/2514183X17752902]; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Horvath S, 2014, BIOL PSYCHIAT, V75, P316, DOI 10.1016/j.biopsych.2013.06.010; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iancu OD, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00174; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kelley RL, 2017, CLIN EXP REPROD MED, V44, P119, DOI 10.5653/cerm.2017.44.3.119; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Malki K, 2013, PHARMACOGENOMICS, V14, P1979, DOI [10.2217/PGS.13.154, 10.2217/pgs.13.154]; Maschietto M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0098-9; McCamphill PK, 2015, J NEUROSCI, V35, P4403, DOI 10.1523/JNEUROSCI.2376-14.2015; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Mukthavaram R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0627-5; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Pinheiro J., 2018, NLME LINEAR NONLINEA; Popescu BFG, 2014, ACTA NEUROPATHOLOGIC; Querol-Vilaseca M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0893-7; Rieckmann A, 2018, P NATL ACAD SCI USA, V115, P10160, DOI 10.1073/pnas.1804641115; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sanfilippo C, 2017, MOL CELL NEUROSCI, V85, P162, DOI 10.1016/j.mcn.2017.10.001; Saxena Ashwini, 2017, Mol Neuropsychiatry, V3, P108, DOI 10.1159/000480349; Simats A, 2016, BBA-MOL BASIS DIS, V1862, P411, DOI 10.1016/j.bbadis.2015.10.025; Simoes SN, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S19-S9; Simoes SN, 2015, ABORDAGEM INTEGRACAO; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Tan MC, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00124; Tiberi L, 2014, CANCER CELL, V26, P797, DOI 10.1016/j.ccell.2014.10.021; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158; Wu Y, 2017, SCHIZOPHRENIA BULL, V43, P459, DOI 10.1093/schbul/sbw102; Xu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05846-4; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zuo LJ, 2016, PSYCHIAT GENET, V26, P109, DOI 10.1097/YPG.0000000000000129	58	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210431	10.1371/journal.pone.0210431	http://dx.doi.org/10.1371/journal.pone.0210431			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645614	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200029
J	Hsu, WH; Shen, YC; Shiao, YJ; Kuo, CH; Lu, CK; Lin, TY; Ku, WC; Lin, YL				Hsu, Wei-Hsiang; Shen, Yuh-Chiang; Shiao, Young-Ji; Kuo, Ching-Hua; Lu, Chung-Kuang; Lin, Tai-Yuan; Ku, Wei-Chi; Lin, Yun-Lian			Combined proteomic and metabolomic analyses of cerebrospinal fluid from mice with ischemic stroke reveals the effects of a Buyang Huanwu decoction in neurodegenerative disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; BIOMARKER; PROTEIN; CSF; HYPOXANTHINE; MECHANISMS; XANTHINE; DEMENTIA; PLASMA	Ischemic stroke is one of the most common causes of death worldwide and is a major cause of acquired disability in adults. However, there is still a need for an effective drug for its treatment. Buyang Huanwu decoction (BHD), a traditional Chinese medicine (TCM) prescription, has long been used clinically to aid neurological recovery after stroke. To establish potential clinical indicators of BHD efficacy in stroke treatment and prognosis, we conducted a combined proteomic and metabolomic analysis of cerebrospinal fluid (CSF) samples in a mouse stroke model. CSF samples were obtained from male mice with acute ischemic stroke induced by middle cerebral ischemic/reperfusion (CI/R) injury, some of which were then treated with BHD. Label-free quantitative proteomics was conducted using nano-LC-MS/MS on an LTQ Orbitrap mass and metabolomic analysis was performed using nanoprobe NMR and UHPLC-QTOF-MS. The results showed that several proteins and metabolites were present at significantly different concentrations in the CSF samples from mice with CI/R alone and those treated with BHD. These belonged to pathways related to energy demand, inflammatory signaling, cytoskeletal regulation, Wnt signaling, and neuroprotection against neurodegenerative diseases. In conclusion, our in silico data suggest that BHD treatment is not only protective but can also ameliorate defects in pathways affected by neurological disorders. These data shed light on the mechanism whereby BHD may be effective in the treatment and prevention of stroke-related neurodegenerative disease.	[Hsu, Wei-Hsiang; Lin, Yun-Lian] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Shen, Yuh-Chiang; Shiao, Young-Ji; Lu, Chung-Kuang] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan; [Kuo, Ching-Hua; Lin, Yun-Lian] Natl Taiwan Univ, Dept Pharm, Taipei, Taiwan; [Lin, Tai-Yuan; Ku, Wei-Chi] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan	China Medical University Taiwan; National Research Institute of Chinese Medicine; National Taiwan University; Fu Jen Catholic University	Lin, YL (corresponding author), China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan.; Lin, YL (corresponding author), Natl Taiwan Univ, Dept Pharm, Taipei, Taiwan.; Ku, WC (corresponding author), Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan.	089052@mail.fju.edu.tw; yllin5212@gmail.com	Shiao, Young-Ji/AAA-9647-2022; Ku, Wei-Chi/F-1031-2010	Ku, Wei-Chi/0000-0001-8438-3210; Lin, Tai-Yuan/0000-0002-9958-5234	Ministry of Science and Technology of Taiwan [MOST 103-2320-B-039-055-MY3, 102-2320-B-030-012-MY2, 104-2320-B-039-055-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from Ministry of Science and Technology of Taiwan (MOST 102-2320-B-039-055-MY3, 102-2320-B-030-012-MY2, and 103-2320-B-039-055-MY3).; This work was supported by the Ministry of Science and Technology of Taiwan (MOST 103-2320-B-039-055-MY3, 102-2320-B-030-012-MY2, and 104-2320-B-039-055-MY3). We thank the Mass Spectrometry Laboratory of Tzong Jwo Jang, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan, for the assistance on proteomics analyses. We are also grateful for Mr. Yen-Ming Chao assisting in <SUP>1</SUP>H-NMR analysis, Dr. Yu-Lun Kuo for the IPA analysis, and Professor Kuo-Tong Liu, Department of Chinese Martial Arts and Graduate Institute of Sport Coaching Science, Chinese Culture University, Taiwan, for his kindly providing BHD materials.	ALOM J, 1991, ANN NEUROL, V30, P735, DOI 10.1002/ana.410300518; [Anonymous], [No title captured]; Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bruggink KA, 2015, J NEUROCHEM, V134, P1152, DOI 10.1111/jnc.13216; Chen HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140823; Chen HJ, 2012, METABOLOMICS, V8, P974, DOI 10.1007/s11306-011-0394-0; Chen LH, 2011, CHINESE J ETHNOMEDIC, V15, P102; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cruz T, 2014, METABOLITES, V4, P115, DOI 10.3390/metabo4010115; Cunningham R, 2013, J PROTEOME RES, V12, P719, DOI 10.1021/pr300785h; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; DEGRELL I, 1988, ARCH GERONTOL GERIAT, V7, P173, DOI 10.1016/0167-4943(88)90029-5; Dieks JK, 2013, J ALZHEIMERS DIS, V34, P387, DOI 10.3233/JAD-121810; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Hao CZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/630124; Jellinger K, 2006, EUR J NEUROL, V13, pE1, DOI 10.1111/j.1468-1331.2006.00926.x; Kelly-Spratt KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019721; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Kimberly WT, 2013, STROKE, V44, P1389, DOI 10.1161/STROKEAHA.111.000397; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; Liu Chuanzhen, 2003, J Tradit Chin Med, V23, P243; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Llano DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182098; Luo L, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4072658; MARTINEZ M, 1993, J NEURAL TRANSM-PARK, V6, P1, DOI 10.1007/BF02252617; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Menzie J, 2014, AMINO ACIDS, V46, P31, DOI 10.1007/s00726-012-1382-z; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morimoto K., 1987, NO SHINKEI GEKA, V15, P25; NIKLASSON F, 1988, UPSALA J MED SCI, V93, P225, DOI 10.3109/03009738809178548; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Pla V, 2013, BRAIN PATHOL, V23, P274, DOI 10.1111/j.1750-3639.2012.00644.x; Pluta R, 2004, FOLIA NEUROPATHOL, V42, P181; Prestwich EG, 2013, CHEM RES TOXICOL, V26, P538, DOI 10.1021/tx300473n; Regeniter A, 2009, CLIN NEUROL NEUROSUR, V111, P313, DOI 10.1016/j.clineuro.2008.12.004; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Sjodin S, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0160-z; Smith JS, 2014, PROTEOMICS, V14, P1102, DOI 10.1002/pmic.201300241; Srivastava K, 2013, J CEREBR BLOOD F MET, V33, P1928, DOI 10.1038/jcbfm.2013.151; Stover JF, 1997, NEUROSCI LETT, V238, P25, DOI 10.1016/S0304-3940(97)00840-9; Talelli P, 2004, ARCH NEUROL-CHICAGO, V61, P983, DOI 10.1001/archneur.61.6.983-b; THOMPSON EJ, 2005, CSF PROTEINS BIOCH A; Voevodskaya O, 2016, NEUROLOGY, V86, P1754, DOI 10.1212/WNL.0000000000002672; Wang HW, 2011, J ETHNOPHARMACOL, V138, P22, DOI 10.1016/j.jep.2011.06.033; Wang WR, 2011, J ETHNOPHARMACOL, V137, P214, DOI 10.1016/j.jep.2011.05.008; Wang Y, 2013, MOL BIOSYST, V9, P431, DOI 10.1039/c2mb25224d; Watabe-Rudolph M, 2012, NEUROLOGY, V78, P569, DOI 10.1212/WNL.0b013e318247caa1; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zenzmaier C, 2009, J NEUROCHEM, V110, P653, DOI 10.1111/j.1471-4159.2009.06158.x; Zhang QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033722; Zhou JY, 2009, J PROTEOME RES, V8, P5387, DOI 10.1021/pr900564f	60	11	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209184	10.1371/journal.pone.0209184	http://dx.doi.org/10.1371/journal.pone.0209184			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645580	gold, Green Submitted, Green Published			2022-12-26	WOS:000455810200007
J	Pang, YY; Zhang, C; Xu, MJ; Huang, GY; Cheng, YX; Yang, XZ				Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen			The transcriptome sequencing and functional analysis of eyestalk ganglions in Chinese mitten crab (Eriocheir sinensis) treated with different photoperiods	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; POPULATION-GROWTH; CIRCADIAN-RHYTHM; PYRUVATE-KINASE; DAILY TORPOR; METABOLISM; PHOTOTRANSDUCTION; IDENTIFICATION; INHIBITION; EXPRESSION	Photoperiod plays an important role in individual growth, development, and metabolism in crustaceans. The growth and reproduction of crabs are closely related to the photoperiod. However, as of yet, there are still no transcriptomic reports of eyestalk ganglions treated under different photoperiods in the Chinese mitten crab (Eriocheir sinensis), which is a benthonic crab with high commercial value in Asia. In this study, we collected the eyestalk ganglions of crabs that were reared under different photoperiods, including a control group (L: D = 12 h: 12 h, named CC), a constant light group (L: D = 24 h: 0 h, named LL) and a constant darkness group (L: D = 0 h: 24 h, named DD). RNA sequencing was performed on these tissues in order to examine the effects of different photoperiods. The total numbers of clean reads from the CC, LL and DD groups were 48,772,584 bp, 53,943,281 bp and 53,815,178 bp, respectively. After de novo assembly, 161,380 unigenes were obtained and were matched with different databases. The DEGs were significantly enriched in phototransduction and energy metabolism pathways. Results from RT-qPCR showed that TRP channel protein (TRP) in the phototransduction pathway had a significantly higher level of expression in LL and DD groups than in the CC group. We found that the downregulation of the pyruvate dehydrogenase complex (PDC) gene and the upregulation phosphoenolpyruvate carboxykinase (PPC) gene were involved in energy metabolism processes in LL or DD. In addition, we also found that the upregulation of the expression level of the genes G alpha q, pyruvate kinase (PK), NADH peroxidase (NADH) and ATPase is involved in phototransduction and energy metabolism. These results may shed some light on the molecular mechanism underlying the effect of photoperiod in physiological activity of E. sinensis.	[Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China; [Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China	Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University	Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China.; Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China.	Chengyongxucrab@163.com; zny119@163.com			National Natural Science Foundation of China [41876190]; Fishery Science and Technology Projects in Jiangsu Province [d2018_4]; Shandong Joint Fund [NSFC: U1706209]; Aquaculture Engineering Research Platform in Shanghai [16DZ2281200]; China Agriculture Research System [CARS-48]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fishery Science and Technology Projects in Jiangsu Province; Shandong Joint Fund; Aquaculture Engineering Research Platform in Shanghai; China Agriculture Research System	This work was supported by National Natural Science Foundation of China (grant no. (No41876190)), Fishery Science and Technology Projects in Jiangsu Province(d2018_4), Shandong Joint Fund (NSFC: U1706209), the Aquaculture Engineering Research Platform in Shanghai Established by Shanghai Science and Technology Commission [grant number 16DZ2281200], and the China Agriculture Research System [grant number CARS-48].	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Ban M, 2006, FISHERIES SCI, V72, P128, DOI 10.1111/j.1444-2906.2006.01126.x; Barriga-Montoya C, 2017, COMP BIOCHEM PHYS A, V203, P297, DOI 10.1016/j.cbpa.2016.10.008; Bebas P, 2002, J EXP BIOL, V205, P37; Bellono NW, 2013, CHANNELS, V7, P243, DOI 10.4161/chan.25322; Bernardi P, 2015, CIRC RES, V116, P1850, DOI 10.1161/CIRCRESAHA.115.306557; Biasibetti-Brendler H, 2018, MOL NEUROBIOL, V55, P4098, DOI 10.1007/s12035-017-0634-z; Brown JCL, 2007, AM J PHYSIOL-REG I, V293, pR1833, DOI 10.1152/ajpregu.00310.2007; Cui L., 2017, B ENVIRON CONTAM TOX, V2017, P1, DOI DOI 10.1007/S00128-016-2015-0; Ding ZL, 2017, AQUACULT NUTR, V23, P1136, DOI 10.1111/anu.12482; Drezon-Tepler M., 1995, MARINE ECOLOGY PROGR, V40, DOI [10.1016/j.aquaculture.2011.11.027, DOI 10.1016/J.AQUACULTURE.2011.11.027]; Espinosa-Chaurand D, 2017, AQUACULTURE, V479, P225, DOI 10.1016/j.aquaculture.2017.05.029; Farhadi A, 2016, AQUAC RES, V47, P2518, DOI 10.1111/are.12700; Fitzgibbon QP, 2012, AQUACULTURE, V368, P48, DOI 10.1016/j.aquaculture.2012.09.018; Forward RB, 2016, BIOL BULL-US, V230, P15, DOI 10.1086/BBLv230n1p15; Gao XL, 2016, AQUACULTURE, V452, P52, DOI 10.1016/j.aquaculture.2015.09.005; Glantz RM, 2000, J NEUROSCI, V20, P1780; Groeneveld J, 2015, ECOL MODEL, V303, P78, DOI 10.1016/j.ecolmodel.2015.02.009; Guo L, 2018, BIOTECHNOL BIOENG, V115, P1571, DOI 10.1002/bit.26580; Hamasaki K, 2016, AQUAC RES, V47, P2506, DOI 10.1111/are.12699; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hardie DG, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0774; Heldmaier G, 1999, AM J PHYSIOL-ENDOC M, V276, pE896, DOI 10.1152/ajpendo.1999.276.5.E896; Hoelters L, 2016, GEN COMP ENDOCR, V237, P43, DOI 10.1016/j.ygcen.2016.07.024; Huang XS, 2014, ANIM REPROD SCI, V150, P139, DOI 10.1016/j.anireprosci.2014.09.004; Hui M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178417; Jia ZH, 2018, DEV COMP IMMUNOL, V82, P94, DOI 10.1016/j.dci.2017.12.030; Dutra BK, 2008, COMP BIOCHEM PHYS C, V147, P179, DOI 10.1016/j.cbpc.2007.09.004; Keirsse-Haquin J, 2017, EUROPEAN BIOPHYSICS, V47, P205, DOI [10.2983/35.033.0220, DOI 10.2983/35.033.0220]; Le M, 2018, ENVIRON RES, V163, P80, DOI 10.1016/j.envres.2018.01.027; Lee CH, 2018, FOOD CHEM, V258, P359, DOI 10.1016/j.foodchem.2018.03.088; Li SJ, 2017, GENETICA, V145, P175, DOI 10.1007/s10709-017-9956-z; Liu Y, 2017, LETT APPL MICROBIOL, V65, P395, DOI 10.1111/lam.12784; Loredo-Ranjel R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175046; Fanjul-Moles ML, 2009, PHOTOCHEM PHOTOBIOL, V85, P78, DOI 10.1111/j.1751-1097.2008.00399.x; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; Matsuda H, 2012, AQUACULTURE, V326, P136, DOI 10.1016/j.aquaculture.2011.11.027; Maurer CM, 2010, J NEUROSCI, V30, P11962, DOI 10.1523/JNEUROSCI.2848-10.2010; Mendoza-Vargas L, 2017, INVERTEBR NEUROSCI, V17, DOI 10.1007/s10158-017-0199-6; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Mitchell J, 1998, BIOCHEMISTRY-US, V37, P9064, DOI 10.1021/bi972768a; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Moraes MN, 2017, BBA-MOL CELL RES, V1864, P324, DOI 10.1016/j.bbamcr.2016.11.010; Morata N, 2015, POLAR BIOL, V38, P67, DOI 10.1007/s00300-013-1417-2; Moreno A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45744; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nelson-Mora J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083937; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nogueira N, 2018, AQUAC RES, V49, P93, DOI 10.1111/are.13437; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; Olguin-Leon P, 2017, AQUAC RES, V48, P5587, DOI 10.1111/are.13380; Patil YN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P106, DOI 10.1086/667808; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; PICONES A, 1990, J EXP BIOL, V150, P111; Suagee JK, 2010, COMP BIOCHEM PHYS B, V155, P322, DOI 10.1016/j.cbpb.2009.11.019; Taylor MR, 2004, P NATL ACAD SCI USA, V101, P4584, DOI 10.1073/pnas.0307074101; Tian Y, 2012, SCI CHINA LIFE SCI, V55, P27, DOI 10.1007/s11427-012-4272-4; Trivedi AK, 2015, COMP BIOCHEM PHYS A, V184, P34, DOI 10.1016/j.cbpa.2015.01.011; Wadsworth T, 2014, J INSECT PHYSIOL, V71, P68, DOI 10.1016/j.jinsphys.2014.10.003; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang XD, 2014, J SHELLFISH RES, V33, P511, DOI 10.2983/35.033.0220; Wang ZQ, 2017, AQUACULTURE, V477, P6, DOI 10.1016/j.aquaculture.2017.04.026; Wei BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182087; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Xie XX, 2017, CHRONOBIOL INT, V34, P1094, DOI 10.1080/07420528.2017.1341906; Yang XZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193999; Yufera M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13514-w; Zhai YF, 2016, J PEST SCI, V89, P679, DOI 10.1007/s10340-016-0760-9; Zhou YY, 2018, P NATL ACAD SCI USA, V115, pE11864, DOI 10.1073/pnas.1813162115	70	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210414	10.1371/journal.pone.0210414	http://dx.doi.org/10.1371/journal.pone.0210414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645610	Green Submitted, gold, Green Published			2022-12-26	WOS:000455810200027
J	Sukiennicki, GM; Marciniak, W; Muszynska, M; Baszuk, P; Gupta, S; Bialkowska, K; Jaworska-Bieniek, K; Durda, K; Lener, M; Pietrzak, S; Gromowski, T; Prajzendanc, K; Lukomska, A; Waloszczyk, P; Wojcik, JZ; Scott, R; Lubinski, J; Jakubowska, A				Sukiennicki, Grzegorz Mariusz; Marciniak, Wojciech; Muszynska, Magdalena; Baszuk, Piotr; Gupta, Satish; Bialkowska, Katarzyna; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Lener, Marcin; Pietrzak, Sandra; Gromowski, Tomasz; Prajzendanc, Karolina; Lukomska, Alicja; Waloszczyk, Piotr; Wojcik, Janusz Zenon; Scott, Rodney; Lubinski, Jan; Jakubowska, Anna			Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence	PLOS ONE			English	Article							SERUM FERRITIN LEVELS; SUPEROXIDE-DISMUTASE; TRACE-ELEMENT; DIETARY IRON; HEME IRON; RISK; POLYMORPHISM; VARIANTS; CHINESE; STORES	Background Lung cancer is the most common adult malignancy accounting for the largest proportion of cancer related deaths. Iron (Fe) is an essential trace element and is a component of several major metabolic pathways playing an important role in many physiological processes. In this study we evaluated the association between Fe concentration in serum, iron metabolism parameters and genetic variaton in 7 genes involved in iron metabolism and anti-oxidative processes with the incidence of lung cancer in Poland. Materials and methods The study included 200 lung cancer patients and 200 matched healthy control subjects. We analyzed serum iron concentration and iron metabolism parameters (TIBC, UIBC, serum ferritin and transferrin saturation), and genotyped seven variants in seven genes: HFE, TFR1, HAMP, TF, SOD2, CAT and GPX1. Results Lung cancer patients compared to their matched controls had significantly higher mean serum iron level (p = 0.01), ferritin level (p = 0.007) and TIBC (p = 0.006). Analysis revealed that higher concentration of iron and ferritin (IVth quartile) compared to the lower concentration (Ist quartile) was associated with over 2-fold increased lung cancer incidence. We also found that higher transferrin saturation (p = 0.01) and lower TIBC (p<0.01) are associated with better survival of lung cancer patients. The analysis of polymorphisms in iron related genes did not reveal a significant difference between lung cancer patients and controls. However, rs10421768 in HAMP showed a borderline statistically significant correlation with lung cancer risk (OR = 2.83, p = 0.05). Conclusions The results of this case control study indicate that higher body iron represented by higher Fe and ferritin levels may be associated with lung cancer incidence. Rs10421768 in HAMP may be associated with about 3-times higher lung cancer risk. Higher Fe body content may be associated with better survival of lung cancer patients.	[Sukiennicki, Grzegorz Mariusz; Baszuk, Piotr; Bialkowska, Katarzyna; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Lener, Marcin; Pietrzak, Sandra; Gromowski, Tomasz; Prajzendanc, Karolina; Lukomska, Alicja; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Marciniak, Wojciech; Muszynska, Magdalena; Lubinski, Jan] Read Gene SA, Grzepnica, Dobra Szczecins, Poland; [Gupta, Satish] Strand Life Sci, Bangalore, Karnataka, India; [Waloszczyk, Piotr] Independent Lab Pathol, Szczecin, Poland; [Wojcik, Janusz Zenon] Pomeranian Med Univ, Dept Gen Thorac Surg & Transplantat, Szczecin, Poland; [Scott, Rodney] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW, Australia; [Scott, Rodney] NSW Hlth Pathol Newcastle, Div Mol Med, Newcastle, NSW, Australia; [Jakubowska, Anna] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; University of Newcastle; Pomeranian Medical University	Sukiennicki, GM (corresponding author), Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland.	gsukiennicki@wp.pl	Jakubowska, Anna/O-8050-2014; Lubinski, Jan/C-4420-2017; Scott, Rodney/B-2827-2013	Jakubowska, Anna/0000-0002-5650-0501; Lubinski, Jan/0000-0003-2931-3003; Bialkowska, Katarzyna/0000-0001-8489-6665; Scott, Rodney/0000-0001-7724-3404; Pietrzak, Sandra/0000-0001-8024-5013; Marciniak, Wojciech/0000-0001-7270-0063	National Science Centre [DEC-2013/11/N/NZ4/02250]; Read-Gene S.A.; Strand Life Sciences; Zdunomed	National Science Centre(National Science Centre, Poland); Read-Gene S.A.; Strand Life Sciences; Zdunomed	This work was supported by National Science Centre, grant no. DEC-2013/11/N/NZ4/02250. The funder Read-Gene S.A. provided support in the form of salaries for authors WM, MM and JL. The funder Strand Life Sciences provided support in the form of salaries for author SG. The funder Zdunomed provided support in the form of salaries for author PW. The specific roles of these authors are stated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore S, 2008, CLIN CHEM LAB MED, V46, P1450, DOI 10.1515/CCLM.2008.304; Bravo IDB, 2007, J TRACE ELEM MED BIO, V21, P14, DOI 10.1016/j.jtemb.2007.09.017; Bruno F, 2010, HAEMATOL-HEMATOL J, V95, P849, DOI 10.3324/haematol.2009.018986; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Cobanoglu U, 2010, ASIAN PAC J CANCER P, V11, P1383; COX R, 1986, EUR J CANCER CLIN ON, V22, P831, DOI 10.1016/0277-5379(86)90370-6; Ho JC, 2006, J THORAC ONCOL, V1, P648; Howlader N., 2016, SEER CANC STAT REV; Jafarian-Dehkordi A, 2008, DARU, V16, P160; Ji M, 2014, TUMOR BIOL, V35, P10195, DOI 10.1007/s13277-014-2317-y; KAKARI S, 1991, ANTICANCER RES, V11, P2107; Kang SW, 2015, INT J CLIN EXP MED, V8, P14647; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; KNEKT P, 1994, INT J CANCER, V56, P379, DOI 10.1002/ijc.2910560315; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Lee DH, 2005, NUTR CANCER, V52, P130, DOI 10.1207/s15327914nc5202_3; Li SX, 2016, BIOMED PHARMACOTHER, V80, P127, DOI 10.1016/j.biopha.2016.03.010; Lipinski P, 2014, KOSMOS, V63, P299; Lorenzi M, 2006, INT J BIOL MARKER, V21, P235, DOI 10.1177/172460080602100407; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; MILMAN N, 1991, BRIT J CANCER, V64, P895, DOI 10.1038/bjc.1991.421; Muka T, 2017, EUR J NUTR, V56, P1637, DOI 10.1007/s00394-016-1210-4; Raaschou-Nielsen O, 2007, CANCER LETT, V247, P293, DOI 10.1016/j.canlet.2006.05.006; Radio FC, 2015, BLOOD CELL MOL DIS, V55, P71, DOI 10.1016/j.bcmd.2015.04.001; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Sawayama H, 2018, INT J CLIN ONCOL, V23, P671, DOI 10.1007/s10147-018-1274-7; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shi HB, 2014, J CANCER RES THER, V10, P681, DOI 10.4103/0973-1482.139156; Shi ZM, 2017, BRIT J NUTR, V117, P572, DOI [10.1017/S000711451700040X, 10.1017/s000711451700040x]; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; STEVENS RG, 1988, NEW ENGL J MED, V319, P1047, DOI 10.1056/NEJM198810203191603; Tasevska N, 2009, AM J CLIN NUTR, V89, P1884, DOI 10.3945/ajcn.2008.27272; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; VANASPEREN IA, 1995, INT J EPIDEMIOL, V24, P665; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05661-x; Wen CP, 2014, CANCER RES, V74, P6589, DOI 10.1158/0008-5472.CAN-14-0360; Zhang L, 2017, ANN ONCOL, V28, P1124, DOI 10.1093/annonc/mdx046; Zhang Meng, 2015, Asian Pac J Cancer Prev, V16, P4633; Zhou W, 2005, EPIDEMIOLOGY, V16, P772, DOI 10.1097/01.ede.0000181311.11585.59	40	22	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208610	10.1371/journal.pone.0208610	http://dx.doi.org/10.1371/journal.pone.0208610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640897	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000006
J	Kompotiatis, P; Wiley, BM; Jentzer, JC; Kashani, KB				Kompotiatis, Panagiotis; Wiley, Brandon M.; Jentzer, Jacob C.; Kashani, Kianoush B.			Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy	PLOS ONE			English	Article							ELECTRONIC SEARCH STRATEGIES; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; PULMONARY-HYPERTENSION; AMERICAN-SOCIETY; TRICUSPID REGURGITATION; EUROPEAN-ASSOCIATION; HEART-FAILURE; RECOMMENDATIONS; AKI	Main objectives Echocardiographic parameters have been used to predict outcomes for specific intensive care unit (ICU) populations. We sought to define echocardiographic parameters for ICU patients receiving continuous renal replacement therapy (CRRT). Design, setting, participants, and measurements This is a historical cohort study of consecutive ICU patients at Mayo Clinic (Rochester, Minnesota) who received CRRT from December 9, 2006, through November 13, 2015. Only patients with an echocardiographic examination within 7 days of CRRT initiation were considered. Results The study included 1,276 patients. Decreased left ventricular ejection fraction (LVEF; <= 45%) was noted in 361/1,120 (32%) and increased right ventricular systolic pressure (RVSP; >= 40 mm Hg) was noted in 529/798 (66%). Right ventricular systolic dysfunction was observed in 320/820 (39%). The most common valvular abnormality was tricuspid regurgitation (244/1,276 [19%]). Stratification of these parameters by ICU type (medical, surgical, cardiothoracic, cardiac) showed that most echocardiographic abnormalities were significantly more prevalent among cardiac ICU patients: LVEF <= 45% (67/105 [64%]), RVSP >= 40 mm Hg (63/79 [80%]) and tricuspid regurgitation (50/130 [38%]). We compared patients with acute kidney injury (AKI) vs end-stage renal disease and showed that decreased LVEF (284/921 [31%] vs 78/201 [39%]), was significantly less prevalent among patients with AKI, but increased RVSP was more prevalent (445/651 [68%] vs 84/147 [57%]) with AKI. Conclusions ICU patients who required CRRT had increased prevalence of pulmonary hypertension and right and left ventricular systolic dysfunction. Prediction of adverse outcomes with echocardiographic parameters in this patient population can lead to identification of modifiable risk factors.	[Kompotiatis, Panagiotis; Kashani, Kianoush B.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Wiley, Brandon M.; Jentzer, Jacob C.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA; [Kashani, Kianoush B.] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kashani, KB (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Kashani, KB (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	kashani.kianoush@mayo.edu	Wiley, Brandon/Z-5879-2019; Wiley, Brandon M./AAG-6306-2020	Kashani, Kianoush/0000-0003-2184-3683; Wiley, Brandon/0000-0003-3651-7231	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) [UL1 TR002377]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002377] Funding Source: NIH RePORTER	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). This study was not funded, and the grant is for the first author's training as part of the Clinical and Translational Science certificate program.	Alsara A, 2011, MAYO CLIN PROC, V86, P382, DOI 10.4065/mcp.2010.0802; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bellomo R, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0260-y; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Chen KP, 2016, CLIN J AM SOC NEPHRO, V11, P602, DOI 10.2215/CJN.08080715; Etchecopar-Chevreuil C, 2008, INTENS CARE MED, V34, P250, DOI 10.1007/s00134-007-0929-z; Haji K, 2018, J CARDIOTHOR VASC AN, V32, P354, DOI 10.1053/j.jvca.2017.08.026; HARNETT JD, 1995, KIDNEY INT, V47, P884, DOI 10.1038/ki.1995.132; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Hickson LJ, 2016, J AM COLL CARDIOL, V67, P1173, DOI 10.1016/j.jacc.2015.12.052; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Husain-Syed F, 2015, J AM COLL CARDIOL, V65, P2433, DOI 10.1016/j.jacc.2015.04.024; Jentzer JC, 2016, J INTENSIVE CARE MED, V31, P369, DOI 10.1177/0885066615583652; Jue J, 1992, J Am Soc Echocardiogr, V5, P613; Kanji HD, 2014, J CRIT CARE, V29, P700, DOI 10.1016/j.jcrc.2014.04.008; Kellum JA, 2015, J AM SOC NEPHROL, V26, P2231, DOI 10.1681/ASN.2014070724; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Klein AL, 2013, J AM SOC ECHOCARDIOG, V26, P965, DOI 10.1016/j.echo.2013.06.023; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Metcalfe W, 2002, QJM-INT J MED, V95, P579, DOI 10.1093/qjmed/95.9.579; Mutlak D, 2007, J AM SOC ECHOCARDIOG, V20, P405, DOI 10.1016/j.echo.2006.09.013; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Ostermann M, 2016, BLOOD PURIFICAT, V42, P224, DOI 10.1159/000448506; Pulido JN, 2012, MAYO CLIN PROC, V87, P620, DOI 10.1016/j.mayocp.2012.01.018; Rabindranath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003773.pub3; Roberts MA, 2011, AM J KIDNEY DIS, V58, P64, DOI 10.1053/j.ajkd.2011.01.024; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Ronco C, 2008, INTENS CARE MED, V34, P2139, DOI 10.1007/s00134-008-1258-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SAGIE A, 1994, J AM COLL CARDIOL, V24, P446, DOI 10.1016/0735-1097(94)90302-6; Sanfilippo F, 2015, INTENS CARE MED, V41, P1004, DOI 10.1007/s00134-015-3748-7; Santosh S, 2019, NEPHROLOGY, V24, P74, DOI 10.1111/nep.13183; Schrier RW, 2008, CLIN J AM SOC NEPHRO, V3, P1232, DOI 10.2215/CJN.01960408; See KC, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0343-9; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Stamm Jason A, 2011, Pulm Circ, V1, P95, DOI 10.4103/2045-8932.78104; Sturgess DJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8931; Tang MY, 2018, AM J KIDNEY DIS, V72, P75, DOI 10.1053/j.ajkd.2017.11.018; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vallabhajosyula S, 2018, J INTENSIVE CARE MED, V33, P680, DOI 10.1177/0885066616684774; Vallabhajosyula S, 2018, SHOCK, V49, P144, DOI 10.1097/SHK.0000000000000952; Vallabhajosyula S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0319-9; Villa G, 2015, CRIT CARE CLIN, V31, P839, DOI 10.1016/j.ccc.2015.06.015; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Wong BT, 2015, J CRIT CARE, V30, P975, DOI 10.1016/j.jcrc.2015.05.003; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209994	10.1371/journal.pone.0209994	http://dx.doi.org/10.1371/journal.pone.0209994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633756	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100011
J	Oh, G; Abner, EL; Fardo, DW; Freeman, PR; Moga, DC				Oh, Gyeon; Abner, Erin L.; Fardo, David W.; Freeman, Patricia R.; Moga, Daniela C.			Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study	PLOS ONE			English	Article							CENTER NACC DATABASE; UNITED-STATES; CHRONIC PAIN; PRESCRIBING OPIOIDS; OVERDOSE DEATHS; CDC GUIDELINE; SAS PROCEDURE; POPULATION; DEMENTIA; RISK	Background Given the controversy around the effectiveness of opioid treatment for chronic pain and the lack of detailed guidance for prescribing opioids in older adults, the objectives of this study were to estimate the trajectories and predictors of opioid use in older adults. Methods Data were extracted from the National Alzheimer's Coordinating Center (2005-2017). Group-based trajectory modeling was used to identify the patterns of opioid use (any or strong) among participants age 65+. We used multivariable logistic regression with backward selection to evaluate demographics and comorbidities as potential predictors of trajectory membership. Results Among 13,059 participants, four trajectories were identified for the use of both any opioids and strong opioids (minimal-users, incident chronic-users, discontinuing-users, and prevalent chronic-users). For any opioids, female sex (adjusted odds ratio = 1.23; 95% confidence interval = 1.03-1.46), black vs. white (1.47; 1.18-1.82), year of education (0.96; 0.94-0.99), type of residence (independent group vs. private: 1.77; 1.38-2.26, care facility vs. private: 1.89; 1.20-2.97), hypertension (1.44; 1.20-1.72), cardiovascular disease (1.30; 1.09-1.55), urinary incontinence (1.45; 1.19-1.78), dementia (0.73; 0.57-0.92), number of medications (1 to 4 vs. none: 0.48; 0.36-0.64, 5 or more vs. none: 0.67; 0.50-0.88), and antidepressant agent (1.38; 1.14-1.67) were associated with incident chronic-use vs. non-use. For strong opioids, female sex (1.27; 1.04-1.56), type of residence (independent group vs. private: 1.90; 1.43-2.53, care facility vs. private: 2.37; 1.44-3.90), current smoking (1.68; 1.09-2.60), hypertension (1.49; 1.21-1.83), urinary incontinence (1.45; 1.14-1.84), dementia (0.73; 0.55-0.97), number of medications (1 to 4 vs. none: 0.46; 0.32-0.65, 5 or more vs. none: 0.59; 0.42-0.83), and antidepressant agent (1.55; 1.24-1.93) were associated with incident chronic-use vs. non-use. Conclusion Given that chronic opioid use was more prevalent in participants who were more vulnerable (i.e., older age, with multiple comorbidities, and polypharmacy), further studies should evaluate the safety and efficacy of using opioids in this population.	[Oh, Gyeon; Abner, Erin L.; Moga, Daniela C.] Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA; [Abner, Erin L.; Fardo, David W.; Moga, Daniela C.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Abner, Erin L.; Fardo, David W.] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Freeman, Patricia R.; Moga, Daniela C.] Univ Kentucky, Dept Pharm Practice & Sci, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Moga, DC (corresponding author), Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA.; Moga, DC (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Moga, DC (corresponding author), Univ Kentucky, Dept Pharm Practice & Sci, Lexington, KY 40506 USA.	daniela.moga@uky.edu	Freeman, Patricia/W-2473-2019; Freeman, Patricia R./L-3752-2019	Freeman, Patricia/0000-0002-4749-6563; Fardo, David/0000-0002-7207-4696; Moga, Daniela/0000-0002-3648-8197; Oh, GYeon/0000-0001-7203-8460	National Institute on Aging [R01AG054130]; NIA/NIH [U01 AG016976]; NIA [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854];  [P30 AG008017];  [P30 AG010161];  [P50 AG047366];  [P30 AG010129];  [P50 AG016573];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG053760];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P30 AG049638];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGING [U01AG016976, P50AG016573, P50AG008702, P30AG013854, P50AG005681, P30AG010133, R01AG054130, P30AG013846, P30AG028383, P50AG047366, P50AG005142, P50AG005138, P30AG010161, P30AG035982, P30AG008017, P30AG049638, P30AG010124, P50AG033514, P50AG005131, P50AG047270, P30AG053760, P50AG005134, P50AG005146, P30AG019610, P50AG005136, P50AG047266, P50AG005133, P50AG023501, P30AG012300, P30AG008051, P50AG025688, P50AG016574, P30AG010129] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by grant R01AG054130 to DCM from the National Institute on Aging. There was no additional external funding received for this study. The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded. ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Bell JS, 2011, PAIN, V152, P543, DOI 10.1016/j.pain.2010.11.003; Berecki-Gisolf J, 2017, AUST NZ J PUBL HEAL, V41, P85, DOI 10.1111/1753-6405.12568; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Horgas AL, 2018, PAIN MED; Hunnicutt JN, 2017, J AM GERIATR SOC; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Kunik ME, 2010, J CLIN PSYCHIAT, V71, P1145, DOI 10.4088/JCP.08m04703oli; Kuo YF, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.002; Lalic S, 2018, BR J CLIN PHARM; Lalic S, 2018, BRIT J CLIN PHARMACO, V84, P1267, DOI 10.1111/bcp.13556; Mantyselka P, 2004, AGE AGEING, V33, P496, DOI 10.1093/ageing/afh165; McAuliffe L, 2012, INT J OLDER PEOPLE N, V7, P219, DOI 10.1111/j.1748-3743.2012.00331.x; McCaffery Margo, 2010, PAIN ASSESSMENT PHAR; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Mojtabai R., 2017, PHARMACOEPIDEMIOL DR; Molton IR, 2014, AM PSYCHOL, V69, P197, DOI 10.1037/a0035794; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Nagin D., 2005, GROUP BASED MODELING, Vx; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Rolita L, 2013, J AM GERIATR SOC, V61, P335, DOI 10.1111/jgs.12148; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Scherder E, 2009, PAIN, V145, P276, DOI 10.1016/j.pain.2009.04.007; Shega J, 2007, J PAIN, V8, P373, DOI 10.1016/j.jpain.2007.03.003; Shield KD, 2013, PAIN RES MANAG, V18, P69, DOI 10.1155/2013/651649; Sutradhar R, 2017, CANCER-AM CANCER SOC, V123, P4286, DOI 10.1002/cncr.30839; Thielke SM, 2017, CLIN J PAIN, V33, P198, DOI 10.1097/AJP.0000000000000409; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Wilder-Smith OHG, 2005, EUR J PAIN, V9, P137, DOI 10.1016/j.ejpain.2004.07.011	41	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210341	10.1371/journal.pone.0210341	http://dx.doi.org/10.1371/journal.pone.0210341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633773	Green Submitted, Green Published, gold			2022-12-26	WOS:000455485100018
J	Gu, Y; Lu, XQ; Zhang, BH; Zhao, Y; Yu, DH; Gao, LX; Cui, GM; Wu, L; Zhou, T				Gu, Yu; Lu, Xiaoqi; Zhang, Baohua; Zhao, Ying; Yu, Dahua; Gao, Lixin; Cui, Guimei; Wu, Liang; Zhou, Tao			Automatic lung nodule detection using multi-scale dot nodule-enhancement filter and weighted support vector machines in chest computed tomography	PLOS ONE			English	Article							FALSE-POSITIVE REDUCTION; CT IMAGES; ACTIVE CONTOUR; SEGMENTATION; VESSELS; SYSTEM; CAD	A novel CAD scheme for automated lung nodule detection is proposed to assist radiologists with the detection of lung cancer on CT scans. The proposed scheme is composed of four major steps: (1) lung volume segmentation, (2) nodule candidate extraction and grouping, (3) false positives reduction for the non-vessel tree group, and (4) classification for the vessel tree group. Lung segmentation is performed first. Then, 3D labeling technology is used to divide nodule candidates into two groups. For the non-vessel tree group, nodule candidates are classified as true nodules at the false positive reduction stage if the candidates survive the rule-based classifier and are not screened out by the dot filter. For the vessel tree group, nodule candidates are extracted using dot filter. Next, RSFS feature selection is used to select the most discriminating features for classification. Finally, WSVM with an undersampling approach is adopted to discriminate true nodules from vessel bifurcations in vessel tree group. The proposed method was evaluated on 154 thin-slice scans with 204 nodules in the LIDC database. The performance of the proposed CAD scheme yielded a high sensitivity (87.81%) while maintaining a low false rate (1.057 FPs/scan). The experimental results indicate the performance of our method may be better than the existing methods.	[Gu, Yu; Lu, Xiaoqi; Zhang, Baohua] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Gu, Yu; Lu, Xiaoqi; Zhang, Baohua; Zhao, Ying; Yu, Dahua; Gao, Lixin; Cui, Guimei; Wu, Liang; Zhou, Tao] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Inner Mongolia Key Lab Pattern Recognit & Intelli, Baotou, Inner Mongolia, Peoples R China; [Gao, Lixin] Inner Mongolia Univ Sci & Technol, Sch Foreign Languages, Baotou, Inner Mongolia, Peoples R China	Shanghai University; Inner Mongolia University of Science & Technology; Inner Mongolia University of Science & Technology	Lu, XQ (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.; Lu, XQ; Cui, GM (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Inner Mongolia Key Lab Pattern Recognit & Intelli, Baotou, Inner Mongolia, Peoples R China.	lxiaoqi@imut.edu.cn; cguimei1@163.com	, 谷宇/ABW-8361-2022; Yu, Dahua/N-7242-2013	, 谷宇/0000-0003-4345-6932; Yu, Dahua/0000-0001-7850-7512	National Natural Science Foundation of China [61841204, 81460279, 61771266, 61763039, 61663036, 81571753, 81301281, 61261028, 61179019]; Natural Science Foundation of Inner Mongolia [2018LH08066, 2015MS0604, 2014MS0828]; Inner Mongolia College Science and Technology Research Project [NJZY145, NJZZ14161]; Inner Mongolia University of Science and Technology Innovation Fund [2016QDW-S04, 2015QNGG03, 2014QNGG08, 2014QNG07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia; Inner Mongolia College Science and Technology Research Project; Inner Mongolia University of Science and Technology Innovation Fund	This work was funded by the National Natural Science Foundation of China (grant numbers. 61841204 to YG, 81460279 to YZ, 61771266 to XL, 61763039 to GC, 61663036 to BZ, 81571753 to DY, 81301281 to DY, 61261028 to BZ, and 61179019 to XL); Natural Science Foundation of Inner Mongolia (grant numbers 2018LH08066 to YZ, 2015MS0604 to YG and 2014MS0828 to YZ), Inner Mongolia College Science and Technology Research Project (grant numbers NJZY145 to YG and NJZZ14161 to YZ), and Inner Mongolia University of Science and Technology Innovation Fund (grant numbers 2016QDW-S04 to LG, 2015QNGG03 to DY, 2014QNGG08 to YZ, and 2014QNG07 to BZ).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Anand A, 2010, AMINO ACIDS, V39, P1385, DOI 10.1007/s00726-010-0595-2; [Anonymous], 2017, MEDICAL IMAGE COMPUT, DOI DOI 10.1007/978-3-319-66179-7_72; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Armato SG, 2001, MED PHYS, V28, P1552, DOI 10.1118/1.1387272; Austin JHM, 1996, RADIOLOGY, V200, P327, DOI 10.1148/radiology.200.2.8685321; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen B, 2012, INT J COMPUT ASS RAD, V7, P465, DOI 10.1007/s11548-011-0638-5; Chumerin N, 2006, COMP 2 FEATURE EXTRA; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; de Carvalho AO, 2014, ARTIF INTELL MED, V60, P165, DOI 10.1016/j.artmed.2013.11.002; El-Baz A., 2013, INT J BIOMEDICAL IMA, V2013; Firmino M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-41; Ge ZY, 2005, MED PHYS, V32, P2443, DOI 10.1118/1.1944667; Gong J, 2018, PHYS MEDICA, V46, P124, DOI 10.1016/j.ejmp.2018.01.019; Gu Y, 2018, COMPUT BIOL MED, V103, P220, DOI 10.1016/j.compbiomed.2018.10.011; Hosseini-Asl E, 2016, IEEE T BIO-MED ENG, V63, P952, DOI 10.1109/TBME.2015.2482387; Janecek A., 2008, NEW CHALLENGES FEATU; Javaid M, 2016, COMPUT METH PROG BIO, V135, P125, DOI 10.1016/j.cmpb.2016.07.031; Jodas DS, 2016, EXPERT SYST APPL, V46, P1, DOI 10.1016/j.eswa.2015.10.016; Khalid S, 2014, SCI INF C SAI 2014; Li B, 2012, INT J COMPUTATIONAL, V4, P960; Li CF, 2018, IEEE ACCESS, V6, P16060, DOI 10.1109/ACCESS.2018.2817023; Li Q, 2003, MED PHYS, V30, P2040, DOI 10.1118/1.1581411; Li Q, 2008, ACAD RADIOL, V15, P165, DOI 10.1016/j.acra.2007.09.018; Li Z., 2015, IEEE T SERV COMPUT, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0124949; Li ZC, 2015, IEEE T IMAGE PROCESS, V24, P5343, DOI 10.1109/TIP.2015.2479560; Torres EL, 2015, MED PHYS, V42, P1477, DOI 10.1118/1.4907970; Lu L, 2015, MED PHYS, V42, P5042, DOI 10.1118/1.4927573; Lu X, 2015, OPTIK INT J LIGHT EL, V127, P1893; Pohjalainen J., 2013, COMPUTER SPEECH LANG, V29, P145; Reboucas PP, 2019, NEURAL COMPUT APPL, V31, P901, DOI 10.1007/s00521-017-3048-y; Reboucas PP, 2017, MED IMAGE ANAL, V35, P503, DOI 10.1016/j.media.2016.09.002; Riccardi A, 2011, MED PHYS, V38, P1962, DOI 10.1118/1.3560427; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sivakumar S, 2013, INT J ENG TECHNOL, V5, P179; Soliman A, 2017, IEEE T MED IMAGING, V36, P263, DOI 10.1109/TMI.2016.2606370; Sun T, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054726, 10.1371/journal.pone.0063559]; Tan M, 2011, MED PHYS, V38, P5630, DOI 10.1118/1.3633941; Teramoto A, 2013, INT J COMPUT ASS RAD, V8, P193, DOI 10.1007/s11548-012-0767-5; Wang B, 2015, MED PHYS, V42, P1241, DOI 10.1118/1.4907961; Wu S, 2012, 2012 3 GLOB C INT SY; Xie HT, 2019, PATTERN RECOGN, V85, P109, DOI 10.1016/j.patcog.2018.07.031; Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227; Zhang F, 2014, OPTIK, V125, P2383, DOI 10.1016/j.ijleo.2013.10.111; Zhang W, 2016, J MED IMAG HEALTH IN, V6, P1345, DOI 10.1166/jmihi.2016.1924; Zhang WH, 2017, COMPUT BIOL MED, V91, P168, DOI 10.1016/j.compbiomed.2017.10.005; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003; Zhou SJ, 2014, BIOMED SIGNAL PROCES, V13, P62, DOI 10.1016/j.bspc.2014.03.010; Zhu WT, 2018, IEEE WINT CONF APPL, P673, DOI 10.1109/WACV.2018.00079	51	24	25	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210551	10.1371/journal.pone.0210551	http://dx.doi.org/10.1371/journal.pone.0210551			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629724	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000108
J	Spettel, K; Barousch, W; Makristathis, A; Zeller, I; Nehr, M; Selitsch, B; Lackner, M; Rath, PM; Steinmann, J; Willinger, B				Spettel, Kathrin; Barousch, Wolfgang; Makristathis, Athanasios; Zeller, Iris; Nehr, Marion; Selitsch, Brigitte; Lackner, Michaela; Rath, Peter-Michael; Steinmann, Joerg; Willinger, Birgit			Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; AZOLE RESISTANCE; ECHINOCANDIN RESISTANCE; SACCHAROMYCES-CEREVISIAE; FKS MUTATIONS; CASPOFUNGIN; FLUCONAZOLE; SUSCEPTIBILITY; ERG11; MECHANISMS	Introduction/Objectives An increase in antifungal resistant Candida strains has been reported in recent years. The aim of this study was to detect mutations in resistance genes of azole-resistant, echinocandin-resistant or multi-resistant strains using next generation sequencing technology, which allows the analysis of multiple resistance mechanisms in a high throughput setting. Methods Forty clinical Candida isolates (16 C. albicans and 24 C. glabrata strains) with MICs for azoles and echinocandins above the clinical EUCAST breakpoint were examined. The genes ERG11, ERG3, TAC1 and GSC1 (FKS1) in C. albicans, as well as ERG11, CgPDR1, FKS1 and FKS2 in C. glabrata were sequenced. Results Fifty-four different missense mutations were identified, 13 of which have not been reported before. All nine echinocandin-resistant Candida isolates showed mutations in the hot spot (HS) regions of FKS1, FKS2 or GSC1. In ERG3 two homozygous premature stop codons were identified in two highly azole-resistant and moderately echinocandin-resistant C. albicans strains. Seven point mutations in ERG11 were determined in azole-resistant C. albicans whereas in azole-resistant C. glabrata, no ERG11 mutations were detected. In 10 out of 13 azole-resistant C. glabrata, 12 different potential gain-of-function mutations in the transcription factor CgPDR1 were verified, which are associated with an overexpression of the efflux pumps CDR1/2. Conclusion This study showed that next generation sequencing allows the thorough investigation of a large number of isolates more cost efficient and faster than conventional Sanger sequencing. Targeting different resistance genes and a large sample size of highly resistant strains allows a better determination of the relevance of the different mutations, and to differentiate between causal mutations and polymorphisms.	[Spettel, Kathrin; Barousch, Wolfgang; Makristathis, Athanasios; Zeller, Iris; Nehr, Marion; Selitsch, Brigitte; Willinger, Birgit] Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria; [Lackner, Michaela] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria; [Rath, Peter-Michael; Steinmann, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Steinmann, Joerg] Paracelsus Med Univ, Inst Clin Hyg Med Microbiol & Infectiol, Nurnberg, Germany	Medical University of Vienna; Medical University of Innsbruck; University of Duisburg Essen	Willinger, B (corresponding author), Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria.	birgit.willinger@meduniwien.ac.at	Lackner, Michaela/Q-9471-2018	Spettel, Kathrin/0000-0002-8901-8770; Willinger, Birgit/0000-0001-7921-5749	Pfizer Austria; Pfizer	Pfizer Austria(Pfizer); Pfizer(Pfizer)	This work was supported by a grant from Pfizer Austria. The funder had no role in study design, data analysis and preparation of the manuscript and in the decision to publish. Pure substance of micafungin was provided by Astellas GmbH, Austria. BW has received a grant by Pfizer and served on the speaker's bureau of Pfizer, Merck Sharpe & Dohme, Basilea, Gilead and Astellas.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Andrews S., 2010, FASTQC QUALITY CONTR; Arendrup M. C., EDUCAST DEFINITIVE D; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste AT, 2009, EUKARYOT CELL, V8, P1250, DOI 10.1128/EC.00069-09; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Desnos-Ollivier M, 2008, ANTIMICROB AGENTS CH, V52, P3092, DOI 10.1128/AAC.00088-08; Silva DBD, 2016, MEM I OSWALDO CRUZ, V111, P192, DOI 10.1590/0074-02760150400; Dudiuk C, 2015, J CLIN MICROBIOL, V53, P2037, DOI 10.1128/JCM.00398-15; European Committee on Antimicrobial Susceptibility Testing, 2013, AN RAT CLIN BREAKP V, V2013; Favre B, 1999, MICROBIOL-SGM, V145, P2715, DOI 10.1099/00221287-145-10-2715; Ferrari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017589; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Flowers SA, 2015, ANTIMICROB AGENTS CH, V59, P450, DOI 10.1128/AAC.03470-14; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P3690, DOI 10.1128/AAC.00443-09; Garnaud C, 2015, J ANTIMICROB CHEMOTH, V70, P2556, DOI 10.1093/jac/dkv139; Healey KR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11128; Illumina, 2013, 16S METAGENOMIC SEQU; Johnson ME, 2012, EUKARYOT CELL, V11, P952, DOI 10.1128/EC.00082-12; Johnson ME, 2011, ANTIMICROB AGENTS CH, V55, P3774, DOI 10.1128/AAC.01811-10; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Katiyar SK, 2012, ANTIMICROB AGENTS CH, V56, P6304, DOI 10.1128/AAC.00813-12; Klotz U, 2016, MYCOSES, V59, P312, DOI 10.1111/myc.12472; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lamb DC, 1997, J BIOL CHEM, V272, P5682, DOI 10.1074/jbc.272.9.5682; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Manastir L, 2011, MYCOSES, V54, P99, DOI 10.1111/j.1439-0507.2009.01766.x; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P2131, DOI 10.1093/jac/dks186; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3185, DOI 10.1128/JCM.00946-09; Pfaller MA, 2014, J CLIN MICROBIOL, V52, P3223, DOI 10.1128/JCM.00782-14; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rybak JM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00651-17; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Saraya T, 2014, J CLIN MICROBIOL, V52, P2709, DOI 10.1128/JCM.03593-13; Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Umesha S, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0436-4; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-167; Wiederhold NP, 2011, ANTIMICROB AGENTS CH, V55, P3254, DOI 10.1128/AAC.01750-10; Xu YH, 2015, ARCH MICROBIOL, V197, P1087, DOI 10.1007/s00203-015-1146-8; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Zimbeck AJ, 2010, ANTIMICROB AGENTS CH, V54, P5042, DOI 10.1128/AAC.00836-10	52	38	41	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210397	10.1371/journal.pone.0210397	http://dx.doi.org/10.1371/journal.pone.0210397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629653	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000079
J	Wilkinson, CM; Fedor, BA; Aziz, JR; Nadeau, CA; Brar, PS; Clark, JJA; Colbourne, F				Wilkinson, Cassandra M.; Fedor, Brittany A.; Aziz, Jasmine R.; Nadeau, Colby A.; Brar, Paul S.; Clark, Julia J. A.; Colbourne, Frederick			Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CHLORIDE HOMEOSTASIS; SEIZURE ACTIVITY; INJURY; COLLAGENASE; FUROSEMIDE; STROKE; HYPERTENSION; FREQUENCY; HEMATOMA	After intracerebral hemorrhage (ICH), brain edema commonly occurs and can cause death. Along with edema, there are significant alterations in the concentrations of key ions such as sodium, potassium, and chloride, which are essential to brain function. NKCC1, a cation-chloride cotransporter, is upregulated after brain damage, such as traumatic injury and ischemic stroke. NKCC1 brings sodium and chloride into the cell, possibly worsening ion dyshomeostasis. Bumetanide, a specific NKCC1 antagonist, blocks the transport of chloride into cells, and thus should attenuate the increases in chloride, which should lessen brain edema and improve neuronal functioning post-ICH, as with other injuries. We used the collagenase model of ICH to test whether bumetanide treatment for three days (vs. vehicle) would improve outcome. We gave bumetanide beginning at two hours or seven days post-ICH and measured behavioural outcome, edema, and brain ion content after treatment. There was some evidence for a minor reduction in edema after early dosing, but this did not improve behaviour or lessen injury. Contrary to our hypothesis, bumetanide did not normalize ion concentrations after late dosing. Bumetanide did not improve behavioural outcome or affect lesion volume. After ICH, bumetanide is safe to use in rats but does not improve functional outcome in the majority of animals.	[Wilkinson, Cassandra M.; Aziz, Jasmine R.; Nadeau, Colby A.; Brar, Paul S.; Clark, Julia J. A.; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Fedor, Brittany A.; Colbourne, Frederick] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Colbourne, F (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082	Canada Research Chair award; Undergraduate Research Initiative award; Alberta Innovates Health Solutions award; Heart and Stroke Foundation of Canada [G-16-00014065]	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Undergraduate Research Initiative award; Alberta Innovates Health Solutions award; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	FC is supported by a Canada Research Chair award (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). CMW is supported by an Undergraduate Research Initiative award (https://www.ualberta.ca/undergraduate-research-initiative/). JRA was supported by an Alberta Innovates Health Solutions award (http://albertain.com/companies/alberta-innovates-health-solutions/). This research was supported by the Heart and Stroke Foundation of Canada to FC (G-16-00014065, http://www.heartandstroke.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2008, VASC HEALTH RISK MAN, V4, P715; Bachmann O, 2003, J PHYSIOL-LONDON, V549, P525, DOI 10.1113/jphysiol.2002.030205; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Biffi A, 2016, BRAIN, V139, P2694, DOI 10.1093/brain/aww199; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; BRATER DC, 1983, CLIN PHARMACOL THER, V34, P207, DOI 10.1038/clpt.1983.154; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; DIXON DW, 1981, J CLIN PHARMACOL, V21, P680, DOI 10.1002/j.1552-4604.1981.tb05683.x; Eftekhari S, 2013, EPILEPSIA, V54, pe9, DOI 10.1111/j.1528-1167.2012.03654.x; Fernandez-Bouzas A, 2002, CLIN ELECTROENCEPHAL, V33, P70, DOI 10.1177/155005940203300205; Hiploylee C, 2014, EXP NEUROL, V255, P49, DOI 10.1016/j.expneurol.2014.02.017; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kaila K, 2010, EPILEPSIA, V51, P52, DOI 10.1111/j.1528-1167.2010.02838.x; Keep RF, 2008, ACT NEUR S, V105, P73; Keep RF, 2014, FLUIDS BARRIERS CNS, V11, DOI [10.1186/2045-8118-11-11, DOI 10.1186/2045-8118-11-11]; Klahr AC, 2016, THER HYPOTHERMIA TEM, V6, P40, DOI 10.1089/ther.2015.0028; Klahr AC, 2015, TRANSL STROKE RES, V6, P29, DOI 10.1007/s12975-014-0361-y; KONECKE LL, 1981, J CLIN PHARMACOL, V21, P688, DOI 10.1002/j.1552-4604.1981.tb05684.x; LEE SH, 1994, J PHARMACOKINET BIOP, V22, P1, DOI 10.1007/BF02353407; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; Merkler AE, 2018, STROKE, V49, P1319, DOI 10.1161/STROKEAHA.117.020178; Mesko MF, 2011, INT J MASS SPECTROM, V307, P137, DOI 10.1016/j.ijms.2011.04.009; Nadeau CA, 2018, TRANSL STROKE RES, DOI [10.1007/s12975-018-0636-910.1007/s12975-018-0636-9, DOI 10.1007/S12975-018-0636-910.1007/S12975-018-0636-9]; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Portbury SD, 2018, METALLOMICS, V10, P846, DOI 10.1039/c8mt00068a; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Romermann K, 2017, NEUROPHARMACOLOGY, V117, P182, DOI 10.1016/j.neuropharm.2017.02.006; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rubenstein JLR, 2013, CELLULAR MIGRATION F, DOI [10.1016/C2011-0-07731-1, DOI 10.1016/C2011-0-07731-1]; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah QA, 2007, J NEUROL SCI, V261, P74, DOI 10.1016/j.jns.2007.04.036; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sun D, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P501; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Tollner K, 2015, EUR J PHARMACOL, V746, P167, DOI 10.1016/j.ejphar.2014.11.019; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; van der Heijden M, 1998, J CLIN PHARMACOL, V38, P630, DOI 10.1002/j.1552-4604.1998.tb04470.x; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang F, 2016, BRAIN STRUCT FUNCT, V222, P1, DOI [10.1007/s00429-016-1218-9, DOI 10.1007/S00429-016-1218-9]; Wang GB, 2014, INT J CLIN EXP PATHO, V7, P1487; Williamson MR, 2017, TRANSL STROKE RES, V8, P386, DOI 10.1007/s12975-017-0530-x; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Xu WS, 2017, MOL NEUROBIOL, V54, P2406, DOI 10.1007/s12035-016-9819-0; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001	52	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210660	10.1371/journal.pone.0210660	http://dx.doi.org/10.1371/journal.pone.0210660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629699	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000121
J	Yuen, KCP; Qiu, XY; Mou, HY; Xi, X				Yuen, Kevin Chi Pun; Qiu, Xin Yue; Mou, Hong Yu; Xi, Xin			The MAndarin spoken word-Picture IDentification test in noise-Adaptive (MAPID-A) measures subtle speech-recognition-in-noise changes and spatial release from masking in very young children	PLOS ONE			English	Article							NORMAL-HEARING; NORMATIVE DATA; OLIVOCOCHLEAR BUNDLE; AGE; INTELLIGIBILITY; ANTIMASKING; INVOLVEMENT; GROWTH; QUIET; SOUND	Background Spatial release of masking (SRM) is a measure of an individual's ability to perform speech-noise segregation, which is usually quantified by the extent of improvement of the individual's speech recognition performance when the noise is switched from a spatially co-located position (e.g., speech and noise both presented from the front) to a spatially separated position (e.g., speech presented from the front and noise presented from the right side) with reference to the target speech. SRM is a combined measure of head shadow and binaural unmasking benefits. SRM has only been investigated in young children at group level but not at individual participant level in the international literature due to the lack of reliable speech recognition test materials able to detect subtle statistically significant within-participant changes in speech-recognition-in-noise thresholds. Method The performance to signal-to-noise ratio (P-SNR) functions of twenty-four disyllabic words were obtained from 40 native Mandarin-speaking children aged 3.6-6.2 years with reported normal speech, language and hearing. The test items' difficulty levels were homogenized by adjusting the speech intensity level of each item so that the adjusted signal-to-noise ratio for 50% correct score (SNR-50%) point of each item would overlap at the mean SNR-50% point of all test items. In the MAPID-A, the homogenized test items were randomly presented in an adaptive testing procedure at a fixed noise intensity level, but the speech intensity level of the upcoming test item varied in 2-dB SNR steps depending on the recognition result of the previous test item. The SNR reversal point is marked by a change from a decrease to an increase in the SNR or vice versa. Two successive SNR reversal points marked the boundaries of an excursion. The mid-points from 12 excursions (in dB SNR) were averaged to produce the adaptive SNR-50% measure (aSNR-50%). Results The aSNR-50% results were obtained from another 12 children aged 4.8-5.3 years with reported normal speech, language and hearing. The average 99% confidence interval (CI) of all participants' mean aSNR-50% values was +/- 1.61 dB SNR; therefore, 3.22 dB SNR was the average critical difference required to confirm a significant difference in the scores obtained from the same participant between two test conditions. Statistically significant within-participant SRM was identified in 95% of the participants; in other words, aSNR-50% obtained from the spatially separated condition outperformed aSNR-50% obtained from the spatially co-located condition. The adaptive testing procedure was highly reliable, with an within-participant test-retest reliability of 90.6%. and significantly limited testing time to an average of 4.2 min. This research study has fulfilled its aim on detecting subtle within-participant SRM in very young children starting from 4 years of age with a reliable statistical procedure. MAPID-A offers a reliable and efficient clinical tool to investigate speech-recognition-in- noise and SRM performances in young Mandarin-speaking children. Conclusions The narrow CIs, high test-retest reliability, and short testing time has proven that the MAPID-A is a promising sensitive, reliable and time-efficient clinical tool to detect subtle within-participant speech-recognition-in-noise changes in children as young as 4-5 years. The MAPID-A offers a clinical tool to behaviorally track young children's development in speech-recognition-in-noise and SRM, and to potentially review the development of the auditory neural pathway and the cerebral dominance for speech-recognition-in-noise in young children.	[Yuen, Kevin Chi Pun; Qiu, Xin Yue] Educ Univ Hong Kong, Dept Special Educ & Counselling, Tai Po, Hong Kong, Peoples R China; [Yuen, Kevin Chi Pun; Qiu, Xin Yue] Educ Univ Hong Kong, Integrated Ctr Wellbeing I WELL, Tai Po, Hong Kong, Peoples R China; [Mou, Hong Yu] Chinese Acad Sci, Shanghai Acoust Lab, Bion Ear & Sound Technol Lab, Shanghai, Peoples R China; [Xi, Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK); Chinese Academy of Sciences; Chinese People's Liberation Army General Hospital	Yuen, KCP (corresponding author), Educ Univ Hong Kong, Dept Special Educ & Counselling, Tai Po, Hong Kong, Peoples R China.; Yuen, KCP (corresponding author), Educ Univ Hong Kong, Integrated Ctr Wellbeing I WELL, Tai Po, Hong Kong, Peoples R China.	cpyuen@eduhk.hk		Xi, Xin/0000-0001-7806-8396	General Research Fund, University Grants Committee, Research Grant Council, Hong Kong [18100415]	General Research Fund, University Grants Committee, Research Grant Council, Hong Kong	This study was supported by General Research Fund, University Grants Committee, Research Grant Council, Hong Kong, https://www.ugc.edu.hk/eng/rgc/index.html (Project number: 18100415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Ambrose SE, 2014, EAR HEARING, V35, P139, DOI 10.1097/AUD.0b013e3182a76768; American Speech-Language-Hearing Association, 2005, AC ED SEETT POS STAT; Anderson J., 2007, HDB CENTRAL AUDITORY, V1, P207; Anzo M, 2002, ANN HUM BIOL, V29, P373, DOI 10.1080/03014460110089526; Barker BA, 2004, COGNITION, V94, pB45, DOI 10.1016/j.cognition.2004.06.001; Bhagat SP, 2010, NEUROSCI LETT, V485, P94, DOI 10.1016/j.neulet.2010.08.069; Bidelman GM, 2015, NEUROREPORT, V26, P483, DOI 10.1097/WNR.0000000000000376; Bregman A.S., 1990, AUDITORY SCENE ANAL; Breznitz Z., 2006, FLUENCY READING SYNC; Cameron S, 2006, INT J AUDIOL, V45, P99, DOI 10.1080/14992020500377931; Ching TYC, 2011, J ACOUST SOC AM, V129, P368, DOI 10.1121/1.3523295; CLIFTON RK, 1988, DEV PSYCHOL, V24, P477, DOI 10.1037/0012-1649.24.4.477; Crandell CC, 2000, LANG SPEECH HEAR SER, V31, P362, DOI 10.1044/0161-1461.3104.362; EGAN JP, 1948, LARYNGOSCOPE, V58, P955, DOI 10.1288/00005537-194809000-00002; ELLIOTT LL, 1979, J ACOUST SOC AM, V66, P12, DOI 10.1121/1.383065; Fallon M, 2000, J ACOUST SOC AM, V108, P3023, DOI 10.1121/1.1323233; Fels J, 2004, ACTA ACUST UNITED AC, V90, P918; Garadat SN, 2007, J ACOUST SOC AM, V121, P1047, DOI 10.1121/1.2409863; Giraud AL, 1995, BRAIN RES, V705, P15, DOI 10.1016/0006-8993(95)01091-2; Hall JW, 2002, EAR HEARING, V23, P159, DOI 10.1097/00003446-200204000-00008; HYND GW, 1979, J EXP CHILD PSYCHOL, V28, P445, DOI 10.1016/0022-0965(79)90074-2; Ihlefeld A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045296; Jamieson Donald G, 2004, J Am Acad Audiol, V15, P508, DOI 10.3766/jaaa.15.7.5; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Lapierre MA, 2012, PEDIATRICS, V130, P839, DOI 10.1542/peds.2011-2581; Litovsky Ruth, 2015, Handb Clin Neurol, V129, P55, DOI 10.1016/B978-0-444-62630-1.00003-2; Litovsky RY, 2005, J ACOUST SOC AM, V117, P3091, DOI 10.1121/1.1873913; Lovett RES, 2012, J SPEECH LANG HEAR R, V55, P865, DOI 10.1044/1092-4388(2011/11-0096); MACLEOD A, 1990, British Journal of Audiology, V24, P29, DOI 10.3109/03005369009077840; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; MILLER GA, 1947, PSYCHOL BULL, V44, P105, DOI 10.1037/h0055960; Misurelli SM, 2012, J ACOUST SOC AM, V132, P380, DOI 10.1121/1.4725760; MOORE DR, 1991, AUDIOLOGY, V30, P125; Moore DR, 2004, SPRINGER HDB AUDITOR; Muchnik C, 2004, AUDIOL NEURO-OTOL, V9, P107, DOI 10.1159/000076001; Murphy J, 2011, INT J PEDIATR OTORHI, V75, P489, DOI 10.1016/j.ijporl.2011.01.002; Myhrum M, 2016, EAR HEARING, V37, P80, DOI 10.1097/AUD.0000000000000224; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Nishi K, 2010, J ACOUST SOC AM, V127, P3177, DOI 10.1121/1.3377080; Nissen SL, 2005, INT J AUDIOL, V44, P379, DOI 10.1080/14992020500147615; NOZZA RJ, 1988, J SPEECH HEAR RES, V31, P212, DOI 10.1044/jshr.3102.212; Picard M, 2001, AUDIOLOGY, V40, P221; PLOMP R, 1977, ACUSTICA, V38, P186; PLOMP R, 1976, ACUSTICA, V34, P201; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Schienkiewitz A, 2011, ACTA PAEDIATR, V100, pe28, DOI 10.1111/j.1651-2227.2011.02173.x; Stollman MHP, 2003, INT J AUDIOL, V42, P303, DOI 10.3109/14992020309101322; Stuart A, 2005, EAR HEARING, V26, P78, DOI 10.1097/00003446-200502000-00007; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Vaillancourt V, 2008, EAR HEARING, V29, P453, DOI 10.1097/01.aud.0000310792.55221.0c; Van Deun L, 2010, EAR HEARING, V31, P702, DOI 10.1097/AUD.0b013e3181e40dfe; Vitevitch MS, 1999, BRAIN LANG, V68, P306, DOI 10.1006/brln.1999.2116; Wightman FL, 2005, J ACOUST SOC AM, V118, P3164, DOI 10.1121/1.2082567; Wilson RH, 2010, J SPEECH LANG HEAR R, V53, P1111, DOI 10.1044/1092-4388(2010/09-0270); Yuen KCP, 2014, J SPEECH LANG HEAR R, V57, P2005, DOI 10.1044/2014_JSLHR-H-13-0060; Yuen Kevin C P, 2009, Cochlear Implants Int, V10 Suppl 1, P138, DOI 10.1179/cim.2009.10.Supplement-1.138	59	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209768	10.1371/journal.pone.0209768	http://dx.doi.org/10.1371/journal.pone.0209768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629627	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000032
J	Kumar, R; Gong, HL; Liu, LY; Ramos-Solis, N; Seye, CI; Derbigny, WA				Kumar, Ramesh; Gong, Haoli; Liu, Luyao; Ramos-Solis, Nicole; Seye, Cheikh I.; Derbigny, Wilbert A.			TLR3 deficiency exacerbates the loss of epithelial barrier function during genital tract Chlamydia muridarum infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; JUNCTION MOLECULE NECTIN-1; FEMALE REPRODUCTIVE-TRACT; GAMMA-INTERFERON; TRACHOMATIS INFECTION; IMMUNE-RESPONSE; FACTOR CPAF; IFN-BETA; T-CELLS	Problem Chlamydia trachomatis infections are often associated with acute syndromes including cervicitis, urethritis, and endometritis, which can lead to chronic sequelae such as pelvic inflammatory disease (PID), chronic pelvic pain, ectopic pregnancy, and tubal infertility. As epithelial cells are the primary cell type productively infected during genital tract Chlamydia infections, we investigated whether Chlamydia has any impact on the integrity of the host epithelial barrier as a possible mechanism to facilitate the dissemination of infection, and examined whether TLR3 function modulates its impact. Method of study We used wild-type and TLR3-deficient murine oviduct epithelial (OE) cells to ascertain whether C. muridarum infection had any effect on the epithelial barrier integrity of these cells as measured by transepithelial resistance (TER) and cell permeability assays. We next assessed whether infection impacted the transcription and protein function of the cellular tight-junction (TJ) genes for claudins1-4, ZO-1, JAM1 and occludin via quantitative real-time PCR (qPCR) and western blot. Results qPCR, immunoblotting, transwell permeability assays, and TER studies show that Chlamydia compromises cellular TJ function throughout infection in murine OE cells and that TLR3 deficiency significantly exacerbates this effect. Conclusion Our data show that TLR3 plays a role in modulating epithelial barrier function during Chlamydia infection of epithelial cells lining the genital tract. These findings propose a role for TLR3 signaling in maintaining the integrity of epithelial barrier function during genital tract Chlamydia infection, a function that we hypothesize is important in helping limit the chlamydial spread and subsequent genital tract pathology.	[Kumar, Ramesh; Gong, Haoli; Liu, Luyao; Ramos-Solis, Nicole; Derbigny, Wilbert A.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Gong, Haoli; Liu, Luyao] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Seye, Cheikh I.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Central South University; Indiana University System; Indiana University Bloomington	Derbigny, WA (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	wderbign@iupui.edu	Kumar, Ramesh/U-8358-2019; Kumar, Ramesh/A-8258-2019		National Institutes of Health [1R01AI104944]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (https://www.nih.gov/) Grant 1R01AI104944 awarded to WAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Belair C, 2009, CLIN MICROBIOL INFEC, V15, P806, DOI 10.1111/j.1469-0691.2009.02960.x; Borkowski AW, 2015, J INVEST DERMATOL, V135, P569, DOI 10.1038/jid.2014.354; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carrasco SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195165; CDC, 2018, NEW CDC AN SHOWS STE; CDC, 2004, DSTDP FACTS CHLAM US; CDC, 2017, 2015 SEX TRANSM DIS; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; da Costa CUP, 2004, EUR J IMMUNOL, V34, P2874, DOI 10.1002/eji.200425101; Dai J, 2016, MICROBES INFECT, V18, P190, DOI 10.1016/j.micinf.2015.11.003; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; DARVILLE T, 2000, PERSISTENT BACTERIAL, P229; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; Derbigny WA, 2012, INFECT IMMUN, V80, P254, DOI 10.1128/IAI.05549-11; Derbigny WA, 2010, J IMMUNOL, V185, P6689, DOI 10.4049/jimmunol.1001548; Ebihara T, 2008, HEPATOLOGY, V48, P48, DOI 10.1002/hep.22337; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hering NA, 2017, ANN NY ACAD SCI, V1405, P177, DOI 10.1111/nyas.13405; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Ho LS, 2010, CELL BIOL INT, V34, P951, DOI 10.1042/CBI20100303; Hu SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119235; Hu YJ, 2013, MOL BIOL REP, V40, P6123, DOI 10.1007/s11033-013-2724-y; Igietseme JU, 1998, INFECT IMMUN, V66, P4030; Ito JI, 1999, INFECT IMMUN, V67, P5518, DOI 10.1128/IAI.67.10.5518-5521.1999; Jiang W, 2008, MOL IMMUNOL, V45, P2038, DOI 10.1016/j.molimm.2007.10.019; Johansson M, 1997, INFECT IMMUN, V65, P1032, DOI 10.1128/IAI.65.3.1032-1044.1997; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kraus J, 2004, ANN NEUROL, V56, P192, DOI 10.1002/ana.20161; Lander HM, 2014, AM J TROP MED HYG, V90, P993, DOI 10.4269/ajtmh.13-0382; Lien E, 2009, CURR MOL MED, V9, P52, DOI 10.2174/156652409787314453; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacIntyre A, 2002, FEMS MICROBIOL LETT, V217, P167, DOI 10.1016/S0378-1097(02)01066-2; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Minagar A, 2003, ENDOTHELIUM-J ENDOTH, V10, P299, DOI 10.1080/10623320390272299; Mukura LR, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12764; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Prozialeck WC, 2002, INFECT IMMUN, V70, P2605, DOI 10.1128/IAI.70.5.2605-2613.2002; Roan NR, 2008, CELL MICROBIOL, V10, P9, DOI 10.1111/j.1462-5822.2007.01069.x; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Schachter J., 1980, CHLAMYDIAE PSITTACOS; Sun J, 2008, MICROBIOL-SGM, V154, P1290, DOI 10.1099/mic.0.2007/015164-0; Sun JR, 2009, MICROBES INFECT, V11, P12, DOI 10.1016/j.micinf.2008.10.001; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525	61	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0207422	10.1371/journal.pone.0207422	http://dx.doi.org/10.1371/journal.pone.0207422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625140	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400007
J	Sharma, A; Bandyopadhayaya, S; Chowdhury, K; Sharma, T; Maheshwari, R; Das, A; Chakrabarti, G; Kumar, V; Mandal, CC				Sharma, Ankit; Bandyopadhayaya, Shreetama; Chowdhury, Kaushik; Sharma, Tanu; Maheshwari, Rekha; Das, Amlan; Chakrabarti, Gopal; Kumar, Vipin; Mandal, Chandi C.			Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC-CANCER; LDL CHOLESTEROL; FATTY-ACID; SIMVASTATIN; EXPRESSION; GROWTH; TRANSCRIPTION; KINASE; LIVER	Metformin, a widely prescribed anti-diabetic drug, shows anticancer activity in various cancer types. Few studies documented that there was a decreased level of LDL and total cholesterol in blood serum of metformin users. Based on these views, this study aimed to determine if metformin exhibits anticancer activity by alleviating cholesterol level in cancer cells. The present study found that treatment of breast cancer MDA-MB-231 cells with metformin significantly decreased cholesterol content with concomitant inhibition of various cholesterol regulatory genes (e.g., HMGCoR, LDLR and SREBP1). Metformin decreased cell viability, migration and stemness in metastatic MDA-MB-231 cells. Similarly, metformin treatment suppressed expressions of anti-apoptotic genes BCL2 and Bcl-xL, and mesenchymal genes vimentin, N-cadherin, Zeb1 and Zeb2 with simultaneous enhancement of apoptotic caspase 3 and Bax, and epithelial genes E-cadherin and keratin 19 expressions, confirming an inhibitory effect of metformin in tumorigenesis. Similar to metformin, depletion of cholesterol by methyl beta cyclodextrin (MBCD) diminished cell viability, migration, EMT and stemness in breast cancer cells. Moreover, metformin-inhibited cell viability, migration, colony and sphere formations were reversed back by cholesterol treatment. Similarly, cholesterol treatment inverted metformin-reduced several gene expressions (e.g., Bcl-xL, BCL2, Zeb1, vimentin, and BMI-1). Additionally, zymography data demonstrated that cholesterol upregulated metformin-suppressed MMP activity. These findings suggested that metformin revealed anticancer activity by lowering of cholesterol content in breast cancer cells. Thus, this study, for the first time, unravelled this additional mechanism of metformin-mediated anticancer activity.	[Sharma, Ankit; Bandyopadhayaya, Shreetama; Chowdhury, Kaushik; Sharma, Tanu; Mandal, Chandi C.] Cent Univ Rajasthan, Sch Life Sci, Dept Biochem, Ajmer, India; [Maheshwari, Rekha] JLN Hosp, Dept Surg, Ajmer, India; [Das, Amlan] Natl Inst Technol, Dept Biotechnol, Ravangla, India; [Chakrabarti, Gopal] Univ Calcutta, Dept Biotechnol, Kolkata, India; [Chakrabarti, Gopal] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Kumar, Vipin] Cent Univ Rajasthan, Dept Pharm, Ajmer, India	Central University of Rajasthan (CURAJ); National Institute of Technology (NIT System); National Institute of Technology Sikkim; University of Calcutta; University of Calcutta; Central University of Rajasthan (CURAJ)	Mandal, CC (corresponding author), Cent Univ Rajasthan, Sch Life Sci, Dept Biochem, Ajmer, India.	chandicmandal@gmail.com	Das, Amlan/HHC-0898-2022	Das, Amlan/0000-0002-9295-3743; Mandal, Chandi/0000-0002-2292-6635; Chowdhury, Kaushik/0000-0001-5359-2458	University Grants Commission (UGC) [30-49/2014 (BSR)]; Department of Biotechnology (DBT) [6242 P9/RGCB/PMD/DBT/CCML/2015]; Indo-Russia project [INT/RUS/RFBR/P-256]; DST-SERB [EMR 2014/000928]; Central University of Rajasthan, India; DST-INSPIRE fellowship by DST, India [IF140765]	University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indo-Russia project; DST-SERB; Central University of Rajasthan, India; DST-INSPIRE fellowship by DST, India	This work is supported by University Grants Commission (UGC) [30-49/2014 (BSR)], Department of Biotechnology (DBT) [6242 P9/RGCB/PMD/DBT/CCML/2015], Indo-Russia project [INT/RUS/RFBR/P-256] (CCM), DST-SERB (EMR 2014/000928) (VK) and Central University of Rajasthan, India. TS is supported by DST-INSPIRE fellowship [IF140765] provided by DST, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha YK, 2016, TUMOR BIOL, V37, P8529, DOI 10.1007/s13277-016-4988-z; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Babcook MA, 2014, MOL CANCER THER, V13, P2288, DOI 10.1158/1535-7163.MCT-14-0451; BENNIS F, 1993, INT J CANCER, V55, P640, DOI 10.1002/ijc.2910550421; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Chowdhury K, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00593; Chowdhury K, 2017, CANCER INVEST, V35, P403, DOI 10.1080/07357907.2017.1309548; Cignarelli A, 2018, DIABETES RES CLIN PR; Das A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068224; Gallagher EJ, 2017, ONCOGENE, V36, P6462, DOI 10.1038/onc.2017.247; GAMBLE W, 1978, J LIPID RES, V19, P1068; Ghosh-Choudhury N, 2013, J BIOL CHEM, V288, P24503, DOI 10.1074/jbc.M113.455733; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Han BY, 2015, TUMOR BIOL, V36, P6295, DOI 10.1007/s13277-015-3315-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Lei Y, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0184-9; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu Z, 2018, BIOCH BIOPHYSICAL RE; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Mandal CC, 2016, TUMOR BIOL, V37, P9635, DOI 10.1007/s13277-016-4799-2; Mandal Chandi C, 2014, J Cancer Sci Ther, V6, P510; Mandal CC, 2016, J BIOL CHEM, V291, P1148, DOI 10.1074/jbc.M115.668939; Mandal CC, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00165; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2012, CARCINOGENESIS, V33, P1897, DOI 10.1093/carcin/bgs198; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Mandal CC, 2010, BIOCHEM BIOPH RES CO, V402, P602, DOI 10.1016/j.bbrc.2010.10.063; Martin BJ, 2012, INT J BREAST CANC, V412581, P31; Martin BJ, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/412581; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mohammad N, 2014, MOL CANCER, V13, P1476; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nieva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046456; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; RUDLING MJ, 1990, CANCER RES, V50, P483; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Siqingaowa, 2017, BIOCHEM BIOPH RES CO, V488, P136, DOI 10.1016/j.bbrc.2017.05.023; Stranzl A, 1997, BREAST CANCER RES TR, V42, P195, DOI 10.1023/A:1005754026205; Sun Y, 2015, TUMOR BIOL, V36, P4133, DOI 10.1007/s13277-015-3047-5; Teranishi T, 2007, METABOLISM, V56, P1418, DOI 10.1016/j.metabol.2007.06.005; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Wahdan-Alaswad RS, 2014, HORM CANCER-US, V5, P374, DOI 10.1007/s12672-014-0188-8; Wulffele MG, 2004, J INTERN MED, V256, P1, DOI 10.1111/j.1365-2796.2004.01328.x; Xu T, 2015, DIABETES CARE, V38, P1858, DOI 10.2337/dc15-0658; Yamaguchi R, 2015, FEBS LETT, V589, P4097, DOI 10.1016/j.febslet.2015.11.009; Yamato I, 2012, CANCER RES, V72, P4829, DOI 10.1158/0008-5472.CAN-12-0328; Zhang J, 2014, BIOCHEM BIOPH RES CO, V452, P746, DOI 10.1016/j.bbrc.2014.08.154; Zhang RR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0249-0; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	49	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209435	10.1371/journal.pone.0209435	http://dx.doi.org/10.1371/journal.pone.0209435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625181	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400038
J	Kang, ES; Hwang, JS; Lee, WJ; Lee, GH; Choi, MJ; Paek, KS; Lim, DS; Seo, HG				Kang, Eun Sil; Hwang, Jung Seok; Lee, Won Jin; Lee, Gyeong Hee; Choi, Mi-Jung; Paek, Kyung Shin; Lim, Dae-Seog; Seo, Han Geuk			Ligand-activated PPAR delta inhibits angiotensin II-stimulated hypertrophy of vascular smooth muscle cells by targeting ROS	PLOS ONE			English	Article							PTEN-MEDIATED INHIBITION; RECEPTOR-DELTA; OXIDATIVE STRESS; INDUCED HYPERTENSION; INDUCED SENESCENCE; NOX1; PROLIFERATION; KERATINOCYTES; MACROPHAGE; APOPTOSIS	We investigated the effect of peroxisome proliferator-activated receptor delta (PPAR delta) on angiotensin II (Ang II)-triggered hypertrophy of vascular smooth muscle cells (VSMCs). Activation of PPAR delta by GW501516, a specific ligand of PPAR delta, significantly inhibited Ang II stimulated protein synthesis in a concentration-dependent manner, as determined by [H-3]-leucine incorporation. GW501516-activated PPAR delta also suppressed Ang II-induced generation of reactive oxygen species (ROS) in VSMCs. Transfection of small interfering RNA (siRNA) against PPAR delta significantly reversed the effects of GW501516 on [H-3]-leucine incorporation and ROS generation, indicating that PPAR delta is involved in these effects. By contrast, these GW501516-mediated actions were potentiated in VSMCs transfected with siRNA against NADPH oxidase (NOX) 1 or 4, suggesting that ligand-activated PPAR delta elicits these effects by modulating NOX-mediated ROS generation. The phosphatidylinositol 3-kinase inhibitor LY294002 also inhibited Ang II-stimulated [H-3]-leucine incorporation and ROS generation by preventing membrane translocation of Rac1. These observations suggest that PPAR delta is an endogenous modulator of Ang II -triggered hypertrophy of VSMCs, and is thus a potential target to treat vascular diseases associated with hypertrophic changes of VSMCs.	[Kang, Eun Sil; Hwang, Jung Seok; Lee, Won Jin; Lee, Gyeong Hee; Choi, Mi-Jung; Seo, Han Geuk] Konkuk Univ, Coll Sang Huh Life Sci, Seoul, South Korea; [Paek, Kyung Shin] Semyung Univ, Dept Nursing, Jechon, South Korea; [Lim, Dae-Seog] CHA Univ, Dept Biotechnol, Seongnam, South Korea	Konkuk University; Semyung University; Pochon Cha University	Seo, HG (corresponding author), Konkuk Univ, Coll Sang Huh Life Sci, Seoul, South Korea.	hgseo@konkuk.ac.kr		Lee, Won Jin/0000-0003-1164-8198	Konkuk University	Konkuk University	This work was supported by Konkuk University in 2017 to HGS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 2018, J VASC RES, V55, P75, DOI 10.1159/000486570; Barth BM, 2009, MOL CELL NEUROSCI, V41, P274, DOI 10.1016/j.mcn.2009.03.007; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Didion SP, 2016, HYPERTENSION, V67, P501, DOI 10.1161/HYPERTENSIONAHA.115.06737; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Diep QN, 2002, HYPERTENSION, V40, P866, DOI 10.1161/01.HYP.0000037969.41360.CC; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Ham SA, 2012, BIOCHEM J, V444, P27, DOI 10.1042/BJ20111832; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; Hwang JS, 2016, MOL PHARMACOL, V90, P522, DOI 10.1124/mol.116.104679; Hwang JS, 2015, INT J BIOCHEM CELL B, V62, P54, DOI 10.1016/j.biocel.2015.02.014; Kim HJ, 2010, CELL MOL LIFE SCI, V67, P2119, DOI 10.1007/s00018-010-0328-4; Kim HJ, 2008, CIRC RES, V102, P193, DOI 10.1161/CIRCRESAHA.107.158477; Kim HJ, 2011, J BIOL CHEM, V286, P44585, DOI 10.1074/jbc.M111.222562; Kim HJ, 2011, BIOCHEM BIOPH RES CO, V406, P564, DOI 10.1016/j.bbrc.2011.02.091; Kim HJ, 2009, CIRC RES, V105, P16, DOI 10.1161/CIRCRESAHA.108.189159; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Liu JH, 2003, ARTERIOSCL THROM VAS, V23, P776, DOI 10.1161/01.ATV.0000066684.37829.16; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Pesant M, 2006, CARDIOVASC RES, V69, P440, DOI 10.1016/j.cardiores.2005.10.019; Romero M, 2016, J PHARMACOL EXP THER, V358, P151, DOI 10.1124/jpet.116.233106; Sawada N, 2010, CURR OPIN PHARMACOL, V10, P116, DOI 10.1016/j.coph.2009.11.004; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Takahashi T, 1996, FEBS LETT, V397, P89, DOI 10.1016/S0014-5793(96)01145-3; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Tao L, 2003, CIRCULATION, V108, P2805, DOI 10.1161/01.CIR.0000097003.49585.5E; Toral M, 2017, AM J PHYSIOL-HEART C, V312, pH189, DOI 10.1152/ajpheart.00155.2016; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Wagner KD, 2016, PPAR RES, V2016, DOI 10.1155/2016/7631085; Weber DS, 2005, AM J PHYSIOL-HEART C, V288, pH37, DOI 10.1152/ajpheart.00638.2004; Yamakawa T, 2003, EUR J PHARMACOL, V478, P39, DOI 10.1016/j.ejphar.2003.08.044; Yoo T, 2018, DIABETES, V67, P360, DOI 10.2337/db17-0499; Zhang CX, 2003, AM J PHYSIOL-HEART C, V285, pH2563, DOI 10.1152/ajpheart.00435.2003	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210482	10.1371/journal.pone.0210482	http://dx.doi.org/10.1371/journal.pone.0210482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620754	Green Published, gold, Green Submitted			2022-12-26	WOS:000455161300038
J	Kim, D; Ho, CH; Park, DSR; Kim, J				Kim, Dasol; Ho, Chang-Hoi; Park, Doo-Sun R.; Kim, Jinwon			Influence of vertical wind shear on wind- and rainfall areas of tropical cyclones making landfall over South Korea	PLOS ONE			English	Article							WESTERN NORTH PACIFIC; EXTRATROPICAL TRANSITION; PART I; CONVECTIVE ASYMMETRIES; STORM MOTION; LIFE-CYCLE; SIZE; INTENSITY; PRECIPITATION; EVOLUTION	The wind- and rainfall areas of tropical cyclones (TCs) making landfall over South Korea were examined for the period 1998-2013 by using the Modern Era Retrospective Analysis for Research and Applications, version 2 (MERRA-2) and Tropical Rainfall Measuring Mission (TRMM) 3B42 data. Here, the wind- and rainfall areas were defined as the regions where wind speeds and precipitation rates exceed 14 m s(-1) and 80 mm day(-1) within 1000 km from the TC center, respectively. In general, TCs show significantly asymmetric wind and rainfall structures, with strong vertical wind shear appearing over South Korea during the landfall period. The rainfall area significantly increases with environmental vertical wind shear while the wind area is not sensitive to it. Composite analyses of the cases of strong and weak vertical wind shear confirm that the increase of rainfall area is related to the asymmetric convection (rising/sinking motion in the downshear-left/upshear-right side) induced by the vertical wind shear. This work highlights the importance of local atmospheric environment in determining the area primarily affected by strong winds or heavy rainfall during TC landfalls.	[Kim, Dasol; Ho, Chang-Hoi] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Park, Doo-Sun R.] Chosun Univ, Dept Earth Sci, Gwangju, South Korea; [Kim, Jinwon] Korea Meteorol Adm, Natl Inst Meteorol Sci, Jeju Do, South Korea	Seoul National University (SNU); Chosun University; Korea Meteorological Administration (KMA); National Institute of Meteorological Sciences	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.; Park, DSR (corresponding author), Chosun Univ, Dept Earth Sci, Gwangju, South Korea.	hoch@cpl.snu.ac.kr; dsrpark@chosun.ac.kr	Park, Doo-Sun R/H-2793-2014; Kim, Dasol/GWR-1499-2022; Ho, Chang-Hoi/H-8354-2015; Park, Doo-Sun/U-9448-2019	Park, Doo-Sun R/0000-0002-4871-1341; Kim, Dasol/0000-0001-9523-8887; Park, Doo-Sun/0000-0002-4871-1341; Ho, Chang-Hoi/0000-0002-1372-0037	Korea Meteorological Administration Research and Development Program [KM12018-07510]	Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA))	This study was funded by the Korea Meteorological Administration Research and Development Program under Grant [KM12018-07510]. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bosart LF, 2000, MON WEATHER REV, V128, P322, DOI 10.1175/1520-0493(2000)128<0322:EIOTRI>2.0.CO;2; Bosilovich MG., 2015, NASATM2015104606, V43; Brennan MJ, 2009, WEATHER FORECAST, V24, P621, DOI 10.1175/2008WAF2222188.1; Cangialosi JP, 2016, WEATHER FORECAST, V31, P1293, DOI 10.1175/WAF-D-15-0158.1; Chan JCL, 2003, J ATMOS SCI, V60, P1560, DOI 10.1175/1520-0469(2003)60<1560:CAAWTC>2.0.CO;2; Chan KTF, 2015, INT J CLIMATOL, V35, P4843, DOI 10.1002/joc.4307; Chan KTF, 2014, Q J ROY METEOR SOC, V140, P2235, DOI 10.1002/qj.2292; Chan KTF, 2013, MON WEATHER REV, V141, P3985, DOI 10.1175/MWR-D-12-00204.1; Chan KTF, 2012, MON WEATHER REV, V140, P811, DOI 10.1175/MWR-D-10-05062.1; Chavas DR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044558; Chavas DR, 2016, J CLIMATE, V29, P2923, DOI 10.1175/JCLI-D-15-0731.1; Chen SYS, 2006, MON WEATHER REV, V134, P3190, DOI 10.1175/MWR3245.1; Chen YJ, 2013, J GEOPHYS RES-ATMOS, V118, P2184, DOI 10.1002/jgrd.50250; Chen YS, 2003, J ATMOS SCI, V60, P2294, DOI 10.1175/1520-0469(2003)060<2294:ASIASL>2.0.CO;2; Choi KS, 2010, INT J CLIMATOL, V30, P1472, DOI 10.1002/joc.1986; Cocks SB, 2002, MON WEATHER REV, V130, P1989, DOI 10.1175/1520-0493(2002)130<1989:VOTOWP>2.0.CO;2; Corbosiero KL, 2003, J ATMOS SCI, V60, P366, DOI 10.1175/1520-0469(2003)060<0366:TRBSMV>2.0.CO;2; Corbosiero KL, 2002, MON WEATHER REV, V130, P2110, DOI 10.1175/1520-0493(2002)130<2110:TEOVWS>2.0.CO;2; Czajkowski J, 2014, WEATHER CLIM SOC, V6, P202, DOI 10.1175/WCAS-D-13-00024.1; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; Demuth JL, 2006, J APPL METEOROL CLIM, V45, P1573, DOI 10.1175/JAM2429.1; Evans C, 2017, MON WEATHER REV, V145, P4317, DOI 10.1175/MWR-D-17-0027.1; Evans JL, 2003, MON WEATHER REV, V131, P909, DOI 10.1175/1520-0493(2003)131<0909:OIOTLC>2.0.CO;2; FLATAU M, 1994, J ATMOS SCI, V51, P2589, DOI 10.1175/1520-0469(1994)051<2589:TROBPI>2.0.CO;2; Frank WM, 1999, MON WEATHER REV, V127, P2044, DOI 10.1175/1520-0493(1999)127<2044:EOEFUT>2.0.CO;2; FRANK WM, 1977, MON WEATHER REV, V105, P1136, DOI 10.1175/1520-0493(1977)105<1136:TSAEOT>2.0.CO;2; Frank WM, 2001, MON WEATHER REV, V129, P2249, DOI 10.1175/1520-0493(2001)129<2249:EOVWSO>2.0.CO;2; FRANK WM, 1980, J APPL METEOROL, V19, P219, DOI 10.1175/1520-0450(1980)019<0219:RAFOMS>2.0.CO;2; Hanley D, 2001, MON WEATHER REV, V129, P2570, DOI 10.1175/1520-0493(2001)129<2570:ACSOTI>2.0.CO;2; Harr PA, 2000, MON WEATHER REV, V128, P2613, DOI 10.1175/1520-0493(2000)128<2613:ETOTCO>2.0.CO;2; Hill KA, 2009, MON WEATHER REV, V137, P3294, DOI 10.1175/2009MWR2679.1; Hoffman RN, 2005, WEATHER FORECAST, V20, P476, DOI 10.1175/WAF841.1; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jiang HY, 2011, J APPL METEOROL CLIM, V50, P1255, DOI [10.1175/2011JAMC2662.1, 10.1175/2010JAMC2662.1]; Jiang HY, 2010, J CLIMATE, V23, P1526, DOI 10.1175/2009JCLI3303.1; Jones SC, 2003, WEATHER FORECAST, V18, P1052, DOI 10.1175/1520-0434(2003)018<1052:TETOTC>2.0.CO;2; JONES SC, 1995, Q J ROY METEOR SOC, V121, P821, DOI 10.1002/qj.49712152406; Kim D, 2018, J CLIMATE, V31, P4605, DOI [10.1175/JCLI-D-17-0712.1, 10.1175/jcli-d-17-0712.1]; Kim JH, 2005, J CLIMATE, V18, P5344, DOI 10.1175/JCLI3601.1; Kim JH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027430; Kimball SK, 2004, J CLIMATE, V17, P3555, DOI 10.1175/1520-0442(2004)017<3555:AYCONA>2.0.CO;2; Kimball SK, 2008, MON WEATHER REV, V136, P3822, DOI 10.1175/2008MWR2304.1; Klein PM, 2000, WEATHER FORECAST, V15, P373, DOI 10.1175/1520-0434(2000)015<0373:ETOWNP>2.0.CO;2; Klein PM, 2002, MON WEATHER REV, V130, P2240, DOI 10.1175/1520-0493(2002)130<2240:ETOWNP>2.0.CO;2; Knaff JA, 2007, WEATHER FORECAST, V22, P781, DOI 10.1175/WAF1026.1; Knaff JA, 2007, WEATHER FORECAST, V22, P71, DOI 10.1175/WAF965.1; Knaff JA, 2014, J CLIMATE, V27, P455, DOI 10.1175/JCLI-D-13-00096.1; Li YB, 2014, Q J ROY METEOR SOC, V140, P1866, DOI 10.1002/qj.2259; Lin YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7591; Lonfat M, 2004, MON WEATHER REV, V132, P1645, DOI 10.1175/1520-0493(2004)132<1645:PDITCU>2.0.CO;2; Loridan T, 2014, J APPL METEOROL CLIM, V53, P421, DOI 10.1175/JAMC-D-13-0257.1; Matyas CJ, 2014, PHYS GEOGR, V35, P93, DOI 10.1080/02723646.2014.893476; Matyas CJ, 2013, J APPL METEOROL CLIM, V52, P1085, DOI 10.1175/JAMC-D-12-0153.1; Matyas CJ, 2010, METEOROL ATMOS PHYS, V106, P135, DOI 10.1007/s00703-009-0056-1; MERRILL RT, 1984, MON WEATHER REV, V112, P1408, DOI 10.1175/1520-0493(1984)112<1408:ACOLAS>2.0.CO;2; MOLINARI J, 1989, J ATMOS SCI, V46, P1093, DOI 10.1175/1520-0469(1989)046<1093:EIOHIP>2.0.CO;2; Murakami H, 2014, GEOPHYS RES LETT, V41, P2133, DOI 10.1002/2014GL059519; Park DSR, 2016, NAT HAZARDS, V82, P1301, DOI 10.1007/s11069-016-2244-x; Park DSR, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/5/054003; Peng MS, 1999, J ATMOS SCI, V56, P1404, DOI 10.1175/1520-0469(1999)056<1404:ANSOTC>2.0.CO;2; Ritchie EA, 2003, MON WEATHER REV, V131, P2112, DOI 10.1175/1520-0493(2003)131<2112:SOTETO>2.0.CO;2; Schenkel BA, 2012, J CLIMATE, V25, P3453, DOI 10.1175/2011JCLI4208.1; SHAPIRO LJ, 1983, J ATMOS SCI, V40, P1984, DOI 10.1175/1520-0469(1983)040<1984:TABLFU>2.0.CO;2; Stiles BW, 2014, IEEE T GEOSCI REMOTE, V52, P7418, DOI 10.1109/TGRS.2014.2312333; Wang YQ, 2009, J ATMOS SCI, V66, P1250, DOI 10.1175/2008JAS2737.1; Wong MLM, 2004, J ATMOS SCI, V61, P1859, DOI 10.1175/1520-0469(2004)061<1859:TCIIVW>2.0.CO;2; Xu J, 2010, J ATMOS SCI, V67, P1831, DOI 10.1175/2010JAS3387.1; Yang MJ, 2008, J ATMOS SCI, V65, P3095, DOI 10.1175/2008JAS2453.1; Ying M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045729; Yokoyama C, 2008, MON WEATHER REV, V136, P3848, DOI 10.1175/2008MWR2408.1; Yu ZF, 2009, J APPL METEOROL CLIM, V48, P2227, DOI 10.1175/2009JAMC2143.1; Zhai AR, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064019; Zick SE, 2015, J GEOPHYS RES-ATMOS, V120, P1651, DOI 10.1002/2014JD022417	73	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209885	10.1371/journal.pone.0209885	http://dx.doi.org/10.1371/journal.pone.0209885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615642	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900031
J	Cabrejos, DAL; Alexandrino, AV; Pereira, CM; Mendonca, DC; Pereira, HD; Novo-Mansur, MTM; Garratt, RC; Goto, LS				Leonardo Cabrejos, Diego Antonio; Alexandrino, Andre Vessoni; Pereira, Camila Malvessi; Mendonca, Deborah Cezar; Pereira, Humberto D'Muniz; Marques Novo-Mansur, Maria Teresa; Garratt, Richard Charles; Goto, Leandro Seiji			Structural characterization of a pathogenicity-related superoxide dismutase codified by a probably essential gene in Xanthomonas citri subsp. citri	PLOS ONE			English	Article							CAMPESTRIS PV. CAMPESTRIS; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; PERIPLASMIC COPPER; BACILLUS-CEREUS; PLANT DEFENSE; PREDICTION; INFECTION; STRESS; DEHYDROGENASE	Citrus canker is a plant disease caused by the bacteria Xanthomonas citrisubsp. citri that affects all domestic varieties of citrus. Some annotated genes from the X citri subsp. citri genome are assigned to an interesting class named "pathogenicity, virulence and adaptation". Amongst these is sodM, which encodes for the gene product XcSOD, one of four superoxide dismutase homologs predicted from the genome. SODs are widespread enzymes that play roles in the oxidative stress response, catalyzing the degradation of the deleterious superoxide radical. In Xanthomonas, SOD has been associated with pathogenesis as a counter measure against the plant defense response. In this work we initially present the 1.8 angstrom crystal structure of XcSOD, a manganese containing superoxide dismutase from Xanthomonas citrisubsp. citri. The structure bears all the hallmarks of a dimeric member of the MnSOD family, including the conserved hydrogen-bonding network residues. Despite the apparent gene redundancy, several attempts to obtain a sodM deletion mutant were unsuccessful, suggesting the encoded protein to be essential for bacterial survival. This intriguing observation led us to extend our structural studies to the remaining three SOD homologs, for which comparative models were built. The models imply that X citri subsp. citri produces an iron-containing SOD which is unlikely to be catalytically active along with two conventional Cu,ZnSODs. Although the latter are expected to possess catalytic activity, we propose they may not be able to replace XcSOD for reasons such as distinct subcellular compartmentalization or differential gene expression in pathogenicity-inducing conditions.	[Leonardo Cabrejos, Diego Antonio; Mendonca, Deborah Cezar; Pereira, Humberto D'Muniz; Garratt, Richard Charles] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Cristalog, Lab Biol Estrut, Sao Carlos, SP, Brazil; [Alexandrino, Andre Vessoni; Pereira, Camila Malvessi; Marques Novo-Mansur, Maria Teresa; Goto, Leandro Seiji] Univ Fed Sao Carlos, Dept Genet & Evolucao, LBBMA, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Goto, LS (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, LBBMA, Sao Carlos, SP, Brazil.	seiji_L@hotmail.com	garratt, richard c/F-6921-2011; Alexandrino, André Vessoni/M-9295-2016; Leonardo, Diego A./AAU-4769-2021; Mansur, Maria Teresa Marques Novo/G-4779-2012	Alexandrino, André Vessoni/0000-0002-0111-3491; Leonardo, Diego A./0000-0003-4264-3074; Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Cezar Mendonca, Deborah/0000-0002-5336-5228	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior, CAPES-PNPD Institucional [23038.006942/2011-31]; "Fundagao de Amparo a Pesquisa do Estado de Sao Paulo", FAPESP [07/50910-2]; INBEQMeDI -INCT/FAPESP [14/15546-1]; CNPq [550514/2011-2]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior, CAPES-PNPD Institucional; "Fundagao de Amparo a Pesquisa do Estado de Sao Paulo", FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INBEQMeDI -INCT/FAPESP; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by "Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior, CAPES-PNPD Institucional 23038.006942/2011-31 to MTMNM,"Fundagao de Amparo a Pesquisa do Estado de Sao Paulo", FAPESP Proc. 07/50910-2 to MTMNM and INBEQMeDI -INCT/FAPESP and CNPq (Project numbers 14/15546-1 and 550514/2011-2 respectively to RCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrou AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152405; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artier J, 2018, MOL PLANT PATHOL, V19, P143, DOI 10.1111/mpp.12507; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Bebien M, 2002, J BACTERIOL, V184, P1556, DOI 10.1128/JB.184.6.1556-1564.2002; BENITEZ LV, 1974, J BIOL CHEM, V249, P6234; BENOV LT, 1994, J BIOL CHEM, V269, P25310; Bleicher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027786; Bordo D, 1999, J MOL BIOL, V285, P283, DOI 10.1006/jmbi.1998.2267; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Cappelletti PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017614; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Carnielli CM, 2017, J PROTEOMICS, V151, P251, DOI 10.1016/j.jprot.2016.05.007; CHAMNONGPOL S, 1995, APPL ENVIRON MICROB, V61, P393, DOI 10.1128/AEM.61.1.393-396.1995; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dhar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063919; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Facincani AP, 2014, FUNCT INTEGR GENOMIC, V14, P205, DOI 10.1007/s10142-013-0340-5; FEE JA, 1991, MOL MICROBIOL, V5, P2599, DOI 10.1111/j.1365-2958.1991.tb01968.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Goto LS, 2016, BBA-PROTEINS PROTEOM, V1864, P1658, DOI 10.1016/j.bbapap.2016.08.014; Greenleaf WB, 2004, BIOCHEMISTRY-US, V43, P7038, DOI 10.1021/bi049888k; Guan Y, 1998, BIOCHEMISTRY-US, V37, P4722, DOI 10.1021/bi972394l; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; HASSAN HM, 1987, J BIOL CHEM, V262, P17173; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HASSAN HM, 1977, J BACTERIOL, V132, P505, DOI 10.1128/JB.132.2.505-510.1977; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Hearn AS, 2003, BIOCHEMISTRY-US, V42, P2781, DOI 10.1021/bi0266481; Hilario E, 2012, ACTA CRYSTALLOGR D, V68, P846, DOI 10.1107/S0907444912014126; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hugouvieux V, 1998, MOL PLANT MICROBE IN, V11, P537, DOI 10.1094/MPMI.1998.11.6.537; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang Y, 2011, ACTA CRYSTALLOGR F, V67, P1173, DOI 10.1107/S1744309111029186; Keith KE, 2007, INFECT IMMUN, V75, P2451, DOI 10.1128/IAI.01556-06; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim YC, 1999, PHYSIOL MOL PLANT P, V55, P327, DOI 10.1006/pmpp.1999.0240; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; LIOCHEV SI, 1991, J BIOL CHEM, V266, P8747; Liu P, 2007, ACTA CRYSTALLOGR F, V63, P1003, DOI 10.1107/S1744309107054127; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467, DOI 10.1104/pp.105.2.467; Mehta A, 2001, PROTEOMICS, V1, P1111, DOI 10.1002/1615-9861(200109)1:9<1111::AID-PROT1111>3.0.CO;2-7; MOODY CS, 1984, J BIOL CHEM, V259, P2821; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Moreira LM, 2005, OMICS, V9, P43, DOI 10.1089/omi.2005.9.43; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; PRIVALLE CT, 1987, P NATL ACAD SCI USA, V84, P2723, DOI 10.1073/pnas.84.9.2723; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Savatin DV, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00470; Schmalhausen EV, 1999, FEBS LETT, V452, P219, DOI 10.1016/S0014-5793(99)00627-4; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith SG, 1996, MOL PLANT MICROBE IN, V9, P584, DOI 10.1094/MPMI-9-0584; Soares MR, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-55; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; STEINMAN HM, 1993, J BACTERIOL, V175, P1198, DOI 10.1128/JB.175.4.1198-1202.1993; Tang YL, 2012, VET MICROBIOL, V158, P360, DOI 10.1016/j.vetmic.2012.02.028; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; TSUKUDA K, 1983, AGR BIOL CHEM TOKYO, V47, P2865, DOI 10.1080/00021369.1983.10866031; Turrens JF, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P219; Wang YJ, 2007, FEMS MICROBIOL LETT, V272, P206, DOI 10.1111/j.1574-6968.2007.00759.x; Wang ZS, 2005, J CHROMATOGR B, V826, P114, DOI 10.1016/j.jchromb.2005.08.010; Watt SA, 2005, PROTEOMICS, V5, P153, DOI 10.1002/pmic.200400905; Watt SA, 2006, J BIOTECHNOL, V126, P78, DOI 10.1016/j.jbiotec.2006.02.022; Webb B., 2002, CURRENT PROTOCOLS BI; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wintjens R, 2008, PROTEINS, V70, P1564, DOI 10.1002/prot.21650; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121	87	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209988	10.1371/journal.pone.0209988	http://dx.doi.org/10.1371/journal.pone.0209988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615696	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900033
J	Sakuma, A; Ochi, HW; Yoshioka, M; Yamanaka, N; Ikezawa, M; Guruge, KS				Sakuma, Akiko; Ochi, Haruyo Wasada; Yoshioka, Miyako; Yamanaka, Noriko; Ikezawa, Mitsutaka; Guruge, Keerthi S.			Changes in hepato-renal gene expression in microminipigs following a single exposure to a mixture of perfluoroalkyl acids	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PERFLUOROOCTANE SULFONATE; HUMAN BLOOD; SERUM; PFOA; BIOMARKERS; CHEMICALS; PLASMA; CHEMISTRY; APOPTOSIS	It is evident that some perfluoroalkyl acids (PFAAs), a group of globally dispersed pollutants, have long biological half-lives in humans and farm animals. However, the effects of PFAAs in domestic animals have not been fully elucidated. The present study investigated how exposure to a single dose of a mixture of 10 PFAAs influenced hepatic and renal gene expression and histopathology, as well as plasma clinical biochemistry, in microminipigs (MMPigs) over 21 days. In animals treated with PFAAs, the mRNA expression of twelve genes related to fatty acid metabolism was upregulated in the kidney, while only few of these genes were induced in the liver. The expression of several kidney injury-associated genes such as, IGFBP1, IGFBP6, GCLC X2, GCLC X3, MSGT1, OLR1 was upregulated in the kidney. Interestingly, the expression of IGFBP-genes was differentially altered in the liver and kidney. Our findings thus identified hepato-renal gene expression changes in MMPigs that were associated with various molecular pathways including peroxisome proliferation, lipid metabolism, kidney injury, and apoptosis. Furthermore, serum HDL levels were significantly decreased following exposure to PFAAs, whereas no significant histopathological changes were detected, as compared to the vehicle group. Taken together, the present study provided the first indication that a single exposure to a mixture of PFAAs can produce changes in MMPig renal gene expression that were observed three weeks post exposure, suggesting that more attention should be paid to the kidney as a primary target organ of PFAAs.	[Sakuma, Akiko] Miyagi Prefectural Sendai Livestock Hyg Serv Ctr, Miyagino Ku, Sendai, Miyagi, Japan; [Sakuma, Akiko] Tohoku Univ, Grad Sch Agr Sci, Cellular Biol Lab, Aoba Ku, Sendai, Miyagi, Japan; [Ochi, Haruyo Wasada] Kumamoto Prefectural Cent Livestock Hyg Serv Ctr, Minami Ku, Kumamoto, Kumamoto, Japan; [Yoshioka, Miyako; Yamanaka, Noriko; Ikezawa, Mitsutaka; Guruge, Keerthi S.] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan; [Guruge, Keerthi S.] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Guruge, Keerthi S.] Univ Southern Queensland, Ctr Crop Hlth, Toowoomba Campus, Toowoomba, Qld, Australia	Tohoku University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University; University of Southern Queensland	Guruge, KS (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan.; Guruge, KS (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan.; Guruge, KS (corresponding author), Univ Southern Queensland, Ctr Crop Hlth, Toowoomba Campus, Toowoomba, Qld, Australia.	guruge@affrc.go.jp	Guruge, Keerthi/AAW-4155-2021	Guruge, Keerthi S./0000-0002-5492-3084				Andersen ME, 2006, TOXICOLOGY, V227, P156, DOI 10.1016/j.tox.2006.08.004; [Anonymous], 2008, EFSA J; Bost PC, 2016, ENVIRON RES, V151, P145, DOI 10.1016/j.envres.2016.07.027; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Cheon YW, 2005, AM J PHYSIOL-REG I, V288, pR1525, DOI 10.1152/ajpregu.00751.2004; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Eriksson U, 2017, ENVIRON POLLUT, V220, P168, DOI 10.1016/j.envpol.2016.09.036; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Fletcher T, 2013, ENVIRON INT, V57-58, P2, DOI 10.1016/j.envint.2013.03.008; Guruge KS, 2008, CHEMOSPHERE, V73, pS210, DOI 10.1016/j.chemosphere.2006.12.105; Guruge KS, 2016, J APPL TOXICOL, V36, P68, DOI 10.1002/jat.3145; Guruge KS, 2006, TOXICOL SCI, V89, P93, DOI 10.1093/toxsci/kfj011; Guruge KS, 2005, J ENVIRON MONITOR, V7, P371, DOI 10.1039/b412532k; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491; Kelly KJ, 2008, AM J PHYSIOL-RENAL, V294, pF1136, DOI 10.1152/ajprenal.00396.2007; Koide S, 2003, J AM COLL CARDIOL, V41, P539, DOI 10.1016/S0735-1097(02)02866-8; Kowalczyk J, 2013, J AGR FOOD CHEM, V61, P2903, DOI 10.1021/jf304680j; Kudo N, 2002, CHEM-BIOL INTERACT, V139, P301, DOI 10.1016/S0009-2797(02)00006-6; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116, DOI 10.1161/01.ATV.20.4.1116; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lupton SJ, 2015, J AGR FOOD CHEM, V63, P10988, DOI 10.1021/acs.jafc.5b04565; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Nakayama Shoji, 2005, Environ Sci, V12, P293; Nickerson T, 1998, ENDOCRINOLOGY, V139, P807, DOI 10.1210/en.139.2.807; Numata J, 2014, J AGR FOOD CHEM, V62, P6861, DOI 10.1021/jf405827u; Oh YM, 2012, KIDNEY RES CLIN PRAC, V31, P26, DOI 10.1016/j.krcp.2011.12.005; Olsen GW, 2007, INT ARCH OCC ENV HEA, V81, P231, DOI 10.1007/s00420-007-0213-0; Olsen GW, 1999, J OCCUP ENVIRON MED, V41, P799, DOI 10.1097/00043764-199909000-00012; Powell DR, 1997, J CLIN ENDOCR METAB, V82, P2978, DOI 10.1210/jc.82.9.2978; Qing XP, 2006, ARTHRITIS RHEUM-US, V54, P2198, DOI 10.1002/art.21934; Ren HZ, 2009, REPROD TOXICOL, V27, P266, DOI 10.1016/j.reprotox.2008.12.011; Rosen MB, 2017, TOXICOLOGY, V387, P95, DOI 10.1016/j.tox.2017.05.013; Rosen MB, 2010, PPAR RES, V2010, DOI 10.1155/2010/794739; Sayanthooran S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0440-x; Schaffert CS, 2011, WORLD J GASTROENTERO, V17, P2552, DOI 10.3748/wjg.v17.i20.2552; Schwartz N, 2007, ANN NY ACAD SCI, V1109, P265, DOI 10.1196/annals.1398.032; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Shankar A, 2011, AM J EPIDEMIOL, V174, P893, DOI 10.1093/aje/kwr171; SHIROTA K, 1986, JPN J VET SCI, V48, P15; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Watkins DJ, 2013, ENVIRON HEALTH PERSP, V121, P625, DOI 10.1289/ehp.1205838; Yoo H, 2009, ECOTOX ENVIRON SAFE, V72, P26, DOI 10.1016/j.ecoenv.2007.09.007; Yu H, 1999, J CLIN LAB ANAL, V13, P166, DOI 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.3.CO;2-O; Zhu LY, 2016, TOXINS, V8, DOI 10.3390/toxins8120373	45	5	5	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210110	10.1371/journal.pone.0210110	http://dx.doi.org/10.1371/journal.pone.0210110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608957	Green Submitted, gold, Green Published			2022-12-26	WOS:000454952800047
J	Capri, M; Morsiani, C; Santoro, A; Moriggi, M; Conte, M; Martucci, M; Bellavista, E; Fabbri, C; Giampieri, E; Albracht, K; Fluck, M; Ruoss, S; Brocca, L; Canepari, M; Longa, E; Di Giulio, I; Bottinelli, R; Cerretelli, P; Salvioli, S; Gelfi, C; Franceschi, C; Narici, M; Rittweger, J				Capri, Miriam; Morsiani, Cristina; Santoro, Aurelia; Moriggi, Manuela; Conte, Maria; Martucci, Morena; Bellavista, Elena; Fabbri, Cristina; Giampieri, Enrico; Albracht, Kirsten; Fluck, Martin; Ruoss, Severin; Brocca, Lorenza; Canepari, Monica; Longa, Emanuela; Di Giulio, Irene; Bottinelli, Roberto; Cerretelli, Paolo; Salvioli, Stefano; Gelfi, Cecilia; Franceschi, Claudio; Narici, Marco; Rittweger, Joern			Recovery from 6-month spaceflight at the International Space Station: muscle-related stress into a proinflammatory setting	FASEB JOURNAL			English	Article						microRNA-206; inflamma-miRs; proteasome; SERPINA1	CIRCULATING MICRORNAS; SKELETAL-MUSCLE; INFLAMMATION; SENESCENCE; EXPRESSION; LONGEVITY; RELEVANCE; EXERCISE; TISSUES; MIR-21	The Sarcolab pilot study of 2 crewmembers, investigated before and after a 6-mo International Space Station mission, has demonstrated the substantial muscle wasting and weakness, along with disruption of muscle's oxidative metabolism. The present work aimed at evaluating the pro/anti-inflammatory status in the same 2 crewmembers (A, B). Blood circulating (c-)microRNAs (miRs), c-proteasome, c-mitochondrial DNA, and cytokines were assessed by real-time quantitative PCR or ELISA tests. Time series analysis was performed (i.e., before flight and after landing) at 1 and 15 d of recovery (R+1 and R+15, respectively). C-biomarkers were compared with an age-matched control population and with 2-dimensional proteomic analysis of the 2 crewmembers' muscle biopsies. Striking differences were observed between the 2 crewmembers at R+1, in terms of inflamma-miRs (c-miRs-21-5p, -126-3p, and -146a-5p), muscle specific (myo)-miR-206, c-proteasome, and IL-6/leptin, thus making the 2 astronauts dissimilar to each other. Final recovery levels of c-proteasome, c-inflamma-miRs, and c-myo-miR-206 were not reverted to the baseline values in crewmember A. In both crewmembers, myo-miR-206 changed significantly after recovery. Muscle biopsy of astronaut A showed an impressive 80% increase of alpha-1-antitrypsin, a target of miR-126-3p. These results point to a strong stress response induced by spaceflight involving muscle tissue and the proinflammatory setting, where inflamma-miRs and myo-miR-206 mediate the systemic recovery phase after landing.	[Capri, Miriam; Morsiani, Cristina; Santoro, Aurelia; Conte, Maria; Martucci, Morena; Bellavista, Elena; Fabbri, Cristina; Salvioli, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Capri, Miriam; Morsiani, Cristina; Santoro, Aurelia; Conte, Maria; Martucci, Morena; Fabbri, Cristina; Giampieri, Enrico; Salvioli, Stefano] Univ Bologna, Galvani Interdept Ctr, Bologna, Italy; [Giampieri, Enrico] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Moriggi, Manuela; Cerretelli, Paolo] CNR, Natl Res Council, Inst Mol Bioimaging & Physiol, IBFM, Milan, Italy; [Moriggi, Manuela; Cerretelli, Paolo] Italian Natl Olymp Comm CONI, Rome, Italy; [Albracht, Kirsten] FH Aachen Univ Appl Sci, Fac Med Engn & Technomath, Aachen, Germany; [Albracht, Kirsten] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Fluck, Martin; Ruoss, Severin] Univ Zurich, Dept Orthopaed, Zurich, Switzerland; [Brocca, Lorenza; Canepari, Monica; Bottinelli, Roberto] Univ Pavia, Dept Mol Med, Pavia, Italy; [Longa, Emanuela] Univ Pavia, Sport Med Ctr, Pavia, Italy; [Di Giulio, Irene] Kings Coll London, Ctr Human & Appl Physiol Sci, London, England; [Bottinelli, Roberto] Sci Inst Pavia, Inst Hospitalizat & Sci Care IRCCS, Fdn Salvatore Maugeri, Pavia, Italy; [Gelfi, Cecilia] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Gelfi, Cecilia] IRCCS, Ist Ortoped Galeazzi, Milan, Italy; [Franceschi, Claudio] Lobachevsky State Univ Nizhny Novgorod, Natl Res Univ UNN, Dept Appl Math, Inst Informat Technol Math & Mech ITMM, Nizhny Novogoro, Russia; [Narici, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Rittweger, Joern] Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany	University of Bologna; University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); German Sport University Cologne; University of Zurich; University of Pavia; University of Pavia; University of London; King's College London; Istituti Clinici Scientifici Maugeri IRCCS; University of Milan; IRCCS Istituto Ortopedico Galeazzi; Lobachevsky State University of Nizhni Novgorod; University of Padua; Helmholtz Association; German Aerospace Centre (DLR); University of Cologne	Morsiani, C (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Alma Mater Studiorum, Via San Giacomo 12, I-40126 Bologna, Italy.	cristina.morsiani2@unibo.it	Rittweger, Jörn/A-4308-2009; Bottinelli, Roberto/AAC-1904-2020; MORIGGI, MANUELA/AAB-5477-2021; Ruoss, Severin/AAH-6121-2021; Giampieri, Enrico/AAC-7354-2022	Rittweger, Jörn/0000-0002-2223-8963; Bottinelli, Roberto/0000-0002-4960-7490; MORIGGI, MANUELA/0000-0002-4718-0307; Ruoss, Severin/0000-0001-8896-635X; Giampieri, Enrico/0000-0003-2269-2338; Santoro, Aurelia/0000-0002-7187-1116; Albracht, Kirsten/0000-0002-4271-2511; Di Giulio, Irene/0000-0002-4987-6914; Conte, Maria/0000-0002-4621-9898	European Space Agency (ESA); DLR [2475 030]; Ricerca Fondamentale Orientata (RFO); Project Digital Personalised Medicine-Healthy Ageing: Network Analysis of Big Multiomics Data to Search from New Diagnostic, Prognostic, and Therapeutic Targets (DPM-AGEING) [14.Y26.31.0026]; Italian Ministry of Education, University, and Research (MIUR) [PRIN 2015FBNB5Y]	European Space Agency (ESA)(European Space Agency); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Ricerca Fondamentale Orientata (RFO); Project Digital Personalised Medicine-Healthy Ageing: Network Analysis of Big Multiomics Data to Search from New Diagnostic, Prognostic, and Therapeutic Targets (DPM-AGEING); Italian Ministry of Education, University, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The authors thank the European Space Agency (ESA) for its support, with great help from Patrik Sundblad, Simone Thomas, and Marine le-Gouic (all from the ESA). Peter Gauger and Wolfram Sies [German Aerospace Center (DLR), Cologne, Germany] were instrumental in the preparation of human testing devices. Asa Beijer (DLR) helped with preprocessing of the muscle samples. This study was supported by internal funding from the DLR (2475 030, Muscle Mechanics and Metabolism); the Ricerca Fondamentale Orientata (RFO) (to M. Capri); and by the Project Digital Personalised Medicine-Healthy Ageing: Network Analysis of Big Multiomics Data to Search from New Diagnostic, Prognostic, and Therapeutic Targets (DPM-AGEING) (14.Y26.31.0026 to C. Franceschi); and by the Italian Ministry of Education, University, and Research (MIUR; Grant PRIN 2015FBNB5Y to C.G.). C.G., C.F., M.N., and J.R. share senior authorship. The authors declare no conflicts of interest.	Bektas A, 2017, J LEUKOCYTE BIOL, V102, P977, DOI 10.1189/jlb.3RI0716-335R; Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P31, DOI 10.1097/00075197-200301000-00006; Bucci L, 2013, BIOGERONTOLOGY, V14, P261, DOI 10.1007/s10522-013-9428-5; Calabrese V, 2018, FREE RADICAL BIO MED, V115, P80, DOI 10.1016/j.freeradbiomed.2017.10.379; Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001; Capitanio D, 2009, PROTEOMICS, V9, P2004, DOI 10.1002/pmic.200701162; Carpentier WR, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-018-0040-5; Carrieri G, 2004, AGING CELL, V3, P443, DOI 10.1111/j.1474-9728.2004.00129.x; Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; De Gasperi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13105-9; Dianzani C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43718; Dittrich A, 2018, CELL PHYSIOL BIOCHEM, V45, P429, DOI 10.1159/000486920; Egerer K, 2002, J RHEUMATOL, V29, P2045; Fleshner M, 2017, TRENDS IMMUNOL, V38, P768, DOI 10.1016/j.it.2017.08.002; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Gabler NB, 2011, MED CARE, V49, P761, DOI 10.1097/MLR.0b013e318215d90d; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gomes CPC, 2014, BIOMARKERS, V19, P585, DOI 10.3109/1354750X.2014.952663; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; Hochberg AM, 2000, J AOAC INT, V83, P1349; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; Ikemoto M, 2001, FASEB J, V15, P1279, DOI 10.1096/fj.00-0629fje; Irwin MR, 2017, NEUROPSYCHOPHARMACOL, V42, P129, DOI 10.1038/npp.2016.148; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lombardi G, 2016, ENDOCRINE, V54, P284, DOI 10.1007/s12020-015-0834-0; Margolis LM, 2017, J GERONTOL A-BIOL, V72, P1319, DOI 10.1093/gerona/glw243; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Ng SB, 2011, BLOOD, V118, P4919, DOI 10.1182/blood-2011-07-364224; Olivieri F, 2017, MECH AGEING DEV, V165, P162, DOI 10.1016/j.mad.2016.12.004; Olivieri F, 2014, AGING-US, V6, P771, DOI 10.18632/aging.100693; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989; Rittweger J, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-018-0052-1; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salvioli S, 2009, CANCER IMMUNOL IMMUN, V58, P1909, DOI 10.1007/s00262-008-0639-6; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Schwendner P, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0345-8; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Simionescu-Bankston A, 2016, J MOL MED, V94, P853, DOI 10.1007/s00109-016-1443-y; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Stahn AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15560-w; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Vigano A, 2011, PROTEOMICS, V11, P4202, DOI 10.1002/pmic.201000804; Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29; Wardle SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122107; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	63	13	13	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5168	5180		10.1096/fj.201801625R	http://dx.doi.org/10.1096/fj.201801625R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30620616	hybrid, Green Published			2022-12-26	WOS:000462888500044
J	Kiser, PD; Kolesnikov, AV; Kiser, JZ; Dong, ZQ; Chaurasia, B; Wang, LP; Summers, SA; Hoang, T; Blackshaw, S; Peachey, NS; Kefalov, VJ; Palczewski, K				Kiser, Philip D.; Kolesnikov, Alexander V.; Kiser, Jianying Z.; Dong, Zhiqian; Chaurasia, Bhagirath; Wang, Liping; Summers, Scott A.; Thanh Hoang; Blackshaw, Seth; Peachey, Neal S.; Kefalov, Vladimir J.; Palczewski, Krzysztof			Conditional deletion of Des1 in the mouse retina does not impair the visual cycle in cones	FASEB JOURNAL			English	Article						retinoid cycle; sphingolipid delta(4) desaturase; Degs1; photoreceptor; Muller glia	CERAMIDE BIOSYNTHESIS; PIGMENT REGENERATION; BINDING PROTEINS; VITAMIN-A; IDENTIFICATION; CELLS; MICE; INHIBITION; DIHYDROCERAMIDE; ISOMERASE	Cone photoreceptors are essential for vision under moderate to high illuminance and allow color discrimination. Their fast dark adaptation rate and resistance to saturation are believed to depend in part on an intraretinal visual cycle that supplies 11-cis-retinaldehyde to cone opsins. Candidate enzymes of this pathway have been reported, but their physiologic contribution to cone photoresponses remains unknown. Here, we evaluate the role of a candidate retinol isomerase of this pathway, sphingolipid delta 4 desaturase 1 (Des1). Single-cell RNA sequencing analysis revealed Des1 expression not only in Muller glia but also throughout the retina and in the retinal pigment epithelium. We assessed cone functional dependence on Muller cell-expressed Des1 through a conditional knockout approach. Floxed Des1 mice, on a guanine nucleotide-binding protein subunit alpha transducin 1 knockout (Gnat1(-/-)) background to allow isolated recording of cone-driven photoresponses, were bred with platelet-derived growth factor receptor alpha (Pdgfr alpha)-Cre mice to delete Des1 in Muller cells. Conditional knockout of Des1 expression, as shown by tissue-selective Des1 gene recombination and reduced Des1 catalytic activity, caused no gross changes in the retinal structure and had no effect on cone sensitivity or dark adaptation but did slightly accelerate the rate of cone phototransduction termination. These results indicate that Des1 expression in Muller cells is not required for cone visual pigment regeneration in the mouse.	[Kiser, Philip D.; Peachey, Neal S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Kiser, Philip D.; Kiser, Jianying Z.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kolesnikov, Alexander V.; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Dong, Zhiqian] Polgenix Inc, Cleveland, OH USA; [Chaurasia, Bhagirath; Wang, Liping; Summers, Scott A.] Univ Utah, Dept Nutr & Integrat Physiol NUIP, Salt Lake City, UT USA; [Chaurasia, Bhagirath; Wang, Liping; Summers, Scott A.] Univ Utah, Diabet & Metab Res Ctr, Salt Lake City, UT USA; [Thanh Hoang; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Sch Med, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Kiser, Philip D.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Kiser, Philip D.] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Washington University (WUSTL); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Johns Hopkins University; Cleveland Clinic Foundation; University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 837 Hlth Sci Rd, Irvine, CA 92617 USA.	pkiser@uci.edu	/AAE-5384-2020; Kolesnikov, Alexander V/O-1840-2016; Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Summers, Scott/0000-0002-4919-0592; DONG, ZHIQIAN/0000-0002-8748-4532	U.S. Department of Veterans Affairs [IK2BX002683]; Research Career Scientist Award; U.S. National Institutes of Health (NIH) National Eye Institute [R01EY009339, R01EY024864, R01EY019312, R01EY021126, R24EY027283, R01DK115824, P30EY011373, P30EY025585, P30EY002687]; American Diabetes Association; American Heart Association; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY020560, R24EY024864, R24EY027283, P30EY011373, P30EY002687, R01EY025696, R01EY009339, P30EY025585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115824] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank David Peck and Elizabeth Bulman (both of Case Western Reserve University) for assistance with animal breeding, genotyping, and husbandry. This research was supported by funding from the U.S. Department of Veterans Affairs (IK2BX002683 to P.D.K.); a Research Career Scientist Award (to N.S.P.); the U.S. National Institutes of Health (NIH) National Eye Institute (R01EY009339 to K.P. and P.D.K., R01EY024864 to K.P., R01EY019312 to V.J.K., R01EY021126 to K.P. and V.J.K., R24EY027283 to K.P., P.D.K., V.J.K., S.B., and N.S.P., R01DK115824 to S.A.S., P30EY011373 to the Department of Ophthalmology and Visual Sciences at Case Western Reserve University, P30EY025585 to the Cleveland Clinic Cole Eye Institute, and P30EY002687 to the Department of Ophthalmology and Visual Sciences at Washington University); the American Diabetes Association (to S.A.S); the American Heart Association (to S.A.S.). The authors acknowledge departmental support from a Research to Prevent Blindness unrestricted grant. S.A.S. is a consultant and shareholder of Centaurus Therapeutics. The remaining authors declare no competing financial interests.	Arne JM, 2017, J LIPID RES, V58, P719, DOI 10.1194/jlr.M073692; Barak A, 2001, INVEST OPHTH VIS SCI, V42, P247; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Brush RS, 2010, INVEST OPHTH VIS SCI, V51, P4422, DOI 10.1167/iovs.09-5134; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen H, 2013, J LIPID RES, V54, P1616, DOI 10.1194/jlr.M035048; Chen H, 2012, ADV EXP MED BIOL, V723, P553, DOI 10.1007/978-1-4614-0631-0_70; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu J, 2014, J EXP MED, V211, P281, DOI 10.1084/jem.20131494; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Kaylor JJ, 2014, P NATL ACAD SCI USA, V111, P7302, DOI 10.1073/pnas.1319142111; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Leneuve P, 2001, BIOTECHNIQUES, V31, P1156, DOI 10.2144/01315rr05; Liu L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190253; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Muniz A, 2009, BIOCHEMISTRY-US, V48, P6854, DOI 10.1021/bi9002937; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; SAARI JC, 1982, J BIOL CHEM, V257, P13329; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Scrucca L, 2016, R J, V8, P289; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Xue YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02549-8; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	54	18	18	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5782	5792		10.1096/fj.201802493R	http://dx.doi.org/10.1096/fj.201802493R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30645148	hybrid, Green Published			2022-12-26	WOS:000462888500091
J	de Cozar, JMG; Gerards, M; Teeri, E; George, J; Dufour, E; Jacobs, HT; Joers, P				Gonzalez de Cozar, Jose M.; Gerards, Mike; Teeri, Eveliina; George, Jack; Dufour, Eric; Jacobs, Howard T.; Joers, Priit			RNase H1 promotes replication fork progression through oppositely transcribed regions of Drosophila mitochondrial DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; DNA replication; RNA; genomic instability; ribonuclease; heteroduplex; locomotor dysfunction; mtDNA; replication fork; RNase H; genome stability; insect rnh1	R-LOOPS; ALTERNATIVE OXIDASE; ACCESSORY SUBUNIT; POLYMERASE-GAMMA; BINDING PROTEIN; MTDNA; TFAM; EMBRYOGENESIS; MAINTENANCE; REGRESSION	Mitochondrial DNA (mtDNA) replication uses a simple core machinery similar to those of bacterial viruses and plasmids, but its components are challenging to unravel. Here, we found that, as in mammals, the single Drosophila gene for RNase H1 (rnh1) has alternative translational start sites, resulting in two polypeptides, targeted to either mitochondria or the nucleus. RNAi-mediated rnh1 knockdown did not influence growth or viability of S2 cells, but compromised mtDNA integrity and copy number. rnh1 knockdown in intact flies also produced a phenotype of impaired mitochondrial function, characterized by respiratory chain deficiency, locomotor dysfunction, and decreased lifespan. Its overexpression in S2 cells resulted in cell lethality after 5-9 days, attributable to the nuclearly localized isoform. rnh1 knockdown and overexpression produced opposite effects on mtDNA replication intermediates. The most pronounced effects were seen in genome regions beyond the major replication pauses where the replication fork needs to progress through a gene cluster that is transcribed in the opposite direction. RNase H1 deficiency led to an accumulation of replication intermediates in these zones, abundant mtDNA molecules joined by four-way junctions, and species consistent with fork regression from the origin. These findings indicate replication stalling due to the presence of unprocessed RNA/DNA heteroduplexes, potentially leading to the degradation of collapsed forks or to replication restart by a mechanism involving strand invasion. Both mitochondrial RNA and DNA syntheses were affected by rnh1 knockdown, suggesting that RNase H1 also plays a role in integrating or coregulating these processes in Drosophila mitochondria.	[Gonzalez de Cozar, Jose M.; Gerards, Mike; Teeri, Eveliina; George, Jack; Dufour, Eric; Jacobs, Howard T.; Joers, Priit] Tampere Univ, Fac Med & Hlth Technol, FI-33014 Tampere, Finland; [Gonzalez de Cozar, Jose M.; Gerards, Mike; Teeri, Eveliina; George, Jack; Dufour, Eric; Jacobs, Howard T.; Joers, Priit] Tampere Univ, Tampere Univ Hosp, FI-33014 Tampere, Finland; [Jacobs, Howard T.] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Joers, Priit] Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia; [Gerards, Mike] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, NL-6229 ER Maastricht, Netherlands	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Tartu; Maastricht University	Jacobs, HT (corresponding author), Tampere Univ, Fac Med & Hlth Technol, FI-33014 Tampere, Finland.; Jacobs, HT (corresponding author), Tampere Univ, Tampere Univ Hosp, FI-33014 Tampere, Finland.; Jacobs, HT (corresponding author), Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland.	howard.jacobs@tuni.fi	Dufour, Eric/AAF-6210-2020	Gonzalez de Cozar, Jose M./0000-0002-2487-8585; Joers, Priit/0000-0002-9248-1774; Jacobs, Howard/0000-0003-1895-6003; Dufour, Eric/0000-0001-6690-5329; Morikka, Jack/0000-0002-0053-4171	Academy of Finland Centre of Excellence Grant [272376]; Estonian Research Council Grant [PUT573]; University of Tampere; Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation;  [256615]	Academy of Finland Centre of Excellence Grant; Estonian Research Council Grant(Estonian Research Council); University of Tampere; Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); 	This work was supported by Academy of Finland Centre of Excellence Grant 272376 and Academy Professorship Grant 256615 (to H. T. J.), Estonian Research Council Grant PUT573 (to P. J.), the University of Tampere, the Tampere University Hospital Medical Research Fund, and the Sigrid Juselius Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Amon JD, 2016, ELIFE, V5, DOI 10.7554/eLife.20533; Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006; Ciesielski GL, 2018, NUCLEIC ACIDS RES, V46, P3034, DOI 10.1093/nar/gky094; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; El Hage A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004716; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Filippov V, 2001, MOL GENET GENOMICS, V265, P771, DOI 10.1007/s004380100483; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Fuste JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112; Holt IJ, 2016, METHODS MOL BIOL, V1351, P95, DOI 10.1007/978-1-4939-3040-1_8; Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506; Joers P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003800; Joers P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053249; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005; Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEWIS DL, 1994, MOL BIOL EVOL, V11, P523; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Maric C, 2014, CHROMOSOMA, V123, P577, DOI 10.1007/s00412-014-0471-z; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; Maul RW, 2017, J MOL BIOL, V429, P3255, DOI 10.1016/j.jmb.2016.12.020; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Parajuli S, 2017, J BIOL CHEM, V292, P15216, DOI 10.1074/jbc.M117.787473; Petzold C, 2015, J BIOL CHEM, V290, P14626, DOI 10.1074/jbc.M115.655134; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013; Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shen W, 2017, NUCLEIC ACIDS RES, V45, P10672, DOI 10.1093/nar/gkx710; Shi YH, 2016, NUCLEIC ACIDS RES, V44, P5732, DOI 10.1093/nar/gkw302; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001; Sugimoto T, 2008, EXP CELL RES, V314, P103, DOI 10.1016/j.yexcr.2007.08.015; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Tannous E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09969; Wang YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074513; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071006; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yang Z, 2017, PLANT CELL, V29, P2478, DOI 10.1105/tpc.17.00305; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Young SK, 2016, J BIOL CHEM, V291, P16927, DOI 10.1074/jbc.R116.733899	62	9	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4331	4344		10.1074/jbc.RA118.007015	http://dx.doi.org/10.1074/jbc.RA118.007015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30635398	Green Published, hybrid			2022-12-26	WOS:000462969500005
J	Broer, A; Gauthier-Coles, G; Rahimi, F; van Geldermalsen, M; Dorsch, D; Wegener, A; Holst, J; Broer, S				Broer, Angelika; Gauthier-Coles, Gregory; Rahimi, Farid; van Geldermalsen, Michelle; Dorsch, Dieter; Wegener, Ansgar; Holst, Jeff; Broer, Stefan			Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; stress response; glutamine; homeostasis; signal transduction; amino acid harmonizer; ASCT1; GCN2; SNAT1; SNAT2; cancer; starvation response	GLUTAMINE UPTAKE; TUMOR-GROWTH; ASCT2/SLC1A5; INHIBITION; PATHWAY; PROTEIN; LAT1	The neutral amino acid transporter solute carrier family 1 member 5 (SLC1A5 or ASCT2) is overexpressed in many cancers. To identify its roles in tumors, we employed 143B osteosarcoma cells and HCC1806 triple-negative breast cancer cells with or without ASCT2 deletion. ASCT2ko 143B cells grew well in standard culture media, but ASCT2 was required for optimal growth at <0.5 mm glutamine, with tumor spheroid growth and monolayer migration of 143B ASCT2ko cells being strongly impaired at lower glutamine concentrations. However, the ASCT2 deletion did not affect matrix-dependent invasion. ASCT2ko 143B xenografts in nude mice exhibited a slower onset of growth and a higher number of small tumors than ASCT2wt 143B xenografts, but did not differ in average tumor size 25 days after xenotransplantation. ASCT2 deficiency was compensated by increased levels of sodium neutral amino acid transporter 1 (SNAT1 or SLC38A1) and SNAT2 (SLC38A2) in ASCT2ko 143B cells, mediated by a GCN2 EIF2 kinase (GCN2)-dependent pathway, but this compensation was not observed in ASCT2ko HCC1806 cells. Combined SNAT1 silencing and GCN2 inhibition significantly inhibited growth of ASCT2ko HCC1806 cells, but not of ASCT2ko 143B cells. Similarly, pharmacological inhibition of l-type amino acid transporter 1 (LAT1) and GCN2 significantly inhibited growth of ASCT2ko HCC1806 cells, but not of ASCT2ko 143B cells. We conclude that cancer cells with reduced transporter plasticity are more vulnerable to disruption of amino acid homeostasis than cells with a full capacity to up-regulate redundant transporters by an integrated stress response.	[Broer, Angelika; Gauthier-Coles, Gregory; Rahimi, Farid; Broer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [van Geldermalsen, Michelle] Univ Sydney, Centenary Inst, Origins Canc Program, Sydney, NSW, Australia; [van Geldermalsen, Michelle] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Dorsch, Dieter; Wegener, Ansgar] Merck KGaA, D-64293 Darmstadt, Germany; [Holst, Jeff] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Holst, Jeff] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	Australian National University; University of Sydney; Centenary Institute; University of Sydney; Merck KGaA; University of New South Wales Sydney; University of New South Wales Sydney	Broer, S (corresponding author), Australian Natl Univ, Coll Sci, Res Sch Biol, Bldg 134, Canberra, ACT 2601, Australia.	stefan.broeer@anu.edu.au	Holst, Jeff/H-7634-2012; Rahimi, Farid/E-6522-2018; Broer, Stefan/A-1286-2008	Holst, Jeff/0000-0002-0377-9318; Rahimi, Farid/0000-0002-0920-8188; Broer, Stefan/0000-0002-8040-1634; Gauthier-Coles, Gregory/0000-0002-4725-5313	Merck KGaA speed grant; Australian Research Council [DP180101702]; Cancer Council New South Wales [RG17-04, RG18-06]	Merck KGaA speed grant; Australian Research Council(Australian Research Council); Cancer Council New South Wales(Cancer Council New South Wales)	This work was supported in part by a Merck KGaA speed grant (to S. B.), Australian Research Council Discovery Project Grant DP180101702 (to S. B.), and Cancer Council New South Wales Grants RG17-04 and RG18-06 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Bothwell PJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072093; Broer A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00785; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chiu M, 2017, AMINO ACIDS, V49, P1365, DOI 10.1007/s00726-017-2436-z; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cormerais Y, 2018, J BIOL CHEM, V293, P2877, DOI 10.1074/jbc.RA117.001342; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Dorsch D., 2014, Patent No. [WO/2014/135244, 2014135244]; Dorsch D., 2016, AM CHEM SOC M PHIL A; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Hassanein M, 2015, INT J CANCER, V137, P1587, DOI 10.1002/ijc.29535; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; KALLINOWSKI F, 1987, J CANCER RES CLIN, V113, P209, DOI 10.1007/BF00396375; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Lu HQ, 2016, CANCER LETT, V381, P23, DOI 10.1016/j.canlet.2016.07.020; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Nakamura A, 2018, P NATL ACAD SCI USA, V115, pE7776, DOI 10.1073/pnas.1805523115; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Scalise M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00243; Schulte ML, 2018, NAT MED, V24, P194, DOI 10.1038/nm.4464; Schulte ML, 2016, BIOORG MED CHEM LETT, V26, P1044, DOI 10.1016/j.bmcl.2015.12.031; Suzuki M, 2017, BIOCHEM BIOPH RES CO, V482, P651, DOI 10.1016/j.bbrc.2016.11.089; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; van Geldermalsen M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4599-8; Wang Q, 2015, AM J CANCER RES, V5, P1281; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518	36	35	37	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4012	4026		10.1074/jbc.RA118.006378	http://dx.doi.org/10.1074/jbc.RA118.006378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30635397	Green Published, hybrid			2022-12-26	WOS:000461854400017
J	McCulloch, KM; Yamakawa, I; Shifrin, DA; McConnell, RE; Foegeding, NJ; Singh, PK; Mao, SL; Tyska, MJ; Iverson, TM				McCulloch, Kathryn M.; Yamakawa, Izumi; Shifrin, David A., Jr.; McConnell, Russell E.; Foegeding, Nora J.; Singh, Prashant K.; Mao, Suli; Tyska, Matthew J.; Iverson, T. M.			An alternative N-terminal fold of the intestine-specific annexin A13a induces dimerization and regulates membrane-binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						annexin; protein structure; protein folding; membrane fusion; oligomerization; calcium regulation; intestinal microvilli; membrane curvature; structure-function	CRYSTAL-STRUCTURE; COMPLEX PROVIDES; CALCIUM; SYNEXIN; A2; CHANNELS; FORM	Annexin proteins function as Ca2+-dependent regulators of membrane trafficking and repair that may also modulate membrane curvature. Here, using high-resolution confocal imaging, we report that the intestine-specific annexin A13 (ANX A13) localizes to the tips of intestinal microvilli and determined the crystal structure of the ANX A13a isoform to 2.6 resolution. The structure revealed that the N terminus exhibits an alternative fold that converts the first two helices and the associated helix-loop-helix motif into a continuous -helix, as stabilized by a domain-swapped dimer. We also found that the dimer is present in solution and partially occludes the membrane-binding surfaces of annexin, suggesting that dimerization may function as a means for regulating membrane binding. Accordingly, as revealed by in vitro binding and cellular localization assays, ANX A13a variants that favor a monomeric state exhibited increased membrane association relative to variants that favor the dimeric form. Together, our findings support a mechanism for how the association of the ANX A13a isoform with the membrane is regulated.	[McCulloch, Kathryn M.; Yamakawa, Izumi; Singh, Prashant K.; Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Shifrin, David A., Jr.; McConnell, Russell E.; Foegeding, Nora J.; Mao, Suli; Tyska, Matthew J.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [McCulloch, Kathryn M.] Calif State Polytech Univ Pomona, Pomona, CA 91768 USA; [McConnell, Russell E.] Codiak Biosci, Cambridge, MA 02139 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; California State University System; California State Polytechnic University Pomona	Iverson, TM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	tina.iverson@vanderbilt.edu		McCulloch, Kathryn/0000-0001-9077-3821	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health [P30DK058404]; National Institutes of Health [GM095633, DK075555, DK095811, DK111949]; National Institutes of Health Training Grant in Molecular Biophysics [T32GM008320]; National Institutes of Health Training Grant in Mechanisms of Vascular Disease [T32 HL007751]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK075555, R01DK111949, R01DK095811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Molecular Biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Mechanisms of Vascular Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by pilot funds from Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404 (to T. M. I.). This work was also supported by National Institutes of Health Grants GM095633 (to T. M. I.) and DK075555, DK095811, and DK111949 (to M. J. T.), National Institutes of Health Training Grant in Molecular Biophysics T32GM008320 (to N. J. F.), and National Institutes of Health Training Grant in Mechanisms of Vascular Disease T32 HL007751 (to K. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burmann BM, 2012, CELL, V150, P291, DOI 10.1016/j.cell.2012.05.042; Capila I, 2001, STRUCTURE, V9, P57, DOI 10.1016/S0969-2126(00)00549-9; Choi SH, 2009, MOL BIOCHEM PARASIT, V163, P48, DOI 10.1016/j.molbiopara.2008.09.009; CONCHA NO, 1992, FEBS LETT, V314, P159, DOI 10.1016/0014-5793(92)80964-I; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; Dempsey BR, 2012, STRUCTURE, V20, P1737, DOI 10.1016/j.str.2012.08.004; Ecsedi P, 2017, STRUCTURE, V25, P1195, DOI 10.1016/j.str.2017.06.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FavierPerron B, 1996, BIOCHEMISTRY-US, V35, P1740, DOI 10.1021/bi952092o; Fernandez-Lizarbe S, 2017, BIOL CHEM, V398, P359, DOI 10.1515/hsz-2016-0242; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grega-Larson NE, 2015, MOL BIOL CELL, V26, P3803, DOI 10.1091/mbc.E15-06-0443; Hatoum D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169925; HUBER R, 1992, Behring Institute Mitteilungen, P107; Iglesias JM, 2002, MOL BIOL EVOL, V19, P608, DOI 10.1093/oxfordjournals.molbev.a004120; Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leow CY, 2014, FEBS J, V281, P1209, DOI 10.1111/febs.12700; Liu YD, 2015, BRIT J PHARMACOL, V172, P1664, DOI 10.1111/bph.12978; LUECKE H, 1995, NATURE, V378, P512, DOI 10.1038/378512a0; Massey-Harroche D, 1998, J CELL SCI, V111, P3007; Mazerik JN, 2012, J BIOL CHEM, V287, P13104, DOI 10.1074/jbc.M111.336313; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozorowski G, 2013, ACTA CRYSTALLOGR D, V69, P92, DOI 10.1107/S0907444912043429; PIGAULT C, 1994, J MOL BIOL, V236, P199, DOI 10.1006/jmbi.1994.1129; POLLARD HB, 1989, METHOD CELL BIOL, V31, P207; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; Rety S, 2005, J MOL BIOL, V345, P1131, DOI 10.1016/j.jmb.2004.11.015; Rezvanpour A, 2011, J BIOL CHEM, V286, P40174, DOI 10.1074/jbc.M111.244038; ROJAS E, 1987, FEBS LETT, V217, P25, DOI 10.1016/0014-5793(87)81235-8; ROJAS E, 1990, J BIOL CHEM, V265, P21207; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; TAIT JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P187, DOI 10.1016/0003-9861(92)90111-9; Turnay J, 2005, BIOCHEM J, V389, P899, DOI 10.1042/BJ20041918; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WICE BM, 1992, J CELL BIOL, V116, P405, DOI 10.1083/jcb.116.2.405; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3454	3463		10.1074/jbc.RA118.004571	http://dx.doi.org/10.1074/jbc.RA118.004571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30610115	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000461853900013
J	Zygiel, EM; Nelson, CE; Brewer, LK; Oglesby-Sherrouse, AG; Nolan, EM				Zygiel, Emily M.; Nelson, Cassandra E.; Brewer, Luke K.; Oglesby-Sherrouse, Amanda G.; Nolan, Elizabeth M.			The human innate immune protein calprotectin induces iron starvation responses in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); bacteria; iron; innate immunity; metal homeostasis; calprotectin; nutritional immunity; phenazine; virulence; metal sequestration	NUTRITIONAL IMMUNITY; METAL SEQUESTRATION; HOST; MANGANESE; DEFENSE; PYOVERDINE; EXPRESSION; PATHWAYS; ACCUMULATION; LACTOFERRIN	Most microbial pathogens have a metabolic iron requirement, necessitating the acquisition of this nutrient in the host. In response to pathogen invasion, the human host limits iron availability. Although canonical examples of nutritional immunity are host strategies that limit pathogen access to Fe(III), little is known about how the host restricts access to another biologically relevant oxidation state of this metal, Fe(II). This redox species is prevalent at certain infection sites and is utilized by bacteria during chronic infection, suggesting that Fe(II) withholding by the host may be an effective but unrecognized form of nutritional immunity. Here, we report that human calprotectin (CP; S100A8/S100A9 or MRP8/MRP14 heterooligomer) inhibits iron uptake and induces an iron starvation response in Pseudomonas aeruginosa cells by sequestering Fe(II) at its unusual His(6) site. Moreover, under aerobic conditions in which the Fe(III) oxidation state is favored, Fe(II) withholding by CP was enabled by (i) its ability to stabilize this redox state in solution and (ii) the production and secretion of redox-active, P. aeruginosa-produced phenazines, which reduce Fe(III) to Fe(II). Analyses of the interplay between P. aeruginosa secondary metabolites and CP indicated that Fe(II) withholding alters P. aeruginosa physiology and expression of virulence traits. Lastly, examination of the effect of CP on cell-associated metal levels in diverse human pathogens revealed that CP inhibits iron uptake by several bacterial species under aerobic conditions. This work implicates CP-mediated Fe(II) sequestration as a component of nutritional immunity in both aerobic and anaerobic milieus during P. aeruginosa infection.	[Zygiel, Emily M.; Nolan, Elizabeth M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Nelson, Cassandra E.; Brewer, Luke K.; Oglesby-Sherrouse, Amanda G.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Oglesby-Sherrouse, Amanda G.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Nolan, EM (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Oglesby-Sherrouse, AG (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.; Oglesby-Sherrouse, AG (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	aoglesby@rx.umaryland.edu; lnolan@mit.edu	Nelson, Cassandra/U-7963-2017	Nelson, Cassandra/0000-0002-7284-5198; Oglesby, Mandy/0000-0003-4440-3840	National Institutes of Health [R01 GM126376, T32 AI095190, T32 GM066706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706, R01GM126376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM126376 (to E. M. N. and A. G. O.-S.), T32 AI095190 (to C. E. N.), and T32 GM066706 (to L. K. B.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aron AT, 2017, P NATL ACAD SCI USA, V114, P12669, DOI 10.1073/pnas.1708747114; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Besold AN, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00133b; Braud A, 2010, ENV MICROBIOL REP, V2, P419, DOI 10.1111/j.1758-2229.2009.00126.x; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; Cowley ES, 2015, MBIO, V6, DOI 10.1128/mBio.00767-15; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Cunrath O, 2016, ENVIRON MICROBIOL, V18, P3258, DOI 10.1111/1462-2920.12971; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Diaz-Ochoa VE, 2016, CELL HOST MICROBE, V19, P814, DOI 10.1016/j.chom.2016.05.005; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Djapgne L, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00704-17; Garcia YM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006125; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Green M. R., 2012, MOL CLONING LAB MANU, P1346; Hadley RC, 2018, BIOCHEMISTRY-US, V57, P2846, DOI 10.1021/acs.biochem.8b00309; Hayden JA, 2013, J AM CHEM SOC, V135, P775, DOI 10.1021/ja3096416; Hernandez ME, 2004, APPL ENVIRON MICROB, V70, P921, DOI 10.1128/AEM.70.2.921-928.2004; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kelliher JL, 2016, PROG MOL BIOL TRANSL, V142, P1, DOI 10.1016/bs.pmbts.2016.05.002; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mastropasqua MC, 2018, J TRACE ELEM MED BIO, V48, P74, DOI 10.1016/j.jtemb.2018.03.009; Meirelles LA, 2018, MOL MICROBIOL, V110, P995, DOI 10.1111/mmi.14132; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; Minandri F, 2016, INFECT IMMUN, V84, P2324, DOI 10.1128/IAI.00098-16; Nakashige TG, 2017, METALLOMICS, V9, P1086, DOI 10.1039/c7mt00044h; Nakashige TG, 2017, J AM CHEM SOC, V139, P8828, DOI 10.1021/jacs.7b01212; Nakashige TG, 2015, NAT CHEM BIOL, V11, P765, DOI [10.1038/NCHEMBIO.1891, 10.1038/nchembio.1891]; Nguyen AT, 2015, BIOMETALS, V28, P433, DOI 10.1007/s10534-015-9848-6; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Radin JN, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00642-18; Radin JN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006040; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Reinhart AA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00764-16; Reinhart AA, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120126; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Wakeman CA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11951; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; WILKINSON MM, 1988, J CELL SCI, V91, P221; Xiao R, 1997, MICROBIOL-UK, V143, P2509, DOI 10.1099/00221287-143-7-2509; Zygiel EM, 2018, ANNU REV BIOCHEM, V87, P621, DOI 10.1146/annurev-biochem-062917-012312	65	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3549	3562		10.1074/jbc.RA118.006819	http://dx.doi.org/10.1074/jbc.RA118.006819			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622135	Green Published, hybrid			2022-12-26	WOS:000461853900020
J	Mukai, R; Park, DH; Okunuki, Y; Hasegawa, E; Klokman, G; Kim, CB; Krishnan, A; Gregory-Ksander, M; Husain, D; Miller, JW; Connor, KM				Mukai, Ryo; Park, Dong Ho; Okunuki, Yoko; Hasegawa, Eiichi; Klokman, Garrett; Kim, Clifford B.; Krishnan, Anitha; Gregory-Ksander, Meredith; Husain, Deeba; Miller, Joan W.; Connor, Kip M.			Mouse model of ocular hypertension with retinal ganglion cell degeneration	PLOS ONE			English	Article							AUTOMATED KINETIC PERIMETRY; ELEVATED INTRAOCULAR-PRESSURE; ANGLE-CLOSURE; EXPERIMENTAL GLAUCOMA; FIELD DEFECTS; IRIS ATROPHY; DEATH; SUSCEPTIBILITY; PROTECTION; MUTATIONS	Objectives Ocular hypertension is a primary risk factor for glaucoma and results in retinal ganglion cell (RGC) degeneration. Current animal models of glaucoma lack severe RGC cell death as seen in glaucoma, making assessment of physiological mediators of cell death difficult. We developed a modified mouse model of ocular hypertension whereby long-lasting elevation of intraocular pressure (IOP) is achieved, resulting in significant reproducible damage to RGCs. Results In this model, microbeads are mixed with hyaluronic acid and injected into the anterior chamber of C57BL/6J mice. The hyaluronic acid allows for a gradual release of microbeads, resulting in sustained blockage of Schlemm's canal. IOP elevation was bimodal during the course of the model's progression. The first peak occurred 1 hours after beads injection, with an IOP value of 44.69 +/- 6.00 mmHg, and the second peak occurred 6-12 days post-induction, with an IOP value of 34.91 +/- 5.21 mmHg. RGC damage was most severe in the peripheral retina, with a loss of 64.1% compared to that of untreated eyes, while the midperiphery exhibited a 32.4% loss, 4 weeks following disease induction. Conclusions These results suggest that sustained IOP elevation causes more RGC damage in the periphery than in the midperiphery of the retina. This model yields significant and reproducible RGC degeneration.	[Mukai, Ryo; Park, Dong Ho; Okunuki, Yoko; Klokman, Garrett; Kim, Clifford B.; Husain, Deeba; Miller, Joan W.; Connor, Kip M.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA 02115 USA; [Mukai, Ryo] Gunma Univ, Dept Ophthalmol, Grad Sch Med Sci, Maebashi, Gunma, Japan; [Park, Dong Ho] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Ophthalmol, Sch Med, Daegu, South Korea; [Hasegawa, Eiichi] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Krishnan, Anitha; Gregory-Ksander, Meredith] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Gunma University; Kyungpook National University; Kyungpook National University Hospital; Kyushu University; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Connor, KM (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA 02115 USA.	Kip_Connor@meei.harvard.edu	Gregory-Ksander, Meredith/AAG-1413-2019; Okunuki, Yoko/ABE-8090-2020	Gregory-Ksander, Meredith/0000-0002-7193-0032; Okunuki, Yoko/0000-0002-1612-7925; Mukai, Ryo/0000-0003-1796-9232; Husain, Deeba/0000-0002-8494-0950	Research to Prevent Blindness; Harvard Department of Ophthalmology and Massachusetts Eye and Ear Infirmary; Massachusetts Lions Eye Research Fund; Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03027966]; Korea Health Technology R&D Project of the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1501];  [R01EY022084/S1]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harvard Department of Ophthalmology and Massachusetts Eye and Ear Infirmary; Massachusetts Lions Eye Research Fund; Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Technology R&D Project of the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; 	This study was supported by a Special Scholar Award (to K.M.C.), Medical Student Fellowship Grant (to C.B.K.), and an unrestricted grant (to J.W.M.) from Research to Prevent Blindness; Special thanks to the Harvard Department of Ophthalmology and Massachusetts Eye and Ear Infirmary for supporting this research (K.M.C.); the Massachusetts Lions Eye Research Fund (KMC); and by Grants R01EY022084/S1 (to K.M.C.) and by the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2017R1D1A1B03027966) (to D.H.P), and the Korea Health Technology R&D Project of the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C1501) (to D.H.P).	Agarwal A MD., 2012, GASS ATLAS MACULAR D, P437; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P4314, DOI 10.1167/iovs.03-0137; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Andreatta W, 2014, J GLAUCOMA, V23, P206, DOI 10.1097/IJG.0000000000000042; ARMALY MF, 1980, ARCH OPHTHALMOL-CHIC, V98, P2163, DOI 10.1001/archopht.1980.01020041015002; Bailey Freund DS K, 2017, THE RETINAL ATLAS, P493; BALLON BJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P1730, DOI 10.1001/archopht.1992.01080240070033; Bayer AU, 2001, EXP EYE RES, V72, P667, DOI 10.1006/exer.2001.1004; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chatterjee A, 2013, EXP EYE RES, V115, P106, DOI 10.1016/j.exer.2013.06.017; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cone FE, 2012, EXP EYE RES, V99, P27, DOI 10.1016/j.exer.2012.04.006; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Garway-Heath DF, 2013, OPHTHALMOLOGY, V120, P68, DOI 10.1016/j.ophtha.2012.07.028; Ito YA, 2016, JOVE-J VIS EXP, DOI 10.3791/53731; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kiyota N, 2015, CLIN EXP OPHTHALMOL, V43, P841, DOI 10.1111/ceo.12562; Klatt C, 2010, OPHTHALMOLOGE, V107, P446, DOI 10.1007/s00347-009-2018-x; Krishnan A, 2016, J IMMUNOL, V197, P4626, DOI 10.4049/jimmunol.1601488; Kuroiwa S, 1998, INVEST OPHTH VIS SCI, V39, P610; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lau LI, 2003, OPHTHALMOLOGY, V110, P1890, DOI 10.1016/S0161-6420(03)00666-3; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Ma J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125695; Matsumoto Y, 2014, JPN J OPHTHALMOL, V58, P290, DOI 10.1007/s10384-014-0311-y; Michaelides M, 2010, J GLAUCOMA, V19, P643, DOI 10.1097/IJG.0b013e3181d12dea; MILLER KN, 1989, ARCH OPHTHALMOL-CHIC, V107, P1316, DOI 10.1001/archopht.1989.01070020386041; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Neufeld AH, 1999, SURV OPHTHALMOL, V43, pS129, DOI 10.1016/S0039-6257(99)00010-7; Nguyen C, 2013, INVEST OPHTH VIS SCI, V54, P1767, DOI 10.1167/iovs.12-10952; Pease ME, 2011, INVEST OPHTH VIS SCI, V52, P858, DOI 10.1167/iovs.10-5556; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rovere G, 2016, INVEST OPHTH VIS SCI, V57, P6652, DOI 10.1167/iovs.16-20146; Samsel PA, 2011, INVEST OPHTH VIS SCI, V52, P1671, DOI 10.1167/iovs.09-3921; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Smedowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05910; SONTY S, 1981, OPHTHALMOLOGY, V88, P225; Stephen J., 2013, RETINA, P1039; STEWART WC, 1988, ARCH OPHTHALMOL-CHIC, V106, P202; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vidal-Sanz M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00235; WERNER EB, 1979, OPHTHALMOLOGY, V86, P1875; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Yang Q, 2012, INVEST OPHTH VIS SCI, V53, P3733, DOI 10.1167/iovs.12-9814; Yokoyama Y, 2014, BIOCHEM BIOPH RES CO, V451, P510, DOI 10.1016/j.bbrc.2014.08.009; Zhu YL, 2013, MOL VIS, V19, P2360	58	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208713	10.1371/journal.pone.0208713	http://dx.doi.org/10.1371/journal.pone.0208713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640920	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000007
J	Quaglia, D; Alejaldre, L; Ouadhi, S; Rousseau, O; Pelletier, JN				Quaglia, Daniela; Alejaldre, Lorea; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.			Holistic engineering of Cal-A lipase chain-length selectivity identifies triglyceride binding hot-spot	PLOS ONE			English	Article							CANDIDA-ANTARCTICA LIPASE; DIRECTED EVOLUTION; FATTY-ACIDS; SATURATED MEDIUM; COMBINATORIAL; BIOCATALYSTS; HYDROLYSIS; STRATEGIES; ENZYMES; ASSAY	Through the application of a region-focused saturation mutagenesis and randomization approach, protein engineering of the Cal-A enzyme was undertaken with the goal of conferring new triglyceride selectivity. Little is known about the mode of triglyceride binding to Cal-A. Engineering Cal-A thus requires a systemic approach. Targeted and randomized Cal-A libraries were created, recombined using the Golden Gate approach and screened to detect variants able to discriminate between long-chain (olive oil) and short-chain (tributyrin) triglyceride substrates using a high-throughput in vivo method to visualize hydrolytic activity. Discriminative variants were analyzed using an in-house script to identify predominant substitutions. This approach allowed identification of variants that exhibit strong discrimination for the hydrolysis of short-chain triglycerides and others that discriminate towards hydrolysis of long-chain triglycerides. A clear pattern emerged from the discriminative variants, identifying the 217-245 helix-loop-helix motif as being a hot-spot for triglyceride recognition. This was the consequence of introducing the entire mutational load in selected regions, without putting a strain on distal parts of the protein. Our results improve our understanding of the Cal-A lipase mode of action and selectivity. This holistic perspective to protein engineering, where parts of the gene are individually mutated and the impact evaluated in the context of the whole protein, can be applied to any protein scaffold.	[Quaglia, Daniela; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ, Canada; [Quaglia, Daniela; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.] Univ Montreal, CGCC, Montreal, PQ, Canada; [Quaglia, Daniela; Alejaldre, Lorea; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Alejaldre, Lorea; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Pelletier, JN (corresponding author), Univ Montreal, Dept Chim, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, CGCC, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ, Canada.	joelle.pelletier@umontreal.ca		Quaglia, Daniela/0000-0003-3756-3782; Alejaldre, Lorea/0000-0003-3086-5446	Natural Sciences and Engineering Research Council of Canada [227853]; Canada Foundation for Innovation [11510]; CGCC; Quebec Centre for Green Chemistry and Catalysis; Fonds Quebecois pour la Recherche sur la Nature et les Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CGCC; Quebec Centre for Green Chemistry and Catalysis; Fonds Quebecois pour la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This work was supported by Natural Sciences and Engineering Research Council of Canada grant 227853 to JNP and Canada Foundation for Innovation grant 11510 to JNP. SO received a scholarship from CGCC, the Quebec Centre for Green Chemistry and Catalysis, which is funded by les Fonds Quebecois pour la Recherche sur la Nature et les Technologies (FQRNT).	Akanbi TO, 2017, FOOD CHEM, V229, P509, DOI 10.1016/j.foodchem.2017.02.099; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Borrelli GM, 2015, INT J MOL SCI, V16, P20774, DOI 10.3390/ijms160920774; Boskou D., 2006, OLIVE OIL COMPOSITIO, DOI [10.4324/9781003040217, DOI 10.4324/9781003040217]; Brundiek H, 2012, EUR J LIPID SCI TECH, V114, P1148, DOI 10.1002/ejlt.201200106; Brundiek HB, 2012, ANGEW CHEM INT EDIT, V51, P412, DOI 10.1002/anie.201106126; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Cozens C, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky067; Damborsky J, 2009, CURR OPIN CHEM BIOL, V13, P26, DOI 10.1016/j.cbpa.2009.02.021; Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022; de Maria PD, 2005, J MOL CATAL B-ENZYM, V37, P36, DOI 10.1016/j.molcatb.2005.09.001; Denard CA, 2015, CURR OPIN CHEM BIOL, V25, P55, DOI 10.1016/j.cbpa.2014.12.036; Divakar K, 2014, ANAL BIOCHEM, V448, P38, DOI 10.1016/j.ab.2013.11.031; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Ericsson DJ, 2008, J MOL BIOL, V376, P109, DOI 10.1016/j.jmb.2007.10.079; Gillam EMJ, 2014, METHODS MOL BIOL, V1179, P1, DOI 10.1007/978-1-4939-1053-3; He YJ, 2017, FOOD CHEM, V219, P230, DOI 10.1016/j.foodchem.2016.09.149; JOERGER RD, 1994, LIPIDS, V29, P377, DOI 10.1007/BF02537305; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Li Y, 2014, BIOTECHNOL BIOENG, V111, P1273, DOI 10.1002/bit.25240; Miettinen H, 2013, INT DAIRY J, V32, P61, DOI 10.1016/j.idairyj.2013.05.007; Nyyssola A, 2015, INT DAIRY J, V41, P16, DOI 10.1016/j.idairyj.2014.09.003; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Porter JL, 2016, CHEMBIOCHEM, V17, P197, DOI 10.1002/cbic.201500280; Quaglia D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171741; Reetz MT, 2013, ANGEW CHEM INT EDIT, V52, P2658, DOI 10.1002/anie.201207842; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Sandstrom AG, 2012, P NATL ACAD SCI USA, V109, P78, DOI 10.1073/pnas.1111537108; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Scrutton NS, 2017, IUCRJ, V4, P5, DOI 10.1107/S2052252516019692; Stoytcheva M, 2012, CURR ANAL CHEM, V8, P400, DOI 10.2174/157341112801264879; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanaka S, 2018, ACS CHEM BIOL, V13, P1487, DOI 10.1021/acschembio.8b00384; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Zorn K, 2018, ADV SYNTH CATAL, V360, P4115, DOI 10.1002/adsc.201800889	38	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210100	10.1371/journal.pone.0210100	http://dx.doi.org/10.1371/journal.pone.0210100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640952	gold, Green Published, Green Submitted			2022-12-26	WOS:000455808000018
J	Conley, ZC; Carlson-Banning, KM; Carter, AG; de la Cova, A; Song, YC; Zechiedrich, L				Conley, Zachary C.; Carlson-Banning, Kimberly M.; Carter, Ashley G.; de la Cova, Alejandro; Song, Yongcheng; Zechiedrich, Lynn			Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; ACINETOBACTER-BAUMANNII; SWARMING MOTILITY; VIRULENCE FACTORS; RCS PHOSPHORELAY; GENE-REGULATION; OUTER-MEMBRANE; POLYMYXIN-B; LIPOPOLYSACCHARIDE; OLAMINE	New antibiotics are needed against antibiotic-resistant gram-negative bacteria. The repurposed antifungal drug, ciclopirox, equally blocks antibiotic-susceptible or multidrug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates, indicating that it is not affected by existing resistance mechanisms. Toward understanding how ciclopirox blocks growth, we screened E. coli mutant strains and found that disruption of genes encoding products involved in galactose salvage, enterobacterial common antigen synthesis, and transport of the iron binding siderophore, enterobactin, lowered the minimum inhibitory concentration of ciclopirox needed to block growth of the mutant compared to the isogenic parent strain. We found that ciclopirox induced enterobactin production and that this effect is strongly affected by the deletion of the galactose salvage genes encoding UDP-galactose 4-epimerase, galE, or galactose-1-phosphate uridylyltransferase, galT. As disruption of ECA synthesis activates the regulation of capsular synthesis (Rcs) phosphorelay, which inhibits bacterial swarming and promotes biofilm development, we test whether ciclopirox prevents activation of the Rcs pathway. Sub-inhibitory concentrations of ciclopirox increased swarming of the E. coli laboratory K12 strain BW25113 but had widely varying effects on swarming or surface motility of clinical isolate E. coli, A. baumannii, and K. pneumoniae. There was no effect of ciclopirox on biofilm production, suggesting it does not target Rcs. Altogether, our data suggest ciclopirox-mediated alteration of lipopolysaccharides stimulates enterobactin production and affects bacterial swarming.	[Conley, Zachary C.; Carlson-Banning, Kimberly M.; Zechiedrich, Lynn] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Conley, Zachary C.; Carlson-Banning, Kimberly M.; Carter, Ashley G.; de la Cova, Alejandro; Zechiedrich, Lynn] Baylor Coll Med, Dept Virol & Microbiol, Houston, TX 77030 USA; [de la Cova, Alejandro] Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Song, Yongcheng; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Carlson-Banning, Kimberly M.] Univ Texas Southwestern, Dallas, TX USA; [Carter, Ashley G.] Alabama Coll Osteopath Med, Dothan, AL USA	Baylor College of Medicine; Baylor College of Medicine; State University System of Florida; University of Florida; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zechiedrich, L (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019	Zechiedrich, Lynn/0000-0003-0533-1637	National Institutes of Health [R01 GM115501]; Molecular Basis of Infectious Diseases [T32 AI55449]; CPRIT grant [RP160283]; Baylor-UT Houston CFAR [P30AI1036211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Basis of Infectious Diseases; CPRIT grant; Baylor-UT Houston CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM115501 (to L.Z.). Z.C.C. was supported, in part, by the Molecular Basis of Infectious Diseases grant T32 AI55449 (Norris S and Koehler TM, co-PIs). A.d.l.C. and A. G.C. were participants of the Baylor College of Medicine SMART program supported by the CPRIT grant RP160283 and the Baylor-UT Houston CFAR grant P30AI1036211, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; ALPERMANN HG, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1328; Armbruster CE, 2013, J BACTERIOL, V195, P1305, DOI 10.1128/JB.02136-12; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Belas R, 2014, TRENDS MICROBIOL, V22, P517, DOI 10.1016/j.tim.2014.05.002; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; Bernier KM, 2018, ANTIVIR RES, V156, P102, DOI 10.1016/j.antiviral.2018.06.010; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Carabarin-Lima A, 2016, J MED MICROBIOL, V65, P729, DOI 10.1099/jmm.0.000291; Carlson-Banning KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069646; Castelli ME, 2011, J BACTERIOL, V193, P63, DOI 10.1128/JB.00839-10; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Conley ZC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006805; COPPI G, 1992, FARMACO, V47, P779; COPPI G, 1993, J CHEMOTHERAPY, V5, P302; Doerfel LK, 2013, BIOPOLYMERS, V99, P837, DOI 10.1002/bip.22341; EVANS ME, 1993, J INFECT DIS, V167, P1336, DOI 10.1093/infdis/167.6.1336; Fernandez L, 2013, ANTIMICROB AGENTS CH, V57, P110, DOI 10.1128/AAC.01583-12; Folsom JP, 2014, J BACTERIOL, V196, P2748, DOI 10.1128/JB.01606-14; Frawley ER, 2014, MOL MICROBIOL, V93, P609, DOI 10.1111/mmi.12709; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Hanauske-Abel HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074414; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; Harshey RM, 2015, J MOL BIOL, V427, P3683, DOI 10.1016/j.jmb.2015.07.025; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Horiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108642; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Jayaseelan S, 2014, WORLD J MICROB BIOT, V30, P1159, DOI 10.1007/s11274-013-1552-5; Caceres CJ, 2016, ANTIVIR RES, V134, P192, DOI 10.1016/j.antiviral.2016.09.006; Jorgenson MA, 2016, MOL MICROBIOL, V100, P1, DOI 10.1111/mmi.13284; Kalynych S, 2015, PROTEIN SCI, V24, P58, DOI 10.1002/pro.2586; Kalynych S, 2014, FEMS MICROBIOL REV, V38, P1048, DOI 10.1111/1574-6976.12070; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kebouchi M, 2018, J BIOL CHEM, V293, P497, DOI 10.1074/jbc.M117.804443; KELLNER HM, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1337; Kim KS, 2015, J ANTIBIOT, V68, P395, DOI 10.1038/ja.2014.164; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Ko SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027844; Lee SJ, 2014, MBIO, V5, DOI 10.1128/mBio.00972-13; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; McQueary CN, 2012, J MICROBIOL, V50, P434, DOI 10.1007/s12275-012-1555-1; McRose DL, 2018, J BIOL INORG CHEM, V23, P983, DOI 10.1007/s00775-018-1617-x; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mihailidou C, 2017, ONCOTARGET, V9, P10360, DOI [DOI 10.18632/ONCOTARGET.23164, 10.18632/oncotarget.23164]; Mihailidou C, 2017, ANTIOXID REDOX SIGN, V27, P185, DOI 10.1089/ars.2016.6671; Mihailidou C, 2016, PFLUG ARCH EUR J PHY, V468, P1957, DOI 10.1007/s00424-016-1887-5; Minden MD, 2014, AM J HEMATOL, V89, P363, DOI 10.1002/ajh.23640; Moon K, 2009, MOL MICROBIOL, V19, P389, DOI [10.1016/j.asieco.2008.09.006.EAST, DOI 10.1016/J.ASIECO.2008.09.006.EAST]; Morgan-Linnell SK, 2009, ANTIMICROB AGENTS CH, V53, P235, DOI 10.1128/AAC.00665-08; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Morikawa M, 2000, BBA-MOL CELL BIOL L, V1488, P211, DOI 10.1016/S1388-1981(00)00124-4; MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nakao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051241; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Nicolaou SA, 2013, APPL ENVIRON MICROB, V79, P7210, DOI 10.1128/AEM.02322-13; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Ogasawara H, 2012, MICROBIOL-SGM, V158, P1482, DOI 10.1099/mic.0.057745-0; Organization WH, 2017, PRIOR PATH GUID DISC; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; OZENBERGER BA, 1987, J BACTERIOL, V169, P3638, DOI 10.1128/jb.169.8.3638-3646.1987; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; POOLE K, 1990, J BACTERIOL, V172, P6991, DOI 10.1128/jb.172.12.6991-6996.1990; Qian JH, 2014, BIOCHEMISTRY-US, V53, P1250, DOI 10.1021/bi4015665; Rahman A, 2001, J BACTERIOL, V183, P6509, DOI 10.1128/JB.183.22.6509-6516.2001; Rangel-Vega A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00282; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Ross KL, 2004, MOL GENET METAB, V83, P103, DOI 10.1016/j.ymgme.2004.07.005; SAKURAI K, 1978, CHEMOTHERAPY, V24, P68, DOI 10.1159/000237762; Santos JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1101, DOI 10.1016/j.bbapap.2015.01.010; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Sen S, 2013, EXP HEMATOL, V41, P799, DOI 10.1016/j.exphem.2013.04.012; Shen Tao, 2018, Genes Cancer, V9, P39, DOI 10.18632/genesandcancer.166; Shen Tao, 2017, Genes Cancer, V8, P505, DOI 10.18632/genesandcancer.135; Shin J, 2018, BIOCHEM BIOPH RES CO, V500, P296, DOI 10.1016/j.bbrc.2018.04.063; Sigle HC, 2005, J ANTIMICROB CHEMOTH, V55, P663, DOI 10.1093/jac/dki089; Skiebe E, 2012, INT J MED MICROBIOL, V302, P117, DOI 10.1016/j.ijmm.2012.03.003; Subissi A, 2010, DRUGS, V70, P2133, DOI 10.2165/11538110-000000000-00000; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10; U.S. Department of Health and Human Services Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Urquiza P, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7467; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Wayne P.A., 2006, M100S16 CLIN LAB STA; Welch TJ, 2005, INFECT IMMUN, V73, P5864, DOI 10.1128/IAI.73.9.5864-5872.2005; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001; Yuan BS, 2018, MOL MED REP, V17, P4291, DOI 10.3892/mmr.2018.8418; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007; Zhou H, 2017, BIOCHEM PHARMACOL, V116, P39, DOI [10.1016/j.bcp.2016.07, DOI 10.1016/J.BCP.2016.07]; Zhou HY, 2014, ONCOTARGET, V5, P10140, DOI 10.18632/oncotarget.2471; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	101	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210547	10.1371/journal.pone.0210547	http://dx.doi.org/10.1371/journal.pone.0210547			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633761	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100029
J	Koiv, V; Arbo, K; Maivali, U; Kisand, V; Roosaare, M; Remm, M; Tenson, T				Koiv, Viia; Arbo, Kroot; Maivali, Ulo; Kisand, Veljo; Roosaare, Mart; Remm, Maido; Tenson, Tanel			Endophytic bacterial communities in peels and pulp of five root vegetables	PLOS ONE			English	Article							GUT MICROBIOTA; PLANT; IMPACT; ASSOCIATIONS; RHIZOSPHERE; PROBIOTICS; DIVERSITY; INFECTION; DYNAMICS; DEPENDS	Plants contain endophytic bacteria, whose communities both influence plant growth and can be an important source of probiotics. Here we used deep sequencing of a 16S rRNA gene fragment and bacterial cultivation to independently characterize the microbiomes of five plant species from divergent taxonomic orders-potato (Solanum tuberosum), carrot (Daucus sativus), beet (Beta vulgaris), neep (Brassica napus spp. napobrassica), and topinambur (Helianthus tuberosus). We found that both species richness and diversity tend to be higher in the peel, where Alphaproteobacteria and Actinobacteria dominate, while Gamma-proteobacteria and Firmicutes dominate in the pulp. A statistical analysis revealed that the main characteristic features of the microbiomes of plant species originate from the peel microbiomes. Topinambur pulp displayed an interesting characteristic feature: it contained up to 10(8) CFUs of lactic acid bacteria, suggesting its use as a source of probiotic bacteria. We also detected Listeria sp., in topinambur pulps, however, the 16S rRNA gene fragment is unable to distinguish between pathogenic versus non-pathogenic species, so the evaluation of this potential health risk is left to a future study.	[Koiv, Viia; Arbo, Kroot; Maivali, Ulo; Kisand, Veljo; Tenson, Tanel] Univ Tartu, Inst Technol, Tartu, Estonia; [Roosaare, Mart; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia	University of Tartu; University of Tartu	Koiv, V (corresponding author), Univ Tartu, Inst Technol, Tartu, Estonia.	viia.koiv@ut.ee	Kisand, Veljo/H-2466-2012; Remm, Maido/L-9072-2019	Kisand, Veljo/0000-0002-5535-1639; Remm, Maido/0000-0003-3966-8422	Estonian Research Council [PUT-134, IUT2-22, IUT34-11]; European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering [SLTTI16143T]	Estonian Research Council(Estonian Research Council); European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering	TT, UM, VK, KA: Estonian Research Council IUT2-22. https://www.etis.ee/Portal/Projects/Display/db4a3ea8-611d-4be5-af16-a18d2d861873?lang= ENG. MR, MRo: Estonian Research Council IUT34-11. https://www.etis.ee/Portal/Projects/Display/2493d2a9-1edf-4a53-a6d1- 9cbf469758c3?lang=ENG. TT, UM: European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering SLTTI16143T https://www.etis.ee/Portal/Projects/Display/e6209fe6-9b6a-4a8e-9ad4-89ecc5c60cc2?lang=ENG.Ki: Estonian Research Council PUT-134 https://www.etis.ee/Portal/Projects/Display/08c424fe-696c-45cb-9bc0-fdd02f9af2a2?lang=ENG.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHAROUSI ZS, 2016, INT J MICROBIOL, V2016, DOI DOI 10.1155/2016/4292417; Angel R, 2016, MICROB ECOL, V72, P394, DOI 10.1007/s00248-016-0779-8; Bamberger C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020244; Bazanella M, 2017, AM J CLIN NUTR, V106, P1274, DOI 10.3945/ajcn.117.157529; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Berg G, 2014, MICROB BIOTECHNOL, V7, P487, DOI 10.1111/1751-7915.12159; Bergey DH, 2005, BERGEYS MANUAL SYSTE, DOI [10.1345/aph.1P777, DOI 10.1345/APH.1P777]; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Browne HP, 2017, NAT REV MICROBIOL, V15, P531, DOI 10.1038/nrmicro.2017.50; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dees MW, 2015, APPL ENVIRON MICROB, V81, P1530, DOI 10.1128/AEM.03470-14; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Edwards JA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003862; Fitzpatrick CR, 2018, P NATL ACAD SCI USA, V115, pE1157, DOI 10.1073/pnas.1717617115; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Fragiadakis GK, 2019, GUT MICROBES, V10, P216, DOI 10.1080/19490976.2018.1494103; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Gharechahi J, 2017, MICROB BIOTECHNOL, V10, P1663, DOI 10.1111/1751-7915.12751; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gurry T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30783-1; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hale VL, 2018, MICROB ECOL, V75, P515, DOI 10.1007/s00248-017-1041-8; Hanchi H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01791; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hartman K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0220-z; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Izquierdo E, 2009, FOOD MICROBIOL, V26, P16, DOI 10.1016/j.fm.2008.08.002; Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274; Kecskemeti E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160852; Koiv V, 2015, SCI REP-UK, V5, DOI 10.1038/srep11606; Lang JM, 2014, PEERJ, V2, DOI 10.7717/peerj.659; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Lehtimaki J, 2018, P NATL ACAD SCI USA, V115, P4897, DOI 10.1073/pnas.1719785115; Li F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00187; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mezzasalma V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00946; Minervini F, 2015, APPL ENVIRON MICROB, V81, P6736, DOI 10.1128/AEM.01852-15; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Moronta-Barrios F, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010014; Nithya A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0974-x; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Oksanen F.J., 2017, VEGAN COMMUNITY ECOL; Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Rascovan N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28084; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rosenblueth M, 2004, ARCH MICROBIOL, V181, P337, DOI 10.1007/s00203-004-0661-9; Sanders ME, 2010, GUT MICROBES, V1, P164, DOI 10.4161/gmic.1.3.12127; Santos-Medellin C, 2017, MBIO, V8, DOI [10.1128/mbio.00764-17, 10.1128/mBio.00764-17]; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Seo WT, 2010, J KOREAN SOC APPL BI, V53, P493, DOI 10.3839/jksabc.2010.075; Shortt C, 2018, EUR J NUTR, V57, P25, DOI 10.1007/s00394-017-1546-4; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Warnes G. R, 2016, COMPREHENSIVE R ARCH; Wassermann B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17949-z; World Health Organization, 2015, INCR FRUIT VEG CONS; Xu L, 2018, P NATL ACAD SCI USA, V115, pE4284, DOI 10.1073/pnas.1717308115; Yeoh YK, 2016, ENVIRON MICROBIOL, V18, P1338, DOI 10.1111/1462-2920.12925; Zhang CH, 2016, ISME J, V10, P2235, DOI 10.1038/ismej.2016.13; Zhang YZ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0304-4	79	14	14	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210542	10.1371/journal.pone.0210542	http://dx.doi.org/10.1371/journal.pone.0210542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633764	Green Submitted, Green Published, gold			2022-12-26	WOS:000455485100028
J	Liu, JY; Parrish, JR; Hines, J; Mansfield, L; Finley, RL				Liu, Jiayou; Parrish, Jodi R.; Hines, Julie; Mansfield, Linda; Finley, Russell L., Jr.			A proteome-wide screen of Campylobacter jejuni using protein microarrays identifies novel and conformational antigens	PLOS ONE			English	Article							HUMAN-ANTIBODY RESPONSE; MEMBRANE-PROTEIN; SERA; GENE; IMMUNOGENICITY; COLONIZATION; PURIFICATION; INFECTIONS; EXPRESSION; SEQUENCE	Campylobacter jejuni (C. jejuni) is a foodborne intestinal pathogen and major cause of gastroenteritis worldwide. C. jejuni proteins that are immunogenic have been sought for their potential use in the development of biomarkers, diagnostic assays, or subunit vaccines for humans or livestock. To identify new immunogenic C. jejuni proteins, we used a native protein microarray approach. A protein chip, with over 1400 individually purified GST-tagged C. jejuni proteins, representing over 86% of the proteome, was constructed to screen for antibody titers present in test sera raised against whole C. jejuni cells. Dual detection of GST signals was incorporated as a way of normalizing the variation of protein concentrations contributing to the antibody staining intensities. We detected strong signals to 102 C. jejuni antigens. In addition to antigens recognized by antiserum raised against C. jejuni, parallel experiments were conducted to identify antigens cross-reactive to antiserum raised against various serotypes of E. coli or Salmonella or to healthy human sera. This led to the identification of 34 antigens specifically recognized by the C. jejuni antiserum, only four of which were previously known. The chip approach also allowed identification of conformational antigens. We demonstrate in the case of Cj1621 that antigen signals are lost to denaturing conditions commonly used in other approaches to identify immunogens. Antigens identified in this study include those possessing sequence features indicative of cell surface localization, as well as those that do not. Together, our results indicate that the unbiased chip-based screen can help reveal the full repertoire of host antibodies against microbial proteomes.	[Liu, Jiayou; Parrish, Jodi R.; Hines, Julie; Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Mansfield, Linda] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA; [Liu, Jiayou] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA	Wayne State University; Michigan State University; Wayne State University	Finley, RL (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.; Finley, RL (corresponding author), Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA.	rfinley@wayne.edu		Mansfield, Linda S./0000-0002-7523-7577; Finley, Russ/0000-0003-1144-6887	State of Michigan, Michigan Life Sciences Corridor; NIAID, NIH, Department of Health and Human Services [N01-AI-30058]; Enteric Research Investigational Network Cooperative Research Center (ERIN CRC) grant [U19AI090872]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121748] Funding Source: NIH RePORTER	State of Michigan, Michigan Life Sciences Corridor; NIAID, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Enteric Research Investigational Network Cooperative Research Center (ERIN CRC) grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JL, JRP, JH, and RLF, received support for this work from the State of Michigan, Michigan Life Sciences Corridor funding to the Michigan Proteome Consortium; LM received support for all contributions to from the NIAID, NIH, Department of Health and Human Services, under contract no. N01-AI-30058 and Enteric Research Investigational Network Cooperative Research Center (ERIN CRC) grant U19AI090872. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arai M, 2003, GENE, V304, P77, DOI 10.1016/S0378-1119(02)01181-2; Bacon DJ, 2002, INFECT IMMUN, V70, P6242, DOI 10.1128/IAI.70.11.6242-6250.2002; Baqar S, 2008, INFECT IMMUN, V76, P3170, DOI 10.1128/IAI.00076-08; BURNENS A, 1995, J CLIN MICROBIOL, V33, P2826, DOI 10.1128/JCM.33.11.2826-2832.1995; CDC U, 2013, ANTIBIOTIC RESISTANC; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Chen CS, 2009, MOL CELL PROTEOMICS, V8, P1765, DOI 10.1074/mcp.M800593-MCP200; Chen PC, 2015, MOL CELL PROTEOMICS, V14, P510, DOI 10.1074/mcp.M114.045930; Coelho PSR, 2015, J PROTEOME RES, V14, P3924, DOI 10.1021/acs.jproteome.5b00365; Connerton PL, 1999, LETT APPL MICROBIOL, V28, P233, DOI 10.1046/j.1365-2672.1999.00491.x; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Du LF, 2008, WORLD J GASTROENTERO, V14, P6244, DOI 10.3748/wjg.14.6244; Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172; Haab BB, 2001, GENOME BIOL, V2; Hansson I, 2018, TRANSBOUND EMERG DIS, V65, P30, DOI 10.1111/tbed.12870; He YQ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/297505; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; Hoppe S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-12; Hu YQ, 2014, J MICROBIOL BIOTECHN, V24, P363, DOI 10.4014/jmb.1311.11019; Hu YQ, 2013, BBA-GEN SUBJECTS, V1830, P5229, DOI 10.1016/j.bbagen.2013.06.042; Jain R, 2019, INTERDISCIP SCI, V11, P337, DOI 10.1007/s12539-017-0260-5; Kempsell KE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00747; Kuhn KG, 2012, DIAGN MICR INFEC DIS, V74, P113, DOI 10.1016/j.diagmicrobio.2012.06.004; Liang L, 2015, CURR OPIN INFECT DIS, V28, P438, DOI 10.1097/QCO.0000000000000193; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Loshaj-Shala A, 2018, J NEUROIMMUNOL, V317, P77, DOI 10.1016/j.jneuroim.2018.01.006; MacBeath G, 2000, SCIENCE, V289, P1760; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Meunier M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188472; Meunier M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5715790; Miller JC, 2003, PROTEOMICS, V3, P56, DOI 10.1002/pmic.200390009; MILLS SD, 1984, INFECT IMMUN, V43, P739, DOI 10.1128/IAI.43.2.739-743.1984; NACHAMKIN I, 1989, J CLIN MICROBIOL, V27, P2195, DOI 10.1128/JCM.27.10.2195-2198.1989; Nielsen LN, 2012, CLIN VACCINE IMMUNOL, V19, P113, DOI 10.1128/CVI.05161-11; NUIJTEN PJM, 1991, INFECT IMMUN, V59, P1100, DOI 10.1128/IAI.59.3.1100-1105.1991; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Pawelec D, 1997, FEMS IMMUNOL MED MIC, V19, P137, DOI 10.1111/j.1574-695X.1997.tb01083.x; Pawelec DP, 2000, FEMS MICROBIOL LETT, V185, P43, DOI 10.1111/j.1574-6968.2000.tb09038.x; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Riddle MS, 2016, VACCINE, V34, P2903, DOI 10.1016/j.vaccine.2016.02.080; Schmidt-Ott R, 2005, J MED MICROBIOL, V54, P761, DOI 10.1099/jmm.0.46040-0; WENMAN WM, 1985, J CLIN MICROBIOL, V21, P108, DOI 10.1128/JCM.21.1.108-112.1985; WHO OIE FAO, 2017, EARLY IMPLEMENTATION; Wyszynska A, 2008, CURR MICROBIOL, V57, P181, DOI 10.1007/s00284-008-9171-3; Wyszyznska Agnieszka, 2002, Acta Microbiol Pol, V51, P313; Yeh HY, 2015, ARCH MICROBIOL, V197, P353, DOI 10.1007/s00203-014-1062-3; Yeh HY, 2013, MICROBIOL RES, V168, P192, DOI 10.1016/j.micres.2012.11.010; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Zeng Ximin, 2010, J Vaccines Vaccin, V1; Zeng XM, 2009, INFECT IMMUN, V77, P5437, DOI 10.1128/IAI.00666-09; Zhang QJ, 2000, INFECT IMMUN, V68, P5679, DOI 10.1128/IAI.68.10.5679-5689.2000; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	53	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210351	10.1371/journal.pone.0210351	http://dx.doi.org/10.1371/journal.pone.0210351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633767	gold, Green Submitted, Green Published			2022-12-26	WOS:000455485100019
J	Matheus, Z; Francini, RB; Pereira, GH; Moraes, FC; de Moura, RL; Brasileiro, PS; Amado, GM				Matheus, Zaira; Francini-Filho, Ronaldo Bastos; Pereira-Filho, Guilherme Henrique; Moraes, Fernando C.; de Moura, Rodrigo L.; Brasileiro, Poliana S.; Amado-Filho, Gilberto Menezes			Benthic reef assemblages of the Fernando de Noronha Archipelago, tropical South-west Atlantic: Effects of depth, wave exposure and cross-shelf positioning	PLOS ONE			English	Article							REMOTE ST PETER; CORAL-REEFS; COMMUNITY STRUCTURE; CLIMATE-CHANGE; BASE-LINES; FISH; RESILIENCE; CONSERVATION; BIOGEOGRAPHY; COMPETITION	Oceanic islands can be relatively isolated from overfishing and pollution sources, but they are often extremely vulnerable to climate and anthropogenic stress due to their small size and unique assemblages that may rely on a limited larval supply for replenishment. Vulnerability may be especially high when these islands bear permanent human populations or are subjected to regular or intermittent fishing. Since the late 1970's, Brazil has been establishing marine protected areas (MPAs) around its four oceanic island groups, which concentrate high endemism levels and are considered peripheral outposts of the Brazilian Biogeographic Province. In 2018, the Brazilian legally marine protected area increased > 10-fold, but most of the similar to 1,000,000 km(2) of MPAs around Brazil's oceanic islands are still unknown and unprotected. Here, we provide the first detailed quantitative baseline of benthic reef assemblages, including shallow and mesophotic zones, of the Fernando de Noronha Archipelago (FNA). The archipelago is partially protected as a no-take MPA and recognized by the UNESCO as a World Heritage Site, but also represents the only Brazilian oceanic island with a large permanent human population (3,000 people), mass tourism (up to 90,000 people per year) and a permanent small-scale fishing community. The influence of depth, wave exposure, and distance from the island and shelf edge on the structure of benthic assemblages was assessed from benthic photoquadrats obtained in 12 sites distributed in the lee and windward shores of the archipelago. Unique assemblages and discriminating species were identified using Multivariate Regression Trees, and environmental drivers of dominant assemblages' components were evaluated using Boosted Regression Trees. A total of 128 benthic taxa were recorded and 5 distinct assemblages were identified. Distance to the insular slope, depth and exposure were the main drivers of assemblages' differentiation. Our results represent an important baseline for evaluating changes in benthic assemblages due to increased local and global stressors.	[Matheus, Zaira; Moraes, Fernando C.; Brasileiro, Poliana S.; Amado-Filho, Gilberto Menezes] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Francini-Filho, Ronaldo Bastos] Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, PB, Brazil; [Pereira-Filho, Guilherme Henrique] Univ Fed Sao Paulo, Lab Ecol & Conservacao Marinha, Inst Mar, Campus Baixada Santista, Santos, SP, Brazil; [de Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Inst Biol, Lab Sistemas Avancados Gestao Prod SAGE, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Rio De Janeiro, RJ, Brazil	Jardim Botanico do Rio de Janeiro; Universidade Federal da Paraiba; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Amado, GM (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil.; Pereira, GH (corresponding author), Univ Fed Sao Paulo, Lab Ecol & Conservacao Marinha, Inst Mar, Campus Baixada Santista, Santos, SP, Brazil.	pereira.filho@unifesp.br; gfilho@jbrj.gov.br	Pereira-Filho, Guilherme-Henrique/I-2946-2013; Francini-Filho, Ronaldo/I-5708-2012; de Moura, Rodrigo Leao/AAL-5781-2020	Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Francini-Filho, Ronaldo/0000-0002-7678-6797; de Moura, Rodrigo Leao/0000-0002-5597-6196	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [447101/2014-5]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Grant 447101/2014-5 to GHPF - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Individual grants from CNPq (to GHPF, GMAF, RLdM and RBFF), from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio Janeiro (FAPERJ) (to GMAF), and from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to ZM and FCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2016, MAR BIODIVERS, V46, P933, DOI 10.1007/s12526-015-0441-6; Amado GM, 2012, AQUAT BOT, V101, P41, DOI 10.1016/j.aquabot.2012.03.016; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Balata D, 2011, MAR BIOL, V158, P2459, DOI 10.1007/s00227-011-1747-y; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bruno JF, 2014, MAR POLLUT BULL, V80, P24, DOI 10.1016/j.marpolbul.2014.01.010; Chaves LTC, 2013, MAR FRESHWATER RES, V64, P1101, DOI 10.1071/MF13054; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; de Eston V.R., 1986, Boletim do Instituto Oceanografico, V34, P37; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Duing W, 1980, PHYSICA1 OCEANOGRAPH; Edgar GJ, 2016, ANNU REV MAR SCI, V8, P435, DOI 10.1146/annurev-marine-122414-033921; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fonseca A. C., 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/179128; Foster MS, 1985, HDB PHYCOLOGICAL MET, P199; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; Giglio VJ, 2018, MAR POLICY, V96, P13, DOI 10.1016/j.marpol.2018.07.017; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Littler DS, 2000, LITTLER MM CARIBBEAN; Longo GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127176; Magalhaes GM, 2015, B MAR SCI, V91, P377, DOI 10.5343/bms.2014.1044; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meirelles PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130084; Moraes F., 2011, ESPONJAS ILHAS OCEAN; Moraes F, 2007, J MAR BIOL ASSOC UK, V87, P1387, DOI 10.1017/S0025315407058316; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Pereira GH, 2012, J COASTAL RES, V28, P261, DOI 10.2112/11T-00007.1; Pereira-Filho GH, 2015, B MAR SCI, V91, P45, DOI 10.5343/bms.2014.1067; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pinheiro HT, 2017, NATURE, V549, P82, DOI 10.1038/nature23680; Rocha LA, 2018, SCIENCE, V361, P281, DOI 10.1126/science.aaq1614; Rosa MR, 2016, CORAL REEFS, V35, P113, DOI 10.1007/s00338-015-1368-x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandin SA, 2012, OECOLOGIA, V168, P1079, DOI 10.1007/s00442-011-2156-0; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Zar JH, 1999, BIOSTATISTICAL ANAL	55	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210664	10.1371/journal.pone.0210664	http://dx.doi.org/10.1371/journal.pone.0210664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629719	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000122
J	Diniz, MA; Tighiouart, M; Rogatko, A				Diniz, Marcio Augusto; Tighiouart, Mourad; Rogatko, Andre			Comparison between continuous and discrete doses for model based designs in cancer dose finding	PLOS ONE			English	Article							I CLINICAL-TRIALS; REASSESSMENT METHOD; OVERDOSE CONTROL; ESCALATION; EWOC; BAD	Despite of an extensive statistical literature showing that discretizing continuous variables results in substantial loss of information, categorization of continuous variables has been a common practice in clinical research and in cancer dose finding (phase I) clinical trials. The objective of this study is to quantify the loss of information incurred by using a discrete set of doses to estimate the maximum tolerated dose (MTD) in phase I trials, instead of a continuous dose support. Escalation With Overdose Control and Continuous Reassessment Method were used because they are model-based designs where dose can be specified either as continuous or as a set of discrete levels. Five equally spaced sets of doses with different interval lengths and three sample sizes with sixteen scenarios were evaluated to compare the operating characteristics between continuous and discrete dose designs by Monte Carlo simulation. Loss of information was quantified by safety and efficiency measures. We conclude that if there is insufficient knowledge about the true MTD value, as commonly happens in phase I clinical trials, a continuous dose scheme minimizes information loss. If one is required to implement a design using discrete doses, then a scheme with 9 to 11 doses may yield similar results to the continuous dose scheme.	[Diniz, Marcio Augusto; Tighiouart, Mourad; Rogatko, Andre] Samuel Oschin Comprehens Canc Inst, Biostat & Bionformat Res Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Diniz, MA (corresponding author), Samuel Oschin Comprehens Canc Inst, Biostat & Bionformat Res Ctr, Los Angeles, CA 90048 USA.	marcio.diniz@cshs.org		Diniz, Marcio Augusto/0000-0002-2427-7843	NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant [UL1 TR001881-01]; National Cancer Institute [R01 CA188480-01A1, U01 CA232859-01]; NATIONAL CANCER INSTITUTE [R01CA188480, U01CA232859] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number, Grant UL1 TR001881-01 (A.R. and M.T.), National Cancer Institute Grant R01 CA188480-01A1 (M.T. and A. R.) and National Cancer Institute, Grant U01 CA232859-01 (MAD, MT, AR). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Babb J, 1998, STAT MED, V17, P1103, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9; Babb JS, 2001, STAT MED, V20, P2079, DOI 10.1002/sim.848; Borghaei H, 2009, J CLIN ONCOL, V27, P4116, DOI 10.1200/JCO.2008.20.2515; Cheng JD, 2004, J CLIN ONCOL, V22, P602, DOI 10.1200/JCO.2004.12.034; Chu PL, 2009, J STAT PLAN INFER, V139, P1146, DOI 10.1016/j.jspi.2008.07.005; Chu YY, 2016, STAT MED, V35, P3497, DOI 10.1002/sim.6933; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; CONNOR RJ, 1972, J AM STAT ASSOC, V67, P601, DOI 10.2307/2284446; COX DR, 1957, J AM STAT ASSOC, V52, P543, DOI 10.2307/2281704; Diniz MA, 2016, R PACKAGE ESCALATION; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Garrett-Mayer E, 2006, CLIN TRIALS, V3, P57, DOI 10.1191/1740774506cn134oa; Halfdanarson TR, 2010, CURR ONCOL REP, V12, P247, DOI 10.1007/s11912-010-0103-6; Hu B, 2013, CLIN TRIALS, V10, P216, DOI 10.1177/1740774510382800; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Irwin JR, 2003, J MARKETING RES, V40, P366, DOI 10.1509/jmkr.40.3.366.19237; LAGAKOS SW, 1988, STAT MED, V7, P257, DOI 10.1002/sim.4780070126; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Lee SM, 2009, CLIN TRIALS, V6, P227, DOI 10.1177/1740774509105076; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Mazumdar M, 2003, STAT MED, V22, P559, DOI 10.1002/sim.1333; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Piantadosi S, 1998, CANCER CHEMOTH PHARM, V41, P429, DOI 10.1007/s002800050763; Rogatko A, 2016, ESCALATION OVERDOSE; Rogatko A, 2007, J CLIN ONCOL, V25, P4982, DOI 10.1200/JCO.2007.12.1012; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Schumacher M, 1997, STAT MED, V16, P2813, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2813::AID-SIM701>3.0.CO;2-Z; Tighiouart M, 2005, STAT MED, V24, P2183, DOI 10.1002/sim.2106; Tighiouart M, 2010, STAT SCI, V25, P217, DOI 10.1214/10-STS333; van Brummelen EMJ, 2016, J PHARMACOKINET PHAR, V43, P235, DOI 10.1007/s10928-016-9466-0; WARTENBERG D, 1991, AM J EPIDEMIOL, V133, P1058, DOI 10.1093/oxfordjournals.aje.a115815; WEINBERG CR, 1995, EPIDEMIOLOGY, V6, P345; Weingart Saul N, 2008, J Natl Compr Canc Netw, V6 Suppl 3, pS1; Wheeler GM, 2017, STAT MED, V36, P2499, DOI 10.1002/sim.7280	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210139	10.1371/journal.pone.0210139	http://dx.doi.org/10.1371/journal.pone.0210139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625194	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400074
J	Oladipupo, SO; Callaghan, A; Holloway, GJ; Gbaye, OA				Oladipupo, Seun Olaitan; Callaghan, Amanda; Holloway, Graham J.; Gbaye, Olajire Ayodele			Variation in the susceptibility of Anopheles gambiae to botanicals across a metropolitan region of Nigeria	PLOS ONE			English	Article							KNOCKDOWN RESISTANCE KDR; INSECTICIDE RESISTANCE; AEDES-AEGYPTI; ESSENTIAL OILS; IMPACT; MECHANISMS; MOSQUITOS; GENES	Pesticide resistance is normally associated with genetic changes, resulting in varied responses to insecticides between different populations. There is little evidence of resistance to plant allelochemicals; it is likely that their efficacy varies between genetically diverse populations, which may lead to the development of resistance in the future. This study evaluated the response of Anopheles gambiae (larvae and adults) from spatially different populations to acetone extracts of two botanicals, Piper guineense and Eugenia aromatica. Mosquito samples from 10 locations within Akure metropolis in Southwest Nigeria were tested for variation in susceptibility to the toxic effect of botanical extracts. The spatial distribution of the tolerance magnitude (T.M.) of the mosquito populations to the botanicals was also mapped. The populations of An. gambiae manifested significant differences in their level of tolerance to the botanicals. The centre of the metropolis was the hot spot of tolerance to the botanicals. There was a significant positive correlation between the adulticidal activities of both botanicals and initial knockdown. Hence, knockdown by these botanicals could be a predictor of their subsequent mortality. In revealing variation in response to botanical pesticides, our work has demonstrated that any future use of botanicals as alternative environmentally friendly vector control chemicals needs to be closely monitored to ensure that resistance does not develop.	[Oladipupo, Seun Olaitan; Gbaye, Olajire Ayodele] Fed Univ Technol Akure, Dept Biol, Akure, Nigeria; [Oladipupo, Seun Olaitan] Auburn Univ, Dept Entomol & Plant Pathol, Funchess Hall, Aurburn, AL USA; [Callaghan, Amanda; Holloway, Graham J.] Univ Reading, Sch Biol Sci, Ctr Wildlife Assessment & Conservat, Reading, Berks, England	Auburn University System; Auburn University; University of Reading	Gbaye, OA (corresponding author), Fed Univ Technol Akure, Dept Biol, Akure, Nigeria.	oagbaye@futa.edu.ng		Callaghan, Amanda/0000-0002-2731-3352; Oladipupo, Seun/0000-0001-8312-7012; Gbaye, Olajire/0000-0002-2988-5223				ADDAEMENSAH I, 1986, PLANTA MED, P432; ADDAEMENSAH I, 1977, PHYTOCHEMISTRY, V16, P483, DOI 10.1016/S0031-9422(00)94334-6; Aguirre-Obando OA, 2016, REV BRAS ENTOMOL, V60, P94, DOI 10.1016/j.rbe.2015.11.009; AINA S. A., 2009, ACAD J ENTOMOL, V2, P31; Akinkurolere R. O., 2011, Jordan Journal of Biological Sciences (JJBS), V4, P237; Akinkurolere RO, 2007, INT J MED PARASITIC, V34, P1; [Anonymous], 1998, WHOCDCMAL98; [Anonymous], 2005, WORLD MALARIA REPORT; [Anonymous], 1986, WHO TECHN REP SER, V737; Awolola ST, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-236; Ayorinde A, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev045; Balogun M., 2016, IJPPR HUMAN, V6, P368; Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10149, DOI 10.1007/s11356-017-9960-y; Bissinger BW, 2010, PESTIC BIOCHEM PHYS, V96, P63, DOI 10.1016/j.pestbp.2009.09.010; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Deepa CB, 2011, CURRENT BIOTICA, V5, P237; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dodson BL, 2011, VECTOR-BORNE ZOONOT, V11, P1493, DOI 10.1089/vbz.2011.0662; Effiom OE, 2012, GLO J SCI FRONT RES, V12, P4621; El-Wakeil NE, 2013, GESUNDE PFLANZ, V65, P125, DOI 10.1007/s10343-013-0308-3; FENG R, 1995, EXPERIENTIA, V51, P831, DOI 10.1007/BF01922438; Feyereisen R., 2005, P1; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Finney DJ, 1981, PROBIT ANAL STAT TRE, P112; Gillies MT, PUBLICATIONS S AFRIC, V52, P1; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P106, DOI 10.1016/S1995-7645(11)60047-3; Guillemaud T, 1997, INSECT MOL BIOL, V6, P319; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; HERATH PRJ, 1981, J TROP MED HYG, V84, P87; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, V78, P307; Huang Y, 2002, J STORED PROD RES, V38, P403, DOI 10.1016/S0022-474X(01)00042-X; Insecticide Resistance Action Committee (IRAC), 2011, PREV MAN INS RES VEC, P11; Kim CH, 2012, ACTA TROP, V122, P94, DOI 10.1016/j.actatropica.2011.12.006; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Medeiros E. da S., 2013, African Journal of Biotechnology, V12, P836; Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9; Nkya TE, 2012, INSECT BIOCHEM MOLEC, V43, P410; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Norris EJ, 2015, J MED ENTOMOL, V52, P993, DOI 10.1093/jme/tjv090; Ohaga S. O., 2007, Journal of Biological Sciences, V7, P1215; Ojimelukwe P. C., 2000, Journal of Sustainable Agriculture and the Environment, V2, P47; Okorie PN, 2015, MED VET ENTOMOL, V29, P44, DOI 10.1111/mve.12089; OKORIE TG, 1998, NIGERIAN J SCI, V32, P79; Olayinka-Olagunju JO, 2014, J ENV SCI TOXICOL FO, V7, P37; Owoeye J.O., 2016, URBAN STUD RES, V2016, P4673019, DOI [10.1155/2016/4673019, DOI 10.1155/2016/4673019]; Owusu HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03918-z; Owusu HF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0971-6; Oyeniyi EA, 2015, J STORED PROD RES, V63, P15, DOI 10.1016/j.jspr.2015.05.005; PHILOGENE BJR, 1986, J CHEM ECOL, V12, P893, DOI 10.1007/BF01020259; Pimsamarn S, 2009, DENGUE B, V3, P194; Polson KA, 2001, DENGUE BULL, V25, P79; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Rajeswary M, 2014, INT J PURE APPL ZOOL, V2, P196; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Service MW, 1980, GUID MED ENT MACM TR; Tennyson SK, 2012, ASIAN PAC J TROP BIO, P1842; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; WHO, 2009, 10 FACTS MAL; World Health Organization (WHO), 1996, WHOVBC75583; Wu XY, 2017, J ECON ENTOMOL, V110, P1203, DOI 10.1093/jee/tox072	65	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210440	10.1371/journal.pone.0210440	http://dx.doi.org/10.1371/journal.pone.0210440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625231	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000455359400089
J	Perdomo-Celis, F; Velilla, PA; Taborda, NA; Rugeles, MT				Perdomo-Celis, Federico; Velilla, Paula A.; Taborda, Natalia A.; Teresa Rugeles, Maria			An altered cytotoxic program of CD8(+) T-cells in HIV-infected patients despite HAART-induced viral suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; GRANZYME-B; GASTROINTESTINAL MUCOSA; HIV-1-INFECTED PATIENTS; PERFORIN EXPRESSION; CD8+T LYMPHOCYTES; CD38 EXPRESSION; MEMORY SUBSETS; EFFECTOR	Despite the suppression of viral replication induced by the highly active anti-retroviral therapy (HAART), an increased immune activation and inflammatory state persists in HIV-infected patients, contributing to lower treatment response and immune reconstitution, and development of non-AIDS conditions. The chronic activation and inflammation affect the functionality and differentiation of CD8(+) T-cells, particularly reducing their cytotoxic capacity, which is critical in the control of HIV replication. Although previous studies have shown that HAART induce a partial immune reconstitution, its effect on CD8(+) T-cells cytotoxic function, as well as its relationship with the inflammatory state, is yet to be defined. Here, we characterized the functional profile of polyclonal and HIV-specific CD8(+) T-cells, based on the expression of cell activation and differentiation markers, in individuals chronically infected with HIV, under HAART. Compared with seronegative controls, CD8(+) T-cells from patients on HAART exhibited a low degranulation capacity (surface expression of CD107a), with consequent low secreted levels and high intracellular expression of granzyme B and perforin. This degranulation defect was particularly observed in those cells expressing the activation marker HLA-DR, which were further characterized as effector memory cells with high expression of CD57. The expression of CD107a, but not of granzyme B and perforin, in CD8(+) T-cells from HIV-infected patients on HAART reached levels similar to those in seronegative controls when the treatment duration was higher than 25 months. In addition, the expression of CD107a was negatively correlated with the expression of exhaustion markers on CD8(+) T-cells and the plasma inflammatory molecule sCD14. Thus, despite HAART-induced viral suppression, CD8(+) T-cells from HIV-infected patients have an alteration in their cytotoxic program. This defect is associated with the cellular activation, differentiation and exhaustion state, as well as with the inflammation levels, and can be partially recovered with a long and continuous treatment.	[Perdomo-Celis, Federico; Velilla, Paula A.; Taborda, Natalia A.; Teresa Rugeles, Maria] Univ Antioquia, UdeA, Grp Inmunovirol, Fac Med, Medellin, Colombia; [Taborda, Natalia A.] Corp Univ Remington, Grp Invest Biomed Uniremington, Programa Med, Fac Ciencias Salud, Medellin, Colombia	Universidad de Antioquia	Rugeles, MT (corresponding author), Univ Antioquia, UdeA, Grp Inmunovirol, Fac Med, Medellin, Colombia.	maria.rugeles@udea.edu.co		Velilla, Paula A/0000-0003-0885-1320; Rugeles, Maria T./0000-0001-7855-1409; Taborda Vanegas, Natalia Andrea/0000-0001-6085-855X; Perdomo Celis, Federico/0000-0003-0119-8306	Universidad de Antioquia, UdeA; COLCIENCIAS [111571249724, 111577757051]; Corporacion Universitaria Remington Uniremington [4000000063-16, 4000000121-17]	Universidad de Antioquia, UdeA; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Corporacion Universitaria Remington Uniremington	This study was supported by Universidad de Antioquia, UdeA, COLCIENCIAS (Codes: 111571249724 and 111577757051, to MTR and PAV) (http://www.colciencias.gov.co) and Corporacion Universitaria Remington Uniremington (Codes: 4000000063-16 and 4000000121-17 to NAT) (http://www<SUP>.</SUP>uniremington.edu.co).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; Taborda NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136292; Appay V, 2002, J IMMUNOL, V169, P607, DOI 10.4049/jimmunol.169.1.607-a; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; BERREBI G, 1987, P NATL ACAD SCI USA, V84, P1364, DOI 10.1073/pnas.84.5.1364; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Cao LF, 2010, CYTOM PART A, V77A, P534, DOI 10.1002/cyto.a.20887; Cellerai C, 2010, J VIROL, V84, P3868, DOI 10.1128/JVI.02565-09; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chan KS, 2007, J IMMUNOL METHODS, V325, P20, DOI 10.1016/j.jim.2007.05.011; Chatila T, 1989, J IMMUNOL, DOI [10.3847/2041-8205/817/1/L8, DOI 10.3847/2041-8205/817/1/L8]; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chen G, 2001, BLOOD, V98, P156, DOI 10.1182/blood.V98.1.156; Cockerham LR, 2014, AIDS, V28, P1749, DOI 10.1097/QAD.0000000000000314; Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Demers KR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005805; DIANZANI U, 1994, J IMMUNOL, V153, P952; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grybko MJ, 2007, J LEUKOCYTE BIOL, V81, P509, DOI 10.1189/jlb.0206109; Haridas V, 2003, AIDS, V17, P2313, DOI 10.1097/00002030-200311070-00005; Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006; Helleberg M, 2015, J INFECT DIS, V211, P1726, DOI 10.1093/infdis/jiu669; Hersperger AR, 2008, CYTOM PART A, V73A, P1050, DOI 10.1002/cyto.a.20596; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hua S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101920; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kalokhe AS, 2015, J INFECT DIS, V211, P635, DOI 10.1093/infdis/jiu505; Kassahn D, 2009, CELL DEATH DIFFER, V16, P115, DOI 10.1038/cdd.2008.133; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; Kiniry BE, 2017, MUCOSAL IMMUNOL, V10, P1008, DOI 10.1038/mi.2016.100; Kiniry BE, 2018, J IMMUNOL, V200, P1876, DOI 10.4049/jimmunol.1701532; Kuerten S, 2008, AIDS RES HUM RETROV, V24, P62, DOI 10.1089/aid.2007.0125; Lancki DW, 1987, J IMMUNOL, DOI [10.1093/brain/awg057, DOI 10.1093/BRAIN/AWG057]; Larbi A, 2014, CYTOM PART A, V85A, P25, DOI 10.1002/cyto.a.22351; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; Mbitikon-Kobo FM, 2012, J IMMUNOL METHODS, V375, P252, DOI 10.1016/j.jim.2011.09.008; McBrien JB, 2018, EUR J IMMUNOL, V48, P898, DOI 10.1002/eji.201747172; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Onlamoon N, 2012, CYTOM PART B-CLIN CY, V82B, P35, DOI 10.1002/cyto.b.20616; Pakker NG, 1999, AIDS, V13, P203, DOI 10.1097/00002030-199902040-00008; Pardo J, 2003, INT IMMUNOL, V15, P1441, DOI 10.1093/intimm/dxg141; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Perdomo-Celis F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02502; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pietersma FL, 2010, CLIN INFECT DIS, V50, P717, DOI 10.1086/650455; Resino S, 2004, CLIN INFECT DIS, V38, P412, DOI 10.1086/380793; Roberts ER, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006135; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Shekhar K, 2014, P NATL ACAD SCI USA, DOI [10.1073/pnas, DOI 10.1073/PNAS]; Simonetta F, 2014, J VIROL, V88, P11861, DOI 10.1128/JVI.02013-14; Steel A, 2008, HIV MED, V9, P118, DOI 10.1111/j.1468-1293.2007.00528.x; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; Tanko RF, 2018, CLIN IMMUNOL, V195, P127, DOI 10.1016/j.clim.2018.06.001; Tenca C, 2003, INT IMMUNOL, V15, P1105, DOI 10.1093/intimm/dxg111; Trabattoni D, 2004, AIDS, V18, P859, DOI 10.1097/00002030-200404090-00003; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Tsegaye A, 2003, CLIN IMMUNOL, V109, P338, DOI 10.1016/j.clim.2003.08.008; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Zelinskyy G, 2005, J VIROL, V79, P10619, DOI 10.1128/JVI.79.16.10619-10626.2005; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	76	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210540	10.1371/journal.pone.0210540	http://dx.doi.org/10.1371/journal.pone.0210540			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625227	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400095
J	Thamsen, M; Ghosh, R; Auyeung, VC; Brumwell, A; Chapman, HA; Backes, BJ; Perara, G; Maly, DJ; Sheppard, D; Papa, FR				Thamsen, Maike; Ghosh, Rajarshi; Auyeung, Vincent C.; Brumwell, Alexis; Chapman, Harold A.; Backes, Bradley J.; Perara, Gayani; Maly, Dustin J.; Sheppard, Dean; Papa, Feroz R.			Small molecule inhibition of IRE1 alpha kinase/RNase has anti-fibrotic effects in the lung	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HERMANSKY-PUDLAK-SYNDROME; ALLOSTERIC INHIBITION; APOPTOSIS; FIBROSIS; DYSFUNCTION; DISEASE; IRE1	Endoplasmic reticulum stress (ER stress) has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a disease of progressive fibrosis and respiratory failure. ER stress activates a signaling pathway called the unfolded protein response (UPR) that either restores homeostasis or promotes apoptosis. The bifunctional kinase/RNase IRE1 alpha is a UPR sensor/effector that promotes apoptosis if ER stress remains high and irremediable (i.e., a "terminal" UPR). Using multiple small molecule inhibitors against IRE1 alpha, we show that ER stress-induced apoptosis of murine alveolar epithelial cells can be mitigated in vitro. In vivo, we show that bleomycin exposure to murine lungs causes early ER stress to activate IRE1 alpha and the terminal UPR prior to development of pulmonary fibrosis. Small-molecule IRE1 alpha kinase-inhibiting RNase attenuators (KIRAs) that we developed were used to evaluate the contribution of IRE1 alpha activation to bleomycin-induced pulmonary fibrosis. One such KIRA-KIRA7-provided systemically to mice at the time of bleomycin exposure decreases terminal UPR signaling and prevents lung fibrosis. Administration of KIRA7 14 days after bleomycin exposure even promoted the reversal of established fibrosis. Finally, we show that KIRA8, a nanomolar-potent, monoselective KIRA compound derived from a completely different scaffold than KIRA7, likewise promoted reversal of established fibrosis. These results demonstrate that IRE1 alpha may be a promising target in pulmonary fibrosis and that kinase inhibitors of IRE1 alpha may eventually be developed into efficacious anti-fibrotic drugs.	[Thamsen, Maike; Ghosh, Rajarshi; Auyeung, Vincent C.; Brumwell, Alexis; Chapman, Harold A.; Backes, Bradley J.; Sheppard, Dean; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Thamsen, Maike; Ghosh, Rajarshi; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Thamsen, Maike; Ghosh, Rajarshi; Papa, Feroz R.] Univ Calif San Francisco, QBI, San Francisco, CA 94143 USA; [Thamsen, Maike; Ghosh, Rajarshi; Auyeung, Vincent C.; Backes, Bradley J.; Sheppard, Dean; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Auyeung, Vincent C.; Brumwell, Alexis; Chapman, Harold A.; Sheppard, Dean] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA; [Brumwell, Alexis; Chapman, Harold A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Perara, Gayani; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Perara, Gayani; Maly, Dustin J.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Papa, Feroz R.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Papa, FR (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Papa, FR (corresponding author), Univ Calif San Francisco, QBI, San Francisco, CA 94143 USA.; Papa, FR (corresponding author), Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA.; Papa, FR (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	frpapa@medicine.ucsf.edu		Papa, Feroz/0000-0002-3684-9108; Ghosh, Rajarshi/0000-0002-5780-8241; Auyeung, Vincent/0000-0001-6273-1595	National Heart Lung and Blood Institute [P01 HL108794]; UCSF Multidisciplinary Training Program in Lung Disease (National Heart Lung and Blood Institute) [5T32 HL007185]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108794, F32HL145990, R01HL145037, T32HL007185] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UCSF Multidisciplinary Training Program in Lung Disease (National Heart Lung and Blood Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by P01 HL108794 from the National Heart Lung and Blood Institute to F.R.P. and D.S.. V.C.A. was supported by the UCSF Multidisciplinary Training Program in Lung Disease (5T32 HL007185 from the National Heart Lung and Blood Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Burman A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99543; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Collard HR, 2007, RESP MED, V101, P1350, DOI 10.1016/j.rmed.2006.10.002; Feldman HC, 2016, ACS CHEM BIOL, V11, P2195, DOI 10.1021/acschembio.5b00940; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harrington PE, 2015, ACS MED CHEM LETT, V6, P68, DOI 10.1021/ml500315b; Heindryckx F, 2016, EMBO MOL MED, V8, P729, DOI 10.15252/emmm.201505925; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hsu HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14612-5; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kamp DW, 2013, AM J RESP CELL MOL, V49, P892, DOI 10.1165/rcmb.2013-0053OC; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Mahavadi P, 2010, AM J RESP CRIT CARE, V182, P207, DOI 10.1164/rccm.200909-1414OC; Maly DJ, 2014, NAT CHEM BIOL, V10, P892, DOI 10.1038/nchembio.1664; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Morita S., 2017, CELL METAB, V25; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Somborac-Bacura A, 2013, EXP PHYSIOL, V98, P316, DOI 10.1113/expphysiol.2012.067249; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Vaughan A, 2015, PROTOC EXCH, P1, DOI [10.1038/protex.2015.017, DOI 10.1038/PROTEX.2015.017]; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wolters PJ, 2018, LANCET RESP MED, V6, P154, DOI 10.1016/S2213-2600(18)30007-9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	42	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209824	10.1371/journal.pone.0209824	http://dx.doi.org/10.1371/journal.pone.0209824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625178	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400058
J	Arabi, Y; Jawdat, D; Bouchama, A; Tamim, H; Tamimi, W; Al-Balwi, M; Al-Dorzi, HM; Sadat, M; Afesh, L; Abdullah, ML; Mashaqbeh, W; Sakhija, M; Hussein, MA; ElObeid, A; Al-Dawood, A				Arabi, Yaseen; Jawdat, Dunia; Bouchama, Abderrezak; Tamim, Hani; Tamimi, Waleed; Al-Balwi, Mohammed; Al-Dorzi, Hasan M.; Sadat, Musharaf; Afesh, Lara; Abdullah, Mashan L.; Mashaqbeh, Walid; Sakhija, Maram; Hussein, Mohamed A.; ElObeid, Adila; Al-Dawood, Abdulaziz			Permissive underfeeding, cytokine profiles and outcomes in critically ill patients	PLOS ONE			English	Article							ENTERAL NUTRITION; WEIGHT-LOSS; INFLAMMATION; STANDARD; EXERCISE; MARKERS; SEPSIS; ADULTS; MICE; DIET	Background During critical illness in humans, the effects of caloric restriction on the inflammatory response are not well understood. The aim of this study is to examine the associations of caloric restriction, inflammatory response profiles and outcomes in critically ill patients. Methods This is a sub-study of the PermiT trial (Permissive Underfeeding or Standard Enteral Feeding in Critically III Adults Trial- ISRCTN68144998). Serum samples were collected on study days 1, 3, 5, 7 and 14 and analyzed for a panel of 29 cytokines. We used principal component analysis to convert possibly correlated variables (cytokine levels) into a limited number of linearly uncorrelated variables (principal components). We constructed repeated measures mixed linear models to assess whether permissive underfeeding compared to standard feeding was associated with difference cytokine levels over time. Results A total of 72 critically ill patients were enrolled in this study (permissive underfeeding n = 36 and standard feeding n = 36). Principal component analysis identified 6 components that were responsible for 78% of the total variance. When adjusted to principal components, permissive underfeeding was not associated with 90-day mortality (adjusted odds ratio 1.75, 95% confidence interval 0.44, 6.95, p = 0.43) or with incident renal replacement therapy. The cytokines did not differ with time between permissive underfeeding and standard feeding groups. Conclusions The association of permissive underfeeding compared to standard feeding with mortality was not influenced by the inflammatory profile. Permissive underfeeding compared to standard feeding was not associated with differences in the serum levels of cytokines in critically ill patients.	[Arabi, Yaseen; Al-Dorzi, Hasan M.; Sadat, Musharaf; Afesh, Lara; Sakhija, Maram; Al-Dawood, Abdulaziz] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Intens Care Dept, Riyadh, Saudi Arabia; [Jawdat, Dunia; Mashaqbeh, Walid] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, King Abdullah Int Med Res Ctr, Cord Blood Bank, Riyadh, Saudi Arabia; [Bouchama, Abderrezak; Abdullah, Mashan L.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, King Abdullah Int Med Res Ctr, Dept Expt Med, Riyadh, Saudi Arabia; [Tamim, Hani] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon; [Tamimi, Waleed; Al-Balwi, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Dept Clin Lab, Riyadh, Saudi Arabia; [Hussein, Mohamed A.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Dept Biostat & Bioinformat, Riyadh, Saudi Arabia; [ElObeid, Adila] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Dept Biobank, Riyadh, Saudi Arabia	King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); American University of Beirut; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC)	Arabi, Y (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Intens Care Dept, Riyadh, Saudi Arabia.	yaseenarabi@yahoo.com	Abdullah, Mashan L/E-7650-2019; Abdullah, Mashan/L-7606-2019; hussein, mohamed/GYU-6912-2022; Arabi, Yaseen/ABF-3316-2020	Abdullah, Mashan L/0000-0002-4628-1536; Abdullah, Mashan/0000-0002-4628-1536; Arabi, Yaseen/0000-0001-5735-6241; Al-Dorzi, Hasan M/0000-0002-3772-8949; Al Balwi, Mohammed/0000-0003-2910-0390; BOUCHAMA, abderrezak/0000-0003-3089-5936	King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia [AT 32-25 KACST]	King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia	The study was funded from King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia under Grant Number - AT 32-25 KACST to Y.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami R, 2010, DARU, V18, P103; Allingstrup MJ, 2017, INTENS CARE MED, V43, P1637, DOI 10.1007/s00134-017-4880-3; American Dietetic Association, 2000, MAN CLIN DIET, P1; Arabi YM, 2017, AM J RESP CRIT CARE, V195; Arabi YM, 2017, INTENS CARE MED, V43, P1239, DOI 10.1007/s00134-017-4711-6; Arabi YM, 2015, NEW ENGL J MED, V372, P2398, DOI 10.1056/NEJMoa1502826; Arabi YM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-191; Bastarache JA, 2012, JPEN-PARENTER ENTER, V36, P732, DOI 10.1177/0148607111433054; Blanch L, 2017, INTENS CARE MED, V43, P557, DOI 10.1007/s00134-016-4583-1; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Casaer MP, 2017, INTENS CARE MED, V43, P1720, DOI 10.1007/s00134-017-4881-2; Darmon M, 2015, INTENS CARE MED, V41, P1132, DOI 10.1007/s00134-015-3801-6; Eckerwall GE, 2006, ANN SURG, V244, P959, DOI 10.1097/01.sla.0000246866.01930.58; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fjell CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079207; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Guzy C, 2009, EUR J NUTR, V48, P12, DOI 10.1007/s00394-008-0754-3; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Marik PE, 2016, INTENS CARE MED, V42, P316, DOI 10.1007/s00134-015-4131-4; Matsuzaki J, 2001, J NUTR, V131, P2139, DOI 10.1093/jn/131.8.2139; Hermsdorff HHM, 2009, ENDOCRINE, V36, P445, DOI 10.1007/s12020-009-9248-1; Moller K, 2016, PROSTAG LEUKOTR ESS, V106, P39, DOI 10.1016/j.plefa.2015.12.001; Nicklas BJ, 2004, AM J CLIN NUTR, V79, P544; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Nikolich-Zugich J, 2005, EXP GERONTOL, V40, P884, DOI 10.1016/j.exger.2005.06.007; Pene F, 2017, INTENS CARE MED, V43, P1154, DOI 10.1007/s00134-017-4840-y; Reignier J, 2018, LANCET, V391, P133, DOI [10.1016/S0140-6736(17)32146-3, 10.1016/s0140-6736(17)32146-3]; Rice TW, 2011, CRIT CARE MED, V39, P967, DOI 10.1097/CCM.0b013e31820a905a; Rimmele T, 2011, CRIT CARE, V15, DOI 10.1186/cc9411; Rugeles SJ, 2013, INDIAN J CRIT CARE M, V17, P343, DOI 10.4103/0972-5229.123438; Smith AR, 2011, J MED MICROBIOL, V60, P359, DOI 10.1099/jmm.0.026401-0; Starr ME, 2016, CRIT CARE MED, V44, pE509, DOI 10.1097/CCM.0000000000001475; Van Dyck L, 2018, NUTR CLIN PRACT, V33, P339, DOI 10.1002/ncp.10084; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0701-z; Zusman O, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1538-4	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209669	10.1371/journal.pone.0209669	http://dx.doi.org/10.1371/journal.pone.0209669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615631	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900024
J	Januschowski, K; Schnichels, S; Hurst, J; Hohenadl, C; Reither, C; Rickmann, A; Pohl, L; Bartz-Schmidt, KU; Spitzer, MS				Januschowski, Kai; Schnichels, Sven; Hurst, Jose; Hohenadl, Christine; Reither, Charlotte; Rickmann, Annekatrin; Pohl, Lisa; Bartz-Schmidt, Karl-Ulrich; Spitzer, Martin S.			Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute	PLOS ONE			English	Article							PERFUSED BOVINE RETINA; HYALURONIC-ACID; ORGAN-CULTURE; MODEL; BIOCOMPATIBILITY; SURGERY	Purpose To characterize the biophysical properties of an artificial vitreous body substitute (VBS), which consists of a biocompatible, cross-linked, hyaluronic acid (HA)-based hydrogel, by analysing the VBS's influence on intraocular pressure (IOP) and retinal integrity in distinct ex vivo eye models in order to evaluate the its potential for in vivo biocompatibility testing. Methods Pig eyes were obtained immediately postmortem, and VBS was injected after core-vitrectomy. IOP was followed for 24 h (n = 5). VBS influence on retinal integrity was investigated using isolated bovine retinas superfused with an oxygen saturated nutrient solution. An electroretinogram (ERG) was recorded on explanted bovine retinae using silver/silver chloride electrodes; after application of VBS for 2 min, a washout period of 70 min was employed. The percentage of a-and b-wave reduction at the end of the washout phase was compared to baseline values (n = 5). Data were calculated throughout as the mean and the standard deviation. qRT-PCR (Bax/Bcl-2-ratio, GFAP-and PGP9.5-levels) or western blot analysis was used to test for toxicity of Princess Volume after 24 h (and beta-3 tubulin with GAPDH as a control gene). Significance was estimated by Student's t-test; p <= 0.05 was considered to be statistically significant. Results The IOP increased non-significantly by 10% after 24 h. Short-term biocompatibility testing using isolated superfused bovine retinas showed neither significant reductions of the b wave nor the a-wave amplitudes (b-wave reduction 14.2%, p>0.05; a-wave reduction 23.9%, p>0.05). qRT-PCR and western blot analysis did not reveal significant toxicity after 24 h. Conclusions The manufactured HA-based hydrogel showed highly favourable biophysical characteristics in the explored ex vivo models, justifying in vivo studies enabling the assessment of biocompatibility.	[Januschowski, Kai; Rickmann, Annekatrin] Eye Clin Sulzbach Saar, Sulzbach, Germany; [Januschowski, Kai; Schnichels, Sven; Hurst, Jose; Pohl, Lisa; Bartz-Schmidt, Karl-Ulrich] Univ Eye Clin Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Hohenadl, Christine; Reither, Charlotte] Croma Pharma GmbH, Leobendorf, Austria; [Spitzer, Martin S.] Univ Eye Clin Hamburg Eppendorf, Hamburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Januschowski, K (corresponding author), Eye Clin Sulzbach Saar, Sulzbach, Germany.; Januschowski, K (corresponding author), Univ Eye Clin Tubingen, Ctr Ophthalmol, Tubingen, Germany.	Kai.januschowski@med.uni-tuebingen.de		Hurst, Jose/0000-0002-8697-2569; Schnichels, Sven/0000-0002-2385-5517	Croma Pharma GmbH, Austria; BfR [1328-506]	Croma Pharma GmbH, Austria; BfR	Parts of the experiments were financed by Croma Pharma GmbH, Austria. The BfR (grant number 1328-506) supported this research project. The funder Croma provided support in the form of salaries for authors Hohenadl and Reither, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann B, 2006, INVEST OPHTH VIS SCI, V47, P2011, DOI 10.1167/iovs.05-1393; Ebner M, 2017, CURR EYE RES, V42, P1130, DOI 10.1080/02713683.2017.1297461; Gao QY, 2015, INT J OPHTHALMOL-CHI, V8, P437, DOI 10.3980/j.issn.2222-3959.2015.03.01; Januschowski K, 2015, INVEST OPHTH VIS SCI, P211; Januschowski K, 2015, JOVE-J VIS EXP, DOI 10.3791/52270; Januschowski K, 2012, ATLA-ALTERN LAB ANIM, V40, P23, DOI 10.1177/026119291204000107; JOHNSON DH, 1989, EXP EYE RES, V49, P113, DOI 10.1016/0014-4835(89)90080-8; Kleinberg TT, 2011, SURV OPHTHALMOL, V56, P300, DOI 10.1016/j.survophthal.2010.09.001; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; Luke M, 2008, GRAEF ARCH CLIN EXP, V246, P817, DOI 10.1007/s00417-007-0761-8; Luke M, 2005, BRAIN RES PROTOC, V16, P27, DOI 10.1016/j.brainresprot.2005.09.001; Mariacher S, 2015, OPHTHALMOLOGE, V112, P572, DOI 10.1007/s00347-015-0057-z; Mukhopadhyay A, 2002, MOL VIS, V8, P271; Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042; PRUETT RC, 1979, ARCH OPHTHALMOL-CHIC, V97, P2325, DOI 10.1001/archopht.1979.01020020541006; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Santhanam S, 2016, ACTA BIOMATER, V43, P327, DOI 10.1016/j.actbio.2016.07.051; Schnichels S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172895; Schramm C, 2012, INVEST OPHTH VIS SCI, V53, P613, DOI 10.1167/iovs.11-7322; Shaarawy T, 2004, BRIT J OPHTHALMOL, V88, P950, DOI 10.1136/bjo.2003.035535; Spitzer MS, 2012, CURR EYE RES, V37, P463, DOI 10.3109/02713683.2012.658593; Spitzer MS, 2015, OPHTHALMOLOGE Z DTSC, V112, P552; Su XY, 2015, BIOMACROMOLECULES, V16, P3093, DOI 10.1021/acs.biomac.5b01091; Suri S, 2006, J BIOMED MATER RES A, V79A, P650, DOI 10.1002/jbm.a.30917; Swindle KE, 2008, J BIOMED MATER RES A, V87A, P656, DOI 10.1002/jbm.a.31769; Wong R, 2011, ACTA OPHTHALMOL, V89, P365, DOI 10.1111/j.1755-3768.2009.01703.x	26	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209217	10.1371/journal.pone.0209217	http://dx.doi.org/10.1371/journal.pone.0209217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615640	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900018
J	Li, Y; Shen, M; Long, M				Li, Yuan; Shen, Min; Long, Mo			A preliminary study of auditory mismatch response on the day of cochlear implant activation in children with hearing aids prior implantation	PLOS ONE			English	Article							NEGATIVITY MMN; SPEECH-PERCEPTION; DEAF-CHILDREN; LANGUAGE; POTENTIALS; INFANTS; DISCRIMINATION; MATURATION; VOWEL	Objective The study aimed to explore the characteristics of auditory mismatch response (MMR) in hearing-impaired children on the day when the cochlear implant (CI) was started (power-up) and the speech processor was programmed, and to investigate the effects of wearing hearing aids (HAs) before cochlear implantation on the early stage of postoperative auditory cortex plasticity, providing some demonstrative data for the objective evaluation of postoperative early auditory ability in children who underwent cochlear implantation. Methods The participants were 34 children with profound sensorineural hearing loss, who underwent cochlear implantation. The classical passive Oddball paradigm was adopted, using a pair of vowels which only have different lexical tones. The standard stimulus was /a2/ and the devious stimulus was /a4/. Results 1) On the day of CI activation, the auditory MMR has been elicited in 30 children; the MMR incidence was 88%. 2) We observed both positive and negative auditory MMR waveforms. And logistic regression analysis showed that it was influenced by the age at cochlear implantation. 3) The duration with HA before surgery significantly influenced the MMR latency. The children with longer duration of HA use have much earlier latency of MMR. 4) There was a significant positive correlation between the age at HA use initiation and MMR amplitude. Earlier initial HA use was associated with smaller amplitude. Conclusions MMR in response to Mandarin lexical tone can be recorded in most pediatric patients who had experience with HA on the day of CI power up. MMR is closely associated with the age at cochlear implantation, duration of HA use, and the age at HA use initiation. Hearing impaired children should wear HA as early as possible and ensure consistent usage.	[Li, Yuan] China Japan Friendship Hosp, Beijing, Peoples R China; [Shen, Min; Long, Mo] China Rehabil Res Ctr Hearing & Speech Impairment, Beijing, Peoples R China	China-Japan Friendship Hospital	Shen, M; Long, M (corresponding author), China Rehabil Res Ctr Hearing & Speech Impairment, Beijing, Peoples R China.	sarah_shen@126.com; crrcdclongmo@sohu.com		Shen, Min/0000-0003-1430-1675	Beijing Natural Science Foundation of China [7172251]; National Socical Science Foundation of China [13AYY004]; General Programs in China-Japan Friendship Hospital [2015-1-MS-5]; China Rehabilitation Research Center for Hearing and Speech Impairment [201404]	Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); National Socical Science Foundation of China; General Programs in China-Japan Friendship Hospital; China Rehabilitation Research Center for Hearing and Speech Impairment	This research is partially supported by Beijing Natural Science Foundation of China (grant No: 7172251) and National Socical Science Foundation of China (grant No: 13AYY004) and General Programs funded in China-Japan Friendship Hospital (grant No: 2015-1-MS-5) and Projects funded in China Rehabilitation Research Center for Hearing and Speech Impairment (grant No: 201404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Speech-Language-Hearing Association, NON TRADITIONAL REF; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; [曹永茂 Cao Yongmao], 2003, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V25, P240; [陈涛 Chen Tao], 2012, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V20, P574; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P449, DOI 10.1162/089892900562264; Guttorm TK, 2005, CORTEX, V41, P291, DOI 10.1016/S0010-9452(08)70267-3; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; Lee CY, 2012, NEUROPSYCHOLOGIA, V50, P3228, DOI 10.1016/j.neuropsychologia.2012.08.025; Liang MJ, 2014, OTOL NEUROTOL, V35, pE7, DOI 10.1097/MAO.0000000000000181; Liu HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095587; [刘欣 Liu Xin], 2015, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V23, P287; Lonka E, 2013, ACTA OTO-LARYNGOL, V133, P853, DOI 10.3109/00016489.2013.780293; Martin BA, 2008, EAR HEARING, V29, P285, DOI 10.1097/AUD.0b013e3181662c0e; Martin-Loeches M, 2001, J INTELL DISABIL RES, V45, P63, DOI 10.1046/j.1365-2788.2001.00292.x; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nicholas JG, 2006, EAR HEARING, V27, P286, DOI 10.1097/01.aud.0000215973.76912.c6; Nikolopoulos TP, 2005, INT J PEDIATR OTORHI, V69, P175, DOI 10.1016/j.ijporl.2004.08.016; Partanen E, 2013, NON TRADITIONAL REF; Roman Stephane, 2005, HEARING RES, V201; Shafer VL, 2011, J PHONETICS, V39, P527, DOI 10.1016/j.wocn.2010.11.010; Shafer VL, 2010, EAR HEARING, V31, P735, DOI 10.1097/AUD.0b013e3181e5d1a7; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; [申敏 Shen Min], 2014, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V20, P1001; Soli SD, 2012, INT J PEDIATR OTORHI, V76, P1255, DOI 10.1016/j.ijporl.2012.05.015; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Tong XH, 2014, BRAIN LANG, V138, P61, DOI 10.1016/j.bandl.2014.09.004; Tong XH, 2014, PSYCHOPHYSIOLOGY, V51, P1158, DOI 10.1111/psyp.12257; Turgeon C, 2014, CLIN NEUROPHYSIOL, V125, P827, DOI 10.1016/j.clinph.2013.09.035; van Leeuwen T, 2007, NEUROREPORT, V18, P857, DOI 10.1097/WNR.0b013e3280c1e2bf; Vavatzanidis NK, 2015, J COGNITIVE NEUROSCI, V27, P2427, DOI 10.1162/jocn_a_00868; [王俊 Wang Jun], 2015, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V23, P66; Wang LY, 2013, INT J PEDIATR OTORHI, V77, P1350, DOI 10.1016/j.ijporl.2013.05.033; Yuan Hao, 2015, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V29, P1671; Zheng Y., 2011, CHIN SCI J HEAR SPEE, V5, P19	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210457	10.1371/journal.pone.0210457	http://dx.doi.org/10.1371/journal.pone.0210457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG5UW	30615690	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900076
J	Palmbos, PL; Wang, Y; Bankhead, A; Kelleher, AJ; Wang, LD; Yang, HB; Ahmet, ML; Gumkowski, ER; Welling, SD; Magnuson, B; Leflein, J; Hiles, GL; Abel, EV; Dziubinski, ML; Urs, S; Day, ML; Ljungman, ME; Simeone, DM				Palmbos, Phillip L.; Wang, Yin; Bankhead, Armand, III; Kelleher, Alan J.; Wang, Lidong; Yang, Huibin; Ahmet, McKenzie L.; Gumkowski, Erica R.; Welling, Samuel D.; Magnuson, Brian; Leflein, Jacob; Hiles, Guadalupe Lorenzatti; Abel, Ethan V.; Dziubinski, Michele L.; Urs, Sumithra; Day, Mark L.; Ljungman, Mats E.; Simeone, Diane M.			ATDC mediates a TP63-regulated basal cancer invasive program	ONCOGENE			English	Article							BLADDER-CANCER; MOLECULAR CLASSIFICATION; TRIM29; GENOME; SUBTYPES; PROGNOSIS; MIGRATION; TAXONOMY; ISOFORMS; REQUIRES	Basal subtype cancers are deadly malignancies but the molecular events driving tumor lethality are not completely understood. Ataxia-telangiectasia group D complementing gene (ATDC, also known as TRIM29), is highly expressed and drives tumor formation and invasion in human bladder cancers but the factor(s) regulating its expression in bladder cancer are unknown. Molecular subtyping of bladder cancer has identified an aggressive basal subtype, which shares molecular features of basal/squamous tumors arising in other organs and is defined by activation of a TP63-driven gene program. Here, we demonstrate that ATDC is linked with expression of TP63 and highly expressed in basal bladder cancers. We find that TP63 binds to transcriptional regulatory regions of ATDC and KRT14 directly, increasing their expression, and that ATDC and KRT14 execute a TP63-driven invasive program. In vivo, ATDC is required for TP63-induced bladder tumor invasion and metastasis. These results link TP63 and the basal gene expression program to ATDC and to aggressive tumor behavior. Defining ATDC as a molecular determinant of aggressive, basal cancers may lead to improved biomarkers and therapeutic approaches.	[Palmbos, Phillip L.; Wang, Yin; Kelleher, Alan J.; Ahmet, McKenzie L.; Gumkowski, Erica R.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Palmbos, Phillip L.; Wang, Yin; Bankhead, Armand, III; Welling, Samuel D.; Magnuson, Brian; Leflein, Jacob; Hiles, Guadalupe Lorenzatti; Abel, Ethan V.; Dziubinski, Michele L.; Urs, Sumithra; Ljungman, Mats E.] Univ Michigan, Med Ctr, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Bankhead, Armand, III; Magnuson, Brian] Univ Michigan, Med Ctr, Dept Biostat, Ann Arbor, MI 48109 USA; [Bankhead, Armand, III] Univ Michigan, Med Ctr, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Wang, Lidong; Simeone, Diane M.] NYU Langone Hlth, Dept Surg, New York, NY 10016 USA; [Wang, Lidong; Simeone, Diane M.] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY 10016 USA; [Yang, Huibin; Ljungman, Mats E.] Univ Michigan, Med Ctr, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Hiles, Guadalupe Lorenzatti; Day, Mark L.] Univ Michigan, Med Ctr, Dept Urol, Ann Arbor, MI 48109 USA; [Dziubinski, Michele L.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] NYU Langone Hlth, Dept Pathol, New York, NY 10016 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; NYU Langone Medical Center; NYU Langone Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; NYU Langone Medical Center	Palmbos, PL (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA.; Palmbos, PL (corresponding author), Univ Michigan, Med Ctr, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	ppalmbos@med.umich.edu		Lorenzatti, Guadalupe/0000-0002-8423-3279	University of Michigan Cancer Center Core Grant [CA046592-26S3]; NIH [K08 CA201335, R01 CA17483601]; BCAN YIA; ASCO YIA; NATIONAL CANCER INSTITUTE [K08CA201335, P30CA046592] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002240] Funding Source: NIH RePORTER	University of Michigan Cancer Center Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCAN YIA; ASCO YIA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by grants from the University of Michigan Cancer Center Core Grant CA046592-26S3, NIH K08 CA201335 (PLP), BCAN YIA (PLP), ASCO YIA (PLP), and NIH R01 CA17483601 (DMS).	Cai BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041742; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Choi W, 2017, EUR UROL, V72, P354, DOI 10.1016/j.eururo.2017.03.010; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Dukel M, 2016, J BIOL CHEM, V291, P21541, DOI 10.1074/jbc.M116.730960; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaya JM, 2015, J UROLOGY, V193, P1144, DOI 10.1016/j.juro.2014.10.098; Guo GC, 2017, CELL ONCOL, V40, P157, DOI 10.1007/s13402-016-0312-6; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Han AL, 2017, ONCOGENE, V36, P5243, DOI 10.1038/onc.2017.149; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hovelson DH, 2018, EUR UROL, V74, P741, DOI 10.1016/j.eururo.2018.06.047; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lai W, 2013, DIS ESOPHAGUS, V26, P817, DOI 10.1111/j.1442-2050.2012.01400.x; Lee SH, 2015, J EXP MED, V212, P1061, DOI 10.1084/jem.20141601; Leivo MZ, 2016, PATHOLOGY, V48, P543, DOI 10.1016/j.pathol.2016.05.008; Lerner SP, 2016, BLADDER CANCER, V2, P37, DOI 10.3233/BLC-150037; Masuda Y, 2015, BBA-MOL CELL RES, V1853, P2296, DOI 10.1016/j.bbamcr.2015.05.035; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Palmbos PL, 2015, CANCER RES, V75, P5155, DOI 10.1158/0008-5472.CAN-15-0603; Qiu F, 2015, INT J CLIN EXP PATHO, V8, P5053; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Seiler Roland, 2017, Eur Urol, V72, P544, DOI 10.1016/j.eururo.2017.03.030; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sjodahl G, 2017, J PATHOL, V242, P113, DOI 10.1002/path.4886; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Tamura S, 2018, BLADDER CANCER, V4, P77, DOI 10.3233/BLC-170144; Tang ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063676; Velez-delValle C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24389; Wang FR, 2018, J CELL BIOL, V217, P4314, DOI 10.1083/jcb.201712130; Wang LD, 2015, GENE DEV, V29, P171, DOI 10.1101/gad.253591.114; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wang Y, 2018, JOVE-J VIS EXP, DOI 10.3791/58345; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xu WH, 2016, ONCOL REP, V36, P1411, DOI 10.3892/or.2016.4941; 2010, MOL CELL BIOL, V30, P3004, DOI DOI 10.1128/MCB.01023-09	44	9	10	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3340	3354		10.1038/s41388-018-0646-9	http://dx.doi.org/10.1038/s41388-018-0646-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30643195	Green Accepted			2022-12-26	WOS:000466610000002
J	Cho, YK; Park, D; Yang, AM; Chen, F; Chuong, AS; Klapoetke, NC; Boyden, ES				Cho, Yong Ku; Park, Demian; Yang, Aimei; Chen, Fei; Chuong, Amy S.; Klapoetke, Nathan C.; Boyden, Edward S.			Multidimensional screening yields channelrhodopsin variants having improved photocurrent and order-of-magnitude reductions in calcium and proton currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						optogenetics; calcium; protein engineering; physiology; neurobiology; channelrhodopsin; proton; screening	ION SELECTIVITY; LIGHT; PHOSPHORYLATION; ACTIVATION; EXPRESSION; EXCITATION; CHANNEL; TOOLS	Channelrhodopsins (ChRs) are light-gated ion channels in widespread use in neuroscience for mediating the genetically targetable optical control of neurons (optogenetics). ChRs pass multiple kinds of ions, and although nonspecific ChR-mediated conductance is not an issue in many neuroscience studies, conductance of calcium and protons, which can mediate diverse cellular signals, may be undesirable in some instances. Here, we turned our attention to the creation of ChRs that have high cation photocurrent but pass fewer calcium ions and protons. We developed an automated, time-resolved screening method capable of rapidly phenotyping channelrhodopsin-2 (ChR2) variants. We found substitution mutations throughout ChR2 that could boost current while altering ion selectivity and observed that the mutations that reduced calcium or proton conductance have additive effects. By combining four mutations, we obtained a ChR, ChromeQ, with improved photocurrent that possesses order-of-magnitude reductions in calcium and proton conductance and high fidelity in driving repetitive action potentials in neurons. The approach presented here offers a viable pathway toward customization of complex physiological properties of optogenetic tools. We propose that our screening method not only enables elucidation of new ChR variants that affect microbial opsin performance but may also reveal new principles of optogenetic protein engineering.	MIT, Dept Biol Engn, McGovern Inst, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, McGovern Inst, Media Lab, E25-618, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Koch Inst, E25-618, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyden, ES (corresponding author), MIT, Media Lab, Dept Biol Engn, Bldg E15 E15-485,20 Ames St, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Media Lab, Dept Brain & Cognit Sci, Bldg E15 E15-485,20 Ames St, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), McGovern Inst, Bldg E15 E15-485,20 Ames St, Cambridge, MA 02139 USA.	esb@media.mit.edu		Cho, Yong Ku/0000-0001-5621-521X	ATT Foundation; Benesse Foundation; Defense Advanced Research Projects Agency (DARPA) Living Foundries Program [HR0011-12-C-0068]; Harvard/Massachusetts Institute of Technology (MIT) Joint Grants Program in Basic Neuroscience; Human Frontiers Science Program; MIT McGovern Institute; MIT Media Lab; MIT Neurotechnology Fund; New York Stem Cell Foundation-Robertson Investigator Award; National Institutes of Health (NIH) Director's New Innovator Award [1DP2OD002002]; NIH EUREKA Award [1R01NS075421]; NIH [1R01DA029639]; National Science Foundation (NSF) CAREER Award [CBET 1053233]; SkTech; Wallace H. Coulter Foundation; MIT McGovern Institute Neurotechnology (MINT) Program; MIT Media Lab Consortia; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029639] Funding Source: NIH RePORTER	ATT Foundation; Benesse Foundation; Defense Advanced Research Projects Agency (DARPA) Living Foundries Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Harvard/Massachusetts Institute of Technology (MIT) Joint Grants Program in Basic Neuroscience; Human Frontiers Science Program(Human Frontier Science Program); MIT McGovern Institute; MIT Media Lab; MIT Neurotechnology Fund; New York Stem Cell Foundation-Robertson Investigator Award; National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH EUREKA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); SkTech; Wallace H. Coulter Foundation; MIT McGovern Institute Neurotechnology (MINT) Program; MIT Media Lab Consortia; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the AT&T Foundation, the Benesse Foundation, Jerry and Marge Burnett, Defense Advanced Research Projects Agency (DARPA) Living Foundries Program Grant HR0011-12-C-0068, the Harvard/Massachusetts Institute of Technology (MIT) Joint Grants Program in Basic Neuroscience, the Human Frontiers Science Program, the MIT McGovern Institute and McGovern Institute Neurotechnology (MINT) Program, the MIT Media Lab and Media Lab Consortia, the MIT Neurotechnology Fund (and its generous donors), the New York Stem Cell Foundation-Robertson Investigator Award, National Institutes of Health (NIH) Director's New Innovator Award 1DP2OD002002, NIH EUREKA Award 1R01NS075421, NIH Grant 1R01DA029639, National Science Foundation (NSF) CAREER Award CBET 1053233, SkTech, and the Wallace H. Coulter Foundation (all to E. S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal N, 2009, PROTEOMICS, V9, P1099, DOI 10.1002/pmic.200800368; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Figueiredo M, 2014, CELL CALCIUM, V56, P208, DOI 10.1016/j.ceca.2014.07.007; Gonzalez JE, 2002, RECEPTOR CHANNEL, V8, P283, DOI 10.1080/10606820214644; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; Govorunova EG, 2016, PHOTOCHEM PHOTOBIOL, V92, P257, DOI 10.1111/php.12558; Gradmann D, 2002, J MEMBRANE BIOL, V189, P93, DOI 10.1007/s00232-002-1006-8; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Perea G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4262; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Richards R, 2017, J BIOL CHEM, V292, P7314, DOI 10.1074/jbc.M116.770321; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stuart A., 2010, KENDALLS ADV THEORY, V1; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Volkov O, 2017, SCIENCE, V358, DOI 10.1126/science.aan8862; Wang SY, 2016, METHODS MOL BIOL, V1408, P243, DOI 10.1007/978-1-4939-3512-3_16; Wietek J, 2016, J BIOL CHEM, V291, P4121, DOI 10.1074/jbc.M115.699637; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	15	15	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3806	3821		10.1074/jbc.RA118.006996	http://dx.doi.org/10.1074/jbc.RA118.006996			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30610117	Green Published, hybrid			2022-12-26	WOS:000461854400001
J	Cui, WT; Xiao, GJ; Jiang, SW; Qian, LL; Cai, CB; Li, B; Xie, SS; Gao, T; Li, K				Cui, Wen-Tao; Xiao, Gao-Jun; Jiang, Sheng-Wang; Qian, Li-Li; Cai, Chun-Bo; Li, Biao; Xie, Shan-Shan; Gao, Ting; Li, Kui			Effect of ZFN-edited myostatin loss-of-function mutation on gut microbiota in Meishan pigs	PLOS ONE			English	Article							GENE	Intestine contains the body's second largest genetic information, so a relatively stable micro-biota ecosystems and interactions between intestinal micro-organisms play a pivotal role in the normal growth and development in animals. The establishment of intestinal microflora is affected by a variety of factors such as species, environmental factors, developmental stage, organizational structure and physiological characteristics of various parts of the digestive tract. Gene editing technology such as ZFN has recently been used as a new approach to replace the traditional transgenic technology and to make genetic modifications in animals. However, it is not known if genetic modification by gene editing technology will have any impact on gut microbiota. In this study, by sequencing 16S rRNA collected from rectum, we investigated the effects of ZFN-mediated myostatin (MSTN) loss-of-function mutation (MSTN-/-) on gut microbiota in Meishan pigs. Our results showed that the fecal microbial composition is very similar between MSTN-/- Meishan pigs and wild type Meishan pigs. Although significant differences in certain individual strains were observed, all the dominant microorganism species are basically the same between MSTN-/- and wild type pigs. However, these differences do not adversely affect MSTN-/- Meishan pigs. Thus, it is concluded that ZFN-mediated MSTN loss-of-function mutation did not have any adverse effect on the gut microbiota in Meishan pigs.	[Cui, Wen-Tao; Xiao, Gao-Jun; Jiang, Sheng-Wang; Qian, Li-Li; Cai, Chun-Bo; Li, Biao; Xie, Shan-Shan; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Qian, Li-Li; Cai, Chun-Bo; Gao, Ting] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Cui, WT (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	cuiwentao@caas.cn	xie, shanshan/GSM-8999-2022; 钱, 钱丽丽/GWV-8162-2022		National Transgenic Project of China [2016ZX08006-001]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]; Safety Evaluation Project of Transgenic Animals and Feeding Materials [2011-G11]	National Transgenic Project of China; Agricultural Science and Technology Innovation Program; Safety Evaluation Project of Transgenic Animals and Feeding Materials	This work was supported by the National Transgenic Project of China (2016ZX08006-001), the Agricultural Science and Technology Innovation Program (ASTIP-IAS05), and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11) to LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Cai CB, 2017, ONCOTARGET, V8, P34911, DOI 10.18632/oncotarget.16822; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Evans NJ, 2011, APPL ENVIRON MICROB, V77, P138, DOI 10.1128/AEM.00993-10; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Inoue R, 2005, J GEN APPL MICROBIOL, V51, P257, DOI 10.2323/jgam.51.257; Legault C, 1985, J Reprod Fertil Suppl, V33, P151; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu XF, 2014, CURR MICROBIOL, V68, P657, DOI 10.1007/s00284-014-0528-5; Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nan Chun-yan, 2013, Chinese Journal of Parasitology and Parasitic Diseases, V31, P114; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Wang QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150937; Xiao GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165843; Yang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep35692; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	25	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210619	10.1371/journal.pone.0210619	http://dx.doi.org/10.1371/journal.pone.0210619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645618	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200041
J	Stewart, JAE; Butterfield, HS; Richmond, JQ; Germano, DJ; Westphal, MF; Tennant, EN; Sinervo, B				Stewart, Joseph A. E.; Butterfield, H. Scott; Richmond, Jonathan Q.; Germano, David J.; Westphal, Michael F.; Tennant, Erin N.; Sinervo, Barry			Habitat restoration opportunities, climatic niche contraction, and conservation biogeography in California's San Joaquin Desert	PLOS ONE			English	Article							NOSED LEOPARD LIZARD; BIODIVERSITY; MANAGEMENT; FARMLAND; EXTREMES; GRASSES; ECOLOGY; MODELS; WATER; RISK	A recent global trend toward retirement of farmland presents opportunities to reclaim habitat for threatened and endangered species. We examine habitat restoration opportunities in one of the world's most converted landscapes, California's San Joaquin Desert (SJD). Despite the presence of 35 threatened and endangered species, agricultural expansion continues to drive habitat loss in the SJD, even as marginal farmland is retired. Over the next decades a combination of factors, including salinization, climate change, and historical groundwater overdraft, are projected to lead to the retirement of more than 2,000 km(2) of farmland in the SJD. To promote strategic habitat protection and restoration, we conducted a quantitative assessment of habitat loss and fragmentation, habitat suitability, climatic niche stability, climate change impacts, habitat protection, and reintroduction opportunities for an umbrella species of the SJD, the endangered blunt-nosed leopard lizard (Gambelia sila). We use our suitability models, in conjunction with modern and historical land use maps, to estimate the historical and modern rate of habitat loss to development. The estimated amount of habitat lost since the species became protected under endangered species law in 1967 is greater than the total amount of habitat currently protected through public ownership and conservation easement. We document climatic niche contraction and associated range contraction away from the more mesic margins of the species' historical distribution, driven by the anthropogenic introduction of exotic grasses and forbs. The impact of exotic species on G. sila range dynamics appears to be still unfolding. Finally, we use NASA fallowed area maps to identify 610 km(2) of fallowed or retired agricultural land with high potential to again serve as habitat. We discuss conservation strategies in light of the potential for habitat restoration and multiple drivers of ongoing and historical habitat loss.	[Stewart, Joseph A. E.; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Stewart, Joseph A. E.; Sinervo, Barry] Univ Calif Santa Cruz, Inst Study Ecol & Evolutionary Climate Impacts, Santa Cruz, CA 95064 USA; [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA; [Richmond, Jonathan Q.] US Geol Survey, San Diego, CA USA; [Germano, David J.] Calif State Univ Bakersfield, Dept Biol, Bakersfield, CA USA; [Westphal, Michael F.] US Bur Land Management, Marina, CA USA; [Tennant, Erin N.] Calif Dept Fish & Wildlife, Lands Unit, Cent Reg, Fresno, CA USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Nature Conservancy; United States Department of the Interior; United States Geological Survey; California State University System; California State University Bakersfield	Stewart, JAE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.; Stewart, JAE (corresponding author), Univ Calif Santa Cruz, Inst Study Ecol & Evolutionary Climate Impacts, Santa Cruz, CA 95064 USA.	jaes@ucsc.edu	Stewart, Joseph/AAA-4647-2020	Stewart, Joseph/0000-0001-5915-6892	US BLM [L12AC20104]; Nature Conservancy [12112012-1361]; California Department of Fish and Wildlife; NSF [EF-1241848]; Institute for the Study of Ecological Effects of Climate Impacts	US BLM; Nature Conservancy; California Department of Fish and Wildlife; NSF(National Science Foundation (NSF)); Institute for the Study of Ecological Effects of Climate Impacts	This work was supported by a Grant from US BLM to Regents of University of California Santa Cruz Award #L12AC20104, www.grants.gov. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. This work also received support from a Grant from The Nature Conservancy to Regents of the University of California Santa Cruz #12112012-1361, www.nature.org. The funder had a role in decision to publish, and preparation of the manuscript. The California Department of Fish and Wildlife supported this project and had a role in decision to publish, and preparation of the manuscript. An NSF grant EF-1241848 to B. Sinervo supported this work. The funder did not have a role in decision to publish or preparation of the manuscript. A grant from the Institute for the Study of Ecological Effects of Climate Impacts to J. Stewart supported this work. The funder did not have a role in decision to publish or preparation of the manuscript.	AghaKouchak A, 2014, GEOPHYS RES LETT, V41, P8847, DOI 10.1002/2014GL062308; Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; ALLEN EB, 1995, USDA INTERM, V315, P7; [Anonymous], 1998, RECOVERY PLAN UPLAND; Ausubel JH, 2013, POPUL DEV REV, V38, P221, DOI 10.1111/j.1728-4457.2013.00561.x; Bailey CV, 2015, W WILD, V2, P23; Baillie J. E., 2004, 2004 IUCN RED LIST T, DOI [10.2305/IUCN.CH.2005.3.en, DOI 10.2305/IUCN.CH.2005.3.EN]; Bean WT, 2014, J APPL ECOL, V51, P1116, DOI 10.1111/1365-2664.12281; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cismowski G., 2006, SALINITY CENTRAL VAL; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Cypher Brian L., 2013, Canid News, V16, P25; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Germano DJ, 2007, SOUTHWEST NAT, V52, P318, DOI 10.1894/0038-4909(2007)52[318:FHOTBL]2.0.CO;2; Germano DJ, 2012, J WILDLIFE MANAGE, V76, P670, DOI 10.1002/jwmg.316; Germano DJ, 2011, NAT AREA J, V31, P138, DOI 10.3375/043.031.0206; Germano DJ, 2005, J HERPETOL, V39, P1, DOI 10.1670/0022-1511(2005)039[0001:PEOBLL]2.0.CO;2; GERMANO DJ, 1992, T W SEC WIL, V28, P38; Germano DJ, 2001, WILDLIFE SOC B, V29, P551; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Goldingay RL, 1997, KANGAROO RATS CALIFO, V3, P47; Gozdowski D, 2015, J SOIL SCI PLANT NUT, V15, P639; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Grimes AJ, 2014, SOUTHWEST NAT, V59, P38, DOI 10.1894/F06-GC-233.1; Hanak E, 2017, WATER STRESS CHANGIN, DOI [10.13140/RG.2.2.3179.31522, DOI 10.13140/RG.2.2.3179.31522]; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Jennings Mark R., 1995, Catalogue of American Amphibians and Reptiles, V612, P1; Kelly Patrick A., 2005, University of California Publications in Zoology, V133, P57; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Laymon S, 2010, ATWELL ISLAND RESTOR; Lortie CJ, 2018, ECOSPHERE, V9, P1, DOI [10.1093/annonc/mdy039/4835470, DOI 10.1093/ANNONC/MDY039/4835470]; Means D.B., 1975, J BIOGEOGR, V2, P253, DOI [10.2307/3037999, DOI 10.2307/3037999]; MONTANUCCI RICHARD R., 1965, HERPETOLOGICA, V21, P270; Mueller, 2015, FALLOWED AREA MAPPIN; Nelson C, 2003, CENTRAL VALLEY HIST; Olmstead A., 2003, CALIFORNIA AGR DIMEN, P1; Pearce D, 2015, THESIS; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Richmond JQ, 2017, MOL ECOL, V26, P3618, DOI 10.1111/mec.14125; Schoups G, 2005, P NATL ACAD SCI USA, V102, P15352, DOI 10.1073/pnas.0507723102; Schulman L, 2007, J BIOGEOGR, V34, P1388, DOI 10.1111/j.1365-2699.2007.01716.x; Sinervo B, 2018, INTEGR ZOOL, V13, P450, DOI 10.1111/1749-4877.12315; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stewart JAE, 2016, CLIMATE CHANGE VULNE, DOI [10.13140/RG.2.2.13009.33124/1, DOI 10.13140/RG.2.2.13009.33124/1]; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thorne JH, 2016, CLIMATE CHANGE VULNE, DOI [10.1371/journal.pone.0029507, DOI 10.1371/JOURNAL.PONE.0029507]; United States Fish and Wildlife Service, 2010, BLUNT NOS LEOP LIZ G; USFWS (U. S. Fish and Wildlife Service), 1967, FED REGISTER, V32, P4001; Vicenzi N, 2017, BIOL CONSERV, V206, P151, DOI 10.1016/j.biocon.2016.12.030; Wang SY, 2014, GEOPHYS RES LETT, V41, P3220, DOI 10.1002/2014GL059748; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; Wester L., 1981, Madrono, V28, P231; Westphal MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154838; Williams D. F., 1992, ENDANGERED SENSITIVE, P65	64	9	9	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210766	10.1371/journal.pone.0210766	http://dx.doi.org/10.1371/journal.pone.0210766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645624	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200051
J	Xi, R; Murthy, PKL; Tung, KL; Guy, CD; Wan, J; Li, F; Wang, Z; Li, XD; Varanko, A; Rakhilin, N; Xin, YN; Liu, BT; Qian, SB; Su, LS; Han, Y; Shen, XL				Xi, Rui; Murthy, Preetish Kadur Lakshminarasimha; Tung, Kuei-Ling; Guy, Cynthia D.; Wan, Ji; Li, Feng; Wang, Zhuo; Li, Xiaodong; Varanko, Anastasia; Rakhilin, Nikolai; Xin, Yongning; Liu, Botao; Qian, Shu-Bing; Su, Lishan; Han, Yan; Shen, Xiling			SENP3-mediated host defense response contains HBV replication and restores protein synthesis	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; OXIDATIVE STRESS; MOLECULAR-BIOLOGY; SUMO MODIFICATION; TUMOR-SUPPRESSOR; SENP3; SUMOYLATION; INFECTION; IQGAP2; CELLS	Certain organs are capable of containing the replication of various types of viruses. In the liver, infection of Hepatitis B virus (HBV), the etiological factor of Hepatitis B and hepatocellular carcinoma (HCC), often remains asymptomatic and leads to a chronic carrier state. Here we investigated how hepatocytes contain HBV replication and promote their own survival by orchestrating a translational defense mechanism via the stress-sensitive SUMO-2/3-specific peptidase SENP3. We found that SENP3 expression level decreased in HBV-infected hepatocytes in various models including HepG2-NTCP cell lines and a humanized mouse model. Downregulation of SENP3 reduced HBV replication and boosted host protein translation. We also discovered that IQGAP2, a Ras GTPase-activating-like protein, is a key substrate for SENP3-mediated de-SUMOylation. Downregulation of SENP3 in HBV infected cells facilitated IQGAP2 SUMOylation and degradation, which leads to suppression of HBV gene expression and restoration of global translation of host genes via modulation of AKT phosphorylation. Thus, The SENP3-IQGAP2 de-SUMOylation axis is a host defense mechanism of hepatocytes that restores host protein translation and suppresses HBV gene expression.	[Xi, Rui; Murthy, Preetish Kadur Lakshminarasimha; Rakhilin, Nikolai; Han, Yan; Shen, Xiling] Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA; [Xi, Rui; Tung, Kuei-Ling; Han, Yan; Shen, Xiling] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA; [Xi, Rui; Tung, Kuei-Ling; Han, Yan; Shen, Xiling] Duke Univ, Duke Canc Inst, Durham, NC USA; [Murthy, Preetish Kadur Lakshminarasimha] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Tung, Kuei-Ling; Varanko, Anastasia] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Guy, Cynthia D.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Wan, Ji; Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Coll Human Ecol, Ithaca, NY 14853 USA; [Li, Feng; Wang, Zhuo; Li, Xiaodong; Su, Lishan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Li, Feng] Guangzhou Eighth Peoples Hosp, Inst Infect Dis, Guangzhou, Guangdong, Peoples R China; [Rakhilin, Nikolai] Cornell Univ, Coll Engn, Sch Elect & Comp Engn, Ithaca, NY USA; [Xin, Yongning] Qingdao Municipal Hosp, Dept Gastroenterol, Qingdao, Peoples R China; [Xin, Yongning] Digest Dis Key Lab Qingdao, Qingdao, Peoples R China; [Xin, Yongning] Qingdao Univ, Med Coll, Qingdao, Peoples R China; [Liu, Botao] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA	Duke University; Duke University; Duke University; Cornell University; Cornell University; Duke University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cornell University; Qingdao Municipal Hospital; Qingdao University; University of Massachusetts System; University of Massachusetts Worcester	Han, Y; Shen, XL (corresponding author), Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA.; Han, Y; Shen, XL (corresponding author), Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA.; Han, Y; Shen, XL (corresponding author), Duke Univ, Duke Canc Inst, Durham, NC USA.	yhan58@gmail.com; xiling.shen@duke.edu	li, xiaofeng/GXF-9442-2022; Murthy, Preetish Kadur Lakshminarasimha/AFK-2904-2022; li, xiao/GSN-6181-2022; Wan, Ji/K-1344-2014	Murthy, Preetish Kadur Lakshminarasimha/0000-0002-9762-8376; Varanko, Anastasia/0000-0003-2763-5842; Li, Feng/0000-0003-3169-6349; Wan, Ji/0000-0002-5279-0345	National Institutes of Health [NIH R21CA201963, R35GM122465, U01CA214300]; National Science Foundation [NSF 1350659]; Shanghai Pujiang Program [13PJ1406100]; National Natural Science Foundation of China [81302086]; Ministry of Education of China [20130073120007]; NSF [DGE 1545220]; NATIONAL CANCER INSTITUTE [R21CA201963, U01CA214300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122465, R01GM122814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the National Institutes of Health NIH R21CA201963, R35GM122465, U01CA214300, and the National Science Foundation NSF 1350659 to X.S.; Shanghai Pujiang Program (No. 13PJ1406100), National Natural Science Foundation of China (No. 81302086) Ministry of Education of China (No. 20130073120007) to Y.H.; NSF DGE 1545220 to R.X. (Integrative Bioinformatics for Investigating and Engineering Microbiomes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The co-author Dr. Yan Han performed related work when she was a postdoc at Duke University. She left Duke and joined CuraCloud in February 2017 and has not performed any work related to the manuscript since then. She is currently employed by CuraCloud. The co-author Dr. Ji Wan performed related work when he was a postdoc at Cornell University. He left Cornell and joined CuraCloud in April 2017, and has not performed any work related to the manuscript since then. He is currently employed by CuraCloud. CuraCloud did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CuraCloud has not provided any form of funding to work related to the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Balmasova I. P., 2016, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P119; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; Bility MT, 2012, NAT PROTOC, V7, P1608, DOI 10.1038/nprot.2012.083; Brisac C, 2016, J HEPATOL, V65, P972, DOI 10.1016/j.jhep.2016.06.028; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Ghaleb AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129314; Gingras Ac, 1998, GENES DEV, V12; Gnatenko DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071826; Guo HT, 2007, J VIROL, V81, P10072, DOI 10.1128/JVI.00541-07; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Han Y, 2014, CELL RES, V24, P842, DOI 10.1038/cr.2014.74; Han Y, 2012, P NATL ACAD SCI USA, V109, P12467, DOI 10.1073/pnas.1208138109; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; KOCK J, 1993, J VIROL, V67, P4867; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li F, 2014, SCI REPORTS, V4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Minosse C, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.28751; Murphy CM, 2016, CELL REP, V16, P2846, DOI 10.1016/j.celrep.2016.08.026; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Rawat S, 2015, J VIROL, V89, P999, DOI 10.1128/JVI.02440-14; Ren YH, 2014, ONCOTARGET, V5, P7093, DOI 10.18632/oncotarget.2197; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; Samal J, 2015, VIROLOGY, V484, P234, DOI 10.1016/j.virol.2015.06.011; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaitheesvaran B, 2014, METABOLOMICS, V10, P920, DOI 10.1007/s11306-014-0639-9; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang Y, 2012, ACTA PHARMACOL SIN, V33, P953, DOI 10.1038/aps.2012.40; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Xie YY, 2012, BBA-MOL BASIS DIS, V1822, P875, DOI 10.1016/j.bbadis.2012.02.019; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645	52	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209179	10.1371/journal.pone.0209179	http://dx.doi.org/10.1371/journal.pone.0209179			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640896	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000010
J	Zuo, PY; Wang, YA; Liu, J; Hu, SY; Zhao, GX; Huang, LJ; Lin, DH				Zuo, Peiying; Wang, Yinan; Liu, Jia; Hu, Siyuan; Zhao, Guoxiang; Huang, Lijie; Lin, Danhua			Effects of early adversity on the brain: Larger-volume anterior cingulate cortex in AIDS orphans	PLOS ONE			English	Article							INSTITUTIONAL DEPRIVATION; MESSENGER-RNA; CHILD-ABUSE; LIFE STRESS; HIPPOCAMPAL; AMYGDALA; PSYCHOPATHOLOGY; ABNORMALITIES; FRAMEWORK	Multiple studies have revealed that adolescent AIDS orphans have more psychosocial problems than healthy adolescents. However, little is known about whether and how the brain structures of adolescent AIDS orphans differ from those of healthy adolescents. Here, we used magnetic resonance imaging to compare adolescent AIDS orphans reared in institutions (N = 20) with a sex- and age-matched group of healthy adolescents reared in families (N = 20) in China using a voxel-based morphometry analysis. First, we found that both total gray-and white-matter volumes did not differ between groups. Second, after correcting for age, sex, and total gray-matter volume, the AIDS orphan group demonstrated smaller hippocampal volumes, larger anterior cingulate cortex (ACC) volumes, and no differences in the amygdala. Third, a whole-brain analysis identified higher gray-matter volume of the ACC in the AIDS orphan group than in the control group. The preliminary findings of this study highlight the need for future research to confirm the sensitivity of the hippocampus and ACC to early adversity.	[Zuo, Peiying; Lin, Danhua] Beijing Normal Univ, Inst Dev Psychol, Beijing, Peoples R China; [Wang, Yinan; Liu, Jia; Hu, Siyuan] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing, Peoples R China; [Zhao, Guoxiang] Henan Univ, Dept Psychol, Kaifeng, Peoples R China; [Huang, Lijie] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Huang, Lijie] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Henan University; Beijing Normal University; Beijing Normal University	Lin, DH (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing, Peoples R China.	danhualin@bnu.edu.cn		Liu, Jia/0000-0003-0383-0934	National Social Science Foundation of China [15ZDB138]	National Social Science Foundation of China	This work was supported by the National Social Science Foundation of China (15ZDB138).	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avishai-Eliner S, 2001, ENDOCRINOLOGY, V142, P89, DOI 10.1210/en.142.1.89; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Brett Z., 2014, INT J BEHAV DEV; Brett ZH, 2015, DEV PSYCHOPATHOL, V27, P347, DOI 10.1017/S0954579415000036; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4; Carrion VG, 2009, PSYCHIAT RES-NEUROIM, V172, P226, DOI 10.1016/j.pscychresns.2008.07.008; Chi P, 2015, PSYCHOL SCI; Chi PL, 2013, AIDS BEHAV, V17, P2554, DOI 10.1007/s10461-012-0290-2; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cluver LD, 2008, J ADOLESCENT HEALTH, V42, P410, DOI 10.1016/j.jadohealth.2007.09.022; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fang X, 2009, J PEDIATR PSYCHOL; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Good CD, 2002, BIOMEDICAL IMAGING 2, P16; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Hodel AS, 2015, NEUROIMAGE, V105, P112, DOI 10.1016/j.neuroimage.2014.10.020; Hughes V, 2012, NATURE, V490, P165, DOI 10.1038/490165a; Kong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097071; Kreppner JM, 2001, J ABNORM CHILD PSYCH, V29, P513; Li XM, 2008, J ASSOC NURSE AIDS C, V19, P147, DOI 10.1016/j.jana.2007.08.004; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; McCrory E, 2011, FRONT PSYCHIATRY, P2; McCrory E, 2012, J ROY SOC MED, V105, P151, DOI 10.1258/jrsm.2011.110222; McLaughlin KA, 2014, BIOL PSYCHIAT, V76, P629, DOI 10.1016/j.biopsych.2013.08.016; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Rametti G, 2007, SCHIZOPHR RES, V96, P62, DOI 10.1016/j.schres.2007.04.034; Richert KA, 2006, DEPRESS ANXIETY, V23, P17, DOI 10.1002/da.20131; Richter L., 2004, GENERATION RISK HIVA, V109, P9; Rutter M, 2010, MONOGR SOC RES CHILD, V75, P212, DOI 10.1111/j.1540-5834.2010.00557.x; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Tottenham N, 2009, FRONT HUM NEUROSCI, P3; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Vijayakumar N, 2014, SOCIAL COGNITIVE AFF; Wang Y, 2018, REPORT ADV PSYCHOL 2, P191; Yi S, IMPROVING ED OPPORTU; Zhao Q, 2009, J ASSOC NURSE AIDS C, V20, P122, DOI 10.1016/j.jana.2008.09.009	50	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210489	10.1371/journal.pone.0210489	http://dx.doi.org/10.1371/journal.pone.0210489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640928	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000033
J	Fotedar, S; Lukehurst, S; Jackson, G; Snow, M				Fotedar, Seema; Lukehurst, Sherralee; Jackson, Gary; Snow, Michael			Molecular tools for identification of shark species involved in depredation incidents in Western Australian fisheries	PLOS ONE			English	Article							CARCHARHINUS-TILSTONI; HAMMERHEAD SHARKS; C.-LIMBATUS; DNA; PCR; TRADE; CONSERVATION; MANAGEMENT; BYCATCH; RATIOS	Shark depredation is an issue of concern in some Western Australian recreational and commercial fisheries where it can have economic, social and ecological consequences. Knowledge of the shark species involved is fundamental to developing effective management strategies to mitigate the impacts of depredation. Identification of the species responsible is difficult as direct observation of depredation events is uncommon and evaluating bite marks on fish has a high degree of uncertainty. The use of trace DNA techniques has provided an alternative method for species identification. We demonstrate proof of concept for a targeted DNA barcoding approach to identify shark species using trace DNA found at bite marks on recovered remains of hooked fish. Following laboratory validation, forensic analysis of swabs collected from samples of bitten demersal fish, led to the definitive identification of shark species involved in 100% of the incidences of depredation (n = 16).	[Fotedar, Seema; Lukehurst, Sherralee; Jackson, Gary; Snow, Michael] Govt Western Australia, Dept Primary Ind & Reg Dev, Hillarys, WA, Australia; [Lukehurst, Sherralee] Univ Western Australia, Sch Biol Sci, Ctr Evolutionary Biol, Crawley, WA, Australia	University of Western Australia	Fotedar, S (corresponding author), Govt Western Australia, Dept Primary Ind & Reg Dev, Hillarys, WA, Australia.	seema.fotedar@dpird.wa.gov.au						Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Chuang PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147290; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Cozza K, 1996, BIOL CONSERV, V78, P329, DOI 10.1016/S0006-3207(96)00053-5; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Farley S, 2014, WILDLIFE SOC B, V38, P370, DOI 10.1002/wsb.391; Feitosa LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21683-5; Fields AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114844; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Glen AS, 2010, CONSERV GENET, V11, P1099, DOI 10.1007/s10592-009-9888-y; Green SJ, 2005, APPL ENVIRON MICROB, V71, P4721, DOI 10.1128/AEM.71.8.4721-4727.2005; Greig TW, 2005, FISH B-NOAA, V103, P516; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoey JJ, 1999, CAPTAINS REPORT MULT; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Jarman SN, 2004, J FISH BIOL, V65, P586, DOI 10.1111/j.0022-1112.2004.00466.x; Jauniaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108993; Johnson GJ, 2017, J FISH BIOL, V90, P39, DOI 10.1111/jfb.13102; Kagi J., 2016, ABC NEWS; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kemper Catherine M., 2003, P208; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Mandelman JW, 2008, REV FISH BIOL FISHER, V18, P427, DOI 10.1007/s11160-008-9084-z; Marlow NJ, 2015, AUST J ZOOL, V63, P18, DOI 10.1071/ZO14024; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mitchell JD, 2018, REV FISH BIOL FISHER, V28, P715, DOI 10.1007/s11160-018-9528-z; Mitchell JD, 2018, MAR ECOL PROG SER, V587, P141, DOI 10.3354/meps12412; Morgan JAT, 2012, CONSERV GENET, V13, P455, DOI 10.1007/s10592-011-0298-6; Morgan JAT, 2011, MOL ECOL RESOUR, V11, P813, DOI 10.1111/j.1755-0998.2011.03023.x; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Rabearisoa N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202037; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Remeslo AV, 2015, J NAT HIST, V49, P2483, DOI 10.1080/00222933.2015.1040477; Robinson Louise Anne, 2013, P367; Romanov E., 2007, WORKSH DEPR TUN LONG, P7; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; Shivji MS, 2005, CONSERV GENET, V6, P1035, DOI 10.1007/s10592-005-9082-9; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Tobe SS, 2010, FORENSIC SCI MED PAT, V6, P195, DOI 10.1007/s12024-010-9168-7; van Oorschot Roland Ah, 2010, Investig Genet, V1, P14, DOI 10.1186/2041-2223-1-14; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148	54	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210500	10.1371/journal.pone.0210500	http://dx.doi.org/10.1371/journal.pone.0210500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633772	Green Submitted, gold, Green Published			2022-12-26	WOS:000455485100026
J	Hankerson, BR; Schierhorn, F; Prishchepov, AV; Dong, CX; Eisfelder, C; Muller, D				Hankerson, Brett R.; Schierhorn, Florian; Prishchepov, Alexander V.; Dong, Changxing; Eisfelder, Christina; Mueller, Daniel			Modeling the spatial distribution of grazing intensity in Kazakhstan	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NET PRIMARY PRODUCTIVITY; LAND-COVER DATA; LIVESTOCK DISTRIBUTIONS; CHALLENGES; BIODIVERSITY; YEAR-2000; PATTERNS; STEPPES	With increasing affluence in many developing countries, the demand for livestock products is rising and the increasing feed requirement contributes to pressure on land resources for food and energy production. However, there is currently a knowledge gap in our ability to assess the extent and intensity of the utilization of land by livestock, which is the single largest land use in the world. We developed a spatial model that combines fine-scale livestock numbers with their associated energy requirements to distribute livestock grazing demand onto a map of energy supply, with the aim of estimating where and to what degree pasture is being utilized. We applied our model to Kazakhstan, which contains large grassland areas that historically have been used for extensive livestock production but for which the current extent, and thus the potential for increasing livestock production, is unknown. We measured the grazing demand of Kazakh livestock in 2015 at 286 Petajoules, which was 25% of the estimated maximum sustainable energy supply that is available to livestock for grazing. The model resulted in a grazed area of 1.22 million km(2), or 48% of the area theoretically available for grazing in Kazakhstan, with most utilized land grazed at low intensities (average offtake rate was 13% of total biomass energy production). Under a conservative scenario, our estimations showed a production potential of 0.13 million tons of beef additional to 2015 production (31% increase), and much more with utilization of distant pastures. This model is an important step forward in evaluating pasture use and available land resources, and can be adapted at any spatial scale for any region in the world.	[Hankerson, Brett R.; Schierhorn, Florian; Dong, Changxing; Mueller, Daniel] Leibniz Inst Agr Dev Transit Econ IAMO, Halle, Saale, Germany; [Hankerson, Brett R.; Mueller, Daniel] Humboldt Univ, Dept Geog, Berlin, Germany; [Prishchepov, Alexander V.] Univ Copenhagen, Dept Geosci & Nat Resource Management IGN, Copenhagen, Denmark; [Prishchepov, Alexander V.] Kazan Fed Univ, Inst Environm Sci, Kazan, Russia; [Eisfelder, Christina] German Aerosp Ctr DLR, German Remote Sensing Data Ctr DFD, Oberpfaffenhofen, Germany; [Mueller, Daniel] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, Berlin, Germany	Leibniz Institut fur Agrarentwicklung in Transformationsokonomien (IAMO); Humboldt University of Berlin; University of Copenhagen; Kazan Federal University; Helmholtz Association; German Aerospace Centre (DLR); Humboldt University of Berlin	Hankerson, BR (corresponding author), Leibniz Inst Agr Dev Transit Econ IAMO, Halle, Saale, Germany.; Hankerson, BR (corresponding author), Humboldt Univ, Dept Geog, Berlin, Germany.	hankerson@iamo.de	, IAMO/G-2328-2012; Change, Structural/W-8306-2019; Mueller, Daniel/A-4454-2009; Müller, Daniel/AAI-4867-2021; Prishchepov, Alexander/H-6708-2012	, IAMO/0000-0001-7922-9665; Change, Structural/0000-0002-2459-4646; Mueller, Daniel/0000-0001-8988-0718; Müller, Daniel/0000-0001-8988-0718; Prishchepov, Alexander/0000-0003-2375-1651	Leibniz-Gemeinschaft [SAW-2012-IAMO-7]; Open Access Fund of the Leibniz Association	Leibniz-Gemeinschaft; Open Access Fund of the Leibniz Association	Funded by Leibniz-Gemeinschaft to DM. Grant number: SAW-2012-IAMO-7. URL: https://www.leibniz-gemeinschaft.de/start/. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimaev Illya I., 2008, P151, DOI 10.1007/978-1-4020-4906-4_7; [Anonymous], 2016, OPENSTREETMAP DAT EX; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Association for the Conservation of Biodiversity of Kazakhstan, 2018, ALT DAL CONS IN; BARET F, 1992, PLANT SOIL, V140, P137, DOI 10.1007/BF00012815; Behnke R., 2008, SOCIOECONOMIC CAUSES; Behnke R, 2016, LAND USE POLICY, V52, P103, DOI 10.1016/j.landusepol.2015.12.012; Bouwman AF, 2005, AGR SYST, V84, P121, DOI 10.1016/j.agsy.2004.05.006; Brinkert A, 2015, BIODIVERS CONSERV, P1; Chang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127554; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Coughenour M, SOCIOECONOMIC CAUSES; Eisfelder C, 2017, ECOL INDIC, V72, P13, DOI 10.1016/j.ecolind.2016.07.042; Eisfelder C, 2014, J ARID ENVIRON, V103, P17, DOI 10.1016/j.jaridenv.2013.12.005; Ellis J., 2003, Prospects for pastoralism in Kazakstan and Turkmenistan: from state farms to private flocks, P52; Erb KH, 2016, HUMAN ENVIRON INTERA, P295, DOI 10.1007/978-3-319-33326-7_13; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; Fetzel T, 2017, GLOBAL BIOGEOCHEM CY, V31, P1089, DOI 10.1002/2016GB005601; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garnett Tara, 2017, GRAZED CONFUSED RUMI; Gilbert M, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.227; Giri C, 2005, REMOTE SENS ENVIRON, V94, P123, DOI 10.1016/j.rse.2004.09.005; Goldewijk KK, 2007, J LAND USE SCI, V2, P167, DOI 10.1080/17474230701622940; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Grebennikov VG, 2012, PERENNIAL GRASSES PA; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hall W. B., 1998, Rangeland Journal, V20, P177, DOI 10.1071/RJ9980177; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Herrero M, 2009, CURR OPIN ENV SUST, V1, P111, DOI 10.1016/j.cosust.2009.10.003; Holechek J.L., 1988, RANGELANDS, V10, P10, DOI DOI 10.2307/4000362; Holzel N., 2002, Journal for Nature Conservation, V10, P75, DOI 10.1078/1617-1381-00009; IIASA FAO, 2012, GLOB AGR ZON GAEZ V3; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Kamp J, 2016, BIODIVERS CONSERV, V25, P2521, DOI 10.1007/s10531-016-1083-0; Kamp J, 2015, J APPL ECOL, V52, P1578, DOI 10.1111/1365-2664.12527; Kamp J, 2012, AGR ECOSYST ENVIRON, V155, P41, DOI 10.1016/j.agee.2012.03.023; Kamp J, 2009, IBIS, V151, P452, DOI 10.1111/j.1474-919X.2009.00938.x; KazStat, 2008, RES 1 NAT AGR CENS; Kerven C, 2016, LAND USE POLICY, V52, P392, DOI 10.1016/j.landusepol.2015.12.030; Klein I, 2012, APPL GEOGR, V35, P219, DOI 10.1016/j.apgeog.2012.06.016; Kock RA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao2314; Kraemer R, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/5/054012; Krausmann F, 2008, ECOL ECON, V65, P471, DOI 10.1016/j.ecolecon.2007.07.012; Kuemmerle T, 2013, CURR OPIN ENV SUST, V5, P484, DOI 10.1016/j.cosust.2013.06.002; Low F, 2015, APPL GEOGR, V62, P377, DOI 10.1016/j.apgeog.2015.05.009; Manceron S, 2014, OCL OILS FAT CROP LI, V21, DOI 10.1051/ocl/2014020; McNaughton SJ, 1996, ECOLOGY, V77, P974, DOI 10.2307/2265518; Meyfroidt P, 2016, GLOBAL ENVIRON CHANG, V37, P1, DOI 10.1016/j.gloenvcha.2016.01.003; Milner-Gulland EJ, 2001, ORYX, V35, P340, DOI 10.1017/S0030605300032105; Mirzabaev A, 2016, J ARID LAND, V8, P93, DOI 10.1007/s40333-015-0057-5; Nasiev BN, 2014, P ORENBURG STATE AGR, P54; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; NHSS, 2015, RES CENS CONSTR BUIL; Nicolas G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150424; O'Mara FP, 2011, ANIM FEED SCI TECH, V166-67, P7, DOI 10.1016/j.anifeedsci.2011.04.074; Olcott MB, 1995, KAZAKHS HOOVER I PRE; Petrick M, 2013, WORLD DEV, V43, P164, DOI 10.1016/j.worlddev.2012.09.015; Pflugmacher D, 2011, REMOTE SENS ENVIRON, V115, P3539, DOI 10.1016/j.rse.2011.08.016; Phelps LN, 2017, GLOBAL CHANGE BIOL, V23, P4457, DOI 10.1111/gcb.13732; Propastin PA, 2012, INT J REMOTE SENS, V33, P1465, DOI 10.1080/01431161.2011.577105; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Robinson S, 2016, AGR SYST, V143, P169, DOI 10.1016/j.agsy.2015.12.018; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Robinson S, 2003, J ARID ENVIRON, V53, P419, DOI 10.1006/jare.2002.1047; Robinson S, 2016, HUM ECOL, P1; Robinson Sarah., 2000, PASTORALISM LAND DEG; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Safin KM, 2011, BASHKIR STATE AGRARI, P5; Schierhorn F, 2016, GLOB FOOD SECUR-AGR, V11, P84, DOI 10.1016/j.gfs.2016.08.001; Shelestov A, 2017, FRONT EARTH SC-SWITZ, V5, P1, DOI 10.3389/feart.2017.00017; Smil V, 1999, BIOSCIENCE, V49, P299, DOI 10.2307/1313613; Sommer R, 2013, AGR ECOSYST ENVIRON, V178, P78, DOI 10.1016/j.agee.2013.06.011; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x; WALKER JW, 1985, J RANGE MANAGE, V38, P90, DOI 10.2307/3899343; Wang D, 2005, 20 INT GRASSL C DUBL; Webber B. L., 2015, Sheep & Goat Research Journal, V30, P18; Wesche K., 2012, EURASIAN STEPPES ECO, P3, DOI [10.1007/978-94-007-3886-7_1, DOI 10.1007/978-94-007-3886-7_]; Wint W., 2007, GRIDDED LIVESTOCK WO; Wirsenius, 2000, HUMAN USE LAND ORGAN; Wisskirchen K, 2013, GEOSCI MODEL DEV, V6, P1623, DOI 10.5194/gmd-6-1623-2013; Yan L, 2014, REMOTE SENS ENVIRON, V144, P42, DOI 10.1016/j.rse.2014.01.006; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zhazylbekov NA, 2008, NUTR LIVESTOCK POULT	86	17	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210051	10.1371/journal.pone.0210051	http://dx.doi.org/10.1371/journal.pone.0210051			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633752	Green Published, Green Accepted, gold			2022-12-26	WOS:000455485100013
J	Clark, B; Panzone, LA; Stewart, GB; Kyriazakis, I; Niemi, JK; Latvala, T; Tranter, R; Jones, P; Frewer, LJ				Clark, Beth; Panzone, Luca A.; Stewart, Gavin B.; Kyriazakis, Ilias; Niemi, Jarkko K.; Latvala, Terhi; Tranter, Richard; Jones, Philip; Frewer, Lynn J.			Consumer attitudes towards production diseases in intensive production systems	PLOS ONE			English	Article							FARM-ANIMAL WELFARE; RISK-FACTORS; PIG FARMERS; FOOD; CITIZENS; QUALITY; METAANALYSIS; WILLINGNESS; PREFERENCES; CONFIDENCE	Many members of the public and important stakeholders operating at the upper end of the food chain, may be unfamiliar with how food is produced, including within modern animal production systems. The intensification of production is becoming increasingly common in modern farming. However, intensive systems are particularly susceptible to production diseases, with potentially negative consequences for farm animal welfare (FAW). Previous research has demonstrated that the public are concerned about FAW, yet there has been little research into attitudes towards production diseases, and their approval of interventions to reduce these. This research explores the public's attitudes towards, and preferences for, FAW interventions in five European countries (Finland, Germany, Poland, Spain and the UK). An online survey was conducted for broilers (n = 789), layers (n = 790) and pigs (n = 751). Data were analysed by means of Kruskal-Wallis ANOVA, exploratory factor analysis and structural equation modelling. The results suggest that the public have concerns regarding intensive production systems, in relation to FAW, naturalness and the use of antibiotics. The most preferred interventions were the most "proactive" interventions, namely improved housing and hygiene measures. The least preferred interventions were medicine-based, which raised humane animal care and food safety concerns amongst respondents. The results highlighted the influence of the identified concerns, perceived risks and benefits on attitudes and subsequent behavioural intention, and the importance of supply chain stakeholders addressing these concerns in the subsequent communications with the public.	[Clark, Beth; Panzone, Luca A.; Stewart, Gavin B.; Kyriazakis, Ilias; Frewer, Lynn J.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Niemi, Jarkko K.; Latvala, Terhi] Nat Resources Inst Finland Luke, Seinajoki, Finland; [Tranter, Richard; Jones, Philip] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	Newcastle University - UK; Natural Resources Institute Finland (Luke); University of Reading	Frewer, LJ (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	lynn.frewer@newcastle.ac.uk	Niemi, Jarkko/ABG-8512-2020; Latvala, Terhi/D-9866-2013; Panzone, Luca/I-3086-2019; Clark, Beth/A-5561-2015	Niemi, Jarkko/0000-0002-9545-3509; Panzone, Luca/0000-0003-2382-3635; Latvala, Terhi/0000-0002-8855-7377; Jones, Philip/0000-0003-3464-5424; Clark, Beth/0000-0002-9828-6806; Kyriazakis, Ilias/0000-0001-7703-3626	European Union's Seventh Framework Programme for research, technological development and demonstration [613574]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 613574 to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Ajzen I., 2011, THEORY PLANNED BEHAV; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Asveld L, 2015, J AGR ENVIRON ETHIC, V28, P571, DOI 10.1007/s10806-015-9542-2; Bauman Z, 2014, INT POLIT SOCIOL, V8, P121, DOI 10.1111/ips.12048; Benard M, 2013, J AGR ENVIRON ETHIC, V26, P1015, DOI 10.1007/s10806-013-9438-y; Bengtsson B, 2014, UPSALA J MED SCI, V119, P96, DOI 10.3109/03009734.2014.901445; Bennett RM, 2012, VALUATION ANIMAL WEL; Bernard JC, 2009, AM J AGR ECON, V91, P826, DOI 10.1111/j.1467-8276.2009.01258.x; Boogaard BK, 2011, J AGR ENVIRON ETHIC, V24, P259, DOI 10.1007/s10806-010-9256-4; Breakwell GM, 2003, PUBLIC PERCEPTIONS A; Broom DM, 2010, J VET MED EDUC, V37, P83, DOI 10.3138/jvme.37.1.83; Byrne B. M, 2001, INT J TEST, V1, P327, DOI DOI 10.1080/15305058.2001.9669479; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Conti GO, 2015, FOOD CONTROL, V50, P937, DOI 10.1016/j.foodcont.2014.10.050; Contributors.s, 2016, SEMTOOLS US TOOLS ST; Corp I, 2011, IBM SPSS STAT WIND V; D'Eath RB, 2014, ANIMAL, V8, P1479, DOI 10.1017/S1751731114001359; Dawkins MS, 2017, ANIM PROD SCI, V57, P201, DOI 10.1071/AN15383; de Jonge J, 2008, APPETITE, V51, P311, DOI 10.1016/j.appet.2008.03.008; Department of Environment FaRA, 2017, AV INFL BIRD FLU WIN; European Commission, 2007, ATT EU CIT AN WELF; Evermann J, 2010, STRUCT EQU MODELING, V17, P677, DOI 10.1080/10705511.2010.510070; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fischer ARH, 2009, FOOD QUAL PREFER, V20, P576, DOI 10.1016/j.foodqual.2009.06.008; Food and Acriculture Organization of the United Nations Organization WH, 1998, APPL RISK COMM FOOD; Fraser D., 2005, ALTERNATIVE INTERPRE; Frewer L, 2004, TOXICOL LETT, V149, P391, DOI 10.1016/j.toxlet.2003.12.049; Frewer L., 2002, SCI PUBLIC POLICY, V29, P137, DOI DOI 10.3152/147154302781781092; GILBERT M, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0133381; Griffiths R., 2004, MEAT SCI, V66, P259, DOI [10.1016/S0309-1740(03)00130-X, DOI 10.1016/S0309-1740(03)00130-X]; Grunert KG, 2006, MEAT SCI, V74, P149, DOI 10.1016/j.meatsci.2006.04.016; Harper G., 2001, CONSUMER CONCERNS AN; High Level Panel of Experts on Food Security and Nutrition, 2016, SUST AGR DEV FOOD SE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudson JA, 2017, TRENDS FOOD SCI TECH, V69, P131, DOI 10.1016/j.tifs.2017.09.007; Hughes P, 2002, ANTIBIOTICS ANIMAL G; Jones P, 2016, LIST STAKEHOLDER PRE; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KilBride AL, 2012, PREV VET MED, V104, P281, DOI 10.1016/j.prevetmed.2011.11.011; Kirk SFL, 2002, APPETITE, V38, P189, DOI 10.1006/appe.2001.0478; Kjaernes U, 2007, FARM ANIMAL WELFARE; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Lassoued R, 2015, FOOD POLICY, V52, P99, DOI 10.1016/j.foodpol.2014.12.003; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lusk JL., 2007, CONSUMER PREFERENCES; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Miele M, 2011, ANIM WELFARE, V20, P103; Niemi J. K., 2016, Review of Agricultural, Food and Environmental Studies, V97, P215, DOI 10.1007/s41130-016-0022-5; Niemi JK, 2015, QUANTIFICATION COSTS; Nocella G, 2012, PSYCHOL MARKET, V29, P850, DOI 10.1002/mar.20569; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pandolfi F, 2017, PREV VET MED, V137, P1, DOI 10.1016/j.prevetmed.2016.12.005; Pandolfi F, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00041; Papadopoulos GA, 2010, VET J, V184, P167, DOI 10.1016/j.tvjl.2009.01.010; Perry BD, 2013, P NATL ACAD SCI USA, V110, P20871, DOI 10.1073/pnas.1012953108; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poinhos R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110614; Poortinga W, 2005, RISK ANAL, V25, P199, DOI 10.1111/j.0272-4332.2005.00579.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Rosseel Y., 2011, LAVAAN R PACKAGE STR; Scudamore JM, 2007, REV SCI TECH OIE, V26, P451, DOI 10.20506/rst.26.2.1755; Spooner JM, 2014, LIVEST SCI, V163, P150, DOI 10.1016/j.livsci.2014.02.011; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van Dijk H, 2011, RISK ANAL, V31, P429, DOI 10.1111/j.1539-6924.2010.01505.x; Van Kleef E, 2007, RISK ANAL, V27, P1565, DOI 10.1111/j.1539-6924.2007.00989.x; Vanhonacker F, 2010, J AGR ENVIRON ETHIC, V23, P551, DOI 10.1007/s10806-010-9235-9; Velde H. te, 2002, Journal of Agricultural & Environmental Ethics, V15, P203, DOI 10.1023/A:1015012403331; Verbeke W, 2010, MEAT SCI, V84, P284, DOI 10.1016/j.meatsci.2009.05.001; Willgert KJE, 2014, PREV VET MED, V113, P268, DOI 10.1016/j.prevetmed.2013.10.004; You KG, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5163-0; Zhong YQ, 2017, FOOD CONTROL, V73, P1532, DOI 10.1016/j.foodcont.2016.11.016; Zingg A, 2012, FOOD POLICY, V37, P226, DOI 10.1016/j.foodpol.2012.02.001	85	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210432	10.1371/journal.pone.0210432	http://dx.doi.org/10.1371/journal.pone.0210432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629667	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000455483000089
J	Fan, ZY; Liao, ZJ; Zong, XN; Zhang, SM				Fan, Zhaoyang; Liao, Zijun; Zong, Xinnan; Zhang, Shuaiming			Differences in prevalence of prehypertension and hypertension in children and adolescents in the eastern, central and western regions of China from 1991-2011 and the associated risk factors	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; BODY-MASS INDEX; WAIST CIRCUMFERENCE; PREDICTS HYPERTENSION; METABOLIC SYNDROME; NATIONAL-HEART; OBESE CHILDREN; TRENDS; OVERWEIGHT; HEIGHT	The present study aimed to estimate the differences in rates of prehypertension and hypertension in children and adolescents among three regions with different socioeconomic status in China, and explore the corresponding risk factors associated with prehypertension and hypertension to guide the prevention. Blood pressure measurements of 13 762 children and adolescents aged 6-17 years were obtained from a prospective national survey (the China Health and Nutrition Survey, 1991-2011). Prehypertension and hypertension were defined by age and gender, according to China's standard criteria. Chi-square tests were used to compare the differences in the prevalence of prehypertension and hypertension among three regions. Trend chi-square tests were used to detect the trends in rates of pre-hypertension and hypertension over survey years. Logistic regression models were used to detect the potential risk factors of prehypertension and hypertension in children and adolescents. During the survey years, the overall prevalence of prehypertension and hypertension were 6.0% and 10.6%. The corresponding rates in the western region were lowest, but increased rapidly over the two decades (84.0% and 122.6% increases respectively, P<0.001). The overall hypertension rate remained high in the eastern region, despite the slower increase (24.2% increase). In the central region, although the prehypertension rate remained stable, the rate of hypertension had a 94.8% increase these years (P<0.0001). According to the results of logistic regression, age, body mass index (BMI) and waist/height ratio (WHtR) were associated with prehypertension and hypertension. Children and adolescents in the eastern region had the highest level of prehypertension and hypertension, while the rapid increase of blood pressure in the western and central regions were also supposed to concern. Improvement of the healthy lifestyle is urgent for prehypertension and hypertension prevention in children and adolescents.	[Fan, Zhaoyang; Zhang, Shuaiming] Capital Inst Pediat, Dept Early Child Dev, Beijing, Peoples R China; [Liao, Zijun] Peking Univ, Inst Reprod & Child Hlth, Key Lab Reprod Hlth, Minist Hlth,Hlth Sci Ctr, Beijing, Peoples R China; [Liao, Zijun] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Zong, Xinnan] Capital Inst Pediat, Dept Growth, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Peking University; Peking University; Capital Institute of Pediatrics (CIP)	Fan, ZY (corresponding author), Capital Inst Pediat, Dept Early Child Dev, Beijing, Peoples R China.	fanzhaoyang@126.com						[Anonymous], CHIN J EVID BASED PE; Berenson GS, 1995, AM J MED SCI, V310, pS22, DOI 10.1097/00000441-199512000-00005; BLUMENTHAL S, 1977, PEDIATRICS, V59, P797; Chen C, 2018, CANCER BIOL THER, V19, P1065, DOI 10.1080/15384047.2018.1480291; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; CHNSs, CHIN HLTH NUTR SURV; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 1996, J PEDIATR-US, V129, P208, DOI 10.1016/S0022-3476(96)70244-5; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Dong B, 2013, AM J HYPERTENS, V26, P997, DOI 10.1093/ajh/hpt050; Fu JF, 2007, INT J OBESITY, V31, P15, DOI 10.1038/sj.ijo.0803453; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Hansen ML, 2007, JAMA-J AM MED ASSOC, V298, P874, DOI 10.1001/jama.298.8.874; Hu YH, 2011, J INT MED RES, V39, P23, DOI 10.1177/147323001103900103; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Leung LCK, 2011, ARCH DIS CHILD, V96, P804, DOI 10.1136/adc.2010.202770; Levine DA, 2013, STROKE, V44, P3243, DOI 10.1161/STROKEAHA.113.003051; Li YC, 2017, INT J CARDIOL, V227, P516, DOI 10.1016/j.ijcard.2016.10.110; Liang YJ, 2011, BLOOD PRESSURE, V20, P45, DOI 10.3109/08037051.2010.524085; Lu X, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-24; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Muntner P, 2004, JAMA-J AM MED ASSOC, V291, P2107, DOI 10.1001/jama.291.17.2107; POPKIN BM, 1995, OBES RES, V3, pS135, DOI 10.1002/j.1550-8528.1995.tb00456.x; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Tareque MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127954; Wan YP, 2009, WORLD J PEDIATR, V5, P269, DOI 10.1007/s12519-009-0051-0; Wen M, 2016, J BIOSOC SCI, V48, P129, DOI 10.1017/S002193201500005X; Willig AL, 2010, AM J HYPERTENS, V23, P904, DOI 10.1038/ajh.2010.82; Xu HQ, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/987159; Yan WL, 2015, ETHNIC HEALTH, V20, P365, DOI 10.1080/13557858.2014.921894; Yan WL, 2016, J HYPERTENS, V34, P2337, DOI 10.1097/HJH.0000000000001114; Yan WL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-195; Yao SJ, 2001, J DEV STUD, V38, P167, DOI 10.1080/00220380412331322301; Yiannikouris F, 2010, CURR OPIN NEPHROL HY, V19, P195, DOI 10.1097/MNH.0b013e3283366cd0	39	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210591	10.1371/journal.pone.0210591	http://dx.doi.org/10.1371/journal.pone.0210591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629671	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000114
J	Goshu, YA; Yitayew, AE				Goshu, Yitayal Ayalew; Yitayew, Azeb Ewinetu			Malaria knowledge and its associated factors among pregnant women attending antenatal clinic of Adis Zemen Hospital, North-western Ethiopia, 2018	PLOS ONE			English	Article								Introduction In Ethiopia, the burden of malaria during pregnancy remains a public health problem. Having a good malaria knowledge leads to practicing the prevention of malaria and seeking a health care. Researches regarding pregnant women's knowledge on malaria in Ethiopia is limited. So the aim of this study was to assess malaria knowledge and its associated factors among pregnant woman, 2018. Methods An institutional-basedcross-sectional study was conducted in Adis Zemen Hospital. Data were collected using pre-tested, an interviewer-administered structured questionnaire among 236 mothers. Women's knowledge on malaria was measured using six malariarelated questions (cause of malaria, mode of transmission, signs and symptoms, complication and prevention of malaria). The collected data were entered using Epidata version 3.1 and exported to SPSS version 20 for analysis. Bivariate and multivariate logistic regressions were computed to identify predictor variables at 95% confidence interval. Variables having P value of < 0.05 were considered as predictor variables of malaria knowledge. Result A total of 235 pregnant women participated which makes the response rate 99.6%. One hundred seventy two pregnant women (73.2%) of mothers had good knowledge on malaria. Women who were from urban (AOR; 2.4: CI; 1.8, 5.7), had better family monthly income (AOR; 3.4: CI; 2.7, 3.8), attended education (AOR; 1.8: CI; 1.4, 3.5) were more knowledgeable. Conclusion and recommendation Majority of participants had good knowledge on malaria. Educational status, household monthly income and residence werepredictors of malaria knowledge. Increasing women's knowledge especially for those who are from rural, have no education, and have low monthly income is still needed.	[Goshu, Yitayal Ayalew; Yitayew, Azeb Ewinetu] Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre, Tabor, Ethiopia		Goshu, YA; Yitayew, AE (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre, Tabor, Ethiopia.	ayalewyitayal@gmail.com; yitayal@ymail.com	Goshu, Yitayal Ayalew/J-7479-2019	Goshu, Yitayal Ayalew/0000-0002-3760-4903				Aguzie ION, 2018, CLIN MOTHER CHILD HL, V15, P1; Akaba GO, 2013, NIGER J CLIN PRACT, V16, P201, DOI 10.4103/1119-3077.110162; Assefa Y, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000318; Ayiisi AE, 2017, SCI J PUBLIC HLTH, V5, P254, DOI [10.11648/j.sjph.20170503.24, DOI 10.11648/J.SJPH.20170503.24]; Beyene B.H., 2015, SCI J PUBLIC HLTH, V3, P303, DOI 10.11648/j.sjph.20150303.11; Central Statistical Agency, 2018, NAT SURV; Centre for Disease Prevention and Control, 2017, CDC MAL PROGR; Centre for disease prevention and control, 2018, CDC AB MAL; De Beaudrap P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-139; Dombrowski JG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199415; EDHS, 2016, EDHS ETH MIN HLTH SU; Emmanuela E.A., 2011, TANZANIA J HLTH RES, V13; Fuge TG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0755-7; Geremew M., 2016, J TROP DIS, V4, P217, DOI [10.4172/2329-891X.1000217, DOI 10.4172/2329-891X.1000217]; Hamza TAAN., 2017, AM J BIOSCIENCE, V5, P80, DOI 10.11648/j.ajbio.20170505.12; Henok A, 2015, HLTH SCI J, V10, P1; Jimee H, 2007, PLOS ONE, V5, DOI [10.1371/journal.pone.0011692, DOI 10.1371/JOURNAL.PONE.0011692]; Kimbi HK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-883; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Masaad TTM, 2017, SCI J CLIN MED, V6, P24, DOI [10.11648/j.sjcm.20170602.11, DOI 10.11648/J.SJCM.20170602.11]; Nega D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123630; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Obol James, 2011, Malar Res Treat, V2011, P107987, DOI 10.4061/2011/107987; Ojong IN, 2013, HAMDARD MED, V56; Omaka-Omari LN, 2015, RES HUMANIT SOC SCI, V5, P10; Omer SA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2028-0; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; van Eijk AM, 2015, LANCET GLOB HEALTH, V3, pE617, DOI 10.1016/S2214-109X(15)00049-2; World Health Organisation (WHO), 2017, NEED PREV MOSQ BIT U; World Health Organization, 2018, WORLD MAL FACT; World Health Organization, 2017, DEPRESSION; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180508; 2011, WORLD MAL REP 2011, P1	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210221	10.1371/journal.pone.0210221	http://dx.doi.org/10.1371/journal.pone.0210221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629651	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000063
J	Liu, M; Yang, Y; Xie, F; Guo, JG; Wang, SY; Yang, HP; Wang, S				Liu, Miao; Yang, Yang; Xie, Fei; Guo, Jiagia; Wang, Siyuan; Yang, Houpu; Wang, Shu			Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SENTINEL LYMPH-NODE; DISSECTION; ULTRASONOGRAPHY; CYTOLOGY; TRIAL; METASTASIS; MANAGEMENT; NOMOGRAM; UTILITY	Background and objectives The role of ultrasound (US) guided biopsy in selecting patients for an upfront lymph node dissection (ALND) has been controversial following the publication of the American College of Surgeons (ACOSOG) Z0011 data. The purpose of this study was to investigate if patients with positive axillary lymph nodes (LNs) proven by US guided biopsy should be recommended for ALND and to analyze the utility of preoperative US and US guided biopsy in planning axillary surgery to avoid both unnecessary ALND and unnecessary SLNB. Methods Patients with a positive preoperative LN biopsy were identified and evaluated to determine their suitability for inclusion according to the criteria proposed in the Z0011 data. The correlation of the number of suspicious nodes found using US with the number of positive nodes on ALND was studied. Results A total of 261 breast cancer patients who had a positive preoperative LN needle biopsy were identified, among them, 79 patients with cT1-2N0 breast cancer and ALND were enrolled in the study. Thirty-one patients (39.2%) had <= 2 positive nodes identified in pathology and 10 patients (12.7%) met all of the Z0011 criteria and might have been spared ALND. A significantly greater proportion of women with. 3 positive nodes during ALND had > 1 abnormal LN identified using US compared to women with <= 2 positive LNs found using ALND (66.7% vs. 6.5%, p<0.0001). Conclusion US with needle biopsy is valuable to patients with multiple suspicious nodes found using US while SLND without US guided needle biopsy is suggested if only one abnormal LN is detected on US in the post-Z0011 era.	[Liu, Miao; Yang, Yang; Xie, Fei; Guo, Jiagia; Wang, Siyuan; Yang, Houpu; Wang, Shu] Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China	Peking University	Wang, S (corresponding author), Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China.	shuwang@pkuph.edu.cn						Aigner J, 2013, ANN SURG ONCOL, V20, P1538, DOI 10.1245/s10434-012-2798-0; Baruah BP, 2010, BRIT J SURG, V97, P680, DOI 10.1002/bjs.6964; Boland MR, 2015, EJSO-EUR J SURG ONC, V41, P559, DOI 10.1016/j.ejso.2015.01.011; Bonnema J, 1997, WORLD J SURG, V21, P270, DOI 10.1007/s002689900227; Boughey JC, 2010, ANN SURG ONCOL, V17, P953, DOI 10.1245/s10434-010-0919-1; Caretta-Weyer H, 2012, AM J SURG, V204, P308, DOI 10.1016/j.amjsurg.2011.10.016; Caudle AS, 2014, ANN SURG ONCOL, V21, P3440, DOI 10.1245/s10434-014-3813-4; Choi JJ, 2011, J ULTRAS MED, V30, P429, DOI 10.7863/jum.2011.30.4.429; Delpech Y, 2013, ANN SURG ONCOL, V20, P2556, DOI 10.1245/s10434-013-2917-6; Dengel LT, 2014, ANN SURG ONCOL, V21, P22, DOI 10.1245/s10434-013-3200-6; Diepstraten SCE, 2014, ANN SURG ONCOL, V21, P51, DOI 10.1245/s10434-013-3229-6; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hieken TJ, 2013, SURGERY, V154, P831, DOI 10.1016/j.surg.2013.07.017; Houssami N, 2011, ANN SURG, V254, P243, DOI 10.1097/SLA.0b013e31821f1564; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Kwak HY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-104; Lee MC, 2011, ANN SURG ONCOL, V18, P72, DOI 10.1245/s10434-010-1171-4; Leenders MWH, 2012, BREAST, V21, P578, DOI 10.1016/j.breast.2012.05.008; Liu M, 2011, ZHONGHUA PU TONG WAI, V26, P25; Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15241; Mittendorf EA, 2012, ANN SURG, V255, P109, DOI 10.1097/SLA.0b013e318238f461; National Comprehensive Cancer Network (NCCN), 2012, CLIN PRACT GUID ONC; Ngui NK, 2013, ANZ J SURG, V83, P924, DOI 10.1111/ans.12388; Pilewskie M, 2016, ANN SURG ONCOL, V23, P1123, DOI 10.1245/s10434-015-4944-y; Posther KE, 2005, ANN SURG, V242, P593, DOI 10.1097/01.sla.0000184210.68646.77; Sahoo S, 2007, AM J SURG, V194, P524, DOI 10.1016/j.amjsurg.2007.07.006; Sever A, 2009, BRIT J SURG, V96, P1295, DOI 10.1002/bjs.6725; Solon JG, 2012, J AM COLL SURGEONS, V214, P12, DOI 10.1016/j.jamcollsurg.2011.09.024; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Verbanck J, 1997, J CLIN ULTRASOUND, V25, P53, DOI 10.1002/(SICI)1097-0096(199702)25:2<53::AID-JCU1>3.0.CO;2-I; Verheuvel NC, 2015, ANN SURG ONCOL, V22, P409, DOI 10.1245/s10434-014-4071-1; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782	33	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210437	10.1371/journal.pone.0210437	http://dx.doi.org/10.1371/journal.pone.0210437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629686	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000091
J	Niazi, RK; Sun, JH; Have, CT; Hollensted, M; Linneberg, A; Pedersen, O; Nielsen, JS; Rungby, J; Grarup, N; Hansen, T; Gjesing, AP				Niazi, Robina Khan; Sun, Jihua; Have, Christian Theil; Hollensted, Mette; Linneberg, Allan; Pedersen, Oluf; Nielsen, Jens Steen; Rungby, Jorgen; Grarup, Niels; Hansen, Torben; Gjesing, Anette Prior			Increased frequency of rare missense PPP1R3B variants among Danish patients with type 2 diabetes	PLOS ONE			English	Article							GLYCOGEN-TARGETING SUBUNIT; GLYCEMIC TRAITS; POPULATION; IDENTIFICATION; ASSOCIATION; PREGNANCY; MELLITUS; LOCUS; GENE	Background PPP1R3B has been suggested as a candidate gene for monogenic forms of diabetes as well as type 2 diabetes (T2D) due to its association with glycaemic trait and its biological role in glycogen synthesis. Objectives To study if rare missense variants in PPP1R3B increase the risk of maturity onset diabetes of the young (MODY), T2D or affect measures of glucose metabolism. Method Targeted resequencing of PPP1R3B was performed in 8,710 samples; MODY patients with unknown etiology (n = 54), newly diagnosed patients with T2D (n = 2,930) and population-based control individuals (n = 5,726, of whom n = 4,569 had normal glucose tolerance). All population-based sampled individuals were examined using an oral glucose tolerance test. Results Among n = 396 carriers, we identified twenty-three PPP1R3B missense mutations, none of which segregated with MODY. The burden of likely deleterious PPP1R3B variants was significantly increased with a total of 17 carriers among patients with T2D (0.58% (95% CI: 0.36-0.93)) compared to 18 carriers among non-diabetic individuals (0.31% (95% CI: 0.20-0.49)), resulting in an increased risk of T2D (OR (95% CI) = 2.57 (1.14-5.79), p = 0.02 (age and sex adjusted)). Furthermore, carriers with diabetes had less abdominal fat and a higher serum concentration of LDL-cholesterol compared to patients with T2D without rare missense PPP1R3B variants. In addition, non-diabetic carriers had a higher birth weight compared to non-carriers. Conclusion Rare missense PPP1R3B variants may predispose to T2D.	[Niazi, Robina Khan] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad, Pakistan; [Sun, Jihua] BGI Europe, Copenhagen, Denmark; [Have, Christian Theil; Hollensted, Mette; Pedersen, Oluf; Grarup, Niels; Hansen, Torben; Gjesing, Anette Prior] Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Linneberg, Allan] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Nielsen, Jens Steen] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Nielsen, Jens Steen; Rungby, Jorgen] Odense Univ Hosp, SDCO, DD2, Odense, Denmark; [Rungby, Jorgen] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark	International Islamic University, Pakistan; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital	Gjesing, AP (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	anette.gjesing@sund.ku.dk	Rungby, Jørgen/AAQ-4332-2021; Gjesing, Anette/ACC-7521-2022; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Nielsen, Jens Steen/N-5218-2018	Gjesing, Anette/0000-0003-4580-1576; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Hollensted, Mette/0000-0001-5572-3183; Linneberg, Allan/0000-0002-0994-0184; Nielsen, Jens Steen/0000-0003-3179-1186	European Union [667191]; Steno Diabetes Center; Danish Diabetes Academy; Danish Medical Research Council; European Novo Nordisk Foundation [NNF15CC0018486]; Danish Diabetes Association; Danish Agency for Science [09-067009, 09-075724]; BGI	European Union(European Commission); Steno Diabetes Center; Danish Diabetes Academy; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Novo Nordisk Foundation; Danish Diabetes Association; Danish Agency for Science; BGI	This project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 667191 (authors awarded: APG, NG and TH). In addition, the study was supported from the Steno Diabetes Center, the Danish Diabetes Academy, the Danish Medical Research Council, the European Novo Nordisk Foundation (Immunometabolism, NNF15CC0018486) and the Danish Diabetes Association. The DD2 cohort was funded by the Danish Agency for Science (grant no. 09-067009 and 09-075724) (authors awarded: JSN and JR). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). The BGI provided support in the form of salaries for author [JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dunn JS, 2006, ANN HUM GENET, V70, P587, DOI 10.1111/j.1469-1809.2005.00248.x; Gao R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-13; Gedebjerg A, 2018, J DIABETES COMPLICAT, V32, P34, DOI 10.1016/j.jdiacomp.2017.09.010; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hayes MG, 2013, DIABETES, V62, P3282, DOI 10.2337/db12-1692; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kim SH, 2004, DIABETES, V53, P1375, DOI 10.2337/diabetes.53.5.1375; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lau C, 2011, DIABETES METAB, V37, P546, DOI 10.1016/j.diabet.2011.06.001; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mehta MB, 2017, J BIOL CHEM, V292, P10444, DOI 10.1074/jbc.M116.766329; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; Munro S, 2002, DIABETES, V51, P591, DOI 10.2337/diabetes.51.3.591; Pezzolesi MG, 2004, DIABETES, V53, P486, DOI 10.2337/diabetes.53.2.486; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang K, 2010, NUCL ACIDS RES, V38; World Health Organization, 1999, WHO DIAGN CLASS DI 1; Zhan XW, 2016, BIOINFORMATICS, V32, P1423, DOI 10.1093/bioinformatics/btw079; Zibrova D, 2008, BIOCHEM J, V412, P359, DOI 10.1042/BJ20071483	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210114	10.1371/journal.pone.0210114	http://dx.doi.org/10.1371/journal.pone.0210114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629617	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000051
J	McGivern, RF; Mosso, M; Freudenberg, A; Handa, RJ				McGivern, Robert F.; Mosso, Matthew; Freudenberg, Adam; Handa, Robert J.			Sex related biases for attending to object color versus object position are reflected in reaction time and accuracy	PLOS ONE			English	Article							GENDER-DIFFERENCES; MENTAL ROTATION; TOY PREFERENCES; JOINT ATTENTION; MEMORY; TASK; CHILDHOOD; PARALLEL; HORMONES; INFANTS	Processing of visual features related to objects and space relations occurs within separate cortical streams that interact with selective attention. Such separation has implications for cognitive development because the perception of 'what' and 'where' provide a neural foundation for the development of aspects of higher cognition. Thus, a small attentional bias in early development for attending to one aspect over the other might influence subsequent higher cognitive processing in tasks involving object recognition and space relations. We examined 134 men and women for evidence of an inherent sex-related bias for attending to basic perceptual features related to object discrimination versus object position. Each stimulus consisted of a circle located in one of 9 positions within a surrounding frame. Circles were one of three shades of blue or red. These stimuli were used in a match-to-sample paradigm where participants were required to match circles on the basis of color or spatial position. The first stimulus appeared in the center of the screen for 400 msec and the matching stimulus subsequently appeared for 400 msec oriented 5 degrees to the right or left of center. The same stimuli were used to test the perception of color and position, with order of testing counterbalanced across participants. Results showed significantly longer reaction times in females compared with males, with better accuracy to discriminate color when that color was tested before position. Males showed better accuracy when object position was tested before color discrimination. A second experiment employed the same procedure, but enhanced selective attention by adding an endogenous cue that predicted the right or left location for the appearance of the matching stimulus. This manipulation greatly attenuated the sex differences in reaction time and accuracy compared to Experiment 1, suggesting that the sex-related attentional biases are strongly coupled to bottom-up processing. Overall, the sex related attentional biases toward processing object characteristics versus object position location suggest a differential manifestation of biased competition between the weighted systems of dorsal and ventral stream processing. Results are discussed with how a developmental bias in the processing objects versus space relations may contribute to adult cognitive sex differences in humans and animals.	[McGivern, Robert F.; Mosso, Matthew; Freudenberg, Adam] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Handa, Robert J.] Colorado State Univ, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA	California State University System; San Diego State University; Colorado State University	McGivern, RF (corresponding author), San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.	rmcgivern@sdsu.edu						Alexander GM, 2009, ARCH SEX BEHAV, V38, P427, DOI 10.1007/s10508-008-9430-1; Alexander GM, 2003, ARCH SEX BEHAV, V32, P7, DOI 10.1023/A:1021833110722; Alexander GM, 2002, EVOL HUM BEHAV, V23, P467, DOI 10.1016/S1090-5138(02)00107-1; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; BERENBAUM SA, 1992, PSYCHOL SCI, V3, P203, DOI 10.1111/j.1467-9280.1992.tb00028.x; Bomyea J., 2017, PSYCHOPATHOL REV, V4, P218, DOI [10.5127/pr.037214, DOI 10.5127/PR.037214, 10.3389/fnint.2012.00089, DOI 10.3389/FNINT.2012.00089]; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; Capraro V, 2017, COGN PROCESS, V18, P399, DOI 10.1007/s10339-017-0822-9; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Connellan J, 2000, INFANT BEHAV DEV, V23, P113, DOI 10.1016/S0163-6383(00)00032-1; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Desimone R, 2005, ANNU REV NEUROSCI, V18, P193, DOI [10.1080/17470210903464253, DOI 10.1080/17470210903464253]; Dobkins KR, 2009, J VISION, V9, DOI 10.1167/9.10.19; EISENBERG N, 1982, CHILD DEV, V53, P81, DOI 10.2307/1129639; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Freud E, 2018, J COGNITIVE NEUROSCI, V30, P1047, DOI 10.1162/jocn_a_01262; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Gilligan C., 1982, A DIFFERENT VOICE; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Guillem F, 2005, BRAIN COGNITION, V57, P84, DOI 10.1016/j.bandc.2004.08.026; Gur RC, 1999, J NEUROSCI, V19, P4065; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hamilton C., 2008, COGNITION SEX DIFFER; Handa RJ, 2015, CURR EYE RES, V40, P110, DOI 10.3109/02713683.2014.952826; Hassett JM, 2008, HORM BEHAV, V54, P359, DOI 10.1016/j.yhbeh.2008.03.008; Hausmann M, 2009, PSYCHONEUROENDOCRINO, V34, P389, DOI 10.1016/j.psyneuen.2008.09.019; Hoffman ML., 2008, HDB EMOTIONS, P440; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Johnson MH, 2011, DEV COGN NEUROS-NETH, V1, P7, DOI 10.1016/j.dcn.2010.07.003; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Kravitz DJ, 2011, ATTEN PERCEPT PSYCHO, V73, P2434, DOI 10.3758/s13414-011-0201-z; Le S, 2002, BRAIN, V125, P58, DOI 10.1093/brain/awf004; Levine SC, 1999, DEV PSYCHOL, V35, P940, DOI 10.1037/0012-1649.35.4.940; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Martinez-Trujillo JC, 2014, NEW VISUAL NEUROSCIENCES, P1107; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McGivern RF, 1998, PERS INDIV DIFFER, V25, P223, DOI 10.1016/S0191-8869(98)00017-8; McGivern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032238; Melloni L, 2012, CEREB CORTEX, V22, P2943, DOI 10.1093/cercor/bhr384; Merritt P, 2007, PERS INDIV DIFFER, V43, P597, DOI 10.1016/j.paid.2007.01.016; Milner AD, 2017, EXP BRAIN RES, V235, P1297, DOI 10.1007/s00221-017-4917-4; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Mundy P, 2007, CHILD DEV, V78, P938, DOI 10.1111/j.1467-8624.2007.01042.x; Neuhaus AH, 2009, HUM BRAIN MAPP, V30, P2997, DOI 10.1002/hbm.20724; Olafsen KS, 2006, INFANT BEHAV DEV, V29, P554, DOI 10.1016/j.infbeh.2006.07.004; Perry CJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00084; Pletzer B, 2017, PHYSIOL BEHAV, V179, P384, DOI 10.1016/j.physbeh.2017.07.012; Pruden SM, 2011, DEVELOPMENTAL SCI, V14, P1417, DOI 10.1111/j.1467-7687.2011.01088.x; RIZZOLATTI G, 2006, 23 PROBLEMS SYSTEMS, P367; Schultheiss OC, 2012, BRAIN COGNITION, V80, P214, DOI 10.1016/j.bandc.2012.07.001; Stoet G, 2017, PSYCHOL RES-PSYCH FO, V81, P571, DOI 10.1007/s00426-016-0763-4; Stoet G, 2010, Q J EXP PSYCHOL, V63, P633, DOI 10.1080/17470210903464253; Stuijfzand S, 2016, SEX ROLES, V75, P434, DOI 10.1007/s11199-016-0649-3; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vallortigara G, 1996, BEHAV PROCESS, V36, P289, DOI 10.1016/0376-6357(95)00063-1; Voyer D, 2007, PSYCHON B REV, V14, P23, DOI 10.3758/BF03194024; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Wilcox T, 2012, DEV PSYCHOL, V48, P1091, DOI 10.1037/a0026529; Zeki S, 2016, EUR J NEUROSCI, V44, P2515, DOI 10.1111/ejn.13270	62	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210272	10.1371/journal.pone.0210272	http://dx.doi.org/10.1371/journal.pone.0210272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625223	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400081
J	Prates, P; Moreira, BC; da Silva, MDS; Veloso, TGR; Sturmer, SL; Fernandes, RBA; Mendonca, ED; Kasuya, MCM				Prates Junior, Paulo; Moreira, Bruno Coutinho; Soares da Silva, Marliane de Cassia; Reis Veloso, Tomas Gomes; Sturmer, Sidney Luiz; Alves Fernandes, Raphael Braganca; Mendonca, Eduardo de Sa; Megumi Kasuya, Maria Catarina			Agroecological coffee management increases arbuscular mycorrhizal fungi diversity	PLOS ONE			English	Article							COMMUNITY STRUCTURE; RAIN-FOREST; SPORES; SOIL; AGROFORESTRY; ABUNDANCE; SYSTEMS; ARABICA; ROOTS; COLONIZATION	Agroecology aims to maintain ecosystem services by minimizing the impact of agriculture and promoting the use of biological potential. Arbuscular mycorrhizal fungi (AMF) are elements which are key to improving crop productivity and soil quality. It is pertinent to understand how agricultural management in the tropics affects the AMF spatio-temporal community composition, especially in crops of global importance, such as coffee (Coffea arabica L.). Soil and root samples were collected from three localities under three management systems (agroecological, conventional and forest fragment), during the phenological stages of coffee (flowering, grain filling, harvesting). Spores were extracted for morphological identification and molecular community analysis by PCR-DGGE. Dendrograms were prepared and the bands were sequenced and analyzed by bioinformatics. No differences were observed in the richness of morphospecies between management systems, localities and period, but little is known about tropical species. Molecular analysis showed that the agroecological management system was similar to natural forest and with a higher diversity indices than conventional management. Locality and period of sample affect AMF community composition. It is necessary to associate classical taxonomic evaluations with molecular biological techniques because different approaches can lead to different outcomes. This study contributes to the understanding of the impact of agriculture management systems on AMF and provides evidence that agroecology is a management system applicable to sustainable coffee production.	[Prates Junior, Paulo; Soares da Silva, Marliane de Cassia; Reis Veloso, Tomas Gomes; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Moreira, Bruno Coutinho] Univ Fed Vale Sao Francisco, Colegiado Engn Agron, Petrolina, PE, Brazil; [Sturmer, Sidney Luiz] Univ Reg Blumenau, Dept Ciencias Nat, Blumenau, SC, Brazil; [Alves Fernandes, Raphael Braganca] Univ Fed Vicosa, Dept Solos, Vicosa, MG, Brazil; [Mendonca, Eduardo de Sa] Univ Fed Espirito Santo, Dept Prod Vegetal, Alegre, ES, Brazil	Universidade Federal de Vicosa; Universidade Federal do Vale do Sao Francisco; Universidade Regional de Blumenau (FURB); Universidade Federal de Vicosa; Universidade Federal do Espirito Santo	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	Moreira, Bruno C/H-8516-2018; Stürmer, Sidney/O-2616-2019; de Cássia S da Silva, Marliane/G-4068-2012; Stürmer, Sidney L/B-6593-2014; Kasuya, Maria Catarina Megumi/E-1123-2013; Fernandes, Raphael B. A./A-1709-2009	de Cássia S da Silva, Marliane/0000-0003-4678-7876; Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; Fernandes, Raphael B. A./0000-0002-8611-1355; Sturmer, Sidney/0000-0003-3213-1841; Prates Junior, Paulo/0000-0003-1027-6150; Moreira, Bruno Coutinho/0000-0002-6290-9282; MENDONCA, EDUARDO/0000-0003-3284-7129	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CNPq [309.163/2015-3]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was performed by Brazilian Research Agencies: CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), and Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais). SLS thanks CNPq for a Research Assistantship (Grant 309.163/2015-3).	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Altieri MA, 2015, AGRON SUSTAIN DEV, V35, P869, DOI 10.1007/s13593-015-0285-2; Alvarez VH, 2000, B INFORM, P27; Alves EP, 2015, CIENC AGROTEC, V39, P232, DOI 10.1590/S1413-70542015000300004; Andrade SAL, 2009, J AGR SCI-CAMBRIDGE, V147, P105, DOI 10.1017/S0021859608008344; Bainard LD, 2011, PEDOBIOLOGIA, V54, P57, DOI 10.1016/j.pedobi.2010.11.001; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Bhattacharya S, 2002, BIOL AGRIC HORTIC, V20, P125, DOI 10.1080/01448765.2002.9754956; Bonfim Joice Andrade, 2010, Bragantia, V69, P201, DOI 10.1590/S0006-87052010000100025; Brundrett M, 1996, WORKING MYCORRHIZAS; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Cardoso IM, 2003, AGROFOREST SYST, V58, P33, DOI 10.1023/A:1025479017393; Cardoso IM, 2001, AGR SYST, V69, P235, DOI 10.1016/S0308-521X(01)00028-2; Cardoso IM, 2006, AGR ECOSYST ENVIRON, V116, P72, DOI 10.1016/j.agee.2006.03.011; Cogo FD, 2017, ARBUSCULAR MYCORRHIZ, DOI [10.1016/j.soilbio.2015.08.037, DOI 10.1016/J.SOILBIO.2015.08.037]; CONAB, 2016, AC SAFR BRAS, P68; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; De Beenhouwer M, 2015, SOIL BIOL BIOCHEM, V91, P133, DOI 10.1016/j.soilbio.2015.08.037; De Beenhouwer M, 2015, AGRON SUSTAIN DEV, V35, P241, DOI 10.1007/s13593-014-0231-8; de Souza HN, 2012, AGROFOREST SYST, V85, P247, DOI 10.1007/s10457-012-9498-4; Defelipo B.V., 1997, ANALISE QUIMICA SOLO; Dobo B, 2018, AGROFOREST SYST, V92, P525, DOI 10.1007/s10457-016-0042-9; Douds DD, 1999, AGR ECOSYST ENVIRON, V74, P77, DOI 10.1016/S0167-8809(99)00031-6; Duru M, 2015, AGRON SUSTAIN DEV, V35, P1237, DOI 10.1007/s13593-015-0318-x; EMBRAPA, 2011, MAN MET AN SOL, V2nd; Fernandes RA, 2016, CAN J SOIL SCI, V96, P271, DOI 10.1139/cjss-2015-0011; Fitter A, 2012, NEW PHYTOL, V193, P1, DOI 10.1111/j.1469-8137.2011.03995.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gliessman S. R., 2014, AGROECOLOGY ECOLOGY; Guadarrama P, 1999, MYCORRHIZA, V8, P267, DOI 10.1007/s005720050244; Hart MM, 2015, NEW PHYTOL, V207, P235, DOI 10.1111/nph.13340; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Posada RH, 2018, AGROFOREST SYST, V92, P555, DOI 10.1007/s10457-016-0030-0; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Johnson NC, 1993, CAN FERTILIZATION SO, P749, DOI [10.2307/1942106, DOI 10.2307/1942106]; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kahiluoto H, 2012, PLANT SOIL, V350, P85, DOI 10.1007/s11104-011-0884-x; Koorem K, 2017, PLANT SOIL, V410, P259, DOI 10.1007/s11104-016-3004-0; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Ma WK, 2005, SOIL BIOL BIOCHEM, V37, P1589, DOI 10.1016/j.soilbio.2005.01.020; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Arias RM, 2012, AGROFOREST SYST, V85, P179, DOI 10.1007/s10457-011-9414-3; Muleta D, 2008, BIOL FERT SOILS, V44, P653, DOI 10.1007/s00374-007-0261-3; Muleta D, 2007, FOREST ECOL MANAG, V241, P145, DOI 10.1016/j.foreco.2007.01.021; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Opik M, 2016, SCIENCE, V351, DOI 10.1126/science.aad5495; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Siqueira JO, 1998, MYCORRHIZA, V7, P293, DOI 10.1007/s005720050195; Smith FA, 2011, PLANT SOIL, V348, P63, DOI 10.1007/s11104-011-0865-0; Smith SE, 2011, PLANT PHYSIOL, V156, P1050, DOI 10.1104/pp.111.174581; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P191, DOI 10.1016/B978-012370526-6.50008-8; Soteras F, 2016, APPL SOIL ECOL, V98, P272, DOI 10.1016/j.apsoil.2015.09.003; Staddon PL, 2003, GLOBAL CHANGE BIOL, V9, P186, DOI 10.1046/j.1365-2486.2003.00593.x; Tchabi A, 2008, MYCORRHIZA, V18, P181, DOI 10.1007/s00572-008-0171-8; Vaast P, 1996, MYCORRHIZA, V6, P493, DOI 10.1007/s005720050153; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Heijden MGA, 2015, NEW PHYTOL, V205, P1406, DOI 10.1111/nph.13288; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; Wetzel K, 2014, SOIL BIOL BIOCHEM, V72, P88, DOI 10.1016/j.soilbio.2014.01.033; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Zangaro W, 2013, MYCORRHIZA, V23, P221, DOI 10.1007/s00572-012-0464-9	71	29	30	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0209093	10.1371/journal.pone.0209093	http://dx.doi.org/10.1371/journal.pone.0209093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620745	Green Published, gold, Green Submitted			2022-12-26	WOS:000455161300005
J	Hong, SH				Hong, Song Hee			Potential for physician communication to build favorable medication beliefs among older adults with hypertension: A cross-sectional survey	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; CLINICAL-OUTCOMES; ADHERENCE; POLYPHARMACY; MEDICINES; GENDER; SEX	Older adults suffering from hypertension form firm medication beliefs through lifetime medication management, which significantly affect their medication adherence and treatment outcomes. Understanding whether the patient-physician communication has the potential to change medication beliefs will help design an effective communication strategy to foster favorable medication beliefs. This study aims to determine whether the patient-physician communication is associated with medication beliefs among older adults with hypertension and controls socio-demographics and clinical characteristics. Further, it examines how the association varies with two different types of medication beliefs (medication overuse and harm) for each domain of communication (informative and interpersonal). A self-administered cross-sectional survey was conducted for members of seven senior centers in a metropolitan area of the United States between August and December of 2013. A total of 211 senior members suffering from hypertension completed the questionnaire, which included the Primary Care Assessment Survey (PCAS) and the Beliefs about Medicines Questionnaire (BMQ). The former had two domains of patient-physician communication-informative and interpersonal while the latter measured medication harm and overuse beliefs. Interpersonal patient-physician communication significantly explained the medication overuse beliefs (beta = -0.28, p < 0.05), whereas neither interpersonal nor informative communication significantly explained the medication harm beliefs. Females (beta = 1.29, p < 0.01) and participants with higher education (beta = 2.66, p = 0.02) more strongly believed that medications are overprescribed. However, participants with low income more strongly believed that medications are harmful. Patient-physician communication, if it touches upon interpersonal aspects, has the potential to change medication overuse beliefs among older adults with hypertension. Identification of the significant factors which affect medication beliefs, will inform the design of a patient-centric communication program that fosters favorable medication beliefs among geriatric hypertensive patients.	[Hong, Song Hee] Seoul Natl Univ, Coll Pharm, Social & Adm Pharm, Seoul, South Korea; [Hong, Song Hee] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hong, SH (corresponding author), Seoul Natl Univ, Coll Pharm, Social & Adm Pharm, Seoul, South Korea.; Hong, SH (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea.	songhhong@snu.ac.kr						AlRuthia YS H S, 2015, GERIATRIC NURSING, pS0197; Brandstetter S, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0175-6; Carmen DeNavas-Walt BDP, 2015, INCOME POVERTY US 20; Council GM, 2013, PERS BEL MED PRACT; Dagli Rushabh J, 2014, J Int Oral Health, V6, pi; Donaldson M, 1994, DEFINING PRIMARY CAR; Dyche L, 2007, J GEN INTERN MED, V22, P1035, DOI 10.1007/s11606-007-0153-0; Feinauer J. J, 2015, DESERET NEWS; Fernandez-Arias M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112875; Fisher JA, 2007, QUAL INQ, V13, P875, DOI 10.1177/1077800407304460; Fisher JA, 2011, AM J PUBLIC HEALTH, V101, P2217, DOI 10.2105/AJPH.2011.300279; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Graham Suzanne, 2008, Perm J, V12, P67; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Home R, 1997, REPRESENTATIONS MEDI; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Ie K, 2017, J AM BOARD FAM MED, V30, P528, DOI 10.3122/jabfm.2017.04.170121; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Kumar K, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0103-0; Lemmens T, 2003, J LAW MED ETHICS, V31, P398, DOI 10.1111/j.1748-720X.2003.tb00103.x; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Marhankova JH, 2014, AGEING SOC, V34, P1482, DOI 10.1017/S0144686X13000275; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; Mazor KM, 2013, J COMMUNICATION HEAL; McDonald-Miszczak L, 2004, J AGING HEALTH, V16, P591, DOI 10.1177/0898264304265772; Mukete BN, 2016, J CLIN HYPERTENS, V18, P10, DOI 10.1111/jch.12624; Nafradi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186458; Peckham C, 2016, PHYS COMPENSATION RE; Pfoertner TK, 2011, INT J PUBLIC HEALTH, V56, P373, DOI 10.1007/s00038-010-0154-3; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Porteous T, 2010, PATIENT EDUC COUNS, V79, P225, DOI 10.1016/j.pec.2009.07.037; Rajpura J, 2014, J MANAGE CARE PHARM, V20, P58, DOI 10.18553/jmcp.2014.20.1.58; Rajpura JR, 2013, J PHARM PRACTICE; Regitz-Zagrosek V, 2012, SEX GENDER DIFFERENC, DOI [10.1159/000337036, DOI 10.1159/000337036]; Ruppar TM, 2012, GERIATR NURS, V33, P89, DOI 10.1016/j.gerinurse.2012.01.006; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; SALEM S A M, 1978, Age and Ageing, V7, P68, DOI 10.1093/ageing/7.2.68; Schneider AE, 2014, J URBAN HEALTH, V91, P1033, DOI 10.1007/s11524-014-9906-3; Schuz B, 2011, J PSYCHOSOM RES, V70, P179, DOI 10.1016/j.jpsychores.2010.07.014; Seruga B, 2016, LANCET ONCOL, V17, pE209, DOI 10.1016/S1470-2045(16)00152-2; Shiyanbola OO, 2013, RES SOC ADMIN PHARM, V9, P446, DOI 10.1016/j.sapharm.2012.07.003; Stein M., 2015, WASHINGTON POST; Subramanian SV, 2002, ANNU REV PUBL HEALTH, V23, P287, DOI 10.1146/annurev.publhealth.23.100901.140540; Thom DH, 2001, J FAM PRACTICE, V50, P323; Unni EJ, 2011, PATIENT EDUC COUNS, V83, P265, DOI 10.1016/j.pec.2010.05.006; Veehof LJG, 1999, EUR J CLIN PHARMACOL, V55, P533, DOI 10.1007/s002280050669; Yoon Sung Sug Sarah, 2015, NCHS Data Brief, P1	49	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210169	10.1371/journal.pone.0210169	http://dx.doi.org/10.1371/journal.pone.0210169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG5UW	30615656	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900047
J	Zhou, L; Tang, X; Li, XY; Bai, YT; Buxbaum, JN; Chen, G				Zhou, Li; Tang, Xin; Li, Xinyi; Bai, Yuting; Buxbaum, Joel N.; Chen, Gong			Identification of transthyretin as a novel interacting partner for the delta subunit of GABA(A) receptors	PLOS ONE			English	Article							TONIC INHIBITION; ALZHEIMERS-DISEASE; SLEEP; GENE; TRAFFICKING; DYSFUNCTION; PLASTICITY; MICE	GABA(A) receptors (GABA(A)-Rs) play critical roles in brain development and synchronization of neural network activity. While synaptic GABA(A)-Rs can exert rapid inhibition, the extrasynaptic GABA(A)-Rs can tonically inhibit neuronal activity due to constant activation by ambient GABA. The delta subunit-containing GABA(A)-Rs are expressed abundantly in the cerebellum, hippocampus and thalamus to mediate the major tonic inhibition in the brain. While electrophysiological and pharmacological properties of the delta-GABA(A)-Rs have been well characterized, the molecular interacting partners of the delta-GABA(A)-Rs are not clearly defined. Here, using a yeast two hybrid screening assay, we identified transthyretin (TTR) as a novel regulatory molecule for the delta-GABA(A)-Rs. Knockdown of TTR in cultured cerebellar granule neurons significantly decreased the delta receptor expression; whereas overexpressing TTR in cortical neurons increased the delta receptor expression. Electrophysiological analysis confirmed that knockdown or overexpression of TTR in cultured neurons resulted in a corresponding decrease or increase of tonic currents. Furthermore, in vivo analysis of TTR-/- mice revealed a significant decrease of the surface expression of the delta-GABA(A)-Rs in cerebellar granule neurons. Together, our studies identified TTR as a novel regulator of the delta-GABA(A)-Rs.	[Zhou, Li; Tang, Xin; Bai, Yuting; Chen, Gong] Penn State Univ, Huck Inst Life Sci, Dept Biol, University Pk, PA 16802 USA; [Li, Xinyi; Buxbaum, Joel N.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Scripps Research Institute	Zhou, L; Chen, G (corresponding author), Penn State Univ, Huck Inst Life Sci, Dept Biol, University Pk, PA 16802 USA.	li.zhou.sci@gmail.com; gongchen@psu.edu		Chen JNU, Gong/0000-0002-1857-3670	National Institutes of Health [MH083911, AG045656]; Endowment Fund from Pennsylvania State University; NATIONAL INSTITUTE ON AGING [R01AG045656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endowment Fund from Pennsylvania State University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institutes of Health (MH083911 and AG045656) and an Endowment Fund from Pennsylvania State University to G.C.	BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brouillette J, 2008, NEUROBIOL AGING, V29, P1721, DOI 10.1016/j.neurobiolaging.2007.04.007; Buxbaum J, 2003, AMYLOID, V10, P2; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P2302, DOI 10.1016/j.bbadis.2013.09.011; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Faulhaber J, 1997, PSYCHOPHARMACOLOGY, V130, P285, DOI 10.1007/s002130050241; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kilpatrick CL, 2016, J BIOL CHEM, V291, P27371, DOI 10.1074/jbc.M116.732768; Lewis DA, 2011, CURR OPIN NEUROBIOL, V21, P866, DOI 10.1016/j.conb.2011.05.013; Li XY, 2013, J NEUROSCI, V33, P19423, DOI 10.1523/JNEUROSCI.2561-13.2013; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Li XY, 2011, J NEUROSCI, V31, P12483, DOI 10.1523/JNEUROSCI.2417-11.2011; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Nusser Z, 1998, J NEUROSCI, V18, P1693; Schreiber G, 1990, AM J PHYSL 2, V258, pR338, DOI [10.1152/ajpregu.1990.258.2.R338, DOI 10.1152/AJPREGU.1990.258.2.R338]; Scimemi A, 2006, EUR J NEUROSCI, V24, P1157, DOI 10.1111/j.1460-9568.2006.04989.x; Shen H, 2010, SCIENCE, V327, P1515, DOI 10.1126/science.1184245; Silva CS, 2017, NEUROBIOL AGING, V59, P10, DOI 10.1016/j.neurobiolaging.2017.07.002; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sun CC, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-23; Winsky-Sommerer R, 2007, EUR J NEUROSCI, V25, P1893, DOI 10.1111/j.1460-9568.2007.05455.x; Wu X, 2013, J BIOL CHEM, V288, P25053, DOI 10.1074/jbc.M113.491464; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210094	10.1371/journal.pone.0210094	http://dx.doi.org/10.1371/journal.pone.0210094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615651	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900039
J	Aquino-Martinez, R; Monroe, DG; Ventura, F				Aquino-Martinez, Ruben; Monroe, David G.; Ventura, Francesc			Calcium mimics the chemotactic effect of conditioned media and is an effective inducer of bone regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTORS; EXTRACELLULAR CALCIUM; CALVARIAL DEFECT; MIGRATION; DIFFERENTIATION; QUANTIFICATION; MACROPHAGES; SIGNALS; SURFACE	Background After bone resorption, ions and degraded organic components are co-released into the extracellular space. Ions and growth factors, although different in their biological nature, induce a common and coordinated chemotactic effect. Conditioned media has been used successfully in bone regeneration by promoting endogenous cell recruitment. Likewise, calcium alone act as a paracrine chemotactic signal, inducing the host's undifferentiated progenitor cell infiltration into the implanted biomaterials. The aim of the present study was to compare the chemotactic effect of calcium and conditioned media in primary calvarial cells. Methods The chemotactic cell response was evaluated in vitro using an agarose spot and a wound healing assay. In addition, we used a calvarial bone explant model ex-vivo. The healing potential was also tested through an in vivo model, a critical-size calvarial bone defect in mice. For the in vivo experiment, cell-free calcium-containing or conditioned media-containing scaffolds were implanted, and MSC's seeded scaffolds were used as positive control. After seven weeks post-implantation, samples were retrieved, and bone regeneration was evaluated by mu CT and histological analysis. Osteogenic gene expression was evaluated by qPCR. Results We found that chemotactic cell migration in response to either calcium or conditioned media was equivalent in vitro and ex vivo. Accordingly, mu CT analysis showed that bone regeneration induced by the MSC's seeded scaffolds was similar to that obtained with cell-free calcium or conditioned media-containing scaffolds. Pre-treatment with SB202190, a highly selective p38 inhibitor, abrogated the chemotactic effect induced by conditioned media. In contrast, p38 activity was not essential for the calcium-induced chemotaxis. Moreover, BAPTA-AM treatment, a cytosolic calcium chelator, decreased the chemotactic effect and the expression of key osteogenic genes induced by calcium or conditioned media. Conclusion We show that calcium ions alone not only mimic the conditioned media chemotactic effect, but also induce an osteogenic effect similar to that produced by transplanted MSC's in vivo. Furthermore, the chemotactic effect induced by conditioned media is calcium and p38 dependent. The rise in cytosolic calcium might integrate the different signaling pathways triggered by conditioned media and extracellular Ca2+. This calcium-driven in situ bone regeneration is a promising and convenient alternative to promote endogenous cell recruitment into the injured bone site. This pre-clinical cell-free and growth factor-free approach might avoid the disadvantages of the ex vivo cell manipulation.	[Aquino-Martinez, Ruben; Ventura, Francesc] Univ Barcelona, IDIBELL, Dept Ciencies Fisiol, Barcelona, Spain; [Aquino-Martinez, Ruben; Monroe, David G.] Mayo Clin, Dept Med, Div Endocrinol, Coll Med, Rochester, MN USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Mayo Clinic	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencies Fisiol, Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/K-9700-2014; Ventura, Francesc/ABG-2285-2020	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Monroe, David/0000-0002-4818-0114; Aquino-Martinez, Ruben/0000-0003-1564-2279	Ministry of Education, Spanish Government [BFU 2014-56313, BFU201782421-P]; N.I.H. [R01 AR068275]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068275] Funding Source: NIH RePORTER	Ministry of Education, Spanish Government; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Ministry of Education, Spanish Government (BFU 2014-56313 and BFU201782421-P to F.V.) and the N.I.H. (R01 AR068275 to D.G.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M., 2017, SCI REP-UK, V7, P1; Aquino-Martinez RN, 2015, MESENCHYMAL STEM CEL, P1, DOI [10.1089/ten.tea.2015.018.PMID:26414873, DOI 10.1089/TEN.TEA.2015.018]; Aquino-Martinez R, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0713-0; Aquino-Martinez R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178158; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Berger CEM, 2001, J BONE MINER RES, V16, P2092, DOI 10.1359/jbmr.2001.16.11.2092; Boudot C, 2010, BONE, V46, P1416, DOI 10.1016/j.bone.2010.01.383; Cypher T J, 1996, J Foot Ankle Surg, V35, P413; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047; Espinosa A, 2004, J ENDOCRINOL, V182, P339, DOI 10.1677/joe.0.1820339; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004; HAUSCHKA PV, 1988, CIBA F SYMP, V136, P207; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Ichida M, 2011, FEBS LETT, V585, P4018, DOI 10.1016/j.febslet.2011.11.014; Ishida K, 2013, BIOCHEM BIOPH RES CO, V432, P677, DOI 10.1016/j.bbrc.2013.02.019; Katagiri W, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12333; Katagiri W, 2017, MAX PLAST RECONSTR S, V39, DOI 10.1186/s40902-017-0106-4; Katagiri W, 2016, HEAD FACE MED, V12, DOI 10.1186/s13005-016-0101-5; Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002; Leclerc C, 2011, BIOCHIMIE, V93, P2102, DOI 10.1016/j.biochi.2011.06.032; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Maguire Greg, 2013, Commun Integr Biol, V6, pe26631, DOI 10.4161/cib.26631; Martinez VG, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0659-2; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Monroe DG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-104; MOOLENAAR WH, 1984, J BIOL CHEM, V259, P8066; Naddeo P, 2015, DENT MATER, V31, P235, DOI 10.1016/j.dental.2014.12.015; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.tea.2011.0325, 10.1089/ten.TEA.2011.0325]; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Suzuki J, 2000, MOL CELL BIOL, V20, P4658, DOI 10.1128/MCB.20.13.4658-4665.2000; Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100; Vinader V, 2011, J PHARMACOL TOX MET, V64, P213, DOI 10.1016/j.vascn.2011.01.004; Viti F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148173; Wang J, 2017, ACTA BIOMATER, V51, P447, DOI 10.1016/j.actbio.2017.01.059; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0; Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085; Wu RX, 2018, APPL MATER TODAY, V11, P144, DOI 10.1016/j.apmt.2018.02.004; Wu XH, 2014, MICROSC RES TECHNIQ, V77, P1037, DOI 10.1002/jemt.22433; Wu XH, 2010, MICROSC RES TECHNIQ, V73, P540, DOI 10.1002/jemt.20792; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12694	56	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210301	10.1371/journal.pone.0210301	http://dx.doi.org/10.1371/journal.pone.0210301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608979	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800060
J	Fukuhara, S; Nakajima, H; Sugimoto, S; Kodo, K; Shigehara, K; Morimoto, H; Tsuma, Y; Moroto, M; Mori, J; Kosaka, K; Morimoto, M; Hosoi, H				Fukuhara, Shota; Nakajima, Hisakazu; Sugimoto, Satoru; Kodo, Kazuki; Shigehara, Keiichi; Morimoto, Hidechika; Tsuma, Yusuke; Moroto, Masaharu; Mori, Jun; Kosaka, Kitaro; Morimoto, Masafumi; Hosoi, Hajime			High-fat diet accelerates extreme obesity with hyperphagia in female heterozygous Mecp2-null mice	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; BROWN ADIPOSE-TISSUE; AGRP NEURONS; MUTANT MICE; FOOD-INTAKE; DELETION; LEPTIN; METABOLISM; MECHANISMS; EXPRESSION	Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutation of the methyl-CpG-binding protein 2 (MECP2) gene. Although RTT has been associated with obesity, the underlying mechanism has not yet been elucidated. In this study, female heterozygous Mecp2-null mice (Mecp(2+/-) mice), a model of RTT, were fed a normal chow diet or high-fat diet (HFD), and the changes in molecular signaling pathways were investigated. Specifically, we examined the expression of genes related to the hypothalamus and dopamine reward circuitry, which represent a central network of feeding behavior control. In particular, dopamine reward circuitry has been shown to regulate hedonic feeding behavior, and its disruption is associated with HFD-related changes in palatability. The Mecp(2+/-) mice that were fed the normal chow showed normal body weight and food consumption, whereas those fed the HFD showed extreme obesity with hyperphagia, an increase of body fat mass, glucose intolerance, and insulin resistance compared with wild-type mice fed the HFD (WT-HFD mice). The main cause of obesity in Mecp(2+/-)-HFD mice was a remarkable increase in calorie intake, with no difference in oxygen consumption or locomotor activity. Agouti-related peptide mRNA and protein levels were increased, whereas proopiomelanocortin mRNA and protein levels were reduced in Mecp(2+/-)-HFD mice with hyperleptinemia, which play an essential role in appetite and satiety in the hypothalamus. The conditioned place preference test revealed that Mecp(2+/-) mice preferred the HFD. Tyrosine hydroxylase and dopamine transporter mRNA levels in the ventral tegmental area, and dopamine receptor and dopamine- and cAMP-regulated phosphoprotein mRNA levels in the nucleus accumbens were significantly lower in Mecp(2+/-)-HFD mice than those of WT-HFD mice. Thus, HFD feeding induced dysregulation of food intake in the hypothalamus and dopamine reward circuitry, and accelerated the development of extreme obesity associated with addiction-like eating behavior in Mecp(2+/-) mice.	[Fukuhara, Shota; Nakajima, Hisakazu; Sugimoto, Satoru; Shigehara, Keiichi; Morimoto, Hidechika; Tsuma, Yusuke; Moroto, Masaharu; Mori, Jun; Kosaka, Kitaro; Morimoto, Masafumi; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Nakajima, Hisakazu; Kodo, Kazuki] Kyoto Prefectural Univ Med, North Med Ctr, Dept Pediat, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Nakajima, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan.; Nakajima, H (corresponding author), Kyoto Prefectural Univ Med, North Med Ctr, Dept Pediat, Kyoto, Japan.	hisakazu@koto.kpu-m.ac.jp	Nakajima, Hisakazu/AAH-7764-2021	Nakajima, Hisakazu/0000-0002-3678-9918	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K01686]; MORINAGA Foundation for Health Nutrition	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MORINAGA Foundation for Health Nutrition	This work was funded by Grant-in-Aid of Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number, 15K01686) and supported by a research grant from the MORINAGA Foundation for Health & Nutrition.	Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bhattacherjee A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010097; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Cordeira JW, 2010, J NEUROSCI, V30, P2533, DOI 10.1523/JNEUROSCI.5768-09.2010; Deng JL, 2017, DIABETES, V66, P640, DOI 10.2337/db16-0954; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Feng JA, 2010, NAT NEUROSCI, V13, P1039, DOI 10.1038/nn0910-1039; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Higuchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038609; Jie V, NAT NEUROSCI, V13, P1128, DOI [10.1038/nn.2614, DOI 10.1038/NN.2614]; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kleefstra T, 2002, CLIN GENET, V61, P359, DOI 10.1034/j.1399-0004.2002.610507.x; Kodo K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173661; Kyle SM, 2016, HUM MOL GENET, V25, P3029, DOI 10.1093/hmg/ddw156; Lee AK, 2010, NUTRITION, V26, P411, DOI 10.1016/j.nut.2009.05.007; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Miralves J, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-16; Motil KJ, 2012, J PEDIATR GASTR NUTR, V55, P292, DOI 10.1097/MPG.0b013e31824b6159; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Park MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109527; Pitcher MR, 2013, HUM MOL GENET, V22, P2626, DOI 10.1093/hmg/ddt111; Psoni S, 2010, PEDIATR RES, V67, P551, DOI 10.1203/PDR.0b013e3181d4ecf7; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Roux JC, 2008, NEUROSCI LETT, V447, P82, DOI 10.1016/j.neulet.2008.09.045; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Smeets EEJ, 2011, MOL SYNDROMOL, V2, P113, DOI 10.1159/000337637; Sugimoto S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-14; Torres-Andrade R, 2014, EXP PHYSIOL, V99, P1229, DOI 10.1113/expphysiol.2014.079798; Vucetic Z, 2012, J NEUROCHEM, V120, P891, DOI 10.1111/j.1471-4159.2012.07649.x; Wang XR, 2014, DIABETOLOGIA, V57, P236, DOI 10.1007/s00125-013-3072-0; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Yang XY, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00149; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005; Zhang W, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00136; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	45	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210184	10.1371/journal.pone.0210184	http://dx.doi.org/10.1371/journal.pone.0210184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608967	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800051
J	Niemi, M; Liukkonen, L; Koivuniemi, M; Auttila, M; Rautio, A; Kunnasranta, M				Niemi, Marja; Liukkonen, Lauri; Koivuniemi, Meeri; Auttila, Miina; Rautio, Anni; Kunnasranta, Mervi			Winter behavior of Saimaa ringed seals: Non-overlapping core areas as indicators of avoidance in breeding females	PLOS ONE			English	Article							PHOCA-HISPIDA-SAIMENSIS; HOME-RANGE; PERINATAL-MORTALITY; CLIMATE-CHANGE; PUSA-HISPIDA; HABITAT USE; POPULATION; ICE; TERRITORIALITY; MOVEMENTS	Climate change, together with increasing human activity, poses a threat to the breeding success of endangered landlocked ringed seals (Phoca hispida saimensis). In this study, we estimated the spatial ecology of Saimaa ringed seals during the breeding season in the ice-covered period of December-April. The telemetry data on tagged seals (n = 20), with a total of 25 separate tracking periods and birth lair locations (n = 59) of non-tagged seals, were studied to estimate the movement ecology and breeding density. The movements of the ringed seals were more restricted during the ice-covered season; the total home range size (average 7.4 km(2)) in winter was 13 times smaller than that in summer. Individual tagged seals occupied an average of 5 +/- 3 SD subnivean haul outs (snow lairs or ice cavities), and the mean distance between the haul outs was 1.6 +/- 1.1 SD km (range 0.2-5.9 km). Moreover, our data indicated that ringed seal females likely exhibited breeding time avoidance of each other's core areas, which may indicate some degree of territoriality. This was supported by the findings that the core areas (mean 1.2 km(2)) of tagged adult females (n = 9), did not overlap with each other. Also data on non-tagged seals showed that females did not give birth to pups within the core area radius of other parturient females. This study, together with earlier findings on the home ranges of nursed pups and perinatal mortality rates, has implications into land usage planning in Lake Saimaa by highlighting the need of undisturbed area between seal lairs and anthropogenic disturbances.	[Niemi, Marja; Liukkonen, Lauri; Koivuniemi, Meeri; Rautio, Anni; Kunnasranta, Mervi] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Auttila, Miina] Metsahallitus, Pk & Wildlife Finland, Savonlinna, Finland; [Kunnasranta, Mervi] Nat Resources Inst Finland, Joensuu, Finland	University of Eastern Finland; Natural Resources Institute Finland (Luke)	Niemi, M (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.	marja.niemi@uef.fi		Niemi, Marja/0000-0002-1516-8346	Saimaa seal LIFE [LIFE12NAT/FI/000367]; Raija and Ossi Tuuliainen Foundation [2485/02.07.02/2010]; WWF Finland [2421/02.07.02/2010]	Saimaa seal LIFE; Raija and Ossi Tuuliainen Foundation; WWF Finland	This study was financially supported by "Saimaa seal LIFE" (LIFE12NAT/FI/000367, http://ec.europa.eu/environment/life/ to MKun), Raija and Ossi Tuuliainen Foundation (#2485/02.07.02/2010, http://www.tuuliaisensaatio.fi to MKun) and WWF Finland (#2421/02.07.02/2010, https://wwf.fi/en/ to Mkun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, HYLJ 2018, V2018; Auttila M., 2015, ENDANGERED SAIMAA RI, P194; Auttila M, 2016, MAR MAMMAL SCI, V32, P252, DOI 10.1111/mms.12256; Auttila M, 2014, ANN ZOOL FENN, V51, P526, DOI 10.5735/086.051.0601; Bernstein NP, 2007, AM MIDL NAT, V157, P162, DOI 10.1674/0003-0031(2007)157[162:HRAPIT]2.0.CO;2; Blondel DV, 2009, J MAMMAL, V90, P715, DOI 10.1644/08-MAMM-A-009R2.1; Born EW, 2004, ARCTIC, V57, P129; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gjertz I, 2000, POLAR BIOL, V23, P651, DOI 10.1007/s003000000143; HAMMILL MO, 1991, CAN J FISH AQUAT SCI, V48, P2471, DOI 10.1139/f91-288; Harkonen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002006; Harwood LA, 2000, ARCTIC, V53, P422, DOI 10.14430/arctic872; Harwood LA, 2012, ARCTIC, V65, P377; Haugen AO, 1942, ECOLOGY, V23, P354, DOI 10.2307/1930675; Helle E., 1984, ACTA ZOOL FENN, V172, P125; Kelly BP, 2001, FINGERPRINTS OF CLIMATE CHANGE, P43; KELLY BP, 1990, CAN J ZOOL, V68, P2503, DOI 10.1139/z90-350; Kelly BP, 1996, CAN J ZOOL, V74, P1547, DOI 10.1139/z96-169; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Knott C, 2008, INT J PRIMATOL, V29, P975, DOI 10.1007/s10764-008-9278-1; Koivuniemi M, 2016, ENDANGER SPECIES RES, V30, P29, DOI 10.3354/esr00723; Kokko H, 1998, ANIM CONSERV, V1, P47, DOI 10.1111/j.1469-1795.1998.tb00225.x; Koskelal JT, 2002, ANN ZOOL FENN, V39, P59; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Kovacs KM, 2012, MAR MAMMAL SCI, V28, P414, DOI 10.1111/j.1748-7692.2011.00479.x; Krafft BA, 2007, MAR ECOL PROG SER, V335, P199, DOI 10.3354/meps335199; Kristal MB, 2012, ECOL FOOD NUTR, V51, P177, DOI 10.1080/03670244.2012.661325; Kunnasranta M, 2002, ACTA THERIOL, V47, P63, DOI 10.1007/BF03193567; Kunnasranta M, 2001, POLAR BIOL, V24, P171, DOI 10.1007/s003000000192; Kunnasranta Mervi, 2016, Suomen Riista, V62, P71; Kuusisto E., 1999, SAIMAA LIVING LAKE; LAVIGNE DM, 1979, J MAMMAL, V60, P854, DOI 10.2307/1380211; Liukko U-M, 2016, SUOMEN NISAKKAIDEN U; Liukkonen L, 2017, ENDANGER SPECIES RES, V34, P283, DOI 10.3354/esr00856; LYDERSEN C, 1989, POLAR BIOL, V9, P489, DOI 10.1007/BF00261031; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; McLaren I.A., 1958, BIOL RINGED SEAL PHO; Miller JA, 2014, ANIM BEHAV, V87, P147, DOI 10.1016/j.anbehav.2013.10.023; Niemi M., 2013, BEHAV ECOLOGY SAIMAA, P129; Niemi M, 2013, ENDANGER SPECIES RES, V22, P115, DOI 10.3354/esr00541; Niemi Marja, 2012, Endangered Species Research, V19, P99, DOI 10.3354/esr00468; Niemi M, 2013, MAR MAMMAL SCI, V29, P1, DOI 10.1111/j.1748-7692.2011.00521.x; Oksanen SM, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0058-1; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Powell RA, 2000, METH C CONS, P65; Rautio A, 2013, ANN ZOOL FENN, V50, P107, DOI 10.5735/086.050.0110; Rautio A, 2009, MAR MAMMAL SCI, V25, P920, DOI 10.1111/j.1748-7692.2009.00299.x; RYG M, 1990, CAN J ZOOL, V68, P470, DOI 10.1139/z90-069; Schmidt K, 1997, ACTA THERIOL, V42, P289, DOI 10.4098/AT.arch.97-30; Sipila T., 1990, Finnish Game Research, V47, P3; Sipila T., 1990, Finnish Game Research, V47, P11; Sipila T, 2003, THESIS U HELSINKI; Sipila Tero, 1998, NAMMCO Scientific Publications, V1, P83; Smith T.G., 1987, CANADIAN B FISHERIES, V216; Smith TG, 2001, POLAR BIOL, V24, P215, DOI 10.1007/s003000000198; SMITH TG, 1981, CAN J ZOOL, V59, P966, DOI 10.1139/z81-135; Steinmann AR, 2005, ACTA THERIOL, V50, P197, DOI 10.1007/BF03194483; Stirling I, 2004, ARCTIC, V57, P59; Valtonen M, 2015, ANN ZOOL FENN, V52, P51, DOI 10.5735/086.052.0205; Valtonen M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-22; Valtonen M, 2012, CONSERV GENET, V13, P1231, DOI 10.1007/s10592-012-0367-5; White G.C., 1990, ANAL WILDLIFE RADIO; Wolff JO, 1998, ETHOL ECOL EVOL, V10, P227, DOI 10.1080/08927014.1998.9522854; Yurkowski DJ, 2016, MAR ECOL PROG SER, V562, P237, DOI 10.3354/meps11950; Yurkowski DJ, 2011, J MAMMAL, V92, P803, DOI 10.1644/10-MAMM-A-082.1	67	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210266	10.1371/journal.pone.0210266	http://dx.doi.org/10.1371/journal.pone.0210266			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608980	gold, Green Submitted, Green Published			2022-12-26	WOS:000454952800055
J	Zarranz-Ventura, J; Sala-Puigdollers, A; Velazquez-Villoria, D; Figueras-Roca, M; Copete, S; Distefano, L; Boixadera, A; Garcia-Arumi, J; Adan, A; Alforja, S; Casaroli-Marano, RP; Giralt, J; Llorens, V; Mesquida, M; Navarro-Angulo, MJ; Pelegrin, L; Zapata, MA				Zarranz-Ventura, Javier; Sala-Puigdollers, Anna; Velazquez-Villoria, Daniel; Figueras-Roca, Marc; Copete, Sergio; Distefano, Laura; Boixadera, Anna; Garcia-Arumi, Jose; Adan, Alfredo; Alforja, Socorro; Casaroli-Marano, Ricardo P.; Giralt, Joan; Llorens, Victor; Mesquida, Marina; Navarro-Angulo, Manuel J.; Pelegrin, Laura; Zapata, Miguel Angel		Hosp Clinic Hosp Vall Hebron Intra	Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; 0.7 MG; OZURDEX; 3-YEAR; SAFETY	Purpose To evaluate the long-term cumulative probability of intraocular pressure (IOP) elevation with the intravitreal dexamethasone implant (IDI) when used to treat different indications: diabetic macular edema, uveitis, retinal vein occlusion. Methods 705 IDI injections (429 eyes) were assessed and Kaplan-Meier graphs were generated to assess: the probability of different levels of IOP elevation (IOP >= 21, >= 25 or >= 35 mmHg), IOP change >= 10 mmHg, initiation of IOP-lowering treatment, glaucoma surgery, IOP change with repeat injections and IOP elevation in eyes with glaucoma and ocular hypertension (OHT). Results The cumulative probability of IOP. 21,. 25 and. 35 mmHg was 50%-60%, 25%-30% and 6%-7% at 12-24 months, respectively. The probability of initiating IOP-lowering medication was 31%-54% at 12-24 months. Glaucoma and OHT eyes had a higher probability of mild IOP elevation (>= 21 mmHg, 65.1%, 75% and 57.8%, p = 0.01), yet a similar moderate (>= 25 mmHg, 22.3%, 28% and 30.2%, p = 0.91) and severe elevation of IOP (>= 35 mmHg, 3.7%, 7.1% and 4%, p = 0.71) as normal eyes. Glaucoma surgery was required in only 0.9% cases (4/429). At baseline, 8.8% of the treated eyes had glaucoma, 6.7% OHT and 16.9% were already on IOP-lowering medication. Conclusions In the long-term (24 months), IOP elevation is common, generally mild (30% IOP, >= 25 mmHg) and well-tolerated, resolving with topical treatment (54%) and rarely requiring surgery (0.9%).	[Zarranz-Ventura, Javier; Sala-Puigdollers, Anna; Figueras-Roca, Marc; Adan, Alfredo] Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain; [Velazquez-Villoria, Daniel; Copete, Sergio; Distefano, Laura; Boixadera, Anna; Garcia-Arumi, Jose] Hosp Vall de Hebron, Dept Oftalmol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari Vall d'Hebron	Zarranz-Ventura, J (corresponding author), Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain.	jzarranz@hotmail.com	Figueras-Roca, Marc/G-9095-2017; Zarranz-Ventura, Javier/AAB-5390-2021; Zapata, Miguel Ángel/AAB-9552-2019; Llorens Bellés, Víctor/V-3892-2019	Figueras-Roca, Marc/0000-0002-0548-0539; Zarranz-Ventura, Javier/0000-0003-2338-8143; Llorens Bellés, Víctor/0000-0002-7375-1564; Sala-Puigdollers, Anna/0000-0001-5792-6937; Distefano, Laura N/0000-0003-2319-1324; Boixadera, Anna/0000-0003-2000-9478; Garcia-Arumi, Jose/0000-0001-8827-1160; Velazquez Villoria, Daniel/0000-0002-8677-6859				Adan A, 2013, RETINA-J RET VIT DIS, V33, P1435, DOI 10.1097/IAE.0b013e31827e247b; Arcinue CA, 2013, J OCUL PHARMACOL TH, V29, P501, DOI 10.1089/jop.2012.0180; Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024; Boyer DS, 2011, RETINA-J RET VIT DIS, V31, P915, DOI 10.1097/IAE.0b013e318206d18c; Capone A, 2014, RETINA-J RET VIT DIS, V34, P342, DOI 10.1097/IAE.0b013e318297f842; Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285; Chhablani J, 2016, EYE, V30, P426, DOI 10.1038/eye.2015.246; Haller JA, 2011, OPHTHALMOLOGY, V118, P2453, DOI 10.1016/j.ophtha.2011.05.014; Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032; Jimenez-Gomez B, 2015, Arch Soc Esp Oftalmol, V90, P421, DOI 10.1016/j.oftal.2015.01.006; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lam WC, 2015, CLIN OPHTHALMOL, V9, P1255, DOI 10.2147/OPTH.S80500; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Lowder C, 2011, ARCH OPHTHALMOL-CHIC, V129, P545, DOI 10.1001/archophthalmol.2010.339; Malcles A, 2017, RETINA-J RET VIT DIS, V37, P1352, DOI 10.1097/IAE.0000000000001369; Maturi RK, 2016, RETINA-J RET VIT DIS, V36, P1143, DOI 10.1097/IAE.0000000000001004; Mazzarella S, 2015, OPHTHALMIC RES, V54, P143, DOI 10.1159/000438759; Robinson MR, 2012, EXPERT REV CLIN PHAR, V5, P629, DOI [10.1586/ECP.12.55, 10.1586/ecp.12.55]; Tomkins-Netzer O, 2014, OPHTHALMOLOGY, V121, P1649, DOI 10.1016/j.ophtha.2014.02.003; Whitcup SM, 2015, ANN NY ACAD SCI, V1358, P1, DOI 10.1111/nyas.12824; Zarranz-Ventura J, 2014, AM J OPHTHALMOL, V158, P1136, DOI 10.1016/j.ajo.2014.09.003	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209997	10.1371/journal.pone.0209997	http://dx.doi.org/10.1371/journal.pone.0209997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608950	Green Submitted, gold, Green Published			2022-12-26	WOS:000454952800035
J	Nishio, M; Miyachi, Y; Otani, J; Tane, S; Omori, H; Ueda, F; Togashi, H; Sasaki, T; Mak, TW; Nakao, K; Fujita, Y; Nishina, H; Maehama, T; Suzuki, A				Nishio, Miki; Miyachi, Yousuke; Otani, Junji; Tane, Shoji; Omori, Hirofumi; Ueda, Fumihito; Togashi, Hideru; Sasaki, Takehiko; Mak, Tak Wah; Nakao, Kazuwa; Fujita, Yasuyuki; Nishina, Hiroshi; Maehama, Tomohiko; Suzuki, Akira			Hippo pathway controls cell adhesion and context-dependent cell competition to influence skin engraftment efficiency	FASEB JOURNAL			English	Article						YAP1; MOB1; fibronectin	REGULATES YAP; CANCER; GROWTH; PROMOTES; METASTASIS; PROTEIN; MYC; DIFFERENTIATION; GLYCOPROTEIN; PROGRESSION	Cell competition is involved in mammalian embryogenesis and tumor elimination and progression. It was previously shown that, whereas NIH3T3 mouse fibroblasts expressing high levels of the yes-associated protein 1(YAP1) target TEA domain family (TEAD) transcription factors become "winners" in cell competitions, Madin-Darby canine kidney cells expressing activated YAP1 become "losers" and are eliminated from culture monolayers. Thus, YAP1's role in cell competitions is clearly context dependent. Here, we show that keratinocytes overexpressing a constitutively activated YAP1 mutant lose in in vitro competitions with control cells conducted in standard tissue culture dishes and undergo apical extrusion. Similarly, cells in which endogenous YAP1 is activated by NF2 knockdown become losers. The YAP1-overexpressing cells exhibit a decrease in cell-matrix adhesion because of defective expression of adhesion molecules such as fibronectin-1. Cell adhesion-mediated proliferation is also impaired. However, because of intrinsic factors, YAP1-expressing cells proliferate faster than control cells when cocultured in dishes impeding cell adhesion. In vivo, Mob1a/b-deficient (YAP1-activated) epidermis, which shows decreased expression of type XVII collagen, cannot be engrafted successfully onto donor mice. YAP1-activated skin grafts shrink away from surrounding control skin, and the epidermis peels off the basement membrane. Our data show that YAP1 activation controls cell competition in part by decreasing cell adhesion.	[Nishio, Miki; Miyachi, Yousuke; Otani, Junji; Omori, Hirofumi; Ueda, Fumihito; Togashi, Hideru; Maehama, Tomohiko; Suzuki, Akira] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo, Japan; [Nishio, Miki; Miyachi, Yousuke; Tane, Shoji; Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Div Canc Genet, Fukuoka, Fukuoka, Japan; [Sasaki, Takehiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Lipid Biol, Tokyo, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan; [Mak, Tak Wah] Univ Hlth Network, Univ Toronto, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Mak, Tak Wah] Univ Hlth Network, Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Fujita, Yasuyuki] Hokkaido Univ, Grad Sch Chem Sci & Engn, Inst Genet Med, Div Mol Oncol, Sapporo, Hokkaido, Japan	Kobe University; Kyushu University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Kyoto University; Hokkaido University	Maehama, T; Suzuki, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, Kusunoki Cho 7-5-1, Kobe, Hyogo 6500017, Japan.	tmaehama@med.kobe-u.ac.jp; suzuki@med.kobe-u.ac.jp	Suzuki, Akira/GYD-6697-2022; Maehama, Tomohiko/AAX-8926-2020; Maehama, Tomohiko/HGB-4896-2022	Suzuki, Akira/0000-0002-5950-8808; Maehama, Tomohiko/0000-0002-9685-2317; Togashi, Hideru/0000-0002-3967-5940; Sasaki, Takehiko/0000-0003-1837-3748; Omori, Hirofumi/0000-0002-7932-2090; Ueda, Fumihito/0000-0003-1241-1643	Japanese Society for the Promotion of Science (JSPS) [15K21757, 17H01400, 26114005]; Japanese Agency for Medical Research and Development (AMED) [16770279]; Uehara Memorial Foundation; Shinnihon Advanced Medical Research Foundation; Daiichi-Sankyo Scholarship Donation Program; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; Nanken-Kyoten, Tokyo Medical and Dental University (TMDU)	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); Shinnihon Advanced Medical Research Foundation; Daiichi-Sankyo Scholarship Donation Program; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; Nanken-Kyoten, Tokyo Medical and Dental University (TMDU)	The authors thank A. Fujimoto, M. Kamihashi, and M. Suzuki (all from Kyushu University), and Y. Shimono, K. Okada, and M. Fukumoto (all from Kobe University) for expert technical assistance and critical discussions. The authors are grateful for the funding provided by the Japanese Society for the Promotion of Science (JSPS; Grants 15K21757, 17H01400, and 26114005 to A.S.); the Japanese Agency for Medical Research and Development (AMED; Grant 16770279 to A.S.); the Uehara Memorial Foundation (to A.S.); the Shinnihon Advanced Medical Research Foundation (to A.S.); the Daiichi-Sankyo Scholarship Donation Program (to A.S.); the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; and Nanken-Kyoten, Tokyo Medical and Dental University (TMDU). The authors declare no conflicts of interest.	Abbi S, 2002, HISTOL HISTOPATHOL, V17, P1163, DOI 10.14670/HH-17.1163; Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Baker NE, 2011, CURR BIOL, V21, pR11, DOI 10.1016/j.cub.2010.11.030; Chiba T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28383; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; de Beco S, 2012, DEV DYNAM, V241, P831, DOI 10.1002/dvdy.23783; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Goto H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.159244; Grieve AG, 2014, J CELL SCI, V127, P3331, DOI 10.1242/jcs.147926; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Hu XB, 2014, PATHOL ONCOL RES, V20, P805, DOI 10.1007/s12253-014-9757-y; Ishihara E, 2018, CANCERS, V10, DOI 10.3390/cancers10040122; Kajita M, 2015, J BIOCHEM, V158, P15, DOI 10.1093/jb/mvv050; Kajita M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5428; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kim HM, 2015, TUMOR BIOL, V36, P1207, DOI 10.1007/s13277-014-2735-x; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Liu R, 2015, ONCOTARGET, V6, P935, DOI 10.18632/oncotarget.2822; Mamada H, 2015, J CELL SCI, V128, P790, DOI 10.1242/jcs.163675; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morata G, 2007, DEV CELL, V13, P1, DOI 10.1016/j.devcel.2007.06.002; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nakatani K, 2017, J BIOCHEM, V161, P237, DOI 10.1093/jb/mvw074; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Nishio M, 2017, GENES CELLS, V22, P6, DOI 10.1111/gtc.12461; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Otsubo K, 2017, ONCOGENE, V36, P4201, DOI 10.1038/onc.2017.58; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Porazinski S, 2015, NATURE, V521, P217, DOI 10.1038/nature14215; Powell AM, 2005, CLIN EXP DERMATOL, V30, P682, DOI 10.1111/j.1365-2230.2005.01937.x; Sabra H, 2017, J BIOL CHEM, V292, P19179, DOI 10.1074/jbc.M117.808063; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Shigeeda W, 2017, ONCOTARGET, V8, P93729, DOI 10.18632/oncotarget.20750; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Thongon N, 2016, ONCOTARGET, V7, P26551, DOI 10.18632/oncotarget.8437; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; del Campo CV, 2014, CELL REP, V8, P1741, DOI 10.1016/j.celrep.2014.08.005; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Wang T, 2018, BBA-MOL BASIS DIS, V1864, P1744, DOI 10.1016/j.bbadis.2018.02.020; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin K, 2018, BIOCHEM BIOPH RES CO, V496, P76, DOI 10.1016/j.bbrc.2017.12.170; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu SY, 2015, ONCOTARGET, V6, P2951, DOI 10.18632/oncotarget.3095; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	59	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5548	5560		10.1096/fj.201802005R	http://dx.doi.org/10.1096/fj.201802005R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640535	Bronze			2022-12-26	WOS:000462888500073
J	Paul, HA; Collins, KH; Nicolucci, AC; Urbanski, SJ; Hart, DA; Vogel, HJ; Reimer, RA				Paul, Heather A.; Collins, Kelsey H.; Nicolucci, Alissa C.; Urbanski, Stefan J.; Hart, David A.; Vogel, Hans J.; Reimer, Raylene A.			Maternal prebiotic supplementation reduces fatty liver development in offspring through altered microbial and metabolomic profiles in rats	FASEB JOURNAL			English	Article						oligofructose; pregnancy; steatosis; gut microbiota; insulin sensitivity	COLONY-STIMULATING FACTOR; DIET-INDUCED OBESITY; GUT MICROBIOTA; SKELETAL-MUSCLE; INDUCED INFLAMMATION; LIPID-METABOLISM; DISEASE; PREGNANCY; FORMATE; GLUCOSE	A maternal high-fat/sucrose diet, in the presence of maternal obesity, can program increased susceptibility to obesity and metabolic disease in offspring. In particular, nonalcoholic fatty liver disease risk is associated with poor maternal nutrition and obesity status, which may manifest via alterations in gut microbiota. Here, we report that in a preclinical model of diet-induced maternal obesity, maternal supplementation of a high-fat/sucrose diet with the prebiotic oligofructose improves glucose tolerance, insulin sensitivity, and hepatic steatosis in offspring following a long-term high-fat/sucrose dietary challenge compared with offspring of untreated dams. These improvements are associated with alterations in gut microbial composition and serum inflammatory profiles in early life and improvements in inflammatory and fatty-acid gene expression profiles in tissues. Serum metabolomics analysis highlights potential metabolic links between the gut microbiota and the degree of steatosis, including alterations in 1-carbon metabolism. Overall, our data suggest that maternal prebiotic intake protects offspring against hepatic steatosis and insulin resistance following 21 wk of high fat/sucrose diet, which is in part due to alterations in gut microbiota.	[Paul, Heather A.; Vogel, Hans J.; Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Urbanski, Stefan J.] Univ Calgary, Dept Pathol & Lab Med, Cumming Sch Med, Calgary, AB, Canada; [Collins, Kelsey H.; Nicolucci, Alissa C.; Hart, David A.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Bionucl Magnet Resonance NMR Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947	Canadian Institutes of Health Research [MOP 115076]; Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship; Alberta Innovates Health Solutions Doctoral Scholarship; Canadian Institutes of Health Research Doctoral Scholarship; Honorary Walter Killam Doctoral Scholarship; Alberta Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Health Solutions Doctoral Scholarship; Canadian Institutes of Health Research Doctoral Scholarship(Canadian Institutes of Health Research (CIHR)); Honorary Walter Killam Doctoral Scholarship; Alberta Cancer Foundation	The authors thank Kristine Lee and Carolyn Hewitt (both from the University of Calgary) for technical assistance. This work was supported by a research grant from the Canadian Institutes of Health Research (MOP 115076). H.A.P. was supported by an Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship, an Alberta Innovates Health Solutions Doctoral Scholarship, and a Canadian Institutes of Health Research Doctoral Scholarship. K.H.C. was supported by a Canadian Institutes of Health Research Doctoral Scholarship, an Honorary Walter Killam Doctoral Scholarship, and an Alberta Innovates Health Solutions Doctoral Scholarship. H.J.V. acknowledges funding from the Alberta Cancer Foundation. R.A.R. previously held a research grant from Beneo-Orafti, the manufacturer of Raftilose P95, for a project unrelated to the current work. The authors declare no other conflicts of interest.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Barr J, 2012, J PROTEOME RES, V11, P2521, DOI 10.1021/pr201223p; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Bomhof MR, 2016, FASEB J, V30, P2720, DOI 10.1096/fj.201600151R; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020; Brosnan ME, 2016, ANNU REV NUTR, V36, P369, DOI 10.1146/annurev-nutr-071715-050738; Caluwaerts S, 2007, METABOLISM, V56, P1431, DOI 10.1016/j.metabol.2007.06.007; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2017, NAT REV GASTRO HEPAT, V14, P321, DOI 10.1038/nrgastro.2017.54; Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P1989, DOI 10.1016/j.joca.2015.03.014; Collins KH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00112; Collins KH, 2016, J ORTHOP RES, V34, P2069, DOI 10.1002/jor.23230; Collins KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37278; Collins KH, 2016, J ORTHOP RES, V34, P1010, DOI 10.1002/jor.23103; Cordero P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091041; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Simino LAD, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0168-4; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; Furmento VA, 2014, PLACENTA, V35, P937, DOI 10.1016/j.placenta.2014.09.003; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Gralka E, 2015, AM J CLIN NUTR, V102, P1313, DOI 10.3945/ajcn.115.110536; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Heimann E, 2016, ADIPOCYTE, V5, P359, DOI 10.1080/21623945.2016.1252011; Hu CY, 2015, P NATL ACAD SCI USA, V112, P11318, DOI 10.1073/pnas.1513509112; Huang JL, 2012, TRANSGENIC RES, V21, P1311, DOI 10.1007/s11248-012-9615-1; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Liang QD, 2015, EUR J MASS SPECTROM, V21, P801, DOI 10.1255/ejms.1395; Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109757, 10.1371/journal.pone.0090827]; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mack I, 2016, SCI REP-UK, V6, DOI 10.1038/srep26752; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Miegueu P, 2013, INT J OBESITY, V37, P366, DOI 10.1038/ijo.2012.73; Mitrou P, 2011, EXP CLIN ENDOCR DIAB, V119, P484, DOI 10.1055/s-0030-1269846; Morrow GP, 2015, J BIOL CHEM, V290, P2244, DOI 10.1074/jbc.M114.600718; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Mulligan CM, 2017, J ENDOCRINOL, V235, pR1, DOI [10.1530/JOE-17-0303, 10.1530/joe-17-0303]; Nam HH, 2017, ONCOTARGET, V8, P97965, DOI 10.18632/oncotarget.18967; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Newsome PN, 2018, LANCET GASTROENTEROL, V3, P25, DOI 10.1016/S2468-1253(17)30326-6; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Parnell JA, 2012, LIVER INT, V32, P701, DOI 10.1111/j.1478-3231.2011.02730.x; Parnell JA, 2010, BRIT J NUTR, V103, P1577, DOI 10.1017/S0007114509993539; Paschos P, 2009, HIPPOKRATIA, V13, P9; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Reinhardt C, 2009, J PEDIATR GASTR NUTR, V48, P249, DOI 10.1097/MPG.0b013e318183187c; Sohn K, 2017, SEMIN FETAL NEONAT M, V22, P284, DOI 10.1016/j.siny.2017.07.002; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stoppeler S, 2013, LAB ANIM-UK, V47, P43, DOI 10.1177/0023677212473717; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Tsao CH, 2014, J LIPID RES, V55, P385, DOI 10.1194/jlr.M041392; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Walkers AK, 2017, TRENDS ENDOCRIN MET, V28, P63, DOI 10.1016/j.tem.2016.10.004; Walter TJ, 2014, AM J PHYSIOL-GASTR L, V306, pG849, DOI 10.1152/ajpgi.00426.2013; Wan XY, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/6489012; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010011; Wei W, 2017, GENE, V636, P23, DOI 10.1016/j.gene.2017.08.036; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; Wree A., 2017, HEPATOLOGY, V67, P461; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592	84	30	30	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5153	5167		10.1096/fj.201801551R	http://dx.doi.org/10.1096/fj.201801551R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629464	Bronze			2022-12-26	WOS:000462888500043
J	Chepurny, OG; Matsoukas, MT; Liapakis, G; Leech, CA; Milliken, BT; Doyle, RP; Holz, GG				Chepurny, Oleg G.; Matsoukas, Minos-Timotheos; Liapakis, George; Leech, Colin A.; Milliken, Brandon T.; Doyle, Robert P.; Holz, George G.			Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucagon; G protein-coupled receptor (GPCR); pharmacology; fluorescence resonance energy transfer (FRET); type 2 diabetes; GLP-1; high-throughput microplate assay	DEPENDENT INSULINOTROPIC POLYPEPTIDE; PANCREATIC BETA-CELLS; NEUROPEPTIDE YY2 RECEPTOR; CRYO-EM STRUCTURE; PEPTIDE-1 RECEPTOR; PROTEIN-KINASE; FUNCTIONAL EXPRESSION; GLUCOSE-HOMEOSTASIS; BLOOD-GLUCOSE; CLONING	G protein-coupled receptors (GPCRs) for glucagon (GluR) and glucagon-like peptide-1 (GLP-1R) are normally considered to be highly selective for glucagon and GLP-1, respectively. However, glucagon secreted from pancreatic -cells may accumulate at high concentrations to exert promiscuous effects at the -cell GLP-1R, as may occur in the volume-restricted microenvironment of the islets of Langerhans. Furthermore, systemic administration of GluR or GLP-1R agonists and antagonists at high doses may lead to off-target effects at other receptors. Here, we used molecular modeling to evaluate data derived from FRET assays that detect cAMP as a read-out for GluR and GLP-1R activation. This analysis established that glucagon is a nonconventional GLP-1R agonist, an effect inhibited by the GLP-1R orthosteric antagonist exendin(9-39) (Ex(9-39)). The GluR allosteric inhibitors LY2409021 and MK 0893 antagonized glucagon and GLP-1 action at the GLP-1R, whereas des-His(1)-[Glu(9)]glucagon antagonized glucagon action at the GluR, while having minimal inhibitory action versus glucagon or GLP-1 at the GLP-1R. When testing Ex(9-39) in combination with des-His(1)-[Glu(9)]glucagon in INS-1 832/13 cells, we validated a dual agonist action of glucagon at the GluR and GLP-1R. Hybrid peptide GGP817 containing glucagon fused to a fragment of peptide YY (PYY) acted as a triagonist at the GluR, GLP-1R, and neuropeptide Y2 receptor (NPY2R). Collectively, these findings provide a new triagonist strategy with which to target the GluR, GLP-1R, and NPY2R. They also provide an impetus to reevaluate prior studies in which GluR and GLP-1R agonists and antagonists were assumed not to exert promiscuous actions at other GPCRs.	[Chepurny, Oleg G.; Doyle, Robert P.; Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Leech, Colin A.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Matsoukas, Minos-Timotheos] Univ Patras, Dept Pharm, Patras 26500, Greece; [Liapakis, George] Univ Crete, Dept Pharmacol, Sch Med, Iraklion 71003, Crete, Greece; [Milliken, Brandon T.; Doyle, Robert P.] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Patras; University of Crete; Syracuse University	Doyle, RP; Holz, GG (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.; Holz, GG (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.; Doyle, RP (corresponding author), Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA.	rpdoyle@syr.edu; holzg@upstate.edu	Matsoukas, Minos-Timotheos/B-8746-2012; Doyle, Robert P/W-1921-2018; Holz, George G/A-3386-2012	Matsoukas, Minos-Timotheos/0000-0002-4642-8163; Holz, George/0000-0002-1781-3580	National Institutes of Health [R01-DK069575]; Holz Laboratory Diabetes Research Fund; SUNY Upstate Medical University Health Science Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Holz Laboratory Diabetes Research Fund; SUNY Upstate Medical University Health Science Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK069575 (to G. G. H.) and by the Holz Laboratory Diabetes Research Fund, dedicated to Mignon M. Holz of the SUNY Upstate Medical University Health Science Center Foundation. Syracuse University holds patent rights on GGP817 conceived of by R. P. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Brandt SJ, 2018, PEPTIDES, V100, P190, DOI 10.1016/j.peptides.2017.12.021; Calabria AC, 2012, DIABETES, V61, P2585, DOI 10.2337/db12-0166; Capozzi ME, 2018, ENDOCR REV, V39, P719, DOI 10.1210/er.2018-00117; Chabenne J, 2014, MOL METAB, V3, P293, DOI 10.1016/j.molmet.2014.01.006; Chambers AP, 2017, CELL METAB, V25, P927, DOI 10.1016/j.cmet.2017.02.008; Chepurny OG, 2002, ENDOCRINOLOGY, V143, P2303, DOI 10.1210/en.143.6.2303; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; Chepurny OG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22106-1; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Cooper J, 1997, BRIT J PHARMACOL, V122, P546, DOI 10.1038/sj.bjp.0701401; Cypess A. M., 1999, THESIS; D'Alessio D, 2016, J DIABETES INVEST, V7, P50, DOI 10.1111/jdi.12466; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Donath MY, 2013, DIABETES CARE, V36, pS145, DOI 10.2337/dcS13-2015; Dong MQ, 2008, MOL ENDOCRINOL, V22, P1489, DOI 10.1210/me.2008-0025; Dumont Y, 2000, BRIT J PHARMACOL, V129, P1075, DOI 10.1038/sj.bjp.0703162; Engel SS, 2011, DIABETES, V60, pA85; Evers A, 2017, J MED CHEM, V60, P4293, DOI 10.1021/acs.jmedchem.7b00174; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Gault VA, 2013, J BIOL CHEM, V288, P35581, DOI 10.1074/jbc.M113.512046; GOKE R, 1993, J BIOL CHEM, V268, P19650; GREMLICH S, 1995, DIABETES, V44, P1202, DOI 10.2337/diabetes.44.10.1202; GROMADA J, 1995, FEBS LETT, V373, P182, DOI 10.1016/0014-5793(95)01070-U; Guzman CB, 2017, DIABETES OBES METAB, V19, P1521, DOI 10.1111/dom.12958; Habib AM, 2013, DIABETOLOGIA, V56, P1413, DOI 10.1007/s00125-013-2887-z; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Holz G. G., 2015, CYCLIC NUCLEOTIDE SI, P35; Holz George G, 2005, Sci STKE, V2005, ppe2; Holz GG, 2003, CURR MED CHEM, V10, P2471, DOI 10.2174/0929867033456648; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Karageorgos V, 2018, HORM-INT J ENDOCRINO, V17, P45, DOI 10.1007/s42000-018-0009-5; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; Kazda CM, 2016, DIABETES CARE, V39, P1241, DOI 10.2337/dc15-1643; Kelly RP, 2015, DIABETES OBES METAB, V17, P414, DOI 10.1111/dom.12446; Kim SJ, 2005, J BIOL CHEM, V280, P28692, DOI 10.1074/jbc.M504913200; Kjaergaard M, 2019, NEUROPEPTIDES, V73, P89, DOI 10.1016/j.npep.2018.11.004; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Koebel MR, 2016, J CHEM INF MODEL, V56, P2298, DOI 10.1021/acs.jcim.6b00236; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Leech CA, 2011, PROG BIOPHYS MOL BIO, V107, P236, DOI 10.1016/j.pbiomolbio.2011.07.005; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liapakis G, 2017, CURR MED CHEM, V24, P3323, DOI 10.2174/0929867324666170303162416; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Muller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; O'Malley TJ, 2014, DIABETES-METAB RES, V30, P661, DOI 10.1002/dmrr.2534; Parker SL, 2008, BRIT J PHARMACOL, V153, P420, DOI 10.1038/sj.bjp.0707445; ROSE PM, 1995, J BIOL CHEM, V270, P22661, DOI 10.1074/jbc.270.39.22661; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sanchez-Garrido MA, 2017, DIABETOLOGIA, V60, P1851, DOI 10.1007/s00125-017-4354-8; Sathananthan M, 2013, DIABETES, V62, P2752, DOI 10.2337/db13-0140; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Schwede F, 2015, MOL ENDOCRINOL, V29, P988, DOI 10.1210/me.2014-1330; Scott RV, 2018, PEPTIDES, V100, P36, DOI 10.1016/j.peptides.2017.11.013; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Skow MA, 2016, DIABETES OBES METAB, V18, P847, DOI 10.1111/dom.12685; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Svendsen B, 2018, CELL REP, V25, P1127, DOI 10.1016/j.celrep.2018.10.018; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Xiong YS, 2012, J MED CHEM, V55, P6137, DOI 10.1021/jm300579z; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	81	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3514	3531		10.1074/jbc.RA118.005682	http://dx.doi.org/10.1074/jbc.RA118.005682			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622136	Green Published, hybrid			2022-12-26	WOS:000461853900018
J	Watari, M; Ikuta, T; Yamada, D; Shihoya, W; Yoshida, K; Tsunoda, SP; Nureki, O; Kandori, H				Watari, Masahito; Ikuta, Tatsuya; Yamada, Daichi; Shihoya, Wataru; Yoshida, Kazuho; Tsunoda, Satoshi P.; Nureki, Osamu; Kandori, Hideki			Spectroscopic study of the transmembrane domain of a rhodopsin-phosphodiesterase fusion protein from a unicellular eukaryote	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphodiesterase; spectroscopy; photoreceptor; proton transport; structure-function; rhodopsin; microbial rhodopsin; photoisomerization; proton transfer; structural change; optogenetics; light-activated enzyme; chromophore	ANABAENA SENSORY RHODOPSIN; INDUCED STRUCTURAL-CHANGES; INTERNAL WATER-MOLECULES; HYDROGEN-BONDED WATER; SCHIFF-BASE REGION; MICROBIAL RHODOPSINS; FTIR SPECTROSCOPY; ADENYLYL-CYCLASE; BACTERIORHODOPSIN; CHANNELRHODOPSIN-2	The choanoflagellate Salpingoeca rosetta contains a chimeric rhodopsin protein composed of an N-terminal rhodopsin (Rh) domain and a C-terminal cyclic nucleotide phosphodiesterase (PDE) domain. The Rh-PDE enzyme light-dependently decreases the concentrations of cyclic nucleotides such as cGMP and cAMP. Photoexcitation of purified full-length Rh-PDE yields an M intermediate with a deprotonated Schiff base, and its recovery is much faster than that of the enzyme domain. To gain structural and mechanistic insights into the Rh domain, here we expressed and purified the transmembrane domain of Rh-PDE, Rh-PDE(TMD), and analyzed it with transient absorption, light-induced difference UV-visible, and FTIR spectroscopy methods. These analyses revealed that the K intermediate forms within 0.005 ms and converts into the M intermediate with a time constant of 4 ms, with the latter returning to the original state within 4 s. FTIR spectroscopy revealed that all-trans to 13-cis photoisomerization occurs as the primary event during which chromophore distortion is located at the middle of the polyene chain, allowing the Schiff base to form a stronger hydrogen bond. We also noted that the peptide backbone of the -helix becomes deformed upon M intermediate formation. Results from site-directed mutagenesis suggested that Glu-164 is protonated and that Asp-292 acts as the only Schiff base counterion in Rh-PDE. A strong reduction of enzymatic activity in a D292N variant, but not in an E164Q variant, indicated an important catalytic role of the negative charge at Asp-292. Our findings provide further mechanistic insights into rhodopsin-mediated, light-dependent regulation of second-messenger levels in eukaryotic microbes.	[Watari, Masahito; Yamada, Daichi; Yoshida, Kazuho; Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ikuta, Tatsuya; Shihoya, Wataru; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tsunoda, Satoshi P.] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Nagoya Institute of Technology; Nagoya Institute of Technology; University of Tokyo; Japan Science & Technology Agency (JST)	Kandori, H (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan.; Kandori, H (corresponding author), Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan.	kandori@nitech.ac.jp	Tsunoda, Satoshi/AAN-7023-2021; NUREKI, OSAMU/G-4960-2014	Ikuta, Tatsuya/0000-0002-8597-0609; Tsunoda, Satoshi/0000-0003-3636-1521	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17J30010, 18K14634, 18K06109, 16H06294, 25104009, 15H02391, 18H03986]; CREST, Japan Science and Technology Agency [JPMJCR1753]; PRESTO, Japan Science and Technology Agency [JPMJPR1688]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 17J30010 and 18K14634 (to W. S.), 18K06109 (to S. P. T.) and 16H06294 (to O. N.), and 25104009, 15H02391, and 18H03986 (to H. K.); by CREST, Japan Science and Technology Agency, Grant JPMJCR1753 (to H. K.); and by PRESTO, Japan Science and Technology Agency, Grant JPMJPR1688 (to S. P. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P12287, DOI 10.1021/bi050841o; Furutani Y, 2004, BIOCHEMISTRY-US, V43, P5204, DOI 10.1021/bi036316b; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; Ikeda D, 2007, BIOCHEMISTRY-US, V46, P5365, DOI 10.1021/bi700143g; Inaguma A, 2015, J BIOL CHEM, V290, P11623, DOI 10.1074/jbc.M115.642256; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Inoue K, 2012, J PHYS CHEM B, V116, P5888, DOI 10.1021/jp302357m; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kandori H, 2002, BIOCHEMISTRY-US, V41, P6026, DOI 10.1021/bi025585j; Kandori H., 2011, SUPRAMOLECULAR PHOTO, P571; Kawanabe A, 2006, BIOCHEMISTRY-US, V45, P4362, DOI 10.1021/bi052324b; Kawanabe A, 2007, J AM CHEM SOC, V129, P8644, DOI 10.1021/ja072085a; Lamarche LB, 2017, BIOCHEMISTRY-US, V56, P5812, DOI 10.1021/acs.biochem.7b00519; Lorenz-Fonfria VA, 2015, P NATL ACAD SCI USA, V112, pE5796, DOI 10.1073/pnas.1511462112; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Mizuide N, 2006, BIOCHEMISTRY-US, V45, P10674, DOI 10.1021/bi060958s; Moltke S, 1995, BIOPHYS J, V69, P2074, DOI 10.1016/S0006-3495(95)80078-0; Muroda K, 2012, BIOCHEMISTRY-US, V51, P4677, DOI 10.1021/bi300485r; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Shibata N, 2005, BIOCHEMISTRY-US, V44, P7406, DOI 10.1021/bi050122+; Singh M, 2018, BIOCHEMISTRY-US, V57, P5041, DOI 10.1021/acs.biochem.8b00637; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Sumii M, 2005, BIOCHEMISTRY-US, V44, P15159, DOI 10.1021/bi0513498; Tanimoto T, 2003, BIOCHEMISTRY-US, V42, P2300, DOI 10.1021/bi026990d; Tian YH, 2018, BIOCHEM J, V475, P1121, DOI 10.1042/BCJ20180010; Tsunoda SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179232; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	46	17	17	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3432	3443		10.1074/jbc.RA118.006277	http://dx.doi.org/10.1074/jbc.RA118.006277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622140	Green Published, hybrid			2022-12-26	WOS:000461853900011
J	Martin-Galiano, AJ; Lopez, D				Martin-Galiano, Antonio J.; Lopez, Daniel			Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells	PLOS ONE			English	Article							CLASS-I MOLECULES; PRESENTED PEPTIDES; T-LYMPHOCYTES; DEFICIENT; REPERTOIRE; ABUNDANCE; PROTEINS; REVEALS; LIGANDS; GENE	The transporter associated with antigen processing (TAP) is a key element of the major histocompatibility complex (MHC) class I antigen processing and presentation pathway. Nonfunctional TAP complexes impair the translocation of cytosol-derived proteolytic peptides to the endoplasmic reticulum lumen. This drastic reduction in the available peptide repertoire leads to a significant decrease in MHC class I cell surface expression. Using mass spectrometry, different studies have analyzed the cellular MHC class I ligandome from TAP-deficient cells, but the analysis of the parental proteins, the source of these ligands, still deserves an in-depth analysis. In the present report, several bioinformatics protocols were applied to investigate the nature of parental proteins for the previously identified TAP-independent MHC class I ligands. Antigen processing in TAP-deficient cells mainly focused on small, abundant or highly integral transmembrane proteins of the cellular proteome. This process involved abundant proteins of the central RNA metabolism. In addition, TAP-independent ligands were preferentially cleaved from the N- and C-terminal ends with respect to the central regions of the parental proteins. The abundance of glycine, proline and aromatic residues in the C-terminal sequences from TAP-independently processed proteins allows the accessibility and specificity required for the proteolytic activities that generates the TAP-independent ligandome. This limited proteolytic activity towards a set of preferred proteins in a TAP-negative environment would therefore suffice to promote the survival of TAP-deficient individuals.	[Martin-Galiano, Antonio J.] Inst Salud Carlos III, Unidad Bioinformat, Ctr Nacl Microbiol, Madrid, Spain; [Lopez, Daniel] Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Martin-Galiano, AJ (corresponding author), Inst Salud Carlos III, Unidad Bioinformat, Ctr Nacl Microbiol, Madrid, Spain.; Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Madrid, Spain.	mgaliano@isciii.es; dlopez@isciii.es	López, Daniel/I-2632-2014	López, Daniel/0000-0003-0268-5878; Martin-Galiano, Antonio Javier/0000-0002-6662-329X	Spanish Ministry of Economy (MINECO/FEDER) [SAF2014-58052]; Accion Estrategica en Salud 2019	Spanish Ministry of Economy (MINECO/FEDER); Accion Estrategica en Salud 2019	This work was supported by the Spanish Ministry of Economy (MINECO/FEDER) grant SAF2014-58052 and Accion Estrategica en Salud 2019 to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029805; Del Val M, 2013, MOL IMMUNOL, V55, P117, DOI 10.1016/j.molimm.2012.10.018; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Dengjel J, 2006, CLIN CANCER RES, V12, P4163, DOI 10.1158/1078-0432.CCR-05-2470; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Fortier M. H., 2008, J EXP MED; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; Juncker AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007448; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Lopez D, 2013, EXPERT REV VACCINES, V12, P1077, DOI 10.1586/14760584.2013.825447; Lorente E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059118; Lorente E, 2011, J BIOL CHEM, V286, P38054, DOI 10.1074/jbc.M111.281808; Mommen GPM, 2016, MOL CELL PROTEOMICS, V15, P1412, DOI 10.1074/mcp.M115.055780; Mylonas R, 2018, MOL CELL PROTEOMICS, V17, P2347, DOI 10.1074/mcp.RA118.000877; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Scholz E, 2016, ARTHRITIS RHEUMATOL, V68, P2412, DOI 10.1002/art.39736; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; Unanue ER, 2016, ANNU REV IMMUNOL, V34, P265, DOI 10.1146/annurev-immunol-041015-055420; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; Wilkins MR, 1999, METH MOL B, V112, P531; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	43	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210583	10.1371/journal.pone.0210583	http://dx.doi.org/10.1371/journal.pone.0210583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645615	Green Published, gold, Green Submitted			2022-12-26	WOS:000455810200036
J	Alves, DFR; Greco, LSL; Barros-Alves, SD; Hirose, GL				Rodrigues Alves, Douglas Fernandes; Lopez Greco, Laura S.; Barros-Alves, Samara de Paiva; Hirose, Gustavo Luis			Sexual system, reproductive cycle and embryonic development of the red-striped shrimp Lysmata vittata, an invader in the western Atlantic Ocean	PLOS ONE			English	Article							PROTANDRIC SIMULTANEOUS HERMAPHRODITISM; CALLINECTES-SAPIDUS RATHBUN; OVARIAN DEVELOPMENT; INVASIVE CRAB; LIFE-HISTORY; ZOEAL STAGES; DECAPODA; CARIDEA; HIPPOLYTIDAE; BRACHYURA	Several decapod crustaceans are invaders, but little is known about the biological characteristics that potentiate the success of these decapods in invaded ecosystems. Here, we evaluate and describe some aspects of the reproductive biology and development of Lysmata vittata, an invasive shrimp species in the Atlantic Ocean. In addition, we intend to provide important insights into the biology of invasion by comparing the reproductive traits of this shrimp with some of the predictions about aquatic invasive species. We used experimental and laboratory observations to evaluate the functionality of protandric simultaneous hermaphroditism (PSH), the macro and microscopic development of the ovarian portion of the ovotestes, the reproductive cycle, and the embryonic development of L. vittata. We confirm the functionality of PSH in L. vittata. This shrimp has a rapid reproductive cycle; the ovarian portion of the ovotestes develops (mean +/- SD) 6.28 +/- 1.61 days after spawning. Embryonic development also occurs over a short time, with a mean (+/- SD) of 8.37 +/- 0.85 days. The larvae hatch without macroscopically visible yolk reserves. Our study provides evidence that the invasive shrimp L. vittata has reproductive and embryonic developmental characteristics (i.e., short generation time and high reproductive capacity) that may be favorable to the establishment of populations during invasive processes.	[Rodrigues Alves, Douglas Fernandes; Hirose, Gustavo Luis] Univ Fed Sergipe, Dept Biol, Sao Cristovao, Sergipe, Brazil; [Rodrigues Alves, Douglas Fernandes; Hirose, Gustavo Luis] Univ Fed Sergipe, Programa Posgrad Ecol & Conservacao, Sao Cristovao, Sergipe, Brazil; [Lopez Greco, Laura S.] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat,IBBEA, Dept Biodiversidad & Biol Expt,Lab Biol Exactas &, Buenos Aires, DF, Argentina; [Barros-Alves, Samara de Paiva] Univ Fed Uberlandia, Lab Ecol Ecossistemas Aqua, Uberlandia, MG, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal de Uberlandia	Alves, DFR (corresponding author), Univ Fed Sergipe, Dept Biol, Sao Cristovao, Sergipe, Brazil.; Alves, DFR (corresponding author), Univ Fed Sergipe, Programa Posgrad Ecol & Conservacao, Sao Cristovao, Sergipe, Brazil.	douglas_biologo@yahoo.com.br	Alves, Douglas Fernandes Rodrigues/AAB-8944-2021; Barros-Alves, Samara de Paiva/G-2249-2012; Hirose, Gustavo/D-9603-2012	Alves, Douglas Fernandes Rodrigues/0000-0003-4363-6511; Barros-Alves, Samara de Paiva/0000-0001-7216-3421; Hirose, Gustavo/0000-0001-7484-0393	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); PROEF grants (CAPES/FAPITEC/) [88881.157451/2017-01]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PROEF grants (CAPES/FAPITEC/)	DFRA thanks CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for Research Scholarships (Programa Nacional de Pos Doutorado/Capes - PNPD). This study was supported by PROEF grants (CAPES/FAPITEC/#88881.157451/2017-01).	Ahyong ST, 2010, ZOOTAXA, P341; Baeza JA, 2013, ZOOL J LINN SOC-LOND, V168, P699, DOI 10.1111/zoj.12044; Baeza JA, 2008, J CRUSTACEAN BIOL, V28, P148, DOI 10.1651/07-2839R.1; Baeza JA, 2013, MOL PHYLOGENET EVOL, V69, P46, DOI 10.1016/j.ympev.2013.05.013; Baeza JA, 2007, BEHAV ECOL SOCIOBIOL, V61, P365, DOI 10.1007/s00265-006-0265-2; Baeza J. Antonio, 2009, Smithsonian Contributions to the Marine Sciences, P95; Baeza JA, 2007, J NAT HIST, V41, P2843, DOI 10.1080/00222930701770778; Bauer RT, 2006, INTEGR COMP BIOL, V46, P430, DOI 10.1093/icb/icj036; Bauer RT, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P277, DOI 10.1007/978-0-387-77101-4_14; Bauer RT, 2005, J MAR BIOL ASSOC UK, V85, P101, DOI 10.1017/S0025315405010891h; Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Bauer RT, 2004, J CRUSTACEAN BIOL, V24, P131, DOI 10.1651/C-2426; Bauer RT, 1991, CRUSTACEAN SEXUAL BI; Bauer RT., 2005, J CRUSTACEAN BIOL, V25, P319, DOI [10.1651/0278-0372(2005)025[0319:BR]2.0.CO;2, DOI 10.1651/0278-0372(2005)025[0319:BR]2.0.CO;2]; Bazin E, 2014, BIOL INVASIONS, V16, P875, DOI 10.1007/s10530-013-0544-6; Brillon S, 2005, MAR BIOL, V147, P895, DOI 10.1007/s00227-005-1633-6; Calado R, 2007, J EXP MAR BIOL ECOL, V351, P226, DOI 10.1016/j.jembe.2007.06.022; Calado R, 2007, AQUACULTURE, V263, P68, DOI 10.1016/j.aquaculture.2006.10.013; Crawley, 2013, STAT COMPUTING INTRO; D'Udekem C, 2002, CRUSTACEANA, V75, P1149, DOI 10.1163/156854002763270545; Dineen JF, 2001, J CRUSTACEAN BIOL, V21, P774, DOI 10.1651/0278-0372(2001)021[0774:LHLDAN]2.0.CO;2; da Silva GMF, 2009, AQUAC RES, V40, P798, DOI 10.1111/j.1365-2109.2009.02165.x; Fiedler G. Curt, 1998, Pacific Science, V52, P161; Fletcher D. J., 1995, International Zoo Yearbook, V34, P73, DOI 10.1111/j.1748-1090.1995.tb00661.x; Garcia L, 2018, BIOINVASIONS REC, V7, P191, DOI 10.3391/bir.2018.7.2.12; Garcia-Guerrero M, 2003, COMP BIOCHEM PHYS A, V135, P147, DOI 10.1016/S1095-6433(02)00354-9; Garcia-Guerrero MU, 2005, CRUSTACEANA, V78, P1089, DOI 10.1163/156854005775361089; Gonzalez-Pisani X, 2013, ZOOTAXA, V3718, P301, DOI 10.11646/zootaxa.3718.4.1; GORE R H, 1972, Crustaceana (Leiden), V22, P67, DOI 10.1163/156854072X00688; Gregati RA, 2010, AQUACULTURE, V306, P185, DOI 10.1016/j.aquaculture.2010.05.009; Gust N, 2006, BIOL INVASIONS, V8, P339, DOI 10.1007/s10530-004-8243-y; Hanson E, 2008, BIOL INVASIONS, V10, P603, DOI 10.1007/s10530-007-9156-3; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hertzler P. L., 2015, EVOLUTIONARY DEV BIO, V4, P63; Hiller A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03410-8; Keunecke KA, 2009, CRUSTACEANA, V82, P753, DOI 10.1163/156854009X423175; Klann M, 2014, ZOOMORPHOLOGY, V133, P295, DOI 10.1007/s00435-014-0224-9; Klotz W, 2013, AQUAT INVASIONS, V8, P333, DOI 10.3391/ai.2013.8.3.09; Lardies MA, 2008, EVOL ECOL RES, V10, P747; Lenz M, 2018, BIOL INVASIONS, V20, P3107, DOI 10.1007/s10530-018-1762-8; Greco LSL, 2007, ACTA ZOOL-STOCKHOLM, V88, P223, DOI 10.1111/j.1463-6395.2007.00269.x; Mantelatto F, 1999, CRUSTACEANA, V72, P39, DOI [10.1163/156854099504068, DOI 10.1163/156854099504068]; Marin IN, 2012, RUSS J MAR BIOL+, V38, P359, DOI 10.1134/S1063074012040062; Marin I, 2012, CRUSTACEANA, V85, P123, DOI 10.1163/156854012X623548; Martins J, 2007, J CRUSTACEAN BIOL, V27, P220, DOI 10.1651/C-2597.1; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Negri M, 2018, BIOL INVASIONS, V20, P1771, DOI 10.1007/s10530-018-1660-0; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Alves DFR, 2018, ZOOTAXA, V4526, P41, DOI 10.11646/zootaxa.4526.1.3; Romero-Carvajal A, 2018, BIOL BULL-US, V234, P165, DOI 10.1086/698468; Sant'Anna BS, 2012, AQUAT INVASIONS, V7, P347, DOI 10.3391/ai.2012.7.3.006; Almeida ASE, 2018, INVERTEBR REPROD DEV, V62, P257, DOI 10.1080/07924259.2018.1509903; Soledade GO, 2013, J CRUSTACEAN BIOL, V33, P66, DOI 10.1163/1937240X-00002122; Stasolla G, 2014, BIOINVASIONS REC, V3, P39, DOI 10.3391/bir.2014.3.1.07; Tavares M, 2011, INVAD NAT SPRING SER, V6, P251, DOI 10.1007/978-94-007-0591-3_7; Triay-Portella R, 2017, MAR BIOL RES, V13, P174, DOI 10.1080/17451000.2016.1239018; Tropea C, 2013, ACTA ZOOL-STOCKHOLM, V94, P462, DOI 10.1111/j.1463-6395.2012.00575.x; Turner R. L., 1979, REPROD ECOLOGY MARIN, P25; Tziouveli V, 2012, AQUACULT INT, V20, P201, DOI 10.1007/s10499-011-9496-y; Wang YR, 2018, ZOOTAXA, V4392, P28, DOI 10.11646/zootaxa.4392.1.2; Yang Hoi Jeong, 2010, Korean Journal of Systematic Zoology, V26, P261; Zar JH., 2010, BIOSTAT ANAL, V5th	62	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210723	10.1371/journal.pone.0210723	http://dx.doi.org/10.1371/journal.pone.0210723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645636	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200048
J	Dunk, JR; Woodbridge, B; Schumaker, N; Glenn, EM; White, B; LaPlante, DW; Anthony, RG; Davis, RJ; Halupka, K; Henson, P; Marcot, BG; Merola-Zwartjes, M; Noon, BR; Raphael, MG; Caicco, J; Hansen, DL; Mazurek, MJ; Thrailkill, J				Dunk, Jeffrey R.; Woodbridge, Brian; Schumaker, Nathan; Glenn, Elizabeth M.; White, Brendan; LaPlante, David W.; Anthony, Robert G.; Davis, Raymond J.; Halupka, Karl; Henson, Paul; Marcot, Bruce G.; Merola-Zwartjes, Michele; Noon, Barry R.; Raphael, Martin G.; Caicco, Jody; Hansen, Dan L.; Mazurek, Mary Jo; Thrailkill, James			Conservation planning for species recovery under the Endangered Species Act: A case study with the Northern Spotted Owl	PLOS ONE			English	Article							BARRED OWLS; HABITAT SELECTION; HOME-RANGE; CLIMATE-CHANGE; DEMOGRAPHIC PERFORMANCE; DISTRIBUTION MODELS; PACIFIC-NORTHWEST; CASCADE MOUNTAINS; NEST SITES; UNCERTAINTY	The northern spotted owl (Strix occidentalis caurina) was listed as threatened under the U. S. Endangered Species Act (ESA) in 1990. We applied modern spatial conservation theory and models to evaluate several candidate critical habitat networks, and sought an efficient conservation solution that encompassed the highest value lands for spotted owl recovery rather than maximizing the total area of potential critical habitat. We created a map of relative habitat suitability, which served as input to the spatial conservation prioritization program Zonation. We used the spatially-explicit individual-based population model HexSim to estimate and compare simulated spotted owl population outcomes among a suite of candidate critical habitat networks that varied in size and spatial arrangement under alternative scenarios of future habitat suitability and barred owl (S. varia) effects. We evaluated simulated spotted owl population outcomes, including total population size, and extinction and quasi-extinction likelihoods for 108 combinations of candidate critical habitat networks by habitat change by barred owl scenarios, both range-wide and within 11 distinct portions of the owl's range. Barred owl encounter rates and the amount and suitability of habitat had substantial effects on simulated spotted owl populations. When barred owl encounter rates were high, changes in the amount and suitability of habitat had minimal impacts on population performance. Under lowered barred owl encounter rates, candidate critical habitat networks that included most existing high suitability habitat supported a high likelihood of long-term population persistence. Barred owls are currently the primary driving force behind poor population performance of NSOs; however, our models demonstrated that a sufficient area of high suitability habitat remains essential for recovery when effects of barred owls can be reduced. The modeling approach we employed is sufficiently flexible to incorporate new information about spotted owls as it becomes available and could likely be applied to conservation planning for other species.	[Dunk, Jeffrey R.] Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA; [Woodbridge, Brian] US Fish & Wildlife Serv, Western Golden Eagle Conservat, Corvallis, OR USA; [Schumaker, Nathan] US EPA, Environm Res Lab, 200 SW 35Th St, Corvallis, OR 97333 USA; [Glenn, Elizabeth M.; White, Brendan; Henson, Paul; Caicco, Jody] US Fish & Wildlife Serv, Portland, OR USA; [LaPlante, David W.] Nat Resources Geospatial, Smontague, CA USA; [Anthony, Robert G.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Davis, Raymond J.] US Forest Serv, Forestry Sci Lab, Corvallis, OR USA; [Halupka, Karl] US Fish & Wildlife Serv, Wenatchee, WA USA; [Marcot, Bruce G.] US Forest Serv, USDA, Pacific Northwest Res Stn, Portland, OR USA; [Merola-Zwartjes, Michele] US Fish & Wildlife Serv, Reg Endangered Species Listing Div 1, Portland, OR USA; [Noon, Barry R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Noon, Barry R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Raphael, Martin G.] US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA USA; [Hansen, Dan L.; Mazurek, Mary Jo] Humboldt State Univ Sponsored Programs Fdn, Arcata, CA USA; [Thrailkill, James] US Fish & Wildlife Serv, USDI, Roseburg, OR USA	California State University System; California State Polytechnic University, Humboldt; United States Department of the Interior; US Fish & Wildlife Service; United States Environmental Protection Agency; United States Department of the Interior; US Fish & Wildlife Service; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service; Colorado State University; Colorado State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service	Dunk, JR (corresponding author), Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA.	Jeffrey.Dunk@humboldt.edu		Schumaker, Nathan/0000-0002-4331-825X; Dunk, Jeffrey/0000-0002-3213-9272	USFWS [134250BJ151, F12AC01135, 81333BG035, 81333BG036, 13420]	USFWS(US Fish & Wildlife Service)	This work was supported in part by USFWS Agreements 134250BJ151 and F12AC01135 to JRD, and USFWS Agreements 81333BG035, 81333BG036, and 13420 -BJ to DL. The information in this document has been funded in part by the U.S. Environmental Protection Agency.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akcakaya HR, 1998, BIODIVERS CONSERV, V7, P875, DOI 10.1023/A:1008867602813; Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; Anthony RG, 2006, WILDLIFE MONOGR, P1; BARROWS C, 1978, Western Birds, V9, P1; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Bell DM, 2015, FOREST ECOL MANAG, V358, P154, DOI 10.1016/j.foreco.2015.09.007; Bingham BB, 1997, CONSERV BIOL, V11, P127, DOI 10.1046/j.1523-1739.1997.95331.x; Blakesley J.A., 2004, SCI EVALUATION STATU; BLAKESLEY JA, 1992, J WILDLIFE MANAGE, V56, P388, DOI 10.2307/3808840; Bodine EN, 2017, NAT RESOUR MODEL, V30, DOI 10.1111/nrm.12131; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Buchanan JB, 1998, CONSERV BIOL, V12, P238, DOI 10.1046/j.1523-1739.1998.97278.x; Burnham Kenneth P., 1996, Studies in Avian Biology, V17, P92; Camaclang Abbey, 2014, CONSERV BIOL, V29, P482, DOI DOI 10.1111/C0BI.12428; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Carroll C, 2008, CONSERV BIOL, V22, P1026, DOI 10.1111/j.1523-1739.2008.00931.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Clark D. A., 2007, THESIS; Comfort EJ, 2016, LANDSCAPE ECOL, V31, P1227, DOI 10.1007/s10980-015-0330-1; Correia RA, 2018, MITIG ADAPT STRAT GL, V23, P371, DOI 10.1007/s11027-017-9738-z; Davis R. J., 2011, PNWGTR850 USDA FOR S; Davis R.J., 2015, PNWGTR911 PAC NW RES; Diller LV, 2016, J WILDLIFE MANAGE, V80, P691, DOI 10.1002/jwmg.1046; Diller LV, 2014, WILDLIFE SOC B, V38, P211, DOI 10.1002/wsb.381; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; Dunk J. R., 2014, IDENTIFYING EVALUATI; Dunk JR, 2004, ECOL APPL, V14, P713, DOI 10.1890/02-5322; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FORSMAN E D, 1984, Wildlife Monographs, P1; Forsman ED, 2005, J RAPTOR RES, V39, P365; Forsman ED, 2002, WILDLIFE MONOGR, P1; Forsman ED, 2015, J RAPTOR RES, V49, P109, DOI 10.3356/rapt-49-02-109-128.1; Forsman ED, 2011, STUD AVIAN BIOL, P1; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; FRANKLIN AB, 1999, RANGE WIDE STATUS TR; Franklin J. F., 2004, SCI EVALUATION STATU; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Gabriel MW, 2018, AVIAN CONSERV ECOL, V13, DOI 10.5751/ACE-01134-130102; GANEY JL, 1993, WILSON BULL, V105, P645; Glenn EM, 2017, LANDSCAPE ECOL, V32, P563, DOI 10.1007/s10980-016-0467-6; Glenn EM, 2010, BIOL CONSERV, V143, P2543, DOI 10.1016/j.biocon.2010.06.021; Glenn EM, 2004, J WILDLIFE MANAGE, V68, P33, DOI 10.2193/0022-541X(2004)068[0033:SOHAHU]2.0.CO;2; Gremel S, 2005, THESIS; Grimm V., 2005, PRINCETON SERIES THE; Grinnell J., 1917, Auk Cambridge Mass, V34; Gutierrez RJ, 2007, BIOL INVASIONS, V9, P181, DOI 10.1007/s10530-006-9025-5; GUTIERREZ RJ, 1995, BIRDS N AM, V179; Hagmann RK, 2017, FOREST ECOL MANAG, V389, P374, DOI 10.1016/j.foreco.2016.12.029; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hamer TE, 2007, CONDOR, V109, P750, DOI 10.1650/0010-5422(2007)109[750:HRAAHS]2.0.CO;2; Heinrichs J. A., ECOLOGICAL MODELLING, V359, P449; Heinrichs JA, 2010, BIOL CONSERV, V143, P2229, DOI 10.1016/j.biocon.2010.06.009; Hershey KT, 1998, J WILDLIFE MANAGE, V62, P1398, DOI 10.2307/3802006; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Holm SR, 2016, WILDLIFE SOC B, V40, P615, DOI 10.1002/wsb.714; Huff M. H., 2006, SPATIALLY EXPLICIT E, V650; HUNTER JE, 1995, CONDOR, V97, P684, DOI 10.2307/1369177; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Irwin LL, 2018, J WILDLIFE MANAGE, V82, P202, DOI 10.1002/jwmg.21339; Kelly EG, 2003, CONDOR, V105, P45, DOI 10.1650/0010-5422(2003)105[45:ABODSO]2.0.CO;2; LaHaye WS, 1999, CONDOR, V101, P324, DOI 10.2307/1369995; Lint J., 1999, GEN TECHNICAL REPORT; Lint J. B., 1990, INT SCI COMM CONS NO; Loman ZG, 2018, LANDSCAPE ECOL, V33, P77, DOI 10.1007/s10980-017-0582-z; MARCOT B G, 1980, Western Birds, V11, P79; Marcot B. G., 1997, PNWGTR408 USDA FOR S; Marcot BG, 2015, NAT RESOUR MODEL, V28, P37, DOI 10.1111/nrm.12056; Marcot BG, 2013, NAT RESOUR MODEL, V26, P194, DOI 10.1111/j.1939-7445.2012.00134.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Meyer JS, 1998, WILDLIFE MONOGR, P5; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; MURPHY DD, 1992, ECOL APPL, V2, P3, DOI 10.2307/1941885; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Noon Barry R., 1996, P139; NOON BR, 1990, J WILDLIFE MANAGE, V54, P18, DOI 10.2307/3808895; Ohmann JL, 2014, REMOTE SENS ENVIRON, V151, P3, DOI 10.1016/j.rse.2013.08.048; Ohmann JL, 2002, CAN J FOREST RES, V32, P725, DOI [10.1139/x02-011, 10.1139/X02-011]; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peterson AT, 2003, CONSERV BIOL, V17, P1161, DOI 10.1046/j.1523-1739.2003.02206.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Raphael M. G., 2014, 0910831 JFSP; Reed J. Michael, 2006, P164; Reyers B, 2010, CONSERV BIOL, V24, P957, DOI 10.1111/j.1523-1739.2010.01497.x; RIPPLE WJ, 1991, J WILDLIFE MANAGE, V55, P316, DOI 10.2307/3809156; Schilling J.W., 2009, THESIS; Schumaker NH, 2018, LANDSCAPE ECOL, V33, P197, DOI 10.1007/s10980-017-0605-9; Schumaker NH, 2014, LANDSCAPE ECOL, V29, P579, DOI 10.1007/s10980-014-0004-4; Singleton P. H., 2013, THESIS; Smith AG, 2017, MATH BIOSCI, V291, P46, DOI 10.1016/j.mbs.2017.07.003; Solis D. M, 1983, THESIS; SOLIS DM, 1990, CONDOR, V92, P739, DOI 10.2307/1368693; Spies T., 1998, PNWGTR438 USDA FOR S; Stalberg D., 2009, LANDSCAPE URBAN PLAN, V90, P76; Thome DM, 1999, J WILDLIFE MANAGE, V63, P44, DOI 10.2307/3802486; United States Fish Wildlife Service [USFWS], 2011, REV REC PLAN NO SPOT; US Fish and Wildlife Service, 1990, FED REGISTER, V55, P26114; USDA (US Department of Agriculture) Forest Service and USDI BLM (Bureau of Land Management), 1994, REC DEC AM FOR SERV; USFWS (U. S. Fish and Wildlife Service), 1992, DRAFT FIN REC NO SPO; USFWS (US Fish and Wildlife Service), 2012, FED REGISTER, V77, P71876; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens J. D., 2012, THESIS; Wiens JD, 2017, J RAPTOR RES, V51, P234, DOI 10.3356/JRR-16-77.1; Wiens JD, 2014, WILDLIFE MONOGR, V185, P1, DOI 10.1002/wmon.1009; Yackulic CB, 2014, ECOLOGY, V95, P265, DOI 10.1890/13-0012.1; Yaffee SL., 1994, WISDOM SPOTTED OWL P; Zabel CJ, 2003, ECOL APPL, V13, P1027, DOI 10.1890/02-5084	115	13	13	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210643	10.1371/journal.pone.0210643	http://dx.doi.org/10.1371/journal.pone.0210643			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640947	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000037
J	Fracasso, BD; Rangel, JO; Machado, AG; Curuja, FS; Lopes, A; Olsen, V; Clausell, N; Biolo, A; Rohde, LE; Andrades, M				Fracasso, Bianca de Moraes; Rangel, Juliana Oliveira; Machado, Alessandra Goncalves; Curuja, Fernanda Severo; Lopes, Amanda; Olsen, Virgilio; Clausell, Nadine; Biolo, Andreia; Rohde, Luis Eduardo; Andrades, Michael			Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction	PLOS ONE			English	Article							HEART-FAILURE; IMMUNE MATURATION; N-EPSILON-(CARBOXYMETHYL)LYSINE; DISEASE; LYSINE; AGES; RAT	Circulating advanced glycation end products (AGE) and their receptor, RAGE, are increased after a myocardial infarction (MI) episode and seem to be associated with worse prognosis in patients. Despite the increasing importance of these molecules in the course of cardiac diseases, they have never been characterized in an animal model of MI. Thus, the aim of this study was to characterize AGE formation and RAGE expression in plasma and cardiac tissue during cardiac remodeling after MI in rats. Adult male Wistar rats were randomized to receive sham surgery (n = 15) or MI induction (n = 14) by left anterior descending coronary artery ligation. The MI group was stratified into two subgroups based on postoperative left ventricular ejection fraction: low (MIlowEF) and intermediate (MIintermEF). Echocardiography findings and plasma levels of AGEs, protein carbonyl, and free amines were assessed at baseline and 2, 30, and 120 days postoperatively. At the end of follow-up, the heart was harvested for AGE and RAGE evaluation. No differences were observed in AGE formation in plasma, except for a decrease in absorbance in MIlowEF at the end of follow-up. A decrease in yellowish-brown AGEs in heart homogenate was found, which was confirmed by immunodetection of N-epsilon-carboxymethyl-lysine. No differences could be seen in plasma RAGE levels among the groups, despite an increase in MI groups over the time. However, MI animals presented an increase of 50% in heart RAGE at the end of the follow-up. Despite the inflammatory and oxidative profile of experimental MI in rats, there was no increase in plasma AGE or RAGE levels. However, AGE levels in cardiac tissue declined. Thus, we suggest that the rat MI model should be employed with caution when studying the AGE-RAGE signaling axis or anti-AGE drugs for not reflecting previous clinical findings.	[Fracasso, Bianca de Moraes; Rangel, Juliana Oliveira; Machado, Alessandra Goncalves; Curuja, Fernanda Severo; Lopes, Amanda; Olsen, Virgilio; Clausell, Nadine; Biolo, Andreia; Rohde, Luis Eduardo; Andrades, Michael] Hosp Clin Porto Alegre, Expt Res Ctr, Cardiovasc Res Lab, Porto Alegre, RS, Brazil; [Fracasso, Bianca de Moraes; Rangel, Juliana Oliveira; Machado, Alessandra Goncalves; Clausell, Nadine; Biolo, Andreia; Rohde, Luis Eduardo; Andrades, Michael] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol & Cardiovasc Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Andrades, M (corresponding author), Hosp Clin Porto Alegre, Expt Res Ctr, Cardiovasc Res Lab, Porto Alegre, RS, Brazil.; Andrades, M (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Cardiol & Cardiovasc Sci, Porto Alegre, RS, Brazil.	meandrades@hcpa.edu.br	Clausell, Nadine Oliveira/C-7813-2016; Rohde, Luis Eduardo/I-4216-2013; Andrades, Michael/S-5394-2019	Clausell, Nadine Oliveira/0000-0003-4207-3809; Andrades, Michael/0000-0003-0337-9661; Biolo, Andreia/0000-0002-8579-4158; Lopes, Amanda/0000-0002-8390-2821	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre [13-0445]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre 13-0445 (FIPE-HCPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2007, J CLIN BIOCHEM NUTR, V41, P97, DOI 10.3164/jcbn.2007014; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Almeida F, 2013, CARDIOVASC THER, V31, pE79, DOI 10.1111/1755-5922.12039; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrades ME, 2009, CHEM-BIOL INTERACT, V180, P478, DOI 10.1016/j.cbi.2009.04.005; Ashraf JM, 2015, IUBMB LIFE, V67, P897, DOI 10.1002/iub.1450; Baidoshvili A, 2006, ARTERIOSCL THROM VAS, V26, P2497, DOI 10.1161/01.ATV.0000245794.45804.ab; Boschetto P, 2013, EUR J CLIN INVEST, V43, P562, DOI 10.1111/eci.12079; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao WW, 2015, ARCH BIOCHEM BIOPHYS, V580, P112, DOI 10.1016/j.abb.2015.07.003; Cao WW, 2014, APPL BIOCHEM BIOTECH, V172, P4062, DOI 10.1007/s12010-014-0804-7; Cebe T, 2014, AGE, V36, DOI 10.1007/s11357-014-9728-y; Chang KC, 2004, BRIT J PHARMACOL, V142, P1099, DOI 10.1038/sj.bjp.0705831; Cohen MM, 2013, AM J MED GENET A, V161, P2750, DOI 10.1002/ajmg.a.36181; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Guilbaud A, 2016, FOODS, V5, DOI 10.3390/foods5040084; Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009; Hayashi CM, 2002, LAB INVEST, V82, P795, DOI 10.1097/01.LAB.0000018826.59648.07; Kilkenny C., 2013, ANIMALS, V4, P35, DOI DOI 10.3390/ani4010035; Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Maneewong K, 2011, INDIAN J CLIN BIOCHE, V26, P389, DOI 10.1007/s12291-011-0118-2; McAlindon E, 2015, HEART, V101, P155, DOI 10.1136/heartjnl-2013-304289; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Peron Alessandra P. O. N., 2006, Arq. Bras. Cardiol., V86, P105, DOI 10.1590/S0066-782X2006000200005; Ramasamy Ravichandran, 2012, Curr Heart Fail Rep, V9, P107, DOI 10.1007/s11897-012-0089-5; Raposeiras-Roubin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074302; Raposeiras-Roubin S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-102; Raposeiras-Roubin S, 2011, AM J CARDIOL, V107, P938, DOI 10.1016/j.amjcard.2010.11.011; Raposeiras-Roubin S, 2010, EUR J HEART FAIL, V12, P1092, DOI 10.1093/eurjhf/hfq117; Sharma C, 2015, J FOOD SCI TECH MYS, V52, P7561, DOI 10.1007/s13197-015-1851-y; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; Vidart J, 2014, J CLIN ENDOCR METAB, V99, P4537, DOI 10.1210/jc.2014-2192; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vollenbrock CE, 2017, J DIABETES, V9, P308, DOI 10.1111/1753-0407.12498; Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019; Zhang F, 2011, J SURG RES, V171, P871, DOI 10.1016/j.jss.2010.04.027	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209964	10.1371/journal.pone.0209964	http://dx.doi.org/10.1371/journal.pone.0209964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633750	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100008
J	Asan, AS; Gok, S; Sahin, M				Asan, Ahmet S.; Gok, Sinan; Sahin, Mesut			Electrical fields induced inside the rat brain with skin, skull, and dural placements of the current injection electrode	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL CURRENT STIMULATION; MOTOR CORTEX; EXCITABILITY; MODELS; SAFETY; MODULATION; MONTAGES; PURKINJE; TDCS	Transcranial electrical stimulation (tES) is rapidly becoming an indispensable clinical tool with its different forms. Animal data are crucially needed for better understanding of the underlying mechanisms of tES. For reproducibility of results in animal experiments, the electric fields (E-Fields) inside the brain parenchyma induced by the injected currents need to be predicted accurately. In this study, we measured the electrical fields in the rat brain perpendicular to the brain surface, i. e. vertical electric field (VE-field), when the stimulation electrode was placed over the skin, skull, or dura mater through a craniotomy hole. The E-field attenuation through the skin was a few times larger than that of the skull and the presence of skin substantially reduced the VE-field peak at the cortical surface near the electrode. The VE-field declined much quicker in the gray matter underneath the pial surface than it did in the white matter, and thus the large VE-fields were contained mostly in the gray matter. The transition at the gray/white matter border caused a significant peak in the VE-field, as well as at other local inhomogeneties. A conductivity value of 0.57 S/m is predicted as a global value for the whole brain by matching our VE-field measurements to the field profile given by analytical equations for volume conductors. Finally, insertion of the current return electrode into the shoulder, submandibular, and hind leg muscles had virtually no effects on the measured E-field amplitudes in the cortex underneath the epidural electrodes.	[Asan, Ahmet S.; Gok, Sinan; Sahin, Mesut] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	New Jersey Institute of Technology	Sahin, M (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	sahin@njit.edu		Gok, Sinan/0000-0003-2291-6549	National Institute of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [R21 NS101386]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS101386] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grant (R21 NS101386) to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2017, CLIN NEUROPHYSIOL, V128, P1774, DOI 10.1016/j.clinph.2017.06.001; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Cantrell DR, 2008, J NEURAL ENG, V5, P54, DOI 10.1088/1741-2560/5/1/006; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Chhatbar PY, 2017, BRAIN STIMUL, V10, P553, DOI 10.1016/j.brs.2017.02.007; CREUTZFELDT O, 1962, EXP NEUROL, V5, P436, DOI 10.1016/0014-4886(62)90056-0; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dockery CA, 2011, NEUROBIOL LEARN MEM, V96, P452, DOI 10.1016/j.nlm.2011.06.018; Faria P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066017; Gasca F, 2011, I IEEE EMBS C NEUR E, P36; HAYES KJ, 1950, ARCH NEURO PSYCHIATR, V63, P102, DOI 10.1001/archneurpsyc.1950.02310190108008; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.18834; Jackson MP, 2016, CLIN NEUROPHYSIOL, V127, P3425, DOI 10.1016/j.clinph.2016.08.016; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Miranda PC, 2009, CLIN NEUROPHYSIOL, V120, P1183, DOI 10.1016/j.clinph.2009.03.023; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; NEWMAN J, 1966, J ELECTROCHEM SOC, V113, P501, DOI 10.1149/1.2424003; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Noetscher GM, 2014, IEEE T BIO-MED ENG, V61, P2488, DOI 10.1109/TBME.2014.2322774; Opitz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31236; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Ruffini G, 2013, IEEE T NEUR SYS REH, V21, P333, DOI 10.1109/TNSRE.2012.2200046; Smitt JW, 1944, ACTA PSYCH NEUROL, V19, P529, DOI 10.1111/j.1600-0447.1944.tb04586.x; Tanaka T, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00006; TERZUOLO CA, 1956, P NATL ACAD SCI USA, V42, P687, DOI 10.1073/pnas.42.9.687; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; WILEY JD, 1982, IEEE T BIO-MED ENG, V29, P381, DOI 10.1109/TBME.1982.324910; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012	39	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0203727	10.1371/journal.pone.0203727	http://dx.doi.org/10.1371/journal.pone.0203727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629578	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000004
J	Sagrillo-Fagundes, L; Bienvenue-Pariseault, J; Vaillancourt, C				Sagrillo-Fagundes, Lucas; Bienvenue-Pariseault, Josianne; Vaillancourt, Cathy			Melatonin: The smart molecule that differentially modulates autophagy in tumor and normal placental cells	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER CELLS; HUMAN TROPHOBLAST; LC3 LIPIDATION; IN-VITRO; ACTIVATION; STABILITY; MITOPHAGY; INTERPLAY; PATHWAYS	Melatonin has protective roles in normal cells and cytotoxic actions in cancer cells, with effects involving autophagy and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor pathways. Hypoxia/reoxygenation (H/R) induces oxidative damage and apoptosis. These consequences activate autophagy, which degrades damaged cellular content, as well as activates Nrf2 the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor, and thereby the expression of protective genes. Melatonin has protective roles in normal cells and cytotoxic actions in cancer cells, with effects involving autophagy and Nrf2 pathways. The current study shows melatonin to differentially modulate autophagy and Nrf2 pathways in tumor and normal placental cells exposed to H/R. BeWo, a human placental choriocarcinoma cell line, and primary villous cytotrophoblasts isolated from normal term placenta, were maintained in normoxia (8% O-2) for 24 h or exposed to hypoxia (0.5% of O-2 for 4 h) followed by 20 h of normoxia, creating a situation of H/R, in the presence or absence of 1 mM melatonin. Melatonin induced a 7-fold increase in the activation of 5' adenosine monophosphate-activated protein kinase (AMPK) a, an upstream modulator of autophagy, rising to a 16-fold increase in BeWo cells co-exposed to H/R and melatonin, compared to controls. H/R induced autophagosome formation via the increased expression of Beclin-1 (by 94%) and ATG7 (by 97%) in BeWo cells. Moreover, H/R also induced autophagic activity, indicated by the by the 630% increase in P62, and increased Nrf2 by 314% in BeWo cells. In H/R conditions, melatonin reduced autophagic activity by 74% and Nrf2 expression activation by 300%, leading to BeWo cell apoptosis. In contrast, In human primary villous cytotrophoblasts, H/R induced autophagy and Nrf2, which melatonin further potentiated, thereby affording protection against H/R. This study demonstrates that melatonin differentially modulates autophagy and the Nrf2 pathway in normal vs. tumor trophoblast cells, being cytoprotective in normal cells whilst increasing apoptosis in tumoral trophoblast cells.	[Sagrillo-Fagundes, Lucas; Bienvenue-Pariseault, Josianne; Vaillancourt, Cathy] INRS, Inst Armand Frappier, Laval, PQ, Canada; [Sagrillo-Fagundes, Lucas; Bienvenue-Pariseault, Josianne; Vaillancourt, Cathy] INRS, Biomed Res Ctr, Laval, PQ, Canada; [Sagrillo-Fagundes, Lucas; Bienvenue-Pariseault, Josianne; Vaillancourt, Cathy] Univ Quebec Montreal, Ctr Interdisciplinary Res Well Being Hlth Soc & E, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; University of Quebec Montreal	Vaillancourt, C (corresponding author), INRS, Inst Armand Frappier, Laval, PQ, Canada.; Vaillancourt, C (corresponding author), INRS, Biomed Res Ctr, Laval, PQ, Canada.; Vaillancourt, C (corresponding author), Univ Quebec Montreal, Ctr Interdisciplinary Res Well Being Hlth Soc & E, Montreal, PQ, Canada.	cathy.vaillancourt@iaf.inrs.ca		Vaillancourt, Cathy/0000-0003-0543-6244	Natural Sciences and Engineering Research Council of Canada (NSERC) [262011]; NSERC Undergraduate Student Research Award (URSA); Ministere de l'Education, du loisir et du sport (MELS) du Quebe, Fonds de recherche du Quebec-Nature et technologies (FRQ-NT); Fondation Armand Frappier	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Student Research Award (URSA); Ministere de l'Education, du loisir et du sport (MELS) du Quebe, Fonds de recherche du Quebec-Nature et technologies (FRQ-NT); Fondation Armand Frappier	This research was supported by grants from: the Natural Sciences and Engineering Research Council of Canada (NSERC) (no. 262011) to CV; NSERC Undergraduate Student Research Award (URSA) studentship awards to JBP; Ministere de l'Education, du loisir et du sport (MELS) du Quebe, Fonds de recherche du Quebec-Nature et technologies (FRQ-NT) and studentship from Fondation Armand Frappier to LSF.	Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Chan SHH, 2014, ANTIOXID REDOX SIGN, V20, P146, DOI 10.1089/ars.2013.5230; Chen BS, 2012, ENDOCRINOLOGY, V153, P4946, DOI 10.1210/en.2012-1472; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Coto-Montes A, 2012, MOL CELL ENDOCRINOL, V361, P12, DOI 10.1016/j.mce.2012.04.009; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujiwara N, 2016, J BIOL CHEM, V291, P10858, DOI 10.1074/jbc.M115.704908; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gamboa JL, 2012, PFLUG ARCH EUR J PHY, V463, P327, DOI 10.1007/s00424-011-1057-8; Hardeland R, 2014, INT J MOL SCI, V15, P18221, DOI 10.3390/ijms151018221; Heazell AEP, 2009, REPROD BIOMED ONLINE, V18, P111, DOI 10.1016/S1472-6483(10)60432-4; Hofstetter CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030059; Ireland KE, 2018, REPROD SCI, V25, P120, DOI 10.1177/1933719117704908; Iwasaki S, 2005, J PINEAL RES, V39, P261, DOI 10.1111/j.1600-079X.2005.00244.x; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kimball SR, 2008, J PINEAL RES, V44, P379, DOI 10.1111/j.1600-079X.2007.00539.x; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kweider N., 2015, PREGNANCY HYPERTENS, V5, P66, DOI DOI 10.1016/J.PREGHY.2014.10.131; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Lanoix D, 2008, J PINEAL RES, V45, P50, DOI 10.1111/j.1600-079X.2008.00555.x; Lanoix D, 2013, MOL CELL ENDOCRINOL, V381, P35, DOI 10.1016/j.mce.2013.07.010; Lanoix D, 2012, MOL CELL ENDOCRINOL, V348, P1, DOI 10.1016/j.mce.2011.08.025; Lee SE, 2013, J PINEAL RES, V54, P80, DOI 10.1111/j.1600-079X.2012.01027.x; Liu SW, 2017, FEBS OPEN BIO, V7, P798, DOI 10.1002/2211-5463.12223; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Ordonez R, 2015, J PINEAL RES, V59, P178, DOI 10.1111/jpi.12249; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Petroff MG, 2006, METH MOLEC MED, V121, P203; Reiter RJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040843; Rote NS, 2005, PLACENTA, V26, P686, DOI 10.1016/j.placenta.2004.09.003; Sagrillo-Fagundes L, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12520; Sagrillo-Fagundes L, 2016, JOVE-J VIS EXP, DOI 10.3791/54228; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shen YQ, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12461; Shida M, 2016, INT J ONCOL, V48, P1379, DOI 10.3892/ijo.2016.3359; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Yin X, 2013, INT J GYNECOL CANCER, V23, P630, DOI 10.1097/IGC.0b013e3182892cee; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6	48	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0202458	10.1371/journal.pone.0202458	http://dx.doi.org/10.1371/journal.pone.0202458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629581	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000003
J	Szymanska-Czerwinska, M; Jodelko, A; Zareba-Marchewka, K; Niemczuk, K				Szymanska-Czerwinska, Monika; Jodelko, Agnieszka; Zareba-Marchewka, Kinga; Niemczuk, Krzysztof			Shedding and genetic diversity of Coxiella burnetii in Polish dairy cattle	PLOS ONE			English	Article							Q-FEVER OUTBREAK; GENOTYPIC DIVERSITY; BULK MILK; RAW-MILK; PREVALENCE; COWS; HERD; GOATS; MLVA	Q fever is a worldwide zoonotic disease reported in humans and many animal species including cattle. The aims of this study were to evaluate the prevalence of Coxiella (C.) burnetii shedding in Polish dairy cattle herds and to identify the pathogen's genotypes and sequence types (STs) using multiple-locus variable number tandem repeat analysis (MLVA) and multispacer sequence typing (MST) methods. The presence of C. burnetii DNA was detected using a commercial real-time PCR kit, targeting the IS1111 element. Overall, 1,439 samples from 279 herds were tested including: 897 individual milk specimens, 101 bulk tank milk samples, 409 genital tract swabs and 32 placentas. Furthermore, 30 consumer milk samples, including 10 from vending machines and 77 dairy products were also analyzed. C. burnetii shedding was confirmed in 31.54% of tested cattle herds as well as in 69.16% of consumer milk and dairy products. Among real-time PCR-positive samples, 49 specimens obtained from 49 cattle herds and 8 samples of purchased dairy products were selected for genotyping. Overall, five previously known MLVA genotypes (I, J, BG, BE, and NM) and three new ones (proposed as PL1, PL2, and PL3) were identified. Two MST sequence types were recorded: ST16 and a novel sequence (ST61). The new genotypes and sequence types need further research particularly into their pathogenicity to humans.	[Szymanska-Czerwinska, Monika; Jodelko, Agnieszka; Zareba-Marchewka, Kinga; Niemczuk, Krzysztof] Natl Vet Res Inst, Dept Cattle & Sheep Dis, Pulawy, Poland; [Szymanska-Czerwinska, Monika] Natl Vet Res Inst, Lab Serol Diag, Pulawy, Poland	National Veterinary Institute - National Research Institute; National Veterinary Institute - National Research Institute	Jodelko, A (corresponding author), Natl Vet Res Inst, Dept Cattle & Sheep Dis, Pulawy, Poland.	agnieszka.jodelko@piwet.pulawy.pl	Szymańska-Czerwińska, Monika/ABI-7174-2020; Niemczuk, Krzysztof/AAV-7798-2021; Zaręba-Marchewka, Kinga/AAX-3839-2020; Jodełko, Agnieszka/ABI-7256-2020	Szymańska-Czerwińska, Monika/0000-0001-8974-0870; Niemczuk, Krzysztof/0000-0003-1611-9770; Zaręba-Marchewka, Kinga/0000-0003-0657-4171; Jodełko, Agnieszka/0000-0002-4821-4847	National Science Centre, Poland [2015/17/D/NZ7/00816]	National Science Centre, Poland(National Science Centre, Poland)	This scientific work was funded by the National Science Centre, Poland (Grant No. 2015/17/D/NZ7/00816, SONATA 9) https://ncn.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Anastacio S, 2016, TRANSBOUND EMERG DIS, V63, pE293, DOI 10.1111/tbed.12275; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Astobiza I, 2012, J DAIRY SCI, V95, P1632, DOI 10.3168/jds.2011-4721; Astobiza I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-241; Bauer AE, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0517-3; Ceglie L, 2015, MICROBES INFECT, V17, P776, DOI 10.1016/j.micinf.2015.09.029; Chmielewski T, 2009, POL J MICROBIOL, V58, P9; Clark NJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3135-4; Cooper A, 2013, VECTOR-BORNE ZOONOT, V13, P12, DOI 10.1089/vbz.2011.0853; Di Domenico M, 2014, VECTOR-BORNE ZOONOT, V14, P710, DOI 10.1089/vbz.2014.1587; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Galiero A, 2016, INT J FOOD MICROBIOL, V237, P47, DOI 10.1016/j.ijfoodmicro.2016.08.008; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gonzalez-Barrio D, 2016, MICROB ECOL, V72, P890, DOI 10.1007/s00248-016-0786-9; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; Jodelko A, 2015, B VET I PULAWY, V59, P479, DOI 10.1515/bvip-2015-0071; Klaassen CHW, 2009, EMERG INFECT DIS, V15, P613, DOI 10.3201/eid1504.081612; Loftis AD, 2010, FOODBORNE PATHOG DIS, V7, P1453, DOI 10.1089/fpd.2010.0579; Magnino S, 2009, LARGE ANIM REV, V15, P3; Pearson T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-41; Pexara A, 2018, TRENDS FOOD SCI TECH, V71, P65, DOI 10.1016/j.tifs.2017.11.004; Pinero A, 2015, INFECT GENET EVOL, V31, P231, DOI 10.1016/j.meegid.2015.02.006; Public Health England, V DIC DIV CALC TOOL; Reichel R, 2012, RES VET SCI, V93, P1217, DOI 10.1016/j.rvsc.2012.04.007; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Santos AS, 2012, INT J MED MICROBIOL, V302, P253, DOI 10.1016/j.ijmm.2012.08.003; Signs KA, 2012, CLIN INFECT DIS, V55, P1387, DOI 10.1093/cid/cis690; Stein A, 1999, CLIN INFECT DIS, V29, P617, DOI 10.1086/598643; Sulyok KM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-107; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P2156, DOI 10.1128/JCM.06831-11; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11; Tilburg JJHC, 2013, THESIS; Valla G, 2014, LARGE ANIM REV, V20, P51; Van den Brom R, 2015, VET MICROBIOL, V181, P119, DOI 10.1016/j.vetmic.2015.07.011; Velasova M, 2017, J DAIRY SCI, V100, P9215, DOI 10.3168/jds.2016-11863	38	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210244	10.1371/journal.pone.0210244	http://dx.doi.org/10.1371/journal.pone.0210244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629637	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000065
J	Mark, E; Goldsman, D; Gurbaxani, B; Keskinocak, P; Sokol, J				Mark, Ethan; Goldsman, David; Gurbaxani, Brian; Keskinocak, Pinar; Sokol, Joel			Using machine learning and an ensemble of methods to predict kidney transplant survival	PLOS ONE			English	Article							DECEASED DONOR KIDNEYS; SCORE; MODELS	We used an ensemble of statistical methods to build a model that predicts kidney transplant survival and identifies important predictive variables. The proposed model achieved better performance, measured by Harrell's concordance index, than the Estimated Post Transplant Survival model used in the kidney allocation system in the U.S., and other models published recently in the literature. The model has a five-year concordance index of 0.724 (in comparison, the concordance index is 0.697 for the Estimated Post Transplant Survival model, the state of the art currently in use). It combines predictions from random survival forests with a Cox proportional hazards model. The rankings of importance for the model's variables differ by transplant recipient age. Better survival predictions could eventually lead to more efficient allocation of kidneys and improve patient outcomes.	[Mark, Ethan; Goldsman, David; Gurbaxani, Brian; Keskinocak, Pinar; Sokol, Joel] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Gurbaxani, Brian] Ctr Dis Control & Prevent, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Centers for Disease Control & Prevention - USA	Mark, E (corresponding author), Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA.	emark3@gatech.edu	Mark, Ethan/AAB-5114-2019	Mark, Ethan/0000-0002-6404-9140	Carlos and Marguerite Mason Trust; Arnold Foundation	Carlos and Marguerite Mason Trust; Arnold Foundation	This research has been supported in part by the Carlos and Marguerite Mason Trust, the Arnold Foundation, and by the following Georgia Tech benefactors: William W. George, Andrea Laliberte, Claudia L. and J. Paul Raines, and Richard E. "Rick" and Charlene Zalesky. Any opinions, findings, conclusions, or recommendations are those of the authors and do not necessarily reflect the views of the funding organizations or the CDC.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2014, GUIDE CALCULATING IN; [Anonymous], 2016, ORGAN PROCUREMENT TR; Baskin-Bey ES, 2007, AM J KIDNEY DIS, V49, P284, DOI 10.1053/j.ajkd.2006.10.018; Brown TS, 2012, AM J NEPHROL, V36, P561, DOI 10.1159/000345552; Chow EKH, 2013, AM J TRANSPLANT, V13, P1227, DOI 10.1111/ajt.12206; Clayton PA, 2014, AM J TRANSPLANT, V14, P1922, DOI 10.1111/ajt.12761; COX DR, 1972, J R STAT SOC B, V34, P187; Graf E, 1999, STAT MED, V18, P2529; Harrell F.E.J., 2020, HMISC HARRELL MISCEL; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hothorn T, 2004, STAT MED, V23, P77, DOI 10.1002/sim.1593; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasiske BL, 2010, AM J KIDNEY DIS, V56, P947, DOI 10.1053/j.ajkd.2010.06.020; Krikov S, 2007, ASAIO J, V53, P592, DOI 10.1097/MAT.0b013e318145b9f7; Li B, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0264-0; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Simon N, 2011, J STAT SOFTW, V39, P1; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Wolfe RA, 2008, AM J TRANSPLANT, V8, P997, DOI 10.1111/j.1600-6143.2008.02177.x; Wolfe RA, 2009, AM J TRANSPLANT, V9, P1523, DOI 10.1111/j.1600-6143.2009.02708.x	26	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209068	10.1371/journal.pone.0209068	http://dx.doi.org/10.1371/journal.pone.0209068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625130	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400025
J	Ramirez-Fernandez, L; Trefault, N; Caru, M; Orlando, J				Ramirez-Fernandez, Lia; Trefault, Nicole; Caru, Margarita; Orlando, Julieta			Seabird and pinniped shape soil bacterial communities of their settlements in Cape Shirreff, Antarctica	PLOS ONE			English	Article							KING-GEORGE ISLAND; SOUTH SHETLAND ISLANDS; ROSS SEA REGION; ORNITHOGENIC SOILS; LIVINGSTON ISLAND; FUR SEALS; TERRESTRIAL ECOSYSTEMS; PYGOSCELID PENGUINS; MIROUNGA-LEONINA; DRY VALLEY	Seabirds and pinnipeds play an important role in biogeochemical cycling by transferring nutrients from aquatic to terrestrial environments. Indeed, soils rich in animal depositions have generally high organic carbon, nitrogen and phosphorus contents. Several studies have assessed bacterial diversity in Antarctic soils influenced by marine animals; however most have been conducted in areas with significant human impact. Thus, we chose Cape Shirreff, Livingston Island, an Antarctic Specially Protected Area designated mainly to protect the diversity of marine vertebrate fauna, and selected sampling sites with different types of animals coexisting in a relatively small space, and where human presence and impact are negligible. Using 16S rRNA gene analyses through massive sequencing, we assessed the influence of animal concentrations, via their modification of edaphic characteristics, on soil bacterial diversity and composition. The nutrient composition of soils impacted by Antarctic fur seals and kelp gulls was more similar to that of control soils (i.e. soils without visible presence of plants or animals), which may be due to the more active behaviour of these marine animals compared to other species. Conversely, the soils from concentrations of southern elephant seals and penguins showed greater differences in soil nutrients compared to the control. In agreement with this, the bacterial communities of the soils associated with these animals were most different from those of the control soils, with the soils of penguin colonies also possessing the lowest bacterial diversity. However, all the soils influenced by the presence of marine animals were dominated by bacteria belonging to Gammaproteobacteria, particularly those of the genus Rhodanobacter. Therefore, we conclude that the modification of soil nutrient composition by marine vertebrates promotes specific groups of bacteria, which could play an important role in the recycling of nutrients in terrestrial Antarctic ecosystems.	[Ramirez-Fernandez, Lia; Caru, Margarita; Orlando, Julieta] Univ Chile, Fac Sci, Dept Ecol Sci, Lab Microbial Ecol, Santiago, Chile; [Trefault, Nicole] Univ Mayor, Fac Sci, Ctr Gen Ecol & Environm GEMA, Santiago, Chile	Universidad de Chile; Universidad Mayor	Orlando, J (corresponding author), Univ Chile, Fac Sci, Dept Ecol Sci, Lab Microbial Ecol, Santiago, Chile.	jorlando@u.uchile.cl	Orlando, Julieta/E-1399-2014	Orlando, Julieta/0000-0002-2902-8870; Ramirez, Lia/0000-0002-7686-1291	Instituto Antartico Chileno (INACH); INACH [F_02-10, RG_14-14]; CONICYT-PIA [ACT172065]; National Commission for Scientific and Technological Research (CONICYT, Chile)	Instituto Antartico Chileno (INACH); INACH; CONICYT-PIA; National Commission for Scientific and Technological Research (CONICYT, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Instituto Antartico Chileno (INACH; http://www.inach.cl/inach/) projects lead by Julieta Orlando. The Antarctic campaign was funded by INACH F_02-10 and the experimental procedures by INACH RG_14-14 (JO). In addition, we appreciate the support of the project CONICYT-PIA ACT172065 (GAB; http://www.antarcticgenomics.cl) (JO). Lia Ramirez-Fernandez acknowledges a scholarship from the National Commission for Scientific and Technological Research (CONICYT, Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2016, POLAR BIOL, V39, P1225, DOI 10.1007/s00300-015-1841-6; Aislabie J, 2009, CAN J MICROBIOL, V55, P21, DOI 10.1139/W08-126; ASPA 149, 2016, ANTARCTIC SPECIALLY; Ball BA, 2015, POLAR BIOL, V38, P1357, DOI 10.1007/s00300-015-1699-7; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Barbosa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153215; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Black CE, 2016, POLAR BIOL, V39, P405, DOI 10.1007/s00300-015-1807-8; Bokhorst S, 2007, POLAR BIOL, V30, P1315, DOI 10.1007/s00300-007-0292-0; Bonin CA, 2016, J EXP MAR BIOL ECOL, V476, P72, DOI 10.1016/j.jembe.2015.12.008; Braun C, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.18206; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Cho GY, 2017, INT J SYST EVOL MICR, V67, P1387, DOI 10.1099/ijsem.0.001825; Chong CW, 2012, GEODERMA, V181, P45, DOI 10.1016/j.geoderma.2012.02.017; Chong CW, 2010, SOIL BIOL BIOCHEM, V42, P601, DOI 10.1016/j.soilbio.2009.12.009; Chong CW, 2009, POLAR BIOL, V32, P1571, DOI 10.1007/s00300-009-0656-8; Cowan DA, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00005, DOI 10.3389/FMICB.2014.00005]; Dahal RH, 2017, INT J SYST EVOL MICR, V67, P1185, DOI 10.1099/ijsem.0.001786; Daneri GA, 2015, POLAR BIOL, V38, P665, DOI 10.1007/s00300-014-1629-0; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Emslie SD, 2014, QUATERN INT, V352, P4, DOI 10.1016/j.quaint.2014.07.031; Farina JM, 2003, J ANIM ECOL, V72, P873, DOI 10.1046/j.1365-2656.2003.00760.x; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Favero M, 1998, POLAR BIOL, V19, P32; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Ganzert L, 2011, FEMS MICROBIOL ECOL, V76, P476, DOI 10.1111/j.1574-6941.2011.01068.x; Gil-Delgado JA, 2013, POLAR BIOL, V36, P607, DOI 10.1007/s00300-012-1280-6; Green SJ, 2010, APPL ENVIRON MICROB, V76, P3244, DOI 10.1128/AEM.03069-09; Grimaldi W, 2011, POLAR REC, V47, P56, DOI 10.1017/S0032247410000100; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrington A, 2017, POLAR BIOL, V40, P471, DOI 10.1007/s00300-016-1959-1; Harris C.M., 2015, IMPORTANT BIRD AREAS; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Herman RW, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3142-9; Hernandez J, 2007, POLAR BIOL, V30, P1227, DOI 10.1007/s00300-007-0282-2; Hernandez Jorge, 2016, Infection Ecology & Epidemiology, V6, P32112, DOI 10.3402/iee.v6.32112; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; Huckstadt LA, 2012, OECOLOGIA, V169, P395, DOI 10.1007/s00442-011-2202-y; Hughes KA, 2004, ANTARCT SCI, V16, P293, DOI 10.1017/S095410200400210X; Hughes KA, 2010, GLOBAL ENVIRON CHANG, V20, P96, DOI 10.1016/j.gloenvcha.2009.09.005; Kim OS, 2012, J MICROBIOL, V50, P1081, DOI 10.1007/s12275-012-2655-7; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lisnizer N, 2015, MAR BIOL RES, V11, P738, DOI 10.1080/17451000.2014.993652; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MYRCHA A, 1991, Polish Polar Research, V12, P3; Naveen R, 2017, STATE OF ANTARCTIC P; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Nie YG, 2012, SCI TOTAL ENVIRON, V433, P132, DOI 10.1016/j.scitotenv.2012.06.022; Niederberger TD, 2008, ENVIRON MICROBIOL, V10, P1713, DOI 10.1111/j.1462-2920.2008.01593.x; Osman LP, 2004, POLAR BIOL, V27, P92, DOI 10.1007/s00300-003-0555-3; Pan Q, 2013, J ENVIRON SCI-CHINA, V25, P1649, DOI 10.1016/S1001-0742(12)60229-0; Pertierra LR, 2013, ANTARCT SCI, V25, P318, DOI 10.1017/S095410201200082X; Pietrzak K, 2009, AMLR ANTARCTIC MARIN; Polito MJ, 2015, MAR ECOL PROG SER, V519, P221, DOI 10.3354/meps11095; Prakash O, 2012, INT J SYST EVOL MICR, V62, P2457, DOI 10.1099/ijs.0.035840-0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Roesch LFW, 2012, APPL SOIL ECOL, V61, P7, DOI 10.1016/j.apsoil.2012.04.009; Rombola E, 2003, POLAR BIOL, V26, P41, DOI 10.1007/s00300-002-0444-1; Roosens L, 2007, J ENVIRON MONITOR, V9, P822, DOI 10.1039/b708103k; Sadzawka A, 2000, METODOS DE ANALISIS; Santamans AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181901; Schaefer CEGR, 2008, GEODERMA, V144, P104, DOI 10.1016/j.geoderma.2007.10.018; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shravage BV, 2007, MICROBIOL RES, V162, P15, DOI 10.1016/j.micres.2006.01.005; Simas FNB, 2007, GEODERMA, V138, P191, DOI 10.1016/j.geoderma.2006.11.011; Smellie JL, 1996, J S AM EARTH SCI, V9, P265, DOI 10.1016/0895-9811(96)00012-0; Smith JL, 2010, ANTARCT SCI, V22, P673, DOI 10.1017/S0954102010000763; Smith VR, 2005, SOIL BIOL BIOCHEM, V37, P81, DOI 10.1016/j.soilbio.2004.07.026; Smith VR, 2003, SOIL BIOL BIOCHEM, V35, P77, DOI 10.1016/S0038-0717(02)00240-7; Staniland IJ, 2004, MAR ECOL PROG SER, V275, P263, DOI 10.3354/meps275263; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Sun LG, 2004, POLAR BIOL, V27, P670, DOI 10.1007/s00300-004-0635-z; Sun LG, 2002, ATMOS ENVIRON, V36, P4977, DOI 10.1016/S1352-2310(02)00340-0; Tatur A, 1997, POLAR BIOL, V17, P405, DOI 10.1007/s003000050135; TATUR A, 1984, Polish Polar Research, V5, P31; Tatur A., 1990, P POL BIOL CIT, V3, P133; Teixeira LCRS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066109; Tejedo P, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.10888; Tin T, 2009, ANTARCT SCI, V21, P3, DOI 10.1017/S0954102009001722; Tscherko D, 2003, ARCT ANTARCT ALP RES, V35, P34, DOI 10.1657/1523-0430(2003)035[0034:BAEAOT]2.0.CO;2; Turner J, 2016, NATURE, V535, P411, DOI 10.1038/nature18645; VOLKMAN NJ, 1980, CONDOR, V82, P373, DOI 10.2307/1367558; Wang NF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01188; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Yang JE, 1998, SOIL SCI SOC AM J, V62, P1108, DOI 10.2136/sssaj1998.03615995006200040036x; Yew WC, 2018, POLAR BIOL, V41, P269, DOI 10.1007/s00300-017-2189-x; Zdanowski MK, 2005, SOIL BIOL BIOCHEM, V37, P581, DOI 10.1016/j.soilbio.2004.08.020; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zhu RB, 2015, SCI REP-UK, V5, DOI 10.1038/srep17231; Zhu RB, 2013, J GEOPHYS RES-BIOGEO, V118, P1773, DOI 10.1002/2013JG002398; Zhu RB, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002130; Zhu RB, 2011, SCI TOTAL ENVIRON, V409, P3789, DOI 10.1016/j.scitotenv.2011.06.034; Zhu RB, 2009, ANTARCT SCI, V21, P427, DOI 10.1017/S0954102009990204; Zwolicki A, 2015, POLAR BIOL, V38, P1645, DOI 10.1007/s00300-015-1730-z	99	6	6	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209887	10.1371/journal.pone.0209887	http://dx.doi.org/10.1371/journal.pone.0209887			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625192	gold, Green Published, Green Submitted			2022-12-26	WOS:000455359400060
J	Nagaoka, T; Takigami, M; Seki, Y; Uzawa, K; Paredes, DA; Roldan, PSA; Chocano, DM				Nagaoka, Tomohito; Takigami, Mai; Seki, Yuji; Uzawa, Kazuhiro; Paredes, Diana Aleman; Andia Roldan, Percy Santiago; Morales Chocano, Daniel			Bioarchaeological evidence of decapitation from Pacopampa in the northern Peruvian highlands	PLOS ONE			English	Article							SCANNING ELECTRON-MICROSCOPY; SACRIFICIAL VICTIMS; TROPHY HEADS; CONCHOPATA; BUTCHERY; ORIGINS; MOCHE	Little is known about the precise date of the emergence of decapitation in a ritual context and the presence of systematic postmortem modification patterns in the ancient Central Andes. The ceremonial complex at Pacopampa in the northern Peruvian highlands provides early osteological evidence of decapitation in six individuals dating to the latter half of the Late Final Formative Periods (500-50 BC) and to the Early Cajamarca Period (AD 200-450). Based on osteological evidence, and when taken together with archaeological settings and settlement patterns, researchers can be certain that those whose heads were disembodied were not likely to have been involved in organized battles. In addition, the similarities in the cut-mark distribution, direction, and cross-sectional morphology of each individual's remains, as well as the characteristics of selected individuals, imply that the decapitated individuals were carefully prepared using a standardized method and that those who modified the heads may have been professional decapitators. This study offers indisputable bioarchaeological evidence of ritualistic offerings of human skulls and systematic postmortem modification patterns, which is consistent with a contemporaneous iconographic motif of decapitation and extends the chronology of this practice back to the Formative Period in the northern Peruvian highlands.	[Nagaoka, Tomohito] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan; [Takigami, Mai] Yamagata Univ, Yamagata, Japan; [Seki, Yuji] Natl Museum Ethnol, Suita, Osaka, Japan; [Uzawa, Kazuhiro] Univ East Asia, Fac Human Sci, Shimonoseki, Yamaguchi, Japan; [Paredes, Diana Aleman; Andia Roldan, Percy Santiago; Morales Chocano, Daniel] Univ Nacl Mayor San Marcos, Lima, Peru	Saint Marianna University; Yamagata University; Universidad Nacional Mayor de San Marcos	Nagaoka, T (corresponding author), St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan.	nagaoka@marianna-u.ac.jp			JSPS Kakenhi [23222003, 15K07241, 16H02729, 16H05639]	JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS Kakenhi 23222003 (Y.S.) http://www.jsps.go.jp/j-grantsinaid/12_kiban/ichiran_23/shinki.htmL#jinbun; JSPS Kakenhi 23222003 (Y.S.) https://www.jsps.go.jp/j-grantsinaid/12_kiban/ichiran_23/e-data/e29_seki.pdf; JSPS Kakenhi 15K07241 (T.N.) https://kaken.nii.ac.nii.ac.jp/ja/grant/KAKENHI-PROJECT-15K07241/; JSPS Kakenhi 16H02729 (Y.S.) https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-16H02729/2016/; JSPS Kakenhi 16H05639 (KU.) https://kaken.nii.ac.jp/en/grantKAKENHI-PROJECT-16H05639/.	Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; BOURGET S, 2001, RITUAL SACRIFICE ANC, P93; Burger R., 1984, PREHISTORIC OCCUPATI; Burger R. L., 1992, CHAVIN ORIGINS ANDEA; Chacon RJ, 2007, INTERD CONTRIB ARCH, P1, DOI 10.1007/978-0-387-48303-0; Cook G., 2001, RITUAL SACRIFICE ANC, P1; CORDYCOLLINS A, 2001, RITUAL SACRIFICE ANC, P21; Donnan CB., 1976, LATIN AM STUDIES PUB; Engel F. A., 1963, T AM PHILOS SOC, V53, P1, DOI DOI 10.2307/1005956; Fitzsimmons J.L., 2015, LIVING DEAD ANDES, P101; Ghezzi I, 2006, ANDEAN ARCHAEOLOGY III: NORTH AND SOUTH, P67, DOI 10.1007/0-387-28940-2_4; Girald R, 1977, VIOLENCE SACRED; Gose Peter, 2003, CONVERSION OLD WORLD, P140; Greenfield HJ, 1999, J ARCHAEOL SCI, V26, P797, DOI 10.1006/jasc.1998.0348; Hamilton LS, 2016, RITUAL VIOLENCE ANCI, P29; Izumi S., 1972, ANDES 4 EXCAVATIONS; Klaus DK, 2016, RITUAL VIOLENCE ANCI, P1; Knudson KJ, 2009, J ANTHROPOL ARCHAEOL, V28, P244, DOI 10.1016/j.jaa.2008.10.006; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lumbreras L., 1981, PREHISTORY AYACUCHO, VII, P167; Morales D, 1980, DIOS FELINO PACOPAMP; Nagaoka T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185421; Nagaoka T, 2012, ANAT SCI INT, V87, P234, DOI 10.1007/s12565-011-0120-z; Onuki Y., 1995, KUNTUR WASI CERRO BL; Onuki Y., 1993, SENRI ETHNOLOGICAL S, V37, P69; PROULX DA, 1989, CULTURES CONFLICT CU, P73; PROULX DA, 2001, RITUAL SACRIFICE ANC, P119; Quilter J., 1989, LIFE DEATH PALOMA SO; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reichlen B., 1973, REV MUSEO NACL, V39, P143; Rick John W., 2008, CHAVIN ART ARCHITECT, P3; Rockwood C., 1991, FRACTURES ADULTS; ROSE JJ, 1983, AM J PHYS ANTHROPOL, V62, P255, DOI 10.1002/ajpa.1330620305; Seki Y, 2014, SENRI ETHNOLOGICAL S, V89, P1; Seki Y., 2014, CTR CEREMONIAL ANDIN, V89, P175; Seki Y, 2010, B ARQUEOLOGIA PUCP, V12, P69; Shimada Izumi, 1994, PAMPA GRANDE MOCHICA; SHIPMAN P, 1984, PALEOBIOLOGY, V10, P358, DOI 10.1017/S0094837300008320; SHIPMAN P, 1981, ANN NY ACAD SCI, V376, P357, DOI 10.1111/j.1749-6632.1981.tb28179.x; SHIPMAN P, 1983, J ARCHAEOL SCI, V10, P465, DOI 10.1016/0305-4403(83)90061-4; Sutter RC, 2007, AM J PHYS ANTHROPOL, V132, P193, DOI 10.1002/ajpa.20514; Terada K., 1985, FORMATIVE PERIOD CAJ; Toyne JM, 2014, J ARCHAEOL SCI, V42, P15, DOI 10.1016/j.jas.2013.10.036; Tung TA, VIOLENCE RITUAL WARI; Tung TA, 2008, CURR ANTHROPOL, V49, P915, DOI 10.1086/591318; Tung TA, 2008, AM J PHYS ANTHROPOL, V136, P294, DOI 10.1002/ajpa.20812; Tung TA, 2007, AM J PHYS ANTHROPOL, V133, P941, DOI 10.1002/ajpa.20565; Tung TA, 2011, J ANTHROPOL ARCHAEOL, V30, P247, DOI 10.1016/j.jaa.2011.06.005; Tung TA, 2007, INTERD CONTRIB ARCH, P479; Ubelaker D.H., 1989, MANUALS ARCHEOLOGY S, V2; Verano J. W., 2001, RITUAL SACRIFICE ANC, P165; VERANO JW, 1995, TOMBS LIVING ANDEAN, P189; WAKEBE T, 1990, Nagasaki Igakkai Zasshi, V65, P805; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; WALKER PL, 1977, AM ANTIQUITY, V42, P605, DOI 10.2307/278934	56	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210458	10.1371/journal.pone.0210458	http://dx.doi.org/10.1371/journal.pone.0210458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG7HM	30620764	Green Published, gold, Green Submitted			2022-12-26	WOS:000455161300034
J	Chao, X; Wang, GQ; Tang, YP; Dong, CH; Li, H; Wang, B; Wu, JQ; Zhao, JR				Chao, Xu; Wang, Guoquan; Tang, Yuping; Dong, Changhu; Li, Hong; Wang, Bin; Wu, Jieqiong; Zhao, Jiarong			The effects and mechanism of peiminine-induced apoptosis in human hepatocellular carcinoma HepG2 cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYCLE ARREST; KAPPA-B; PATHWAYS; INHIBITION; INDUCTION; GROWTH; DRUG	Peiminine is a compound isolated from Bolbostemma paniculatum (Maxim) Franquet (Cucurbitaceae family), which has demonstrated antitumor activities. But its precise molecular mechanism underlying antitumor activity remain elusive. In this study, peiminine-induced apoptosis towards human hepatocellular carcinoma and its molecular mechanism were investigated. MTT assay was employed to assess anticancer effects of peiminine upon Hela, HepG2, SW480 and MCF-7 cell lines. Nuclear staining and flow cytometry were carried out to detect apoptosis induced by peiminine. Mitochondrial membrane potential evaluation and Western blot analysis were performed to investigate the mechanism of peiminine-induced apoptosis. The results showed peiminine reduced the viability of HepG2 cells in a time- and dose-dependent manner and had an IC50 of 4.58 mu g/mL at 24h. Peiminine significantly increased the percentage of apoptotic cells and the mitochondrial membrane potential dose-dependently in HepG2 cells. The results of Western blotting indicated the expressions of Bcl-2, procaspase-3, procaspase-8, procaspase-9, and PARP decreased in HepG2 cells treated with peiminine, while the expressions of Box, caspase-3, caspase-8, caspase-9, and cleaved PARP(1) increased. The result suggests that peiminine can induce apoptosis in human hepatocellular carcinoma HepG2 cells through both extrinsic and intrinsic apoptotic pathways.	[Chao, Xu; Dong, Changhu; Li, Hong; Wu, Jieqiong] Shaanxi Univ Chinese Med, Affiliated Hosp 2, Xianyang, Shaanxi, Peoples R China; [Chao, Xu; Zhao, Jiarong] Shaanxi Univ Chinese Med, Coll Basic Med Sci, Xian, Shaanxi, Peoples R China; [Wang, Guoquan; Tang, Yuping; Wang, Bin] Shaanxi Univ Chinese Med, Coll Pharm, Xian, Shaanxi, Peoples R China	Shaanxi University of Chinese Medicine; Shaanxi University of Chinese Medicine; Shaanxi University of Chinese Medicine	Chao, X (corresponding author), Shaanxi Univ Chinese Med, Affiliated Hosp 2, Xianyang, Shaanxi, Peoples R China.; Chao, X (corresponding author), Shaanxi Univ Chinese Med, Coll Basic Med Sci, Xian, Shaanxi, Peoples R China.; Tang, YP (corresponding author), Shaanxi Univ Chinese Med, Coll Pharm, Xian, Shaanxi, Peoples R China.	chaoxu2004@126.com; yupingtang9@126.com			National Natural Science Foundation of China [81774132]; Shaanxi Provincial Traditional Chinese Medicine Administration [JCPT038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Traditional Chinese Medicine Administration	This study was supported by the National Natural Science Foundation of China (81774132) and the Shaanxi Provincial Traditional Chinese Medicine Administration (JCPT038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.313; Alam AHMK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167536; Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Chen CN, 2007, CANCER LETT, V245, P218, DOI 10.1016/j.canlet.2006.01.016; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Cheung CSF, 2007, CANCER LETT, V253, P224, DOI 10.1016/j.canlet.2007.01.025; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Deepa M, 2013, NUTR CANCER, V65, P305, DOI 10.1080/01635581.2013.748924; Denicourt C, 2004, SCIENCE, V305, P1411, DOI 10.1126/science.1102974; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2004, CURR CANCER DRUG TAR, V4, P569, DOI 10.2174/1568009043332763; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Gomes A, 2011, TOXICON, V58, P85, DOI 10.1016/j.toxicon.2011.05.008; Han SI, 2008, BMB REP, V41, P1; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Jin Z, 2005, CANCER BIOL THER, P4139; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kugawa F, 2000, BIOL PHARM BULL, V23, P930; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Lyu Q, 2015, BIOCHEM BIOPH RES CO, V462, P38, DOI 10.1016/j.bbrc.2015.04.102; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Park C, 2008, TOXICOL IN VITRO, V22, P1573, DOI 10.1016/j.tiv.2008.06.010; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Saxena A, 2010, CHEM-BIOL INTERACT, V188, P580, DOI 10.1016/j.cbi.2010.09.029; Tu S, 2015, EXP THER MED, V10, P193, DOI 10.3892/etm.2015.2476; Yang L, 2007, CANCER LETT, V256, P267, DOI 10.1016/j.canlet.2007.06.018; Zheng Z, 2017, ONCOTARGET, V8, P47619, DOI 10.18632/oncotarget.17411; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	33	19	22	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0201864	10.1371/journal.pone.0201864	http://dx.doi.org/10.1371/journal.pone.0201864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615617	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900002
J	Wahabi, H; Fayed, A; Tunkar, SMS; Bakhsh, H; Al-Hazmi, AM; Esmaeil, S; Siddiqui, AR				Wahabi, Hayfaa; Fayed, Amel; Tunkar, Safaa M. S.; Bakhsh, Hanadi; Al-Hazmi, Ali M.; Esmaeil, Samia; Siddiqui, Amna R.			Incidence and contributing factors of glucose intolerance in Saudi postpartum women: Subgroup analysis from RAHMA study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; FOLLOW-UP; PREVENTION; PREVALENCE; HYPERGLYCEMIA; PREDICTORS; PREGNANCY; ARABIA	Objectives The objectives of this study were to determine incidence and risk factors of glucose intolerance one year after delivery in a sub-cohort of Riyadh Mother and Baby Cohort Study (RAHMA) study. Methods This is a follow-up study of a sub-cohort from RAHMA study from King Khalid University Hospital (KKUH). All women from RAHMA database who completed one year since delivery at KKUH were contacted by phone to participate in the study. Previously collected data from RAHMA registry for each participant were linked to this study data. Clinical data measured for each participant included current weight and height to calculate the BMI and waist circumference. Blood tests done for each participant were fasting blood glucose (FPG) and HbA1c. Based on the blood tests results, participants were classified into three groups; diabetic, pre-diabetic and normal. The incidence of diabetes and prediabetes was calculated for the whole cohort. Clinical, biochemical, and sociodemographic predictors of glucose intolerance were compared between the three groups. Risk factors with P-value less than 0.05 were tested in multivariate regression model with bootstrapping to calculate the relative risk (RR) and its 95% Bias corrected Confidence Interval (C.I.) Results From the sub-cohort, 407 women fulfilled the inclusion criteria and agreed to participate in the study. From the study participants; 250 (61.4%) women were normoglycemic, 142 (35%) women had prediabetes and 15 (3.6%) women were diabetic. Following multivariable regression analysis only history of gestational diabetes mellitus (GDM), (RR 1.74, 95% CI (1.06 to 2.84), P = 0.01), obesity (RR 1.69, 95% CI (1.01-3.11), P = 0.04) and diastolic blood pressure, (RR 1.04, 95% CI (1.01-1.09), P = 0.03) remained as predictors of postpartum glucose intolerance. Conclusion The incidence of postpartum glucose intolerance (diabetes and prediabetes) is very high in Saudi women. Both GDM and obesity are strong predictors of glucose intolerance.	[Wahabi, Hayfaa; Esmaeil, Samia] King Saud Univ, Coll Med, Chair Evidence Based Healthcare & Knowledge Trans, Riyadh, Saudi Arabia; [Fayed, Amel; Bakhsh, Hanadi] Princess Nourah Bint Abdulrahman Univ, Coll Med, Clin Dept, Riyadh, Saudi Arabia; [Fayed, Amel] Alexandria Univ, High Inst Publ Hlth, Dept Biostat, Alexandria, Egypt; [Tunkar, Safaa M. S.; Al-Hazmi, Ali M.; Siddiqui, Amna R.] King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia; [Al-Hazmi, Ali M.] King Saud Univ, Coll Med, Prince Sattam Bin Abdul Aziz Res Chair Epidemiol, Riyadh, Saudi Arabia; [Siddiqui, Amna R.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	King Saud University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Alexandria University; King Saud University; King Saud University; Aga Khan University	Fayed, A (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Med, Clin Dept, Riyadh, Saudi Arabia.; Fayed, A (corresponding author), Alexandria Univ, High Inst Publ Hlth, Dept Biostat, Alexandria, Egypt.	fayedam_200@hotmail.com	Siddiqui, Amna/HHS-6259-2022; Fayed, Amel/H-8588-2016	Fayed, Amel/0000-0003-3395-0486	Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University [225-X-38]	Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University(Princess Nourah bint Abdulrahman University)	This study is funded by The Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University (Grant number 225-X-38).	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Al-Quwaidhi AJ, 2014, DIABETES RES CLIN PR, V103, P496, DOI 10.1016/j.diabres.2013.12.036; Al-Rubeaan K, 2015, J DIABETES, V7, P622, DOI 10.1111/1753-0407.12224; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS94, DOI 10.2337/dc16-S015; [Anonymous], 2015, WHO GLOBAL DATABASE; Armstrong C, 2018, AM FAM PHYSICIAN, V97, P413; Aroda VR, 2015, J CLIN ENDOCR METAB, V100, P1646, DOI 10.1210/jc.2014-3761; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011970.pub2; Capula C, 2014, DIABETES RES CLIN PR, V105, P223, DOI 10.1016/j.diabres.2014.05.008; Cheung NW, 2006, J DIABETES COMPLICAT, V20, P21, DOI 10.1016/j.jdiacomp.2005.05.001; Cho GJ, 2016, J CLIN ENDOCR METAB, V101, P2923, DOI 10.1210/jc.2015-3761; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14; Eades CE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0457-8; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Gunderson EP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000490; Herath H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179647; Hod M, 2015, INT J GYNECOL OBSTET, V131, pS16, DOI 10.1016/j.ijgo.2015.02.010; Jiwani A, 2012, J MATERN-FETAL NEO M, V25, P600, DOI 10.3109/14767058.2011.587921; Leuridan L, 2015, PRIM CARE DIABETES, V9, P244, DOI 10.1016/j.pcd.2015.03.007; Lobner K, 2006, DIABETES, V55, P792, DOI 10.2337/diabetes.55.03.06.db05-0746; Majeed A, 2014, DIABETES RES CLIN PR, V103, P218, DOI 10.1016/j.diabres.2013.11.008; Marseille E, 2013, J MATERN-FETAL NEO M, V26, P802, DOI 10.3109/14767058.2013.765845; Nouhjah S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/9786436; O'Reilly SL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002092; Peacock AS, 2014, WOMEN BIRTH, V27, pE7, DOI 10.1016/j.wombi.2014.09.002; Rayanagoudar G, 2016, DIABETOLOGIA, V59, P1403, DOI 10.1007/s00125-016-3927-2; Robert AA, 2017, CURR DIABETES REV, V13, P59, DOI 10.2174/1573399812666160126142605; RYAN EA, 1988, J CLIN ENDOCR METAB, V67, P341, DOI 10.1210/jcem-67-2-341; Shahbazian H, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0245-7; Tovar A, 2011, PREV CHRONIC DIS, V8; Vambergue A, 2008, DIABETIC MED, V25, P58, DOI 10.1111/j.1464-5491.2007.02306.x; Wahabi H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6878263; Wahabi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150297	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210024	10.1371/journal.pone.0210024	http://dx.doi.org/10.1371/journal.pone.0210024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615670	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900035
J	Chiba, T; Nakahara, T; Kohda, F; Ichiki, T; Manabe, M; Furue, M				Chiba, Takahito; Nakahara, Takeshi; Kohda, Futoshi; Ichiki, Toshio; Manabe, Motomu; Furue, Masutaka			Measurement of trihydroxy-linoleic acids in stratum corneum by tape-stripping: Possible biomarker of barrier function in atopic dermatitis	PLOS ONE			English	Article							ESSENTIAL FATTY-ACID; SKIN BARRIER; OMEGA-HYDROXYCERAMIDES; CERAMIDE; LIPIDS; EPIDERMIS	Epidermal ceramides are indispensable lipids that maintain the functions of the stratum corneum. Esterified omega-hydroxyacyl-sphingosine (EOS) ceramide with a linoleate moiety is one of the most important ceramide species for forming cornified lipid envelopes. This linoleate moiety is eventually metabolized to trihydroxy-linoleic acid (triol, 9,10,13-trihydroxy-11-Eoctadecenoic acid). Thus, we assumed that a decrease of triols might reflect skin barrier dysfunction. Against this background, the purposes of this study were to measure the triols by a simple tape-stripping method and to determine the correlation between the amount of triols and transepidermal water loss (TEWL) as an indicator of barrier dysfunction in atopic dermatitis patients. Twenty Japanese subjects with normal skin and 20 atopic dermatitis patients were enrolled in this study. TEWL was measured and triols of the stratum corneum were analyzed by tape-stripping. The results showed for the first time that triols in the stratum corneum could be simply measured using the tape-stripping method. The triol levels in atopic dermatitis patients were much higher than those in healthy subjects. Moreover, the triol levels correlated with TEWL of non-lesional forearm skin in patients with atopic dermatitis. The results suggest that the assaying of triol levels via non-invasive tape-stripping could be beneficial for monitoring barrier function in atopic dermatitis.	[Chiba, Takahito; Manabe, Motomu] Akita Univ, Grad Sch Med, Dept Dermatol & Plast Surg, Akita, Japan; [Nakahara, Takeshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Fukuoka, Japan; [Kohda, Futoshi; Ichiki, Toshio] Aso Iizuka Hosp, Dept Dermatol, Fukuoka, Fukuoka, Japan	Akita University; Kyushu University	Chiba, T (corresponding author), Akita Univ, Grad Sch Med, Dept Dermatol & Plast Surg, Akita, Japan.	chiba-t@gipc.akita-u.ac.jp						Al-Amoudi A, 2005, J INVEST DERMATOL, V124, P764, DOI 10.1111/j.0022-202X.2005.23630.x; Bleck O, 1999, J INVEST DERMATOL, V113, P894, DOI 10.1046/j.1523-1747.1999.00809.x; Chiba T, 2016, J BIOL CHEM, V291, P14540, DOI 10.1074/jbc.M115.711267; Di Nardo A, 1998, ACTA DERM-VENEREOL, V78, P27; Dick A, 2017, BRIT J DERMATOL, V177, pE119, DOI 10.1111/bjd.15406; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; Dreher F, 1998, ACTA DERM-VENEREOL, V78, P186; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Elias PM, 2014, J ALLERGY CLIN IMMUN, V134, P781, DOI 10.1016/j.jaci.2014.05.048; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P314, DOI 10.1016/j.bbalip.2013.09.011; Elias PM, 2009, CURR OPIN ALLERGY CL, V9, P437, DOI 10.1097/ACI.0b013e32832e7d36; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; HEDBERG CL, 1988, J INVEST DERMATOL, V91, P169, DOI 10.1111/1523-1747.ep12464438; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Krieg P, 2013, J INVEST DERMATOL, V133, P172, DOI 10.1038/jid.2012.250; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; LODEN M, 1992, BRIT J DERMATOL, V126, P137, DOI 10.1111/j.1365-2133.1992.tb07810.x; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; MANKU MS, 1984, BRIT J DERMATOL, V110, P643, DOI 10.1111/j.1365-2133.1984.tb04698.x; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; Masukawa Y, 2009, J LIPID RES, V50, P1708, DOI 10.1194/jlr.D800055-JLR200; Meguro S, 2000, ARCH DERMATOL RES, V292, P463, DOI 10.1007/s004030000160; Mehta HH, 2018, INDIAN J DERMATOL VE, V84, DOI 10.4103/ijdvl.IJDVL_1151_15; Munoz-Garcia A, 2014, BBA-MOL CELL BIOL L, V1841, P401, DOI 10.1016/j.bbalip.2013.08.020; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Tawada C, 2014, J INVEST DERMATOL, V134, P712, DOI 10.1038/jid.2013.364; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; van Smeden J, 2011, J LIPID RES, V52, P1211, DOI 10.1194/jlr.M014456; WERTZ PW, 1989, J INVEST DERMATOL, V92, P109, DOI 10.1111/1523-1747.ep13071317; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WERTZ PW, 1983, J LIPID RES, V24, P759; WRIGHT S, 1991, EUR J CLIN NUTR, V45, P501; Yamanashi H, 2018, J LIPID RES, V59, P684, DOI 10.1194/jlr.M082701; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496	34	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210013	10.1371/journal.pone.0210013	http://dx.doi.org/10.1371/journal.pone.0210013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608955	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800039
J	Fuentes-Claramonte, P; Martin-Subero, M; Salgado-Pineda, P; Alonso-Lana, S; Moreno-Alcazar, A; Argila-Plaza, I; Santo-Angles, A; Albajes-Eizagirre, A; Anguera-Camos, M; Capdevila, A; Sarro, S; McKenna, PJ; Pomarol-Clotet, E; Salvador, R				Fuentes-Claramonte, Paola; Martin-Subero, Marta; Salgado-Pineda, Pilar; Alonso-Lana, Silvia; Moreno-Alcazar, Ana; Argila-Plaza, Isabel; Santo-Angles, Aniol; Albajes-Eizagirre, Anton; Anguera-Camos, Maria; Capdevila, Antoni; Sarro, Salvador; McKenna, Peter J.; Pomarol-Clotet, Edith; Salvador, Raymond			Shared and differential default-mode related patterns of activity in an autobiographical, a self-referential and an attentional task	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; NETWORK ACTIVITY; RESTING-STATE; MEMORY; BRAIN; MIND; CONNECTIVITY; REFLECTION; ORGANIZATION	The default-mode network (DMN) comprises a set of brain regions that show deactivations during performance of attentionally demanding tasks, but also activation during certain processes including recall of autobiographical memories and processing information about oneself, among others. However, the DMN is not activated in a homogeneous manner during performance of such tasks, so it is not clear to what extent its activation patterns correspond to deactivation patterns seen during attention-demanding tasks. In this fMRI study we compared patterns of activation in response to an autobiographical memory task to those observed in a self/other-reflection task, and compared both to deactivations observed during the n-back working memory task. Autobiographical recall and self-reflection activated several common DMN areas, which were also deactivated below baseline levels by the n-back task. Activation in the medial temporal lobe was seen during autobiographical recall but not the self/other task, and right angular gyrus activity was specifically linked to other-reflection. ROI analysis showed that most, but not all DMN regions were activated above baseline levels during the autobiographical memory and self-reflection tasks. Our results provide evidence for the usefulness of the autobiographical memory task to study DMN activity and support the notion of interacting subsystems within this network.	[Fuentes-Claramonte, Paola; Martin-Subero, Marta; Salgado-Pineda, Pilar; Alonso-Lana, Silvia; Argila-Plaza, Isabel; Santo-Angles, Aniol; Albajes-Eizagirre, Anton; Anguera-Camos, Maria; Sarro, Salvador; McKenna, Peter J.; Pomarol-Clotet, Edith; Salvador, Raymond] FIDMAG Germanes Hosp Res Fdn, Barcelona, Spain; [Fuentes-Claramonte, Paola; Martin-Subero, Marta; Salgado-Pineda, Pilar; Alonso-Lana, Silvia; Moreno-Alcazar, Ana; Albajes-Eizagirre, Anton; Sarro, Salvador; McKenna, Peter J.; Pomarol-Clotet, Edith; Salvador, Raymond] CIBERSAM Ctr Invest Biomed Red Salud Mental, Barcelona, Spain; [Martin-Subero, Marta] Univ Autonoma Barcelona, Barcelona, Spain; [Moreno-Alcazar, Ana] Parc Salut Mar, Ctr Forum Res Unit, Inst Neuropsiquiatria & Addicc, Barcelona, Spain; [Moreno-Alcazar, Ana] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Capdevila, Antoni] HSCSP, Radiol Unit, Barcelona, Spain; [Capdevila, Antoni] CIBER BBN Ctr Invest Biomed Red Bioingn Biomat &, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Pomarol-Clotet, E (corresponding author), FIDMAG Germanes Hosp Res Fdn, Barcelona, Spain.; Pomarol-Clotet, E (corresponding author), CIBERSAM Ctr Invest Biomed Red Salud Mental, Barcelona, Spain.	epomarol-clotet@fidmag.com	Alonso-Lana, Silvia/H-3101-2017; Fuentes-Claramonte, Paola/AAC-1196-2021; Sarro, Salvador/E-7806-2010	Alonso-Lana, Silvia/0000-0002-3063-6929; Fuentes-Claramonte, Paola/0000-0002-1428-7976; Salgado-Pineda, Pilar/0000-0001-7720-0885; Moreno-Alcazar, Ana/0000-0002-3392-5590; Albajes-Eizagirre, Anton/0000-0001-7767-6568; Argila, Isabel/0000-0002-1604-4708; Salvador, Raymond/0000-0001-5557-1562; Sarro, Salvador/0000-0003-1835-2189; Santo-Angles, Aniol/0000-0002-2539-9957; Pomarol-Clotet, Edith/0000-0002-8159-8563	CIBERSAM; Catalonian Government [2014-SGR-1573]; Plan Nacional de I+D+i 2013-2016: Juan de la Cierva-formacion contract [FJCI-2015-25278]; Instituto de Salud Carlos III; European Union (ERDF/ESF, "Investing in your future"): Miguel Servet Research contracts [CPII13/00018, MS10/00596]; Rio Hortega contract [CM15/00024]; PFIS contract [FI16/00311];  [PI14/01151];  [PI14/01148];  [PI14/01691]	CIBERSAM; Catalonian Government; Plan Nacional de I+D+i 2013-2016: Juan de la Cierva-formacion contract; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union (ERDF/ESF, "Investing in your future"): Miguel Servet Research contracts; Rio Hortega contract; PFIS contract; ; ; 	This work was supported by the CIBERSAM and the Catalonian Government (2014-SGR-1573 to FIDMAG); also by a grant from the Plan Nacional de I+D+i 2013-2016: Juan de la Cierva-formacion contract (FJCI-2015-25278 to PF-C); and by the Instituto de Salud Carlos III, co-funded by European Union (ERDF/ESF, "Investing in your future"): Miguel Servet Research contracts (CPII13/00018 to RS and MS10/00596 to EP-C), Rio Hortega contract (CM15/00024 to MM-S), PFIS contract (FI16/00311 to AA-E) and Research Project Grants (PI14/01151 to RS, PI14/01148 to EP-C and PI14/01691 to PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the CIBERSAM and the Catalonian Government (2014-SGR-1573 to FIDMAG). Also by a grant from the Plan Nacional de I+D+i 2013- 2016: Juan de la Cierva- formacion contract (FJCI- 2015- 25278 to PF-C). And by the Instituto de Salud Carlos III, co-funded by European Union (ERDF/ESF, "Investing in your future"): Miguel Servet Research contracts (CPII13/00018 to RS and MS10/00596 to EP-C), Rio Hortega contract (CM15/00024 to MM-S), PFIS contract (FI16/00311 to AA-E) and Research Project Grants (PI14/01151 to RS, PI14/01148 to EP-C and PI14/01691 to PM).	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2004, NEUROIMAGE, V23, P1460, DOI 10.1016/j.neuroimage.2004.08.007; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2014, NEUROIMAGE, V91, P324, DOI 10.1016/j.neuroimage.2014.01.032; Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bado P, 2014, HUM BRAIN MAPP, V35, P3302, DOI 10.1002/hbm.22403; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bergstrom ZM, 2015, CEREB CORTEX, V25, P2648, DOI 10.1093/cercor/bhu063; Braga RM, 2017, NEURON, V95, P457, DOI 10.1016/j.neuron.2017.06.038; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CROVITZ HF, 1974, B PSYCHONOMIC SOC, V4, P517; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Eddy CM, 2016, NEUROPSYCHOLOGIA, V89, P465, DOI 10.1016/j.neuropsychologia.2016.07.030; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Gusnard DA, 2005, CONSCIOUS COGN, V14, P679, DOI 10.1016/j.concog.2005.04.004; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Holt DJ, 2011, BIOL PSYCHIAT, V69, P415, DOI 10.1016/j.biopsych.2010.10.003; Jenkins AC, 2011, SOC NEUROSCI-UK, V6, P211, DOI 10.1080/17470919.2010.507948; Knyazev GG, 2015, INT J PSYCHOPHYSIOL, V95, P322, DOI 10.1016/j.ijpsycho.2014.12.006; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krienen FM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0526; Kucyi A, 2016, P NATL ACAD SCI USA, V113, P13899, DOI 10.1073/pnas.1611743113; Landin-Romero R, 2015, PSYCHOL MED, V45, P1315, DOI 10.1017/S0033291714002426; Modinos G, 2010, PSYCHOL MED, V40, P1423, DOI 10.1017/S0033291709991875; Modinos G, 2011, NEUROPSYCHOLOGY, V25, P295, DOI 10.1037/a0021747; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; Oertel-Knochel V, 2012, J NERV MENT DIS, V200, P296, DOI 10.1097/NMD.0b013e31824ceef7; Philippi CL, 2015, SOC COGN AFFECT NEUR, V10, P318, DOI 10.1093/scan/nsu070; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sali AW, 2016, J NEUROSCI, V36, P445, DOI 10.1523/JNEUROSCI.2323-15.2016; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; van der Meer L, 2013, SCHIZOPHRENIA BULL, V39, P1352, DOI 10.1093/schbul/sbs122; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Yarkoni T, 2011, FRONT NEUROINFORM, DOI [DOI 10.3389/CONF.FNINF.2011.08.00058, 10.3389/conf.fninf.2011.08.00058]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209376	10.1371/journal.pone.0209376	http://dx.doi.org/10.1371/journal.pone.0209376			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG4NS	30608970	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800020
J	Hong, SY; Xu, JF; Li, Y; Andrade, J; Hoover, P; Kaminski, PJ; Laimins, LA				Hong, Shiyuan; Xu, Junfen; Li, Yan; Andrade, Jorge; Hoover, Paul; Kaminski, Paul J.; Laimins, Laimonis A.			Topoisomerase II beta-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation	ONCOGENE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; DNA-DAMAGE RESPONSE; LIFE-CYCLE; IN-VIVO; REPLICATION; TOPBP1; E6; P53; STABILITY; CANCER	High-risk human papillomaviruses (HPVs) constitutively activate ataxia telangiectasia mutated (ATM) and ataxia telangiectasia- and Rad3-related (ATR) DNA damage repair pathways for viral genome amplification. HPVs activate these pathways through the immune regulator STAT-5. For the ATR pathway, STAT-5 increases expression of the topoisomerase II beta-binding protein 1 (TopBP1), a scaffold protein that binds ATR and recruits it to sites of DNA damage. TopBP1 also acts as a transcriptional regulator, and we investigated how this activity influenced the HPV life cycle. We determined that TopBP1 levels are increased in cervical intraepithelial neoplasias as well as cervical carcinomas, consistent with studies in HPV-positive cell lines. Suppression of TopBP1 by shRNAs impairs HPV genome amplification and activation of the ATR pathway but does not affect the total levels of ATR and CHK1. In contrast, knockdown reduces the expression of other DNA damage factors such as RAD51 and Mre11 but not BRCA2 or NBS1. Interestingly, TopBP1 positively regulates the expression of E2F1, a TopBP1-binding partner, and p73 in HPV-positive cells in contrast to its effects in other cell types. TopBP1 transcriptional activity is regulated by AKT, and treatment with AKT inhibitors suppresses expression of E2F1 and p73 without interfering with ATR signaling. Importantly, the levels of p73 are elevated in HPV-positive cells and its knockdown impairs HPV genome amplification. This demonstrates that p73, like p63 and p53, is an important regulator of the HPV life cycle that is controlled by the transcriptional activating properties of the multifunctional TopBP1 protein.	[Hong, Shiyuan; Hoover, Paul; Kaminski, Paul J.; Laimins, Laimonis A.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Xu, Junfen] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynecol Oncol, Hangzhou 310006, Zhejiang, Peoples R China; [Li, Yan; Andrade, Jorge] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Zhejiang University; University of Chicago	Hong, SY; Laimins, LA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	shiyuan-hong@northwestern.edu; l-laimins@northwestern.edu	Fan, Qing/AAI-8294-2021	Kaminski, Paul/0000-0002-5513-2962; Andrade, Jorge/0000-0003-3210-2186	NCI [CA059655, CA142861]; ACS [IRG-15-173-21]; National Natural Scientific Foundation of China [81702552]; NATIONAL CANCER INSTITUTE [R01CA059655, R01CA142861] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from NCI (CA059655 and CA142861) to L.A.L., ACS grant IRG-15-173-21 to S.H., and National Natural Scientific Foundation of China (No. 81702552) to J.X.	Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Andrews S., 2010, FASTQC QUALITY CONTR; Chappell WH, 2016, J VIROL, V90, P2639, DOI 10.1128/JVI.02495-15; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; Connell C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032442; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; DiMaio D, 2013, VIROLOGY, V445, P99, DOI 10.1016/j.virol.2013.05.006; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donaldson MM, 2012, J VIROL, V86, P12806, DOI 10.1128/JVI.01002-12; Doorbar J, 2013, VIROLOGY, V445, P80, DOI 10.1016/j.virol.2013.07.008; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Edwards TG, 2013, J VIROL, V87, P3979, DOI 10.1128/JVI.03473-12; Fang YF, 2014, CANCER BIOL THER, V15, P1268, DOI 10.4161/cbt.29691; Fehrmann Frauke, 2005, Methods Mol Biol, V292, P317; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Gunasekharan V, 2012, J VIROL, V86, P5393, DOI 10.1128/JVI.07239-11; Gunasekharan VK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005747; Habiger C, 2016, J VIROL, V90, P694, DOI 10.1128/JVI.02137-15; Hartley KA, 2002, J VIROL, V76, P5014, DOI 10.1128/JVI.76.10.5014-5023.2002; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Hong SY, 2017, J ZHEJIANG UNIV-SC B, V18, P215, DOI 10.1631/jzus.B1600306; Hong SY, 2015, MBIO, V6, DOI 10.1128/mBio.02006-15; Hong SY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003295; Hong SY, 2011, J VIROL, V85, P9486, DOI 10.1128/JVI.05007-11; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kidiyoor GR, 2016, DNA REPAIR, V44, P143, DOI 10.1016/j.dnarep.2016.05.020; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; LECHNER MS, 1992, EMBO J, V11, P3045, DOI 10.1002/j.1460-2075.1992.tb05375.x; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2013, MOL CELL BIOL, V33, P4685, DOI 10.1128/MCB.00373-13; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Lorenz LD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003717; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mehta K, 2018, MBIO, V9, DOI 10.1128/mBio.00064-18; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Mighty KK, 2011, J VIROL, V85, P8863, DOI 10.1128/JVI.00750-11; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Niklison-Chirou MV, 2016, MOL NEUROBIOL, V53, P4509, DOI 10.1007/s12035-015-9381-1; OCONNOR M, 1995, VIROLOGY, V207, P77, DOI 10.1006/viro.1995.1053; OFFORD EA, 1990, J VIROL, V64, P4792, DOI 10.1128/JVI.64.10.4792-4798.1990; Pacini L, 2015, J VIROL, V89, P11396, DOI 10.1128/JVI.02151-15; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sedman J, 1995, EMBO J, V14, P6218, DOI 10.1002/j.1460-2075.1995.tb00312.x; Spurgeon ME, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080219; Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj.cdd.4400995; Stunkel W, 1999, J VIROL, V73, P1918; Thomas JT, 1999, P NATL ACAD SCI USA, V96, P8449, DOI 10.1073/pnas.96.15.8449; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Wallace NA, 2015, ANNU REV VIROL, V2, P403, DOI 10.1146/annurev-virology-100114-055021; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan X, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.69; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; J VIROL, V74, P5198	68	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3274	3287		10.1038/s41388-018-0633-1	http://dx.doi.org/10.1038/s41388-018-0633-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30631149	Green Accepted			2022-12-26	WOS:000465557200012
J	Louault, K; Bonneaud, TL; Seveno, C; Gomez-Bougie, P; Nguyen, F; Gautier, F; Bourgeois, N; Loussouarn, D; Kerdraon, O; Barille-Nion, S; Jezequel, P; Campone, M; Amiot, M; Juin, PP; Souaze, F				Louault, K.; Bonneaud, T. L.; Seveno, C.; Gomez-Bougie, P.; Nguyen, F.; Gautier, F.; Bourgeois, N.; Loussouarn, D.; Kerdraon, O.; Barille-Nion, S.; Jezequel, P.; Campone, M.; Amiot, M.; Juin, P. P.; Souaze, F.			Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers	ONCOGENE			English	Article							BCL-2; CARCINOMA; DETERMINANT; SENSITIVITY; APOPTOSIS; FEATURES; IMPACT; IL-6	Selective inhibition of BCL-2 is expected to enhance therapeutic vulnerability in luminal estrogen receptor-positive breast cancers. We show here that the BCL-2 dependency of luminal tumor cells is nevertheless mitigated by breast cancer-associated fibroblasts (bCAFs) in a manner that defines MCL-1 as another critical therapeutic target. bCAFs favor MCL-1 expression and apoptotic resistance in luminal cancer cells in a IL-6 dependent manner while their own, robust, survival also relies on MCL-1. Studies based on ex vivo cultures of human luminal breast cancer tissues further argue that the contribution of stroma-derived signals to MCL-1 expression shapes BCL-2 dependency. Thus, MCL-1 inhibitors are beneficial for targeted apoptosis of breast tumor ecosystems, even in a subtype where MCL-1 dependency is not intrinsically driven by oncogenic pathways.	[Louault, K.; Bonneaud, T. L.; Seveno, C.; Nguyen, F.; Gautier, F.; Bourgeois, N.; Barille-Nion, S.; Jezequel, P.; Campone, M.; Juin, P. P.; Souaze, F.] Univ Nantes, Univ Angers, INSERM, CRCINA,Team 8, Nantes, France; [Louault, K.; Bonneaud, T. L.; Seveno, C.; Gomez-Bougie, P.; Gautier, F.; Bourgeois, N.; Kerdraon, O.; Barille-Nion, S.; Jezequel, P.; Campone, M.; Amiot, M.; Juin, P. P.; Souaze, F.] SIRIC ILIAD, Nantes, France; [Gomez-Bougie, P.; Amiot, M.] Univ Nantes, Univ Angers, INSERM, CRCINA,Team 10, Nantes, France; [Nguyen, F.] Nantes Atlantic Coll Vet Med Food Sci & Engn, ONIRIS, Anim Canc, Nantes, France; [Gautier, F.; Kerdraon, O.; Jezequel, P.; Campone, M.; Juin, P. P.] ICO Rene Gauducheau, St Herblain, France; [Loussouarn, D.] CHU Nantes, Serv Anat Pathol, Nantes, France; [Juin, P. P.; Souaze, F.] CNRS GDR3697 Micronit, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes	Juin, PP; Souaze, F (corresponding author), Univ Nantes, Univ Angers, INSERM, CRCINA,Team 8, Nantes, France.; Juin, PP; Souaze, F (corresponding author), SIRIC ILIAD, Nantes, France.; Juin, PP (corresponding author), ICO Rene Gauducheau, St Herblain, France.; Juin, PP; Souaze, F (corresponding author), CNRS GDR3697 Micronit, Tours, France.	philippe.juin@univ-nantes.fr; frederique.souaze@univ-nantes.fr	JUIN, Philippe/Q-1338-2019; JUIN, Philippe P/H-3636-2014; Barille-nion, sophie/W-8103-2019; souazé, frédérique/AAE-6478-2021	JUIN, Philippe/0000-0002-4997-3888; JUIN, Philippe P/0000-0002-4997-3888; Barille-nion, sophie/0000-0001-5171-9937; Louault, Kevin/0000-0002-2325-5757; Gomez Bougie, Patricia/0000-0002-4846-4782; Nguyen, Frederique/0000-0001-7203-2982; Frederique, Souaze/0000-0003-0476-2603	CIFRE grant (ANRT contract) [20150995]; Ligue contre le cancer; Odyssea; Canceropole Grand Ouest (MATURE project 2017-18); ARC [R15083NN]; ANR [15-CE18-0008]; INCa; DGOS (SIRIC ILIAD, INCa-DGOS Inserm) [12558]	CIFRE grant (ANRT contract)(French National Research Agency (ANR)); Ligue contre le cancer(Ligue nationale contre le cancer); Odyssea; Canceropole Grand Ouest (MATURE project 2017-18); ARC(Australian Research Council); ANR(French National Research Agency (ANR)); INCa(Institut National du Cancer (INCA) France); DGOS (SIRIC ILIAD, INCa-DGOS Inserm)	This research was performed within the framework of a CIFRE grant (ANRT contract #20150995) for K. Louault at CRCINA and ONCOTHEREX. T.L Bonneaud was supported by a fellowship from Ligue contre le cancer. This work was supported by Odyssea, Canceropole Grand Ouest (MATURE project 2017-18), ARC (R15083NN), ANR (15-CE18-0008), INCa and DGOS (SIRIC ILIAD, INCa-DGOS Inserm-12558).	Campbell KJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0035-2; Campone M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-110; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; Dousset C, 2017, BRIT J HAEMATOL, V179, P684, DOI 10.1111/bjh.14251; Foight GW, 2014, ACS CHEM BIOL, V9, P1962, DOI 10.1021/cb500340w; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Hendrayani SF, 2016, ONCOTARGET, V7, P41974, DOI 10.18632/oncotarget.9633; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jezequel P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0550-y; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kumar S, 2017, BLOOD, V130, P2401, DOI 10.1182/blood-2017-06-788786; Labovsky V, 2016, TUMOR BIOL, V37, P13377, DOI 10.1007/s13277-016-5268-7; Lagares D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3765; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Ma YF, 2017, ADV CLIN EXP MED, V26, P421, DOI 10.17219/acem/62120; Marusyk A, 2016, CANCER RES, V76, P6495, DOI 10.1158/0008-5472.CAN-16-1457; Merino D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7049; Mertens JC, 2013, CANCER RES, V73, P897, DOI 10.1158/0008-5472.CAN-12-2130; Montero J, 2018, CELL DEATH DIFFER, V25, P56, DOI 10.1038/cdd.2017.183; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Qiao AX, 2016, FRONT MED-PRC, V10, P33, DOI 10.1007/s11684-016-0431-5; Romagnoli M, 2007, LEUKEMIA, V21, P1070, DOI 10.1038/sj.leu.2404602; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2017, CANCER RES, V77, P1927, DOI 10.1158/0008-5472.CAN-16-2129; Sansone P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10442; Seveno C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3214; Trecesson SD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01079-1; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Winslow S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0530-2; Xiao Y, 2015, MOL CANCER THER, V14, P1837, DOI 10.1158/1535-7163.MCT-14-0928; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Young AIJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0781-6	39	28	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3261	3273		10.1038/s41388-018-0635-z	http://dx.doi.org/10.1038/s41388-018-0635-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30631150	Green Published, hybrid			2022-12-26	WOS:000465557200011
J	Meng, FT; Kassa, T; Strader, MB; Soman, J; Olson, JS; Alayash, AI				Meng, Fantao; Kassa, Tigist; Strader, Michael Brad; Soman, Jayashree; Olson, John S.; Alayash, Abdu I.			Substitutions in the subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hemoglobin; gene therapy; mass spectrometry (MS); hypoxia; oxidation-reduction (redox); redox reactions; sickle-cell disease	HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; GENE-THERAPY; HEME; TYROSINE; MUTATION; BINDING; OXYHEMOGLOBIN; DYSFUNCTION	After reacting with hydrogen peroxide (H2O2), sickle-cell hemoglobin (HbS, E6V) remains longer in a highly oxidizing ferryl form (HbFe(4+)=O) and induces irreversible oxidation of hot-spot amino acids, including Cys-93. To control the damaging ferryl heme, here we constructed three HbS variants. The first contained a redox-active Tyr in subunits (F41Y), a substitution present in Hb Mequon; the second contained the Asp (K82D) found in the cleft of Hb Providence; and the third had both of these substitutions. Both the single Tyr-41 and Asp-82 constructs lowered the oxygen affinity of HbS but had little or no effects on autoxidation or heme loss kinetics. In the presence of H2O2, both rHbS F41Y and F41Y/K82D enhanced ferryl Hb reduction by providing a pathway for electrons to reduce the heme via the Tyr-41 side chain. MS analysis of Cys-93 revealed moderate inhibition of thiol oxidation in the HbS single F41Y variant and dramatic 3- to 8-fold inhibition of cysteic acid formation in rHbS K82D and F41Y/K82D, respectively. Under hypoxia, K82D and F41Y/K82D HbS substitutions increased the delay time by approximate to 250 and 600 s before the onset of polymerization compared with the rHbS control and rHbS F41Y, respectively. Moreover, at 60 degrees C, rHbS K82D exhibited superior structural stability. Asp-82 also enhanced the function of Tyr as a redox-active amino acid in the rHbS F41Y/K82D variant. We conclude that the K82D and F41Y substitutions add significant resistance to oxidative stress and anti-sickling properties to HbS and therefore could be potential genome-editing targets.	[Meng, Fantao; Kassa, Tigist; Strader, Michael Brad; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, White Oak Campus, Silver Spring, MD 20993 USA; [Soman, Jayashree; Olson, John S.] Rice Univ, BioSci Dept, Houston, TX 77251 USA	US Food & Drug Administration (FDA); Rice University	Alayash, AI (corresponding author), US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, White Oak Campus, Silver Spring, MD 20993 USA.	abdu.alayash@fda.hhs.gov			National Institutes of Health from NHLBI [HL110900]; Robert A. Welch Foundation [C-0612]; United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert A. Welch Foundation(The Welch Foundation); United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL110900 from NHLBI (to J. S. O. and A. I. A.), Robert A. Welch Foundation Grant C-0612 (to J. S. O.), and United States Food and Drug Administration (MODSCI) (to A. I. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham B, 2011, BIOCHEMISTRY-US, V50, P9752, DOI 10.1021/bi200876e; ADACHI K, 1979, J BIOL CHEM, V254, P7765; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alayash AI, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010002; Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; ASAKURA T, 1974, P NATL ACAD SCI USA, V71, P1594, DOI 10.1073/pnas.71.5.1594; Azar S, 2017, MED CLIN N AM, V101, P375, DOI 10.1016/j.mcna.2016.09.009; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; BAUDIN V, 1992, BIOCHIM BIOPHYS ACTA, V1159, P223, DOI 10.1016/0167-4838(92)90029-D; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; BONAVENTURA J, 1976, J BIOL CHEM, V251, P7563; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Cellmer T, 2016, NAT STRUCT MOL BIOL, V23, P459, DOI 10.1038/nsmb.3197; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Dumoulin A, 1996, PROTEIN SCI, V5, P114; EATON W A, 1987, Blood, V70, P1245; Eaton WA, 2017, BLOOD, V129, P2719, DOI 10.1182/blood-2017-02-765891; GALE RE, 1988, BRIT J HAEMATOL, V70, P251, DOI 10.1111/j.1365-2141.1988.tb02472.x; GARROD ARCHIBALD, 1928, BRIT MED JOUR, V1, P1099; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Ghatge MS, 2016, J STRUCT BIOL, V194, P446, DOI 10.1016/j.jsb.2016.04.003; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Gizi A, 2011, BLOOD CELL MOL DIS, V46, P220, DOI 10.1016/j.bcmd.2011.01.002; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Jagadeeswaran R, 2017, HEMATOL-AM SOC HEMAT, P440, DOI 10.1182/asheducation-2017.1.440; Jagadeeswaran R, 2017, EXP HEMATOL, V50, P46, DOI 10.1016/j.exphem.2017.02.003; Jana S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120451; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kassa T, 2015, J BIOL CHEM, V290, P27939, DOI 10.1074/jbc.M115.651257; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; Meng FT, 2017, ANAL BIOCHEM, V521, P11, DOI 10.1016/j.ab.2017.01.002; Mitra A, 2017, HEMOGLOBIN, V41, P300, DOI 10.1080/03630269.2017.1399905; Mollan TL, 2014, FREE RADICAL BIO MED, V69, P265, DOI 10.1016/j.freeradbiomed.2014.01.030; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Niihara Y, 1998, AM J HEMATOL, V58, P117, DOI 10.1002/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P274, DOI 10.1016/j.freeradbiomed.2007.06.030; Reeder BJ, 2012, J AM CHEM SOC, V134, P7741, DOI 10.1021/ja211745g; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Silkstone GGA, 2016, BIOCHEM J, V473, P3371, DOI 10.1042/BCJ20160243; Simons M, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180370; Strader MB, 2017, BIOCHEM J, V474, P4171, DOI 10.1042/BCJ20170491; Strader MB, 2017, ANTIOXID REDOX SIGN, V26, P777, DOI 10.1089/ars.2016.6805; Strader MB, 2014, J BIOL CHEM, V289, P22342, DOI 10.1074/jbc.M114.568980; Tam MF, 2015, J BIOL CHEM, V290, P21762, DOI 10.1074/jbc.M115.658054; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Weickert MJ, 1999, APPL ENVIRON MICROB, V65, P640	60	7	8	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4145	4159		10.1074/jbc.RA118.006452	http://dx.doi.org/10.1074/jbc.RA118.006452			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30630954	Green Published, hybrid			2022-12-26	WOS:000461854400026
J	Singh, SP; Kukshal, V; Galletto, R				Singh, Saurabh P.; Kukshal, Vandna; Galletto, Roberto			A stable tetramer is not the only oligomeric state that mitochondrial single-stranded DNA binding proteins can adopt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; oligomerization; analytical ultracentrifugation; fluorescence; biophysics; mitochondria; DNA replication	PLASMODIUM-FALCIPARUM SSB; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MODE TRANSITIONS; COMPLEXES; IDENTIFICATION; EQUILIBRIUM; MULTIPLE; MUTANT; ACIDS	Mitochondrial single-stranded DNA (ssDNA)-binding proteins (mtSSBs) are required for mitochondrial DNA replication and stability and are generally assumed to form homotetramers, and this species is proposed to be the one active for ssDNA binding. However, we recently reported that the mtSSB from Saccharomyces cerevisiae (ScRim1) forms homotetramers at high protein concentrations, whereas at low protein concentrations, it dissociates into dimers that bind ssDNA with high affinity. In this work, using a combination of analytical ultracentrifugation techniques and DNA binding experiments with fluorescently labeled DNA oligonucleotides, we tested whether the ability of ScRim1 to form dimers is unique among mtSSBs. Although human mtSSBs and those from Schizosaccharomyces pombe, Xenopus laevis, and Xenopus tropicalis formed stable homotetramers, the mtSSBs from Candida albicans and Candida parapsilosis formed stable homodimers. Moreover, the mtSSBs from Candida nivariensis and Candida castellii formed tetramers at high protein concentrations, whereas at low protein concentrations, they formed dimers, as did ScRim1. Mutational studies revealed that the ability to form either stable tetramers or dimers depended on a complex interplay of more than one amino acid at the dimer-dimer interface and the C-terminal unstructured tail. In conclusion, our findings indicate that mtSSBs can adopt different oligomeric states, ranging from stable tetramers to stable dimers, and suggest that a dimer of mtSSB may be a physiologically relevant species that binds to ssDNA in some yeast species.	[Singh, Saurabh P.; Kukshal, Vandna; Galletto, Roberto] Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Galletto, R (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA.	galletto@biochem.wustl.edu	Singh, Saurabh Pratap/AAI-2988-2020	Singh, Saurabh Pratap/0000-0001-7604-645X; Galletto, Roberto/0000-0001-6435-122X	NIGMS, National Institutes of Health [2R01GM098509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098509] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health (2R01GM098509 to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony E, 2012, J MOL BIOL, V420, P284, DOI 10.1016/j.jmb.2012.04.022; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; BARAT M, 1981, CHROMOSOMA, V82, P583, DOI 10.1007/BF00295014; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1991, J BIOL CHEM, V266, P1616; Carlini L, 1998, FEBS LETT, V430, P197, DOI 10.1016/S0014-5793(98)00655-3; KHAMIS MI, 1987, J BIOL CHEM, V262, P10938; KHAMIS MI, 1987, FEBS LETT, V211, P155, DOI 10.1016/0014-5793(87)81427-8; Landwehr M, 2002, BIOL CHEM, V383, P1325, DOI 10.1515/BC.2002.151; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1988, BIOCHEM PHARMACOL, V37, P1781, DOI 10.1016/0006-2952(88)90443-1; Nishio M, 2006, DNA SEQUENCE, V17, P287, DOI 10.1080/10425170600857608; Nosek J, 1999, J BIOL CHEM, V274, P8850, DOI 10.1074/jbc.274.13.8850; Qian YF, 2017, J BIOL CHEM, V292, P13068, DOI 10.1074/jbc.M117.791392; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Singh SP, 2018, NUCLEIC ACIDS RES, V46, P7193, DOI 10.1093/nar/gky530; Tomaska L, 1997, J BIOL CHEM, V272, P3049, DOI 10.1074/jbc.272.5.3049; Tomaska L, 2001, J MOL BIOL, V305, P61, DOI 10.1006/jmbi.2000.4254; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Webster G, 1997, FEBS LETT, V411, P313, DOI 10.1016/S0014-5793(97)00747-3; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153	26	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4137	4144		10.1074/jbc.RA118.007048	http://dx.doi.org/10.1074/jbc.RA118.007048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30617184	Green Published, hybrid			2022-12-26	WOS:000461854400025
J	Wang, MM; Toda, K; Block, A; Maeda, HA				Wang, Minmin; Toda, Kyoko; Block, Anna; Maeda, Hiroshi A.			TAT1 and TAT2 tyrosine aminotransferases have both distinct and shared functions in tyrosine metabolism and degradation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; plant biochemistry; metabolism; secondary metabolism; plant physiology; tyrosine; amino acid catabolism; aromatic amino acids; dark induced senescence; tocopherols; tyrosine; tyrosine aminotransferase; plant metabolism; 4-hydroxyphenylpyruvate; secondary metabolite	BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; AMINO-ACID BIOSYNTHESIS; P-HYDROXYPHENYLPYRUVATE DIOXYGENASE; ELECTRON-TRANSFER FLAVOPROTEIN; FUMARYLACETOACETATE HYDROLASE; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; SUBCELLULAR-LOCALIZATION; AROGENATE DEHYDROGENASE; TOCOPHEROL SYNTHESIS; NITRITE REDUCTASE	Plants produce various l-tyrosine (Tyr)-derived compounds that are critical for plant adaptation and have pharmaceutical or nutritional importance for human health. Tyrosine aminotransferases (TATs) catalyze the reversible reaction between Tyr and 4-hydroxyphenylpyruvate (HPP), representing the entry point in plants for both biosynthesis of various natural products and Tyr degradation in the recycling of energy and nutrients. To better understand the roles of TATs and how Tyr is metabolized in planta, here we characterized single and double loss-of-function mutants of TAT1 (At5g53970) and TAT2 (At5g36160) in the model plant Arabidopsis thaliana. As reported previously, tat1 mutants exhibited elevated and decreased levels of Tyr and tocopherols, respectively. The tat2 mutation alone had no impact on Tyr and tocopherol levels, but a tat1 tat2 double mutant had increased Tyr accumulation and decreased tocopherol levels under high-light stress compared with the tat1 mutant. Relative to WT and the tat2 mutant, the tat1 mutant displayed increased vulnerability to continuous dark treatment, associated with an early drop in respiratory activity and sucrose depletion. During isotope-labeled Tyr feeding in the dark, we observed that the tat1 mutant exhibits much slower C-13 incorporation into tocopherols, fumarate, and other tricarboxylic acid (TCA) cycle intermediates than WT and the tat2 mutant. These results indicate that TAT1 and TAT2 function together in tocopherol biosynthesis, with TAT2 having a lesser role, and that TAT1 plays the major role in Tyr degradation in planta. Our study also highlights the importance of Tyr degradation under carbon starvation conditions during dark-induced senescence in plants.	[Wang, Minmin; Toda, Kyoko; Maeda, Hiroshi A.] Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA; [Toda, Kyoko] Natl Agr & Food Res Org NARO, Inst Crop Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058518, Japan; [Block, Anna] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32608 USA; [Wang, Minmin] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Wisconsin System; University of Wisconsin Madison; National Agriculture & Food Research Organization - Japan; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Maeda, HA (corresponding author), Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA.	maeda2@wisc.edu	Block, Anna/AAF-2556-2020	Block, Anna/0000-0003-1689-4005; Maeda, Hiroshi/0000-0003-0246-694X	National Science Foundation [IOS-1354971]; Agricultural Research Service, United States Department of Agriculture [6036-11210-001-00D]	National Science Foundation(National Science Foundation (NSF)); Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by National Science Foundation Grant IOS-1354971 (to H. A. M.) and by Agricultural Research Service, United States Department of Agriculture, Project 6036-11210-001-00D (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], [No title captured]; Aoki Y, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv165; Aprile A, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1473-4; Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Araujo WL, 2011, PLANT PHYSIOL, V157, P55, DOI 10.1104/pp.111.182188; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Arnold A, 2014, PLANT PHYSIOL, V165, P1380, DOI 10.1104/pp.114.235358; Aryal UK, 2014, PLANT CELL, V26, P3867, DOI 10.1105/tpc.114.127563; Avila-Ospina L, 2014, J EXP BOT, V65, P3799, DOI 10.1093/jxb/eru039; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Block A, 2014, PLANT CELL, V26, P1938, DOI 10.1105/tpc.114.125807; Block A, 2013, J BIOL CHEM, V288, P27594, DOI 10.1074/jbc.M113.492769; Brockington SF, 2015, NEW PHYTOL, V207, P1170, DOI 10.1111/nph.13441; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Collakova E, 2003, PLANT PHYSIOL, V131, P632, DOI 10.1104/pp.015222; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dixon DP, 2006, PLANT SCI, V171, P360, DOI 10.1016/j.plantsci.2006.04.008; Dormann P, 2007, PLANTA, V225, P269, DOI 10.1007/s00425-006-0438-2; DURAND R, 1974, FEBS LETT, V39, P218, DOI 10.1016/0014-5793(74)80054-2; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Engqvist MKM, 2011, J BIOL CHEM, V286, P11382, DOI 10.1074/jbc.M110.194175; Falk J, 2002, J PLANT PHYSIOL, V159, P1245, DOI 10.1078/0176-1617-00804; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; FIEDLER E, 1982, PLANTA, V155, P511, DOI 10.1007/BF01607575; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Garcia I, 1997, BIOCHEM J, V325, P761, DOI 10.1042/bj3250761; GELFAND DH, 1977, J BACTERIOL, V130, P429, DOI 10.1128/JB.130.1.429-440.1977; Granadino B, 1997, GENOMICS, V43, P115, DOI 10.1006/geno.1997.4805; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Grierson D, 2013, MOL BIOL BIOCH FRUIT, P43, DOI DOI 10.1002/9781118593714.CH3; Gu LP, 2010, PLANT J, V61, P579, DOI 10.1111/j.1365-313X.2009.04083.x; Han CY, 2013, PLANT PHYSIOL, V162, P1956, DOI 10.1104/pp.113.216804; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hollander-Czytko H, 2005, J PLANT PHYSIOL, V162, P767, DOI 10.1016/j.jplph.2005.04.019; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Iraqui I, 1998, MOL GEN GENET, V257, P238, DOI 10.1007/s004380050644; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Ishizaki K, 2006, PLANT J, V47, P751, DOI 10.1111/j.1365-313X.2006.02826.x; Jander G, 2004, PLANT J, V39, P465, DOI 10.1111/j.1365-313X.2004.02140.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; KRUPINSKA K, 1992, PLANTA, V186, P294, DOI 10.1007/BF00196259; LADU BN, 1955, J BIOL CHEM, V217, P777; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Latimer S, 2018, PLANT J, V95, P358, DOI 10.1111/tpj.13955; Lee EJ, 2011, PLANT PHYSIOL, V157, P1067, DOI 10.1104/pp.111.185512; Lee RH, 2001, J EXP BOT, V52, P1117, DOI 10.1093/jexbot/52.358.1117; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P1374, DOI 10.1016/j.phytochem.2005.04.029; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; LOFFELHARDT W, 1979, FEBS LETT, V104, P332, DOI 10.1016/0014-5793(79)80845-5; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; Mehere P, 2010, PROTEIN CELL, V1, P1023, DOI 10.1007/s13238-010-0128-5; MEYER CR, 1988, PLANT PHYSIOL, V86, P325, DOI 10.1104/pp.86.2.325; MIFLIN BJ, 1967, NATURE, V214, P1133, DOI 10.1038/2141133a0; MIFLIN BJ, 1974, PLANT PHYSIOL, V54, P550, DOI 10.1104/pp.54.4.550; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Munne-Bosch S, 2002, PLANTA, V214, P608, DOI 10.1007/s004250100646; Nishimura K, 2016, PLANT PHYSIOL, V171, P2280, DOI 10.1104/pp.16.00330; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; NOVELLI GD, 1967, ANNU REV BIOCHEM, V36, P449, DOI 10.1146/annurev.bi.36.070167.002313; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Peng C, 2015, PLANT PHYSIOL, V169, P1807, DOI 10.1104/pp.15.00461; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Phornphutkul C, 2002, NEW ENGL J MED, V347, P2111, DOI 10.1056/NEJMoa021736; Pires MV, 2016, PLANT CELL ENVIRON, V39, P1304, DOI 10.1111/pce.12682; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prabhu PR, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/549572; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riewe D, 2012, PLANT J, V71, P850, DOI 10.1111/j.1365-313X.2012.05035.x; Rippert P, 2002, PLANT MOL BIOL, V48, P361, DOI 10.1023/A:1014018926676; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; RISE M, 1989, PLANT PHYSIOL, V89, P1028, DOI 10.1104/pp.89.4.1028; RUBIN JL, 1979, PLANT PHYSIOL, V64, P727, DOI 10.1104/pp.64.5.727; Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146; Schenck CA, 2018, PHYTOCHEMISTRY, V149, P82, DOI 10.1016/j.phytochem.2018.02.003; Schenck CA, 2017, NAT CHEM BIOL, V13, P1029, DOI [10.1038/nchembio.2414, 10.1038/NCHEMBIO.2414]; Schenck CA, 2015, NAT CHEM BIOL, V11, P52, DOI 10.1038/nchembio.1693; Siehl DL, 2014, PLANT PHYSIOL, V166, P1162, DOI 10.1104/pp.114.247205; Singh RK, 2011, J EXP BOT, V62, P3375, DOI 10.1093/jxb/err006; Stacey MG, 2016, PLANT PHYSIOL, V172, P1506, DOI 10.1104/pp.16.00941; Starke I, 2001, FRESEN J ANAL CHEM, V371, P380, DOI 10.1007/s002160100941; Torrens-Spence MP, 2018, MOL PLANT, V11, P205, DOI 10.1016/j.molp.2017.12.007; Tsegaye Y, 2002, PLANT PHYSIOL BIOCH, V40, P913, DOI 10.1016/S0981-9428(02)01461-4; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; van Wijk KJ, 2015, ANNU REV PLANT BIOL, V66, P75, DOI 10.1146/annurev-arplant-043014-115547; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395; Wang MM, 2018, PHYTOCHEM REV, V17, P131, DOI 10.1007/s11101-017-9520-6; Wang MM, 2016, PHYTOCHEMISTRY, V132, P16, DOI 10.1016/j.phytochem.2016.09.007; WHISTANC.GR, 1970, BIOCHEM J, V117, P593, DOI 10.1042/bj1170593; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Xu JJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01305; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Zhi TT, 2016, PLANTA, V244, P557, DOI 10.1007/s00425-016-2530-6	109	22	24	2	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3563	3576		10.1074/jbc.RA118.006539	http://dx.doi.org/10.1074/jbc.RA118.006539			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30630953	Green Published, hybrid			2022-12-26	WOS:000461853900021
J	Gamba, CD; Damasceno, KA; Ferreira, IC; Rodrigues, MA; Gomes, DA; Alves, MR; Rocha, RM; Lima, AE; Ferreira, E; Cassali, GD				Gamba, Conrado de Oliveira; Damasceno, Karine Araujo; Ferreira, Izabel Cristina; Rodrigues, Michele Angela; Gomes, Dawidson Assis; Alves, Mariana Resende; Rocha, Rafael Malagoli; Lima, Alessandra Estrela; Ferreira, Enio; Cassali, Geovanni Dantas			The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; CELL-ADHESION MOLECULES; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; DOWN-REGULATION; SIP1; TUMOR; PROGRESSION; GRADE; SNAIL	The E-cadherin loss has frequently been associated with transcriptional repression mediated by transcription factors, such as the Zinc Finger E-Box Binding Homeobox-2 (ZEB2). Invasive micropapillary carcinomas (IMPCs) of the breast are aggressive neoplasms frequently related to lymph node metastasis and poor overall survival. In the canine mammary gland, IMPCs has just been reported and, based on its behavioral similarity with the human IMPCs, appears to be a good spontaneous model to this human entity. This study aimed to evaluate the relationship between E-cadherin and ZEB2 in a spontaneous canine model of invasive micropapillary carcinoma of the mammary gland. The correlation among gene expression (ZEB2 and CDH1) and clinicopathological findings was also explored. Nineteen cases of IMPC of the canine mammary gland were obtained, protein and mRNA expression were investigated through immunohistochemistry and RNA In Situ Hybridization, respectively. To better understand the relationship between E-cadherin and ZEB2, immunofluorescence was performed in canine IMPCs. Immunohistochemically, most of IMPCs showed 1+ (14/19, 73.7%) for E-cadherin; and positivity for ZEB2 was diagnosed in 47.4% of the IMPCs. Regarding the RNA In Situ Hybridization (ISH), most of IMPCs showed 4+ and 0+ for E-cadherin (CDH1) and ZEB2 respectively. Through immunofluorescence, the first and second more frequent combinatorial group were E-cadherin(+)ZEB2(-) and E-cadherin(+)ZEB2(+); neoplastic cells showing concomitantly weak expression for E-cadherin and positivity for ZEB2 were frequently observed. A negative correlation was observed between E-cadherin and progesterone receptor expression in IMPCs. Based on these results, canine mammary IMPCs show E-cadherin lost and, at times reveals nuclear positivity for the transcription factor ZEB2 that seems to exert transcriptional repression of the CDH1.	[Gamba, Conrado de Oliveira; Damasceno, Karine Araujo; Ferreira, Izabel Cristina; Rodrigues, Michele Angela; Ferreira, Enio; Cassali, Geovanni Dantas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Gamba, Conrado de Oliveira] Univ Oeste Santa Catarina, Curso Med Vet, Campus Aproximado Campos Novos, Campos Novos, SC, Brazil; [Damasceno, Karine Araujo] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil; [Gomes, Dawidson Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Alves, Mariana Resende; Rocha, Rafael Malagoli] AC Camargo Canc Ctr, Int Ctr Res Canc CIPE, Sao Paulo, SP, Brazil; [Lima, Alessandra Estrela] Univ Fed Bahia, Escola Med Vet, Dept Patol & Clin, Salvador, BA, Brazil	Universidade Federal de Minas Gerais; Universidade do Oeste de Santa Catarina; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; A.C.Camargo Cancer Center; Universidade Federal da Bahia	Cassali, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.	cassalig@icb.ufmg.br	Ferreira, Enio/AAC-8167-2022; Gomes, Dawidson Assis/O-1372-2013; DAMASCENO, KARINE ARAÚJO/AAV-6002-2021; DAMASCENO, KARINE/AAO-3340-2021	Ferreira, Enio/0000-0002-1835-0303; Gomes, Dawidson Assis/0000-0001-7714-991X; DAMASCENO, KARINE ARAÚJO/0000-0003-2087-1690; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [035/98, 112/04]; Conselho Nacional de Desenvolvimento e Pesquisa (CNPq) [14/2011, 470696/2011-7]; Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG) [CBS: 838/96, 919/97, 1005/01, CDS 572/04]; Universidade do Oeste de Santa Catarina (Unoesc) (Edital - Fundo de apoio a pesquisa, FAPE) [18/UNOESC-R/2018]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade do Oeste de Santa Catarina (Unoesc) (Edital - Fundo de apoio a pesquisa, FAPE)	This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br) (Projects CAPES/ICCTI, 035/98; and CAPES/GRICES, 112/04) (GDC), Conselho Nacional de Desenvolvimento e Pesquisa (CNPq) (http://www.cnpq.br) (Edital Universal 14/2011; Processo 470696/2011-7) (GDC), Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG) (http://fapemig.br/pt) (Projects CBS: 838/96, 919/97, 1005/01, CDS 572/04) (GDC) and Universidade do Oeste de Santa Catarina (Unoesc) (https://www.unoesc.edu.br) (Edital - Fundo de apoio a pesquisa, FAPE, No 18/UNOESC-R/2018) (COG).	Alves MR, 2014, VIRCHOWS ARCH, V465, P321, DOI 10.1007/s00428-014-1629-z; Badyal RK, 2016, APPL IMMUNOHISTO M M, V24, P151, DOI 10.1097/PAI.0000000000000167; Cassali G. D., 2014, BRAZILIAN J VET PATH, V7, P1; Dai YH, 2012, DIGEST DIS SCI, V57, P1253, DOI 10.1007/s10620-012-2042-6; Damasceno KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160419; De La Cruz C, 2004, PATHOL INT, V54, P90, DOI 10.1111/j.1440-1827.2004.01590.x; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Elston CW, 1998, BREAST, DOI [10.3892/ijo.2013.2059, DOI 10.3892/IJO.2013.2059]; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062558; Galvan JA, 2015, BRIT J CANCER, V112, P1944, DOI 10.1038/bjc.2015.177; Gamba CO, 2015, J COMP PATHOL, V153, P256, DOI 10.1016/j.jcpa.2015.08.006; Gamba CO, 2014, RES VET SCI, V97, P554, DOI 10.1016/j.rvsc.2014.09.016; Gamba CO, 2013, VET J, V196, P241, DOI 10.1016/j.tvjl.2012.08.022; Gamba CD, 2017, RES VET SCI, V115, P189, DOI 10.1016/j.rvsc.2017.04.012; Geradts J, 2011, HUM PATHOL, V42, P1125, DOI 10.1016/j.humpath.2010.11.004; Gong Y, 2005, HISTOPATHOLOGY, V46, P24, DOI 10.1111/j.1365-2559.2004.01981.x; Guriec N, 1995, INVAS METAST, V16, P19; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; He Y, 2017, ONCOGENE, V36, P3490, DOI 10.1038/onc.2016.492; Hegarty SV, 2015, PROG NEUROBIOL, V132, P81, DOI 10.1016/j.pneurobio.2015.07.001; Heimann R, 2000, CANCER RES, V60, P298; Hunt NCA, 1997, VIRCHOWS ARCH, V430, P285, DOI 10.1007/BF01092751; Jouppila-Matto A, 2015, HISTOL HISTOPATHOL, V30, P569, DOI 10.14670/HH-30.569; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Karihtala P, 2013, BREAST CANCER RES TR, V138, P81, DOI 10.1007/s10549-013-2442-0; Kong YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134045; Kurahara H, 2012, J SURG ONCOL, V105, P655, DOI 10.1002/jso.23020; Lee H, 2014, VIRCHOWS ARCH, V464, P213, DOI 10.1007/s00428-013-1518-x; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Luna-More S, 2000, PATHOL RES PRACT, V196, P35, DOI 10.1016/S0344-0338(00)80019-9; Misdorp W., 1999, HISTOLOGICAL CLASSIF; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; OKA H, 1993, CANCER RES, V53, P1696; OKA H, 1992, VIRCHOWS ARCH A, V421, P149, DOI 10.1007/BF01607048; Park D, 2007, APMIS, V115, P52, DOI 10.1111/j.1600-0463.2007.apm_524.x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng Z, 2014, WORLD J GASTROENTERO, V20, P5403, DOI 10.3748/wjg.v20.i18.5403; Pettinato G, 2004, AM J CLIN PATHOL, V121, P857, DOI 10.1309/XTJ7VHB49UD78X60; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Prislei S, 2015, ROLE PROGNOSTIC SIGN, V6, DOI [10.18632/oncotarget.3943, DOI 10.18632/ONCOTARGET.3943]; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Rakha EA, 2005, HISTOPATHOLOGY, V46, P685, DOI 10.1111/j.1365-2559.2005.02156.x; Rodrigues MA, 2016, PATHOL RES PRACT, V212, P340, DOI 10.1016/j.prp.2015.11.017; Sakamoto K, 2012, ANN SURG ONCOL, V19, P612, DOI 10.1245/s10434-011-2052-1; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; SIRIAUNKGUL S, 1993, MODERN PATHOL, V6, P660; UMBAS R, 1992, CANCER RES, V52, P5104; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yan B, 2014, INT J CLIN EXP MED, V7, P4352; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Zheng X, 2015, INT J CLIN EXP MED, V8, P18689	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209497	10.1371/journal.pone.0209497	http://dx.doi.org/10.1371/journal.pone.0209497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645591	gold, Green Submitted, Green Published			2022-12-26	WOS:000455810200010
J	Kramar, MK; Tinta, T; Lucic, D; Malej, A; Turk, V				Kramar, Maja Kos; Tinta, Tinkara; Lucic, Davor; Malej, Alenka; Turk, Valentina			Bacteria associated with moon jellyfish during bloom and post-bloom periods in the Gulf of Trieste (northern Adriatic)	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CORAL DENDRONEPHTHYA SP; AURELIA-AURITA; GELATINOUS ZOOPLANKTON; ORGANIC-MATTER; SOFT CORAL; ANTIBACTERIAL ACTIVITY; POPULATION-DYNAMICS; NESTED PCR; CRUDE-OIL	Jellyfish are a prominent component of the plankton community. They frequently form conspicuous blooms which may interfere with different human enterprises. Among the aspects that remain understudied are jellyfish associations with microorganisms having potentially important implications for organic matter cycling. To the best of our knowledge, this study is the first to investigate the bacterial community associated with live moon jellyfish (Aurelia solida, Scyohozoa) in the Adriatic Sea. Using 16S rRNA clone libraries and culture-based methods, we have analyzed the bacterial community composition of different body parts: the exumbrella surface, oral arms, and gastric cavity, and investigated possible differences in medusa-associated bacterial community structure at the time of the jellyfish population peak, and during the senescent phase at the end of bloom. Microbiota associated with moon jellyfish was different from ambient seawater bacterial assemblage and varied between different body parts. Betaproteobacteria (Burkholderia, Cupriavidus and Achromobacter) dominated community in the gastral cavity of medusa, while Alphaproteobacteria (Phaeobacter, Ruegeria) and Gammaproteobacteria (Stenotrophomonas, Alteromonas, Pseudoalteromonas and Vibrio) prevailed on 'outer' body parts. Bacterial community structure changed during senescent phase, at the end of the jellyfish bloom, showing an increased abundance of Gammaproteobacteria, exclusively Vibrio. The results of cultured bacterial isolates showed the dominance of Gammaproeteobacteria, especially Vibrio and Pseudoalteromonas in all body parts. Our results suggest that jellyfish associated bacterial community might have an important role for the host, and that anthropogenic pollution in the Gulf of Trieste might affect their community structure.	[Kramar, Maja Kos; Tinta, Tinkara; Malej, Alenka; Turk, Valentina] Natl Inst Biol, Marine Biol Stn Piran, Piran, Slovenia; [Tinta, Tinkara] Univ Vienna, Dept Limnol & Biooceanog, Ctr Funct Ecol, Vienna, Austria; [Lucic, Davor] Univ Dubrovnik, Inst Marine & Coastal Res, Dubrovnik, Croatia	National Institute of Biology - Slovenia; University of Vienna; University of Dubrovnik	Turk, V (corresponding author), Natl Inst Biol, Marine Biol Stn Piran, Piran, Slovenia.	Valentina.Turk@nib.si	turk, Valentina/AAV-8033-2020; Tinta, Tinkara/L-8912-2016	Turk, Valentina/0000-0002-3932-1974; Malej, Alenka/0000-0001-6650-4795; Tinta, Tinkara/0000-0001-6740-8973	Ministry of Higher Education, Science and Technology of the R Slovenia [ARRS-34503, BI-HR/12-13-030]; Ministry of Science, Education and Sport of the Croatia [BI-HR/12-13-030]; European Union [793778]	Ministry of Higher Education, Science and Technology of the R Slovenia; Ministry of Science, Education and Sport of the Croatia; European Union(European Commission)	This work was supported by: Ministry of Higher Education, Science and Technology of the R Slovenia (ARRS-34503 Maja Kos Kramar), Bilateral cooperation with the Ministry of Science, Education and Sport of the Croatia and Ministry of Higher Education, Science and Technology of the R Slovenia (BI-HR/12-13-030 Dr. Davor Lucic and Dr. Valentina Turk; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie (grant agreement No 793778 Tinkara Tinta).	Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; ALMEDA R, 2013, PLOS ONE, V8; Apprill A., 2017, FRONTIERS MARINE SCI, V4, P9; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Ates RML, 2017, PLANKTON BENTHOS RES, V12, P71; Bacosa HP, 2012, INT BIODETER BIODEGR, V74, P109, DOI 10.1016/j.ibiod.2012.04.022; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Blanchet M, 2015, ENVIRON SCI POLLUT R, V22, P13638, DOI 10.1007/s11356-014-3848-x; Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Clarke K.R., 2006, PRIMER V6 MANUAL TUT; Cleary DW, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw159; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Daley MC, 2016, MAR BIOL RES, V12, P1088, DOI 10.1080/17451000.2016.1228974; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2016, MICROBIOL MOL BIOL R, V80, P91, DOI 10.1128/MMBR.00037-15; Daniels C, 2012, FEMS MICROBIOL ECOL, V82, P90, DOI 10.1111/j.1574-6941.2012.01409.x; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Deng MC, 2014, MAR POLLUT BULL, V83, P79, DOI 10.1016/j.marpolbul.2014.04.018; Briz LD, 2017, MAR BIOL RES, V13, P630, DOI 10.1080/17451000.2016.1274403; Dinasquet J, 2012, FRONTIERS MICROBIOLO, V3, P1; Dobretsov S, 2004, J EXP MAR BIOL ECOL, V299, P35, DOI 10.1016/j.jembe.2003.08.011; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Doyle TK, 2014, JELLYFISH BLOOMS, P1; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P706, DOI 10.4319/lo.1979.24.4.0706; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Garren M, 2012, ISME J, V6, P1159, DOI 10.1038/ismej.2011.180; Gemmell BJ, 2016, MAR POLLUT BULL, V113, P483, DOI 10.1016/j.marpolbul.2016.08.065; Gerdts G, 2013, HELGOLAND MAR RES, V67, P757, DOI 10.1007/s10152-013-0361-4; Giloteaux L, 2010, APPL ENVIRON MICROB, V76, P2856, DOI 10.1128/AEM.02023-09; Giraffa G, 2000, J MICROBIOL METH, V42, P175, DOI 10.1016/S0167-7012(00)00172-X; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Graham WM, 2014, FRONT ECOL ENVIRON, V12, P515, DOI 10.1890/130298; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; Grossart HP, 2013, FRONTIERS MICROBIOLO, V4, P2012; Hagstrom A, 2018, AQUAT MICROB ECOL, V80, P15, DOI 10.3354/ame01838; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANSSON LJ, 1995, MAR BIOL, V121, P527, DOI 10.1007/BF00349462; Hao W., 2014, BACTERIAL COMMUNITIE; Harayama Shigeaki, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P63; Harder T, 2003, FEMS MICROBIOL ECOL, V43, P337, DOI 10.1111/j.1574-6941.2003.tb01074.x; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; HEEGER T, 1987, MAR BIOL, V96, P391, DOI 10.1007/BF00412523; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hocevar S, 2018, MAR ECOL PROG SER, V591, P155, DOI 10.3354/meps12387; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Holmstrom C, 2002, FEMS MICROBIOL ECOL, V41, P47, DOI 10.1111/j.1574-6941.2002.tb00965.x; Hong YH, 2017, FRONTIERS MICROBIOLO, V8, P1; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Johnston IS, 2007, CORAL REEFS, V26, P375, DOI 10.1007/s00338-007-0208-z; Juhasz AL, 1997, J APPL MICROBIOL, V83, P189, DOI 10.1046/j.1365-2672.1997.00220.x; Kittelmann S, 2005, J EXP MAR BIOL ECOL, V327, P201, DOI 10.1016/j.jembe.2005.06.020; Kogovsek T, 2018, SCI TOTAL ENVIRON, V626, P982, DOI 10.1016/j.scitotenv.2018.01.011; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Lane D., 1991, NUCL ACID TECHNIQUES, p[329, xxix]; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Lucas CH, 2014, GLOBAL ECOL BIOGEOGR, V23, P701, DOI 10.1111/geb.12169; Lynam CP, 2005, MAR ECOL PROG SER, V298, P157, DOI 10.3354/meps298157; Malai V., 2001, PHYS OCEANOGRAPHY AD, P167, DOI DOI 10.1007/978-94-015-9819-4_6; Malej A, 2012, CAH BIOL MAR, V53, P337; Manzari C, 2015, BIOL INVASIONS, V17, P923, DOI 10.1007/s10530-014-0810-2; Maravic A, 2012, INT J ENVIRON HEAL R, V22, P531, DOI 10.1080/09603123.2012.667797; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ovchinnikova TV, 2006, BIOCHEM BIOPH RES CO, V348, P514, DOI 10.1016/j.bbrc.2006.07.078; Palomo S, 2013, MAR DRUGS, V11, P1071, DOI 10.3390/md11041071; Patwa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11387; Pitt Kylie A., 2014, P79; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; PRINCE RC, 1993, CRIT REV MICROBIOL, V19, P217, DOI 10.3109/10408419309113530; PURCELL JE, 1985, B MAR SCI, V37, P739; PURCELL JE, 1991, HYDROBIOLOGIA, V216, P335, DOI 10.1007/BF00026483; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Radwan M, 2010, MAR BIOTECHNOL, V12, P350, DOI 10.1007/s10126-009-9239-5; Ramsak A, 2012, HYDROBIOLOGIA, V690, P69, DOI 10.1007/s10750-012-1053-9; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Riemann L, 2006, MAR ECOL PROG SER, V325, P29, DOI 10.3354/meps325029; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Scorrano S, 2017, ZOOL J LINN SOC-LOND, V180, P243, DOI 10.1111/zoj.12494; SHANKS AL, 1988, MAR ECOL PROG SER, V45, P81, DOI 10.3354/meps045081; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Tang KW, 2010, AQUAT MICROB ECOL, V61, P261, DOI 10.3354/ame01424; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thakur NL, 2000, J CHEM ECOL, V26, P57, DOI 10.1023/A:1005485310488; Tinta T, 2015, ENVIRON MICROBIOL, V17, P3581, DOI 10.1111/1462-2920.12519; Tinta T, 2016, J EXP MAR BIOL ECOL, V475, P19, DOI 10.1016/j.jembe.2015.10.018; Tinta T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039274; Tinta T, 2010, HYDROBIOLOGIA, V645, P179, DOI 10.1007/s10750-010-0223-x; Titelman J, 2006, MAR ECOL PROG SER, V325, P43, DOI 10.3354/meps325043; Turk Valentina, 2007, Annales Series Historia Naturalis, V17, P197; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Vodopivec M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa75d9; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Webster NS, 2007, FEMS MICROBIOL ECOL, V59, P81, DOI 10.1111/j.1574-6941.2006.00195.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Weiland-Brauer N, 2015, APPL ENV MICROBIOLOG, V81; West EJ, 2009, HYDROBIOLOGIA, V616, P151, DOI 10.1007/s10750-008-9586-7; Zobell CE, 1946, CHRONICA BOT	116	25	26	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0198056	10.1371/journal.pone.0198056	http://dx.doi.org/10.1371/journal.pone.0198056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645606	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200001
J	Shteyer, E; Shekhtman, L; Zinger, T; Harari, S; Gafanovich, I; Wolf, D; Ivgi, H; Barsuk, R; Dery, I; Armoni, D; Rivkin, M; Pipalia, R; Eliav, MC; Skorochod, Y; Breuer, GS; Tur-Kaspa, R; Wiener, YW; Stern, A; Cotler, SJ; Dahari, H; Lurie, Y				Shteyer, Eyal; Shekhtman, Louis; Zinger, Tal; Harari, Sheri; Gafanovich, Inna; Wolf, Dana; Ivgi, Hefziba; Barsuk, Rima; Dery, Ilana; Armoni, Daniela; Rivkin, Mila; Pipalia, Rahul; Eliav, Michal Cohen; Skorochod, Yizhak; Breuer, Gabriel S.; Tur-kaspa, Ran; Wiener, Yonit Weil; Stern, Adi; Cotler, Scott J.; Dahari, Harel; Lurie, Yoav			Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography	PLOS ONE			English	Article							VIRUS-INFECTION; CHIMPANZEES; HCV; TRANSMISSION; RESPONSES; IL28B	Background & aims Acute hepatitis C (AHC) is not frequently identified because patients are usually asymptomatic, although may be recognized after iatrogenic exposures such as needle stick injuries, medical injection, and acupuncture. We describe an outbreak of AHC among 12 patients who received IV saline flush from a single multi-dose vial after intravenous contrast administration for a computerized tomography (CT) scan. The last patient to receive IV contrast with saline flush from a multi-dose vial at the clinic on the previous day was known to have chronic HCV genotype 1b (termed potential source, PS). Here we sought to confirm (via genetic analysis) the source of infection and to predict the minimal contaminating level of IV saline flush needed to transmit infectious virus to all patients. Methods In order to confirm the source of infection, we sequenced the HCV E1E2 region in 7 CT patients, in PS, and in 2 control samples from unrelated patients also infected with HCV genotype 1b. A transmission probabilistic model was developed to predict the contamination volume of blood that would have been sufficient to transmit infectious virus to all patients. Results Viral sequencing showed close clustering of the cases with the PS. The transmission probabilistic model predicted that contamination of the multi-dose saline vial with 0.6-8.7 microliters of blood would have been sufficient to transmit infectious virus to all patients. Conclusion Analysis of this unique cohort provides a new understanding of HCV transmission with respect to contaminating volumes and viral titers.	[Shteyer, Eyal] Shaare Zedek Med Ctr, Juliet Keidan Pediat Gastroenterol Inst, Jerusalem, Israel; [Shteyer, Eyal; Gafanovich, Inna; Ivgi, Hefziba; Barsuk, Rima; Dery, Ilana; Armoni, Daniela; Eliav, Michal Cohen; Skorochod, Yizhak; Breuer, Gabriel S.; Wiener, Yonit Weil; Lurie, Yoav] Hebrew Univ Jerusalem, Jerusalem, Israel; [Shekhtman, Louis; Pipalia, Rahul; Cotler, Scott J.; Dahari, Harel] Loyola Univ Med Ctr, Dept Med, Program Expt & Theoret Modeling, Div Hepatol, Maywood, IL 60153 USA; [Shekhtman, Louis] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel; [Zinger, Tal; Harari, Sheri; Stern, Adi] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, Dept Mol Microbiol & Biotechnol, Tel Aviv, Israel; [Gafanovich, Inna; Ivgi, Hefziba; Barsuk, Rima; Dery, Ilana; Armoni, Daniela; Eliav, Michal Cohen; Skorochod, Yizhak; Breuer, Gabriel S.; Wiener, Yonit Weil; Lurie, Yoav] Shaare Zedek Med Ctr, Liver Unit, Jerusalem, Israel; [Wolf, Dana; Rivkin, Mila] Hadassah Hebrew Univ Med Ctr, Clin Virol Unit, Jerusalem, Israel; [Tur-kaspa, Ran] Bar Ilan Univ, Fac Med Galilee, Safed, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Loyola University Chicago; Bar Ilan University; Tel Aviv University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Bar Ilan University	Shteyer, E (corresponding author), Shaare Zedek Med Ctr, Juliet Keidan Pediat Gastroenterol Inst, Jerusalem, Israel.; Shteyer, E (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	eyals@szmc.org.il	Breuer, Gabriel/AAD-1349-2020	Stern, Adi/0000-0002-2919-3542; Breuer, Gabriel/0000-0003-0398-3471; Zinger, Tal/0000-0002-5580-5282	U.S. National Institute of Health (NIH) [R01-AI078881, R01GM121600]; Shaare Zedek Medical Center; Hadassah Medical Center; Tel Aviv; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121600] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shaare Zedek Medical Center; Hadassah Medical Center; Tel Aviv; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the U.S. National Institute of Health (NIH) grants R01-AI078881 and R01GM121600 (H. Dahari), internal funding of Shaare Zedek Medical Center (E. Shteyer), internal funding of Hadassah Medical Center (D. Wolf) and Internal funding of Tel Aviv (A. Stern). There was no additional external funding received for this study.	Benson AA, 2018, DIGEST LIVER DIS, V50, P630, DOI 10.1016/j.dld.2018.03.011; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Canini L, 2015, ANTIVIR THER, V20, P149, DOI 10.3851/IMP2806; Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060; Engle RE, 2008, J MED VIROL, V80, P72, DOI 10.1002/jmv.21043; Fabrizi F, 2010, CLIN LIVER DIS, V14, P49, DOI 10.1016/j.cld; FATEH A, 2005, PUBMED; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Germain JM, 2005, INFECT CONT HOSP EP, V26, P789, DOI 10.1086/502618; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Katayama K, 2004, INTERVIROLOGY, V47, P57, DOI 10.1159/000076643; Knoll A, 2001, LAB INVEST, V81, P251; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; Lazarus JV, 2017, J HEPATOL, V67, P665, DOI 10.1016/j.jhep.2017.06.033; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lurie Y, 2007, J GASTROEN HEPATOL, V22, P158, DOI 10.1111/j.1440-1746.2006.04491.x; Major M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4496; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Operskalski EA, 2003, TRANSFUSION, V43, P1433, DOI 10.1046/j.1537-2995.2003.00475.x; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; POZZETTO B, 2014, WORLD JOURNAL OF GAS, V12, P18; SCHVARCZ R, 1997, INFECTION, V3, P1; Shemer-Avni Y, 2007, CLIN INFECT DIS, V45, pE32, DOI 10.1086/520014; Shteyer E, 2017, THER ADV GASTROENTER, V10, P429, DOI 10.1177/1756283X17694808; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2005, CLIN LIVER DIS, V9, P383, DOI 10.1016/j.cld.2005.05.003; Venegas M, 2011, WORLD J GASTROENTERO, V17, P3636, DOI 10.3748/wjg.v17.i31.3636; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Widell A, 1999, ANN INTERN MED, V130, P130, DOI 10.7326/0003-4819-130-2-199901190-00007; WJG, 1965, PUBMED; WJG, PUBMED	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210173	10.1371/journal.pone.0210173	http://dx.doi.org/10.1371/journal.pone.0210173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645600	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200019
J	Blennow, K; Persson, E; Persson, J				Blennow, Kristina; Persson, Erik; Persson, Johannes			Are values related to culture, identity, community cohesion and sense of place the values most vulnerable to climate change?	PLOS ONE			English	Article							SEA-LEVEL RISE; ECOSYSTEM SERVICES; LOCAL VALUES; R PACKAGE; PERCEPTIONS; ADAPTATION; VALUATION; RESPONSES; SCIENCE; MODELS	Values related to culture, identity, community cohesion and sense of place have sometimes been downplayed in the climate change discourse. However, they have been suggested to be not only important to citizens but the values most vulnerable to climate change. Here we test four empirical consequences of the suggestion: (i) at least 50% of the locations citizens' consider to be the most important locations in their municipality are chosen because they represent these values, (ii) locations representing these values have a high probability of being damaged by climate change induced sea level rise, (iii) citizens for which these values are particularly strongly held less strongly believe in the local effects of climate change, and (iv) citizens for which these values are particularly strongly held less strongly believe that they have experienced the effects of climate change. The tests were made using survey data collected in 2014 from 326 citizens owning property in Hoganas municipality, Sweden, and included values elicited using a new methodology separating instrumental values from end values, and using the former (which strictly speaking should be seen as estimates of usefulness rather than as aims in themselves) as stepping stones to pinpoint the latter, that represent the true interests of the respondents. The results provide the first evidence that, albeit frequent, values related to culture, identity, community cohesion and sense of place are not the values most vulnerable to climate change. This in turn indicates a need to further investigate the vulnerability of these values to climate change, using a methodology that clearly distinguishes between instrumental and end values.	[Blennow, Kristina; Persson, Erik] Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden; [Persson, Johannes] Lund Univ, Dept Philosophy, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University	Blennow, K (corresponding author), Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden.	Kristina.Blennow@slu.se	Blennow, Kristina/D-7388-2016	Blennow, Kristina/0000-0002-7602-5322; Persson, Johannes/0000-0003-4568-1850; Persson, Erik/0000-0002-5000-948X	Myndigheten for Samhallsskydd och Beredskap [2011-243]; Riksbankens Jubileumsfond [M14-0138:1]; Svenska Forskningsradet Formas	Myndigheten for Samhallsskydd och Beredskap; Riksbankens Jubileumsfond; Svenska Forskningsradet Formas(Swedish Research Council Formas)	This work was supported by Myndigheten for Samhallsskydd och Beredskap, grant 2011-243, https://www.msb.se/; Riksbankens Jubileumsfond, M14-0138: 1, http://www.rj.se/; Svenska Forskningsradet Formas, http://www.formas.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2013, NAT CLIM CHANGE, V3, P112, DOI [10.1038/NCLIMATE1666, 10.1038/nclimate1666]; Adger WN, 2010, CLIMATE CHANGE SCI P; Blennow K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155137; Blennow K, 2014, FORESTRY, V87, P219, DOI 10.1093/forestry/cpt032; Blennow K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050182; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Brody SD, 2008, ENVIRON BEHAV, V40, P72, DOI 10.1177/0013916506298800; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; BRUUN P, 1988, J COASTAL RES, V4, P627; Carlsson-Kanyama A, 2012, FOIR3441SE SWED DEF; Chee YE, 2004, BIOL CONSERV, V120, P549, DOI 10.1016/j.biocon.2004.03.028; DAVIDSON D, 1963, J PHILOS, V60, P685, DOI 10.2307/2023177; de Bruin Waendi Bruine, 2014, Environment Systems & Decisions, V34, P591, DOI 10.1007/s10669-014-9513-6; de Leeuw J, 2006, STAT SOC BEHAV SCI, P107; DHI, 2013, OV KLIM HOG KOMM AVS; Garrod G., 1999, EC VALATION ENV; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Graham S, 2018, WORLD DEV, V108, P332, DOI 10.1016/j.worlddev.2017.12.008; Graham S, 2014, GLOBAL ENVIRON CHANG, V29, P41, DOI 10.1016/j.gloenvcha.2014.07.013; Harvatt J, 2011, J RISK RES, V14, P63, DOI 10.1080/13669877.2010.503935; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hothorn T, LAB RECURSIVE PARTYT; Hume D., 1777, ENQUIRIES HUMAN UNDE, V3rd; IPBES, 2015, PREL GUID REG DIV CO; Janitza S, 2016, COMPUT STAT DATA AN, V96, P57, DOI 10.1016/j.csda.2015.10.005; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; LimeSurvey Project Team, 2015, LIMESURVEY OP SOURC; Mair P, 2010, J STAT SOFTW, V32, P1; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Meyer D, 2006, J STAT SOFTW, V17, P1, DOI [DOI 10.18637/JSS.V017.I03, 10.18637/jss.v017.i03]; Midgley PM, MANAGING RISKS EXTRE; Mortreux C, 2009, GLOBAL ENVIRON CHANG, V19, P105, DOI 10.1016/j.gloenvcha.2008.09.006; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; O'Brien KL, 2010, WIRES CLIM CHANGE, V1, P232, DOI 10.1002/wcc.30; O'Brien KL, 2009, ADAPTING TO CLIMATE CHANGE: THRESHOLDS, VALUES, GOVERNANCE, P164; ONeil R, 1997, ENVIRON ETHICS, V19, P45, DOI 10.5840/enviroethics199719138; ONEILL J, 1992, MONIST, V75, P119, DOI 10.5840/monist19927527; Persson E., 2008, THESIS; POULTON EC, 1968, PSYCHOL BULL, V69, P1, DOI 10.1037/h0025267; R CORE TEAM, 2016, R LANG ENV STAT COMP; Rabinowicz Wlodek, 1999, P AR SOC, V20, P20; Raymond CM, 2011, CLIMATIC CHANGE, V104, P653, DOI 10.1007/s10584-010-9806-9; Rulleau B, 2015, J ENVIRON PLANN MAN, V58, P482, DOI 10.1080/09640568.2013.862492; Sagiv L, 2017, NAT HUM BEHAV, V1, P630, DOI 10.1038/s41562-017-0185-3; SGU, SKAN ER GEOL MAP TOO; Sieber R, 2006, ANN ASSOC AM GEOGR, V96, P491, DOI 10.1111/j.1467-8306.2006.00702.x; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Thomas M, 2015, GLOBAL ENVIRON CHANG, V33, P71, DOI 10.1016/j.gloenvcha.2015.04.009; Wallace KJ, 2007, BIOL CONSERV, V139, P235, DOI 10.1016/j.biocon.2007.07.015; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; Wilson MA, 2002, ECOL ECON, V41, P431, DOI 10.1016/S0921-8009(02)00092-7	55	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210426	10.1371/journal.pone.0210426	http://dx.doi.org/10.1371/journal.pone.0210426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629690	Green Published, gold			2022-12-26	WOS:000455483000088
J	Emmert, M; Schuster-Amft, C; de Bruin, ED; McCaskey, MA				Emmert, Maria; Schuster-Amft, Corina; de Bruin, Eling D.; McCaskey, Michael A.			Comparison of proprioceptive acuity of the cervical spine in healthy adults and adults with chronic non-specific low back pain: A cross-sectional study	PLOS ONE			English	Article							HEAD REPOSITIONING ACCURACY; NECK PAIN; SENSORIMOTOR FUNCTION; MOTOR CONTROL; NORMAL RANGE; POSITION; ERROR; DISABILITY; MOTION; CLASSIFICATION	Background It has been suggested that patients with chronic non-specific low back pain (CNSLBP) perform poorly in postural tasks when compared to healthy individuals. Despite its importance in posture and alignment of the trunk in relation to the head, neck proprioception has not been examined in patients with low back pain. The purpose of this study was to compare neck proprioception in patients with CNSLBP with healthy individuals. Methods Cervical joint reposition error was measured five times consecutively in the neutral head position, 30 degrees and 60 degrees left and right head rotation. The main outcome measure was the mean cervical joint repositioning error of the head. Results Forty-six participants with (n = 24, 54 +/- 16yrs SD, 14 females) and without (n = 22, 36 +/- 13yrs SD, 13 females) CNSLBP were included in the study. Comparison of mean cervical joint repositioning error between patients and healthy controls showed no statistically significant group difference in any of the applied positions. The range of deviation in CNSLBP patients was between 1.57 degrees and 3.27 degrees compared to 1.46 degrees to 2.26 degrees in healthy controls. An overshooting tendency for both groups was found in the neutral head position. Conclusion The ability to accurately position the head does not seem to be impaired in patients with CNSLBP. This may suggest that sensorimotor control is affected on other levels of the movement system and future research should focus on methods to identify the source of these aberrations.	[Emmert, Maria; Schuster-Amft, Corina; McCaskey, Michael A.] Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland; [Emmert, Maria] ZHAW Sch Hlth Profess, Winterthur, Switzerland; [Schuster-Amft, Corina] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [de Bruin, Eling D.; McCaskey, Michael A.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet	McCaskey, MA (corresponding author), Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland.; McCaskey, MA (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.	michael.mccaskey@alumni.ethz.ch	Schuster, Corina/B-6939-2008; de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385; Schuster-Amft, Corina/0000-0003-1120-4423	cantonal department of health and social services of the Canton of Argovia, Switzerland; ETH Zurich; Reha Rheinfelden, Switzerland	cantonal department of health and social services of the Canton of Argovia, Switzerland; ETH Zurich(ETH Zurich); Reha Rheinfelden, Switzerland	MM and CS were partially funded by a grant from the cantonal department of health and social services of the Canton of Argovia (www.ag.ch/dgs), Switzerland. Internal funding was provided by MM and CS's employer, Reha Rheinfelden, Switzerland. EdB was funded by his employer, ETH Zurich, as part of his teaching activity (student supervision). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors had unrestricted access to the data. There was no additional external funding received for this study.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Artz NJ, 2015, CLIN BIOMECH, V30, P260, DOI 10.1016/j.clinbiomech.2015.01.005; Astfalck RG, 2013, MANUAL THER, V18, P410, DOI 10.1016/j.math.2013.02.005; BfS, 2012, GES SCHWEIZ 2012; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2013, SPINAL CONTROL REHAB, P219; de Vries J, 2015, MANUAL THER, V20, P736, DOI 10.1016/j.math.2015.04.015; Delitto A, 2012, J ORTHOP SPORT PHYS, V42, pA1, DOI 10.2519/jospt.2012.42.4.A1; DEYO RA, 1988, ARCH PHYS MED REHAB, V69, P1044; Dolan KJ, 2006, MANUAL THER, V11, P202, DOI 10.1016/j.math.2006.03.003; Dugailly PM, 2015, EUR SPINE J, V24, P2885, DOI 10.1007/s00586-015-4263-9; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; Georgy EE, 2011, ASIAN SPINE J, V5, P201, DOI 10.4184/asj.2011.5.4.201; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hill R, 2009, MANUAL THER, V14, P110, DOI 10.1016/j.math.2008.02.008; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Humphreys BK, 2008, J MANIP PHYSIOL THER, V31, P540, DOI 10.1016/j.jmpt.2008.08.007; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Langevin HM, 2007, MED HYPOTHESES, V68, P74, DOI 10.1016/j.mehy.2006.06.033; Lansade C, 2009, SPINE, V34, P2900, DOI 10.1097/BRS.0b013e3181b4f667; Lee J, 2014, J PHYS THER SCI, V26, P595, DOI 10.1589/jpts.26.595; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Mano Hiroaki, 2018, Wellcome Open Res, V3, P19, DOI 10.12688/wellcomeopenres.14069.1; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; McCaskey MA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-382; Miekisiak G, 2013, SPINE, V38, pE237, DOI 10.1097/BRS.0b013e31827e948b; Nagai T, 2014, AVIAT SPACE ENVIR MD, V85, P529, DOI 10.3357/ASEM.3874.2014; Newcomer KL, 2000, SPINE, V25, P2488, DOI 10.1097/00007632-200010010-00011; Noh KH, 2015, J PHYS THER SCI, V27, P293, DOI 10.1589/jpts.27.293; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Pettorossi VE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00895; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Rausch Osthoff Anne-Kathrin, 2015, Spine (Phila Pa 1976), V40, pE97, DOI 10.1097/BRS.0000000000000677; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Ribeiro F, 2011, FACTORS INFLUENCING; Ribeiro F, 2007, EUR REV AGING PHYS A, V4, P71, DOI 10.1007/s11556-007-0026-x; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Stanton TR, 2016, PHYS THER, V96, P876, DOI 10.2522/ptj.20150241; Stedman TL, 2006, STEDMANS MED DICT; Strimpakos N, 2011, J BODYW MOV THER, V15, P114, DOI 10.1016/j.jbmt.2009.06.003; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zusman M, 2013, J MULTIDISCIP HEALTH, V6, P197, DOI 10.2147/JMDH.S44117	55	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209818	10.1371/journal.pone.0209818	http://dx.doi.org/10.1371/journal.pone.0209818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629608	gold, Green Submitted, Green Published			2022-12-26	WOS:000455483000034
J	Hodgins, B; Pillet, S; Landry, N; Ward, BJ				Hodgins, Breanna; Pillet, Stephane; Landry, Nathalie; Ward, Brian James			A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HEMAGGLUTININ; ANTIBODY; PROTECTION; CHALLENGE; PATHOLOGY; PATTERNS; BEARING; INDUCE; AGE	Background The elderly are at high risk from influenza, in part because immunity wanes with age and through the accumulation of comorbidities. A novel plant-derived virus-like-particle (VLP) vaccine bearing influenza hemagglutinin can induce a balanced humoral and cellular response in old mice (16-18 months) while split virion vaccines elicit mostly antibodies. Because mice also collect comorbidities and lose immune competence as they age, we wished to determine how the plant-derived VLP vaccine would perform in animals approaching the end of their life-span. Materials and methods Old (24-26 months) female BALB/c mice received two intramuscular doses of H1-VLP vaccine, an inactivated H1N1 vaccine (IIV) (both based on A/H1N1/California/07/09) (3 mu g each) or PBS. Serum was collected on day 42 and humoral responses were measured by enzyme-linked immunosorbent assay (ELISA), microneutralization (MN) and hemagglutination inhibition (HI) assays. Influenza-specific splenocyte CD4(+) & CD8(+) T cell responses were measured by flow cytometry. Full body computed tomography (CT) and structured necropsies were performed on day 42. Comorbidities including reduced lung volume (kyphosis), masses, abscesses, etc. were assessed using a standard scoring system (1-21) and mice with scores >= 5 were considered to have important comorbidities. Results Overall, 53.3% of the animals had significant comorbidities. Three weeks post-boost, HI and MN titres were mostly undetectable but ELISA titres were significantly higher in the H1-VLP animals compared to the IIV group (GMT (95% CI): 961 (427, 2163) vs 425 (200, 903): p = 0.03). Both CD4(+)(TNF alpha, IFN gamma) and CD8(+) (IFN gamma) T cell responses were also greater in the H1-VLP group than the IIV. Conclusions Even in very old mice with comorbidities, the plant-made H1-VLP vaccine elicited a stronger and more balanced immune response than IIV. Animals with fewer comorbidities tended to have the better composite (humoral and cellular) responses. These novel vaccines have the potential to address some of the limitations of the limitations of current vaccines in the elderly.	[Hodgins, Breanna] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Pillet, Stephane; Ward, Brian James] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Pillet, Stephane; Landry, Nathalie; Ward, Brian James] Medicago Inc, Quebec City, PQ, Canada	McGill University; McGill University	Ward, BJ (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.; Ward, BJ (corresponding author), Medicago Inc, Quebec City, PQ, Canada.	brian.ward@mcgill.ca		Ward, Brian/0000-0003-3251-958X; Hodgins, Breanna/0000-0002-7744-4377	Canadian Institutes of Health Research [34469]; Medicago Inc; Ministere des Finances et de l'Economie du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medicago Inc; Ministere des Finances et de l'Economie du Quebec	This work was supported in part by a Canadian Institutes of Health Research grant to BJW (#34469) and an academic-industry team award led by BJW that was co-funded by Medicago Inc and the Ministere des Finances et de l'Economie du Quebec with project oversight by Genome Quebec. The funders had no direct role in study design, data collection and analysis or decision to publish. NL is an employee at Medicago Inc. and both SP and BJW receive partial salary support from Medicago Inc. The company also provided research materials and other 'in-kind' support for the work. The specific roles of these authors are articulated in the 'author contributions' section.	BRONSON RT, 1993, AGING-CLIN EXP RES, V5, P253, DOI 10.1007/BF03324169; Cai MY, 2017, ACTA BIOCH BIOPH SIN, V49, P74, DOI 10.1093/abbs/gmw118; Centers for Disease Control and Prevention NCfIaRDN, 2017, INFL FLU WHAT YOU SH; Combadiere B, 2010, Pathol Biol (Paris), V58, pe79, DOI 10.1016/j.patbio.2010.01.010; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; DiazGranados CA, 2015, VACCINE, V33, P4565, DOI 10.1016/j.vaccine.2015.07.003; FAGIOLO U, 1993, AGING-CLIN EXP RES, V5, P451, DOI 10.1007/BF03324202; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hendin HE, 2017, VACCINE, V35, P2592, DOI 10.1016/j.vaccine.2017.03.058; Hodgins B, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00273-17; Landry N, 2014, CLIN IMMUNOL, V154, P164, DOI 10.1016/j.clim.2014.08.003; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Makarkov AI, 2017, VACCINE, V35, P4629, DOI 10.1016/j.vaccine.2017.07.012; McElhaney JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00041; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Mysliwska J, 2004, EXP GERONTOL, V39, P1447, DOI 10.1016/j.exger.2004.08.005; Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202; Piccirillo JF, 2008, CRIT REV ONCOL HEMAT, V67, P124, DOI 10.1016/j.critrevonc.2008.01.013; Pillet S, 2015, VACCINE, V33, P6282, DOI 10.1016/j.vaccine.2015.09.065; Pillet S, 2016, CLIN IMMUNOL, V168, P72, DOI 10.1016/j.clim.2016.03.008; Ren ZG, 2015, VIRUS RES, V200, P9, DOI 10.1016/j.virusres.2015.01.007; RODERICK TH, 1961, SCIENCE, V134, P48, DOI 10.1126/science.134.3471.48; Roghani T, 2017, AGING CLIN EXP RES, V29, P567, DOI 10.1007/s40520-016-0617-3; Stadlbauer D, 2017, FRONT MED-PRC, V11, P471, DOI 10.1007/s11684-017-0602-z; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sukoff Rizzo Stacey J, 2018, Curr Protoc Mouse Biol, V8, pe45, DOI 10.1002/cpmo.45; Trucchi C, 2015, J Prev Med Hyg, V56, pE37; Valkenburg SA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01479; Ward BJ, 2018, HUM VACC IMMUNOTHER, V14, P647, DOI 10.1080/21645515.2017.1413518; Weinberger B, 2012, CLIN MICROBIOL INFEC, V18, P100, DOI 10.1111/j.1469-0691.2012.03944.x; Xia SJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8426874; Yam KK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00207; Yam KK, 2013, CLIN VACCINE IMMUNOL, V20, P459, DOI 10.1128/CVI.00619-12; Young B, 2017, VACCINE, V35, P212, DOI 10.1016/j.vaccine.2016.11.013; Young KR, 2015, FASEB J, V29, P3817, DOI 10.1096/fj.15-270421	36	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210009	10.1371/journal.pone.0210009	http://dx.doi.org/10.1371/journal.pone.0210009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629622	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000040
J	Popping, S; Hullegie, SJ; Boerekamps, A; Rijnders, BJA; de Knegt, RJ; Rockstroh, JK; Verbon, A; Boucher, CAB; Nichols, BE; van de Vijver, DAMC				Popping, Stephanie; Hullegie, Sebastiaan J.; Boerekamps, Anne; Rijnders, Bart J. A.; de Knegt, Robert J.; Rockstroh, Juergen K.; Verbon, Annelies; Boucher, Charles A. B.; Nichols, Brooke E.; van de Vijver, David A. M. C.			Early treatment of acute hepatitis C infection is cost-effective in HIV-infectedmen-who-have-sex-with-men	PLOS ONE			English	Article							REAL-WORLD EFFECTIVENESS; DIRECT-ACTING ANTIVIRALS; VIRUS-INFECTION; GENOTYPE 1; HEPATOCELLULAR-CARCINOMA; PREEXPOSURE PROPHYLAXIS; REINFECTION INCIDENCE; POSITIVE MEN; INJECT DRUGS; HCV	Background Treatment of hepatitis C virus infections (HCV) with direct acting antivirals (DAA) can prevent new infections since cured individuals cannot transmit HCV. However, as DAAs are expensive, many countries defer treatment to advances stages of fibrosis, which results in ongoing transmission. We assessed the epidemiological impact and cost-effectiveness of treatment initiation in different stages of infection in the Netherlands where the epidemic is mainly concentrated among HIV-infected MSMs. Methods We calibrated a deterministic mathematical model to the Dutch HCV epidemic among HIV-infected MSM to compare three different DAA treatment scenarios: 1) immediate treatment, 2) treatment delayed to chronic infection allowing spontaneous clearance to occur, 3) treatment delayed until F2 fibrosis stage. All scenarios are simulated from 2015 onwards. Total costs, quality adjusted life years (QALY), incremental cost-effectiveness ratios (ICERs), and epidemiological impact were calculated from a providers perspective over a lifetime horizon. We used a DAA price of (sic)35,000 and 3% discounting rates for cost and QALYs. Results Immediate DAA treatment lowers the incidence from 1.2/100 person-years to 0.2/100 person-years (interquartile range 0.1-0.2) and the prevalence from 5.0/100 person-years to 0.5/100 person-years (0.4-0.6) after 20 years. Delayed treatment awaiting spontaneous clearance will result in a similar reduction. However, further delayed treatment to F2 will increases the incidence and prevalence. Earlier treatment will cost society (sic)68.3 and (sic)75.1 million over a lifetime for immediate and awaiting until the chronic stage, respectively. The cost will increase if treatment is further delayed until F2 to (sic)98.4 million. Immediate treatment will prevent 7070 new infections and gains 3419 (3019-3854) QALYs compared to F2 treatment resulting in a cost saving ICER. Treatment in the chronic stage is however dominated. Conclusions Early DAA treatment for HIV-infected MSM is an excellent and sustainable tool to meet the WHO goal of eliminating HCV in 2030.	[Popping, Stephanie; Boucher, Charles A. B.; Nichols, Brooke E.; van de Vijver, David A. M. C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Hullegie, Sebastiaan J.; Boerekamps, Anne; Rijnders, Bart J. A.; Verbon, Annelies] Erasmus MC, Dept Internal Med & Infect Dis, Rotterdam, Netherlands; [de Knegt, Robert J.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Rockstroh, Juergen K.] Bonn Univ Hosp, Dept Internal Med, Bonn, Germany; [Nichols, Brooke E.] Boston Univ, Dept Global Hlth, Boston, MA 02215 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Bonn; Boston University	Popping, S (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	s.popping@erasmusmc.nl	Nichols, Brooke E./V-5496-2019; De Knegt, Robert/X-4629-2019; rijnders, bart/AAB-2868-2019	Nichols, Brooke E./0000-0003-4682-4999; De Knegt, Robert/0000-0003-0934-6975; rijnders, bart/0000-0003-3343-9610; van de Vijver, David/0000-0001-5877-8526	Gilead Sciences [NL-2018-000171, 215001269]; Gilead [215001269, IN-NL-987-4558/4652/4653]; MSD [SDD 343462, MSD IISA11/jul/2015]; ViiV Healthcare [14-0614-ViiV]; Janssen [771290]; Boehringer [S14064/32844]	Gilead Sciences(Gilead Sciences); Gilead(Gilead Sciences); MSD; ViiV Healthcare; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer(Boehringer Ingelheim)	Stephanie Popping: reports funding in the form of a unrestricted educational grant by Gilead Sciences [NL-2018-000171] and grants from Gilead [215001269], MSD [SDD 343462], ViiV Healthcare [14-0614-ViiV], and Janssen [771290]. Bart J.A. Rijnders: reports grants from MSD [MSD IISA11/jul/2015], Gilead [IN-NL-987-4558/4652/4653] and honoraria from Jansen-Cilag, BMS, Pfizer and Viiv Robert J. de Knegt: Reports honoraria for consulting or speaking (last 5 years): AbbVie, BMS, Gilead, Janssen-Cilag, Merck/MSD, and Roche. Jurgen K. Rockstroh: reports honaria for lectures and/or consultancies from Abbott, AbbVie, Bionor, BMS, Cipla, Gilead, Janssen, Merck, Roche, Viiv Charles A.B. Boucher: reports grants from Gilead sciences [NL-2018-000171] and [215001269], MSD [SDD 343462], ViiV Healthcare [14-0614-ViiV], Janssen [771290], and Boehringer [S14064/32844]]. David A.M.C. van de Vijver: reports grants from Gilead sciences [NL-2018-000171] and [215001269], MSD [SDD 343462], ViiV Healthcare [14-0614-ViiV], and Janssen [771290].	AASLD- IDSA, 2017, REC TEST MAN TREAT H; Annemans L., 2008, HLTH EC NONECONOMICS; [Anonymous], 2017, J HEPATOL, V66, P153, DOI DOI 10.1016/j.jhep.2016.09.001; Ard van Sighem LG, 2014, MONITORING REPORT 20; Backus LI, 2016, HEPATOLOGY, V64, P405, DOI 10.1002/hep.28625; Berenguer J, 2018, HEPATOLOGY; Blaxhult A, 2014, INT J STD AIDS, V25, P493, DOI 10.1177/0956462413515192; Boerekamps A, 2018, CLIN INFECT DIS, V66, P1360, DOI 10.1093/cid/cix1007; Boersma C, 2010, VALUE HEALTH, V13, P853, DOI 10.1111/j.1524-4733.2010.00736.x; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Bruins BJ, 2017, DEN HAAG; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Cotte L, 2018, LIVER INT; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Forns X, 2017, LANCET INFECT DIS; Gowda C, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy076; Grady BPX, 2012, EUR J GASTROEN HEPAT, V24, P1302, DOI 10.1097/MEG.0b013e32835702a8; Hoornenborg E, 2017, AIDS, V31, P1603, DOI 10.1097/QAD.0000000000001522; Hullegie SJ, 2016, J HEPATOL, V64, P807, DOI 10.1016/j.jhep.2015.12.004; Hullegie SJ, 2015, CLIN MICROBIOL INFEC; Hullegie SJ, 2015, J HEPATOL, P62; Ingiliz P, 2017, J HEPATOL, V66, P282, DOI 10.1016/j.jhep.2016.09.004; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Leyten, 2016, CLIN MICROBIOL INFEC, V22, P209; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Mantovani LG, 2016, HEPATOLOGY; Marshall AD, 2018, LANCET GASTROENTEROL, V3, P125, DOI 10.1016/S2468-1253(17)30284-4; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Martin NK, 2016, CLIN INFECT DIS; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mcgreal-bellone SC A., 2012, PHS60 HLTH RELATED Q, V15, pA528; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Midgard H, 2016, J HEPATOL, V65, pS33, DOI 10.1016/j.jhep.2016.07.012; Newsum AM, 2018, SEX TRANSM DIS; Nichols BE, 2016, LANCET INFECT DIS, V16, P1423, DOI 10.1016/S1473-3099(16)30311-5; Nichols BE, 2014, JAIDS-J ACQ IMM DEF, V66, P221, DOI 10.1097/QAI.0000000000000145; Pardo M, 2007, J VIRAL HEPATITIS, V14, P36, DOI 10.1111/j.1365-2893.2006.00783.x; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Popping BENS, 2016, INTERNSIVE HEPATITIS; ROSE KA, 1991, J FORECASTING, V10, P117, DOI 10.1002/for.3980100108; Ryom L., 2017, EACS GUID 9 0 2017; Salazar-Vizcaya L, 2016, HEPATOLOGY, V64, P1856, DOI 10.1002/hep.28769; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Scott N, 2016, J GASTROEN HEPATOL, V31, P872, DOI 10.1111/jgh.13223; Sighem A, 2014, MONITORING REPORT 20; Smith DJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1807-5; Tan SS, 2012, INT J TECHNOL ASSESS, V28, P152, DOI 10.1017/S0266462312000062; Tapper EB, 2017, J VIRAL HEPATITIS, V24, P22, DOI 10.1111/jvh.12611; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Santen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163488; Van Sighem A, 2015, HIV MONITORING REPOR; van Sighemea A., 2016, HIV MONITORING REPOR; van-Sighem A, 2013, MONITORING REPORT 20; Vanhommerig JW, 2014, JAIDS-J ACQ IMM DEF, V66, pE111, DOI 10.1097/QAI.0000000000000208; Virlogeux V, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0979-1; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; WHO, 2017, WHO PUBLISHES LIST B; Zorginstituut Nederland, 2015, KOST PRAKT DIEM	67	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210179	10.1371/journal.pone.0210179	http://dx.doi.org/10.1371/journal.pone.0210179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629662	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000058
J	Dias, FJ; Fazan, VPS; Cury, DP; de Almeida, SRY; Borie, E; Fuentes, R; Coutinho-Netto, J; Watanabe, IS				Jose Dias, Fernando; Sassoli Fazan, Valeria Paula; Cury, Diego Pulzatto; Yokomizo de Almeida, Sonia Regina; Borie, Eduardo; Fuentes, Ramon; Coutinho-Netto, Joaquim; Watanabe, Ii-sei			Growth factors expression and ultrastructural morphology after application of low-level laser and natural latex protein on a sciatic nerve crush-type injury	PLOS ONE			English	Article							GENE-EXPRESSION; NEUROTROPHIC FACTOR; CORD FORMATION; REGENERATION; THERAPY; TISSUE; REPAIR; PROLIFERATION; CELLS; ANGIOGENESIS	The effects of low-level laser therapy (LLLT) and natural latex protein (F1, Hevea brasiliensis) were evaluated on crush-type injuries (15kg) to the sciatic nerve in the expressions of nerve growth factor (NGF) and vascular endothelium growth factor (VEGF) and ultrastructural morphology to associate with previous morphometric data using the same protocol of injury and treatment. Thirty-six male rats were allocated into six experimental groups (n = 6): 1-Control; 2-Exposed nerve; 3-Injured nerve; 4-LLLT (15J/cm(2), 780nm, 30mW, Continuous Wave) treated injured nerve; 5-F1 (0,1mg) treated injured nerve; and 6-LLLT&F1 treated injured nerve. Four or eight weeks after, sciatic nerve samples were processed for analysis. NGF expression were higher (p<0.05) four weeks after in all injured groups in comparison to Control (Med: 0.8; Q1:0; Q3:55.5% area). Among them, the Injured (Med:70.7; Q1:64.4; Q3:77.5% area) showed the highest expression, and F1 (Med: 17.3; Q1:14.1; Q3:21.7% area) had the lowest. At week 8, NGF expressions decreased in the injured groups. VEGF was expressed in all groups; its higher expression was observed in the injured groups 4 weeks after (Injured. Med: 29.5; F1. Med:17.7 and LLLT&F1. Med:19.4% area). At week 8, a general reduction of VEGF expression was noted, remaining higher in F1 (Med:35.1; Q1.30.6; Q3.39.6% area) and LLLT&F1 (Med:18.5; Q1:16; Q3:25% area). Ultrastructural morphology revealed improvements in the treated groups; 4 weeks after, the F1 group presented greater quantity and diameter of the nerve fibers uniformly distributed. Eight weeks after, the F1 and LLLT&F1 showed similar characteristics to the non-injured groups. In summary, these results and our previous studies indicated that F1 and LLLT may favorably influence the healing of nerve crush injury. Four weeks after nerve injury F1 group showed the best results suggesting recovery acceleration; at 8th week F1 and LLLT& F1 groups presented better features and higher vascularization that could be associated with VEGF maintenance.	[Jose Dias, Fernando; Borie, Eduardo; Fuentes, Ramon] Univ La Frontera, Dent Sch, CICO Res Ctr Dent Sci, Dept Integral Dent, Temuco, Chile; [Sassoli Fazan, Valeria Paula] Univ Sao Paulo, Dept Surg & Anat, Sch Med Ribeirao Preto, Ribeirao Preto, Brazil; [Cury, Diego Pulzatto; Yokomizo de Almeida, Sonia Regina; Watanabe, Ii-sei] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Coutinho-Netto, Joaquim] Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, Ribeirao Preto, Brazil	Universidad de La Frontera; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Dias, FJ (corresponding author), Univ La Frontera, Dent Sch, CICO Res Ctr Dent Sci, Dept Integral Dent, Temuco, Chile.	fernando.dias@ufrontera.cl	Cury, Diego Pulzatto/N-9870-2015; Dias, Fernando Jose/AAP-7420-2020; Cury, Diego Pulzatto/AAS-5015-2021; Dias, Fernando Jose/D-8228-2014	Cury, Diego Pulzatto/0000-0002-8571-7144; Dias, Fernando Jose/0000-0001-9945-9185; Watanabe, Ii-sei/0000-0002-1000-1467	"DIUFRO - Direccion de Investigacion Universidad de La Frontera" [DI17-0115]; FAPESP - Sao Paulo Research Foundation (Brazil) [2014/07253-4]	"DIUFRO - Direccion de Investigacion Universidad de La Frontera"; FAPESP - Sao Paulo Research Foundation (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by "DIUFRO - Direccion de Investigacion Universidad de La Frontera", Project DI17-0115 to FJD, http://investigacion.ufro.cl/; FAPESP - Sao Paulo Research Foundation (Brazil) -Project 2014/07253-4 to FJD, http://www.fapesp.br/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomes LEA, 2012, PHOTOMED LASER SURG, V30, P642, DOI 10.1089/pho.2012.3242; Acosta CMR, 2013, CNS NEUROL DISORD-DR, V12, P1242; Alberts B., 2010, MOL BIOL CELL; Alcantara CC, 2013, LASER SURG MED, V45, P246, DOI 10.1002/lsm.22129; Alves MM, 2017, ABCD-ARQ BRAS CIR DI, V30, P93, DOI 10.1590/0102-6720201700020004; Andrade TAM, 2011, BRAZ J MED BIOL RES, V44, P1036, DOI 10.1590/S0100-879X2011007500116; Araujo LA, 2018, BRAZ J BIOL, V78, P271, DOI 10.1590/1519-6984.06316; Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201; Brassolatti P, 2018, J TISSUE VIABILITY, V27, P249, DOI 10.1016/j.jtv.2018.10.001; Chang CJ, 2009, TISSUE ENG PT A, V15, P547, DOI 10.1089/ten.tea.2007.0342; Chen XQ, 2018, FREE RADICAL BIO MED, V114, P52, DOI 10.1016/j.freeradbiomed.2017.10.341; Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8; Camara CND, 2011, ACTA CIR BRAS, V26, P12, DOI 10.1590/S0102-86502011000100004; Dias FJ, 2015, J NEUROL SCI, V349, P129, DOI 10.1016/j.jns.2014.12.043; Dias FJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597863; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Felix SP, 2013, MICROSURG, V33, P468, DOI 10.1002/micr.22109; Ferguson TA, 2011, J TISSUE ENG, V2, DOI 10.1177/2041731411418392; Szezerbaty SKF, 2018, LASER MED SCI, V33, P315, DOI 10.1007/s10103-017-2375-7; Giacca M, 2012, GENE THER, V19, P622, DOI 10.1038/gt.2012.17; Guo H, 2016, NEURAL REGEN RES, V11, P174, DOI 10.4103/1673-5374.175067; Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Ishikawa N, 2007, J BIOMED MATER RES A, V83A, P33, DOI 10.1002/jbm.a.31126; Issa JPM, 2012, GERODONTOLOGY, V29, P258, DOI 10.1111/j.1741-2358.2011.00526.x; Jang CH, 2012, INT J PEDIATR OTORHI, V76, P1823, DOI 10.1016/j.ijporl.2012.09.009; Johnson-Weaver B, 2018, CURR OPIN PHARMACOL, V41, P89, DOI 10.1016/j.coph.2018.05.004; Kashyap MP, 2018, MOL NEUROBIOL, V55, P6939, DOI 10.1007/s12035-018-0885-3; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Kim JR, 2013, TISSUE ENG PT A, V19, P2674, DOI [10.1089/ten.tea.2012.0735, 10.1089/ten.TEA.2012.0735]; Kim YS, 2013, BIOCHEM BIOPH RES CO, V431, P740, DOI 10.1016/j.bbrc.2013.01.045; Lecht S, 2010, VASC PHARMACOL, V53, P107, DOI 10.1016/j.vph.2010.04.005; Li BH, 2012, OR SURG OR MED OR PA, V113, pE26, DOI 10.1016/j.tripleo.2011.07.002; Li RJ, 2014, CELL BIOCHEM BIOPHYS, V68, P449, DOI 10.1007/s12013-013-9742-1; Lundborg G, 2003, J PERIPHER NERV SYST, V8, P209, DOI 10.1111/j.1085-9489.2003.03027.x; de Albornoz PM, 2011, BRIT MED BULL, V100, P73, DOI 10.1093/bmb/ldr005; Ziago EKM, 2017, LASER MED SCI, V32, P369, DOI 10.1007/s10103-016-2126-1; Medalha CC, 2012, LASER MED SCI, V27, P629, DOI 10.1007/s10103-011-1008-9; Meek MF, 2004, TISSUE ENG, V10, P1027, DOI 10.1089/ten.2004.10.1027; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Mendonca RJ, 2010, PHYTOTHER RES, V24, P764, DOI 10.1002/ptr.3043; Mligiliche Nurru L., 2003, Anatomical Science International, V78, P156, DOI 10.1046/j.0022-7722.2003.00056.x; Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010; Ganga MVM, 2012, ACTA CIR BRAS, V27, P885, DOI 10.1590/S0102-86502012001200010; Muniz KL, 2015, MUSCLE NERVE, V52, P869, DOI 10.1002/mus.24602; Ohta M, 2018, INT J MOL MED, V42, P1484, DOI 10.3892/ijmm.2018.3714; Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Barreiros VCP, 2014, GROWTH FACTORS, V32, P164, DOI 10.3109/08977194.2014.952727; Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x; Rahbek UL, 2005, PFLUG ARCH EUR J PHY, V450, P355, DOI 10.1007/s00424-005-1436-0; Raimondo S, 2011, ANN ANAT, V193, P334, DOI 10.1016/j.aanat.2011.03.001; Raimondo S, 2009, INT REV NEUROBIOL, V87, P81, DOI 10.1016/S0074-7742(09)87005-0; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Rochkind S, 2016, PHOTOMED LASER SURG, V34, P585, DOI 10.1089/pho.2016.4206; Rochkind S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E8; Rovak JM, 2004, J RECONSTR MICROSURG, V20, P53, DOI 10.1055/s-2004-818050; Sampaio RB, 2010, CURR EYE RES, V35, P56, DOI 10.3109/02713680903374216; Shen CC, 2011, INJURY, V42, P803, DOI 10.1016/j.injury.2011.02.005; Shibuya A, 2015, INHIBITORY IMMUNOREC, DOI [10.1007/978-4-431-55651-0_8, DOI 10.1007/978-4-431-55651-0_8]; Teixeira LD, 2012, CLIN EXP IMMUNOL, V168, P285, DOI 10.1111/j.1365-2249.2012.04582.x; Urzua U, 2012, HORM METAB RES, V44, P656, DOI 10.1055/s-0032-1304617; Wang WX, 2011, ACTA PHARMACOL SIN, V32, P1483, DOI 10.1038/aps.2011.141; Wang Y, 2018, INT J TUBERC LUNG D, V22, P1227, DOI 10.5588/ijtld.18.0027; Xiao L, 2013, HUM CELL, V26, P91, DOI 10.1007/s13577-013-0069-4; Yang CC, 2016, J TISSUE ENG REGEN M, V10, P120, DOI 10.1002/term.1714; Yang J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00978; Yazdani SO, 2012, J PHOTOCH PHOTOBIO B, V107, P9, DOI 10.1016/j.jphotobiol.2011.11.001; Yen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027514; Zettler C, 1996, J NEUROSCI RES, V46, P581, DOI 10.1002/(SICI)1097-4547(19961201)46:5<581::AID-JNR7>3.0.CO;2-F; Zhao Juan, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P107	72	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210211	10.1371/journal.pone.0210211	http://dx.doi.org/10.1371/journal.pone.0210211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625210	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400077
J	Ma, L; Yang, YX; Zhao, XW; Wang, F; Gao, ST; Bu, DP				Ma, Lu; Yang, Yongxin; Zhao, Xiaowei; Wang, Fang; Gao, Shengtao; Bu, Dengpan			Heat stress induces proteomic changes in the liver and mammary tissue of dairy cows independent of feed intake: An iTRAQ study	PLOS ONE			English	Article							LACTATING HOLSTEIN COWS; GENE-EXPRESSION; SHOCK PROTEINS; MILK-COMPOSITION; METABOLISM; CELLS; GLAND; IDENTIFICATION; PERFORMANCE; NUTRITION	Heat stress decreases milk yield and deleteriously alters milk composition. Reduced feed intake partially explains some of the consequences of heat stress, but metabolic changes in the mammary tissue and liver associated with milk synthesis have not been thoroughly evaluated. In the current study, changes of protein abundance in the mammary tissue and liver between heat-stressed cows with ad libitum intake and pair-fed thermal neutral cows were investigated using the iTRAQ proteomic approach. Most of the differentially expressed proteins from mammary tissue and liver between heat-stressed and pair-fed cows were involved in Gene Ontology category of protein metabolic process. Pathway analysis indicated that differentially expressed proteins in the mammary tissue were related to pyruvate, glyoxylate and dicarboxylate metabolism pathways, while those in the liver participated in oxidative phosphorylation and antigen processing and presentation pathways. Several heat shock proteins directly interact with each other and were considered as central "hubs" in the protein interaction network. These findings provide new insights to understand the turnover of protein biosynthesis pathways within hepatic and mammary tissue that likely contribute to changes in milk composition from heat-stressed cows.	[Ma, Lu; Yang, Yongxin; Zhao, Xiaowei; Wang, Fang; Gao, Shengtao; Bu, Dengpan] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Yang, Yongxin; Zhao, Xiaowei] Anhui Acad Agr Sci, Inst Anim Sci & Vet Med, Hefei, Anhui, Peoples R China; [Bu, Dengpan] World Agroforestry Ctr, Joint Lab Agroforestry & Sustainable Anim Husb, CAAS ICRAF, Beijing, Peoples R China; [Bu, Dengpan] CICAPS, Hunan Coinnovat Ctr Anim Prod Safety, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Anhui Academy of Agricultural Sciences	Bu, DP (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China.; Bu, DP (corresponding author), World Agroforestry Ctr, Joint Lab Agroforestry & Sustainable Anim Husb, CAAS ICRAF, Beijing, Peoples R China.; Bu, DP (corresponding author), CICAPS, Hunan Coinnovat Ctr Anim Prod Safety, Changsha, Hunan, Peoples R China.	budengpan@126.com			National Natural Science Foundation of China [31872383, 31372341]; National Key Research and Development Program of China [2018YFD0501600]; Beijing Dairy Industry Innovation Team [BAIC06-2018]; Agricultural Science and Technology Innovation Program [ASTIP-IAS07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Beijing Dairy Industry Innovation Team; Agricultural Science and Technology Innovation Program	The project was supported by the National Natural Science Foundation of China (31872383, 31372341), the National Key Research and Development Program of China (2018YFD0501600), Beijing Dairy Industry Innovation Team (BAIC06-2018) and the Agricultural Science and Technology Innovation Program (ASTIP-IAS07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by the National Natural Science Foundation of China (31872383, 31372341), the National Key Research and Development Program of China (2018YFD0501600), Beijing Dairy Industry Innovation Team (BAIC06-2018), and the Agricultural Science and Technology Innovation Program (ASTIP-IAS07). The authors are grateful to Alex Evans (University College Dublin, Ireland) for careful reading of the manuscript.	Areshkov PO, 2012, INT J BIOL SCI, V8, P39, DOI 10.7150/ijbs.8.39; Baumgard LH, 2012, J ANIM SCI, V90, P1855, DOI 10.2527/jas.2011-4675; Bernabucci U, 2015, J DAIRY SCI, V98, P1815, DOI 10.3168/jds.2014-8788; Bernabucci U, 2010, J SUPERCRIT FLUID, V55, P616, DOI [10.1111/asj.12375, DOI 10.1111/ASJ.12375]; BICKERSTAFFE R, 1974, J AGR SCI-CAMBRIDGE, V82, P71, DOI 10.1017/S0021859600050243; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Capuco AV, 2005, J MAMMARY GLAND BIOL, V10, P5, DOI 10.1007/s10911-005-2536-3; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Collier R J, 2006, J Anim Sci, V84 Suppl, pE1; Cowley FC, 2015, J DAIRY SCI, V98, P2356, DOI 10.3168/jds.2014-8442; Deb R, 2014, GENE, V536, P435, DOI 10.1016/j.gene.2013.11.086; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; FLANAGAN SW, 1995, AM J PHYSIOL-REG I, V268, pR28, DOI 10.1152/ajpregu.1995.268.1.R28; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao ST, 2017, J DAIRY SCI, V100, P5040, DOI 10.3168/jds.2016-11913; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gaughan JB, 2013, J ANIM SCI, V91, P120, DOI 10.2527/jas.2012-5294; Gorniak T, 2014, ARCH ANIM NUTR, V68, P358, DOI 10.1080/1745039X.2014.950451; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Hengel SM, 2012, PROTEOMICS, V12, P3138, DOI 10.1002/pmic.201200168; HIGGINBOTHAM GE, 1989, J DAIRY SCI, V72, P2554, DOI 10.3168/jds.S0022-0302(89)79396-6; Hu H, 2016, ANIM PROD SCI, V56, P918, DOI 10.1071/AN14420; Hu H, 2016, ANIM SCI J, V87, P84, DOI 10.1111/asj.12375; KAGAWA Y, 1990, INT J BIOCHEM, V22, P219; KELLEY RO, 1967, J DAIRY SCI, V50, P531, DOI 10.3168/jds.S0022-0302(67)87460-5; Lamp O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125264; LANDRY J, 1982, CANCER RES, V42, P2457; Leman G, 2015, INT J BIOCHEM CELL B, V65, P91, DOI 10.1016/j.biocel.2015.05.017; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu J, 2014, J ANIM SCI, V92, P2494, DOI 10.2527/jas.2013-7152; Miller N, 2006, J DAIRY SCI, V89, P4669, DOI 10.3168/jds.S0022-0302(06)72517-6; Min L, 2015, J ZHEJIANG UNIV-SC B, V16, P541, DOI 10.1631/jzus.B1400341; Moseley P L, 2000, Exerc Sport Sci Rev, V28, P128; Rawson P, 2012, J PROTEOMICS, V75, P4429, DOI 10.1016/j.jprot.2012.04.019; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rhoads RP, 2013, ADV NUTR, V4, P267, DOI 10.3945/an.112.003376; Salama AAK, 2014, SMALL RUMINANT RES, V121, P73, DOI 10.1016/j.smallrumres.2013.11.021; SCHNEIDER PL, 1988, J ANIM SCI, V66, P112, DOI 10.2527/jas1988.661112x; SHYY TT, 1989, J CELL BIOL, V108, P997, DOI 10.1083/jcb.108.3.997; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Skibiel AL, 2016, J DAIRY SCI S5, V94, P617; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; Stiening CM, 2008, J DAIRY SCI, V91, P1053, DOI 10.3168/jds.2007-0161; Tian H, 2015, J PROTEOMICS, V125, P17, DOI 10.1016/j.jprot.2015.04.014; Van Laer E, 2015, ANIMAL, V9, P1547, DOI 10.1017/S1751731115000816; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Wall EH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-296; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang L, 2013, J DAIRY SCI, V96, P6863, DOI 10.3168/jds.2013-6846; Yang YX, 2013, J PROTEOME RES, V12, P1660, DOI 10.1021/pr301001m; Zachut M, 2013, J DAIRY SCI, V96, P5656, DOI 10.3168/jds.2012-6142; Zhao FQ, 2007, J DAIRY SCI, V90, pE76, DOI 10.3168/jds.2006-470	58	16	17	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209182	10.1371/journal.pone.0209182	http://dx.doi.org/10.1371/journal.pone.0209182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625175	gold, Green Published, Green Submitted			2022-12-26	WOS:000455359400029
J	Kumar, A; Pluckthun, A				Kumar, Abhinav; Pluckthun, Andreas			In vivo assembly and large-scale purification of a GPCR - G alpha fusion with G beta gamma, and characterization of the active complex	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYO-EM STRUCTURE; DETERGENT STABILITY; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; NEUROTENSIN; EXPRESSION; BINDING; G-ALPHA(Q); EFFICIENT	G protein coupled receptors (GPCRs) are central players in recognizing a variety of stimuli to mediate diverse cellular responses. This myriad of functions is accomplished by their modular interactions with downstream intracellular transducers, such as heterotrimeric G proteins and arrestins. Assembling a specific GPCR-G protein pair as a purified complex for their structural and functional investigations remains a challenging task, however, because of the low affinity of the interaction. Here, we optimized fusion constructs of the G alpha subunit of the heterotrimeric G protein and engineered versions of rat Neurotensin receptor 1 (NTR1), coexpressed and assembled in vivo with G beta and G gamma. This was achieved by using the baculovirus-based MultiBac system. We thus generated a functional receptor-G protein fusion complex, which can be efficiently purified using ligand-based affinity chromatography on large scales. Additionally, we utilized a purification method based on a designed ankyrin repeat protein tightly binding to Green Fluorescent Protein (GFP-DARPin) that may be used as a generic approach for a large-scale purification of GPCR-G protein fusion complexes for which no ligands column can be generated. The purification methods described herein will support future studies that aim to understand the structural and functional framework of GPCR activation and signaling.	[Kumar, Abhinav; Pluckthun, Andreas] Univ Zurich, Dept Biochem, Zurich, Switzerland	University of Zurich	Pluckthun, A (corresponding author), Univ Zurich, Dept Biochem, Zurich, Switzerland.	plueckthun@bioc.uzh.ch	Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306; Kumar, Abhinav/0000-0002-7696-0134	Schweizerische Nationalfonds [31003A_153143, 31003A_182334]	Schweizerische Nationalfonds(Swiss National Science Foundation (SNSF))	This work was funded by the Schweizerische Nationalfonds, grant 31003A_153143 and 31003A_182334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifano M, 2010, CLIN CANCER RES, V16, P4401, DOI 10.1158/1078-0432.CCR-10-0659; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Chen QY, 2018, TRENDS BIOCHEM SCI, V43, P412, DOI 10.1016/j.tibs.2018.03.005; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Egloff P, 2015, PROTEIN EXPRES PURIF, V108, P106, DOI 10.1016/j.pep.2014.10.006; Egloff P, 2014, P NATL ACAD SCI USA, V111, pE655, DOI 10.1073/pnas.1317903111; Feierler J, 2011, J BIOL CHEM, V286, P43282, DOI 10.1074/jbc.M111.256909; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Griebel G, 2015, CURR PHARM DESIGN, V21, P3807, DOI 10.2174/1381612821666150605105859; Grisshammer R, 2001, FEBS LETT, V493, P101, DOI 10.1016/S0014-5793(01)02281-5; Haldimann A, 1996, P NATL ACAD SCI USA, V93, P14361, DOI 10.1073/pnas.93.25.14361; Hansen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15711-z; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Heakal Y, 2011, CANCER BIOL THER, V12, P427, DOI 10.4161/cbt.12.5.15984; Hildebrandt JD, 2006, MOL PHARMACOL, V69, P1079, DOI 10.1124/mol.106.022921; Hillenbrand M, 2015, P NATL ACAD SCI USA, V112, pE1181, DOI 10.1073/pnas.1417573112; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Krumm BE, 2016, SCI REP-UK, V6, DOI 10.1038/srep38564; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Maeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098714; Mahoney JP, 2016, CURR OPIN STRUC BIOL, V41, P247, DOI 10.1016/j.sbi.2016.11.005; Marino SF, 2009, FEBS J, V276, P4515, DOI 10.1111/j.1742-4658.2009.07158.x; Milic D, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00066; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2007, CURR OPIN PHARMACOL, V7, P521, DOI 10.1016/j.coph.2007.06.007; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; Sato T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111930; Schlinkmann KM, 2012, J MOL BIOL, V422, P414, DOI 10.1016/j.jmb.2012.05.039; Schlinkmann KM, 2012, P NATL ACAD SCI USA, V109, P9810, DOI 10.1073/pnas.1202107109; Schmitz AL, 2014, CHEM BIOL, V21, P890, DOI 10.1016/j.chembiol.2014.06.003; Scott DJ, 2014, BBA-BIOMEMBRANES, V1838, P2817, DOI 10.1016/j.bbamem.2014.07.015; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Wenzel-Seifert K, 1998, BIOCHEM J, V334, P519, DOI 10.1042/bj3340519; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Zhang XJ, 2015, TRENDS BIOCHEM SCI, V40, P79, DOI 10.1016/j.tibs.2014.12.005; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhou Qiang, 2017, Biophys Rep, V3, P43, DOI 10.1007/s41048-017-0038-7	52	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210131	10.1371/journal.pone.0210131	http://dx.doi.org/10.1371/journal.pone.0210131			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620756	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000455161300015
J	Spirova, EN; Ivanov, IA; Kasheverov, IE; Kudryavtsev, DS; Shelukhin, IV; Garifulina, AI; Son, LV; Lummis, SCR; Malca-Garcia, GR; Bussmann, RW; Hennig, L; Giannis, A; Tsetlin, VI				Spirova, Ekaterina N.; Ivanov, Igor A.; Kasheverov, Igor E.; Kudryavtsev, Denis S.; Shelukhin, Irina V.; Garifulina, Alexandra I.; Son, Lina V.; Lummis, Sarah C. R.; Malca-Garcia, Gonzalo R.; Bussmann, Rainer W.; Hennig, Lothar; Giannis, Athanassios; Tsetlin, Victor I.			Curare alkaloids from Matis Dart Poison: Comparison with d-tubocurarine in interactions with nicotinic, 5-HT3 serotonin and GABA(A) receptors	PLOS ONE			English	Article							AMINOBUTYRIC-ACID GABA; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; ALLOSTERIC MODULATORS; ALPHA-BUNGAROTOXIN; ION CHANNELS; ANTAGONISTS; INHIBITION; INSIGHTS	Several novel bisbenzylisoquinoline alkaloids (BBIQAs) have recently been isolated from a Matis tribe arrow poison and shown by two-electrode voltage-clamp to inhibit mouse muscle nicotinic acetylcholine receptors (nAChR). Here, using radioligand assay with Aplysia californica AChBP and radioiodinated a-bungarotoxin ([I-125]-alpha Bgt), we show that BBIQA1, BBIQA2, and d-tubocurarine (d-TC) have similar affinities to nAChR orthosteric site. However, a competition with [I-125]-alpha Bgt for binding to the Torpedo californica muscle-type nAChR revealed that BBIQAs1, 2, and 3 are less potent (IC(50)s = 26.3, 8.75, and 17.0 mu M) than d-TC (IC50 = 0.39 mu M), while with alpha 7 nAChR in GH(4)C(1) cells, BBIQA1 was less potent that d-TC (IC(50)s = 162 mu M and 7.77 mu M, respectively), but BBIQA2 was similar (IC50 = 5.52 mu M). In inhibiting the Ca2+ responses induced by acetylcholine in Neuro2a cells expressing the mouse adult alpha 1 beta 1 epsilon delta nAChR or human a7 nAChR, BBIQAs1 and 2 had similar potencies to d-TC (IC(50)s in the range 0.75-3.08 mu M). Our data suggest that BBIQA1 and BBIQA2 can inhibit adult muscle alpha 1 beta 1 epsilon delta nAChR by both competitive and noncompetitive mechanisms. Further experiments on neuronal alpha 3 beta 2, alpha 4 beta 2, and alpha 9 alpha 10 nAChRs, expressed in Xenopus laevis oocytes, showed that similar potencies for BBIQAs1, 2, and d-TC. With alpha 3 beta 2 gamma 2 GABA(A)R currents were almost completely inhibited by d-TC at a high (100 mu M) concentration, but BBIQAs1 and 2 were less potent (only 40-50% inhibition), whereas in competition with Alexa Fluor 546-alpha-cobratoxin for binding to alpha 1 beta 3 gamma 2 GABA(A)R in Neuro2a cells, d-TC and these analogs had comparable affinities. Especially interesting effects of BBIQAs1 and 2 in comparison with d-TC were observed for 5-HT3AR: BBIQA1 and BBIQA2 were 5- and 87-fold less potent than d-TC (IC50 = 22.63 nM). Thus, our results reveal that these BBIQAs differ from d-TC in their potencies towards certain Cys-loop receptors, and we suggest that understanding the reasons behind this might be useful for future drug design.	[Spirova, Ekaterina N.; Ivanov, Igor A.; Kasheverov, Igor E.; Kudryavtsev, Denis S.; Shelukhin, Irina V.; Garifulina, Alexandra I.; Son, Lina V.; Tsetlin, Victor I.] Russian Acad Sci, Dept Mol Neuroimmune Signaling, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Kasheverov, Igor E.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia; [Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge, England; [Malca-Garcia, Gonzalo R.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Bussmann, Rainer W.] Museo Nacl Ciencias Nat, La Paz, Bolivia; [Hennig, Lothar; Giannis, Athanassios] Univ Leipzig, Inst Organ Chem, Fak Chem & Mineral, Leipzig, Germany; [Tsetlin, Victor I.] PhysBio MEPhI, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; University of Cambridge; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Leipzig University; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)	Tsetlin, VI (corresponding author), Russian Acad Sci, Dept Mol Neuroimmune Signaling, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Giannis, A (corresponding author), Univ Leipzig, Inst Organ Chem, Fak Chem & Mineral, Leipzig, Germany.; Tsetlin, VI (corresponding author), PhysBio MEPhI, Moscow, Russia.	giannis@uni-leipzig.de; vits@mx.ibch.ru	Shelukhina, Irina/AHE-5496-2022; Kudryavtsev, Denis S/O-4811-2015; Ivanov, Igor A/R-7543-2017; Bussmann, Rainer W/A-6105-2010	Shelukhina, Irina/0000-0003-3476-1441; Kudryavtsev, Denis S/0000-0002-0313-9193; Bussmann, Rainer W/0000-0002-3524-5273; Garifulina, Aleksandra/0000-0003-4746-5051; Ivanov, Igor/0000-0001-6785-4420; Malca Garcia, Gonzalo Rodolfo/0000-0002-6680-4314	Russian Science Foundation [16-14-00215]; Russian Foundation for Basic Research Grant [18-04-01366]; Medical Research Council [MR L021676]; MRC [MR/L021676/1] Funding Source: UKRI	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research Grant(Russian Foundation for Basic Research (RFBR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of ENS, IAI, DSK, IVS, AIG, LVS, and VIT was supported by the Russian Science Foundation Grant 16-14-00215 (http://rscf.ru/en). The work of IEK was supported by the Russian Foundation for Basic Research Grant 18-04-01366 (http://www.rfbr.ru/rffi/eng). The work of SCRL was supported by a Medical Research Council Grant MR L021676 (https://mrc.ukri.org/). GRM, RWB, LH, AG received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bertrand D, 2018, BIOCHEM PHARMACOL, V151, P214, DOI 10.1016/j.bcp.2017.12.008; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bowman WC, 2006, BRIT J PHARMACOL, V147, pS277, DOI 10.1038/sj.bjp.0706404; BOWMAN WC, 1988, ANESTHESIOLOGY, V69, P57, DOI 10.1097/00000542-198807000-00009; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burgos CF, 2016, MOL PHARMACOL, V90, P318, DOI 10.1124/mol.116.105726; Chatzidaki A, 2015, NEUROPHARMACOLOGY, V97, P75, DOI 10.1016/j.neuropharm.2015.05.006; Chua HC, 2017, ADV PHARMACOL, V79, P1, DOI 10.1016/bs.apha.2017.03.003; daCosta CJB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9057; Dani JA, 2015, INT REV NEUROBIOL, V124, P3, DOI 10.1016/bs.irn.2015.07.001; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Fagerlund MJ, 2009, ANESTHESIOLOGY, V110, P1244, DOI 10.1097/ALN.0b013e31819fade3; Foucault-Fruchard L, 2017, NEURAL REGEN RES, V12, P1418, DOI 10.4103/1673-5374.215244; Gahring LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175367; Garcia GRM, 2015, J NAT PROD, V78, P2537, DOI 10.1021/acs.jnatprod.5b00457; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; Groot-Kormelink PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163129; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Heier Tom, 2010, Tidsskr Nor Laegeforen, V130, P398, DOI 10.4045/tidsskr.08.0323; Hone AJ, 2018, BRIT J PHARMACOL, V175, P1915, DOI 10.1111/bph.13931; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Jonsson M, 2006, ANESTHESIOLOGY, V105, P521, DOI 10.1097/00000542-200609000-00016; KARPEN JW, 1986, BIOCHEMISTRY-US, V25, P1786, DOI 10.1021/bi00355a050; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kudryavtsev D, 2014, MAR DRUGS, V12, P1859, DOI 10.3390/md12041859; Kudryavtsev DS, 2015, J BIOL CHEM, V290, P22747, DOI 10.1074/jbc.M115.648824; Lemoine D, 2012, CHEM REV, V112, P6285, DOI 10.1021/cr3000829; Lien CA, 2011, BRIT J ANAESTH, V107, P60, DOI 10.1093/bja/aer341; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Meakin GH, 2001, PAEDIATR ANAESTH, V11, P523, DOI 10.1046/j.1460-9592.2001.00661.x; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murebwayire S, 2009, J PHARM PHARMACOL, V61, P103, DOI [10.1211/jpp/61.01.0014, 10.1211/jpp.61.01.0014]; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Paul M, 2005, ANESTH ANALG, V101, P715, DOI 10.1213/01.ANE.0000160531.65953.77; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; SAVARESE JJ, 1975, ANESTHESIOLOGY, V42, P236, DOI 10.1097/00000542-197503000-00002; Semwal DK, 2014, J ETHNOPHARMACOL, V155, P1011, DOI 10.1016/j.jep.2014.06.054; Shelukhina I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181936; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Szabo AK, 2014, NEUROPHARMACOLOGY, V81, P42, DOI 10.1016/j.neuropharm.2014.01.033; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Tuba Z, 2002, CURR MED CHEM, V9, P1507, DOI 10.2174/0929867023369466; Vemparala S, 2010, ACCOUNTS CHEM RES, V43, P103, DOI 10.1021/ar900149j; Vulfius CA, 2016, TOXICON, V121, P70, DOI 10.1016/j.toxicon.2016.08.020; Wang HL, 2003, J BIOL CHEM, V278, P32284, DOI 10.1074/jbc.M304366200; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wintersteiner O, 1943, SCIENCE, V97, P467, DOI 10.1126/science.97.2525.467; WOTRING VE, 1995, NEUROSCIENCE, V67, P293, DOI 10.1016/0306-4522(95)00011-7; Wu ZS, 2015, ACTA PHARMACOL SIN, V36, P895, DOI 10.1038/aps.2015.66; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang R, 2007, BIOCHEMISTRY-US, V46, P1194, DOI 10.1021/bi0616100; Zoli M, 2017, CURR NEUROPHARMACOL, DOI [10.2174/1570159X15666170912110450002, DOI 10.2174/1570159X15666170912110450002]	63	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210182	10.1371/journal.pone.0210182	http://dx.doi.org/10.1371/journal.pone.0210182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608952	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800050
J	Das, S; Bar-Sagi, D				Das, Shipra; Bar-Sagi, Dafna			BTK signaling drives CD1d(hi)CD5(+) regulatory B-cell differentiation to promote pancreatic carcinogenesis	ONCOGENE			English	Article							BRUTONS TYROSINE KINASE; T-CELLS; AUTOIMMUNITY; INHIBITION; CANCER; TUMOR; ACTIVATION; EXPRESSION	The immune microenvironment of pancreatic ductal adenocarcinoma (PDA) is comprised of a heterogeneous population of cells that are critical for disease evolution. Prominent among these are the specialized CD1d(hi)CD5(+) regulatory B (B-reg) cells that exert a pro-tumorigenic role by promoting tumor cell proliferation. Dissecting the molecular pathways regulating this immune sub-population can thus be valuable for uncovering potential therapeutic targets. Here, we investigate Bruton's tyrosine kinase (BTK), a key B-cell kinase, as a potential regulator of CD1d(hi)CD5(+) B-reg differentiation in the pancreatic tumor microenvironment. Treatment of cytokine-induced B cells in vitro with the high specificity BTK inhibitor Tirabrutinib inhibited CD1d(hi)CD5(+) B-reg differentiation and production of IL-10 and IL-35, essential mediators of B-reg immunosuppressive functions. The BTK signaling pathway was also found to be active in vivo in PanIN-associated regulatory B cells. Tirabrutinib treatment of mice bearing orthotopic Kras(G12D)-pancreatic lesions severely compromised stromal accumulation of the CD1d(hi)CD5(+) B-reg population. This was accompanied by an increase in stromal CD8(+)IFN gamma(+) cytotoxic T cells and significant attenuation of tumor cell proliferation and PanIN growth. Our results uncover a novel role for BTK in regulating CD1d(hi)CD5(+) B-reg differentiation and emphasize its potential as a therapeutic target for pancreatic cancer.	[Das, Shipra; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Bar-Sagi, D (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	dafna.bar-sagi@nyulangone.org		Bar-Sagi, Dafna/0000-0003-2597-8948	National Institutes of Health/National Cancer Institute [P30CA016087]; Gilead Sciences, Inc., Foster City, CA, USA; NIH/NCI [CA210263]; Lustgarten Foundation Pancreatic Cancer Convergence Dream Team grant [SU2C-AACR-DT14-14]; NATIONAL CANCER INSTITUTE [R35CA210263, P30CA016087] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gilead Sciences, Inc., Foster City, CA, USA(Gilead Sciences); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation Pancreatic Cancer Convergence Dream Team grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank L.J. Taylor for help with article preparation and members of the Bar-Sagi lab for valuable discussions and comments. The authors also thank NYU Langone's Cytometry and Cell Sorting Laboratory, which is supported in part by grant P30CA016087 from the National Institutes of Health/National Cancer Institute, for providing cell sorting/flow cytometry technologies. This work was supported in part by Gilead Sciences, Inc., Foster City, CA, USA, by NIH/NCI grant CA210263 (D.B.-S.) and by the Lustgarten Foundation Pancreatic Cancer Convergence Dream Team grant SU2C-AACR-DT14-14 (to D.B.-S.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Brunner C, 2002, IMMUNOBIOLOGY, V206, P432, DOI 10.1078/0171-2985-00192; Burger JA, 2018, NAT REV CANCER, V18, P148, DOI 10.1038/nrc.2017.121; Corneth OBJ, 2016, J IMMUNOL, V197, P58, DOI 10.4049/jimmunol.1600208; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Delitto D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1820-x; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Egwuagu CE, 2015, CRIT REV IMMUNOL, V35, P49, DOI 10.1615/CritRevImmunol.2015012558; Granville CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005061; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Isaza-Correa JM, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0057-5; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Lee KE, 2016, CANCER DISCOV, V6, P256, DOI 10.1158/2159-8290.CD-15-0822; MATSUDA T, 1995, BLOOD, V85, P627, DOI 10.1182/blood.V85.3.627.bloodjournal853627; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Mielgo A, 2013, BMB REP, V46, P131, DOI 10.5483/BMBRep.2013.46.3.036; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; Ponader S, 2014, J CLIN ONCOL, V32, P1830, DOI 10.1200/JCO.2013.53.1046; Pylayeva-Gupta Y, 2016, CLIN CANCER RES, V22, P4973, DOI 10.1158/1078-0432.CCR-16-0743; Pylayeva-Gupta Y, 2016, CANCER DISCOV, V6, P247, DOI 10.1158/2159-8290.CD-15-0843; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rahib L, 2016, JAMA ONCOL, V2, P1209, DOI 10.1001/jamaoncol.2016.0585; Rishi A, 2015, SEMIN ONCOL, V42, P28, DOI 10.1053/j.seminoncol.2014.12.004; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Schmidt NW, 2006, J IMMUNOL, V177, P7203, DOI 10.4049/jimmunol.177.10.7203; Schwartz M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0145-x; Stromnes IM, 2014, CARCINOGENESIS, V35, P1451, DOI 10.1093/carcin/bgu115; Tai YT, 2012, BLOOD, V120, P1877, DOI 10.1182/blood-2011-12-396853; Unek T, 2013, HEPATO-GASTROENTEROL, V60, P2085, DOI 10.5754/hge.13421; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Zdanov S, 2016, CANCER IMMUNOL RES, V4, P354, DOI 10.1158/2326-6066.CIR-15-0241; Zhang JJ, 2018, CANCERS, V10, DOI 10.3390/cancers10020039; Zhang YQ, 2014, CANCER IMMUNOL RES, V2, P423, DOI 10.1158/2326-6066.CIR-14-0016-T; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	40	37	40	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3316	3324		10.1038/s41388-018-0668-3	http://dx.doi.org/10.1038/s41388-018-0668-3			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30635655	Green Accepted			2022-12-26	WOS:000465557200015
J	Kurano, M; Tsuneyama, K; Morimoto, Y; Nishikawa, M; Yatomi, Y				Kurano, Makoto; Tsuneyama, Koichi; Morimoto, Yuki; Nishikawa, Masako; Yatomi, Yutaka			Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice	FASEB JOURNAL			English	Article						sphingosine 1-phosphate; HDL; mesangial proliferation; renal fibrosis	GLUCOSE-INDUCED FIBROSIS; SPHINGOSINE 1-PHOSPHATE; LYMPHOCYTE EGRESS; SIGNALING PATHWAY; LDL RECEPTOR; SPHINGOSINE-1-PHOSPHATE; PROGRESSION; PROTECTS; APOM; OVEREXPRESSION	Because the association between sphingosine 1-phosphate (S1P)/apolipoprotein M (ApoM) and chronic kidney diseases has not been established, we investigated the involvement of S1P/ApoM in the phenotypes of IgA nephropathy in hyper-IgA (HIGA) mice. The overexpression of ApoM in adenoviral gene transfer ameliorated the phenotypes of IgA nephropathy in HIGA mice, whereas the knockdown of ApoM with siRNA caused deterioration. When ApoM-overexpressing HIGA mice were treated with VPC23019, an antagonist against S1P receptor 1 (S1P1) and 3 (S1P3), we observed that the protective effects of ApoM were reversed, whereas JTE013, an antagonist against S1P2, did not inhibit the effects. We also found that S1P bound to albumin accelerated the proliferation of MES13 cells and the fibrotic changes of HK2 cells, which were inhibited by JTE013, whereas S1P bound to ApoM suppressed these changes, which were inhibited by VPC23019. These results suggest that S1P bound to ApoM possesses properties protective against the phenotypes of IgA nephropathy through S1P1 and S1P3, whereas S1P bound to albumin exerts deteriorating effects through S1P2. ApoM may be useful as a therapeutic target to treat or retard the progression of IgA nephropathy.	[Kurano, Makoto; Nishikawa, Masako; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Tsuneyama, Koichi; Morimoto, Yuki] Univ Tokushima, Inst Biomed Sci, Dept Pathol & Lab Med, Grad Sch, Tokushima, Japan	University of Tokyo; Tokushima University	Kurano, M; Yatomi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurano-tky@umin.ac.jp; yatoyuta-tky@umin.ac.jp		Tsuneyama, Koichi/0000-0002-0670-9868; Yatomi, Yutaka/0000-0003-1719-4297	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)/Agency for Medical Research and Development (AMED); Leading Advanced Projects for Medical Innovation (LEAP) from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI [16H06236]; Research Fund of Mitsukoshi Health and Welfare Foundation 2017; Japan Heart Foundation; Astellas Grant for Research on Atherosclerosis Update; MSD Life Science Foundation, a Public Interest Incorporated Foundation;  [15H05906]	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)/Agency for Medical Research and Development (AMED); Leading Advanced Projects for Medical Innovation (LEAP) from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Fund of Mitsukoshi Health and Welfare Foundation 2017; Japan Heart Foundation; Astellas Grant for Research on Atherosclerosis Update; MSD Life Science Foundation, a Public Interest Incorporated Foundation; 	This work was supported by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)/Agency for Medical Research and Development (AMED), Leading Advanced Projects for Medical Innovation (LEAP) from AMED, Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas 15H05906 (to Y.Y.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 16H06236 (to M.K.), Research Fund of Mitsukoshi Health and Welfare Foundation 2017 (to M.K.), Japan Heart Foundation and Astellas Grant for Research on Atherosclerosis Update (to M.K.), and MSD Life Science Foundation, a Public Interest Incorporated Foundation (to M.K.). The authors declare no conflicts of interest.	Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Bajwa A, 2015, J AM SOC NEPHROL, V26, P908, DOI 10.1681/ASN.2013121351; Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462; Borup A, 2015, CURR OPIN LIPIDOL, V26, P48, DOI 10.1097/MOL.0000000000000142; Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Christoffersen C, 2012, J LIPID RES, V53, P2198, DOI 10.1194/jlr.P023697; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Coppo R, 2017, J NEPHROL, V30, P339, DOI 10.1007/s40620-016-0360-z; Coppo R, 2017, PEDIATR NEPHROL, V32, P725, DOI 10.1007/s00467-016-3390-9; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Ding BS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87058; Faber K, 2006, MOL ENDOCRINOL, V20, P212, DOI 10.1210/me.2005-0209; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Hanafusa N, 2002, NEPHROL DIAL TRANSPL, V17, P580, DOI 10.1093/ndt/17.4.580; Hanai K, 2012, NEPHROL DIAL TRANSPL, V27, P1070, DOI 10.1093/ndt/gfr417; Huang KS, 2012, J HUMAN RESOURCE ADU, V8, P7; Imasawa T, 2010, EXP TOXICOL PATHOL, V62, P53, DOI 10.1016/j.etp.2009.02.068; Ishizawa S, 2014, CLIN EXP NEPHROL, V18, P844, DOI 10.1007/s10157-014-0933-x; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Katsuma S., 2001, Pharmacogenomics Journal, V1, P211; Kleinwort A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020391; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; Kurano M, 2018, J ATHEROSCLER THROMB, V25, P16, DOI 10.5551/jat.RV17010; Kurano M, 2017, ARTERIOSCL THROM VAS, V37, P506, DOI 10.1161/ATVBAHA.116.308692; Kurano M, 2016, BRIT J PHARMACOL, V173, P222, DOI 10.1111/bph.13360; Kurano M, 2015, J BIOL CHEM, V290, P2477, DOI 10.1074/jbc.M114.596445; Kurano M, 2014, BBA-MOL CELL BIOL L, V1841, P1217, DOI 10.1016/j.bbalip.2014.05.002; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Lai KN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.1; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu MX, 2014, J BIOL CHEM, V289, P2801, DOI 10.1074/jbc.M113.499913; Liu WH, 2012, EXP CELL RES, V318, P936, DOI 10.1016/j.yexcr.2012.02.020; Maixnerova D, 2016, J NEPHROL, V29, P535, DOI 10.1007/s40620-016-0299-0; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Mishima Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181288; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Poti F, 2014, CARDIOVASC RES, V103, P395, DOI 10.1093/cvr/cvu136; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Rodrigues JC, 2017, CLIN J AM SOC NEPHRO, V12, P677, DOI 10.2215/CJN.07420716; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shiohira S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.172; Swendeman SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2722; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Takahashi C, 2017, J ATHEROSCLER THROMB, V24, P954, DOI 10.5551/jat.37663; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Tian T, 2017, CLIN EXP IMMUNOL, V190, P68, DOI 10.1111/cei.13003; Tu ST, 2010, ARCH INTERN MED, V170, P155, DOI 10.1001/archinternmed.2009.471; Uranbileg B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149462; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yaghobian D, 2016, CLIN EXP PHARMACOL P, V43, P56, DOI 10.1111/1440-1681.12494; Yang ZY, 2016, PHARMACOL RES, V111, P226, DOI 10.1016/j.phrs.2016.05.035; Yang ZY, 2016, EXP CELL RES, V346, P241, DOI 10.1016/j.yexcr.2016.06.005; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006	65	16	17	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5181	5195		10.1096/fj.201801748R	http://dx.doi.org/10.1096/fj.201801748R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629456	Bronze			2022-12-26	WOS:000462888500045
J	Zhu, WW; Xu, RY; Du, JY; Fu, Y; Li, S; Zhang, P; Liu, LK; Jiang, HB				Zhu, Weiwen; Xu, Rongyao; Du, Jinying; Fu, Yu; Li, Sheng; Zhang, Ping; Liu, Laikui; Jiang, Hongbing			Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw	FASEB JOURNAL			English	Article						wound healing; inflammation; Toll-like receptors; NF-kappa B	MEDICATION-RELATED OSTEONECROSIS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; MOUSE MODEL; KAPPA-B; ACTIVATION; REGENERATION; PATHOGENESIS; PHENOTYPE; RESPONSES	Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a detrimental side effect of the long-term administration of bisphosphonates. Although macrophages were reported to be an important mediator of BRONJ, the detailed potential mechanism of BRONJ remains unclear. Here, we reported an elevated TLR-4 expression in macrophages under action of zoledronic acid (ZA), resulting in enhanced M1 macrophage polarization and decreased M2 macrophage polarization both in vitro and in vivo. After inhibiting the TLR-4 signaling pathway, the activation of the TLR-4/NF-kappa B signaling pathway and the induction of NF-kappa B nuclear translocation and production of proinflammatory cytokines by ZA were suppressed in macrophages, thereby inhibiting M1 macrophage polarization. By utilizing the TLR-4(-/-) mice, development of BRONJ was markedly ameliorated, and M1 macrophages were significantly attenuated in the extraction socket tissues in the TLR-4(-/-) mice. Importantly, the systemic administration of the TLR-4 inhibitor TAK-242 improved the wound healing of the extraction socket and decreased the incidence rate of BRONJ. Taken together, our findings suggest that TLR-4-mediated macrophage polarization participates in the pathogenesis of BRONJ in mice, and TLR-4 may be a potential target for the prevention and therapeutic treatment of BRONJ.	[Zhu, Weiwen; Xu, Rongyao; Du, Jinying; Fu, Yu; Li, Sheng; Zhang, Ping; Jiang, Hongbing] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing, Jiangsu, Peoples R China; [Liu, Laikui] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral Pathol, Nanjing, Jiangsu, Peoples R China; [Zhu, Weiwen; Xu, Rongyao; Du, Jinying; Jiang, Hongbing] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, 136 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jiang, HB (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, 136 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	jhb@njmu.edu.cn	Xu, Rongyao/AHB-8403-2022; Jiang, Hongbing/AAQ-6331-2021	Xu, Rongyao/0000-0002-1508-437X; Zhu, Weiwen/0000-0002-9736-5692; Jiang, Hongbing/0000-0002-3748-0381	National Natural Science Foundation of China [81771092]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions [2014-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program for the Development of Jiangsu Higher Education Institutions	The authors are grateful to Wen Sun (Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University) for support with the cell culture. The authors also thank Jialin Lin and Zhenxing Zhang (both from Jiangsu Key Laboratory of Oral Diseases) for assistance with some of the mice procedures. This work was supported by National Natural Science Foundation of China Grant 81771092, and a project funded by the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (2014-37). The authors declare no conflicts of interest.	Adapala NS, 2016, AM J PATHOL, V186, P2987, DOI 10.1016/j.ajpath.2016.06.024; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Chen T, 2016, BRAIN BEHAV IMMUN, V56, P42, DOI 10.1016/j.bbi.2016.04.004; Chiu YG, 2017, EXPERT OPIN BIOL TH, V17, P119, DOI 10.1080/14712598.2017.1263614; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Davies LC, 2015, IMMUNOLOGY, V144, P541, DOI 10.1111/imm.12451; Dou C, 2018, J BONE MINER RES, V33, P899, DOI 10.1002/jbmr.3364; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Fowler DW, 2017, CANCER IMMUNOL IMMUN, V66, P1205, DOI 10.1007/s00262-017-2011-1; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; Gross C, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1230-8; Hao SS, 2017, BIOMATERIALS, V140, P16, DOI 10.1016/j.biomaterials.2017.06.013; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keskinruzgar A, 2016, J ORAL MAXIL SURG, V74, P68, DOI 10.1016/j.joms.2015.07.005; Kim S, 2017, J BONE MINER RES, V32, P309, DOI 10.1002/jbmr.2985; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee KC, 2015, J HEPATOL, V63, P1405, DOI 10.1016/j.jhep.2015.07.035; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nagaoka Y, 2015, J DENT RES, V94, P594, DOI 10.1177/0022034514564187; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Pazianas M, 2011, JNCI-J NATL CANCER I, V103, P232, DOI 10.1093/jnci/djq516; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Ristow O, 2014, J CANCER RES CLIN, V140, P487, DOI 10.1007/s00432-014-1588-4; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sun ST, 2016, BIOCONJUGATE CHEM, V27, P329, DOI 10.1021/acs.bioconjchem.5b00369; Sun W, 2017, J BONE MINER RES, V32, P1469, DOI 10.1002/jbmr.3117; Wang D, 2018, CLIN SCI, V132, P943, DOI 10.1042/CS20180083; Wang YK, 2018, J BONE MINER RES, V33, P732, DOI 10.1002/jbmr.3352; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Xu RY, 2018, AGING CELL, V17, DOI 10.1111/acel.12794; Xu RY, 2016, EXP GERONTOL, V84, P71, DOI 10.1016/j.exger.2016.09.001; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yamaguchi T, 2016, INFECT IMMUN, V84, P2802, DOI 10.1128/IAI.00461-16; Yuan HM, 2017, ACTA BIOCH BIOPH SIN, V49, P935, DOI 10.1093/abbs/gmx092; Zhang QZ, 2015, J BONE MINER RES, V30, P2300, DOI 10.1002/jbmr.2577; Zhang QZ, 2013, CLIN CANCER RES, V19, P3176, DOI 10.1158/1078-0432.CCR-13-0042; Zhang Y, 2018, BIOCHEM PHARMACOL, V147, P104, DOI 10.1016/j.bcp.2017.11.012; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	49	50	57	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5208	5219		10.1096/fj.201801791RR	http://dx.doi.org/10.1096/fj.201801791RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624969	Bronze			2022-12-26	WOS:000462888500047
J	Wu, TC; Chang, CC; Leu, HB; Huang, PH; Lin, SJ; Chen, JW				Wu, Tao-Cheng; Chang, Chia-Chi; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen			Phorbol ester-induced angiogenesis of endothelial progenitor cells: The role of NADPH oxidase-mediated, redox-related matrix metalloproteinase pathways	PLOS ONE			English	Article							PROTEIN-KINASE-C; ISCHEMIA-INDUCED NEOVASCULARIZATION; PKC-ALPHA; INHIBITION; MATRIX-METALLOPROTEINASE-9; MECHANISMS; MONOCYTES; TARGET; MMP-9	Endothelial progenitor cells (EPCs) may contribute to ischemia-induced angiogenesis in atherosclerotic diseases. The protein kinase C (PKC) family is involved in the regulation of angiogenesis, however the role of PKC alpha in EPCs during angiogenesis is unclear. The aim of this study was to evaluate the role of PKC alpha in EPCs during angiogenesis. Phorbol-12-myristate-13-acetate (PMA), a PKC alpha activator, significantly increased the activity and expression of matrix metalloproteinases (MMP) -2 and -9 in human (late outgrowth) EPCs in vitro. The MMPs promoted the migratory function and vascular formation of EPCs, which then contributed to neovascularization in a mouse hindlimb-ischemia model. Reactive oxygen species derived from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enhanced the expression of MMPs to increase the bioactivity of EPCs during angiogenesis. The mitogen-activated protein kinase (MAPK) signal pathway was associated with the activation of NADPH oxidase. PMA extensively activated the extracellular signal-regulated kinase (Erk) signal pathway to increase the expression of MMP-9. PMA also activated the p38, Erk, and c-Jun N-terminal kinase signal pathways to increase the expression of MMP-2. PMA-stimulated EPCs enhanced neovascularization in a mouse model of hindlimb ischemia via nuclear factor-kappa B translocation to up-regulation of the expression of MMP-2 and MMP-9. PMA could activate PKCa and promote the angiogenesis capacity of human EPCs via NADPH oxidase-mediated, redox-related, MMP-2 and MMP-9 pathways. The PKC alpha activated, NADPH oxidase-mediated, redox-related MMP pathways could contribute to the function of human EPCs for ischemia-induced neovascularization, which may provide novel insights into the potential modification of EPCs for therapeutic angiogenesis.	[Wu, Tao-Cheng; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Wu, Tao-Cheng; Chang, Chia-Chi; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Chang, Chia-Chi; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chen, JW (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.; Chen, JW (corresponding author), Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.; Chen, JW (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan.; Chen, JW (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.	jwchen@vghtpe.gov.tw			Taipei Veterans General Hospital [V102E1-006, V103E1-005]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by the funding from Taipei Veterans General Hospital (V102E1-006 and V103E1-005 to JW Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Corti F, 2013, J BIOL CHEM, V288, P12712, DOI 10.1074/jbc.M113.452383; de la Rosa CM, 2013, J PHARMACOL EXP THER, V345, P15, DOI 10.1124/jpet.112.200881; Diebold I, 2012, J CELL SCI, V125, P956, DOI 10.1242/jcs.094060; Dopheide JF, 2016, ANGIOGENESIS, V19, P67, DOI 10.1007/s10456-015-9489-y; Haidari M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-105; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; MONTESANO R, 1987, J CELL PHYSIOL, V130, P284, DOI 10.1002/jcp.1041300215; Moriya J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0180-9; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Scoditti E, 2014, ATHEROSCLEROSIS, V232, P17, DOI 10.1016/j.atherosclerosis.2013.10.017; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shahin R, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0010; Shin Y, 2007, EXP MOL MED, V39, P97, DOI 10.1038/emm.2007.11; Singh RM, 2017, HEART FAIL REV, V22, P843, DOI 10.1007/s10741-017-9634-3; Singh Rishi Kant, 2017, BioMolecular Concepts, V8, P143, DOI 10.1515/bmc-2017-0005; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wu TC, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0243-y; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107; Zhi KK, 2016, ANGIOGENESIS, V19, P311, DOI 10.1007/s10456-016-9504-y	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209426	10.1371/journal.pone.0209426	http://dx.doi.org/10.1371/journal.pone.0209426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645596	Green Submitted, gold, Green Published			2022-12-26	WOS:000455810200009
J	Motta, D; Santos, AAB; Winkler, I; Machado, BAS; Pereira, DADI; Cavalcanti, AM; Fonseca, EOL; Kirchner, F; Badaro, R				Motta, Daniel; Bandeira Santos, Alex Alisson; Winkler, Ingrid; Souza Machado, Bruna Aparecida; Dias Imperial Pereira, Daniel Andre; Cavalcanti, Alexandre Morais; Lins Fonseca, Eduardo Oyama; Kirchner, Frank; Badaro, Roberto			Application of convolutional neural networks for classification of adult mosquitoes in the field	PLOS ONE			English	Article							AEDES-AEGYPTI; SPATIAL-DISTRIBUTION; CHIKUNGUNYA VIRUS; ZIKA; DIPTERA; SYSTEM	Dengue, chikungunya and Zika are arboviruses transmitted by mosquitos of the genus Aedes and have caused several outbreaks in world over the past ten years. Morphological identification of mosquitos is currently restricted due to the small number of adequately trained professionals. We implemented a computational model based on a convolutional neural network (CNN) to extract features from mosquito images to identify adult mosquitoes from the species Aedes aegypti, Aedes albopictus and Culex quinquefasciatus. To train the CNN to perform automatic morphological classification of mosquitoes, we used a dataset that included 4,056 mosquito images. Three neural networks, including LeNet, AlexNet and GoogleNet, were used. During the validation phase, the accuracy of the mosquito classification was 57.5% using LeNet, 74.7% using AlexNet and 83.9% using GoogleNet. During the testing phase, the best result (76.2%) was obtained using GoogleNet; results of 52.4% and 51.2% were obtained using LeNet and AlexNet, respectively. Significantly, accuracies of 100% and 90% were achieved for the classification of Aedes and Culex, respectively. A classification accuracy of 82% was achieved for Aedes females. Our results provide information that is fundamental for the automatic morphological classification of adult mosquito species in field. The use of CNN's is an important method for autonomous identification and is a valuable and accessible resource for health workers and taxonomists for the identification of some insects that can transmit infectious agents to humans.	[Motta, Daniel; Bandeira Santos, Alex Alisson; Winkler, Ingrid; Souza Machado, Bruna Aparecida; Dias Imperial Pereira, Daniel Andre; Cavalcanti, Alexandre Morais; Badaro, Roberto] Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil; [Souza Machado, Bruna Aparecida; Lins Fonseca, Eduardo Oyama; Badaro, Roberto] Hlth Inst Technol CIMATEC ITS, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil; [Kirchner, Frank] DFKI, Res Ctr Artificial Intelligence, Bremen, Germany	German Research Center for Artificial Intelligence (DFKI)	Machado, BAS (corresponding author), Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.; Machado, BAS (corresponding author), Hlth Inst Technol CIMATEC ITS, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.	brunam@fieb.org.br	Winkler, Ingrid/AAU-9884-2020; Santos, Alex A.B./J-4829-2012; Machado, Bruna Aparecida Souza/C-3130-2016; Motta, Daniel/AAW-1869-2021; Machado, Bruna/AAP-6877-2021; Kirchner, Frank/P-6503-2016	Winkler, Ingrid/0000-0001-6505-6636; Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Kirchner, Frank/0000-0002-1713-9784				Arthur BJ, 2014, J ACOUST SOC AM, V135, P933, DOI 10.1121/1.4861233; Batista G. E. A. P. A., 2011, Proceedings of the 2011 Tenth International Conference on Machine Learning and Applications (ICMLA 2011), P364, DOI 10.1109/ICMLA.2011.145; Bova J, 2016, J AM MOSQUITO CONTR, V32, P244, DOI 10.2987/15-6535.1; Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; CDC C for DC and P, 2016, SURV CONTR AED AEG A, P1, DOI [10.1371/journal.pntd.0004043, DOI 10.1371/JOURNAL.PNTD.0004043]; Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029; de Souza VMA, 2013, 2013 BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS), P76, DOI 10.1109/BRACIS.2013.21; del Carpio-Orantes L, 2018, J ASIA-PAC BIODIVERS, V11, P317, DOI 10.1016/j.japb.2018.01.002; Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020; Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933; Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59; Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Karthika P, 2018, ACTA TROP, V183, P84, DOI 10.1016/j.actatropica.2018.04.006; Kesavaraju B, 2012, J AM MOSQUITO CONTR, V28, P330, DOI 10.2987/12-6254R.1; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026; Lorenz C, 2015, ACTA TROP, V152, P165, DOI 10.1016/j.actatropica.2015.09.011; Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524; Mewara A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2854-0; Mundada R., 2013, IOSR J ELECT COMMUN, V5, P57, DOI DOI 10.9790/2834-565763; Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/S1473-3099(18)30269-X, 10.1016/s1473-3099(18)30269-x]; Ouyang TH, 2015, COMPUT ELECTRON AGR, V118, P47, DOI 10.1016/j.compag.2015.08.021; Pan American Health Organization, 2017, TOOL DIAGN CAR PAT S; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Sanchez AH, 2017, P REL MAINT S; Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015; Schaper S, 2006, REV BIOL TROP, V54, P847; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schneider J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162493; Shin JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161015; Sifferlin Alexandra, 2018, TIME; Silva DF, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P99, DOI 10.1109/ICMLA.2013.24; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448; van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020; Wang JN, 2012, KNOWL-BASED SYST, V33, P102, DOI 10.1016/j.knosys.2012.03.014; WHO, 2017, GLOBAL VECTOR CONTRO, V2030, P47; Yang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13122; Yao Q, 2012, J INTEGR AGR, V11, P978, DOI 10.1016/S2095-3119(12)60089-6; Zhong YH, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051489	48	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210829	10.1371/journal.pone.0210829	http://dx.doi.org/10.1371/journal.pone.0210829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640961	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000050
J	Heller, AA; Spence, DM				Heller, Andrew A.; Spence, Dana M.			A rapid method for post-antibiotic bacterial susceptibility testing	PLOS ONE			English	Article							DEVELOPMENT SUCCESS RATES; ANTIBIOTIC SUSCEPTIBILITY; DISC DIFFUSION; ATP; DECLINE	Antibiotic susceptibility testing is often performed to determine the most effective antibiotic treatment for a bacterial infection, or perhaps to determine if a particular strain of bacteria is becoming drug resistant. Such tests, and others used to determine efficacy of candidate antibiotics during the drug discovery process, have resulted in a demand for more rapid susceptibility testing methods. Here, we have developed a susceptibility test that utilizes chemiluminescent determination of ATP release from bacteria and the overall optical density (OD600) of the bacterial solution. Bacteria release ATP during a growth phase or when they are lysed in the presence of an effective antibiotic. Because optical density increases during growth phase, but does not change during bacterial lysing, an increase in the ATP: optical density ratio after the bacteria have reached the log phase of growth (which is steady) would indicate antibiotic efficacy. Specifically, after allowing a kanamycin-resistant strain of Escherichia coli (E. coli) to pass through the growth phase and reach steady state, the addition of levofloxacin, an antibiotic to which E. coli is susceptible, resulted in a significant increase in the ATP: OD600 ratio in comparison to the use of kanamycin alone (1.80 +/- 0.50 vs. 1.12 +/- 0.28). This difference could be measured 20 minutes after the addition of the antibiotic, to which the bacteria are susceptible, to the bacterial sample. Furthermore, this method also proved useful with gram positive bacteria, as the addition of kanamycin to a chloramphenicol-resistant strain of Bacillus subtilis (B. subtilis) resulted in an ATP: OD600 ratio of 2.14 +/- 0.26 in comparison to 0.62 +/- 0.05 for bacteria not subjected to the antibiotic to which the bacteria are susceptible. Collectively, these results suggest that measurement of the ATP: OD600 ratio may provide a susceptibility test for antibiotic efficacy that is more rapid and quantitative than currently accepted techniques.	[Heller, Andrew A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Heller, Andrew A.; Spence, Dana M.] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA; [Spence, Dana M.] Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Spence, DM (corresponding author), Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA.; Spence, DM (corresponding author), Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA.	spenceda@msu.edu			National Institutes of Health [GM110406]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (GM110406 to DMS); www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti MO, 2016, J CLIN MICROBIOL, V54, P2194, DOI 10.1128/JCM.00822-16; Amodio E, 2014, J INFECT PUBLIC HEAL, V7, P92, DOI 10.1016/j.jiph.2013.09.005; Badiee P, 2011, IRAN J MICROBIOL, V3, P183; Berndt ER, 2015, HEALTH AFFAIR, V34, P245, DOI 10.1377/hlthaff.2014.1029; BLAIR JM, 2014, NAT REV MICROBIOL, V13, P42, DOI DOI 10.1038/NRMICR03380; Bottari B, 2015, TRENDS FOOD SCI TECH, V44, P36, DOI 10.1016/j.tifs.2015.02.012; Botts RT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01922; Buzon-Duran L, 2018, FOOD MICROBIOL, V72, P220, DOI 10.1016/j.fm.2017.11.018; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Ghafur A, 2014, J MICROBIOLOGY INFEC, V4; Gupta P, 2015, J CLIN DIAGN RES, V9, pDC4, DOI 10.7860/JCDR/2015/10467.5395; Halder S, 2017, P NATL ACAD SCI USA, V114, pE10677, DOI 10.1073/pnas.1711467114; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Hombach M, 2017, J ANTIMICROB CHEMOTH, V72, P1659, DOI 10.1093/jac/dkx026; House W., 2015, NAT ACT PLAN COMB AN; Ivancic V, 2008, J CLIN MICROBIOL, V46, P1213, DOI 10.1128/JCM.02036-07; Ivanova EP, 2006, INT MICROBIOL, V9, P37; Iwase T, 2010, J CLIN MICROBIOL, V48, P1949, DOI 10.1128/JCM.01941-09; Jooma S, 2015, J LAW BIOSCI, V2, P129, DOI 10.1093/jlb/lsv005; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Juhas M, 2015, CRIT REV MICROBIOL, V41, P101, DOI 10.3109/1040841X.2013.804031; Jutkina J, 2016, SCI TOTAL ENVIRON, V548, P131, DOI 10.1016/j.scitotenv.2016.01.044; Leong C, 2017, J CLIN MICROBIOL, V55, P1883, DOI 10.1128/JCM.00338-17; Luo JP, 2009, ANAL BIOCHEM, V394, P1, DOI 10.1016/j.ab.2009.05.021; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Meir-Gruber L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164873; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Miller JH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00263; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Obama B., 2014, EXECUTIVE ORDER COMB; Ogata SK, 2014, BRAZ J MICROBIOL, V45, P1439, DOI 10.1590/S1517-83822014000400039; Pruller S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123883; Ranque S, 2012, J CLIN MICROBIOL; Ratnayake PU, 2016, PROTEIN EXPRES PURIF, V117, P6, DOI 10.1016/j.pep.2015.08.021; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Van Duijkeren E, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0019-2017; Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Zowawi HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15082	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210534	10.1371/journal.pone.0210534	http://dx.doi.org/10.1371/journal.pone.0210534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629681	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000104
J	Kurm, V; van der Putten, WH; Hol, WHG				Kurm, Viola; van der Putten, Wim H.; Hol, W. H. Gera			Cultivation-success of rare soil bacteria is not influenced by incubation time and growth medium	PLOS ONE			English	Article							PURE CULTURE; ACTINOBACTERIA; MICROORGANISMS; CULTURABILITY; COMMUNITIES; BIOSPHERE; ABUNDANT; SIZE	Rare bacterial species have recently attracted interest due to their many potential beneficial functions. However, only little is known about their cultivability. In this study we test the hypotheses that the use of flow cell-sorting for cultivation results in a high proportion of rare soil bacterial isolates relative to bacterial taxa that are abundant in soil. Moreover, we investigate whether different oligotrophic cultivation media and a prolonged incubation time increase the number of cultivated rare species. In a cultivation study we used flow cell sorting to select for small cells and to separate single cells, and grew bacteria on different oligotrophic media with prolonged incubation times. The abundance of the isolates in the field was assessed by comparing them to a 454-sequencing dataset from the same soil. Consequentially, all bacterial isolates were classified as either rare (<0.01% relative abundance) or abundant (>0.01% relative abundance) in the field soil. We found more bacterial taxa among the isolates that were abundant in soil than would be expected by the proportion of abundant species in the field. Neither incubation time nor growth medium had an influence on the recovery of rare species. However, we did find differences in time until visible growth on the plate between different phylogenetic classes of the isolates. These results indicate that rare cultivable species are active and not more likely to be dormant than abundant species, as has been suggested as a reason for their rarity. Moreover, future studies should be aware of the influence incubation time might have on the phylogenetic composition of the isolate collection.	[Kurm, Viola; van der Putten, Wim H.; Hol, W. H. Gera] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands; [Kurm, Viola] Wageningen Plant Res Biointeract & Plant Hlth, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Kurm, V (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.; Kurm, V (corresponding author), Wageningen Plant Res Biointeract & Plant Hlth, Wageningen, Netherlands.	viola.kurm@wur.nl	van der Putten, Wim H/C-3707-2011; KNAW, NIOO-KNAW/A-4320-2012; Kurm, Viola/F-2329-2016	van der Putten, Wim H/0000-0002-9341-4442; KNAW, NIOO-KNAW/0000-0002-3835-159X; Kurm, Viola/0000-0003-1261-9778				Aanderud ZT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00024; Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; [Anonymous], 2016, LOW ABUNDANT SOIL BA; Archer E., 2016, RFPERMUTE ESTIMATE P; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Berns AE, 2008, EUR J SOIL SCI, V59, P540, DOI 10.1111/j.1365-2389.2008.01016.x; BONNER WA, 1972, REV SCI INSTRUM, V43, P404, DOI 10.1063/1.1685647; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Dell'Anno A, 2012, ENVIRON POLLUT, V167, P85, DOI 10.1016/j.envpol.2012.03.043; Flather Curtis H., 2007, P40; Foladori P, 2007, WATER RES, V41, P235, DOI 10.1016/j.watres.2006.08.021; Fox J., 2019, R COMPANION APPL REG, V.; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Geisen S, 2014, EUR J PROTISTOL, V50, P153, DOI 10.1016/j.ejop.2014.01.007; Green P, 2002, COMPUTER PROGRAM DOC; Hamaki T, 2005, J BIOSCI BIOENG, V99, P485, DOI 10.1263/jbb.99.485; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kato S, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00807-18; Kurm V, 2017, ECOLOGY, V98, P555, DOI 10.1002/ecy.1670; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; McCaig AE, 2001, FEMS MICROBIOL ECOL, V35, P37, DOI 10.1111/j.1574-6941.2001.tb00786.x; Mitsui H, 1997, J MICROBIOL METH, V30, P103, DOI 10.1016/S0167-7012(97)00052-3; Morrissey EM, 2016, ISME J, V10, P2336, DOI 10.1038/ismej.2016.28; Portillo MC, 2013, APPL ENVIRON MICROB, V79, P7610, DOI 10.1128/AEM.02710-13; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Senechkin IV, 2010, MICROB ECOL, V60, P829, DOI 10.1007/s00248-010-9670-1; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7; SRINIVASAN MC, 1991, WORLD J MICROB BIOT, V7, P171, DOI 10.1007/BF00328987; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Tanaka T, 2014, APPL ENVIRON MICROB, V80, P7659, DOI 10.1128/AEM.02741-14; Vage S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101415; van de Voorde TFJ, 2012, OIKOS, V121, P1251, DOI 10.1111/j.1600-0706.2011.19964.x; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; VanInsberghe D, 2013, APPL ENVIRON MICROB, V79, P2096, DOI 10.1128/AEM.03112-12; WHANG K, 1988, A VAN LEEUW J MICROB, V54, P19, DOI 10.1007/BF00393955; Wilhelm L, 2014, ENV MICROBIOL	46	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210073	10.1371/journal.pone.0210073	http://dx.doi.org/10.1371/journal.pone.0210073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629606	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000046
J	Schopfer, LM; Lockridge, O; David, E; Hinrichs, SH				Schopfer, Lawrence M.; Lockridge, Oksana; David, Emilie; Hinrichs, Steven H.			Purification of human butyrylcholinesterase from frozen Cohn fraction IV-4 by ion exchange and Hupresin affinity chromatography	PLOS ONE			English	Article							LARGE-SCALE PURIFICATION; HUMAN-PLASMA; CHOLINESTERASE ACTIVITY; RICH PEPTIDES; SERUM; BIOSCAVENGER; PROTECTION; COMPONENTS; TOXICITY; PROTEINS	Human butyrylcholinesterase (HuBChE) is being developed as a therapeutic for protection from the toxicity of nerve agents. An enriched source of HuBChE is Cohn fraction IV-4 from pooled human plasma. For the past 40 years, purification of HuBChE has included affinity chromatography on procainamide-Sepharose. The present report supports a new affinity sorbent, Hupresin, for purification of HuBChE from Cohn fraction IV-4. Nine batches of 70-80 kg frozen Cohn fraction were extracted with water, filtered, and chromatographed on 30 L of Q-Ceramic ion exchange sorbent at pH 4.5. The 4% pure Q-eluent was pumped onto 4.2 L Hupresin, where contaminants were washed off with 0.3 M NaCl in 20 mM sodium phosphate pH 8.0, before 99% pure HuBChE was eluted with 0.1 M tetramethylammonium bromide. The average yield was 1.5 g of HuBChE from 80 kg Cohn paste. Recovery of HuBChE was reduced by 90% when the paste was stored at -20 degrees C for 1 year, and reduced 100% when stored at 4 degrees C for 24h. No reduction in HuBChE recovery occurred when paste was stored at -80 degrees C for 3 months or 3 years. Hupresin and procainamide-Sepharose were equally effective at purifying HuBChE from Cohn fraction. HuBChE in Cohn fraction required 1000-fold purification to attain 99% purity, but 15,000-fold purification when the starting material was plasma. HuBChE (P06276) purified from Cohn fraction was a 340 kDa tetramer of 4 identical N-glycated subunits, stable for years in solution or as a lyophilized product.	[Schopfer, Lawrence M.; Lockridge, Oksana] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [David, Emilie] CHEMFORASE, Mont St Aignan, France; [Hinrichs, Steven H.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Lockridge, O (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA.	olockrid@unmc.edu		Lockridge, Oksana/0000-0002-8345-3640	United States Defense Threat Reduction Agency [HDTRA1-14-1-0056]; Fred & Pamela Buffett Cancer Center Support Grant from NIH [P30CA036727]; Normandie Universite; Universite de Rouen Normandie; French Ministry of Higher Education and Research; Bpifrance; Normandie Incubation; Reseau Entreprendre Normandie Seine; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER	United States Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Fred & Pamela Buffett Cancer Center Support Grant from NIH; Normandie Universite; Universite de Rouen Normandie; French Ministry of Higher Education and Research; Bpifrance; Normandie Incubation; Reseau Entreprendre Normandie Seine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by contract HDTRA1-14-1-0056 (to SH) from the United States Defense Threat Reduction Agency and by the Fred & Pamela Buffett Cancer Center Support Grant P30CA036727 from NIH. CHEMFORASE thanks Normandie Universite, Universite de Rouen Normandie, The French Ministry of Higher Education and Research, Bpifrance, Normandie Incubation and Reseau Entreprendre Normandie Seine for financial support as well as the members of its scientific board for their valuable advice. Emilie David, President of the CHEMFORASE Company, synthesized Hupresin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the U.S. Defense Threat Reduction Agency or the U.S. Department of Health and Human Services. Use of trade names is for identification only and does not imply endorsement by U.S. or French government agencies.	BARTELS CF, 1992, AM J HUM GENET, V50, P1086; BARTELS CF, 1992, AM J HUM GENET, V50, P1104; Bonichon M, 2018, ANAL BIOANAL CHEM, V410, P1039, DOI 10.1007/s00216-017-0640-z; Boyko KM, 2019, BIOCHIMIE, V156, P196, DOI 10.1016/j.biochi.2018.10.017; Brawner A, 2016, CHEM-BIOL INTERACT, V249, P19, DOI 10.1016/j.cbi.2016.02.015; Brazzolotto X, 2012, FEBS J, V279, P2905, DOI 10.1111/j.1742-4658.2012.08672.x; BROOMFIELD CA, 1991, J PHARMACOL EXP THER, V259, P633; COHEN JA, 1954, J CLIN INVEST, V33, P459, DOI 10.1172/JCI102917; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; DAS P K, 1970, Biochemical Journal, V116, P875; Garfin DE, 2003, ESSENTIAL CELL BIOL, V1, P197; Grunwald J, 1997, J BIOCHEM BIOPH METH, V34, P123, DOI 10.1016/S0165-022X(97)01208-6; HARRIS H, 1962, NATURE, V196, P1296, DOI 10.1038/1961296a0; Kolarich D, 2008, PROTEOMICS, V8, P254, DOI 10.1002/pmic.200700720; LAMOTTA RV, 1971, CLIN CHEM, V17, P135; Leung MR, 2018, P NATL ACAD SCI US; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P12945; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOCKRIDGE O, 1978, J BIOL CHEM, V253, P361; Lockridge O, 2005, J MED CBR DEF, V3; Lockridge O, 2018, J CHROMATOGR B, V1102, P109, DOI 10.1016/j.jchromb.2018.10.026; Lynch TJ, 1997, TOXICOL APPL PHARM, V145, P363, DOI 10.1006/taap.1997.8187; MASSON P, 1989, BIOCHIM BIOPHYS ACTA, V998, P258, DOI 10.1016/0167-4838(89)90282-3; MUNKNER T, 1961, ACTA PHARMACOL TOX, V18, P170; Nachon F, 2002, EUR J BIOCHEM, V269, P630, DOI 10.1046/j.0014-2956.2001.02692.x; NEITLICH HW, 1966, J CLIN INVEST, V45, P380, DOI 10.1172/JCI105353; Onder S, 2018, CHEM RES TOXICOL, V31, P520, DOI 10.1021/acs.chemrestox.8b00083; Onder S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00713; OSTERGAARD D, 1988, ACTA ANAESTH SCAND, V32, P266, DOI 10.1111/j.1399-6576.1988.tb02727.x; Peng H, 2016, CHEM-BIOL INTERACT, V259, P63, DOI 10.1016/j.cbi.2016.02.007; Peters T., 1996, ALL ALBUMIN BIOCH GE; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P2465, DOI 10.1016/0006-2952(93)90228-O; Ronco C, 2011, CHEMMEDCHEM, V6, P876, DOI 10.1002/cmdc.201000523; RUBINSTEIN HM, 1978, J MED GENET, V15, P27, DOI 10.1136/jmg.15.1.27; Saxena A, 2008, PROTEIN EXPRES PURIF, V61, P191, DOI 10.1016/j.pep.2008.05.021; Saxena A, 2006, J MOL NEUROSCI, V30, P145, DOI 10.1385/JMN:30:1:145; Saxena A, 2010, PROCESS BIOCHEM, V45, P1313, DOI 10.1016/j.procbio.2010.04.021; Sun W, 2009, LIFE SCI, V85, P657, DOI 10.1016/j.lfs.2009.09.005; SURGENOR DM, 1954, J AM CHEM SOC, V76, P6049, DOI 10.1021/ja01652a055; SVENSMARK O, 1963, BIOCHIM BIOPHYS ACTA, V67, P441; Weber A, 2011, VOX SANG, V100, P285, DOI 10.1111/j.1423-0410.2010.01415.x	43	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209795	10.1371/journal.pone.0209795	http://dx.doi.org/10.1371/journal.pone.0209795			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625168	gold, Green Submitted, Green Published			2022-12-26	WOS:000455359400056
J	Gebremariam, AD; Tiruneh, SA; Abate, BA; Engidaw, MT; Asnakew, DT				Gebremariam, Alemayehu Digssie; Tiruneh, Sofonyas Abebaw; Abate, Bedilu Abebe; Engidaw, Melaku Tadege; Asnakew, Desalegn Tesfa			Adherence to iron with folic acid supplementation and its associated factors among pregnant women attending antenatal care follow up at Debre Tabor General Hospital, Ethiopia, 2017	PLOS ONE			English	Article							ANEMIA	Introduction Nutritional anemia is a major public health problem throughout the world, particularly in developing countries. Iron with folic acid supplementation (IFAS) is recommended to mitigate anemia and its resulting complications during pregnancy. There has been limited study on IFAS adherence of pregnant women in the study area. The aim of this study was to assess adherence to IFAS and its associated factors among pregnant women attending antenatal care service in Debre Tabor General Hospital, Ethiopia. Methods An institution-based cross-sectional study was conducted from January 9 to April 8, 2017, at Debre Tabor General Hospital. A total of 262 study participants were included and selected by systematic random sampling. The entire interviewed questionnaire was checked and entered into EpiData version 3.1 and then exported to SPSS version 20 for windows for analysis. IFAS adherence status was defined as, if pregnant mothers took 65% or more of the IFAS which is equivalent to taking IFAS at least 4 days a week during the 1-month period preceding the study. Regressions were fitted to identify independent predictors of IFAS adherence. A P-value of less than 0.05 was used to declare statistical significance. Results A total of 241 pregnant women were included (92% response rate), of which 107 (44%) were adherent to IFAS. Only 39% received IFAS counseling, and 52% had some knowledge of IFAS. Gravidity (AOR = 2.92 95% CI (1.61, 5.30)), gestational age at first ANC visit (AOR = 3.67, 95% CI (1.94, 6.97)), pregnant women who got advice about IFAS (AOR = 2.04, 95% CI (1.12, 3.75)), current anemia (AOR = 2.22, 95% CI (1.45, 4.29)), and had knowledge about IFAS (AOR = 3.27, 95% CI (1.80, 5.95)) were statistically associated with adherence to IFAS among pregnant women. Conclusion Overall, IFAS adherence among pregnant women was low. The associated factors with adherence of IFAS were counseling and knowledge, early ANC attendance, pregnancy history, and current anemia diagnosis. IFAS counseling by health workers was low but, when given, was associated with improved IFAS adherence. Health workers and health extension workers should consistently counsel on IFAS benefits during ANC visit, to improve IFAS adherence during the current and subsequent pregnancies.	[Gebremariam, Alemayehu Digssie; Tiruneh, Sofonyas Abebaw; Abate, Bedilu Abebe; Engidaw, Melaku Tadege; Asnakew, Desalegn Tesfa] Debre Tabor Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Tabor, Ethiopia		Gebremariam, AD (corresponding author), Debre Tabor Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Tabor, Ethiopia.	metsagu@yahoo.com	Engidaw, Melaku Tadege/S-4873-2019	Engidaw, Melaku Tadege/0000-0002-1970-5102; Digssie, Alemayehu/0000-0002-9449-6689				Abebaw B., 2016, THESIS; [Anonymous], 2013, NATL NUTR PROGRAMME; Birhanu Tesfaye Molla, 2018, BMC Res Notes, V11, P345, DOI 10.1186/s13104-018-3433-3; Central Statistical Agency, 2016, DHS PROGR; Gebre A., 2015, INT J NUTR FOOD SCI, V4, P161, DOI [10.11648/j.ijnfs.20150402.16, DOI 10.11648/J.IJNFS.20150402.16]; Gebreamlak B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169415; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Haile MT, 2017, COMPLIANCE PRENATAL, P7; HERCBERG S, 1992, BAILLIERE CLIN HAEM, V5, P143, DOI 10.1016/S0950-3536(11)80039-9; Jufar AH, 2014, J HEMATOL THROMB DIS, V2, P125, DOI [10.4172/2329-8790.1000125, DOI 10.4172/2329-8790.1000125]; Kamau MW, 2018, BMC PUBLIC HEALTH, V18, P1, DOI DOI 10.1186/S12889-018-5437-2; Kassa Getachew Mullu, 2017, BMC Hematol, V17, P17, DOI 10.1186/s12878-017-0090-z; Kiwanuka Tusuubira S, 2017, BMC Res Notes, V10, P510, DOI 10.1186/s13104-017-2834-z; Lacerte P, 2011, ASIA-PAC J PUBLIC HE, V23, P315, DOI 10.1177/1010539511403133; Lone F W, 2004, East Mediterr Health J, V10, P801; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mekonnen Ataguade A Z, 2017, WORLD J PHARM LIFE S, V3, P68; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; Mesfin EA, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.136.7187; Mithra P, 2013, Afr Health Sci, V13, P880, DOI 10.4314/ahs.v13i4.3; Murugan R., 2018, INT J THERAPEUT APPL, V35, P60; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Pena-Rosas JP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub5; Project S, 2014, SPRING NUTR TECH BR; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Sadore AA, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/781973; Salhan S, 2012, ANEMIA, V2012, DOI 10.1155/2012/608658; Shewasinad S, 2017, J PREGNANCY CHILD HE, V2017, P335, DOI [10.4172/2376-127X.1000335, DOI 10.4172/2376-127X.1000335]; Titaley CR, 2010, AM J CLIN NUTR, V92, P235, DOI 10.3945/ajcn.2009.29093; WHO, 2012, WORLD HEAL ORGAN, P1; Zafar M, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-437, 10.1186/1471-2393-14-344]; Zakia M, 2011, MED J CAIRO U, V79, P115	33	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210086	10.1371/journal.pone.0210086	http://dx.doi.org/10.1371/journal.pone.0210086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615646	Green Submitted, gold, Green Published			2022-12-26	WOS:000455045900038
J	Mann, J; Githaka, JM; Buckland, TW; Yang, N; Montpetit, R; Patel, N; Li, L; Baksh, S; Godbout, R; Lemieux, H; Goping, IS				Mann, Jasdeep; Githaka, John Maringa; Buckland, Timothy W.; Yang, Ning; Montpetit, Rachel; Patel, Namrata; Li, Lei; Baksh, Shairaz; Godbout, Roseline; Lemieux, Helene; Goping, Ing Swie			Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism	ONCOGENE			English	Article							DEATH AGONIST BAD; PROAPOPTOTIC BAD; BH3 DOMAIN; PHOSPHORYLATION; SURVIVAL; PROTEIN; EXPRESSION; RESPIRATION; INACTIVATE; GLYCOLYSIS	The Bcl-2-associated death promoter BAD is a prognostic indicator for good clinical outcome of breast cancer patients; however, whether BAD affects breast cancer biology is unknown. Here we showed that BAD increased cell growth in breast cancer cells through two distinct mechanisms. Phosphorylation of BAD at S118 increased S99 phosphorylation, 14-3-3 binding and AKT activation to promote growth and survival. Through a second, more prominent pathway, BAD stimulated mitochondrial oxygen consumption in a novel manner that was downstream of substrate entry into the mitochondria. BAD stimulated complex I activity that facilitated enhanced cell growth and sensitized cells to apoptosis in response to complex I blockade. We propose that this dependence on oxidative metabolism generated large but nonaggressive cancers. This model identifies a non-canonical role for BAD and reconciles BAD-mediated tumor growth with favorable outcomes in BAD-high breast cancer patients.	[Mann, Jasdeep; Githaka, John Maringa; Buckland, Timothy W.; Yang, Ning; Montpetit, Rachel; Patel, Namrata; Baksh, Shairaz; Goping, Ing Swie] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Li, Lei; Baksh, Shairaz; Godbout, Roseline; Goping, Ing Swie] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada; [Baksh, Shairaz] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; [Lemieux, Helene] Univ Alberta, Dept Med, Edmonton, AB T6G 2H7, Canada; [Lemieux, Helene] Univ Alberta, Fac St Jean, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Goping, IS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.; Goping, IS (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada.	igoping@ualberta.ca	Baksh, Shairaz/GRX-2106-2022; Buckland, Timothy/AAV-9022-2021; Godbout, Roseline/I-4639-2016	Godbout, Roseline/0000-0002-4779-9265; lemieux, Helene/0000-0002-8864-6062	Women and Children's Health Research Institute; Canadian Breast Cancer Foundation; Alberta Cancer Foundation	Women and Children's Health Research Institute; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Alberta Cancer Foundation	We thank Dr. Bernard Lemire (University of Alberta), Dr. Thomas Simmen (University of Alberta), and Dr. Manijeh Pasdar (University of Alberta) for their generous gift of reagents. Additionally, we acknowledge all Goping lab members for the meaningful discussions and contributions to this work. This work was supported by operating grants from the Women and Children's Health Research Institute, Canadian Breast Cancer Foundation and Alberta Cancer Foundation to ISG.	Adachi M, 2002, CELL DEATH DIFFER, V9, P1240, DOI 10.1038/sj.cdd.4401097; Adams LD, 2004, CURR PROTOC MOL BIOL; Al-Bazz YO, 2009, EUR J CANCER, V45, P694, DOI 10.1016/j.ejca.2008.11.044; Cairns RA, 2011, COLD SH Q B, V76, P299, DOI 10.1101/sqb.2011.76.012856; Cannings E, 2007, BREAST CANCER RES TR, V102, P173, DOI 10.1007/s10549-006-9323-8; Chattopadhyay A, 2001, ONCOGENE, V20, P4507, DOI 10.1038/sj.onc.1204584; Craik AC, 2010, ONCOGENE, V29, P5381, DOI 10.1038/onc.2010.272; Czernick M, 2009, BIOCHEM BIOPH RES CO, V379, P145, DOI 10.1016/j.bbrc.2008.12.025; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; FALOONA GR, 1969, BIOCHEMISTRY-US, V8, P4497, DOI 10.1021/bi00839a041; Fouque A, 2016, CELL DEATH DIFFER, V23, P1702, DOI 10.1038/cdd.2016.61; Gimenez-Cassina A, 2014, CELL METAB, V19, P272, DOI 10.1016/j.cmet.2013.12.001; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; GOPING IS, 1995, FEBS LETT, V373, P45; Grun D, 2016, ONCOGENE, V35, P4379, DOI 10.1038/onc.2015.507; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Joshi S, 2015, CELL REP, V13, P1895, DOI 10.1016/j.celrep.2015.10.059; Lee KH, 2008, ONCOL RES, V17, P23, DOI 10.3727/096504008784046072; Lee KH, 2010, ONCOL RES, V19, P67, DOI 10.3727/096504010X12864748215043; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Marchion DC, 2011, CLIN CANCER RES, V17, P6356, DOI 10.1158/1078-0432.CCR-11-0735; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Maslyar DJ, 2001, ONCOGENE, V20, P5087, DOI 10.1038/sj.onc.1204662; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Osundiji MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028016; Pandya V, 2016, ONCOTARGET, V7, P33272, DOI 10.18632/oncotarget.8924; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sinicrope FA, 2008, CLIN CANCER RES, V14, P4128, DOI 10.1158/1078-0432.CCR-07-5160; Smith AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006224; Smith TAD, 2000, BRIT J BIOMED SCI, V57, P170; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang J, 2010, J THEOR BIOL, V266, P231, DOI 10.1016/j.jtbi.2010.06.009; YANG N, 2017, CELL DEATH DIS, V8; Yu YY, 2015, INT J CLIN EXP PATHO, V8, P13075; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200; 1999, J BIOL CHEM, V274, P3485; 2001, MOL PHARM, V60, P1325	56	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3325	3339		10.1038/s41388-018-0673-6	http://dx.doi.org/10.1038/s41388-018-0673-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30635657	Green Published, hybrid			2022-12-26	WOS:000466610000001
J	Gold, A; Eini, L; Nissim-Rafinia, M; Viner, R; Ezer, S; Erez, K; Aqaqe, N; Hanania, R; Milyavsky, M; Meshorer, E; Goldberg, M				Gold, Ayala; Eini, Lital; Nissim-Rafinia, Malka; Viner, Ruth; Ezer, Shlomit; Erez, Keren; Aqaqe, Nasma; Hanania, Rotem; Milyavsky, Michael; Meshorer, Eran; Goldberg, Michal			Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response	ONCOGENE			English	Article							TRICHOSTATIN-A; APOPTOSIS; THERAPY; INDUCTION; SURVIVAL; SCREEN; AGENTS	The cancer stem cell (CSC) model suggests that a subpopulation of cells within the tumor, the CSCs, is responsible for cancer relapse and metastasis formation. CSCs hold unique characteristics, such as self-renewal, differentiation abilities, and resistance to chemotherapy, raising the need for discovering drugs that target CSCs. Previously we have found that the antihypertensive drug spironolactone impairs DNA damage response in cancer cells. Here we show that spironolactone, apart from inhibiting cancerous cell growth, is also highly toxic to CSCs. Notably, we demonstrate that CSCs have high basal levels of DNA double-strand breaks (DSBs). Mechanistically, we reveal that spironolactone does not damage the DNA but impairs DSB repair and induces apoptosis in cancer cells and CSCs while sparing healthy cells. In vivo, spironolactone treatment reduced the size and CSC content of tumors. Overall, we suggest spironolactone as an anticancer reagent, toxic to both cancer cells and, particularly to, CSCs.	[Gold, Ayala; Eini, Lital; Nissim-Rafinia, Malka; Viner, Ruth; Ezer, Shlomit; Erez, Keren; Hanania, Rotem; Meshorer, Eran; Goldberg, Michal] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Nissim-Rafinia, Malka; Meshorer, Eran] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Aqaqe, Nasma; Milyavsky, Michael] Tel Aviv Univ, Sackler Fac Med, Dept Pathol, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine	Meshorer, E; Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel.; Meshorer, E (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel.	eran.meshorer@mail.huji.ac.il; goldbergm@mail.huji.ac.il		Meshorer, Eran/0000-0003-4777-986X; Goldberg, Michal/0000-0001-9397-2383	Israel Science Foundation [1353/12, 1140/17]; Israel Cancer Association [20171152]; DKFZ-MOST Collaboration [CA180]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; DKFZ-MOST Collaboration	This work was supported by grant 1353/12 from the Israel Science Foundation and grant 20171152 from the Israel Cancer Association, with the generous assistance of Nancy and Peter Brown through the ICA USA to MG, and by grant 1140/17 from the Israel Science Foundation and CA180 from the DKFZ-MOST Collaboration to EM.	Alekseev S, 2014, CHEM BIOL, V21, P398, DOI 10.1016/j.chembiol.2013.12.014; Bake M., 2008, NAT REP STEM CELLS, DOI [10.1038/stemcells.2008.153, DOI 10.1038/STEMCELLS.2008.153]; Bandhavkar S, 2016, CANCER MED-US, V5, P649, DOI 10.1002/cam4.629; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Biechonski S, 2017, CARCINOGENESIS, V38, P367, DOI 10.1093/carcin/bgx002; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chadwick JA, 2015, FASEB J, V29, P4544, DOI 10.1096/fj.15-276782; Chang CH, 2015, STEM CELL REP, V5, P378, DOI 10.1016/j.stemcr.2015.07.009; Chen YL, 2012, J CELL BIOCHEM, V113, P3643, DOI 10.1002/jcb.24228; Cheung-Ong K, 2013, CHEM BIOL, V20, P648, DOI 10.1016/j.chembiol.2013.04.007; Choi YH, 2005, INT J ONCOL, V27, P473; Chuang YW, 2017, J HYPERTENS, V35, P170, DOI 10.1097/HJH.0000000000001130; Clarke MF, 2005, BIOL BLOOD MARROW TR, V11, P14, DOI 10.1016/j.bbmt.2004.11.011; Dictus C, 2007, J NEUROSCI METH, V161, P250, DOI 10.1016/j.jneumeth.2006.11.012; Ferguson LR, 2015, SEMIN CANCER BIOL, V35, pS5, DOI 10.1016/j.semcancer.2015.03.005; Funder JW, 2013, INTEGR BLOOD PRESS C, V6, P129, DOI 10.2147/IBPC.S13783; GARDINER P, 1989, J CLIN PHARMACOL, V29, P342, DOI 10.1002/j.1552-4604.1989.tb03339.x; Gavande NS, 2016, PHARMACOL THERAPEUT, V160, P65, DOI 10.1016/j.pharmthera.2016.02.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Kotsantis P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13087; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Leung WH, 2013, J EXP MED, V210, P2675, DOI 10.1084/jem.20122292; Louka M, 2015, ADVANCES IN DNA REPAIR, P415, DOI 10.5772/61355; LUMB G, 1978, J ENVIRON PATHOL TOX, V1, P641; Ferreira JRO, 2013, TOXICOL IN VITRO, V27, P1458, DOI 10.1016/j.tiv.2013.03.010; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Peitzsch C, 2017, SEMIN CANCER BIOL, V44, P10, DOI 10.1016/j.semcancer.2017.02.011; Rajanna A, 2016, MED HYPOTHESES, V88, P83, DOI 10.1016/j.mehy.2015.11.009; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Shahar OD, 2014, NUCLEIC ACIDS RES, V42, P5689, DOI 10.1093/nar/gku217; Shaked Y, 2016, NAT REV CLIN ONCOL, V13, P611, DOI 10.1038/nrclinonc.2016.57; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Struthers A, 2008, CLIN CARDIOL, V31, P153, DOI 10.1002/clc.20324; Taghiyev AF, 2005, CANCER BIOL THER, V4, P382; Torres CM, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1644; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e	39	17	20	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3103	3118		10.1038/s41388-018-0654-9	http://dx.doi.org/10.1038/s41388-018-0654-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30622338				2022-12-26	WOS:000465557200001
J	Wang, QL; Liszt, KI; Deloose, E; Canovai, E; Thijs, T; Farre, R; Ceulemans, LJ; Lannoo, M; Tack, J; Depoortere, I				Wang, Qiaoling; Liszt, Kathrin I.; Deloose, Eveline; Canovai, Emilio; Thijs, Theo; Farre, Ricard; Ceulemans, Laurens J.; Lannoo, Matthias; Tack, Jan; Depoortere, Inge			Obesity alters adrenergic and chemosensory signaling pathways that regulate ghrelin secretion in the human gut	FASEB JOURNAL			English	Article						sympathetic nervous system; bitter taste receptor; glucose sensors; nutrient sensing	COUPLED RECEPTOR REPERTOIRE; BITTER TASTE RECEPTORS; GASTRIC GHRELIN; ACYLATED PEPTIDE; CELLS; SENSITIVITY; SWEET; WEIGHT; SOMATOSTATIN; SUPPRESSION	Chemosensory signaling in organs such as the mouth and gut contributes to the mechanisms that control metabolism. We investigated the chemosensory pathways that regulate secretion of the hunger hormone ghrelin in response to neurotransmitters, bitter and sweet tastants at the cellular level in the human gut mucosa, and the disturbances in this regulatory pathway induced by obesity. Obesity impaired ghrelin protein production and adrenalin-induced ghrelin secretion in fundic cells, which was counterbalanced by somatostatin. Bitter agonists selective for taste receptor type 2 (TAS2Rs), TAS2R5 and TAS2R10 stimulated ghrelin secretion in fundic cells. The stimulatory effect of the broadly tuned bitter agonist, denatonium benzoate, was selectively blunted by obesity in the small intestine but not in the fundus. Luminal glucose concentrations inhibited ghrelin secretion via sodium-dependent glucose cotransporter and taste receptor type 1 member 3. Obesity altered the sensitivity of the ghrelin cell to glucose in the small intestine but not in the fundus. Sweet taste receptor activation inhibited bitter taste signaling of the ghrelin cell. In conclusion, obesity impairs the sympathetic drive that controls ghrelin release in the fundus and affects the sensitivity of the ghrelin cell to bitter and sweet stimuli in the small intestine but not in the fundus. Region-selective targeting of gut taste receptors in obesity is indicated.	[Wang, Qiaoling; Liszt, Kathrin I.; Deloose, Eveline; Thijs, Theo; Farre, Ricard; Tack, Jan; Depoortere, Inge] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Canovai, Emilio; Ceulemans, Laurens J.] Univ Hosp Leuven, Dept Abdominal Surg & Transplant Coordinat, Leuven, Belgium; [Lannoo, Matthias] Univ Hosp Leuven, Dept Abdominal Surg, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Depoortere, I (corresponding author), Univ Leuven, Gut Peptide Res Lab, Translat Res Ctr Gastrointestinal Disorders TARGI, Gasthuisberg O&N1,Box 701, B-3000 Leuven, Belgium.	inge.depoortere@kuleuven.be	Canovai, Emilio/F-5985-2018; Farre, Ricard/M-9275-2013; Farre, Ricard/O-4549-2016; lannoo, matthias/AAB-1706-2020; Depoortere, Inge/I-5019-2013	Canovai, Emilio/0000-0003-4921-466X; Farre, Ricard/0000-0001-7158-171X; Farre, Ricard/0000-0001-7158-171X; Ceulemans, Laurens/0000-0002-4261-7100; Lannoo, matthias/0000-0001-7815-1157; Liszt, Kathrin/0000-0003-2507-0630; Thijs, Theo/0000-0001-5226-2633; Depoortere, Inge/0000-0002-0289-2175; Tack, Jan/0000-0002-3206-6704	research Foundation Flanders [FWO G073615N, 12R2618N]; Methusalem grant from KU Leuven; Chinese Scholarship Council (CSC) [201508370091]	research Foundation Flanders(FWO); Methusalem grant from KU Leuven; Chinese Scholarship Council (CSC)(China Scholarship Council)	The authors thank L. Nys (Translational Research Center for Gastrointestinal Disorders, University of Leuven) for her skillful technical assistance and doctors from the bariatric surgery team (University Hospitals Leuven) for recruiting the obese patients. This work was supported by grants from the research Foundation Flanders (FWO G073615N and 12R2618N), a Methusalem grant from KU Leuven, and the Chinese Scholarship Council (CSC; 201508370091). The authors declare no conflicts of interest.	Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Avau B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145538; Bertoli S, 2014, WORLD J DIABETES, V5, P717, DOI 10.4239/wjd.v5.i5.717; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chao DHM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29094; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Dadan J, 2009, FOLIA HISTOCHEM CYTO, V47, P307, DOI 10.2478/v10042-009-0033-z; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; De Waele K, 2008, EUR J ENDOCRINOL, V159, P381, DOI 10.1530/EJE-08-0462; Deloose E, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13171; Deloose E, 2017, AM J CLIN NUTR, V105, P580, DOI 10.3945/ajcn.116.138297; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Egerod KL, 2015, ENDOCRINOLOGY, V156, P3909, DOI 10.1210/EN.2015-1388; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; English PJ, 2002, J CLIN ENDOCR METAB, V87, P2984, DOI 10.1210/jc.87.6.2984; Foster-Schubert KE, 2008, J CLIN ENDOCR METAB, V93, P1971, DOI 10.1210/jc.2007-2289; Gagnon J, 2012, ENDOCRINOLOGY, V153, P3646, DOI 10.1210/en.2012-1040; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hardikar S, 2017, APPETITE, V111, P158, DOI 10.1016/j.appet.2016.12.017; Iven J, 2019, NUTR NEUROSCI, V22, P850, DOI 10.1080/1028415X.2018.1457841; Iwakura H, 2011, ENDOCRINOLOGY, V152, P2619, DOI 10.1210/en.2010-1455; Jaggupilli A, 2019, FASEB J, V33, P501, DOI 10.1096/fj.201800521RR; Jaggupilli A, 2016, INT J BIOCHEM CELL B, V77, P184, DOI 10.1016/j.biocel.2016.03.005; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kok BP, 2018, MOL METAB, V16, P76, DOI 10.1016/j.molmet.2018.07.013; Laermans J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16748; Laffitte A, 2014, CURR OPIN CLIN NUTR, V17, P379, DOI 10.1097/MCO.0000000000000058; Lee RJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7703; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Liszt KI, 2017, P NATL ACAD SCI USA, V114, pE6260, DOI 10.1073/pnas.1703728114; Mani BK, 2016, J CLIN INVEST, V126, P3467, DOI 10.1172/JCI86270; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meyer-Gerspach AC, 2018, AM J CLIN NUTR, V107, P707, DOI 10.1093/ajcn/nqy004; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mundinger TO, 2006, ENDOCRINOLOGY, V147, P2893, DOI 10.1210/en.2005-1182; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nguyen NQ, 2015, J CLIN ENDOCR METAB, V100, P968, DOI 10.1210/jc.2014-3144; Olabi A, 2018, NUTR RES, V49, P48, DOI 10.1016/j.nutres.2017.10.001; Overberg J, 2012, ARCH DIS CHILD, V97, P1048, DOI 10.1136/archdischild-2011-301189; Park DC, 2015, ACTA OTO-LARYNGOL, V135, P478, DOI 10.3109/00016489.2014.975370; Park J, 2015, BIOCHEM BIOPH RES CO, V468, P306, DOI 10.1016/j.bbrc.2015.10.107; Parker BA, 2005, CLIN ENDOCRINOL, V62, P539, DOI 10.1111/j.1365-2265.2005.02254.x; Proserpio C, 2016, CHEM SENSES, V41, P169, DOI 10.1093/chemse/bjv072; Pydi SP, 2015, BIOCHEMISTRY-US, V54, P2622, DOI 10.1021/acs.biochem.5b00265; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Ritze Y, 2016, NEUROGASTROENT MOTIL, V28, P806, DOI 10.1111/nmo.12773; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; Roudnitzky N, 2016, CHEM SENSES, V41, P3, DOI 10.1093/chemse/bjw067; SAITO H, 1982, CANCER, V50, P560, DOI 10.1002/1097-0142(19820801)50:3<560::AID-CNCR2820500329>3.0.CO;2-I; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Steensels S, 2018, ANNU REV PHYSIOL, V80, P117, DOI 10.1146/annurev-physiol-021317-121332; Steensels S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120795; Steinert RE, 2012, AM J PHYSIOL-ENDOC M, V302, pE666, DOI 10.1152/ajpendo.00457.2011; Tamboli RA, 2016, AM J PHYSIOL-ENDOC M, V311, pE252, DOI 10.1152/ajpendo.00082.2016; Tentolouris N, 2004, HORM METAB RES, V36, P559, DOI 10.1055/s-2004-825761; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Uchida A, 2014, MOL METAB, V3, P717, DOI 10.1016/j.molmet.2014.07.009; Vancleef L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15725; Vancleef L, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700804; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walters DE, 1996, TRENDS FOOD SCI TECH, V7, P399, DOI 10.1016/S0924-2244(96)10040-6; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Wolnerhanssen BK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08487-9; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107; Zigman JM, 2016, TRENDS ENDOCRIN MET, V27, P54, DOI 10.1016/j.tem.2015.09.010	69	30	30	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4907	4920		10.1096/fj.201801661RR	http://dx.doi.org/10.1096/fj.201801661RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30629462	Bronze, Green Accepted			2022-12-26	WOS:000462888500022
J	Starr, ML; Sparks, RP; Arango, AS; Hurst, LR; Zhao, ZY; Lihan, M; Jenkins, JL; Tajkhorshid, E; Fratti, RA				Starr, Matthew L.; Sparks, Robert P.; Arango, Andres S.; Hurst, Logan R.; Zhao, Zhiyu; Lihan, Muyun; Jenkins, Jermaine L.; Tajkhorshid, Emad; Fratti, Rutilio A.			Phosphatidic acid induces conformational changes in Sec18 protomers that prevent SNARE priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidic acid; diacylglycerol; SNARE proteins; membrane fusion; membrane lipid; Lipin1; NSF; Pah1; Sec17; Sec18	SENSITIVE FUSION PROTEIN; PARTICLE MESH EWALD; MEMBRANE-FUSION; YEAST VACUOLE; MOLECULAR-DYNAMICS; REGULATORY LIPIDS; SPONTANEOUS CURVATURE; PHOSPHOLIPASE D1; BINDING-SITES; ALPHA-SNAP	Eukaryotic cell homeostasis requires transfer of cellular components among organelles and relies on membrane fusion catalyzed by SNARE proteins. Inactive SNARE bundles are reactivated by hexameric N-ethylmaleimide-sensitive factor, vesicle-fusing ATPase (Sec18/NSF)-driven disassembly that enables a new round of membrane fusion. We previously found that phosphatidic acid (PA) binds Sec18 and thereby sequesters it from SNAREs and that PA dephosphorylation dissociates Sec18 from the membrane, allowing it to engage SNARE complexes. We now report that PA also induces conformational changes in Sec18 protomers and that hexameric Sec18 cannot bind PA membranes. Molecular dynamics (MD) analyses revealed that the D1 and D2 domains of Sec18 contain PA-binding sites and that the residues needed for PA binding are masked in hexameric Sec18. Importantly, these simulations also disclosed that a major conformational change occurs in the linker region between the D1 and D2 domains, which is distinct from the conformational changes that occur in hexameric Sec18 during SNARE priming. Together, these findings indicate that PA regulates Sec18 function by altering its architecture and stabilizing membrane-bound Sec18 protomers.	[Starr, Matthew L.; Sparks, Robert P.; Hurst, Logan R.; Tajkhorshid, Emad; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Arango, Andres S.; Zhao, Zhiyu; Lihan, Muyun; Tajkhorshid, Emad; Fratti, Rutilio A.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jenkins, Jermaine L.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Rochester	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	rfratti@illinois.edu	Tajkhorshid, Emad/AAN-8323-2021	Zhao, Zhiyu/0000-0001-9758-5073; Sparks, Robert/0000-0002-0485-8317	National Institutes of Health [R01-GM101132, P41-GM104601, U01-GM111251, U54-GM087519]; National Science Foundation [MCB 1818310]; Office of Naval Research ONR [N0001416-1-2535]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101132, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research ONR(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM101132 (to R. A. F.), and P41-GM104601, U01-GM111251, and U54-GM087519 (to E T.), National Science Foundation Grant MCB 1818310 (to R. A. F.), and the Office of Naval Research ONR Grant N0001416-1-2535 (to E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Capelluto DGS, 2014, BIOPHYS J, V106, P1101, DOI 10.1016/j.bpj.2014.01.032; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hew K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143947; HEYDUK T, 1989, BIOCHEMISTRY-US, V28, P6914, DOI 10.1021/bi00443a021; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Humphrey W., 1996, J MOL GRAPHICS, V14, P33; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jo SW, 2014, ADV PROTEIN CHEM STR, V96, P235, DOI 10.1016/bs.apcsb.2014.06.002; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Karunakaran S, 2013, TRAFFIC, V14, P650, DOI 10.1111/tra.12064; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Miner GE, 2017, TRAFFIC, V18, P315, DOI 10.1111/tra.12479; Miner GE, 2016, J BIOL CHEM, V291, P17651, DOI 10.1074/jbc.M116.725366; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Pande VS, 2010, METHODS, V52, P99, DOI 10.1016/j.ymeth.2010.06.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qi YF, 2015, BIOPHYS J, V109, P2012, DOI 10.1016/j.bpj.2015.10.008; Roberts RL, 1999, J CELL SCI, V112, P3667; Rogasevskaia TP, 2015, J BIOL CHEM, V290, P28683, DOI 10.1074/jbc.M115.681429; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schreiner E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-190; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sparks RP, 2019, METHODS MOL BIOL, V1860, P199, DOI 10.1007/978-1-4939-8760-3_12; Sparks RP, 2019, METHODS MOL BIOL, V1860, P191, DOI 10.1007/978-1-4939-8760-3_11; Sparks RP, 2016, BIOCHEM BIOPH RES CO, V479, P551, DOI 10.1016/j.bbrc.2016.09.108; Starr ML, 2016, TRAFFIC, V17, P1091, DOI 10.1111/tra.12423; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Vermaas JV, 2017, BIOCHEMISTRY-US, V56, P281, DOI 10.1021/acs.biochem.6b00468; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Vollrath F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05625; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; Yavuz H, 2018, J BIOL CHEM, V293, P8645, DOI 10.1074/jbc.RA118.003313; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhao ML, 2016, J MOL BIOL, V428, P1912, DOI 10.1016/j.jmb.2015.10.026; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148; Zick M, 2013, MOL BIOL CELL, V24, P3746, DOI 10.1091/mbc.E13-07-0419	85	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3100	3116		10.1074/jbc.RA118.006552	http://dx.doi.org/10.1074/jbc.RA118.006552			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30617180	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000464980100011
J	Fitzhugh, MC; Whitehead, PS; Johnson, L; Cai, JM; Baxter, LC; Rogalsky, C				Fitzhugh, Megan C.; Whitehead, Peter S.; Johnson, Lisa; Cai, Julia M.; Baxter, Leslie C.; Rogalsky, Corianne			A functional MRI investigation of crossmodal interference in an audiovisual Stroop task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SUPERIOR TEMPORAL SULCUS; COLOR-WORD TEST; COGNITIVE CONTROL; PREFRONTAL CORTEX; MULTISENSORY INTEGRATION; ATTENTIONAL CONTROL; TEST-PERFORMANCE; VISUAL SPEECH; BRAIN	The visual color-word Stroop task is widely used in clinical and research settings as a measure of cognitive control. Numerous neuroimaging studies have used color-word Stroop tasks to investigate the neural resources supporting cognitive control, but to our knowledge all have used unimodal (typically visual) Stroop paradigms. Thus, it is possible that this classic measure of cognitive control is not capturing the resources involved in multisensory cognitive control. The audiovisual integration and crossmodal correspondence literatures identify regions sensitive to congruency of auditory and visual stimuli, but it is unclear how these regions relate to the unimodal cognitive control literature. In this study we aimed to identify brain regions engaged by crossmodal cognitive control during an audiovisual color-word Stroop task, and how they relate to previous unimodal Stroop and audiovisual integration findings. First, we replicated previous behavioral audiovisual Stroop findings in an fMRI-adapted audiovisual Stroop paradigm: incongruent visual information increased reaction time towards an auditory stimulus and congruent visual information decreased reaction time. Second, we investigated the brain regions supporting cognitive control during an audiovisual color-word Stroop task using fMRI. Similar to unimodal cognitive control tasks, a left superior parietal region exhibited an interference effect of visual information on the auditory stimulus. This superior parietal region was also identified using a standard audiovisual integration localizing procedure, indicating that audiovisual integration resources are sensitive to cognitive control demands. Facilitation of the auditory stimulus by congruent visual information was found in posterior superior temporal cortex, including in the posterior STS which has been found to support audiovisual integration. The dorsal anterior cingulate cortex, often implicated in unimodal Stroop tasks, was not modulated by the audiovisual Stroop task. Overall the findings indicate that an audiovisual color-word Stroop task engages overlapping resources with audiovisual integration and overlapping but distinct resources compared to unimodal Stroop tasks.	[Fitzhugh, Megan C.] Arizona State Univ, Interdisciplinary Neurosci Grad Degree Program, Tempe, AZ USA; [Fitzhugh, Megan C.; Whitehead, Peter S.; Johnson, Lisa; Cai, Julia M.; Rogalsky, Corianne] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA; [Fitzhugh, Megan C.; Baxter, Leslie C.] Barrow Neurol Inst, Keller Ctr Imaging Innovat, Phoenix, AZ 85013 USA; [Fitzhugh, Megan C.; Baxter, Leslie C.] St Josephs Hosp, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Rogalsky, C (corresponding author), Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA.	Corianne.rogalsky@asu.edu		Rogalsky, Corianne/0000-0002-0499-9355; Whitehead, Peter/0000-0002-1966-0848; Fitzhugh, Megan/0000-0001-5275-7361; Baxter, Leslie/0000-0002-3971-863X	Arizona State University	Arizona State University	Funding was provided by Arizona State University awarded to Corianne Rogalsky. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sharmeen Maze at the Keller Center for Imaging Innovation at the Barrow Neurological Institute for her critical assistance in fMRI data acquisition. Funding was provided by Arizona State University.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amer T, 2016, TRENDS COGN SCI, V20, P905, DOI 10.1016/j.tics.2016.10.002; Baayen RH, 2010, INT J PSYCHOL RES, V3, P12; Balk MH, 2010, NEUROREPORT, V21, P822, DOI 10.1097/WNR.0b013e32833d138f; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Beauchamp MS, 2010, J NEUROSCI, V30, P2414, DOI 10.1523/JNEUROSCI.4865-09.2010; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bugg JM, 2008, MEM COGNITION, V36, P1484, DOI 10.3758/MC.36.8.1484; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Christensen TA, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00236; COHEN G, 1979, COGNITIVE PSYCHOL, V11, P412, DOI 10.1016/0010-0285(79)90019-7; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COWAN N, 1987, PERCEPT PSYCHOPHYS, V41, P393, DOI 10.3758/BF03203031; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; DALRYMPLEALFORD EC, 1972, PERCEPT PSYCHOPHYS, V11, P274, DOI 10.3758/BF03210377; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Donohue SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062802; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; GREEN EJ, 1981, PERCEPT PSYCHOPHYS, V30, P459, DOI 10.3758/BF03204842; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HAMERS JF, 1972, J VERB LEARN VERB BE, V11, P303, DOI 10.1016/S0022-5371(72)80091-4; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; HINTZMAN DL, 1972, J EXP PSYCHOL, V95, P458, DOI 10.1037/h0033644; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Ikeda Y, 2011, PSYCHOL REP, V108, P577, DOI 10.2466/04.10.22.PR0.108.2.577-584; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KLEIN GS, 1964, AM J PSYCHOL, V77, P576, DOI 10.2307/1420768; Koelewijn T, 2009, J EXP PSYCHOL HUMAN, V35, P1303, DOI 10.1037/a0013901; Lachaud CM, 2011, APPL PSYCHOLINGUIST, V32, P389, DOI 10.1017/S0142716410000457; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Laurienti PJ, 2003, HUM BRAIN MAPP, V19, P213, DOI 10.1002/hbm.10112; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Manwell LA, 2004, PSYCHON B REV, V11, P458, DOI 10.3758/BF03196595; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Matthews SC, 2004, NEUROIMAGE, V22, P1151, DOI 10.1016/j.neuroimage.2004.03.005; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V33, P266, DOI 10.3758/BF03202864; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Ojanen V, 2005, NEUROIMAGE, V25, P333, DOI 10.1016/j.neuroimage.2004.12.001; Okada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068959; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Perrachione TK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00055; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; PIETERS JM, 1981, CORTEX, V17, P369, DOI 10.1016/S0010-9452(81)80024-X; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Ramachandran VS, 2018, SYNAESTHESIA A WINDO, P33; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; REDDING GM, 1977, PERCEPT MOTOR SKILL, V45, P11, DOI 10.2466/pms.1977.45.1.11; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; SMITH LB, 1992, COGNITIVE PSYCHOL, V24, P99, DOI 10.1016/0010-0285(92)90004-L; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Szycik GR, 2008, BRAIN RES, V1220, P142, DOI 10.1016/j.brainres.2007.08.027; Talairach J, 1988, CO PLANAR STEREOTAXI, P11078, DOI [10.1073/pnas.0704320104, DOI 10.1073/PNAS.0704320104]; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Venezia JH, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00174; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	106	4	4	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210736	10.1371/journal.pone.0210736	http://dx.doi.org/10.1371/journal.pone.0210736			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645634	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200049
J	Guzman-Otazo, J; Gonzales-Siles, L; Poma, V; Bengtsson-Palme, J; Thorell, K; Flach, CF; Iniguez, V; Sjoling, A				Guzman-Otazo, Jessica; Gonzales-Siles, Lucia; Poma, Violeta; Bengtsson-Palme, Johan; Thorell, Kaisa; Flach, Carl-Fredrik; Iniguez, Volga; Sjoling, Asa			Diarrheal bacterial pathogens and multi-resistant enterobacteria in the Choqueyapu River in La Paz, Bolivia	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; BETA-LACTAMASE GENES; MULTIPLEX PCR ASSAYS; CTX-M; WATER-QUALITY; WASTE-WATER; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; MOLECULAR CHARACTERIZATION	Water borne diarrheal pathogens might accumulate in river water and cause contamination of drinking and irrigation water. The La Paz River basin, including the Choqueyapu River, flows through La Paz city in Bolivia where it is receiving sewage, and residues from inhabitants, hospitals, and industry. Using quantitative real-time PCR (qPCR), we determined the quantity and occurrence of diarrheagenic Escherichia coli (DEC), Salmonella enterica, Klebsiella pneumoniae, Shigella spp. and total enterobacteria in river water, downstream agricultural soil, and irrigated crops, during one year of sampling. The most abundant and frequently detected genes were gapA and eltB, indicating presence of enterobacteria and enterotoxigenic E. coli (ETEC) carrying the heat labile toxin, respectively. Pathogen levels in the samples were significantly positively associated with high water conductivity and low water temperature. In addition, a set of bacterial isolates from water, soil and crops were analyzed by PCR for presence of the genes bla(CTX-M), bla(KPC), bla(NDM), bla(VIM) and bla(OXA-48). Four isolates were found to be positive for bla(CTX-M) genes and whole genome sequencing identified them as E. coli and one Enterobacter cloacae. The E. coli isolates belonged to the emerging, globally disseminated, multi-resistant E. coli lineages ST648, ST410 and ST162. The results indicate not only a high potential risk of transmission of diarrheal diseases by the consumption of contaminated water and vegetables but also the possibility of antibiotic resistance transfer from the environment to the community.	[Guzman-Otazo, Jessica; Poma, Violeta; Iniguez, Volga] Univ Mayor San Andres, Inst Biol Mol & Biotecnol, La Paz, Bolivia; [Guzman-Otazo, Jessica; Thorell, Kaisa; Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Gonzales-Siles, Lucia; Bengtsson-Palme, Johan; Flach, Carl-Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Bengtsson-Palme, Johan; Flach, Carl-Fredrik] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden; [Bengtsson-Palme, Johan] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA	Universidad Mayor de San Andres; Karolinska Institutet; University of Gothenburg; University of Gothenburg; University of Wisconsin System; University of Wisconsin Madison	Guzman-Otazo, J (corresponding author), Univ Mayor San Andres, Inst Biol Mol & Biotecnol, La Paz, Bolivia.; Guzman-Otazo, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	jessica.guzman.otazo@ki.se	Flach, Carl-Fredrik/AAL-1006-2020; Gonzales Strömberg, Lucia/GYQ-8934-2022; Bengtsson-Palme, Johan/K-3871-2012	Gonzales Strömberg, Lucia/0000-0001-7441-8483; Bengtsson-Palme, Johan/0000-0002-6528-3158; Flach, Carl-Fredrik/0000-0002-4101-5095	Swedish International Development Cooperation Agency (Sida); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)/Swedish Water [SWWA 13-102]; International Science Program (ISP); FORMAS	Swedish International Development Cooperation Agency (Sida); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)/Swedish Water(Swedish Research Council Formas); International Science Program (ISP); FORMAS(Swedish Research Council Formas)	This work was supported by the Swedish International Development Cooperation Agency (Sida) to [VI and AS], and a Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)/Swedish Water funded project on Risk-Based Decision Support for Safe Drinking Water [SWWA 13-102] to [AS]. The project is part of a Sweden-Bolivia Sida-Universidad Mayor de San Andres (UMSA) development program. JG-O acknowledges the financial support from the International Science Program (ISP). JB-P acknowledges financial support from FORMAS. The findings and conclusions contained in the article are those of the authors and do not necessarily reflect positions or policies of funder institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelowo OO, 2018, ENVIRON SCI POLLUT R, V25, P2744, DOI 10.1007/s11356-017-0686-7; Ahmed D, 2013, J APPL MICROBIOL, V114, P1223, DOI 10.1111/jam.12109; Alvarez R, 2008, RENEW ENERG, V33, P726, DOI 10.1016/j.renene.2007.05.001; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; Anbazhagan D, 2011, BRAZ J MICROBIOL, V42, P448, DOI 10.1590/S1517-83822011000200006; Archundia D, 2017, SCI TOTAL ENVIRON, V576, P671, DOI 10.1016/j.scitotenv.2016.10.129; Bajaj P, 2015, SCI TOTAL ENVIRON, V505, P350, DOI 10.1016/j.scitotenv.2014.09.084; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Banna MH, 2014, SENSOR ACTUAT B-CHEM, V193, P434, DOI 10.1016/j.snb.2013.12.002; Bartoloni A, 2016, INT J INFECT DIS, V43, P1, DOI 10.1016/j.ijid.2015.12.008; Begum YA, 2007, CAN J MICROBIOL, V53, P19, DOI 10.1139/W06-098; Ben Said L, 2016, SCI TOTAL ENVIRON, V550, P1103, DOI 10.1016/j.scitotenv.2016.01.042; Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5; Bengtsson-Palme J, 2018, FEMS MICROBIOL REV, V42, P68, DOI 10.1093/femsre/fux053; Bengtsson-Palme J, 2017, CURR OPIN FOOD SCI, V14, P66, DOI 10.1016/j.cofs.2017.01.010; Borgogna TR, 2016, MICROB DRUG RESIST, V22, P312, DOI 10.1089/mdr.2015.0197; Burke RM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-708; Cabal A, 2013, APPL ENVIRON MICROB, V79, P4170, DOI 10.1128/AEM.00537-13; Delgado DYC, 2016, BRAZ J INFECT DIS, V20, P627, DOI 10.1016/j.bjid.2016.07.001; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Celenza G, 2006, J ANTIMICROB CHEMOTH, V57, P975, DOI 10.1093/jac/dkl055; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Conte D, 2017, ECOTOX ENVIRON SAFE, V136, P62, DOI 10.1016/j.ecoenv.2016.10.031; Dropa M, 2016, ENVIRON SCI POLLUT R, V23, P4953, DOI 10.1007/s11356-016-6079-5; Escandon-Vargas K, 2017, EXPERT REV ANTI-INFE, V15, P277, DOI 10.1080/14787210.2017.1268918; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Ewers C, 2014, J ANTIMICROB CHEMOTH, V69, P1224, DOI 10.1093/jac/dkt516; Fernandes MR, 2018, INFECT GENET EVOL, V66, P48, DOI 10.1016/j.meegid.2018.09.009; Ferreira JC, 2014, DIAGN MICR INFEC DIS, V80, P304, DOI 10.1016/j.diagmicrobio.2014.09.012; Galfi H, 2016, J HYDROL, V539, P125, DOI 10.1016/j.jhydrol.2016.05.006; Garcia-Fulgueiras V, 2013, New Microbes New Infect, V1, P44, DOI 10.1002/nmi2.25; Gebreyes WA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003257; Gonzales L, 2013, J MED MICROBIOL, V62, P1697, DOI 10.1099/jmm.0.060798-0; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Hayashi M, 2004, ENVIRON MONIT ASSESS, V96, P119, DOI 10.1023/B:EMAS.0000031719.83065.68; Hoorfar J, 2000, J CLIN MICROBIOL, V38, P3429, DOI 10.1128/JCM.38.9.3429-3435.2000; INE, ENC SAL 2016; Irrgang A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02318; Janzon A, 2009, HELICOBACTER, V14, P237, DOI 10.1111/j.1523-5378.2009.00692.x; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; Kabayiza JC, 2014, PEDIATR INFECT DIS J, V33, P1037, DOI 10.1097/INF.0000000000000448; Kney AD, 2007, J ENVIRON MANAGE, V82, P519, DOI 10.1016/j.jenvman.2006.01.014; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Larsson DGJ, 2018, ENVIRON INT, V117, P132, DOI 10.1016/j.envint.2018.04.041; Loock MM, 2015, WATER SA, V41, P705, DOI [10.4314/wsa.v41i5.14, 10.4314/WSA.V41I5.14]; Lothigius A, 2008, J APPL MICROBIOL, V104, P1128, DOI 10.1111/j.1365-2672.2007.03628.x; Lothigius A, 2010, J APPL MICROBIOL, V108, P1441, DOI 10.1111/j.1365-2672.2009.04548.x; Lyew D, 2001, WATER RES, V35, P2081, DOI 10.1016/S0043-1354(00)00473-5; Marti E, 2014, TRENDS MICROBIOL, V22, P36, DOI 10.1016/j.tim.2013.11.001; Mokomane M, 2017, THERAPEUTIC ADV INFE; Nascimento T, 2017, SCI TOTAL ENVIRON, V598, P910, DOI 10.1016/j.scitotenv.2017.03.207; Nicklasson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035827; Nuesch-Inderbinen M, 2018, J GLOB ANTIMICROB RE, V13, P53, DOI 10.1016/j.jgar.2018.03.001; Ohno A, 1997, AM J TROP MED HYG, V57, P438, DOI 10.4269/ajtmh.1997.57.438; Ortega-Paredes D, 2018, INT J FOOD MICROBIOL, V280, P41, DOI 10.1016/j.ijfoodmicro.2018.04.037; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poma V, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2132-6; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Qin SS, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.117; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Rozwandowicz M, 2018, J ANTIMICROB CHEMOTH, V73, P1121, DOI 10.1093/jac/dkx488; Furlan JPR, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-017-6453-x; Ruiz SJ, 2011, J CLIN MICROBIOL, V49, P1993, DOI 10.1128/JCM.00045-11; Sartori L, 2017, J GLOB ANTIMICROB RE, V11, P145, DOI 10.1016/j.jgar.2017.10.009; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sellera FP, 2018, MAR POLLUT BULL, V135, P183, DOI 10.1016/j.marpolbul.2018.07.012; Sennati S, 2016, J GLOB ANTIMICROB RE, V4, P70, DOI 10.1016/j.jgar.2015.10.007; Sevillano E, 2012, J MED MICROBIOL, V61, P80, DOI 10.1099/jmm.0.032722-0; Shaw RK, 2011, ENV MICROBIOL REP, V3, P112, DOI 10.1111/j.1758-2229.2010.00195.x; Silva KC, 2016, ANTIMICROB AGENTS CH, V60, P2505, DOI 10.1128/AAC.02788-15; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Sjoling A, 2006, MICROBES INFECT, V8, P2797, DOI 10.1016/j.micinf.2006.08.011; Skarbovik E, 2015, ACTA AGR SCAND B-S P, V65, P63, DOI 10.1080/09064710.2014.966751; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Wiejaczka L, 2015, WATER RESOUR+, V42, P362, DOI 10.1134/S0097807815030070; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zarfel G, 2017, SCI TOTAL ENVIRON, V593, P399, DOI 10.1016/j.scitotenv.2017.03.138	82	19	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210735	10.1371/journal.pone.0210735	http://dx.doi.org/10.1371/journal.pone.0210735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640938	gold, Green Published, Green Submitted			2022-12-26	WOS:000455808000043
J	Coyle, R; Feher, M; Jones, S; Hamilton, M; de Lusignan, S				Coyle, Rachel; Feher, Michael; Jones, Simon; Hamilton, Mark; de Lusignan, Simon			Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; MYOCARDIAL-INFARCTION; UNITED-STATES; 52 COUNTRIES; PREDICTORS; PREVALENCE; AWARENESS; RISK	Background Hypertension is a major cause of preventable disability and death globally and affects more than one in four adults in England. Unwarranted variation is variation in access, quality, outcome or value which is unexplained by differences in the condition or patient characteristics and which reduces quality and efficiency. Distinguishing unwarranted from variation due to clinical, organisational or patient factors can be challenging. We carried out this study to explore inter-practice variation in the diagnosis and management of hypertension in the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network database, a large, representative surveillance database. Methods and finding We carried out a cross-sectional study using primary care data extracted from the electronic health records of 1,271,419 adults registered at RCGP RSC general practices on 31st December 2016. Logistic regression was used to indirectly standardise practice-level hypertension prevalence and control against the RCGP RSC population, adjusted for age, gender, ethnicity, deprivation, co-morbidity, NHS region and practice size. Inter-practice variation was demonstrated using funnel plots with 95% and 99.8% control limits. The prevalence of detected hypertension was 18.4% (95% CI 18.4-18.5), n = 234,165. Uncontrolled hypertension was present in 146,553 of 196,052 individuals, 25.2% (25.1-25.4), in whom blood pressure had been recorded in the previous year. Hypertension management varied markedly between practices with a three-fold difference in prevalence, 13.5-38.4%, and a four-fold difference in the proportion of uncontrolled hypertension, 11.8-47.9%. Despite adjustment for sociodemographic and practice characteristics funnel plots demonstrated marked over-dispersion. Conclusions Substantial variation in the prevalence of diagnosed hypertension and the management of hypertension was only partially explained by characteristics captured within a routine data-set. The over-dispersion suggests variation is not fully explained by these factors and that context, behaviour and processes of care delivery may contribute to variation. Routine data sources in isolation to not provide sufficient contextual data to diagnose the causes of variation.	[Coyle, Rachel; Feher, Michael; de Lusignan, Simon] Univ Surrey, Dept Clin & Expt Med, London, England; [Jones, Simon] NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY USA; [Hamilton, Mark] Surrey Heartlands Clin Acad, Guildford, Surrey, England	University of Surrey; New York University	Coyle, R (corresponding author), Univ Surrey, Dept Clin & Expt Med, London, England.	rachelcoyle@nhs.net	de Lusignan, Smion/S-7838-2019	de Lusignan, Smion/0000-0002-8553-2641; Jones, Simon/0000-0002-8267-5647	Public Health England	Public Health England	The patients and practices that are members of the RCGP Research and Surveillance Centre and allow their data to be shared; EMIS, In Practice Systems and TPP SystmOne who helped facilitate data extraction; Apollo Medical Systems for expertise in secure data processing; the core surveillance function of RCGP Research and Surveillance Centre, which is funded by Public Health England; and Rachel Byford and Julian Sherlock, SQL developers, for their help with database management and data extraction.	Angell SY, 2008, CIRC-CARDIOVASC QUAL, V1, P46, DOI 10.1161/CIRCOUTCOMES.108.791954; Baltaci D, 2013, EUR REV MED PHARMACO, V17, P1884; Buchan IE, 2017, J EPIDEMIOL COMMUN H, V71, P928, DOI 10.1136/jech-2017-209195; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Corallo AN, 2014, HEALTH POLICY, V114, P5, DOI 10.1016/j.healthpol.2013.08.002; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Corsino L, 2011, J CLIN HYPERTENS, V13, P106, DOI 10.1111/j.1751-7176.2010.00385.x; Costa FF, 2018, J CLIN HYPERTENS, V20, P125, DOI 10.1111/jch.13139; Dartm. Inst. Health Policy Clin. Pract, 2018, DARTM ATL HLTH CAR; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; Djulbegovic B, 2015, J EVAL CLIN PRACT, V21, P1121, DOI 10.1111/jep.12486; Egan B., 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI DOI 10.1001/JAMA.2010.650; Filipiak KJ, 2018, KARDIOL POL, V76, P353, DOI 10.5603/KP.a2017.0211; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fuller L., 2017, ADULT HLTH TRENDS; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Glover J A, 1938, Proc R Soc Med, V31, P1219; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Health Research Authority, 2017, DEF RES; Israels A., 2013, STAT METHODS CHATPER; Kelly E., DOES GP PRACTICE SIZ, DOI [10.1186/1477-7525-11-102, DOI 10.1186/1477-7525-11-102]; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; Mercuri M, 2015, ACAD MED, V90, P191, DOI 10.1097/ACM.0000000000000542; Mercuri M, 2011, J EVAL CLIN PRACT, V17, P671, DOI 10.1111/j.1365-2753.2011.01689.x; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; National Institute for Health and Care Excellence, 2015, NG28 TYP 2 DIAB AD M; National Institute for Health and Care Excellence, 2010, CG101 CHRON OBSTR PU; National Institute for Health and Care Excellence, 2016, HYP AD DIAGN MAN GUI; National Institute for Health and Care Excellence, 2015, NG17 TYP 1 DIAB AD D; National Institute for Health and Care Excellence, 2014, CG181 CARD DIS RISK; National Institute of Health and Care Excellence, 2010, CG108 CHRON HEART FA; National Institute of Health and Care Excellence, 2015, CG182 CHRON KIDN DIS; NHS England, 2017, NHS RIGHTC SHIFT VAL; Paddison CAM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006172; Persell SD, 2010, ANN INTERN MED, V152, P225, DOI 10.7326/0003-4819-152-4-201002160-00007; Public Health England, 2018, FUNN PLOTS TECHN BRI; Public Health England, 2018, ATL VAR; Public Health England, 2014, TACKL HIGH BLOOD PRU; Public Health England, 2015, TACKL UNW VAR HEALTH; Rowan CG, 2015, PHARMACOEPIDEM DR S, V24, P1170, DOI 10.1002/pds.3849; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; The King's Fund, 2013, TIM THINK DIFF; WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1; Willis TA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177949; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210657	10.1371/journal.pone.0210657	http://dx.doi.org/10.1371/journal.pone.0210657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629703	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000119
J	Miranda-CasoLuengo, R; Lu, JN; Williams, EJ; Miranda-CasoLuengo, AA; Carrington, SD; Evans, ACO; Meijer, WG				Miranda-CasoLuengo, Raul; Lu, Junnan; Williams, Erin J.; Miranda-CasoLuengo, Aleksandra A.; Carrington, Stephen D.; Evans, Alexander C. O.; Meijer, Wim G.			Delayed differentiation of vaginal and uterine microbiomes in dairy cows developing postpartum endometritis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FUNCTIONAL-ANALYSIS; HEALTHY; METRITIS; DIVERSITY; COMMUNITY; DISEASE; AMPLIFICATION; PARTURITION; PYOMETRA	Bacterial overgrowth in the uterus is a normal event after parturition. In contrast to the healthy cow, animals unable to control the infection within 21 days after calving develop postpartum endometritis. Studies on the Microbial Ecology of the bovine reproductive tract have focused on either vaginal or uterine microbiomes. This is the first study that compares both microbiomes in the same animals. Terminal Restriction Fragment Length Polymorphism of the 16S rRNA gene showed that despite large differences associated to individuals, a shared community exist in vagina and uterus during the postpartum period. The largest changes associated with development of endometritis were observed at 7 days post-partum, a time when vaginal and uterine microbiomes were most similar. 16S rRNA pyrosequencing of the vaginal microbiome at 7 days postpartum showed at least three different microbiome types that were associated with later development of postpartum endometritis. All three microbiome types featured reduced bacterial diversity. Taken together, the above findings support a scenario where disruption of the compartmentalization of the reproductive tract during parturition results in the dispersal and mixing of the vaginal and uterine micro-biomes, which subsequently are subject to differentiation. This differentiation was observed early postpartum in the healthy cow. In contrast, loss of bacterial diversity and dominance of the microbiome by few bacterial taxa were related to a delayed succession at 7DPP in cows that at 21 DPP or later were diagnosed with endometritis.	[Miranda-CasoLuengo, Raul; Lu, Junnan; Miranda-CasoLuengo, Aleksandra A.; Meijer, Wim G.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Miranda-CasoLuengo, Raul; Lu, Junnan; Miranda-CasoLuengo, Aleksandra A.; Meijer, Wim G.] Univ Coll Dublin, UCD Conway Inst, Dublin, Ireland; [Williams, Erin J.; Carrington, Stephen D.] Univ Coll Dublin, UCD Sch Vet Med, Vet Sci Ctr, Dublin, Ireland; [Evans, Alexander C. O.] Univ Coll Dublin, UCD Sch Agr & Food Sci, Dublin, Ireland; [Lu, Junnan] Univ Michigan, Sch Med, Pediat Infect Dis, Ann Arbor, MI 48109 USA; [Williams, Erin J.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Williams, Erin J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Miranda-CasoLuengo, Aleksandra A.] Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin; University of Michigan System; University of Michigan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Trinity College Dublin	Miranda-CasoLuengo, R (corresponding author), Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland.; Miranda-CasoLuengo, R (corresponding author), Univ Coll Dublin, UCD Conway Inst, Dublin, Ireland.; Williams, EJ (corresponding author), Univ Coll Dublin, UCD Sch Vet Med, Vet Sci Ctr, Dublin, Ireland.; Williams, EJ (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.; Williams, EJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	miranda.raul@ucd.ie; erin.williams@ed.ac.uk	Miranda-CasoLuengo, Raul/H-3438-2019	Miranda-CasoLuengo, Raul/0000-0002-9294-6578; Evans, Alexander/0000-0002-6344-6224; Carrington, Stephen Dennis/0000-0002-8051-5906; Meijer, Wim/0000-0003-1302-4338; Williams, Erin/0000-0002-6429-5747; Lu, Junnan/0000-0002-9962-4504	Science foundation Ireland [07/SRC/B1156]; Department of Agriculture, Food and the Marine [13-S-472]	Science foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture, Food and the Marine	This study was funded by Science foundation Ireland (http://www.sfi.ie/) grant number 07/SRC/B1156 (ACOE) and the Department of Agriculture, Food and the Marine (https://www.agriculture.gov.ie/) grant number 13-S-472 (EJW, ACOE, WGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane M, 2017, THERIOGENOLOGY, V103, P117, DOI 10.1016/j.theriogenology.2017.07.039; Bicalho MLS, 2017, J DAIRY SCI, V100, P3850, DOI 10.3168/jds.2016-12058; Bicalho MLS, 2017, J DAIRY SCI, V100, P3863, DOI 10.3168/jds.2016-12061; Bicalho MLS, 2017, J DAIRY SCI, V100, P3043, DOI 10.3168/jds.2016-11623; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carneiro LC, 2016, REPROD BIOL, V16, P1, DOI 10.1016/j.repbio.2015.12.002; Chapwanya A, 2012, REPROD FERT DEVELOP, V24, P1028, DOI 10.1071/RD11153; Crowe MA, 2012, J ANIM SCI, V90, P1722, DOI 10.2527/jas.2011-4674; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ELLIOTT L, 1968, AM J VET RES, V29, P77; Foley C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1967-5; Foley C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-489; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; GRIFFIN J F T, 1974, Theriogenology, V1, P91, DOI 10.1016/0093-691X(74)90052-1; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Jeon SJ, 2018, VET MICROBIOL, V214, P132, DOI 10.1016/j.vetmic.2017.12.022; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Knudsen LRV, 2016, THERIOGENOLOGY, V86, P642, DOI 10.1016/j.theriogenology.2016.02.016; Knudsen LRV, 2015, VET MICROBIOL, V175, P319, DOI 10.1016/j.vetmic.2014.12.006; Laguardia-Nascimento M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143294; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; OLSON JD, 1984, AM J VET RES, V45, P2251; Peng Y, 2013, FOLIA MICROBIOL, V58, P593, DOI 10.1007/s12223-013-0238-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rodrigues NF, 2015, GENET MOL RES, V14, P6518, DOI 10.4238/2015.June.12.4; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Santos TMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053048; Sheldon IM, 2008, VET J, V176, P115, DOI 10.1016/j.tvjl.2007.12.031; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Wang J, 2016, ANAEROBE, V38, P1, DOI 10.1016/j.anaerobe.2015.11.004; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wang Y, 2018, THERIOGENOLOGY, V108, P306, DOI 10.1016/j.theriogenology.2017.12.028; Wang Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-19; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	46	30	30	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0200974	10.1371/journal.pone.0200974	http://dx.doi.org/10.1371/journal.pone.0200974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629579	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000002
J	Atcheson, E; Bauza, K; Reyes-Sandoval, A				Atcheson, Erwan; Bauza, Karolis; Reyes-Sandoval, Arturo			A probabilistic model of pre-erythrocytic malaria vaccine combination in mice	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TO-BLOOD INOCULA; CIRCUMSPOROZOITE PROTEIN; POPULATION-DYNAMICS; PROTECTIVE IMMUNITY; EFFICACY MODEL; PHASE-3 TRIAL; HOST DYNAMICS; GROWTH-RATE; PARASITE	Malaria remains one the world's most deadly infectious diseases, with almost half a million deaths and over 150 million clinical cases each year. An effective vaccine would contribute enormously to malaria control and will almost certainly be required for eventual eradication of the disease. However, the leading malaria vaccine candidate, RTS,S, shows only 30-50% efficacy under field conditions, making it less cost-effective than long-lasting insecticide treated bed nets. Other subunit malaria vaccine candidates, including TRAP-based vaccines, show no better protective efficacy. This has led to increased interest in combining subunit malaria vaccines as a means of enhancing protective efficacy. Mathematical models of the effect of combining such vaccines on protective efficacy can help inform optimal vaccine strategies and decision-making at all stages of the clinical process. So far, however, no such model has been developed for pre-clinical murine studies, the stage at which all candidate antigens and combinations begin evaluation. To address this gap, this paper develops a mathematical model of vaccine combination adapted to murine malaria studies. The model is based on simple probabilistic assumptions which put the model on a firmer theoretical footing than previous clinical models, which rather than deriving a relationship between immune responses and protective efficacy posit the relationship to be either exponential or Hill curves. Data from pre-clinical murine malaria studies are used to derive values for unknowns in the model which in turn allows simulations of vaccine combination efficacy and suggests optimal strategies to pursue. Finally, the ability of the model to shed light on fundamental biological variables of murine malaria such as the blood stage growth rate and sporozoite infectivity is explored.	[Atcheson, Erwan; Bauza, Karolis; Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Reyes-Sandoval, A (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	arturo.reyes@ndm.ox.ac.uk		Reyes-Sandoval, Arturo/0000-0002-2648-1696	Wellcome Trust Career Development Fellowship [097395/Z/11/Z]; MRC [MR/N019008/1] Funding Source: UKRI	Wellcome Trust Career Development Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Career Development Fellowship. grant number 097395/Z/11/Z, (https://wellcome.ac.uk/what-we-do/directories/research-career-development-fellowships-people-funded) to A. Reyes-Sandoval. The sponsor did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Atcheson E, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00114-18, 10.1128/iai.00114-18]; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Bauza K, 2016, INFECT IMMUN, V84, P622, DOI 10.1128/IAI.01063-15; Bauza K, 2014, INFECT IMMUN, V82, P1277, DOI 10.1128/IAI.01187-13; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Billman ZP, 2016, INFECT IMMUN, V84, P2233, DOI 10.1128/IAI.01439-15; Burda PC, 2017, MBIO, V8, DOI [10.1128/mBio.00139-17, 10.1128/mbio.00139-17]; Chatterjee S, 2004, PARASITOL RES, V92, P459, DOI 10.1007/s00436-004-1074-z; Churcher TS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006108; Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Cromer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055961; Datta D, 2017, VACCINE, V35, P264, DOI 10.1016/j.vaccine.2016.11.072; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Douglas AD, 2013, J INFECT DIS, V208, P340, DOI 10.1093/infdis/jit156; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Frank R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01137; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Gibbons PL, 2007, INT J PARASITOL, V37, P1569, DOI 10.1016/j.ijpara.2007.05.001; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Gravenor MB, 1998, P NATL ACAD SCI USA, V95, P7620, DOI 10.1073/pnas.95.13.7620; Hegge S, 2010, FASEB J, V24, P5003, DOI 10.1096/fj.10-164814; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hoshen MB, 2000, PARASITOLOGY, V121, P227, DOI 10.1017/S0031182099006368; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Kennedy M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-421; Khoury DS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09412; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; KWIATKOWSKI D, 1991, P NATL ACAD SCI USA, V88, P5111, DOI 10.1073/pnas.88.12.5111; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; Mensah VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167951; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MOORTHY VS, 2009, MALARIA J, V8; Murray L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06295-9; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Olsen TM, 2018, J IMMUNOL, V201, P1984, DOI 10.4049/jimmunol.1800740; Pichyangkul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171826; Pinkevych M, 2015, J INFECT DIS, V211, P1121, DOI 10.1093/infdis/jiu561; Pinkevych M, 2014, J INFECT DIS, V209, P1136, DOI 10.1093/infdis/jit613; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Rampling T, 2016, J INFECT DIS, V214, P772, DOI 10.1093/infdis/jiw244; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; RUSSELL ES, 1951, P SOC EXP BIOL MED, V78, P761; SALMAN AM, 2017, SCI REP UK, V7; Sastry A. S, 2014, ESSENTIALS MED PARAS; Saul A, 2008, PARASITOLOGY, V135, P1497, DOI 10.1017/S0031182008000280; Saul A, 1998, PARASITOLOGY, V117, P405, DOI 10.1017/S0031182098003230; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; SHIN SCJ, 1982, J PROTOZOOL, V29, P448, DOI 10.1111/j.1550-7408.1982.tb05431.x; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; SINDEN RE, 1990, B WORLD HEALTH ORGAN, V68, P115; Spaccapelo R, 1997, LANCET, V350, P335, DOI 10.1016/S0140-6736(97)24031-6; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Spencer AJ, 2017, J IMMUNOL, V198, P2006, DOI 10.4049/jimmunol.1601209; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VANDERBERG JP, 1977, EXP PARASITOL, V42, P169, DOI 10.1016/0014-4894(77)90075-3; VERHAVE JP, 1985, ANN SOC BELG MED TR, V65, P35; VERHAVE JP, 1980, INT J NUCL MED BIOL, V7, P149, DOI 10.1016/0047-0740(80)90033-9; Walker AS, 2015, AM J TROP MED HYG, V93, P1254, DOI 10.4269/ajtmh.14-0767; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; White MT, 2011, P ROY SOC B-BIOL SCI, V278, P1298, DOI 10.1098/rspb.2010.1697; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2016, WORLD MAL REP 2016; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x; YOELI M, 1966, MIL MED, V131, P900, DOI 10.1093/milmed/131.suppl_9.900; Zheng L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1711-2	80	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209028	10.1371/journal.pone.0209028	http://dx.doi.org/10.1371/journal.pone.0209028			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625136	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400024
J	Carminati, C; Boillat, P; Schmid, F; Vontobel, P; Hovind, J; Morgano, M; Raventos, M; Siegwart, M; Mannes, D; Gruenzweig, C; Trtik, P; Lehmann, E; Strobl, M; Kaestner, A				Carminati, Chiara; Boillat, Pierre; Schmid, Florian; Vontobel, Peter; Hovind, Jan; Morgano, Manuel; Raventos, Marc; Siegwart, Muriel; Mannes, David; Gruenzweig, Christian; Trtik, Pavel; Lehmann, Eberhard; Strobl, Markus; Kaestner, Anders			Implementation and assessment of the black body bias correction in quantitative neutron imaging	PLOS ONE			English	Article							POROUS-MEDIA; INDUSTRIAL APPLICATIONS; SCATTERING CORRECTIONS; FUEL-CELLS; RADIOGRAPHY; TOMOGRAPHY; FACILITY; MONOCHROMATOR; PROGRESS; OBJECTS	We describe in this paper the experimental procedure, the data treatment and the quantification of the black body correction: an experimental approach to compensate for scattering and systematic biases in quantitative neutron imaging based on experimental data. The correction algorithm is based on two steps; estimation of the scattering component and correction using an enhanced normalization formula. The method incorporates correction terms into the image normalization procedure, which usually only includes open beam and dark current images (open beam correction). Our aim is to show its efficiency and reproducibility: we detail the data treatment procedures and quantitatively investigate the effect of the correction. Its implementation is included within the open source CT reconstruction software MuhRec. The performance of the proposed algorithm is demonstrated using simulated and experimental CT datasets acquired at the ICON and NEUTRA beamlines at the Paul Scherrer Institut.	[Carminati, Chiara; Boillat, Pierre; Schmid, Florian; Vontobel, Peter; Hovind, Jan; Morgano, Manuel; Raventos, Marc; Siegwart, Muriel; Mannes, David; Gruenzweig, Christian; Trtik, Pavel; Lehmann, Eberhard; Strobl, Markus; Kaestner, Anders] Paul Scherrer Inst, Lab Neutron Scattering & Imaging, Villigen, Switzerland; [Boillat, Pierre; Siegwart, Muriel] Paul Scherrer Inst, Electrochem Lab, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Carminati, C (corresponding author), Paul Scherrer Inst, Lab Neutron Scattering & Imaging, Villigen, Switzerland.	chiara.carminati@psi.ch	Kaestner, Anders P/A-4440-2014; Boillat, Pierre/N-9296-2016; Carminati, Chiara/J-8265-2014	Kaestner, Anders P/0000-0003-4054-4726; Boillat, Pierre/0000-0002-5683-8086; Carminati, Chiara/0000-0002-1155-5752; Mannes, David/0000-0003-4028-7504; Raventos Tato, Marc/0000-0002-0538-1020	European Union's Horizon 2020 research and innovation programme [654000]	European Union's Horizon 2020 research and innovation programme	This project receives funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 654000, recipient Dr. C. Carminati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens A, 2005, SPECTROCHIM ACTA B, V60, P1503, DOI 10.1016/j.sab.2005.10.006; Balasko M, 2005, IEEE T NUCL SCI, V52, P330, DOI 10.1109/TNS.2005.843648; Bazylak A, 2009, INT J HYDROGEN ENERG, V34, P3845, DOI 10.1016/j.ijhydene.2009.02.084; Boillat P, 2018, OPT EXPRESS, V26, P15769, DOI 10.1364/OE.26.015769; Boillat P, 2017, CURR OPIN ELECTROCHE, V5, P3, DOI 10.1016/j.coelec.2017.07.012; Boillat P, 2010, ELECTROCHEM SOLID ST, V13, pB25, DOI 10.1149/1.3279636; Boin M, 2012, J APPL CRYSTALLOGR, V45, P603, DOI 10.1107/S0021889812016056; BROOKS RA, 1976, PHYS MED BIOL, V21, P390, DOI 10.1088/0031-9155/21/3/004; Buzug T.M., 2008, COMPUTED TOMOGRAPHY; Carminati A, 2010, PLANT SOIL, V332, P163, DOI 10.1007/s11104-010-0283-8; FRANKE R, 1982, COMPUT MATH APPL, V8, P273, DOI 10.1016/0898-1221(82)90009-8; Grunzweig C, 2013, PHYSCS PROC, V43, P231, DOI 10.1016/j.phpro.2013.03.027; Hassan MH, 2009, NUCL INSTRUM METH B, V267, P2545, DOI 10.1016/j.nimb.2009.05.062; Hassanein R, 2005, NUCL INSTRUM METH A, V542, P353, DOI 10.1016/j.nima.2005.01.161; Hassanein R, 2006, PHYSICA B, V385-86, P1194, DOI 10.1016/j.physb.2006.05.406; Kaestner A, 2008, ADV WATER RESOUR, V31, P1174, DOI 10.1016/j.advwatres.2008.01.022; Kaestner A, 2018, MUHREC NEW FACE ADDE; Kaestner AP, 2011, NUCL INSTRUM METH A, V659, P387, DOI 10.1016/j.nima.2011.08.022; Kaestner AP, 2016, SOLID EARTH, V7, P1281, DOI 10.5194/se-7-1281-2016; Kaestner AP, 2011, NUCL INSTRUM METH A, V651, P156, DOI 10.1016/j.nima.2011.01.129; Kardjilov N, 2005, NUCL INSTRUM METH A, V542, P336, DOI 10.1016/j.nima.2005.01.159; Kardjilov N, 2005, NUCL INSTRUM METH A, V542, P16, DOI 10.1016/j.nima.2005.01.005; Kardjilov N, 2018, MAT TODAY; Kardjilov N, 2011, MATER TODAY, V14, P248, DOI 10.1016/S1369-7021(11)70139-0; Lefmann K., 1999, NEUTRON NEWS, V10, P20, DOI [10.1080/10448639908233684, DOI 10.1080/10448639908233684]; Lehmann EH, 2007, NUCL INSTRUM METH A, V576, P389, DOI 10.1016/j.nima.2007.03.017; Lehmann E.H., 2001, NONDESTRUCT TEST EVA, V16, P191, DOI DOI 10.1080/10589750108953075; Lehmann EH, 2018, J ARCHAEOL SCI-REP, V20, P239, DOI 10.1016/j.jasrep.2018.05.004; Liu SQ, 2014, SCI CHINA PHYS MECH, V57, P244, DOI 10.1007/s11433-013-5362-4; Mannes D, 2009, HOLZFORSCHUNG, V63; Otsu N., THRESHOLD SELECTION; Peetermans S, 2014, NUCL INSTRUM METH A, V757, P28, DOI 10.1016/j.nima.2014.04.033; Perfect E, 2014, EARTH-SCI REV, V129, P120, DOI 10.1016/j.earscirev.2013.11.012; Radebe MJ, 2011, NUCL INSTRUM METH A, V651, P282, DOI 10.1016/j.nima.2011.02.023; Rant J, 2006, APPL RADIAT ISOTOPES, V64, P7, DOI 10.1016/j.apradiso.2005.06.003; Raventos M, 2018, J APPL CRYSTALLOGR, V51, P386, DOI 10.1107/S1600576718001607; Schulz M, 2009, NUCL INSTRUM METH A, V605, P33, DOI 10.1016/j.nima.2009.01.123; Shokri N, 2008, WATER RESOUR RES, V44; Strobl M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/24/243001; Treimer W, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2384801; Tremsin AS, 2011, NUCL INSTRUM METH A, V628, P415, DOI 10.1016/j.nima.2010.07.014; Tremsin AS, 2011, NUCL INSTRUM METH A, V651, P145, DOI 10.1016/j.nima.2011.01.066; Trtik P, 2016, J PHYS CONF SER, V746, DOI 10.1088/1742-6596/746/1/012004; Vontobel P, 2006, PHYSICA B, V385, P475, DOI 10.1016/j.physb.2006.05.252; Zawisky M, 2004, J NUCL MATER, V327, P188, DOI 10.1016/j.jnucmat.2004.02.011	45	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210300	10.1371/journal.pone.0210300	http://dx.doi.org/10.1371/journal.pone.0210300			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608985	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800059
J	Kthiri, A; Hidouri, S; Wiem, T; Jeridi, R; Sheehan, D; Landouls, A				Kthiri, Ameni; Hidouri, Slah; Wiem, Tahri; Jeridi, Roua; Sheehan, David; Landouls, Ahmed			Biochemical and biomolecular effects induced by a static magnetic field in Saccharomyces cerevisiae: Evidence for oxidative stress	PLOS ONE			English	Article							GENE-EXPRESSION; YEAST; EXPOSURE; VIABILITY; RESPONSES; MEMBRANE; PROTEINS; GROWTH	Exposure to static magnetic fields (SMF) can cause changes in microorganism metabolism altering key subcellular functions. The purpose of this study was to investigate whether an applied SMF could induce biological effects on growth of Saccharomyces cerevisiae, and then to probe biochemical and bio-molecular responses. We found a decrease in growth and viability under SMF (250mT) after 6h with a significant decrease in colony forming units followed by an increase between 6 h and 9 h. Moreover, measurements of antioxidant enzyme activities (catalase, superoxide dismutase, glutathione peroxidase) demonstrated a particular profile suggesting oxidative stress. For instance, SOD and catalase activities increased in magnetized cultures after 9 h compared with unexposed samples. However, SMF exposure caused a decrease in glutathione peroxidase activity. Finally, SMF caused an increase in MDA levels as well as the content of protein carbonyl groups after 6 and 9 h of exposure.	[Kthiri, Ameni; Hidouri, Slah; Wiem, Tahri; Jeridi, Roua; Landouls, Ahmed] Carthage Univ, Lab Biochem & Mol Biol, Fac Sci Bizerte Zarzouna, Bizerte, Tunisia; [Kthiri, Ameni; Sheehan, David] Univ Coll Cork, Environm Res Inst, Western Gateway Bldg,Western Rd, Cork, Ireland; [Kthiri, Ameni; Sheehan, David] Univ Coll Cork, Sch Biochem & Cell Biol, Western Gateway Bldg,Western Rd, Cork, Ireland; [Sheehan, David] Khalifa Univ Sci & Technol, Dept Chem, Coll Arts & Sci, Abu Dhabi, U Arab Emirates	Universite de Carthage; University College Cork; University College Cork; Khalifa University of Science & Technology	Sheehan, D (corresponding author), Univ Coll Cork, Environm Res Inst, Western Gateway Bldg,Western Rd, Cork, Ireland.; Sheehan, D (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Western Gateway Bldg,Western Rd, Cork, Ireland.; Sheehan, D (corresponding author), Khalifa Univ Sci & Technol, Dept Chem, Coll Arts & Sci, Abu Dhabi, U Arab Emirates.	david.sheehan@ku.ac.ae	Sheehan, David/ABB-5315-2020	Landoulsi, Ahmed/0000-0002-5101-7641				Amara S, 2007, ENVIRON TOXICOL PHAR, V23, P193, DOI 10.1016/j.etap.2006.09.001; Amara S, 2006, ARCH MED RES, V37, P947, DOI 10.1016/j.arcmed.2006.06.004; Bayliak M, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1013, DOI 10.1134/S0006297906090100; BEERS RF, 1952, J BIOL CHEM, V195, P133; Binninger DM, 1997, BIOELECTROCH BIOENER, V43, P83, DOI 10.1016/S0302-4598(96)05180-X; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Costa WMV, 2002, FREE RADICAL BIO MED, V33, P1507, DOI 10.1016/S0891-5849(02)01086-9; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; Davies MS, 1996, BIOELECTROMAGNETICS, V17, P154, DOI 10.1002/(SICI)1521-186X(1996)17:2<154::AID-BEM10>3.0.CO;2-S; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Egami S, 2010, BIOELECTROMAGNETICS, V31, P622, DOI 10.1002/bem.20599; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Fojt L, 2004, BIOELECTROCHEMISTRY, V63, P337, DOI 10.1016/j.bioelechem.2003.11.010; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Friedl AA, 1998, GENETICS, V148, P975; Galvanovskis J, 1998, BIOELECTROCH BIOENER, V46, P161, DOI 10.1016/S0302-4598(98)00143-3; Ghodbane S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/602987; Hanini R, 2017, CURR MICROBIOL, V74, P930, DOI 10.1007/s00284-017-1264-4; Iwasaka M, 2004, BIOELECTROCHEMISTRY, V65, P59, DOI 10.1016/j.bioelechem.2004.04.002; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kabuto H, 2001, Pathophysiology, V7, P283, DOI 10.1016/S0928-4680(00)00062-6; KUBOTA K, 1995, J PERIODONTOL, V66, P2, DOI 10.1902/jop.1995.66.1.2; Kula B, 1996, BIOELECTROCH BIOENER, V39, P27, DOI 10.1016/0302-4598(95)01843-3; Kurzeja E, 2013, INT J MOL SCI, V14, P15017, DOI 10.3390/ijms140715017; Laramee CB, 2014, BIOELECTROMAGNETICS, V35, P406, DOI 10.1002/bem.21857; Laszlo J, 2010, BIOELECTROMAGNETICS, V31, P220, DOI 10.1002/bem.20551; LENZ AG, 1989, ANAL BIOCHEM, V177, P419, DOI 10.1016/0003-2697(89)90077-8; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024697; Ljubuncic P, 2000, GUT, V47, P710, DOI 10.1136/gut.47.5.710; Mattsson MO, 2012, TOXICOLOGY, V301, P1, DOI 10.1016/j.tox.2012.06.011; McCann J, 1998, MUTAT RES-REV MUTAT, V411, P45, DOI 10.1016/S1383-5742(98)00006-4; Mizuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066528; Motta MA, 2001, BIOTECHNOL PROGR, V17, P970, DOI 10.1021/bp010076e; Nakasono S, 2000, RADIAT RES, V154, P208, DOI 10.1667/0033-7587(2000)154[0208:EOEMFO]2.0.CO;2; Nakasono S, 2003, RADIAT RES, V160, P25, DOI 10.1667/RR3006; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Novak J, 2007, BIOELECTROCHEMISTRY, V70, P115, DOI 10.1016/j.bioelechem.2006.03.029; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Polavarapu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114766; Politanski P, 2010, INT J OCCUP MED ENV, V23, P377, DOI 10.2478/v10001-010-0041-4; Pompella A, 1997, INT J VITAM NUTR RES, V67, P289; Ruiz-Gomez MJ, 2004, BIOELECTROCHEMISTRY, V64, P151, DOI 10.1016/j.bioelechem.2004.04.003; Sabo J, 2002, BIOELECTROCHEMISTRY, V56, P227, DOI 10.1016/S1567-5394(02)00027-0; Shahandashti SSK, 2013, MOL BIOL REP, V40, P893, DOI 10.1007/s11033-012-2130-x; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; STEELS EL, 1994, MICROBIOL-SGM, V140, P569, DOI 10.1099/00221287-140-3-569; Strasak L, 2002, BIOELECTROCHEMISTRY, V55, P161, DOI 10.1016/S1567-5394(01)00152-9; Sullivan K, 2011, BIOELECTROMAGNETICS, V32, P140, DOI 10.1002/bem.20624; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; Vergallo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113530; WOLFF SP, 1986, TRENDS BIOCHEM SCI, V11, P27, DOI 10.1016/0968-0004(86)90228-8; Xie TD, 1997, BIOPHYS J, V72, P2496, DOI 10.1016/S0006-3495(97)78894-5	55	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209843	10.1371/journal.pone.0209843	http://dx.doi.org/10.1371/journal.pone.0209843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608963	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800027
J	Krassovka, J; Borgschulze, A; Sahlender, B; Logters, T; Windolf, J; Grotheer, V				Krassovka, Julia; Borgschulze, Annika; Sahlender, Benita; Loegters, Tim; Windolf, Joachim; Grotheer, Vera			Blue light irradiation and its beneficial effect on Dupuytren's fibroblasts	PLOS ONE			English	Article							DISEASE; GROWTH; CONTRACTURE; DIFFERENTIATION; MYOFIBROBLAST; STIMULATION; CELLS; BETA	Dupuytren's contracture is a fibroproliferative disorder affecting the palmar fascia of the hand. Most affected are the ring fingers, and little fingers of middle-aged men. Symptomatic for this disease is the increased proliferation and differentiation of fibroblasts to myofibroblasts, which is accompanied by an elevated alpha-SMA expression. The present study evaluated the therapeutic benefit of blue light (lambda = 453 nm, 38 mW/cm(2), continuous radiance, spot size 10-12 cm(2)) as well as the molecular mechanism mediating this effect. It could be determined that blue light significantly diminished the induced alpha-SMA protein expression in both normal palmar fibroblasts and Duypuytren's fibroblasts. The beneficial effect mediated by this irradiance, radiant exposure and wavelength was associated with an elevated reactive oxygen species generation. Furthermore, the data underlines the potential usefulness of blue light irradiation as a promising therapy option for Dupuytren's disease, especially for relapse prevention, and may represent a useful strategy to treat further fibrotic diseases, such as keloids, hypertrophic scarring, and scleroderma.	[Krassovka, Julia; Borgschulze, Annika; Sahlender, Benita; Loegters, Tim; Windolf, Joachim; Grotheer, Vera] Heinrich Heine Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Grotheer, V (corresponding author), Heinrich Heine Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany.	vera.grotheer@med.uni-duesseldorf.de						Adamskaya N, 2011, INJURY, V42, P917, DOI 10.1016/j.injury.2010.03.023; Badalamente MA, 2000, J HAND SURG-AM, V25A, P629, DOI 10.1053/jhsu.2000.6918; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boulton M, 2004, PHOTOCH PHOTOBIO SCI, V3, P759, DOI 10.1039/b400108g; Feldman G, 2017, ISR MED ASSOC J, V19, P648; Fischer MR, 2013, EXP DERMATOL, V22, P558, DOI 10.1111/exd.12193; Gorgidze LA, 1998, BIOSCIENCE REP, V18, P215, DOI 10.1023/A:1020104914726; Gudmundsson KG, 2001, SCAND J RHEUMATOL, V30, P31; Jemec B, 1999, J HAND SURG-BRIT EUR, V24B, P511, DOI 10.1054/jhsb.1999.0251; KARU T, 1994, INT J RADIAT BIOL, V65, P691, DOI 10.1080/09553009414550811; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Krause C, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-14; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Meek RMD, 2002, J HAND SURG-BRIT EUR, V27B, P270, DOI 10.1054/jhsb.2001.0742; Niemz MH, 2007, LASER TISSUE INTERAC; Ohara M, 2003, CANCER SCI, V94, P205, DOI 10.1111/j.1349-7006.2003.tb01420.x; Oplander C, 2011, J PHOTOCH PHOTOBIO B, V103, P118, DOI 10.1016/j.jphotobiol.2011.02.018; Pavelic SK, 2009, J PATHOL, V217, P524, DOI 10.1002/path.2483; Picardo NE, 2012, SURG-J R COLL SURG E, V10, P151, DOI 10.1016/j.surge.2012.01.004; Rayan GM, 2007, J BONE JOINT SURG AM, P89; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Shaw RB, 2007, PLAST RECONSTR SURG, V120, p44E, DOI 10.1097/01.prs.0000278455.63546.03; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Shnitkind Elaine, 2006, J Drugs Dermatol, V5, P605; Stromberg J, 2016, J HAND SURG-AM, V41, P873, DOI 10.1016/j.jhsa.2016.06.014; Taflinski L, 2014, EXP DERMATOL, V23, P240, DOI 10.1111/exd.12353; TOMASEK JJ, 1986, J HAND SURG-AM, V11A, P365, DOI 10.1016/S0363-5023(86)80143-5; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33719; Wilutzky B, 1998, HISTOL HISTOPATHOL, V13, P67, DOI 10.14670/HH-13.67	32	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209833	10.1371/journal.pone.0209833	http://dx.doi.org/10.1371/journal.pone.0209833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633751	Green Published, gold, Green Submitted			2022-12-26	WOS:000455485100006
J	Laffranchi, M; Elliston, ELK; Gangemi, F; Berardelli, R; Lomas, DA; Irving, JA; Fra, A				Laffranchi, Mattia; Elliston, Emma L. K.; Gangemi, Fabrizio; Berardelli, Romina; Lomas, David A.; Irving, James A.; Fra, Annamaria			Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general population	PLOS ONE			English	Article							REACTIVE CENTER LOOP; SERPIN-PROTEINASE COMPLEX; Z ALPHA(1)-ANTITRYPSIN; CONFORMATIONAL-CHANGE; PROTEASE COMPLEX; HINGE REGION; ACTIVE-SITE; INHIBITOR; ANTITHROMBIN; INSERTION	Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity, mainly by neutrophil elastase (HNE), in the lung parenchyma. This is the result of a substantial reduction of circulating alpha-1-antitrypsin (AAT) and the presence in the plasma of inactive polymers of AAT. Moreover, some AAT mutants have reduced intrinsic activity toward HNE, as demonstrated for the common Z mutant, as well as for other rarer variants. Here we report the identification and characterisation of the novel AAT reactive centre loop variant Gly349Arg (p.G373R) present in the ExAC database. This AAT variant is secreted at normal levels in cellular models of AATD but shows a severe reduction in anti-HNE activity. Biochemical and molecular dynamics studies suggest it exhibits unfavourable RCL presentation to cognate proteases and compromised insertion of the RCL into beta-sheet A. Identification of a fully dysfunctional AAT mutant that does not show a secretory defect underlines the importance of accurate genotyping of patients with pulmonary AATD manifestations regardless of the presence of normal levels of AAT in the circulation. This subtype of disease is reminiscent of dysfunctional phenotypes in anti-thrombin and C1-inibitor deficiencies so, accordingly, we classify this variant as the first pure functionally-deficient (type II) AATD mutant.	[Laffranchi, Mattia; Gangemi, Fabrizio; Berardelli, Romina; Fra, Annamaria] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Elliston, Emma L. K.; Lomas, David A.; Irving, James A.] UCL, UCL Resp, London, England; [Elliston, Emma L. K.; Lomas, David A.; Irving, James A.] UCL, Inst Struct & Mol Biol, London, England	University of Brescia; University of London; University College London; University of London; Birkbeck University London; University College London	Fra, A (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.; Irving, JA (corresponding author), UCL, UCL Resp, London, England.; Irving, JA (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	j.irving@ucl.ac.uk; annamaria.fra@unibs.it	Laffranchi, Mattia/GZK-2643-2022; Laffranchi, Mattia/AAF-5731-2019; Irving, James A/I-8467-2015; Fra, Annamaria/I-5532-2012; Irving, James/P-3860-2019	Laffranchi, Mattia/0000-0002-0556-6068; Fra, Annamaria/0000-0002-4327-3004; Irving, James/0000-0003-3204-6356; Berardelli, Romina/0000-0001-5167-0504	Medical Research Council UK Programme grant [MR/N024842/1]; UCLH NIHR Biomedical Research Centre; Fondazione Cariplo [2013-0967]; Italian association Alfa1-AT; Wellcome Trust PhD studentship; MRC [MR/N024842/1] Funding Source: UKRI	Medical Research Council UK Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH NIHR Biomedical Research Centre; Fondazione Cariplo(Fondazione Cariplo); Italian association Alfa1-AT; Wellcome Trust PhD studentship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DAL acknowledges funding from a Medical Research Council UK (url: mrc.ukri.org/) Programme grant (MR/N024842/1) and the support of the UCLH NIHR Biomedical Research Centre. AF acknowledges funding from Fondazione Cariplo (2013-0967) (url: www.fondazionecariplo.it) and by the Italian association Alfa1-AT. ELKE is the recipient of a Wellcome Trust PhD studentship (url: wellcome.ac.uk). Computing resources of FG were provided by CINECA (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aguila S, 2017, J BIOL CHEM, V292, P16513, DOI 10.1074/jbc.M117.787325; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Andersen OJ, 2017, BIOCHEMISTRY-US, V56, P634, DOI 10.1021/acs.biochem.6b00839; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Caccia S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16667-w; Carugati A, 2001, MOL IMMUNOL, V38, P161, DOI 10.1016/S0161-5890(01)00040-2; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Cook L, 1996, PATHOLOGY, V28, P242, DOI 10.1080/00313029600169074; Corral J, 2018, THROMB RES, V169, P23, DOI 10.1016/j.thromres.2018.07.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Fra AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038405; Fra A, 2018, METHODS MOL BIOL, V1826, P109, DOI 10.1007/978-1-4939-8645-3_7; Fra A, 2016, EUR RESPIR J, V47, P1005, DOI 10.1183/13993003.00940-2015; Giacopuzzi E, 2018, HUM MUTAT, V39, P1203, DOI 10.1002/humu.23562; Haq I, 2016, AM J RESP CELL MOL, V54, P71, DOI 10.1165/rcmb.2015-0154OC; Haq I, 2013, BIOSCIENCE REP, V33, P499, DOI 10.1042/BSR20130038; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; JORG M, 1985, THROMB RES, V39, P323, DOI 10.1016/0049-3848(85)90228-2; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; KOIDE T, 1984, P NATL ACAD SCI-BIOL, V81, P289, DOI 10.1073/pnas.81.2.289; Laffranchi M, 2018, HUM MOL GENET, V27, P1785, DOI 10.1093/hmg/ddy090; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lukacs CM, 1998, BIOCHEMISTRY-US, V37, P3297, DOI 10.1021/bi972359e; Maddur AA, 2013, J BIOL CHEM, V288, P32020, DOI 10.1074/jbc.M113.510990; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Medicina D, 2009, HUM MUTAT, V30, pE771, DOI 10.1002/humu.21043; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2017, FEBS J, V284, P2110, DOI 10.1111/febs.14111; Nyon MP, 2012, STRUCTURE, V20, P504, DOI 10.1016/j.str.2012.01.012; OKAYAMA H, 1991, AM J HUM GENET, V48, P1154; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; RAO NV, 1991, J BIOL CHEM, V266, P9540; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ronzoni R, 2016, HUM MOL GENET, V25, P642, DOI 10.1093/hmg/ddv501; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Tan L, 2014, EUR RESPIR J, V43, P1501, DOI 10.1183/09031936.00111213; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Tiberio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059410; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Yamasaki M, 2010, J BIOL CHEM, V285, P30752, DOI 10.1074/jbc.M110.156042; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0206955	10.1371/journal.pone.0206955	http://dx.doi.org/10.1371/journal.pone.0206955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633749	Green Published, Green Submitted, gold			2022-12-26	WOS:000455485100001
J	Tanaka, T; Nishimura, F; Kakiuchi, C; Kasai, K; Kimura, M; Haruno, M				Tanaka, Toshiko; Nishimura, Fumichika; Kakiuchi, Chihiro; Kasai, Kiyoto; Kimura, Minoru; Haruno, Masahiko			Interactive effects of OXTR and GAD1 on envy-associated behaviors and neural responses	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RECEPTOR GENE OXTR; ECONOMIC DECISION-MAKING; POLYMORPHISM OXTR; SOCIAL COGNITION; ULTIMATUM GAME; GABA LEVELS; OXYTOCIN; AMYGDALA; BRAIN	Inequity aversion (negative feelings induced by outcome differences between the self and other) plays a key role in human social behaviors. The neurotransmitters oxytocin and GABA have been implicated in neural responses to inequity. However, it remains poorly understood not only how individual genetic factors related to oxytocin and GABA affect the neural mechanisms behind inequity aversion, but also how these genes interact. To address these issues, we examined relationships between genotypes, behavioral decisions and brain activities during the ultimatum game. We identified interactive effects between the polymorphisms of the oxytocin receptor gene (OXTR) and glutamate decarboxylase 1 gene for GABA synthesis (GAD1) on envy aversion (i.e., disadvantageous inequity aversion) and on envy-induced activity in the dorsal ACC (dACC). Thus, our integrated approach suggested interactive genetic effects between OXTR and GAD1 on envy aversion and the underlying neural substrates.	[Tanaka, Toshiko; Haruno, Masahiko] NICT, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Nishimura, Fumichika; Kakiuchi, Chihiro; Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Kimura, Minoru] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Nishimura, Fumichika] Univ Tokyo, Div Counseling & Support, Bunkyo Ku, Tokyo, Japan; [Kakiuchi, Chihiro] Univ Tokyo, Disabil Serv Off, Bunkyo Ku, Tokyo, Japan	National Institute of Information & Communications Technology (NICT) - Japan; University of Tokyo; University of Tokyo; University of Tokyo	Tanaka, T (corresponding author), NICT, Ctr Informat & Neural Networks, Suita, Osaka, Japan.	toshiko_t@nict.go.jp	Kakiuchi, Chihiro/AAO-1103-2020	Kasai, Kiyoto/0000-0002-4443-4535	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Center of innovation at Osaka University [17H06314, 26242087]; JST AIP-PRISM [JPMJCR18ZR]	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Center of innovation at Osaka University; JST AIP-PRISM	This work was supported by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), the Center of innovation at Osaka University, Grant-in-Aid for Scientific Reserch (KAKENHI) (17H06314 and 26242087) and JST AIP-PRISM (JPMJCR18ZR). These funders had roles in data collection, analysis, and preparation of manuscripts.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Apps MAJ, 2016, NEURON, V90, P692, DOI 10.1016/j.neuron.2016.04.018; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccia ML, 2013, NEUROSCIENCE, V253, P155, DOI 10.1016/j.neuroscience.2013.08.048; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chang SW, 2015, P NATL ACAD SCI USA, V112, P15012, DOI [10.1073/pnas.1520704112, DOI 10.1073/PNAS.1520704112]; Colic L, 2018, J NEUROSCI, V38, P5067, DOI 10.1523/JNEUROSCI.1985-17.2018; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Eckstein M, 2017, NEUROIMAGE, V149, P458, DOI 10.1016/j.neuroimage.2017.01.078; Eden AS, 2015, J NEUROSCI, V35, P6020, DOI 10.1523/JNEUROSCI.3659-14.2015; Fatfouta R, 2018, SOC NEUROSCI-UK, V13, P61, DOI 10.1080/17470919.2016.1252795; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Feng CL, 2015, HUM BRAIN MAPP, V36, P591, DOI 10.1002/hbm.22649; Fliessbach K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00165; Gabay AS, 2014, NEUROSCI BIOBEHAV R, V47, P549, DOI 10.1016/j.neubiorev.2014.10.014; Gospic K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001054; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haruno M, 2014, J COGNITIVE NEUROSCI, V26, P1861, DOI 10.1162/jocn_a_00589; Haruno M, 2010, NAT NEUROSCI, V13, P160, DOI 10.1038/nn.2468; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20236; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Karlsson Linner R, 2018, BIORXIV, DOI [10.1101/261081, DOI 10.1101/261081]; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Klackl J, 2013, BIOL PSYCHOL, V92, P387, DOI 10.1016/j.biopsycho.2012.11.010; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kodaka F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041338; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Levar N, 2017, NEUROIMAGE, V158, P136, DOI 10.1016/j.neuroimage.2017.06.055; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; Lockwood PL, 2015, J NEUROSCI, V35, P13720, DOI 10.1523/JNEUROSCI.1703-15.2015; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Marenco S, 2010, NEUROPSYCHOPHARMACOL, V35, P1708, DOI 10.1038/npp.2010.35; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Nihonsugi T, 2015, J NEUROSCI, V35, P3412, DOI 10.1523/JNEUROSCI.3885-14.2015; Nishina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137089; Ogawa T., 1998, TRH244 ATR; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Qi J, 2012, ADDICT BIOL, V17, P758, DOI 10.1111/j.1369-1600.2012.00439.x; Radke S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00193; Riem MME, 2013, EUR NEUROPSYCHOPHARM, V23, P1288, DOI 10.1016/j.euroneuro.2013.01.011; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Sabihi S, 2017, NEUROPHARMACOLOGY, V125, P1, DOI 10.1016/j.neuropharm.2017.06.024; Saito Y, 2014, SOC COGN AFFECT NEUR, V9, P1443, DOI 10.1093/scan/nst136; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sesarini CV, 2015, PSYCHIAT RES, V229, P580, DOI 10.1016/j.psychres.2015.07.077; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Stankova T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-17; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tsang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062322; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x; Yu RJ, 2014, HUM BRAIN MAPP, V35, P3290, DOI 10.1002/hbm.22402; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	74	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210493	10.1371/journal.pone.0210493	http://dx.doi.org/10.1371/journal.pone.0210493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633779	gold, Green Published, Green Submitted			2022-12-26	WOS:000455485100025
J	Huang, WS; Chu, IM				Huang, Wei-Shun; Chu, I-Ming			Injectable polypeptide hydrogel/inorganic nanoparticle composites for bone tissue engineering	PLOS ONE			English	Article							STATIC MAGNETIC-FIELDS; MESENCHYMAL STEM-CELLS; IN-VITRO; HYDROXYAPATITE NANOPARTICLES; OSTEOGENIC DIFFERENTIATION; SECONDARY STRUCTURE; HYDROGELS; CALCIUM; SCAFFOLDS; ANTIBACTERIAL	The general concept of tissue engineering is to restore biological function by replacing defective tissues with implantable, biocompatible, and easily handleable cell-laden scaffolds. In this study, osteoinductive and osteoconductive super paramagnetic Fe3O4 nanoparticles (MNP) and hydroxyapatite (HAP) nanoparticles were incorporated into a di-block copolymer based thermo-responsive hydrogel, methoxy(polyethylene glycol)-polyalanine (mPA), at various concentrations to afford composite, injectable hydrogels. Incorporating nanoparticles into the thermo-responsive hydrogel increased the complex viscosity and decreased the gelation temperature of the starting hydrogel. Functionally, the integration of inorganic nanoparticles modulated bio-markers of bone differentiation and enhanced bone mineralization. Moreover, this study adopted the emerging method of using either a supplementary static magnetic field (SMF) or a moving magnetic field to elicit biological response. These results demonstrate that combining external (magnet) and internal (scaffold) magne-tisms is a promising approach for bone regeneration.	[Huang, Wei-Shun; Chu, I-Ming] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan	National Tsing Hua University	Chu, IM (corresponding author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.	imchu@che.nthu.edu.tw	Chu, I-Ming/AAL-1148-2021	HUANG, WEI SHUN/0000-0001-6381-5184	Ministry of Science and Technology (Taiwan) [104-2221-E-007-126-MY3]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the grant 104-2221-E-007-126-MY3 from the Ministry of Science and Technology (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007; Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016; Chirinos JR, 2014, J ANAL ATOM SPECTROM, V29, P1292, DOI 10.1039/c4ja00066h; Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Chung HJ, 2009, NANO TODAY, V4, P429, DOI 10.1016/j.nantod.2009.08.008; Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047; Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Fan D, 2014, CIRC RES, V114, P889, DOI 10.1161/CIRCRESAHA.114.302335; Fu YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091581; Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z; Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t; Gao TJ, 1996, J BIOMED MATER RES, V32, P505, DOI 10.1002/(SICI)1097-4636(199612)32:4<505::AID-JBM2>3.0.CO;2-V; Gloria A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0833; Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/anie.200200546; Haraguchi K, 2007, MACROMOLECULAR S, DOI [10.1002/masy.200750318, DOI 10.1002/MASY.200750318]; Haraguchi K, 2007, CURR OPIN SOLID ST M, V11, P47, DOI 10.1016/j.cossms.2008.05.001; Hou RX, 2013, COLLOID SURFACE B, V103, P318, DOI 10.1016/j.colsurfb.2012.10.067; Huang HM, 2006, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000203464.35561.be; Karadzic I, 2015, J BIOMED MATER RES A, V103, P350, DOI 10.1002/jbm.a.35180; Kim EC, 2015, BIOELECTROMAGNETICS, V36, P267, DOI 10.1002/bem.21903; Kim SJ, 2014, ACS APPL MATER INTER, V6, P17034, DOI 10.1021/am504652y; Kim U, 2007, P NATL ACAD SCI USA, V104, P20708, DOI 10.1073/pnas.0708760104; Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Lee H, 2007, J AM CHEM SOC, V129, P12739, DOI 10.1021/ja072210i; Lee JS, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043201; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Li DW, 2014, ACS APPL MATER INTER, V6, P9402, DOI 10.1021/am5017792; Li L, 2008, J MATER CHEM, V18, P4079, DOI 10.1039/b806090h; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Lin Y, 2005, NATURE, V434, P55, DOI 10.1038/nature03310; Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3; Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1; Luo F, 2012, ORTHOPEDICS, V35, pE526, DOI 10.3928/01477447-20120327-11; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; MCDONALD F, 1993, BIOELECTROMAGNETICS, V14, P187, DOI 10.1002/bem.2250140302; Meng J, 2013, SCI REPORTS, V3, DOI [10.1016/j.bone.2013.07.015, DOI 10.1016/J.BONE.2013.07.015]; Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045; Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504; Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034; Panseri S, 2013, BONE, V56, P432, DOI 10.1016/j.bone.2013.07.015; Panseri S, 2012, J BIOMED MATER RES A, V100A, P2278, DOI 10.1002/jbm.a.34167; Park MH, 2014, ADV HEALTHC MATER, V3, P1782, DOI 10.1002/adhm.201400140; Peng S, 2017, MAT SCI ENG C-MATER, V76, P181, DOI 10.1016/j.msec.2017.02.130; Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1; Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k; Pozebon D, 2014, J ANAL ATOM SPECTROM, V29, P2204, DOI 10.1039/c4ja00250d; Rea SM, 2004, J MATER SCI-MATER M, V15, P997, DOI 10.1023/B:JMSM.0000042685.63383.86; Remya NS, 2014, COLLOID SURFACE B, V117, P389, DOI 10.1016/j.colsurfb.2014.02.004; Ren KX, 2016, BIOMACROMOLECULES, V17, P3862, DOI 10.1021/acs.biomac.6b00884; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Su DH, 2016, ACS APPL MATER INTER, V8, P9619, DOI 10.1021/acsami.6b00891; Sun C, 2008, SMALL, V4, P372, DOI 10.1002/smll.200700784; Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tsutsumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086834; Uskokovic V, 2013, ACS APPL MATER INTER, V5, P2422, DOI 10.1021/am4000694; Wongwitwichot P, 2010, Open Biomed Eng J, V4, P279, DOI 10.2174/1874120701004010279; Wu ATH, 2015, BIOMACROMOLECULES, V16, P166, DOI 10.1021/bm501356c; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264; Zhang XY, 2006, BIOELECTROMAGNETICS, V27, P1, DOI 10.1002/bem.20165; Zhang YX, 2016, POLYMER, V86, P32, DOI 10.1016/j.polymer.2016.01.030; Zhao RB, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2353-y; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	74	24	24	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210285	10.1371/journal.pone.0210285	http://dx.doi.org/10.1371/journal.pone.0210285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629660	Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000069
J	Neilsen, BK; Frodyma, DE; McCall, JL; Fisher, KW; Lewis, RE				Neilsen, Beth K.; Frodyma, Danielle E.; McCall, Jamie L.; Fisher, Kurt W.; Lewis, Robert E.			eERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells	PLOS ONE			English	Article							FEMALE FLIGHT ATTENDANTS; CLOCK GENE-EXPRESSION; CIRCADIAN CLOCK; BREAST-CANCER; MAMMALIAN TIMELESS; DNA-REPLICATION; COLORECTAL-CANCER; TIPIN; COMPLEX; MAINTENANCE	The cell cycle is under circadian regulation. Oncogenes can dysregulate circadian-regulated genes to disrupt the cell cycle, promoting tumor cell proliferation. As a regulator of G2/M arrest in response to DNA damage, the circadian gene Timeless Circadian Clock (TIMELESS) coordinates this connection and is a potential locus for oncogenic manipulation. TIMELESS expression was evaluated using RNASeq data from TCGA and by RT-qPCR and western blot analysis in a panel of colon cancer cell lines. TIMELESS expression following ERK inhibition was examined via western blot. Cell metabolic capacity, propidium iodide, and CFSE staining were used to evaluate the effect of TIMELESS depletion on colon cancer cell survival and proliferation. Cell metabolic capacity following TIMELESS depletion in combination with Wee1 or CHK1 inhibition was assessed. TIMELESS is overexpressed in cancer and required for increased cancer cell proliferation. ERK activation promotes TIMELESS expression. TIMELESS depletion increases gamma H2AX, a marker of DNA damage, and triggers G2/M arrest via increased CHK1 and CDK1 phosphorylation. TIMELESS depletion in combination with Wee1 or CHK1 inhibition causes an additive decrease in cancer cell metabolic capacity with limited effects in non-transformed human colon epithelial cells. The data show that ERK activation contributes to the overexpression of TIMELESS in cancer. Depletion of TIMELESS increases gamma H2AX and causes G2/M arrest, limiting cell proliferation. These results demonstrate a role for TIMELESS in cancer and encourage further examination of the link between circadian rhythm dysregulation and cancer cell proliferation.	[Neilsen, Beth K.; Frodyma, Danielle E.; McCall, Jamie L.; Fisher, Kurt W.; Lewis, Robert E.] Univ Nebraska Med Ctr, Eppley Inst, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Fisher, Kurt W.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [McCall, Jamie L.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; West Virginia University	Lewis, RE (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	rlewis@unmc.edu	McCall, Jamie/K-8085-2019	McCall, Jamie/0000-0001-5914-6336; Fisher, Kurt/0000-0002-8391-390X	National Cancer Institute [CA157774, CA203397, CA009476, CA036727]; National Institutes of Health [GM104320, GM121316]; NATIONAL CANCER INSTITUTE [F30CA203397, T32CA009476] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by multiple grants including: National Cancer Institute (CA157774) to Dr. Robert E. Lewis; National Cancer Institute (CA203397) to Dr. Beth K. Neilsen; National Cancer Institute (CA009476) to Mrs. Danielle E. Frodyma; National Cancer Institute (CA036727) to Dr. Robert E. Lewis; National Institutes of Health (GM104320) to Dr. Robert E. Lewis; National Institutes of Health (GM121316) to Dr. Robert E. Lewis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Buja A, 2006, J WOMENS HEALTH, V15, P98, DOI 10.1089/jwh.2006.15.98; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chi LM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0838-1; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dheekollu J, 2013, J VIROL, V87, P3699, DOI 10.1128/JVI.02211-12; Dheekollu J, 2011, J VIROL, V85, P5853, DOI 10.1128/JVI.02425-10; Dheekollu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019596; Fisher KW, 2015, MOL CELL BIOL, V35, P3866, DOI 10.1128/MCB.00528-15; Fu A, 2012, MOL CARCINOGEN, V51, P923, DOI 10.1002/mc.20862; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Inaguma Y, 2015, NEUROSCI RES, V92, P21, DOI 10.1016/j.neures.2014.10.017; Kawada M, 1997, BIOCHEM BIOPH RES CO, V231, P735, DOI 10.1006/bbrc.1997.6179; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; Lamont EW, 2007, SLEEP MED, V8, P547, DOI 10.1016/j.sleep.2006.11.002; Leman AR, 2012, CELL CYCLE, V11, P2337, DOI 10.4161/cc.20810; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Li ZX, 2000, P NATL ACAD SCI USA, V97, P10038, DOI 10.1073/pnas.97.18.10038; Mao YY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-498; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mazzoccoli G, 2011, CHRONOBIOL INT, V28, P841, DOI 10.3109/07420528.2011.615182; McCall JL, 2016, MOL CELL BIOL, V36, P2246, DOI 10.1128/MCB.00087-16; Mormont MC, 2000, CLIN CANCER RES, V6, P3038; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Reilly LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017157; Potts MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004657; Rafnsson V, 2001, CANCER CAUSE CONTROL, V12, P95, DOI 10.1023/A:1008983416836; Reszka E, 2016, ADV CLIN CHEM, V75, P53, DOI 10.1016/bs.acc.2016.03.005; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smith-Roe SL, 2013, CELL CYCLE, V12, P332, DOI 10.4161/cc.23177; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Urtishak KA, 2009, J BIOL CHEM, V284, P8768, DOI 10.1074/jbc.M806103200; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Xie S, 2015, MOL CELL, V60, P163, DOI 10.1016/j.molcel.2015.07.031; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Yoshida K, 2013, CANCER SCI, V104, P171, DOI 10.1111/cas.12068; You SJ, 2005, BREAST CANCER RES TR, V91, P47, DOI 10.1007/s10549-004-6603-z; Young LM, 2015, CELL REP, V13, P451, DOI 10.1016/j.celrep.2015.09.017; Zhang WJ, 2017, INT J ONCOL, V50, P173, DOI 10.3892/ijo.2016.3784	49	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209224	10.1371/journal.pone.0209224	http://dx.doi.org/10.1371/journal.pone.0209224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629587	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000021
J	Samreen, S; Sarfraz, M; Hussain, MZ				Samreen, Shamaila; Sarfraz, Muhammad; Hussain, Malik Zawwar			A quadratic trigonometric spline for curve modeling	PLOS ONE			English	Article								An imperative curve modeling technique has been established with a view to its applications in various disciplines of science, engineering and design. It is a new spline method using piecewise quadratic trigonometric functions. It possesses error bounds of order 3. The proposed curve model also owns the most favorable geometric properties. The proposed spline method accomplishes C-2 smoothness and produces a Quadratic Trigonometric Spline (QTS) with the view to its applications in curve design and control. It produces a C-2 quadratic trigonometric alternative to the traditional cubic polynomial spline (CPS) because of having four control points in its piecewise description. The comparison analysis of QTS and CPS verifies the QTS as better alternate to CPS. Also, the time analysis proves QTS computationally efficient than CPS.	[Samreen, Shamaila] Univ Engn & Technol, Dept Math, Lahore, Pakistan; [Samreen, Shamaila; Hussain, Malik Zawwar] Univ Punjab, Dept Math, Lahore, Pakistan; [Sarfraz, Muhammad] Kuwait Univ, Dept Informat Sci, Coll Comp Sci & Engn, Safat, Kuwait	University of Engineering & Technology Lahore; University of Punjab; Kuwait University	Samreen, S (corresponding author), Univ Engn & Technol, Dept Math, Lahore, Pakistan.; Samreen, S (corresponding author), Univ Punjab, Dept Math, Lahore, Pakistan.	shamailasamreen16@gmail.com		Sarfraz, Muhammad/0000-0003-3196-9132				Barsky B.A., 1981, THESIS; Boehm W., 1985, COMPUT AIDED GEOM D, V2, P313; CLINE AK, 1974, COMMUN ACM, V17, P218, DOI 10.1145/360924.360971; Dierckx P., 1989, Computer-Aided Geometric Design, V6, P279, DOI 10.1016/0167-8396(89)90029-0; Farin G, 1996, CURVES SURFACES CAGD; Foley T. A., 1986, Computer-Aided Geometric Design, V3, P281, DOI 10.1016/0167-8396(86)90004-X; FOLEY TA, 1987, ACM T MATH SOFTWARE, V13, P68, DOI 10.1145/23002.23004; Hussain MZ, 2014, COMPUT APPL MATH, V33, P411, DOI 10.1007/s40314-013-0071-1; Lewis J., 1975, SIAM SIGNUM M SAN FR; Nielson G.M., 1974, COMPUT AIDED GEOM D, P209; PRUESS S, 1979, MATH COMPUT, V33, P1273, DOI 10.1090/S0025-5718-1979-0537971-6; Samreen S, 2017, PROCEEDINGS 2017 INTERNATIONAL CONFERENCE ON COMPUTATIONAL SCIENCE AND COMPUTATIONAL INTELLIGENCE (CSCI), P246, DOI 10.1109/CSCI.2017.39; Sarfraz M, 2004, COMPUT GRAPH-UK, V28, P539, DOI 10.1016/j.cag.2004.04.009; SARFRAZ M, 1992, COMPUT GRAPH, V16, P69, DOI 10.1016/0097-8493(92)90073-5; SARFRAZ M, 1995, ENG COMPUT, V11, P94, DOI 10.1007/BF01312203; SARFRAZ M, 1994, COMPUT GRAPH, V18, P707, DOI 10.1016/0097-8493(94)90165-1; Sarfraz M., 1994, SERIES MATH INFORM, V9, P83; Sarfraz M., 2003, ADV GEOMETRIC MODELI, P81; Sarfraz M., 2018, 2018 INT C SCI COMP; Sarfraz M, 2018, ALEX ENG J, V57, P1041, DOI 10.1016/j.aej.2017.02.016; Sarfraz M, 2017, INT J IMAGE GRAPH, V17, DOI 10.1142/S0219467817500152; Sarfraz M, 2016, I C COMP GRAPH IM VI, P29, DOI 10.1109/CGiV.2016.15; Sarfraz M, 2010, INT J COMPUT MATH, V87, P797, DOI 10.1080/00207160802196009	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208015	10.1371/journal.pone.0208015	http://dx.doi.org/10.1371/journal.pone.0208015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629600	Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000009
J	Carbonara, P; Dioguardi, M; Cammarata, M; Zupa, W; Vazzana, M; Spedicato, MT; Lembo, G				Carbonara, Pierluigi; Dioguardi, Maria; Cammarata, Matteo; Zupa, Walter; Vazzana, Mirella; Spedicato, Maria Teresa; Lembo, Giuseppe			Basic knowledge of social hierarchies and physiological profile of reared sea bass Dicentrarchus labrax (L.)	PLOS ONE			English	Article							DOMINANT-SUBORDINATE RELATIONSHIPS; BRAIN SEROTONERGIC ACTIVITY; RAINBOW-TROUT; SWIMMING PERFORMANCE; PLASMA-CORTISOL; FEEDING-BEHAVIOR; COPING STYLES; STRESS RESPONSIVENESS; OXYGEN-CONSUMPTION; DISEASE RESISTANCE	The effects of social hierarchies (dominant/subordinate individuals), such as aggressiveness, feeding order, and territoriality, are some of the characteristics used for describing fish behaviour. Social hierarchy patterns are still poorly understood in European-reared sea bass (Dicentrarchus labrax). In this work, we examine the social interactions among captive fish integrating behavioural and physiological profiles. Groups of three fish with EMG (electromyogram) radio transmitters were monitored for two weeks via video recording. Plasma levels of cortisol, glucose, lactate and lysozyme as well as haematological parameters such as haemoglobin, haematocrit and RBCC (red blood cell count) were measured at the beginning and end of the experiments. Behaviour and muscle activity were monitored daily. The results highlighted that the social hierarchic order was established after one to two days, and it was maintained throughout the experimental period. Dominant and subordinate fish (beta and gamma) showed significant differences in muscle activity, hormonal profile (cortisol), aspecific immunity (lysozyme), carbohydrate metabolism (lactate) and behavioural patterns (food order and aggressiveness). This holistic approach helps to provide insights into the physiological status of the subordinate (beta and gamma) and dominant individuals. These data have wide implications for aquaculture practice.	[Carbonara, Pierluigi; Zupa, Walter; Spedicato, Maria Teresa; Lembo, Giuseppe] COISPA Tecnol & Ric Stn Sperimentale Studio Risor, Bari, Italy; [Dioguardi, Maria; Cammarata, Matteo; Vazzana, Mirella] Univ Palermo, Via Archirafi 18, Palermo, Italy; [Dioguardi, Maria; Cammarata, Matteo; Vazzana, Mirella] CoNISMa, Piazzale Flaminio 9, Rome, Italy	University of Palermo; CoNISMa	Carbonara, P (corresponding author), COISPA Tecnol & Ric Stn Sperimentale Studio Risor, Bari, Italy.	carbonara@coispa.it	Carbonara, Pierluigi/A-9231-2018; CAMMARATA, Matteo/AAK-7616-2021	Carbonara, Pierluigi/0000-0002-2529-2535; CAMMARATA, Matteo/0000-0002-5497-1246; Spedicato, Maria Teresa/0000-0001-9939-9426; Lembo, Giuseppe/0000-0002-9899-6189; Vazzana, Mirella/0000-0001-6437-9409	Ritmare [SP2_WP4_A23_U003]	Ritmare	This work received support from Ritmare SP2_WP4_A23_U003.	ABBOTT JC, 1985, CAN J FISH AQUAT SCI, V42, P1702, DOI 10.1139/f85-213; Algers B., 2009, EFSA J, V954, P1, DOI DOI 10.2903/J.EFSA.2009.954; Alsop DH, 1997, J EXP BIOL, V200, P2337; Balfry SK, 2001, DIS AQUAT ORGAN, V47, P39, DOI 10.3354/dao047039; Barnabe G., 1980, DICENTRARCHUS LABRAX; Bas P. C., 2002, MAR MEDITERRANEO REC; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BEITINGER TL, 1990, J GREAT LAKES RES, V16, P495, DOI 10.1016/S0380-1330(90)71443-8; Benhaim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065872; Benhaim D, 2012, APPL ANIM BEHAV SCI, V136, P63, DOI 10.1016/j.applanim.2011.11.010; Bernier NJ, 2001, NEUROENDOCRINOLOGY, V73, P248, DOI 10.1159/000054642; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; BLANCHARD DC, 1993, BEHAV BRAIN RES, V58, P113, DOI 10.1016/0166-4328(93)90096-9; Blanchard RJ, 1998, AGGRESSIVE BEHAV, V24, P307; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cammarata M, 2012, BRAIN BEHAV IMMUN, V26, P580, DOI 10.1016/j.bbi.2012.01.008; Carbonara P, 2015, AQUAC RES, V46, P2133, DOI 10.1111/are.12369; Carbonara P, 2010, MAR FRESHW BEHAV PHY, V43, P283, DOI 10.1080/10236244.2010.504046; Chandroo KP, 2005, AQUAC RES, V36, P1226, DOI 10.1111/j.1365-2109.2005.01347.x; Cooke SJ, 2004, FISH FISH, V5, P21, DOI 10.1111/j.1467-2960.2004.00136.x; Currie S, 2010, P ROY SOC B-BIOL SCI, V277, P905, DOI 10.1098/rspb.2009.1562; DeVries AC, 2003, PHYSIOL BEHAV, V79, P399, DOI 10.1016/S0031-9384(03)00152-5; Di-Poi C, 2007, PHYSIOL BEHAV, V90, P559, DOI 10.1016/j.physbeh.2006.11.005; DiBattista JD, 2005, J EXP BIOL, V208, P2707, DOI 10.1242/jeb.01690; Edeline E, 2010, P ROY SOC B-BIOL SCI, V277, P843, DOI 10.1098/rspb.2009.1724; EJIKE C, 1980, T AM FISH SOC, V109, P423, DOI 10.1577/1548-8659(1980)109&lt;423:SASHRI&gt;2.0.CO;2; Ellis T, 2012, FISH PHYSIOL BIOCHEM, V38, P163, DOI 10.1007/s10695-011-9568-y; Fanouraki E, 2008, BEHAVIOUR, V145, P1267, DOI 10.1163/156853908785765818; Farrell AP, 1998, J EXP BIOL, V201, P2183; Ferrari S, 2015, APPL ANIM BEHAV SCI, V167, P74, DOI 10.1016/j.applanim.2015.03.006; Ferrari S, 2014, APPL ANIM BEHAV SCI, V161, P131, DOI 10.1016/j.applanim.2014.09.019; Fietta P, 2009, PSYCHIAT CLIN NEUROS, V63, P613, DOI 10.1111/j.1440-1819.2009.02005.x; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Food Agric. Organ. UN, 2016, STAT WORLD FISH AQ 2; *FSBI, 2002, 2 FSBI; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Gornati R, 2004, GENE, V341, P111, DOI 10.1016/j.gene.2004.06.020; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Hoglund E, 2001, PHYSIOL BEHAV, V74, P381, DOI 10.1016/S0031-9384(01)00571-6; Houston A.H., 1990, P273; Huntingford F, 2005, BEHAVIOUR, V142, P1207, DOI 10.1163/156853905774539382; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; Iversen M, 2003, AQUACULTURE, V221, P549, DOI 10.1016/S0044-8486(03)00111-X; Johnsson JI, 1997, ETHOLOGY, V103, P267; Kavadias S, 2004, J APPL ICHTHYOL, V17, P115; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Koolhaas JM, 1997, ACTA PHYSIOL SCAND, V161, P69; Kramer M, 1999, NEUROSCI BIOBEHAV R, V23, P937, DOI 10.1016/S0149-7634(99)00027-5; Lembo G, 2008, FISHERIES MANAG ECOL, V15, P333, DOI 10.1111/j.1365-2400.2008.00638.x; Lembo G, 2007, HYDROBIOLOGIA, V582, P271, DOI 10.1007/s10750-006-0538-9; Lupi P, 2010, J ANIM SCI, V4, P167; Martin P, 1988, MEASURING BEHAV, P48; Martins CIM, 2012, FISH PHYSIOL BIOCHEM, V38, P17, DOI 10.1007/s10695-011-9518-8; Martins CIM, 2011, APPL ANIM BEHAV SCI, V133, P109, DOI 10.1016/j.applanim.2011.05.001; Martins CIM, 2006, APPL ANIM BEHAV SCI, V97, P323, DOI 10.1016/j.applanim.2005.07.003; McCarthy ID, 1999, J FISH BIOL, V55, P854, DOI 10.1006/jfbi.1999.1044; McFarlane WJ, 2004, AQUACULTURE, V239, P467, DOI 10.1016/j.aquaculture.2004.05.039; Millot S, 2008, AQUACULTURE, V274, P87, DOI 10.1016/j.aquaculture.2007.11.004; Millot S, 2009, AQUAT LIVING RESOUR, V22, P363, DOI 10.1051/alr/2009048; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Mylonas CC, 2005, AQUACULTURE, V246, P467, DOI 10.1016/j.aquaculture.2005.02.046; NELISSEN MHJ, 1988, ANN SOC ROY ZOOL BEL, V118, P41; Nelson JA, 1996, J EXP BIOL, V199, P1295; Okland F, 2002, ADV FISH TELEMETRY, P51; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Pichavant K, 2001, J FISH BIOL, V59, P875, DOI [10.1006/jfbi.2001.1702, 10.1111/j.1095-8649.2001.tb00158.x]; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Quintella BR, 2005, J FISH BIOL, V66, P97, DOI 10.1111/j.0022-1112.2005.00584.x; Reale D., 2010, SOCIAL BEHAV GENES E, P527, DOI [10.1017/CBO9780511781360.033, DOI 10.1017/CB09780511781360.033]; Rivers JJ, 2010, SOCIAL PSYCHOL POWER, V3, P87; Santos GA, 2010, AQUACULTURE, V299, P73, DOI 10.1016/j.aquaculture.2009.11.018; Santulli A, 1999, MAR POLLUT BULL, V38, P1105, DOI 10.1016/S0025-326X(99)00136-8; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schreck C.B., 1997, P145; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; Sloman KA, 2002, J FISH BIOL, V61, P1, DOI 10.1111/j.1095-8649.2002.tb01733.x; Sloman KA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P383, DOI 10.1086/320426; Sorensen M, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-92; Sullivan G.H., 1963, BIO TELEMETRY USE TE, P83; Terova G, 2005, GENE, V357, P144, DOI 10.1016/j.gene.2005.06.016; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; Varsamos S, 2006, FISH SHELLFISH IMMUN, V20, P83, DOI 10.1016/j.fsi.2005.04.005; Vazzana M, 2002, AQUACULTURE, V210, P231, DOI 10.1016/S0044-8486(01)00818-3; Wang WB, 2005, J FISH BIOL, V67, P779, DOI 10.1111/j.0022-1112.2005.00779.x; Weyts FAA, 1999, FISH SHELLFISH IMMUN, V9, P1, DOI 10.1006/fsim.1998.0170; Winberg S, 1998, AM J PHYSIOL-REG I, V274, pR645, DOI 10.1152/ajpregu.1998.274.3.R645; WINBERG S, 1993, J EXP BIOL, V179, P213; WINBERG S, 1993, J EXP BIOL, V179, P197; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wood AW, 1996, CAN J FISH AQUAT SCI, V53, P2424, DOI 10.1139/cjfas-53-11-2424; Zupa W, 2015, MAR FRESHW BEHAV PHY, V48, P341, DOI 10.1080/10236244.2015.1073456	98	16	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208688	10.1371/journal.pone.0208688	http://dx.doi.org/10.1371/journal.pone.0208688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625155	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400015
J	Huang, Y; Lu, H; Li, L				Huang, Ying; Lu, Hao; Li, Liang			Human scalp evoked potentials related to the fusion between a sound source and its simulated reflection	PLOS ONE			English	Article							INTERAURAL CORRELATION; INFERIOR COLLICULUS; AUDITORY-CORTEX; BREAK; SENSITIVITY; DELAY; FREQUENCY; MASKING; NEURONS; SPEECH	The auditory system needs to fuse the direct wave (lead) from a sound source and its time-delayed reflections (lag) to achieve a single sound image perception. This lead-lag fusion plays crucial roles in auditory processing in reverberant environments. Here, we investigated neural correlates of the lead-lag fusion by tracking human cortical potentials evoked by a break in the correlation (BIC) between the lead and lag when the time delay between the two was 0, 2, or 4 ms. The BIC evoked a scalp potential consisting of an N1 and a P2 component. Both components were modulated by the delay. The effects of the delay on the amplitude of the two components were similar, an increase of the delay resulting in a decrease of the amplitude. In contrast, the delay differently modulated the latency of the two components, an increase of the delay resulting in an increase of the P2 latency but not an increase of the N1 latency. Similar to the P2 latency, the reaction time for subjective detection of the BIC also increased with the delay. These findings suggest that both the N1 and the P2 evoked by the BIC are neural correlates of the lead-lag fusion and that, relative to the N1, the P2 may be more closely related to listeners' perception of the fusion. Our study thus provides a neurophysiological and objective approach for investigating the fusion between the direct sound wave from a sound source and its reflections.	[Huang, Ying] Leibniz Inst Neurobiol, Special Lab Primate Neurobiol, Magdeburg, Germany; [Huang, Ying; Lu, Hao; Li, Liang] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Huang, Ying; Lu, Hao; Li, Liang] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China; [Huang, Ying; Lu, Hao; Li, Liang] Peking Univ, Speech & Hearing Res Ctr, Beijing, Peoples R China; [Huang, Ying; Lu, Hao; Li, Liang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing, Peoples R China; [Huang, Ying] Otto Von Guericke Univ, Ctr Behav Brain Sci, Magdeburg, Germany; [Li, Liang] Beijing Inst Brain Disorders, Beijing, Peoples R China	Leibniz Institut fur Neurobiologie (LIN); Peking University; Peking University; Peking University; Peking University; Otto von Guericke University	Huang, Y (corresponding author), Leibniz Inst Neurobiol, Special Lab Primate Neurobiol, Magdeburg, Germany.; Huang, Y; Li, L (corresponding author), Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China.; Huang, Y; Li, L (corresponding author), Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China.; Huang, Y; Li, L (corresponding author), Peking Univ, Speech & Hearing Res Ctr, Beijing, Peoples R China.; Huang, Y; Li, L (corresponding author), Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing, Peoples R China.; Huang, Y (corresponding author), Otto Von Guericke Univ, Ctr Behav Brain Sci, Magdeburg, Germany.; Li, L (corresponding author), Beijing Inst Brain Disorders, Beijing, Peoples R China.	Ying.Huang@lin-magdeburg.de; liangli@pku.edu.cn			European Regional Development Fund "CBBS Neuronetwork"; National Natural Science Foundation of China [31170985]; Beijing Municipal Science and Tech Commission [Z161100002616017]; National High Technology Research and Development Program of China (863 Program) [2015AA016306]; National Undergraduate Innovational Experimentation Program	European Regional Development Fund "CBBS Neuronetwork"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Tech Commission; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Undergraduate Innovational Experimentation Program	This study was supported by the European Regional Development Fund "CBBS Neuronetwork" to YH, the National Natural Science Foundation of China (31170985) to LL, the Beijing Municipal Science and Tech Commission (Z161100002616017) to LL, and the National High Technology Research and Development Program of China (863 Program: 2015AA016306) to LL, and the National Undergraduate Innovational Experimentation Program to HL.	Akeroyd MA, 1999, J ACOUST SOC AM, V105, P2807, DOI 10.1121/1.426897; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Blauert J., 1997, SPATIAL HEARING PSYC; Boehnke SE, 2002, J ACOUST SOC AM, V112, P1617, DOI 10.1121/1.1504857; Bregman A.S., 1990, AUDITORY SCENE ANAL; Budd TW, 2003, NEUROIMAGE, V20, P1783, DOI 10.1016/j.neuroimage.2003.07.026; Chait M, 2005, J NEUROSCI, V25, P8518, DOI 10.1523/JNEUROSCI.1266-05.2005; Coffey CS, 2006, HEARING RES, V221, P1, DOI 10.1016/j.heares.2006.06.005; Culling JF, 2007, J ACOUST SOC AM, V122, P2803, DOI 10.1121/1.2785035; Edmonds BA, 2009, J ACOUST SOC AM, V125, P3865, DOI 10.1121/1.3120412; Fitzpatrick DC, 2000, J NEUROSCI, V20, P1605; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Huang Y, 2008, HEARING RES, V244, P51, DOI 10.1016/j.heares.2008.07.006; Huang Y, 2009, J EXP PSYCHOL HUMAN, V35, P1618, DOI 10.1037/a0015791; Huang Y, 2009, J ACOUST SOC AM, V126, P300, DOI 10.1121/1.3147504; Huang Y, 2008, NEUROREPORT, V19, P1673, DOI 10.1097/WNR.0b013e32831576c7; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kong LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126342; Kong LZ, 2012, J ACOUST SOC AM, V132, pEL114, DOI 10.1121/1.4734241; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063106; Li L, 2005, HEARING RES, V202, P235, DOI 10.1016/j.heares.2004.10.007; Li L, 2009, EAR HEARING, V30, P273, DOI 10.1097/AUD.0b013e318198703d; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; PERROTT D R, 1987, Journal of Auditory Research, V27, P59; Qu TS, 2013, EAR HEARING, V34, P280, DOI 10.1097/AUD.0b013e31826e4fe1; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shackleton TM, 2005, JARO-J ASSOC RES OTO, V6, P244, DOI 10.1007/s10162-005-0005-8; Shinn-Cunningham B, 2003, 2003 IEEE WORKSHOP ON APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS PROCEEDINGS, P79, DOI 10.1109/ASPAA.2003.1285824; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; Wang Q, 2015, J NEUROPHYSIOL, V114, P2258, DOI 10.1152/jn.00645.2015; YIN TCT, 1987, J NEUROPHYSIOL, V58, P562, DOI 10.1152/jn.1987.58.3.562	31	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209173	10.1371/journal.pone.0209173	http://dx.doi.org/10.1371/journal.pone.0209173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625162	gold, Green Published, Green Submitted			2022-12-26	WOS:000455359400028
J	Lai, YL; Su, YC; Kao, CH; Liang, JA				Lai, Yo-Liang; Su, Yuan-Chih; Kao, Chia-Hung; Liang, Ji-An			Increased risk of varicella-zoster virus infection in patients with breast cancer after adjuvant radiotherapy: A population-based cohort study	PLOS ONE			English	Article							HERPES-ZOSTER; HODGKINS-DISEASE; WOMEN	Background/Purpose Limited evidence has been obtained on varicella-zoster virus (VZV) infection in patients with breast cancer as a complication related to adjuvant radiotherapy. We conducted a cohort study aimed to assess the risk of VZV infection in this patient setting. Materials and methods We used the National Health Insurance Research Database to identify 65,981 patients with breast cancer in Taiwan who underwent breast surgery between 2000 and 2011. After a 1:1 propensity score match was obtained between patients with and without radiotherapy, a competing risk regression model was constructed to estimate the hazard ratios and the incidence rate difference (IRD) of VZV infection in the patients with breast cancer receiving radiotherapy and those not receiving radiotherapy. Results After adjusting for covariates, the radiotherapy cohort showed a 1.51-fold higher risk (95% confidence interval = 1.06-5.16, p = 0.02, IRD = 4.98/10000 person-years) of subsequent VZV infection than the nonradiotherapy cohort. Furthermore, VZV infection risk was 3.85-fold higher among patients aged > 65 years who received radiotherapy than among those of the same age who did not receive radiotherapy (95% confidence interval = 1.1-13.4, p < 0.05, IRD = 11.09/10000 person-years). The risk increased with adjusted hazard ratio of 6.6 (95% confidence interval I = 1.51-28.8, p < 0.05, IRD = 32.01/10,000 person-years) and 7.08 (95% confidence interval = 1.64-30.5, p < 0.01, IRD = 35.72/10,000 person-years) in follow-up period less than 3 months and 3-5 months respectively. Conclusion Radiotherapy was associated with an increased risk of VZV infection among patients with breast cancer. The risk was significantly higher in older patient (>65 years old) and/or those who received chemotherapy. Regular clinical follow-up and additional serological testing in the first 5 months after radiotherapy are recommended.	[Lai, Yo-Liang; Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Lai, Yo-Liang] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Su, Yuan-Chih] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Liang, Ji-An] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.; Liang, JA (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.	d4615@mail.cmuh.org.tw		Liang, Ji-An/0000-0002-4170-7155	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital [DMR-107-192]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004); China Medical University Hospital (DMR-107-192); Academia Sinica Stroke Biosignature Project (BM10701010021); MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005); Tseng-Lien Lin Foundation, Taichung, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, BREAST CANC FACTS FI; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Dunst Juergen, 2000, Strahlentherapie und Onkologie, V176, P513, DOI 10.1007/PL00002318; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Ferlay J, 2010, IARC CANCERBASE, V2; Guignard AP, 2014, INFECTION, V42, P729, DOI 10.1007/s15010-014-0645-x; GUINEE VF, 1985, CANCER-AM CANCER SOC, V56, P642, DOI 10.1002/1097-0142(19850801)56:3<642::AID-CNCR2820560334>3.0.CO;2-N; Jansen K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-372; Kim ST, 2012, ONCOLOGY-BASEL, V82, P126, DOI 10.1159/000334739; Koo S, 2014, TRANSPL INFECT DIS, V16, P17, DOI 10.1111/tid.12149; Masci G, 2006, ONCOLOGY-BASEL, V71, P164, DOI 10.1159/000106065; McCrary ML, 1999, J AM ACAD DERMATOL, V41, P1, DOI 10.1016/S0190-9622(99)70398-1; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Mueller NH, 2008, NEUROL CLIN, V26, P675, DOI 10.1016/j.ncl.2008.03.011; Ramirez-Fort MK, 2018, J CLIN VIROL, V98, P18, DOI 10.1016/j.jcv.2017.11.004; REBOUL F, 1978, CANCER, V41, P95, DOI 10.1002/1097-0142(197801)41:1<95::AID-CNCR2820410114>3.0.CO;2-Q; RUSTHOVEN JJ, 1988, ARCH INTERN MED, V148, P1561, DOI 10.1001/archinte.148.7.1561; SCHIMPFF SC, 1975, AM J MED, V59, P695, DOI 10.1016/0002-9343(75)90230-2; Whelan TJ, 2015, NEW ENGL J MED, V373, P307, DOI 10.1056/NEJMoa1415340	19	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209365	10.1371/journal.pone.0209365	http://dx.doi.org/10.1371/journal.pone.0209365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625182	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400036
J	Chhetri, VS; Fontenot, K; Strahan, R; Yemmireddy, VK; Cason, C; Kharel, K; Adhikari, A				Chhetri, Vijay Singh; Fontenot, Kathryn; Strahan, Ronald; Yemmireddy, Veerachandra K.; Cason, Cameron; Kharel, Karuna; Adhikari, Achyut			Attachment strength and on-farm die-off rate of Escherichia coli on watermelon surfaces	PLOS ONE			English	Article							FRESH PRODUCE; BIOFILM FORMATION; UNITED-STATES; RELATIVE-HUMIDITY; CURLI EXPRESSION; IRRIGATION WATER; ROMAINE LETTUCE; E.-COLI; SURVIVAL; SALMONELLA	Pre-harvest contamination of produce has been a major food safety focus. Insight into the behavior of enteric pathogens on produce in pre-harvest conditions will aid in developing pre-harvest and post-harvest risk management strategies. In this study, the attachment strength (S-R) and die-off rate of E. coli on the surface of watermelon fruits and the efficacy of aqueous chlorine treatment against strongly attached E. coli population were investigated. Watermelon seedlings were transplanted into eighteen plots. Prior to harvesting, a cocktail of generic E. coli (ATCC 23716, 25922 and 11775) was inoculated on the surface of the watermelon fruits (n = 162) and the attachment strength (SR) values and the daily die-off rates were examined up to 6 days by attachment assay. After 120 h, watermelon samples were treated with aqueous chlorine (150 ppm free chlorine for 3 min). The S(R)value of the E. coli cells on watermelon surfaces significantly increased (P<0.05) from 0.04 to 0.99 in the first 24 h, which was primarily due to the decrease in loosely attached population, given that the population of strongly attached cells was constant. Thereafter, there was no significant change in S(R)values, up to 120 h. The daily die-off rate of E. coli ranged from -0.12 to 1.3 log CFU/cm(2). The chlorine treatment reduced the E. coli level by 4.2 log CFU/cm(2) (initial level 5.6 log CFU/cm(2)) and 0.62 log CFU/cm(2) (initial level 1.8 log CFU/cm(2)), on the watermelons that had an attachment time of 30 min and 120 h respectively. Overall, our findings revealed that the population of E. colion watermelon surfaces declined over time in an agricultural environment. Microbial contamination during pre-harvest stages may promote the formation of strongly attached cells on the produce surfaces, which could influence the efficacy of post-harvest washing and sanitation techniques.	[Chhetri, Vijay Singh; Yemmireddy, Veerachandra K.; Cason, Cameron; Kharel, Karuna; Adhikari, Achyut] Louisiana State Univ, Agr Ctr, Sch Nutr & Food Sci, Baton Rouge, LA 70803 USA; [Fontenot, Kathryn; Strahan, Ronald] Louisiana State Univ, Agr Ctr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Adhikari, A (corresponding author), Louisiana State Univ, Agr Ctr, Sch Nutr & Food Sci, Baton Rouge, LA 70803 USA.	acadhikari@agcenter.lsu.edu	Chhetri, Vijay/AAR-4980-2020; Kharel, Karuna/HBK-5168-2022; Yemmireddy, Veerachandra/AHD-5555-2022		USDA National Institute of Food and Agriculture, Hatch project [1006167]	USDA National Institute of Food and Agriculture, Hatch project	This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 1006167. The project was awarded to Dr. Achyut Adhikari. The sponsors did not play any role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Abberton CL, 2016, APPL ENVIRON MICROB, V82, P5320, DOI 10.1128/AEM.01569-16; Ackers ML, 1998, J INFECT DIS, V177, P1588, DOI 10.1086/515323; Adhikari A, 2016, J FOOD PROTECT, V79, P1673, DOI 10.4315/0362-028X.JFP-16-115; Alegbeleye OO, 2018, FOOD MICROBIOL, V73, P177, DOI 10.1016/j.fm.2018.01.003; Allende A, 2018, FOOD MICROBIOL, V75, P82, DOI 10.1016/j.fm.2018.01.016; Annous BA, 2005, J FOOD SAFETY, V25, P276, DOI 10.1111/j.1745-4565.2005.00024.x; Atwill ER, 2015, J FOOD PROTECT, V78, P240, DOI 10.4315/0362-028X.JFP-14-277; Barker-Reid F, 2009, J FOOD PROTECT, V72, P458, DOI 10.4315/0362-028X-72.3.458; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Bezanson G, 2012, J FOOD PROTECT, V75, P480, DOI 10.4315/0362-028X.JFP-11-306; Boyer RR, 2007, J FOOD PROTECT, V70, P1339, DOI 10.4315/0362-028X-70.6.1339; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brooks AN, 2011, WIRES SYST BIOL MED, V3, P544, DOI 10.1002/wsbm.136; Byrne L, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.31.20866; Chhetri VS, 2018, J FOOD SAFETY, V38, DOI 10.1111/jfs.12520; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Crowe SJ, 2015, MMWR-MORBID MORTAL W, V64, P1221, DOI 10.15585/mmwr.mm6443a4; de Carvalho Carla C C R, 2007, Recent Pat Biotechnol, V1, P49, DOI 10.2174/187220807779813965; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; Ells TC, 2006, INT J FOOD MICROBIOL, V111, P34, DOI 10.1016/j.ijfoodmicro.2006.04.033; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; FDA US, 2015, FSMA FIN RUL PROD SA; Fleming P, 2005, COMMODITY SPECIFIC F, P1; Gautam D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105248; Gelting RJ, 2011, AGR WATER MANAGE, V98, P1395, DOI 10.1016/j.agwat.2011.04.004; Graca A, 2017, FOOD CONTROL, V73, P775, DOI 10.1016/j.foodcont.2016.09.046; Gradl JA, 2017, FOOD DRUG LAW J, V72, P451; Harris LJ, 2012, J FOOD PROTECT, V75, P2251, DOI 10.4315/0362-028X.JFP-12-252; Herman KM, 2015, EPIDEMIOL INFECT, V143, P3011, DOI 10.1017/S0950268815000047; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hutchison ML, 2008, J APPL MICROBIOL, V105, P848, DOI 10.1111/j.1365-2672.2008.03811.x; Iturriaga MH, 2003, J FOOD PROTECT, V66, P1756, DOI 10.4315/0362-028X-66.10.1756; Jahid IK, 2012, FOOD SCI BIOTECHNOL, V21, P299, DOI 10.1007/s10068-012-0041-1; Kondo N, 2006, J FOOD PROTECT, V69, P323, DOI 10.4315/0362-028X-69.2.323; Lee WH, 2011, ENVIRON SCI TECHNOL, V45, P1412, DOI 10.1021/es1035305; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Macarisin D, 2012, FOODBORNE PATHOG DIS, V9, P160, DOI 10.1089/fpd.2011.1020; Monier JM, 2005, MICROB ECOL, V49, P343, DOI 10.1007/s00248-004-0007-9; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; Nyeleti C, 2004, J APPL MICROBIOL, V97, P617, DOI 10.1111/j.1365-2672.2004.02335.x; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Olmez H, 2010, LWT-FOOD SCI TECHNOL, V43, P964, DOI 10.1016/j.lwt.2010.02.005; Park S, 2012, J FOOD PROTECT, V75, P2055, DOI 10.4315/0362-028X.JFP-12-160; Parnell TL, 2005, INT J FOOD MICROBIOL, V99, P59, DOI 10.1016/j.ijfoodmicro.2004.07.014; Patel J, 2011, J APPL MICROBIOL, V110, P737, DOI 10.1111/j.1365-2672.2010.04933.x; Patel J, 2010, INT J FOOD MICROBIOL, V139, P41, DOI 10.1016/j.ijfoodmicro.2010.02.005; Phaiboun A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004198; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Scharff R.L., 2010, PRODUCE SAFETY PROJE; Sela S, 2005, APPL ENVIRON MICROB, V71, P4052, DOI 10.1128/AEM.71.7.4052-4056.2005; Stine SW, 2005, J FOOD PROTECT, V68, P1352, DOI 10.4315/0362-028X-68.7.1352; Tomas-Callejas A, 2011, INT J FOOD MICROBIOL, V151, P216, DOI 10.1016/j.ijfoodmicro.2011.08.027; TOYOFUKU M, 2016, BIOSCI BIOTECH BIOCH, V80, P7, DOI [DOI 10.1080/09168451.2015.1058701, 10.1080/09168451.2015.1058701]; Ukuku DO, 2002, J FOOD PROTECT, V65, P1093, DOI 10.4315/0362-028X-65.7.1093; Ukuku DO, 2001, J FOOD PROTECT, V64, P1286, DOI 10.4315/0362-028X-64.9.1286; Van Gerven N, 2015, TRENDS MICROBIOL, V23, P693, DOI 10.1016/j.tim.2015.07.010; Walsh KA, 2014, FOODBORNE PATHOG DIS, V11, P945, DOI 10.1089/fpd.2014.1812; Weller DL, 2017, FOOD MICROBIOL, V68, P24, DOI 10.1016/j.fm.2017.06.009; Weller DL, 2017, J FOOD PROTECT, V80, P1214, DOI [10.4315/0362-028X.JFP-16-419, 10.4315/0362-028x.jfp-16-419]; Wood JD, 2010, INT J FOOD MICROBIOL, V143, P198, DOI 10.1016/j.ijfoodmicro.2010.08.022; Xu AX, 2016, INT J FOOD MICROBIOL, V224, P28, DOI 10.1016/j.ijfoodmicro.2016.02.013; Yu KH, 2001, J FOOD PROTECT, V64, P1334, DOI 10.4315/0362-028X-64.9.1334	64	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210115	10.1371/journal.pone.0210115	http://dx.doi.org/10.1371/journal.pone.0210115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620744	Green Submitted, Green Published, gold			2022-12-26	WOS:000455161300014
J	Ji, SX; Oruc, T; Mead, L; Rehman, MF; Thomas, CM; Butterworth, S; Winn, PJ				Ji, Shuangxi; Oruc, Tugce; Mead, Liam; Rehman, Muhammad Fayyaz; Thomas, Christopher Morton; Butterworth, Sam; Winn, Peter James			DeepCDpred: Inter-residue distance and contact prediction for improved prediction of protein structure	PLOS ONE			English	Article							DIRECT-COUPLING ANALYSIS; ACCURATE PREDICTION	Rapid, accurate prediction of protein structure from amino acid sequence would accelerate fields as diverse as drug discovery, synthetic biology and disease diagnosis. Massively improved prediction of protein structures has been driven by improving the prediction of the amino acid residues that contact in their 3D structure. For an average globular protein, around 92% of all residue pairs are non-contacting, therefore accurate prediction of only a small percentage of inter-amino acid distances could increase the number of constraints to guide structure determination. We have trained deep neural networks to predict inter-residue contacts and distances. Distances are predicted with an accuracy better than most contact prediction techniques. Addition of distance constraints improved de novo structure predictions for test sets of 158 protein structures, as compared to using the best contact prediction methods alone. Importantly, usage of distance predictions allows the selection of better models from the structure pool without a need for an external model assessment tool. The results also indicate how the accuracy of distance prediction methods might be improved further.	[Ji, Shuangxi; Oruc, Tugce; Mead, Liam; Rehman, Muhammad Fayyaz; Thomas, Christopher Morton; Butterworth, Sam; Winn, Peter James] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Butterworth, Sam] Univ Manchester, Sch Hlth Sci, Manchester Acad Hlth Sci Ctr, Div Pharm & Optometry, Manchester M13 9PL, Lancs, England; [Rehman, Muhammad Fayyaz] Univ Sargodha, Dept Chem, Sargodha, Pakistan	University of Birmingham; University of Manchester; University of Sargodha	Winn, PJ (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	p.j.winn@bham.ac.uk	Rehman, Muhammad Fayyaz ur/U-4491-2018; Thomas, Christopher M/J-8258-2017	Rehman, Muhammad Fayyaz ur/0000-0003-2901-7212; Thomas, Christopher M/0000-0002-2810-0455; Winn, Peter/0000-0003-4706-723X; Butterworth, Sam/0000-0002-6549-3753	Darwin Trust of Edinburgh; University of Birmingham	Darwin Trust of Edinburgh; University of Birmingham	Tugce Drug was funded by the Darwin Trust of Edinburgh and Shuangxi Ji by an Elite Scholarship from the University of Birmingham.	Adhikari B, 2018, BIOINFORMATICS, V34, P1466, DOI 10.1093/bioinformatics/btx781; Berezovsky IN, 2007, PLOS COMPUT BIOL, V3, P498, DOI 10.1371/journal.pcbi.0030052; Claussen JC, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005361; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; Ekeberg M, 2014, J COMPUT PHYS, V276, P341, DOI 10.1016/j.jcp.2014.07.024; Galitsky Boris, 2003, In Silico Biology, V3, P241; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Golkov V., 2016, ADV NEURAL INF PROCE, V29, P4222; He BJ, 2017, BIOINFORMATICS, V33, P2296, DOI 10.1093/bioinformatics/btx164; Hsieh CJ, 2014, J MACH LEARN RES, V15, P2911; Jones DT, 2015, BIOINFORMATICS, V31, P999, DOI 10.1093/bioinformatics/btu791; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Khor BY, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0014-1; Kukic Predrag, 2014, BMC Bioinformatics, V15, DOI 10.1186/1471-2105-15-6; Maghrabi AHA, 2017, NUCLEIC ACIDS RES, V45, pW416, DOI 10.1093/nar/gkx332; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Michel M, 2017, BIOINFORMATICS, V33, pI23, DOI 10.1093/bioinformatics/btx239; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Simons KT, 1999, PROTEINS, P171; Skwark MJ, 2013, BIOINFORMATICS, V29, P1815, DOI 10.1093/bioinformatics/btt259; Walsh I, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-5; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	27	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0205214	10.1371/journal.pone.0205214	http://dx.doi.org/10.1371/journal.pone.0205214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620738	Green Published, gold, Green Submitted			2022-12-26	WOS:000455161300003
J	Johnson, N; Leighton, P; Pailthorpe, C; Dias, J; Adams, S; Aiyenuro, O; Amirfeyz, R; Atroshi, I; Bebbington, A; Bhowal, B; Bindra, R; Bostock, S; Brinsden, MD; Brown, DJ; Campbell, D; Chojnowski, A; Compson, J; Costa, ML; Desmukh, S; Downing, ND; Eardley, W; Eckersley, R; Forward, DP; Giddins, G; Grewal, R; Hobby, JL; Kakar, S; Kopylov, P; Lewis, C; Logan, AJ; McArthur, J; McEachan, JE; McQueen, MM; Milner, S; Miranda, S; Murphy, A; Ng, A; Osterman, AL; Patil, S; Punwar, S; Reed, MR; Riddick, A; Schuind, F; Talwalkar, SC; Tan, S; Tang, JB; White, C				Johnson, Nick; Leighton, Paul; Pailthorpe, Charles; Dias, Joseph; Adams, S.; Aiyenuro, O.; Amirfeyz, R.; Atroshi, I; Bebbington, A.; Bhowal, B.; Bindra, R.; Bostock, S.; Brinsden, M. D.; Brown, D. J.; Campbell, D.; Chojnowski, A.; Compson, J.; Costa, M. L.; Desmukh, S.; Downing, N. D.; Eardley, W.; Eckersley, R.; Forward, D. P.; Giddins, G.; Grewal, R.; Hobby, J. L.; Kakar, S.; Kopylov, P.; Lewis, C.; Logan, A. J.; McArthur, J.; McEachan, J. E.; McQueen, M. M.; Milner, S.; Miranda, S.; Murphy, A.; Ng, A.; Osterman, A. L.; Patil, S.; Punwar, S.; Reed, M. R.; Riddick, A.; Schuind, F.; Talwalkar, S. C.; Tan, S.; Tang, J. B.; White, C.		Distal Radius Fracture Delphi Stud	Defining displacement thresholds for surgical intervention for distal radius fractures - A Delphi study	PLOS ONE			English	Article							VOLAR LOCKING-PLATE; PERCUTANEOUS FIXATION; MALUNITED FRACTURES; INTERNAL-FIXATION; KIRSCHNER WIRES; ADULT PATIENTS; DRAFFT	Distal radius fractures are very common yet controversy exists regarding which require treatment and is reflected by significant variation in surgical intervention rate. Evidence regarding which fractures would benefit from intervention is varied and largely poor quality. This study had three aims; identify which radiographic parameters are clinically important; quantify the threshold of displacement at which intervention should occur and investigate which patient factors influence the decision to intervene. A modified three round Delphi study was carried out and responses were qualitatively analysed. The Delphi panel was composed of three groups of national and international expert surgeons: hand and wrist surgeons, trauma surgeons, and international researchers. 46 participants initially agreed to take part. 43 completed the first round and all then completed three rounds. Participants were asked questions based around case vignettes in patients of three ages (38, 58, 75 years). For all age groups ulnar variance was ranked as the most important extra-articular parameter, step was ranked as the most important intra-articular parameter. Agreed thresholds were the same for all parameters for patients aged 38 and 58. Surgeons would intervene with +2 mm ulnar variance, 10 degrees dorsal tilt, 2mm step and 3mm gap. In patients aged 75 the agreed thresholds were 20 degrees dorsal tilt, 3mm step and 4mm gap, consensus was not achieved for ulnar variance. Mental capacity, pre-injury functional level and medical co-morbidities were ranked as the most important factors influencing the decision to intervene. Qualitative analysis suggested that pre-injury function was the main theme within these factors. Our findings provide useful advice about which parameters should be measured and radiographic thresholds for intervention. These thresholds may then be modified depending on important patient factors. This information can help guide clinicians with management decisions and reduce variation.	[Johnson, Nick; Dias, Joseph] Univ Hosp Leicester, Acad Team Musculoskeletal Surg, Leicester, Leics, England; [Leighton, Paul] Univ Nottingham, Queens Med Ctr, Nottingham, England; [Pailthorpe, Charles] Royal Berkshire Hosp, Reading, Berks, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Nottingham; Royal Berkshire Hospital	Johnson, N (corresponding author), Univ Hosp Leicester, Acad Team Musculoskeletal Surg, Leicester, Leics, England.	nj94@le.ac.uk	Deshmukh, Sharief/E-3682-2014	Deshmukh, Sharief/0000-0003-3700-8164; Bindra, Randip/0000-0003-1552-9057; johnson, Nick/0000-0002-5543-6384; Leighton, Paul/0000-0001-5208-0274	British Society for Surgery of the Hand; Orthopaedic Trauma Society; British Orthopaedic Association; Chartered Society of Physiotherapy; British Geriatric Society	British Society for Surgery of the Hand; Orthopaedic Trauma Society; British Orthopaedic Association; Chartered Society of Physiotherapy; British Geriatric Society	The production of the Distal Radius Fracture Blue Book was kindly supported by the following professional groups:; British Society for Surgery of the Hand, British Orthopaedic Association, Orthopaedic Trauma Society, Chartered Society of Physiotherapy and British Geriatric Society	Anderson M, 2017, OUTCOMES DISTAL RADI; Batra S, 2002, INJURY, V33, P499, DOI 10.1016/S0020-1383(01)00174-7; Blue Book Committee BSfSotH, 2018, BEST PRACT MAN DIST; Care NHSR, 2011, NHS ATL VAR HEALTHC; Chaudhry H, 2015, CLIN ORTHOP RELAT R, V473, P3017, DOI 10.1007/s11999-015-4347-1; Chung KC, 2011, J BONE JOINT SURG AM, V93A, P2154, DOI 10.2106/JBJS.J.012802; Costa ML, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19170; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Dias J J, 1988, J R Coll Surg Edinb, V33, P303; Fanuele J, 2009, J BONE JOINT SURG AM, V91A, P1313, DOI 10.2106/JBJS.H.00448; Forward DP, 2008, J BONE JOINT SURG BR, V90B, P629, DOI 10.1302/0301-620X.90B5.19448; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Karantana A, 2013, J BONE JOINT SURG AM, V95A, P1737, DOI 10.2106/JBJS.L.00232; KOPYLOV P, 1993, J HAND SURG-BRIT EUR, V18B, P45, DOI 10.1016/0266-7681(93)90195-L; Kreder HJ, 2005, J BONE JOINT SURG BR, V87B, P829, DOI 10.1302/0301-620X.87B6.15539; Lichtman DM, 2010, J AM ACAD ORTHOP SUR, V18, P180, DOI 10.5435/00124635-201003000-00007; McKay SD, 2001, J HAND SURG-AM, V26A, P916, DOI 10.1053/jhsu.2001.26662; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P404, DOI 10.1302/0301-620X.78B3.0780404; Mulley AG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4073; Ng CY, 2011, J BONE JOINT SURG BR, V93B, P145, DOI 10.1302/0301-620X.93B2.25631; O'Neill TW, 2001, OSTEOPOROSIS INT, V12, P555, DOI 10.1007/s001980170076; Plant CE, 2017, BONE JOINT J, V99B, P376, DOI 10.1302/0301-620X.99B3.35819; Salling N, 2016, NATL CLIN GUIDELINE; TALEISNIK J, 1984, J HAND SURG-AM, V9A, P350, DOI 10.1016/S0363-5023(84)80222-1; Tubeuf S, 2015, BONE JOINT J, V97B, P1082, DOI 10.1302/0301-620X.97B8.35234; Walenkamp MMJ, 2017, NED TIJDSCHR GENEES, V161, pD1042; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Zong SL, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0252-2	28	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210462	10.1371/journal.pone.0210462	http://dx.doi.org/10.1371/journal.pone.0210462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620763	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300035
J	Johri, M; Sylvestre, MP; Kone, GK; Chandra, D; Subramanian, SV				Johri, Mira; Sylvestre, Marie-Pierre; Kone, Georges Karna; Chandra, Dinesh; Subramanian, S. V.			Effects of improved drinking water quality on early childhood growth in rural Uttar Pradesh, India: A propensity-score analysis	PLOS ONE			English	Article							NUTRITIONAL INTERVENTIONS; DIARRHEAL DISEASE; SANITATION; UNDERNUTRITION; HEALTH; INCOME; BANGLADESH; COUNTRIES; PROGRAM; IMPACT	Context Recent randomised controlled trials in Bangladesh and Kenya concluded that household water treatment, alone or in combination with upgraded sanitation and handwashing, did not reduce linear growth faltering or improve other child growth outcomes. Whether these results are applicable in areas with distinct constellations of water, sanitation and hygiene (WaSH) risks is unknown. Analysis of observational data offers an efficient means to assess the external validity of trial findings. We studied whether a water quality intervention could improve child growth in a rural Indian setting with higher levels of circulating pathogens than the original trial sites. Methods We analysed a cross-sectional dataset including a microbiological measure of household water quality. All households accessed water from an improved source. We applied propensity score methods to emulate a randomised trial investigating the hypothesis that receipt of drinking water meeting Sustainable Development Goal (SDG) 6.1 quality standards for absence of faecal contamination leads to improved growth. Growth outcomes (stunting, underweight, wasting, and their corresponding Z-scores) were assessed in children 12-23 months of age. For each outcome, we estimated the mean and 95% confidence interval of the absolute risk difference between treatment groups. Findings Of 1088 households, 442 (40.62%) received drinking water meeting SDG 6.1 standards. The adjusted risk of child underweight was 7.4% (1.3% to 13.4%) lower among those drinking water satisfying SDG 6.1 norms than among controls. Evidence concerning the relationship of drinking water meeting SDG 6.1 norms to length-for-age and weight-for-age was inconclusive, and there was no apparent relationship with stunting or wasting. Conclusions In contexts characterised by high pathogen transmission, water quality improvements have the potential to reduce the proportion of underweight children, but are unlikely to impact stunting or wasting. Further research is required to assess how these modelled benefits can best be achieved in real world settings.	[Johri, Mira; Sylvestre, Marie-Pierre; Chandra, Dinesh] CRCHUM, Montreal, PQ, Canada; [Johri, Mira] Univ Montreal, Ecole Sante Publ, Dept Adm Sante, Montreal, PQ, Canada; [Sylvestre, Marie-Pierre] Univ Montreal, Ecole Sante Publ, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Kone, Georges Karna] Abt Associates Inc, Hlth Finance & Governance FHG, Port Au Prince, Haiti; [Subramanian, S. V.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Harvard University; Harvard T.H. Chan School of Public Health	Johri, M (corresponding author), CRCHUM, Montreal, PQ, Canada.; Johri, M (corresponding author), Univ Montreal, Ecole Sante Publ, Dept Adm Sante, Montreal, PQ, Canada.	mira.johri@umontreal.ca	Sylvestre, Marie-Pierre/CAF-5219-2022; Johri, Mira/D-5104-2013	Sylvestre, Marie-Pierre/0000-0001-5803-4615; Johri, Mira/0000-0001-5642-787X	Bill & Melinda Gates Foundation [OPP1067851]; Canadian Institutes for Health Research (CIHR) [299960]; IC-IMPACTS (the India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability): A Canadian Network Centre of Excellence	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); IC-IMPACTS (the India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability): A Canadian Network Centre of Excellence	The Bill & Melinda Gates Foundation (OPP1067851), the Canadian Institutes for Health Research (CIHR) (299960), and IC-IMPACTS (the India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability): A Canadian Network Centre of Excellence funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], JOINT MON PROGR JMP; [Anonymous], JOINT MON PROGR JMP; Arnold BF, 2018, LANCET GLOB HEALTH, V6, pE616, DOI 10.1016/S2214-109X(18)30229-8; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Boisson S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001497; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Clasen TF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub3; Coffey D, 2017, WHERE INDIA GOES ABA; Coffey D, 2018, LANCET GLOB HEALTH, V6, pE615, DOI 10.1016/S2214-109X(18)30225-0; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cumming O, 2018, LANCET GLOB HEALTH, V6, pE613, DOI 10.1016/S2214-109X(18)30192-X; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Daniels ME, 2015, AM J TROP MED HYG, V93, P596, DOI 10.4269/ajtmh.15-0111; Duflo Esther, 2015, PWPMPRC2015008; Eisenberg JNS, 2007, AM J PUBLIC HEALTH, V97, P846, DOI 10.2105/AJPH.2006.086207; Ercumen A, 2018, ENVIRON SCI TECHNOL, V52, P12089, DOI 10.1021/acs.est.8b02988; Ercumen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121907; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Freeman MC, 2017, INT J HYG ENVIR HEAL, V220, P928, DOI 10.1016/j.ijheh.2017.05.007; Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143; Humphrey JH, 2015, CLIN INFECT DIS, V61, pS685, DOI 10.1093/cid/civ844; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Johri M, 2015, J EPIDEMIOL COMMUNIT; Johri M, 2016, J NUTR, V146, P1402, DOI 10.3945/jn.115.226290; Johri M, 2014, LANCET, V383, P1379, DOI 10.1016/S0140-6736(14)60673-5; Kim R, 2017, SOC SCI MED, V187, P144, DOI 10.1016/j.socscimed.2017.06.017; Luby SP, 2018, LANCET GLOB HEALTH, V6, pE302, DOI 10.1016/S2214-109X(17)30490-4; Lutter CK, 2011, B WORLD HEALTH ORGAN, V89, P22, DOI 10.2471/BLT.10.078618; Murcott S, 2015, PROCEDIA ENGINEER, V107, P237, DOI 10.1016/j.proeng.2015.06.078; Null C, 2018, LANCET GLOB HEALTH, V6, pE316, DOI 10.1016/S2214-109X(18)30005-6; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shields KF, 2015, ENVIRON HEALTH PERSP, V123, P1222, DOI 10.1289/ehp.1409002; Spears D, 2013, POLICY RESEARCH WORK; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; United Nations, SUST DEV KNOWL PLATF; United Nations, 2017, UN WAT COORD UNS WOR, P6; United Nations Childrens Fund World Health Organization World Bank Group, LEV TRENDS CHILD MAL; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2011, GUID DRINK WAT QUAL; WHO, 2006, WHO CHILD GROWTH STA; WHO/UNICEF, 2017, SAF MAN DRINK WAT TH; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organization, 2011, WHO ANTHR 3 2 2 I GR; WORLD HEALTH ORGANIZATION (WHO); UNITED NATIONS CHILDREN'S FUND (UNICEF), 2017, PROGR DRINK WAT SAN, DOI DOI 10.1111/TMI.12329	53	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0209054	10.1371/journal.pone.0209054	http://dx.doi.org/10.1371/journal.pone.0209054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG7HM	30620737	gold, Green Published, Green Submitted			2022-12-26	WOS:000455161300004
J	Alfaro-Saldana, E; Hernandez-Sanchez, A; Patron-Soberano, OA; Astello-Garcia, M; Mendez-Cabanas, JA; Garcia-Meza, JV				Alfaro-Saldana, Elvia; Hernandez-Sanchez, Araceli; Araceli Patron-Soberano, O.; Astello-Garcia, Marizel; Alfredo Mendez-Cabanas, J.; Viridiana Garcia-Meza, J.			Sequence analysis and confirmation of the type IV pili-associated proteins PilY1, PilW and PilV in Acidithiobacillus thiooxidans	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CRYOELECTRON MICROSCOPY; PROVIDES INSIGHTS; CRYSTAL-STRUCTURE; DATABASE; DISSOLUTION; GENERATION; MOTILITY; GENOME; DOMAIN	Acidithiobacillus thiooxidans is an acidophilic chemolithoautotrophic bacterium widely used in the mining industry due to its metabolic sulfur-oxidizing capability. The biooxidation of sulfide minerals is enhanced through the attachment of At. thiooxidans cells to the mineral surface. The Type IV pili (TfP) of At. thiooxidans may play an important role in the bacteria attachment since TfP play a key adhesive role in the attachment and colonization of different surfaces. In this work, we report for the first time the mRNA sequence of three TfP proteins from At. thiooxidans, the adhesin protein PilY1 and the TfP pilins PilW and PilV. The nucleotide sequences of these TfP proteins show changes in some nucleotide positions with respect to the corresponding annotated sequences. The bioinformatic analyses and 3D modeling of protein structures sustain their classification as TfP proteins, as structural homologs of the corresponding proteins of Ps. aeruginosa, results that sustain the role of PilY1, PilW and PilV in pili assembly. Also, that PilY1 comprises the conserved Neisseria-PilC (superfamily) domain of the tip-associated adhesin, while PiIW of the superfamily of putative TfP assembly proteins and PilV belongs to the superfamily of TfP assembly protein. In addition, the analyses suggested the presence of specific functional domains involved in adhesion, energy transduction and signaling functions. The phylogenetic analysis indicated that the PilY1 of Acidithiobacillus genus forms a cohesive group linked with iron- and/or sulfur-oxidizing microorganisms from acid mine drainage or mine tailings.	[Alfaro-Saldana, Elvia; Astello-Garcia, Marizel; Viridiana Garcia-Meza, J.] Univ Autonoma San Luis Potosi, Met, Geomicrobiol, San Luis Potosi, Mexico; [Alfaro-Saldana, Elvia; Hernandez-Sanchez, Araceli; Alfredo Mendez-Cabanas, J.] Univ Autonoma San Luis Potosi, Inst Fis, Biofis Mol, San Luis Potosi, Mexico; [Araceli Patron-Soberano, O.] Inst Potosino Invest Cient & Tecnol, Div Biol Mol, San Luis Potosi, Mexico	Universidad Autonoma de San Luis Potosi; Universidad Autonoma de San Luis Potosi; Instituto Potosino Investigacion Cientifica y Tecnologica	Garcia-Meza, JV (corresponding author), Univ Autonoma San Luis Potosi, Met, Geomicrobiol, San Luis Potosi, Mexico.	jvgm@uaslp.mx	Mendez, J Alfredo/E-2031-2015	Mendez, J Alfredo/0000-0002-2859-7086; Patron, Araceli/0000-0001-6272-2226	Mexican Council of Science and Technology (CONACyT) [CB -2012-01-177646, CONACyT-264704, CVu 431502]	Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support for this work comes from the Mexican Council of Science and Technology (CONACyT; https://www.conacyt.gob.mx).Projects CB -2012-01-177646 and CONACyT-264704, and Doctoral scholarship awarded (CVu 431502).	Acuna LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078237; Alm RA, 1996, MOL MICROBIOL, V22, P161; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bevilaqua D, 2009, MINER ENG, V22, P254, DOI 10.1016/j.mineng.2008.07.010; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Broeker NK, 2013, GLYCOBIOLOGY, V23, P59, DOI 10.1093/glycob/cws126; Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x; Conrad JC, 2012, RES MICROBIOL, V163, P619, DOI 10.1016/j.resmic.2012.10.016; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crundwell FK, 2013, HYDROMETALLURGY, V139, P132, DOI 10.1016/j.hydromet.2013.08.003; DALRYMPLE B, 1987, J MOL EVOL, V25, P261, DOI 10.1007/BF02100020; Diaz M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020113; Echeverria-Vega A, 2015, HYDROMETALLURGY, V157, P107, DOI 10.1016/j.hydromet.2015.07.018; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Franz LP, 2011, ACTA CRYSTALLOGR D, V67, P124, DOI 10.1107/S0907444910051954; Goosens VJ, 2017, P NATL ACAD SCI USA, V114, pE4978, DOI 10.1073/pnas.1618539114; Hallberg KB, 2011, EXTREMOPHILES, V15, P271, DOI 10.1007/s00792-011-0359-2; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Johnson MDL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029629; Jones DS, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00673-17; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kadnikov VV, 2016, MICROBIOLOGY+, V85, P449, DOI [10.1134/S002626171604010X, 10.7868/S0026365616040108]; Kelly DP, 2000, INT J SYST EVOL MICR, V50, P511, DOI 10.1099/00207713-50-2-511; Krishnan V, 2013, ACTA CRYSTALLOGR D, V69, P1073, DOI 10.1107/S0907444913004642; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li YQ, 2010, CURR MICROBIOL, V60, P17, DOI 10.1007/s00284-009-9494-8; Li YQ, 2014, J BASIC MICROB, V54, P226, DOI 10.1002/jobm.201200300; Lopez-Cazares I, 2017, MINERALS-BASEL, V7, DOI 10.3390/min7090156; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Nassif X, 1997, GENE, V192, P149, DOI 10.1016/S0378-1119(96)00802-5; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Panda SK, 2009, INT J SYST EVOL MICR, V59, P2171, DOI 10.1099/ijs.0.007120-0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Reardon PN, 2013, J BIOL CHEM, V288, P29260, DOI 10.1074/jbc.M113.498527; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Travisany D, 2014, RES MICROBIOL, V165, P743, DOI 10.1016/j.resmic.2014.08.004; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valdes J, 2011, J BACTERIOL, V193, P7003, DOI 10.1128/JB.06281-11; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Van Gerven N, 2011, PROG MOL BIOL TRANSL, V103, P21, DOI 10.1016/B978-0-12-415906-8.00005-4; Wang FB, 2017, STRUCTURE, V25, P1423, DOI 10.1016/j.str.2017.07.016; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	59	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0199854	10.1371/journal.pone.0199854	http://dx.doi.org/10.1371/journal.pone.0199854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615628	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900001
J	Munoz-Ceron, J; Marin-Careaga, V; Pena, L; Mutis, J; Ortiz, G				Munoz-Ceron, Joe; Marin-Careaga, Varinia; Pena, Laura; Mutis, Jorge; Ortiz, Gloria			Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags	PLOS ONE			English	Article							INTEROBSERVER RELIABILITY; NONTRAUMATIC HEADACHE; CLASSIFICATION; FREQUENCY; FEATURES	Introduction Non-traumatic headaches account for 0.5 to 4.5% at the emergency department (ED). Although primary headaches represent the most common causes, the likelihood of ominous etiology has to be considered by clinicians in order to avoid diagnostic and therapeutic pitfalls. Due to the absence of biological or imaging findings to diagnose primary headaches we hypothesize ICHD 3(International Headache criteria 3) criteria as a useful tool at the moment to identify and to establish a difference between those patients who are undergoing primary headaches and those who will need advanced diagnostic strategies. Objectives To determine the usefulness of ICHD 3 criteria to differentiate primary from non-primary headaches at the emergency department (ED). Methods During five weeks all the patients complaining of headache attended at the triage unit at the ED were interviewed, examined and classified as having primary or non-primary headaches by means of ICHD 3 criteria. Those patients with primary headaches were treated according to standard of care protocols and followed up by means of phone call communication after 48 hours to assure satisfactory outcome. Those patients classified as having non-primary headaches (secondary headaches and neuralgias) were admitted for additional diagnostic and therapeutic interventions. Between both groups we compared the prevalence of fulfilled criteria for primary headaches and the proportion of traditional red flags such as age, sleep headache onset, associated symptoms, abnormal neurological exam, sudden onset, and nonresponse to analgesics in addition to previous consultation before this evaluation. Results Headache was responsible for 244 (2.3%) out of 10450 admissions at the ED, 77.8% were females. Primary, non-primary (secondary plus neuralgias) and unclassified headaches were 59.4%, 32% and 8.6% respectively. Migraine and cervical myofascial pain were the most frequent etiologies for primary and non-primary causes respectively. Factors associated to non-primary etiologies were immunosuppression (OR: 2.7 IC 95% 2.3-3.3) and age older than 50 (OR: 2.7 IC 95% 2.01-3.62). Abnormal neurological exam, sudden and sleep headache onset were not statistically significant. Factors found to be associated with primary headaches were: fulfilling ICHD 3 criteria (OR: 18.7, IC95% 7.1-48.6), history of migraine (OR: 2.9 IC 95% 2.1-3.9), and history of similar episodes (OR: 2.7 IC 95% 2.3-3.3). Conclusion This data suggests that fulfilling ICHD 3 criteria could be useful to differentiate primary from non-primary headaches. This observation is also valid for immunosuppression, age older than 50, history of migraine and history of similar episodes.	[Munoz-Ceron, Joe; Marin-Careaga, Varinia; Pena, Laura; Ortiz, Gloria] Univ Rosario, Hosp MEDERI, Dept Neurol, Bogota, Colombia; [Munoz-Ceron, Joe] Clin Univ Colombia, Fdn Univ Sanitas, Dept Neurol, Bogota, Colombia; [Marin-Careaga, Varinia] Soc Boliviana Neurol, La Paz, Bolivia; [Mutis, Jorge] Fdn Cardio Infantil, Bogota, Colombia	Universidad del Rosario; Fundacion Cardioinfantil - Instituto de Cardiologia	Munoz-Ceron, J (corresponding author), Univ Rosario, Hosp MEDERI, Dept Neurol, Bogota, Colombia.; Munoz-Ceron, J (corresponding author), Clin Univ Colombia, Fdn Univ Sanitas, Dept Neurol, Bogota, Colombia.	Joemunoz@centrodolordecabeza.com	MUNOZ-CERON, JOE/AAM-9512-2021	MUNOZ, JOE/0000-0002-3318-9351	Rosario University	Rosario University	The study was supported by the Rosario University, there was no role in data collection, analysis, decision to publish or preparation of the manuscript. The research department gave recommendations to prepare the research protocol.	Ang SH, 2009, ANN ACAD MED SINGAP, V38, P1007; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Casado V, 2011, NEUROLOGIA, V26, P193, DOI [10.1016/j.nrl.2010.09.005, DOI 10.1016/J.NRL.2010.09.005]; Coban E, 2016, ANN SAUDI MED, V36, P51, DOI 10.5144/0256-4947.2016.51; Cortelli P, 2004, HEADACHE, V44, P587, DOI 10.1111/j.1526-4610.2004.446007.x; Friedman BW, 2007, ANN EMERG MED, V49, P409, DOI 10.1016/j.annemergmed.2006.11.004; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; GRANELLA F, 1994, CEPHALALGIA, V14, P16, DOI 10.1046/j.1468-2982.1994.1401016.x; Jimenez-Caballero PE, 2005, REV NEUROLOGIA, V40, P648, DOI 10.33588/rn.4011.2004507; Knox J, 2012, Acute Med, V11, P144; LEICHT MJ, 1980, ANN EMERG MED, V9, P404, DOI 10.1016/S0196-0644(80)80152-1; Locker T, 2004, EMERG MED J, V21, P327, DOI 10.1136/emj.2003.012351; Locker TE, 2006, HEADACHE, V46, P954, DOI 10.1111/j.1526-4610.2006.00448.x; Ceron JFM, 2008, NEUROLOGIA, V23, P415; Nye BL, 2015, HEADACHE, V55, P1301, DOI 10.1111/head.12648; Rizos T, 2011, EUR J NEUROL, V18, P430, DOI 10.1111/j.1468-1331.2010.03170.x; Rueda-Sanchez M, 2005, REV NEUROLOGIA, V40, P209, DOI 10.33588/rn.4004.2004124; Samaan Z, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-7; Smetana GW, 2000, ARCH INTERN MED, V160, P2729, DOI 10.1001/archinte.160.18.2729	19	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0208728	10.1371/journal.pone.0208728	http://dx.doi.org/10.1371/journal.pone.0208728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615622	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900013
J	You, JHS; Ming, WK; Tsang, OTY; Chan, PKS				You, Joyce H. S.; Ming, Wai-kit; Tsang, Owen Tak-yin; Chan, Paul Kay-sheung			Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults	PLOS ONE			English	Article							POSTHERPETIC NEURALGIA; ISCHEMIC ATTACK; RISK; EFFICACY; STROKE	Background Adjuvanted herpes zoster (HZ) subunit (HZ/su) vaccine is recommended for healthy adults aged >= 50 years, yet vaccine efficacy is expected to wane over time. Age-sex specific cost-effectiveness analyses of HZ/su vaccine are warranted to inform decision-making on vaccine policy. We aimed to determine the optimal gender-specific age for cost-effective HZ/su vaccination in Hong Kong. Methods A Markov model was used to compare outcomes with and without HZ/su in healthy males and females at age 50-80 years. Model outcome measures were total cost, HZ cases, and HZ-associated quality-adjusted life-years (QALYs) loss. Incremental cost per QALY saved (ICER) by HZ/su was estimated for each age-sex group. Sensitivity analyses were performed to examine robustness of model results. Results HZ/su reduced incidence of HZ in both males and females aged 50-80 years and the numbers needed to vaccinate to avoid one HZ case were lowest at age 60 years for males (6.05) and females (5.50). The highest QALY-saved occurred in females (0.00396 QALYs) and males (0.00379 QALYs) who were vaccinated at 60 years old. The ICERs were lowest at age 60-70 years for both genders. Using 1 x gross domestic product per capita of Hong Kong (USD46,153) as willingness-to-pay threshold, HZ/su vaccine was accepted to be cost-effective for all female and male age groups at vaccine cost = USD160, for female aged 50-79 years and male aged 54-74 years at vaccine cost = USD200, and for female aged 59-71 years at vaccine cost = USD240. Conclusions HZ/su vaccine is more likely to be cost-effective for males and females aged between 6070 years than the extreme age groups (less than 60 years and older than 70 years) in Hong Kong. The age range for cost-effective acceptance of HZ/su vaccine appears to be broader in females than males given the same vaccine cost and willingness-to-pay threshold.	[You, Joyce H. S.; Ming, Wai-kit] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Hong Kong, Peoples R China; [Ming, Wai-kit] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Tsang, Owen Tak-yin] Princess Margaret Hosp, Dept Geriatr Med, Hong Kong, Peoples R China; [Chan, Paul Kay-sheung] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Peoples R China	Chinese University of Hong Kong; Harvard University; Harvard Medical School; Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Pharm, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	You, Joyce H. S./C-2984-2008; Ming, Wai-kit/AAH-5989-2019; Chan, Paul KS/J-9360-2013	You, Joyce H. S./0000-0002-5763-7403; Ming, Wai-kit/0000-0002-8846-7515; Chan, Paul KS/0000-0002-6360-4608	Health and Medical Research Fund, Food and Health Bureau, The Government of the Hong Kong SAR, China [15140432]	Health and Medical Research Fund, Food and Health Bureau, The Government of the Hong Kong SAR, China	JHSY received support from Health and Medical Research Fund (project number 15140432), Food and Health Bureau, The Government of the Hong Kong SAR, China. Funder website: https://rfs1.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html.The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Census and Statistics Department Hong Kong SAR, WOMEN MEN HONG KONG; Census and Statistics Department The Government of Hong Kong SAR, NAT INC; Centers for Disease Control and Prevention, SINGL HERP ZOST VACC; Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; Erskine N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181565; Harvey MJ, 2018, VACCINE, V36, P6237, DOI 10.1016/j.vaccine.2018.06.059; Helgason S, 2000, BRIT MED J, V321, P794, DOI 10.1136/bmj.321.7264.794; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Kawai K, 2017, MAYO CLIN PROC, V92, P1806, DOI 10.1016/j.mayocp.2017.10.009; Kim MC, 2017, J AM COLL CARDIOL, V70, P295, DOI 10.1016/j.jacc.2017.05.015; Kwon SU, 2016, CLIN MICROBIOL INFEC, V22, P542, DOI 10.1016/j.cmi.2016.03.003; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Le P, 2018, JAMA INTERN MED, V178, P248, DOI 10.1001/jamainternmed.2017.7431; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Minassian C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001919; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Patel MS, 2008, INFECT CONT HOSP EP, V29, P1157, DOI 10.1086/591975; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yawn BP, 2011, MAYO CLIN PROC, V86, P88, DOI 10.4065/mcp.2010.0618; You JHS, 2018, VACCINE, V36, P4610, DOI 10.1016/j.vaccine.2018.06.049; Zhang YT, 2017, J STROKE CEREBROVASC, V26, P1807, DOI 10.1016/j.jstrokecerebrovasdis.2017.04.013	23	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210005	10.1371/journal.pone.0210005	http://dx.doi.org/10.1371/journal.pone.0210005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608953	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800037
J	Ge, XL; Li, GY; Jiang, L; Jia, LQ; Zhang, ZZ; Li, XL; Wang, RR; Zhou, M; Zhou, YH; Zeng, ZY; Xiang, JJ; Li, Z				Ge, Xiaolu; Li, Gui-yuan; Jiang, Lin; Jia, Liqing; Zhang, Zhezhe; Li, Xiaoling; Wang, Ranran; Zhou, Ming; Zhou, Yanhong; Zeng, Zhaoyang; Xiang, Juanjuan; Li, Zheng			Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STATISTICS; DOWN-REGULATION; IDENTIFICATION; MALAT1; ANRIL; GENE	Long noncoding RNAs (lncRNAs) play an important role in lung adenocarcinoma (LUAD) metastasis. Here, we found that lncRNA chromatin-associated RNA 10 (CAR10) was upregulated in the tumor tissue of patients with LUAD and enhanced tumor metastasis in vitro and in vivo. Mechanistically, CAR10 induced epithelial-to-mesenchymal transition (EMT) by directly binding with miR-30 and miR-203 and then regulating the expression of SNAH and SNAI2. CAR10 overexpression was positively correlated with a poor prognosis in LUAD patients, whereas overexpression of both CAR10 and SNAI was correlated with even worse clinical outcomes. In conclusion, the CAR10/miR-30/203/SNAI axis is a novel and potential therapeutic target for LUAD.	[Ge, Xiaolu; Li, Gui-yuan; Jiang, Lin; Jia, Liqing; Zhang, Zhezhe; Li, Xiaoling; Zhou, Ming; Zhou, Yanhong; Zeng, Zhaoyang; Xiang, Juanjuan; Li, Zheng] Cent South Univ, Hunan Canc Hosp, Key Lab Carcinogenesis, Chinese Minist Hlth, Changsha, Hunan, Peoples R China; [Ge, Xiaolu; Li, Gui-yuan; Jiang, Lin; Jia, Liqing; Zhang, Zhezhe; Li, Xiaoling; Zhou, Ming; Zhou, Yanhong; Zeng, Zhaoyang; Xiang, Juanjuan; Li, Zheng] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Ge, Xiaolu; Li, Gui-yuan; Jiang, Lin; Jia, Liqing; Zhang, Zhezhe; Li, Xiaoling; Zhou, Ming; Zhou, Yanhong; Zeng, Zhaoyang; Xiang, Juanjuan; Li, Zheng] Cent South Univ, Sch Basic Med Sci, Canc Res Inst, Changsha, Hunan, Peoples R China; [Ge, Xiaolu; Li, Zheng] Cent South Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Changsha, Hunan, Peoples R China; [Wang, Ranran] Cent South Univ, Xiangya Hosp 2, Dept Thorac & Cardiovasc Surg, Changsha 410011, Hunan, Peoples R China; [Li, Zheng] Cent South Univ, High Resolut Mass Spectrometry Lab, Adv Res Ctr, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Li, Z (corresponding author), Cent South Univ, Hunan Canc Hosp, Key Lab Carcinogenesis, Chinese Minist Hlth, Changsha, Hunan, Peoples R China.; Li, Z (corresponding author), Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China.; Li, Z (corresponding author), Cent South Univ, Sch Basic Med Sci, Canc Res Inst, Changsha, Hunan, Peoples R China.; Li, Z (corresponding author), Cent South Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Changsha, Hunan, Peoples R China.; Li, Z (corresponding author), Cent South Univ, High Resolut Mass Spectrometry Lab, Adv Res Ctr, Changsha, Hunan, Peoples R China.	lizheng@csu.edu.cn	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022	LI, ZHENG/0000-0002-3758-8165; Jia, Liqing/0000-0003-1734-6043; Xiaolu, Ge/0000-0002-5533-7749	Overseas Expertise Introduction Project for Discipline Innovation (111 Project) [111-2-12]; National Natural Science Foundation of China [81602030]; National Undergraduate Free Exploration Program of Central South University [201810533372]; Open-End Fund for the Valuable and Precision Instruments of Central South University [CSUZC2014044]	Overseas Expertise Introduction Project for Discipline Innovation (111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Undergraduate Free Exploration Program of Central South University; Open-End Fund for the Valuable and Precision Instruments of Central South University	This study was supported by grants from the Overseas Expertise Introduction Project for Discipline Innovation (111 Project, No. 111-2-12), the National Natural Science Foundation of China (81602030), the National Undergraduate Free Exploration Program of Central South University (201810533372), and the Open-End Fund for the Valuable and Precision Instruments of Central South University (No. CSUZC2014044).	Alves CP, 2013, STEM CELLS, V31, P2827, DOI 10.1002/stem.1547; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Guo HY, 2014, ONCOTARGET, V5, P8625, DOI 10.18632/oncotarget.2349; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Jen JY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0674-z; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang SM, 2016, MOL MED REP, V13, P4101, DOI 10.3892/mmr.2016.5010; Kao CJ, 2014, ONCOGENE, V33, P2495, DOI 10.1038/onc.2013.200; Klingenberg M, 2018, HEPATOLOGY, V68, P1817, DOI 10.1002/hep.30102; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Lin L, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0247-7; Liu H, 2017, ONCOTARGET, V8, P101899, DOI 10.18632/oncotarget.22058; Liu MJ, 2016, ONCOL REP, V36, P1679, DOI 10.3892/or.2016.4909; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492; Otsuki Y, 2018, DEV DYNAM, V247, P462, DOI 10.1002/dvdy.24596; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pillai R, 2011, J MOL DIAGN, V13, P48, DOI 10.1016/j.jmoldx.2010.11.001; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; Rodriguez Luis G, 2005, Methods Mol Biol, V294, P23; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shen LQ, 2015, J NEURO-ONCOL, V121, P101, DOI 10.1007/s11060-014-1613-0; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Travis WD, 2014, PATHOLOGE, V35, P188, DOI 10.1007/s00292-014-1974-3; Van Grembergen O, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600220; Wang D, 2017, EUR REV MED PHARMACO, V21, P4584; Wang Q, 2017, ONCOTARGET, V8, P2558, DOI 10.18632/oncotarget.13708; Wei MM, 2016, ONCOTARGET, V7, P59556, DOI 10.18632/oncotarget.10006; Wei YZ, 2017, ONCOTARGET, V8, P71430, DOI 10.18632/oncotarget.19864; Wen X, 2018, J CELL BIOCHEM, V119, P1827, DOI 10.1002/jcb.26344; Xiang Y, 2017, CELL PHYSIOL BIOCHEM, V42, P357, DOI 10.1159/000477479; Xu S, 2018, ONCOL REP, V39, P2376, DOI 10.3892/or.2018.6316; Yuan S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0472-6; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743; Zhou M, 2016, ONCOTARGET, V7, P29720, DOI 10.18632/oncotarget.8825	41	54	56	2	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3061	3076		10.1038/s41388-018-0645-x	http://dx.doi.org/10.1038/s41388-018-0645-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30617305	Green Published, hybrid			2022-12-26	WOS:000465167600014
J	Fan, HH; Yu, IS; Lin, YH; Wang, SY; Liaw, YH; Chen, PL; Yang, TL; Lin, SW; Chen, YT				Fan, Hsiang-Hsuan; Yu, I-Shing; Lin, Yin-Hung; Wang, Shin-Yu; Liaw, Ying-Hsuan; Chen, Pei-Lung; Yang, Tsung-Lin; Lin, Shu-Wha; Chen, You-Tzung			P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies	FASEB JOURNAL			English	Article						genome editing; somatic mutagenesis; genetic screen	P53 GAIN; GROWTH-CHARACTERISTICS; IN-VITRO; TUMORIGENESIS; MODEL; MICE; DEFICIENT; MUTATIONS; CRISPR/CAS9; GENOMICS	The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology facilitates somatic genome editing to reveal cooperative genetic interactions at the cellular level without extensive breeding between different mutant animals. Here we propose a transgenic inducible Cas9 effector-CRISPR mutagen (ICE CRIM) mouse model in which CRISPR/Cas9-mediated somatic mutagenesis events can occur in response to Cre expression. The well-known tumor suppressor gene, Trp53, and 2 important DNA mismatch repair genes, Mlh1 and Msh2, were selected to be our somatic mutagenesis targets. Amplicon-based sequencing was performed to validate the editing efficiency and to identify the mutant allelic series. Crossed with various Cre lines, the Trp53 ICE CRIM alleles were activated to generate targeted cancer gene somatic or germ line mutant variants. We provide experimental evidence to show that an activated ICE CRIM can mutate both targeted alleles within a cell. Simultaneous disruption of multiple genes was also achieved when there were multiple single-guide RNA expression cassettes embedded within an activated ICE CRIM. Our mouse model can be used to generate mutant pools in vivo, which enables a functional screen to be performed in situ. Our results also provide evidence to support a monoclonal origin of hematopoietic neoplasms and to indicate that DNA mismatch repair deficiency accelerates tumorigenesis in Trp53 mutant genetic background.	[Fan, Hsiang-Hsuan; Lin, Yin-Hung; Wang, Shin-Yu; Liaw, Ying-Hsuan; Chen, Pei-Lung; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Grad Inst Med Genom & Prote, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Lab Anim Ctr, Taipei, Taiwan; [Yang, Tsung-Lin; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan; [Yang, Tsung-Lin; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan; [Lin, Shu-Wha; Chen, You-Tzung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Ctr Genom Med, Taipei, Taiwan; [Chen, Pei-Lung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Chen, Pei-Lung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yu, IS (corresponding author), Natl Taiwan Univ, Coll Med, Lab Anim Ctr, 10F 2,Xuzhou Rd, Taipei 100, Taiwan.; Chen, YT (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, 5F 2,Xuzhou Rd, Taipei 100, Taiwan.	isyu@ntu.edu.tw; youtzungchen@ntu.edu.tw	; Chen, Pei-Lung/A-3520-2010	CHEN, YOU-TZUNG/0000-0001-6510-3420; Chen, Pei-Lung/0000-0002-5640-3074	Ministry of Science and Technology [104-2311-B-002-016, 105-2311-B-002-006, 106-2320-B-002-048-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors are thankful for the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility for Biopharmaceuticals, Ministry of Science and Technology (Taipei, Taiwan). The authors also appreciate technical assistance provided by Dr. Cheng-Yen Huang (The First Core Laboratory, Branch Office of Medical Research and Development, National Taiwan University College of Medicine). This work was supported by the Ministry of Science and Technology (Grants 104-2311-B-002-016, 105-2311-B-002-006, and 106-2320-B-002-048-MY2 to Y.-T.C.). The authors declare no conflicts of interest.	Alemany A, 2018, NATURE, V556, P108, DOI 10.1038/nature25969; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Beil-Wagner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21377; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00654-2; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Halperin SO, 2018, NATURE, V560, P248, DOI 10.1038/s41586-018-0384-8; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Knudson CM, 2001, CANCER RES, V61, P659; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; Kucera GT, 1996, DEV BIOL, V173, P162, DOI 10.1006/dbio.1996.0014; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee MK, 2008, J CELL SCI, V121, P1899, DOI 10.1242/jcs.022822; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Masciarelli S, 2014, ONCOGENE, V33, P1601, DOI 10.1038/onc.2013.106; McCarthy A, 2007, J PATHOL, V211, P389, DOI 10.1002/path.2124; MILLER CW, 1992, CANCER RES, V52, P1695; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PURDIE CA, 1994, ONCOGENE, V9, P603; Roper J, 2017, NAT BIOTECHNOL, V35, P569, DOI 10.1038/nbt.3836; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Shafarenko M, 1997, CARCINOGENESIS, V18, P1423, DOI 10.1093/carcin/18.7.1423; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toft NJ, 2002, ONCOGENE, V21, P6299, DOI 10.1038/sj.onc.1205727; Ueki K, 2002, CLIN CANCER RES, V8, P196; van Oers JMM, 2014, ONCOGENE, V33, P3939, DOI 10.1038/onc.2013.365; Voskamp P, 2012, INT J CANCER, V131, P1267, DOI 10.1002/ijc.27391; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Young LC, 2007, CARCINOGENESIS, V28, P2131, DOI 10.1093/carcin/bgm153; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	69	1	1	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5571	5584		10.1096/fj.201802027R	http://dx.doi.org/10.1096/fj.201802027R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640520	Bronze			2022-12-26	WOS:000462888500075
J	Liu, ZK; Li, C; Kang, NL; Malhi, H; Shah, VH; Maiers, JL				Liu, Zhikui; Li, Chao; Kang, Ningling; Malhi, Harmeet; Shah, Vijay H.; Maiers, Jessica L.			Transforming growth factor (TGF) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; endoplasmic reticulum stress (ER stress); collagen; fibronectin; apoptosis signal-regulating kinase 1 (ASK1); c-Jun N-terminal kinase (JNK); cell signaling; adefovir dipivoxil; C; EBP; IRE1; p300	ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTIONAL INHIBITORY PROTEIN; BETA C/EBP-BETA; MESSENGER-RNA; ER STRESS; LIVER; EXPRESSION; FIBROSIS; REVERSAL; PATHWAY	Transforming growth factor (TGF) potently activates hepatic stellate cells (HSCs), which promotes production and secretion of extracellular matrix (ECM) proteins and hepatic fibrogenesis. Increased ECM synthesis and secretion in response to TGF is associated with endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). TGF and UPR signaling pathways are tightly intertwined during HSC activation, but the regulatory mechanism that connects these two pathways is poorly understood. Here, we found that TGF treatment of immortalized HSCs (i.e. LX-2 cells) induces phosphorylation of the UPR sensor inositol-requiring enzyme 1 (IRE1) in a SMAD2/3-procollagen I-dependent manner. We further show that IRE1 mediates HSC activation downstream of TGF and that its role depends on activation of a signaling cascade involving apoptosis signaling kinase 1 (ASK1) and c-Jun N-terminal kinase (JNK). ASK1-JNK signaling promoted phosphorylation of the UPR-associated transcription factor CCAAT/enhancer binding protein (C/EBP), which is crucial for TGF- or IRE1-mediated LX-2 activation. Pharmacological inhibition of C/EBP expression with the antiviral drug adefovir dipivoxil attenuated TGF-mediated activation of LX-2 or primary rat HSCs in vitro and hepatic fibrogenesis in vivo. Finally, we identified a critical relationship between C/EBP and the transcriptional regulator p300 during HSC activation. p300 knockdown disrupted TGF- or UPR-induced HSC activation, and pharmacological inhibition of the C/EBP-p300 complex decreased TGF-induced HSC activation. These results indicate that TGF-induced IRE1 signaling is critical for HSC activation through a C/EBP-p300-dependent mechanism and suggest C/EBP as a druggable target for managing fibrosis.	[Liu, Zhikui; Li, Chao; Malhi, Harmeet; Shah, Vijay H.; Maiers, Jessica L.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Kang, Ningling] Univ Minnesota, Hormel Inst, Tumor Microenvironm & Metastasis, 801 16th Ave NE, Austin, MN 55912 USA; [Liu, Zhikui; Li, Chao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China	Mayo Clinic; University of Minnesota System; Xi'an Jiaotong University	Maiers, JL (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN 55905 USA.	maiers.jessica1@mayo.edu	Maiers, Jessica/AAL-8037-2021	Malhi, Harmeet/0000-0002-0882-4990	NIDDK, National Institutes of Health [K01 DK112915, RO1 DK111378, R01 DK59615, P30DK084567]; NCI, National Institutes of Health [R01 CA160069]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA160069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK111378, K01DK112915] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants K01 DK112915, RO1 DK111378, R01 DK59615, and P30DK084567; NCI, National Institutes of Health, Grant R01 CA160069; and a research fellowship from the China Scholarship Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attard FA, 2000, ARCH BIOCHEM BIOPHYS, V378, P57, DOI 10.1006/abbi.2000.1803; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dodig M, 2007, AM J PHYSIOL-GASTR L, V293, pG154, DOI 10.1152/ajpgi.00432.2006; Dou CW, 2018, GASTROENTEROLOGY, V154, P2209, DOI 10.1053/j.gastro.2018.02.015; Drinane MC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92821; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Feig JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188135; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Garcia-Trevijano ER, 1999, HEPATOLOGY, V29, P960, DOI 10.1002/hep.510290346; Heindryckx F, 2016, EMBO MOL MED, V8, P729, DOI 10.15252/emmm.201505925; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iraburu MJ, 2000, HEPATOLOGY, V31, P1086, DOI 10.1053/he.2000.5981; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Jakobs A, 2016, J BIOL CHEM, V291, P26098, DOI 10.1074/jbc.M116.748129; Jiang Joy X, 2013, Curr Pathobiol Rep, V1, P215; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kim RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39342; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Koo JH, 2016, GASTROENTEROLOGY, V150, P181, DOI 10.1053/j.gastro.2015.09.039; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Loomba R, 2018, HEPATOLOGY, V67, P549, DOI 10.1002/hep.29514; Maiers JL, 2017, HEPATOLOGY, V65, P983, DOI 10.1002/hep.28921; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; de Galarreta MR, 2016, BBA-MOL CELL RES, V1863, P2115, DOI 10.1016/j.bbamcr.2016.05.002; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang JQ, 2013, TOXICOL APPL PHARM, V266, P307, DOI 10.1016/j.taap.2012.11.007; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Yang JQ, 2016, CURR MED CHEM, V23, P4706, DOI 10.2174/0929867323666160927142349; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Younossi ZM, 2018, LIVER INT, V38, P1849, DOI 10.1111/liv.13706; Zaini MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42603; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	50	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3137	3151		10.1074/jbc.RA118.005761	http://dx.doi.org/10.1074/jbc.RA118.005761			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30610118	Green Published, hybrid			2022-12-26	WOS:000464980100014
J	Rodriguez, MZ; Comin, CH; Casanova, D; Bruno, OM; Amancio, DR; Costa, LD; Rodrigues, FA				Rodriguez, Mayra Z.; Comin, Cesar H.; Casanova, Dalcimar; Bruno, Odemir M.; Amancio, Diego R.; Costa, Luciano da F.; Rodrigues, Francisco A.			Clustering algorithms: A comparative approach	PLOS ONE			English	Article							SOM NEURAL-NETWORK; K-MEANS ALGORITHM; DISCRIMINANT-ANALYSIS; SPECTRAL METHODS; R-PACKAGE; MODEL; SELECTION; KERNEL	Many real-world systems can be studied in terms of pattern recognition tasks, so that proper use (and understanding) of machine learning methods in practical applications becomes essential. While many classification methods have been proposed, there is no consensus on which methods are more suitable for a given dataset. As a consequence, it is important to comprehensively compare methods in many possible scenarios. In this context, we performed a systematic comparison of 9 well-known clustering methods available in the R language assuming normally distributed data. In order to account for the many possible variations of data, we considered artificial datasets with several tunable properties (number of classes, separation between classes, etc). In addition, we also evaluated the sensitivity of the clustering methods with regard to their parameters configuration. The results revealed that, when considering the default configurations of the adopted methods, the spectral approach tended to present particularly good performance. We also found that the default configuration of the adopted implementations was not always accurate. In these cases, a simple approach based on random selection of parameters values proved to be a good alternative to improve the performance. All in all, the reported approach provides subsidies guiding the choice of clustering algorithms.	[Rodriguez, Mayra Z.; Amancio, Diego R.; Rodrigues, Francisco A.] Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil; [Comin, Cesar H.] Univ Fed Sao Carlos, Dept Comp Sci, Sao Carlos, SP, Brazil; [Casanova, Dalcimar] Fed Univ Technol, Curitiba, Parana, Brazil; [Bruno, Odemir M.; Costa, Luciano da F.] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Tecnologica Federal do Parana; Universidade de Sao Paulo	Comin, CH (corresponding author), Univ Fed Sao Carlos, Dept Comp Sci, Sao Carlos, SP, Brazil.	chcomin@gmail.com	da F. Costa, Luciano/H-5475-2011; Comin, Cesar H/G-2229-2012; Casanova, Dalcimar/J-1588-2012; Rodrigues, Francisco A./E-4418-2011; Bruno, Odemir/AAU-7209-2020; Bruno, Odemir M/A-5279-2009; Amancio, Diego Raphael/I-1071-2012	da F. Costa, Luciano/0000-0001-5203-4366; Comin, Cesar H/0000-0003-1207-4982; Rodrigues, Francisco A./0000-0002-0145-5571; Bruno, Odemir/0000-0002-2945-1556; Bruno, Odemir M/0000-0002-2945-1556; Casanova, Dalcimar/0000-0002-1905-4602	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [15/18942-8, 18/09125-4, 14/20830-0, 16/19069-9, 14/08026-1, 11/50761-2, 15/22308-2]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307797/2014-7, 307333/2013-2]; Nucleo de Apoio a Pesquisa (LdFC); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nucleo de Apoio a Pesquisa (LdFC); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant nos. 15/18942-8 and 18/09125-4 for CHC, 14/20830-0 and 16/19069-9 for DRA, 14/08026-1 for OMB and 11/50761-2 and 15/22308-2 for LdFC), CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant nos. 307797/2014-7 for OMB and 307333/2013-2 for LdFC), Nucleo de Apoio a Pesquisa (LdFC) and CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Finance Code 001).	Abdullah Z, 2011, PROCD SOC BEHV, V28, DOI 10.1016/j.sbspro.2011.11.022; Abu Abbas O, 2008, INT ARAB J INF TECHN, V5, P320; Aggarwal C.C., 2012, MINING TEXT DATA, P77, DOI [DOI 10.1007/978-1-4614-3223-44, 10.1007/978-1-4614-3223-4, 10.1007/978-1-4614-3223-4_4, DOI 10.1007/978-1-4614-3223-4_4]; Aggarwal CC, 2013, DATA CLUSTERING ALGO, V2; Amancio DR, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03005; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amancio DR, 2012, J INFORMETR, V6, P427, DOI 10.1016/j.joi.2012.02.005; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; BENAIM M, 1992, EUROPHYS LETT, V19, P241, DOI 10.1209/0295-5075/19/3/015; Berge L, 2012, J STAT SOFTW, V46, P1; BERKHIN P, 2006, SURVEY CLUSTERING DA, P25, DOI DOI 10.1007/3-540-28349-8_2; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Bouveyron C, 2007, COMPUT STAT DATA AN, V52, P502, DOI 10.1016/j.csda.2007.02.009; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brun M, 2007, PATTERN RECOGN, V40, P807, DOI 10.1016/j.patcog.2006.06.026; Burdick D, 2001, PROC INT CONF DATA, P443, DOI 10.1109/ICDE.2001.914857; Camastra F, 2005, IEEE T PATTERN ANAL, V27, P801, DOI 10.1109/TPAMI.2005.88; Colavizza G, 2016, J INFORMETR, V10, P1037, DOI 10.1016/j.joi.2016.07.009; Costa IG, 2004, GENET MOL BIOL, V27, P623, DOI 10.1590/S1415-47572004000400025; Cover TM, 2012, ELEMENTS INFORM THEO, V2; de Arruda GF, 2012, PHYSICA A, V391, P6174, DOI 10.1016/j.physa.2012.07.007; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dhillon I. S., 2004, CITESEER; Dougherty ER, 2002, J COMPUT BIOL, V9, P105, DOI 10.1089/10665270252833217; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Erman J., 2006, P 2006 SIGCOMM WORKS, DOI 10.1145/11 62678.1162679; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fayyad U, 1996, AI MAG, V17, P37; Filippone M, 2008, PATTERN RECOGN, V41, P176, DOI 10.1016/j.patcog.2007.05.018; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2003, J CLASSIF, V20, P263, DOI 10.1007/s00357-003-0015-3; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Fraley C, 1998, SIAM J SCI COMPUT, V20, P270, DOI 10.1137/S1064827596311451; Garcia C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156576; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Guha S, 2003, IEEE T KNOWL DATA EN, V15, P515, DOI 10.1109/TKDE.2003.1198387; Guha S, 2001, INFORM SYST, V26, P35, DOI 10.1016/S0306-4379(01)00008-4; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Han J, 2006, DATA MINING CONCEPTS, V2; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hirschberger M, 2007, EUR J OPER RES, V177, P1610, DOI 10.1016/j.ejor.2005.10.014; Horn R.A., 1990, MATRIX ANAL, DOI [DOI 10.1017/CBO9780511810817, 10.1017/CBO9780511810817]; Huang JB, 2013, KNOWL-BASED SYST, V40, P111, DOI 10.1016/j.knosys.2012.11.015; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hwang C.R., 1988, ACTA APPL MATH, V12, P108; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK, 2004, ICPR 2004 P 17 INT C, V1; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jing L, 2007, IEEE T KNOWL DATA EN, V19, P1026, DOI 10.1109/TKDE.2007.1048; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Jung YG, 2014, BIOTECHNOL BIOTEC EQ, V28, pS44, DOI 10.1080/13102818.2014.949045; Karypis G, 1999, COMPUTER, V32, P68, DOI 10.1109/2.781637; Kaufman L, 2009, SERIES PROBABILITY M; Kaufman L., 1990, FINDING GROUPS DATA; Khashei M, 2010, EXPERT SYST APPL, V37, P479, DOI 10.1016/j.eswa.2009.05.044; Kinnunen T, 2011, PATTERN RECOGN LETT, V32, P1604, DOI 10.1016/j.patrec.2011.06.023; Kou G, 2014, INFORM SCIENCES, V275, P1, DOI 10.1016/j.ins.2014.02.137; Kriegel HP, 2012, WIRES DATA MIN KNOWL, V2, P351, DOI 10.1002/widm.1057; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Lei Y, 2017, PATTERN RECOGN, V65, P58, DOI 10.1016/j.patcog.2016.12.003; Liu Y, 2010, 2010 IEEE INT C DATA, P911, DOI [10.1109/ICDM.2010.35, DOI 10.1109/ICDM.2010.35]; Luczak M, 2018, J INTELL FUZZY SYST, V34, P373, DOI 10.3233/JIFS-171393; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mangiameli P, 1996, EUR J OPER RES, V93, P402, DOI 10.1016/0377-2217(96)00038-0; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; McKight P.E, 2010, CORSINI ENCYCLO PSYC, P1, DOI [DOI 10.1002/9780470479216.CORPSY0491, 10.1002/9780470479216.corpsy0491]; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mingoti SA, 2006, EUR J OPER RES, V174, P1742, DOI 10.1016/j.ejor.2005.03.039; Naeni LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157988; Nascimento MCV, 2011, EUR J OPER RES, V211, P221, DOI 10.1016/j.ejor.2010.08.012; Ng AY, 2002, ADV NEUR IN, V14, P849; Parsons L, 2004, WORKSH CLUST HIGH DI, P48; Parsons L., 2004, ACM SIGKDD EXPLORATI, V6, P90, DOI [10.1145/1007730.1007731, DOI 10.1145/1007730.1007731]; Pirim H, 2012, COMPUT OPER RES, V39, P3046, DOI 10.1016/j.cor.2012.03.008; R Development Core Team, 2006, R LANG ENV STAT COMP; Raykov YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162259; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Ridgeway G, 2003, DATA MIN KNOWL DISC, V7, P301, DOI 10.1023/A:1024084221803; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sequeira K., 2002, P 8 ACM SIGKDD INT C, P386, DOI DOI 10.1145/775047.775103; Silva JA, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2522968.2522981; Sim K, 2013, DATA MIN KNOWL DISC, V26, P332, DOI 10.1007/s10618-012-0258-x; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; UCI, BREAST CANC WISC; Ultsch A, 2005, P WORKSHOP SELF ORG, P75; Verma Deepak, 2003, U OFWASHINGTON TECH, V1, P1; Viana MP, 2013, J INFORMETR, V7, P371, DOI 10.1016/j.joi.2012.12.005; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Williams G, 1997, ADV TOPICS ARTIFICIA, V1342, P340; Witten I.H., 2005, DATA MINING PRACTICA; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	106	175	174	12	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210236	10.1371/journal.pone.0210236	http://dx.doi.org/10.1371/journal.pone.0210236			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645617	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200022
J	Varkila, MRJ; Vos, AG; Barth, RE; Tempelman, HA; Deville, WLJ; Coutinho, RA; Grobbee, DE; Klipstein-Grobusch, K				Varkila, Meri R. J.; Vos, Alinda G.; Barth, Roos E.; Tempelman, Hugo A.; Deville, Walter L. J.; Coutinho, Roel A.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin			The association between HIV infection and pulmonary function in a rural African population	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; LUNG-FUNCTION; ANTIRETROVIRAL THERAPY; RESPIRATORY SYMPTOMS; REFERENCE VALUES; TOBACCO USE; DISEASE; TUBERCULOSIS; RISK; EPIDEMIOLOGY	Objectives HIV infection has been associated with an impaired lung function in high-income countries, but the association between HIV infection and pulmonary function in Sub-Saharan Africa remains unclear. This study aims to investigate the relation between HIV infection and pulmonary function in a rural African population. Methods A cross-sectional study was conducted among HIV-positive and HIV-negative adults in a rural area in South Africa, as part of the Ndlovu Cohort Study. A respiratory questionnaire and post-bronchodilator spirometry were performed. Multivariable regression analysis was used to investigate whether HIV was independently associated with a decrease in post-bronchodilator FEV1/FVC ratio considering age, sex, body mass index, respiratory risk factors and a history of a pulmonary infection (tuberculosis (TB) or a pneumonia). Possible mediation by a history of pulmonary infection was tested by removing this variable from the final model. Results Two hundred and one consecutive participants were enrolled in the study in 2016, 84 (41.8%) were HIV-positive (82.1% on ART). The median age was 38 (IQR 29-51) years. Following multivariable analysis HIV was not significantly associated to a decline in post-bronchodilator FEV1/FVC ratio (beta -0.017, p 0.18). However, upon removal of a history of a pulmonary infection from the final model HIV was significantly related to post-bronchodilator FEV1/FVC ratio, beta -0.026, p 0.03. Conclusions Pulmonary function is affected by HIV infection which most likely results from co-infection with TB or other pneumonia. Further research should focus on the influence of a pulmonary infection, most notably TB, on pulmonary function, especially as the incidence of TB is high in HIV infection.	[Varkila, Meri R. J.; Vos, Alinda G.; Deville, Walter L. J.; Coutinho, Roel A.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Vos, Alinda G.; Barth, Roos E.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Vos, Alinda G.] Univ Witwatersrand Johannesburg, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Tempelman, Hugo A.; Deville, Walter L. J.] Ndlovu Care Grp, Groblersdal, South Africa; [Grobbee, Diederick E.] Acad Contract Res Org, Julius Clin Res, Zeist, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Div Epidemiol & Biostat, Sch Publ Hlth, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; University of Witwatersrand	Vos, AG (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.; Vos, AG (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.; Vos, AG (corresponding author), Univ Witwatersrand Johannesburg, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa.	a.g.vos-8@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Vos, Alinda/0000-0002-9551-6223; Deville, Walter/0000-0001-9854-1718; Varkila, Meri/0000-0002-2831-0292				Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Akanbi MO, 2015, J AIDS CLIN RES, V6; Amaral AFS, 2015, EUR RESPIR J, V46, P1104, DOI 10.1183/13993003.02325-2014; [Anonymous], 2012, GLOB REP UNAIDS REP; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; Bigna JJ, 2018, LANCET GLOB HEALTH, V6, pE182, DOI 10.1016/S2214-109X(17)30451-5; Brandli O, 1996, THORAX, V51, P277, DOI 10.1136/thx.51.3.277; Chakrabarti Biswajit, 2007, Int J Chron Obstruct Pulmon Dis, V2, P263; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; COTES JE, 1987, LANCET, V2, P1028; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Diaz PT, 2003, CHEST, V123, P1977, DOI 10.1378/chest.123.6.1977; DOCKERY DW, 1985, AM REV RESPIR DIS, V131, P511, DOI 10.1164/arrd.1985.131.4.511; Drummond MB, 2015, AIDS, V29, P1691, DOI 10.1097/QAD.0000000000000750; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619; Gautam SS, 2016, COPD, V13, P790, DOI 10.1080/15412555.2016.1191456; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Hayden LP, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0273-8; Institute for Health Metrics and Evaluation Human Development Network The The World Bank, 2013, GLOB BURD DIS GEN EV; Isara AR, 2014, EURASIAN J MED, V46, P203, DOI 10.5152/eajm.2014.0051; Janssens JP, 2005, CLIN CHEST MED, V26, P469, DOI 10.1016/j.ccm.2005.05.004; Kristoffersen US, 2012, CLIN PHYSIOL FUNCT I, V32, P288, DOI 10.1111/j.1475-097X.2012.01124.x; Kunisaki KM, 2016, LANCET RESP MED, V4, P980, DOI 10.1016/S2213-2600(16)30319-8; Lalley PM, 2013, RESP PHYSIOL NEUROBI, V187, P199, DOI 10.1016/j.resp.2013.03.012; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; Mengersen K, 2011, SCI TOTAL ENVIRON, V409, P1378, DOI 10.1016/j.scitotenv.2011.01.016; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; North CM, 2018, LUNG, V196, P49, DOI 10.1007/s00408-017-0080-8; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Pefura-Yone EW, 2015, RESP MED, V109, P247, DOI 10.1016/j.rmed.2014.12.003; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Petrache I, 2008, THORAX, V63, P463, DOI 10.1136/thx.2007.079111; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Risso K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169359; Ronit A, 2018, THORAX, V73, P431, DOI 10.1136/thoraxjnl-2017-211079; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sreeramareddy CT, 2018, TOB CONTROL, V27, P26, DOI 10.1136/tobaccocontrol-2016-053266; Stenton C, 2008, OCCUP MED-OXFORD, V58, P226, DOI 10.1093/occmed/kqm162; Twigg Homer L 3rd, 2007, Drug Discov Today Dis Mech, V4, P95, DOI 10.1016/j.ddmec.2007.11.001; UNAIDS, 2014, THE GAP REP; van Gemert F, 2015, LANCET GLOB HEALTH, V3, pE44, DOI 10.1016/S2214-109X(14)70337-7; Vos A, 2017, EUR J PREV CARDIOL, V24, P1043, DOI 10.1177/2047487317702039; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2002, WORLD HLTH SURV 2002	50	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210573	10.1371/journal.pone.0210573	http://dx.doi.org/10.1371/journal.pone.0210573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645622	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200035
J	Ajamian, M; Steer, D; Rosella, G; Gibson, PR				Ajamian, Mary; Steer, David; Rosella, Gennaro; Gibson, Peter R.			Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems	PLOS ONE			English	Article							TIGHT JUNCTIONS; HAPTOGLOBIN; DISEASE; PERMEABILITY; IDENTIFICATION; POLYMORPHISM; MODULATOR; PROTEIN; GLUTEN; C3	The protein, zonulin, has emerged as a popular serological marker to assess the integrity of the intestinal mucosal barrier. However, there is limited information on the utility of serum zonulin to indicate gastrointestinal disease and the validity of zonulin detection in widely-used commercial assays. The current study reports differences in zonulin levels across patient groups with gastrointestinal dysfunction compared with healthy individuals, though methodological inconsistencies indicated that actual zonulin protein was not detected by the commercial assays applied. The nature of the assays' detected antigen was investigated using immunoprecipitation followed by mass spectrometric analysis and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by protein staining. Top matches of the assays' detected antigen included haptoglobin and complement C3 for the assay manufactured by CUSABIO (Wuhan, China) and complement C3 for the assay manufactured by Immundiagnostik AG (Bensheim ,Germany). These findings confirm that current commercial zonulin assays are not detecting the actual protein as prehaptoglobin-2. Until assay methodology is improved, we advise the greater scientific and medical community to exercise caution in considering the measurement of serum zonulin as a marker of mucosal barrier integrity.	[Ajamian, Mary; Rosella, Gennaro; Gibson, Peter R.] Monash Univ, Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Steer, David] Monash Biomed Prote Facil, Clayton, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Ajamian, M (corresponding author), Monash Univ, Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia.	Mary.Ajamian@monash.edu			Australian-American Fulbright Commission	Australian-American Fulbright Commission	MA received a Fulbright Scholarship from the Australian-American Fulbright Commission (https://www.fulbright.org.au/) to undertake research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro MR CC, 2014, UNITED EUROPEAN G S1, V2; Beswick L, 2018, J CROHNS COLITIS, V12, P289, DOI 10.1093/ecco-jcc/jjx146; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Di Pierro M, 2001, J BIOL CHEM, V276, P19160, DOI 10.1074/jbc.M009674200; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Fasano A, 2012, ANN NY ACAD SCI, V1258, P25, DOI 10.1111/j.1749-6632.2012.06538.x; Fasano A, 2012, CLIN REV ALLERG IMMU, V42, P71, DOI 10.1007/s12016-011-8291-x; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; Hollon J, 2015, NUTRIENTS, V7, P1565, DOI 10.3390/nu7031565; Khaleghi S, 2016, THER ADV GASTROENTER, V9, P37, DOI 10.1177/1756283X15616576; Koch W, 2002, CLIN CHEM, V48, P1377; Kuo SJ, 2015, J FORMOS MED ASSOC, V114, P943, DOI 10.1016/j.jfma.2014.01.016; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017; Newnham E, 2017, J GASTROENTEROLOGY H; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Scheffler L., 2017, BIORXIV, DOI [10.1101/157578, DOI 10.1101/157578]; Scheffler L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00022; Sina C, 2018, SEMIN IMMUNOL, V37, P66, DOI 10.1016/j.smim.2018.02.008; Sunderhauf A, 2017, MOL IMMUNOL, V90, P227, DOI 10.1016/j.molimm.2017.08.003; TOSI M, 1989, J MOL BIOL, V208, P709, DOI 10.1016/0022-2836(89)90161-7; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang WL, 2000, J CELL SCI, V113, P4435; Wicher KB, 2006, P NATL ACAD SCI USA, V103, P4168, DOI 10.1073/pnas.0508723103; Wicher KB, 2004, P NATL ACAD SCI USA, V101, P14390, DOI 10.1073/pnas.0405692101	30	74	76	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210728	10.1371/journal.pone.0210728	http://dx.doi.org/10.1371/journal.pone.0210728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640940	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000041
J	Mohamed, N; Timofeyeva, Y; Jamrozy, D; Rojas, E; Hao, L; de Monerri, NCS; Hawkins, J; Singh, G; Cai, B; Liberator, P; Sebastian, S; Donald, RGK; Scully, IL; Jones, CH; Creech, CB; Thomsen, I; Parkhill, J; Peacock, SJ; Jansen, KU; Holden, MTG; Anderson, AS				Mohamed, Naglaa; Timofeyeva, Yekaterina; Jamrozy, Dorota; Rojas, Eduardo; Hao, Li; de Monerri, Natalie C. Silmon; Hawkins, Julio; Singh, Guy; Cai, Bing; Liberator, Paul; Sebastian, Shite; Donald, Robert G. K.; Scully, Ingrid L.; Jones, C. Hal; Creech, C. Buddy; Thomsen, Isaac; Parkhill, Julian; Peacock, Sharon J.; Jansen, Kathrin U.; Holden, Matthew T. G.; Anderson, Annaliesa S.			Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States	PLOS ONE			English	Article							METHICILLIN-RESISTANT; SEROTYPE 5; IN-VITRO; BACTERIAL VIRULENCE; CONJUGATE VACCINE; CLUMPING FACTOR; PCR STRATEGY; ANTIBODIES; HEALTH; VIVO	Staphylococcus aureus capsular polysaccharides (CP) are important virulence factors under evaluation as vaccine antigens. Clinical S. aureus isolates have the biosynthetic capability to express either CP5 or CP8 and an understanding of the relationship between CP genotype/phenotype and S. aureus epidemiology is valuable. Using whole genome sequencing, the clonal relatedness and CP genotype were evaluated for disease-associated S. aureus isolates selected from the Tigecycline Evaluation and Surveillance Trial (T. E. S. T) to represent different geographic regions in the United States (US) during 2004 and 2009-10. Thirteen prominent clonal complexes (CC) were identified, with CC5, 8, 30 and 45 representing >80% of disease isolates. CC5 and CC8 isolates were CP type 5 and, CC30 and CC45 isolates were CP type 8. Representative isolates from prevalent CC were susceptible to in vitro opsonophagocytic killing elicited by anti-CP antibodies, demonstrating that susceptibility to opsonic killing is not linked to the genetic lineage. However, as not all S. aureus isolates may express CP, isolates representing the diversity of disease isolates were assessed for CP production. While approximately 35% of isolates (primarily CC8) did not express CP in vitro, CP expression could be clearly demonstrated in vivo for 77% of a subset of these isolates (n = 20) despite the presence of mutations within the capsule operon. CP expression in vivo was also confirmed indirectly by measuring an increase in CP specific antibodies in mice infected with CP5 or CP8 isolates. Detection of antigen expression in vivo in relevant disease states is important to support the inclusion of these antigens in vaccines. Our findings confirm the validity of CP as vaccine targets and the potential of CP-based vaccines to contribute to S. aureus disease prevention.	[Mohamed, Naglaa; Timofeyeva, Yekaterina; Rojas, Eduardo; Hao, Li; de Monerri, Natalie C. Silmon; Hawkins, Julio; Singh, Guy; Cai, Bing; Liberator, Paul; Sebastian, Shite; Donald, Robert G. K.; Scully, Ingrid L.; Jones, C. Hal; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA; [Jamrozy, Dorota; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Creech, C. Buddy; Thomsen, Isaac] Vanderbilt Univ, Sch Med, Vanderbilt Vaccine Res Program, Dept Pediat,Div Pediat Infect Dis, 221 Kirkland Hall, Nashville, TN 37235 USA; [Peacock, Sharon J.] London Sch Hyg & Trop Med, London, England; [Holden, Matthew T. G.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	Pfizer; Wellcome Trust Sanger Institute; Vanderbilt University; University of London; London School of Hygiene & Tropical Medicine; University of St Andrews	Anderson, AS (corresponding author), Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA.	annaliesa.anderson@pfizer.com	Peacock, Sharon J/ABE-6331-2020; Parkhill, Julian/G-4703-2011; Holden, Matthew TG/K-6449-2014; Donald, Robert George Konrad/GNP-4958-2022	Parkhill, Julian/0000-0002-7069-5958; Holden, Matthew TG/0000-0002-4958-2166; Creech, Clarence/0000-0002-8276-9053; Peacock, Sharon/0000-0002-1718-2782	Pfizer Vaccine Research	Pfizer Vaccine Research	This study was sponsored by Pfizer Vaccine Research who provided support in the form of salaries for authors NM, YT, ER, LH, NSM, JH, GS, BC, PL, SS, RGKD, ILS, CHJ, KUJ and ASA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson AS, 2012, HUM VACC IMMUNOTHER, V8, P1585, DOI 10.4161/hv.21872; Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Benjamin DK, 2006, J PERINATOL, V26, P290, DOI 10.1038/sj.jp.7211496; BLOCK SL, 2015, PEDIATR INFECT DIS J, V4, P3; BOETZER M, BIOINFORMATICS, P578; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; BOUCHILLON SK, 2005, DIAGN MICROBIOL INFE, V8, P18; BOYLEVAVRA S, 2006, LAB INVEST, V12, P6; CHAMBERS HF, NATURE REVIEWS MICRO, P629; Chaves-Moreno D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33174; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2009, J INFECT DIS, V200, P1371, DOI 10.1086/606011; Cocchiaro JL, 2006, MOL MICROBIOL, V59, P948, DOI 10.1111/j.1365-2958.2005.04978.x; Cook J, 2009, HUM VACCINES, V5, P254, DOI 10.4161/hv.5.4.6765; David MZ, 2012, INFECT CONT HOSP EP, V33, P782, DOI 10.1086/666640; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DAVID MZ, 2011, PUBMED, V5, P3; De Montalembert M, 2015, PEDIATR BLOOD CANCER, V62, P1427, DOI 10.1002/pbc.25502; Diekema DJ, 2014, INFECT CONT HOSP EP, V35, P285, DOI 10.1086/675283; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; FATTOM A, 1974, PUBMED; FATTOM A, 2014, PUBMED, V12, P9; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; FATTOM AI, 1998, PUBMED, V9, P24; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Giersing BK, 2016, VACCINE, V34, P2962, DOI 10.1016/j.vaccine.2016.03.110; GOERKE C, MOL MICROBIOL, P1439; GOETGHEBEUR M, 2008, PUBMED, V10, P17; GUIDRY AJ, 1991, J DAIRY SCI, V74, P3360, DOI 10.3168/jds.S0022-0302(91)78525-1; Gupta RK, 2013, J INFECT DIS, V208, P1841, DOI 10.1093/infdis/jit367; Hallin M, 2007, J ANTIMICROB CHEMOTH, V59, P465, DOI 10.1093/jac/dkl535; Handke LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077874; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; HARRISON LH, J INFECT DIS, P1208; HAWKINS J, 2012, A RECOMBINANT CLUMPI; Herbert S, 1997, Pneumologie, V51, P1043; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsu LY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0643-z; Hsu LY, 2015, MBIO, V16, P81; Inouye M, 2014, PUBMED, V6, P90; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jamrozy DM, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000058; Jansen KU, 2013, VACCINE, V31, P2723, DOI 10.1016/j.vaccine.2013.04.002; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Jenkins A, 2015, MBIO, V6, DOI 10.1128/mBio.02272-14; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KOSER CU, 2012, PUBMED, V6, P15; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Lattar SM, 2009, INFECT IMMUN, V77, P1968, DOI 10.1128/IAI.01214-08; LATTAR SM, INFECT IMMUN, P83; LEE CY, 2001, INFEC AGENT, P35; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Li WJ, 2014, INT J MED MICROBIOL, V304, P958, DOI 10.1016/j.ijmm.2014.06.002; LIMBAGO B, J CLIN MICROBIOL, P1344; LINDSAY JA, 2005, PUBMED, V12, P31; Liu B, 2017, VIRULENCE, V8, P859, DOI 10.1080/21505594.2016.1270494; LUONG T, 2010, PUBMED, V12, P7; Luong TT, 2006, MICROBIOL-SGM, V152, P3123, DOI 10.1099/mic.0.29177-0; MA X, ANTIMICROB AGENTS CH, P1147; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; MATSON MAGD, 2001, ICAAC, P5; MCADOW M, 2011, PLOS PATHOG, V7, P10; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; McNamara Peter J., 2008, P89; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; MOHAMED N, 2017, THE BRITISH JOURNAL, V104, P2; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; MURPHY E, 2011, HUM VACCINES, V1, P20; Murphy E, 2011, HUM VACCINES, V7, P51, DOI 10.4161/hv.7.0.14562; Nanra JS, 2009, VACCINE, V27, P3276, DOI 10.1016/j.vaccine.2009.01.062; NANRA JS, 2012, PUBMED, V12, P20; Nissen M, 2015, VACCINE, V33, P1846, DOI 10.1016/j.vaccine.2015.02.024; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; OUYANG S, 1999, PUBMED, V4, P10; OUYANG S, 1997, MOL MICROBIOL, V2, P1; Page AJ, 2016, MICROB GENOMICS, V2; Park S, 2014, INFECT IMMUN, V82, P5049, DOI 10.1128/IAI.02373-14; Pasquale TR, 2013, INT J INFECT DIS, V17, pE398, DOI 10.1016/j.ijid.2012.12.013; PMID, 2006, PUBMED; PMID, 2012, PUBMED, V6, P27; PMID, PUBMED; PMID, 2011, PUBMED, V11, P29; PMID, 2015, PUBMED, V2, P19; PMID, 2017, PUBMED, V3, P30; PMID, 2004, PUBMED, V1, P17; PMID, PUBMED, P144; PMID, 2012, PUBMED, V16, P7391; PMID, 2017, PUBMED, V1, P26; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; RASMUSSEN G, 2013, PLOS ONE, V10, P17; ROGHMANN M, J HOSP INFECT, P27; ROZEMEIJER W, 2015, PUBMED, V2, P27; Rupp ME, 2007, ANTIMICROB AGENTS CH, V51, P4249, DOI 10.1128/AAC.00570-07; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Scully IL, 2018, HUM VACC IMMUNOTHER, V14, P81, DOI 10.1080/21645515.2017.1386360; Scully IL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00109; Sharma-Kuinkel BK, 2015, BIOINFORMATICS, V2, DOI 10.1093/ofid/ofv093; SHARMAKUINKEL BK, 2015, PUBMED, V7, P28; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; SOELL M, 1995, PUBMED, V4, P1; SOMPOLINSKY D, 1985, J CLIN MICROBIOL, V22, P828, DOI 10.1128/JCM.22.5.828-834.1985; Spoor LE, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000036; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; SUN FJIQ, 2011, PUBMED, V11, P30; Sutter DE, 2011, FEMS IMMUNOL MED MIC, V63, P16, DOI 10.1111/j.1574-695X.2011.00822.x; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; TALAN DA, R J; TENOVER FC, J CLIN MICROBIOL, P108; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Timofeyeva Yekaterina, 2014, Methods Mol Biol, V1085, P85, DOI 10.1007/978-1-62703-664-1_4; TROTTER CL, VACCINE, P4434; Tuchscherr LPN, 2008, INFECT IMMUN, V76, P5738, DOI 10.1128/IAI.00874-08; VANWAMEL W, 2002, MICROB PATHOGENESIS, V8, P31; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; WYRES KL, J INFECT DIS, P439; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	130	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208356	10.1371/journal.pone.0208356	http://dx.doi.org/10.1371/journal.pone.0208356			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30641545	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000455808000004
J	Monamele, CG; Njifon, HLM; Vernet, MA; Njankouo, MR; Kenmoe, S; Yahaya, AA; Deweerdt, L; Nono, R; Mbacham, W; Anong, DN; Akoachere, JF; Njouom, R				Monamele, Chavely Gwladys; Njifon, Hermann Landry Munshili; Vernet, Marie-Astrid; Njankouo, Mohamadou Ripa; Kenmoe, Sebastien; Yahaya, Ali Ahmed; Deweerdt, Louis; Nono, Raphael; Mbacham, Wilfred; Anong, Damian Nota; Akoachere, Jane Francis; Njouom, Richard			Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; VIRUSES; HEMAGGLUTININ; EPIDEMIOLOGY; A(H3N2); H1N1	In 2009, Influenza A(H1N1)pdm09 caused the first influenza pandemic of the 21st century with high mortality rates of about 284 500 deaths. This virus, however, continues to circulate as a seasonal influenza virus and to cause illness and deaths worldwide. In this study, we describe the genetic diversity of A(H1N1)pdm09 viruses collected between 2014 and 2016 in Cameroon. Three gene segments (HA, NA and M) of Cameroon strains were studied. The phylogenetic tree of the coding nucleotide sequences was generated by MEGA version 6.0 using a Maximum Likelihood method. The NA and M protein coding sequences were analyzed for the reported genetic markers of resistance against neuraminidase inhibitors and adamantanes, while predicted vaccine efficacy was estimated using the P-epitope method. Overall 39 strains were obtained. Phylogenetic analysis of the HA gene of influenza A(H1N1)pdm09 showed that Cameroon strains belonged to two major clades. The 2014 Cameroon sequences belonged to clade 6C while all sequences collected between 2015 and 2016 belonged to clade 6B. Majority of the samples had some mutations in the NA gene notably: I117M, N248D, and N369K while the amantadine-resistant M mutant, S31N, was found to be absent only in the two sequences collected in 2014. Overall, A/California/07/2009 vaccine strain showed a predicted vaccine efficacy of 24.55% to 35.77% against Cameroon A(H1N1)pdm09 strains circulating between 2014 and 2016. Our findings confirms the fast evolution of A(H1N1)pdm09 since its first introduction and highlights on the importance of influenza vaccine in reducing the burden caused by influenza in the community.	[Monamele, Chavely Gwladys; Vernet, Marie-Astrid; Njankouo, Mohamadou Ripa; Kenmoe, Sebastien; Njouom, Richard] Ctr Pasteur Cameroon, Natl Influenza Ctr, Yaounde, Cameroon; [Monamele, Chavely Gwladys; Anong, Damian Nota; Akoachere, Jane Francis] Univ Buea, Buea, Cameroon; [Njifon, Hermann Landry Munshili; Deweerdt, Louis; Nono, Raphael] Ctr Pasteur Cameroon, Annex Of Garoua, Garoua, Cameroon; [Njifon, Hermann Landry Munshili; Mbacham, Wilfred] Univ Yaounde I, Yaounde, Cameroon; [Yahaya, Ali Ahmed] WHO, Reg Off Africa, Brazzaville, Rep Congo	University of Yaounde I; World Health Organization	Njouom, R (corresponding author), Ctr Pasteur Cameroon, Natl Influenza Ctr, Yaounde, Cameroon.	njouom@pasteur-yaounde.org		Hermann Landry, Munshili Njifon/0000-0002-7181-9836; KENMOE, SEBASTIEN/0000-0002-5536-080X	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes [6 DESP060001-01-01]	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes	This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes.	[Anonymous], 2018, SEAS INFL VACC EFF 2; [Anonymous], 2004, PREDICTION N GLYCOSY; Barr IG, 2014, VACCINE, V32, P4713, DOI 10.1016/j.vaccine.2014.02.014; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Eshaghi A, 2014, INFLUENZA OTHER RESP, V8, P250, DOI 10.1111/irv.12219; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Han Y, 2016, VIRUS GENES, V52, P606, DOI 10.1007/s11262-016-1358-2; Horm SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110713; Hurt AC, 2016, ANTIVIR RES, V132, P178, DOI 10.1016/j.antiviral.2016.06.001; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Korsun N, 2017, INFECT GENET EVOL, V49, P241, DOI 10.1016/j.meegid.2017.01.027; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Monamele GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184411; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Nelson MI, 2014, J INFECT DIS, V210, P121, DOI 10.1093/infdis/jiu047; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Potdar VA, 2014, INDIAN J MED RES, V140, P244; Sanou AM, 2018, INFLUENZA OTHER RESP, V12, P490, DOI 10.1111/irv.12539; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; Wedde M, 2015, INT J MED MICROBIOL, V305, P762, DOI 10.1016/j.ijmm.2015.08.030; WHO, 2018, INFL SEAS MED CTR; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Ogranization (WHO), 2018, LAB METH TEST ANT SU; World Health Organization, WHO REC COMP INFL VI	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210119	10.1371/journal.pone.0210119	http://dx.doi.org/10.1371/journal.pone.0210119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640922	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000019
J	Sinn, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW				Sinn, Dong Hyun; Choi, Gyu-Seong; Park, Hee Chul; Kim, Jong Man; Kim, Honsoul; Song, Kyoung Doo; Kang, Tae Wook; Lee, Min Woo; Rhim, Hyunchul; Hyun, Dongho; Cho, Sung Ki; Shin, Sung Wook; Jeong, Woo Kyoung; Kim, Seong Hyun; Il Yu, Jeong; Ha, Sang Yun; Lee, Su Jin; Lim, Ho Yeong; Kim, Kyunga; Ahn, Joong Hyun; Kang, Wonseok; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Joh, Jae-Won; Lim, Hyo Keun; Paik, Seung Woon			Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients	PLOS ONE			English	Article							COMPLEXITY SCIENCE; MANAGEMENT; GUIDELINES; OUTCOMES; TEAM; THERAPY; CANCER; CARE	Background Given the complexity of managing hepatocellular carcinoma (HCC),a multidisciplinary approach (MDT) is recommended to optimize management of HCC patients. However, evidence suggesting that MDT improves patient outcome is limited. Methods We performed a retrospective cohort study of all patients newly-diagnosed with HCC between 2005 and 2013 (n = 6,619). The overall survival (OS) rates between the patients who were and were not managed via MDT were compared in the entire cohort (n = 6,619), and in the exactly matched cohort (n = 1,396). Results In the entire cohort, the 5-year survival rate was significantly higher in the patients who were managed via MDT compared to that of the patients who were not (71.2% vs. 49.4%, P < 0.001), with an adjusted hazard ratio (HR) of 0.47 (95% confidence interval [CI]; 0.41-0.53). In the exactly matched cohort, the 5-year survival rate was higher in patients who were managed via MDT (71.4% vs. 58.7%, P < 0.001; HR [95% CI] = 0.67 [0.56-0.80]). The survival benefit of MDT management was observed in most pre-defined subgroups, and was especially significant in patients with poor liver function (ALBI grade 2 or 3), intermediate or advanced tumor stage (BCLC stage B or C), or high alphafetoprotein levels (>= 200 ng/ml). Conclusion MDT management was associated with improved overall survival in HCC patients, indicating that MDT management can be a valuable option to improve outcome of HCC patients. This warrants prospective evaluations.	[Sinn, Dong Hyun; Lee, Su Jin; Lim, Ho Yeong; Kang, Wonseok; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Choi, Gyu-Seong; Kim, Jong Man; Joh, Jae-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Park, Hee Chul; Il Yu, Jeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Honsoul; Song, Kyoung Doo; Kang, Tae Wook; Lee, Min Woo; Rhim, Hyunchul; Hyun, Dongho; Cho, Sung Ki; Shin, Sung Wook; Jeong, Woo Kyoung; Kim, Seong Hyun; Lim, Hyo Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Honsoul; Song, Kyoung Doo; Kang, Tae Wook; Lee, Min Woo; Rhim, Hyunchul; Hyun, Dongho; Cho, Sung Ki; Shin, Sung Wook; Jeong, Woo Kyoung; Kim, Seong Hyun; Lim, Hyo Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Ha, Sang Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Kyunga; Ahn, Joong Hyun] Samsung Med Ctr, Res Inst Future Med, Stat & Data Ctr, Seoul, South Korea; [Lim, Hyo Keun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Paik, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.; Lim, HK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.; Lim, HK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea.; Lim, HK (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	hyokeun.lim@samsung.com; sw.paik@samsung.com	Jeong, Woo Kyoung/ABE-7025-2021; Kim, Jong Man/AAH-5295-2020	Jeong, Woo Kyoung/0000-0002-0676-2116; Park, Hee Chul/0000-0003-0385-9681; Ahn, Joong Hyun/0000-0002-5768-5990; Lee, Su Jin/0000-0003-3405-9935				Agarwal PD, 2017, J CLIN GASTROENTEROL, V51, P845, DOI 10.1097/MCG.0000000000000825; Bertuccio P, 2017, J HEPATOL, V67, P302, DOI 10.1016/j.jhep.2017.03.011; Blanc JF, 2015, CLIN RES HEPATOL GAS, V39, P180, DOI 10.1016/j.clinre.2014.10.003; Bolondi L, 2013, DIGEST LIVER DIS, V45, P712, DOI 10.1016/j.dld.2013.01.012; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Chang TT, 2008, HPB, V10, P405, DOI 10.1080/13651820802356572; Charriere B, 2017, J SURG ONCOL, V115, P330, DOI 10.1002/jso.24500; Cho EJ, 2017, CLIN MOL HEPATOL, V23, P205, DOI 10.3350/cmh.2017.0104; De Ieso PB, 2013, BRIT J CANCER, V109, P2295, DOI 10.1038/bjc.2013.586; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Gashin L, 2014, HPB, V16, P1009, DOI 10.1111/hpb.12280; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kim BH, 2018, CLIN MOL HEPATOL, V24, P1, DOI 10.3350/cmh.2017.0112; Kim KM, 2016, LIVER INT, V36, P1490, DOI 10.1111/liv.13107; Korean-Liver-Canc-Study-Grp-KLCSG, 2015, GUT LIVER, V9, P267, DOI 10.5009/gnl14460; Lee HW, 2016, CLIN MOL HEPATOL, V22, P309, DOI 10.3350/cmh.2016.0042; Moon H, 2017, J CANCER RES CLIN, V143, P2327, DOI 10.1007/s00432-017-2480-9; Nathan H, 2013, ANN SURG ONCOL, V20, P448, DOI 10.1245/s10434-012-2619-5; Serper M, 2017, GASTROENTEROLOGY, V152, P1954, DOI 10.1053/j.gastro.2017.02.040; SHIN DONG HYUN, 2016, Journal of Liver Cancer, V16, P101; Soares KC, 2014, ANN SURG ONCOL, V21, P1059, DOI 10.1245/s10434-013-3419-2; Yopp AC, 2014, ANN SURG ONCOL, V21, P1287, DOI 10.1245/s10434-013-3413-8; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Zaky S, 2015, TURK J GASTROENTEROL, V26, P498, DOI 10.5152/tjg.2015.0158; Zhang J, 2013, CURR ONCOL, V20, pE123, DOI 10.3747/co.20.1297; Zhu RX, 2016, GUT LIVER, V10, P332, DOI 10.5009/gnl15257	28	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210730	10.1371/journal.pone.0210730	http://dx.doi.org/10.1371/journal.pone.0210730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640924	gold, Green Published, Green Submitted			2022-12-26	WOS:000455808000042
J	Muehlemann, N; Jouaneton, B; de Leotoing, L; Chale, JJ; Fernandes, J; Kagi, G; Sarikaya, H; Arnold, M				Muehlemann, Natalia; Jouaneton, Baptiste; de Leotoing, Lucie; Chale, Jean-Jacques; Fernandes, Jerome; Kagi, Georg; Sarikaya, Hakan; Arnold, Marcel			Hospital costs impact of post ischemic stroke dysphagia: Database analyses of hospital discharges in France and Switzerland	PLOS ONE			English	Article								Introduction Oropharyngeal dysphagia is frequent in hospitalized post-stroke patients and is associated with increased mortality and comorbidities. The aim of our analysis was to evaluate the impact of dysphagia on Length of Hospital Stay (LOS) and costs. The hospital perspective was used to assess costs. Methods Hospital discharge databases comparing hospital stays for ischemic stroke associated with dysphagia vs stroke without dysphagia in France and Switzerland were analyzed. The French Medical Information System Program (PMSI) database analysis focused on 62'297 stays for stroke in the public sector. 6'037 hospital stays for stroke were analyzed from the Swiss OFS (Office federal de la statistique: Statistique des couts par cas 2012) database. Diagnosis codes and listing of procedures were used to identify dysphagia in stroke patients. Results Patients with post-stroke dysphagia accounted for 8.4% of stroke hospital stays in Switzerland, which is consistent with recently reported prevalence of dysphagia at hospital discharge (Arnold et al, 2016). The French database analysis identified 4.2% stays with post-stroke dysphagia. We hypothesize that the difference between the Swiss and French datasets may be explained by the limitations of an analysis based on diagnosis and procedure coding. Patients with post-stroke dysphagia stayed longer at hospitals (LOS of 23.7 vs. 11.8 days in France and LOS of 14.9 vs. 8.9 days in Switzerland) compared with patients without post-stroke dysphagia. Post-stroke dysphagia was associated with about (sic)3'000 and CHF14'000 cost increase in France and Switzerland respectively. Discussion In this study post-stroke dysphagia was associated with increased LOS and higher hospital costs. It is difficult to isolate the impact of dysphagia in patients with multiple symptoms and disabilities impacting rehabilitation and recovery. After adjusting for confounding factors by matching stays according to age, sex and stroke complications, post-stroke dysphagia association with increased LOS and higher hospital costs was found to be independent of sensory or motor complications. Conclusion Post-stroke dysphagia is associated with increased length of hospital stay and higher hospital costs.	[Muehlemann, Natalia] Nestle Hlth Sci, Epalinges, Switzerland; [Jouaneton, Baptiste; de Leotoing, Lucie] HEVA, Lyon, France; [Chale, Jean-Jacques] Geneva Univ Hosp, Finance Dept, Geneva, Switzerland; [Fernandes, Jerome] Grp OC Sante, Montpellier, France; [Kagi, Georg] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Sarikaya, Hakan; Arnold, Marcel] Univ Hosp Berne, Dept Neurol, Bern, Switzerland	University of Geneva; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern	Muehlemann, N (corresponding author), Nestle Hlth Sci, Epalinges, Switzerland.	natalia.muehlemann@nestle.com		Muehlemann, Natalia/0000-0001-5167-904X	Nestle Health Science, Nestec S.A., Vevey, Switzerland; HEVA, Lyon, France	Nestle Health Science, Nestec S.A., Vevey, Switzerland(Nestle SA); HEVA, Lyon, France	This study was sponsored by Nestle Health Science, Nestec S.A., Vevey, Switzerland, through research contracts with HEVA, Lyon, France to L.L. HEVA was commissioned by Nestle Health Science to perform databases analysis and statistical analysis. In collaboration with coauthors, the funder was involved in study design, data interpretation, decision to publish and preparation of the manuscript. The funder was not involved in databases analysis and statistical analysis. All authors had full access to the data. All authors had final responsibility for the decision to submit for publication.	Arnold M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148424; Bonilha HS, 2014, DYSPHAGIA, V29, P545, DOI 10.1007/s00455-014-9543-8; Clave P, 2015, NAT REV GASTRO HEPAT, V12, P259, DOI 10.1038/nrgastro.2015.49; De Peretti C, 2012, BEH; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; NICE, 2008, NICE NATL CLIN GUIDE	6	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210313	10.1371/journal.pone.0210313	http://dx.doi.org/10.1371/journal.pone.0210313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629665	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000073
J	Sillivan, SE; Jones, ME; Jamieson, S; Rumbaugh, G; Miller, CA				Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Rumbaugh, Gavin; Miller, Courtney A.			Bioinformatic analysis of long-lasting transcriptional and translational changes in the basolateral amygdala following acute stress	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MICRORNA; MEMORY; DISORDERS; NETWORKS; MIRBASE; SYSTEM; RATS	Stress profoundly impacts the brain and increases the risk of developing a psychiatric disorder. The brain's response to stress is mediated by a number of pathways that affect gene expression and protein function throughout the cell. Understanding how stress achieves such dramatic effects on the brain requires an understanding of the brain's stress response pathways. The majority of studies focused on molecular changes have employed repeated or chronic stress paradigms to assess the long-term consequences of stress and have not taken an integrative genomic and/or proteomic approach. Here, we determined the lasting impact of a single stressful event (restraint) on the broad molecular profile of the basolateral amygdala complex (BLC), a key brain region mediating emotion, memory and stress. Molecular profiling performed thirty days post-restraint consisted of small RNA sequencing, RNA sequencing and quantitative mass spectrometry and identified long-lasting changes in microRNA (miRNA), messenger RNA (mRNA) and proteins. Alignment of the three datasets further delineated the regulation of stress-specific pathways which were validated by qPCR and Western Blot analysis. From this analysis, mir-29a-5p was identified as a putative regulator of stress-induced adaptations in the BLC. Further, a number of predicted mir-29a-5p targets are regulated at the mRNA and protein level. The concerted and long-lasting disruption of multiple molecular pathways in the amygdala by a single stress event is expected to be sufficient to alter behavioral responses to a wide array of future experiences, including exposure to additional stressors.	[Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Miller, Courtney A.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Rumbaugh, Gavin; Miller, Courtney A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Sillivan, Stephanie E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA	Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Miller, CA (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.; Miller, CA (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	cmiller@scripps.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902	National Institute of Mental Health [MH105400]; National Institute on Drug Abuse [DA041469]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA041469, K99DA041469] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grants from the National Institute of Mental Health (MH105400 to CAM) and the National Institute on Drug Abuse (DA041469 to SS). The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; Bagot RC, 2016, NEURON, V90, P969, DOI 10.1016/j.neuron.2016.04.015; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104; Cathomas F, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12475; Cohen JL, 2017, BEHAV BRAIN RES, V319, P110, DOI 10.1016/j.bbr.2016.11.015; Daskalakis NP, 2018, BIOL PSYCHIAT, V83, P849, DOI 10.1016/j.biopsych.2018.01.009; Duval ER, 2015, THER CLIN RISK MANAG, V11, P115, DOI 10.2147/TCRM.S48528; Filatova EV, 2014, DOKL BIOCHEM BIOPHYS, V456, P116, DOI 10.1134/S1607672914030107; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griggs EM, 2013, J NEUROSCI, V33, P1734, DOI 10.1523/JNEUROSCI.2873-12.2013; Haramati S, 2011, J NEUROSCI, V31, P14191, DOI 10.1523/JNEUROSCI.1673-11.2011; Jarome TJ, 2013, NEUROBIOL LEARN MEM, V105, P107, DOI 10.1016/j.nlm.2013.03.009; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Korn CW, 2017, BIOL PSYCHIAT, V82, P522, DOI 10.1016/j.biopsych.2017.01.018; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewy R. L., 2018, SCHIZOPHR RES; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mannironi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073385; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; Mifsud KR, 2017, NEUROENDOCRINOLOGY, V104, P157, DOI 10.1159/000445875; Moreira PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163245; Novais A, 2017, NEUROBIOL STRESS, V6, P44, DOI 10.1016/j.ynstr.2016.11.004; Okkels N, 2017, SCHIZOPHRENIA BULL, V43, P180, DOI 10.1093/schbul/sbw082; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Pfau ML, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00144; Ranjbar H, 2017, CLIN EXP PHARMACOL P, V44, P470, DOI 10.1111/1440-1681.12727; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rumbaugh G, 2015, NEUROPSYCHOPHARMACOL, V40, P2307, DOI 10.1038/npp.2015.93; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharanova NE, 2016, B EXP BIOL MED+, V161, P355, DOI 10.1007/s10517-016-3413-3; Sillivan SE, 2017, BIOL PSYCHIAT, V82, P924, DOI 10.1016/j.biopsych.2017.06.030; Sousa N, 2016, MOL PSYCHIATR, V21, P302, DOI 10.1038/mp.2015.196; Sun JD, 2015, CELL REP, V12, P449, DOI 10.1016/j.celrep.2015.06.023; Syed S. A., 2017, EARLY LIFE STRESS MO, V1; Vaisvaser S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146236; Van't Veer A, 2013, PSYCHOPHARMACOLOGY, V229, P435, DOI 10.1007/s00213-013-3195-5; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vyas S., 2016, NEURAL PLAST, V2016, DOI [10.1155/2016/6391686, DOI 10.1155/2016/6391686]; Windischberger C, 2010, NEUROIMAGE, V49, P1161, DOI 10.1016/j.neuroimage.2009.10.013; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Zhou M, 2018, NEUROSCIENCE, V376, P24, DOI 10.1016/j.neuroscience.2018.02.010	55	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209846	10.1371/journal.pone.0209846	http://dx.doi.org/10.1371/journal.pone.0209846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629705	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000036
J	Fukami, T; Koga, H; Goto, M; Ando, M; Matsuoka, S; Tohyama, A; Yamamoto, H; Nakamura, S; Koyanagi, T; To, Y; Kondo, H; Eguchi, F; Tsujioka, H				Fukami, Tatsuya; Koga, Hidenobu; Goto, Maki; Ando, Miho; Matsuoka, Sakiko; Tohyama, Atsushi; Yamamoto, Hiroko; Nakamura, Sumie; Koyanagi, Takahiro; To, Yoko; Kondo, Haruhiko; Eguchi, Fuyuki; Tsujioka, Hiroshi			Incidence and risk factors for postpartum hemorrhage among transvaginal deliveries at a tertiary perinatal medical facility in Japan	PLOS ONE			English	Article							OUTCOMES	Postpartum hemorrhage (PPH) remains a leading cause of maternal death worldwide, and it is important to understand the relative contributions of different risk factors. We assessed the incidence of these among cases of transvaginal delivery. Between June 2013 and July 2016, a prospective cohort study was conducted at a tertiary perinatal medical facility in Japan. Women were administered a questionnaire to ascertain risk factors for PPH, defined as a blood loss of 1,000 ml or more assessed using a calibrated under-buttocks drape and collection vessel at childbirth. We analyzed 1,068 transvaginal deliveries of singleton pregnancies. The incidence of PPH was 8.7%, and of severe PPH (1,500 ml blood loss or more) was 2.1%. Risk factors for postpartum hemorrhage among the deliveries were: fetal macrosomia (over 4000 g); pregnancy-induced hypertension; pregnancy generated by assisted reproductive technology; severe vaginal or perineal lacerations; and weight gain over 15 kg during pregnancy. Such high weight gain significantly increased the incidence of PPH compared with women showing less than 10 kg weight gain during pregnancy. Monitoring these identified risk factors could enable extra vigilance during labor, and preparedness for managing PPH in all women giving birth.	[Fukami, Tatsuya; Goto, Maki; Ando, Miho; Matsuoka, Sakiko; Tohyama, Atsushi; Yamamoto, Hiroko; Nakamura, Sumie; Koyanagi, Takahiro; To, Yoko; Kondo, Haruhiko; Eguchi, Fuyuki; Tsujioka, Hiroshi] ASO Iizuka Hosp, Dept Obstet & Gynecol, Iizuka, Fukuoka, Japan; [Koga, Hidenobu] ASO Iizuka Hosp, Dept Hlth Informat Management, Iizuka, Fukuoka, Japan; [Koga, Hidenobu] ASO Iizuka Hosp, Supporting Unit Med Res, Iizuka, Fukuoka, Japan		Fukami, T (corresponding author), ASO Iizuka Hosp, Dept Obstet & Gynecol, Iizuka, Fukuoka, Japan.	fukami@med.nagoya-u.ac.jp		Fukami, Tatsuya/0000-0002-3261-5136				Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; [Anonymous], 2015, TRENDS MAT MORT 1990; Bais JMJ, 2004, EUR J OBSTET GYN R B, V115, P166, DOI 10.1016/j.ejogrb.2003.12.008; Calvert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041114; Davies GAL, 2005, OBSTET GYNECOL, V105, P294, DOI 10.1097/01.AOG.0000148264.20909.bb; Elenis E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0687-9; Ford JB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0788-5; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Magann EF, 2005, SOUTH MED J, V98, P681, DOI 10.1097/01.SMJ.0000163309.53317.B8; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636; Shmueli A, 2016, J MATERN-FETAL NEO M, V28, P1; Sosa CG, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.005; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; Sterweil P, 2006, OBSTET GYNECOL, V108, P1039; Thompson JF, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-5; von Schmidt auf Altenstadt JF, 2015, PLOS ONE, V8; Zhu LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35141	20	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208873	10.1371/journal.pone.0208873	http://dx.doi.org/10.1371/journal.pone.0208873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625154	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400019
J	Rubin, M; Miller, AD; Katoh-Kurasawa, M; Dinh, C; Kuspa, A; Shaulsky, G				Rubin, Michelle; Miller, Amber D.; Katoh-Kurasawa, Mariko; Dinh, Christopher; Kuspa, Adam; Shaulsky, Gad			Cooperative predation in the social amoebae Dictyostelium discoideum	PLOS ONE			English	Article							PROTEIN; RELATEDNESS; COMPLEXITY; BACTERIA; GENES; KILL	The eukaryotic amoeba Dictyostelium discoideum is commonly used to study sociality. The amoebae cooperate during development, exhibiting altruism, cheating, and kin-discrimination, but growth while preying on bacteria has been considered asocial. Here we show that Dictyostelium are cooperative predators. Using mutants that grow poorly on Gram-negative bacteria but grow well on Gram-positive bacteria, we show that growth depends on cell-density and on prey type. We also found synergy, by showing that pairwise mixes of different mutants grow well on live Gram-negative bacteria. Moreover, wild-type amoebae produce diffusible factors that facilitate mutant growth and some mutants exploit the wild type in mixed cultures. Finding cooperative predation in D. discoideum should facilitate studies of this fascinating phenomenon, which has not been amenable to genetic analysis before.	[Rubin, Michelle] Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA; [Miller, Amber D.; Katoh-Kurasawa, Mariko; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dinh, Christopher; Kuspa, Adam] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	gadi@bcm.edu		Shaulsky, Gad/0000-0002-0532-0551	National Institute of Child Health and Human Development through National Institutes of Health (NIH) [P01 HD39691]; National Institute of General Medical Sciences from NIH [T32 GM008231]; National Institute of General Medical Sciences [R35 GM118016]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897, R35GM118016, T32GM008231] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development through National Institutes of Health (NIH); National Institute of General Medical Sciences from NIH; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Child Health and Human Development through the National Institutes of Health (NIH) grant number P01 HD39691. MR was partially supported by National Institute of General Medical Sciences grant T32 GM008231 from the NIH. GS was partially supported by National Institute of General Medical Sciences grant R35 GM118016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Assas L, 2015, J BIOL DYNAM, V9, P288, DOI 10.1080/17513758.2015.1077999; Beauchamp G., 2014, SOCIAL PREDATION GRO; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Brock DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3385; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; Buttery NJ, 2012, BIOL LETTERS, V8, P794, DOI 10.1098/rsbl.2012.0421; Chan G, 2007, SCIENCE, V317; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Cosson P, 2014, CELL MICROBIOL, V16, P816, DOI 10.1111/cmi.12291; Dinh C, 2018, SCIENCE, V361, P402, DOI 10.1126/science.aat2058; DiSalvo S, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0328-x; Dunn JD, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01906; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Evans AGL, 2012, MICROBIOL-SGM, V158, P2742, DOI 10.1099/mic.0.060343-0; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Foster KR, 2004, NATURE, V429, P343, DOI 10.1038/429343a; Fox J., 2017, USING R COMMANDER PO; Fox J., 2017, RCMDR R COMMANDER; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gilbert OM, 2012, P ROY SOC B-BIOL SCI, V279, P2619, DOI 10.1098/rspb.2011.2514; Hirose S, 2015, DEVELOPMENT, V142, P3561, DOI 10.1242/dev.123281; Ho HI, 2013, CURR BIOL, V23, P1590, DOI 10.1016/j.cub.2013.06.049; Jin T, 1998, MOL BIOL CELL, V9, P2949, DOI 10.1091/mbc.9.10.2949; Khare A, 2009, NATURE, V461, P980, DOI 10.1038/nature08472; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Li CLF, 2016, GENOME RES, V26, P1268, DOI 10.1101/gr.205682.116; Li SI, 2011, TRENDS GENET, V27, P48, DOI 10.1016/j.tig.2010.11.003; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Nasser W, 2013, CURR BIOL, V23, P862, DOI 10.1016/j.cub.2013.04.034; Ostrowski EA, 2015, CURR BIOL, V25, P1661, DOI 10.1016/j.cub.2015.04.059; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanders D, 2017, PROTIST, V168, P311, DOI 10.1016/j.protis.2017.04.001; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Strassmann JE, 2016, J EUKARYOT MICROBIOL, V63, P378, DOI 10.1111/jeu.12307; SUSSMAN M, 1954, J GEN MICROBIOL, V10, P110, DOI 10.1099/00221287-10-1-110; Sussman M., 1987, METHODS CELL BIOL, V28; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Wong E, 2002, DEVELOPMENT, V129, P3839; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938	49	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209438	10.1371/journal.pone.0209438	http://dx.doi.org/10.1371/journal.pone.0209438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625171	gold, Green Submitted, Green Published			2022-12-26	WOS:000455359400039
J	Flikweert, ER; Diercks, RL; Izaks, GJ; Wendt, KW; Stevens, M; Reininga, IHF				Flikweert, Elvira R.; Diercks, Ronald L.; Izaks, Gerbrand J.; Wendt, Klaus W.; Stevens, Martin; Reininga, Inge H. F.			Strict adherence to evidence-based protocol in choice of implants and surgical technique leads to fewer hip fracture reoperations	PLOS ONE			English	Article							COMPLICATIONS	Background and purpose Surgery for hip fractures is frequently followed by complications that hinder the rehabilitation. Only part of the complications are surgery-related, however these, including reoperation may have the highest impact. Operative protocols are designed to treat all patients equally, according to evidence based guidelines. Aim of this study was to investigate the association between strict adherence to an operative protocol and postoperative complications, especially reoperations. Materials and methods A retrospective analyses of a prospective cohort. The cohort included all patients aged >= 60 treated fora hip fracture at University Medical Center Groningen between July 2009 and June 2013. The files of the patients were searched for complications, including reoperations. To evaluate adherence to the operative protocol all X-rays were retrospectively reviewed and the fracture type was reclassified. This retrospective fracture classification was compared with the treatment method used. Logistic regression analyses were used to assess whether patients that were not treated strictly according to the operative protocol have higher odds of developing a complication or of undergoing a reoperation. Results The study population consisted of 479 patients with a mean age of 78.4 (SD 9.5) years. Reoperation was performed in 11% of the patients during the follow-up period. The operative protocol was not followed strictly in 12% of the patients. When the operative protocol was not followed, the odds of having a reoperation was 2.41 times higher (p = 0.02). The overall complication rate was 75% and did not differ in both groups. Conclusion Strict adherence to an evidence-based operative protocol is of major importance toward preventing implant-related problems and reoperations	[Flikweert, Elvira R.; Wendt, Klaus W.; Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Traumatol, Groningen, Netherlands; [Diercks, Ronald L.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Flikweert, ER (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg Traumatol, Groningen, Netherlands.	elviraflikweert@hotmail.com	Stevens, Martin/A-5196-2013; Reininga, Inge H.F./H-4250-2013; Izaks, Gerbrand/F-5089-2014	Stevens, Martin/0000-0001-8183-6894; Reininga, Inge H.F./0000-0003-1341-845X; Izaks, Gerbrand/0000-0003-3213-7637; Diercks, Ronald/0000-0001-9873-208X	Biomet and Trauma Centre Northern Netherlands, a special department of University Medical Centre Groningen	Biomet and Trauma Centre Northern Netherlands, a special department of University Medical Centre Groningen	This study was supported by a grant, as part of a greater research project, from Biomet and Trauma Centre Northern Netherlands, a special department of University Medical Centre Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CA, 2012, SOUTH MED J, V105, P306, DOI 10.1097/SMJ.0b013e3182574bfd; Dy CJ, 2012, J ORTHOP TRAUMA, V26, P379, DOI 10.1097/BOT.0b013e3182242678; Flikweert ER, 2014, BMC MUSCULOSKELET DI, V15, DOI DOI 188-2474-15-188; Heetveld M J, 2005, Ned Tijdschr Geneeskd, V149, P984; Leung AHC, 2011, J TRAUMA, V71, P1390, DOI 10.1097/TA.0b013e31821f7e60; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Palm H, 2012, ACTA ORTHOP, V83, P26, DOI 10.3109/17453674.2011.652887; Parker Martyn J, 2010, ARTHROPLASTIES BONE; Parker Martyn J, 2006, REPLACEMENT ARTHROPL; Parker Martyn J, 2010, GAMMA OTHER CEPHALOC; Van Vugt AB, 2008, RICHTLIJN BEHANDELIN	11	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210239	10.1371/journal.pone.0210239	http://dx.doi.org/10.1371/journal.pone.0210239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615662	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900054
J	Lim, JH; Lee, DH; Lee, SH; Kim, JS; Jung, HC; Cho, SH				Lim, Joo Hyun; Lee, Dong Ho; Lee, So Hee; Kim, Joo Sung; Jung, Hyun Chae; Cho, Sang-Heon			Asthma under control is inversely related with erosive esophagitis among healthy adults	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BRONCHIAL-ASTHMA; PREVALENCE; SYMPTOMS; EPIDEMIOLOGY; POPULATION; DIAGNOSIS; DISTAL	Background Some recent studies suggested that reflux esophagitis is positively correlated with asthma. However, there are debates on this issue. The aim of this study is to clarify the true association between reflux esophagitis and asthma in a large population. Methods Medical records of subjects who received health surveillance checkup between January 2005 and December 2011 were reviewed. Their endoscopic findings, medical history, body mass index, and smoking history were analyzed. Erosive esophagitis was defined as endoscopically detected mucosal break at the Z-line, irrespective of reflux symptom. Information about asthma history was obtained from their questionnaires and medical records. Results Out of the total 15,999 patients, 986 had erosive esophagitis and 376 had asthma. In this population, erosive esophagitis was inversely related with asthma in univariable analysis (OR, 0.586; 95% CI, 0.342-1.003, p=0.049). In multivariable analysis, asthma was demonstrated as an independent negative risk factor for erosive esophagitis (OR, 0.472; 95% CI, 0.257-0.869, p=0.016), under adjustment with age (OR, 1.000; 95% CI, 0.994-1.006, p= 0.977), male sex (OR, 2.092; 95% CI, 1.683-2.601, p<0.001), body mass index (OR, 1.115; 95% CI, 1.090-1.141, p <0.001), smoking (OR, 1.584; 95% CI, 1.318-1.902, p< 0.001), and urban residence (OR, 1.363; 95% CI, 1.149-1.616, p<0.001). Likewise, erosive esophagitis was shown to be an independent negative risk factor for asthma (OR, 0.558; 95% CI, 0.324-0.960, p=0.035) under adjustment with age (OR, 1.025; 95% CI, 1.015-1.034, p <0.001), male sex (OR, 0.861; 95% CI, 0.691-1.074, p=0.185), and body mass index (OR, 1.067; 95% CI, 1.030-1.106, p<0.001) in multivariable analysis. Conclusions Contrary to previous studies, this large scale data showed inverse association between erosive esophagitis and asthma. Further studies investigating the clear mechanism of this phenomenon are warranted.	[Lim, Joo Hyun; Lee, So Hee; Kim, Joo Sung] Seoul Natl Univ Hosp, Healthcare Res Inst, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Lee, Dong Ho] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Joo Sung; Jung, Hyun Chae; Cho, Sang-Heon] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, DH (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.	dhljohn@yahoo.co.kr						[Anonymous], 2014, GLOBAL ASTHMA REPORT, P20; Balson BM, 1998, ANN ALLERG ASTHMA IM, V81, P159, DOI 10.1016/S1081-1206(10)62803-7; Bor S, 2005, AM J GASTROENTEROL, V100, P759, DOI 10.1111/j.1572-0241.2005.41065.x; CASTELL DO, 1989, CHEST, V96, P2, DOI 10.1378/chest.96.1.2; CASTELL DO, 1995, CHEST, V108, P1186, DOI 10.1378/chest.108.5.1186; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Dunbar KB, 2016, JAMA-J AM MED ASSOC, V315, P2104, DOI 10.1001/jama.2016.5657; Eryuksel E, 2006, J ASTHMA, V43, P539, DOI 10.1080/02770900600857234; Field SK, 1996, CHEST, V109, P316, DOI 10.1378/chest.109.2.316; Field SK, 1998, CHEST, V114, P275, DOI 10.1378/chest.114.1.275; Field SK, 1999, J ASTHMA, V36, P631, DOI 10.3109/02770909909055415; Field SK, 1999, CHEST, V115, P848, DOI 10.1378/chest.115.3.848; GASTAL OL, 1994, CHEST, V106, P1793, DOI 10.1378/chest.106.6.1793; GUSTAFSSON PM, 1990, ARCH DIS CHILD, V65, P1255, DOI 10.1136/adc.65.11.1255; Havemann BD, 2007, GUT, V56, P1654, DOI 10.1136/gut.2007.122465; HOWARD PJ, 1992, WORLD J SURG, V16, P288, DOI 10.1007/BF02071535; Kiljander TO, 2006, AM J RESP CRIT CARE, V173, P1091, DOI 10.1164/rccm.200507-1167OC; Lee H, 2012, DIS ESOPHAGUS, V25, P595, DOI 10.1111/j.1442-2050.2011.01299.x; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Mathew JL, 2004, POSTGRAD MED J, V80, P701, DOI 10.1136/pgmj.2004.019265; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Seo Pyoung Ju, 2010, J Neurogastroenterol Motil, V16, P291, DOI 10.5056/jnm.2010.16.3.291; SONTAG SJ, 1990, GASTROENTEROLOGY, V99, P613, DOI 10.1016/0016-5085(90)90945-W; SONTAG SJ, 1992, GUT, V33, P872, DOI 10.1136/gut.33.7.872; Sontag SJ, 2000, J CLIN GASTROENTEROL, V30, pS9; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Theodoropoulos DS, 1999, ALLERGY, V54, P651, DOI 10.1111/j.1398-9995.1999.00093.x; Thomson ABR, 2003, ALIMENT PHARM THER, V17, P1481, DOI 10.1046/j.1365-2036.2003.01646.x; Vincent D, 1997, EUR RESPIR J, V10, P2255, DOI 10.1183/09031936.97.10102255; World Health Organization, 2007, 2021 CURR STAT ISS C; Zagari RM, 2006, DIGEST LIVER DIS, V38, pS24	32	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210490	10.1371/journal.pone.0210490	http://dx.doi.org/10.1371/journal.pone.0210490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615668	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900077
J	Lyman, CC; Holyoak, GR; Meinkoth, K; Wieneke, X; Chillemi, KA; DeSilva, U				Lyman, C. C.; Holyoak, G. R.; Meinkoth, K.; Wieneke, X.; Chillemi, K. A.; DeSilva, U.			Canine endometrial and vaginal microbiomes reveal distinct and complex ecosystems	PLOS ONE			English	Article							BACTERIAL-FLORA; UTERINE; DIVERSITY; HEALTHY; BITCHES; HYPERPLASIA; MICROFLORA; VAGINOSIS; ABORTION; CYCLE	The objective of this study was to characterize the normal microbiome of healthy canine vagina and endometrium and to determine the effect of the stage of estrous, on the resident microbiome. Cranial vaginal swabs and uterine biopsy samples were collected from twenty-five bitches in five different stages of estrous at elective ovariohysterectomy (OVH). Over 4 million reads of the V4 region of 16S rDNA gene were obtained and used for further analyses. A total of 317 genera belonging to 24 known phyla were identified. The endometrium was higher in bacterial diversity while the vagina was higher in richness. Proteobacteria, Bacteroidetes and Firmicutes were the most abundant phyla observed across all samples. Hydrotalea, Ralstonia, and Fusobacterium accounted for nearly 60% of the OTUs identified in the vagina while organisms identified in the endometrium were more evenly distributed. Pseudomonas, Staphylococcus, and Corynebacterium were the prominent genera in the endometrium. The microbiome of the endometrium was distinctly different from that of the vagina. There was large animal-to-animal variation. Other than the vaginal microbiome of bitches in estrus (i.e. in heat), there were no distinct clustering of the organisms based on the stage of estrous. These findings establish the presence of a resident microbiome of the endometrium throughout all stages of estrous cycle.	[Lyman, C. C.; Holyoak, G. R.; Meinkoth, K.; Chillemi, K. A.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Clin Sci, Stillwater, OK 74078 USA; [Wieneke, X.; DeSilva, U.] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Lyman, CC (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Clin Sci, Stillwater, OK 74078 USA.	candace.lyman@okstate.edu		DeSilva, Udaya/0000-0003-2517-6566; Holyoak, Gilbert Reed/0000-0003-2528-2748	Center for Veterinary Health Sciences, Oklahoma State University; Oklahoma Agricultural Experiment Station	Center for Veterinary Health Sciences, Oklahoma State University; Oklahoma Agricultural Experiment Station	This study was supported by the Center for Veterinary Health Sciences, Oklahoma State University, to CCL; and Oklahoma Agricultural Experiment Station, to UD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ALLEN WE, 1982, J SMALL ANIM PRACT, V23, P325, DOI 10.1111/j.1748-5827.1982.tb01674.x; ANSBACHE.R, 1967, AM J OBSTET GYNECOL, V99, P394, DOI 10.1016/S0002-9378(16)34549-5; BABA E, 1983, AM J VET RES, V44, P606; Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; Bian GR, 2016, ENVIRON MICROBIOL, V18, P1566, DOI 10.1111/1462-2920.13272; Braundmeier AG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00097; Delucchi L, 2008, CAN VET J, V49, P991; Ding JM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01967; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Franasiak JM, 2016, J ASSIST REPROD GEN, V33, P129, DOI 10.1007/s10815-015-0614-z; Franasiak JM, 2015, FERTIL STERIL, V104, P1341, DOI 10.1016/j.fertnstert.2015.10.021; GILBERT GL, 1981, MED J AUSTRALIA, V1, P585, DOI 10.5694/j.1326-5377.1981.tb135843.x; Giudice LC, 2016, AM J OBSTET GYNECOL, V215, P682, DOI 10.1016/j.ajog.2016.09.085; Graham EM, 2012, VET CLIN N AM-SMALL, V42, P561, DOI 10.1016/j.cvsm.2012.01.013; Groppetti D, 2012, THERIOGENOLOGY, V77, P1549, DOI 10.1016/j.theriogenology.2011.11.022; Gunay U, 2010, J ANIM VET ADV, V9, P478; HADLEY JC, 1975, J SMALL ANIM PRACT, V16, P249, DOI 10.1111/j.1748-5827.1975.tb05741.x; HEDSTROM OR, 1987, VET PATHOL, V24, P419, DOI 10.1177/030098588702400509; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Hutchins RG, 2014, J VET INTERN MED, V28, P300, DOI 10.1111/jvim.12299; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jacobson JC, 2014, CONTRACEPTION, V90, P130, DOI 10.1016/j.contraception.2014.04.006; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P518, DOI 10.1099/ijs.0.023002-0; Karstrup CC, 2017, THERIOGENOLOGY, V92, P167, DOI 10.1016/j.theriogenology.2017.01.026; Khan I, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00104; Ko JC, 2010, TOP COMPANION ANIM M, V25, P92, DOI 10.1053/j.tcam.2010.03.001; Kustritz MVR, 2006, THERIOGENOLOGY, V66, P567, DOI 10.1016/j.theriogenology.2006.05.003; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Laurusevicius SA, 2008, VET ZOOTECH-LITH, V41, P76; Li QH, 2017, MBIO, V8, DOI [10.1128/mbio.01703-16, 10.1128/mBio.01703-16]; Ljubin-Sternak S, 2014, J PATHOG, V2014, DOI 10.1155/2014/183167; Lorenzen E, 2015, VET RES, V46, DOI 10.1186/s13567-015-0274-0; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; Maksimovic A, 2012, VET REC, V171, P375, DOI 10.1136/vr.100886; Marrazzo JM, 2013, J INFECT DIS, V207, P1481, DOI 10.1093/infdis/jit050; Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184; Metzler-Zebeli BU, 2015, APPL ENVIRON MICROB, V81, P8489, DOI 10.1128/AEM.02756-15; Mitra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16865; Moore SG, 2017, J DAIRY SCI, V100, P4953, DOI 10.3168/jds.2017-12592; Moreno I, 2017, FERTIL STERIL, V108, P32, DOI 10.1016/j.fertnstert.2017.05.034; OLSON PNS, 1978, J AM VET MED ASSOC, V172, P708; PELZER E, 2015, PLACENTA, V36, pA23; Peng Y, 2013, FOLIA MICROBIOL, V58, P593, DOI 10.1007/s12223-013-0238-6; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Pretzer SD, 2008, THERIOGENOLOGY, V70, P320, DOI 10.1016/j.theriogenology.2008.04.035; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Santos TMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053048; Schlafer DH, 2008, THERIOGENOLOGY, V70, P349, DOI 10.1016/j.theriogenology.2008.04.041; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schultheiss PC, 1999, J VET DIAGN INVEST, V11, P560, DOI 10.1177/104063879901100618; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Sirota I, 2014, SEMIN REPROD MED, V32, P35, DOI 10.1055/s-0033-1361821; Srinivasan S, 2012, PLOS ONE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STROM B, 1993, AM J VET RES, V54, P891; Swartz Jeffrey D, 2014, Front Vet Sci, V1, P19, DOI 10.3389/fvets.2014.00019; Theron J, 2000, CRIT REV MICROBIOL, V26, P37, DOI 10.1080/10408410091154174; Threlfall W, 2008, CANINE BREEDING SOUN; VANDEPLASSCHE M, 1991, VLAAMS DIERGEN TIJDS, V60, P207; Verstraelen H, 2016, PEERJ, V4, DOI 10.7717/peerj.1602; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Wassenaar TM, 2014, LETT APPL MICROBIOL, V59, P572, DOI 10.1111/lam.12334; Watts JR, 1996, J SMALL ANIM PRACT, V37, P54, DOI 10.1111/j.1748-5827.1996.tb01936.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Willyard C, 2018, NATURE, V553, P264, DOI 10.1038/d41586-018-00664-8; Xia Q, 2016, INFECT GENET EVOL, V44, P479, DOI 10.1016/j.meegid.2016.08.001; Yang X, 2016, J ZOO WILDLIFE MED, V47, P671, DOI 10.1638/2015-0203a.1; Yildirim S, 2014, ISME J, V8, P2431, DOI 10.1038/ismej.2014.90; Zheng HongHua, 2000, Chinese Journal of Veterinary Medicine, V26, P47; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	79	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210157	10.1371/journal.pone.0210157	http://dx.doi.org/10.1371/journal.pone.0210157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615657	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900046
J	Nyari, S; Booth, R; Quigley, BL; Waugh, CA; Timms, P				Nyari, Sharon; Booth, Rosemary; Quigley, Bonnie L.; Waugh, Courtney A.; Timms, Peter			Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus)	PLOS ONE			English	Article							T-CELL RESPONSES; IFN-GAMMA; TRACHOMATIS INFECTION; ADAPTIVE IMMUNITY; INTERFERON; RETROVIRUS; INNATE; CHLORAMPHENICOL; IDENTIFICATION; PATHOGENICITY	Chlamydia pecorum is responsible for causing ocular infection and disease which can lead to blindness in koalas (Phascolarctos cinereus). Antibiotics are the current treatment for chlamydial infection and disease in koalas, however, they can be detrimental for the koala's gastrointestinal tract microbiota and in severe cases, can lead to dysbiosis and death. In this study, we evaluated the therapeutic effects provided by a recombinant chlamydial major outer membrane protein (MOMP) vaccine on ocular disease in koalas. Koalas with ocular disease (unilateral or bilateral) were vaccinated and assessed for six weeks, evaluating any changes to the conjunctival tissue and discharge. Samples were collected pre- and post-vaccination to evaluate both humoral and cell-mediated immune responses. We further assessed the infecting C. pecorum genotype, host MHC class II alleles and presence of koala retrovirus type (KoRV-B). Our results clearly showed an improvement in the clinical ocular disease state of all seven koalas, post-vaccination. We observed increases in ocular mucosal IgA antibodies to whole C. pecorum elementary bodies, post-vaccination. We found that systemic cell-mediated immune responses to interferon-y, interleukin-6 and interleukin-17A were not significantly predictive of ocular disease in koalas. Interestingly, one koala did not have as positive a clinical response (in one eye primarily) and this koala was infected with a C. pecorum genotype (E') that was not used as part of the vaccine formula (MOMP genotypes A, F and G). The predominant MHC class II alleles identified were DAb*19, DAb*21 and DBb*05, with no two koalas identified with the same genetic sequence. Additionally, KoRV-B, which is associated with chlamydial disease outcome, was identified in two (29%) ocular diseased koalas, which still produced vaccine induced immune responses and clinical ocular improvements post-vaccination. Our findings show promise for the use of a recombinant chlamydial MOMP vaccine for the therapeutic treatment of ocular disease in koalas.	[Nyari, Sharon; Quigley, Bonnie L.; Waugh, Courtney A.; Timms, Peter] Univ Sunshine Coast, Sippy Downs, Qld, Australia; [Booth, Rosemary] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Waugh, Courtney A.] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway	University of the Sunshine Coast; Norwegian University of Science & Technology (NTNU)	Timms, P (corresponding author), Univ Sunshine Coast, Sippy Downs, Qld, Australia.	ptimms@usc.edu.au		Timms, Peter/0000-0002-1682-0025; Waugh, Courtney/0000-0001-5234-4137	Australian Research Council Linkage program; Redlands City Council; Koala action Inc.	Australian Research Council Linkage program(Australian Research Council); Redlands City Council; Koala action Inc.	This work was supported by an Australian Research Council Linkage program received by PT, the Redlands City Council and Koala action Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht LJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7678542; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Black LA, 2013, J VET PHARMACOL THER, V36, P478, DOI 10.1111/jvp.12024; Bodley K., 2008, MED AUSTR MAMMALS; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; BRUNHAM RC, 1983, INFECT IMMUN, V39, P1491, DOI 10.1128/IAI.39.3.1491-1494.1983; Budd C, 2017, AUST VET J, V95, P343, DOI 10.1111/avj.12617; Burton MJ, 2007, BRIT MED BULL, V84, P99, DOI 10.1093/bmb/ldm034; Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Chaban B., 2017, J VIROL, DOI [10.1128/JVI.01871-17, DOI 10.1128/JVI.01871-17]; Cohen CR, 2005, J INFECT DIS, V192, P591, DOI 10.1086/432070; Dahlhausen KE, 2018, PEERJ, V6, DOI 10.7717/peerj.4452; Desclozeaux M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178786; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Fiebig U, 2006, J VIROL, V80, P5651, DOI 10.1128/JVI.02597-05; Filipovic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180551; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gondek DC, 2009, J IMMUNOL, V183, P1313, DOI 10.4049/jimmunol.0900295; Gonzalez-Astudillo V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42587; Govendir M, 2012, J VET PHARMACOL THER, V35, P147, DOI 10.1111/j.1365-2885.2011.01307.x; Griffith JE, 2010, J VET PHARMACOL THER, V33, P595, DOI 10.1111/j.1365-2885.2010.01169.x; Gulley JL, 2013, HUM VACC IMMUNOTHER, V9, P219, DOI 10.4161/hv.22106; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Ikehata M, 2000, FEMS IMMUNOL MED MIC, V27, P35, DOI 10.1111/j.1574-695X.2000.tb01409.x; Islam MM, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00714-17; Ito JI, 1999, INFECT IMMUN, V67, P5518, DOI 10.1128/IAI.67.10.5518-5521.1999; Johnston SD, 2015, VET PATHOL, V52, P1254, DOI 10.1177/0300985815570069; Kaplanski G, 2003, TRENDS IMMUNOLOGY, V24; Karunakaran KP, 2010, HUM VACCINES, V6, P676, DOI 10.4161/hv.6.8.12299; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khan SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156094; Khan SA, 2016, VACCINE, V34, P775, DOI 10.1016/j.vaccine.2015.12.050; Khan SA, 2014, VACCINE, V32, P5781, DOI 10.1016/j.vaccine.2014.08.037; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; Kollipara A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074808; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Kumari J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/632632; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; Lau QT, 2014, PEERJ, V2, DOI 10.7717/peerj.443; Legione AR, 2016, J MED MICROBIOL, V65, P420, DOI 10.1099/jmm.0.000241; Lin YY, 2010, SEMIN IMMUNOPATHOL, V32, P79, DOI 10.1007/s00281-009-0191-2; Longbottom D, 2003, J MED MICROBIOL, V52, P537, DOI 10.1099/jmm.0.05093-0; Loomis WP, 2002, CURR OPIN MICROBIOL, V5, P87, DOI 10.1016/S1369-5274(02)00291-6; Maher IE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163780; Maher IE, 2014, PEERJ, V2, DOI 10.7717/peerj.280; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; McColl K A, 1984, VET REC, V115, P25; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Neuman H, 2018, FEMS MICROBIOL REV, V42, P489, DOI 10.1093/femsre/fuy018; Nyari S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200112; Nyari S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190114; OBENDORF DL, 1983, J WILDLIFE DIS, V19, P123, DOI 10.7589/0090-3558-19.2.123; OSAWA R, 1993, AUST J ZOOL, V41, P599, DOI 10.1071/ZO9930599; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Perry LL, 1997, J IMMUNOL, V158, P3344; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Quigley BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27253-z; Redgrove KA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00534; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Satpathy G, 2017, INDIAN J OPHTHALMOL, V65, P97, DOI 10.4103/ijo.IJO_870_16; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schett G, 2018, RHEUMATOLOGY, V57, P43, DOI 10.1093/rheumatology/kex513; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Sturdevant GL, 2010, INFECT IMMUN, V78, P3660, DOI 10.1128/IAI.00386-10; Sun X, 2017, MICROBES INFECT, V19, P536, DOI 10.1016/j.micinf.2017.08.007; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Turula H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050237; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Vasilevsky S, 2014, CLIN MICROBIOL REV, V27, P346, DOI 10.1128/CMR.00105-13; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Waugh C, 2016, BIOLOGICALS, V44, P588, DOI 10.1016/j.biologicals.2016.09.006; Waugh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146934; Waugh CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00137-4; Waugh CA, 2015, VACCINE, V33, P855, DOI 10.1016/j.vaccine.2014.12.052; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhang DJ, 2000, INFECT IMMUN, V68, P3074, DOI 10.1128/IAI.68.6.3074-3078.2000; Zhang JW, 2007, J CLIN INVEST, V117, P871, DOI 10.1172/JCI31860	88	9	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210245	10.1371/journal.pone.0210245	http://dx.doi.org/10.1371/journal.pone.0210245			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615687	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900055
J	Tremelling, J; All, A; Lleras, L; Cancel, A; Jenkins, D; Pina, C; Goldstein, D; Broxton, C; Hamel, S				Tremelling, Jeff; All, Allen; Lleras, Luis; Cancel, Aida; Jenkins, David; Pina, Carolina; Goldstein, Damani; Broxton, Clancy; Hamel, Steve			Poor quality male latex condoms found in Dominican Republic: Quality assurance evaluation and public health impact	PLOS ONE			English	Article								Male condoms are important to prevent transmission of HIV (and other STIs) and unwanted pregnancies. Research was conducted to evaluate the quality of male condoms available in the Dominican Republic market based on preliminary concerns of suspect product. Based on international testing standards (ISO 4074 and ASTM D 3492-08), condoms were sampled across ten prominent brands within the market and evaluated for airburst pressure/volume, freedom from holes, visual defects, package seal integrity, packaging and marking, lubricant quantity, and dimensions. Five of the brands were found to have extensive quality problems, where holes were found in 5.7% to 17.5% of the condoms (depending on the brand). Between 5.1% and 30.5% of these condoms failed to meet the requirements for air burst properties, and violations in regulatory labeling where observed. Three additional brands were compliant for the other tests, but were found to have the same challenges with labeling violations as the previous five brands. Two brands were found to be fully compliant with all aspects of the evaluation. The level of defects observed in these samples would greatly increase the risk of HIV transmission (and other STIs) and unwanted pregnancies. When projected on the annual market of male condoms sold in the Dominican Republic (similar to 26 million), potentially over 1 million condoms could be estimated to adversely impact the health risk of the end-user. These results prompted action by the Dominican Republic regulatory authorities to investigate and remove poor quality product from the market. This research study emphasizes the need for continued vigilance towards increased regulatory and market surveillance efforts to better protect public health interests.	[Tremelling, Jeff; All, Allen; Lleras, Luis; Cancel, Aida; Jenkins, David; Hamel, Steve] FHI 360, Prod Qual & Compliance, Durham, NC USA; [Pina, Carolina; Goldstein, Damani] US Agcy Int Dev, Santo Domingo, Dominican Rep; [Broxton, Clancy] US Agcy Int Dev, Washington, DC 20523 USA; [Lleras, Luis] Eurofins Lancaster Labs PSS, Winston Salem, NC USA; [Goldstein, Damani] Publ Hlth Team, London, England	FHI 360; United States Agency for International Development (USAID); United States Agency for International Development (USAID); Public Health England	Jenkins, D (corresponding author), FHI 360, Prod Qual & Compliance, Durham, NC USA.	djenkins@fhi360.org	Jenkins, David/K-8021-2019	Jenkins, David/0000-0001-6698-272X; Tremelling, Jeffery/0000-0003-4185-9666	USAID funding Advancing Partners & Communities (APC) [AID-OM-A-12-00047]; USAID Global Health Supply Chain Quality Assurance Program [AID-OM-C-15-00001]	USAID funding Advancing Partners & Communities (APC)(United States Agency for International Development (USAID)); USAID Global Health Supply Chain Quality Assurance Program(United States Agency for International Development (USAID))	This work was supported through USAID funding Advancing Partners & Communities (APC) cooperative agreement number AID-OM-A-12-00047 (implemented by JSI Research & Training Institute, Inc., in partnership with FHI 360) and Contract No. AID-OM-C-15-00001, USAID Global Health Supply Chain Quality Assurance Program (implemented by FHI 360). USAID staff (indicated co-authors) contributed to study design, project management, and manuscript preparation.	[Anonymous], 2002, 40742002E ISO; [Anonymous], 2008, D376703 ASTM INT; [Anonymous], 2015, PROTECTION RACKET MI; [Anonymous], 2015, SALUD PUBLICA RETIRA; [Anonymous], 2011, INFORM NACL AVANCES; [Anonymous], 2014, POOR QUAL COND COULD; [Anonymous], 2008, D349208 ASTM; [Anonymous], 2014, 40742014E ISO; [Anonymous], 2012, COND DOM REP MARK AN; Bassat Q, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1357-8; Belew S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004057; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Comedy Central, 2012, NON TRADITIONAL REF, V5; Dorlo TPC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001544; Gerofi J, 2017, POLYM TEST, V59, P38, DOI 10.1016/j.polymertesting.2017.01.005; Gerofi J, 2016, POLYM TEST, V54, P260, DOI 10.1016/j.polymertesting.2016.07.004; Hachem R, 2016, J PHARMACEUT BIOMED, V124, P34, DOI 10.1016/j.jpba.2016.02.022; Institute for Quality Management in Healthcare (IQMH), 2019, MEDICAL LAB ACCREDIT; ISO, 1999, 285911999 ISO; Kaur H, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0544; Leslie T, 2009, EMERG INFECT DIS, V15, P1753, DOI 10.3201/eid1511.090886; Monge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095353; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Summers C, 2016, ETHIOPIA THROW AWAY; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; UNFPA WHO and UNAIDS, 2015, WHO UNAIDS POS STAT; Warner L, 2011, CONTRACEPTIVE TECHNO; WHO, 2010, MAL LAT COND SPEC PR; 2009, TIMES INDIA	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210150	10.1371/journal.pone.0210150	http://dx.doi.org/10.1371/journal.pone.0210150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615647	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900044
J	Bredlau, JP; Kester, KM				Bredlau, Justin P.; Kester, Karen M.			Evolutionary relationships of courtship songs in the parasitic wasp genus, Cotesia (Hymenoptera: Braconidae)	PLOS ONE			English	Article							CONGREGATA SAY HYMENOPTERA; FOODPLANT COMPLEX SOURCES; BIOLOGICAL-CONTROL; RUBECULA HYMENOPTERA; PHYLOGENETIC-RELATIONSHIPS; ACOUSTIC COMMUNICATION; LACEWINGS NEUROPTERA; GENETIC-DIVERGENCE; MATING SUCCESS; BEHAVIOR	Acoustic signals play an important role in premating isolation based on sexual selection within many taxa. Many male parasitic wasps produce characteristic courtship songs used by females in mate selection. In Cotesia (Hymenoptera: Braconidae: Microgastrinae), courtship songs are generated by wing fanning with repetitive pulses in stereotypical patterns. Our objectives were to sample the diversity of courtship songs within Cotesia and to identify e underlying patterns of differentiation. We compared songs among 12 of ca. 80 Cotesia species in North America, including ten species that have not been recorded previously. For Cotesia congregata, we compared songs of wasps originating from six different host-food-plant sources, two of which are considered incipient species. Songs of emergent males from wild caterpillar hosts in five different families were recorded, and pattern, frequency, and duration of song elements analyzed. Principal component analysis converted the seven elements characterized into four uncorrelated components used in a hierarchical cluster analysis and grouped species by similarity of song structure. Species songs varied significantly in duration of repeating pulse and buzz elements and/or in fundamental frequency. Cluster analysis resolved similar species groups in agreement with the most recent molecular phylogeny for Cotesia spp., indicating the potential for using courtship songs as a predictor of genetic relatedness. Courtship song analysis may aid in identifying closely related cryptic species that overlap spatially, and provide insight into the evolution of this highly diverse and agriculturally important taxon.	[Bredlau, Justin P.; Kester, Karen M.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Bredlau, Justin P.] Virginia Commonwealth Univ, Integrat Life Sci, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Kester, KM (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	kmkester@vcu.edu		Kester, Karen M/0000-0001-6052-7806; Bredlau, Justin/0000-0001-6722-9764	Thomas F. & Kate Miller Jeffress Memorial Trust Fund [J-976]; Virginia Academy of Science Small Project Grant	Thomas F. & Kate Miller Jeffress Memorial Trust Fund; Virginia Academy of Science Small Project Grant	This project was partially supported by a grant from the Thomas F. & Kate Miller Jeffress Memorial Trust Fund (J-976) to KMK and a Virginia Academy of Science Small Project Grant to KMK & JPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Avila GA, 2017, B ENTOMOL RES, V107, P439, DOI 10.1017/S0007485316001127; Banks JC, 2006, MOL PHYLOGENET EVOL, V41, P690, DOI 10.1016/j.ympev.2006.06.001; BARBOSA P, 1991, ECOLOGY, V72, P1567, DOI 10.2307/1940956; BECKAGE NE, 1994, ARCH INSECT BIOCHEM, V26, P165, DOI 10.1002/arch.940260209; Benelli G, 2016, INSECT SCI, V23, P603, DOI 10.1111/1744-7917.12201; Bezemer TM, 2010, ECOL ENTOMOL, V35, P341, DOI 10.1111/j.1365-2311.2010.01184.x; Bezier A, 2009, J INVERTEBR PATHOL, V101, P194, DOI 10.1016/j.jip.2009.04.006; Bredlau JP, 2015, ANN ENTOMOL SOC AM, V108, P1026, DOI 10.1093/aesa/sav089; Bredlau JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062051; Canale A, 2013, B ENTOMOL RES, V103, P303, DOI 10.1017/S0007485312000715; Charif R. A., 2008, RAVEN PRO 1 3 USERS; Chevignon G, 2014, J VIROL, V88, P8795, DOI 10.1128/JVI.00209-14; Danci A, 2006, BIOL CONTROL, V39, P225, DOI 10.1016/j.biocontrol.2006.07.009; Danci A, 2010, ENTOMOL EXP APPL, V136, P142, DOI 10.1111/j.1570-7458.2010.01013.x; Dupas S, 2008, J HERED, V99, P491, DOI 10.1093/jhered/esn047; Eberhard MJB, 2013, J INSECT BEHAV, V26, P352, DOI 10.1007/s10905-012-9352-6; FIELD SA, 1993, J INSECT BEHAV, V6, P737, DOI 10.1007/BF01201673; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; GORDH G, 1978, HILGARDIA, V46, P37, DOI 10.3733/hilg.v46n02p037; Henry CS, 2004, ANIM BEHAV, V68, P879, DOI 10.1016/j.anbehav.2003.10.032; Henry CS, 1999, SYST ENTOMOL, V24, P335, DOI 10.1046/j.1365-3113.1999.00085.x; Henry CS, 2002, ANN ENTOMOL SOC AM, V95, P172, DOI 10.1603/0013-8746(2002)095[0172:DTTCCI]2.0.CO;2; Henry CS, 1999, EVOLUTION, V53, P1165, DOI [10.2307/2640820, 10.1111/j.1558-5646.1999.tb04530.x]; Herlihy MV, 2012, FLA ENTOMOL, V95, P461, DOI 10.1653/024.095.0230; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; Iglesias PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176119; Joyce AL, 2010, ENTOMOL EXP APPL, V137, P153, DOI 10.1111/j.1570-7458.2010.01048.x; Joyce AL, 2008, ENTOMOL EXP APPL, V127, P39, DOI 10.1111/j.1570-7458.2008.00670.x; Joyce AL, 2014, EVOL ECOL, V28, P361, DOI 10.1007/s10682-013-9682-7; Joyce AL, 2010, BIOCONTROL, V55, P573, DOI 10.1007/s10526-010-9278-x; Kaiser L, 2017, GENETICA, V145, P455, DOI 10.1007/s10709-017-9989-3; Kankare M, 2005, ANN ENTOMOL SOC AM, V98, P382, DOI 10.1603/0013-8746(2005)098[0382:GDAHCS]2.0.CO;2; Kankare M, 2004, MOL PHYLOGENET EVOL, V32, P207, DOI 10.1016/j.ympev.2003.11.013; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kester KM, 2015, ANN ENTOMOL SOC AM, V108, P1014, DOI 10.1093/aesa/sav088; KESTER KM, 1991, J INSECT BEHAV, V4, P727, DOI 10.1007/BF01052227; KESTER KM, 1994, OECOLOGIA, V99, P151, DOI 10.1007/BF00317096; Klappert K, 2007, EVOLUTION, V61, P1481, DOI 10.1111/j.1558-5646.2007.00125.x; Krombein KV, 1979, CATALOG HYMENOPTERA, V2, P1253; Lentz AJ, 2008, J INSECT BEHAV, V21, P34, DOI 10.1007/s10905-007-9102-3; Lentz-Ronning AJ, 2013, J INSECT BEHAV, V26, P165, DOI 10.1007/s10905-012-9345-5; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; MCNEIL JN, 1995, J CHEM ECOL, V21, P959, DOI 10.1007/BF02033801; Michel-Salzat A, 2004, SYST ENTOMOL, V29, P371, DOI 10.1111/j.0307-6970.2004.00246.x; Montealegre-Z F, 2004, SYST ENTOMOL, V29, P21, DOI 10.1111/j.1365-3113.2004.00223.x; Muirhead KA, 2012, MOL PHYLOGENET EVOL, V63, P904, DOI 10.1016/j.ympev.2012.03.003; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Nattier R, 2011, ZOOL SCR, V40, P479, DOI 10.1111/j.1463-6409.2011.00485.x; Oliveira C.C., 2013, SPECIATION NATURAL P, P137; Packert M, 2014, AVIAN RES, V5, DOI 10.1186/s40657-014-0002-x; Percy DM, 2006, INVERTEBR SYST, V20, P431, DOI 10.1071/IS05057; Quicke D. L. J., 1997, PARASITIC WASPS; RITCHIE MG, 1995, J EVOLUTION BIOL, V8, P463, DOI 10.1046/j.1420-9101.1995.8040463.x; Rodriguez JJ, 2013, INSECT CONSERV DIVER, V6, P530, DOI 10.1111/icad.12003; SIVINSKI J, 1989, ANN ENTOMOL SOC AM, V82, P116, DOI 10.1093/aesa/82.1.116; Smith MA, 2013, MOL ECOL RESOUR, V13, P168, DOI 10.1111/1755-0998.12038; Stireman JO, 2002, ECOL ENTOMOL, V27, P588, DOI 10.1046/j.1365-2311.2002.00450.x; Sueur J, 2006, CONT T ENT, P207; Tietz H. M, 1972, INDEX DESCRIBED LIFE; Van Driesche RG, 2008, FLA ENTOMOL, V91, P22, DOI 10.1653/0015-4040(2008)091[0022:BCOPRI]2.0.CO;2; VANDENASSEM J, 1980, ENTOMOL EXP APPL, V27, P293, DOI 10.1007/BF00333840; Veltsos P, 2012, ECOL EVOL, V2, P80, DOI 10.1002/ece3.75; Vigoder FM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0900-8; Villagra CA, 2011, B ENTOMOL RES, V101, P573, DOI 10.1017/S0007485311000174; VINSON S B, 1972, Environmental Entomology, V1, P409, DOI 10.1093/ee/1.4.409; Whitfield James B., 2000, P97; Whitfield JB, 2018, ANNU REV ENTOMOL, V63, P389, DOI 10.1146/annurev-ento-020117-043405; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Whitfield JB, 2002, SYST ENTOMOL, V27, P337, DOI 10.1046/j.1365-3113.2002.00183.x; YOSHIDA S, 1978, ENTOMOL EXP APPL, V23, P152, DOI 10.1007/BF00290630; Zhao M, 2017, IBIS, V159, P204, DOI 10.1111/ibi.12426	72	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210249	10.1371/journal.pone.0210249	http://dx.doi.org/10.1371/journal.pone.0210249			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608965	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800054
J	Cuamatzi-Flores, J; Esquivel-Naranjo, E; Nava-Galicia, S; Lopez-Munguia, A; Arroyo-Becerra, A; Villalobos-Lopez, MA; Bibbins-Martinez, M				Cuamatzi-Flores, J.; Esquivel-Naranjo, E.; Nava-Galicia, S.; Lopez-Munguia, A.; Arroyo-Becerra, A.; Villalobos-Lopez, M. A.; Bibbins-Martinez, M.			Differential regulation of Pleurotus ostreatus dye peroxidases gene expression in response to dyes and potential application of recombinant Pleos-DyP1 in decolorization	PLOS ONE			English	Article							ENZYME	Dye-decolorizing peroxidase (DyP) from the white rot basidiomycete Pleurotus ostreatus is a heme peroxidase able to oxidize diverse substrates, including recalcitrant phenols and dyes. This study analyzed the effect of chemical dyes on P. ostreatus growth, DyP activity and the expression of four Pleos-dyp genes during the time-course of Pleurotus ostreatus cultures containing either Acetyl Yellow G (AYG), Remazol Brilliant Blue R (RBBR) or Acid Blue 129 (AB129) dyes. Additionally, Pleos DyP1 was heterologously expressed in the filamentous fungus Trichoderma atroviride in order to explore the potential of a secreted recombinant enzyme for decolorizing different dyes in cultures and plate assays. The addition of dyes had an induction effect on the enzymatic activity, with the fermentations undertaken using RBBR and AYG dyes presenting the highest total DyP activity. DyP gene expression profiles displayed up/down regulation during the culture of three Pleos-dyp genes (Pleos-dyp1, Pleos-dyp2 and Pleos-dyp4), while Pleos-dyp3 transcript was not detected under any of the culture conditions studied. A 14-fold relative induction level (log2) increase for Pleos-dyp2 and Pleos-dyp4 in AB129 and AYG, respectively, was also found. The presence of AB129 resulted in the highest Pleos-dyp1 gene induction and repression level, corresponding to 11.83 and -14.6-fold relative expression and repression levels, respectively. The lowest expression level of all genes was observed in RBBR, a response which is associated with the growth phase. The filamentous fungus Trichoderma atroviride was successfully transformed for the heterologous expression of Pleos-dyp1. The modified strains (TaDyP) were able to decolorize mono-azo, di-azo, anthraquinone and anthracenedione dyes with extracellular DyP1 activity found in the culture supernatant. After 96 h of culture, the recombinant TaDyP strains were able to degrade (decolorize) 77 and 34% of 0.05mM AB129 and 0.25mM AYG, respectively.	[Cuamatzi-Flores, J.; Nava-Galicia, S.; Arroyo-Becerra, A.; Villalobos-Lopez, M. A.; Bibbins-Martinez, M.] Inst Politecn Nacl, Ctr Invest Biotecnol Aplicada, Tepetitla De Lardizabal, Tlaxcala, Mexico; [Esquivel-Naranjo, E.] Univ Autonoma Queretaro, Fac Ciencias Nat, Ave Ciencias S-N Juriquilla, Queretaro, Mexico; [Lopez-Munguia, A.] Univ Autonoma Mexcio, Inst Biotecnol, Av Univ, Cuernavaca, Morelos, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Queretaro	Bibbins-Martinez, M (corresponding author), Inst Politecn Nacl, Ctr Invest Biotecnol Aplicada, Tepetitla De Lardizabal, Tlaxcala, Mexico.	mbibbinsm@ipn.mx	Arroyo-Becerra, Analilia/AAI-1369-2021; Bibbins, Martha/AAG-4826-2020; Esquivel, Edgardo/GLR-3607-2022; Villalobos-López, Miguel Angel/P-2492-2017	Arroyo-Becerra, Analilia/0000-0002-3055-7518; Bibbins, Martha/0000-0001-9980-5041; Villalobos-López, Miguel Angel/0000-0002-8640-342X; Lopez Munguia, Agustin/0000-0003-4204-4936; Cuamatzi-Flores, Jorge/0000-0001-6007-5723; ESQUIVEL-NARANJO, EDGARDO ULISES/0000-0002-1934-7042	Instituto Politecnico Nacional (IPN) [SIP 20181110]; CONACYT [589318]	Instituto Politecnico Nacional (IPN); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Instituto Politecnico Nacional (IPN) Project No. SIP 20181110, which is gratefully acknowledged (www.ipn.mx).JC-F was a postgraduate fellow with a CONACYT fellowship No. 589318 (http://www.conacyt.gob.mx).	Amara S, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02826-17; Avram A., 2018, BIOCATALYSIS, V4, P1, DOI 10.1515/boca- 2018-0001; Balcazar-Lopez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147997; Behrens CJ, 2016, APPL BIOCHEM BIOTECH, V179, P1404, DOI 10.1007/s12010-016-2073-0; Cohen R, 2001, ENVIRON MICROBIOL, V3, P312, DOI 10.1046/j.1462-2920.2001.00197.x; Duan ZH, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0648-6; Faraco V, 2007, WORLD J MICROB BIOT, V23, P889, DOI 10.1007/s11274-006-9303-5; Fernandez-fueyo E., 2012, P NATL ACAD SCI USA, V109, P8352; Fernandez-Fueyo E, 2015, APPL MICROBIOL BIOT, V99, P8927, DOI 10.1007/s00253-015-6665-3; Fernandez-Fueyo E, 2014, FUNGAL GENET BIOL, V72, P150, DOI 10.1016/j.fgb.2014.02.003; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-2; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Garrido-Bazan V, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0263-3; Goudopoulou A, 2010, APPL MICROBIOL BIOT, V88, P541, DOI 10.1007/s00253-010-2750-9; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; Knop D, 2015, APPL MICROBIOL BIOT, V99, P1025, DOI 10.1007/s00253-014-6256-8; Lauber C, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0463-5; Linde D, 2015, ARCH BIOCHEM BIOPHYS, V574, P66, DOI 10.1016/j.abb.2015.01.018; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025; Zelena K, 2014, BIOTECHNOL ADV, V32, P1382, DOI 10.1016/j.biotechadv.2014.08.006	29	8	8	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209711	10.1371/journal.pone.0209711	http://dx.doi.org/10.1371/journal.pone.0209711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608975	Green Submitted, Green Published, gold			2022-12-26	WOS:000454952800024
J	Panagopoulou, M; Karaglani, M; Balgkouranidou, I; Biziota, E; Koukaki, T; Karamitrousis, E; Nena, E; Tsamardinos, I; Kolios, G; Lianidou, E; Kakolyris, S; Chatzaki, E				Panagopoulou, Maria; Karaglani, Makrina; Balgkouranidou, Ioanna; Biziota, Eirini; Koukaki, Triantafillia; Karamitrousis, Evaggelos; Nena, Evangelia; Tsamardinos, Ioannis; Kolios, George; Lianidou, Evi; Kakolyris, Stylianos; Chatzaki, Ekaterini			Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers	ONCOGENE			English	Article							SOX17 PROMOTER METHYLATION; TUMOR DNA; DIAGNOSTIC MARKER; LIQUID BIOPSY; NUCLEIC-ACIDS; PLASMA DNA; EXPRESSION; BLOOD; INTEGRITY; BIOMARKER	Blood circulating cell-free DNA (ccfDNA) is a suggested biosource of valuable clinical information for cancer, meeting the need for a minimally-invasive advancement in the route of precision medicine. In this paper, we evaluated the prognostic and predictive potential of ccfDNA parameters in early and advanced breast cancer. Groups consisted of 150 and 16 breast cancer patients under adjuvant and neoadjuvant therapy respectively, 34 patients with metastatic disease and 35 healthy volunteers. Direct quantification of ccfDNA in plasma revealed elevated concentrations correlated to the incidence of death, shorter PFS, and non-response to pharmacotherapy in the metastatic but not in the other groups. The methylation status of a panel of cancer-related genes chosen based on previous expression and epigenetic data (KLK10, SOX17, WNT5A, MSH2, GATA3) was assessed by quantitative methylation-specific PCR. All but the GATA3 gene was more frequently methylated in all the patient groups than in healthy individuals (all p < 0.05). The methylation of WNT5A was statistically significantly correlated to greater tumor size and poor prognosis characteristics and in advanced stage disease with shorter OS. In the metastatic group, also SOX17 methylation was significantly correlated to the incidence of death, shorter PFS, and OS. KLK10 methylation was significantly correlated to unfavorable clinicopathological characteristics and relapse, whereas in the adjuvant group to shorter DFI. Methylation of at least 3 or 4 genes was significantly correlated to shorter OS and no pharmacotherapy response, respectively. Classification analysis by a fully automated, machine learning software produced a single-parametric linear model using ccfDNA plasma concentration values, with great discriminating power to predict response to chemotherapy (AUC 0.803, 95% CI [0.606, 1.000]) in the metastatic group. Two more multi-parametric signatures were produced for the metastatic group, predicting survival and disease outcome. Finally, a multiple logistic regression model was constructed, discriminating between patient groups and healthy individuals. Overall, ccfDNA emerged as a highly potent predictive classifier in metastatic breast cancer. Upon prospective clinical evaluation, all the signatures produced could aid accurate prognosis.	[Panagopoulou, Maria; Karaglani, Makrina; Balgkouranidou, Ioanna; Kolios, George; Chatzaki, Ekaterini] Democritus Univ Thrace, Med Sch, Lab Pharmacol, Alexandroupolis 68100, Greece; [Balgkouranidou, Ioanna; Biziota, Eirini; Koukaki, Triantafillia; Karamitrousis, Evaggelos; Kakolyris, Stylianos] Democritus Univ Thrace, Med Sch, Dept Oncol, Alexandroupolis 68100, Greece; [Nena, Evangelia] Democritus Univ Thrace, Lab Hyg & Environm Protect, Med Sch, Alexandroupolis 68100, Greece; [Tsamardinos, Ioannis] Univ Crete, Dept Comp Sci, Voutes, Greece; [Tsamardinos, Ioannis] Gnosis Data Anal, Voutes 70013, Crete, Greece; [Lianidou, Evi] Univ Athens, Dept Chem, Lab Analyt Chem, Anal Circulating Tumor Cells, Athens, Greece; [Chatzaki, Ekaterini] Fdn Res & Technol Hellas, Voutes 70013, Crete, Greece	Democritus University of Thrace; Democritus University of Thrace; Democritus University of Thrace; University of Crete; National & Kapodistrian University of Athens; Foundation for Research & Technology - Hellas (FORTH)	Chatzaki, E (corresponding author), Democritus Univ Thrace, Med Sch, Lab Pharmacol, Alexandroupolis 68100, Greece.; Chatzaki, E (corresponding author), Fdn Res & Technol Hellas, Voutes 70013, Crete, Greece.	achatzak@med.duth.gr	Chatzaki, Ekaterini/AAW-9507-2020; Chatzaki, Ekaterini/CAF-7645-2022; Nena, Evangelia/AAD-9385-2019; Kolios, George/N-6641-2013	Chatzaki, Ekaterini/0000-0002-5832-4257; Nena, Evangelia/0000-0003-0381-4715; Kolios, George/0000-0002-2066-4782; Karaglani, Makrina/0000-0002-9853-3571; Lianidou, Evi/0000-0002-7796-5914	Act: "PROGRAM FOR THE GRANTING OF SCHOLARSHIPS FOR POSTGRADUATE STUDIES OF SECOND CYCLE STUDIES"; State Scholarship Foundation in Greece (IKY) (Operational Program "Human Resources Development-Education and Lifelong Learning", Partnership Agreement PA 2014-2020)	Act: "PROGRAM FOR THE GRANTING OF SCHOLARSHIPS FOR POSTGRADUATE STUDIES OF SECOND CYCLE STUDIES"; State Scholarship Foundation in Greece (IKY) (Operational Program "Human Resources Development-Education and Lifelong Learning", Partnership Agreement PA 2014-2020)	Ms Maria Panagopoulou received a scholarship for the implementation of her PhD Thesis, co-funded through the Act: "PROGRAM FOR THE GRANTING OF SCHOLARSHIPS FOR POSTGRADUATE STUDIES OF SECOND CYCLE STUDIES". State Scholarship Foundation in Greece (IKY) (Operational Program "Human Resources Development-Education and Lifelong Learning", Partnership Agreement PA 2014-2020).	Agassi R, 2015, AM J CLIN PATHOL, V143, P18, DOI 10.1309/AJCPI5YHG0OGFAHM; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; ANKER P, 1975, CANCER RES, V35, P2375; Balgkouranidou I, 2016, CLIN CHEM LAB MED, V54, P1385, DOI 10.1515/cclm-2015-0776; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Catarino R, 2008, DNA CELL BIOL, V27, P415, DOI 10.1089/dna.2008.0744; Chimonidou M, 2013, CLIN CHEM, V59, P270, DOI 10.1373/clinchem.2012.191551; Cooper SJ, 2010, ONCOGENE, V29, P2905, DOI 10.1038/onc.2010.64; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Fu DY, 2010, BREAST CANCER RES TR, V119, P601, DOI 10.1007/s10549-009-0339-8; Fu DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000637; Hattermann K, 2008, ANAL BIOCHEM, V377, P62, DOI 10.1016/j.ab.2008.03.014; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Jonsson M, 2002, CANCER RES, V62, P409; Kappil MA, 2016, ANTICANCER RES, V36, P4039; Kioulafa M, 2009, ANN ONCOL, V20, P1020, DOI 10.1093/annonc/mdn733; Laktionov PP, 2004, NUCLEOS NUCLEOT NUCL, V23, P879, DOI 10.1081/NCN-200026035; Lamb YN, 2017, MOL DIAGN THER, V21, P225, DOI 10.1007/s40291-017-0259-y; LEON SA, 1977, CANCER RES, V37, P646; Leris ACA, 2005, ANTICANCER RES, V25, P731; Li B, 2001, CANCER RES, V61, P8014; LI Y, 2015, BMC CANCER, V15; List M, 2014, J INTEGR BIOINFORMAT, V11, pCP4, DOI 10.2390/biecoll-jib-2014-236; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Jun-Liang, 2016, Chronic Dis Transl Med, V2, P223, DOI 10.1016/j.cdtm.2016.12.001; Madhavan D, 2014, BREAST CANCER RES TR, V146, P163, DOI 10.1007/s10549-014-2946-2; Markaki M, 2018, EBIOMEDICINE, V31, P36, DOI 10.1016/j.ebiom.2018.03.027; Mastoraki S, 2018, CLIN CANCER RES, V24, P1500, DOI 10.1158/1078-0432.CCR-17-1181; Matthaios D, 2016, ONCOL LETT, V12, P748, DOI 10.3892/ol.2016.4649; McCleskey BC, 2015, AM J CLIN PATHOL, V144, P756, DOI 10.1309/AJCP5MMR1FJVVTPK; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Mouliere F, 2015, P NATL ACAD SCI USA, V112, P3178, DOI 10.1073/pnas.1501321112; Olsson E, 2015, EMBO MOL MED, V7, P1034, DOI 10.15252/emmm.201404913; Orfanoudaki G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03557-4; Pantel K, 2013, CANCER RES, V73, P6384, DOI 10.1158/0008-5472.CAN-13-2030; Salvi S, 2016, ONCOTARGETS THER, V9, P6549, DOI 10.2147/OTT.S100901; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Tan GQ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010197; Tangvarasittichai O, 2015, INDIAN J CLIN BIOCHE, V30, P55, DOI 10.1007/s12291-013-0407-z; Trifa F, 2013, TUMOR BIOL, V34, P1625, DOI 10.1007/s13277-013-0694-2; Tsamardinos I, 2018, MACH LEARN, V107, P1895, DOI 10.1007/s10994-018-5714-4; Umetani N, 2006, J CLIN ONCOL, V24, P4270, DOI 10.1200/JCO.2006.05.9493; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; van der Meide WF, 2011, GYNECOL ONCOL, V123, P116, DOI 10.1016/j.ygyno.2011.06.015; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; 2008, BIOCELL, V32, P237	53	84	90	2	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3387	3401		10.1038/s41388-018-0660-y	http://dx.doi.org/10.1038/s41388-018-0660-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30643192				2022-12-26	WOS:000466610000005
J	Pidugu, VK; Wu, MM; Yen, AH; Pidugu, HB; Chang, KW; Liu, CJ; Lee, TC				Pidugu, Vijaya Kumar; Wu, Meei-Maan; Yen, Ai-Hsin; Pidugu, Hima Bindu; Chang, Kuo-Wei; Liu, Chung-Ji; Lee, Te-Chang			IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASIS; INTERFERON-INDUCED PROTEIN; IFN-INDUCED PROTEIN; REPEATS 3 IFIT3; NECK-CANCER; PROGNOSTIC MARKER; ANNEXIN A2; HEAD; INVASION	IFIT1 and IFIT3 are abundant products of interferon-stimulating genes. While the importance of IFIT1 and IFIT3 in the prognosis of cancer has been reported, the molecular basis of IFIT1 and IFIT3 in cancer progression remains unexplored. In the present study, we investigated the modes of action and the clinical significance of IFIT1 and IFIT3 in oral squamous cell carcinoma (OSCC). Ectopic expression of IFIT1 or IFIT3 induced OSCC cell invasion by promoting the epithelial-mesenchymal transition, whereas IFIT1 or IFIT3 knockdown exhibited opposite effects. Overexpression of IFIT1 or IFIT3 promoted tumor growth, regional and distant metastasis in xenograft and orthotopic nude mice models. Most importantly, IFIT1 or IFIT3 overexpression increased the levels of p-EGFR(Y1068) and p-AKT(S473) in OSCC cells and also enhanced tumor inhibitory effect of gefitinib. By immunoprecipitation and LC-MS/MS analysis, we found that IFIT1 and IFIT3 interacted with ANXA2 that enhanced p-EGFR(Y1068) endosomal recycling. Depletion of ANXA2 using siRNA therefore abolished p-EGFR(Y1068) and p-AKT(S473) expression in IFIT1- or IFIT3-overexpressed cells. Furthermore, a significant positive association of increased IFIT1 and IFIT3 expression with advanced T-stage, lymph node metastasis, perineural invasion, lymphovascular invasion, extranodal extension, and poor overall survival rate was confirmed in OSCC patients. We also found a statistically positive correlation of p-EGFR(Y1068) expression with IFIT1 and IFIT3 in OSCC tumors and poor clinical outcome in patients. Collectively, we demonstrated a novel role of IFIT1 and IFIT3 in driving OSCC progression and metastasis by interacting with ANXA2 and hence enhancing p-EGFR recycling and its downstream signaling.	[Pidugu, Vijaya Kumar; Lee, Te-Chang] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan; [Pidugu, Vijaya Kumar; Lee, Te-Chang] Acad Sinica, Taipei, Taiwan; [Pidugu, Vijaya Kumar; Yen, Ai-Hsin; Pidugu, Hima Bindu; Lee, Te-Chang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Wu, Meei-Maan] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei 11031, Taiwan; [Chang, Kuo-Wei] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 11221, Taiwan; [Liu, Chung-Ji] Mackay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei 10449, Taiwan; [Lee, Te-Chang] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Lee, TC (corresponding author), Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan.; Lee, TC (corresponding author), Acad Sinica, Taipei, Taiwan.; Lee, TC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.; Liu, CJ (corresponding author), Mackay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei 10449, Taiwan.; Lee, TC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 11221, Taiwan.	cjliu@ms2.mmh.org.tw; bmtcl@ibms.sinica.edu.tw	Yen, Ai-Hsin/AAS-8409-2021; Pidugu, Vijaya Kumar/B-2798-2012; Lee, TC/B-3245-2011	Pidugu, Vijaya Kumar/0000-0001-5435-0100; Lee, TC/0000-0003-4448-1507; Yen, Ai-Hsin/0000-0001-9469-360X	Ministry of Science and Technology [NSC 101-2321-B-001-044, NSC 102-2321-B-001-032, MOST 103-2321-B-001-019, MOST 104-2320-B-001-008]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the Ministry of Science and Technology (NSC 101-2321-B-001-044, NSC 102-2321-B-001-032, MOST 103-2321-B-001-019, and MOST 104-2320-B-001-008), Taiwan (T.C. Lee).	Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bossi P, 2016, ONCOTARGET, V7, P74362, DOI 10.18632/oncotarget.11413; Bruzzese F, 2006, CLIN CANCER RES, V12, P617, DOI 10.1158/1078-0432.CCR-05-1671; Chen IH, 2003, BRIT J CANCER, V89, P681, DOI 10.1038/sj.bjc.6601171; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Danish HH, 2013, BREAST J, V19, P231, DOI 10.1111/tbj.12097; de Graauw M, 2014, ONCOGENE, V33, P2610, DOI 10.1038/onc.2013.219; Diamond MS, 2014, CYTOKINE GROWTH F R, V25, P543, DOI 10.1016/j.cytogfr.2014.05.002; Fang YT, 2012, J CELL PHYSIOL, V227, P2775, DOI 10.1002/jcp.23026; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Huang SF, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3586-9; Jimenez L, 2015, ARCH PATHOL LAB MED, V139, P1334, DOI 10.5858/arpa.2014-0498-RA; Kapoor C, 2015, INDIAN J CANCER, V52, P417, DOI 10.4103/0019-509X.176750; Kirby AM, 2006, BRIT J CANCER, V94, P631, DOI 10.1038/sj.bjc.6602999; Krisanaprakornkit Suttichai, 2012, ISRN Oncol, V2012, P681469, DOI 10.5402/2012/681469; Lai KC, 2013, ONCOGENE, V32, P3686, DOI 10.1038/onc.2012.384; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Lang JY, 2014, FUTURE ONCOL, V10, P1635, DOI [10.2217/fon.14.44, 10.2217/FON.14.44]; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; Matsushita Y, 2015, INT J ORAL MAX SURG, V44, P543, DOI 10.1016/j.ijom.2015.01.018; Mehra R, 2011, DRUG RESIST UPDATE, V14, P260, DOI 10.1016/j.drup.2011.08.002; Moon C, 2010, EXP BIOL MED, V235, P907, DOI 10.1258/ebm.2009.009181; Moreira J, 2017, DRUGS, V77, P843, DOI 10.1007/s40265-017-0734-0; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Niess H, 2015, ONCOTARGET, V6, P3306, DOI 10.18632/oncotarget.2494; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Perea S, 2004, J CLIN ONCOL, V22, p196S; Ribeiro FAP, 2014, ANTICANCER RES, V34, P1547; Rao SVK, 2013, ASIAN PAC J CANCER P, V14, P5567, DOI 10.7314/APJCP.2013.14.10.5567; Rivera C, 2014, ONCOL LETT, V8, P7, DOI 10.3892/ol.2014.2103; Schmid SL, 2017, J CELL BIOL, V216, P2623, DOI 10.1083/jcb.201705017; Shetty PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044299; Shield KD, 2017, CA-CANCER J CLIN, V67, P51, DOI 10.3322/caac.21384; Shingaki S, 2003, AM J SURG, V185, P278, DOI 10.1016/S0002-9610(02)01378-8; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Staquicini DI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03470-w; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Yang JL, 2007, BJU INT, V99, P1539, DOI 10.1111/j.1464-410X.2007.06778.x; Yang JL, 2005, CANCER LETT, V225, P61, DOI 10.1016/j.canlet.2004.11.041; Yang YY, 2017, HEPATOLOGY, V66, P152, DOI 10.1002/hep.29156; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoon H, 2015, J HISTOCHEM CYTOCHEM, V63, P114, DOI 10.1369/0022155414561498; Zhang JF, 2016, HUM PATHOL, V52, P136, DOI 10.1016/j.humpath.2016.01.013; Zhao Y, 2017, J CANCER RES CLIN, V143, P1061, DOI 10.1007/s00432-017-2351-4; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175; [No title captured], DOI DOI 10.1016/J.JFMA.2015.10.011	64	33	34	4	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3232	3247		10.1038/s41388-018-0662-9	http://dx.doi.org/10.1038/s41388-018-0662-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30626937				2022-12-26	WOS:000465557200009
J	Miikkulainen, P; Hogel, H; Seyednasrollah, F; Rantanen, K; Elo, LL; Jaakkola, PM				Miikkulainen, Petra; Hogel, Heidi; Seyednasrollah, Fatemeh; Rantanen, Krista; Elo, Laura L.; Jaakkola, Panu M.			Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cancer biology; hypoxia; hypoxia-inducible factor (HIF); mRNA decay; ccRCC; Egl-9 family hypoxia-inducible factor 3 (EGLN3); post-transcriptional regulation; prolyl hydroxylase PHD3; renal cell carcinoma	PROLYL HYDROXYLASES; GENE-EXPRESSION; TRANSCRIPTION; HIF-1-ALPHA; PROTEIN; TRANSLATION; PROTEASOME; STABILITY; CANCER; HIF-1	Most clear cell renal cell carcinomas (ccRCCs) have inactivation of the von Hippel-Lindau tumor suppressor protein (pVHL), resulting in the accumulation of hypoxia-inducible factor -subunits (HIF-) and their downstream targets. HIF-2 expression is particularly high in ccRCC and is associated with increased ccRCC growth and aggressiveness. In the canonical HIF signaling pathway, HIF-prolyl hydroxylase 3 (PHD3) suppresses HIF-2 protein by post-translational hydroxylation under sufficient oxygen availability. Here, using immunoblotting and immunofluorescence staining, qRT-PCR, and siRNA-mediated gene silencing, we show that unlike in the canonical pathway, PHD3 silencing in ccRCC cells leads to down-regulation of HIF-2 protein and mRNA. Depletion of other PHD family members had no effect on HIF-2 expression, and PHD3 knockdown in non-RCC cells resulted in the expected increase in HIF-2 protein expression. Accordingly, PHD3 knockdown decreased HIF-2 target gene expression in ccRCC cells and expression was restored upon forced HIF-2 expression. The effect of PHD3 depletion was pinpointed to HIF2A mRNA stability. In line with these in vitro results, a strong positive correlation of PHD3 and HIF2A mRNA expression in ccRCC tumors was detected. Our results suggest that in contrast to the known negative regulation of HIF-2 in most cell types, high PHD3 expression in ccRCC cells maintains elevated HIF-2 expression and that of its target genes, which may enhance kidney cancer aggressiveness.	[Miikkulainen, Petra; Hogel, Heidi; Seyednasrollah, Fatemeh; Rantanen, Krista; Elo, Laura L.; Jaakkola, Panu M.] Univ Turku, Turku Ctr Biotechnol, Tykistokatu 6, FIN-20520 Turku, Finland; [Miikkulainen, Petra; Hogel, Heidi; Seyednasrollah, Fatemeh; Rantanen, Krista; Elo, Laura L.; Jaakkola, Panu M.] Abo Akad Univ, Tykistokatu 6, FIN-20520 Turku, Finland; [Miikkulainen, Petra; Hogel, Heidi; Jaakkola, Panu M.] Univ Turku, Fac Med, Dept Med Biochem, Kiinamyllynkatu 10, FIN-20520 Turku, Finland; [Seyednasrollah, Fatemeh] Univ Turku, Dept Math & Stat, Vesilinnantie 5, FIN-20520 Turku, Finland; [Jaakkola, Panu M.] Univ Helsinki, Helsinki Univ Hosp Canc Ctr, Haartmaninkatu 4, FIN-00290 Helsinki, Finland; [Jaakkola, Panu M.] Univ Helsinki, Dept Oncol, Haartmaninkatu 4, FIN-00290 Helsinki, Finland; [Hogel, Heidi] Univ Turku, Turku PET Ctr, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland; [Hogel, Heidi] Turku Univ Hosp, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Helsinki; University of Helsinki; University of Turku; University of Turku	Jaakkola, PM (corresponding author), Univ Turku, Turku Ctr Biotechnol, Tykistokatu 6, FIN-20520 Turku, Finland.; Jaakkola, PM (corresponding author), Abo Akad Univ, Tykistokatu 6, FIN-20520 Turku, Finland.; Jaakkola, PM (corresponding author), Univ Turku, Fac Med, Dept Med Biochem, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.; Jaakkola, PM (corresponding author), Univ Helsinki, Helsinki Univ Hosp Canc Ctr, Haartmaninkatu 4, FIN-00290 Helsinki, Finland.; Jaakkola, PM (corresponding author), Univ Helsinki, Dept Oncol, Haartmaninkatu 4, FIN-00290 Helsinki, Finland.	panjaa@utu.fi	Jaakkola, Panu M/B-4355-2012; Högel, Heidi/A-1814-2019; Elo, Laura/A-9449-2015	Högel, Heidi/0000-0001-6592-5723; Elo, Laura/0000-0001-5648-4532; Jaakkola, Panu/0000-0002-2365-4985	Cancer Foundation Finland; Sigrid Juselius Foundation; Turku University Hospital [EVO1303]; Helsinki University Hospital; University of Turku Graduate School; Finnish Cultural Foundation Varsinais-Suomi Regional fund	Cancer Foundation Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital; Helsinki University Hospital; University of Turku Graduate School; Finnish Cultural Foundation Varsinais-Suomi Regional fund(Finnish Cultural Foundation)	This work was supported by Cancer Foundation Finland (to P. M. and P. M. J.), The Sigrid Juselius Foundation (to P. M. J.), Turku University Hospital (EVO1303) (to P. M., H. H. and P. M. J.), Helsinki University Hospital (to P. M. and P. M. J.), The University of Turku Graduate School (to P. M.), and Finnish Cultural Foundation Varsinais-Suomi Regional fund (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article. This article contains Figs. S1-S4 and Table S1.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015062; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bremm A, 2014, EMBO REP, V15, P1268, DOI 10.15252/embr.201438850; Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cui XG, 2017, ONCOTARGET, V8, P24840, DOI 10.18632/oncotarget.15266; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Fu LP, 2015, MOL CANCER RES, V13, P870, DOI 10.1158/1541-7786.MCR-14-0423; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gonzalez-Flores A, 2014, ONCOGENE, V33, P891, DOI 10.1038/onc.2013.9; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hogel H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0410-5; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jaakkola PM, 2013, BIOL CHEM, V394, P449, DOI 10.1515/hsz-2012-0330; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liu XD, 2015, ONCOGENE, V34, P2450, DOI 10.1038/onc.2014.199; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miikkulainen P, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0167-y; Minton DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120649; Mohlin S, 2015, CANCER RES, V75, P4617, DOI 10.1158/0008-5472.CAN-15-0708; Moniz S, 2015, J CELL SCI, V128, P3082, DOI 10.1242/jcs.168864; Nayak BK, 2013, ONCOGENE, V32, P3147, DOI 10.1038/onc.2012.333; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; OHH M, 1995, J CELL BIOCHEM, V59, P202, DOI 10.1002/jcb.240590210; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sala MA, 2018, J BIOL CHEM, V293, P271, DOI 10.1074/jbc.RA117.000440; Sato E, 2008, CLIN CANCER RES, V14, P6916, DOI 10.1158/1078-0432.CCR-08-0466; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Schodel J, 2016, EUR UROL, V69, P646, DOI 10.1016/j.eururo.2015.08.007; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Tanaka T, 2011, J CANCER RES CLIN, V137, P789, DOI 10.1007/s00432-010-0940-6; Turner KJ, 2002, CANCER RES, V62, P2957; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yao TT, 2012, SEMIN CELL DEV BIOL, V23, P523, DOI 10.1016/j.semcdb.2012.02.006	50	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3760	3771		10.1074/jbc.RA118.004902	http://dx.doi.org/10.1074/jbc.RA118.004902			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30617181	Green Published, hybrid			2022-12-26	WOS:000461853900036
J	Hjelmso, MH; Mollerup, S; Jensen, RH; Pietroni, C; Lukjancenko, O; Schultz, AC; Aarestrup, FM; Hansen, AJ				Hjelmso, Mathis Hjort; Mollerup, Sarah; Jensen, Randi Holm; Pietroni, Carlotta; Lukjancenko, Oksana; Schultz, Anna Charlotte; Aarestrup, Frank M.; Hansen, Anders Johannes			Metagenomic analysis of viruses in toilet waste from long distance flights-A new procedure for global infectious disease surveillance	PLOS ONE			English	Article							RESPIRATORY VIRUSES; BINDING-SITES; CHILDREN; BURDEN; EPIDEMIOLOGY; MORTALITY; HEPATITIS; IDENTIFICATION; CORONAVIRUS; MULTIPLE	Human viral pathogens are a major public health threat. Reliable information that accurately describes and characterizes the global occurrence and transmission of human viruses is essential to support national and global priority setting, public health actions, and treatment decisions. However, large areas of the globe are currently without surveillance due to limited health care infrastructure and lack of international cooperation. We propose a novel surveillance strategy, using metagenomic analysis of toilet material from international air flights as a method for worldwide viral disease surveillance. The aim of this study was to design, implement, and evaluate a method for viral analysis of airplane toilet waste enabling simultaneous detection and quantification of a wide range of human viral pathogens. Toilet waste from 19 international airplanes was analyzed for viral content, using viral capture probes followed by high-throughput sequencing. Numerous human pathogens were detected including enteric and respiratory viruses. Several geographic trends were observed with samples originating from South Asia having significantly higher viral species richness as well as higher abundances of salivirus A, aichivirus A and enterovirus B, compared to samples originating from North Asia and North America. In addition, certain city specific trends were observed, including high numbers of rotaviruses in airplanes departing from Islamabad. Based on this study we believe that central sampling and analysis at international airports could be a useful supplement for global viral surveillance, valuable for outbreak detection and for guiding public health resources.	[Hjelmso, Mathis Hjort; Lukjancenko, Oksana; Aarestrup, Frank M.] Tech Univ Denmark, Res Grp Genom Epidemiol, Lyngby, Denmark; [Mollerup, Sarah; Jensen, Randi Holm; Pietroni, Carlotta; Hansen, Anders Johannes] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Schultz, Anna Charlotte] Tech Univ Denmark, Natl Food Inst, Div Microbiol & Prod, Lyngby, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Hjelmso, MH (corresponding author), Tech Univ Denmark, Res Grp Genom Epidemiol, Lyngby, Denmark.	mathishjelmsoe@gmail.com	Hansen, Anders Johannes/A-5608-2013; Lukjancenko, Oksana/B-9049-2019; Schultz, Anna C/N-4898-2016	Hansen, Anders Johannes/0000-0002-1890-2702; Lukjancenko, Oksana/0000-0003-0102-0364; Schultz, Anna C/0000-0003-1484-9120; Aarestrup, Frank/0000-0002-7116-2723; Mollerup, Sarah/0000-0003-2429-4018; Hjelmso, Mathis Hjort/0000-0001-9716-624X	Innovation Fund Denmark [019-2011-2]; European Union [643476]; Villum Foundation [VKR023052]	Innovation Fund Denmark; European Union(European Commission); Villum Foundation(Villum Fonden)	This study has received funding from the Innovation Fund Denmark, https://innovationsfonden.dk/en, (The GenomeDenmark platform, grant no. 019-2011-2) (AHJ) and the European Union's Horizon 2020 research and innovation programme, https://ec.europa.eu/programmes/horizon2020/en/, under grant agreement no 643476 (COMPARE) (FMA), and The Villum Foundation, https://veluxfoundations.dk/en, (VKR023052) (FMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamlan FS, 2015, J INFECT DEV COUNTR, V9, P128, DOI 10.3855/jidc.6101; [Anonymous], 2014, R LANG ENV STAT COMP; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P2, DOI 10.1021/ez5003715; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Boros A, 2018, VIROLOGY, V525, P62, DOI 10.1016/j.virol.2018.09.008; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; Chan PKS, 2013, J THORAC DIS, V5, pS118, DOI 10.3978/j.issn.2072-1439.2013.06.19; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960; Furtak V, 2016, EUROSURVEILLANCE, V21, P40, DOI 10.2807/1560-7917.ES.2016.21.15.30193; Ganesh Balasubramanian, 2014, VirusDisease, V25, P223, DOI 10.1007/s13337-014-0207-y; Gaunt ER, 2011, J CLIN VIROL, V52, P215, DOI 10.1016/j.jcv.2011.07.017; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Graf EH, 2016, J CLIN MICROBIOL, V54, P1000, DOI 10.1128/JCM.03060-15; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hjelmso MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170199; Itta KC, 2016, INT J INFECT DIS, V52, P14, DOI 10.1016/j.ijid.2016.09.015; Jensen RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122636; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Khamrin Pattara, 2014, VirusDisease, V25, P195, DOI 10.1007/s13337-014-0200-5; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Kolde R., 2018, PHEATMAP PRETTY HEAT; Krishnamurthy SR, 2018, VIROLOGY, V516, P108, DOI 10.1016/j.virol.2018.01.006; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Li H., 2013, PREPRINT, P1, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LOGRIPPO GA, 1952, J LAB CLIN MED, V39, P970; Mangili A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.IOL5-0009-2015; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mee ET, 2016, VACCINE, V34, P2035, DOI 10.1016/j.vaccine.2015.12.020; Muhlemann B, 2018, NATURE, V557, P418, DOI 10.1038/s41586-018-0097-z; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petersen TN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11444; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santos N, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.04.004; Shan TL, 2010, EMERG INFECT DIS, V16, P1303, DOI 10.3201/eid1608.100087; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Socan M, 2012, CENT EUR J PUBL HEAL, V20, P156, DOI 10.21101/cejph.a3735; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Todd S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004869; Tsiodras S, 2014, EURO SURVEILL, V19; Vinner L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13201; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang XW, 2005, WATER SCI TECHNOL, V52, P213, DOI 10.2166/wst.2005.0266; World Bank (2020a), AIR TRANSP PASS CARR; YAMASHITA T, 1995, MICROBIOL IMMUNOL, V39, P433, DOI 10.1111/j.1348-0421.1995.tb02225.x; Yu JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130977	64	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210368	10.1371/journal.pone.0210368	http://dx.doi.org/10.1371/journal.pone.0210368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640944	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000024
J	Emanuel, A; Qiu, HY; Barker, D; Takla, T; Gillum, K; Neimuth, N; Kodihalli, S				Emanuel, Andrew; Qiu, Hongyu; Barker, Douglas; Takla, Teresa; Gillum, Karen; Neimuth, Nancy; Kodihalli, Shantha			Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model	PLOS ONE			English	Article							TOXIN TYPE-A; CLOSTRIDIUM-BOTULINUM; NEUROTOXIN SEROTYPES; IDENTIFICATION; CHALLENGES; ANTIBODIES; VACCINES; STRAIN	Background Botulism is a disease caused by neurogenic toxins that block acetylcholine release, resulting in potentially life threatening neuroparalysis. Seven distinct serotypes of botulinum neurotoxins (BoNTs) have been described and are found in nature world-wide. This, combined with ease of production, make BoNTs a significant bioweapon threat. An essential countermeasure to this threat is an antitoxin to remove circulating toxin. An antitoxin, tradename BAT (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine)), has been developed and its efficacy evaluated against all seven serotypes in guinea pigs. Methods and findings Studies were conducted to establish the lethal dose and clinical course of intoxication for all seven toxins, and post-exposure prophylactic efficacy of BAT product. Animals were monitored for signs of intoxication and mortality for 14 days. Guinea pig intramuscular LD50s (GPIMLD(50)) for all BoNTs ranged from 2.0 (serotype C) to 73.2 (serotype E) of mouse intraperitoneal LD50 units. A dose of 4x GPIMLD(50) was identified as the appropriate toxin dose for use in subsequent efficacy and post-exposure prophylaxis studies. The main clinical signs observed included hind limb paralysis, weak limb, change in breathing rate/pattern, and forced abdominal respiration. Mean time to onset of clinical signs ranged from 12 hours (serotype E) to 39 hours (serotype G). Twelve hours post-intoxication was selected as the appropriate time point for intervention for all serotypes apart from E where 6 hours was selected because of the rapid onset and progression of clinical signs. Post-exposure treatment with BAT product resulted in a significantly (p<0.0001) higher survival at >0.008 scaled human dose for serotypes A, B, C, F and G, at >0.2x for serotype D and >0.04x for serotype E. Conclusions These studies confirm the efficacy of BAT as a post-exposure prophylactic therapy against all seven known BoNT serotypes.	[Emanuel, Andrew; Qiu, Hongyu; Barker, Douglas; Takla, Teresa; Kodihalli, Shantha] Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada; [Gillum, Karen; Neimuth, Nancy] Battelle Biomed Res Ctr, Columbus, OH USA		Kodihalli, S (corresponding author), Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada.	skodihalli@ebsi.com			Emergent BioSolutions Canada Inc. - Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) [HHSO100200600017C]	Emergent BioSolutions Canada Inc. - Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS)	The funder Emergent BioSolutions Canada Inc. provided support in the form of salaries for authors [AE, DB, TT, SK]. The specific roles of these authors are articulated in the 'author contributions' section. Additionally, this work was funded by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) under contract HHSO100200600017C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. None of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleem FH, 2011, J PHARMACOL EXP THER, V338, P503, DOI 10.1124/jpet.111.180653; Anderson J, 2015, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, 2ND EDITION, P361, DOI 10.1016/B978-0-12-800159-2.00028-2; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1454; [Anonymous], 2007, AN CAR POL MAN; BALL AP, 1979, Q J MED, V48, P473; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Carlella M.A., 1964, PHS999FP1 PUBL, P113; Centers for Disease Control, 2018, NAT BOT SURV SUMM 20; Chen ZXP, 2012, TOXINS, V4, P1196, DOI 10.3390/toxins4111196; Cheng LW, 2011, TOXICON, V58, P62, DOI 10.1016/j.toxicon.2011.05.003; CICCARELLI AS, 1977, APPL ENVIRON MICROB, V34, P843, DOI 10.1128/AEM.34.6.843-848.1977; Dorner MB, 2013, CURR TOP MICROBIOL, V364, P219, DOI 10.1007/978-3-642-33570-9_11; European Centre for Disease Prevention and Control, 2018, BOT ANN EP REP 2018; Finney D.J., 1971, PROBIT ANAL; Gao W, 2018, CURR OPIN MICROBIOL, V41, P76, DOI 10.1016/j.mib.2017.11.030; Greenbaum SB, 2012, BIODEFENSE RES METHO, P415; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Hansbauer EM, 2016, ANALYST, V141, P5281, DOI [10.1039/c6an00693k, 10.1039/C6AN00693K]; Harvey SM, 2002, J CLIN MICROBIOL, V40, P2260, DOI 10.1128/JCM.40.6.2260-2262.2002; HATHEWAY CH, 1984, J INFECT DIS, V150, P407, DOI 10.1093/infdis/150.3.407; IIDA H, 1970, JPN J MED SCI BIOL, V23, P344; Kodihalli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186892; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Macdonald TE, 2011, APPL ENVIRON MICROB, V77, P8625, DOI 10.1128/AEM.05155-11; McCarty CL, 2015WEEKLY      0731, P20; McLellan K, 1996, TOXICON, V34, P975, DOI 10.1016/0041-0101(96)00070-0; METZGER JF, 1979, REV INFECT DIS, V1, P689; Middlebrook JL, BOTULINUM TOXINS MED, P643; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nelson W., 1982, APPL LIFE DATA ANAL, DOI [10.1021/es60130a004, DOI 10.1021/ES60130A004]; Peck MW, 2017, TOXINS, V9, DOI 10.3390/toxins9010038; Pellett S, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00100-15; Pirazzini M, 2017, EXPERT OPIN DRUG DIS, V12, P497, DOI 10.1080/17460441.2017.1303476; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Rusnak JM, 2009, HUM VACCINES, V5, P794, DOI 10.4161/hv.9420; Sesardic D, 2004, MOVEMENT DISORD, V19, pS85, DOI 10.1002/mds.20021; SESARDIC D, 1994, J ROY SOC MED, V87, P307; Sheridan RE, 2001, TOXICON, V39, P651, DOI 10.1016/S0041-0101(00)00189-6; Simpson LL, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P891, DOI 10.1016/B978-0-12-369408-9.00046-9; Smith LA, 2007, CRIT REV IMMUNOL, V27, P303, DOI 10.1615/CritRevImmunol.v27.i4.20; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Zhang SC, 2018, CELL HOST MICROBE, V23, P169, DOI 10.1016/j.chom.2017.12.018; Zhang SC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14130	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209019	10.1371/journal.pone.0209019	http://dx.doi.org/10.1371/journal.pone.0209019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633746	gold, Green Published, Green Submitted			2022-12-26	WOS:000455485100004
J	Ara, G; Khanam, M; Rahman, AS; Islam, Z; Farhad, S; Sanin, KI; Khan, SS; Rahman, MM; Majoor, H; Ahmed, T				Ara, Gulshan; Khanam, Mansura; Rahman, Ahmed Shafiqur; Islam, Zhahirul; Farhad, Shahriar; Sanin, Kazi Istiaque; Khan, Sihan Sadat; Rahman, Mohammad Mahbobor; Majoor, Herma; Ahmed, Tahmeed			Effectiveness of micronutrient-fortified rice consumption on anaemia and zinc status among vulnerable women in Bangladesh	PLOS ONE			English	Article							IRON STATUS; SERUM ZINC; HEMOGLOBIN CONCENTRATION; SCHOOL-CHILDREN; PREVALENCE; DEFICIENCY; ABSORPTION; GROWTH; FORTIFICATION; MORBIDITY	Micronutrient deficiency is one of the biggest public health concerns in Bangladesh. As per World Health Organisation (WHO) in the 2016 report, 40% women of reproductive age suffer from anaemia. According to the National Micronutrient Survey 2011-2012, 57% women suffer from zinc deficiency. The objective of the present study was to determine the effectiveness of fortified rice (FFR in addressing anaemia and zinc deficiency among vulnerable women. Baseline and endline surveys were conducted among female Vulnerable Group Development (VDG) beneficiaries in five districts in Bangladesh before and after 12 months of FFR distribution. The intervention group received 30 kg FFR; the control group received 30 kg non-FFR for every month from January 2013 to December 2013. The sample sizes were 870 women (435/group) at baseline and 800 (400/group) at endline. Difference-in-difference (DID) was estimated to measure the effect of FFR on anaemia and serum zinc. In the baseline survey, 39% of the FFR group and 34% of the non-FFR group had anaemia. At endline, 34% of women in the FFR group were anaemic compared to 40.7% in the non-FFR group. At endline, prevalence of anaemia was reduced in the FFR group by 4.8% but increased in the non-FFR group by 6.7%. The DID estimation showed the reduction in anaemia after 12 months of FFR consumption was significant (p = 0.035). The DID in mean haemoglobin level after 12 months of FFR consumption was also statistically significant (p = 0.002). Zinc deficiency decreased by 6% in the FFR group at endline, though the DID was not significant. Most of the respondents of the FFR group reported that they received their entitled rice on a regular basis however only half of the non-FFR respondents received every month in 12 months. Anaemia was significantly associated with not consuming fortified rice, geographical region, older age and heavy menstrual bleeding (P<0.05). FFR reduced anaemia and zinc deficiency prevalence. Replacement of regular rice with FFR in the VGD programme is recommended to reduce anaemia among vulnerable groups.	[Ara, Gulshan; Khanam, Mansura; Rahman, Ahmed Shafiqur; Islam, Zhahirul; Farhad, Shahriar; Sanin, Kazi Istiaque; Khan, Sihan Sadat; Ahmed, Tahmeed] Icddr B, Dhaka, Bangladesh; [Rahman, Mohammad Mahbobor; Majoor, Herma] United Nations World Food Programme, IDB Bhaban, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Ara, G (corresponding author), Icddr B, Dhaka, Bangladesh.	gulshan.ara@icddrb.org		Islam, Dr. Zhahirul/0000-0003-0935-8079	United nations World Food Programme [1209]; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Agency; Department for International Development, UK	United nations World Food Programme; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC)(CGIAR); Swedish International Development Agency; Department for International Development, UK	This research is supported by the United nations World Food Programme Grant #1209, http://www1.wfp.org/countries/bangladesh.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted at the icddr, b Centre for Health and Population Research, Bangladesh with the support of the United Nations World Food Programme. The icddr, b thanks the WFP for its commitment to the Centre's research efforts. We also thank the VGD participants and field staff for their encouragement and support. The icddr, b also acknowledges with gratitude the commitment of the Government of Bangladesh to the Centre's research efforts, and also gratefully acknowledges the following donors who provided unrestricted support: the Government of the People's Republic of Bangladesh, Global Affairs Canada (GAC), the Swedish International Development Agency, and the Department for International Development, UK.	Ahmed F, 2016, J NUTR SCI, V5; Ahmed F, 2000, PUBLIC HEALTH NUTR, V3, P385, DOI 10.1017/S1368980000000446; Allen L, 2006, GUIDELINES FOOD FORT; Angeles-Agdeppa I, 2008, INT J VITAM NUTR RES, V78, P74, DOI 10.1024/0300-9831.78.2.74; [Anonymous], 2013, ICDDRB UNDEFINED BAN; Badii A, 2012, INT J PREVENTIVE MED, V3, pS124; Bagni UV, 2009, CAD SAUDE PUBLICA, V25, P291, DOI 10.1590/S0102-311X2009000200007; Balasubramaniam P, 1992, J Postgrad Med, V38, P8; Bhandari S, 2015, INT SCH RES NOT, V2015; Bhargava A, 2001, J NUTR, V131, P758, DOI 10.1093/jn/131.3.758; Broadley M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P191, DOI 10.1016/B978-0-12-384905-2.00007-8; Brown KH, 2007, AM J CLIN NUTR, V85, P538, DOI 10.1093/ajcn/85.2.538; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; de Pee S, 2014, ANN NY ACAD SCI, V1324, P55, DOI 10.1111/nyas.12478; de Romana DL, 2005, AM J CLIN NUTR, V81, P637; Eisenstaedt R, 2006, BLOOD REV, V20, P213, DOI 10.1016/j.blre.2005.12.002; Engle-Stone R, 2011, J NUTR, V141, P2233, DOI 10.3945/jn.111.145805; Garcia-Banuelos ML, 2014, J ELEM, V19; Hasan M, 2017, CUREUS, V9; Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94; Hotz C, 2005, J NUTR, V135, P1102, DOI 10.1093/jn/135.5.1102; Hotz C, 2008, FOOD NUTR BULL, V29, P140, DOI 10.1177/156482650802900208; Hunt JM, 2002, J NUTR, V132, p794S, DOI 10.1093/jn/132.4.794S; Hyder SMZ, 2001, PUBLIC HEALTH NUTR, V4, P79, DOI 10.1079/PHN200055; Islam MZ, 2001, EUR J CLIN NUTR, V55, P598, DOI 10.1038/sj.ejcn.1601190; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Khambalia A, 2009, J NUTR, V139, P1179, DOI 10.3945/jn.108.101022; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Lindstrom E, 2011, ACTA OBSTET GYN SCAN, V90, P47, DOI 10.1111/j.1600-0412.2010.01014.x; Makipour S, 2008, SEMIN HEMATOL, V45, P250, DOI 10.1053/j.seminhematol.2008.06.003; Malpeli A, 2013, BIOL TRACE ELEM RES, V155, P176, DOI 10.1007/s12011-013-9780-y; Martorell R, 2015, AM J CLIN NUTR, V101, P210, DOI 10.3945/ajcn.114.097709; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Moran VH, 2012, NUTRIENTS, V4, P841, DOI 10.3390/nu4080841; Organization WH, 2001, GUID PROGR MAN, P47; Perignon M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010029; PERRY DF, 1990, J ASSOC OFF ANA CHEM, V73, P619; Piccoli NB, 2012, FOOD NUTR BULL, V33, pS360, DOI 10.1177/15648265120334S312; Pinkaew S, 2013, J NUTR, V143, P362, DOI 10.3945/jn.112.166058; Research NI of P Training Mitra Associates International M, 2009, BANGL DEM HLTH SURV; Roy SK, 2007, J HEALTH POPUL NUTR, V25, P67; Sampath Cdr S, 2007, AM J OBSTET GYNECOL, V63, P233; Seshadri S, 2001, BRIT J NUTR, V85, pS87, DOI 10.1079/BJN2000299; Shah D, 2013, COCHRANE DATABASE SY; Shahabuddin A.K.M., 2000, Indian Journal of Pediatrics, V67, P93, DOI 10.1007/BF02726173; Stallkamp G, 2006, SIGHT LIFE, V3, P16; Strengthening Public Financial Management for Social Protection (SPFMSP), DIAGN STUD VULN GROU; Thankachan P, 2012, J NUTR, V142, P846, DOI 10.3945/jn.111.149021; Unnevehr L, 2007, ADDRESSING MICRONUTR; Whitley E, 2002, CRIT CARE, V6, P335; Winichagoon P, 2006, J NUTR, V136, P1617, DOI 10.1093/jn/136.6.1617	52	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210501	10.1371/journal.pone.0210501	http://dx.doi.org/10.1371/journal.pone.0210501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629717	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000097
J	Nava, AC; Pino, ZMS; Perez, AMH; Hernandez, MEH; Sanchez, MJD; Manzano, JMS				Cubo Nava, Ana; Soto Pino, Zandra M.; Haro Perez, Ana M.; Hernandez Hernandez, M. Estrella; Doyague Sanchez, M. Jose; Sayagues Manzano, Jose M.			Medical versus surgical treatment of first trimester spontaneous abortion: A cost-minimization analysis	PLOS ONE			English	Article							EARLY-PREGNANCY FAILURE; MISSED MISCARRIAGE; MANAGEMENT; MISOPROSTOL; EXPECTANT; CURETTAGE; TRIAL	Background Traditionally the gold-standard technique for the treatment of spontaneous abortion has been uterine evacuation by aspiration curettage. However, many studies have proposed medical treatment with misoprostol as an alternative to the conventional surgical treatment. The aim of this study was to apply cost minimization methods to compare the cost and effectiveness of the use of vaginal misoprostol as a medical treatment for first trimester spontaneous abortion with those of evacuation curettage as a surgical treatment. Methodology/Principal findings We present a longitudinal, prospective and quasi-experimental research study including a total of 547 patients diagnosed with first-trimester spontaneous abortion, in the period from January 2013 to December 2015. Patients were offered medical treatment with 800 mg vaginal misoprostol or evacuation curettage. Patients treated with misoprostol were followed-up at 7 days and a transvaginal ultrasound was performed to confirm the success of the treatment. If it failed, a second dose of 800 mg of vaginal misoprostol was prescribed and a new control ultrasound was performed. In case of failure of medical treatment after the second dose of misoprostol, evacuation curettage was indicated. The effectiveness of each of the treatment options was calculated using a decision tree. The cost minimization study was carried out by weighting each cost according to the effectiveness of each branch of the treatment. Of the 547 patients who participated in the study, 348 (64%) chose medical treatment and 199 (36%) chose surgical treatment. The overall effectiveness of medical treatment was 81% (283/348) and surgical treatment of 100%. The estimated final cost for medical treatment was (sic) 461.92 compared to (sic) 2038.72 for surgical treatment, which represents an estimated average saving per patient of (sic) 1576.8. Conclusions/Significance Medical treatment with misoprostol is a cheaper alternative to surgery: in the Spanish Public Healthcare System, it is five times more inexpensive than curettage. Given its success rates higher than 80%, mild side effects, controllable with additional medication and the high degree of overall satisfaction, it should be prioritized over the evacuation curettage in patients who meet the treatment criteria.	[Cubo Nava, Ana; Soto Pino, Zandra M.; Hernandez Hernandez, M. Estrella; Doyague Sanchez, M. Jose] Complejo Asistencial Univ Salamanca, Dept Obstet & Gynecol, Salamanca, Spain; [Haro Perez, Ana M.] Complejo Asistencial Univ Salamanca, Dept Prevent Med & Publ Hlth, Salamanca, Spain; [Sayagues Manzano, Jose M.] Complejo Asistencial Univ Salamanca, Dept Hematol, Salamanca, Spain; [Sayagues Manzano, Jose M.] Inst Biomed Res IBSAL, Salamanca, Spain		Nava, AC (corresponding author), Complejo Asistencial Univ Salamanca, Dept Obstet & Gynecol, Salamanca, Spain.	amcubo@saludcastillayleon.es	NAVA, ANA MARIA CUBO/L-4535-2019; Nava, Ana M Cubo/D-4848-2019; Nava, Ana María Cubo/AAN-3445-2020	Nava, Ana María Cubo/0000-0003-4473-4914	Institute for Biomedical Research (IBSAL), Salamanca, Spain	Institute for Biomedical Research (IBSAL), Salamanca, Spain	This work was supported by the Institute for Biomedical Research (IBSAL), Salamanca, Spain, has paid for the publication fees (Article Processing Charges) of this manuscript. There was no additional external funding received for this study. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2012, AUST NZ J OBSTET GYN, V52, P39, DOI 10.1111/j.1479-828X.2011.01382.x; Creinin MD, 2004, OBSTET GYNECOL, V103, P851, DOI 10.1097/01.AOG.0000124271.23499.84; Creinin MD, 2000, CONTRACEPTION, V62, P117, DOI 10.1016/S0010-7824(00)00151-7; DEJONGE ETM, 1995, BRIT MED J, V311, P662, DOI 10.1136/bmj.311.7006.662; Diop A, 2009, CONTRACEPTION, V79, P456, DOI 10.1016/j.contraception.2008.11.016; Graziosi GCM, 2005, HUM REPROD, V20, P1067, DOI 10.1093/humrep/deh709; Graziosi GCM, 2004, HUM REPROD, V19, P1894, DOI 10.1093/humrep/deh344; Ministerio de Sanidad Servicios Sociales e Igualdad, REG ALT HOSP GEN SIS; Neilson JP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007223.pub3; OMS, PROGR EPI INFO; Rausch M, 2012, FERTIL STERIL, V97, P355, DOI 10.1016/j.fertnstert.2011.11.044; Reeves MF, 2009, ULTRASOUND OBST GYN, V34, P104, DOI 10.1002/uog.6404; Rubio Cebrian S., 2012, METODOLOGI TIPO ESTU; Rubio-Terres C, 2004, MED CLIN-BARCELONA, V122, P668, DOI 10.1157/13061390; Sayagues JM, 2018, HARVARD DATAVERSE, DOI [10.7910/DVN/HNGE05, DOI 10.7910/DVN/HNGE05]; SEGO, 2011, PROGR OBST GIN, V54, P207, DOI DOI 10.1016/J.POG.2010.10.008; Shankar M, 2007, J OBSTET GYNAECOL, V27, P283, DOI 10.1080/01443610701213927; Sifakis Stavros, 2005, Archives of Gynecology and Obstetrics, V272, P183, DOI 10.1007/s00404-004-0697-8; Trinder J, 2006, BMJ-BRIT MED J, V332, P1235, DOI 10.1136/bmj.38828.593125.55; Xia W, 2011, GYNECOL OBSTET INVES, V72, P257, DOI 10.1159/000328313; You JHS, 2005, HUM REPROD, V20, P2873, DOI 10.1093/humrep/dei163; Zhang J, 2005, NEW ENGL J MED, V353, P761, DOI 10.1056/NEJMoa044064	22	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210449	10.1371/journal.pone.0210449	http://dx.doi.org/10.1371/journal.pone.0210449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629715	Green Published, gold			2022-12-26	WOS:000455483000092
J	Thorogood, M; Goudge, J; Kabudula, CW; Limbani, F; Roseleur, J; Gomez-Olive, FX				Thorogood, Margaret; Goudge, Jane; Kabudula, Chodziwadziwa Whiteson; Limbani, Felix; Roseleur, Jacqueline; Gomez-Olive, Francesc Xavier			Time to review policy on screening for, and managing, hypertension in South Africa: Evidence from primary care	PLOS ONE			English	Review							HEALTH; PREVALENCE; MANAGEMENT	Background Current policy in South Africa requires measurement of blood pressure at every visit in primary care. The number of patients regularly visiting primary care clinics for routine care is increasing rapidly, causing long queues, and unmanageable workloads. Methods We used data collected during a randomised control trial in primary care clinics in South Africa to estimate how changes in policy might affect workloads and improve identification of undiagnosed hypertension. Results The prevalence of raised blood pressure increased with age; 65% of individuals aged over 60 years had a raised blood pressure, and 49% of them were not on any treatment. Over three months, eight health facilities saw 8,947 individual chronic disease patients, receiving 22,323 visits from them. Of these visits, 60% were related to hypertension, with or without HIV, and a further 35% were related to HIV alone. Long waits for blood pressure checks caused friction at all levels of the clinics. Blood pressure machines frequently broke down due to heavy use, and high blood pressures readings were often ignored. If chronic disease patients without a diagnosis of hypertension had their blood pressure checked only once a year, the number of checks would be reduced by more than 80%. Individuals with hypertension had a blood pressure check on average once every 7 weeks, but South African guidelines recommend that this should be done every 3 months at most. Conclusions The numbers of chronic disease patients in primary care clinics in South Africa is rising rapidly. New policies for measuring blood pressure in these patients attending clinics are urgently needed.	[Thorogood, Margaret] Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England; [Thorogood, Margaret] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Goudge, Jane; Limbani, Felix; Roseleur, Jacqueline] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa; [Kabudula, Chodziwadziwa Whiteson; Gomez-Olive, Francesc Xavier] Univ Witwatersrand, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa	University of Warwick; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Thorogood, M (corresponding author), Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England.; Thorogood, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	m.thorogood@warwick.ac.uk	Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Kabudula, Chodziwadziwa/AAV-6704-2021; Roseleur, Jacqueline/O-5691-2019	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Roseleur, Jacqueline/0000-0003-4990-1312; Kabudula, Chodziwadziwa/0000-0002-5867-0336; LIMBANI, FELIX/0000-0003-0176-7011; Goudge, Jane/0000-0001-6555-7510	UK Medical Research Council under The Global Alliance for Chronic Diseases programme [MR/J016020/1]; MRC [MR/J016020/1] Funding Source: UKRI	UK Medical Research Council under The Global Alliance for Chronic Diseases programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council under The Global Alliance for Chronic Diseases programme (grant reference MR/J016020/1) to MT.	Durao S, 2015, SAMJ S AFR MED J, V105, P98, DOI [10.7196/SAMJ.8819, 10.7196/samj.8819]; Gaziano TA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4117-y; Goudge J, 2017, BMJ GLOB HEALTH; Goudge J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000577; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Knowledge Translation Unit UoCTLI, 2016, AD PRIM CAR GUID 201; Limbani FT, 2018, BMJ GLOB HEALTH; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Mahomed OH, 2014, J HEALTH CARE POOR U, V25, P1723, DOI 10.1353/hpu.2014.0176; Maurer Jurgen, 2015, Am J Epidemiol, V181, P180, DOI 10.1093/aje/kwu339; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Norman R, 2007, SAMJ S AFR MED J, V97, P692; Seedat Y K, 2011, S Afr Med J, V102, P57; South African National AIDS Council Trust, 2015, S AFR GLOB RESP PROG; Steyn K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20796; Thorogood M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-435; UNAIDS, 2015, HIV PREV POP AD 15 4; UNAIDS, 2018, NEW MID YEAR EST REV	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208983	10.1371/journal.pone.0208983	http://dx.doi.org/10.1371/journal.pone.0208983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629585	Green Published, gold			2022-12-26	WOS:000455483000019
J	Mertens, S; Gallone, B; Steensels, J; Herrera-Malaver, B; Cortebeek, J; Nolmans, R; Saels, V; Vyas, VK; Verstrepen, KJ				Mertens, Stijn; Gallone, Brigida; Steensels, Jan; Herrera-Malaver, Beatriz; Cortebeek, Jeroen; Nolmans, Robbe; Saels, Veerle; Vyas, Valmik K.; Verstrepen, Kevin J.			Reducing phenolic off-flavors through CRISPR-based gene editing of the FDC1 gene in Saccharomyces cerevisiae x Saccharomyces eubayanus hybrid lager beer yeasts	PLOS ONE			English	Article							NATURAL HYBRIDS; INDUSTRIAL YEASTS; GENOME SEQUENCE; BAYANUS; DOMESTICATION; KUDRIAVZEVII; DIVERSITY; EVOLUTION; STRAINS; IDENTIFICATION	Today's beer market is challenged by a decreasing consumption of traditional beer styles and an increasing consumption of specialty beers. In particular, lager-type beers (pilsner), characterized by their refreshing and unique aroma and taste, yet very uniform, struggle with their sales. The development of novel variants of the common lager yeast, the interspecific hybrid Saccharomyces pastorianus, has been proposed as a possible solution to address the need of product diversification in lager beers. Previous efforts to generate new lager yeasts through hybridization of the ancestral parental species (S. cerevisiae and S. eubayanus) yielded strains with an aromatic profile distinct from the natural biodiversity. Unfortunately, next to the desired properties, these novel yeasts also inherited unwanted characteristics. Most notably is their phenolic off-flavor (POF) production, which hampers their direct application in the industrial production processes. Here, we describe a CRISPR-based gene editing strategy that allows the systematic and meticulous introduction of a natural occurring mutation in the FDC1 gene of genetically complex industrial S. cerevisiae strains, S. eubayanus yeasts and interspecific hybrids. The resulting cis-genic POF- variants show great potential for industrial application and diversifying the current lager beer portfolio.	[Mertens, Stijn; Gallone, Brigida; Steensels, Jan; Herrera-Malaver, Beatriz; Cortebeek, Jeroen; Nolmans, Robbe; Saels, Veerle; Verstrepen, Kevin J.] Katholieke Univ Leuven, Lab Genet & Genom, CMPG, Leuven, Belgium; [Mertens, Stijn; Gallone, Brigida; Steensels, Jan; Herrera-Malaver, Beatriz; Cortebeek, Jeroen; Nolmans, Robbe; Saels, Veerle; Verstrepen, Kevin J.] VIB Ctr Microbiol, Lab Syst Biol, Bioincubator, Leuven, Belgium; [Mertens, Stijn; Gallone, Brigida; Steensels, Jan; Herrera-Malaver, Beatriz; Cortebeek, Jeroen; Nolmans, Robbe; Saels, Veerle; Verstrepen, Kevin J.] Katholieke Univ Leuven, Leuven Inst Beer Res, Bioincubator, Leuven, Belgium; [Gallone, Brigida] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Gallone, Brigida] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Vyas, Valmik K.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Verstrepen, KJ (corresponding author), Katholieke Univ Leuven, Lab Genet & Genom, CMPG, Leuven, Belgium.; Verstrepen, KJ (corresponding author), VIB Ctr Microbiol, Lab Syst Biol, Bioincubator, Leuven, Belgium.; Verstrepen, KJ (corresponding author), Katholieke Univ Leuven, Leuven Inst Beer Res, Bioincubator, Leuven, Belgium.	kevin.verstrepen@biw.vib-kuleuven.be	Gallone, Brigida/AAI-2454-2021; Verstrepen, Kevin/AAA-4343-2021	Gallone, Brigida/0000-0003-3045-5949; Vyas, Valmik/0000-0003-2849-3399; Verstrepen, Kevin/0000-0002-3077-6219; Saels, Veerle/0000-0001-9989-1605	Vlaams Instituut voor Biotechnologie (VIB); European Molecular Biology Organization Young Investigator Programme (EMBO YIP); InBev-Baillet Latour Fonds; FWO; VLAIO [131210]; European Research Council (ERC) [CoG682009]	Vlaams Instituut voor Biotechnologie (VIB); European Molecular Biology Organization Young Investigator Programme (EMBO YIP); InBev-Baillet Latour Fonds; FWO(FWO); VLAIO; European Research Council (ERC)(European Research Council (ERC))	Research in the laboratory of K.J.V. is supported by Vlaams Instituut voor Biotechnologie (VIB), European Molecular Biology Organization Young Investigator Programme (EMBO YIP), InBev-Baillet Latour Fonds, FWO, VLAIO (grant 131210 of S.M.) and a European Research Council (ERC) Consolidator Grant CoG682009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WG, 2016, FUNGAL GENET BIOL, V89, P10, DOI 10.1016/j.fgb.2015.11.002; Baker E, 2015, MOL BIOL EVOL, V32, P2818, DOI 10.1093/molbev/msv168; Bellon JR, 2011, APPL MICROBIOL BIOT, V91, P603, DOI 10.1007/s00253-011-3294-3; Bhuiya MW, 2015, APPL ENVIRON MICROB, V81, P4216, DOI 10.1128/AEM.00762-15; Borneman AR, 2012, FEMS YEAST RES, V12, P88, DOI 10.1111/j.1567-1364.2011.00773.x; Boynton PJ, 2014, YEAST, V31, P449, DOI 10.1002/yea.3040; Brachmann CB, 1998, YEAST, V14, P115; Colen L, 2016, J AGR ECON, V67, P186, DOI 10.1111/1477-9552.12128; de Vries ARG, 2018, BIORXIV; de Vries ARG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0835-1; Denby CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03293-x; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Diderich JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01640; Dujon BA, 2017, GENETICS, V206, P717, DOI 10.1534/genetics.116.199216; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Edenbrandt AK, 2018, FOOD QUAL PREFER, V69, P44, DOI 10.1016/j.foodqual.2018.04.007; Rodriguez ME, 2014, FEMS YEAST RES, V14, P948, DOI 10.1111/1567-1364.12183; Gallone B, 2016, CELL, V166, P1397, DOI 10.1016/j.cell.2016.08.020; Gibson B, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox038; Gibson B, 2015, YEAST, V32, P17, DOI 10.1002/yea.3033; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Hebly M, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov005; Hothorn T., 2013, MULTCOMP SIMULTANEOU; Ishii T, 2017, GM CROPS FOOD, V8, P44, DOI 10.1080/21645698.2016.1261787; Jakounas T, 2015, METAB ENG, V28, P213, DOI 10.1016/j.ymben.2015.01.008; Krogerus K, 2018, FRONT MICROBIOL, V9; Krogerus K, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0679-8; Krogerus K, 2015, J IND MICROBIOL BIOT, V42, P769, DOI 10.1007/s10295-015-1597-6; Le Jeune C, 2007, FEMS YEAST RES, V7, P540, DOI 10.1111/j.1567-1364.2007.00207.x; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Lopandic K, 2018, YEAST, V35, P21, DOI 10.1002/yea.3294; Maclean CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-1; Magalhaes F, 2017, J IND MICROBIOL BIOT, V44, P1203, DOI 10.1007/s10295-017-1947-7; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Mertens S, 2015, APPL ENV MICROBIOL, V81; Mertens S, 2017, J AM SOC BREW CHEM, V75, P318, DOI 10.1094/ASBCJ-2017-4142-01; Muir A, 2011, FEMS YEAST RES, V11, P552, DOI 10.1111/j.1567-1364.2011.00745.x; Mukai N, 2014, J BIOSCI BIOENG, V118, P50, DOI 10.1016/j.jbiosc.2013.12.017; Nikulin J, 2018, YEAST, V35, P113, DOI 10.1002/yea.3246; Arroyo-Lopez FN, 2009, INT J FOOD MICROBIOL, V131, P120, DOI 10.1016/j.ijfoodmicro.2009.01.035; Orozco P., 2018, ARGENTINA BRAZIL MER; Piotrowski JS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-46; Querol A, 2009, FEMS MICROBIOL LETT, V293, P1, DOI 10.1111/j.1574-6968.2008.01480.x; Rainieri S, 2003, J BIOSCI BIOENG, V96, P1; Sander JD, 2014, NATURE BIOTECHNOLOGY; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; SIKORSKI RS, 1989, GENETICS, V122, P19; Snoek T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0216-0; Steensels J, 2014, APPL ENVIRON MICROB, V80, P6965, DOI 10.1128/AEM.02235-14; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Steensels J, 2014, ANNU REV MICROBIOL, V68, P61, DOI 10.1146/annurev-micro-091213-113025; Stovicek V, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox030; Team R, 2013, R LANG ENV STAT COMP; Vanbeneden N, 2008, FOOD CHEM, V107, P221, DOI 10.1016/j.foodchem.2007.08.008; VIGENTINI I, 2017, FRONT MICROBIOL, V8, P87037; Vyas VK, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00154-18; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wickham H, 2008, VEGAN COMMUNITY ECOL, DOI [10.1093/bioinformatics/btp033, DOI 10.1093/BIOINFORMATICS/BTP033]	63	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209124	10.1371/journal.pone.0209124	http://dx.doi.org/10.1371/journal.pone.0209124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625138	gold, Green Published, Green Submitted			2022-12-26	WOS:000455359400027
J	Huang, YC; Li, SH; Lu, HI; Hsu, CC; Wang, YM; Lin, WC; Chen, CJ; Ho, KW; Chiu, NT				Huang, Yung-Cheng; Li, Shau-Hsuan; Lu, Hung-I; Hsu, Chien-Chin; Wang, Yu-Ming; Lin, Wei-Che; Chen, Chao-Jung; Ho, Kuo-Wei; Chiu, Nan-Tsing			Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ESOPHAGOGASTRIC JUNCTION CANCER; RESPONSE ASSESSMENT; CHEMORADIATION; SURGERY; SURVIVAL; THERAPY; (18)FDG-PET; RESECTION; ACCURACY	Objectives Post-chemoradiotherapy (CRT) FDG PET is a useful prognosticator of esophageal cancer. However, debate on the diverse criteria of previous publications preclude worldwide multi-center comparisons, and even a universal practice guide. We aimed to validate a simple qualitative interpretation criterion of post-CRT FDG PET for outcome stratification and compare it with other criteria. Methods The post-CRT FDG PET of 114 patients with esophageal squamous cell carcinoma (ESCC) were independently interpreted using a qualitative 4-point scale (Qual(4ps)) that identified focal esophageal FDG uptake greater than liver uptake as residual tumor. Cohen's K coefficient (K) was used to measure interobserver agreement of Qual(4ps). The Kaplan-Meier method and Cox proportional hazards regression analyses were used for survival analysis. Other criteria included a different qualitative approach (Qual(BK)), maximal standardized uptake values (SUVmax3.4, SUVmax2.5), relative change of SUVmax, between pre- and post-CRT FDG PET (Delta SUVmax), mean standardized uptake values (SUVmax) metabolic volume (MV) and total lesion glycolysis (TLG). Results Overall interobserver agreement on the Qual(4ps) criterion was excellent (K: 0.95). Except the Qual(BK), SUVmax2.5, and TLG, all the other criteria were significant predictors for overall survival (OS). Multivariable analysis showed only Qual(4ps) (HR: 15.41; P = 0.005) and AJCC stage (HR: 2.47; P = 0.007) were significant independent variables. The 2-year OS rates of Qual(4ps)(-) patients undergoing CRT alone (68.4%) and patients undergoing trimodality therapy (62.5%) were not significant different, but the 2-year OS rates of Qual(4ps)(+) patients undergoing CRT alone (10.0%) were significantly lower than in patients undergoing trimodality therapy (42.1%). Conclusions The Qual(4ps) criterion is reproducible for assessing the response of ESCC to CRT, and valuable for predicting survival. It may add value to response-adapted treatment for ESCC patients, and help to decide whether surgery is warranted after CRT.	[Huang, Yung-Cheng; Hsu, Chien-Chin] Kaohsiung Chang Gung Mem Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Huang, Yung-Cheng; Li, Shau-Hsuan; Hsu, Chien-Chin] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Li, Shau-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan; [Lu, Hung-I] Kaohsiung Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Kaohsiung, Taiwan; [Wang, Yu-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Lin, Wei-Che] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Chen, Chao-Jung] Yuans Gen Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Chen, Chao-Jung] Meiho Univ, Dept Hlth Business Adm, Pingtung, Taiwan; [Ho, Kuo-Wei] Chang Gung Mem Hosp, Dept Nucl Med, Chiayi, Taiwan; [Chiu, Nan-Tsing] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Nucl Med, Coll Med, Tainan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Chiu, NT (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Nucl Med, Coll Med, Tainan, Taiwan.	ntchiu@mail.ncku.edu.tw		Wang, Yu-Ming/0000-0002-2441-7551	Chang Gung Memorial Hospital in Kaohsiung [CMRPG8F0681]	Chang Gung Memorial Hospital in Kaohsiung	This study was supported by research grant [CMRPG8F0681] from the Chang Gung Memorial Hospital in Kaohsiung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam Mahmoud, 2010, Hematol Oncol Stem Cell Ther, V3, P179; Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; Blackstock AW, 2006, J GASTROINTEST CANC, V37, P7, DOI 10.1385/IJGC:37:1:7; Chang AC, 2008, ANN THORAC SURG, V85, P424, DOI 10.1016/j.athoracsur.2007.10.007; Connors RC, 2007, J AM COLL SURGEONS, V205, P735, DOI 10.1016/j.jamcollsurg.2007.07.001; Dimick JB, 2005, ANN THORAC SURG, V80, P282, DOI 10.1016/j.athoracsur.2005.01.044; Downey RJ, 2003, J CLIN ONCOL, V21, P428, DOI 10.1200/JCO.2003.04.013; Higuchi I, 2008, J THORAC CARDIOV SUR, V136, P205, DOI 10.1016/j.jtcvs.2008.02.016; Huang YC, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-016-0171-7; Ilson DH, 2012, CANCER-AM CANCER SOC, V118, P2820, DOI 10.1002/cncr.26591; Jeong Y, 2014, J SURG ONCOL, V109, P472, DOI 10.1002/jso.23514; Makino T, 2010, SURGERY, V148, P908, DOI 10.1016/j.surg.2010.02.016; Marcus C, 2014, J NUCL MED, V55, P1411, DOI 10.2967/jnumed.113.136796; Mariette C, 2007, LANCET ONCOL, V8, P545, DOI 10.1016/S1470-2045(07)70172-9; Monjazeb AM, 2010, J CLIN ONCOL, V28, P4714, DOI 10.1200/JCO.2010.30.7702; Murthy SB, 2010, ONCOLOGY-BASEL, V78, P316, DOI 10.1159/000319938; Patnana SV, 2010, CANCER-AM CANCER SOC, V116, P4487, DOI 10.1002/cncr.25431; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Scarsbrook A, 2017, EUR J NUCL MED MOL I, V44, P581, DOI 10.1007/s00259-016-3537-8; Schollaert P, 2014, J GASTROINTEST SURG, V18, P894, DOI 10.1007/s11605-014-2488-2; Sheikhbahaei S, 2016, J NUCL MED, V57, P855, DOI 10.2967/jnumed.115.165480; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Swisher SG, 2017, J THORAC ONCOL, V12, P368, DOI 10.1016/j.jtho.2016.10.002; Westerterp M, 2005, RADIOLOGY, V236, P841, DOI 10.1148/radiol.2363041042; Zhu W, 2012, BRIT J RADIOL, V85, pE694, DOI 10.1259/bjr/29946900	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210055	10.1371/journal.pone.0210055	http://dx.doi.org/10.1371/journal.pone.0210055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615636	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900036
J	Kobayashi, K; Ando, K; Seki, T; Hamada, T; Suzuki, K; Ishiguro, N; Hasegawa, Y; Imagama, S				Kobayashi, Kazuyoshi; Ando, Kei; Seki, Taisuke; Hamada, Takashi; Suzuki, Koji; Ishiguro, Naoki; Hasegawa, Yukiharu; Imagama, Shiro			Carotid artery plaque screening using abdominal aortic calcification on lumbar radiographs	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; ELDERLY-PEOPLE; WALL THICKNESS; STROKE; RISK; ATHEROSCLEROSIS; EVENTS; PROGRESSION; PREDICTOR	Aim Arteriosclerotic disease is increasing due to aging of the population, and is associated with diabetes, hypertension, hyperlipidemia, obesity, and smoking. This disease may result in fatal cerebrovascular disease, and especially cardiogenic cerebral embolism caused by artery plaque-based atherothrombotic cerebral infarction. The study was performed to examine the relationship of abdominal aortic calcification (AAC) on lumbar radiographs with carotid intima-media complex thickness (IMT), factors associated with carotid artery plaque, and cutoff values in middle-aged and elderly people. Patients and methods The subjects were 309 healthy volunteers (average age 63 years) who attended a health checkup supported by a local government in 2015. The AAC-24 score was determined on lumbar lateral standing radiographs and was categorized as 0 (54% of subjects),1-4 (31%), and >= 5 (severe, 15%). Carotid ultrasonography was used to evaluate IMT of the common carotid artery. Carotid artery plaque was defined as IMT >1.1 mm. Body mass index (BMI), hypertension, diabetes mellitus (DM), dyslipidemia, smoking, alcohol intake, and osteoporosis were examined. Results Of 309 cases, 142 (46%) had AAC and 104 (34%) had carotid artery plaque. Thus, 15% (n = 45) had severe AAC. Age, prevalence of DM and carotid artery plaque increased with severity of AAC. In patients with carotid artery plaque (n =104), age (67.8 7.5 vs. 61.0 +/- 10.1 years), % male (56% vs. 39%), BMI (22.9 +/- 2.8 vs. 23.7 +/- 3.5), AAC rate (58% vs. 40%) and AAC-24 score (3 (0, 8) vs. 0 (0, 2)) were all significantly higher than in those (n = 205) without carotid artery plaque. In multivariate analysis, age (OR 1.172), male gender (OR 1.654), AAC (OR 1.352), and AAC-24 >5 (OR 4.191) were significantly associated with carotid artery plaque. Combining AAC-24 with age significantly increased the AUC from 0.632 to 0.834 (p<0.05). Conclusion There was a significant relationship between AAC on lumbar radiographs and carotid IMT.	[Kobayashi, Kazuyoshi; Ando, Kei; Seki, Taisuke; Hamada, Takashi; Ishiguro, Naoki; Imagama, Shiro] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Suzuki, Koji] Fujita Hlth Univ, Sch Hlth Sci, Fac Med Technol, Toyoake, Aichi, Japan; [Hasegawa, Yukiharu] Kansai Univ Welf Sci, Dept Rehabil, Osaka, Japan	Nagoya University; Fujita Health University	Imagama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan.	imagama@med.nagoya-u.ac.jp		Suzuki, Koji/0000-0002-3235-9558				Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; del Sol AI, 2001, STROKE, V32, P1532, DOI 10.1161/01.STR.32.7.1532; Goncalves FB, 2012, HEART, V98, P988, DOI 10.1136/heartjnl-2011-301464; GROBBEE DE, 1994, J INTERN MED, V236, P567, DOI 10.1111/j.1365-2796.1994.tb00847.x; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; HANDA N, 1995, STROKE, V26, P1781, DOI 10.1161/01.STR.26.10.1781; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Imagama S, 2017, MOD RHEUMATOL, V27, P1051, DOI 10.1080/14397595.2017.1285856; Imagama S, 2014, EUR SPINE J, V23, P1414, DOI 10.1007/s00586-014-3251-9; Imagama S, 2013, EUR SPINE J, V22, P1346, DOI 10.1007/s00586-013-2721-9; Imagama S, 2012, EUR SPINE J, V21, P2149, DOI 10.1007/s00586-012-2207-1; Imagama S, 2011, SPINE, V36, P2293, DOI 10.1097/BRS.0b013e3182254a18; Imagama Shiro, 2011, Arch Osteoporos, V6, P13, DOI 10.1007/s11657-011-0052-1; Imagama S, 2011, EUR SPINE J, V20, P954, DOI 10.1007/s00586-010-1606-4; Japan Atherosclerosis Society, 2007, J Atheroscler Thromb, P5; Kauppila LI, 1997, SPINE, V22, P1642, DOI 10.1097/00007632-199707150-00023; MITCHELL JRA, 1977, ATHEROSCLEROSIS, V27, P437, DOI 10.1016/0021-9150(77)90162-9; Nakahara M, 2016, J SPINE RES, V7, P357; NAKATSUKA K, 1997, J BONE MINER METAB, V15, P218; Nezu T, 2016, J ATHEROSCLER THROMB, V23, P18, DOI 10.5551/jat.31989; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; PROBSTFIELD JL, 1995, AM J CARDIOL, V76, pC47, DOI 10.1016/S0002-9149(99)80470-6; SALONEN R, 1991, J INTERN MED, V229, P225, DOI 10.1111/j.1365-2796.1991.tb00336.x; Schousboe JT, 2008, J BONE MINER RES, V23, P409, DOI 10.1359/JBMR.071024; Sillesen H, 2017, EUR HEART J CARDIOVA; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Szulc P, 2015, BONE, V81, P16, DOI 10.1016/j.bone.2015.06.019; The Joint Committee of, 2006, NEUROSONOLOGY, V19, P49; Toyoda K, 2017, J STROKE CEREBROVASC, V26, P595, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.113; Wada S, 2017, J ATHEROSCLER THROMB, V2017; Watanabe H, 2003, ATHEROSCLEROSIS, V166, P67, DOI 10.1016/S0021-9150(02)00304-0; Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529; WITTEMAN JCM, 1993, CIRCULATION, V88, P2156, DOI 10.1161/01.CIR.88.5.2156	39	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209175	10.1371/journal.pone.0209175	http://dx.doi.org/10.1371/journal.pone.0209175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615654	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900017
J	Qu, Z; Wei, XM; Chen, SQ				Qu, Zhong; Wei, Xue-Ming; Chen, Si-Qi			An algorithm of image mosaic based on binary tree and eliminating distortion error	PLOS ONE			English	Article								The traditional image mosaic result based on SIFT feature points extraction, to some extent, has distortion errors: the larger the input image set, the greater the spliced panoramic distortion. To achieve the goal of creating a high-quality panorama, a new and improved algorithm based on the A-KAZE feature is proposed in this paper. This includes changing the way reference image are selected and putting forward a method for selecting a reference image based on the binary tree model, which takes the input image set as the leaf node set of a binary tree and uses the bottom-up approach to construct a complete binary tree. The root node image of the binary tree is the ultimate panorama obtained by stitching. Compared with the traditional way, the novel method improves the accuracy of feature points detection and enhances the stitching quality of the panorama. Additionally, the improved method proposes an automatic image straightening model to rectify the panorama, which further improves the panoramic distortion. The experimental results show that the proposed method cannot only enhance the efficiency of image stitching processing, but also reduce the panoramic distortion errors and obtain a better quality panoramic result.	[Qu, Zhong; Wei, Xue-Ming; Chen, Si-Qi] Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China; [Qu, Zhong] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China; [Qu, Zhong] Chongqing Engn Res Ctr Software Qual Assurance Te, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; Chongqing University of Posts & Telecommunications	Qu, Z (corresponding author), Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China.; Qu, Z (corresponding author), Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China.; Qu, Z (corresponding author), Chongqing Engn Res Ctr Software Qual Assurance Te, Chongqing, Peoples R China.	quzhong@cqupt.edu.cn		Qu, Zhong/0000-0001-7013-4854	Chongqing Basic and Frontier Research Project [cstc2015jcyjBX0090]	Chongqing Basic and Frontier Research Project	This work is supported by Chongqing Basic and Frontier Research Project under Grant No. cstc2015jcyjBX0090. The authors wish to thank the associate editors and anonymous reviewers for their valuable comments and suggestions on this article.	Alcantarilla PF, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.13; Alcantarilla PF, 2012, LECT NOTES COMPUT SC, V7577, P214, DOI 10.1007/978-3-642-33783-3_16; Alers H, 2015, J ELECTRON IMAGING, V24, DOI 10.1117/1.JEI.24.2.023030; [Anonymous], IEEE T MOB COMPUT; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Bonny Moushumi Zaman, 2017, INT WORKSH COMP INT, P198; Brown M, 2007, INT J COMPUT VISION, V74, P59, DOI 10.1007/s11263-006-0002-3; Chadha A, 2017, IEEE T MULTIMEDIA, V19, P1596, DOI 10.1109/TMM.2017.2673415; Chen YS, 2016, LECT NOTES COMPUT SC, V9909, P186, DOI 10.1007/978-3-319-46454-1_12; Guo YL, 2014, IEEE T MULTIMEDIA, V16, P1377, DOI 10.1109/TMM.2014.2316145; Huang CM, 2015, IEEE SENS J, V15, P5910, DOI 10.1109/JSEN.2015.2449879; Lee C, 2014, IEEE SIGNAL PROC LET, V21, P1045, DOI 10.1109/LSP.2014.2323404; Li N, 2018, IEEE T MULTIMEDIA, V20, P1365, DOI 10.1109/TMM.2017.2771566; Li ZQ, 2016, IEEE ROBOT AUTOM LET, V1, P295, DOI 10.1109/LRA.2016.2519946; Liu XB, 2017, NEUROCOMPUTING, V235, P131, DOI 10.1016/j.neucom.2017.01.006; Liu Y, 2015, J VIS COMMUN IMAGE R, V31, P208, DOI 10.1016/j.jvcir.2015.06.021; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma L, 2016, IEEE T MULTIMEDIA, V18, P2228, DOI 10.1109/TMM.2016.2614187; Prasanna P, 2016, IEEE T AUTOM SCI ENG, V13, P591, DOI 10.1109/TASE.2014.2354314; Qu Z, 2018, IET IMAGE PROCESS, V12, P1361, DOI 10.1049/iet-ipr.2017.1064; Qu Z, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/428076; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Shibata T, 2016, J ELECTRON IMAGING, V25, DOI 10.1117/1.JEI.25.1.013016; Song FH, 2013, ADV INTELL SYST, V181, P879; Tang Y, 2012, INT J DIGITAL CONTEN, V6, P17; Wang ZC, 2016, MULTIMED TOOLS APPL, V75, P2725, DOI [10.1007/s11042-015-2619-0, 10.1007/s11042-014-2135-7]; Yang K, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060581; Yang Y, 2017, IEEE T INSTRUM MEAS, V66, P691, DOI 10.1109/TIM.2017.2658098; Zaragoza J, 2014, IEEE T PATTERN ANAL, V36, P1285, DOI 10.1109/TPAMI.2013.247; Zhang BH, 2016, NEUROCOMPUTING, V174, P733, DOI 10.1016/j.neucom.2015.09.092; Zhang BK, 2015, ASIAPAC SIGN INFO PR, P459, DOI 10.1109/APSIPA.2015.7415313; Zhang Q, 2017, J ELECTRON IMAGING, V26, DOI 10.1117/1.JEI.26.1.010501; Zhao SM, 2017, NEUROCOMPUTING, V234, P174, DOI 10.1016/j.neucom.2016.12.055	33	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210354	10.1371/journal.pone.0210354	http://dx.doi.org/10.1371/journal.pone.0210354			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615680	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900067
J	Takashima, Y; Kawaguchi, A; Iwadate, Y; Hondoh, H; Fukai, J; Kajiwara, K; Hayano, A; Yamanaka, R				Takashima, Yasuo; Kawaguchi, Atsushi; Iwadate, Yasuo; Hondoh, Hiroaki; Fukai, Junya; Kajiwara, Koji; Hayano, Azusa; Yamanaka, Ryuya			MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma	PLOS ONE			English	Article							GENE-EXPRESSION; PRIMARY CNS; RNA INTERFERENCE; RISK SCORE; BIOMARKERS; SERUM	MicroRNAs (miRNAs) are small RNA molecules that inhibit gene function by suppressing translation of target genes. However, in primary central nervous system lymphoma (PCNSL), the biological significance of miRNAs is largely unknown, although some miRNAs are known to be prognosis markers. Here, we analyzed 847 miRNAs expressed in 27 PCNSL specimens using microarray profiling and surveyed miRNA signature for prognostic prediction. Of these, 16 miRNAs were expressed in 27 PCNSL specimens at a frequency of 48%. Their variable importance measured by Random forest model revealed miR-192, miR-486, miR-28, miR-52, miR-181b, miR-194, miR-197, miR-93, miR-708, and let-7g as having positive effects; miR-29b-2*, miR-126, and miR-182 as having negative effects; and miR-18a*, miR-425, and miR-30d as neutral. After principal component analysis, the prediction formula for prognosis, consisting of the expression values of the above-mentioned miRNAs, clearly divided Kaplan-Meier survival curves by the calculated Z-score (HR = 6.4566, P = 0.0067). The 16 miRNAs were enriched by gene ontology terms including angiogenesis, cell migration and proliferation, and apoptosis, in addition to signaling pathways including TGF-beta/SMAD, Notch, TNF, and MAPKinase. Their target genes included BCL2-related genes, HMGA2 oncogene, and LIN28B cancer stem cell marker. Furthermore, three miRNAs including miR-181b, miR-30d, and miR-93, selected from the 16 miRNAs, also showed comparable results for survival (HR = 8.9342, P = 0.0007), suggestive of a miRNA signature for prognostic prediction in PCNSL. These results indicate that this miRNA signature is useful for prognostic prediction in PCNSL and would help us understand target pathways for therapies in PCNSL.	[Takashima, Yasuo; Hayano, Azusa; Yamanaka, Ryuya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan; [Kawaguchi, Atsushi] Saga Univ, Ctr Comprehens Community Med, Fac Med, Saga, Japan; [Iwadate, Yasuo] Chiba Univ, Grad Sch Med Sci, Dept Neurosurg, Chiba, Japan; [Hondoh, Hiroaki] Toyama Prefectural Cent Hosp, Dept Neurosurg, Toyama, Japan; [Fukai, Junya] Wakayama Med Univ, Dept Neurol Surg, Sch Med, Wakayama, Japan; [Kajiwara, Koji] Yamaguchi Univ, Grad Sch Med Sci, Dept Neurosurg, Ube, Yamaguchi, Japan	Kyoto Prefectural University of Medicine; Saga University; Chiba University; Wakayama Medical University; Yamaguchi University	Yamanaka, R (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan.	ryaman@koto.kpu-m.ac.jp		Takashima, Yasuo/0000-0001-8876-6673; Yamanaka, Ryuya/0000-0003-2941-7996	MEXT KAKENHI [16H05441, 18K09001]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported the MEXT KAKENHI Grant Numbers 16H05441 and 18K09001. There was no additional external funding received for this study.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ahmadvand M, 2018, LEUKEMIA RES, V70, P45, DOI 10.1016/j.leukres.2018.05.006; Anfossi S, 2018, ADV EXP MED BIOL, V1056, P87, DOI 10.1007/978-3-319-74470-4_6; [Anonymous], 2016, PRIMARY CENTRAL NERV; Baraniskin A, 2018, J NEURO-ONCOL, V137, P463, DOI 10.1007/s11060-018-2749-0; Baraniskin A, 2012, J NEURO-ONCOL, V109, P239, DOI 10.1007/s11060-012-0908-2; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Fang C, 2012, ANN HEMATOL, V91, P553, DOI 10.1007/s00277-011-1350-9; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Giza DE, 2015, ADV EXP MED BIOL, V889, P23, DOI 10.1007/978-3-319-23730-5_2; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Iwadate Y, 2014, J NEURO-ONCOL, V117, P261, DOI 10.1007/s11060-014-1379-4; Jorgensen LK, 2015, DAN MED J, V62; Kanayama T, 2016, PRIMARY CENTRAL NERV, P81; Kawaguchi A, 2016, PRIMARY CENTRAL NERV, P67; Kawaguchi A, 2013, CANCER SCI, V104, P1205, DOI 10.1111/cas.12214; Kawaguchi A, 2012, CLIN CANCER RES, V18, P5672, DOI 10.1158/1078-0432.CCR-12-0596; Khare D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187722; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leivonen SK, 2017, BLOOD CANCER J, V7, DOI 10.1038/s41408-017-0033-8; Lim EL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0568-y; Lopez-Santillan Maria, 2018, Oncotarget, V9, P22850, DOI 10.18632/oncotarget.25230; Louis, 2016, WHO CLASSIFICATION G; Meng YY, 2018, GENE, V642, P205, DOI 10.1016/j.gene.2017.11.022; Montesinos-Rongen M, 2008, LEUKEMIA, V22, P400, DOI 10.1038/sj.leu.2405019; Moss EG, 2001, CURR BIOL, V11, pR772, DOI 10.1016/S0960-9822(01)00467-5; Pillar N, 2017, ONCOTARGET, V8, P86020, DOI 10.18632/oncotarget.20902; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Roth P, 2015, EUR J CANCER, V51, P382, DOI 10.1016/j.ejca.2014.10.028; Royer-Perron L, 2017, CURR OPIN NEUROL, V30, P669, DOI 10.1097/WCO.0000000000000492; Rubenstein JL, 2006, BLOOD, V107, P3716, DOI 10.1182/blood-2005-03-0897; Shalaby T, 2015, INT J MOL SCI, V16, P29103, DOI 10.3390/ijms161226150; Sugita Y, 2016, PRIMARY CENTRAL NERV, P9; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Takashima Yasuo, 2018, Oncotarget, V9, P27471, DOI 10.18632/oncotarget.25463; Takashima Yasuo, 2018, Oncotarget, V9, P19065, DOI 10.18632/oncotarget.24897; Takashima Y, 2016, HEPATOLOGY, V64, P245, DOI 10.1002/hep.28548; Thyagarajan A, 2018, J PHARMACOL EXP THER, V364, P1, DOI 10.1124/jpet.117.242636; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; Ultimo S, 2018, J CELL PHYSIOL, V233, P5642, DOI 10.1002/jcp.26290; Wei D, 2015, MOL NEUROBIOL, V51, P1452, DOI 10.1007/s12035-014-8822-6; Weiss B, 1999, CELL MOL LIFE SCI, V55, P334, DOI 10.1007/s000180050296; Zheng B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00936	45	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210400	10.1371/journal.pone.0210400	http://dx.doi.org/10.1371/journal.pone.0210400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615673	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900073
J	Banerjee, D; Raghunathan, A				Banerjee, Deepanwita; Raghunathan, Anu			Constraints-based analysis identifies NAD(+) recycling through metabolic reprogramming in antibiotic resistant Chromobacterium violaceum	PLOS ONE			English	Article							SP NOV.; EVOLUTION; BACTERIAL; MODELS	In the post genomic era, high throughput data augment stoichiometric flux balance models to compute accurate metabolic flux states, growth and energy phenotypes. Investigating altered metabolism in the context of evolved resistant genotypes potentially provide simple strategies to overcome drug resistance and induce susceptibility to existing antibiotics. A genome-scale metabolic model (GSMM) for Chromobacterium violaceum, an opportunistic human pathogen, was reconstructed using legacy data. Experimental constraints were used to represent antibiotic susceptible and resistant populations. Model predictions were validated using growth and respiration data successfully. Differential flux distribution and metabolic reprogramming were identified as a response to antibiotics, chloramphenicol and streptomycin. Streptomycin resistant populations (StrpR) redirected tricarboxylic acid (TCA) cycle flux through the glyoxylate shunt. Chloramphenicol resistant populations (ChlR) resorted to overflow metabolism producing acetate and formate. This switch to fermentative metabolism is potentially through excess reducing equivalents and increased NADH/NAD ratios. Reduced proton gradients and changed Proton Motive Force (PMF) induced by antibiotics were also predicted and verified experimentally using flow cytometry based membrane potential measurements. Pareto analysis of NADH and ATP maintenance showed the decoupling of electron transfer and ATP synthesis in StrpR. Redox homeostasis and NAD(+) cycling through rewiring metabolic flux was implicated in re-sensitizing antibiotic resistant C. violaceum. These approaches can be used to probe metabolic vulnerabilities of resistant pathogens. On the verge of a post-antibiotic era, we foresee a critical need for systems level understanding of pathogens and host interaction to extend shelf life of antibiotics and strategize novel therapies.	[Banerjee, Deepanwita; Raghunathan, Anu] CSIR, Natl Chem Lab, Chem Engn Div, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Raghunathan, A (corresponding author), CSIR, Natl Chem Lab, Chem Engn Div, Pune, Maharashtra, India.	anu.raghunathan@ncl.res.in	Banerjee, Deepanwita/AAD-5528-2021	Banerjee, Deepanwita/0000-0002-0083-0608; Raghunathan, Anu/0000-0002-7063-9606	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [GAP302126]; Department of Science and Technology (DST), Ministry of Science and Technology, Government of India [GAP292826]; INSPIRE fellowship, Department of Science and Technology (DST), Ministry of Science and Technology, Government of India [DST/INSPIRE fellowship/2011/[229], IF110498]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Department of Science and Technology (DST), Ministry of Science and Technology, Government of India; INSPIRE fellowship, Department of Science and Technology (DST), Ministry of Science and Technology, Government of India	This work was supported by AR: GAP302126, Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; AR: GAP292826, Department of Science and Technology (DST), Ministry of Science and Technology, Government of India. DB: INSPIRE fellowship, Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, Sanction No. DST/INSPIRE fellowship/2011/[229] and Reg. No. IF110498.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Banerjee D, 2018, CURR SCI, P114; Banerjee D, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0427-z; Batista JH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02213; Carey MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3905-1; Creczynski-Pasa Tania B, 2004, Genet Mol Res, V3, P162; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; DEMOSS RD, 1959, J BACTERIOL, V77, P137, DOI 10.1128/JB.77.2.137-141.1959; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Dunphy LJ, 2018, CURR OPIN BIOTECH, V51, P70, DOI 10.1016/j.copbio.2017.11.014; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Ebrahim A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156157; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Iscla I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5891; Lima-Bittencourt CI, 2011, ANTON LEEUW INT J G, V99, P355, DOI 10.1007/s10482-010-9501-x; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Martin PAW, 2007, INT J SYST EVOL MICR, V57, P993, DOI 10.1099/ijs.0.64611-0; Martinez JL, 2011, FEMS MICROBIOL REV, V35, P768, DOI 10.1111/j.1574-6976.2011.00282.x; Mehi O, 2014, MOL BIOL EVOL, V31, P2793, DOI 10.1093/molbev/msu223; MILLER DP, 1988, CAN J MICROBIOL, V34, P249, DOI 10.1139/m88-046; Paez P. L., 2013, BIOMED RES INT, V2013, P1, DOI DOI 10.1155/2013/276524; Pant ND, 2015, CASE REP MED, V2015, DOI 10.1155/2015/652036; Peng B, 2015, CELL METAB, V21, P249, DOI 10.1016/j.cmet.2015.01.008; Raghunathan A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-118; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Su YB, 2018, P NATL ACAD SCI USA, V115, pE1578, DOI 10.1073/pnas.1714645115; Su YB, 2015, J PROTEOME RES, V14, P1612, DOI 10.1021/pr501285f; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013; Yen Dunphy LJ, 2018, NETWORK ANAL REVEALS, P1, DOI [10.1101/303289, DOI 10.1101/303289]; Young CC, 2008, INT J SYST EVOL MICR, V58, P877, DOI 10.1099/ijs.0.65573-0; Zampieri M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167028	39	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210008	10.1371/journal.pone.0210008	http://dx.doi.org/10.1371/journal.pone.0210008			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608971	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800038
J	Dankai, W; Khunamornpong, S; Siriaunkgul, S; Soongkhaw, A; Janpanao, A; Utaipat, U; Kitkumthorn, N; Mutirangura, A; Srisomboon, J; Lekawanvijit, S				Dankai, Wiyada; Khunamornpong, Surapan; Siriaunkgul, Sumalee; Soongkhaw, Aungsumalee; Janpanao, Arphawan; Utaipat, Utaiwan; Kitkumthorn, Nakarin; Mutirangura, Apiwat; Srisomboon, Jatupol; Lekawanvijit, Suree			Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; CERVICAL (PRE)CANCER; PROMOTER METHYLATION; SELF-SAMPLES; SCRAPES; CADM1; CANCERS; LESIONS; TRIAGE; TSLC1	Cervical cancer is the fourth most common malignancy affecting women worldwide. The development of disease is related to high-risk human papillomavirus (hrHPV) infection. Cytology has been the most recommended triage for primary cervical (pre)cancer screening despite relatively low sensitivity. Recently, genomic DNA methylation has been proposed as an additional marker to increase sensitivity for detecting cervical precancerous lesion. This study aimed to evaluate the performance of methylation status of three tumor suppressor genes (CADM1, FAM19A4, and MAL) and HPV genotyping in detection of cytologic and histologic abnormalities in cervical cancer screening. Two hundred and sixty samples with available frozen cell pellets including 70 randomly selected cases of negative for intraepithelial lesion or malignancy (NILM)&HPV-negative, 70 randomly selected cases of NILM&HPV-positive, and 120 cytologic abnormalities & HPV-positive from a population-based cervical cancer screening program (n = 7,604) were investigated for the DNA methylation pattern of CADM1, FAM19A4, and MAL. Of 120 cytologic abnormalities & HPV-positive cases, there were 115 available histologic results. HPV52 and HPV58 were most commonly found in histologic HSIL+. The methylation levels of CADM1, FAM19A4, and MAL were elevated with the severity of cytologic abnormality which significantly increased by 3.37, 6.65 and 2 folds, respectively, in cytologic HSIL comparing with NILM. A significant increase in methylation levels of these three genes was also observed in histologic HSIL+ compared with negative histology but only CADM1 showed a significant higher methylation level than histologic LSIL. Using the ROC curve analysis, DNA methylation levels of FAM19A4 performed best in differentiating high-grade cytology (ASC-H+ from NILM/ASC-US/LSIL), followed by CADM1 and MAL. Whilst the CADM1 methylation performed best in distinguishing histologic HSIL+ from negative/LSIL with an area under the ROC curve of 0.684, followed by MAL (0.663) and FAM19A4 (0.642). Interestingly, after combining high DNA methylation levels to HPV16/18 genotypes, rates of histologic HSIL+ detection were substantially increased from 25% to 79.55% for CADM1, 77.27% for FAM19A4, and 72.73% for MAL, respectively. The rate further increased up to 95.45% when at least one of three genes had a high methylation level. This suggests a possible role of genomic DNA methylation, especially CADM1, in detecting histologic HSIL+ lesions in combination with hrHPV testing.	[Dankai, Wiyada; Khunamornpong, Surapan; Siriaunkgul, Sumalee; Soongkhaw, Aungsumalee; Janpanao, Arphawan; Srisomboon, Jatupol; Lekawanvijit, Suree] Chiang Mai Univ, Gynecol Canc Res Cluster, Fac Med, Chiang Mai, Thailand; [Dankai, Wiyada; Khunamornpong, Surapan; Siriaunkgul, Sumalee; Lekawanvijit, Suree] Chiang Mai Univ, Dept Pathol, Fac Med, Chiang Mai, Thailand; [Utaipat, Utaiwan] Chiang Mai Univ, Res Inst Hlth Sci RIHES, Chiang Mai, Thailand; [Kitkumthorn, Nakarin] Mahidol Univ, Dept Oral Biol, Fac Dent, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Fac Med, Bangkok, Thailand; [Srisomboon, Jatupol] Chiang Mai Univ, Dept Gynecol, Fac Med, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Mahidol University; Chulalongkorn University; Chiang Mai University	Lekawanvijit, S (corresponding author), Chiang Mai Univ, Gynecol Canc Res Cluster, Fac Med, Chiang Mai, Thailand.; Lekawanvijit, S (corresponding author), Chiang Mai Univ, Dept Pathol, Fac Med, Chiang Mai, Thailand.	slekawan@hotmail.com			Faculty of Medicine, Chiang Mai University [071/2560]; Center of Excellence, Chiang Mai University; National Science and Technology Development Agency (NSTDA), Thailand [P-15-50169]	Faculty of Medicine, Chiang Mai University; Center of Excellence, Chiang Mai University; National Science and Technology Development Agency (NSTDA), Thailand	This work was supported by the Faculty of Medicine, Chiang Mai University (Grant no 071/2560) to WD, Center of Excellence, Chiang Mai University to WD, and National Science and Technology Development Agency (NSTDA), Thailand (Grant no P-15-50169) to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorastos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119755; Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bhat S, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694573; Bierkens M, 2013, INT J CANCER, V133, P1293, DOI 10.1002/ijc.28138; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Clarke MA, 2017, INT J CANCER, V141, P701, DOI 10.1002/ijc.30781; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; De Strooper LMA, 2016, GYNECOL ONCOL, V141, P341, DOI 10.1016/j.ygyno.2016.02.012; De Strooper LMA, 2014, CANCER PREV RES, V7, P1251, DOI 10.1158/1940-6207.CAPR-14-0237; De Strooper LMA, 2014, CANCER EPIDEM BIOMAR, V23, P1933, DOI 10.1158/1055-9965.EPI-14-0347; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gustafson KS, 2004, CANCER CYTOPATHOL, V102, P259, DOI 10.1002/cncr.20425; Hesselink AT, 2011, CLIN CANCER RES, V17, P2459, DOI 10.1158/1078-0432.CCR-10-2548; Huang SX, 1997, INT J CANCER, V70, P408, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;408::AID-IJC6&gt;3.0.CO;2-#; Hwang T, 1999, J KOREAN MED SCI, V14, P593, DOI 10.3346/jkms.1999.14.6.593; Khunamornpong S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158184; Ki EY, 2016, INT J GYNECOL CANCER, V26, P176, DOI 10.1097/IGC.0000000000000582; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lorincz AT, 2016, ACTA CYTOL, V60, P501, DOI 10.1159/000450595; Luttmer R, 2016, BRIT J CANCER, V115, P579, DOI 10.1038/bjc.2016.200; Luttmer R, 2016, INT J CANCER, V138, P992, DOI 10.1002/ijc.29824; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Overmeer RM, 2008, J PATHOL, V215, P388, DOI 10.1002/path.2367; Overmeer RM, 2011, INT J CANCER, V129, P2218, DOI 10.1002/ijc.25890; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Shen-Gunther J, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0263-9; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Steenbergen RDM, 2004, JNCI-J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031; Steenbergen RDM, 2013, J PATHOL, V231, P53, DOI 10.1002/path.4210; Takehara Kazuhiro, 2011, Patholog Res Int, V2011, P246936, DOI 10.4061/2011/246936; Woo HJ, 2015, INT J ONCOL, V46, P2656, DOI 10.3892/ijo.2015.2945; Zeng ZY, 2016, J CANCER, V7, P1037, DOI 10.7150/jca.14971; Zhang LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180618	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210289	10.1371/journal.pone.0210289	http://dx.doi.org/10.1371/journal.pone.0210289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608989	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800058
J	Tang, H; Jiang, LX; Zhu, CL; Liu, R; Wu, YF; Yan, Q; Liu, M; Jia, YX; Chen, J; Qin, YR; Lee, VHF; Luo, SX; Wang, QM; Guan, XY				Tang, Hong; Jiang, Lingxi; Zhu, Cailei; Liu, Raymond; Wu, Yufeng; Yan, Qian; Liu, Ming; Jia, Yongxu; Chen, Juan; Qin, Yanru; Lee, Victor Ho-Fun; Luo, Suxia; Wang, Qiming; Guan, Xin-Yuan			Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinomay	ONCOGENE			English	Article							CHROMOSOME 3P; GENETIC ALTERATIONS; HIGH-FREQUENCY; BETA-CATENIN; CANCER; SUPPRESSOR; LUNG; NEUROPILIN-1; METHYLATION; ABERRATIONS	Esophageal squamous cells carcinoma (ESCC) is a major common thoracic tumor characterized by distinctly high incidences and mortality rates. Despite advances in multimodality therapy, the mortality rate of ESCC remains high and understanding of molecular alterations leading to the development and progression of ESCC is still very limited. In this study, a new tumor suppressor candidate, cell adhesion molecule with homology to L1CAM (CHL1), located at 3p26 which was frequently deleted in ESCC was identified. Reduced expression of CHL1 correlated with poor differentiation, increased invasion, and lymph-node metastasis, advanced tumor stage, and decreased overall survival. Methylation-specific PCR and FISH assays revealed that down-regulation of CHL1 in both ESCC cell lines and clinical samples were associated with promoter hypermethylation and loss of heterozygosity. Functional studies using lentiviral-based overexpression and knockdown systems provided direct support of CHL1 to function as an important tumor suppressor with both anti-proliferation and anti-metastasis abilities, through Merlin and SEMA3B-Np1-mediated inhibition of AKT signaling pathway. Further characterization of CHL1 may provide a novel therapeutic target in ESCC treatment.	[Tang, Hong; Wu, Yufeng; Luo, Suxia; Wang, Qiming] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Internal Med, Zhengzhou, Henan, Peoples R China; [Tang, Hong; Jiang, Lingxi; Zhu, Cailei; Liu, Raymond; Yan, Qian; Chen, Juan; Lee, Victor Ho-Fun; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Jiang, Lingxi] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Key Lab Gastr Neoplasms, Shanghai, Peoples R China; [Liu, Ming] Guangzhou Med Univ, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou, Guangdong, Peoples R China; [Jia, Yongxu; Qin, Yanru] Zhengzhou Univ, Dept Clin Oncol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China	Zhengzhou University; University of Hong Kong; Shanghai Jiao Tong University; Guangzhou Medical University; Zhengzhou University	Luo, SX; Wang, QM (corresponding author), Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Internal Med, Zhengzhou, Henan, Peoples R China.; Guan, XY (corresponding author), Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Peoples R China.	luosxrm@163.com; qimingwang1006@126.com; xyguan@hku.hk	; /A-3639-2009	Lee, Victor/0000-0002-6283-978X; /0000-0003-1874-9805; LIU, MING/0000-0003-3222-8715; Wu, Yufeng/0000-0003-0510-0388	National Key R&D Program of China [2017YFC1309000]; Shenzhen Peacock Team Project [KQTD2015033117210153]; National Natural Science Foundation of China [81472250, 81602061, 81772554]; Hong Kong Research Grant Council [HKU/7668/11 M, 767313, C7038-14G, C7027-14G]; Health and Medical Research Fund [04150826]; Natural Science Foundation of Henan Province [182300410376, 182300410297, 162300410300]	National Key R&D Program of China; Shenzhen Peacock Team Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); Health and Medical Research Fund; Natural Science Foundation of Henan Province	This work was supported by grants from National Key R&D Program of China (2017YFC1309000), Shenzhen Peacock Team Project (KQTD2015033117210153), National Natural Science Foundation of China (81472250, 81602061, and 81772554), the Hong Kong Research Grant Council grants including GRF (HKU/7668/11 M and 767313), CRF (C7038-14G and C7027-14G), Health and Medical Research Fund (04150826), and Natural Science Foundation of Henan Province (182300410376, 182300410297, and 162300410300). Professor XY Guan is Sophie YM Chan Professor in cancer research.	Ackermann S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-840; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan ASC, 2000, CANCER RES, V60, P5365; Chen J, 2012, CHIN J CANCER, V31, P215, DOI 10.5732/cjc.011.10364; DALBAGNI G, 1993, LANCET, V342, P469, DOI 10.1016/0140-6736(93)91595-D; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guan XY, 2001, CANCER RES, V61, P3806; Knosel T, 2005, CLIN EXP METASTAS, V22, P533, DOI 10.1007/s10585-005-5239-7; Kou CH, 2015, BIOCHEM BIOPH RES CO, V464, P519, DOI 10.1016/j.bbrc.2015.06.173; Kwong D, 2004, HUM PATHOL, V35, P309, DOI 10.1016/j.humpath.2003.10.020; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Loginov VI, 2009, MOL BIOL+, V43, P1014, DOI 10.1134/S0026893309060156; Ming XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13568; Miyoshi Y, 1998, CANCER RES, V58, P2524; OGASAWARA S, 1995, CANCER RES, V55, P891; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Ognibene Marzia, 2018, Oncotarget, V9, P25903, DOI 10.18632/oncotarget.25403; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Portale G, 2006, J AM COLL SURGEONS, V202, P588, DOI 10.1016/j.jamcollsurg.2005.12.022; PRESTI JC, 1991, CANCER RES, V51, P5405; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Raju SC, 2015, ORAL ONCOL, V51, P470, DOI 10.1016/j.oraloncology.2015.01.014; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Uchida K, 2011, ONCOL REP, V26, P463, DOI 10.3892/or.2011.1327; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Xie D, 2003, INT J CANCER, V107, P896, DOI 10.1002/ijc.11514; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yen CC, 2007, LUNG CANCER, V57, P292, DOI 10.1016/j.lungcan.2007.04.007; Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076; Zhu C, 2009, ONCOGENE, V28, P2821, DOI 10.1038/onc.2009.137; 2001, CANCER, V92, P2769; 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516	41	17	18	4	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3119	3133		10.1038/s41388-018-0648-7	http://dx.doi.org/10.1038/s41388-018-0648-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30622339				2022-12-26	WOS:000465557200002
J	Kolliopoulos, C; Raja, E; Razmara, M; Heldin, P; Heldin, CH; Moustakas, A; van der Heide, LP				Kolliopoulos, Constantinos; Raja, Erna; Razmara, Masoud; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis; van der Heide, Lars P.			Transforming growth factor (TGF) induces NUAK kinase expression to fine-tune its signaling output	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); cell cycle; epithelial-mesenchymal transition (EMT); myofibroblast; SMAD transcription factor; signal transduction; transforming growth factor beta (TGF-beta); cell signaling; NUAK family kinase	FACTOR-BETA; NEGATIVE REGULATION; PROTEIN; SNARK; DIFFERENTIATION; IDENTIFICATION; COMPLEX; CELLS; ARK5; LKB1	TGF signaling via SMAD proteins and protein kinase pathways up- or down-regulates the expression of many genes and thus affects physiological processes, such as differentiation, migration, cell cycle arrest, and apoptosis, during developmental or adult tissue homeostasis. We here report that NUAK family kinase 1 (NUAK1) and NUAK2 are two TGF target genes. NUAK1/2 belong to the AMP-activated protein kinase (AMPK) family, whose members control central and protein metabolism, polarity, and overall cellular homeostasis. We found that TGF-mediated transcriptional induction of NUAK1 and NUAK2 requires SMAD family members 2, 3, and 4 (SMAD2/3/4) and mitogen-activated protein kinase (MAPK) activities, which provided immediate and early signals for the transient expression of these two kinases. Genomic mapping identified an enhancer element within the first intron of the NUAK2 gene that can recruit SMAD proteins, which, when cloned, could confer induction by TGF. Furthermore, NUAK2 formed protein complexes with SMAD3 and the TGF type I receptor. Functionally, NUAK1 suppressed and NUAK2 induced TGF signaling. This was evident during TGF-induced epithelial cytostasis, mesenchymal differentiation, and myofibroblast contractility, in which NUAK1 or NUAK2 silencing enhanced or inhibited these responses, respectively. In conclusion, we have identified a bifurcating loop during TGF signaling, whereby transcriptional induction of NUAK1 serves as a negative checkpoint and NUAK2 induction positively contributes to signaling and terminal differentiation responses to TGF activity.	[Kolliopoulos, Constantinos; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, S-75123 Uppsala, Sweden; [Kolliopoulos, Constantinos; Raja, Erna; Razmara, Masoud; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis; van der Heide, Lars P.] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, Biomed Ctr, Box 595, S-75124 Uppsala, Sweden; [Razmara, Masoud] Uppsala Univ, Dept Med Sci, Rudbeck Lab, S-75185 Uppsala, Sweden	Uppsala University; Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, S-75123 Uppsala, Sweden.; van der Heide, LP (corresponding author), Univ Amsterdam, Swammardam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	aris.moustakas@imbim.uu.se; L.P.vanderHeide@uva.nl		van der Heide, Lars P./0000-0003-1779-425X; KOLLIOPOULOS, KONSTANTINOS/0000-0001-9564-2900	Ludwig Cancer Research Ltd.; Swedish Research Council [K2010-67X-14936-07-3, K2013-66X-14936-10-5, 2015-02757]; Swedish Cancer Society [CAN 2009/900, CAN 2012/438, CAN 2015/438, CAN 2016/435]; Wenner-Gren Society, Sweden; Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program [MRTN-2005-005428]	Ludwig Cancer Research Ltd.; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Society, Sweden; Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program	This work was supported by Ludwig Cancer Research Ltd.; Swedish Research Council Grants K2010-67X-14936-07-3, K2013-66X-14936-10-5, and 2015-02757; and Swedish Cancer Society Grants CAN 2009/900, CAN 2012/438, CAN 2015/438, and CAN 2016/435. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Wenner-Gren Society, Sweden.; Supported by the Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program (Project MRTN-2005-005428).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Banerjee S, 2014, BIOCHEM J, V461, P233, DOI 10.1042/BJ20140408; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Chang XZ, 2012, J CANCER RES CLIN, V138, P247, DOI 10.1007/s00432-011-1102-1; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Goto K, 2013, J HEPATOL, V59, P942, DOI 10.1016/j.jhep.2013.06.025; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inazuka F, 2012, J BIOL CHEM, V287, P16379, DOI 10.1074/jbc.M111.302687; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kuga W, 2008, BIOCHEM BIOPH RES CO, V377, P1062, DOI 10.1016/j.bbrc.2008.10.143; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; Landesman Y, 1997, CELL SIGNAL, V9, P291, DOI 10.1016/S0898-6568(97)89890-7; Lasagna-Reeves CA, 2016, NEURON, V92, P407, DOI 10.1016/j.neuron.2016.09.022; Lefebvre DL, 2005, BBA-GEN SUBJECTS, V1724, P71, DOI 10.1016/j.bbagen.2005.03.015; Legembre P, 2004, J BIOL CHEM, V279, P46742, DOI 10.1074/jbc.M404334200; Lessard SJ, 2016, J CLIN INVEST, V126, P560, DOI 10.1172/JCI79197; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lonn P, 2012, J BIOL CHEM, V287, P12867, DOI 10.1074/jbc.M111.307249; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moren A, 2011, J BIOL CHEM, V286, P341, DOI 10.1074/jbc.M110.190660; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Namiki T, 2015, CANCER RES, V75, P2708, DOI 10.1158/0008-5472.CAN-13-3209; Namiki T, 2011, P NATL ACAD SCI USA, V108, P6597, DOI 10.1073/pnas.1007694108; Ohmura T, 2012, DEV DYNAM, V241, P1350, DOI 10.1002/dvdy.23816; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; ROSEN CF, 1995, AM J PHYSIOL-CELL PH, V268, pC846, DOI 10.1152/ajpcell.1995.268.4.C846; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Vallenius T, 2011, J CELL SCI, V124, P384, DOI 10.1242/jcs.072660; van der Heide LP, 2011, J BIOL CHEM, V286, P5003, DOI 10.1074/jbc.M110.167379; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	44	14	15	5	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4119	4136		10.1074/jbc.RA118.004984	http://dx.doi.org/10.1074/jbc.RA118.004984			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30622137	Green Published, hybrid			2022-12-26	WOS:000461854400024
J	Suvarna, K; Honda, K; Muroi, M; Kondoh, Y; Osada, H; Watanabe, N				Suvarna, Kruthi; Honda, Kaori; Muroi, Makoto; Kondoh, Yasumitsu; Osada, Hiroyuki; Watanabe, Nobumoto			A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; small molecule; cancer; tumor metastasis; chemical biology; tumor microenvironment; extracellular matrix; cancer-associated fibroblast (CAF); p97; valosin-containing protein (VCP)	COLORECTAL-CANCER; VCP; IDENTIFICATION; METASTASIS; ACTIVATION; STRESS; DRIVES; STROMA; UBXD1	Carcinoma-associated fibroblasts are fibroblasts activated by surrounding cancer cells. Carcinoma-associated fibroblasts exhibit enhanced cell migration, which plays an important role in cancer metastasis. Previously, we demonstrated enhanced migration of NIH3T3 fibroblasts when they were cultured in the presence of MCF7 breast cancer cells. Human fibroblasts displayed a similar phenomenon even when they were co-cultured with cancer cells other than MCF7 cells. In this study, we screened approximate to 16,000 compounds from the RIKEN Natural Products Depository chemical library for inhibitors of enhanced NIH3T3 cell migration in the presence of MCF7. We identified NPD8733 as an inhibitor of cancer cell-enhanced fibroblast migration. This inhibition was observed not only in a wound-healing co-culture assay but also in a Transwell migration assay. Using NPD8733 and a structurally similar but inactive derivative, NPD8126, on immobilized beads, we found that NPD8733, but not NPD8126, specifically binds to valosin-containing protein (VCP)/p97, a member of the ATPase-associated with diverse cellular activities (AAA+) protein family. Using VCP truncation variants, we found that NPD8733 binds to the D1 domain of VCP. Because VCP's D1 domain is important for its function, we concluded that NPD8733 may act on VCP by binding to this domain. siRNA-mediated silencing of VCP in NIH3T3 fibroblasts, but not in MCF7 cells, reduced the migration of the co-cultured NIH3T3 fibroblasts. These results indicate that MCF7 activates the migration of NIH3T3 cells through VCP and that NPD8733 binds VCP and thereby inhibits its activity.	[Suvarna, Kruthi; Honda, Kaori; Watanabe, Nobumoto] RIKEN, Ctr Sustainable Resource Sci, Bioact Cpds Discovery Res Unit, Saitama 3510198, Japan; [Honda, Kaori; Muroi, Makoto; Kondoh, Yasumitsu; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama 3510198, Japan; [Osada, Hiroyuki; Watanabe, Nobumoto] RIKEN, Ctr Sustainable Resource Sci, RIKEN Max Planck Joint Res Div, Saitama 3510198, Japan; [Suvarna, Kruthi; Watanabe, Nobumoto] Tokyo Med Dent Univ, Tokyo 1138510, Japan	RIKEN; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU)	Watanabe, N (corresponding author), RIKEN, Ctr Sustainable Resource Sci, RIKEN Max Planck Joint Res Div, Bioprobe Applicat Res Unit, Wako, Saitama 3510198, Japan.	nwatanab@riken.jp	Suvarna, Kruthi Sharanjeet/HHC-2905-2022; Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Watanabe, Nobumoto/N-6959-2015	Watanabe, Nobumoto/0000-0002-2130-1334; Suvarna, Kruthi/0000-0002-4778-0986; MUROI, Makoto/0000-0002-4323-9527	JSPS KAKENHI [JP16H06276, JP17H06412, JP18H03945, JP17K07783]; NARO Bio-oriented Technology Research Advancement Institution; RIKEN International Program Associate; AMED [JP18cm0106112]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NARO Bio-oriented Technology Research Advancement Institution; RIKEN International Program Associate; AMED	This work was supported in part by JSPS KAKENHI Grants JP16H06276, JP17H06412, JP18H03945, and JP17K07783; AMEDGrant JP18cm0106112, and the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the RIKEN International Program Associate.	Amornsupak K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-955; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Buchsbaum RJ, 2016, CANCERS, V8, DOI 10.3390/cancers8020019; Chapman E, 2015, MOLECULES, V20, P4357, DOI 10.3390/molecules20034357; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Cirri P, 2011, AM J CANCER RES, V1, P482; Truong D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34094; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Fu QF, 2016, MOL CELL BIOCHEM, V418, P189, DOI 10.1007/s11010-016-2746-6; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lundgren K, 2011, J MOL DIAGN, V13, P340, DOI 10.1016/j.jmoldx.2011.01.009; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Sasazawa Y, 2012, ACS CHEM BIOL, V7, P892, DOI 10.1021/cb200492h; Shiga K, 2015, CANCERS, V7, P2443, DOI 10.3390/cancers7040902; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Suvarna K, 2018, CANCER MED-US, V7, P883, DOI 10.1002/cam4.1339; Tashimo Hiroyuki, 2007, Allergol Int, V56, P241, DOI 10.2332/allergolint.O-06-456; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Yeo BK, 2016, ANIM CELLS SYST, V20, P303, DOI 10.1080/19768354.2016.1259181	32	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					2988	2996		10.1074/jbc.RA118.004741	http://dx.doi.org/10.1074/jbc.RA118.004741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30610116	hybrid, Green Published			2022-12-26	WOS:000464980100002
J	Chung, JE; Magis, W; Vu, J; Heo, SJ; Wartiovaara, K; Walters, MC; Kurita, R; Nakamura, Y; Boffelli, D; Martin, DIK; Corn, JE; Dewitt, MA				Chung, Jennifer E.; Magis, Wendy; Vu, Jonathan; Heo, Seok-Jin; Wartiovaara, Kirmo; Walters, Mark C.; Kurita, Ryo; Nakamura, Yukio; Boffelli, Dario; Martin, David I. K.; Corn, Jacob E.; Dewitt, Mark A.			CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells	PLOS ONE			English	Article							HEMOGLOBIN; DISEASE; GENE; LIFE	Sickle Cell Disease and beta-thalassemia, which are caused by defective or deficient adult beta-globin (HBB) respectively, are the most common serious genetic blood diseases in the world. Persistent expression of the fetal beta-like globin, also known gamma-globin, can ameliorate both disorders by serving in place of the adult beta-globin as a part of the fetal hemoglobin tetramer (HbF). Here we use CRISPR-Cas9 gene editing to explore a potential gamma-globin silencer region upstream of the delta-globin gene identified by comparison of naturally-occurring deletion mutations associated with up-regulated gamma-globin. We find that deletion of a 1.7 kb consensus element or select 350 bp sub-regions from bulk populations of cells increases levels of HbF. Screening of individual sgRNAs in one sub-region revealed three single guides that caused increases gamma-globin expression. Deletion of the 1.7 kb region in HUDEP-2 clonal sublines, and in colonies derived from CD34+ hematopoietic stem/progenitor cells (HSPCs), does not cause significant up-regulation of gamma-globin. These data suggest that the 1.7 kb region is not an autonomous gamma-globin silencer, and thus by itself is not a suitable therapeutic target for gene editing treatment of beta-hemoglobinopathies.	[Chung, Jennifer E.; Vu, Jonathan; Corn, Jacob E.; Dewitt, Mark A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Magis, Wendy; Heo, Seok-Jin; Wartiovaara, Kirmo; Walters, Mark C.; Boffelli, Dario; Martin, David I. K.] UCSF Benioff Childrens Hosp, Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Wartiovaara, Kirmo] Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Fac Med, Helsinki, Finland; [Wartiovaara, Kirmo] Univ Helsinki, Clin Genet, HUSLAB, Cent Hosp, Helsinki, Finland; [Walters, Mark C.] UCSF Benioff Childrens Hosp, Div Hematol, Blood & Marrow Transplant Program, Oakland, CA USA; [Kurita, Ryo; Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; RIKEN; University of Tsukuba; University of California System; University of California Berkeley	Corn, JE; Dewitt, MA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Martin, DIK (corresponding author), UCSF Benioff Childrens Hosp, Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dimartin@chori.org; jcorn@berkeley.edu; dewittm@berkeley.edu	Nakamura, Yukio/A-5263-2016	Nakamura, Yukio/0000-0001-8056-4946; Vu, Jonathan/0000-0002-4950-7967; Chung, Jennifer/0000-0003-1332-6301	NIH [S10 OD018174]; Li Ka Shing Foundation; Heritage Medical Research Institute; California Institute of Regenerative Medicine; Siebel foundation; Lam foundation; Jordan Family Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Li Ka Shing Foundation; Heritage Medical Research Institute; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Siebel foundation; Lam foundation; Jordan Family Foundation	This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. Synthetic RNAs for studies presented in Figure 3D were obtained from Synthego, Inc. through their 2017 Synthego Grant Program (MAD). This work was supported by the Li Ka Shing Foundation (JEC), the Heritage Medical Research Institute (JEC), the California Institute of Regenerative Medicine (MAD, JEC), the Siebel foundation (MAD), the Lam foundation (J. Chung), and the Jordan Family Foundation (DKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. Synthetic RNAs for studies presented in Fig 3D were provided by Synthego, Inc. This work was supported by the Li Ka Shing Foundation (J.E.C.), the Heritage Medical Research Institute (J.E.C.), the California Institute of Regenerative Medicine (M.A.D., J.E.C.), the Siebel foundation (M.A.D.), the Lam foundation (J. Chung), and the Jordan Family Foundation (D.I.K.M.).	Antoniani C, 2018, BLOOD, DOI [10.1182/blood-2017-10-811505, 10.1182/blood-2003-11-4069, DOI 10.1182/BLOOD-2017-10-811505]; Appelbaum FR, 2009, THOMAS HEMATOPOIETIC, DOI [10.1002/9781444303537, DOI 10.1002/9781444303537]; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Charlesworth CT, 2018, BIORXIV, DOI [10.1101/243345, DOI 10.1101/243345]; Davis Bruce H, 2004, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0617s28; DeWitt MA, 2017, METHODS, V121, P9, DOI 10.1016/j.ymeth.2017.04.003; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lingeman Emily, 2017, Curr Protoc Mol Biol, V120, DOI 10.1002/cpmb.43; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Long J, 2018, MOL THER, V26, P468, DOI 10.1016/j.ymthe.2017.11.001; McGann PT, 2017, BLOOD, V129, P155, DOI 10.1182/blood-2016-09-702324; Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Wienert B, 2017, BLOOD, V130, P803, DOI 10.1182/blood-2017-02-767400; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113	37	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0208237	10.1371/journal.pone.0208237	http://dx.doi.org/10.1371/journal.pone.0208237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645582	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200005
J	Fickler, A; Staats, S; Rimbach, G; Schulz, C				Fickler, Anna; Staats, Stefanie; Rimbach, Gerald; Schulz, Carsten			Screening dietary biochanin A, daidzein, equol and genistein for their potential to increase DHA biosynthesis in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; COA DESATURASE 1; FISH-OIL; OVARIECTOMIZED RATS; GENE-EXPRESSION; VEGETABLE-OILS; SOY; PHYTOESTROGENS; GROWTH; LIVER	Plant oil utilization in aquafeeds is still the most practical option, although it decreases the content of the nutritionally highly valuable omega-3 fatty acids eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) in fish. Phytoestrogens and their metabolites are putatively able to affect genes encoding proteins centrally involved in the biosynthesis of EPA and DHA due to their estrogenic potential. Thus, the aim of the study was to screen the potential of the phytoestrogens to stimulate the biosynthesis of EPA and DHA in rainbow trout (Oncorhynchus mykiss). Additionally, the potential effects on growth performance, nutrient composition and hepatic lipid metabolism in rainbow trout were investigated. For that, a vegetable oil based diet served as a control diet (C) and was supplemented with 15 g/kg dry matter of biochanin A (BA), daidzein (DA), genistein (G) and equol (EQ), respectively. These five diets were fed to rainbow trout (initial body weight 83.3 +/- 0.4 g) for 52 days. Growth performance and nutrient composition of whole body homogenates were not affected by the dietary treatments. Furthermore, feeding EQ to rainbow trout significantly increased DHA levels by +8% in whole body homogenates compared to samples of fish fed the diet C. A tendency towards increased DHA levels in whole body homogenates was found for fish fed the diet G. Fish fed diets BA and DA lacked these effects. Moreover, EQ and G fed fish showed significantly decreased hepatic mRNA steady state levels for fatty acyl desaturase 2a (delta-6) (fads2a(d6)). In contrast, carnitine palmitoyl transferases 1 (cpt1) hepatic mRNA steady state levels and hepatic Fads2a(d6) protein contents were not affected by the dietary treatment. In conclusion, when combined with dietary vegetable oils, equol and genistein seem to stimulate the biosynthesis of DHA and thereby increase tissue DHA levels in rainbow trout, however, only to a moderate extent.	[Fickler, Anna; Schulz, Carsten] GMA Gesell Marine Aquakultur mbH, Busum, Germany; [Fickler, Anna; Schulz, Carsten] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Staats, Stefanie; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany	University of Kiel; University of Kiel	Fickler, A (corresponding author), GMA Gesell Marine Aquakultur mbH, Busum, Germany.; Fickler, A (corresponding author), Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany.	fickler@gma-buesum.de	Schulz, Carsten/C-2127-2017; Rimbach, Gerald/A-7178-2011	Rimbach, Gerald/0000-0001-7888-4684	Federal Office for Agriculture and Food [BLE 2815NA044]; Land Schleswig-Holstein	Federal Office for Agriculture and Food; Land Schleswig-Holstein	The funder (Federal Office for Agriculture and Food - BLE 2815NA044) provided support in the form of salaries for Anna Fickler, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. Further, the Gesellschaft fur Marine Aquakultur mbH (GMA) is a non-profit company working in aquaculture research which is shared by public institutions. GMA provided research infrastructure, but were not included in conceptualisation of experimental design, data collection and analysis and MS preparation. We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds for the publication fee.; We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds. We would like to thank Dr. Mario Hasler and Jonas Schaler for their statistical advice and Dr. Hubert Wehage at the LUFA-ITL in Kiel, Germany, for the fatty acid analysis. Further, the authors would like to thank Bahne Christiansen, Julian Wessel, Sandra Nevermann and Petra Rettmann for their assistance during the experimental period and in the lab. In addition, we are grateful for the guidance given by Markus Griese, Michael Schlachter and all GMA colleagues for their help during sampling.	[Anonymous], 2015, AQUACULTURE, V448, P365, DOI DOI 10.1016/J.AQUACULTURE.2015.06.023; Bell JG, 2004, LIPIDS, V39, P223, DOI 10.1007/s11745-004-1223-5; Bell MV, 2001, LIPIDS, V36, P1153, DOI 10.1007/s11745-001-0826-1; Bretz F., 2010, MULTIPLE COMP USING, DOI [10.1201/9781420010909-f, DOI 10.1201/9781420010909-F]; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Chacko BK, 2007, J NUTR, V137, P351, DOI 10.1093/jn/137.2.351; Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007; Cleveland BM, 2015, COMP BIOCHEM PHYS C, V170, P28, DOI 10.1016/j.cbpc.2015.02.001; Crespillo A, 2011, BRIT J PHARMACOL, V164, P1899, DOI 10.1111/j.1476-5381.2011.01477.x; Dixon RA, 2002, PHYTOCHEMISTRY, V60, P205, DOI 10.1016/S0031-9422(02)00116-4; Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002; Fickler A, 2018, LIPIDS, V53, P809, DOI 10.1002/lipd.12092; Food and Agriculture Organization, 2015, STAT WORLD FISH AQ 2; Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Gontier-Latonnelle K, 2007, GEN COMP ENDOCR, V150, P298, DOI 10.1016/j.ygcen.2006.10.001; Gonzalez-Bengtsson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164241; Hernandez-Montes E, 2006, BIOCHEM BIOPH RES CO, V346, P851, DOI 10.1016/j.bbrc.2006.05.197; Ishak SD, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-56; Jobling M, 2011, AQUACULT INT, V20, P601, DOI [10.1007/s10499-011-9480-6, DOI 10.1007/S10499-011-9480-6, DOI 10.17226/13039]; Jourdehi AY, 2014, FISH PHYSIOL BIOCHEM, V40, P117, DOI 10.1007/s10695-013-9829-z; Karalazos V, 2007, AQUACULT NUTR, V13, P256, DOI 10.1111/j.1365-2095.2007.00471.x; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; Kitson AP, 2013, PROSTAG LEUKOTR ESS, V89, P81, DOI 10.1016/j.plefa.2013.05.003; Kitson AP, 2010, LIPIDS, V45, P209, DOI 10.1007/s11745-010-3391-6; Klejdus B, 2001, ANAL CHIM ACTA, V450, P81, DOI 10.1016/S0003-2670(01)01370-8; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Latonnelle K, 2002, GEN COMP ENDOCR, V126, P39, DOI 10.1006/gcen.2001.7773; Marks KA, 2013, PROSTAG LEUKOTR ESS, V89, P89, DOI 10.1016/j.plefa.2013.05.002; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mezei O, 2003, J NUTR, V133, P1238; Miller MR, 2008, NUTR RES REV, V21, P85, DOI 10.1017/S0954422408102414; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; RuizLarrea MB, 1997, FREE RADICAL RES, V26, P63, DOI 10.3109/10715769709097785; Sargent John R., 2002, P181; Schiller V.A., 2012, LIPIDS, V47, P897, DOI DOI 10.1007/S11745-012-3697-7; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447, DOI 10.1093/ajcn/76.2.447; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Setchell KDR, 2009, AM J CLIN NUTR, V90, P1029, DOI 10.3945/ajcn.2009.27981; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Torno C, 2019, ANIMAL, V13, P933, DOI 10.1017/S1751731118002458; Torno C, 2017, MAR DRUGS, V15, DOI 10.3390/md15080252; Trattner S, 2008, LIPIDS, V43, P999, DOI 10.1007/s11745-008-3229-7; Turchini G. M., 2010, FISH OIL REPLACEMENT; Turchini GM, 2011, FOOD CHEM, V124, P609, DOI 10.1016/j.foodchem.2010.06.083; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Verbeke G., 2000, LINEAR MIXED MODELS, DOI [10.1007/978-1-4419-0300-6, DOI 10.1007/978-1-4419-0300-6]; Vestergren ALS, 2011, NEUROENDOCRINOL LETT, V32, P41; VOSS A, 1991, J BIOL CHEM, V266, P19995; Wiseman H, 2000, AM J CLIN NUTR, V72, P395; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	60	6	6	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210197	10.1371/journal.pone.0210197	http://dx.doi.org/10.1371/journal.pone.0210197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645603	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200020
J	Kumar, L; Cox, CR; Sarkar, SK				Kumar, Lokender; Cox, Christopher R.; Sarkar, Susanta K.			Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BIOFILM; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; PROTEOLYTIC-ENZYMES; MEMBRANE-PROTEINS; SURFACE PROTEIN; CONGO RED; GROWTH; INFECTIONS; MECHANISMS	Enterococcus faecalis is a major opportunistic pathogen that readily forms protective biofilms leading to chronic infections. Biofilms protect bacteria from detergent solutions, antimicrobial agents, environmental stress, and effectively make bacteria 10 to 1000-fold more resistant to antibiotic treatment. Extracellular proteins and polysaccharides are primary components of biofilms and play a key role in cell survival, microbial persistence, cellular interaction, and maturation of E. faecalis biofilms. Degradation of biofilm components by mammalian proteases is an effective antibiofilm strategy because proteases are known to degrade bacterial proteins leading to bacterial cell lysis and growth inhibition. Here, we show that human matrix metalloprotease-1 inhibits and disrupts E. faecalis biofilms. MMPs are cell-secreted zinc- and calcium-dependent proteases that degrade and regulate various structural components of the extracellular matrix. Human MMP1 is known to degrade type-1 collagen and can also cleave a wide range of substrates. We found that recombinant human MMP1 significantly inhibited and disrupted biofilms of vancomycin sensitive and vancomycin resistant E. faecalis strains. The mechanism of antibiofilm activity is speculated to be linked with bacterial growth inhibition and degradation of biofilm matrix proteins by MMP1. These findings suggest that human MMP1 can potentially be used as a potent antibiofilm agent against E. faecalis biofilms.	[Kumar, Lokender; Sarkar, Susanta K.] Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA; [Cox, Christopher R.] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Colorado School of Mines; Colorado School of Mines	Sarkar, SK (corresponding author), Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA.	ssarkar@mines.edu	Kumar, Lokender/AAY-6862-2020	Kumar, Lokender/0000-0002-0692-0137	Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines	Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines	We acknowledge Reuben Collins for help with SEM imaging and comments on the manuscript.The authors acknowledge a seed funding from the Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines for the research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge a seed funding from the Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Baidamshina DR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46068; Baldassarri L, 2005, INT J ARTIF ORGANS, V28, P1101, DOI 10.1177/039139880502801107; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Baylan O, 2011, MIKROBIYOL BUL, V45, P430; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; BLAKE MS, 1981, INFECT IMMUN, V33, P212, DOI 10.1128/IAI.33.1.212-222.1981; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1; Brinckerhoff CE., 2017, MATRIX METALLOPROTEI, P65; Bulacio María de los Á, 2015, Acta odontol. latinoam., V28, P210; Cathro P, 2016, FEBS OPEN BIO, V6, P586, DOI 10.1002/2211-5463.12075; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Chen C, 2013, J BIOL CHEM, V288, P29440, DOI 10.1074/jbc.M113.502039; Chuang-Smith ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015798; Control CfD Prevention, 2013, ANT RES THREATS US 2; Cui HY, 2016, FOOD FUNCT, V7, P4030, DOI 10.1039/c6fo01201a; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Del Papa MF, 2007, J BACTERIOL, V189, P8835, DOI 10.1128/JB.01311-07; Dittmore A, 2016, P NATL ACAD SCI USA, V113, P8436, DOI 10.1073/pnas.1523228113; Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Dunavant TR, 2006, J ENDODONT, V32, P527, DOI 10.1016/j.joen.2005.09.001; Dunny G.M., 2014, ENTEROCOCCAL BIOFILM; Elchinger PH, 2014, LETT APPL MICROBIOL, V59, P507, DOI 10.1111/lam.12305; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; GIERTSEN E, 1989, SCAND J DENT RES, V97, P233; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Gouran H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31098; GRENIER D, 1994, ORAL MICROBIOL IMMUN, V9, P224, DOI 10.1111/j.1399-302X.1994.tb00062.x; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hoffman SB, 2001, COMP CONT EDUC PRACT, V23, P464, DOI 10.1128/microbiolspec.VMBF-0016-2015; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Ike Yasuyoshi, 2017, Nihon Saikingaku Zasshi, V72, P189, DOI 10.3412/jsb.72.189; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; KOMATSUZAWA H, 1994, J ANTIMICROB CHEMOTH, V34, P885, DOI 10.1093/jac/34.6.885; Kumar L, 2018, PROTEIN EXPRES PURIF, V148, P59, DOI 10.1016/j.pep.2018.04.001; Kumar L, 2013, FITOTERAPIA, V90, P73, DOI 10.1016/j.fitote.2013.06.017; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Law Edward J., 1994, Journal of Burn Care and Rehabilitation, V15, P236, DOI 10.1097/00004630-199405000-00006; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lee SF, 1996, INFECT IMMUN, V64, P1035, DOI 10.1128/IAI.64.3.1035-1038.1996; Lefevre J, 2008, J MOL BIOL, V378, P840, DOI 10.1016/j.jmb.2008.03.044; Leroy C, 2008, BIOFOULING, V24, P11, DOI 10.1080/08927010701784912; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Loughran AJ, 2014, MICROBIOLOGYOPEN, V3, P897, DOI 10.1002/mbo3.214; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Moormeier DE, 2014, MBIO, V5, DOI 10.1128/mBio.01341-14; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nguyen UT, 2014, INT J FOOD MICROBIOL, V187, P26, DOI 10.1016/j.ijfoodmicro.2014.06.025; Niazi SA, 2014, INT ENDOD J, V47, P756, DOI 10.1111/iej.12214; Nissinen L, 2014, BBA-GEN SUBJECTS, V1840, P2571, DOI 10.1016/j.bbagen.2014.03.007; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park JH, 2012, BIOTECHNOL LETT, V34, P655, DOI 10.1007/s10529-011-0825-z; Patterson T, 2007, AM J OBSTET GYNECOL, V197, pS175, DOI 10.1016/j.ajog.2007.10.634; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Ran SJ, 2015, AUST DENT J, V60, P143, DOI 10.1111/adj.12324; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Schallenberger MA, 2012, J BACTERIOL, V194, P2677, DOI 10.1128/JB.00064-12; SELAN L, 1993, ANTIMICROB AGENTS CH, V37, P2618, DOI 10.1128/AAC.37.12.2618; Shukla SK, 2013, J ANTIBIOT, V66, P55, DOI 10.1038/ja.2012.98; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Taglialegna A, 2016, J BACTERIOL, V198, P2579, DOI 10.1128/JB.00122-16; Talebi M, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.23349; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Watters CM, 2016, INFECT DRUG RESIST, V9, P71, DOI 10.2147/IDR.S103101; Zhang XH, 2016, LIVEST SCI, V188, P25, DOI 10.1016/j.livsci.2016.03.017; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	78	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210218	10.1371/journal.pone.0210218	http://dx.doi.org/10.1371/journal.pone.0210218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633757	Green Published, Green Submitted, gold			2022-12-26	WOS:000455485100014
J	Maupin-Furlow, JA				Maupin-Furlow, Julie A.			Putting phage to work in deubiquitinase ligand discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							11 USP11; SENSITIVITY	Inhibiting deubiquitinase (DUB) function is a promising strategy for the treatment of cancers and other human diseases. Of the hundreds of human DUBs, USP11 has emerged as an ideal therapeutic target, as it regulates DNA double-strand break repair by homologous recombination (HR) and other functions central to eukaryotic cell survival. A new study by Spiliotopoulos et al. cleverly uses next-generation phage display (NGPD) to identify peptide ligands that bind USP11 in a unique pocket that impacts HR. The study provides an important step toward novel DUB inhibitors that may reduce the resistance of some cancers to current treatment options.	[Maupin-Furlow, Julie A.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Maupin-Furlow, Julie A.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maupin-Furlow, JA (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.; Maupin-Furlow, JA (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Maupin-Furlow, Julie/AAW-4035-2020	Maupin-Furlow, Julie/0000-0001-6105-0923	National Science Foundation Bilateral BBSRC-NSF/BIO program [1642283]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Bio-sciences, Physical Biosciences Program [DE-FG02-05ER15650]; NIGMS, National Institutes of Health [R01 GM57498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	National Science Foundation Bilateral BBSRC-NSF/BIO program; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Bio-sciences, Physical Biosciences Program(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Bilateral BBSRC-NSF/BIO program Grant 1642283, U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Bio-sciences, Physical Biosciences Program Grant DE-FG02-05ER15650, and NIGMS, National Institutes of Health Grant R01 GM57498. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Deng TG, 2018, P NATL ACAD SCI USA, V115, P4678, DOI 10.1073/pnas.1714938115; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Kapadia B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03028-y; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Spiliotopoulos A, 2019, J BIOL CHEM, V294, P424, DOI 10.1074/jbc.RA118.004469; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Wu HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4214; Zhang EC, 2016, AM J CANCER RES, V6, P2901	10	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					437	438		10.1074/jbc.H118.006803	http://dx.doi.org/10.1074/jbc.H118.006803			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30635442	Green Published, hybrid			2022-12-26	WOS:000456263600005
J	Kim, S; Voss, JL				Kim, Sungshin; Voss, Joel L.			Large-scale network interactions supporting item-context memory formation	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; EPISODIC MEMORY; BRAIN NETWORKS; LONG; RECOLLECTION; SYSTEMS	Episodic memory is thought to involve functional interactions of large-scale brain networks that dynamically reconfigure depending on task demands. Although the hippocampus and closely related structures have been implicated, little is known regarding how large-scale and distributed networks support different memory formation demands. We investigated patterns of interactions among distributed networks while human individuals formed item-context memories for two stimulus categories. Subjects studied object-scene and objectlocation associations in different fMRI sessions. Stimulus-responsive brain regions were organized based on their fMRI interconnectivity into networks and modules using probabilistic module-detection algorithms to maximize measurement of individual differences in modular structure. Although there was a great deal of consistency in the modular structure between object-scene and object-location memory formation, there were also significant differences. Interactions among functional modules predicted later memory accuracy, explaining substantial portions of variability in memory formation success. Increased interactivity of modules associated with internal thought and anti-correlation of these modules with those related to stimulus-evoked processing robustly predicted object-scene memory, whereas decreased interactivity of stimulus-evoked processing modules predicted object-location memory. Assessment of individual differences in network organization therefore allowed identification of distinct patterns of functional interactions that robustly predicted memory formation. This highlights large-scale brain network interactions for memory formation and indicates that although networks are largely robust to task demands, reconfiguration nonetheless occurs to support distinct memory formation demands.	[Kim, Sungshin] IBS, Ctr Neurosci Imaging Res, Suwon, South Korea; [Kim, Sungshin] Sungkyunkwan Univ SKKU, Suwon, South Korea; [Voss, Joel L.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Dept Med Social Sci,Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Northwestern University; Feinberg School of Medicine	Kim, S (corresponding author), IBS, Ctr Neurosci Imaging Res, Suwon, South Korea.; Kim, S (corresponding author), Sungkyunkwan Univ SKKU, Suwon, South Korea.	clmnlab@gmail.com	Kim, Sungshin/AAE-5645-2019	Kim, Sungshin/0000-0001-9500-4677; Voss, Joel/0000-0003-4180-9335	National Institute of Mental Health (US) [R01-MH106512]; Department of Radiology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106512] Funding Source: NIH RePORTER	National Institute of Mental Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Radiology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health (US), R01-MH106512 to JLV; https://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Jonathan O'Neil and Robert Palumbo for data collection and technical support. Data analyses were supported in part through the computational resources and staff contributions provided for the Quest high-performance computing facility at Northwestern University. MRI was performed at the Northwestern University Center for Translational Imaging, supported by the Department of Radiology.	Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuertinger S, 2016, J COGNITIVE NEUROSCI, V28, P2030, DOI 10.1162/jocn_a_01026; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Geib BR, 2017, CEREB CORTEX, V27, P680, DOI 10.1093/cercor/bhv272; GRAF P, 1989, J EXP PSYCHOL LEARN, V15, P930, DOI 10.1037/0278-7393.15.5.930; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim H, 2010, NEUROIMAGE, V49, P1045, DOI 10.1016/j.neuroimage.2009.07.058; Kim S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2768; King DR, 2015, J NEUROSCI, V35, P1763, DOI 10.1523/JNEUROSCI.3219-14.2015; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Mohr H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13217; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newton AT, 2011, HUM BRAIN MAPP, V32, P1649, DOI 10.1002/hbm.21138; Nilakantan AS, 2017, CURR BIOL, V27, P465, DOI 10.1016/j.cub.2016.12.042; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Ritchey M, 2015, PROG BRAIN RES, V219, P45, DOI 10.1016/bs.pbr.2015.04.001; Ritchey M, 2014, J COGNITIVE NEUROSCI, V26, P1085, DOI 10.1162/jocn_a_00533; Ritchey M, 2013, CEREB CORTEX, V23, P2818, DOI 10.1093/cercor/bhs258; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Schedlbauer AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06431; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059204; Westphal AJ, 2017, J NEUROSCI, V37, P3523, DOI 10.1523/JNEUROSCI.2509-16.2017	54	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210167	10.1371/journal.pone.0210167	http://dx.doi.org/10.1371/journal.pone.0210167			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629666	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000056
J	Martinez-Valverde, S; Salinas-Escudero, G; Garcia-Delgado, C; Garduno-Espinosa, J; Moran-Barroso, VF; Granados-Garcia, V; Tiro-Sanchez, MT; Toledano-Toledano, F; Aldaz-Rodriguez, MV				Martinez-Valverde, Silvia; Salinas-Escudero, Guillermo; Garcia-Delgado, Constanza; Garduno-Espinosa, Juan; Moran-Barroso, Veronica F.; Granados-Garcia, Victor; Teresa Tiro-Sanchez, Ma.; Toledano-Toledano, Filiberto; Vanessa Aldaz-Rodriguez, Ma.			Out-of-pocket expenditures and care time for children with Down Syndrome: A single-hospital study in Mexico City	PLOS ONE			English	Article							HEALTH; ADOLESCENTS; COSTS; PROFILE; BURDEN	Aim To examine the burden of out-of-pocket household expenditures and time spent on care by families responsible for children with Down Syndrome (DS). Methods A cross-sectional analysis was performed after surveying families of children with DS. The children all received medical care at the Hospital Infantil de Mexico Federico Gomez (HIMFG), a National Institute of Health. Data were collected on out-of-pocket household expenditures for the medical care of these children. The percentage of such expenditure was calculated in relation to available household expenditure (after subtracting the cost of food/housing), and the percentage of households with catastrophic expenditure. Finally, the time spent on the care of the child was assessed. Results The socioeconomic analysis showed that 67% of the households with children with DS who received medical care in the HIMFG were within the lower four deciles (I-IV) of expenses, indicating a limited ability to pay for medical services. Yearly out-of-pocket expenditures for a child with DS represented 27% of the available household expenditure, which is equivalent to $ 464 for the United States dollars (USD). On average, 33% of families with DS children had catastrophic expenses, and 46% of the families had to borrow money to pay for medical expenses. The percentage of catastrophic expenditure was greater for a household with children aged five or older compared with households with younger children. The regression analysis revealed that the age of the child is the most significant factor determining the time spent on care. Conclusions Some Mexican families of children with DS incur substantial out-of-pocket expenditures, which constitute an economic burden for families of children who received medical care at the HIMFG.	[Martinez-Valverde, Silvia; Salinas-Escudero, Guillermo] Inst Nacl Salud, Hosp Infantil Mexico Federico Gomez, Ctr Estudios Econ & Sociales Salud, Mexico City, DF, Mexico; [Garcia-Delgado, Constanza; Moran-Barroso, Veronica F.] Inst Nacl Salud, Hosp Infantil Mexico Federico Gomez, Dept Genet, Mexico City, DF, Mexico; [Garduno-Espinosa, Juan] Inst Nacl Salud, Hosp Infantil Mexico Federico Gomez, Direcc Invest, Mexico City, DF, Mexico; [Granados-Garcia, Victor] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud Area Envejec, Mexico City, DF, Mexico; [Teresa Tiro-Sanchez, Ma.] Inst Mexicano Seguro Social, Hosp Gen Zona 24, Serv Urgencias, Mexico City, DF, Mexico; [Toledano-Toledano, Filiberto] Inst Nacl Salud, Hosp Infantil Mexico Federico Gomez, Unidad Invest Med Basada Evidencias, Mexico City, DF, Mexico; [Vanessa Aldaz-Rodriguez, Ma.] Univ Nacl Autonoma Mexico, Programa Doctorado Adm & Sistemas Salud, Mexico City, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico	Granados-Garcia, V (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud Area Envejec, Mexico City, DF, Mexico.	vic.granados@gmail.com	Toledano-Toledano, Filiberto/W-1886-2019; Granados-García, Víctor/AAR-5788-2020; Espinosa, Juan Garduño/B-9867-2014	Toledano-Toledano, Filiberto/0000-0002-7126-5351; Granados-García, Víctor/0000-0002-9075-576X; Espinosa, Juan Garduño/0000-0002-3000-4948; Salinas Escudero, Guillermo/0000-0003-4573-4844; Martinez Valverde, Silvia/0000-0002-6467-291X	National Institute of Health in Mexico City [HIM/2009/004]	National Institute of Health in Mexico City	The authors did not receive additional payments for this manuscript. The editing and publishing fees were provided by federal funding assigned to project with registered number HIM/2009/004 conducted at Hospital Infantil de Mexico Federico Gomez (HIMFG), National Institute of Health in Mexico City.	Banco de Mexico, 2016, TIP DE CAMB; Besser LM, 2007, BIRTH DEFECTS RES A, V79, P765, DOI 10.1002/bdra.20404; Bonilla-Chacin M.E., 2013, MEXICAN SOCIAL PROTE; Boulet SL, 2008, J PEDIATR-US, V153, P241, DOI 10.1016/j.jpeds.2008.02.046; BRUST JD, 1992, PUBLIC HEALTH NURS, V9, P177, DOI 10.1111/j.1525-1446.1992.tb00097.x; Connel M, 2000, LIMITS MOTHERS CARIN; Cruz C, 2006, POLITICAS PUBLICAS S; Cruz Carlos, 2006, BIENESTAR POLITICA S, V2, P51; Dawson AL, 2014, BIRTH DEFECTS RES A, V100, P826, DOI 10.1002/bdra.23295; de Castro F, 2017, SALUD PUBLICA MEXICO, V59, P354, DOI 10.21149/8487; de Graaf G, 2015, AM J MED GENET A, V167, P756, DOI 10.1002/ajmg.a.37001; Diario oficial de la federacion, 2016, AC QUE SE EM REGL OP; Rodriguez-Ortega EE, 2012, SALUD PUBLICA MEXICO, V54, pS65, DOI 10.1590/S0036-36342012000700009; Flores-Ramirez F, 2015, ARCH MED RES, V46, P484, DOI 10.1016/j.arcmed.2015.08.001; Geelhoed EA, 2011, J PEDIATR-US, V159, P541, DOI 10.1016/j.jpeds.2011.06.007; Goudie A., 2010, CARING CHILDREN DISA; HOOK EB, 1981, NEW ENGL J MED, V305, P1410, DOI 10.1056/NEJM198112033052312; INEGI, 2015, ENCUESTA INTERCENSAL; Instituto Nacional de Estadistica y Geografia (INEGI), 2020, IND PREC CONS; Instituto Nacional de Estadistica y Geografia -INEGI, 2016, ENC NACL INGR GAST H; Kageleiry A, 2017, AM J MED GENET A, V173, P627, DOI 10.1002/ajmg.a.38050; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Kuhlthau K, 2005, MATERN CHILD HLTH J, V9, P207, DOI 10.1007/s10995-005-4870-x; McGrath RJ, 2011, J PEDIATR-US, V159, P535, DOI 10.1016/j.jpeds.2011.04.019; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; Hernandez EN, 2013, B MED HOSP INFANT M, V70, P499; Presidencia de la Republica, 2011, SEG MED NUEV GEN; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Ruiz Herrera G., 2013, THESIS; Schieve LA, 2009, PEDIATRICS, V123, pE253, DOI 10.1542/peds.2008-1440; Secretaria de Salud, 2007, LIN TECN; Skotko BG, 2011, AM J MED GENET A, V155A, P2360, DOI 10.1002/ajmg.a.34235; Torres A., 2003, CALEIDOSCOPIO SALUD, P209; US Department of Education, 2018, CTR PAR INF RES OFF; Waitzman N., 1996, COST BIRTH DEFECTS E; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K., 2005, DISTRIBUTION HLTH PA	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208076	10.1371/journal.pone.0208076	http://dx.doi.org/10.1371/journal.pone.0208076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629602	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000010
J	Rathore, AS; Sarker, A; Gupta, RD				Rathore, Abhishek Singh; Sarker, Animesh; Gupta, Rinkoo Devi			Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; MONOCLONAL-ANTIBODIES; FUSION-LOOP; DOMAIN-III; VIRUS; GLYCOPROTEIN; PEPTIDE; BINDING; TARGET	Dengue being one of the deadliest diseases of tropical regions, enforces to put continuous efforts for the development of vaccine and effective therapeutics. Most of the antibodies generated during dengue infection are non-neutralizing and cause antibody dependent enhancement. Hence, making a potent neutralizing antibody against all four dengue sero-types could be very effective for the treatment. However, designing a single antibody for all serotypes is difficult due to variation in protein sequences. Therefore, the objective is to identify conserved region of dengue envelope protein and then develop an antibody against that conserved region. Before advancing to the development of such an antibody, it is desirable to validate the interactions between antibody and dengue envelope protein. In silico analysis of such interactions provides a good platform to find out a suitable region to design and construct an antibody against it by analyzing antigen-antibody interaction before synthesizing the antibody. In this study, two highly conserved regions of dengue envelope protein were identified and an scFv was constructed against it. Both scFv and FuBc proteins were expressed in bacterial expression system and binding efficiency was analyzed by SPR analysis with K-D value 2.3 mu M. In order to improve binding efficiency, an in silico scFv mutant library was created which was virtually screened for higher binding efficiency. Six mutants with high binding efficiency were selected for further analysis. The binding ability of these mutants were predicted using simulation analysis which shows these mutations were stabilizing scFv-FuBc complex.	[Rathore, Abhishek Singh; Sarker, Animesh; Gupta, Rinkoo Devi] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	South Asian University (SAU)	Gupta, RD (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rdgupta@sau.ac.in	Gupta, Rinkoo Devi/AAI-9528-2021	Gupta, Rinkoo Devi/0000-0003-1156-9596	South Asian University's "Start-up Fund"; University Grants Commission; University Grants Commission (UGC), India; South Asian University	South Asian University's "Start-up Fund"; University Grants Commission(University Grants Commission, India); University Grants Commission (UGC), India(University Grants Commission, India); South Asian University	This work is financially supported by South Asian University's "Start-up Fund" to RDG and the University Grants Commission (JRF/SRF (2013-2018)) to ASR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ASR thanks University Grants Commission (UGC), India for Senior Research Fellowship. AS and RDG thanks South Asian University for financial support.	[Anonymous], LANCET, DOI 10.1016/S0140-6736(14)60572-9; Bandehpour M, 2017, J THEOR COMPUT CHEM, V16, DOI 10.1142/S0219633617500699; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chen W-H, 2017, VIROL J, P14; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386; Entzminger KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10737-9; Fahimi H, 2014, IRAN J BASIC MED SCI, V17, P836; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; Fleith RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36339; Geng SS, 2015, IMMUNOL RES, V62, P377, DOI 10.1007/s12026-015-8667-8; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Hu GD, 2011, J MOL MODEL, V17, P1919, DOI 10.1007/s00894-010-0892-4; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Ji XF, 2012, BIOINFORM BIOL INSIG, V6, P255, DOI 10.4137/BBI.S10663; Jones ML, 2017, MOL BASEL SWITZ, V22; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Karim HAA, 2015, MOL DYNAMICS SIMULAT, P24; Khor BY, 2017, J MOL GRAPH MODEL, V76, P543, DOI 10.1016/j.jmgm.2017.07.004; Lai B, 2014, INT J MOL SCI, V15, P438, DOI 10.3390/ijms15010438; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai PY, 2014, J GEN VIROL, V95, P2155, DOI 10.1099/vir.0.062562-0; Li TW, 2016, ARCH VIROL, V161, P19, DOI 10.1007/s00705-015-2625-6; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Poosarla VG, 2017, BIOTECHNOL BIOENG, V114, P1331, DOI 10.1002/bit.26244; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Tang CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125307; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; WHO, DENG SEV DENG; Yamanaka A, 2013, J VIROL, V87, P12828, DOI 10.1128/JVI.01874-13	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209576	10.1371/journal.pone.0209576	http://dx.doi.org/10.1371/journal.pone.0209576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629625	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000029
J	Baasch, DM; Farrell, PD; Howlin, S; Pearse, AT; Farnsworth, JM; Smith, CB				Baasch, David M.; Farrell, Patrick D.; Howlin, Shay; Pearse, Aaron T.; Farnsworth, Jason M.; Smith, Chadwin B.			Whooping crane use of riverine stopover sites	PLOS ONE			English	Article							HABITAT; SELECTION	Migratory birds like endangered whooping cranes (Grus americana) require suitable nocturnal roost sites during twice annual migrations. Whooping cranes primarily roost in shallow surface water wetlands, ponds, and rivers. All these features have been greatly impacted by human activities, which present threats to the continued recovery of the species. A portion of one such river, the central Platte River, has been identified as critical habitat for the survival of the endangered whooping crane. Management intervention is now underway to rehabilitate habitat form and function on the central Platte River to increase use and thereby contribute to the survival of whooping cranes. The goal of our analyses was to develop habitat selection models that could be used to direct riverine habitat management activities (i.e., channel widening, tree removal, flow augmentation, etc.) along the central Platte River and throughout the species' range. As such, we focused our analyses on two robust sets of whooping crane observations and habitat metrics the Platte River Recovery Implementation Program (Program or PRRIP) and other such organizations could influence. This included channel characteristics such as total channel width, the width of channel unobstructed by dense vegetation, and distance of forest from the edge of the channel and flow-related metrics like wetted width and unit discharge (flow volume per linear meter of wetted channel width) that could be influenced by flow augmentation or reductions during migration. We used 17 years of systematic monitoring data in a discrete-choice framework to evaluate the influence these various metrics have on the relative probability of whooping crane use and found the width of channel unobstructed by dense vegetation and distance to the nearest forest were the best predictors of whooping crane use. Secondly, we used telemetry data obtained from a sample of 38 birds of all ages over the course of seven years, 2010-2016, to evaluate whooping crane use of riverine habitat within the North-central Great Plains, USA. For this second analysis, we focused on the two metrics found to be important predictors of whooping crane use along the central Platte River, unobstructed channel width and distance to nearest forest or wooded area. Our findings indicate resource managers, such as the Program, have the potential to influence whooping crane use of the central Platte River through removal of in-channel vegetation to increase the unobstructed width of narrow channels and through removal of trees along the bank line to increase unforested corridor widths. Results of both analyses also indicated that increases in relative probability of use by whooping cranes did not appreciably increase with unobstructed views >= 200 m wide and unforested corridor widths that were >= 330 m. Therefore, managing riverine sites for channels widths >200 m and removing trees beyond 165 m from the channel's edge would increase costs associated with implementing management actions such as channel and bank-line disking, removing trees, augmenting flow, etc. without necessarily realizing an additional appreciable increase in use by migrating whooping cranes.	[Baasch, David M.; Farrell, Patrick D.; Farnsworth, Jason M.; Smith, Chadwin B.] Execut Directors Off Platte River Recovery Implem, Kearney, NE 68845 USA; [Howlin, Shay] Western Ecosyst Technol Inc WEST, Cheyenne, WY USA; [Pearse, Aaron T.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey	Baasch, DM (corresponding author), Execut Directors Off Platte River Recovery Implem, Kearney, NE 68845 USA.	baaschd@headwaterscorp.com			Platte River Recovery Implementation Program; Western Ecosystems Technology; United States Geological Survey	Platte River Recovery Implementation Program; Western Ecosystems Technology; United States Geological Survey(United States Geological Survey)	The Platte River Recovery Implementation Program provided support in the form of salaries for authors DMB, PDF, JMF, and CBS, Western Ecosystems Technology provided support in the form of salaries for author SH, and the United States Geological Survey provided support in the form of salaries for author ATP, but none of the funding agencies had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. These affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials.	Aarts G, 2013, J ANIM ECOL, V82, P1135, DOI 10.1111/1365-2656.12061; [Anonymous], 2021, LANG ENV STAT COMP; Armbruster MJ, 1990, BIOL REPORT, V90; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Austin J. E., 2001, COMPREHENSIVE REV OB; Austin JE, 2005, 6 USGS NO PRAIR WILD; Baasch DM, 2010, ECOL MODEL, V221, P565, DOI 10.1016/j.ecolmodel.2009.10.033; Belaire JA, 2014, CONSERV BIOL, V28, P541, DOI 10.1111/cobi.12199; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Biology Workgroup, 1990, PLATT RIV MAN JOINT; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dahl T.E., 1990, WETLAND LOSSES US 17; FAANES C.A., 1992, P N AM CRAN WORKSH, V6, P111; Faanes CA, 1992, P 1988 N AM CRAN WOR, P117; FARMER A.H., 2005, US GEOLOGICAL SURVEY; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hefley TJ, 2015, CONSERV BIOL, V29, P1337, DOI 10.1111/cobi.12515; Howe M.A., 1989, MIGRATION RADIO MARK; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson K. A., 1980, MIGRATION ECOL UNPUB; Johnson K. A., 1982, P 1981 CRAN WORKSH J, P33; Kuyt E., 1992, 74 CAN WILDL SERV; Lingle G.R., 1986, Nebraska Bird Review, V54, P36; Lingle G.R., 1984, Prairie Naturalist, V16, P39; LOVVORN JR, 1981, J WILDLIFE MANAGE, V45, P842, DOI 10.2307/3808093; Manly B.F.J., 2002, RESOURCE SELECTION A; McCracken Marti L., 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P268, DOI 10.2307/1400582; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; McFadden D., 1978, SPATIAL INTERACTION, P79; National Research Council, 2004, END THREAT SPEC PLAT; Pearse Aaron T., 2015, U S Geological Survey Open-File Report, V1166, P1; Pearse AT, 2017, J WILDLIFE MANAGE, V81, P477, DOI 10.1002/jwmg.21215; Pearse AT, 2016, 20161209 US GEOL SUR; Platte River Recovery Implementation Program (PRRIP), 2006, FIN PLATT RIV REC IM; Platte River Whooping Crane Maintenance Trust Inc. (Crane Trust)., 1998, HAB MAN REST ACQ PLA, P70; RStudio Team, 2016, RSTUDIO INT DEV R; Shenk T. M., 1986, WHOOPING CRANE HABIT; Stahlecker DW, 1997, N AM CRAN WORKSH P; U. S. Fish and Wildlife Service (USFWS), 1986, WHOOP CRAN REC PLAN; U. S. Fish and Wildlife Service (USFWS), 1981, PLATT RIV EC STUD; U. S. Geological Survey (USGS), 2016, REM TRACK ARANS WOOD; US Fish and Wildlife Service, 2007, INT REC PLAN WHOOP C, P10; USFWS] UNITED STATES FISH AND WILDLIFE SERVICE, 1978, FED REGISTER, V43, P20938; Ward JP, 1987, P 1985 CRAN WORKSH P, P283; Werbylo KL, 2017, GEOMORPHOLOGY, V278, P163, DOI 10.1016/j.geomorph.2016.11.003; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Ziewitz JW, 1987, UNPUB; [No title captured]	48	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209612	10.1371/journal.pone.0209612	http://dx.doi.org/10.1371/journal.pone.0209612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625185	Green Published, gold			2022-12-26	WOS:000455359400047
J	Wirojsirasak, W; Kalapanulak, S; Saithong, T				Wirojsirasak, Warodom; Kalapanulak, Saowalak; Saithong, Treenut			Pan- and core- gene association networks: Integrative approaches to understanding biological regulation	PLOS ONE			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; CASSAVA MANIHOT-ESCULENTA; STARCH SYNTHASE-I; TRANSCRIPTIONAL REGULATION; PHOTOPERIODIC CONTROL; EXPRESSION PROFILES; GENOME; REVEALS; PROTEIN; FAMILY	The rapid increase in transcriptome data provides an opportunity to access the complex regulatory mechanisms in cellular systems through gene association network (GAN). Nonetheless, GANs derived from single datasets generally allow us to envisage only one side of the regulatory network, even under the particular condition of study. The circumstance is well demonstrated by inconsistent GANs of individual datasets proposed for similar experimental conditions, which always leads to ambiguous interpretation. Here, pan-and core-gene association networks (pan-and core-GANs), analogous to the pan-and core-genome concepts, are proposed to increase the power of inference through the integration of multiple, diverse datasets. The core-GAN represents the consensus associations of genes that were inferred from all individual networks. On the other hand, the pan-GAN represents the extensive gene-gene associations that occurred in each individual network. The pan-and core-GANs prospects were demonstrated based on three time series microarray datasets in leaves of Arabidopsis thaliana grown under diurnal conditions. We showed the overall performance of pan-and core-GANs was more robust to the number of data points in gene expression data compared to the GANs inferred from individual datasets. In addition, the incorporation of multiple data broadened our understanding of the biological regulatory system. While the pan-GAN enabled us to observe the landscape of gene association system, core-GAN highlighted the basic gene-associations in essence of the regulation regulating starch metabolism in leaves of Arabidopsis.	[Wirojsirasak, Warodom; Kalapanulak, Saowalak; Saithong, Treenut] King Mongkuts Univ Technol Thonburi Bang Khun Thi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand; [Kalapanulak, Saowalak; Saithong, Treenut] King Mongkuts Univ Technol Thonburi Bang Khun Thi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi Bang Khun Thi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand.; Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi Bang Khun Thi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.	treenut.sai@kmutt.ac.th	Saithong, Treenut/L-1395-2019	Saithong, Treenut/0000-0003-2888-6854; Wirojsirasak, Warodom/0000-0001-9124-266X	NRCT; NSTDA [P-12-00743]; King Mongkut's University of Technology Thonburi through the KMUTT 55th Anniversary Commemorative Fund	NRCT; NSTDA; King Mongkut's University of Technology Thonburi through the KMUTT 55th Anniversary Commemorative Fund	This work was financially supported by NRCT and NSTDA (P-12-00743) and King Mongkut's University of Technology Thonburi through the KMUTT 55th Anniversary Commemorative Fund (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Ms. Somkid Bumee for providing some data information and suggestions. We also gratefully appreciate the computing facility of Systems Biology and Bioinformatics research group and HPC cluster, King Mongkut's University of Technology Thonburi. This work was financially supported by NRCT and NSTDA (P-12-00743) and King Mongkut's University of Technology Thonburi through the KMUTT 55th Anniversary Commemorative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherfi S, 2013, VIRUS GENES, V47, P550, DOI 10.1007/s11262-013-0965-4; Ball SG, 1998, TRENDS PLANT SCI, V3, P462, DOI 10.1016/S1360-1385(98)01342-9; Berto S, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00031; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cao YN, 2012, RUSS J PLANT PHYSL+, V59, P632, DOI 10.1134/S1021443712050056; Ceballos H, 2007, J AGR FOOD CHEM, V55, P7469, DOI 10.1021/jf070633y; Chaitankar V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S19; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Fang YJ, 2011, J GENET GENOMICS, V38, P567, DOI 10.1016/j.jgg.2011.11.001; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Hu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024988; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Ortiz-Marchena MI, 2014, PLANT CELL, V26, P565, DOI 10.1105/tpc.114.122721; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Kumagai T, 2008, BIOSCI BIOTECH BIOCH, V72, P1539, DOI 10.1271/bbb.80041; Ledger S, 2001, PLANT J, V26, P14; Li L, 2009, PLANT J, V58, P485, DOI 10.1111/j.1365-313X.2009.03793.x; Li YZ, 2010, PLANT MOL BIOL, V74, P573, DOI 10.1007/s11103-010-9698-0; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Obayashi T, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct178; Otani M, 2007, PLANT CELL REP, V26, P1801, DOI 10.1007/s00299-007-0396-6; Ovecka M, 2012, PLANT SIGNAL BEHAV, V7, P1146, DOI 10.4161/psb.21370; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rosa BA, 2012, BIOINFORMATICS, V28, P2773, DOI 10.1093/bioinformatics/bts511; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Saithong T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030232; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Sojikul P, 2015, PLANT MOL BIOL, V88, P531, DOI 10.1007/s11103-015-0340-z; Steele E, 2008, J BIOMED INFORM, V41, P914, DOI 10.1016/j.jbi.2008.01.011; Strunz S, 2014, 10 WORLD C GEN APPL; Tenorio G, 2003, PLANT MOL BIOL, V51, P949, DOI 10.1023/A:1023053420632; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Wang CQ, 2015, PLANT CELL, V27, P1128, DOI 10.1105/tpc.15.00044; Wang CQ, 2014, PLANT CELL, V26, P3589, DOI 10.1105/tpc.114.130252; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wirojsirasak W, 2013, 2 ASEAN PLUS 3 GRAD; Wu M, 2012, BRIEF BIOINFORM, V13, P150, DOI 10.1093/bib/bbr029; Xiao JF, 2015, GENOM PROTEOM BIOINF, V13, P73, DOI 10.1016/j.gpb.2015.01.007; Yan DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13179; Yang J, 2011, J INTEGR PLANT BIOL, V53, P193, DOI 10.1111/j.1744-7909.2010.01018.x; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523; Zhu Y, 2003, J BIOL CHEM, V278, P47803, DOI 10.1074/jbc.M302806200	57	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210481	10.1371/journal.pone.0210481	http://dx.doi.org/10.1371/journal.pone.0210481			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625202	gold, Green Submitted, Green Published			2022-12-26	WOS:000455359400090
J	Selm, KR; Peterson, MN; Hess, GR; Beck, SM; McHale, MR				Selm, Kathryn R.; Peterson, M. Nils; Hess, George R.; Beck, Scott M.; McHale, Melissa R.			Educational attainment predicts negative perceptions women have of their own climate change knowledge	PLOS ONE			English	Article							GENDER-DIFFERENCES; VIEWS; BIAS; VULNERABILITY; INTELLIGENCE; PERFORMANCE; CONFIDENCE; AMBIGUITY; LITERACY; ILLUSION	Education may encourage personal and collective responses to climate change, but climate education has proven surprisingly difficult and complex. Self-perception of knowledge and intelligence represent one factor that may impact willingness to learn about climate change. We explored this possibility with a case study in Raleigh, North Carolina in 2015 (n = 200). Our goal was to test how gender and ethnicity influenced perceptions people had of their own climate change knowledge. Survey respondents were asked how strongly they agreed with the statement "I feel knowledgeable about climate change" (1 = strongly disagree, and 5 = strongly agree). Our survey instrument also included demographic questions about race, age, income, gender, and education, as well as respondent's experience with natural disasters and drought. We observed an interaction between education and gender where women's self-perceived knowledge was higher than men among people with low levels of educational attainment, but was higher for men than women among people with high levels of educational attainment. In addition, minority respondents self-reported lower perceived climate change knowledge than white respondents, regardless of educational attainment. This study enhances our understanding of the gender gap in self-perceptions of climate knowledge by suggesting it is contingent on educational attainment. This could be the result of stereotype-threat experienced by women and minorities, and exacerbated by educational systems. Because people who question their knowledge are often more able to learn, particularly in ideologically charged contexts, highly educated women and minorities may be more successful learning about climate change than white men.	[Selm, Kathryn R.] North Carolina State Univ, Nat Resources Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Peterson, M. Nils] North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Forestry & Environm Resources, Raleigh, NC 27695 USA; [Hess, George R.] North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Beck, Scott M.; McHale, Melissa R.] Colorado State Univ, Nat Resource Ecol Lab, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Colorado State University	Selm, KR (corresponding author), North Carolina State Univ, Nat Resources Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	krselm@ncsu.edu	McHale, Melissa/AIA-0220-2022	McHale, Melissa/0000-0001-7300-2988; Peterson, Nils/0000-0002-4246-1206	National Science Foundation [BCS-0948229]; US Environmental Protection Agency [BCS-0948229]; North Carolina State University's Forestry and Environmental Resources Department	National Science Foundation(National Science Foundation (NSF)); US Environmental Protection Agency(United States Environmental Protection Agency); North Carolina State University's Forestry and Environmental Resources Department	We thank the National Science Foundation, and the US Environmental Protection Agency through a supplemental award (GRH), for their support of this research through the Triangle, NC, Urban Long Term Research Area-Exploratory award (BCS-0948229). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We thank North Carolina State University's Forestry and Environmental Resources Department for providing various resources and support in executing this study. We would especially like to thank Dr. Fikret Isik for his statistical expertise, as well as the students in the Department of Forestry and Environmental Resources at NCSU who aided in the collection and entry of this data.	[Anonymous], CLASSROOM CLIMATE CH; Aronson J, 2004, PSYCHOL SCI, V15, P829, DOI 10.1111/j.0956-7976.2004.00763.x; Ayscue JB, 2015, RACE SOC PROBL, V7, P5, DOI 10.1007/s12552-014-9135-0; BERNARD J, 1988, PSYCHOL WOMEN QUART, V12, P261, DOI 10.1111/j.1471-6402.1988.tb00942.x; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Borghans L, 2009, J EUR ECON ASSOC, V7, P649, DOI 10.1162/JEEA.2009.7.2-3.649; Brooms DR, 2017, J BLACK STUD, V48, P305, DOI 10.1177/0021934717692520; Chaiken S., 1989, UNINTENDED THOUGHT, V212, P212; Clayton S, 2015, NAT CLIM CHANGE, V5, P640, DOI [10.1038/NCLIMATE2622, 10.1038/nclimate2622]; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Dalkvist JA, 2014, J PARAPSYCHOL, V78, P80; de Boer H, 2010, J EDUC PSYCHOL, V102, P168, DOI 10.1037/a0017289; Dillman D. A., 2014, INTERNET PHONE MAIL; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Elliott R, 1996, RES HIGH EDUC, V37, P681, DOI 10.1007/BF01792952; Etzkowitz H., 2000, ATHENA UNBOUND ADV W; Finney C., 2014, BLACK FACES WHITE SP, DOI DOI 10.5149/NORTHCAROLINA/9781469614489.001.0001; Gross M, 2012, J AM SOC INF SCI TEC, V63, P574, DOI 10.1002/asi.21681; Grunspan DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148405; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hannon L, 2014, HISPANIC J BEHAV SCI, V36, P265, DOI 10.1177/0739986314540126; Hewitt P.L., 1991, PSYCHOL ASSESS, V3, P464, DOI [10.1037/1040-3590.3.3.464, DOI 10.1037/1040-3590.3.3.464]; Howe PD, 2013, GLOBAL ENVIRON CHANG, V23, P1488, DOI 10.1016/j.gloenvcha.2013.09.014; Huber CR, 2016, REV EDUC RES, V86, P431, DOI 10.3102/0034654315605917; ISSERMAN AM, 1977, J AM I PLANNERS, V43, P33, DOI 10.1080/01944367708977758; Jacoby-Senghor DS, 2016, J EXP SOC PSYCHOL, V63, P50, DOI 10.1016/j.jesp.2015.10.010; Jacques PJ, 2008, ENVIRON POLIT, V17, P349, DOI 10.1080/09644010802055576; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kissinger J., 2009, P FRONTIERS ED C; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Lavy V., 2015, W20909 NAT BUR EC RE; Liebow N, 2016, HYPATIA, V31, P713, DOI 10.1111/hypa.12265; Litzler E, 2014, RES HIGH EDUC, V55, P810, DOI 10.1007/s11162-014-9333-z; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; Mendez JM, 2010, POLIT RES QUART, V63, P269, DOI 10.1177/1065912908328860; Milfont TL, 2012, RISK ANAL, V32, P1003, DOI 10.1111/j.1539-6924.2012.01800.x; Miller PH, 2006, INT J SCI EDUC, V28, P363, DOI 10.1080/09500690500277664; Moore E, 2003, MEASURING AMB UNPUB; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Mueller CM, 1998, J PERS SOC PSYCHOL, V75, P33, DOI 10.1037/0022-3514.75.1.33; National Research Council, 2009, INF DEC CHANG CLIM; Riegle-Crumb C, 2012, GENDER SOC, V26, P290, DOI 10.1177/0891243211434614; Rosenthal R., 1968, URBAN REV, P16, DOI [10.1007/BF02322211, DOI 10.1007/BF02322211]; SAS 9.4 software, SAS 9 4 SOFTW; Schuldt JP, 2016, CLIMATIC CHANGE, V136, P495, DOI 10.1007/s10584-016-1631-3; Seymour E., 1997, TALKING LEAVING WHY; Shapiro JR, 2012, SEX ROLES, V66, P175, DOI 10.1007/s11199-011-0051-0; Shi J, 2016, NAT CLIM CHANGE, V6, P759, DOI [10.1038/NCLIMATE2997, 10.1038/nclimate2997]; Smith N, 2014, RISK ANAL, V34, P937, DOI 10.1111/risa.12140; Sonnert G, 1997, CONFIGURATIONS, V5, P171, DOI 10.1353/con.1997.0001; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spencer SJ, 2016, ANNU REV PSYCHOL, V67, P415, DOI 10.1146/annurev-psych-073115-103235; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stevenson K, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010006; Stevenson KT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161462; Stevenson KT, 2014, CLIMATIC CHANGE, V126, P293, DOI 10.1007/s10584-014-1228-7; Stoutenborough JW, 2014, ENVIRON SCI POLICY, V37, P23, DOI 10.1016/j.envsci.2013.08.002; Sundblad EL, 2009, ENVIRON BEHAV, V41, P281, DOI 10.1177/0013916508314998; Swindle RW Jr, 2001, APPL DEV SCI, V5, P98, DOI DOI 10.1207/S1532480XADS0502_5; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, J ENV ED, V31, P12; U.S. Bureau of Labor Statistics, 2016, Q CENS EMPL WAG; U.S. Census Bureau, 2017, QUICK FACTS N CAR; U.S. Census Bureau, 2012, 2012 NAT POP PROJ; Waylen AE, 2004, TRANSPORT RES F-TRAF, V7, P323, DOI 10.1016/j.trf.2004.09.009; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P690, DOI 10.1016/j.gloenvcha.2011.01.016	72	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210149	10.1371/journal.pone.0210149	http://dx.doi.org/10.1371/journal.pone.0210149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG4NS	30608960	Green Submitted, gold, Green Published			2022-12-26	WOS:000454952800049
J	Townsend, LK; Medak, KD; Knuth, CM; Peppler, WT; Charron, MJ; Wright, DC				Townsend, Logan K.; Medak, Kyle D.; Knuth, Carly M.; Peppler, Willem T.; Charron, Maureen J.; Wright, David C.			Loss of glucagon signaling alters white adipose tissue browning	FASEB JOURNAL			English	Article						WAT; brown adipose tissue; cold	GENE-EXPRESSION; FAT-CELLS; THERMOGENESIS; FGF21; EXERCISE; MICE; GLUCOSE; OBESITY; BEIGE; PGC-1-ALPHA	Various endocrine factors contribute to cold-induced white adipose tissue (WAT) browning, but glucagon has largely been ignored. The purpose of the current investigation was to determine if glucagon was required for the effects of cold on WAT browning. Utilizing whole-body glucagon receptor knockout (Gcgr(-/-)) mice and their wild-type (WT) littermate controls, we examined the response of inguinal WAT (iWAT) and interscapular brown adipose tissue (BAT) to an acute (48 h) cold stress or challenge with the beta 3-adrenergic agonist CL316,243. The effects of glucagon alone on the induction of thermogenic genes in adipose tissue from C57BL6/J mice were also examined. Gcgr(-/-) mice displayed modest increases in indices of browning at room temperature while displaying a blunted induction of Ucp1, Cidea, and Ffg21 mRNA expression in iWAT following cold exposure. Similarly, cold induced increases in mitochondrial DNA copy number, and the protein content of mitochondrial respiratory chain complexes, UCP1, and PGC1 were attenuated in iWAT from Gcgr(-/-) mice. In BAT, the induction of thermogenic markers following cold exposure was reduced, but the effect was less pronounced than in iWAT. Glucagon treatment increased the expression of thermogenic genes in both iWAT and BAT of C57BL6/J mice. In response to CL316,243, circulating fatty acids, glycerol, and the phosphorylation of hormone-sensitive lipase were attenuated in iWAT of Gcgr(-/-) mice. We provide evidence that glucagon is sufficient for the induction of thermogenic genes in iWAT, and the absence of intact glucagon signaling blunts the cold-induced browning of WAT, possibly due, in part, to impaired adrenergic signaling.	[Townsend, Logan K.; Medak, Kyle D.; Knuth, Carly M.; Peppler, Willem T.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, New York, NY USA; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, New York, NY USA; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Med, Div Endocrinol & Diabet, New York, NY USA	University of Guelph; Yeshiva University; Yeshiva University; Yeshiva University	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca		Wright, David/0000-0003-3867-8901	Natural Sciences and Engineering Research Council of Canada (NSERC); Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario Graduate Scholarship; Dairy Farmers of Ontario Doctoral Research Assistantship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dairy Farmers of Ontario Doctoral Research Assistantship	This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to D.C.W., who is a Tier 2 Canada Research Chair in Lipids, Metabolism and Health. W.T.P. was supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology. L.K.T. was supported by an Ontario Graduate Scholarship, a Dairy Farmers of Ontario Doctoral Research Assistantship, and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship. The authors declare no conflicts of interest.	Atgie C, 1997, AM J PHYSIOL-CELL PH, V273, pC1136, DOI 10.1152/ajpcell.1997.273.4.C1136; Banfi S, 2018, P NATL ACAD SCI USA, V115, pE1249, DOI 10.1073/pnas.1717420115; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; BILLINGTON CJ, 1991, AM J PHYSIOL, V261, pR501, DOI 10.1152/ajpregu.1991.261.2.R501; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BURCELIN R, 1995, GENE, V164, P305, DOI 10.1016/0378-1119(95)00472-I; Buzelle SL, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12312; Castellani LN, 2017, PSYCHONEUROENDOCRINO, V82, P38, DOI 10.1016/j.psyneuen.2017.05.005; Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023; Douris N, 2017, MOL METAB, V6, P854, DOI 10.1016/j.molmet.2017.05.017; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Fischer AW, 2016, AM J PHYSIOL-ENDOC M, V311, pE202, DOI 10.1152/ajpendo.00093.2016; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Foster MT, 2012, ADIPOCYTE, V1, P192, DOI 10.4161/adip.21756; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; HAGEN JH, 1961, J BIOL CHEM, V236, P1023; Hansen JS, 2015, MOL METAB, V4, P551, DOI 10.1016/j.molmet.2015.06.001; HARVEY WD, 1974, ENDOCRINOLOGY, V94, P1254; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Jay O, 2016, AM J PHYSIOL-ENDOC M, V311, pE638, DOI 10.1152/ajpendo.00265.2016; Kazak L, 2017, CELL METAB, V26, P660, DOI 10.1016/j.cmet.2017.08.009; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Keipert S, 2015, MOL METAB, V4, P537, DOI 10.1016/j.molmet.2015.04.006; Kinoshita K, 2014, ENDOCRINOLOGY, V155, P3484, DOI 10.1210/en.2014-1175; Knuth CM, 2018, J PHYSIOL-LONDON, V596, P4375, DOI 10.1113/JP276228; Labbe SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015; Mo QX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93166; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Omar BA, 2014, DIABETES, V63, P101, DOI 10.2337/db13-0710; Patsouris D, 2015, CELL REP, V13, P1538, DOI 10.1016/j.celrep.2015.10.028; Peppler WT, 2018, AM J PHYSIOL-ENDOC M, V314, pE66, DOI 10.1152/ajpendo.00226.2017; Peppler WT, 2017, ADIPOCYTE, V6, P1, DOI 10.1080/21623945.2016.1259778; PEREA A, 1995, HORM METAB RES, V27, P372, DOI 10.1055/s-2007-979981; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Richard JE, 2017, AM J PHYSIOL-ENDOC M, V313, pE344, DOI 10.1152/ajpendo.00418.2016; Salem V, 2016, DIABETES OBES METAB, V18, P72, DOI 10.1111/dom.12585; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; SEITZ HJ, 1981, PFLUG ARCH EUR J PHY, V389, P115, DOI 10.1007/BF00582100; Sepa-Kishi DM, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13592; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Townsend LK, 2019, PFLUG ARCH EUR J PHY, V471, P455, DOI 10.1007/s00424-018-2177-1; Townsend LK, 2018, PSYCHONEUROENDOCRINO, V88, P121, DOI 10.1016/j.psyneuen.2017.12.004; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Wainright KS, 2015, AM J PHYSIOL-REG I, V309, pR594, DOI 10.1152/ajpregu.00042.2015; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110	55	17	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4824	4835		10.1096/fj.201802048RR	http://dx.doi.org/10.1096/fj.201802048RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30615494	Bronze			2022-12-26	WOS:000462888500016
J	Vitzthum, C; Stein, L; Brunner, N; Knittel, R; Fallier-Becker, P; Amasheh, S				Vitzthum, Constanze; Stein, Laura; Brunner, Nora; Knittel, Ria; Fallier-Becker, Petra; Amasheh, Salah			Xenopus oocytes as a heterologous expression system for analysis of tight junction proteins	FASEB JOURNAL			English	Article						tissue barrier; claudins; freeze-fracture electron microscopy; TJ strand formation	BLOOD-BRAIN-BARRIER; EPITHELIAL BARRIER; TRANSPORT; DETERMINANTS; CHANNELS; CLAUDINS; CATION	Claudins (cldns) represent the largest family of transmembrane tight junction (TJ) proteins, determining organ-specific epithelial barrier properties. Because methods for the analysis of multiple cldn interaction are limited, we have established the heterologous Xenopus laevis oocyte expression system for TJ protein assembly and interaction analysis. Oocytes were injected with cRNA encoding human cldn-1, -2, or -3 or with a combination of these and were incubated in pairs for interaction analysis. Immunoblotting and immunohistochemistry were performed, and membrane contact areas were analyzed morphometrically and by freeze fracture electron microscopy. Cldns were specifically detected in membranes of expressing oocytes, and coincubation of oocytes resulted in adhesive contact areas that increased with incubation time. Adjacent membrane areas revealed specific cldn signals, including "kissing-point"-like structures representing homophilic trans-interactions of cldns. Contact areas of oocytes expressing a combination markedly exceeded those expressing single cldns, indicating effects on adhesion. Ultrastructural analysis revealed a self-assembly of TJ strands and a cldn-specific strand morphology.	[Vitzthum, Constanze; Stein, Laura; Brunner, Nora; Amasheh, Salah] Free Univ Berlin, Inst Vet Physiol, Oertzenweg 19b, D-14163 Berlin, Germany; [Knittel, Ria; Fallier-Becker, Petra] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany	Free University of Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Amasheh, S (corresponding author), Free Univ Berlin, Inst Vet Physiol, Oertzenweg 19b, D-14163 Berlin, Germany.	salah.amasheh@fu-berlin.de	Amasheh, Salah/AAG-4035-2021		Deutsche Forschungsgemeinschaft [AM141/4-3, AM141/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank their colleagues at the Institute of Veterinary Physiology, Freie Universitat Berlin, for technical assistance and support and Barbara Drewes and Karin Briest-Forch from the Institute of Veterinary Anatomy as well as the colleagues at the Institute of Veterinary Pathology for excellent help with paraffin embedding. This study was supported by Deutsche Forschungsgemeinschaft Grants AM141/4-3 and AM141/11-1. The authors declare no conflicts of interest.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Amasheh S, 1999, J MEMBRANE BIOL, V172, P169, DOI 10.1007/s002329900594; Amasheh S, 1997, J MEMBRANE BIOL, V155, P247, DOI 10.1007/s002329900177; Amasheh S, 2009, INT J COLORECTAL DIS, V24, P1149, DOI 10.1007/s00384-009-0737-8; Angelow S, 2009, ANN NY ACAD SCI, V1165, P143, DOI 10.1111/j.1749-6632.2009.04038.x; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Doring F, 1996, J PHYSIOL-LONDON, V497, P773; Doring F, 1998, J CLIN INVEST, V101, P2761, DOI 10.1172/JCI1909; Doring F, 1998, J BIOL CHEM, V273, P23211, DOI 10.1074/jbc.273.36.23211; EBIHARA L, 1992, METHOD ENZYMOL, V207, P376; Florian P, 2003, BIOCHEM BIOPH RES CO, V304, P5, DOI 10.1016/S0006-291X(03)00498-4; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Markov AG, 2017, IUBMB LIFE, V69, P290, DOI 10.1002/iub.1622; Markov AG, 2015, IUBMB LIFE, V67, P29, DOI 10.1002/iub.1347; Markov AG, 2011, RESP PHYSIOL NEUROBI, V175, P331, DOI 10.1016/j.resp.2010.12.012; Milatz S, 2015, BIOCHEM J, V468, P449, DOI 10.1042/BJ20150148; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; Radloff J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00579; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tebbe B, 2002, ARCH DERMATOL RES, V294, P14, DOI 10.1007/s00403-001-0290-y; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Vitzthum C, 2015, BBA-BIOMEMBRANES, V1848, P2942, DOI 10.1016/j.bbamem.2015.09.009; Vivaudou M, 2017, METHODS MOL BIOL, V1635, P283, DOI 10.1007/978-1-4939-7151-0_15	31	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5312	5319		10.1096/fj.201801451RR	http://dx.doi.org/10.1096/fj.201801451RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30645152	Bronze			2022-12-26	WOS:000462888500055
J	Karki, P; Ke, YB; Tian, YF; Ohmura, T; Sitikov, A; Sarich, N; Montgomery, CP; Birukova, AA				Karki, Pratap; Ke, Yunbo; Tian, Yufeng; Ohmura, Tomomi; Sitikov, Albert; Sarich, Nicolene; Montgomery, Christopher P.; Birukova, Anna A.			Staphylococcus aureus-induced endothelial permeability and inflammation are mediated by microtubule destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelium; lung injury; inflammation; reactive oxygen species (ROS); histone deacetylase 6 (HDAC6); Staphylococcus aureus (S; aureus); microtubule; barrier disruption; CLASP2; GEF-H1	ACUTE LUNG INJURY; BARRIER DYSFUNCTION; CELLS; EPIDEMIOLOGY; ACTIVATION; PATHWAY; GEF-H1; CLASP2; EXPRESSION; HDAC6	Staphylococcus aureus is a major etiological agent of sepsis and induces endothelial cell (EC) barrier dysfunction and inflammation, two major hallmarks of acute lung injury. However, the molecular mechanisms of bacterial pathogen-induced EC barrier disruption are incompletely understood. Here, we investigated the role of microtubules (MT) in the mechanisms of EC barrier compromise caused by heat-killed S. aureus (HKSA). Using a customized monolayer permeability assay in human pulmonary EC and MT fractionation, we observed that HKSA-induced barrier disruption is accompanied by MT destabilization and increased histone deacetylase-6 (HDAC6) activity resulting from elevated reactive oxygen species (ROS) production. Molecular or pharmacological HDAC6 inhibition rescued barrier function in HKSA-challenged vascular endothelium. The HKSA-induced EC permeability was associated with impaired MT-mediated delivery of cytoplasmic linker-associated protein 2 (CLASP2) to the cell periphery, limiting its interaction with adherens junction proteins. HKSA-induced EC barrier dysfunction was also associated with increased Rho GTPase activity via activation of MT-bound Rho-specific guanine nucleotide exchange factor-H1 (GEF-H1) and was abolished by HDAC6 down-regulation. HKSA activated the NF-B proinflammatory pathway and increased the expression of intercellular and vascular cell adhesion molecules in EC, an effect that was also HDAC6-dependent and mediated, at least in part, by a GEF-H1/Rho-dependent mechanism. Of note, HDAC6 knockout mice or HDAC6 inhibitor-treated WT mice were partially protected from vascular leakage and inflammation caused by both HKSA or methicillin-resistant S. aureus (MRSA). Our results indicate that S. aureus-induced, ROS-dependent up-regulation of HDAC6 activity destabilizes MT and thereby activates the GEF-H1/Rho pathway, increasing both EC permeability and inflammation.	[Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21201 USA; [Ke, Yunbo] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Tian, Yufeng; Ohmura, Tomomi; Sitikov, Albert; Sarich, Nicolene; Montgomery, Christopher P.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Montgomery, Christopher P.] Nationwide Childrens Hosp, Dept Crit Care Med, Columbus, OH 43205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Chicago; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Birukova, AA (corresponding author), Univ Maryland, Sch Med, Pulm & Crit Care Med, 20 Penn St,HSF 2,Rm S143, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu		Montgomery, Christopher/0000-0001-7247-0683	National Institutes of Health from NHLBI [HL107920, HL130431]; National Institutes of Health from NIGMS [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130431, R01HL107920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL107920 and HL130431 from NHLBI and GM114171 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhshi TK, 2014, CYTOSKELETON, V71, P1, DOI 10.1002/cm.21150; Alieva IB, 2013, J CELL BIOCHEM, V114, P2258, DOI 10.1002/jcb.24575; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Bogatcheva NV, 2007, AM J PHYSIOL-LUNG C, V292, pL487, DOI 10.1152/ajplung.00217.2006; Borgas D, 2016, AM J RESP CELL MOL, V54, P683, DOI 10.1165/rcmb.2015-0149OC; Cetinkaya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126028; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Demos-Davies KM, 2014, AM J PHYSIOL-HEART C, V307, pH252, DOI 10.1152/ajpheart.00149.2014; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Engel U, 2014, CYTOSKELETON, V71, P195, DOI 10.1002/cm.21164; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fu PF, 2011, CRIT CARE MED, V39, P2711, DOI 10.1097/CCM.0b013e3182284a5f; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gorshkov BA, 2012, VASC PHARMACOL, V56, P56, DOI 10.1016/j.vph.2011.10.002; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Joshi AD, 2015, AM J PHYSIOL-LUNG C, V309, pL1410, DOI 10.1152/ajplung.00180.2015; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li LF, 2015, SCI REP-UK, V5, DOI 10.1038/srep08895; Maki T, 2015, J MOL BIOL, V427, P2379, DOI 10.1016/j.jmb.2015.05.012; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; McLoughlin A, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12664; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Ni YF, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-33; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Pai AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049209; Paulsen J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0849-4; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Saito S, 2011, BIOCHEM BIOPH RES CO, V408, P630, DOI 10.1016/j.bbrc.2011.04.075; Shahbazi Marta N, 2014, Bioarchitecture, V4, P25, DOI 10.4161/bioa.28177; Shahbazi MN, 2013, J CELL BIOL, V203, P1043, DOI 10.1083/jcb.201306019; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Smurova K M, 2008, Tsitologiia, V50, P49; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746; Tian YF, 2015, BBA-MOL BASIS DIS, V1852, P104, DOI 10.1016/j.bbadis.2014.10.012; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565; Woske HJ, 2001, CRIT CARE, V5, P167, DOI 10.1186/cc1017; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010; Zhang L, 2010, WORLD J SURG, V34, P1676, DOI 10.1007/s00268-010-0493-5; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	70	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3369	3384		10.1074/jbc.RA118.004030	http://dx.doi.org/10.1074/jbc.RA118.004030			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622143	Green Published, hybrid			2022-12-26	WOS:000461853900006
J	Nakazawa, N; Arakawa, O; Ebe, M; Yanagida, M				Nakazawa, Norihiko; Arakawa, Orie; Ebe, Masahiro; Yanagida, Mitsuhiro			Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA topoisomerase; protein phosphorylation; chromosomes; yeast genetics; mitosis; cell cycle; anticancer drug; casein kinase II; chromosome segregation; DNA topoisomerase II; fission yeast; ICRF-193	QUANTITATIVE PHOSPHOPROTEOMICS REVEALS; C-TERMINAL DOMAIN; PROTEIN-KINASE; CELL-CYCLE; IN-VIVO; CK2; DYNAMICS; ALPHA; CHROMOSOMES; MUTANTS	DNA topoisomerase II (topo II) regulates the topological state of DNA and is necessary for DNA replication, transcription, and chromosome segregation. Topo II has essential functions in cell proliferation and therefore is a critical target of anticancer drugs. In this study, using Phos-tag SDS-PAGE analysis in fission yeast (Schizosaccharomyces pombe), we identified casein kinase II (Cka1/CKII)-dependent phosphorylation at the C-terminal residues Ser(1363) and Ser(1364) in topo II. We found that this phosphorylation decreases the inhibitory effect of an anticancer catalytic inhibitor of topo II, ICRF-193, on mitosis. Consistent with the constitutive activity of Cka1/CKII, Ser(1363) and Ser(1364) phosphorylation of topo II was stably maintained throughout the cell cycle. We demonstrate that ICRF-193-induced chromosomal mis-segregation is further exacerbated in two temperature-sensitive mutants, cka1-372 and cka1/orb5-19, of the catalytic subunit of CKII or in the topo II nonphosphorylatable alanine double mutant top2-S1363A,S1364A but not in cells of the phosphomimetic glutamate double mutant top2-S1363E,S1364E. Our results suggest that Ser(1363) and Ser(1364) in topo II are targeted by Cka1/CKII kinase and that their phosphorylation facilitates topo II ATPase activity in the N-terminal region, which regulates protein turnover on chromosome DNA. Because CKII-mediated phosphorylation of the topo II C-terminal domain appears to be evolutionarily conserved, including in humans, we propose that attenuation of CKII-controlled topo II phosphorylation along with catalytic topo II inhibition may promote anticancer effects.	[Nakazawa, Norihiko; Arakawa, Orie; Ebe, Masahiro; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ, Cell Unit G0, Onna Son, Okinawa 9040495, Japan	Okinawa Institute of Science & Technology Graduate University	Nakazawa, N; Yanagida, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Cell Unit G0, Onna Son, Okinawa 9040495, Japan.	nakazawa@oist.jp; myanagid@gmail.com			OIST Graduate University	OIST Graduate University	We thank Drs. Yukinobu Nakaseko and Mitsuko Hatanaka for identification of the cka1-372 mutation in the early stage of this work and Dr. Steven D. Aird for editing the manuscript. We are also grateful for the generous support of OIST Graduate University.	ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Andoh T, 1998, BBA-GENE STRUCT EXPR, V1400, P155, DOI 10.1016/S0167-4781(98)00133-X; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARDENAS ME, 1993, J CELL SCI, V104, P533; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Clarke DJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112438; CORBETT AH, 1992, J BIOL CHEM, V267, P20513; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; DEVORE RF, 1992, CANCER RES, V52, P2156; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Ganapathi RN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00089; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Hanif IM, 2010, INT J BIOCHEM CELL B, V42, P1602, DOI 10.1016/j.biocel.2010.06.010; Haraguchi T, 1997, GENES CELLS, V2, P369, DOI 10.1046/j.1365-2443.1997.1280326.x; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Isabelle C., 2017, TOR1 CK2 KINASES CON, DOI [10.1371/journal.pbio.2000245, DOI 10.1371/JOURNAL.PBIO.2000245]; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Ishida R, 2001, CELL STRUCT FUNCT, V26, P215, DOI 10.1247/csf.26.215; ISHIDA R, 1991, CANCER RES, V51, P4909; Kettenbach AN, 2015, MOL CELL PROTEOMICS, V14, P1275, DOI 10.1074/mcp.M114.045245; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Nakazawa N, 2016, GENES CELLS, V21, P978, DOI 10.1111/gtc.12397; Nakazawa N, 2015, GENES CELLS, V20, P481, DOI 10.1111/gtc.12239; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rusin SF, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00097; SAIJO M, 1990, BIOCHEMISTRY-US, V29, P583, DOI 10.1021/bi00454a036; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; SHIOZAKI K, 1991, MOL CELL BIOL, V11, P6093, DOI 10.1128/MCB.11.12.6093; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; STONE EM, 1993, CURR BIOL, V3, P13, DOI 10.1016/0960-9822(93)90140-J; Su SSY, 1996, J CELL SCI, V109, P1347; Swaffer MP, 2018, CELL REP, V24, P503, DOI 10.1016/j.celrep.2018.06.036; TAAGEPERA S, 1993, P NATL ACAD SCI USA, V90, P8407, DOI 10.1073/pnas.90.18.8407; TAKANO H, 1991, CANCER RES, V51, P3951; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; UEMURA T, 1986, EMBO J, V5, P1003, DOI 10.1002/j.1460-2075.1986.tb04315.x; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WELLS NJ, 1994, J BIOL CHEM, V269, P29746	71	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3772	3782		10.1074/jbc.RA118.004955	http://dx.doi.org/10.1074/jbc.RA118.004955			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635402	Green Published, hybrid			2022-12-26	WOS:000461853900037
J	Han, XN; Huang, J; Lv, JH; Ma, L; Peng, LR; Wang, JP; Nie, XJ; Xia, L; Zan, X				Han, Xiaonian; Huang, Jing; Lv, Jianhua; Ma, Li; Peng, Lirong; Wang, Jinping; Nie, Xiaojing; Xia, Li; Zan, Xin			The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy	PLOS ONE			English	Article							VALPROIC ACID; PHARMACOKINETICS; COMEDICATION; CHILDREN; POLYMORPHISM; TOPIRAMATE; AGE; GLUCURONIDATION; OXCARBAZEPINE; EFFICACY	Objective The aims of this study were to identify the influencing factors such as gender, age, dose and combinations of other antiepileptic drugs (AEDs), especially in triple combinations on the pharmacokinetic of Lamotrigine (LTG) in epilepsy patients of Northwest Chinese Han population. Methods Data of the LTG concentration and clinical information were analyzed retrospectively from a therapeutic drug monitoring (TDM) database at the Clinical Pharmacy Laboratory of Xi'an Central Hospital between January 1, 2016 and January 1, 2018. The independent-sample t-test, one-way ANOVA analysis and Bonferroni and Tamhane T3 post-hoc test, the stepwise multivariate regression analysis were adopted by IBM SPSS, version 22.0. Results 226 serum samples met the inclusion criteria and were evaluated. The mean LTG serum concentration was 5.48 +/- 3.83 mu g/mL. There were no gender differences (P = 0.64), and there were no significant effects by age on LTG serum concentration after age stratification (3-14 years old, 14-45 years old, 45-59 years old) (P = 0.05). Multiple regression analysis showed that the daily LTG dose and co-administration of other AEDs significantly affected LTG serum concentrations. Combination with enzyme-inducer AEDs, the mean steady-state LTG concentration could be decreased by 30.73% compared with LTG monotherapy. Among enzyme-inducer AEDs, particularly strong inducer Carbamazepine (CBZ) could decrease the mean LTG concentration by 53.65%, but weak inducer AEDs such as Oxcarbazepine (OXC) and Topiramate (TPM) had no effect, Valproic acid (VPA) could increase the mean LTG concentration by 93.95%, and the inducer only partially compensated for the inhibitory effect of VPA in triple combination. Conclusions There were no significant gender and age effects, but the LTG daily dose and co-administration of other AEDs significantly affected LTG serum concentration. Combination with enzyme-inducer AEDs, especially CBZ could significantly decrease LTG serum concentrations, VPA could significantly increase LTG serum concentrations, and the inducer only partially compensated for the inhibitory effect of VPA in triple combination. In the clinical setting, these findings can help to estimate LTG concentrations and adjust dosage and evaluate adverse drug reactions.	[Han, Xiaonian; Huang, Jing; Lv, Jianhua; Ma, Li; Peng, Lirong; Wang, Jinping; Nie, Xiaojing; Xia, Li; Zan, Xin] Xian Cent Hosp, Dept Clin Pharm, Xian, Shaanxi, Peoples R China		Han, XN (corresponding author), Xian Cent Hosp, Dept Clin Pharm, Xian, Shaanxi, Peoples R China.	xjtuhxn@126.com						Anderson GD, 1998, ANN PHARMACOTHER, V32, P554, DOI 10.1345/aph.17332; Argikar UA, 2009, XENOBIOTICA, V39, P355, DOI 10.1080/00498250902745082; Bartoli A, 1997, THER DRUG MONIT, V19, P252, DOI 10.1097/00007691-199706000-00002; Battino D, 1997, THER DRUG MONIT, V19, P620, DOI 10.1097/00007691-199712000-00003; Battino D, 2001, THER DRUG MONIT, V23, P217, DOI 10.1097/00007691-200106000-00006; Berry DJ, 2002, EPILEPSIA, V43, P818, DOI 10.1046/j.1528-1157.2002.37701.x; Chang Y, 2014, EUR J CLIN PHARMACOL, V70, P941, DOI 10.1007/s00228-014-1690-1; Doose DR, 2003, EPILEPSIA, V44, P917, DOI 10.1046/j.1528-1157.2003.64402.x; Flesch G, 2004, CLIN DRUG INVEST, V24, P185, DOI 10.2165/00044011-200424040-00001; Gidal BE, 2003, EPILEPSY RES, V57, P85, DOI 10.1016/j.eplepsyres.2003.09.008; Gulcebi MI, 2011, EPILEPSY RES, V95, P1, DOI 10.1016/j.eplepsyres.2011.01.016; Taing KD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169974; Kim HJ, 2015, CLIN CHIM ACTA, V438, P269, DOI 10.1016/j.cca.2014.09.004; Lalic M, 2009, EUR J DRUG METAB PH, V34, P93; Liu LM, 2015, EUR J CLIN PHARMACOL, V71, P1341, DOI 10.1007/s00228-015-1925-9; Ma CL, 2015, PHARMACOGENOMICS, V16, P347, DOI [10.2217/PGS.14.186, 10.2217/pgs.14.186]; MAGDALOU J, 1992, J PHARMACOL EXP THER, V260, P1166; May TW, 1996, THER DRUG MONIT, V18, P523, DOI 10.1097/00007691-199610000-00001; May TW, 1999, THER DRUG MONIT, V21, P175, DOI 10.1097/00007691-199904000-00007; Milosheska D, 2016, BRIT J CLIN PHARMACO, V82, P399, DOI 10.1111/bcp.12984; Nims RW, 1997, DRUG METAB DISPOS, V25, P750; Otoul C, 2007, EPILEPSIA, V48, P2111, DOI 10.1111/j.1528-1167.2007.01201.x; Pisani F, 1999, EPILEPSIA, V40, P1141, DOI 10.1111/j.1528-1157.1999.tb00832.x; Reimers A, 2016, EUR J DRUG METAB PH, V41, P149, DOI 10.1007/s13318-014-0247-0; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; van Dijkman SC, 2018, CLIN PHARMACOKINET, V57, P1039, DOI 10.1007/s40262-017-0614-5; Wang QN, 2015, DRUG METAB PHARMACOK, V30, P209, DOI 10.1016/j.dmpk.2014.12.007; Weintraub D, 2005, ARCH NEUROL-CHICAGO, V62, P1432, DOI 10.1001/archneur.62.9.1432; WnukWV A, 1999, THERAPEUTIC DRUG MON, V21; Yasam VR, 2016, EXPERT REV CLIN PHAR, V9, P1533, DOI 10.1080/17512433.2016.1254041; Yuen AWC P A, 1998, BR J CLIN PHARM, V26, P242; Zhang Shen, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P105	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210600	10.1371/journal.pone.0210600	http://dx.doi.org/10.1371/journal.pone.0210600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645607	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200039
J	Panpetch, W; Somboonna, N; Palasuk, M; Hiengrach, P; Finkelman, M; Tumwasorn, S; Leelahavanichkul, A				Panpetch, Wimonrat; Somboonna, Naraporn; Palasuk, Matanee; Hiengrach, Pratsanee; Finkelman, Malcolm; Tumwasorn, Somying; Leelahavanichkul, Asada			Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium	PLOS ONE			English	Article							INTESTINAL FUNGI; GUT MICROBIOME; COLONIZATION; MICE; ANTIBIOTICS; NORVEGENSIS; INCONSPICUA; TOXIN	Gut fungi may influence the course of Clostridium difficile infection either positively or negatively for the host. Fungi are not prominent in the mouse gut, and C. albicans, the major human gastrointestinal commensal yeast, is in low abundance or absent in mice. Bifidobacterium is one of the probiotics that may attenuate the severity of C. difficile infection. Inflammatory synergy between C. albicans and C. difficile, in gut, may provide a state that more closely resembles human infection and be more suitable for testing probiotic effects. We performed fecal mycobiota analysis and administered C. albicans at 1 day prior to C. difficile dosing. Fecal eukaryotic 18S rDNA analysis demonstrated the presence of Ascomycota, specifically, Candida spp., after oral antibiotics, despite negative fecal fungal culture. C. albicans administration enhanced the severity of the C. difficile infection model as determined by mortality rate, weight loss, gut leakage (FITC-dextran assay), and serum and intestinal tissue cytokines. This occurred without increased fecal C. difficile or bacteremia, in comparison with C. difficile gavage alone. Candida lysate with C. difficile increased IL-8 production from HT-29 and Caco-2 human intestinal epithelial cell-lines. Bifidobacterium attenuated the disease severity of the C. difficile plus Candida model. The reduced severity was associated with decreased Candida burdens in feces. In conclusion, gut C. albicans worsened C. difficile infection, possibly through exacerbation of inflammation. Hence, a mouse model of Clostridium difficile infection with C. albicans present in the gut may better model the human patient condition. Gut fungal mycobiome investigation in patients with C. difficile is warranted and may suggest therapeutic targets.	[Panpetch, Wimonrat; Hiengrach, Pratsanee; Tumwasorn, Somying; Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Somboonna, Naraporn; Palasuk, Matanee] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand; [Finkelman, Malcolm] Associates Cape Cod Inc, East Falmouth, MA USA; [Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand.; Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.	aleelahavanit@gmail.com			Thailand Government Fund [RSA-6080023]; Thailand Research Fund [RES_61_202_30_022]; Chulalongkorn University [760001-HR]; Chulalongkorn University; Cape Cod Inc.	Thailand Government Fund; Thailand Research Fund(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); Chulalongkorn University(Chulalongkorn University); Cape Cod Inc.	This study was supported by Thailand Government Fund (RSA-6080023 to AL) and Thailand Research Fund (RES_61_202_30_022 to AL) and grant for International Research Integration, Chula Research Scholar, Ratchadaphisek Somphot Endowment Fund (2017), Chulalongkorn University (760001-HR to AL). WP was supported by Ratchadaphisek Somphot Fund for Postdoctoral Fellowship, Chulalongkorn University. MF received salary from Cape Cod Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Boonma P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-177; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Evans CT, 2015, CLIN INFECT DIS, V60, pS66, DOI 10.1093/cid/civ140; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Gaulin E, 2007, MOL PLANT PATHOL, V8, P539, DOI [10.1111/j.1364-3703.2007.00413.x, 10.1111/j.1364-3703.2007.00413.X]; Giraldo A, 2014, J CLIN MICROBIOL, V52, P4189, DOI 10.1128/JCM.02027-14; Guitard J, 2015, J CLIN MICROBIOL, V53, P1655, DOI 10.1128/JCM.02913-14; Guitard J, 2013, MED MYCOL, V51, P795, DOI 10.3109/13693786.2013.807444; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hutton ML, 2014, FEMS MICROBIOL LETT, V352, P140, DOI 10.1111/1574-6968.12367; Iizumi T, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0143-z; Issara-Amphorn J, 2018, J INNATE IMMUN, V10, P189, DOI 10.1159/000486321; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kikkert R, 2007, J ENDOTOXIN RES, V13, P140, DOI 10.1177/0968051907080024; Koh AY, 2013, EUKARYOT CELL, V12, P1416, DOI 10.1128/EC.00196-13; Kumamoto CA, 2011, CURR OPIN MICROBIOL, V14, P386, DOI 10.1016/j.mib.2011.07.015; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Leelahavanichkul A, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw204; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Libby DB, 2009, INT J INFECT DIS, V13, pE305, DOI 10.1016/j.ijid.2009.01.014; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Panpetch W, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00700-17; Panpetch W, 2018, SHOCK, V49, P62, DOI 10.1097/SHK.0000000000000896; Panpetch W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181439; Panpetch W, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0861-x; Qiu XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10416; SAMONIS G, 1994, ANTIMICROB AGENTS CH, V38, P602, DOI 10.1128/AAC.38.3.602; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yamaguchi N, 2006, GUT, V55, P954, DOI 10.1136/gut.2005.084954; Yamaguchi N, 2005, J NUTR, V135, P109, DOI 10.1093/jn/135.1.109; Yang AM, 2017, J CLIN INVEST, V127, P2829, DOI 10.1172/JCI90562; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	41	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210798	10.1371/journal.pone.0210798	http://dx.doi.org/10.1371/journal.pone.0210798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645630	gold, Green Submitted, Green Published			2022-12-26	WOS:000455810200056
J	Chu, KA; Chen, W; Hsu, CY; Hung, YM; Wei, JCC				Chu, Kuo-An; Chen, Weishan; Hsu, Chung Y.; Hung, Yao-Min; Wei, James Cheng-Chung			Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan	PLOS ONE			English	Article							SYNOVIAL-FLUID; AUTOIMMUNE; INFECTIONS; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; MECHANISMS; RESPONSES; DISEASE; SYSTEM	Objective An association between Mycoplasma pneumonia ( MP) and rheumatoid arthritis ( RA) had been reported in animal studies for decades. However, clinical evidence for this association is lacking. Therefore, this study aimed to provide epidemiologic evidence to clarify the relationship between MP and development of RA. Methods This 13-year nationwide, population-based, retrospective cohort study analyzed the risk of RA in a cohort of MP patients. We cross linked and compared the database of those with catastrophic illnesses to make sure the diagnoses of RA are correctly labeled. We selected 116,053 hospitalized patients diagnosed with MP between 2000 and 2012 from the Taiwan National Health Insurance Research Database and 464,212 matched controls at a 1: 4 ratio by age, gender, and index year, in relation to the risk of developing RA. The follow-up period referred to the initial diagnosis of MP until the date of RA diagnosis, censoring of RA, or 31st December 2013. The Cox proportional hazard model was used to analyze the association between MP and incidence of RA among patients with different potential risks. Results The adjusted hazard ratio (HR) for incidental RA in the MP group was 1.37 (95% confidence interval CI = 0.87-2.16), compared to non-MP controls. Stratified analysis revealed that the adjusted HR was 3.05 (95% CI = 1.16-7.99, p = 0.02) in a subgroup of patients over the age of 65. The adjusted HR of RA for the MP group among aged <= 19 years and >= 65 years was 3.19 (95% CI = 1.04.9.76) and 4.14 (95% CI = 1.27,13.4) within the first 2 years of follow-up. Conclusion This cohort study demonstrated that patients with MP had a higher risk of developing RA, especially in the first 2 years, in those aged younger than 19 and over 65 .	[Chu, Kuo-An] Kaohsiung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Kaohsiung, Taiwan; [Chu, Kuo-An] Shu Zen Jr Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan; [Chu, Kuo-An; Hung, Yao-Min] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Weishan] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Weishan] China Med Univ, Coll Med, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hung, Yao-Min] Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Hung, Yao-Min] Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Kaohsiung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan	Hung, YM (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hung, YM (corresponding author), Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan.; Hung, YM (corresponding author), Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan.	ymhung1@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; China Medical University Hospital [DMR-107-192]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; China Medical University Hospital; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), the China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), the MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), the China Medical University Hospital (DMR-107-192), the Tseng-Lien Lin Foundation, Taichung, Taiwan, and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Autoimmune Related Diseases Association; National Coalition of Autoimmune Patient Groups, COST BURD AUT DIS LA; Ataee RA, 2015, ARCH IRAN MED, V18, P345, DOI 015186/AIM.004; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BURMESTER GR, 1995, ANNU REV IMMUNOL, V13, P229, DOI 10.1146/annurev.iy.13.040195.001305; Chang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103078; Chaudhry Rama, 2003, Indian J Pathol Microbiol, V46, P433; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; COLE BC, 1976, ANN RHEUM DIS, V35, P14, DOI 10.1136/ard.35.1.14; Cole BC, 1996, ASM NEWS, V62, P471; COLE BC, 1993, ARTHRITIS RHEUM-US, V36, P994, DOI 10.1002/art.1780360717; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Danzer C, 2013, ARCH IMMUNOL THER EX, V61, P175, DOI 10.1007/s00005-013-0216-3; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Guo HM, 2016, J INFECT CHEMOTHER, V22, P162, DOI 10.1016/j.jiac.2015.12.006; HAKKARAINEN K, 1992, ANN RHEUM DIS, V51, P1170, DOI 10.1136/ard.51.10.1170; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hoffman RW, 1997, ARTHRITIS RHEUM-US, V40, P1219, DOI 10.1002/art.1780400705; Jung JY, 2017, KOREAN J INTERN MED, V32, P429, DOI 10.3904/kjim.2016.234; KVIEN TK, 1994, J RHEUMATOL, V21, P115; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; Li Song, 2013, J Clin Cell Immunol, V4; Luo WY, 2008, INFECT IMMUN, V76, P4989, DOI 10.1128/IAI.00667-08; Odeh AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155648; Raaschou P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i262; Rosenblum MD, 2015, J CLIN INVEST, V125, P2228, DOI 10.1172/JCI78088; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Sandberg MEC, 2015, ANN RHEUM DIS, V74, P904, DOI 10.1136/annrheumdis-2014-206493; Schaeverbeke T, 1997, BRIT J RHEUMATOL, V36, P310; TaylorRobinson D, 1996, CLIN INFECT DIS, V23, P671, DOI 10.1093/clinids/23.4.671; Vesely M.C.A., 2012, J PARASITOL RES, V2012, DOI [10.1155/2012/362131, DOI 10.1155/2012/362131]	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210750	10.1371/journal.pone.0210750	http://dx.doi.org/10.1371/journal.pone.0210750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640923	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000044
J	Zhang, JH; Shi, JT; Gao, S; Huo, YZ; Cui, JJ; Shen, H; Liu, GY; He, PM				Zhang, Jianheng; Shi, Jinting; Gao, Song; Huo, Yuanzi; Cui, Jianjun; Shen, Hui; Liu, Guiyan; He, Peimin			Annual patterns of macroalgal blooms in the Yellow Sea during 2007-2017	PLOS ONE			English	Article							LARGEST GREEN-TIDE; ULVA-PROLIFERA; SEAWEED AQUACULTURE; EXPANSION; CHINA; TEMPERATURE; SALINITY; GROWTH; ALGAE; IRRADIANCE	The world's largest macroalgal blooms caused by Ulva prolifera have occurred in the Yellow Sea for 11 consecutive years. The area covered by blooms has been approximately 500 km(2) in previous years, while in 2017, the maximum area decreased significantly to 312 km(2). In this study, we concluded that species competition between Ulva and Sargassum (fast rise of the golden tides), extreme high sea surface temperature and harvest for floating Ulva macroalgae were the three critical factors influencing the sharp reduction in covered area for blooms in 2017. In addition, analysis of annual variations of Pyropia aquaculture area in the Southern Yellow Sea over the past two decades revealed that a great expansion in "Sansha" regions was mainly responsible for the initial blooms in 2007, and that this expansion supported the great biomass of the blooms in following years. Based on these findings, we suggest comprehensive utilization of the macroalgal blooms is a feasible way to control them.	[Zhang, Jianheng; Shi, Jinting; Huo, Yuanzi; Cui, Jianjun; He, Peimin] Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China; [Gao, Song; Liu, Guiyan] State Ocean Administrator, North China Sea Marine Forecasting Ctr, Qingdao, Peoples R China; [Shen, Hui] Jiangsu Inst Marine Fisheries, Nantong, Peoples R China	Shanghai Ocean University	Cui, JJ; He, PM (corresponding author), Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China.	cuijianjun29@163.com; pmhe@shou.edu.cn	Huo, Yuanzi/R-4840-2017; he, peimin/ABG-4220-2021	He, Peimin/0000-0003-3704-7905	National Natural Science Foundation of China [41576163]; National Key R&D Program of China for Blue Granary [2018YFD0901500]; Shanghai Sailing Program [17YF1407900]; Ocean Public Welfare Scientific Research Project, China [201205010]; Jiangsu marine science and technology innovation project [HY2017-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China for Blue Granary; Shanghai Sailing Program; Ocean Public Welfare Scientific Research Project, China; Jiangsu marine science and technology innovation project	This work was funded by National Natural Science Foundation of China (Grant No. 41576163), National Key R&D Program of China for Blue Granary (2018YFD0901500), Shanghai Sailing Program (17YF1407900), the Ocean Public Welfare Scientific Research Project, China (201205010), and the Jiangsu marine science and technology innovation project (HY2017-4).	Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Cai ZiHao, 2016, Acta Agriculturae Zhejiangensis, V28, P1206; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Cui JJ, 2018, MAR POLLUT BULL, V130, P223, DOI 10.1016/j.marpolbul.2018.03.036; Cui JJ, 2015, MAR POLLUT BULL, V101, P660, DOI 10.1016/j.marpolbul.2015.10.033; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; [何华春 He Huachun], 2012, [第四纪研究, Quaternary Sciences], V32, P1161; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005561; Huo YZ, 2013, LIMNOL OCEANOGR, V58, P2206, DOI 10.4319/lo.2013.58.6.2206; Keesing JK, 2011, MAR POLLUT BULL, V62, P1169, DOI 10.1016/j.marpolbul.2011.03.040; Largo DB, 2004, HYDROBIOLOGIA, V512, P247, DOI 10.1023/B:HYDR.0000020333.33039.4b; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2018, LIMNOL OCEANOGR, V63, P1762, DOI 10.1002/lno.10806; Liu XQ, 2016, MAR ENVIRON RES, V119, P189, DOI 10.1016/j.marenvres.2016.06.004; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS, P366, DOI [10.1017/CBO9780511626210, 10.1111/jpy.12398, DOI 10.1111/JPY.12398]; Luning K, 1990, SEAWEEDS THEIR ENV B, P527; Shimada Satoshi, 2003, Phycological Research, V51, P99, DOI 10.1046/j.1440-1835.2003.00296.x; Sousa AI, 2007, J EXP MAR BIOL ECOL, V341, P142, DOI 10.1016/j.jembe.2006.09.020; Su L, 2018, J APPL PHYCOL, V30, P1417, DOI 10.1007/s10811-017-1296-y; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; Wang ZL, 2015, LIMNOL OCEANOGR, V60, P1105, DOI 10.1002/lno.10083; Xiao J, 2016, ACTA OCEANOL SIN, V35, P114, DOI 10.1007/s13131-016-0891-0; Xing QG, 2017, IEEE GEOSCI REMOTE S, V14, P1815, DOI 10.1109/LGRS.2017.2737079; Yan YX, 1999, SCI CHINA SER D, V42, P13, DOI 10.1007/BF02878493; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang JH, 2013, MAR ENVIRON RES, V92, P35, DOI 10.1016/j.marenvres.2013.08.009; Zhang JH, 2017, ESTUAR COAST SHELF S, V189, P58, DOI 10.1016/j.ecss.2017.03.011; Zhang JH, 2016, MAR POLLUT BULL, V104, P101, DOI 10.1016/j.marpolbul.2016.01.056; Zhang JH, 2014, MAR POLLUT BULL, V89, P276, DOI 10.1016/j.marpolbul.2014.09.049; Zhang JH, 2013, J APPL PHYCOL, V25, P795, DOI 10.1007/s10811-012-9972-4; Zhang XW, 2011, LIMNOL OCEANOGR, V56, P233, DOI 10.4319/lo.2011.56.1.0233	34	40	43	9	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210460	10.1371/journal.pone.0210460	http://dx.doi.org/10.1371/journal.pone.0210460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640934	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000029
J	Stefani, MMA; Rosa, PS; Costa, MB; Schetinni, APM; Manhaes, I; Pontes, MAA; Costa, P; Fachin, LRV; Batista, IMFD; Virmond, M; Pereira, E; Penna, MLF; Penna, GO				Araujo Stefani, Mariane Martins; Rosa, Patricia Sammarco; Costa, Mauricio Barcelos; Mendes Schetinni, Antonio Pedro; Manhaes, Igor; Andrade Pontes, Maria Araci; Costa, Patricia; Vincenzi Fachin, Luciana Raquel; Foschiani Dias Batista, Ida Maria; Virmond, Marcos; Pereira, Emilia; Fernandes Penna, Maria Lucia; Penna, Gerson Oliveira			Leprosy survey among rural communities and wild armadillos from Amazonas state, Northern Brazil	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE DNA; PARACOCCIDIOIDES-BRASILIENSIS; DASYPUS-NOVEMCINCTUS; ZOONOTIC LEPROSY; INFECTION; DISEASE; MODEL; PCR	There is evidence that in southern US, leprosy is a zoonosis infecting wild Dasypus novemcinctus armadillos but the extent of this finding is unknown. This ecological study investigated leprosy in rural communities and in wild armadillos from the Brazilian Amazon. The study area was the Mamia Lake of Coari municipality, Amazonas State, Northern region, a hyper endemic leprosy area where residents live on subsistence farming, fishing and armadillo hunting and its meat intake are frequent. The leprosy survey was conducted in sixteen communities by a visiting team of specialists. Local partakers provided wild armadillos to investigate M. leprae infection. Volunteers had complete dermato-neurological examination by a dermatologist with expertise in leprosy diagnosis, suspect skin lesions were biopsied for histopathology (Hematoxylin-eosin/HE, Fite-Faraco/FF staining); slit skin smears were collected. Armadillos' tissue fragments (skins, spleens, livers, lymph nodes, adrenal glands, others) were prepared for histopathology (HE/FF) and for M. leprae repetitive element-RLEP-qPCR. Among 176 volunteers, six new indeterminate leprosy cases were identified (incidence = 3.4%). Suspect skin sections and slit skin smears were negative for bacilli. Twelve wild D. novemcinctus were investigated (48 specimens/96 slides) and histopathological features of M. leprae infection were not found, except for one skin presenting unspecific inflammatory infiltrate suggestive of indeterminate leprosy. Possible traumatic neuroma, granuloma with epithelioid and Langhans cells, foreign-body granuloma were also identified. Granulomatous/non-granulomatous dermatitides were periodic-acid-Schiff/PAS negative for fungus. M. leprae-RLEP-qPCR was negative in all armadillos' tissues; no bacillus was found in histopathology. Our survey in rural communities confirmed the high endemicity for leprosy while one armadillo was compatible with paucibacillary M. leprae infection. At least in the highly endemic rural area of Coari, in the Brazilian Amazon region where infectious sources from untreated multibacillary leprosy are abundant, M. leprae infected armadillos may not represent a major source of infection nor a significant public health concern.	[Araujo Stefani, Mariane Martins] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Rosa, Patricia Sammarco; Vincenzi Fachin, Luciana Raquel; Foschiani Dias Batista, Ida Maria; Virmond, Marcos] Inst Lauro Souza Lima Bauru, Sao Paulo, Brazil; [Costa, Mauricio Barcelos] Univ Fed Goias, Fac Med, Goiania, Go, Brazil; [Mendes Schetinni, Antonio Pedro; Pereira, Emilia] Fundacao Dermatol Trop & Venerol, Manaus, Amazonas, Brazil; [Manhaes, Igor] Univ Fed Rio de Janeiro, Dept Dermatol, Rio De Janeiro, Brazil; [Andrade Pontes, Maria Araci] Ctr Dermatol Dona Libania, Fortaleza, Ceara, Brazil; [Costa, Patricia] Secretaria Municipal Saude, Coari, Amazonas, Brazil; [Fernandes Penna, Maria Lucia] Univ Fed Fluminense, Inst Saude Colet, Niteroi, RJ, Brazil; [Penna, Gerson Oliveira] Univ Brasilia, Ctr Med Trop, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade de Brasilia	Stefani, MMA (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.; Penna, GO (corresponding author), Univ Brasilia, Ctr Med Trop, Brasilia, DF, Brazil.	mmastefani@gmail.com; gerson.penna@fiocruz.br	Fachin, Luciana R. V./N-7054-2013; Penna, Gerson/AAE-5254-2020; Visentainer, Jeane Eliete Laguila/B-3510-2009; Visentainer, Jeane/AAJ-1618-2021	Visentainer, Jeane Eliete Laguila/0000-0002-5815-7903; Penna, Gerson/0000-0001-8967-536X; Fachin, Luciana Raquel Vincenzi/0000-0002-7493-950X	Department of Science and Technology (DECIT) of Brazilian Ministry of Health; Brazilian Council for Research (CNPq) [401791/2014-9]	Department of Science and Technology (DECIT) of Brazilian Ministry of Health(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Brazilian Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Department of Science and Technology (DECIT) of Brazilian Ministry of Health and the Brazilian Council for Research (CNPq process #No 401791/2014-9 to GOP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abide JM, 2008, SOUTH MED J, V101, P635, DOI 10.1097/SMJ.0b013e31816f8610; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P461; Avanzi C, 2016, SCIENCE, V354, P744, DOI 10.1126/science.aah3783; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Bagagli E, 2006, INFECT GENET EVOL, V6, P344, DOI 10.1016/j.meegid.2005.12.002; Pedrini SCB, 2010, BRAZ J INFECT DIS, V14, P47, DOI 10.1590/S1413-86702010000100010; Cardona-Castro N, 2009, LEPROSY REV, V80, P424; Clark BM, 2008, AM J TROP MED HYG, V78, P962, DOI 10.4269/ajtmh.2008.78.962; Deps PD, 2007, REV SOC BRAS MED TRO, V40, P86, DOI 10.1590/S0037-86822007000100019; Deps PD, 2002, INT J LEPROSY, V70, P34; Dhaliwal U, 2003, INT J LEPROSY, V71, P10, DOI 10.1489/1544-581X(2003)71&lt;10:ENLAOI&gt;2.0.CO;2; Job CK, 2000, INT J LEPROSY, V68, P18; KIRCHHEIMER W F, 1972, International Journal of Leprosy and Other Mycobacterial Diseases, V40, P229; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Kirchheimer W F, 1977, Lepr India, V49, P48; Lane JE, 2006, J AM ACAD DERMATOL, V55, P714, DOI 10.1016/j.jaad.2006.02.070; Moises B., 2018, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd.0006532, DOI 10.1371/JOURNAL.PNTD.0006532]; Scollard DM, 2006, CLIN INFECT DIS, V43, pE19, DOI 10.1086/505222; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Sharma I, 2015, INDIAN J MED RES, V142, P680, DOI 10.4103/0971-5916.174554; Sharma R, 2018, INFECT GENET EVOL, V62, P20, DOI 10.1016/j.meegid.2018.04.017; Sharma R, 2015, EMERG INFECT DIS, V21, P2127, DOI 10.3201/eid2112.150501; Sharma R, 2013, DIS MODEL MECH, V6, P19, DOI 10.1242/dmm.010215; SHEPARD CC, 1960, J EXP MED, V112, P445, DOI 10.1084/jem.112.3.445; Shepard CC, 1965, INT J LEPROSY, V33, P657; Azevedo MDS, 2017, BRAZ J INFECT DIS, V21, P71, DOI 10.1016/j.bjid.2016.09.017; STORRS EE, 1974, SCIENCE, V183, P851, DOI 10.1126/science.183.4127.851; Truman R, 2005, LEPROSY REV, V76, P198; Truman R, 2008, SOUTH MED J, V101, P581, DOI 10.1097/SMJ.0b013e318172dd6c; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; TRUMAN RW, 1991, EPIDEMIOL INFECT, V106, P549, DOI 10.1017/S0950268800067613; WALSH GP, 1975, J RETICULOENDOTH SOC, V18, P347; Wilder-Smith EP, 2008, NAT CLIN PRACT NEURO, V4, P656, DOI 10.1038/ncpneuro0941; Zumarraga MJ, 2001, INT J LEPROSY, V69, P21	35	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209491	10.1371/journal.pone.0209491	http://dx.doi.org/10.1371/journal.pone.0209491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629624	Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000026
J	Heins, F; Meermeier, A; Lappe, M				Heins, Frauke; Meermeier, Annegret; Lappe, Markus			Volitional control of saccadic adaptation	PLOS ONE			English	Article							GAIN ADAPTATION; EYE-MOVEMENTS; VISUAL ERROR; PLASTICITY	Saccadic adaptation is assumed to be driven by an unconscious and automatic mechanism. We wondered if the adaptation process is accessible to volitional control, specifically whether any change in saccade gain can be inhibited. Participants were exposed to post-saccadic error by using the double-step paradigm in which a target is presented in a peripheral location and then stepped during the saccade to another location. In one condition, participants were instructed to follow the target step and look at the final target location. In the other condition they were instructed to inhibit the adjustment of saccade amplitude and look at the initial target location. We conducted two experiments, which differed in the size of the intra-saccadic target step. We found that when told to inhibit amplitude adjustment, gain change was close to zero for outward steps, but some adaptation remained for inward steps. Saccadic latency was not affected by the instruction type for inward steps, but when the target was stepped outward, latencies were longer in the inhibition than in the adaptation condition. The results show that volitional control can be exerted on saccadic adaptation. We suggest that volitional control affects the remapping of the target, thus having a larger impact on outward adaptation.	[Heins, Frauke; Meermeier, Annegret; Lappe, Markus] Univ Munster, Dept Psychol, Munster, Germany; [Meermeier, Annegret; Lappe, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany	University of Munster; University of Munster	Heins, F (corresponding author), Univ Munster, Dept Psychol, Munster, Germany.	frauke.heins@uni-muenster.de		Meermeier, Annegret/0000-0002-3090-3927; Heins, Frauke/0000-0001-8093-9840	German Research Foundation [DFG La 952-6, La 952-8]; European Unions Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [734227]	German Research Foundation(German Research Foundation (DFG)); European Unions Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant	This work was supported by the German Research Foundation (DFG La 952-6 and La 952-8) and has received funding from the European Unions Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 734227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL LA, 1978, ANN NEUROL, V4, P313, DOI 10.1002/ana.410040405; Alahyane N, 2007, BRAIN RES, V1135, P107, DOI 10.1016/j.brainres.2006.11.077; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; Becker W, 1989, Rev Oculomot Res, V3, P13; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Collins T, 2012, J NEUROPHYSIOL, V107, P3342, DOI 10.1152/jn.00746.2011; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; FISCHER B, 1992, EXP BRAIN RES, V89, P415; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Golla H, 2005, BRAIN, V128, P1525, DOI 10.1093/brain/awh523; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; HENSON DB, 1978, VISION RES, V18, P63, DOI 10.1016/0042-6989(78)90078-0; KOMMERELL G, 1976, INVEST OPHTH VISUAL, V15, P657; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Nyffeler T, 2007, EUR J NEUROSCI, V26, P1381, DOI 10.1111/j.1460-9568.2007.05758.x; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; STRAUBE A, 1995, VISION RES, V35, P3451, DOI 10.1016/0042-6989(95)00076-Q; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Zimmermann E, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00225; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210020	10.1371/journal.pone.0210020	http://dx.doi.org/10.1371/journal.pone.0210020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629610	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000042
J	Shinomiya, Y; Hoshino, Y				Shinomiya, Yuki; Hoshino, Yukinobu			A proposal of prior probability-oriented clustering in feature encoding strategies	PLOS ONE			English	Article							IMAGE; VECTOR	Codebook-based feature encodings are a standard framework for image recognition issues. A codebook is usually constructed by clusterings, such as the k-means and the Gaussian Mixture Model (GMM). A codebook size is an important factor to decide the trade-off between recognition performance and computational complexity and a traditional framework has the disadvantage to image recognition issues when a large codebook; the number of unique clusters becomes smaller than a designated codebook size because some clusters converge to close positions. This paper focusses on the disadvantage from a perspective of the distribution of prior probabilities and presents a clustering framework including two objectives that are alternated to the k-means and the GMM. Our approach is first evaluated with synthetic clustering datasets to analyze a difference to traditional clustering. In the experiment section, although our approach alternated to the k-means generates similar results to the k-means results, our approach is able to finely tune clusters for our objective. Our approach alternated to the GMM significantly improves our objective and constructs intuitively appropriate clusters, especially for huge and complicatedly distributed samples. In the experiment on image recognition issues, two state-of-the-art encodings, the Fisher Vector (FV) using the GMM and the Vector of Locally Aggregated Descriptors (VLAD) using the k-means, are evaluated with two publicly available image datasets, the Birds and the Butterflies. For the results of the VLAD with our approach, the recognition performances tend to be worse compared to the original VLAD results. On the other hand, the FV using our approach is able to improve the performance, especially in a larger codebook size.	[Shinomiya, Yuki; Hoshino, Yukinobu] Kochi Univ Technol, Sch Syst Engn, Kochi, Japan	Kochi University Technology	Shinomiya, Y (corresponding author), Kochi Univ Technol, Sch Syst Engn, Kochi, Japan.	196005c@gs.kochi-tech.ac.jp		Shinomiya, Yuki/0000-0003-3023-2163				Arandjelovic R, 2013, PROC CVPR IEEE, P1578, DOI 10.1109/CVPR.2013.207; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Birgin EG, 2008, OPTIM METHOD SOFTW, V23, P177, DOI 10.1080/10556780701577730; Bradski G., 2000, DOBBS J SOFTWARE TOO; CONN AR, 1991, SIAM J NUMER ANAL, V28, P545, DOI 10.1137/0728030; Costa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037731; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Franti P, 2006, PATTERN RECOGN, V39, P761, DOI 10.1016/j.patcog.2005.09.012; Gosselin PH, 2014, PATTERN RECOGN LETT, V49, P92, DOI 10.1016/j.patrec.2014.06.011; Johnson S.G., NLOPT NONLINEAR OPTI; Karkkainen I., 2002, DYNAMIC LOCAL SEARCH; Ke Y, 2004, PROC CVPR IEEE, P506; Lazebnik S, 2005, IEEE I CONF COMP VIS, P832, DOI 10.1109/ICCV.2005.10; Lazebnik S., 2004, P BRIT MACH VIS C, V2, P959, DOI DOI 10.5244/C.18.98; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maji S, 2009, IEEE I CONF COMP VIS, P40, DOI 10.1109/ICCV.2009.5459203; Manning C.D., 1999, FDN STAT NATURAL LAN; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nishio M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192892; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perronnin F, 2010, LECT NOTES COMPUT SC, V6314, P143, DOI 10.1007/978-3-642-15561-1_11; Perronnin F, 2007, PROC CVPR IEEE, P2272; Polanski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134256; Powell MJD, 2006, NONCON OPTIM ITS APP, V83, P255; Raghuwanshi SS, 2012, COMP K MEANS MODIFIE; Rowan T.H., 1990, FUNCTIONAL STABILITY; Shinomiya Y, 2016, JOINT INT CONF SOFT, P103, DOI [10.1109/SCIS-ISIS.2016.0034, 10.1109/SCIS&ISIS.2016.45]; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Zhou X, 2010, LECT NOTES COMPUT SC, V6315, P141, DOI 10.1007/978-3-642-15555-0_11	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210146	10.1371/journal.pone.0210146	http://dx.doi.org/10.1371/journal.pone.0210146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629616	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000053
J	Oh, DK; Ji, WJ; Kim, WS; Choi, CM; Yoon, SK; Rho, JK; Lee, JC				Oh, Dong Kyu; Ji, Won Jun; Kim, Woo Sung; Choi, Chang-Min; Yoon, Shin-Kyo; Rho, Jin Kyung; Lee, Jae Cheol			Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; TYROSINE KINASE INHIBITORS; EGFR MUTATION; OPEN-LABEL; MEDIATES RESISTANCE; MULTICENTER; FREQUENCY; POPULATION; CARCINOMAS; MECHANISMS	The efficacy and safety of osimertinib were demonstrated in clinical trials; however, real-world clinical data, particularly the resistance profile, are limited. Here, we investigated the efficacy, safety, and resistance profile of osimertinib in real-world practice. We reviewed medical records of T790M mutation-positive lung cancer patients who started osimertinib between February 2016 and June 2017. Molecular pathologic data of biopsy samples obtained after acquisition of resistance to osimertinib were also analyzed. The study included 23 patients with a median age of 59 years. The median follow-up duration was 11.9 months (IQR, 4.7-15.8). Objective response was achieved in 17 (73.9%) patients, and the disease was controlled in 22 (95.7%) patients. Median progression-free survival (PFS) was 7.4 months (95% CI, 3.6-11.0). Adverse events were minimal except for one case of pneumonitis. Of 14 patients experiencing disease progression, 10 underwent re-biopsy. The T790M mutation disappeared in seven patients (70%), and one showed wild-type conversion. PFS was shorter in the T790M-loss group than in the T790M-persistent group (4.4 vs. 7.7 months). Two patients with small cell transformation responded well to subsequent chemotherapy. One patient developed a C797S mutation that became undetectable after two cycles of gemcitabine and cisplatin followed by six cycles of pembrolizumab, after which the patient responded well to osimertinib. In conclusion, osimertinib showed favorable efficacy and safety in real-world practice comparable to those observed in clinical trials. Repeat biopsy after the acquisition of resistance to osimertinib is helpful to direct further treatment strategies.	[Oh, Dong Kyu; Ji, Won Jun; Kim, Woo Sung; Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Choi, Chang-Min; Yoon, Shin-Kyo; Lee, Jae Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Rho, Jin Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, JC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea.	jclee@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021	Lee, Jae Cheol/0000-0001-5963-0259	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0516, 2018-709]; Asan Institute for Life Sciences, Seoul, Korea	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant HI15C0516), and a grant (2018-709) from the Asan Institute for Life Sciences, Seoul, Korea.	Avizienyte E, 2008, BIOCHEM J, V415, P197, DOI 10.1042/BJ20080728; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Castro AS, 2013, REV PORT PNEUMOL, V19, P7, DOI 10.1016/j.rppneu.2012.08.002; Chang YS, 2016, TUBERC RESPIR DIS, V79, P248, DOI 10.4046/trd.2016.79.4.248; Choi YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056011; Chouaid C, 2014, LUNG CANCER, V86, P170, DOI 10.1016/j.lungcan.2014.08.016; de Mello RA, 2012, TUMOR BIOL, V33, P2061, DOI 10.1007/s13277-012-0465-5; Errihani H, 2013, J THORAC ONCOL, V8, P1212, DOI 10.1097/JTO.0b013e31829f6b4a; Fujiwara Y, 2017, JPN J CLIN ONCOL, V47, P625, DOI 10.1093/jjco/hyx050; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Goss G, 2016, LANCET ONCOL, V17, P1643, DOI 10.1016/S1470-2045(16)30508-3; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Kim DH, 2018, TARGETED ONCOLOGY, DOI [10.1007/s11523-010-05687-z, DOI 10.1007/S11523-010-05687-Z]; Kim HJ, 2012, LUNG CANCER, V75, P321, DOI 10.1016/j.lungcan.2011.08.005; Lee CK, 2017, J THORAC ONCOL, V12, P403, DOI 10.1016/j.jtho.2016.10.007; Lee JK, 2017, J CLIN ONCOL, V35, P3065, DOI 10.1200/JCO.2016.71.9096; Lin CC, 2018, LANCET RESP MED, V6, P107, DOI 10.1016/S2213-2600(17)30480-0; Lin YX, 2014, AM J CANCER RES, V4, P411; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; National Comprehensive Cancer Network, 2018, NCCN CLINICAL PRACTI; Nosaki K, 2016, LUNG CANCER, V101, P1, DOI 10.1016/j.lungcan.2016.07.007; Ortiz-Cuaran S, 2016, CLIN CANCER RES, V22, P4837, DOI 10.1158/1078-0432.CCR-15-1915; Oxnard GR, 2018, JAMA ONCOL, V4, P1527, DOI 10.1001/jamaoncol.2018.2969; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Politi K, 2015, CANCER CELL, V27, P751, DOI 10.1016/j.ccell.2015.05.012; Remon J, 2018, ANN ONCOL, V29, pI20, DOI 10.1093/annonc/mdx704; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Smits AJJ, 2012, CELL ONCOL, V35, P189, DOI 10.1007/s13402-012-0078-4; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Tang ZH, 2018, CANCER LETT, V420, P242, DOI 10.1016/j.canlet.2018.02.004; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tomasello C, 2018, CRIT REV ONCOL HEMAT, V123, P149, DOI 10.1016/j.critrevonc.2018.01.013; Yang Z, 2018, CLIN CANCER RES, V24, P3097, DOI 10.1158/1078-0432.CCR-17-2310; Yu HA, 2015, JAMA ONCOL, V1, P981, DOI 10.1001/jamaoncol.2015.1066; Yu HK, 2013, CLIN CANCER RES, V19, P5340, DOI 10.1158/1078-0432.CCR-12-3685; Yu Z, 2007, CANCER RES, V67, P10417, DOI 10.1158/0008-5472.CAN-07-1248; Zhou CC, 2016, J THORAC ONCOL, V11, P174, DOI 10.1016/j.jtho.2015.10.002; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	46	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210225	10.1371/journal.pone.0210225	http://dx.doi.org/10.1371/journal.pone.0210225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625213	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400079
J	Van Lehnid, RC; Alexander-Katz, A				Van Lehnid, Reid C.; Alexander-Katz, Alfredo			Energy landscape for the insertion of amphiphilic nanoparticles into lipid membranes: A computational study	PLOS ONE			English	Article							MONOLAYER-PROTECTED NANOPARTICLES; RECEPTOR-MEDIATED ENDOCYTOSIS; LIGAND-COATED NANOPARTICLES; GOLD NANOPARTICLES; CELLULAR UPTAKE; AU NANOPARTICLES; FORCE-FIELD; BILAYERS; DELIVERY; PERMEATION	Amphiphilic, monolayer-protected gold nanoparticles (NPs) have been shown to enter cells via a non-endocytic, non-disruptive pathway that could be valuable for biomedical applications. The same NPs were also found to insert into a series of model cell membranes as a precursor to cellular uptake, but the insertion mechanism remains unclear. Previous simulations have demonstrated that an amphiphilic NP can insert into a single leaflet of a planar lipid bilayer, but in this configuration all charged end groups are localized to one side of the bilayer and it is unknown if further insertion is thermodynamically favorable. Here, we use atomistic molecular dynamics simulations to show that an amphiphilic NP can reach the bilayer midplane non-disruptively if charged ligands iteratively "flip" across the bilayer. Ligand flipping is a favorable process that relaxes bilayer curvature, decreases the nonpolar solvent-accessible surface area of the NP monolayer, and increases attractive ligand-lipid electrostatic interactions. Analysis of end group hydration further indicates that iterative ligand flipping can occur on experimentally relevant timescales. Supported by these results, we present a complete energy landscape for the non-disruptive insertion of amphiphilic NPs into lipid bilayers. These findings will help guide the design of NPs to enhance bilayer insertion and non-endocytic cellular uptake, and also provide physical insight into a possible pathway for the translocation of charged biomacromolecules.	[Van Lehnid, Reid C.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Alexander-Katz, Alfredo] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT)	Van Lehnid, RC (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	vanlehn@wisc.edu			MRSEC Program of the National Science Foundation [DMR-0819762]; NSF [DMR-1054671]; National Science Foundation [OCI-1053575]	MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	R.C.V. and A.A.K. acknowledge support by the MRSEC Program of the National Science Foundation under award number DMR-0819762 and from NSF CAREER Award No. DMR-1054671. The simulations in this work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo-Canalejo J, 2015, ACS NANO, V9, P3704, DOI 10.1021/acsnano.5b01285; Atukorale PU, 2018, BIOCONJUGATE CHEM, V29, P1131, DOI 10.1021/acs.bioconjchem.7b00777; Atukorale PU, 2015, NANOSCALE, V7, P11420, DOI 10.1039/c5nr01355k; Black JC, 2014, SOFT MATTER, V10, P2016, DOI 10.1039/c3sm52522h; Burgi T, 2015, NANOSCALE, V7, P15553, DOI 10.1039/c5nr03497c; Carney RP, 2013, ACS NANO, V7, P932, DOI 10.1021/nn3036304; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Charchar P, 2016, SMALL, V12, P2395, DOI [10.1002/smll.201503585, 10.1002/smll.201670092]; Chen PY, 2016, ACS NANO, V10, P11541, DOI 10.1021/acsnano.6b07563; Chen XJ, 2018, NANOSCALE, V10, P2481, DOI 10.1039/c7nr06494b; Cheung DL, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4901740; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Cui Q, 2016, J PHYS CHEM B, V120, P7297, DOI 10.1021/acs.jpcb.6b03976; Dasgupta S, 2014, NANO LETT, V14, P687, DOI 10.1021/nl403949h; Ding HM, 2018, NANOSCALE HORIZ, V3, P6, DOI 10.1039/c7nh00138j; Ding HM, 2015, SMALL, V11, P1055, DOI 10.1002/smll.201401943; Ding HM, 2012, BIOMATERIALS, V33, P5798, DOI 10.1016/j.biomaterials.2012.04.055; Ding HM, 2012, ACS NANO, V6, P1230, DOI 10.1021/nn2038862; Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gkeka P, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003917; Gkeka P, 2013, J PHYS CHEM LETT, V4, P1907, DOI 10.1021/jz400679z; Gordillo GJ, 2014, ACS NANO, V8, P6074, DOI 10.1021/nn501395e; Heikkila E, 2014, J PHYS CHEM C, V118, P11131, DOI 10.1021/jp5024026; Hess B, 2002, J CHEM PHYS, V116, P209, DOI 10.1063/1.1421362; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726i; Jewell CM, 2011, ANGEW CHEM INT EDIT, V50, P12312, DOI 10.1002/anie.201104514; Jiang S, 2013, NANOSCALE, V5, P3127, DOI 10.1039/c3nr34005h; Lee HY, 2013, J AM CHEM SOC, V135, P5950, DOI 10.1021/ja400225n; Leroueil PR, 2008, NANO LETT, V8, P420, DOI 10.1021/nl0722929; Li Y, 2014, SOFT MATTER, V10, P6844, DOI 10.1039/c4sm00236a; Li YF, 2012, NANOSCALE, V4, P3768, DOI 10.1039/c2nr30379e; Lin JQ, 2013, ACS NANO, V7, P10799, DOI 10.1021/nn4040553; Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792; MacCallum JL, 2011, BIOPHYS J, V101, P110, DOI 10.1016/j.bpj.2011.05.038; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Oroskar PA, 2015, LANGMUIR, V31, P1074, DOI 10.1021/la503934c; Park S, 2015, J CHEM THEORY COMPUT, V11, P3466, DOI 10.1021/acs.jctc.5b00232; Pengo P, 2017, EUR BIOPHYS J BIOPHY, V46, P749, DOI 10.1007/s00249-017-1250-6; Poger D, 2012, J CHEM THEORY COMPUT, V8, P4807, DOI 10.1021/ct300675z; Pogodin S, 2012, ACS NANO, V6, P10555, DOI 10.1021/nn3028858; Preiner J, 2007, BIOPHYS J, V93, P930, DOI 10.1529/biophysj.106.096982; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quan XB, 2017, LANGMUIR, V33, P14480, DOI 10.1021/acs.langmuir.7b03544; Rossi G, 2016, ADV PHYS 10, V6149, P1; Sabella S, 2014, NANOSCALE, V6, P7052, DOI 10.1039/c4nr01234h; Salassi S, 2017, J PHYS CHEM C, V121, P10927, DOI 10.1021/acs.jpcc.6b12148; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Simonelli F, 2015, J PHYS CHEM LETT, V6, P3175, DOI 10.1021/acs.jpclett.5b01469; Su CF, 2017, J PHYS CHEM LETT, V8, P4069, DOI 10.1021/acs.jpclett.7b01888; Tahir MA, 2016, BBA-BIOMEMBRANES, V1858, P1207, DOI 10.1016/j.bbamem.2016.01.026; Tatur S, 2013, LANGMUIR, V29, P6606, DOI 10.1021/la401074y; Vacha R, 2011, NANO LETT, V11, P5391, DOI 10.1021/nl2030213; Van Lehn RC, 2017, ACS CENTRAL SCI, V3, P186, DOI 10.1021/acscentsci.6b00365; Van Lehn RC, 2015, SOFT MATTER, V11, P3165, DOI 10.1039/c5sm00287g; Van Lehn RC, 2014, J PHYS CHEM B, V118, P12586, DOI 10.1021/jp506239p; Van Lehn RC, 2014, J PHYS CHEM A, V118, P5848, DOI 10.1021/jp411662c; Van Lehn RC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5482; Van Lehn RC, 2014, SOFT MATTER, V10, P648, DOI 10.1039/c3sm52329b; Van Lehn RC, 2013, J PHYS CHEM C, V117, P20104, DOI 10.1021/jp406035e; Van Lehn RC, 2013, NANO LETT, V13, P4060, DOI 10.1021/nl401365n; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Vorobyov I, 2014, BIOPHYS J, V106, P586, DOI 10.1016/j.bpj.2013.12.027; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Werner M, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5022145; Yang YS, 2014, ACS NANO, V8, P8992, DOI 10.1021/nn502146r; Yue TT, 2012, ACS NANO, V6, P3196, DOI 10.1021/nn205125e; Zhang LY, 2015, J PHYS CHEM LETT, V6, P2530, DOI 10.1021/acs.jpclett.5b00755; Zhang LY, 2015, J PHYS CHEM B, V119, P3786, DOI 10.1021/acs.jpcb.5b00825; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	22	22	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209492	10.1371/journal.pone.0209492	http://dx.doi.org/10.1371/journal.pone.0209492			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625163	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400041
J	Sadrollahi, A; Nuesken, F; Licht, N; Rube, C; Dzierma, Y				Sadrollahi, Alemeh; Nuesken, Frank; Licht, Norbert; Ruebe, Christian; Dzierma, Yvonne			Monte-Carlo simulation of the Siemens Artiste linear accelerator flat 6 MV and flattening filter-free 7 MV beam line	PLOS ONE			English	Article							PHOTON BEAMS; DOSIMETRIC CHARACTERISTICS; RADIOTHERAPY; PARAMETERS; PROSTATE; ECLIPSE; FIELDS; MODEL	The aim of our work is to provide the up-to-now missing information on the Siemens Artiste FFF 7 MV beam line using a Monte-Carlo model fit to the realistic dosimetric measurements at the linear accelerator in clinical use at our department. The main Siemens Artiste 6MV and FFF 7MV beams were simulated using the Geant4 toolkit. The simulations were compared with the measurements with an ionization chamber in a water phantom to verify the validation of simulation and tuning the primary electron parameters. Hereafter, other parameters such as surface dose, spectrum, electron contamination, symmetry, flatness/unflatness, slope, and characteristic off-axis changes were discussed for both Flat and FFF mode. The mean electron energy for the FFF beam was 8.8 MeV and 7.5 MeV for Flat 6 MV, the spread energy and spot size of the selected Gaussian distribution source were 0.4 MeV and 1mm, respectively. The dose rate of the FFF beam was 2.8 (2.96) times higher than for the flattened beam for a field size of 10x10 (20x20) cm(2). The electron contamination has significant contribution to the surface dose especially for the flattened beam. The penumbra, surface dose and the mean energy of photons decrease by removing the flattening filter. Finally, the results show that off-axis changes have no strong effect on the mean energy of FFF beams, while this effect was more considerable for the flattened beam.	[Sadrollahi, Alemeh; Nuesken, Frank; Licht, Norbert; Ruebe, Christian; Dzierma, Yvonne] Saarland Univ, Med Ctr, Dept Radiotherapy & Radiat Oncol, Homburg, Saarland, Germany	Universitatsklinikum des Saarlandes	Sadrollahi, A (corresponding author), Saarland Univ, Med Ctr, Dept Radiotherapy & Radiat Oncol, Homburg, Saarland, Germany.	aleme.sadrollahi@uks.eu						Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Akino Y, 2013, MED PHYS, V40, DOI 10.1118/1.4824920; Allison J, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313400011; [Anonymous], 2013, AUST J BASIC APPL SC; Bell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164616; Bell K, 2016, PHYS MEDICA, V32, P474, DOI 10.1016/j.ejmp.2016.02.011; Benhalouche S, 2011, 2011 JOINT AAPM COMP, V38, P3655; Chofor N, 2011, PHYS MED BIOL, V56, P4355, DOI 10.1088/0031-9155/56/14/009; Cortes-Giraldo M A, 2008, P 2008 IEEE NUC SCI; Czarnecki D, 2017, MED PHYS, V44, P2569, DOI 10.1002/mp.12252; Dalaryd M, 2010, PHYS MED BIOL, V55, P7333, DOI 10.1088/0031-9155/55/23/010; Dowlatabadi H, 2018, J BIOMED PHYS ENG, V8; Dzierma Y, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0250-2; Dzierma Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094371; Dzierma Y, 2014, PRACT RADIAT ONCOL, V4, pE109, DOI 10.1016/j.prro.2013.04.004; Dzierma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053799; Dzierma Y, 2012, MED PHYS, V39, P2595, DOI 10.1118/1.3703835; Fogliata A, 2012, MED PHYS, V39, P6455, DOI 10.1118/1.4754799; Geant4 Collaboration, GEANT4 US GUID APPL; Huang Y, 2012, J APPL CLIN MED PHYS, V13; JABBARI K, 2013, J MED SIGNALS SENS, V3, P172; Jiang S B, 2000, MED PHYS, V27; Kainz K, 2011, MED PHYS, V38, P5104, DOI 10.1118/1.3622612; Kajaria A, 2017, BIOMED RES-INDIA, V28, P1566; Kawrakow I, 2000, MED PHYS, V27, P499, DOI 10.1118/1.598918; Kretschmer M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-133; Liu HH, 1997, MED PHYS, V24, P1960, DOI 10.1118/1.598110; Mesbahi A, 2007, APPL RADIAT ISOTOPES, V65, P1029, DOI 10.1016/j.apradiso.2007.04.023; Mesbahi Asghar, 2007, Radiat Med, V25, P315, DOI 10.1007/s11604-007-0142-6; Mohammed M, 2017, J KING SAUD UNIV SCI, V29, P371, DOI 10.1016/j.jksus.2016.09.008; Pichandi A, 2014, REP PRACT ONCOL RADI, V19, P322, DOI 10.1016/j.rpor.2014.01.004; Ponisch F, 2006, MED PHYS, V33, P1738, DOI 10.1118/1.2201149; Sangeetha S, 2017, RADIAT PHYS CHEM, V135, P63, DOI 10.1016/j.radphyschem.2017.02.029; Sarkar V, 2015, J APPL CLIN MED PHYS, V16, P458, DOI 10.1120/jacmp.v16i2.5351; Seif F, 2015, J Biomed Phys Eng, V5, P31; Seifi Makrani D, 2015, J PARAMEDICAL SCI JP, V6; Serrano B, 2006, RADIAT PROT DOSIM, V119, P506, DOI 10.1093/rpd/nci620; Sigamani A, 2017, REP PRACT ONCOL RADI, V22, P243, DOI 10.1016/j.rpor.2016.12.003; Sikora M, 2007, PHYS MED BIOL, V52, P4449, DOI 10.1088/0031-9155/52/15/006; Toutaoui A, 2014, PHYS MEDICA, V30, P833, DOI 10.1016/j.ejmp.2014.05.007; Vassiliev ON, 2006, MED PHYS, V33, P820, DOI 10.1118/1.2174720; Verhaegen F, 2003, PHYS MED BIOL, V48, pR107, DOI 10.1088/0031-9155/48/21/R01; Walters BRB, 2002, MED PHYS, V29, P2745, DOI 10.1118/1.1517611; Xiao Y, 2015, J APPL CLIN MED PHYS, V16, P12, DOI 10.1120/jacmp.v16i3.5219; Yan Y, ARXIV150906845PHYSME; Yang J, 2004, PHYS MED BIOL, V49, P2657, DOI 10.1088/0031-9155/49/12/013; Yarahmadi M, 2013, Z MED PHYS, V23, P291, DOI 10.1016/j.zemedi.2013.03.011	47	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210069	10.1371/journal.pone.0210069	http://dx.doi.org/10.1371/journal.pone.0210069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620742	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300013
J	Catozzi, C; Cusco, A; Lecchi, C; De Carlo, E; Vecchio, D; Martucciello, A; D'Angelo, L; Francino, O; Bonastre, AS; Ceciliani, F				Catozzi, Carlotta; Cusco, Anna; Lecchi, Cristina; De Carlo, Esterina; Vecchio, Domenico; Martucciello, Alessandra; D'Angelo, Luisa; Francino, Olga; Sanchez Bonastre, Armand; Ceciliani, Fabrizio			Impact of intramammary inoculation of inactivated Lactobacillus rhamnosus and antibiotics on the milk microbiota of water buffalo with subclinical mastitis	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SOMATIC-CELL COUNT; LACTOCOCCUS-LACTIS; BOVINE MASTITIS; LIVE CULTURE; RESISTANCE; INFUSION; STRAIN; INFLAMMATION; MANAGEMENT	Water buffalo mastitis represents a major issue in terms of animal health, cost of therapy, premature culling and decreased milk yeld. The emergence of antibiotic resistance has led to investigate strategies to avoid or reduce antibiotics' based therapies, in particular during sub clinical mastitis. The use of Generally Regarded As Safe bacteria (GRAS) such as Lactobacillus rhamnosus to restore the unbalance in mammary gland microbiota could provide potential corrective measures. The aim of this study was to investigate the changes in milk microbiota after the intramammary treatment with inactivated cultures of Lactobacillus rhamnosus of mammary gland quarters naturally affected by subclinical mastitis as compared to antibiotic therapy.A number of 43 quarters affected by subclinical mastitis with no signs of clinical inflammation and aerobic culture positive for pathogens were included in the study. The experimental design was as follows: 11 quarters were treated with antibiotics, 15 with inactivated cultures of Lactobacillus rhmnosus and 17 with PBS as negative control, by means of intrammary injection. Samples were collected at eight time points, pre- (T-29, T-21, T-15, T-7, T0 days) and post-treatment (T1, T2, and T6 days). Microbiological culture and Somatic Cell Count (SCC) were perfomed on all the samples, and microbiota was determined on milk samples collected at TO and T6 by amplifying the V4 region of 16S rRNA gene by PCR and sequencing using next generation sequencing technique. Treatment with Lactobacillus rhamnosus elicited a strong chemotactic response, as determined by a significant increase of leukocytes in milk, but did not change the microbiological culture results of the treated quarters. For what concerns the analysis of the microbiota, the treatment with Lactobacillus rhamnosus induced the modification in relative abundance of some genera such as Pseudomonas and 5-7N15. As expected, antibiotic treatment caused major changes in microbiota structure with an increase of Methylobacterium relative abundance. No changes were detected after PBS treatment. In conclusion, the present findings demonstrated that the in vivo intrammmary treatment with Lactobacillus rhamnosus has a transient pro-inflammatory activity by increasing SCC and is capable to modify the microbiota of milk after six days from inoculation, albeit slightly, even when the bacterial cultures were heat inactivated. Further studies are necessary to assess the potential use of this GRAS as supportive therapy against mastitis.	[Catozzi, Carlotta; Lecchi, Cristina; Ceciliani, Fabrizio] Univ Milan, Dipartimento Med Vet, Milan, Italy; [Cusco, Anna] Vetgenomics, Ed Eureka PRUAB Campus UAB, Barcelona, Spain; [De Carlo, Esterina; Vecchio, Domenico; Martucciello, Alessandra; D'Angelo, Luisa] Natl Reference Ctr Hyg & Technol Water Buffalo Fa, Ist Zooprofilatt Sperimentale Mezzogiorno, Salerno, Italy; [Francino, Olga; Sanchez Bonastre, Armand] Univ Autonoma Barcelona, SVGM, Sch Vet, Barcelona, Spain	University of Milan; IZS del Mezzogiorno; Autonomous University of Barcelona	Ceciliani, F (corresponding author), Univ Milan, Dipartimento Med Vet, Milan, Italy.	fabrizio.ceciliani@unimi.it	Ceciliani, Fabrizio/Q-6551-2017; Cusco, Anna/F-6262-2019; Cusco, Anna/GRY-5131-2022; D'ANGELO, LUISA/K-4455-2018; Francino, Olga/K-5683-2017; Vecchio, Domenico/I-4102-2013; Catozzi, Carlotta/AAC-1785-2019; De Carlo, Esterina/Q-1309-2016; Lecchi, Cristina/K-8729-2016	Ceciliani, Fabrizio/0000-0002-9199-5757; Cusco, Anna/0000-0002-9574-5755; D'ANGELO, LUISA/0000-0002-9332-0243; Francino, Olga/0000-0002-9022-3835; Vecchio, Domenico/0000-0002-8766-7224; Catozzi, Carlotta/0000-0002-1028-1489; De Carlo, Esterina/0000-0001-7883-1283; Lecchi, Cristina/0000-0002-7262-1696	Progetti di Ricerca Corrente, AM [IZS ME 10/13 RC]	Progetti di Ricerca Corrente, AM	This work was supported by Progetti di Ricerca Corrente, AM - Grant number: nr IZS ME 10/13 RC. AC is affiliated with Vet Genomics, a Spin Off company from UAB. I therefore declare that the funder provided support in the form of salaries for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addis MF, 2016, MOL BIOSYST, V12, P2359, DOI 10.1039/c6mb00217j; Amat S, 2017, LETT APPL MICROBIOL, V64, P343, DOI 10.1111/lam.12723; Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Beecher C, 2009, J DAIRY RES, V76, P340, DOI 10.1017/S0022029909004154; BERGHASH SR, 1983, ANTIMICROB AGENTS CH, V24, P771, DOI 10.1128/AAC.24.5.771; Bokulich NA, 2017, Q2 LONGITUDINAL QIIM; Bouchard DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144831; Bouchard DS, 2013, APPL ENVIRON MICROB, V79, P877, DOI 10.1128/AEM.03323-12; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Camperio C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184218; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Catozzi C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184710; Crispie F, 2008, J DAIRY RES, V75, P374, DOI 10.1017/S0022029908003385; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fagiolo A, 2007, ITAL J ANIM SCI, V6, P200; FAO, 2016, FAO REP; Frola ID, 2013, J DAIRY RES, V80, P28, DOI 10.1017/S0022029912000581; Frola ID, 2012, J DAIRY RES, V79, P84, DOI 10.1017/S0022029911000835; Ganda EK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0291-5; Genis S, 2017, VET MICROBIOL, V204, P174, DOI 10.1016/j.vetmic.2017.04.025; Genis S, 2017, J DAIRY SCI, V100, P479, DOI 10.3168/jds.2016-11671; Gomes F, 2016, CURR MICROBIOL, V72, P377, DOI 10.1007/s00284-015-0958-8; GREENE WA, 1991, J DAIRY SCI, V74, P2976, DOI 10.3168/jds.S0022-0302(91)78483-X; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hertl JA, 2011, J DAIRY SCI, V94, P4863, DOI 10.3168/jds.2010-4000; Hogeveen H, 2017, REV SCI TECH OIE, V36, P217, DOI 10.20506/rst.36.1.2623; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Klostermann K, 2008, J DAIRY RES, V75, P365, DOI 10.1017/S0022029908003373; Kovaleva J, 2014, J CLIN MICROBIOL, V52, P1317, DOI 10.1128/JCM.03561-13; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Lima SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193671; Malvisi M, 2016, J DAIRY SCI, V99, P2288, DOI 10.3168/jds.2015-10161; Marianelli C, 2010, RES MICROBIOL, V161, P673, DOI [10.1016/J.resmic.2010.06.007, 10.1016/j.resmic.2010.06.007]; Mignacca SA, 2017, J MED MICROBIOL, V66, P1798, DOI 10.1099/jmm.0.000641; Moroni P, 2006, J DAIRY SCI, V89, P998, DOI 10.3168/jds.S0022-0302(06)72165-8; Oh NS, 2017, J AGR FOOD CHEM, V65, P4744, DOI 10.1021/acs.jafc.7b01339; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Oliver SP, 2012, VET CLIN N AM-FOOD A, V28, P165, DOI 10.1016/j.cvfa.2012.03.005; Plumed-Ferrer C, 2013, VET MICROBIOL, V167, P592, DOI 10.1016/j.vetmic.2013.09.011; Preethirani PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142717; Rainard P, 2017, VET RES, V48, DOI 10.1186/s13567-017-0429-2; Sahin A, 2016, BUFFALO BULL, V35, P573; Sahin A, 2017, INDIAN J ANIM RES, V51, P35, DOI 10.18805/ijar.1146r; Sahin A, 2016, PAK J ZOOL, V48, P325; Scaccabarozzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142973; Sharma C, 2018, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00237; Tassi R, 2013, J DAIRY SCI, V96, P5129, DOI 10.3168/jds.2013-6741; Thomas CS, 2004, J DAIRY RES, V71, P162, DOI 10.1017/S0022029904000081; Vayssier-Taussat M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00029; Werner B, 2014, J DAIRY SCI, V97, P6964, DOI 10.3168/jds.2014-8314; Wright EA, 2015, VET MICROBIOL, V175, P105, DOI 10.1016/j.vetmic.2014.11.011; Wu Q, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01661; Wu Q, 2016, APPL ENVIRON MICROB, V82, P1173, DOI 10.1128/AEM.03044-15; Yang F, 2016, CHINESE ACAD AGR SCI, V15, DOI [10.1016/S2095-3119(16)61368-0, DOI 10.1016/S2095-3119(16)61368-0]; Zaneveld JR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.121	56	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210204	10.1371/journal.pone.0210204	http://dx.doi.org/10.1371/journal.pone.0210204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615691	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900052
J	Ahmad, I; Karah, N; Nadeem, A; Wai, SN; Uhlin, BE				Ahmad, Irfan; Karah, Nabil; Nadeem, Aftab; Wai, Sun Nyunt; Uhlin, Bernt Eric			Analysis of colony phase variation switch in Acinetobacter baumannii clinical isolates	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; BIOFILM FORMATION; VIRULENCE; INFECTIONS; MECHANISMS	Reversible switching between opaque and translucent colony formation is a novel feature of Acinetobacter baumannii that has been associated with variations in the cell morphology, surface motility, biofilm formation, antibiotic resistance and virulence. Here, we assessed a number of phenotypic alterations related to colony switching in A. baumannii clinical isolates belonging to different multi-locus sequence types. Our findings demonstrated that these phenotypic alterations were mostly strain-specific. In general, the translucent subpopulations of A. baumannii produced more dense biofilms, were more piliated, and released larger amounts of outer membrane vesicles (OMVs). In addition, the translucent subpopulations caused reduced fertility of Caenorhabditis elegans. When assessed for effects on the immune response in RAW 264.7 macrophages, the OMVs isolated from opaque subpopulations of A. baumannii appeared to be more immunogenic than the OMVs from the translucent form. However, also the OMVs from the translucent subpopulations had the potential to evoke an immune response. Therefore, we suggest that OMVs may be considered for development of new immunotherapeutic treatments against A. baumannii infections.	[Ahmad, Irfan; Karah, Nabil; Nadeem, Aftab; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Ahmad, Irfan; Karah, Nabil; Nadeem, Aftab; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, Umea, Sweden; [Ahmad, Irfan] Univ Hlth Sci, Inst Biomed & Allied Hlth Sci, Lahore, Pakistan	Umea University; Umea University; University of Health Science - Pakistan	Uhlin, BE (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.; Uhlin, BE (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	bernt.eric.uhlin@umu.se	Nadeem, Aftab/GRJ-0009-2022; Ahmad, Irfan/C-6523-2019; Uhlin, Bernt Eric/AAO-6292-2021	Nadeem, Aftab/0000-0002-1439-6216; Uhlin, Bernt Eric/0000-0002-2991-8072; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Research Council [2015-03007, 2015-06824, 2016-06598, 349-2007-8673, 829-2006-7431]; Kempe Foundations [JCK-1527, JCK-1724]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundations	This work was supported by BEU (2015-03007, 2015-06824, 2016-06598, 349-2007-8673, 829-2006-7431) from Swedish Research Council (JCK-1527, JCK-1724) from the Kempe Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee S, 2017, J ANTIMICROB CHEMOTH, V72, P2201, DOI 10.1093/jac/dkx131; Chin CY, 2018, NAT MICROBIOL, V3, P563, DOI 10.1038/s41564-018-0151-5; Dexter C, 2015, EXPERT REV ANTI-INFE, V13, P567, DOI 10.1586/14787210.2015.1025055; Gayoso CM, 2014, J PROTEOME RES, V13, P460, DOI 10.1021/pr400603f; Giammanco A, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00310-16; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Jha C, 2017, MICROB PATHOGENESIS, V111, P218, DOI 10.1016/j.micpath.2017.08.048; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Jun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071751; Karah N, 2016, ANTIMICROB AGENTS CH, V60, P1801, DOI 10.1128/AAC.02143-15; Li ZT, 2015, MICROB PATHOGENESIS, V81, P46, DOI 10.1016/j.micpath.2015.03.009; Liao YT, 2015, ANTIMICROB AGENTS CH, V59, P7346, DOI 10.1128/AAC.01343-15; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Longo F, 2014, NEW MICROBIOL, V37, P119; Nwugo CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051936; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Subashchandrabose S, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00013-15; Tipton KA, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.418; Tipton KA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00705-16; Tipton KA, 2015, J BACTERIOL, V197, P2593, DOI 10.1128/JB.00188-15; Vallejo JA, 2015, INT J ANTIMICROB AG; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wang ND, 2014, MBIO, V5, DOI 10.1128/mBio.01163-14; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Wong D, 2017, CLIN MICROBIOL REV, V30, P409, DOI 10.1128/CMR.00058-16	27	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210082	10.1371/journal.pone.0210082	http://dx.doi.org/10.1371/journal.pone.0210082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608966	Green Published, gold			2022-12-26	WOS:000454952800043
J	Canto, SVE; Araujo, MAL; Miranda, AE; Cardoso, ARP; de Almeida, RLF				Elarrat Canto, Surama Valena; Leite Araujo, Maria Alix; Miranda, Angelica Espinosa; Paulo Cardoso, Ana Rita; Freitas de Almeida, Rosa Livia			Fetal and infant mortality of congenital syphilis reported to the Health Information System	PLOS ONE			English	Article							GESTATIONAL SYPHILIS; MATERNAL SYPHILIS; LATIN-AMERICA; RISK-FACTORS; INFECTION; PREGNANCY; OUTCOMES	Background Congenital syphilis (CS) is a major cause of mortality in several countries, especially in Latin America and the Caribbean. This study aimed to analyze fetal and infant mortality of CS reported to the Health Information System in a State in Northeastern Brazil. Methods and results This was a cross-sectional study that analyzed the deaths of CS from 2010 to 2014 through the linkage of the Mortality Information System (SIM) and the Notifiable Diseases Information System (Sinan). The Statistical Package for the Social Sciences (SPSS) version 23.0 was used to calculate the rates of Fetal, Perinatal, Neonatal (early and late), and Postneonatal Mortality. Simple linear regression was performed. Fisher's exact test or Pearson's chi-square test were used for comparison of proportions and Student's t-test was used for comparison of means. Of the 414 cases reported to the SIM as deaths possibly caused by CS, 44 (10.6%) presented CS as the underlying cause. From 2010 to 2014 the Infant Mortality Rate of CS was 16.3 per 100,000 live births (y = 0.65x + 14.33, R-2 = 0.2338, p = 0.003). There was an 89.4% underreporting of deaths. Perinatal deaths and fetal deaths of CS accounted for 87.7% and 73.9% of total deaths, respectively. Conclusions The results of the study revealed a significant Fetal and Infant Mortality rate of CS and demonstrated the importance of using the linkage method in studies that involve the analysis of secondary data obtained from mortality and disease reporting systems. The underreporting of CS as a cause of fetal and infant mortality leads to unawareness of the reality of deaths from this disease, hindering the development of public policies aimed at its prevention.	[Elarrat Canto, Surama Valena; Paulo Cardoso, Ana Rita] Ceara State Secretary Hlth, Dept Hlth Surveillance, Fortaleza, Ceara, Brazil; [Leite Araujo, Maria Alix; Freitas de Almeida, Rosa Livia] Univ Fortaleza, Collect Hlth Post Grad Program, Fortaleza, Ceara, Brazil; [Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Espirito Santo, Spain	Universidade Fortaleza	Canto, SVE (corresponding author), Ceara State Secretary Hlth, Dept Hlth Surveillance, Fortaleza, Ceara, Brazil.	suramaelarrat@hotmail.com	Almeida, Rosa Livia F/M-7962-2018; Miranda, Angelica/AAE-5571-2021	Almeida, Rosa Livia F/0000-0001-6423-543X; Miranda, Angelica/0000-0002-5556-8379; Elarrat Canto, Surama Valena/0000-0001-7760-7888				Akahira-Azuma Moe, 2015, Trop Med Health, V43, P165, DOI 10.2149/tmh.2015-11; Lima EDA, 2012, REV BRAS ENFERM, V65, P578, DOI 10.1590/S0034-71672012000400005; Arnesen L, 2015, INT J GYNECOL OBSTET, V128, P241, DOI 10.1016/j.ijgo.2014.09.017; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Bradley H, 2014, REV PANAM SALUD PUBL, V36, P73; BRASIL. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2012, AT PRE NAT BAIX RISC; Cavagnaro F, 2014, REV CHIL PEDIATR-CHI, V85, P86, DOI 10.4067/S0370-41062014000100012; Centers for Disease Control and Prevention, 2010, CONG SYPH; Correa MM, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00195315, 10.1590/0102-311X00195315]; Campos ALD, 2010, CAD SAUDE PUBLICA, V26, P1747, DOI 10.1590/S0102-311X2010000900008; Maia LTD, 2012, CAD SAUDE PUBLICA, V28, P2163, DOI 10.1590/S0102-311X2012001100016; deAlmeida MF, 1996, REV SAUDE PUBL, V30, P141, DOI 10.1590/S0034-89101996000200005; Feliz Marjorie Cristiane, 2016, Rev. bras. epidemiol., V19, P727, DOI 10.1590/1980-5497201600040004; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Instituto Brasileiro de Geografia e Estatistica, 2010, CEAR CENS DEM 2010; Kamb ML, 2015, DST J BRAS DOENCAS S, V27, P3; Lafetá Kátia Regina Gandra, 2016, Rev. bras. epidemiol., V19, P63, DOI 10.1590/1980-5497201600010006; Lago EG, 2013, SEX TRANSM DIS, V40, P85, DOI 10.1097/OLQ.0b013e31827bd688; Domingues RMSM, 2013, REV SAUDE PUBL, V47, P147, DOI 10.1590/S0034-89102013000100019; Ministerio da Saude, 2001, MAN PROC SIST INF MO; Ministerio da Saude (BR), 2009, MAN VIG OB INF FET C, V2; Ministerio da Saude Organizacao Pan-Americana da Saude Fundacao Oswaldo Cruz, 2009, EXP BRAS SIST INF SA, V2; Miranda AE, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00118215; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Organizacion panamericana de la salud, 2010, IN REG EL TRANSM MAT; Cardoso ARP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167255; Sdve Saude, 2016, B EP SIF; Secretaria da Saude do Estado (Ceara ), 2016, B EP MORT MAT INF FE; Serruya SJ, 2015, SEX HEALTH, V12, P164, DOI 10.1071/SH14191; Su JR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.007; World Health Organization, 2011, METH SURV MON CONG S; Zhang X, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw026; Zhou QH, 2012, NEONATOLOGY, V102, P152, DOI 10.1159/000339291	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209906	10.1371/journal.pone.0209906	http://dx.doi.org/10.1371/journal.pone.0209906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG4NS	30608958	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800030
J	Pisano, S; Muratori, P; Senese, VP; Gorga, C; Siciliano, M; Carotenuto, M; Iuliano, R; Bravaccio, C; Signoriello, S; Gritti, A; Pascotto, A; Catone, G				Pisano, Simone; Muratori, Pietro; Senese, Vincenzo Paolo; Gorga, Chiara; Siciliano, Margherita; Carotenuto, Marco; Iuliano, Raffaella; Bravaccio, Carmela; Signoriello, Simona; Gritti, Antonella; Pascotto, Antonio; Catone, Gennaro			Phantom Phone Signals in youths: Prevalence, correlates and relation to psychopathology	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE SDQ; VIBRATION SYNDROME; STRENGTHS; ASSOCIATION; EXPERIENCES; ADOLESCENTS; VALIDITY; CHILDREN; SAMPLE; USERS	The term Phantom Phone Signals (PPS) refers to the perception of a mobile phone ringing, vibrating and blinking when in fact it did not. Data in youth are lacking, and controversies exist on whether PPS is related to psychopathology. In the present study, we showed data on the prevalence of PPS in a population (N = 2959) of students aged 10 to 14 years. We also explored the possible association between PPS and emotional or behavioural problems. Our results showed that PPS is a relatively common phenomenon with a prevalence rate of 58.9%, being more frequent in females. In univariate and multivariate analyses, we also found an association between the presence of PPS and emotional problems and temper tantrums, after accounting for relevant covariates. PPS is a relevant phenomenon to be considered in youth. It is common and may be a signal for emotional problems.	[Pisano, Simone] AORN Santobono Pausilipon, Dept Neurosci, Naples, Italy; [Muratori, Pietro] IRCCS Stella Maris, Sci Inst Child Neurol & Psychiat, Calambrone, Italy; [Senese, Vincenzo Paolo] Univ Campania Luigi Vanvitelli, Dept Psychol, Naples, Italy; [Gorga, Chiara; Siciliano, Margherita; Carotenuto, Marco; Signoriello, Simona; Pascotto, Antonio] Univ Campania, Dept Mental & Phys Hlth & Prevent Med, Naples, Italy; [Iuliano, Raffaella] Hosp Loreto Mare, Dept Neonatol & Neonatal Pathol, Naples, Italy; [Bravaccio, Carmela] Federico II Univ Naples, Dept Translat Med, Naples, Italy; [Gritti, Antonella; Catone, Gennaro] Suor Orsola Benicasa Univ, Fac Educ Sci, Naples, Italy	IRCCS Fondazione Stella Maris; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II	Pisano, S (corresponding author), AORN Santobono Pausilipon, Dept Neurosci, Naples, Italy.	pisano.simone@gmail.com	Catone, Gennaro/J-1989-2017; Senese, V. P./Z-4550-2019; Muratori, Pietro/AAH-9232-2021; Bravaccio, Carmela/AAB-9598-2022; pisano, simone/K-8657-2016	Catone, Gennaro/0000-0002-1769-4489; Senese, V. P./0000-0003-2299-6040; Muratori, Pietro/0000-0001-7779-779X; Bravaccio, Carmela/0000-0002-6025-2870; pisano, simone/0000-0001-5704-4483; CAROTENUTO, Marco/0000-0002-8136-7597				Aleyasin H, 2018, CURR OPIN NEUROBIOL, V49, P184, DOI 10.1016/j.conb.2018.02.013; Bianchi A, 2015, CYBER PSYCHOL BEHAV, V8, P39; Catone G, 2017, INT J SOC PSYCHIATR, V63, P752, DOI 10.1177/0020764017733765; Chen CP, 2014, NEUROPSYCH DIS TREAT, V10, P2307, DOI 10.2147/NDT.S73038; Deb A, 2015, ASIA-PAC PSYCHIAT, V7, P231, DOI 10.1111/appy.12164; Drouin M, 2012, COMPUT HUM BEHAV, V28, P1490, DOI 10.1016/j.chb.2012.03.013; Gaete J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191809; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gritti A, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-19; GSMA and the Mobile Society Research Institute within NTT DOCOMO, 2014, CHILDR US MOB PHON; Kruger DJ, 2016, CYBERPSYCH BEH SOC N, V19, P56, DOI 10.1089/cyber.2015.0406; Lin YH, 2013, J PSYCHIATR RES, V47, P1254, DOI 10.1016/j.jpsychires.2013.05.023; Lin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065152; Livingstone S, 2014, J CHILD PSYCHOL PSYC, V55, P635, DOI 10.1111/jcpp.12197; Mohammadbeigi A, 2017, ASIAN J PSYCHIATR, V27, P76, DOI 10.1016/j.ajp.2017.02.012; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Pisano S, 2016, CHILD PSYCHIAT HUM D, V47, P792, DOI 10.1007/s10578-015-0612-5; Ronald A, 2014, SCHIZOPHRENIA BULL, V40, P868, DOI 10.1093/schbul/sbt106; Rothberg MB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6914; Schuz J, 2005, BIOELECTROMAGNETICS, pS45, DOI 10.1002/bem.20129; Sherman LE, 2016, PSYCHOL SCI, V27, P1027, DOI 10.1177/0956797616645673; Tanis M, 2015, COMPUT HUM BEHAV, V51, P356, DOI 10.1016/j.chb.2015.04.039; Van Roy B, 2008, J CHILD PSYCHOL PSYC, V49, P1304, DOI 10.1111/j.1469-7610.2008.01942.x; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; Yao SQ, 2009, J ADOLESCENT HEALTH, V45, P55, DOI 10.1016/j.jadohealth.2008.11.006	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210095	10.1371/journal.pone.0210095	http://dx.doi.org/10.1371/journal.pone.0210095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG4NS	30608968	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800044
J	Rakovic, M; Neto, JM; Lopes, RJ; Koblik, EA; Fadeev, IV; Lohman, YV; Aghayan, SA; Boano, G; Pavia, M; Perlman, Y; Kiat, Y; Ben Dov, A; Collinson, JM; Voelker, G; Drovetski, SV				Rakovic, Marko; Neto, Julio M.; Lopes, Ricardo J.; Koblik, Evgeniy A.; Fadeev, Igor V.; Lohman, Yuriy V.; Aghayan, Sargis A.; Boano, Giovanni; Pavia, Marco; Perlman, Yoav; Kiat, Yosef; Ben Dov, Amir; Collinson, J. Martin; Voelker, Gary; Drovetski, Sergei V.			Geographic patterns of mtDNA and Z-linked sequence variation in the Common Chiffchaff and the 'chiffchaff complex'	PLOS ONE			English	Article							STATISTICAL-METHOD; POPULATION; SPECIATION; PHYLOGENY; DIFFERENTIATION; HYPOTHESIS; TIMESCALE; BIRDS	The Common Chiffchaff Phylloscopus collybita is an abundant, polytypic Palearctic bird. Validity of some of its subspecies is controversial and birds from some parts of the species range remain unclassified taxonomically. The relationships among populations from different geographic areas have not been sufficiently explored with molecular data. In this study we analyzed the relationships among the four species in the 'chiffchaff complex' (Common Chiffchaff, Iberian Chiffchaff P. ibericus, Canary Islands Chiffchaff P. canariensis and Mountain Chiffchaff P. sindianus), and the patterns of intraspecific geographic variation in the mtDNA ND2 gene and intron 9 of the Z-linked aconitase gene (ACO1I9) across the Common Chiffchaff range, including a recently discovered population breeding on Mt. Hermon (Anti-Lebanon mountains). Our data supported the monophyly of the chiffchaff complex and its current systematics at the species level. Within the Common Chiffchaff, the Siberian race P. c. tristis was the most differentiated subspecies and may represent a separate or incipient species. Other Common Chiffchaff subspecies also were differentiated in their mtDNA, however, lineages of neighboring subspecies formed wide zones of introgression. The Mt. Hermon population was of mixed genetic origin but contained some birds with novel unique lineage that could not be assigned to known subspecies. All Common Chiffchaff lineages diverged at the end of the Ionian stage of Pleistocene. Lineage sorting of ACO1I9 alleles was not as complete as that of mtDNA. Chiffchaff species were mostly distinct at ACO1I9, except the Common and Canary Islands Chiffchaffs that shared multiple alleles. An AMOVA identified geographic structure in Common Chiffchaff ACO1I9 variation that was broadly consistent with that of mtDNA ND2 gene. The genetic and other data suggest the chiffchaff complex to be a group of evolutionarily young taxa that represent a paradigm of 'species evolution in action' from intergrading subspecies through to apparently complete biological speciation.	[Rakovic, Marko] Nat Hist Museum Belgrade, Belgrade, Serbia; [Neto, Julio M.] Dept Biol, Mol Ecol & Evolut Lab, Ecol Bldg, Lund, Sweden; [Neto, Julio M.; Lopes, Ricardo J.] Univ Porto, CIBIO, InBIO Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Koblik, Evgeniy A.] Moscow MV Lomonosov State Univ, Zool Museum, Dept Ornithol, Moscow, Russia; [Fadeev, Igor V.] State Darwin Museum, Dept Collect, Moscow, Russia; [Aghayan, Sargis A.] Yerevan State Univ, Res Inst Biol, Zool Lab, Yerevan, Armenia; [Boano, Giovanni] Nat Hist Museum Carmagnola, Carmagnola, Italy; [Pavia, Marco] Univ Turin, Dept Earth Sci, Turin, Italy; [Perlman, Yoav] Soc Protect Nat Israel, Israeli Ornithol Ctr, Tel Aviv, Israel; [Kiat, Yosef] Hebrew Univ Jerusalem, Movement Ecol Lab, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, Jerusalem, Israel; [Collinson, J. Martin] Univ Aberdeen Foresterhill, Inst Med Med Sci & Nutr, Aberdeen, Scotland; [Voelker, Gary] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Drovetski, Sergei V.] Smithsonian Inst, Natl Museum Amer Hist, Labs Analyt Biol, Washington, DC 20560 USA	Universidade do Porto; Lomonosov Moscow State University; Yerevan State University; University of Turin; Hebrew University of Jerusalem; University of Aberdeen; Texas A&M University System; Texas A&M University College Station; Smithsonian Institution; Smithsonian National Museum of Natural History	Rakovic, M (corresponding author), Nat Hist Museum Belgrade, Belgrade, Serbia.	markorakovic@gmail.com	Aghayan, Sargis/L-7219-2015; Neto, Júlio Manuel/D-1853-2009; Lopes, Ricardo Jorge/B-1805-2010; Koblik, Evgeny/AAE-4252-2021	Aghayan, Sargis/0000-0001-8516-2778; Neto, Júlio Manuel/0000-0002-4855-3988; Lopes, Ricardo Jorge/0000-0003-2193-5107; Kiat, Yosef/0000-0002-3485-3517; Rakovic, Marko/0000-0002-3658-3362; Drovetski, Serguei/0000-0002-1832-5597; Pavia, Marco/0000-0002-5188-4155	FEDER funds through the COMPETE programme; FEDER funds through the POPH/QREN/FSE funds; FEDER funds through the NORTE2020/PORTUGAL funds [NORTE-01-0145-FEDER-AGRIGEN]; Fundacao para a Ciencia e a Tecnologia/MEC [FCOMP-01-0124-FEDER-008941, PTDC/BIA-BEC/103435/2008, SFRH/BPD/84141/2012]; National Geographic Society; Torino University; Ministarstvo Kulture I Informisanja Republike Srbije (Project: Ptice zapadnog palearktika); Russian Science Foundation [14-50-00029, 14-5000029]	FEDER funds through the COMPETE programme; FEDER funds through the POPH/QREN/FSE funds; FEDER funds through the NORTE2020/PORTUGAL funds; Fundacao para a Ciencia e a Tecnologia/MEC; National Geographic Society(National Geographic Society); Torino University; Ministarstvo Kulture I Informisanja Republike Srbije (Project: Ptice zapadnog palearktika); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by FEDER funds through the COMPETE programme, POPH/QREN/FSE funds to S.V.D. and NORTE2020/PORTUGAL funds (NORTE-01-0145-FEDER-AGRIGEN) to R.J.L., by the Fundacao para a Ciencia e a Tecnologia/MEC to S.V.D. (FCOMP-01-0124-FEDER-008941; PTDC/BIA-BEC/103435/2008) and R.J.L (SFRH/BPD/84141/2012), by the National Geographic Society to S.V.D, by Torino University Grant ex 60% 2017 and 2018 to M. P. and by Ministarstvo Kulture I Informisanja Republike Srbije (Project: Ptice zapadnog palearktika) to M.R. The Russian Science Foundation grant No. 14-50-00029 'Scientific basis of the national biobank - depository of living systems' (to E.A.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Russian Science Foundation grant No. 14-5000029 'Scientific basis of the national biobank - depository of living systems' (to E.A.K).	Baker K, 1997, WARBLERS OF EUROPE; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clarke T, 2006, FIELD GUIDE BIRDS AT; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clement Peter, 1998, British Birds, V91, P361; Clements J.F., 2015, EBIRD CLEMENTS CHECK; Cramp S, 1977, P1; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickinson EC., 2003, HOWARD MOORE COMPLET; Drovetski SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122590; Drovetski SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087570; Drovetski SV, 2013, ECOL EVOL, V3, P1518, DOI 10.1002/ece3.539; Drovetski SV, 2003, J BIOGEOGR, V30, P1173, DOI 10.1046/j.1365-2699.2003.00920.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Garcia-del-Rey E, 2011, FIELD GUIDE BIRDS MA; Hansson MC, 2000, J AVIAN BIOL, V31, P548, DOI 10.1034/j.1600-048X.2000.1310414.x; Head MJ, 2005, GEOL SOC SPEC PUBL, V247, P1, DOI 10.1144/GSL.SP.2005.247.01.01; Helbig AJ, 2002, IBIS, V144, P518, DOI 10.1046/j.1474-919X.2002.00091.x; Helbig AJ, 1996, IBIS, V138, P650, DOI 10.1111/j.1474-919X.1996.tb04767.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loskot VM., 1991, VESTN ZOOL, V3, P76; Marova I, 2013, MOSQUITERO IBERICO, P119; Marova I. M., 2009, Doklady Akademii Nauk, V427, P848; Nei M., 1987, MOL EVOLUTIONARY GEN; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Reeves AB, 2008, J AVIAN BIOL, V39, P567, DOI 10.1111/j.0908-8857.2008.04421.x; Salomon M, 2003, IBIS, V145, P87, DOI 10.1046/j.1474-919X.2003.00122.x; Shipilina D, 2017, ECOL EVOL, V7, P2169, DOI 10.1002/ece3.2782; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Stepanyan L. S., 2003, CONSPECTUS ORNITHOLO; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Ticehurst CB., 1938, SYSTEMATIC REV GENUS	44	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210268	10.1371/journal.pone.0210268	http://dx.doi.org/10.1371/journal.pone.0210268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608988	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800056
J	Hennessy, M; Granade, ME; Hassaninasab, A; Wang, DN; Kwiatek, JM; Han, GS; Harris, TE; Carman, GM				Hennessy, Meagan; Granade, Mitchell E.; Hassaninasab, Azam; Wang, Dana; Kwiatek, Joanna M.; Han, Gil-Soo; Harris, Thurl E.; Carman, George M.			Casein kinase II-mediated phosphorylation of lipin 1 beta phosphatidate phosphatase at Ser-285 and Ser-287 regulates its interaction with 14-3-3 beta protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidate; diacylglycerol; triacylglycerol; 14-3-3 protein; protein kinase; protein phosphorylation; phosphatase; casein kinase II; cell signaling; lipid droplet; lipin 1 PA phosphatase; membrane phospholipid	PHOSPHOLIPASE-D ACTIVITY; SUBCELLULAR-LOCALIZATION; PHOSPHOPROTEOME REVEALS; ACID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; ACETYL-COENZYME; CROSS-TALK; FAT-CELLS; INSULIN; SITES	The mammalian lipin 1 phosphatidate phosphatase is a key regulatory enzyme in lipid metabolism. By catalyzing phosphatidate dephosphorylation, which produces diacylglycerol, the enzyme plays a major role in the synthesis of triacylglycerol and membrane phospholipids. The importance of lipin 1 to lipid metabolism is exemplified by cellular defects and lipid-based diseases associated with its loss or overexpression. Phosphorylation of lipin 1 governs whether it is associated with the cytoplasm apart from its substrate or with the endoplasmic reticulum membrane where its enzyme reaction occurs. Lipin 1 beta is phosphorylated on multiple sites, but less than 10% of them are ascribed to a specific protein kinase. Here, we demonstrate that lipin 1 beta is a bona fide substrate for casein kinase II (CKII), a protein kinase that is essential to viability and cell cycle progression. Phosphoamino acid analysis and phosphopeptide mapping revealed that lipin 1 beta is phosphorylated by CKII on multiple serine and threonine residues, with the former being major sites. Mutational analysis of lipin 1 beta and its peptides indicated that Ser-285 and Ser-287 are both phosphorylated by CKII. Substitutions of Ser-285 and Ser-287 with nonphosphorylatable alanine attenuated the interaction of lipin 1 beta with 14-3-3 beta protein, a regulatory hub that facilitates the cytoplasmic localization of phosphorylated lipin 1. These findings advance our understanding of how phosphorylation of lipin 1 beta phosphatidate phosphatase regulates its interaction with 14-3-3 beta protein and intracellular localization and uncover a mechanism by which CKII regulates cellular physiology.	[Hennessy, Meagan; Hassaninasab, Azam; Kwiatek, Joanna M.; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; [Hennessy, Meagan; Hassaninasab, Azam; Kwiatek, Joanna M.; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Granade, Mitchell E.; Wang, Dana; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Virginia	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu		Carman, George/0000-0003-4951-8233; Hennessy, Meagan/0000-0002-1297-7623; Granade, Mitchell/0000-0003-3134-858X; Kwiatek, Joanna/0000-0001-8934-0922	National Institutes of Health from the United States Public Health Service [GM050679, DK101946]; National Institutes of Health [T32 GM008715]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679, T32GM008715] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM050679 (to G. M. C.) and DK101946 (to T. E. H.) from the United States Public Health Service. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 GM008715.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boroda S, 2017, J BIOL CHEM, V292, P20481, DOI 10.1074/jbc.M117.786574; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; Brognard J, 2011, CURR OPIN GENET DEV, V21, P4, DOI 10.1016/j.gde.2010.10.012; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2019, J BIOL CHEM, V294, P1681, DOI 10.1074/jbc.TM118.004159; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chen ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051320; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; DIGGLE TA, 1991, BIOCHEM J, V279, P545, DOI 10.1042/bj2790545; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fan XY, 2018, CANCER MED-US, V7, P2541, DOI 10.1002/cam4.1483; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Granade ME, 2018, METHOD ENZYMOL, V607, P373, DOI 10.1016/bs.mie.2018.04.028; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; He JQ, 2017, FASEB J, V31, P2893, DOI 10.1096/fj.201601353R; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Hu M, 2013, HEPATOLOGY, V58, P1953, DOI 10.1002/hep.26589; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; Kourti M, 2015, CELL SIGNAL, V27, P1129, DOI 10.1016/j.cellsig.2015.02.017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; Li TY, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04363, 10.1038/s41467-018-04363-w]; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Meana C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97506; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Navratil AR, 2015, ATHEROSCLEROSIS, V242, P424, DOI 10.1016/j.atherosclerosis.2015.08.012; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2007, DIABETES, V56, P2842, DOI 10.2337/db07-1288; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shimizu K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4117; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Vance D.E., 2004, GLYCEROLIPID BIOSYNT, P153; Vance JE, 2018, J LIPID RES, V59, P923, DOI 10.1194/jlr.R084004; Vozenilek AE, 2018, ARTERIOSCL THROM VAS, V38, P324, DOI 10.1161/ATVBAHA.117.310455; Wang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34117; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; Wilkins MR, 1999, METH MOL B, V112, P531; WITTERS LA, 1983, J BIOL CHEM, V258, P5643; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	106	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2365	2374		10.1074/jbc.RA118.007246	http://dx.doi.org/10.1074/jbc.RA118.007246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30617183	hybrid, Green Published			2022-12-26	WOS:000458895400014
J	Cheung, PC; Franks, PA; Kramer, MR; Kay, CM; Drews-Botsch, CD; Welsh, JA; Gazmararian, JA				Cheung, Patricia C.; Franks, Padra A.; Kramer, Michael R.; Kay, Christi M.; Drews-Botsch, Carolyn D.; Welsh, Jean A.; Gazmararian, Julie A.			Elementary school physical activity opportunities and physical fitness of students: A statewide cross-sectional study of schools	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK; AEROBIC FITNESS; UNITED-STATES; WEIGHT STATUS; EDUCATION; OBESITY; CHILDREN; HEALTH; YOUTH	Background Using a cross-sectional design, we assessed the relationship between the time schools provide for physical activity and the proportion of students achieving a healthy aerobic capacity or body mass index. Methods In 2013-2014, physical education and grade-level teachers from 905 of 1,244 Georgia elementary schools provided survey data about the frequency and duration of physical activity opportunities offered before, during, and after school. Log-binomial models related the weekly physical activity minutes provided by schools to the proportion of children in the FitnessGram healthy fitness zone for aerobic capacity or body mass index while adjusting for school characteristics and demographics. Results During-school physical activity time was not associated with student fitness, but schools with before-school physical activity programs had a moderately higher prevalence of healthy aerobic capacity (prevalence ratio among girls: 1.06; 99% confidence interval: 1.00-1.13; prevalence ratio among boys: 1.03; 99% confidence interval: 0.99-1.08). Each additional 30 minutes of recess per week was associated with no more than a 3%-higher proportion of students with healthy body mass indexes (prevalence ratio among girls: 1.01; 99% confidence interval: 1.00-1.03; prevalence ratio among boys: 1.01; 99% confidence interval: 0.99-1.03). Conclusions The amount of physical activity time provided by schools is not strongly associated with school-aggregated student fitness. Future studies should be designed to assess the importance of school-based physical activity time on student fitness, relative to physical activity type and quality.	[Cheung, Patricia C.; Kramer, Michael R.; Drews-Botsch, Carolyn D.; Welsh, Jean A.; Gazmararian, Julie A.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Franks, Padra A.; Kay, Christi M.] HealthMPowers, Norcross, GA USA; [Welsh, Jean A.] Emory Univ, Sch Med, Atlanta, GA USA	Emory University; Emory University	Cheung, PC (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.	pccheun@emory.edu; jagazma@emory.edu	Kramer, Michael R/A-3195-2013; Drews-Botsch, Carolyn/M-8560-2016	Kramer, Michael R/0000-0002-6372-6170; Cheung, Patricia C./0000-0002-2329-0413; Drews-Botsch, Carolyn/0000-0002-8763-7404	Robert Wood Johnson Foundation [71061]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [T32HD052460]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in part, by Robert Wood Johnson Foundation (JAG, award number 71061). PCC received support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health T32 Predoctoral Training Program in Reproductive, Perinatal, and Pediatric Epidemiology (award number T32HD052460). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PAF and CMK are supported by HealthMPowers which conducted the training where some of the data were collected, but HealthMPowers did not have any role in the study design, analysis, decision to publish, or finalization of the manuscript.	Alliance for a Healthier Generation, 2015, HLTH SCH PROGR; Bai Y, 2015, J PEDIATR-US, V167, P662, DOI 10.1016/j.jpeds.2015.05.035; Beam M, 2012, PREV CHRONIC DIS, V9, P9; Camhi SM, 2011, J PEDIATR-US, V159, P303, DOI 10.1016/j.jpeds.2011.01.059; Cawley J, 2013, J HEALTH ECON, V32, P743, DOI 10.1016/j.jhealeco.2013.04.006; Centers for Disease Control and Prevention, 2013, COMPR SCH PHYS ACT P; Centers for Disease Control and Prevention, 2014, SCH HLTH IND SHI SEL; Cheung P, 2019, J SCI MED SPORT, V22, P191, DOI 10.1016/j.jsams.2018.07.015; Cheung PC, 2017, EVALUATION INTERVENT; Cooper Institute, FITNESSGRAM; Dencker M, 2007, EUR J APPL PHYSIOL, V99, P19, DOI 10.1007/s00421-006-0310-x; Dietz WH, 1998, PEDIATRICS, V101, P518; Donnelly JE, 1996, OBES RES, V4, P229, DOI 10.1002/j.1550-8528.1996.tb00541.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisenmann JC, 2007, ACTA PAEDIATR, V96, P1723, DOI 10.1111/j.1651-2227.2007.00534.x; Erfle SE, 2015, J SCHOOL HEALTH, V85, P27, DOI 10.1111/josh.12217; Fakhouri THI, 2013, JAMA PEDIATR, V167, P223, DOI 10.1001/2013.jamapediatrics.122; Foltz JL, 2011, CLIN PEDIATR, V50, P424, DOI 10.1177/0009922810393499; Friedman SL, 2003, ARCH PEDIAT ADOL MED, V157, P185; Ganley KJ, 2011, PEDIATR PHYS THER, V23, P208, DOI 10.1097/PEP.0b013e318227b3fc; Guerrero AD, 2016, J ACAD NUTR DIET, V116, P439, DOI 10.1016/j.jand.2015.08.019; Hollis JL, 2016, PREV MED, V86, P34, DOI 10.1016/j.ypmed.2015.11.018; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Jelalian E, 2012, AM J LIFESTYLE MED, V6, P505, DOI 10.1177/1559827612458633; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Juonala M, 2010, EUR HEART J, V31, P1745, DOI 10.1093/eurheartj/ehq141; Kahan D, 2015, AM J PUBLIC HEALTH, V105, P653, DOI 10.2105/AJPH.2014.302355; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; Kristensen PL, 2013, J SPORT SCI, V31, P188, DOI 10.1080/02640414.2012.723818; Laurson KR, 2011, AM J PREV MED, V41, pS100, DOI 10.1016/j.amepre.2011.07.004; Lounsbery MAF, 2013, J PHYS ACT HEALTH, V10, P496, DOI 10.1123/jpah.10.4.496; Madsen KA, 2009, ARCH PEDIAT ADOL MED, V163, P1014, DOI 10.1001/archpediatrics.2009.181; Martin K, 2012, AUST NZ J PUBL HEAL, V36, P469, DOI 10.1111/j.1753-6405.2012.00914.x; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miller DP, 2011, SOC SCI MED, V72, P677, DOI 10.1016/j.socscimed.2010.12.003; National Center for Education Statistics, FAST FACTS; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Plowman SA., 2013, FITNESSGRAM ACTIVITY, V3, P7; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Resaland GK, 2011, SCAND J MED SCI SPOR, V21, P302, DOI 10.1111/j.1600-0838.2009.01028.x; Richter TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115063; Roberts CK, 2010, J PEDIATR-US, V156, P711, DOI 10.1016/j.jpeds.2009.11.039; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Sallis JF, 1997, AM J PUBLIC HEALTH, V87, P1328, DOI 10.2105/AJPH.87.8.1328; Saydah S, 2013, PEDIATRICS, V131, pE679, DOI 10.1542/peds.2012-2583; Society of Health and Phys, 2016, 2016 SHAP NAT STAT P; UCLA Center to Eliminate Health Disparities, 2007, FAIL FITN PHYS ACT P; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; Zaqout M, 2016, INT J PUBLIC HEALTH, V61, P573, DOI 10.1007/s00038-016-0811-2	49	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210444	10.1371/journal.pone.0210444	http://dx.doi.org/10.1371/journal.pone.0210444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645628	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200032
J	Beasley, I; Cherel, Y; Robinson, S; Betty, E; Hagihara, R; Gales, R				Beasley, Isabel; Cherel, Yves; Robinson, Sue; Betty, Emma; Hagihara, Rie; Gales, Rosemary			Stomach contents of long-finned pilot whales, Globicephala melas mass-stranded in Tasmania	PLOS ONE			English	Article							ACID SIGNATURE ANALYSIS; MARINE MAMMALS; SPERM-WHALES; NEW-ZEALAND; PHYSETER-MACROCEPHALUS; FORAGING ECOLOGY; CLIMATE-CHANGE; FATTY-ACIDS; DIET; CEPHALOPODS	New data are reported from analyses of stomach contents from 114 long-finned pilot whales mass-stranded at four locations around Tasmania, Australia from 1992-2006. Identifiable prey remains were recovered from 84 (74%) individuals, with 30 (26%) individuals (17 females and 13 males) having empty stomachs. Prey remains comprised 966 identifiable lower beaks and 1244 upper beaks, belonging to 17 families (26 species) of cephalopods. Ommastrephidae spp. were the most important cephalopod prey accounting for 16.9% by number and 45.6% by reconstructed mass. Lycoteuthis lorigera was the next most important, followed by Ancistrocheirus lesueurii. Multivariate statistics identified significant differences in diet among the four stranding locations. Long-finned pilot whales foraging off Southern Australia appear to be targeting a diverse assemblage of prey (>= 10 species dominated by cephalopods). This is compared to other similar studies from New Zealand and some locations in the Northern Hemisphere, where the diet has been reported to be primarily restricted to <= 3 species dominated by cephalopods. This study emphasises the importance of cephalopods as primary prey for Southern long-finned pilot whales and other marine vertebrates, and has increased our understanding of long-finned pilot whale diet in Southern Ocean waters.	[Beasley, Isabel] Snubfin Dolphin Project, Colebrook, Tas, Australia; [Beasley, Isabel; Hagihara, Rie] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Cherel, Yves] Univ La Rochelle, CNRS, UMR 7372, CEBC, Villiers En Bois, France; [Robinson, Sue] Biosecur Tasmania, Invas Species Branch, Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia; [Betty, Emma] Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Betty, Emma] Massey Univ, Coll Sci, Inst Nat & Math Sci, Palmerston North, New Zealand; [Gales, Rosemary] Dept Primary Ind Pk Water & Environm, Nat Values Conservat Branch, Hobart, Tas, Australia	James Cook University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Auckland University of Technology; Massey University	Beasley, I (corresponding author), Snubfin Dolphin Project, Colebrook, Tas, Australia.; Beasley, I (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	beasleyisabel@gmail.com	Betty, Emma L./P-9625-2019	Betty, Emma L./0000-0002-9187-1957	Princess Melikoff Trust	Princess Melikoff Trust	This work was funded by the Princess Melikoff Trust. The Princess Melikoff Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; Aoki K, 2013, BEHAV PROCESS, V99, P12, DOI 10.1016/j.beproc.2013.06.002; Baird RW, 2002, MAR ECOL PROG SER, V237, P301, DOI 10.3354/meps237301; Baker A., 2009, MOL METHODS ECOLOGY; Beatson E, 2007, NEW ZEAL J ZOOL, V34, P359, DOI 10.1080/03014220709510095; Beatson E, 2007, NEW ZEAL J ZOOL, V34, P51, DOI 10.1080/03014220709510063; Beatson EL, 2009, NEW ZEAL J ZOOL, V36, P47, DOI 10.1080/03014220909510139; Beatson E, 2007, REV FISH BIOL FISHER, V17, P295, DOI 10.1007/s11160-007-9039-9; Santos MB, 2014, MAR MAMMAL SCI, V30, P1, DOI 10.1111/mms.12015; Betty E, 2013, 20 BIENN C BIOL MAR; Bigg MA, 1985, MARINE MAMMALS FISHE; Bloch D, 1995, DEV MAR BIO, V4, P499; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; BRABYN MW, 1992, J MAMMAL, V73, P469, DOI 10.2307/1382012; Bradshaw CJA, 2003, P ROY SOC B-BIOL SCI, V270, P1283, DOI 10.1098/rspb.2003.2371; Cherel Y, 2005, P ROY SOC B-BIOL SCI, V272, P1601, DOI 10.1098/rspb.2005.3115; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2017, MAR ECOL PROG SER, V565, P197, DOI 10.3354/meps11994; CLARKE M, 1994, ANTARCT SCI, V6, P149, DOI 10.1017/S0954102094000234; Clarke M.R, 1986, HDB IDENTIFICATION C; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; COCKCROFT VG, 1993, Z SAUGETIERKD, V58, P286; Committee on Taxonomy, 2021, LIST MAR MAMM SPEC S; DAILEY M, 1978, J WILDLIFE DIS, V14, P503, DOI 10.7589/0090-3558-14.4.503; De Pierrepont JF, 2005, J MAR BIOL ASSOC UK, V85, P1539, DOI 10.1017/S0025315405012762; de Stephanis R, 2008, MAR BIOL, V154, P603, DOI 10.1007/s00227-008-0953-8; Desportes G., 1988, DIET PILOT WHALE GLO; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Desportes Genevieve, 1993, V14, P233; dos Santos RA, 2001, FISH RES, V52, P99; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Evans K, 2002, MAR MAMMAL SCI, V18, P622, DOI 10.1111/j.1748-7692.2002.tb01063.x; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Fontaine M, 2015, MAR BIOL, V162, P207, DOI 10.1007/s00227-014-2587-3; Furlani D., 2007, OTOLITHS COMMON AUST; GALES R, 1992, MAR MAMMAL SCI, V8, P405, DOI 10.1111/j.1748-7692.1992.tb00055.x; Gales R, 2012, WILDLIFE RES, V39, P520, DOI 10.1071/WR12023; Gannon D, 1997, OCEANOGRAPHIC LIT RE, V9, P1011; Gannon DP, 1997, MAR MAMMAL SCI, V13, P405, DOI 10.1111/j.1748-7692.1997.tb00648.x; Geraci J, 1993, MARINE MAMMALS ASHOR, P175; GERACI JR, 1987, INT J PARASITOL, V17, P407, DOI 10.1016/0020-7519(87)90116-0; Goodall R.N.P., 1985, P566; Guiler ER, 1978, PAPERS P ROYAL SOC T; Horstkottee J, 2008, SYSTEMATICS ECOLOGIC; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Jefferson T.A., 2015, MARINE MAMMALS WORLD; JOBLING M, 1986, SARSIA, V71, P265, DOI 10.1080/00364827.1986.10419696; Lefkaditou E, 2008, HYDROBIOLOGIA, V612, P71, DOI 10.1007/s10750-008-9490-1; Lu CC., 2002, CEPHALOPOD BEAK IDEN; MacLeod CD, 2006, MAR ECOL PROG SER, V326, P295, DOI 10.3354/meps326295; Malcom CR., 1986, HDB IDENTIFICATION C; Mansilla L, 2012, POLAR BIOL, V35, P1929, DOI 10.1007/s00300-012-1222-3; Martin A.R., 1993, Reports of the International Whaling Commission Special Issue, V14, P263; MARTIN AR, 1987, J ZOOL, V211, P11, DOI 10.1111/j.1469-7998.1987.tb07449.x; McManus T, 1984, PAPERS P ROYAL SOC T; MEADOR JP, 1993, CAN J FISH AQUAT SCI, V50, P2698, DOI 10.1139/f93-294; MERCER MC, 1967, J FISH RES BOARD CAN, V24, P2481, DOI 10.1139/f67-195; Meynier L, 2010, J MAMMAL, V91, P1484, DOI 10.1644/09-MAMM-A-299.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nicol D.J., 1988, Australian Zoologist, V24, P59; Olsen E, 2003, MAR BIOL, V142, P13, DOI 10.1007/s00227-002-0934-2; Olson P., 2002, ENCY MARINE MAMMALS, V2 nd, P898; Olson PA, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P701; Oremus M, 2009, BIOL J LINN SOC, V98, P729, DOI 10.1111/j.1095-8312.2009.01325.x; OVERHOLTZ WJ, 1991, FISH B-NOAA, V89, P723; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Perrin WF, 1980, P INT C DETERMINING; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Pinkas L., 1971, Fish Bull California, VNo. 152, P5; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Quick NJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45765; Reid A., 2016, CEPHALOPODS AUSTR SU; Rodhouse P, 1889, REDESCRIPTION MARTIA; Santos MB, 2001, FISH RES, V52, P121, DOI 10.1016/S0165-7836(01)00236-3; SEKIGUCHI K, 1992, S AFR J MARINE SCI, V12, P843; Sergeant DE, 1962, FISHERIES RES BOARD; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Spitz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050096; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Therneau TM., 2015, INTRO RECURSIVE PART; Thiemann GW, 2009, MAR MAMMAL SCI, V25, P243, DOI 10.1111/j.1748-7692.2008.00258.x; Visser F, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2397-y; Visser F, 2014, BEHAVIOUR, V151, P1453, DOI 10.1163/1568539X-00003195; Walters A, 2005, LONG FINNED PILOT WH; WARING GT, 1990, FISH B-NOAA, V88, P347; Wursig B., 2017, ENCY MARINE MAMMALS; Xavier J. C, 2009, CEPHALOPOD BEAK GUID	90	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0206747	10.1371/journal.pone.0206747	http://dx.doi.org/10.1371/journal.pone.0206747			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640963	Green Published, gold, Green Accepted			2022-12-26	WOS:000455808000002
J	Duquette, P; Yeung, M; Mouallif, S; Nakhaipour, HR; Haddad, P; Schecter, R				Duquette, Pierre; Yeung, Michael; Mouallif, Soukaina; Nakhaipour, Hamid Reza; Haddad, Paola; Schecter, Robyn			A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies	PLOS ONE			English	Article							ADHERENCE; FINGOLIMOD; PERSISTENCE; IMPACT	Background Compliance to disease modifying therapy (DMT) is associated with a reduced risk of relapse, lower healthcare resource utilization, and improved health-related quality of life in patients with multiple sclerosis (MS). Our objective was to assess the compliance and discontinuation rates of fingolimod relative to other oral, injectable, and infusible DMTs available on the market at the time of the study in Canada in patients with relapsing-remitting MS (RRMS). Methods and findings We conducted a retrospective claims analysis. Patients with RRMS with. 1 prescription for each DMT were included. Compliance (medication possession ratio of. 80%) and discontinuation (gap > 30 days from the end of the index prescription) were calculated at the 6-, 12-and 24-month time points. Compliance with fingolimod at the 6-, 12-and 24-month time points was 75%, 75% and 70%, respectively; compared with DMF [70% (P < 0.001), 68% (P < 0.001), and 56% (P < 0.001), respectively], and BRACE [53% (P < 0.001), 47% (P < 0.001), and 35% (P < 0.001), respectively]. Compliance with fingolimod was comparable to teriflunomide at each time point, but was higher compared to natalizumab [70% versus 57% (P < 0.001)] at the 24-month time point. At the 6-, 12-and 24-month time points, patients on fingolimod had the lowest discontinuation rate (26%, 24%, and 29%, respectively) compared to BRACE [49% (P < 0.001), 44% (P < 0.001), and 57% (P < 0.001)], respectively], and natalizumab [33% (P < 0.001), 29% (P < 0.001), and 45% (P < 0.001), respectively], and was similar to teriflunomide (26%, 25%, and 31%, respectively). Conclusions The compliance rate in fingolimod treated patients at the 24 month time point was higher than that observed in natalizumab treated patients. The discontinuation rate was lower with fingolimod compared to other DMTs at all time points but was similar to teriflunomide.	[Duquette, Pierre] Univ Montreal, Notre Dame Hosp, Montreal, PQ, Canada; [Yeung, Michael] Univ Calgary, Multiple Sclerosis Clin, Calgary, AB, Canada; [Mouallif, Soukaina; Nakhaipour, Hamid Reza; Haddad, Paola; Schecter, Robyn] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada	Universite de Montreal; University of Calgary; Novartis	Schecter, R (corresponding author), Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada.	robyn.schecter@novartis.com		Schecter, Robyn/0000-0002-7229-121X	Novartis Pharmaceuticals Canada Inc.	Novartis Pharmaceuticals Canada Inc.	This research was funded by Novartis Pharmaceuticals Canada Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Soukaina Mouallif, Hamid Reza Nakhaipour, Paola Haddad, and Robyn Schecter are employees of Novartis Pharmaceuticals Canada Inc. The specific roles of these authors are articulated in the 'author contributions' section.	Agashivala N, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-138; Bergvall Niklas, 2014, J Med Econ, V17, P696, DOI 10.3111/13696998.2014.940422; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Freedman MS, 2018, CAN J NEUROL SCI, V45, P489, DOI 10.1017/cjn.2018.17; Girouard N, 2011, PATIENT PREFER ADHER, V5, P101, DOI 10.2147/PPA.S10506; Johnson Kristen M, 2017, J Manag Care Spec Pharm, V23, P844, DOI 10.18553/jmcp.2017.23.8.844; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Khatri B, 2011, LANCET NEUROL, V10, P520, DOI 10.1016/S1474-4422(11)70099-0; Menzin J, 2013, J MANAGE CARE PHARM, V19, pS24, DOI 10.18553/jmcp.2013.19.s1.S24; MSIF, 2016, ATL MS 2013; Oleen-Burkey M A, 2011, J Med Econ, V14, P739, DOI 10.3111/13696998.2011.618517; Portaccio E, 2009, CNS DRUGS, V23, P453, DOI 10.2165/00023210-200923060-00001; Remington Gina, 2013, Int J MS Care, V15, P36, DOI 10.7224/1537-2073.2011-038; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Wingerchuk DM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3518; Yermakov S, 2015, J MED ECON, V18, P711, DOI 10.3111/13696998.2015.1044276	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210417	10.1371/journal.pone.0210417	http://dx.doi.org/10.1371/journal.pone.0210417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640935	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000028
J	Arhoune, B; Oumokhtar, B; Hmami, F; El Fakir, S; Moutaouakkil, K; Chami, F; Bouharrou, A				Arhoune, Btissam; Oumokhtar, Bouchra; Hmami, Fouzia; El Fakir, Samira; Moutaouakkil, Kaoutar; Chami, Fouzia; Bouharrou, Abdelhak			Intestinal carriage of antibiotic resistant Acinetobacter baumannii among newborns hospitalized in Moroccan neonatal intensive care unit	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MULTIPLEX PCR; RISK-FACTORS; COLONIZATION; GENES; CARBAPENEMASES; PREVALENCE; IMIPENEM; THREAT; SPP.	This study was conducted in order to assess the acquisition rate of Acinetobacter baumannii by newborn screening, on admission and during the discharge process of neonatal intensive care unit. (NICU). Furthermore, we investigated risk factors for potential colonization and molecular epidemiology of isolated resistant bacteria. This prospective study was conducted in the neonatal unit of Hassan II University Hospital of Fez from February 2013 to July 2015. During this period, all consecutive admitted neonates were screened for A. baumannii intestinal carriage, on admission and during the discharge process. Bacteriological and molecular tests were evaluated according to the international standards. This study examines the screening on admission of 455 newborns, 59% of whom were male. The average gestational age and birth weight were 35.2 weeks and 2612.1 g respectively. In total, 277 patients were included in the acquisition study on admission. The prevalence of multi-drug resistant (MDR) A. baumannii strain carriage was 6.5%, while the acquisition rate during the hospital recovery was 13.7%. In this study, 68 MDR A. baumannii isolates were collected. The resistance rates to different antibiotic classes including, Ceftazidime, Gentamycin and Ciprofloxacin varied between 92 and 100%. Moreover, 13% of MDR A. baumannii isolates were carbapenemase producers and 88% harbored bla(OXA-23)gene. On admission, three risk factors were significantly associated with A. baumannii colonization: age (OR, 2.803; IC95%, 1.191-6.596; P = 0.01), gender (OR, 0.382; IC95%, 0.158-0.921; P = 0.03) and the delivery birth at the Maternity of University Hospital (MUH), (OR, 0.196; IC95%, 0.071-0.540; P = 0.002). However during hospitalization, the only risk factor associated with acquisition of A. baumannii was the respiratory distress (OR, 2.270; IC95%, 1.055-4.881; P = 0.03). A high intestinal carriage rate of A. baumannii and multiple antibiotic resistance were found in our NICU. Thus, the spread of MDR A. baumannii should be monitored by an active surveillance strategy.	[Arhoune, Btissam; Oumokhtar, Bouchra; Moutaouakkil, Kaoutar] Sidi Mohammed Ben Abdellah Univ, Fac Med & Pharm, Lab Microbiol & Mol Biol, Fes, Morocco; [Arhoune, Btissam; Chami, Fouzia] Sidi Mohammed Ben Abdellah Univ, Biotechnol Lab, Fac Sci Dhar El Mahraz, Fes, Morocco; [Hmami, Fouzia; Bouharrou, Abdelhak] Univ Hosp Hassan II, Neonatal Intens Care Unit, Fes, Morocco; [El Fakir, Samira] Sidi Mohammed Ben Abdellah Univ, Fac Med & Pharm, Lab Epidemiol & Clin Res, Fes, Morocco	Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez	Oumokhtar, B (corresponding author), Sidi Mohammed Ben Abdellah Univ, Fac Med & Pharm, Lab Microbiol & Mol Biol, Fes, Morocco.	bouchra.oumokhtar@usmba.ac.ma		oumokhtar, bouchra/0000-0001-8186-4000	University Hospital Hassan II (Fez, Morocco)	University Hospital Hassan II (Fez, Morocco)	This study was supported by the University Hospital Hassan II (Fez, Morocco). The institution did not participate in the study design, the collection of data collection, the analysis, the decision to publish, nor the writing of the manuscript.	Aljindan R, 2015, J MED MICROBIOL, V64, P400, DOI 10.1099/jmm.0.000033; Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carbapenemase O, 2010, WORLDWIDE DISSEMINAT, V16, P1; Cisneros-Herreros Jose Miguel, 2005, Enferm Infecc Microbiol Clin, V23 Suppl 3, P46; Corbella X, 1996, RELEVANCE DIGESTIVE; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Djahmi N, 2014, EPIDEMIOLOGY CARBAPE, V2014; Ehlers MM, 2012, ANTIBIOTIC RESISTANT BACTERIA - A CONTINUOUS CHALLENGE IN THE NEW MILLENNIUM, P213; el kadi MA, 2006, MED MALADIES INFECT, V36, P386, DOI 10.1016/j.medmal.2006.05.003; Elkalioubie A, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.09.01; Ertugrul S, 2016, RISK FACTORS HLTH CA, V26; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Feizabadi MM, 2008, JPN J INFECT DIS, V61, P274; Lortholary O, 2016, COLONIZATION ACINETO, V19, P188; Manchanda V, 2010, MULTIDRUG RESISTANT, V3; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Masse J, 2017, EUR J CLIN MICROBIOL, V36, P797, DOI 10.1007/s10096-016-2863-x; Moati A, 2009, PALESTINE, P623; Moghnieh R, 2016, J HOSP INFECT, V92, P47, DOI 10.1016/j.jhin.2015.10.007; Nordmann P., 2010, CARBAPENEMES CHEZ BA, V26; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x; Park SY, 2013, INFECT CHEMOTHER, V45, P325, DOI 10.3947/ic.2013.45.3.325; Playford EG, 2007, CARBAPENEM RESISTANT, P204; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Safari M, 2015, SAUDI J BIOL SCI, V22, P424, DOI 10.1016/j.sjbs.2015.01.004; Thuy DB, PLOS ONE; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Ulu-Kilic A., 2013, OA CRIT CARE, V1; Uwingabiye J, 2017, ANTIMICROB RESIST IN, V6; Wei HM, 2015, J MICROBIOL IMMUNOL, V48, P531, DOI 10.1016/j.jmii.2014.08.025; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yesilbag Z, 2014, BULLET KABUL EDIL TA; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769; Zhang De-Shuang, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P14; Zhou BIN, 2016, CLIN MICROBIOLOGICAL, P3621	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209425	10.1371/journal.pone.0209425	http://dx.doi.org/10.1371/journal.pone.0209425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629614	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000025
J	Braun, C; Alcazar-Roman, AR; Laska, A; Molleken, K; Fleig, U; Hegemann, JH				Braun, Corinna; Alcazar-Roman, Abel R.; Laska, Alexandra; Moelleken, Katja; Fleig, Ursula; Hegemann, Johannes H.			CPn0572, the C. pneumoniae ortholog of TarP, reorganizes the actin cytoskeleton via a newly identified F-actin binding domain and recruitment of vinculin	PLOS ONE			English	Article							CHLAMYDIA EFFECTOR TARP; FISSION YEAST; ARP2/3 COMPLEX; EXPRESSION; INTERACTS; PROMOTE; PROTEIN; SYSTEM; KINASE; ENTRY	Chlamydia pneumoniae is one of the two major species of the Chlamydiaceae family that have a profound effect on human health. C. pneumoniae is linked to a number of severe acute and chronic diseases of the upper and lower respiratory tract including pneumonia, asthma, bronchitis and infection by the pathogen might play a role in lung cancer. Following adhesion, Chlamydiae secrete effector proteins into the host cytoplasm that modulate the actin cytoskeleton facilitating internalization and infection. Members of the conserved TarP protein family comprise such effector proteins that polymerize actin, and in the case of the C. trachomatis TarP protein, has been shown to play a critical role in pathogenesis. In a previous study, we demonstrated that, upon bacterial invasion, the C. pneumoniae TarP family member CPn0572 is secreted into the host cytoplasm and recruits and associates with actin via an actin-binding domain conserved in TarP proteins. We have now extended our analysis of CPn0572 and found that the CPn0572 actin binding and modulating capability is more complex. With the help of the fission yeast system, a second actin modulating domain was identified independent of the actin binding domain. Microscopic analysis of HEp-2 cells expressing different CPn0572 deletion variants mapped this domain to the C-terminal part of the protein as CPn0572(536-755) binds F-actin in vitro and colocalizes with aberrantly thickened actin cables in vivo. Finally, microscopic and bioinformatic analysis revealed the existence of a vinculin binding sequence in CPn0572. Our findings contribute to the understanding of the function of the TarP family and underscore the existence of several actin binding domains and a vinculin binding site for host actin modulation.	[Braun, Corinna; Laska, Alexandra; Moelleken, Katja; Hegemann, Johannes H.] Heinrich Heine Univ, Inst Funct Microbial Genom, Dusseldorf, Germany; [Alcazar-Roman, Abel R.; Fleig, Ursula] Heinrich Heine Univ, Inst Funct Microbial Genom, Eukaryot Microbiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Hegemann, JH (corresponding author), Heinrich Heine Univ, Inst Funct Microbial Genom, Dusseldorf, Germany.	johannes.hegemann@hhu.de		Hegemann, Johannes H./0000-0003-4733-2435; Alcazar-Roman, Abel R./0000-0003-1668-1886	Deutsche Forschungsgemeinschaft [FL 168/5-1, HE 1383/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft research grants FL 168/5-1 (UF) and HE 1383/13-1 (JHH) http://www.dfg.de.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Asadi F, 2016, G3-GENES GENOM GENET, V6, P3399, DOI 10.1534/g3.116.032664; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Blasi F., 1998, Clin Microbiol Infect, V4 Suppl 4, pS1; Blasi Francesco, 1996, Clin Microbiol Infect, V1 Suppl 1, pS14, DOI 10.1111/j.1469-0691.1996.tb00585.x; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Chang F, 2017, MOL BIOL CELL, V28, P1819, DOI 10.1091/mbc.E16-09-0671; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; DAHLEN GH, 1995, ATHEROSCLEROSIS, V114, P165, DOI 10.1016/0021-9150(94)05480-7; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Huang JQ, 2012, J CELL BIOL, V199, P831, DOI 10.1083/jcb.201209044; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Jiwani S, 2012, BIOCHEM BIOPH RES CO, V420, P816, DOI 10.1016/j.bbrc.2012.03.080; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Lamason RL, 2016, CELL, V167, P670, DOI 10.1016/j.cell.2016.09.023; Leonhardt C, 2014, NANOMED-NANOTECHNOL, V10, P679, DOI 10.1016/j.nano.2013.11.008; MARKS J, 1986, J CELL SCI, P229; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Parrett CJ, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00084; Pohlmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004586; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Sriram S, 1999, ANN NEUROL, V46, P6, DOI 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.3.CO;2-D; Thwaites T, 2014, J BIOL CHEM, V289, P30426, DOI 10.1074/jbc.M114.604876; Thwaites TR, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/foimb.2015.00088, 10.3389/fcimb.2015.00088]; Tolchard J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20290-8; Whitewood AJ, 2018, FEBS LETT, V592, P1751, DOI 10.1002/1873-3468.13074; Zilio N, 2012, YEAST, V29, P425, DOI 10.1002/yea.2920; Zrieq R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00511	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210403	10.1371/journal.pone.0210403	http://dx.doi.org/10.1371/journal.pone.0210403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629647	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000080
J	Chavez, RD; Sohn, P; Serra, R				Chavez, Robert Dalton; Sohn, Philip; Serra, Rosa			Prg4 prevents osteoarthritis induced by dominant-negative interference of TGF-ss signaling in mice	PLOS ONE			English	Article							MURINE KNEE-JOINT; ARTICULAR-CARTILAGE; RADIOGRAPHIC OSTEOARTHRITIS; DIFFERENTIAL REGULATION; SOX9 PROTEIN; ZONE PROTEIN; FALLS RISK; BETA; EXPRESSION; PAIN	Objective Prg4, also known as Lubricin, acts as a joint/boundary lubricant. Prg4 has been used to prevent surgically induced osteoarthritis (OA) in mice. Surgically induced OA serves as a good model for post-traumatic OA but is not ideal for recapitulating age-related OA. Reduced expression of the TGF-beta type II receptor (TGF beta R2) is associated with age-related OA in clinical samples, so we previously characterized a mouse model that exhibits OA due to expression of a mutated dominant-negative form of TGF beta R2 (DNIIR). Prg4 expression was significantly reduced in DNIIR mice. Furthermore, we showed that Prg4 was a transcriptional target of TGF-ss via activation of Smad3, the main signal transducing protein for TGF-ss. The objective of the present study was to determine whether maintenance of Prg4, a down-stream transcriptional target of TGF-ss, prevents OA associated with attenuated TGF-ss signaling in mice. Design Wild-type, DNIIR, and bitransgenic mice that express both DNIIR and Prg4, were compared. Mice were assessed with a foot misplacement behavioral test, mu CT, histology, and Western blot. Results Compared to DNIIR mice, bitransgenic DNIIR+Prg4 mice missed 1.3 (0.4, 2.1) fewer steps while walking (mean difference (95% confidence interval)), exhibited a cartilage fibrillation score that was 1.8 (0.4, 3.1) points lower, exhibited cartilage that was 28.2 (0.5, 55.9) mu m thicker, and exhibited an OARSI score that was 6.8 (-0.9, 14.5) points lower. However, maintenance of Prg4 expression did not restore levels of phosphorylated Smad3 in DNIIR mice, indicating Prg4 does not simply stimulate TGF-ss signaling. Conclusions Our results indicate that maintenance of Prg4 expression prevents OA progression associated with reduced TGF-beta signaling in mice. Since there was no evidence that Prg4 acts by stimulating the TGF-ss signaling cascade, we propose that Prg4, a transcriptional target of TGF-ss, attenuates OA progression through its joint lubrication function.	[Chavez, Robert Dalton] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Sohn, Philip; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Serra, R (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	rserra@uab.edu			HHMI [56005705];  [R01 AR062507];  [T32 AR069516];  [P30 NS47466];  [P30 DK079626]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062507, T32AR069516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); ; ; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by R01 AR062507 to RS, HHMI 56005705 (PI Patel) to RDC, and T32 AR069516 (PI Bridges) to RDC. The UAB Neuroscience Behavioral Assessment Core is funded by P30 NS47466. The UAB Small Animal Phenotyping Core is funded by P30 DK079626. The study sponsors had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript.	Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Al-Sharif A, 2015, ARTHRITIS RHEUMATOL, V67, P1503, DOI 10.1002/art.39087; Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; BROWN T D, 1984, Journal of Orthopaedic Research, V2, P190, DOI 10.1002/jor.1100020210; Chavez RD, 2017, OSTEOARTHR CARTILAGE, V25, P332, DOI 10.1016/j.joca.2016.10.007; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Coricor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38616; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; DuRaine GD, 2011, OSTEOARTHR CARTILAGE, V19, P103, DOI 10.1016/j.joca.2010.10.008; EMERY IH, 1973, J ANAT, V116, P103; Falah M, 2010, INT ORTHOP, V34, P621, DOI 10.1007/s00264-010-0959-y; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Gardiner MD, 2015, OSTEOARTHR CARTILAGE, V23, P616, DOI 10.1016/j.joca.2014.12.014; Gleghorn JP, 2009, J ORTHOP RES, V27, P771, DOI 10.1002/jor.20798; IHCWorld, H E STAIN PROT; IHCWorld, SAFR STAIN PROT CART; Iqbal SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18910; Jay GD, 2012, ARTHRITIS RHEUM-US, V64, P1162, DOI 10.1002/art.33461; Kotwal N, 2012, OSTEOARTHR CARTILAGE, V20, P887, DOI 10.1016/j.joca.2012.04.012; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; Levy AS, 1996, AM J SPORT MED, V24, P634, DOI 10.1177/036354659602400512; Neu CP, 2010, ARTHRITIS RHEUM-US, V62, P2680, DOI 10.1002/art.27577; Niikura T, 2007, ARTHRITIS RHEUM, V56, P2312, DOI 10.1002/art.22659; Ogawa H, 2014, GENE DEV, V28, P127, DOI 10.1101/gad.231969.113; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Ramaswamy G, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3762; ROBERTS S, 1986, J BONE JOINT SURG BR, V68, P418, DOI 10.1302/0301-620X.68B3.3733808; Roemhildt ML, 2006, J BIOMECH, V39, P2331, DOI 10.1016/j.jbiomech.2005.07.017; Ruan MZC, 2013, OSTEOARTHR CARTILAGE, V21, P1355, DOI 10.1016/j.joca.2013.06.016; Ruan MZC, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.8; RUAN MZ, 2013, SCI TRANSLATIONAL ME, V0005; Scharstuhl A, 2002, ANN RHEUM DIS, V61, P1095, DOI 10.1136/ard.61.12.1095; Schmidt TA, 2008, OSTEOARTHR CARTILAGE, V16, P90, DOI 10.1016/j.joca.2007.05.009; Scott D, 2012, ARTHRIT CARE RES, V64, P30, DOI 10.1002/acr.20545; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Stuart K, 2017, OSTEOARTHR CARTILAGE, V25, pS415, DOI 10.1016/j.joca.2017.02.717; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Tsonga T, 2015, CLIN ORTHOP SURG, V7, P449, DOI 10.4055/cios.2015.7.4.449; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van Beuningen HM, 2000, OSTEOARTHR CARTILAGE, V8, P25, DOI 10.1053/joca.1999.0267; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; Waller KA, 2017, AM J SPORT MED, V45, P1512, DOI 10.1177/0363546516686965; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110; Wang Q, 2017, OSTEOARTHR CARTILAGE, V25, P1868, DOI 10.1016/j.joca.2017.07.010; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210601	10.1371/journal.pone.0210601	http://dx.doi.org/10.1371/journal.pone.0210601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629676	Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000116
J	Gruenstaeudl, M; Hartmaring, Y				Gruenstaeudl, Michael; Hartmaring, Yannick			EMBL2checklists: A Python package to facilitate the user-friendly submission of plant and fungal DNA barcoding sequences to ENA	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-BIOLOGY; REGION	Background The submission of DNA sequences to public sequence databases is an essential, but insufficiently automated step in the process of generating and disseminating novel DNA sequence data. Despite the centrality of database submissions to biological research, the range of available software tools that facilitate the preparation of sequence data for database submissions is low, especially for sequences generated via plant and fungal DNA bar-coding. Current submission procedures can be complex and prohibitively time expensive for any but a small number of input sequences. A user-friendly software tool is needed that streamlines the file preparation for database submissions of DNA sequences that are commonly generated in plant and fungal DNA barcoding. Methods A Python package was developed that converts DNA sequences from the common EMBL and GenBank flat file formats to submission-ready, tab-delimited spreadsheets (so-called 'checklists') for a subsequent upload to the annotated sequence section of the European Nucleotide Archive (ENA). The software tool, titled 'EMBL2checklists', automatically converts DNA sequences, their annotation features, and associated metadata into the idiosyncratic format of marker-specific ENA checklists and, thus, generates files that can be uploaded via the interactive Webin submission system of ENA. Results EMBL2checklists provides a simple, platform-independent tool that automates the conversion of common DNA barcoding sequences into easily editable spreadsheets that require no further processing but their upload to ENA via the interactive Webin submission system. The software is equipped with an intuitive graphical as well as an efficient command-line interface for its operation. The utility of the software is illustrated by its application in four recent investigations, including plant phylogenetic and fungal metagenomic studies. Discussion EMBL2checklists bridges the gap between common software suites for DNA sequence assembly and annotation and the interactive data submission process of ENA. It represents an easy-to-use solution for plant and fungal biologists without bioinformatics expertise to generate submission-ready checklists from common DNA sequence data. It allows the post-processing of checklists as well as work-sharing during the submission process and solves a critical bottleneck in the effort to increase participation in public data sharing.	[Gruenstaeudl, Michael] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hartmaring, Yannick] Free Univ Berlin, Inst Bioinformat, Berlin, Germany	Free University of Berlin; Free University of Berlin	Gruenstaeudl, M (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	m.gruenstaeudl@fu-berlin.de	Gruenstaeudl, Michael/W-6050-2019	Gruenstaeudl, Michael/0000-0002-1666-1773	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [418670221]; Freie Universitat Berlin (Initiativmittel der Forschungskommission)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Freie Universitat Berlin (Initiativmittel der Forschungskommission)	This investigation was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - project number 418670221 - and by a start-up grant of the Freie Universitat Berlin (Initiativmittel der Forschungskommission), both to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; .	Amid C, 2012, NUCLEIC ACIDS RES, V40, pD43, DOI 10.1093/nar/gkr946; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blaxter M, 2016, SCIENCE, V352, P780, DOI 10.1126/science.aaf7672; Borsch T, 2018, TAXON, V67, P944, DOI 10.12705/675.7; Buyya R, 2005, P IEEE, V93, P698, DOI 10.1109/JPROC.2004.842784; Canal D, 2018, AM J BOT, V105, P1035, DOI 10.1002/ajb2.1111; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dean GH, 2018, APPL PLANT SCI, V6, DOI 10.1002/aps3.1167; Drew Bryan T., 2013, PLoS Biology, V11, P1; Fairbairn DJ, 2011, EVOLUTION, V65, P1, DOI 10.1111/j.1558-5646.2010.01182.x; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hankeln W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024797; Harrison PW, 2019, NUCLEIC ACIDS RES, V47, pD84, DOI 10.1093/nar/gky1078; Hartmaring Y., 2018, AUSBAU SOFTWARE SCRI; Heckenhauer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185861; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang XL, 2012, CONSERV LETT, V5, P399, DOI 10.1111/j.1755-263X.2012.00259.x; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Karsch-Mizrachi I, 2018, NUCLEIC ACIDS RES, V46, pD48, DOI 10.1093/nar/gkx1097; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan S, 2017, J NETW COMPUT APPL, V88, P99, DOI 10.1016/j.jnca.2017.02.013; Kodama Y, 2018, NUCLEIC ACIDS RES, V46, pD30, DOI 10.1093/nar/gkx926; Korotkova N, 2018, J SYST EVOL, V56, P35, DOI 10.1111/jse.12276; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2017, J SYST EVOL, V55, P291, DOI 10.1111/jse.12254; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu JX, 2014, MOL ECOL RESOUR, V14, P1231, DOI 10.1111/1755-0998.12262; Mons Barend, 2017, Information Services & Use, V37, P49, DOI 10.3233/ISU-170824; Mueller J, 2010, PHYDE PHYLOGENETIC D; NEUHAUS H, 1987, CURR GENET, V11, P251, DOI 10.1007/BF00355398; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; Norling Martin, 2018, BMC Res Notes, V11, P584, DOI 10.1186/s13104-018-3686-x; Page A, 2016, J OPEN SOURCE SOFTWA, V1, P8, DOI [10.21105/joss.00080, DOI 10.21105/JOSS.00080]; Pajankar A., 2017, PYTHON UNIT TEST AUT; Pei NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15127; Pirovano W, 2017, BRIEF BIOINFORM, V18, P179, DOI 10.1093/bib/bbv104; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roche DG, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002295; Roche DG, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001779; Roy J, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix102; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Silvester N, 2018, NUCLEIC ACIDS RES, V46, pD36, DOI 10.1093/nar/gkx1125; Soltis DE, 1997, ANN MO BOT GARD, V84, P1, DOI 10.2307/2399952; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tan SL, 2018, ECOL EVOL, V8, P7195, DOI 10.1002/ece3.4254; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Wicke S, 2009, ANAL JARDIN BOT MAD, V66, P285, DOI 10.3989/ajbm.2231; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Williams J, 2018, QUBES ED RESOURCES; Xu JP, 2016, GENOME, V59, P913, DOI 10.1139/gen-2016-0046	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210347	10.1371/journal.pone.0210347	http://dx.doi.org/10.1371/journal.pone.0210347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629718	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000076
J	Ito, JT; Cervilha, DAD; Lourenco, JD; Goncalves, NG; Volpini, RA; Caldini, EG; Landman, G; Lin, CJ; Velosa, APP; Teodoro, WPR; Tiberio, IDLC; Mauad, T; Martins, MD; Macchione, M; Lopes, FDTQD				Ito, Juliana Tiyaki; de Brito Cervilha, Daniela Aparecida; Lourenco, Juliana Dias; Goncalves, Natalia Gomes; Volpini, Rildo Aparecido; Caldini, Elia Garcia; Landman, Gilles; Lin, Chin Jia; Pereira Velosa, Ana Paula; Rosolia Teodoro, Walcy Paganelli; Lopes Calvo Tiberio, Iolanda de Fatima; Mauad, Thais; Martins, Milton de Arruda; Macchione, Mariangela; Quirino dos Santos Lopes, Fernanda Degobbi Tenorio			Th17/Treg imbalance in COPD progression: A temporal analysis using a CS-induced model	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MOUSE MODEL; LUNG; CELLS; EXPRESSION; INFLAMMATION; RESPONSES; IMMUNITY; TH17; REG	Background The imbalance between pro- and anti-inflammatory immune responses plays a pivotal role in chronic obstructive pulmonary disease (COPD) development and progression. To clarify the pathophysiological mechanisms of this disease, we performed a temporal analysis of immune response-mediated inflammatory progression in a cigarette smoke (CS)-induced mouse model with a focus on the balance between Th17 and Treg responses. Methods C57BL/6 mice were exposed to CS for 1, 3 or 6 months to induce COPD, and the control groups were maintained under filtered air conditions for the same time intervals. We then performed functional (respiratory mechanics) and structural (alveolar enlargement) analyses. We also quantified the NF-kappa B, TNF-alpha, CD4, CD8, CD20, IL-17, IL-6, FOXP3, IL-10, or TGF-beta positive cells in peribronchovascular areas and assessed FOXP3 and IL-10 expression through double-label immunofluorescence. Additionally, we evaluated the gene expression of NF-kappa B and TNF in bronchiolar epithelial cells. Results Our CS-induced COPD model exhibited an increased proinflammatory immune response (increased expression of the NF-kappa B, TNF-alpha, CD4, CD8, CD20, IL-17, and IL-6 markers) with a concomitantly decreased anti-inflammatory immune response (FOXP3, IL-10, and TGF-beta markers) compared with the control mice. These changes in the immune responses were associated with increased alveolar enlargement and impaired lung function starting on the first month and third month of CS exposure, respectively, compared with the control mice. Conclusion Our results showed that the microenvironmental stimuli produced by the release of cyto-kines during COPD progression lead to a Th17/Treg imbalance.	[Ito, Juliana Tiyaki; de Brito Cervilha, Daniela Aparecida; Lourenco, Juliana Dias; Lopes Calvo Tiberio, Iolanda de Fatima; Martins, Milton de Arruda; Quirino dos Santos Lopes, Fernanda Degobbi Tenorio] Univ Sao Paulo, Sch Med, Dept Clin Med, Lab Expt Therapeut, Sao Paulo, Brazil; [Goncalves, Natalia Gomes; Lin, Chin Jia] Univ Sao Paulo, Sch Med, Dept Pathol, Lab Mol Pathol, Sao Paulo, Brazil; [Volpini, Rildo Aparecido] Univ Sao Paulo, Sch Med, Dept Clin Med, Basic Res Lab Kidney Dis, Sao Paulo, Brazil; [Caldini, Elia Garcia] Univ Sao Paulo, Sch Med, Dept Pathol, Cell Biol Lab, Sao Paulo, Brazil; [Landman, Gilles] Univ Fed Sao Paulo, Dept Pathol, Multipurpose Lab Mol Pathol, Sao Paulo, Brazil; [Pereira Velosa, Ana Paula; Rosolia Teodoro, Walcy Paganelli] Univ Sao Paulo, Sch Med, Dept Clin Med, Lab Extracellular Matrix, Sao Paulo, Brazil; [Mauad, Thais; Macchione, Mariangela] Univ Sao Paulo, Sch Med, Dept Pathol, Expt Air Pollut Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Ito, JT (corresponding author), Univ Sao Paulo, Sch Med, Dept Clin Med, Lab Expt Therapeut, Sao Paulo, Brazil.	jutiyakito@hotmail.com	Ito, Juliana Tiyaki/Q-8041-2019; Lin, Chin J/B-7895-2013; Lourenço, Juliana D./C-5326-2013; Martins, Milton A/L-7541-2017; Volpini, Rildo Aparecido/L-5690-2019; Goncalves, Natalia/GNP-2099-2022; Caldini, Elia Garcia/F-1105-2011; Macchione, Mariangela/C-6696-2012; Teodoro, Walcy/H-5133-2017; Tibério, Iolanda FLC/C-6461-2012; GonÃalves, Natalia/AAE-7276-2022; Volpini, Rildo A/B-7521-2013; LANDMAN, GILLES/D-5071-2012	Ito, Juliana Tiyaki/0000-0002-9438-5292; Lin, Chin J/0000-0001-7489-560X; Lourenço, Juliana D./0000-0002-9291-5237; Volpini, Rildo Aparecido/0000-0001-6611-2249; Macchione, Mariangela/0000-0003-3335-2654; Teodoro, Walcy/0000-0001-7559-4542; Tibério, Iolanda FLC/0000-0002-5662-7895; Volpini, Rildo A/0000-0001-6611-2249; DTQS Lopes, Fernanda/0000-0002-6402-3055; Gomes Goncalves, Natalia/0000-0002-5253-5483; Caldini, Elia Garcia/0000-0001-5322-3812; LANDMAN, GILLES/0000-0001-7441-3068; Pereira Velosa, Ana Paula/0000-0002-6465-0796	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/15819-8 - FDTQSL]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (demanda social - JTI); Fundacao Faculdade de Medicina through the Programa de Fomento as Atividades de Pesquisa	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (demanda social - JTI); Fundacao Faculdade de Medicina through the Programa de Fomento as Atividades de Pesquisa	The Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant 2014/15819-8 - FDTQSL) played a role in the data collection and analysis, and in preparation of the manuscript. The Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (demanda social - JTI) provided the scholarship to the first author who played a role in the study design, data collection and analysis, and preparation of the manuscript. The Instituto dos Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo - LIM-20 played a role in the data collection. The Fundacao Faculdade de Medicina through the Programa de Fomento as Atividades de Pesquisa supported in the payment of English language review expenses and publication costs.	[Anonymous], 2018, GLOBAL STRATEGY DIAG; Baraldo S, 2008, EUR RESPIR J, V31, P486, DOI 10.1183/09031936.00000608; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0; Chu SY, 2011, INT IMMUNOPHARMACOL, V11, P1780, DOI 10.1016/j.intimp.2011.06.010; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Duan MC, 2016, INFLAMMATION, V39, P1334, DOI 10.1007/s10753-016-0365-8; Eppert BL, 2013, J IMMUNOL, V190, P1331, DOI 10.4049/jimmunol.1202442; Fuke S, 2004, AM J RESP CELL MOL, V31, P405, DOI 10.1165/rcmb.2004-0131OC; Gomes RFM, 2000, J APPL PHYSIOL, V89, P908, DOI 10.1152/jappl.2000.89.3.908; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Hizume DC, 2012, RESP PHYSIOL NEUROBI, V181, P167, DOI 10.1016/j.resp.2012.03.005; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111044; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; Le Rouzic O, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02434-2016; Li HJ, 2015, AM J MED SCI, V349, P392, DOI 10.1097/MAJ.0000000000000447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Rahman MS, 2005, CLIN IMMUNOL, V115, P268, DOI 10.1016/j.clim.2005.01.014; Roos AB, 2015, AM J RESP CRIT CARE, V192, P428, DOI 10.1164/rccm.201409-1689OC; Sales DS, 2017, COPD, V14, P533, DOI 10.1080/15412555.2017.1346069; Shaykhiev R, 2013, GERONTOLOGY, V59, P481, DOI 10.1159/000354173; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411; Toumpanakis D, 2010, AM J RESP CRIT CARE, V182, P1129, DOI 10.1164/rccm.201001-0116OC; Tsoumakidou M, 2011, CURR DRUG TARGETS, V12, P450, DOI 10.2174/138945011794751546; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Wang HY, 2015, CLIN RESPIR J, V9, P330, DOI 10.1111/crj.12147; Wang HY, 2012, INT IMMUNOPHARMACOL, V14, P504, DOI 10.1016/j.intimp.2012.09.011; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; WEIBEL ER, 1963, LAB INVEST, V12, P131; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	43	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209351	10.1371/journal.pone.0209351	http://dx.doi.org/10.1371/journal.pone.0209351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629626	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000023
J	Burnett-Hartman, AN; Hua, XW; Rue, TC; Golchin, N; Kessler, L; Rowhani-Rahbar, A				Burnett-Hartman, Andrea N.; Hua, Xinwei; Rue, Tessa C.; Golchin, Negar; Kessler, Larry; Rowhani-Rahbar, Ali			Risk interval analysis of emergency room visits following colonoscopy in patients with inflammatory bowel disease	PLOS ONE			English	Article							SODIUM-PHOSPHATE; COLONIC ULCERATION; SURVEILLANCE; MORTALITY; COLITIS	Background and aims Prior studies suggest that colonoscopy may exacerbate inflammatory bowel disease (IBD) symptoms. Thus, our study aimed to determine risk of emergency room (ER) visits associated with colonoscopy among IBD patients and evaluate potential modifiers of this risk. Methods The study population included IBD patients in the Multi-Payer Claims Database who were >20 years old and had a colonoscopy from 2007-2010. We used a self-controlled risk interval design and mixed-effects Poisson regression models to calculate risk ratios (RR) and 95% confidence intervals (CI) comparing the incidence of ER visits in the 1-4 weeks following colonoscopy (risk interval) to the incidence of ER visits in the 7-10 weeks after colonoscopy (control interval). We also conducted stratified analyses by patient characteristics, bowel preparation type, and medication. Results There were 212,205 IBD patients with at least 1 colonoscopy from 2007-2010, and 3,699 had an ER visit during the risk and/or control interval. The risk of an ER visit was higher in the 4-week risk interval following colonoscopy compared to the control interval (RR = 1.24; 95% CI: 1.17-1.32). The effect was strongest in those <41 years old (RR = 1.60; 95% CI: 1.21-2.11), in women (RR = 1.32; 95% CI: 1.21-1.44), and in those with sodium phosphate bowel preparation (RR = 2.09; 95% CI: 1.02-4.29). Patients using immunomodulators had no increased risk of ER visits (RR = 0.75;95% CI: 0.35-1.59). Conclusions Our results suggest that there is an increased risk of ER visits following colonoscopy among IBD patients, but that immunomodulators and mild bowel preparation agents may mitigate this risk.	[Burnett-Hartman, Andrea N.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80247 USA; [Burnett-Hartman, Andrea N.; Hua, Xinwei; Rue, Tessa C.; Kessler, Larry; Rowhani-Rahbar, Ali] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Burnett-Hartman, Andrea N.; Hua, Xinwei] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Golchin, Negar] Univ Washington, Sch Pharm, Seattle, WA 98195 USA	Kaiser Permanente; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Burnett-Hartman, AN (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80247 USA.; Burnett-Hartman, AN (corresponding author), Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA.; Burnett-Hartman, AN (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	Andrea.N.Burnett-Hartman@kp.org	Golchin, Negar/AAP-1163-2020	Golchin, Negar/0000-0003-0775-9004; Rowhani-Rahbar, Ali/0000-0002-2705-4485; Burnett-Hartman, Andrea/0000-0003-4009-0680	National Center for Advancing Translational Sciences at the National Institutes of Health [KL2 TR000421]; Department of Defense [W81XWH-15-1-0273]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000421] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences at the National Institutes of Health; Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Center for Advancing Translational Sciences at the National Institutes of Health, KL2 TR000421, and the Department of Defense, W81XWH-15-1-0273, to A.N.BH. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RJ, 2005, AM J GASTROENTEROL, V100, P2603, DOI 10.1111/j.1572-0241.2005.00305_11.x; D'Haens GR, 2014, J CROHNS COLITIS, V8, P726, DOI 10.1016/j.crohns.2014.02.025; Denters MJ, 2013, EUR J GASTROEN HEPAT, V25, P964, DOI 10.1097/MEG.0b013e328361dcd3; Driman DK, 1998, HUM PATHOL, V29, P972, DOI 10.1016/S0046-8177(98)90203-9; Friedman S, 2013, INFLAMM BOWEL DIS, V19, P534, DOI 10.1097/MIB.0b013e3182802a3c; Ghaoui R, 2016, DIGEST LIVER DIS, V48, P940, DOI 10.1016/j.dld.2016.04.005; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Hommes DW, 2004, GASTROENTEROLOGY, V126, P1561, DOI 10.1053/j.gastro.2004.03.023; Karlen P, 1998, GUT, V42, P711, DOI 10.1136/gut.42.5.711; Kim ES, 2017, DIGEST DIS SCI, V62, P2489, DOI 10.1007/s10620-017-4634-7; Lutgens MWMD, 2009, BRIT J CANCER, V101, P1671, DOI 10.1038/sj.bjc.6605359; Menees S, 2007, INFLAMM BOWEL DIS, V13, P12, DOI 10.1002/ibd.20049; Rejchrt S, 2004, GASTROINTEST ENDOSC, V59, P651, DOI 10.1016/S0016-5107(04)00158-0; SCHWESINGER WH, 1979, SURG GYNECOL OBSTET, V148, P270; Singh JA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0513-6; Watts DA, 2002, GASTROINTEST ENDOSC, V55, P584, DOI 10.1067/mge.2002.122582; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Yu JX, 2016, BEST PRACT RES CL GA, V30, P949, DOI 10.1016/j.bpg.2016.10.014	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210262	10.1371/journal.pone.0210262	http://dx.doi.org/10.1371/journal.pone.0210262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625217	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400080
J	Ohene, SA; Bakker, MI; Ojo, J; Toonstra, A; Awudi, D; Klatser, P				Ohene, Sally-Ann; Bakker, Mirjam I.; Ojo, John; Toonstra, Ardon; Awudi, Doris; Klatser, Paul			Extra-pulmonary tuberculosis: A retrospective study of patients in Accra, Ghana	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; HIV-INFECTION; EPIDEMIOLOGY; ASSOCIATION; MORTALITY	Background Information on extrapulmonary TB (EPTB) patients is limited in many African countries including Ghana. The study objective was to describe the epidemiology of EPTB patients diagnosed from different categories of health facilities in Accra, Ghana compared to pulmonary TB (PTB) patients and identify risk factors for mortality among EPTB patients. Method We conducted retrospective analyses of demographic and clinical data accessed from medical records of EPTB and PTB patients from different types of health facilities from June 2010 to December 2013. Factors at diagnosis associated with EPTB compared to pulmonary TB (PTB) and factors associated with treatment outcome death among EPTB patients were assessed using logistic regression. Results Out of 3,342 new TB patients >= 15 years diagnosed, 728 (21.8%) had EPTB with a male: female ratio of 1.17. The EPTB sites commonly affected were disseminated 32.8%, pleura 21%, spine 13%, and Central Nervous System (CNS) 11%. Treatment success rate for EPTB was 70.1% compared to 84.2% for PTB (p<0.001). In logistic regression, HIV positivity (adjusted Odds Ratio [aOR] 3.19; 95% confidence interval [CI] 2.69-3.79) and female gender (aOR 1.59; 95% CI 1.35-1.88) were found to be significantly associated with EPTB compared with PTB. Older age, being HIV positive (aOR 3.15; 95% CI 1.20-8.25) and having CNS TB (aOR 3.88; 95% CI 1.14-13.23) were associated with mortality among EPTB patients. While more EPTB patients were diagnosed in the tertiary hospital, health facility type was not associated with mortality. Conclusion EPTB patients in Accra have a worse treatment outcome compared to PTB patients with mortality of EPTB being associated with HIV, older age and CNS TB. Being HIV positive and female gender were found to be significantly associated with EPTB. Increased awareness of these factors may facilitate early case finding and better management outcomes for these patients.	[Ohene, Sally-Ann] WHO, Country Off, Accra, Ghana; [Bakker, Mirjam I.; Toonstra, Ardon] Royal Trop Inst KIT, KIT Hlth, Amsterdam, Netherlands; [Ojo, John] Univ Ghana, Sch Publ Hlth, Legon, Accra, Ghana; [Awudi, Doris] Ghana Hlth Serv, Natl AIDS STI Control Program, Accra, Ghana; [Klatser, Paul] Amsterdam Inst Global Hlth & Dev, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands	World Health Organization; University of Ghana; Ghana Health Service; University of Amsterdam; Academic Medical Center Amsterdam	Ohene, SA (corresponding author), WHO, Country Off, Accra, Ghana.	salohene@yahoo.com			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Addo KK, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2853-3; Addo Kk, 2007, Ghana Med J, V41, P52; Ade S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095603; Al-Hajoj S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0101667; Amo-Adjei J, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/2049-3258-71-22; [Anonymous], 2010, TREATM TUB GUID; Burton NT, 2011, T ROY SOC TROP MED H, V105, P675, DOI 10.1016/j.trstmh.2011.07.017; Chandir S, 2010, J PAK MED ASSOC, V60, P105; Cherian J J, 2017, Indian J Tuberc, V64, P104, DOI 10.1016/j.ijtb.2016.11.028; Endris Mengistu, 2014, Tuberc Res Treat, V2014, P726193, DOI 10.1155/2014/726193; Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Ghana Health Service/Ministry of Health, NAT TUB HLTH SECT ST; Ghana Health Service National AIDS Control Program, 2017, 2016 HIV SENT SURV R; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Gomes T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-9; Gunal S, 2011, BMC PUBLIC HEALTH, V11, P154; Jamtsho T, 2013, PUBLIC HEALTH ACTION, V3, P38, DOI 10.5588/pha.12.0085; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kourbatova EV, 2006, EUR J EPIDEMIOL, V21, P715, DOI 10.1007/s10654-006-9060-7; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6; Nassikas N., 2015, Ghana Medical Journal, V49, P233, DOI 10.4314/gmj.v49i4.3; Ohene SA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2843-5; Ohene-Yeboah M, 2006, TROP DOCT, V36, P241, DOI 10.1258/004947506778604643; Omari AM, 2014, THESIS; Oshi DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111910; Ozvaran Mustafa Kursat, 2007, Ann Thorac Med, V2, P118, DOI 10.4103/1817-1737.33700; Pefura-Yone E. W., 2013, Indian Journal of Tuberculosis, V60, P107; Penz E, 2015, INT J TUBERC LUNG D, V19, P278, DOI 10.5588/ijtld.14.0262; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Purohit M, 2015, J CLIN DIAGN RES, V9, pEE1, DOI 10.7860/JCDR/2015/12422.5792; Shivakoti R, 2017, INFECTION, V45, P11, DOI 10.1007/s15010-016-0960-5; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Sunnetcioglu A, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0092-2; Tesgaye F, 2014, PUBLIC HEALTH ACTION, V4, pS25, DOI 10.5588/pha.14.0052; Ukwaja Kingsley N, 2016, World J Methodol, V6, P118, DOI 10.5662/wjm.v6.i1.118; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2017, GHAN TUB PROF; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yeboah-Manu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161892; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	43	39	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209650	10.1371/journal.pone.0209650	http://dx.doi.org/10.1371/journal.pone.0209650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625188	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400051
J	Ozana, S; Burda, M; Hykel, M; Malina, M; Prasek, M; Barta, D; Dolny, A				Ozana, Stanislav; Burda, Michal; Hykel, Michal; Malina, Marek; Prasek, Martin; Barta, Daniel; Dolny, Ales			Dragonfly Hunter CZ: Mobile application for biological species recognition in citizen science	PLOS ONE			English	Article							FOREST; DIVERSITY; ODONATA	Citizen science and data collected from various volunteers have an interesting potential in aiding the understanding of many biological and ecological processes. We describe a mobile application that allows the public to map and report occurrences of the odonata species (dragonflies and damselflies) found in the Czech Republic. The application also helps in species classification based on observation details such as date, GPS coordinates, and the altitude, biotope, suborder, and colour. Dragonfly Hunter CZ is a free Android application built on the open-source framework NativeScript using the JavaScript programming language which is now fully available on Google Play. The server side is powered by Apache Server with PHP and MariaDB SQL database. A mobile application is a fast and accurate way to obtain data pertaining to the odonata species, which can be used after expert verification for ecological studies and conservation basis like Red Lists and policy instruments. We expect it to be effective in encouraging Citizen Science and in promoting the proactive reporting of odonates. It can also be extended to the reporting and monitoring of other plant and animal species.	[Ozana, Stanislav; Hykel, Michal; Barta, Daniel; Dolny, Ales] Univ Ostrava, Dept Biol & Ecol, Fac Sci, Ostrava, Czech Republic; [Ozana, Stanislav; Dolny, Ales] Univ Ostrava, Inst Environm Technol, Fac Sci, Ostrava, Czech Republic; [Burda, Michal] Univ Ostrava, Inst Res & Applicat Fuzzy Modeling, CE IT4Innovat, Ostrava, Czech Republic; [Malina, Marek; Prasek, Martin] Univ Ostrava, Dept Informat & Comp, Fac Sci, Ostrava, Czech Republic	University of Ostrava; University of Ostrava; University of Ostrava; University of Ostrava	Dolny, A (corresponding author), Univ Ostrava, Dept Biol & Ecol, Fac Sci, Ostrava, Czech Republic.; Dolny, A (corresponding author), Univ Ostrava, Inst Environm Technol, Fac Sci, Ostrava, Czech Republic.	ales.dolny@osu.cz	Burda, Michal/D-6699-2014; Dolny, Ales/ABA-5480-2020; Ožana, Stanislav/GYJ-3196-2022	Burda, Michal/0000-0002-4182-4407; Dolny, Ales/0000-0002-6245-8442; Malina, Marek/0000-0003-1604-7375; Ozana, Stanislav/0000-0003-2569-9391	Student Grant Competition of University of Ostrava [SGS06/UVAFM/2017, SGS05/UVAFM/2018]; Ministry of Education, Youth and Sports of the Czech Republic [LO1208]	Student Grant Competition of University of Ostrava; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Student Grant Competition of University of Ostrava SGS06/UVAFM/2017, SGS05/UVAFM/2018 and Ministry of Education, Youth and Sports of the Czech Republic in the "National Feasibility Program I", project LO1208 "TEWEP". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua M, 2012, BIODIVERS CONSERV, V21, P1457, DOI 10.1007/s10531-012-0257-7; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bried JT, 2015, FRESHW SCI, V34, P1023, DOI 10.1086/682174; Cao N, 2017, EXPERT SYST APPL, V81, P1, DOI 10.1016/j.eswa.2017.03.033; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; CLAUSNITZER V, 2017, APPL ENV ED COMMUNIC, V16, P196, DOI DOI 10.1080/1533015X.2017.1333050; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dolny A, 2016, VAZKY ISECTA ODONATA; Dolny A., 2007, DRAGONFLIES CZECH RE; Dolny Ales, 2014, Casopis Slezskeho Zemskeho Muzea Serie A Vedy Prirodni, V63, P185; Dolny A, 2012, TROP ZOOL, V25, P141, DOI 10.1080/03946975.2012.717480; Dolny A, 2012, BIOL CONSERV, V145, P109, DOI 10.1016/j.biocon.2011.10.020; Gardiner MM, 2012, FRONT ECOL ENVIRON, V10, P471, DOI 10.1890/110185; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Goldsmith GR, 2016, METHODS ECOL EVOL, V7, P960, DOI 10.1111/2041-210X.12548; Grandcolas Philippe, 2017, Bionomina, V12, P57, DOI 10.11646/bionomina.12.1.7; Harabis F, 2018, BIOL CONSERV, V217, P28, DOI 10.1016/j.biocon.2017.10.021; Joly A, 2016, LECT NOTES COMPUT SC, V9822, P286, DOI 10.1007/978-3-319-44564-9_26; Kalkman VJ, 2008, HYDROBIOLOGIA, V595, P351, DOI 10.1007/s10750-007-9029-x; Kobori H, 2016, ECOL RES, V31, P1, DOI 10.1007/s11284-015-1314-y; Kovac M, 2018, ECOL INDIC, V89, P281, DOI 10.1016/j.ecolind.2018.02.001; Kumar N, COMPUTER VISION ECCV; Minteer BA, 2014, SCIENCE, V344, P816, DOI 10.1126/science.344.6186.816-a; Minteer BA, 2014, SCIENCE, V344, P260, DOI 10.1126/science.1250953; Nature Conservation Agency CR, 2016, NAL DAT OCHR DAT; Samways MJ, 1996, BIOL CONSERV, V78, P279, DOI 10.1016/S0006-3207(96)00032-8; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Therneau T., 2015, PACKAGE RPART, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=RPART; Vilcek T, 2017, 2017 40TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P1516, DOI 10.23919/MIPRO.2017.7973662; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	32	7	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210370	10.1371/journal.pone.0210370	http://dx.doi.org/10.1371/journal.pone.0210370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625219	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400085
J	Yen, YH; Kee, KM; Chen, CH; Hu, TH; Lu, SN; Wang, JH; Hung, CH				Yen, Yi-Hao; Kee, Kwong-Ming; Chen, Chien-Hung; Hu, Tsung-Hui; Lu, Sheng-Nan; Wang, Jing-Houng; Hung, Chao-Hung			Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C	PLOS ONE			English	Article							INTERFERON-FREE THERAPY; HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; PLUS RIBAVIRIN; LIVER; MANAGEMENT; DISEASE; OBESITY; IMPACT; ERADICATION	Background and aim Previous studies have reported that sustained virological response (SVR) to interferon-based treatment reduces the risk of mortality in chronic hepatitis C (CHC) patients, mainly in cirrhotic patients. A population-based study reported that metabolic risk factors increase the risk of mortality in CHC patients. We aim to investigate the association between SVR, metabolic risk factors and mortality in CHC patients with and without advanced fibrosis. Methods We collected data from 1452 CHC patients who underwent interferon-based therapy. All patients underwent liver biopsy prior to therapy. Mild fibrosis was defined as a modified Knodell score of 0-2, while advanced fibrosis was defined as a score of 3-4. Results 1452 patients were followed up for a median (IQR) of 6.6 (4.2-9.4) years, 1124 patients (77.4%) achieved SVR, 619 patients (42.6%) were advanced fibrosis. 14 patients with mild fibrosis and 55 patients with advanced fibrosis died during follow-up period. According to multivariate Cox regression analyses, SVR reduced the risks of all-cause mortality (HR, 0.21; 95% CI, 0.12-0.37; P<0.001), liver-related mortality (HR, 0.19; 95% CI, 0.10-0.38; P<.001), and non-liver-related mortality (HR, 0.26; 95% CI, 0.10-0.71; P = 0.009) in the patients with advanced fibrosis. SVR also reduced the risk of liver-related mortality (HR, 0.09; 95% CI, 0.01-0.60; P = 0.013) in the patients with mild fibrosis. Anti-hypertensive treatment increased the risks of all-cause mortality (HR, 6.1; 95% CI: 1.66-22.54; P = 0.006) and liver-related mortality (HR, 12.3; 95% CI: 1.4-108.5; P = 0.02) in the patients with mild fibrosis. Conclusion SVR and metabolic risk factors are associated with mortality in CHC patients given interferon-based treatment.	[Yen, Yi-Hao; Kee, Kwong-Ming; Chen, Chien-Hung; Hu, Tsung-Hui; Lu, Sheng-Nan; Wang, Jing-Houng; Hung, Chao-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Yen, Yi-Hao; Kee, Kwong-Ming; Chen, Chien-Hung; Hu, Tsung-Hui; Lu, Sheng-Nan; Wang, Jing-Houng; Hung, Chao-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	dr.hu@msa.hinet.net			Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan [CMRPG8G1181]	Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan	This study was supported by Grant CMRPG8G1181 from the Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan. The grant recipient is Dr. Yi-Hao Yen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2005, CLEV CLIN J MED, V72, P1005, DOI 10.3949/ccjm.72.11.1005; Ampuero J, 2018, J HEPATOL, V68, P940, DOI 10.1016/j.jhep.2017.12.019; Antonucci G, 2007, AM J GASTROENTEROL, V102, P1383, DOI 10.1111/j.1572-0241.2007.01201.x; Backus LI, 2018, HEPATOLOGY, V68, P827, DOI 10.1002/hep.29811; Backus LI, 2019, HEPATOLOGY, V69, P487, DOI 10.1002/hep.29408; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Buti M, 2005, J HEPATOL, V42, P639, DOI 10.1016/j.jhep.2004.12.031; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Drazilova S, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/6150861; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Gavin JR, 2000, DIABETES CARE, V23, pS4; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goossens N, 2014, CLIN LIVER DIS, V18, P147, DOI 10.1016/j.cld.2013.09.007; Honda T, 2010, LIVER INT, V30, P527, DOI 10.1111/j.1478-3231.2009.02064.x; Hu CC, 2013, ALIMENT PHARM THER, V37, P81, DOI 10.1111/apt.12112; Izumi N, 2013, J GASTROENTEROL, V48, P382, DOI 10.1007/s00535-012-0641-9; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Janicko M, 2016, WORLD J GASTROENTERO, V22, P6201, DOI 10.3748/wjg.v22.i27.6201; Jung HJ, 2014, CLIN MOL HEPATOL, V20, P38, DOI 10.3350/cmh.2014.20.1.38; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kokudo N, 2015, HEPATOL RES, V45, DOI 10.1111/hepr.12464; Lazo M, 2017, CLIN GASTROENTEROL H, V15, P1957, DOI 10.1016/j.cgh.2017.04.046; Lens S, 2017, AM J GASTROENTEROL, V112, P1400, DOI 10.1038/ajg.2017.157; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Nahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009; Nyberg Anders H, 2016, Gastroenterol Hepatol (N Y), V12, P185; Qadwai S, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/8349150; Rao H, 2017, ALIMENT PHARM THER, V46, P731, DOI 10.1111/apt.14273; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Simmons B, 2015, CLIN INFECT DIS, V61, P730, DOI 10.1093/cid/civ396; Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208858	10.1371/journal.pone.0208858	http://dx.doi.org/10.1371/journal.pone.0208858			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625158	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400018
J	Landwehr, C; Richardson, J; Bint, L; Parsons, R; Sunderland, B; Czarniak, P				Landwehr, Caitlin; Richardson, Jennifer; Bint, Lewis; Parsons, Richard; Sunderland, Bruce; Czarniak, Petra			Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia	PLOS ONE			English	Article							DRUG-USE; CHILDREN; PHARMACOLOGY; MEDICINES; WARDS	Objectives To evaluate the prevalence of off-label and unlicensed prescribing in inpatients at a major paediatric teaching hospital in Western Australia and to identify which drugs are commonly prescribed off-label or unlicensed, including factors influencing such prescribing. Methods A retrospective cross-sectional study was conducted in June, 2013. Patient and prescribing data were collected from 190 inpatient medication chart records which had been randomly selected from all admissions during the second week of February 2013. Drugs were categorised as licensed, off-label or unlicensed, according to their approved Australian registration product information (PI). All drugs were classified according to the Anatomical Therapeutic Chemical (ATC) code. Results There were 120 male and 70 female inpatients. The average age was 6.0 years (+/- 4.7). The study included 1160 prescribed drugs suitable for analysis. The number of drugs prescribed per patient ranged from 1 to 25 with an average of 6.1 (+/- 4.3). More than half (54%) were prescribed off-label. Oxycodone, clonidine, parecoxib and midazolam were always prescribed off-label. The most common off-label drugs were ondansetron (18.5%), fentanyl (12.9%), oxycodone (8.8%) and paracetamol (6.1%). Many ATC classifications included high off-label proportions especially the genitourinary system and sex hormones, respiratory system drugs, systemic hormonal preparations and alimentary tract and metabolism drugs. Conclusions This study highlights that prescribing of paediatric drugs needs to be better supported by existing and new evidence. Incentives should be established to foster the conduct of evidence-based studies in the paediatric population. The current level of off-label prescribing raises issues of unexpected toxicity and adverse drug effects in children that are in some cases severely ill.	[Landwehr, Caitlin; Richardson, Jennifer; Sunderland, Bruce; Czarniak, Petra] Curtin Univ, Sch Pharm & Biomed Sci, Perth, WA, Australia; [Bint, Lewis] Fiona Stanley Hosp, South Metropolitan Hlth Serv, Perth, WA, Australia; [Parsons, Richard] Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Perth, WA, Australia	Curtin University; Curtin University	Czarniak, P (corresponding author), Curtin Univ, Sch Pharm & Biomed Sci, Perth, WA, Australia.	P.Czarniak@curtin.edu.au						[Anonymous], 2016, AUSTR MED HDB; Ballard CDJ, 2013, J PAEDIATR CHILD H, V49, P38, DOI 10.1111/jpc.12065; Beggs Sean, 2009, Paediatr Drugs, V11, P38; Bucheler R, 2002, BRIT MED J, V324, P1311, DOI 10.1136/bmj.324.7349.1311; Choonara I, 2014, ARCH DIS CHILD, V99, P1143, DOI 10.1136/archdischild-2014-306853; Clinical Investigation of Medicinal Products in the Pediatric Population (E11), 2001, CLIN INV MED PROD PE; Conroy S, 1999, ARCH DIS CHILD-FETAL, V80, pF142, DOI 10.1136/fn.80.2.F142; Craig J S, 2001, Ir Med J, V94, P237; Czarniak P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120630; Davido B, 2016, INT J ANTIMICROB AG, V47, P490, DOI 10.1016/j.ijantimicag.2016.04.010; Di Paolo Ermindo R, 2006, Swiss Med Wkly, V136, P218; Dick A, 2003, ALIMENT PHARM THER, V17, P571, DOI 10.1046/j.1365-2036.2003.01441.x; eMIMS, 2013, EMIMS PRESCR INF; Hatala R, 1996, ANN INTERN MED, V124, P717, DOI 10.7326/0003-4819-124-8-199604150-00003; Hill P, 2005, ARCH DIS CHILD, V90, pI17, DOI 10.1136/adc.2004.058867; Hsien L, 2008, PHARM WORLD SCI, V30, P497, DOI 10.1007/s11096-008-9193-8; Joret-Descout P, 2015, INT J CLIN PHARM-NET, V37, P1222, DOI 10.1007/s11096-015-0191-3; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kemp C, 2005, PAEDIAT PHARMACOPEIA; Lee J, 2014, IEEE T IND ELECTRON, V61, P3786, DOI 10.1109/TIE.2013.2266079; Lenk C, 2009, EUR J PEDIATR, V168, P1473, DOI 10.1007/s00431-009-0956-6; Lindell-Osuagwu L, 2009, J CLIN PHARM THER, V34, P277, DOI 10.1111/j.1365-2710.2008.01005.x; Mason J, 2012, EUR J CLIN PHARMACOL, V68, P21, DOI 10.1007/s00228-011-1097-1; Palcevski G, 2012, EUR J CLIN PHARMACOL, V68, P1073, DOI 10.1007/s00228-012-1221-x; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; Rossi S, 2012, AUSTR MED HDB 2012; Sansom L, AUSTR PHARM FORMULAR; Shah SS, 2007, ARCH PEDIAT ADOL MED, V161, P282, DOI 10.1001/archpedi.161.3.282; 't Jong GW, 2001, PEDIATRICS, V108, P1089, DOI 10.1542/peds.108.5.1089; Therapeutics Goods Administration (TGA), PRODUCT INFORMATION; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; World Health Organization, 2017, GLOB ANT RES SURV SY	33	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210237	10.1371/journal.pone.0210237	http://dx.doi.org/10.1371/journal.pone.0210237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620749	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300023
J	Radchenko, T; Fontaine, F; Morettoni, L; Zamora, I				Radchenko, Tatiana; Fontaine, Fabien; Morettoni, Luca; Zamora, Ismael			Software-aided workflow for predicting protease-specific cleavage sites using physicochemical properties of the natural and unnatural amino acids in peptide-based drug discovery	PLOS ONE			English	Article							FAVORABLE BINDING-SITES; ACTIVE-SITE; CASPASE; TOOL; DETERMINANTS; CASCLEAVE; VOLSURF; SERVER; TIME	Peptide drugs have been used in the treatment of multiple pathologies. During peptide discovery, it is crucially important to be able to map the potential sites of cleavages of the proteases. This knowledge is used to later chemically modify the peptide drug to adapt it for the therapeutic use, making peptide stable against individual proteases or in complex medias. In some other cases it needed to make it specifically unstable for some proteases, as peptides could be used as a system to target delivery drugs on specific tissues or cells. The information about proteases, their sites of cleavages and substrates are widely spread across publications and collected in databases such as MEROPS. Therefore, it is possible to develop models to improve the understanding of the potential peptide drug proteolysis. We propose a new workflow to derive protease specificity rules and predict the potential scissile bonds in peptides for individual proteases. WebMetabase stores the information from experimental or external sources in a chemically aware database where each peptide and site of cleavage is represented as a sequence of structural blocks connected by amide bonds and characterized by its physicochemical properties described by Volsurf descriptors. Thus, this methodology could be applied in the case of non-standard amino acid. A frequency analysis can be performed in WebMetabase to discover the most frequent cleavage sites. These results were used to train several models using logistic regression, support vector machine and ensemble tree classifiers to map cleavage sites for several human proteases from four different families (serine, cysteine, aspartic and matrix metalloproteases). Finally, we compared the predictive performance of the developed models with other available public tools PROSPERous and SitePrediction.	[Radchenko, Tatiana; Zamora, Ismael] Pompeu Fabra Univ, Barcelona, Spain; [Radchenko, Tatiana; Fontaine, Fabien; Zamora, Ismael] Lead Mol Design SL, Sant Cugat Del Valles, Spain; [Morettoni, Luca] Mol Discovery Ltd, London, England	Pompeu Fabra University	Radchenko, T; Zamora, I (corresponding author), Pompeu Fabra Univ, Barcelona, Spain.; Radchenko, T; Zamora, I (corresponding author), Lead Mol Design SL, Sant Cugat Del Valles, Spain.	tatiana.radchenko01@estudiant.upf.edu; ismael.zamora@leadmolecular.com			Secretary of Universities and Research of the Department of Economy and Knowledge of the Generalitat de Catalunya through the Industrial Doctorate program of the Government of Catalunya	Secretary of Universities and Research of the Department of Economy and Knowledge of the Generalitat de Catalunya through the Industrial Doctorate program of the Government of Catalunya	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Secretary of Universities and Research of the Department of Economy and Knowledge of the Generalitat de Catalunya through the Industrial Doctorate program of the Government of Catalunya (http//doctoratsindustrals.gencat.cat/es) and funded all travel expenses related to this research. Luca Morettoni is employed by Molecular Discovery Ltd. Molecular Discovery Ltd provided support in the form of salaries for author LM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Lead Molecular Design S.L. provided support in the form of salaries for authors [TR, IZ, FF] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Bao Y, 2019, BRIEF BIOINFORM, V20, P1669, DOI 10.1093/bib/bby041; Belushkin AA, 2014, PROTEOMICS, V14, P42, DOI 10.1002/pmic.201300416; BOOBBYER DNA, 1989, J MED CHEM, V32, P1083, DOI 10.1021/jm00125a025; Boyd SE, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P372; Brink A, 2014, RAPID COMMUN MASS SP, V28, P2695, DOI 10.1002/rcm.7062; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7; Cruciani G, 2000, EUR J PHARM SCI, V11, pS29, DOI 10.1016/S0928-0987(00)00162-7; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Keil B., 1992, SPECIFICITY PROTEOLY, P335, DOI DOI 10.1007/978-3-642-48380-6; Klein J, 2013, PROTEOMICS, V13, P1077, DOI 10.1002/pmic.201200493; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Li FY, 2019, BRIEF BIOINFORM, V20, P2150, DOI 10.1093/bib/bby077; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Marini S, 2019, BIOINFORMATICS, V35, P923, DOI 10.1093/bioinformatics/bty746; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piippo M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-320; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Radchenko T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186461; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Song JN, 2019, BRIEF BIOINFORM, V20, P638, DOI 10.1093/bib/bby028; Song JN, 2018, BIOINFORMATICS, V34, P684, DOI 10.1093/bioinformatics/btx670; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Song JN, 2011, J BIOINF COMPUT BIOL, V9, P149, DOI 10.1142/S0219720011005288; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang MJ, 2014, BIOINFORMATICS, V30, P71, DOI 10.1093/bioinformatics/btt603; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Yan Rong, 2003, AC SPEECH SIGN PROC, V3, DOI [10.1109/ICASSP.2003, DOI 10.1109/ICASSP.2003]; Yang ZR, 2005, BIOINFORMATICS, V21, P1831, DOI 10.1093/bioinformatics/bti281	42	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0199270	10.1371/journal.pone.0199270	http://dx.doi.org/10.1371/journal.pone.0199270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620739	Green Submitted, gold, Green Published			2022-12-26	WOS:000455161300002
J	Dragicevic, CD; Marcenaro, B; Navarrete, M; Robles, L; Delano, PH				Dragicevic, Constantino D.; Marcenaro, Bruno; Navarrete, Marcela; Robles, Luis; Delano, Paul H.			Oscillatory infrasonic modulation of the cochlear amplifier by selective attention	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; BASILAR-MEMBRANE; AUDITORY-CORTEX; TOP-DOWN; SYNCHRONIZATION; SENSITIVITY; MECHANISM; ENTRAINMENT; EMISSIONS; THETA	Evidence shows that selective attention to visual stimuli modulates the gain of cochlear responses, probably through auditory-cortex descending pathways. At the cerebral cortex level, amplitude and phase changes of neural oscillations have been proposed as a correlate of selective attention. However, whether sensory receptors are also influenced by the oscillatory network during attention tasks remains unknown. Here, we searched for oscillatory attention-related activity at the cochlear receptor level in humans. We used an alternating visual/auditory selective attention task and measured electroencephalographic activity simultaneously to distortion product otoacoustic emissions (a measure of cochlear receptor-cell activity). In order to search for cochlear oscillatory activity, the otoacoustic emission signal, was included as an additional channel in the electroencephalogram analyses. This method allowed us to evaluate dynamic changes in cochlear oscillations within the same range of frequencies (1-35 Hz) in which cognitive effects are commonly observed in electroencephalogram works. We found the presence of low frequency (<10 Hz) brain and cochlear amplifier oscillations during selective attention to visual and auditory stimuli. Notably, switching between auditory and visual attention modulates the amplitude and the temporal order of brain and inner ear oscillations. These results extend the role of the oscillatory activity network during cognition in neural systems to the receptor level.	[Dragicevic, Constantino D.; Marcenaro, Bruno; Navarrete, Marcela; Delano, Paul H.] Univ Chile, Fac Med, Neurosci Dept, Santiago, Chile; [Robles, Luis] Univ Chile, Fac Med, ICBM, Programa Fisiol & Biofis, Santiago, Chile; [Delano, Paul H.] Univ Chile, Clin Hosp, Dept Otolaryngol, Santiago, Chile; [Delano, Paul H.] Univ Chile, Biomed Neurosci Inst, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Delano, PH (corresponding author), Univ Chile, Fac Med, Neurosci Dept, Santiago, Chile.; Delano, PH (corresponding author), Univ Chile, Clin Hosp, Dept Otolaryngol, Santiago, Chile.; Delano, PH (corresponding author), Univ Chile, Biomed Neurosci Inst, Santiago, Chile.	pdelano@med.uchile.cl	; Delano, Paul/I-1030-2013	Dragicevic, Constantino/0000-0002-1959-8271; Delano, Paul/0000-0003-2588-4757	CONICYT, CHILE [Fondecyt 1161155]; Fundacion Guillermo Puelma, Santiago, Chile	CONICYT, CHILE(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fundacion Guillermo Puelma, Santiago, Chile	P.H.D. was funded by Proyecto Fondecyt 1161155, from CONICYT, CHILE (www.fondecyt.cl). P.H.D. and L.R. were funded by Fundacion Guillermo Puelma, Santiago, Chile (NO WEBSITE). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aedo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155991; Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; AVAN P, 1992, HEARING RES, V57, P269, DOI 10.1016/0378-5955(92)90156-H; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chakravarthi R, 2012, P NATL ACAD SCI USA, V109, P10599, DOI 10.1073/pnas.1121622109; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Dragicevic CD, 2015, JARO-J ASSOC RES OTO, V16, P223, DOI 10.1007/s10162-015-0509-9; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Hensel J, 2007, HEARING RES, V233, P67, DOI 10.1016/j.heares.2007.07.004; HERNANDEZPEON R, 1956, SCIENCE, V123, P331, DOI 10.1126/science.123.3191.331; Jedrzejczak WW, 2017, PEERJ, V5, DOI 10.7717/peerj.4199; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Leon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036203; Leventhall G, 2007, PROG BIOPHYS MOL BIO, V93, P130, DOI 10.1016/j.pbiomolbio.2006.07.006; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; OATMAN LC, 1971, EXP NEUROL, V32, P341, DOI 10.1016/0014-4886(71)90003-3; PATUZZI R, 1984, HEARING RES, V13, P19, DOI 10.1016/0378-5955(84)90091-1; Phillips JM, 2014, CEREB CORTEX, V24, P1996, DOI 10.1093/cercor/bht050; PICTON TW, 1971, SCIENCE, V173, P351, DOI 10.1126/science.173.3994.351; PUEL JL, 1988, BRAIN RES, V447, P380, DOI 10.1016/0006-8993(88)91144-4; ROBLES L, 1991, NATURE, V349, P413, DOI 10.1038/349413a0; Smith DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00030; Spyropoulos G, 2018, P NATL ACAD SCI USA, V115, pE5614, DOI 10.1073/pnas.1719433115; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Terreros G, 2016, J NEUROSCI, V36, P7198, DOI 10.1523/JNEUROSCI.4031-15.2016; Terreros G, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00134; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Walsh KP, 2015, J ACOUST SOC AM, V137, P2737, DOI 10.1121/1.4919350; Wang WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158465; Wittekindt A, 2014, J NEUROSCI, V34, P9995, DOI 10.1523/JNEUROSCI.4861-13.2014; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786	40	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0208939	10.1371/journal.pone.0208939	http://dx.doi.org/10.1371/journal.pone.0208939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615632	Green Submitted, gold, Green Published			2022-12-26	WOS:000455045900014
J	Scharler, UM; Ayers, MJ				Scharler, Ursula M.; Ayers, Morag J.			Stoichiometric multitrophic networks reveal significance of land-sea interaction to ecosystem function in a subtropical nutrient-poor bight, South Africa	PLOS ONE			English	Article							KWAZULU-NATAL BIGHT; ECOLOGICAL STOICHIOMETRY; FOOD WEBS; ELEMENTAL STOICHIOMETRY; MARINE ECOSYSTEM; DYNAMICS; FISH; RIVER; AGGREGATION; ENERGY	Nearshore marine ecosystems can benefit from their interaction with adjacent ecosystems, especially if they alleviate nutrient limitations in nutrient poor areas. This was the case in our oligo- to mesotrophic study area, the KwaZulu-Natal Bight on the South African subtropical east coast, which is bordered by the Agulhas current. We built stoichiometric, multitrophic ecosystem networks depicting biomass and material flows of carbon, nitrogen and phosphorus in three subsystems of the bight. The networks were analysed to investigate whether the southern, middle and northern bight function similarly in terms of their productivity, transfer efficiency between trophic levels, material cycling, and nutrient limitations. The middle region of the bight was clearly influenced by nutrient additions from the Thukela River, as it had the highest ecosystem productivity, lower transfer efficiencies and degree of cycling. Most nodes in the networks were limited by phosphorus, followed by nitrogen. The middle region adjacent to the Thukela River showed a lower proportion of P limitation especially in summer. Interestingly, there was a clear distinction in sensitivities to nutrient limitations between lower and higher trophic level organisms. This is a reflection of their discrepant nutrient turnover times that are either higher, or lower, than that of the systems, and which might provide a balance to the system through this antagonistic influence. Furthermore, by tracking the stoichiometry through entire food webs it appeared how important the role of lower trophic level organisms was to regulate stoichiometry to more suitable ratios for higher trophic level requirements. Although we gained good insight into the behaviour of the three subsystems in the KZN Bight and the role of terrestrial influence on their functioning, a merged approach of incorporating data on metabolic constraints derived from experiments could further improve the representativeness of multitrophic stoichiometric ecosystem networks.	[Scharler, Ursula M.; Ayers, Morag J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Ayers, Morag J.] Market Econ Ltd, Takapuna, New Zealand	University of Kwazulu Natal	Scharler, UM (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.	scharler@ukzn.ac.za		Scharler, Ursula/0000-0003-0493-2684	African Coelacanth Ecosystem Programme (ACEP), through the South African National Research Foundation	African Coelacanth Ecosystem Programme (ACEP), through the South African National Research Foundation	This research was funded by the African Coelacanth Ecosystem Programme (ACEP), through the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; Abrantes KG, 2015, REV FISH BIOL FISHER, V25, P337, DOI 10.1007/s11160-015-9385-y; ALEEM AA, 1972, MAR BIOL, V15, P200, DOI 10.1007/BF00383550; Allesina S, 2005, ECOL MODEL, V189, P221, DOI 10.1016/j.ecolmodel.2005.04.002; Alongi DM, 2014, BIOGEOCHEMICAL DYNAMICS AT MAJOR RIVER-COASTAL INTERFACES: LINKAGES WITH GLOBAL CHANGE, P373; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; [Anonymous], 2018, SYSTEMS ANAL APPROAC, DOI [10.1007/978-3-319-71486-8_11, DOI 10.1007/978-3-319-71486-8_11]; [Anonymous], [No title captured]; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Ayers MJ, 2013, MAR ECOL PROG SER, V479, P143, DOI 10.3354/meps10192; Ayers MJ, 2011, J MARINE SYST, V88, P298, DOI 10.1016/j.jmarsys.2011.05.006; Baird D, 2008, ESTUAR COAST SHELF S, V80, P339, DOI 10.1016/j.ecss.2008.08.012; Baird D, 2011, ESTUAR COAST SHELF S, V91, P51, DOI 10.1016/j.ecss.2010.10.004; Baird D, 2009, ECOL MODEL, V220, P3465, DOI 10.1016/j.ecolmodel.2009.09.008; Barnes AD, 2018, TRENDS ECOL EVOL, V33, P186, DOI 10.1016/j.tree.2017.12.007; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Bianchi TS, 2014, BIOL DYNAMICS MAJOR; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Carter R.A., 1988, Lecture Notes on Coastal and Estuarine Studies, V26, P152; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Christensen V., 2008, ECOPATH ECOSIM VERSI; Clarke A, 2008, MAR ECOL PROG SER, V369, P25, DOI 10.3354/meps07670; COCKCROFT VG, 1991, S AFR J MARINE SCI, V11, P203, DOI 10.2989/025776191784287538; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P371; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; Czamanski M, 2011, MAR BIOL, V158, P2847, DOI 10.1007/s00227-011-1783-7; de Lecea AM, 2016, AFR J MAR SCI, V38, pS181, DOI 10.2989/1814232X.2016.1142898; De Lecea AM, 2013, MAR ECOL PROG SER, V484, P97, DOI 10.3354/meps10311; de Lecea AM, 2016, MAR FRESHWATER RES, V67, P1750, DOI 10.1071/MF15256; Department of Water Affairs and Forestry, 2004, THUK WAT PROJ DEC SU; DeVries T, 2014, NAT GEOSCI, V7, P890, DOI 10.1038/NGEO2300; Diaz F, 2001, MAR ECOL PROG SER, V211, P51, DOI 10.3354/meps211051; DRINKWATER KF, 1994, AQUAT CONSERV, V4, P135, DOI 10.1002/aqc.3270040205; Eero M, 2016, AMBIO, V45, P649, DOI 10.1007/s13280-016-0788-3; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Evans-White MA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01184; Fath BD, 2013, ECOL MODEL, V252, P214, DOI 10.1016/j.ecolmodel.2012.06.010; Fennessy ST, 2016, AFR J MAR SCI, V38, pS169, DOI 10.2989/1814232X.2016.1140677; Fennessy ST, 2016, AFR J MAR SCI, V38, pS1, DOI 10.2989/1814232X.2016.1141116; FINN JT, 1980, ECOLOGY, V61, P562, DOI 10.2307/1937422; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Freire KMF, 2008, SCI MAR, V72, P477; Galbraith ED, 2015, P NATL ACAD SCI USA, V112, P8199, DOI 10.1073/pnas.1423917112; Garcia NS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00543; Gismervik I, 1997, J PLANKTON RES, V19, P279, DOI 10.1093/plankt/19.2.279; Grenfell SE, 2009, WATER SA, V35, P271; Guastella LA, 2016, AFR J MAR SCI, V38, pS23, DOI 10.2989/1814232X.2016.1159982; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Hessen Dag O., 2008, Freshwater Reviews, V1, P43, DOI 10.1608/FRJ-1.1.3; Heymans JJ, 2011, ICES J MAR SCI, V68, P265, DOI 10.1093/icesjms/fsq065; Higgins KA, 2006, OIKOS, V114, P419; Kang Y, 2013, ACTA OCEANOL SIN, V32, P79, DOI 10.1007/s13131-013-0269-5; Kullback S., 1968, INFORM THEORY STAT; Lamberth SJ, 2009, ESTUAR COAST SHELF S, V84, P527, DOI 10.1016/j.ecss.2009.07.021; Lamont T, 2015, AFR J MAR SCI, V37, P485, DOI 10.2989/1814232X.2015.1108228; Lefebure R, 2013, GLOBAL CHANGE BIOL, V19, P1358, DOI 10.1111/gcb.12134; Leontief, 1951, STRUCTURE AM EC; Liebig J., 1840, CHEM ITS APPL AGR PH; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lucea A, 2005, BIOGEOCHEMISTRY, V73, P303, DOI 10.1007/s10533-004-0059-4; Ludovisi A, 2017, ECOL INDIC, V72, P726, DOI 10.1016/j.ecolind.2016.08.014; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P1907, DOI 10.1016/S0278-4343(00)00053-4; MAC ARTHUR ROBERT H., 1967; MARTIN AK, 1988, COAST ESTUAR STUD, V26, P11, DOI DOI 10.1029/LN026P0011; Mas-Marti E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118520; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; Mitra A, 2005, J PLANKTON RES, V27, P393, DOI 10.1093/plankt/fbi022; Moe SJ, 2005, OIKOS, V109, P29, DOI 10.1111/j.0030-1299.2005.14056.x; Muir D, 2016, AFR J MAR SCI, V38, pS123, DOI 10.2989/1814232X.2016.1146630; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Oczkowski A, 2008, ESTUAR COAST SHELF S, V77, P309, DOI 10.1016/j.ecss.2007.11.028; Oguz T, 2010, MAR ECOL PROG SER, V405, P231, DOI 10.3354/meps08538; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Pretorius M, 2016, AFR J MAR SCI, V38, pS155, DOI 10.2989/1814232X.2016.1144650; Roberts MJ, 2016, AFR J MAR SCI, V38, pS7, DOI 10.2989/1814232X.2016.1175383; Roberts MJ, 2016, AFR J MAR SCI, V38, pS43, DOI 10.2989/1814232X.2016.1194319; Scharler UM, 2016, AFR J MAR SCI, V38, pS205, DOI 10.2989/1814232X.2016.1151829; Scharler UM, 2016, AFR J MAR SCI, V38, pS193, DOI 10.2989/1814232X.2016.1150347; Scharler UM, 2015, OECOLOGIA, V179, P863, DOI 10.1007/s00442-015-3379-2; Scharler UM, 2012, INT C ENV MOD SOFTW, DOI DOI 10.1016/J.ECOLMODEL.2009.04.015; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Ulanowicz, 1986, GROWTH DEV; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; Ulanowicz RE, 1997, ECOL MODEL, V95, P1, DOI 10.1016/S0304-3800(96)00032-4; Ulanowicz RE, 2009, ECOL MODEL, V220, P1886, DOI 10.1016/j.ecolmodel.2009.04.015; Untiedt CB, 2016, AFR J MAR SCI, V38, pS91, DOI 10.2989/1814232X.2016.1144651; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; Welti N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01298	92	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210295	10.1371/journal.pone.0210295	http://dx.doi.org/10.1371/journal.pone.0210295			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615659	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900061
J	Born, J; Michalski, SG				Born, Jennifer; Michalski, Stefan G.			Trait expression and signatures of adaptation in response to nitrogen addition in the common wetland plant Juncus effusus	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; FRESH-WATER WETLAND; POPULATION-STRUCTURE; GENETIC-VARIATION; INTRASPECIFIC VARIABILITY; LOCAL ADAPTATION; ADAPTIVE DIFFERENTIATION; QUANTITATIVE TRAIT; FUNCTIONAL TRAITS; NATURAL-SELECTION	Wetland ecosystems are known to mitigate high nutrient loadings and thus can improve water quality and prevent potential biodiversity loss caused by eutrophication. Plant traits affect wetland processes directly through effects on accumulation or metabolization of substances, and indirectly by affecting microbial transformation processes in the soil. Understanding the causes and consequences of intraspecific variation in plant functional traits and associated ecosystem processes can aid applied ecological approaches such as wetland restoration and construction. Here we investigated molecular variation and phenotypic variation in response to three levels of nitrogen availability for a regional set of populations of the common wetland plant Juncus effusus. We asked whether trait expression reveals signatures of adaptive differentiation by comparing genetic differentiation in quantitative traits and neutral molecular markers (Q(ST)-F-ST comparisons) and relating trait variation to soil conditions of the plant's origin. Molecular analyses showed that samples clustered into three very distinct genetic lineages with strong population differentiation within and among lineages. Differentiation for quantitative traits was substantial but did not exceed neutral expectations when compared across treatments or for each treatment and lineage separately. However, variation in trait expression could be explained by local soil environmental conditions of sample origin, e.g. for aboveground carbon-to-nitrogen (C:N) ratios, suggesting adaptive differentiation to contribute to trait expression even at regional level.	[Born, Jennifer; Michalski, Stefan G.] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Born, J (corresponding author), UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany.	jennifer.born@ufz.de	Michalski, Stefan G/O-5774-2015	Michalski, Stefan G/0000-0002-8969-7355; Riedel, Jennifer/0000-0001-7304-1776	German Research Foundation (DFG) [MI 1500/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG), http://www.dfg.de/, MI 1500/2-1, Stefan G. Michalski.	Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Borin M, 2012, ECOL ENG, V46, P34, DOI 10.1016/j.ecoleng.2012.04.034; Born J, 2017, AQUAT BOT, V136, P138, DOI 10.1016/j.aquabot.2016.10.002; Buchenau F, 1892, JB WISSENSCHAFTLICHE; Carlson JE, 2011, EVOLUTION, V65, P108, DOI 10.1111/j.1558-5646.2010.01131.x; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Colautti RI, 2015, MOL ECOL, V24, P1999, DOI 10.1111/mec.13162; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; De Kort H, 2013, EVOL ECOL, V27, P1081, DOI 10.1007/s10682-012-9624-9; Di Palo F, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00451.1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ervin GN, 2002, OECOLOGIA, V130, P626, DOI 10.1007/s00442-001-0844-x; Esmeijer-Liu AJ, 2009, PLANT SOIL, V316, P311, DOI 10.1007/s11104-008-9783-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gingerich RT, 2011, WETLANDS, V31, P653, DOI 10.1007/s13157-011-0181-8; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gravuer K, 2005, BIOL CONSERV, V124, P155, DOI 10.1016/j.biocon.2005.01.021; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hernandez-Serrano A, 2014, ANN BOT-LONDON, V114, P571, DOI 10.1093/aob/mcu142; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hoffmann G., 1991, VDLUFA METHODENBUCH; Jeglum J., 2006, BIOL PEATLANDS; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kirschner J., 2002, JUNCACEAE; Konarzewski TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049000; Kuschk Peter, 2012, Environmental and Food Safety and Security for South-East Europe and Ukraine. Proceedings, P155, DOI 10.1007/978-94-007-2953-7_15; Lai WL, 2011, WATER RES, V45, P3941, DOI 10.1016/j.watres.2011.05.002; Lecerf A, 2008, BASIC APPL ECOL, V9, P598, DOI 10.1016/j.baae.2007.11.003; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Liu WW, 2016, J ECOL, V104, P173, DOI 10.1111/1365-2745.12487; Macek P, 2007, FUNCT ECOL, V21, P478, DOI 10.1111/j.1365-2435.2007.01266.x; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Mao R, 2014, CHINESE GEOGR SCI, V24, P674, DOI 10.1007/s11769-014-0691-4; Mays PA, 2001, ECOL ENG, V16, P487, DOI 10.1016/S0925-8574(00)00112-9; McKay JK, 2001, P ROY SOC B-BIOL SCI, V268, P1715, DOI 10.1098/rspb.2001.1715; Menon R, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1602-5; Michalski SG, 2017, ECOL EVOL, V7, P3268, DOI 10.1002/ece3.2936; Michalski SG, 2015, ECOL EVOL, V5, P2172, DOI 10.1002/ece3.1481; Michalski SG, 2012, AM J BOT, V99, pE53, DOI 10.3732/ajb.1100322; MORAN MA, 1989, APPL ENVIRON MICROB, V55, P2178, DOI 10.1128/AEM.55.9.2178-2189.1989; Moreira B, 2012, OECOLOGIA, V168, P671, DOI 10.1007/s00442-011-2127-5; Nei M., 1987, MOL EVOLUTIONARY GEN; Nikolausz M, 2008, EUR J SOIL BIOL, V44, P324, DOI 10.1016/j.ejsobi.2008.01.003; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Ogle K., 2012, ENCY THEORETICAL ECO; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; PAMILO P, 1988, ANN ZOOL FENN, V25, P99; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit C, 2001, BIOL CONSERV, V100, P21, DOI 10.1016/S0006-3207(00)00204-4; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Postma JA, 2011, PLANT PHYSIOL, V156, P1190, DOI 10.1104/pp.111.175489; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2014, R LANG ENV STAT COMP; Richards PW, 1941, J ECOL, V29, P375, DOI 10.2307/2256404; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Saengwilai P, 2014, PLANT PHYSIOL, V166, P726, DOI 10.1104/pp.114.241711; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Silfver T, 2007, OECOLOGIA, V152, P707, DOI 10.1007/s00442-007-0695-1; Smialek J, 2006, WETLANDS, V26, P509, DOI 10.1672/0277-5212(2006)26[509:EOAWSN]2.0.CO;2; SPITZE K, 1993, GENETICS, V135, P367; Steinger T, 2002, MOL ECOL, V11, P2583, DOI 10.1046/j.1365-294X.2002.01653.x; STOCKEY A, 1994, J APPL ECOL, V31, P543, DOI 10.2307/2404449; Sutton-Grier AE, 2013, PLANT SOIL, V365, P41, DOI 10.1007/s11104-011-1113-3; terHorst CP, 2016, FUNCT ECOL, V30, P1062, DOI 10.1111/1365-2435.12671; Toth G., 2013, SCI TECHNICAL RES SE; Visser EJW, 2003, PLANT SOIL, V253, P81, DOI 10.1023/A:1024560322835; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039105; White J. R., 2009, WETLANDS HDB; White SA, 2013, ECOL ENG, V61, P207, DOI 10.1016/j.ecoleng.2013.09.020; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; World Resources Institute, 2005, EC HUM WELL BEING WE; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xu ZG, 2006, CHINESE GEOGR SCI, V16, P270, DOI 10.1007/s11769-006-0270-4; Ye QG, 2014, ANN BOT-LONDON, V113, P79, DOI 10.1093/aob/mct255; Yoshida Y, 2008, BREEDING SCI, V58, P301, DOI 10.1270/jsbbs.58.301; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314	87	2	2	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209886	10.1371/journal.pone.0209886	http://dx.doi.org/10.1371/journal.pone.0209886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608976	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800029
J	Wilton, J; Liu, J; Sullivan, A; Rachlis, B; Marchand-Austin, A; Giles, M; Light, L; Rank, C; Burchell, AN; Gardner, S; Sider, D; Gilbert, M; Kroch, AE				Wilton, James; Liu, Juan; Sullivan, Ashleigh; Rachlis, Beth; Marchand-Austin, Alex; Giles, Madison; Light, Lucia; Rank, Claudia; Burchell, Ann N.; Gardner, Sandra; Sider, Doug; Gilbert, Mark; Kroch, Abigail E.		Ontario HIV Epidemiology	Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study	PLOS ONE			English	Article							NEW-YORK-CITY; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; INFECTED PERSONS; UNITED-STATES; CONTINUUM; RETENTION; HEALTH; TIME; PREVENTION	Background The HIV cascade is an important framework for assessing systems of care, but population-based assessment is lacking for most jurisdictions worldwide. We measured cascade indicators over time in a population-based cohort of diagnosed people living with HIV (PLWH) in Ontario, Canada. Methods We created a retrospective cohort of diagnosed PLWH using a centralized laboratory database with HIV diagnostic and viral load (VL) test records linked at the individual-level. Individuals enter the cohort with record of a nominal HIV-positive diagnostic test or VL test, and remain unless administratively lost to follow-up (LTFU, >2 consecutive years with no VL test and no VL test in later years). We calculated the annual percent of diagnosed PLWH (cohort individuals not LTFU) between 2000 and 2015 who were in care (>= 1 VL test), on ART (as documented on VL test requisition) or virally suppressed (<200 copies/ml). We also calculated time from diagnosis to linkage to care and viral suppression among individuals newly diagnosed with HIV. Analyses were stratified by sex and age. Upper/lower bounds were calculated using alternative indicator definitions. Results The number of diagnosed PLWH increased from 8,859 (8,859-11,389) in 2000 to 16,110 (16,110-17,423) in 2015. Over this 16-year period, the percent of diagnosed PLWH who were: in care increased from 81% (63-81%) to 87% (81-87%), on ART increased from 55% (34-60%) to 81% (70-82%) and virally suppressed increased from 41% (23-46%) to 80% (67-81%). Between 2000 and 2014, the percent of newly diagnosed individuals who linked to care within three months of diagnosis or achieved viral suppression within six months of diagnosis increased from 67% to 82% and from 22% to 42%, respectively. Estimates were generally lower for females and younger individuals. Discussion HIV cascade indicators among diagnosed PLWH in Ontario improved between 2000 and 2015, but gaps still remain-particularly for younger individuals.	[Wilton, James; Rachlis, Beth; Giles, Madison; Light, Lucia; Kroch, Abigail E.] Ontario HIV Treatment Network, Data & Appl Sci Impact, Toronto, ON, Canada; [Liu, Juan; Marchand-Austin, Alex; Sider, Doug] Publ Hlth Ontario, Toronto, ON, Canada; [Sullivan, Ashleigh; Rank, Claudia] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Rachlis, Beth; Kroch, Abigail E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada; [Rachlis, Beth] Dignitas Int, Toronto, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Burchell, Ann N.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Burchell, Ann N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gardner, Sandra] Baycrest Hlth Sci, Toronto, ON, Canada; [Gardner, Sandra] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Gilbert, Mark] British Columbia Ctr Dis Control, Clin Prevent Serv, Vancouver, BC, Canada; [Gilbert, Mark] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	Public Health Agency of Canada; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of British Columbia	Kroch, AE (corresponding author), Ontario HIV Treatment Network, Data & Appl Sci Impact, Toronto, ON, Canada.; Kroch, AE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada.	akroch@ohtn.on.ca		Wilton, James/0000-0002-2295-7511; Giles, Madison/0000-0002-6646-2772; Marchand-Austin, Alex/0000-0001-5932-2037				Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; [Anonymous], MED PAYM ASS ONT; [Anonymous], 2016, SUMM MEAS CAN PROGR; [Anonymous], 2017, NEW HIV DIAGN ONT PR; [Anonymous], 2015, HIV AIDS CAN SURV RE; Antoniou Tony, 2013, Open Med, V7, pe98; Antoniou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021748; Backus L, 2015, JAIDS-J ACQ IMM DEF, V69, P474, DOI 10.1097/QAI.0000000000000615; Bourgeois A C, 2017, Can Commun Dis Rep, V43, P248, DOI 10.14745/ccdr.v43i12a01; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Burchell AN, 2015, JAIDS-J ACQ IMM DEF, V70, pE10, DOI 10.1097/QAI.0000000000000690; Campbell CNJ, 2015, AIDS CARE, V27, P1449, DOI 10.1080/09540121.2015.1109584; Chkhartishvili N, 2015, HIV MED, V16, P62, DOI 10.1111/hiv.12172; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colasanti J, 2016, CLIN INFECT DIS, V62, P648, DOI 10.1093/cid/civ941; Dombrowski JC, 2014, JAIDS-J ACQ IMM DEF, V67, P323, DOI 10.1097/QAI.0000000000000302; Dombrowski JC, 2013, JAIDS-J ACQ IMM DEF, V63, P299, DOI 10.1097/QAI.0b013e3182945bc7; Flicker S, 2005, CAN J PUBLIC HEALTH, V96, P308, DOI 10.1007/BF03405172; Fortenberry JD, 2012, J ADOLESCENT HEALTH, V51, P551, DOI 10.1016/j.jadohealth.2012.03.012; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gillis J, 2016, JAIDS-J ACQ IMM DEF, V73, P531, DOI 10.1097/QAI.0000000000001109; Gray KM, 2014, JAIDS-J ACQ IMM DEF, V65, P129, DOI 10.1097/QAI.0000000000000028; Haber N, 2016, CURR OPIN HIV AIDS, V11, P102, DOI 10.1097/COH.0000000000000212; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Hand DJ, 2018, J R STAT SOC A STAT, V181, P555, DOI 10.1111/rssa.12315; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Horberg MA, 2015, AIDS PATIENT CARE ST, V29, P582, DOI 10.1089/apc.2015.0139; Hull M, 2014, CURR HIV-AIDS REP, V11, P496, DOI 10.1007/s11904-014-0237-5; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Kendall CE, 2015, J CLIN EPIDEMIOL, V68, P1301, DOI 10.1016/j.jclinepi.2015.02.008; Kohler P, 2015, AIDS, V29, P2509, DOI 10.1097/QAD.0000000000000878; Lesko CR, 2016, AIDS, V30, P2227, DOI 10.1097/QAD.0000000000001183; Lesko CR, 2015, JAIDS-J ACQ IMM DEF, V70, P489, DOI 10.1097/QAI.0000000000000788; Lourenco L, 2015, LANCET HIV, V2, pE225, DOI 10.1016/S2352-3018(15)00086-7; Lourenco L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115277; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacCarthy Sarah, 2015, J Int AIDS Soc, V18, P19395, DOI 10.7448/IAS.18.1.19395; Medland NA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20634; Miller WC, 2014, SEX TRANSM DIS, V41, P41, DOI 10.1097/OLQ.0000000000000081; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Nosyk B, 2015, AIDS, V29, P1681, DOI 10.1097/QAD.0000000000000746; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Raboud J, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-31; Rachlis B, 2017, AIDS CARE, V29, P828, DOI 10.1080/09540121.2016.1271389; Remis RS, 2013, CAN ASS HIV AIDS RES; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Supervie V, 2016, JAIDS-J ACQ IMM DEF, V73, P348, DOI 10.1097/QAI.0000000000001120; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tepper V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21490; The Ontario Advisory Committee on HIV/AIDS, 2016, HIV AIDS STRAT 2026; Toren KG, 2016, SEX TRANSM DIS, V43, P34, DOI 10.1097/OLQ.0000000000000376; Torian LV, 2014, AM J PUBLIC HEALTH, V104, pE24, DOI 10.2105/AJPH.2014.302080; UNAIDS, 2014, UND FAST TRACK ACC A; Van Beckhoven D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1230-3; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Wiewel EW, 2015, JAIDS-J ACQ IMM DEF, V68, P217, DOI 10.1097/QAI.0000000000000424; Xia Q, 2015, ANN EPIDEMIOL, V25, P226, DOI 10.1016/j.annepidem.2015.01.014; Xia Q, 2015, JAIDS-J ACQ IMM DEF, V68, P351, DOI 10.1097/QAI.0000000000000464; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376; Yoong D, CMAJ OPEN	60	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210096	10.1371/journal.pone.0210096	http://dx.doi.org/10.1371/journal.pone.0210096			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG4NS	30608962	gold, Green Submitted, Green Published			2022-12-26	WOS:000454952800045
J	Karvonen, H; Perttila, R; Niininen, W; Hautanen, V; Barker, H; Murumagi, A; Heckman, CA; Ungureanu, D				Karvonen, Hanna; Perttila, Robert; Niininen, Wilhelmiina; Hautanen, Veera; Barker, Harlan; Murumagi, Astrid; Heckman, Caroline A.; Ungureanu, Daniela			Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELLS; DISEASE; IDENTIFICATION; HEMATOPOIESIS; CHEMOTAXIS; MECHANISMS; INHIBITORS; CROSSTALK; PATHWAYS	B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with TCF3-PBX1 fusion gene expression has constitutively elevated levels of Wnt16b and ROR1 (receptor tyrosine kinase-like orphan receptor), a ligand and a receptor from the Wnt signaling pathway, respectively. Although survival rate is usually high after the initial chemotherapy, many TCF3-PBX1 BCP-ALL patients relapse and subsequently develop treatment resistance, resulting in poor prognosis. Here, we aimed to investigate the molecular signaling associated with Wnt16b and ROR1 overexpression in TCF3-PBX1 cell lines and primary samples, and to identify effective treatment options via ROR1 targeting. We detected higher ROR1 expression on TCF3-PBX1 leukemic cells even at a later stage of patient relapse, providing a strong rationale for the use of ROR1-targeted therapy. We found that Wnt5a-ROR1 signaling enhances proliferation of TCF3-PBX1 cells via RhoA/Rac1 GTPases activation and STAT3 upregulation. Wnt16b also activated the RhoA/Rac1 signaling cascade suggesting the activation of a non-canonical Wnt pathway in TCF3-PBX1 cells. Wnt16 could interact with ROR1 but not in TCF3-PBX1 cells, suggesting that Wnt5a is the ligand signaling via ROR1 in TCF3-PBX1 cells. By high throughput drug-sensitivity testing of TCF3-PBX1 cells before and after ROR1 knockdown we found that targeting ROR1 significantly improves the therapeutic efficacy of Bcl-2 family inhibitors venetoclax and navitoclax, and this synergism was confirmed ex vivo using a drug-resistant primary sample from a relapsed TCF3-PBX1 patient. Our work underlines a new type of targeted combination therapy that could be clinically advantageous for patients with TCF3-PBX1 BCP-ALL.	[Karvonen, Hanna; Perttila, Robert; Niininen, Wilhelmiina; Hautanen, Veera; Barker, Harlan; Ungureanu, Daniela] Tampere Univ, BioMediTech Inst, Tampere, Finland; [Karvonen, Hanna; Perttila, Robert; Niininen, Wilhelmiina; Hautanen, Veera; Barker, Harlan; Ungureanu, Daniela] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Murumagi, Astrid; Heckman, Caroline A.] Univ Helsinki, Helsinki Inst Life Sci, Inst Mol Med Finland FIMM, Helsinki, Finland	Tampere University; Tampere University; University of Helsinki	Ungureanu, D (corresponding author), Tampere Univ, BioMediTech Inst, Tampere, Finland.; Ungureanu, D (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.	daniela.ungureanu@tuni.fi	Perttilä, Robert/S-8006-2019	Perttilä, Robert/0000-0001-8030-7077; Karvonen, Hanna/0000-0002-7815-0709; Hautanen, Veera/0000-0002-6278-4109; Murumagi, Astrid/0000-0002-7797-188X; Ungureanu, Daniela/0000-0002-9314-4972; Heckman, Caroline/0000-0002-4324-8706; Barker, Harlan/0000-0003-4125-2522	Doctoral Program in Medicine and Life Sciences at University of Tampere; Academy of Finland; Center of Excellence for Translational Cancer Biology; Sigrid Juselius Foundation	Doctoral Program in Medicine and Life Sciences at University of Tampere; Academy of Finland(Academy of Finland); Center of Excellence for Translational Cancer Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Doctoral Program in Medicine and Life Sciences at University of Tampere, Academy of Finland, Center of Excellence for Translational Cancer Biology, and the Sigrid Juselius Foundation.	Asem MS, 2016, CANCERS, V8, DOI 10.3390/cancers8090079; Balakrishnan A, 2016, CLIN CANC RES; Bengoa-Vergniory N, 2017, MOL NEUROBIOL, V54, P6213, DOI 10.1007/s12035-016-0151-5; Berger C, 2015, CANCER IMMUNOL RES, V3, P206, DOI 10.1158/2326-6066.CIR-14-0163; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Borcherding N, 2014, PROTEIN CELL, V5, P496, DOI 10.1007/s13238-014-0059-7; Burmeister T, 2010, HAEMATOL-HEMATOL J, V95, P241, DOI 10.3324/haematol.2009.011346; Casagrande G, 2006, HAEMATOLOGICA, V91, P765; CHEN Y, 2017, BLOOD S1, V130; Choi MY, 2018, CELL STEM CELL, V22, P951, DOI 10.1016/j.stem.2018.05.018; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; Dave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052655; DeBruine ZJ, 2017, BRIT J PHARMACOL, V174, P4564, DOI 10.1111/bph.14048; Eldfors S, 2017, LEUKEMIA, V31, P51, DOI 10.1038/leu.2016.202; Geng HM, 2015, CANCER CELL, V27, P409, DOI 10.1016/j.ccell.2015.02.003; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hojjat-Farsangi M, 2018, LEUKEMIA, V32, P2291, DOI 10.1038/s41375-018-0113-1; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Janovska P, 2017, BRIT J PHARMACOL, V174, P4701, DOI 10.1111/bph.13949; Janovska P, 2016, CLIN CANCER RES, V22, P459, DOI 10.1158/1078-0432.CCR-15-0154; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Karjalainen R, 2017, BLOOD, V130, P789, DOI 10.1182/blood-2016-02-699363; Karvonen H, 2017, BLOOD ADV, V1, P2257, DOI 10.1182/bloodadvances.2017010215; Karvonen H, 2017, BIOCHEM SOC T, V45, P457, DOI 10.1042/BST20160272; Katoh M, 2007, INT J MOL MED, V19, P273; Li P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011859; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; Mendrola JM, 2013, BIOCHEM SOC T, V41, P1029, DOI 10.1042/BST20130104; Mihalyova J, 2018, EXP HEMATOL, V61, P10, DOI 10.1016/j.exphem.2018.02.002; Muschen M, 2015, BLOOD, V125, P3688, DOI 10.1182/blood-2015-01-567842; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nygren MK, 2009, EXP HEMATOL, V37, P225, DOI 10.1016/j.exphem.2008.10.007; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rassenti LZ, 2017, P NATL ACAD SCI USA, V114, P10731, DOI 10.1073/pnas.1708264114; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Schreck C, 2014, ANN NY ACAD SCI, V1310, P32, DOI 10.1111/nyas.12384; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193; Yu J, 2017, LEUKEMIA, V31, P1333, DOI 10.1038/leu.2016.368; Yu J, 2016, J CLIN INVEST, V126, P585, DOI 10.1172/JCI83535	50	24	24	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3288	3300		10.1038/s41388-018-0670-9	http://dx.doi.org/10.1038/s41388-018-0670-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30631148				2022-12-26	WOS:000465557200013
J	Ling, TY; Yi, F; Lu, T; Wang, XL; Sun, XJ; Willis, MS; Wu, LQ; Shen, WK; Adelman, JP; Lee, HC				Ling, Tian-You; Yi, Fu; Lu, Tong; Wang, Xiao-Li; Sun, Xiaojing; Willis, Monte S.; Wu, Li-Qun; Shen, Win-Kuang; Adelman, John P.; Lee, Hon-Chi			F-box protein-32 down-regulates small-conductance calcium-activated potassium channel 2 in diabetic mouse atria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; diabetes; cardiomyocyte; cardiovascular disease; ubiquitin ligase; protein degradation; atrial fibrillation; atrogin-1; diabetes mellitus; HL-1 cells; SK channels	CA2+-ACTIVATED K+ CHANNELS; UBIQUITIN-PROTEASOME SYSTEM; SK CHANNELS; FIBRILLATION; DEGRADATION; ROLES; CELLS	Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation, but the underlying ionic mechanism for this association remains unclear. We recently reported that expression of the small-conductance calcium-activated potassium channel 2 (SK2, encoded by KCCN2) in atria from diabetic mice is significantly down-regulated, resulting in reduced SK currents in atrial myocytes from these mice. We also reported that the level of SK2 mRNA expression is not reduced in DM atria but that the ubiquitin-proteasome system (UPS), a major mechanism of intracellular protein degradation, is activated in vascular smooth muscle cells in DM. This suggests a possible role of the UPS in reduced SK currents. To test this possibility, we examined the role of the UPS in atrial SK2 down-regulation in DM. We found that a muscle-specific E3 ligase, F-box protein 32 (FBXO-32, also called atrogin-1), was significantly up-regulated in diabetic mouse atria. Enhanced FBXO-32 expression in atrial cells significantly reduced SK2 protein expression, and siRNA-mediated FBXO-32 knockdown increased SK2 protein expression. Furthermore, co-transfection of SK2 with FBXO-32 complementary DNA in HEK293 cells significantly reduced SK2 expression, whereas co-transfection with atrogin-1F complementary DNA (a nonfunctional FBXO-32 variant in which the F-box domain is deleted) did not have any effects on SK2. These results indicate that FBXO-32 contributes to SK2 down-regulation and that the F-box domain is essential for FBXO-32 function. In conclusion, DM-induced SK2 channel down-regulation appears to be due to an FBXO-32-dependent increase in UPS-mediated SK2 protein degradation.	[Ling, Tian-You; Wu, Li-Qun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China; [Ling, Tian-You; Yi, Fu; Lu, Tong; Wang, Xiao-Li; Sun, Xiaojing; Lee, Hon-Chi] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA; [Yi, Fu] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Dis, Xian 710032, Shaanxi, Peoples R China; [Willis, Monte S.] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Shen, Win-Kuang] Mayo Clin, Dept Cardiovasc Dis, Phoenix, AZ 85259 USA; [Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Shanghai Jiao Tong University; Mayo Clinic; Air Force Military Medical University; Indiana University System; Indiana University Bloomington; Mayo Clinic; Mayo Clinic Phoenix; Oregon Health & Science University	Yi, F; Lee, HC (corresponding author), Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA.	xjcardio@fmmu.edu.cn	yi, fu/HGE-6093-2022; Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643; /0000-0002-0769-5816	National Natural Science Foundation of China [81400248, 81470479]; Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China [DLY201604]; Xijing Hospital, Fourth Military Medical University, Xi'an, China; Mayo Clinic Foundation; American Diabetes Association [ADA 1-12-BS-119, ADA 1-16-IBS-195, ADA 1-18-IBS-210]; NHLBI, National Institute of Health [HL74180, HL080118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074180] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China; Xijing Hospital, Fourth Military Medical University, Xi'an, China; Mayo Clinic Foundation; American Diabetes Association(American Diabetes Association); NHLBI, National Institute of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funding from the National Natural Science Foundation of China (81400248 and 81470479); Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China (DLY201604); Xijing Hospital, Fourth Military Medical University, Xi'an, China; the Mayo Clinic Foundation; the American Diabetes Association (ADA 1-12-BS-119, ADA 1-16-IBS-195, and ADA 1-18-IBS-210), and the NHLBI, National Institute of Health (HL74180 and HL080118). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Black SA, 2002, AM J PUBLIC HEALTH, V92, P543, DOI 10.2105/AJPH.92.4.543; Chang PC, 2015, TRENDS CARDIOVAS MED, V25, P508, DOI 10.1016/j.tcm.2015.01.010; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Ciechanover Aaron, 2006, Proc Am Thorac Soc, V3, P21, DOI 10.1513/pats.200510-106JH; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haugaard MM, 2015, HEART RHYTHM, V12, P825, DOI 10.1016/j.hrthm.2014.12.028; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Ling TY, 2013, HEART RHYTHM, V10, P1001, DOI 10.1016/j.hrthm.2013.03.005; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Mahida S, 2014, HEART RHYTHM, V11, P1233, DOI 10.1016/j.hrthm.2014.03.045; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Movahed MR, 2005, INT J CARDIOL, V105, P315, DOI 10.1016/j.ijcard.2005.02.050; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Qi XY, 2014, CIRCULATION, V129, P430, DOI 10.1161/CIRCULATIONAHA.113.003019; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Shmukler BE, 2001, BBA-GENE STRUCT EXPR, V1518, P36, DOI 10.1016/S0167-4781(01)00166-X; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170219; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; WHO, 2016, GLOB REP PSOR; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Yi F, 2015, J BIOL CHEM, V290, P7016, DOI 10.1074/jbc.M114.607952; Yi F, 2014, J BIOL CHEM, V289, P10853, DOI 10.1074/jbc.M113.520940; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhang XD, 2015, HEART RHYTHM, V12, P1845, DOI 10.1016/j.hrthm.2015.04.046; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	36	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4160	4168		10.1074/jbc.RA118.003837	http://dx.doi.org/10.1074/jbc.RA118.003837			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30635400	Green Published, hybrid			2022-12-26	WOS:000461854400027
J	Silverman, JM; Christy, D; Shyu, CC; Moon, KM; Fernando, S; Gidden, Z; Cowan, CM; Ban, YX; Stacey, RG; Grad, LI; McAlary, L; Mackenzie, IR; Foster, LJ; Cashman, NR				Silverman, Judith M.; Christy, Darren; Shyu, Chih Cheih; Moon, Kyung-Mee; Fernando, Sarah; Gidden, Zoe; Cowan, Catherine M.; Ban, Yuxin; Stacey, R. Greg; Grad, Leslie I.; McAlary, Luke; Mackenzie, Ian R.; Foster, Leonard J.; Cashman, Neil R.			CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exosome (vesicle); amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; proteomics; astrocyte; extracellular vesicles; central nervous system (CNS); secretion; protein homeostasis	NANOPARTICLE TRACKING ANALYSIS; PROTEIN DISULFIDE-ISOMERASE; TRANSGENIC-MOUSE MODEL; PROTEOMIC ANALYSIS; SECRETION PATHWAY; GENE-EXPRESSION; FLOW-CYTOMETRY; MOTOR-NEURONS; DATA SETS; EXOSOMES	Extracellular vesicles (EVs) are secreted by myriad cells in culture and also by unicellular organisms, and their identification in mammalian fluids suggests that EV release also occurs at the organism level. However, although it is clearly important to better understand EVs' roles in organismal biology, EVs in solid tissues have received little attention. Here, we modified a protocol for EV isolation from primary neural cell culture to collect EVs from frozen whole murine and human neural tissues by serial centrifugation and purification on a sucrose gradient. Quantitative proteomics comparing brain-derived EVs from nontransgenic (NTg) and a transgenic amyotrophic lateral sclerosis (ALS) mouse model, superoxide dismutase 1 (SOD1)(G93A), revealed that these EVs contain canonical exosomal markers and are enriched in synaptic and RNA-binding proteins. The compiled brain EV proteome contained numerous proteins implicated in ALS, and EVs from SOD1(G93A) mice were significantly depleted in myelin-oligodendrocyte glycoprotein compared with those from NTg animals. We observed that brain- and spinal cord-derived EVs, from NTg and SOD1(G93A) mice, are positive for the astrocyte marker GLAST and the synaptic marker SNAP25, whereas CD11b, a microglial marker, was largely absent. EVs from brains and spinal cords of the SOD1(G93A) ALS mouse model, as well as from human SOD1 familial ALS patient spinal cord, contained abundant misfolded and nonnative disulfide-cross-linked aggregated SOD1. Our results indicate that CNS-derived EVs from an ALS animal model contain pathogenic disease-causing proteins and suggest that brain astrocytes and neurons, but not microglia, are the main EV source.	[Silverman, Judith M.; Christy, Darren; Shyu, Chih Cheih; Fernando, Sarah; Gidden, Zoe; Cowan, Catherine M.; Ban, Yuxin; Grad, Leslie I.; McAlary, Luke; Cashman, Neil R.] Univ British Columbia, Dept Med, Ctr Brain Hlth, Vancouver, BC V6T 1B5, Canada; [Moon, Kyung-Mee; Stacey, R. Greg; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1B5, Canada; [McAlary, Luke] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Cashman, NR (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC V6T 1B5, Canada.	neil.cashman@vch.ca		Gidden, Zoe/0000-0002-6704-3035; McAlary, Luke/0000-0002-1764-3809; Fernando, Sarah/0000-0001-8862-6830	Bernice Ramsay ALS Canada; Paul Heller Memorial Fund	Bernice Ramsay ALS Canada; Paul Heller Memorial Fund	This work was supported by a Bernice Ramsay ALS Canada grant, along with funding from the Paul Heller Memorial Fund (to J. M. S.). N. R. C. is the Chief Scientific Officer of ProMIS Neurosciences, which has licensed the 3H1 misfolded SOD1-specific antibody technology.	An K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-47; Antonucci Flavia, 2016, Front Synaptic Neurosci, V8, P7, DOI 10.3389/fnsyn.2016.00007; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Bakkar N, 2018, ACTA NEUROPATHOL, V135, P227, DOI 10.1007/s00401-017-1785-8; Basso M, 2013, J BIOL CHEM, V288, P15699, DOI 10.1074/jbc.M112.425066; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bowyer JF, 1999, ANN NY ACAD SCI, V890, P314, DOI 10.1111/j.1749-6632.1999.tb08009.x; Brett SI, 2017, PROSTATE, V77, P1335, DOI 10.1002/pros.23393; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Cestra G, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00085; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Ciryam P, 2017, P NATL ACAD SCI USA, V114, pE3935, DOI 10.1073/pnas.1613854114; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Da Cruz S, 2017, ACTA NEUROPATHOL, V134, P97, DOI 10.1007/s00401-017-1688-8; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Deng JT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01115-6; Ding XB, 2015, ONCOTARGET, V6, P24178, DOI 10.18632/oncotarget.4680; Ditsworth D, 2017, ACTA NEUROPATHOL, V133, P907, DOI 10.1007/s00401-017-1698-6; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gibbs MR, 2017, P NATL ACAD SCI USA, V114, P980, DOI 10.1073/pnas.1613665114; Gillis J, 2010, NAT PROTOC, V5, P1148, DOI 10.1038/nprot.2010.78; Grad LI, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024117; Grad LI, 2015, NEUROBIOL DIS, V77, P257, DOI 10.1016/j.nbd.2015.02.009; Grad LI, 2014, PRION, V8, P331, DOI 10.4161/19336896.2014.983398; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Inglis H, 2015, JOVE-J VIS EXP, DOI 10.3791/52484; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Ito D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5436; Jaronen M, 2013, HUM MOL GENET, V22, P646, DOI 10.1093/hmg/dds472; Jeppesen DK, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25011; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kapur M, 2017, NEURON, V96, P616, DOI 10.1016/j.neuron.2017.09.057; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lederer CW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-26; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McAlary L, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00499; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ngolab J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0445-5; Nolte-'t Hoen ENM, 2012, NANOMED-NANOTECHNOL, V8, P712, DOI 10.1016/j.nano.2011.09.006; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Noor A, 2017, INT J NEUROSCI, V127, P805, DOI 10.1080/00207454.2016.1248240; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; Paschon V, 2016, MOL NEUROBIOL, V53, P2016, DOI 10.1007/s12035-015-9142-1; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Peschl P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00529; Pospichalova V, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.25530; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ravits J, 2014, EXP NEUROL, V262, P121, DOI 10.1016/j.expneurol.2014.07.021; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Song F, 2014, AMYOTROPH LAT SCL FR, V15, P77, DOI 10.3109/21678421.2013.853802; Sproviero D, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00487; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tokuda E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0145-9; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Vestad B, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1344087; Woehlbier U, 2016, EMBO J, V35, P845, DOI 10.15252/embj.201592224; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	94	63	63	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3744	3759		10.1074/jbc.RA118.004825	http://dx.doi.org/10.1074/jbc.RA118.004825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635404	Green Published, hybrid			2022-12-26	WOS:000461853900035
J	Goncalves, LD; Franchi, M; Mathor, MB; Lugao, AB; Carvalho, VH; Medeiros, MHG; Artioli, GG; Varca, GHC				Goncalves, Livia de Souza; Franchi, Mariana; Mathor, Monica B.; Lugao, Ademar B.; Carvalho, Victor H.; Medeiros, Marisa H. G.; Artioli, Guilherme Giannini; Varca, Gustavo H. C.			The molecular structure of beta-alanine is resistant to sterilising doses of gamma radiation	PLOS ONE			English	Article							MUSCLE CARNOSINE; SKELETAL-MUSCLE; SUPPLEMENTATION; EXERCISE; PERFORMANCE; ANSERINE; CA2+	beta-alanine is the rate-limiting point for the endogenous synthesis of carnosine in skeletal muscle. Carnosine has a wide range of implications for health, normal function and exercise performance. Whilst the physiological relevance of carnosine to different tissues remains enigmatic, beta-alanine administration is a useful strategy to investigate the physiological roles of carnosine in humans. Intravenous administration of beta-alanine is an interesting approach to study carnosine metabolism. However, sterilisation is mandatory due to the nature of the administration route. We evaluated whether sterilising doses of gamma radiation damages the molecular structure and leads to the loss of functional characteristics of beta-alanine. Pure beta-alanine was sterilised by gamma radiation in sealed glass vials using a Co-60 multipurpose irradiator at a dose rate of 8.5 kGy.hour(-1) totalising 10, 20, 25 30 and 40 kGy. The molecular integrity was assessed by X-ray Diffraction and changes in content were determined by High Performance Liquid Chromatography (UV-HPLC) and Triple Quadrupole Mass Spectrometer (HPLC/MS-MS). Sterility assurance was evaluated by inoculation assay. To examine whether functional properties were preserved, beta-alanine was infused in one participant, who rated the level of paraesthesia on the skin using a 0-3 scale. Urinary beta-alanine was quantified before and 24-h following beta-alanine infusion using HPLC-ESI+-MS/MS. Irradiation resulted in no change in the crystal structure of beta-alanine, no degradation, and no new peaks were identified in the dose range assayed. The inoculation assay showed the absence of viable microorganisms in all beta-alanine samples, including those that did not undergo irradiation. Intravenous infusion of beta-alanine resulted in paraesthesia and it detected in the urine as per normal. We conclude that gamma radiation is a suitable technique for the sterilisation of beta-alanine. It does not lead to degradation, damage to the beta-alanine structure, content or loss of function within the evaluated irradiation conditions.	[Goncalves, Livia de Souza; Franchi, Mariana; Artioli, Guilherme Giannini] Univ Sao Paulo, Fac Med FMUSP, Rheumatol Div, Appl Physiol & Nutr Res Grp, Sao Paulo, SP, Brazil; [Mathor, Monica B.; Lugao, Ademar B.; Varca, Gustavo H. C.] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Sao Paulo, SP, Brazil; [Carvalho, Victor H.; Medeiros, Marisa H. G.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo	Artioli, GG (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Rheumatol Div, Appl Physiol & Nutr Res Grp, Sao Paulo, SP, Brazil.	artioli@usp.br	Gonçalves, Lívia/Q-1715-2019; Mathor, Monica B/C-3975-2012; Varca, Gustavo H. C./C-2729-2013; Medeiros, Marisa H. G./A-5212-2008; Lugao, Ademar B/B-6847-2013; Carvalho, Victor Henrique/U-8239-2018; Artioli, Guilherme Giannini/K-5925-2013	Gonçalves, Lívia/0000-0003-4859-9078; Mathor, Monica B/0000-0002-7294-9106; Varca, Gustavo H. C./0000-0002-6545-237X; Medeiros, Marisa H. G./0000-0002-5438-1174; Artioli, Guilherme Giannini/0000-0001-8463-2213	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Sao Paulo Research Foundation - FAPESP [2015/22686-7, 2014/11948-8, 2015/13979-0]; Comissao Nacional de Energia Nuclear - CNEN; CNPq; Sao Paulo Research Foundation FAPESP [2013/07937-8]; NAP-Redoxoma (PRPUSP) [2011.1.9352.1.8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Comissao Nacional de Energia Nuclear - CNEN; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-Redoxoma (PRPUSP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: LSG - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; MF - Sao Paulo Research Foundation - FAPESP (#2015/22686-7); GGA-Sao Paulo Research Foundation - FAPESP (#2014/11948-8); GHCV - Sao Paulo Research Foundation - FAPESP(#2015/13979-0) Comissao Nacional de Energia Nuclear - CNEN; VHC - CNPq; MHGM - Sao Paulo Research Foundation FAPESP (#2013/07937-8) and NAP-Redoxoma (PRPUSP: Proc. 2011.1.9352.1.8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Centro de Tecnologia das Radiacoes (CTR/IPEN vertical bar) for beta-alanine irradiation, Rene Ramos de Oliveira and Centro de Ciencia e Tecnologia de Materiais (CCTM/IPEN) for access to X-ray Diffraction, Daniel Lebre and Centro de Espectrometria de Massa Aplicada (CEMSA-Cietec/IPEN) for access to Triple Quadrupole (MS/MS). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES-Finance Code 001).	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Abirami S, 2005, J PHYS CHEM A, V109, P500, DOI 10.1021/jp047399o; Aldini G, 2004, J MASS SPECTROM, V39, P1417, DOI 10.1002/jms.696; [Anonymous], 2009, 1173722009 ISO; Artioli GG, 2010, MED SCI SPORT EXER, V42, P1162, DOI 10.1249/MSS.0b013e3181c74e38; Baguet A, 2009, J APPL PHYSIOL, V106, P837, DOI 10.1152/japplphysiol.91357.2008; Bate-Smith E., 1938, J PHYSL, V92; Baye E, 2016, AMINO ACIDS, V48, P1131, DOI 10.1007/s00726-016-2208-1; Blancquaert L, 2016, J PHYSIOL-LONDON, V594, P4849, DOI 10.1113/JP272050; BOLDYREV AA, 1993, MOL CHEM NEUROPATHOL, V19, P83, DOI 10.1007/BF03160170; BYRNE MM, 1995, AM J PHYSIOL-ENDOC M, V268, pE21, DOI 10.1152/ajpendo.1995.268.1.E21; Carvalho VH, 2018, REDOX BIOL, V18, P222, DOI 10.1016/j.redox.2018.07.009; Chmielewski AG, 2004, RADIAT PHYS CHEM, V71, P17, DOI 10.1016/j.radphyschem.2004.05.040; del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x; Dunnett M, 1999, Equine Vet J Suppl, P499; Dutka TL, 2012, J APPL PHYSIOL, V112, P728, DOI 10.1152/japplphysiol.01331.2011; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4; GOTTSCHALL WC, 1968, J PHYS CHEM-US, V72, P922, DOI 10.1021/j100849a024; Hannah R, 2015, J APPL PHYSIOL, V118, P604, DOI 10.1152/japplphysiol.00991.2014; Harris RC, 1998, J SPORT SCI, V16, P639; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Hipkiss AR, 2017, AGING DIS, V8, P334, DOI 10.14336/AD.2016.1030; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; Ishida K, 2001, RAD DEGRADATION SILK, P2001; ISO, 2012, 1113722012 ISO; Lee Y, 2002, J BIOCHEM MOL BIOL, V35, P590; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Martinho AC, 2013, CELL TISSUE BANK, V14, P117, DOI 10.1007/s10561-012-9306-4; Miller BF, 2005, J APPL PHYSIOL, V98, P856, DOI 10.1152/japplphysiol.00753.2004; Mora L, 2007, J AGR FOOD CHEM, V55, P4664, DOI 10.1021/jf0703809; Nardi DT, 2008, INT J RADIAT BIOL, V84, P937, DOI 10.1080/09553000802460164; ODOWD JJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P241, DOI 10.1016/0304-4165(88)90015-3; PARKER CD, 1985, ANAL CHEM, V57, P698, DOI 10.1021/ac00280a028; PISANO JJ, 1961, J BIOL CHEM, V236, P499; RAHN O, 1945, BACTERIOL REV, V9, P1; Rela P., 2001, UTILIZACAO RADIACAO; Sale C, 2013, AMINO ACIDS, V44, P1477, DOI 10.1007/s00726-013-1476-2; Saunders B, 2017, MED SCI SPORT EXER, V49, P896, DOI 10.1249/MSS.0000000000001173; Saunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396; Schoen P, 2003, CLIN CHEM, V49, P1930, DOI 10.1373/clinchem.2003.019398; Solis MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123857; Sousa JCF, 2017, VIB SPECTROSC, V89, P69, DOI 10.1016/j.vibspec.2017.01.003; Stegen S, 2013, MED SCI SPORT EXER, V45, P1478, DOI 10.1249/MSS.0b013e31828ab073; Stephens FB, 2006, FASEB J, V20, P377, DOI 10.1096/fj.05-4985fje; Swietach P, 2013, P NATL ACAD SCI USA, V110, pE2064, DOI 10.1073/pnas.1222433110; UEMATSU T, 1988, EUR J CLIN PHARMACOL, V34, P213, DOI 10.1007/BF00614562; Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g	49	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210713	10.1371/journal.pone.0210713	http://dx.doi.org/10.1371/journal.pone.0210713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645623	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200046
J	Lee, CH; Choi, SS; Lee, MK; Kim, JE; Chung, DI; Lee, M				Lee, Chung Hun; Choi, Sang Sik; Lee, Mi Kyoung; Kim, Jung Eun; Chung, Dong Ik; Lee, Mido			Electric stimulation-guided epidural analgesia for vaginal delivery: A randomized prospective study	PLOS ONE			English	Article							CONFIRMATION; ANESTHESIA; FAILURE; SPACE	Background The failure rate of epidural anesthesia using the loss of resistance technique is 13-23%. Objectives To investigate the efficacy of epidural electric stimulation-guided epidural analgesia in vaginal delivery. Study design An open label randomized prospective study. Methods Laboring women were randomized to two groups: epidural catheter insertion using only a loss of resistance technique or a loss of resistance technique with confirmation by electric stimulation. Catheters in both groups were initially tested with 3 ml of 1% lidocaine and those with any evidence of motor blockade were considered intrathecal. Sensory blockade and an 11 point numerical rating score for pain were assessed 30 minutes after administration of an epidural bolus of 10 ml of 0.22% ropivacaine with fentanyl. Successful epidural analgesia was defined as a decrease of 2 or more in the pain score and a bilateral L1-T10 sensory blockade. Results Thirty-one patients were randomized to each group. The first 20 patients in each group were enrolled in a pilot study and were also included in the final analysis. One patient in the electric stimulation group was excluded owing to dural puncture by the Tuohy needle. One patient in each group demonstrated motor blockade after test dose and were considered failures. The number (% (95% confidence interval)) of successful cases were 29 out of 30 (97% (85, 100%)) in the electric stimulation group and 24 out of 31 (77% (61, 89%)) in the loss of resistance group (P = 0.053). However, analysis of only patients with absence of motor blockade revealed that 29 out of 29 (100% (92, 100%)) patients in the electric stimulation group and 24 of 29 (80% (63, 91%)) patients in the loss of resistance group had adequate analgesia (P = 0.024). Conclusions Although limited by lack of blinding, small study size and inclusion of pilot study data, this study suggests epidural electric stimulation improves the success rate of subsequent labor analgesia.	[Lee, Chung Hun; Choi, Sang Sik; Lee, Mi Kyoung; Kim, Jung Eun; Chung, Dong Ik; Lee, Mido] Korea Univ, Med Ctr, Guro Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Choi, SS (corresponding author), Korea Univ, Med Ctr, Guro Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	clonidine@empal.com	Choi, Sangsik/HGD-4295-2022		Sewoon Medical Co., Ltd., Seoul, Korea	Sewoon Medical Co., Ltd., Seoul, Korea	The authors have no sources of funding to declare, however, the epidural catheter (RegionalStim (TM)) used in this study was provided by Sewoon Medical Co., Ltd., Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder only provided support in the form of research materials for authors [S. S. C.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agaram R, 2009, INT J OBSTET ANESTH, V18, P10, DOI 10.1016/j.ijoa.2007.10.008; Eappen S, 1998, INT J OBSTET ANESTH, V7, P220, DOI 10.1016/S0959-289X(98)80042-3; Gomar C, 2000, EUR J ANAESTH, V17, P542, DOI 10.1046/j.1365-2346.2000.00733.x; Goobie SM, 2003, ANESTH ANALG, V97, P984, DOI 10.1213/01.ANE.0000080609.05942.38; Grau T, 2002, J CLIN ANESTH, V14, P169, DOI 10.1016/S0952-8180(01)00378-6; Grau T, 2001, BRIT J ANAESTH, V86, P798, DOI 10.1093/bja/86.6.798; Hermanides J, 2012, BRIT J ANAESTH, V109, P144, DOI 10.1093/bja/aes214; Hislop H, 2014, PRINCIPLES MANUAL MU, P1; Jeong JS, 2012, KOREAN J ANESTHESIOL, V63, P238, DOI 10.4097/kjae.2012.63.3.238; Kinsella SM, 2008, ANAESTHESIA, V63, P822, DOI 10.1111/j.1365-2044.2008.05499.x; MICHAEL S, 1989, ANAESTHESIA, V44, P578, DOI 10.1111/j.1365-2044.1989.tb11446.x; Pan PH, 2004, INT J OBSTET ANESTH, V13, P227, DOI 10.1016/j.ijoa.2004.04.008; Silva M, 2010, LOCAL REG ANESTH, V3, P143, DOI 10.2147/LRA.S10237; Sutherland MA, 2009, REGION ANESTH PAIN M, V34, P575, DOI 10.1097/AAP.0b013e3181bfbe1e; Thangamuthu A, 2013, INT J OBSTET ANESTH, V22, P310, DOI 10.1016/j.ijoa.2013.04.013; Toledano RD, 2014, ANESTHESIOLOGY, V121, P9, DOI 10.1097/ALN.0000000000000239; Tsui BCH, 1998, CAN J ANAESTH, V45, P640, DOI 10.1007/BF03012093; Wantman A, 2006, ANAESTHESIA, V61, P370, DOI 10.1111/j.1365-2044.2006.04534.x	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209967	10.1371/journal.pone.0209967	http://dx.doi.org/10.1371/journal.pone.0209967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633755	Green Submitted, Green Published, gold			2022-12-26	WOS:000455485100010
J	Slater, JM; Gilbert, L; Johnson, D; Karley, AJ				Slater, Jennifer M.; Gilbert, Lucy; Johnson, David; Karley, Alison J.			Limited effects of the maternal rearing environment on the behaviour and fitness of an insect herbivore and its natural enemy	PLOS ONE			English	Article							APHIDIUS-ERVI HYMENOPTERA; HOST-PLANT; POPULATION DIFFERENTIATION; GENETIC-VARIATION; PEA APHIDS; GENERALIST; PERFORMANCE; PREFERENCE; CHOICE; SPECIALIST	The maternal rearing environment can affect offspring fitness or phenotype indirectly via 'maternal effects' and can also influence a mother's behaviour and fecundity directly. However, it remains uncertain how the effects of the maternal rearing environment cascade through multiple trophic levels, such as in plant-insect herbivore-natural enemy interactions. Pea aphids (Acyrthosiphon pisum) show differential fitness on host legume species, while generalist aphid parasitoids can show variable fitness on different host aphid species, suggesting that maternal effects could operate in a plant-aphid-parasitoid system. We tested whether the maternal rearing environment affected the behaviour and fitness of aphids by rearing aphids on two plant hosts that were either the same as or different from those experienced by the mothers. A similar approach was used to test the behaviour and fitness of parasitoid wasps in response to maternal rearing environment. Here, the host environment was manipulated at the plant or plant and aphid trophic levels for parasitoid wasps. We also quantified the quality of host plants for aphids and host aphids for parasitoid wasps. In choice tests, aphids and parasitoid wasps had no preference for the plant nor plant and aphid host environment on which they were reared. Aphid offspring experienced 50.8% higher intrinsic rates of population growth, 43.4% heavier offspring and lived 14.9% longer when feeding on bean plants compared to aphids feeding on pea plants, with little effect of the maternal rearing environment. Plant tissue nitrogen concentration varied by 21.3% in response to aphid mothers' rearing environment, and these differences correlated with offspring fitness. Maternal effects in parasitoid wasps were only observed when both the plant and aphid host environment was changed: wasp offspring were heaviest by 10.9-73.5% when both they and their mothers developed in bean-reared pea aphids. Also, parasitoid wasp fecundity was highest by 38.4% when offspring were oviposited in the maternal rearing environment. These findings indicate that maternal effects have a relatively small contribution towards the outcome of plant-aphid-parasitoid interactions.	[Slater, Jennifer M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Slater, Jennifer M.; Karley, Alison J.] James Hutton Inst, Ecol Sci Grp, Dundee, Scotland; [Slater, Jennifer M.; Gilbert, Lucy] James Hutton Inst, Ecol Sci Grp, Aberdeen, Scotland; [Johnson, David] Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England; [Gilbert, Lucy] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Aberdeen; James Hutton Institute; James Hutton Institute; University of Manchester; University of Glasgow	Karley, AJ (corresponding author), James Hutton Inst, Ecol Sci Grp, Dundee, Scotland.	Alison.Karley@hutton.ac.uk		Karley, Alison/0000-0002-0252-2086; Johnson, David/0000-0003-2299-2525	Scottish Food Security Alliance: Crops by the James Hutton Institute; Universities of Aberdeen and Dundee; N8 Agri-Food programme; Scottish Government's Rural and Environment Science and Analytical Services Division	Scottish Food Security Alliance: Crops by the James Hutton Institute; Universities of Aberdeen and Dundee; N8 Agri-Food programme; Scottish Government's Rural and Environment Science and Analytical Services Division	JMS was funded through The Scottish Food Security Alliance: Crops by the James Hutton Institute and the Universities of Aberdeen and Dundee. DJ received support from the N8 Agri-Food programme. LG and AJK were supported by the strategic research programme funded by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babikova Z, 2014, FUNCT ECOL, V28, P375, DOI 10.1111/1365-2435.12181; Babikova Z, 2013, ECOL LETT, V16, P835, DOI 10.1111/ele.12115; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cahenzli F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2856; Cao HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21954; Chesnais Q, 2016, ECOL EVOL, V6, P7882, DOI 10.1002/ece3.2404; Chesnais Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135661; CHOW A, 1992, J INSECT BEHAV, V5, P99, DOI 10.1007/BF01049161; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Donald KJ, 2016, MICROB ECOL, V71, P1, DOI 10.1007/s00248-015-0690-8; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Fei MH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081263; Fei MH, 2014, J ANIM ECOL, V83, P234, DOI 10.1111/1365-2656.12122; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2006, EVOLUTION, V60, P1574, DOI 10.1111/j.0014-3820.2006.tb00502.x; Fox J., 2018, R COMPANION APPL REG, VThird; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gorur G, 2007, ARTHROPOD-PLANT INTE, V1, P187, DOI 10.1007/s11829-007-9017-0; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; He X. Z., 2006, New Zealand Plant Protection, V59, P190; He XZ, 2008, BIOL CONTROL, V45, P281, DOI 10.1016/j.biocontrol.2008.03.003; He XZ, 2006, BIOL CONTROL, V36, P293, DOI 10.1016/j.biocontrol.2005.09.014; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; Hu XS, 2016, ECOL ENTOMOL, V41, P147, DOI 10.1111/een.12282; Johnson SN, 2012, AGR FOREST ENTOMOL, V14, P217, DOI 10.1111/j.1461-9563.2011.00561.x; Jones TS, 2015, ECOL EVOL, V5, P459, DOI 10.1002/ece3.1333; Kaiser MC, 2016, ENTOMOL EXP APPL, V159, P197, DOI 10.1111/eea.12431; Keiser CN, 2013, J INSECT BEHAV, V26, P603, DOI 10.1007/s10905-013-9376-6; Mackauer M, 1996, CAN ENTOMOL, V128, P959, DOI 10.4039/Ent128959-6; McLean AHC, 2009, ECOL ENTOMOL, V34, P330, DOI 10.1111/j.1365-2311.2008.01081.x; McMenemy LS, 2012, ENTOMOL EXP APPL, V144, P56, DOI 10.1111/j.1570-7458.2012.01248.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Nespolo RF, 2015, ECOL EVOL, V5, P5601, DOI 10.1002/ece3.1763; Olivares-Donoso R, 2007, B ENTOMOL RES, V97, P61, DOI 10.1017/S0007485307004774; Orians CM, 2011, OECOLOGIA, V167, P1, DOI 10.1007/s00442-011-1968-2; Rehman A., 2010, J PLANT BREEDING CRO, V2, P299, DOI [10.5897/JPBCS.9000077, DOI 10.1016/J.BEPROC.2010.12.002]; RStudio Team, 2019, RSTUDIO INT DEV R; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; Sasso R, 2009, CHEMOECOLOGY, V19, P195, DOI 10.1007/s00049-009-0023-9; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; Tapia DH, 2015, ANIM BEHAV, V106, P1, DOI 10.1016/j.anbehav.2015.04.027; Ueno T, 2015, EUR J ENTOMOL, V112, P281, DOI 10.14411/eje.2015.048; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; Winter TR, 2010, J CHEM ECOL, V36, P642, DOI 10.1007/s10886-010-9797-z; WYATT IJ, 1977, J APPL ECOL, V14, P757, DOI 10.2307/2402807; Wyckhuys KAG, 2008, B ENTOMOL RES, V98, P361, DOI 10.1017/S000748530800566X; Zehnder CB, 2007, ECOL ENTOMOL, V32, P172, DOI 10.1111/j.1365-2311.2007.00853.x	48	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209965	10.1371/journal.pone.0209965	http://dx.doi.org/10.1371/journal.pone.0209965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633753	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000455485100009
J	Nishiwaki, H; Hasegawa, T; Koiwa, F; Hamano, T; Masakane, I				Nishiwaki, Hiroki; Hasegawa, Takeshi; Koiwa, Fumihiko; Hamano, Takayuki; Masakane, Ikuto			The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry	PLOS ONE			English	Article							DIALYSIS OUTCOMES; ANEMIA MANAGEMENT; PRACTICE PATTERNS; IRON	Background Few clinical studies have directly examined the associations of hemoglobin (Hb) levels after hemodialysis (HD) and of the difference in Hb levels before and after HD (Delta Hb) with patient outcomes. The present study aimed to determine Delta Hb and post-HD Hb levels with nationwide data and to examine their associations with all-cause mortality in patients undergoing HD. Methods This study is based on data from 2008 and 2009 recorded in the Japanese Renal Data Registry. Study endpoints were all-cause mortality within 1-year. The Delta Hb and post-HD Hb level as categorical variables using Cox regression for 1-year mortality, adjusting for potential confounders. Results The median Delta Hb was 1.0 g/dl, and the post-HD Hb level was 11.3 g/d. The median pre-HD Hb level was 10.4 g/dl. The risk of mortality was lower with a Delta Hb of 0 to 1.0 g/dl (adjusted hazard ratio [aHR], 0.90; 95% confidence interval [CI], 0.70-1.01) or > 1.0 g/dl (aHR, 0.73; 95% CI, 0.64-0.84) than with a Delta Hb < 0 g/dl. The risk for mortality was also lower with a post-HD Hb of 10 to 11 g/dl (aHR, 0.82; 95% CI, 0.73-0.92), 11 to 12 g/dl (aHR, 0.77; 95% CI, 0.68-0.87), or > 12 g/dl (aHR, 0.77; 95% CI, 0.68-0.87) than with a post-HD Hb < 10 g/ dl. Conclusions Both a low Delta Hb and a low post-HD Hb level were associated with a higher risk of 1-year mortality.	[Nishiwaki, Hiroki; Hasegawa, Takeshi; Hamano, Takayuki; Masakane, Ikuto] Comm Renal Data Registry, Japanese Soc Dialysis Therapy, Tokyo, Japan; [Nishiwaki, Hiroki; Hasegawa, Takeshi; Koiwa, Fumihiko] Showa Univ, Div Nephrol, Fujigaoka Hosp, Dept Med,Sch Med, Yokohama, Kanagawa, Japan; [Hasegawa, Takeshi] Showa Univ, Off Promoting Med Res, Tokyo, Japan; [Hamano, Takayuki] Osaka Univ, Dept Comprehens Kidney Dis Res, Grad Sch Med, Osaka, Japan; [Masakane, Ikuto] Yabuki Hosp, Yamagata, Japan	Showa University; Showa University; Osaka University	Hasegawa, T (corresponding author), Comm Renal Data Registry, Japanese Soc Dialysis Therapy, Tokyo, Japan.; Hasegawa, T (corresponding author), Showa Univ, Div Nephrol, Fujigaoka Hosp, Dept Med,Sch Med, Yokohama, Kanagawa, Japan.; Hasegawa, T (corresponding author), Showa Univ, Off Promoting Med Res, Tokyo, Japan.	tahasegawa-npr@umin.net	Nishiwaki, Hiroki/I-5001-2019; Hamano, TAKAYUKI/AAZ-4837-2021	Nishiwaki, Hiroki/0000-0001-7365-7685; Hamano, TAKAYUKI/0000-0002-2100-9106; Hasegawa, Takeshi/0000-0003-0420-5583				Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; [Anonymous], 2017, ETH GUID MED HLTH RE; Bellizzi V, 2002, AM J KIDNEY DIS, V40, P549, DOI 10.1053/ajkd.2002.34913; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; del Castillo N, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-60; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; Geller AB, 2010, DIALYSIS TRANSPLANT, V39, P57, DOI 10.1002/dat.20406; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hamano T, 2015, KIDNEY INT SUPPL, V5, P23, DOI 10.1038/kisup.2015.6; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Korzets A, 2002, AM J KIDNEY DIS, V40, P873, DOI 10.1053/ajkd.2002.36594; Maruyama Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143430; Minutolo R, 2003, NEPHROL DIAL TRANSPL, V18, P2606, DOI 10.1093/ndt/gfg387; Movilli E, 2002, AM J KIDNEY DIS, V39, P850, DOI 10.1053/ajkd.2002.32007; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Nishiwaki H, 2018, J VASC ACCESS, V19, P69, DOI 10.5301/jva.5000798; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Sagheb M.M., 2016, NEPHRO UROL MON, V8; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Wong MMY, 2017, AM J KIDNEY DIS, V69, P367, DOI 10.1053/j.ajkd.2016.08.030; Yamamoto H., 2017, RENAL REPLACE THER, V3, P36, DOI [10.1186/s41100-017-0114-y, DOI 10.1186/S41100-017-0114-Y]	25	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210533	10.1371/journal.pone.0210533	http://dx.doi.org/10.1371/journal.pone.0210533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629677	gold, Green Submitted, Green Published			2022-12-26	WOS:000455483000103
J	Lartey, ST; Magnussen, CG; Si, L; de Graaff, B; Biritwum, RB; Mensah, G; Yawson, A; Minicuci, N; Kowal, P; Boateng, GO; Palmer, AJ				Lartey, Stella T.; Magnussen, Costan G.; Si, Lei; de Graaff, Barbara; Biritwum, Richard Berko; Mensah, George; Yawson, Alfred; Minicuci, Nadia; Kowal, Paul; Boateng, Godfred O.; Palmer, Andrew J.			The role of intergenerational educational mobility and household wealth in adult obesity: Evidence from Wave 2 of the World Health Organization's Study on global AGEing and adult health	PLOS ONE			English	Article							INCOME; WOMEN	Background Obesity has emerged as a major risk factor for non-communicable diseases in low and middle-income countries but may not follow typical socioeconomic status (SES)-related gradients seen in higher income countries. This study examines the associations between current and lifetime markers of SES and BMI categories (underweight, normal weight, overweight, obese) and central adiposity in Ghanaian adults. Methods Data from 4,464 adults (2,610 women) who participated in the World Health Organization's Study on global AGEing and adult health (SAGE) Wave 2 were examined. Multilevel multinomial and binomial logistic regression models were used to examine associations. SES markers included parental education, individual education, intergenerational educational mobility and household wealth. Intergenerational educational mobility was classified: stable-low (low parental and low individual education), stable-high (high parental and high individual education), upwardly (low parental and high individual education), or downwardly mobile (high parental and low individual education). Results The prevalence of obesity (12.9%) exceeded the prevalence of underweight (7.2%) in the population. High parental and individual education were significantly associated with higher odds of obesity and central adiposity in women. Compared to the stable low pattern, stable high (obesity: OR = 3.15; 95% CI: 1.96, 5.05; central adiposity: OR = 1.75; 95% CI: 1.03, 2.98) and upwardly (obesity: OR = 1.71; 95% CI: 11.13, 2.60; central adiposity: OR = 1.60; 95% CI: 1.08, 2.37) mobile education patterns were associated with higher odds of obesity and central adiposity in women, while stable high pattern was associated with higher odds of overweight (OR = 1.88; 95% CI: 1.11, 3.19) in men. Additionally, high compared to the lowest household wealth was associated with high odds of obesity and central adiposity in both sexes. Conclusion Stable high and upwardly mobile education patterns are associated with higher odds of obesity and central adiposity in women while the stable high pattern was associated with higher odds of overweight in men.	[Lartey, Stella T.; Magnussen, Costan G.; Si, Lei; de Graaff, Barbara; Palmer, Andrew J.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Magnussen, Costan G.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Si, Lei] Univ New South Wales, George Inst Global Hlth, Kensington, NSW, Australia; [Biritwum, Richard Berko; Mensah, George; Yawson, Alfred] Univ Ghana, Dept Community Hlth, Accra, Ghana; [Minicuci, Nadia] CNR, Neurosci Inst, Padua, Italy; [Kowal, Paul] WHO, Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Boateng, Godfred O.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	University of Tasmania; Menzies Institute for Medical Research; University of Turku; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Ghana; Consiglio Nazionale delle Ricerche (CNR); World Health Organization; University of Newcastle; Harvard University; Harvard T.H. Chan School of Public Health	Palmer, AJ (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	Andrew.Palmer@utas.edu.au	Si, Lei/AAM-3218-2020; Lartey, Stella T/ABA-8491-2020; YAWSON, ALFRED/R-8013-2019; Magnussen, Costan/AAA-8260-2020; MINICUCI, NADIA/D-5237-2016; Boateng, Godfred Odei/AAB-8341-2020; Palmer, Andrew/J-7289-2014; Magnussen, Costan/J-7177-2014	Si, Lei/0000-0002-3044-170X; YAWSON, ALFRED/0000-0003-0159-5686; MINICUCI, NADIA/0000-0002-0970-6531; Boateng, Godfred Odei/0000-0001-5898-6966; Palmer, Andrew/0000-0002-9703-7891; Kowal, Paul/0000-0002-6314-8753; Magnussen, Costan/0000-0002-6238-5730; Lartey, Stella Twumwaa/0000-0001-9519-7886	National Heart Foundation of Australia Future Leader Fellowship [100849]; NHMRC Early Career Fellowship [GNT1139826]; WHO; US National Institute on Aging's Division of Behavioural and Social Science Research (BSR) [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01]; University of Ghana's Department of Community Health	National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); WHO(World Health Organization); US National Institute on Aging's Division of Behavioural and Social Science Research (BSR); University of Ghana's Department of Community Health	The authors received no specific funding for this work. The National Heart Foundation of Australia Future Leader Fellowship (100849) supports Dr. Costan G Magnussen. Dr. Lei Si is supported by a NHMRC Early Career Fellowship (Grant number: GNT1139826). The Study on global AGEing and adult health (SAGE) Wave 2 was supported by WHO and the US National Institute on Aging's Division of Behavioural and Social Science Research (BSR) through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) with WHO. Financial and in-kind support has come from the University of Ghana's Department of Community Health.	Addo J, 2009, PUBLIC HEALTH, V123, P365, DOI 10.1016/j.puhe.2009.02.003; Adu-Gyamfi S., 2016, J ED HUMAN DEV, V5, P158, DOI [https://doi.org/10.15640/jehd.v5n3a17, 10.15640/jehd.v5n3a17, DOI 10.15640/JEHD.V5N3A17]; Agyemang C, 2015, METABOLIC SYNDROME, P1; Akinyemiju TF, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0474-x; Albrecht SS, 2014, J EPIDEMIOL COMMUN H, V68, P842, DOI 10.1136/jech-2014-203814; [Anonymous], 1998, CLIN GUID ID EV TREA; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], ED EXP ACC GHAN REV; Berrios X, 1997, B WORLD HEALTH ORGAN, V75, P99; Biritwum R, 2013, STUDY GLOBAL AGEING; Biritwum Rb, 2005, Ghana Med J, V39, P82; Boatemaa S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5336-6; Boateng GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186947; Boylan SM, 2014, OBES RES CLIN PRACT, V8, pE163, DOI 10.1016/j.orcp.2013.03.006; Brody J., 2002, NUTR BYTES, V8, P1; Cois Annibale, 2015, BMC Obes, V2, P42, DOI 10.1186/s40608-015-0072-2; Dake FAA, 2011, PUBLIC HEALTH NUTR, V14, P1285, DOI 10.1017/S1368980010002879; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Ekoru K, 2018, INT J OBESITY, V42, P487, DOI 10.1038/ijo.2017.240; Ferguson B, 2003, HLTH SYSTEMS PERFORM; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gall SL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-55; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Griebeler ML, 2011, J WOMENS HEALTH, V20, P599, DOI 10.1089/jwh.2009.1850; Groves R., 2014, SURVEY METHODOLOGY; Hazzouri AZA, 2015, OBESITY SILVER SPRIN, V23, P1097; Herd P, 2007, J HEALTH SOC BEHAV, V48, P223, DOI 10.1177/002214650704800302; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kuntz B, 2013, J PUBLIC HEALTH-HEID, V21, P49, DOI 10.1007/s10389-012-0523-x; Lambert M., 2012, UNDERSTANDING BARRIE; Lartey ST, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0074-9; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Mariapun J, 2018, J EPIDEMIOL, V28, P279, DOI 10.2188/jea.JE20170001; McLaren L, 2004, SOC SCI MED, V58, P1575, DOI 10.1016/S0277-9536(03)00209-0; Menard S., 2002, APPL LOGISTIC REGRES; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mendis S, 2014, GLOBAL STATUS REPORT; Ministry of Education, 2017, MIN MED TERM EXP FRA; Muthuri SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0147746, 10.1371/journal.p]; Nayga RM, 2000, APPL ECON, V32, P815, DOI 10.1080/000368400322156; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Ogden C, 2015, NCHS DATA BRIEF, P219; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Rabe-Hesketh S., 2004, U CALIFORNIA BERKELE; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Sartorius B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130218; Scott A, 2013, HEALTH PROMOT INT, V28, P4, DOI 10.1093/heapro/das038; Sinha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021868; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; The World Bank Group, 2015, RIS CIT GHAN TIM ACT; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Winkleby MA, 1999, AM J PUBLIC HEALTH, V82, P816; World Health Organization, 2006, WHO SAGE SURV MAN; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; Yankson Paul W.K., 2012, MOBILE CITY ACCRA UR	58	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208491	10.1371/journal.pone.0208491	http://dx.doi.org/10.1371/journal.pone.0208491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625141	Green Published, Green Accepted, gold			2022-12-26	WOS:000455359400013
J	Lee, KH; Gordon, A; Shedden, K; Kuan, G; Ng, S; Balmaseda, A; Foxman, B				Lee, Kyu Han; Gordon, Aubree; Shedden, Kerby; Kuan, Guillermina; Ng, Sophia; Balmaseda, Angel; Foxman, Betsy			The respiratory microbiome and susceptibility to influenza virus infection	PLOS ONE			English	Article							NASOPHARYNGEAL PNEUMOCOCCAL DENSITY; SYNCYTIAL VIRUS; CHILDREN; RHINOVIRUS; SEVERITY; INFANTS	Influenza is a major cause of morbidity and mortality worldwide. However, vaccine effectiveness has been low to moderate in recent years and vaccine coverage remains low, especially in low- and middle-income countries. Supplementary methods of prevention should be explored to reduce the high burden of influenza. A potential target is the respiratory tract microbiome, complex microbial communities which envelop the respiratory epithelium and play an important role in shaping host immunity. Using a household transmission study, we examined whether the nose/throat microbiota was associated with influenza susceptibility among participants exposed to influenza virus in the household. Further, we characterized changes in the nose/throat microbiota to explore whether community stability was influenced by influenza virus infection. Using a generalized linear mixed effects model, we found a nasal/oropharyngeal community state type (CST) associated with decreased susceptibility to influenza. The CST was rare and transitory among young children but a prevalent and stable CST among adults. Using boosting and linear mixed effects models, we found associations between the nose/throat microbiota and influenza also existed at the taxa level, specifically with the relative abundance of Alloprevotella, Prevotella, and Bacteroides oligotypes. We found high rates of change between bacterial community states among both secondary cases and household contacts who were not infected during follow up. Further work is needed to separate the effect of influenza virus infection from the considerable short-term changes that occur even in the absence of virus. Lastly, age was strongly associated with susceptibility to influenza and the nose/throat bacterial community structure. Although additional studies are needed to determine causality, our results suggest the nose/throat microbiome may be a potential target for reducing the burden of influenza.	[Lee, Kyu Han; Gordon, Aubree; Ng, Sophia; Foxman, Betsy] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Shedden, Kerby] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Shedden, Kerby] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua; [Kuan, Guillermina; Balmaseda, Angel] Sustainable Sci Inst, Managua, Nicaragua; [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Natl Virol Lab, Managua, Nicaragua	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Foxman, B (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	bfoxman@umich.edu	Ng, Sophia/AAA-1461-2019; Gordon, Aubree/X-1113-2019	Ng, Sophia/0000-0001-7817-7744; Gordon, Aubree/0000-0002-9352-7877; Shedden, Kerby/0000-0001-7222-6664; Lee, Kyu Han/0000-0002-0657-1483	National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID) [R21AI119463]; Fogarty International Center [K02TW009483]; Tinker Foundation; University of Michigan Center for Latin America and Caribbean Studies; University of Michigan International Institute; University of Michigan Rackham Graduate School;  [U01AI088654];  [HHSN272201400031C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119463] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Tinker Foundation; University of Michigan Center for Latin America and Caribbean Studies; University of Michigan International Institute(University of Michigan System); University of Michigan Rackham Graduate School(University of Michigan System); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Microbiome analysis was supported by the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID) grant R21AI119463 (BF & AG). Data collection was supported by U01AI088654 (AG) and contract number HHSN272201400031C (AG), and a career development award from the Fogarty International Center (K02TW009483 (AG)). Additional funding came from the Tinker Foundation, University of Michigan Center for Latin America and Caribbean Studies, University of Michigan International Institute, and University of Michigan Rackham Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Berry MA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00365; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; De Lastours V, 2016, EPIDEMIOL INFECT, V144, P3507, DOI 10.1017/S0950268816001473; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Eren AM, 2015, ISME J, V9, P90, DOI 10.1038/ismej.2014.97; Eren AM, 2014, P NATL ACAD SCI USA, V111, pE2875, DOI 10.1073/pnas.1409644111; Fan RR, 2016, EMERG INFECT DIS, V22, P1996, DOI 10.3201/eid2211.160902; Gordon A, 2009, EMERG INFECT DIS, V15, P408, DOI 10.3201/eid1503.080238; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; JEFFERSON T, 2014, BMJ BRIT MED J, V348; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Krone CL, 2014, LANCET RESP MED, V2, P141, DOI 10.1016/S2213-2600(13)70165-6; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lee KH, 2016, EVOL MED PUBLIC HLTH, P95, DOI 10.1093/emph/eow007; Leung NHL, 2015, EPIDEMIOLOGY, V26, P862, DOI 10.1097/EDE.0000000000000340; Levy M, 2017, CURR OPIN MICROBIOL, V35, P8, DOI 10.1016/j.mib.2016.10.003; Luoto R, 2014, J ALLERGY CLIN IMMUN, V133, P405, DOI 10.1016/j.jaci.2013.08.020; Lynch Susan V, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS57, DOI 10.1513/AnnalsATS.201306-158MG; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morgan M., 2017, DIRICHLETMULTINOMIAL; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Paules CI, 2018, NEW ENGL J MED, V378, P7, DOI 10.1056/NEJMp1714916; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; R Core Team, 2017, R A LANGUAGE AND ENV; Rosas-Salazar C, 2016, J INFECT DIS, V214, P1924, DOI 10.1093/infdis/jiw456; Russell RJ, 2013, TXB INFLUENZA; Salk HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162803; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Vesa S, 2001, PEDIATR INFECT DIS J, V20, P574, DOI 10.1097/00006454-200106000-00006; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WHO Global Influenza Programme, 2015, SEAS INFL VACC US LO; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; World Health Organization, IMM VACC BIOL INFL; Zambon M., 2013, TXB INFLUENZA; Zhao XH, 2016, EPIDEMIOLOGY, V27, P143, DOI 10.1097/EDE.0000000000000402	50	55	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0207898	10.1371/journal.pone.0207898	http://dx.doi.org/10.1371/journal.pone.0207898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625134	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400009
J	Cambon, M; Sanchez, O				Cambon, Manuel; Sanchez, Oscar			Analysis of the transcriptional logic governing differential spatial expression in Hh target genes	PLOS ONE			English	Article							DROSOPHILA; ACTIVATION; GRADIENT; LAMBDA; SYSTEM; MODEL	This work provides theoretical tools to analyse the transcriptional effects of certain biochemical mechanisms (i.e. affinity and cooperativity) that have been proposed in previous literature to explain the proper spatial expression of Hedgehog target genes involved in Drosophila development. Specifically we have focused on the expression of decapentaplegic, wingless, stripe and patched. The transcription of these genes is believed to be controlled by enhancer modules able to interpret opposing gradients of the activator and repressor forms of the transcription factor Cubitus interruptus (Ci). This study is based on a thermodynamic approach, which provides expression rates for these genes. These expression rates are controlled by transcription factors which are competing and cooperating for common binding sites. We have made mathematical representations of the different expression rates which depend on multiple factors and variables. The expressions obtained with the model have been refined to produce simpler equivalent formulae which allow for their mathematical analysis. Thanks to this, we can evaluate the correlation between the different interactions involved in transcription and the biological features observed at tissular level. These mathematical models can be applied to other morphogenes to help understand the complex transcriptional logic of opposing activator and repressor gradients.	[Cambon, Manuel; Sanchez, Oscar] Univ Granada, Dept Appl Math, Granada, Spain; [Cambon, Manuel; Sanchez, Oscar] Univ Granada, Excellence Res Unit Modeling Nat MNat, Granada, Spain	University of Granada; University of Granada	Sanchez, O (corresponding author), Univ Granada, Dept Appl Math, Granada, Spain.; Sanchez, O (corresponding author), Univ Granada, Excellence Res Unit Modeling Nat MNat, Granada, Spain.	ossanche@ugr.es	Sánchez, Óscar/K-6470-2014	Sánchez, Óscar/0000-0001-8123-3997	Ministerio de Economia y competitividad (Spain Government) [MTM2014-53406-R, FPI2015/074837]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Andalucia Government) [FQM 954]	Ministerio de Economia y competitividad (Spain Government); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Andalucia Government)	This work has been partially supported by: the Ministerio de Economia y competitividad (Spain Government) research grants numbers MTM2014-53406-R and FPI2015/074837 http://www.mineco.gob.es/portal/site/mineco/and the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Andalucia Government) Project FQM 954, http://www.juntadeandalucia.es/organismos/empleoempresaycornercio.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers GK, 1982, QUANTITATIVE MODEL G, V79, P1129, DOI [10.1073/pnas.79.4.1129, DOI 10.1073/PNAS.79.4.1129]; Aguilar-Hidalgo D, 2015, PHYSICA D, V295, P91, DOI 10.1016/j.physd.2014.12.006; Aguilar-Hidalgo D, 2016, DEV GENES EVOL, V226, P221, DOI 10.1007/s00427-016-0541-8; Aguilar-Hidalgo D, 2013, DEVELOPMENT, V140, P82, DOI 10.1242/dev.082172; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Ay A, 2011, CRIT REV BIOCHEM MOL, V46, P137, DOI 10.3109/10409238.2011.556597; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bisswanger H., 2008, ENZYME KINETICS PRIN; Frank T.D., 2016, SEMA SIMAI SPRING S, VVolume 7, P43, DOI DOI 10.1007/978-3-319-33054-9_3; Frank TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034439; Gilman A, 2002, ANNU REV GENOM HUM G, V3, P341, DOI 10.1146/annurev.genom.3.030502.111004; Gurdziel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145225; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Junker JP, 2014, DEV CELL, V31, P448, DOI 10.1016/j.devcel.2014.10.017; Kicheva A, 2014, SCIENCE, V345, P1577, DOI 10.1126/science.1254927; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Lorberbaum DS, 2016, ELIFE, V5, DOI 10.7554/eLife.13550; Muller B, 2000, DEVELOPMENT, V127, P2999; Parker DS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002077; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Verbeni M, 2013, PHYS LIFE REV, V10, P457, DOI 10.1016/j.plrev.2013.06.004; White MA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.48; Zhou X, 2008, BIOINFORMATICS, V24, P2639, DOI 10.1093/bioinformatics/btn494	32	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209349	10.1371/journal.pone.0209349	http://dx.doi.org/10.1371/journal.pone.0209349			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615641	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900020
J	Grottke, O; van Ryn, J; Zentai, C; Gan, GF; Honickel, M; Rossaint, R; ten Cate, H; Spronk, HMH				Grottke, Oliver; van Ryn, Joanne; Zentai, Christian; Gan, Guanfa; Honickel, Markus; Rossaint, Rolf; ten Cate, Hugo; Spronk, Henri M. H.			Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution	PLOS ONE			English	Article							DIRECT THROMBIN INHIBITOR; HYDROXYETHYL STARCH; PIG MODEL; COAGULOPATHY; COAGULATION; TRAUMA; PHARMACOKINETICS; PHARMACODYNAMICS; TOLERABILITY; MANAGEMENT	Background Idarucizumab is a humanized Fab fragment that specifically reverses dabigatran anticoagulation. In trauma, volume expanders are used for resuscitation to compensate for blood loss and hemorrhagic shock, but it is unknown whether volume expanders influence the binding of dabigatran to its antidote. Using a porcine dilutional coagulopathy model, this study investigated whether volume replacement strategies affect binding of dabigatran to idarucizumab. Methods Twenty-five male pigs were treated orally with dabigatran etexilate (30 mg/kg bid) for 3 days. The following day, animals were anesthetized, infused with dabigatran (total dose 0.645 mg/kg) to achieve supratherapeutic concentrations, and randomized 1:1:1:1:1 (n = 5 per group) to control (no hemodilution) or hemodilution where similar to 50% of blood volume was substituted with Ringer's solution, 6% hydroxyethyl starch 130/0.4, 6% hydroxyethyl starch 200/0.5 or 4% gelatin. Idarucizumab was then administered intravenously (30 mg/kg) and serial blood samples were taken for up to 24 hours to measure diluted thrombin time (corresponding with dabigatran activity), total dabigatran (bound to antidote and free drug) and a panel of coagulation parameters. Results Mean plasma dabigatran levels were 617 +/- 16 ng/mL after infusion and 600 +/- 114 ng/mL after similar to 50% hemodilution with no significant differences between groups. Following treatment with idarucizumab, plasma concentrations of unbound dabigatran decreased markedly, with similar reductions in all groups. Dabigatran-induced prolongation of coagulation parameters was rapidly reversed in all groups. Conclusion This study indicates that several volume expanders used for resuscitation in trauma do not interfere with the binding of idarucizumab to dabigatran.	[Grottke, Oliver; Zentai, Christian; Honickel, Markus; Rossaint, Rolf] RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany; [van Ryn, Joanne] Boehringer Ingelheim GmbH & Co KG, Dept CardioMetab Dis Res, Biberach, Germany; [Gan, Guanfa] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA; [ten Cate, Hugo; Spronk, Henri M. H.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Haemostas, Maastricht, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; Boehringer Ingelheim; Boehringer Ingelheim; Maastricht University	Grottke, O (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany.	ogrottke@ukaachen.de	Cate, Hugo ten/AAM-4000-2021	Grottke, Oliver/0000-0002-0722-3122; Spronk, Henri/0000-0002-3858-334X	Boehringer Ingelheim, Biberach, Germany	Boehringer Ingelheim, Biberach, Germany(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim, Biberach, Germany. The study sponsor had no role in the collection or interpretation of data.	Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Coppola S, 2014, CURR OPIN CRIT CARE, V20, P444, DOI 10.1097/MCC.0000000000000115; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; European Medicines Agency, HYDR STARCH SOL INF; Glund S, 2015, THROMB HAEMOSTASIS, V113, P943, DOI 10.1160/TH14-12-1080; Grottke O, 2010, BRIT J ANAESTH, V105, P789, DOI 10.1093/bja/aeq263; Grottke O, 2015, J AM COLL CARDIOL, V66, P1518, DOI 10.1016/j.jacc.2015.07.051; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Grottke O, 2010, CRIT CARE, V14, DOI 10.1186/cc8960; Hartog CS, 2011, INTENS CARE MED, V37, P1725, DOI 10.1007/s00134-011-2385-z; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rasmussen KC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004498; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schmohl M, 2017, THROMB HAEMOSTASIS, V117, P269, DOI 10.1160/TH16-05-0385; Schramko A, 2010, BRIT J ANAESTH, V104, P691, DOI 10.1093/bja/aeq084; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; van Ryn J, 2014, CLIN LAB MED, V34, P479, DOI 10.1016/j.cll.2014.06.008; Weitz JI, 2012, CIRCULATION, V126, P2428, DOI 10.1161/CIRCULATIONAHA.112.123224; Wilkes MM, 2001, ANN THORAC SURG, V72, P527, DOI 10.1016/S0003-4975(01)02745-X	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209350	10.1371/journal.pone.0209350	http://dx.doi.org/10.1371/journal.pone.0209350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615630	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900021
J	Premji, S; McDonald, SW; Zaychkowsky, C; Zwicker, JD				Premji, Shainur; McDonald, Sheila W.; Zaychkowsky, Carol; Zwicker, Jennifer D.			Supporting healthy pregnancies: Examining variations in nutrition, weight management and substance abuse advice provision by prenatal care providers in Alberta, Canada. A study using the All Our Families cohort	PLOS ONE			English	Article							MARIJUANA USE; OBESE WOMEN; GAIN; OUTCOMES; BIRTH; INFORMATION; MIDWIFERY; PATIENT; TRENDS; VIEWS	Background Pregnancy is a critical time for fetal development, and education of women regarding healthy lifestyle choices is an important function for prenatal care providers, those that provide care to women during pregnancy. Within Canada, women choose to receive pregnancy care from one of a variety of publicly funded care providers. This study examines the association between the type of care provider(s) seen during pregnancy and the provision of advice related to nutrition, weight management and substance abuse. Methods Using data from the Alberta-based All Our Families prospective pregnancy cohort, we conducted bivariate and multivariate analyses to determine the likelihood of receiving advice related to nutrition, weight management, and substance abuse across provider (s) seen. Results Of 3341 women in our sample, 38% saw a single provider during pregnancy and 56% received care from multiple providers. Advice on nutrition was more likely to be provided across all providers, while weight management and substance abuse was less frequently and less consistently discussed. Relative to doctors in low-risk maternity clinics, midwives were most likely to provide nutrition (OR: 3.09, 95% CI: 1.19-8.01) and weight management (OR: 1.99, 95% CI: 1.13-3.50) advice to women. Conclusion Findings suggest that the type of prenatal advice received by women depends on the provider(s) seen during pregnancy. Substance abuse was least likely to be discussed across providers, suggesting important implications given recent cannabis legalization.	[Premji, Shainur; Zwicker, Jennifer D.] Univ Calgary, Sch Publ Policy, Calgary, AB, Canada; [Premji, Shainur; McDonald, Sheila W.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Premji, Shainur; McDonald, Sheila W.; Zaychkowsky, Carol] Alberta Hlth Serv, Populat Publ & Indigenous Hlth, Calgary, AB, Canada; [Zwicker, Jennifer D.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary	Premji, S; Zwicker, JD (corresponding author), Univ Calgary, Sch Publ Policy, Calgary, AB, Canada.; Premji, S (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.; Premji, S (corresponding author), Alberta Hlth Serv, Populat Publ & Indigenous Hlth, Calgary, AB, Canada.; Zwicker, JD (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	Shainur.Premji2@ucalgary.ca; Zwicker1@ucalgary.ca	Premji, Shainur/J-2472-2018	Premji, Shainur/0000-0002-9951-5244	Secondary Analysis to Generate Evidence (SAGE) grant	Secondary Analysis to Generate Evidence (SAGE) grant	Funding was provided through a Secondary Analysis to Generate Evidence (SAGE) grant, administered by PolicyWise for Children and Families (SP, JDZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Health Services, 2016, LOW RISK OBST OPT RE; ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Bai J, 2008, AUST NZ J OBSTET GYN, V48, P454, DOI 10.1111/j.1479-828X.2008.00888.x; Begum F, 2012, J OBSTET GYNAECOL CA, V34, P637, DOI 10.1016/S1701-2163(16)35316-6; Brown QL, 2017, JAMA-J AM MED ASSOC, V317, P207, DOI 10.1001/jama.2016.17383; Day NL, 2011, NEUROTOXICOL TERATOL, V33, P129, DOI 10.1016/j.ntt.2010.07.006; Durand MA, 2010, HEALTH EXPECT, V13, P125, DOI 10.1111/j.1369-7625.2009.00544.x; Duthie EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-231; Eggertson L, 2013, CAN MED ASSOC J, V185, P1562, DOI 10.1503/cmaj.109-4653; Faucher MA, 2015, WOMEN BIRTH, V28, pE70, DOI 10.1016/j.wombi.2015.03.006; Fried PA, 2002, CANNABIS CANNABINOID, P269; Heslehurst N, 2013, MIDWIFERY, V29, P736, DOI 10.1016/j.midw.2012.07.007; Holton S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1538-7; Jarlenski M, 2017, AM J OBSTET GYNECOL, V217, P705, DOI 10.1016/j.ajog.2017.08.015; Jarlenski M, 2016, WOMEN HEALTH ISS, V26, P452, DOI 10.1016/j.whi.2016.03.010; Klein MC, 2009, J OBSTET GYNAECOL CA, V31, P827, DOI 10.1016/S1701-2163(16)34301-8; Kuczkowski KM, 2007, CURR OPIN OBSTET GYN, V19, P578, DOI 10.1097/GCO.0b013e3282f1bf17; Macleod M, 2013, MATERN CHILD NUTR, V9, P467, DOI 10.1111/j.1740-8709.2011.00396.x; McDonald SD, 2012, J OBSTET GYNAECOL CA, V34, P129, DOI 10.1016/S1701-2163(16)35155-6; McDonald SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S2; McNeely J, 2018, ADDICT SCI CLIN PRAC, V13, DOI 10.1186/s13722-018-0110-8; Metcalfe A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-62; O'Brien B, 2011, BIRTH-ISS PERINAT C, V38, P207, DOI 10.1111/j.1523-536X.2011.00482.x; O'Brien B, 2010, J OBSTET GYNAECOL CA, V32, P650, DOI 10.1016/S1701-2163(16)34568-6; Oga EA, 2018, MATERN CHILD HLTH J, V22, P1477, DOI 10.1007/s10995-018-2543-9; Ordean A, 2011, CAN FAM PHYSICIAN, V57, pE430; Phelan S, 2010, AM J OBSTET GYNECOL, V202, DOI [10.1016/j.ajog.2009.06.008, 10.1016/j.ajog.2010.06.051]; Porath A. J., 2018, CLEARING SMOKE CANNA; Public Health Agency of Canada, 2008, CAN PER HLTH REP; Rasmussen KM, 2009, CURR OPIN OBSTET GYN, V21, P521, DOI 10.1097/GCO.0b013e328332d24e; Schuurmans N, 1998, SOGC CLIN PRACTICE G, P1; Stengel MR, 2012, WOMEN HEALTH ISS, V22, pE535, DOI 10.1016/j.whi.2012.09.004; Stone R., 2015, HEAL JUSTICE, V3, P2, DOI [10.1186/s40352-015-0015-5, DOI 10.1186/S40352-015-0015-5]; Tough SC, 2017, INT J EPIDEMIOL, V46, P1389, DOI 10.1093/ije/dyw363; Vitner D, 2019, J MATERN-FETAL NEO M, V32, P2580, DOI [10.1080/14767058.2018.1440546, 10.1080/14767058.2018.1531121]; Whitaker KM, 2016, WOMEN HEALTH ISS, V26, P116, DOI 10.1016/j.whi.2015.10.007; Zelmer Jennifer, 2004, Healthc Q, V7, P21	37	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210290	10.1371/journal.pone.0210290	http://dx.doi.org/10.1371/journal.pone.0210290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG5UW	30615660	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900058
J	Milara, J; Contreras, S; de Diego, A; Calbet, M; Aparici, M; Morcillo, E; Miralpeix, M; Cortijo, J				Milara, Javier; Contreras, Sonia; de Diego, Alfredo; Calbet, Marta; Aparici, Monica; Morcillo, Esteban; Miralpeix, Montserrat; Cortijo, Julio			In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist/beta 2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; CORTICOSTEROID RESISTANCE; NUCLEAR TRANSLOCATION; TRIPLE THERAPY; INFLAMMATION; FLUTICASONE; SALMETEROL; ANTAGONIST; MECHANISMS; FORMOTEROL	Recent evidence indicates that AZD8999 (LAS190792), a novel muscarinic acetylcholine receptor antagonist and beta 2-adrenoceptor agonist (MABA) in development for chronic respiratory diseases, induces potent and sustained relaxant effects in human bronchi by adressing both muscarinic acetylcholine receptors and beta 2-adrenoceptor. However, the anti-inflammatory effects of the AZD8999 monotherapy or in combination with corticosteroids are unknown. This study investigates the anti-inflammatory effects of AZD8999 in monotherapy and combined with fluticasone propionate in neutrophils from healthy and chronic obstructive pulmonary disease (COPD) patients. Peripheral blood neutrophils from healthy and COPD patients were incubated with AZD8999 and fluticasone propionate, individually or in combination, for 1h followed by lipopolysaccharide (LPS) stimulation for 6h. The IL-8, MMP9, IL-1 beta, and GM-CSF release was measured in cell culture supernatants. AZD8999 shows similar to 50% maximum inhibitory effect and similar potency inhibiting the released cytokines in neutrophils from healthy and COPD patients. However, while fluticasone propionate suppresses mediator release in neutrophils from healthy patients, COPD neutrophils are less sensitive. The combination of non-effective concentrations of AZD8999 (0.01nM) with non-effective concentrations of fluticasone propionate (0.1nM) shows synergistic anti-inflammatory effects. The studied mechanisms that may be involved in the synergistic anti-inflammatory effects of this combination include the increase of glucocorticoid receptor (GR) a and MKP1 expression, the induction of glucocorticoid response element (GRE) activation and the decrease of ERK1/2, P38 and GR-Ser226 phosphorylations compared with mono-therapies. In summary, AZD8999 shows anti-inflammatory effects in neutrophils from COPD patients and induces synergistic anti-inflammatory effects when combined with fluticasone propionate, supporting the use of MABA/ICS combination therapy in COPD.	[Milara, Javier] Hosp Clin Univ, Pharm Unit, Valencia, Spain; [Milara, Javier; Morcillo, Esteban] Hlth Res Inst INCLIVA, Valencia, Spain; [Milara, Javier; Morcillo, Esteban; Cortijo, Julio] Hlth Inst Carlos III, CIBERES, Valencia, Spain; [Contreras, Sonia; Morcillo, Esteban; Cortijo, Julio] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain; [de Diego, Alfredo] Univ & Polytech La Fe Hosp, Resp Unit, Valencia, Spain; [Calbet, Marta; Aparici, Monica; Miralpeix, Montserrat] Almirall, R&D Ctr, Barcelona, Spain; [Cortijo, Julio] Univ Gen Hosp Consortium, Res & Teaching Unit, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Valencia; Almirall	Milara, J (corresponding author), Hosp Clin Univ, Pharm Unit, Valencia, Spain.; Milara, J (corresponding author), Hlth Res Inst INCLIVA, Valencia, Spain.; Milara, J (corresponding author), Hlth Inst Carlos III, CIBERES, Valencia, Spain.	xmilara@hotmail.com		De diego, Alfredo/0000-0002-8371-0141; MILARA, JAVIER/0000-0001-6033-4211	CIBERES [CB06/06/0027]; TRACE (Spanish Government) [TRA2009-0311]; Generalitat Valenciana [Prometeu 2017/023/UV];  [SAF2017-82913-R];  [SAF2015-65368-R];  [FIS PI17/02158]	CIBERES; TRACE (Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); ; ; 	This work was supported by SAF2017-82913-R (JC) (https://es.scribd.com/document/368252345/Propuesta-Resolucion-Provisional-Proyectos-Retos-2017) and SAF2015-65368-R (EM) (http://www.idi.mineco.gob.es/stfls/eSede/Ficheros/2016/Anexo_Preseleccionados_Propuesta_Resolucion_Provisional_Proyectos_Retos_2015.pdf) and FIS PI17/02158 (JM), (http://gesdoc.isciii.es/?action=download&id=17/07/2017-9b9c1d8f6d) CIBERES (CB06/06/0027) (JM, EM, JC), http://www.ciberes.org/ and TRACE (TRA2009-0311; Spanish Government),(http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid=4f1d9349c84b0210VgnVCM1000001034e20aRCRD&vgnextchannel=3edb282978ea0210VgnVCM1000001034e20aRCRD) and Prometeu 2017/023/UV (JC, EM) from "Generalitat Valenciana". (http://www.ceice.gva.es/es/web/ciencia/publicador-convocatorias-actuales//asset_publisher/TEuqaq42uy8u/content/subvenciones-programa-prometeo-para-grupos-de-investigacion-de-excelencia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparici M, 2017, PULM PHARMACOL THER, V46, P1, DOI 10.1016/j.pupt.2017.07.003; Barnes PJ, 2017, HANDB EXP PHARMACOL, V237, P93, DOI 10.1007/164_2016_62; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Black JL, 2009, CHEST, V136, P1095, DOI 10.1378/chest.09-0354; Calverley P, 2016, RESPIROLOGY, V21, P581, DOI 10.1111/resp.12690; Cazzola M, 2013, EUR RESPIR J, V42, P885, DOI 10.1183/09031936.00067013; Fabbri LM, 2017, LANCET, V389, P1864, DOI 10.1016/S0140-6736(17)30567-6; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; Gedebjerg A, 2018, LANCET RESP MED, V6, P204, DOI 10.1016/S2213-2600(18)30002-X; Haque R, 2013, J ALLERGY CLIN IMMUN, V132, P1166, DOI 10.1016/j.jaci.2013.07.038; Hegde SS, 2014, J PHARMACOL EXP THER, V351, P190, DOI 10.1124/jpet.114.216861; Kistemaker LEM, 2015, TRENDS PHARMACOL SCI, V36, P164, DOI 10.1016/j.tips.2014.11.005; Kobayashi Y, 2012, PULM PHARMACOL THER, V25, P201, DOI 10.1016/j.pupt.2012.02.005; Kolmus K, 2015, BRAIN BEHAV IMMUN, V45, P297, DOI 10.1016/j.bbi.2014.10.007; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Mercado N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041582; Milara J, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0927-4; Milara J, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0467-8; Milara J, 2014, J ALLERGY CLIN IMMUN, V134, P314, DOI 10.1016/j.jaci.2014.02.001; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Roche N, 2011, EUR RESPIR REV, V20, P175, DOI 10.1183/09059180.00004211; Rossios C, 2012, BRIT J PHARMACOL, V167, P775, DOI 10.1111/j.1476-5381.2012.01864.x; Strandberg K, 2010, PULM PHARMACOL THER, V23, P316, DOI 10.1016/j.pupt.2010.03.004; Suri S, 2008, BIOCHEM PHARMACOL, V76, P645, DOI 10.1016/j.bcp.2008.06.010; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P704, DOI 10.1164/rccm.200408-1041OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Wielders PLML, 2013, EUR RESPIR J, V42, P972, DOI 10.1183/09031936.00165712	33	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210188	10.1371/journal.pone.0210188	http://dx.doi.org/10.1371/journal.pone.0210188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608978	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800053
J	Brix, DM; Tvingsholm, SA; Hansen, MB; Clemmensen, KB; Ohman, T; Siino, V; Lambrughi, M; Hansen, K; Puustinen, P; Gromova, I; James, P; Papaleo, E; Varjosalo, M; Moreira, J; Jaattela, M; Kallunki, T				Brix, Ditte Marie; Tvingsholm, Siri Amanda; Hansen, Malene Bredahl; Clemmensen, Knut Bundgaard; Ohman, Tiina; Siino, Valentina; Lambrughi, Matteo; Hansen, Klaus; Puustinen, Pietri; Gromova, Irina; James, Peter; Papaleo, Elena; Varjosalo, Markku; Moreira, Jose; Jaattela, Marja; Kallunki, Tuula			Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion	ONCOGENE			English	Article							CANCER CELL INVASION; HUMAN-BREAST-CANCER; PROTEIN; EXPRESSION; RECEPTOR; ERBB2; HER2; IDENTIFICATION; PROGRESSION; INHIBITORS	HER2/ErbB2 activation turns on transcriptional processes that induce local invasion and lead to systemic metastasis. The early transcriptional changes needed for ErbB2-induced invasion are poorly understood. Here, we link ErbB2 activation to invasion via ErbB2-induced, SUMO-directed phosphorylation of a single serine residue, S27, of the transcription factor myeloid zinc finger-1 (MZF1). Utilizing an antibody against MZF1-pS27, we show that the phosphorylation of S27 correlates significantly (p < 0.0001) with high-level expression of ErbB2 in primary invasive breast tumors. Phosphorylation of MZF1-S27 is an early response to ErbB2 activation and results in increased transcriptional activity of MZF1. It is needed for the ErbB2-induced expression of MZF1 target genes CTSB and PRKCA, and invasion of single-cells from ErbB2-expressing breast cancer spheroids. The phosphorylation of MZF1-S27 is preceded by poly-SUMOylation of K23, which can make S27 accessible to efficient phosphorylation by PAK4. Based on our results, we suggest for an activation mechanism where phosphorylation of MZF1-S27 triggers MZF1 dissociation from its transcriptional repressors such as the CCCTC-binding factor (CTCF). Our findings increase understanding of the regulation of invasive signaling in breast cancer by uncovering a detailed biological mechanism of how ErbB2 activation can rapidly lead to its invasion-promoting target gene expression and invasion.	[Brix, Ditte Marie; Tvingsholm, Siri Amanda; Hansen, Malene Bredahl; Clemmensen, Knut Bundgaard; Puustinen, Pietri; Jaattela, Marja; Kallunki, Tuula] Danish Canc Soc, Res Ctr, Cell Death & Metab, Ctr Autophagy Recycling & Dis, Strandboulevarden 49, DK-2100 Copenhagen, Denmark; [Ohman, Tiina; Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, Helsinki Inst Life Sci, Helsinki 00014, Finland; [Siino, Valentina] Lund Univ, Inst Immunotechnol, S-22381 Lund, Sweden; [Lambrughi, Matteo; Papaleo, Elena] Danish Canc Soc, Res Ctr, Computat Biol Lab, Ctr Autophagy Recycling & Dis, DK-2100 Copenhagen, Denmark; [Hansen, Klaus] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Gromova, Irina] Danish Canc Soc, Res Ctr, Unit Genome Integr, Ctr Autophagy Recycling & Dis,Breast Canc Biol, DK-2100 Copenhagen, Denmark; [James, Peter] Abo Akad Univ, Turku Ctr Biotechnol, Turku 20014, Finland; [James, Peter] Univ Turku, Turku 20014, Finland; [Moreira, Jose; Kallunki, Tuula] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2200 Copenhagen, Denmark	Danish Cancer Society; University of Helsinki; Lund University; Danish Cancer Society; University of Copenhagen; Danish Cancer Society; Abo Akademi University; University of Turku; University of Turku; University of Copenhagen	Jaattela, M; Kallunki, T (corresponding author), Danish Canc Soc, Res Ctr, Cell Death & Metab, Ctr Autophagy Recycling & Dis, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.; Kallunki, T (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2200 Copenhagen, Denmark.	mj@cancer.dk; tk@cancer.dk	Jäättelä, Marja/AAT-7932-2021; Lambrughi, Matteo/AAF-1749-2020; Papaleo, Elena/M-6629-2014; Varjosalo, Markku/K-6424-2015	Jäättelä, Marja/0000-0001-5950-7111; Kallunki, Tuula/0000-0002-8571-383X; Moreira, Jose/0000-0002-9944-1214; , Elena/0000-0003-2296-898X; Papaleo, Elena/0000-0002-7376-5894; Bredahl Hansen, Malene/0000-0003-2006-3503; Varjosalo, Markku/0000-0002-1340-9732; Hansen, Klaus/0000-0001-9657-8816; Ohman, Tiina/0000-0001-6647-8873; Lambrughi, Matteo/0000-0002-0894-8627; Siino, Valentina/0000-0002-0489-6380	Novo Nordisk Foundation [NNF15OC0017324]; Danish Medical Research Council [0602-02386B]; Danish Cancer Society Scientific Committee (KBVU) [R124-A7854-15-S2, R56-A3108-12-S2]; Danish National Research Foundation [DNRF125]; European Research Council [AdG 340751]; EU-PRACE DECI13th grant; DeiC Pilot Grant 2015-2016 for the Danish Supercomputing Center Computerome	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society Scientific Committee (KBVU); Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council(European Research Council (ERC)European Commission); EU-PRACE DECI13th grant; DeiC Pilot Grant 2015-2016 for the Danish Supercomputing Center Computerome	Funding was provided by the Novo Nordisk Foundation (NNF15OC0017324) (TK), the Danish Medical Research Council (0602-02386B) (TK), the Danish Cancer Society Scientific Committee (KBVU) (R124-A7854-15-S2 and R56-A3108-12-S2) (TK), the Danish National Research Foundation (DNRF125) (MJ), the European Research Council (AdG 340751) (MJ), EU-PRACE DECI13th grant for computational resources (EP), and the DeiC Pilot Grant 2015-2016 for the Danish Supercomputing Center Computerome (EP).	Abdel-Magid AF, 2015, ACS MED CHEM LETT, V6, P17, DOI 10.1021/ml500445c; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bailey TA, 2014, J BIOL CHEM, V289, P30443, DOI 10.1074/jbc.M114.608992; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Brix DM, 2014, MOL ONCOL, V8, P1703, DOI 10.1016/j.molonc.2014.07.004; Deng Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/868131; Dittmer J, 2017, SEMIN CANCER BIOL, V44, P72, DOI 10.1016/j.semcancer.2017.03.006; Duchnowska R, 2015, NEURO-ONCOLOGY, V17, P1241, DOI 10.1093/neuonc/nov012; Egeblad M, 2001, INT J CANCER, V94, P185, DOI 10.1002/ijc.1459; Eguchi T, 2015, J CELL BIOCHEM, V116, P2146, DOI 10.1002/jcb.25203; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Ha BH, 2015, J BIOL CHEM, V290, P12975, DOI 10.1074/jbc.R115.650416; Hamalisto S, 2016, CURR OPIN CELL BIOL, V39, P69, DOI 10.1016/j.ceb.2016.02.009; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Kim KI, 2006, MOL CELLS, V22, P247; Kim S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.33; Ko H, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0035-9; Marshall AD, 2014, CURR OPIN GENET DEV, V24, P8, DOI 10.1016/j.gde.2013.10.011; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Minden Audrey, 2012, ISRN Oncol, V2012, P694201, DOI 10.5402/2012/694201; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noll L, 2008, LEUKEMIA RES, V32, P1582, DOI 10.1016/j.leukres.2008.03.024; Ogawa H, 2003, J BIOL CHEM, V278, P2921, DOI 10.1074/jbc.M207615200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Sander TL, 2000, J BIOL CHEM, V275, P12857, DOI 10.1074/jbc.275.17.12857; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; SEGATTO O, 1988, MOL CELL BIOL, V8, P5570, DOI 10.1128/MCB.8.12.5570; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Subramonian D, 2014, J PROTEOME RES, V13, P3905, DOI 10.1021/pr500119a; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tsai LH, 2015, ONCOGENE, V34, P1641, DOI 10.1038/onc.2014.118; Tural D, 2014, EXPERT REV ANTICANC, V14, P1089, DOI 10.1586/14737140.2014.929946; Tvingsholm SA, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0014-6; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Venur VA, 2016, INT J MOL SCI, P17; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Xiao YX, 2015, ANAL BIOCHEM, V477, P95, DOI 10.1016/j.ab.2014.11.006; Yue CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127420; Yue CH, 2012, CHINESE J PHYSIOL, V55, P31, DOI 10.4077/CJP.2012.AMM109	52	12	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3170	3184		10.1038/s41388-018-0653-x	http://dx.doi.org/10.1038/s41388-018-0653-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30622337	Green Submitted, Green Accepted			2022-12-26	WOS:000465557200005
J	Esneau, C; Raynal, B; Roblin, P; Brule, S; Richard, CA; Fix, J; Eleouet, JF; Galloux, M				Esneau, Camille; Raynal, Bertrand; Roblin, Pierre; Brule, Sebastien; Richard, Charles-Adrien; Fix, Jenna; Eleouet, Jean-Francois; Galloux, Marie			Biochemical characterization of the respiratory syncytial virus N-0-P complex in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; structural model; small-angle X-ray scattering (SAXS); mutagenesis; analytical ultracentrifugation; N-0-P complex; nucleoprotein N; respiratory syncytial virus; structure-function; viral replication	NUCLEOPROTEIN-RNA COMPLEX; CRYSTAL-STRUCTURE; BINDING-SITE; PHOSPHOPROTEIN; IDENTIFICATION; PROTEINS; INSIGHTS; REGION; FORMS	As all the viruses belonging to the Mononegavirales order, the nonsegmented negative-strand RNA genome of respiratory syncytial virus (RSV) is encapsidated by the viral nucleoprotein N. N protein polymerizes along the genomic and anti-genomic RNAs during replication. This requires the maintenance of the neosynthesized N protein in a monomeric and RNA-free form by the viral phosphoprotein P that plays the role of a chaperone protein, forming a soluble N-0-P complex. We have previously demonstrated that residues 1-30 of P specifically bind to N-0. Here, to isolate a stable N-0-P complex suitable for structural studies, we used the N-terminal peptide of P (P40) to purify truncated forms of the N protein. We show that to purify a stable N-0-P-like complex, a deletion of the first 30 N-terminal residues of N (N-30) is required to impair N oligomerization, whereas the presence of a full-length C-arm of N is required to inhibit RNA binding. We generated structural models of the RSV N-0-P with biophysical approaches, including hydrodynamic measurements and small-angle X-ray scattering (SAXS), coupled with biochemical and functional analyses of human RSV (hRSV) N-30 mutants. These models suggest a strong structural homology between the hRSV and the human metapneumovirus (hMPV) N-0-P complexes. In both complexes, the P40-binding sites on N-0 appear to be similar, and the C-arm of N provides a high flexibility and a propensity to interact with the N RNA groove. These findings reveal two potential sites to target on N-0-P for the development of RSV antivirals.	[Esneau, Camille; Richard, Charles-Adrien; Fix, Jenna; Eleouet, Jean-Francois; Galloux, Marie] Univ Paris Saclay, Untie Virol & Immunol Mol, INRA, F-78350 Jouy En Josas, France; [Raynal, Bertrand; Brule, Sebastien] Inst Pasteur, Plate Forme Biophys Mol, C2RT, 25 Rue Docteur Roux, F-75015 Paris, France; [Roblin, Pierre] Synchrotron SOLEIL, F-91410 Lorme Des Merisiers, Saint Aubin, France; [Roblin, Pierre] Univ Paul Sabatier, Lab Genie Chim, UMR 5503, Toulouse, France; [Esneau, Camille] Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; SOLEIL Synchrotron; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Hunter Medical Research Institute; University of Newcastle	Eleouet, JF; Galloux, M (corresponding author), Univ Paris Saclay, Untie Virol & Immunol Mol, INRA, F-78350 Jouy En Josas, France.	jean-francois.eleouet@inra.fr; marie.galloux@inra.fr	Eléouët, Jean-François/AAD-1994-2019; Esneau, Camille/AAD-3239-2022	raynal, Bertrand/0000-0001-5634-0408; Esneau, Camille/0000-0002-5479-1851; ELeouet, Jean-Francois/0000-0002-7361-4885; Brule, Sebastien/0000-0002-8797-6748; RICHARD, Charles-Adrien/0000-0001-5306-2297	French Agence Nationale de la Recherche, specific program ANR Blanc [ANR-13-IVS3-0007]	French Agence Nationale de la Recherche, specific program ANR Blanc(French National Research Agency (ANR))	This work was supported by the French Agence Nationale de la Recherche, specific program ANR Blanc 2013 "Respisyncycell" ANR-13-IVS3-0007. The authors declare that they have no conflicts of interest with the contents of this article.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Aggarwal M, 2018, J VIROL, V92, DOI 10.1128/JVI.01304-17; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Bird GH, 2014, J CLIN INVEST, V124, P2113, DOI 10.1172/JCI71856; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Castel G, 2009, J VIROL, V83, P10808, DOI 10.1128/JVI.00977-09; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chenavas S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003275; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; El Omari K, 2008, ACTA CRYSTALLOGR F, V64, P1019, DOI 10.1107/S1744309108031059; Fix Jenna, 2011, Open Virol J, V5, P103, DOI 10.2174/1874357901105010103; Gaillard V, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02241-16, 10.1128/aac.02241-16]; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; Galloux M, 2012, J VIROL, V86, P8375, DOI 10.1128/JVI.00058-12; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; GarciaBarreno B, 1996, J VIROL, V70, P801; Guryanov SG, 2016, J VIROL, V90, P2849, DOI 10.1128/JVI.02865-15; Hardy RW, 1998, J VIROL, V72, P520, DOI 10.1128/JVI.72.1.520-526.1998; Jamin M, 2017, ADV VIRUS RES, V97, P143, DOI 10.1016/bs.aivir.2016.09.001; Karlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031719; Kirchdoerfer RN, 2015, CELL REP, V12, P140, DOI 10.1016/j.celrep.2015.06.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pereira N, 2017, J BIOL CHEM, V292, P2120, DOI [10.1074/jbc.M116.765958, 10.1074/jbc.m116.765958]; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Rincheval V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00655-9; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Shapiro AB, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0191-2; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868; Zarzycka B, 2016, DRUG DISCOV TODAY, V21, P48, DOI 10.1016/j.drudis.2015.09.011; Zhu TF, 2017, J VIROL, V91, DOI [10.1128/JVI.00996-17, 10.1128/jvi.00996-17]	42	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3647	3660		10.1074/jbc.RA118.006453	http://dx.doi.org/10.1074/jbc.RA118.006453			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30626736	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000461853900027
J	Zhang, YZ; Tada, T; Ozono, S; Yao, WT; Tanaka, M; Yamaoka, S; Kishigami, S; Fujita, H; Tokunaga, K				Zhang, Yanzhao; Tada, Takuya; Ozono, Seiya; Yao, Weitong; Tanaka, Michiko; Yamaoka, Shoji; Kishigami, Satoshi; Fujita, Hideaki; Tokunaga, Kenzo			Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV; membrane protein; glycoprotein; host-pathogen interaction; macrophage; antiviral factor; HIV-1; macrophage; MARCH family; membrane-associated RING-CH	E3 UBIQUITIN LIGASE; COMPLEX CLASS-I; DOWN-REGULATION; ANTIGEN PRESENTATION; MESSENGER-RNA; PROTEIN; STABILIZATION; EXPRESSION; SURFACE; RECOGNITION	Membrane-associated RING-CH 8 (MARCH8) is one of 11 members of the MARCH family of RING finger E3 ubiquitin ligases and down-regulates several membrane proteins (e.g. major histocompatibility complex II [MHC-II], CD86, and transferrin receptor). We recently reported that MARCH8 also targets HIV-1 envelope glycoproteins and acts as an antiviral factor. However, it remains unclear whether other family members might have antiviral functions similar to those of MARCH8. Here we show that MARCH1 and MARCH2 are MARCH family members that reduce virion incorporation of envelope glycoproteins. Infectivity assays revealed that MARCH1 and MARCH2 dose-dependently suppress viral infection. Treatment with type I interferon enhanced endogenous expression levels of MARCH1 and MARCH2 in monocyte-derived macrophages. Expression of these proteins in virus-producing cells decreased the efficiency of viral entry and down-regulated HIV-1 envelope glycoproteins from the cell surface, resulting in reduced incorporation of envelope glycoproteins into virions, as observed in MARCH8 expression. With the demonstration that MARCH1 and MARCH2 are antiviral MARCH family members as presented here, these two proteins join a growing list of host factors that inhibit HIV-1 infection.	[Zhang, Yanzhao; Tada, Takuya; Ozono, Seiya; Yao, Weitong; Tanaka, Michiko; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan; [Ozono, Seiya; Kishigami, Satoshi] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi 4008510, Japan; [Yao, Weitong; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo 1138519, Japan; [Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki 8593298, Japan; [Tada, Takuya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	National Institute of Infectious Diseases (NIID); University of Yamanashi; Tokyo Medical & Dental University (TMDU); Nagasaki International University; New York University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan.	tokunaga@nih.go.jp	Yanzhao, Zhang/AAI-4175-2021; Tada, Takuya/GOP-1100-2022; Tokunaga, Kenzo/Q-9914-2018	Yanzhao, Zhang/0000-0002-1937-4438; Tada, Takuya/0000-0003-0779-9954; Tokunaga, Kenzo/0000-0002-2625-5322; Fujita, Hideaki/0000-0002-4105-4430	Japan Agency for Medical Research and Development (AMED, Research Program on HIV/AIDS) [17fk0410308j0503]; Japan Society for the Promotion of Science (KAKENHI) [18K07156]	Japan Agency for Medical Research and Development (AMED, Research Program on HIV/AIDS)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Agency for Medical Research and Development (AMED, Research Program on HIV/AIDS, 17fk0410308j0503) and the Japan Society for the Promotion of Science (KAKENHI, 18K07156) to K. T. The authors declare that they have no conflicts of interest with the contents of this article.	Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Iyengar PV, 2011, J BIOL CHEM, V286, P39082, DOI 10.1074/jbc.M111.256875; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Korfali N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018762; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Mahmoud L, 2014, RNA BIOL, V11, P124, DOI 10.4161/rna.27863; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Nice TJ, 2010, J IMMUNOL, V185, P5369, DOI 10.4049/jimmunol.1000247; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Tada T, 2015, NAT MED, V21, P1502, DOI 10.1038/nm.3956; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang Y, 2018, VIROLOGY, V518, P293, DOI 10.1016/j.virol.2018.02.003	32	22	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3397	3405		10.1074/jbc.AC118.005907	http://dx.doi.org/10.1074/jbc.AC118.005907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30630952	Green Published, hybrid			2022-12-26	WOS:000461853900008
J	Kim, SH; Kang, PA; Han, K; Lee, SW; Rhee, S				Kim, Sang-Hoon; Kang, Pyeoung-Ann; Han, Keetae; Lee, Seon-Woo; Rhee, Sangkee			Crystal structure of chloramphenicol-metabolizing enzyme EstDL136 from a metagenome	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ESTERASES; ACETYLTRANSFERASE; INSIGHTS; SERVER; CARBOXYLESTERASE; INACTIVATION; PROTEINS; SEQUENCE	Metagenomes often convey novel biological activities and therefore have gained considerable attention for use in biotechnological applications. Recently, metagenome-derived EstDL136 was found to possess chloramphenicol (Cm)-metabolizing features. Sequence analysis showed EstDL136 to be a member of the hormone-sensitive lipase (HSL) family with an Asp-His-Ser catalytic triad and a notable substrate specificity. In this study, we determined the crystal structures of EstDL136 and in a complex with Cm. Consistent with the high sequence similarity, the structure of EstDL136 is homologous to that of the HSL family. The active site of EstDL136 is a relatively shallow pocket that could accommodate Cm as a substrate as opposed to the long acyl chain substrates typical of the HSL family. Mutational analyses further suggested that several residues in the vicinity of the active site play roles in the Cm-binding of EstDL136. These results provide structural and functional insights into a metagenome-derived EstDL136.	[Kim, Sang-Hoon; Kang, Pyeoung-Ann; Han, Keetae; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Seon-Woo] Dong A Univ, Dept Appl Biol, Busan, South Korea	Seoul National University (SNU); Dong A University	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Lee, SW (corresponding author), Dong A Univ, Dept Appl Biol, Busan, South Korea.	seonlee@dau.ac.kr; srheesnu@snu.ac.kr		Rhee, Sangkee/0000-0002-8779-9737; Lee, Seon-Woo/0000-0001-6142-7612	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration of Korea [PJ01325801]; National Research Foundation of Korea from MSIP, Republic of Korea [2017R1A2B4002860]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea from MSIP, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ01325801 to SR), Rural Development Administration of Korea and by the National Research Foundation of Korea grant (2017R1A2B4002860) from MSIP, Republic of Korea (to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bornscheuer UT, 2002, CURR OPIN BIOTECH, V13, P543, DOI 10.1016/S0958-1669(02)00350-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cousin X, 1997, NUCLEIC ACIDS RES, V25, P143, DOI 10.1093/nar/25.1.143; De Simone G, 2004, J MOL BIOL, V343, P137, DOI 10.1016/j.jmb.2004.08.014; De Simone G, 2004, J BIOL CHEM, V279, P6815, DOI 10.1074/jbc.M307738200; DeLano WL, 2002, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giuseppe M, 2012, PROTEIN PEPTIDE LETT, V19, P144, DOI 10.2174/092986612799080400; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HEMILA H, 1994, BBA-LIPID LIPID MET, V1210, P249, DOI 10.1016/0005-2760(94)90129-5; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; NAKANO H, 1977, J ANTIBIOT, V30, P76, DOI 10.7164/antibiotics.30.76; Ohara K, 2014, J BIOL CHEM, V289, P24499, DOI 10.1074/jbc.M113.521856; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Sohaskey CD, 2000, J BACTERIOL, V182, P1930, DOI 10.1128/JB.182.7.1930-1934.2000; Sohaskey CD, 2004, FEMS MICROBIOL LETT, V240, P187, DOI 10.1016/j.femsle.2004.09.028; Sohaskey CD, 1999, ANTIMICROB AGENTS CH, V43, P655, DOI 10.1128/AAC.43.3.655; Tao W, 2012, APPL ENVIRON MICROB, V78, P6295, DOI 10.1128/AEM.01154-12; Tao WX, 2011, J MICROBIOL BIOTECHN, V21, P1203, DOI 10.4014/jmb.1107.07034; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SQ, 2015, J LIPID RES, V56, P1616, DOI 10.1194/jlr.M060673	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210298	10.1371/journal.pone.0210298	http://dx.doi.org/10.1371/journal.pone.0210298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645605	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200024
J	Aslam, MA; Alemdehy, MF; Pritchard, CEJ; Song, JY; Muhaimin, FI; Wijdeven, RH; Huijbers, IJ; Neefjes, J; Jacobs, H				Aslam, Muhammad Assad; Alemdehy, Mir Farshid; Pritchard, Colin E. J.; Song, Ji-Ying; Muhaimin, Fitriari Izzatunnisa; Wijdeven, Ruud H.; Huijbers, Ivo J.; Neefjes, Jacques; Jacobs, Heinz			Towards an understanding of C9orf82 protein/CAAP1 function	PLOS ONE			English	Article							DNA-DAMAGE; PCNA UBIQUITINATION; TOPOISOMERASE-II; BREAKS; ROLES; ETA	C9orf82 protein, or conserved anti-apoptotic protein 1 or caspase activity and apoptosis inhibitor 1 (CAAP1) has been implicated as a negative regulator of the intrinsic apoptosis pathway by modulating caspase expression and activity. In contrast, an independent genome wide screen for factors capable of driving drug resistance to the topoisomerase II (Topo II) poisons doxorubicin and etoposide, implicated a role for the nuclear protein C9orf82 in delaying DSBs repair downstream of Topo II, hereby sensitizing cells to DSB induced apoptosis. To determine its function in a genetically defined setting in vivo and ex vivo, we here employed CRISPR/Cas9 technology in zygotes to generate a C9orf82 knock-out mouse model. C9orf82(ko/ko) mice were born at a Mendelian ratio and did not display any overt macroscopic or histological abnormalities. DSBs repair dependent processes like lymphocyte development and class switch recombination (CSR) appeared normal, arguing against a link between the C9orf82 encoded protein and V(D) J recombination or CSR. Most relevant, primary pre-B cell cultures and Tp53 transformed mouse embryo fibroblasts (MEFs) derived from C9orf82(ko/ko) E14.5 and wild type embryos displayed comparable sensitivity to a number of DNA lesions, including DSBs breaks induced by the topoisomerase II inhibitors, etoposide and doxorubicin. Likewise, the kinetics of.H2AX formation and resolution in response to etoposide of C9orf82 protein proficient, deficient and overexpressing MEFs were indistinguishable. These data argue against a direct role of C9orf82 protein in delaying repair of Topo II generated DSBs and regulating apoptosis. The genetically defined systems generated in this study will be of value to determine the actual function of C9orf82 protein.	[Aslam, Muhammad Assad; Alemdehy, Mir Farshid; Muhaimin, Fitriari Izzatunnisa; Jacobs, Heinz] Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands; [Pritchard, Colin E. J.; Huijbers, Ivo J.] Netherlands Canc Inst, Mouse Clin Canc & Aging Res MCCA Transgen Facil, Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Div Expt Anim Pathol, Amsterdam, Netherlands; [Wijdeven, Ruud H.; Neefjes, Jacques] Leiden Univ, Med Ctr, Dept Chem Immunol, Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jacobs, H (corresponding author), Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands.	h.jacobs@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Muhaimin, Fitriari Izzatunnisa/0000-0002-7466-0947	Netherlands Organisation for Health Research and Development (ZonMw) [91213018]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This research was supported by a Top Grant from the Netherlands Organisation for Health Research and Development (ZonMw, project 91213018) to HJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2014, DNA REPAIR, V19, P169, DOI 10.1016/j.dnarep.2014.03.014; Bredemeyer AL, 2015, CURR BIOL, V25, pR45, DOI 10.1016/j.cub.2014.11.024; Buoninfante Olimpia Alessandra, 2018, Oncotarget, V9, P18832, DOI 10.18632/oncotarget.24777; De Zio D, 2013, ANTIOXID REDOX SIGN, V19, P559, DOI 10.1089/ars.2012.4938; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Izykowska K, 2017, ONCOTARGET, V8, P39627, DOI 10.18632/oncotarget.17383; Krijger PHL, 2011, DNA REPAIR, V10, P1051, DOI 10.1016/j.dnarep.2011.08.005; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Nowsheen S., 2012, Experimental Oncology, V34, P243; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Prochazkova J, 2016, IMMUNOLOGY, V147, P11, DOI 10.1111/imm.12547; Srivastava M, 2015, CHEM BIOL, V22, P17, DOI 10.1016/j.chembiol.2014.11.013; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; Wijdeven RH, 2015, CANCER RES, V75, P4176, DOI 10.1158/0008-5472.CAN-15-0380; Wit N, 2015, NUCLEIC ACIDS RES, V43, P282, DOI 10.1093/nar/gku1301; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025284	17	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210526	10.1371/journal.pone.0210526	http://dx.doi.org/10.1371/journal.pone.0210526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629682	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000101
J	Crans, RAJ; Janssens, J; Daelemans, S; Wouters, E; Raedt, R; Van Dam, D; De Deyn, PP; Van Craenenbroeck, K; Stove, CP				Crans, Rene A. J.; Janssens, Jana; Daelemans, Sofie; Wouters, Elise; Raedt, Robrecht; Van Dam, Debby; De Deyn, Peter P.; Van Craenenbroeck, Kathleen; Stove, Christophe P.			The validation of Short Interspersed Nuclear Elements (SINEs) as a RT-qPCR normalization strategy in a rodent model for temporal lobe epilepsy	PLOS ONE			English	Article							RNA-POLYMERASE-II; KAINIC ACID; REAL-TIME; MESSENGER-RNA; REFERENCE GENES; B2 RNA; RAT MODEL; EXPRESSION; TRANSCRIPTION; SEIZURES	Background In gene expression studies via RT-qPCR many conclusions are inferred by using reference genes. However, it is generally known that also reference genes could be differentially expressed between various tissue types, experimental conditions and animal models. An increasing amount of studies have been performed to validate the stability of reference genes. In this study, two rodent-specific Short Interspersed Nuclear Elements (SINEs), which are located throughout the transcriptome, were validated and assessed against nine reference genes in a model of Temporal Lobe Epilepsy (TLE). Two different brain regions (i.e. hippocampus and cortex) and two different disease stages (i.e. acute phase and chronic phase) of the systemic kainic acid rat model for TLE were analyzed by performing expression analyses with the geNorm and NormFinder algorithms. Finally, we performed a rank aggregation analysis and validated the reference genes and the rodent-specific SINEs (i.e. B elements) individually via Gfap gene expression. Results GeNorm ranked Hprt1, Pgk1 and Ywhaz as the most stable genes in the acute phase, while Gusb and B2m were ranked as the most unstable, being significantly upregulated. The two B elements were ranked as most stable for both brain regions in the chronic phase by geNorm. In contrast, NormFinder ranked the B1 element only once as second best in cortical tissue for the chronic phase. Interestingly, using only one of the two algorithms would have led to skewed conclusions. Finally, the rank aggregation method indicated the use of the B1 element as the best option to normalize target genes, independent of the disease progression and brain region. This result was supported by the expression profile of Gfap. Conclusion In this study, we demonstrate the potential of implementing SINEs-notably the B1 element as a stable normalization factor in a rodent model of TLE, independent of brain region or disease progression.	[Crans, Rene A. J.; Wouters, Elise; Van Craenenbroeck, Kathleen; Stove, Christophe P.] Univ Ghent, L GEST, Toxicol Lab, Dept Bioanal, Ghent, Belgium; [Janssens, Jana; Van Dam, Debby; De Deyn, Peter P.] Univ Antwerp, Lab Neurochem & Behav, Dept Biomed Sci, Inst Born Bunge, Antwerp, Belgium; [Daelemans, Sofie; Raedt, Robrecht] Ghent Univ Hosp, LCEN3, Dept Internal Med, Ghent, Belgium; [Van Dam, Debby; De Deyn, Peter P.] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Van Dam, Debby; De Deyn, Peter P.] Univ Med Ctr Groningen, Alzheimer Res Ctr, Groningen, Netherlands; [De Deyn, Peter P.] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, Antwerp, Belgium; [De Deyn, Peter P.] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, Antwerp, Belgium; [De Deyn, Peter P.] Univ Antwerp, Biobank, Inst Born Bunge, Antwerp, Belgium	Ghent University; University of Antwerp; Ghent University; Ghent University Hospital; University of Groningen; University of Groningen; University of Antwerp	Stove, CP (corresponding author), Univ Ghent, L GEST, Toxicol Lab, Dept Bioanal, Ghent, Belgium.	christophe.stove@ugent.be	Crans, Rene/AAX-5631-2020; Wouters, Elise/AAR-6437-2021; Stove, Christophe/B-6057-2008; Van Dam, Debby/G-1666-2018	Crans, Rene/0000-0003-2832-4405; Stove, Christophe/0000-0001-7126-348X; De Deyn, Peter Paul/0000-0002-2228-2964; Raedt, Robrecht/0000-0002-8939-0169; Van Dam, Debby/0000-0003-4739-6076	Agentschap voor Innovatie door Wetenschap en Techniek by Strategisch Basisonderzoek grant [140028]; Fonds Wetenschappelijk Onderzoek grant [G021715N]; Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office grant [IAP7/16]; Belgian Alzheimer Research Foundation (SAO-FRA) [15002, 2017/0025]	Agentschap voor Innovatie door Wetenschap en Techniek by Strategisch Basisonderzoek grant; Fonds Wetenschappelijk Onderzoek grant; Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office grant; Belgian Alzheimer Research Foundation (SAO-FRA)	This work was supported by the Agentschap voor Innovatie door Wetenschap en Techniek by Strategisch Basisonderzoek grant #140028 (http://www.fwo.be) (RAJC, JJ, SD, EW, RR, DVD, PPDD, KVK, CS), the Fonds Wetenschappelijk Onderzoek grant #G021715N (http://www.fwo.be) (KVK), Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office grant #IAP7/16 (http://belspo.be/iap/) (JJ, DVD) and Belgian Alzheimer Research Foundation (SAO-FRA) grant #15002 and #2017/0025 (http://www.alzh.org/) (DVD, PPDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armagan G, 2012, NEUROCHEM INT, V60, P555, DOI 10.1016/j.neuint.2012.02.015; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Bayrakdar ET, 2013, EPILEPSY RES, V105, P13, DOI 10.1016/j.eplepsyres.2012.12.008; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bojang P, 2018, MOL ONCOL, V12, P1342, DOI 10.1002/1878-0261.12329; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; Crow MK, 2010, AUTOIMMUNITY, V43, P7, DOI 10.3109/08916930903374865; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; DENDUNNEN JT, 1987, NUCLEIC ACIDS RES, V15, P2772; Dridi S, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/545328; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Gholami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176368; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gong H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38513; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hunter RG, 2015, P NATL ACAD SCI USA, V112, P6828, DOI 10.1073/pnas.1411260111; Jarvela JT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-29; Kainate Ben-Ari Y., 2012, JASPERS BASIC MECH E; Khanna P, 2017, Biotech Histochem, V92, P459, DOI 10.1080/10520295.2017.1362474; Kim J, 1996, J MOL BIOL, V261, P322, DOI 10.1006/jmbi.1996.0464; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Latham S, 2016, J CLIN PATHOL, V69, P817, DOI 10.1136/jclinpath-2015-203538; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; Maurer-Morelli CV, 2012, J NEUROSCI METH, V208, P44, DOI 10.1016/j.jneumeth.2012.04.020; Mavragani CP, 2018, J AUTOIMMUN, V88, P75, DOI 10.1016/j.jaut.2017.10.004; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Odom GL, 2004, MOL BIOL EVOL, V21, P2140, DOI 10.1093/molbev/msh225; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Papasotiriou I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171466; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; Rihani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071776; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Tan HP, 2012, HUM MOL GENET, V21, P57, DOI 10.1093/hmg/ddr437; Teneng I, 2007, GENES CELLS, V12, P1101, DOI 10.1111/j.1365-2443.2007.01117.x; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tsirigos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000610; Ullal G, 2005, EPILEPSIA, V46, P616, DOI 10.1111/j.1528-1167.2005.49604.x; Umylny B, 2007, J CELL BIOCHEM, V102, P110, DOI 10.1002/jcb.21278; Van Meter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6011; Van Nieuwenhuyse B, 2015, BRAIN RES, V1627, P1, DOI 10.1016/j.brainres.2015.08.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Veniaminova NA, 2007, GENOMICS, V89, P678, DOI 10.1016/j.ygeno.2007.02.007; Vossaert L, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-21; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Wongpaiboonwattana W, 2013, ASIAN PAC J CANCER P, V14, P3773, DOI 10.7314/APJCP.2013.14.6.3773; Yang JH, 2016, ONCOL LETT, V11, P2673, DOI 10.3892/ol.2016.4232; Yoo JE, 2017, J MICROBIOL BIOTECHN, V27, P816, DOI 10.4014/jmb.1612.12026; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	65	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210567	10.1371/journal.pone.0210567	http://dx.doi.org/10.1371/journal.pone.0210567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629669	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000109
J	Uphoff, CC; Pommerenke, C; Denkmann, SA; Drexler, HG				Uphoff, Cord C.; Pommerenke, Claudia; Denkmann, Sabine A.; Drexler, Hans G.			Screening human cell lines for viral infections applying RNA-Seq data analysis	PLOS ONE			English	Article							BOVINE POLYOMAVIRUS; SEQUENCE; CULTURES	Monitoring viral infections of cell cultures is largely neglected although the viruses may have an impact on the physiology of cells and may constitute a biohazard regarding laboratory safety and safety of bioactive agents produced by cell cultures. PCR, immunological assays, and enzyme activity tests represent common methods to detect virus infections. We have screened more than 300 Cancer Cell Line Encyclopedia RNA sequencing and 60 whole exome sequencing human cell lines data sets for specific viral sequences and general viral nucleotide and protein sequence assessment applying the Taxonomer bioinformatics tool developed by IDbyDNA. The results were compared with our previous findings from virus specific PCR analyses. Both, the results obtained from the direct alignment method and the Taxonomer alignment method revealed a complete concordance with the PCR results: twenty cell lines were found to be infected with five virus species. Taxonomer further uncovered a bovine polyomavirus infection in the breast cancer cell line SK-BR-3 most likely introduced by contaminated fetal bovine serum. RNA-Seq data sets were more sensitive for virus detection although a significant proportion of cell lines revealed low numbers of virus specific alignments attributable to low level nucleotide contamination during RNA preparation or sequencing procedure. Low quality reads leading to Taxonomer false positive results can be eliminated by trimming the sequence data before analysis. One further important result is that no viruses were detected that had never been shown to occur in cell cultures. The results prove that the currently applied testing of cell cultures is adequate for the detection of contamination and for the risk assessment of cell cultures. The results emphasize that next generation sequencing is an efficient tool to determine the viral infection status of human cells.	[Uphoff, Cord C.; Pommerenke, Claudia; Denkmann, Sabine A.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Uphoff, CC (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	cup@dsmz.de						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bofill-Mas S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/192089; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolin S R, 1991, J Vet Diagn Invest, V3, P199; BOLIN SR, 1994, J VIROL METHODS, V48, P211, DOI 10.1016/0166-0934(94)90120-1; Cao SB, 2015, J VIROL, V89, P713, DOI 10.1128/JVI.02570-14; Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Granata I, 2017, PEERJ PREPRINTS, V5; Hempel HA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00156; Kakisi OK, 2013, TRANSFUSION MED, V23, P142, DOI 10.1111/tme.12049; KLUINNELEMANS HC, 1991, LEUKEMIA, V5, P221; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; MacConaill LE, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4428-5; Merten OW, 2002, CYTOTECHNOLOGY, V39, P91, DOI 10.1023/A:1022969101804; Miyazawa M, 1999, J HEPATOL, V31, P967, DOI 10.1016/S0168-8278(99)80304-3; Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P95, DOI 10.14573/altex.1607121; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Pienkowska M, 1998, J HEPATOL, V28, P396, DOI 10.1016/S0168-8278(98)80312-7; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006; SCHUURMAN R, 1991, BIOLOGICALS, V19, P265, DOI 10.1016/S1045-1056(05)80014-4; SCHUURMAN R, 1991, J GEN VIROL, V72, P2739, DOI 10.1099/0022-1317-72-11-2739; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437; Tae H, 2014, GENOMICS, V104, P453, DOI 10.1016/j.ygeno.2014.08.009; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Uphoff CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125622; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; Uryvaev LV, 2012, B EXP BIOL MED+, V153, P77, DOI 10.1007/s10517-012-1648-1; Wessman S J, 1999, Dev Biol Stand, V99, P3; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210404	10.1371/journal.pone.0210404	http://dx.doi.org/10.1371/journal.pone.0210404			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629668	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000081
J	Runge, CA; Withey, JC; Naugle, DE; Fargione, JE; Helmstedt, KJ; Larsen, AE; Martinuzzi, S; Tack, JD				Runge, Claire A.; Withey, John C.; Naugle, David E.; Fargione, Joseph E.; Helmstedt, Kate J.; Larsen, Ashley E.; Martinuzzi, Sebastian; Tack, Jason D.			Single species conservation as an umbrella for management of landscape threats	PLOS ONE			English	Article							GREATER SAGE-GROUSE; LAND-COVER; SELECTION; BIODIVERSITY; FLAGSHIPS; REMOVAL; MAMMALS	Single species conservation unites disparate partners for the conservation of one species. However, there are widespread concerns that single species conservation biases conservation efforts towards charismatic species at the expense of others. Here we investigate the extent to which sage grouse (Centrocercus sp.) conservation, the largest public-private conservation effort for a single species in the US, provides protections for other species from localized and landscape-scale threats. We compared the coverage provided by sage grouse Priority Areas for Conservation (PACs) to 81 sagebrush-associated vertebrate species distributions with potential coverage under multi-species conservation prioritization generated using the decision support tool Zonation. PACs. We found that the current PAC prioritization approach was not statistically different from a diversity-based prioritization approach and covers 23.3% of the landscape, and 24.8%, on average, of the habitat of the 81 species. The proportion of each species distribution at risk was lower inside PACs as compared to the region as a whole, even without management (land use change 30% lower, cheatgrass invasion 19% lower). Whether or not bias away from threat represents the most efficient use of conservation effort is a matter of considerable debate, though may be pragmatic in this landscape where capacity to address these threats is limited. The approach outlined here can be used to evaluate biological equitability of protections provided by flagship species in other settings.	[Runge, Claire A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Withey, John C.] Evergreen State Coll, Grad Program Environm, Olympia, WA 98505 USA; [Naugle, David E.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Fargione, Joseph E.] Nature Conservancy, Minneapolis, MN USA; [Helmstedt, Kate J.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Larsen, Ashley E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Martinuzzi, Sebastian] Univ Wisconsin, SILVIS Lab, Forest & Wildlife Ecol, Madison, WI USA; [Tack, Jason D.] US Fish & Wildlife Serv, Habitat & Populat Evaluat Team, Missoula, MT USA; [Runge, Claire A.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Sustainabil Lab, Tromso, Norway; [Helmstedt, Kate J.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Montana System; University of Montana; Nature Conservancy; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; US Fish & Wildlife Service; UiT The Arctic University of Tromso; Queensland University of Technology (QUT)	Runge, CA (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Runge, CA (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Sustainabil Lab, Tromso, Norway.	claire.runge@uqconnect.edu.au	Helmstedt, Kate/P-7288-2019; Runge, Claire/Q-2110-2018	Larsen, Ashley/0000-0001-7491-9245; Helmstedt, Kate/0000-0003-0201-5348; Runge, Claire/0000-0003-3913-8560	Science for Nature and People Partnership (SNAPP) of The Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS) at the University of California, Santa Barbara; Gordon and Betty Moore Foundation [4641]	Science for Nature and People Partnership (SNAPP) of The Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS) at the University of California, Santa Barbara; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was funded by the Science for Nature and People Partnership (SNAPP), a collaboration of The Nature Conservancy, the Wildlife Conservation Society, and the National Center for Ecological Analysis and Synthesis (NCEAS) at the University of California, Santa Barbara. The project was funded by the Gordon and Betty Moore Foundation Proposal 4641 awarded to JW, DN & JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Bennett JR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2693; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; Carlisle JD, 2018, J WILDLIFE MANAGE, V82, P948, DOI 10.1002/jwmg.21460; Caro TM, 2001, BIOL CONSERV, V98, P251, DOI 10.1016/S0006-3207(00)00105-1; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Cetas ER, 2017, CONSERV BIOL, V31, P203, DOI 10.1111/cobi.12770; Chambers JC, 2017, RANGELAND ECOL MANAG, V70, P149, DOI 10.1016/j.rama.2016.08.005; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Comer P., 2003, ECOLOGICAL SYSTEMS U; Conservation Biology Institute, 2012, PROT AR DAT US PAD U; Copeland HE, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00186.1; Crosby AD, 2015, BIOL CONSERV, V186, P233, DOI 10.1016/j.biocon.2015.03.018; Dobkin D., 2004, SHRUBSTEPPE LANDSCAP; Donnelly JP, 2017, RANGELAND ECOL MANAG, V70, P95, DOI 10.1016/j.rama.2016.10.009; Duvall AL, 2017, RANGELAND ECOL MANAG, V70, P129, DOI 10.1016/j.rama.2016.08.001; Environmental Systems Research Institute (ESRI), 2016, ARCGIS DESKT REL; Falkowski MJ, 2017, RANGELAND ECOL MANAG, V70, P15, DOI 10.1016/j.rama.2016.08.002; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Hanser SE, 2011, STUD AVIAN BIOL, P475; Hebblewhite M., 2017, ENERGY SPRAWL SOLUTI, P39; Holmes AL, 2017, RANGELAND ECOL MANAG, V70, P87, DOI 10.1016/j.rama.2016.10.006; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Jacobson Cynthia, 2012, Human Dimensions of Wildlife, V17, P333, DOI 10.1080/10871209.2012.709310; Jepson P, 2015, CONSERV SOC, V13, P95, DOI 10.4103/0972-4923.161228; Johnson SA, 2017, J NAT CONSERV, V37, P47, DOI 10.1016/j.jnc.2017.03.003; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Maestas J. D., 2016, Rangelands, V38, P120; Magris RA, 2016, ECOGRAPHY, V39, P649, DOI 10.1111/ecog.01507; Markowitz EM, 2013, PREPRINT; Maslo B, 2016, BIOL CONSERV, V203, P233, DOI 10.1016/j.biocon.2016.09.012; McAdoo JK, 2004, USDA FOR SERV P RMRS; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Montana Fish Wildlife & Parks, 2011, UPL GAM BIRD ENH PRO; Natural Resources Conservation Service, 2015, OUTC CONS SAG GROUS; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Poiani KA, 2001, CONSERV BIOL, V15, P513, DOI 10.1046/j.1523-1739.2001.015002513.x; Rich TD, 2005, PSWGTR191 USDA FOR S; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rowland M. M., 2011, SAGEBRUSH ECOSYSTEM, P46; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Runge CA, 2018, SINGLE SPECIES CONSE, DOI [10.5063/F1BC3WSJ, DOI 10.5063/F1BC3WSJ]; Seddon PJ, 2008, ORYX, V42, P240, DOI 10.1017/S003060530806119X; Smith JT, 2016, BIOL CONSERV, V201, P10, DOI 10.1016/j.biocon.2016.06.006; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Sohl TL, 2014, ECOL APPL, V24, P1015, DOI 10.1890/13-1245.1; Stubbs M., 2014, CONSERVATION RESERVE, P42783; Stuber EF, 2018, BIOL CONSERV, V223, P112, DOI 10.1016/j.biocon.2018.04.026; Suring Lowell H., 2005, P150; Suter W, 2002, CONSERV BIOL, V16, P778, DOI 10.1046/j.1523-1739.2002.01129.x; Svejcar T, 2017, PLANT ECOL, V218, P81, DOI 10.1007/s11258-016-0648-z; Thomas-Walters L, 2017, CONSERV LETT, V10, P581, DOI 10.1111/conl.12319; Tulloch VJD, 2015, FRONT ECOL ENVIRON, V13, P91, DOI 10.1890/140022; U.S. Fish and Wildlife Service and U.S. Census Bureau, 2018, 2016 NAT SURV FISH H; University of Wyoming Department of Ecosystem Science, 2016, W US SAG COV RAST; US Fish and Wildlife Service, 2015, GREAT SAG GROUS 2015; US Geological Survey Forest and Rangeland Ecosystem Science Center, 2002, DISTR SAG GROUS N AM; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Verissimo D, 2014, CONSERV LETT, V7, P263, DOI 10.1111/conl.12070; Wisdom MJ, 2003, PROCEDURES REGIONAL; Wisdom MJ, 2005, HABITAT THREATS SAGE, p[5, 5]	67	30	31	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209619	10.1371/journal.pone.0209619	http://dx.doi.org/10.1371/journal.pone.0209619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625183	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400048
J	Guet-McCreight, A; Skinner, FK				Guet-McCreight, Alexandre; Skinner, Frances K.			Using computational models to predict in vivo synaptic inputs to interneuron specific 3 (IS3) cells of CA1 hippocampus that also allow their recruitment during rhythmic states	PLOS ONE			English	Article							POLYPEPTIDE-IMMUNOREACTIVE INTERNEURONS; THETA OSCILLATIONS; PYRAMIDAL CELLS; INHIBITORY SYNAPSES; CELLULAR PROPERTIES; PRINCIPAL NEURONS; CORTICAL CIRCUIT; NETWORK ACTIVITY; LOCAL CIRCUITS; VISUAL-CORTEX	Brain coding strategies are enabled by the balance of synaptic inputs that individual neurons receive as determined by the networks in which they reside. Inhibitory cell types contribute to brain function in distinct ways but recording from specific, inhibitory cell types during behaviour to determine their contributions is highly challenging. In particular, the in vivo activities of vasoactive intestinal peptide-expressing interneuron specific 3 (IS3) cells in the hippocampus that only target other inhibitory cells are unknown at present. We perform a massive, computational exploration of possible synaptic inputs to IS3 cells using multi-compartment models and optimized synaptic parameters. We find that asynchronous, in vivo-like states that are sensitive to additional theta-timed inputs (8 Hz) exist when excitatory and inhibitory synaptic conductances are approximately equally balanced and with low numbers of activated synapses receiving correlated inputs. Specifically, under these balanced conditions, the input resistance is larger with higher mean spike firing rates relative to other activated synaptic conditions investigated. Incoming theta-timed inputs result in strongly increased spectral power relative to baseline. Thus, using a generally applicable computational approach we predict the existence and features of background, balanced states in hippocampal circuits.	[Guet-McCreight, Alexandre; Skinner, Frances K.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Guet-McCreight, Alexandre] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Skinner, Frances K.] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Skinner, Frances K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Guet-McCreight, A; Skinner, FK (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.; Guet-McCreight, A (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Skinner, FK (corresponding author), Univ Toronto, Dept Med Neurol, Toronto, ON, Canada.; Skinner, FK (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	alexandre.guet.mccreight@mail.utoronto.ca; frances.skinner@utoronto.ca	Guet-McCreight, Alexandre/AAD-2265-2020	Guet-McCreight, Alexandre/0000-0002-2377-0337	Natural Sciences and Engineering Research Council of Canada (NSERC) [CGSD2 - 504375 - 2017]; QEII-SST, Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); QEII-SST, Graduate Scholarship	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC): Discovery Grant to FKS and Graduate Scholarship (CGSD2 - 504375 - 2017) to AGM; and QEII-SST, Graduate Scholarship to AGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1996, NEUROSCIENCE, V73, P299, DOI 10.1016/0306-4522(95)00610-9; Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Adesnik H, 2017, NEURON, V95, P1147, DOI 10.1016/j.neuron.2017.08.014; Ahmed OJ, 2014, BMC NEUROSCI S1, V15, pF3, DOI DOI 10.1186/1471-2202-15-S1-F3; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bezaire MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.18566; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Canto CB, 2012, HIPPOCAMPUS, V22, P1256, DOI 10.1002/hipo.20997; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Carnevale NT, 2006, NEURON BOOK; Chamberland S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00165; Chamberland S, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00130; Chiu CQ, 2018, NEURON, V97, P368, DOI 10.1016/j.neuron.2017.12.032; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; David LS, 2017, EXP NEUROL, V292, P102, DOI 10.1016/j.expneurol.2017.03.007; Deneve S, 2016, NAT NEUROSCI, V19, P375, DOI 10.1038/nn.4243; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Ferguson KA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0131-17.2017; Frerking M, 2005, J NEUROPHYSIOL, V94, P1528, DOI 10.1152/jn.00108.2005; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Guet-McCreight A, 2017, F1000RESEARCH, P6; Guet-McCreight A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0087-16.2016; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Ho ECY, 2016, J COMPUT NEUROSCI, V41, P225, DOI 10.1007/s10827-016-0615-7; Huh CYL, 2016, J NEUROSCI, V36, P6605, DOI 10.1523/JNEUROSCI.3951-13.2016; Humphries MD, 2016, ELIFE, V5, DOI 10.7554/eLife.22735; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jackson J, 2016, J NEUROPHYSIOL, V115, P3008, DOI 10.1152/jn.01124.2015; Kamigaki T, 2017, NAT NEUROSCI, V20, P854, DOI 10.1038/nn.4554; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Karnani MM, 2016, NEURON, V90, P86, DOI 10.1016/j.neuron.2016.02.037; Karnani MM, 2016, J NEUROSCI, V36, P3471, DOI 10.1523/JNEUROSCI.3646-15.2016; Katona L, 2014, NEURON, V82, P872, DOI 10.1016/j.neuron.2014.04.007; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kowalski J, 2016, HIPPOCAMPUS, V26, P668, DOI 10.1002/hipo.22550; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Luczak A, 2015, NAT REV NEUROSCI, V16, P745, DOI 10.1038/nrn4026; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Morin F, 2010, J NEUROPHYSIOL, V103, P3472, DOI 10.1152/jn.00848.2009; O'Donnell C, 2017, ELIFE, V6, DOI [10.7554/elife.26724.001, 10.7554/eLife.26724]; Ostojic S, 2011, J NEUROPHYSIOL, V106, P361, DOI 10.1152/jn.00830.2010; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Petersen PC, 2016, ELIFE, V5, DOI 10.7554/eLife.18805; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Piwkowska Z, 2008, J NEUROSCI METH, V169, P302, DOI 10.1016/j.jneumeth.2007.11.010; Ramaswamy S, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00044; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Rosenbaum R, 2017, NAT NEUROSCI, V20, P107, DOI 10.1038/nn.4433; Salz DM, 2016, J NEUROSCI, V36, P7476, DOI 10.1523/JNEUROSCI.0087-16.2016; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; Sekulic V, 2017, ELIFE, V6, DOI 10.7554/eLife.22962; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Sivagnanam S, 2013, CEUR WORKSH P CEUR W, V993; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Stringer C, 2016, ELIFE, V5, DOI 10.7554/eLife.19695; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; TREVINO M, 2016, SCIENCE, V8; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Tyan L, 2014, J NEUROSCI, V34, P4534, DOI 10.1523/JNEUROSCI.3813-13.2014; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varga C, 2014, ELIFE, V3, DOI 10.7554/eLife.04006; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Vida I, 2010, SPR SER COMPUT NEURO, V5, P27, DOI 10.1007/978-1-4419-0996-1_2; Villette V, 2017, SCI REP-UK, V7, DOI 10.1038/srep43388; Vinet J, 2006, NEUROSCIENCE, V143, P189, DOI 10.1016/j.neuroscience.2006.07.019; Witter MP, 2010, SPR SER COMPUT NEURO, V5, P5, DOI 10.1007/978-1-4419-0996-1_1; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yang S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00469; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zhou SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00046	93	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0209429	10.1371/journal.pone.0209429	http://dx.doi.org/10.1371/journal.pone.0209429			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620732	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300006
J	Broertjes, J; Klarenbeek, J; Habani, Y; Langeslag, M; Jalink, K				Broertjes, Jorrit; Klarenbeek, Jeffrey; Habani, Yasmin; Langeslag, Michiel; Jalink, Kees			TRPM7 residue S1269 mediates cAMP dependence of Ca2+ influx	PLOS ONE			English	Article							POTENTIAL MELASTATIN 7; CHANNEL-KINASE TRPM7; BREAST-CANCER CELLS; PHOSPHORYLATION SITES; CATION CHANNEL; CALCIUM; BRADYKININ; MIGRATION	The nonspecific divalent cation channel TRPM7 (transient receptor potential-melastatin-like 7) is involved in many Ca2+ and Mg2+-dependent cellular processes, including survival, proliferation and migration. TRPM7 expression predicts metastasis and recurrence in breast cancer and several other cancers. In cultured cells, it can induce an invasive phenotype by promoting Ca2+-mediated epithelial-mesenchymal transition. We previously showed that in neuroblastoma cells that overexpress TRPM7 moderately, stimulation with Ca2+-mobilizing agonists leads to a characteristic sustained influx of Ca2+. Here we report that sustained influx through TRPM7 is abruptly abrogated by elevating intracellular levels of cyclic adenosine monophosphate (cAMP). Using pharmacological inhibitors and overexpression studies we show that this blockage is mediated by the cAMP effector Protein Kinase A (PKA). Mutational analysis demonstrates that the Serine residue S1269, which is present proximal to the coiled-coil domain within the protein c-terminus, is responsible for sensitivity to cAMP.	[Broertjes, Jorrit; Klarenbeek, Jeffrey; Habani, Yasmin; Langeslag, Michiel; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol 1, Amsterdam, Netherlands; [Langeslag, Michiel] Med Univ Innsbruck, Dept Physiol & Biomed Phys, Innsbruck, Austria	Netherlands Cancer Institute; Medical University of Innsbruck	Jalink, K (corresponding author), Netherlands Canc Inst, Div Cell Biol 1, Amsterdam, Netherlands.	k.jalink@nki.nl		Langeslag, Michiel/0000-0003-4883-7339; Jalink, Kees/0000-0001-7019-3440	KWF kankerbestrijding grant [NKI 2010-4626]	KWF kankerbestrijding grant	Funded by KWF kankerbestrijding grant NKI 2010-4626. To dr K. Jalink.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abiria SA, 2017, P NATL ACAD SCI USA, V114, pE6079, DOI 10.1073/pnas.1707380114; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cai N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42739; Callera GE, 2009, J HYPERTENS, V27, P155, DOI 10.1097/HJH.0b013e3283190582; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Faouzi M, 2017, J PHYSIOL-LONDON, V595, P3165, DOI 10.1113/JP274006; Guilbert A, 2013, EUR J CANCER, V49, P3694, DOI 10.1016/j.ejca.2013.07.008; Jansen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33459; Kim BJ, 2005, GASTROENTEROLOGY, V129, P1504, DOI 10.1053/j.gastro.2005.08.016; Kim TY, 2012, BIOCHEM BIOPH RES CO, V417, P1030, DOI 10.1016/j.bbrc.2011.12.085; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Krapivinsky G, 2014, CELL, V157, P1061, DOI 10.1016/j.cell.2014.03.046; Langeslag M, 2006, THESIS; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Meng XJ, 2013, CANCER LETT, V333, P96, DOI 10.1016/j.canlet.2013.01.031; Middelbeek J, 2016, EUR J CELL BIOL, V95, P465, DOI 10.1016/j.ejcb.2016.06.008; Middelbeek J, 2015, ONCOTARGET, V6, P8760, DOI 10.18632/oncotarget.3315; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Ortega A, 2016, ESC HEART FAIL, V3, P220, DOI 10.1002/ehf2.12085; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Sah R, 2013, P NATL ACAD SCI USA, V110, pE3037, DOI 10.1073/pnas.1311865110; Shen B, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0051-3; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Tian YF, 2018, J CELL MOL MED, V22, P6327, DOI 10.1111/jcmm.13931; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Visser D, 2014, THESIS; Visser D, 2014, EUR J CELL BIOL, V93, P455, DOI 10.1016/j.ejcb.2014.07.001; Visser D, 2013, CELL CALCIUM, V54, P404, DOI 10.1016/j.ceca.2013.09.003; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wrighton KH, 2014, NAT REV MOL CELL BIO, V15, P427, DOI 10.1038/nrm3824; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yee Nelson S, 2014, Cells, V3, P751, DOI 10.3390/cells3030751; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008; Yu Y, 2014, CELL CALCIUM, V55, P252, DOI 10.1016/j.ceca.2014.02.019; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209563	10.1371/journal.pone.0209563	http://dx.doi.org/10.1371/journal.pone.0209563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615643	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900022
J	Owora, AH; Carabin, H; Garwe, T; Anderson, MP				Owora, Arthur H.; Carabin, Helene; Garwe, Tabitha; Anderson, Michael P.			Are we validly assessing major depression disorder risk and associated factors among mothers of young children? A cross-sectional study involving home visitation programs	PLOS ONE			English	Article							CASE-FINDING INSTRUMENTS; MATERNAL DEPRESSION; POSTPARTUM DEPRESSION; UNITED-STATES; SCREENING TOOLS; MENTAL-HEALTH; MISCLASSIFICATION; SYMPTOMS; RELIABILITY; PREDICTORS	Failure to account for misclassification error accruing from imperfect case-finding instruments can produce biased estimates of suspected major depression disorder (MDD) risk factor associations. The objective of this study was to estimate the impact of misclassification error on the magnitude of measures of association between suspected risk factors and MDD assessed using the Center of Epidemiological Studies on Depression-Short Form during the prenatal and postnatal periods. Baseline data were collected from 520 mothers participating in two home visitation studies in Oklahoma City between 2010 and 2014. A Bayesian binomial latent class model was used to compare the prevalence proportion ratio (PPR) between suspected risk factors and MDD with and without adjustment for misclassification error and confounding by period of MDD symptom on-set. Adjustment for misclassification error and confounding by period of MDD on-set (prenatal vs postnatal) showed that the association between suspected risk factors and MDD is underestimated (-) and overestimated (+) differentially in different source populations of low-income mothers. The median bias in the magnitude of PPR estimates ranged between -.47 (95% Bayesian Credible Intervals [BCI]: -10.67, 1.90) for intimate partner violence to +.06 (95%BCI: -0.37, 0.47) for race/ethnicity among native-born US residents. Among recent Hispanic immigrants, bias ranged from -.77 (95%BCI: -15.31, 0.96) for history of childhood maltreatment to +.10 (95%BCI: -0.17, 0.39) for adequacy of family resources. Overall, the extent of bias on measures of association between maternal MDD and suspected risk factors is considerable without adjustment for misclassification error and is even higher for confounding by period of MDD assessment. Consideration of these biases in MDD prevention research is warranted.	[Owora, Arthur H.] Syracuse Univ, Dept Publ Hlth, Falk Coll, Syracuse, NY 13244 USA; [Carabin, Helene; Garwe, Tabitha; Anderson, Michael P.] Univ Oklahoma, Dept Biostat & Epidemiol, Hlth Sci Ctr, Oklahoma City, OK USA	Syracuse University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Owora, AH (corresponding author), Syracuse Univ, Dept Publ Hlth, Falk Coll, Syracuse, NY 13244 USA.	ahowora@syr.edu	Owora, Arthur/X-3389-2019	Owora, Arthur/0000-0002-4580-7428	Administration of Children, Youth, and Families [90CA1764]; Health Resources and Services Administration [D89MC23154]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938] Funding Source: NIH RePORTER	Administration of Children, Youth, and Families; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Administration of Children, Youth, and Families (grant number 90CA1764), Health Resources and Services Administration (grant number D89MC23154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adirim T, 2013, PEDIATRICS, V132, pS59, DOI 10.1542/peds.2013-1021C; Ammerman RI, 2009, CHILD ABUSE NEGLECT, V33, P127, DOI 10.1016/j.chiabu.2008.09.005; Ammerman RT, 2010, AGGRESS VIOLENT BEH, V15, P191, DOI 10.1016/j.avb.2009.12.002; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Beeghly Marjorie, 2003, Matern Child Health J, V7, P157, DOI 10.1023/A:1025132320321; BRENNER H, 1993, J CLIN EPIDEMIOL, V46, P1195, DOI 10.1016/0895-4356(93)90119-L; Bright JI, 1999, J CONSULT CLIN PSYCH, V67, P491, DOI 10.1037/0022-006X.67.4.491; Caronongan P, 2011, GS10F0050LHHSP233200; Chaffin M, 2012, CHILD MALTREATMENT, V17, P242, DOI 10.1177/1077559512457239; Chaudron LH, 2010, PEDIATRICS, V125, pE609, DOI 10.1542/peds.2008-3261; Chazan-Cohen R, 2007, INFANT MENT HEALTH J, V28, P151, DOI 10.1002/imhj.20127; Duggan AK, 2009, J CONSULT CLIN PSYCH, V77, P788, DOI 10.1037/a0015709; DUNST CJ, 1987, CHILD CARE HLTH DEV, V13, P111, DOI 10.1111/j.1365-2214.1987.tb00528.x; Ertel KA, 2011, J WOMENS HEALTH, V20, P1609, DOI 10.1089/jwh.2010.2657; FARR SL, 2011, PREV CHRONIC DIS, V8; Gaynes B. N., 2005, AGENCY HLTH RES QUAL, V119, P1, DOI DOI 10.1037/E439372005-001; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Ghio L, 2015, J AFFECT DISORDERS, V175, P224, DOI 10.1016/j.jad.2015.01.014; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Ji SA, 2011, J PSYCHIATR RES, V45, P213, DOI 10.1016/j.jpsychires.2010.05.017; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kernot J, 2015, ARCH WOMEN MENT HLTH, V18, P255, DOI 10.1007/s00737-014-0461-4; Kerr LK, 2001, WESTERN J MED, V175, P349, DOI 10.1136/ewjm.175.5.349; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131; Owora AH, 2018, PSYCHIAT RES, V261, P80, DOI 10.1016/j.psychres.2017.12.047; Owora AH, 2016, J AFFECT DISORDERS, V205, P335, DOI 10.1016/j.jad.2016.08.014; Owora AH, 2016, J AFFECT DISORDERS, V201, P185, DOI 10.1016/j.jad.2016.05.015; Pereira AT, 2014, J AFFECT DISORDERS, V166, P71, DOI 10.1016/j.jad.2014.04.008; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rothman K., 1998, MODERN EPIDEMIOLOGY; Savoca E., 2004, HLTH SERVICES OUTCOM, P175; SHROUT PE, 1989, J CLIN EPIDEMIOL, V42, P69, DOI 10.1016/0895-4356(89)90027-9; Simon GE, 2002, PSYCHOL MED, V32, P585, DOI 10.1017/S0033291702005457; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Stevens J, 2002, J COMMUNITY PSYCHOL, V30, P551, DOI 10.1002/jcop.10017; Stewart D.E., 2003, U HLTH NETWORK WOMEN; Straus Murray A, 2004, Violence Vict, V19, P507; Tandon SD, 2012, J AFFECT DISORDERS, V136, P155, DOI 10.1016/j.jad.2011.07.014; Tandon SD, 2005, MATERN CHILD HLTH J, V9, P273, DOI 10.1007/s10995-005-0012-8; Weiss R., 1974, DOING OTHERS, P17	48	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209735	10.1371/journal.pone.0209735	http://dx.doi.org/10.1371/journal.pone.0209735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG5UW	30615650	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900028
J	Lania, BG; Morari, J; de Almeida, AR; da Silva, MN; Vieira-Damiani, G; Lins, KD; Cesar, CL; Velloso, LA; Maia, NB; Cintra, ML; Velho, PENF				Lania, Bruno Grosselli; Morari, Joseane; de Almeida, Amanda Roberta; da Silva, Marilene Neves; Vieira-Damiani, Gislaine; Lins, Karina de Almeida; Cesar, Carlos Lenz; Velloso, Licio Augusto; Maia, Nilson Borlina; Cintra, Maria Leticia; Neves Ferreira Velho, Paulo Eduardo			Topical essential fatty acid oil on wounds: Local and systemic effects	PLOS ONE			English	Article							IN-VITRO; INTERLEUKIN-6; CYTOKINE	Background The use of medicinal plants and their derivatives is increasing, and approximately one-third of all traditional herbal medicines are intended for wound treatment. Natural products used in these treatments include vegetable oils, which are rich in essential fatty acids. Once in contact with an ulcerative surface, the oil reaches the blood and lymphatic vessels, thus eliciting systemic effects. Objective This study evaluated the local and possible systemic effects of essential fatty acids (sunflower oil) applied topically to rat wounds. Methods Cutaneous punch wounds (6 mm) were produced on the dorsa of 30 rats. Saline (SS), mineral oil (MO) or essential fatty acid (EFA) solutions were applied topically. Healing was evaluated after 2, 4 and 10 days (n = 5 per group) by visual and histological/morphometric examination, second harmonic generation (SHG) microscopy, and cytokine and growth factor quantification in the scar tissue (real-time PCR) and in serum (ELISA). Results MO/EFA-treated animals had higher IGF-1, leptin, IL-6 and IFN-gamma mRNA expression and lower serum IL-6 levels than the control (SS/MO) animals. SHG analysis showed no difference in collagen density between the animals treated with MO and EFA. Conclusion EFA treatment induces topical (observed by local IGF-1, leptin, IL-6 and IFN-gamma production) and systemic effects, lowering IL-6 levels in the serum. As the oil is widely used to shorten ulcer healing time, studies are needed to evaluate the treatment safety and possible undesired effects.	[Lania, Bruno Grosselli; de Almeida, Amanda Roberta; da Silva, Marilene Neves; Vieira-Damiani, Gislaine; Lins, Karina de Almeida; Neves Ferreira Velho, Paulo Eduardo] Univ Estadual Campinas, Sch Med Sci, Lab Appl Res Dermatol & Bartonella Infect, Campinas, SP, Brazil; [Morari, Joseane; Velloso, Licio Augusto] Univ Estadual Campinas, Sch Med Sci, Cell Signaling Lab, Campinas, SP, Brazil; [Morari, Joseane; Velloso, Licio Augusto] Univ Estadual Campinas, Sch Med Sci, Obes & Comorbid Res Ctr, Campinas, SP, Brazil; [Cesar, Carlos Lenz] Univ Estadual Campinas, Gleb Wataghin Inst Phys, Natl Inst Photon Appl Cell Biol INFABIC, Campinas, SP, Brazil; [Velloso, Licio Augusto; Neves Ferreira Velho, Paulo Eduardo] Univ Estadual Campinas, Sch Med Sci, Dept Clin Med, Campinas, SP, Brazil; [Maia, Nilson Borlina] Univ Estadual Campinas, Agron Inst Campinas, Aromat Plants Div, Campinas, SP, Brazil; [Cintra, Maria Leticia] Univ Estadual Campinas, Dept Pathol Anat, Sch Med Sci, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas; Universidade Estadual de Campinas	Lania, BG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Lab Appl Res Dermatol & Bartonella Infect, Campinas, SP, Brazil.	bruglania@gmail.com	Velloso, Licio/AAJ-3778-2020; Morari Ricciardi de Aguiar, Joseane/AHE-2586-2022; Cintra, Maria Leticia/CAE-8585-2022; Grosselli Lania, Bruno/J-7496-2012	Morari, Joseane/0000-0002-0728-4283; Silva, Marilene/0000-0002-0885-1083; Maia, Nilson/0000-0001-9084-7157; Grosselli Lania, Bruno/0000-0003-4949-7444	Sao Paulo Research Foundation - Fapesp [07/59319-5]; Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp [015/2014, 043/2016]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes [01P-04520-2013]; Fundo de Apoio ao Ensino, a Pesquisa e Extensao, Universidade Estadual de Campinas [0044/17]	Sao Paulo Research Foundation - Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Apoio ao Ensino, a Pesquisa e Extensao, Universidade Estadual de Campinas	This work was supported by grant # 07/59319-5 Sao Paulo Research Foundation - Fapesp - http://www.fapesp.br/en/ - NBM; grant # 015/2014 - Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp - http://www.sbd-sp.org.br/funadersp.php - PENFV; grant #043/2016 - Fundo de Apoio a Dermatologia do Estado de Sao Paulo "Sebastiao Sampaio" - Funadersp - http://www.sbd-sp.org.br/funadersp.php - PENFV; grant # 01P-04520-2013 - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Capes - http://www.capes.gov.br/ - BGL; Fundo de Apoio ao Ensino, a Pesquisa e Extensao, Universidade Estadual de Campinas (0044/17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri FT, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16323; [Anonymous], 2018, RAT CARDIAC PUNCTURE; Beeton Christine, 2007, J Vis Exp, P266, DOI 10.3791/266; Benitez JM, 2004, REV BRAS ALERG IMUNO, V27, P12; Bruzi Luciana Mendes, 2011, Rev. esc. enferm. USP, V45, P522; Budovsky A, 2015, WOUND REPAIR REGEN, V23, P171, DOI 10.1111/wrr.12274; Cavazana WC, 2009, AN BRAS DERMATOL, V84, P229, DOI 10.1590/S0365-05962009000300003; Das U, 2017, PHYTOTHER RES, V31, P579, DOI 10.1002/ptr.5786; de Moura RF, 2016, INT J OBESITY, V40, P471, DOI 10.1038/ijo.2015.188; Declair V, 1997, Ostomy Wound Manage, V43, P48; Declair V, 2002, J BRAS MED, V82, P6; DeMarco S, 2018, WOUND AND PRESSURE U; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Echeli CSB, 2009, TRATAMENTO TOPICO DE; Eichenfield LF, 2009, PEDIATR DERMATOL, V26, P669, DOI 10.1111/j.1525-1470.2009.01042.x; El-Noor MMA, 2017, J FORENSIC LEG MED, V52, P148, DOI 10.1016/j.jflm.2017.09.001; Magalhes MSF, 2008, ACTA CIR BRAS, V23, P262, DOI 10.1590/S0102-86502008000300009; Ferreira AM, 2012, REV ESC ENFERM USP, V46, P752, DOI 10.1590/S0080-62342012000300030; Ghosh PK, 2013, J PHARM PHARM SCI, V16, P760, DOI 10.18433/J3831V; Gokhale AM, 2004, J MICROSC-OXFORD, V216, P25, DOI 10.1111/j.0022-2720.2004.01392.x; Gomes FP, 1981, CAPITULO 14 EXPERIME, V1; GOODMAN L, 1994, J BIOL CHEM, V269, P19250; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Johansson S, 2010, CLIN EXP IMMUNOL, V160, P411, DOI 10.1111/j.1365-2249.2010.04107.x; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Langerhuus SN, 2012, APMIS, V120, P236, DOI 10.1111/j.1600-0463.2011.02834.x; Lania BG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188779; Leung V, 2016, SCI REP-UK, V6, DOI 10.1038/srep31667; Limandjaja GC, 2018, TISSUE ENG PART C-ME, V24, P242, DOI [10.1089/ten.tec.2017.0464, 10.1089/ten.TEC.2017.0464]; Mandelbaum Samuel Henrique, 2003, An. Bras. Dermatol., V78, P521, DOI 10.1590/S0365-05962003000500002; Manhezi AC, 2008, REV BRAS ENFERM, V61, P620, DOI 10.1590/S0034-71672008000500015; Marques Silvio Romero, 2004, Acta Cir. Bras., V19, P196, DOI 10.1590/S0102-86502004000300005; Masi LN, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/945131; Otranto M, 2010, WOUND REPAIR REGEN, V18, P629, DOI 10.1111/j.1524-475X.2010.00617.x; Petry T, 2017, TOXICOL LETT, V280, P70, DOI 10.1016/j.toxlet.2017.07.899; Pieper Barbara, 2003, J Wound Ostomy Continence Nurs, V30, P175, DOI 10.1067/mjw.2003.131; PROTTEY C, 1975, J INVEST DERMATOL, V64, P228, DOI 10.1111/1523-1747.ep12510667; Rocha RPd, 2004, SCI MED, V14, P6; Rodrigues HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165115; SATO K, 1993, CANCER RES, V53, P851; Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540; Seleit I, 2016, APPL IMMUNOHISTO M M, V24, P296, DOI 10.1097/PAI.0000000000000187; Shen HT, 2012, WOUND REPAIR REGEN, V20, P580, DOI 10.1111/j.1524-475X.2012.00812.x; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Steinbrenner I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155582; Tadokoro S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121242; URBANSKI A, 1990, J INVEST DERMATOL, V94, P808, DOI 10.1111/1523-1747.ep12874666; Wahedi HM, 2017, PHYTOMEDICINE, V28, P19, DOI 10.1016/j.phymed.2017.02.005; Wiik H, 2001, CYTOKINE, V14, P188, DOI 10.1006/cyto.2001.0870; Yang WT, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/1583031	52	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210059	10.1371/journal.pone.0210059	http://dx.doi.org/10.1371/journal.pone.0210059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608959	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800041
J	Huynh, MB; Ouidja, MO; Chantepie, S; Carpentier, G; Maiza, A; Zhang, GL; Vilares, J; Raisman-Vozari, R; Papy-Garcia, D				Minh Bao Huynh; Ouidja, Mohand Ouidir; Chantepie, Sandrine; Carpentier, Gilles; Maiza, Auriane; Zhang, Ganlin; Vilares, Joao; Raisman-Vozari, Rita; Papy-Garcia, Dulce			Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau	PLOS ONE			English	Article							HEPARAN-SULFATE GLYCOSAMINOGLYCAN; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; PROTEIN-TAU; STEM-CELLS; IN-VITRO; PROTEOGLYCANS; PROPAGATION; BRAIN; PHOSPHORYLATION	Glycosaminoglycans (GAGs), including heparan sulfates and chondroitin sulfates, are major components of the extracellular matrix. Upon interacting with heparin binding growth factors (HBGF), GAGs participate to the maintaintenance of tissue homeostasis and contribute to self-healing. Although several processes regulated by HBGF are altered in Alzheimer's disease, it is unknown whether the brain GAG capacities to bind and regulate the function of HBGF or of other heparin binding proteins, as tau, are modified in this disease. Here, we show that total sulfated GAGs from hippocampus of Alzheimer's disease have altered capacities to bind and potentiate the activities of growth factors including FGF-2, VEGF, and BDNF while their capacity to bind to tau is remarkable increased. Alterations of GAG structures and capacities to interact with and regulate the activity of heparin binding proteins might contribute to impaired tissue homeostasis in the Alzheimer's disease brain.	[Minh Bao Huynh; Ouidja, Mohand Ouidir; Chantepie, Sandrine; Carpentier, Gilles; Maiza, Auriane; Zhang, Ganlin; Papy-Garcia, Dulce] Univ Paris Est, Univ Paris Est Creteil, Cell Growth Tissue Repair & Regenerat CRRET, CNRS,ERL 9215,EA 4397, Creteil, France; [Vilares, Joao] Univ Fed Sao Paulo, Aging & Neurodegenerat Dis Brain Bank Invest Lab, Sao Paulo, Brazil; [Raisman-Vozari, Rita] Univ Pierre & Marie Curie Paris 6, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universidade Federal de Sao Paulo (UNIFESP); UDICE-French Research Universities; Sorbonne Universite	Papy-Garcia, D (corresponding author), Univ Paris Est, Univ Paris Est Creteil, Cell Growth Tissue Repair & Regenerat CRRET, CNRS,ERL 9215,EA 4397, Creteil, France.	papy@u-pec.fr	Zhang, Gan-Lin/AAW-2082-2021	Carpentier, Gilles/0000-0002-3730-7263; OUIDJA, Mohand Ouidir/0000-0001-7887-8903	H2020 FET OPEN RIA ArrestAD [737390]; Fundation Vaincre Alzheimer [FR-15055]; GDR GAGoSciences [3739]	H2020 FET OPEN RIA ArrestAD; Fundation Vaincre Alzheimer; GDR GAGoSciences	H2020 FET OPEN RIA ArrestAD project number 737390 supported research and gave salary for MBH. Fundation Vaincre Alzheimer grant number FR-15055 supported scholarship for AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to the European H2020 FET OPEN RIA ArrestAD program (No. 737390) and to the 'Fondation Vaincre Alzheimer' (No. FR-15055) for supporting the project that studies the involvement of HS in Alzheimer's disease. We thank Dr. H. van Zoggel for her help on all experiment procedures. Authors thank Dr. D. Biard and N. Rebergue for support and discussions and to GDR GAGoSciences (No. 3739) for supporting GAGs research in France.	Alafuzoff I, 2013, J ALZHEIMERS DIS, V33, pS173, DOI 10.3233/JAD-2012-129024; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Barret A, 2005, J BIOL CHEM, V280, P10516, DOI 10.1074/jbc.M412635200; Benussi L, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00672; Blondet B, 2006, NEUROCHEM RES, V31, P907, DOI 10.1007/s11064-006-9095-x; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Bottaro DP, 2002, ANN NY ACAD SCI, V961, P158, DOI 10.1111/j.1749-6632.2002.tb03071.x; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Del Bo R, 2009, J NEUROL SCI, V283, P66, DOI 10.1016/j.jns.2009.02.318; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghazavi H, 2017, STEM CELL REV REP, V13, P670, DOI 10.1007/s12015-017-9755-z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Hernandez F, 2002, BRAIN RES, V935, P65, DOI 10.1016/S0006-8993(02)02455-1; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiza A, 2018, FEBS LETT, V592, P3806, DOI 10.1002/1873-3468.13082; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Martin R, 2011, BIOCHEM BIOPH RES CO, V414, P587, DOI 10.1016/j.bbrc.2011.09.126; Huynh MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.030; Najjam Saloua, 1997, Biochemical Society Transactions, V25, p3S; Nehme H, 2015, ANAL BIOANAL CHEM, V407, P2821, DOI 10.1007/s00216-015-8495-7; Nowacka MM, 2012, NEUROPEPTIDES, V46, P1, DOI 10.1016/j.npep.2011.05.005; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Oyagi A, 2012, CNS NEUROSCI THER, V18, P803, DOI 10.1111/j.1755-5949.2012.00371.x; Pimentel-Coelho PM, 2012, EUR J NEUROSCI, V35, P1917, DOI 10.1111/j.1460-9568.2012.08126.x; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M504492200; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Sepulveda-Diaz JE, 2015, BRAIN, V138, P1339, DOI 10.1093/brain/awv056; Shute Janis, 2012, Handb Exp Pharmacol, P307, DOI 10.1007/978-3-642-23056-1_13; SNOW AD, 1994, AM J PATHOL, V144, P337; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1988, AM J PATHOL, V133, P456; Solerte SB, 2005, DEMENT GERIATR COGN, V19, P1, DOI 10.1159/000080963; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; Suttkus A, 2016, NEUROSCIENCE, V313, P225, DOI 10.1016/j.neuroscience.2015.11.040; Turner CA, 2012, NEURON, V76, P160, DOI 10.1016/j.neuron.2012.08.037; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verbeek MM, 1999, AM J PATHOL, V155, P2115, DOI 10.1016/S0002-9440(10)65529-0; Wei XJ, 2014, AM J TRANSL RES, V6, P664; Yabe T, 2005, GLYCOBIOLOGY, V15, P982, DOI 10.1093/glycob/cwi090; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024; Zhou Y, 2017, J CELL MOL MED, V21, P1073, DOI 10.1111/jcmm.12946	47	28	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209573	10.1371/journal.pone.0209573	http://dx.doi.org/10.1371/journal.pone.0209573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608949	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800022
J	Zhao, XY; Reebye, V; Hitchen, P; Fan, J; Jiang, HC; Saetrom, P; Rossi, J; Habib, NA; Huang, KW				Zhao, Xiaoyang; Reebye, Vikash; Hitchen, Paul; Fan, Jia; Jiang, Hongchi; Saetrom, Pal; Rossi, John; Habib, Nagy. A.; Huang, Kai-Wen			Mechanisms involved in the activation of C/EBP alpha by small activating RNA in hepatocellular carcinoma	ONCOGENE			English	Article							CELL-CYCLE; BINDING; PROTEIN; BETA; EXPRESSION; CEBPA; REPRESSION; P21; LIP	Hepatocellular carcinoma (HCC) is generally accompanied by high mortality and low cure rate. CCAAT enhancer-binding proteins (CEBPs) are transcriptional regulators that play a key role in maintaining liver function. Altered expression of C/EBP alpha and C/EBP beta occurs in many tumours including HCC. saRNAs are small double-stranded RNAs that enhance target gene expression at the transcriptional level. In this report, we activate CEPBA with saRNAs and suppress CEBPB with siRNAs in cells that represent three different degrees of HCC. We performed functional assays to investigate the effects of enhancing C/EBP alpha and its downstream targets, p21 and albumin across these lines. We also used Mass-spectrometry (MS) subsequent to a ChIP pull-down assay to characterise the components of the protein complex involved in regulating saRNA function. Putative saRNA interacting protein candidates that were identified by MS were knocked-down with siRNAs to investigate its impact on saRNA activity. We confirmed CEBPA-saRNA decreased proliferation and migration in the differentiated lines (HepG3/Hep3B). The undifferentiated line (PLCPRF5) showed saRNA-induced increase in CEBPA but with no loss in proliferation. This effect was reversed when CEBPB was suppressed with CEBPB-siRNA. When interrogating saRNA mode of action; three saRNA interacting proteins, CTR9, HnRNPA2/B1 and DDX5 were identified by MS. Targeted knock-down of these two proteins (by siRNA) abrogated saRNA activity. This study provides insight into how different HCC lines are affected by CEBPA-saRNAs and that endogenous abundance of CEBPB and saRNA accessory proteins may dictate efficacy of CEBPA-saRNA when used in a therapeutic context.	[Zhao, Xiaoyang; Reebye, Vikash; Habib, Nagy. A.] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp, HPB Surg Unit, London W12 0HS, England; [Zhao, Xiaoyang; Fan, Jia] Fudan Univ, Zhongshan Hosp, Dept Surg, Shanghai 200032, Peoples R China; [Zhao, Xiaoyang; Jiang, Hongchi] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin 150001, Heilongjiang, Peoples R China; [Hitchen, Paul] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, NO-7489 Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp Sci, NO-7489 Trondheim, Norway; [Rossi, John] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA; [Huang, Kai-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan	Imperial College London; Fudan University; Harbin Medical University; Imperial College London; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); City of Hope; Beckman Research Institute of City of Hope; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, KW (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.; Huang, KW (corresponding author), Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan.; Huang, KW (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan.	skywing@ntuh.gov.tw	Sætrom, Pål/AAH-1216-2019	Sætrom, Pål/0000-0001-8142-7441; HUANG, KAI-WEN/0000-0001-6375-8714	National Taiwan University Hospital and Imperial College London	National Taiwan University Hospital and Imperial College London	This work was funded by National Taiwan University Hospital and Imperial College London.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Begay V, 2015, J MOL MED, V93, P39, DOI 10.1007/s00109-014-1215-5; Bertran E, 2013, HEPATOLOGY, V58, P2032, DOI 10.1002/hep.26597; Burgess-Beusse BL, 1999, HEPATOLOGY, V29, P597, DOI 10.1002/hep.510290245; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Huan HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153117; Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112; Kuttippurathu L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2492-x; LOPEZCABRERA M, 1991, VIROLOGY, V183, P825, DOI 10.1016/0042-6822(91)91019-D; Lourenco AR, 2017, ONCOGENE, V14, P1; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Ohkoshi S, 2015, WORLD J GASTROENTERO, V21, P12150, DOI 10.3748/wjg.v21.i42.12150; Pabst T, 2009, CLIN CANCER RES, V15, P5303, DOI 10.1158/1078-0432.CCR-08-2941; Portnoy V, 2016, CELL RES, V26, P320, DOI 10.1038/cr.2016.22; Reebye V, 2018, ONCOGENE, V37, P3216, DOI 10.1038/s41388-018-0126-2; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; Tomizawa M, 2002, INT J MOL MED, V9, P597; van der Krieken SE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/324815; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Voutila J, 2017, MOL THER, V25, P2705, DOI 10.1016/j.ymthe.2017.07.018; Welm AL, 2000, J BIOL CHEM, V275, P27406; Xu L, 2001, CANCER RES, V61, P3176; ZHOU DX, 1991, J BIOL CHEM, V266, P23416; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	25	21	21	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3446	3457		10.1038/s41388-018-0665-6	http://dx.doi.org/10.1038/s41388-018-0665-6			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30643190				2022-12-26	WOS:000466610000009
J	Zhou, HY; Yu, CL; Kong, LM; Xu, XL; Yan, JM; Li, YC; An, T; Gong, L; Gong, YX; Zhu, HF; Zhang, HB; Yang, XD; Li, Y				Zhou, Hongyu; Yu, Chunlei; Kong, Lingmei; Xu, Xiaoliang; Yan, Juming; Li, Yingchao; An, Tao; Gong, Liang; Gong, Yaxiao; Zhu, Huifang; Zhang, Hongbin; Yang, Xiaodong; Li, Yan			B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; IN-VITRO PROPAGATION; MTOR; ACTIVATION; PATHWAY; IDENTIFICATION; EXPRESSION; VIABILITY; RECEPTOR; GROWTH	Cancer stem cells (CSCs) have been implicated in metastasis, relapse, and therapeutic resistance of cancer, so successful cancer therapy may therefore require the development of drugs against CSCs or combining anti-CSCs drugs with conventional therapies. The phosphoinositide 3-kinase (PI3K) signaling pathway is one of the most frequently activated signaling pathways in human cancer, playing a central role in tumorigenesis as well as the maintenance of CSCs. Here, we designed and identified B591, a dihydrobenzofuran-imidazolium salt, as a novel specific pan-PI3K inhibitor with potent inhibitory activity against class I PI3K isoforms, which showed effective inhibition of cellular PI3K/mTOR signaling pathway and robust antitumor activity in a set of cancer cell lines. Notably, compared with bulk tumor cell populations, B591 exhibited more potency in suppressing CSCs survival and inducing CSCs apoptosis, and presence of B591 effectively eliminated paclitaxel-enriched CSCs. B591 diminished self-renewal capacity and decreased the expression of epithelial-mesenchymal transition (EMT) markers of CSCs. In vivo, B591 preferentially decreased CSCs levels in mouse xenograft model of human breast cancer as evidenced especially by remarkable reduction of tumor-initiating ability. Consistent with the preferential targeting of CSCs, B591 effectively inhibited breast tumor metastasis and delayed tumor regrowth following paclitaxel treatment. Taken together, our findings establish B591, a novel PI3K inhibitor, as a strong candidate for clinical evaluation as a CSCs targeting agent.	[Zhou, Hongyu; Yu, Chunlei; Kong, Lingmei; Yan, Juming; An, Tao; Gong, Liang; Gong, Yaxiao; Zhu, Huifang; Li, Yan] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Yu, Chunlei] North Sichuan Med Coll, Sch Pharm, Inst Mat Med, Nanchong, Peoples R China; [Xu, Xiaoliang; Li, Yingchao; Zhang, Hongbin; Yang, Xiaodong] Yunnan Univ, Sch Chem Sci & Technol, Minist Educ & Yunnan Prov, Key Lab Med Chem Nat Resource, Kunming, Yunnan, Peoples R China; [Yan, Juming; Gong, Liang; Gong, Yaxiao; Zhu, Huifang] Univ Chinese Acad Sci, Beijing, Peoples R China; [An, Tao; Li, Yan] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; North Sichuan Medical University; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, Y (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.; Zhang, HB; Yang, XD (corresponding author), Yunnan Univ, Sch Chem Sci & Technol, Minist Educ & Yunnan Prov, Key Lab Med Chem Nat Resource, Kunming, Yunnan, Peoples R China.; Li, Y (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming, Yunnan, Peoples R China.	zhanghb@ynu.edu.cn; xdyang@ynu.edu.cn; liyanb@mail.kib.ac.cn	Yu, Chunlei/I-9383-2016	Yu, Chunlei/0000-0002-2934-2122; Yan, Juming/0000-0003-0857-8870; Yang, Xiaodong/0000-0002-8466-5418; Zhou, Hongyu/0000-0001-5852-3953	National Natural Science Foundation of China [U1402227, 21662043, 81302807]; Yunnan Province [U1402227]; Program for Changjiang Scholars and Innovative Research Team in University [IRT17R94]; Exploitation and Utilization of Abundant Natural Products from Plants from Kunming Institute of Botany [KIB2017009]; West Light Foundation of The Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Exploitation and Utilization of Abundant Natural Products from Plants from Kunming Institute of Botany; West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Joint Funds of the National Natural Science Foundation of China and Yunnan Province (U1402227), the Program for Changjiang Scholars and Innovative Research Team in University (IRT17R94), the Exploitation and Utilization of Abundant Natural Products from Plants from Kunming Institute of Botany (KIB2017009), the National Natural Science Foundation of China (No. 21662043, 81302807), and the West Light Foundation of The Chinese Academy of Sciences (H.Z.).	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Akbari-Birgani S, 2016, DRUG DISCOV TODAY, V21, P836, DOI 10.1016/j.drudis.2016.03.004; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Chen XS, 2013, MOL CANCER RES, V11, P1269, DOI 10.1158/1541-7786.MCR-13-0212; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Djuzenova CS, 2016, ONCOTARGET, V7, P38191, DOI 10.18632/oncotarget.9501; Dolgikh N, 2018, CANCER RES, V78, P2000, DOI 10.1158/0008-5472.CAN-17-1737; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hu YP, 2012, AM J CANCER RES, V2, P340; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ilagan E, 2016, TRENDS CANCER, V2, P241, DOI 10.1016/j.trecan.2016.03.008; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Leung ELH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0065-9; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Markham A, 2017, DRUGS, V77, P1247, DOI 10.1007/s40265-017-0771-8; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Miller BW, 2015, CLIN CANCER RES, V21, P1525, DOI 10.1158/1078-0432.CCR-14-2522; Morales GA, 2013, J MED CHEM, V56, P1922, DOI 10.1021/jm301522m; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Peitzsch C, 2017, SEMIN CANCER BIOL, V44, P10, DOI 10.1016/j.semcancer.2017.02.011; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Pulaski BA, 2000, CANCER RES, V60, P2710; Rahman M, 2011, NEUROSURGERY, V68, P531, DOI 10.1227/NEU.0b013e3181ff9eb5; Riaz N, 2018, TRANSL ONCOL, V11, P920, DOI 10.1016/j.tranon.2018.05.002; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Smith AL, 2012, J MED CHEM, V55, P5188, DOI 10.1021/jm300184s; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; WEXLER H, 1966, JNCI-J NATL CANCER I, V36, P641, DOI 10.1093/jnci/36.4.641; Xia P, 2015, AM J CANCER RES, V5, P1602; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	16	17	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3371	3386		10.1038/s41388-018-0674-5	http://dx.doi.org/10.1038/s41388-018-0674-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30635656	hybrid, Green Published			2022-12-26	WOS:000466610000004
J	Murphy, JG; Hoffman, DA				Murphy, Jonathan G.; Hoffman, Dax A.			A polybasic motif in alternatively spliced KChIP2 isoforms prevents Ca2+ regulation of Kv4 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; calcium; dendrite; patch clamp; ion channel; A-type current; EF hand protein; K channel interacting protein; voltage-gated channel	METAL-BINDING PROPERTIES; INTERACTING PROTEINS; POTASSIUM CHANNELS; K+ CHANNELS; ALPHA-SUBUNITS; DNA-BINDING; EXPRESSION; MODULATION; PALMITOYLATION; EXCITABILITY	The Kv4 family of A-type voltage-gated K+ channels regulates the excitability in hippocampal pyramidal neuron dendrites and are key determinants of dendritic integration, spike timing-dependent plasticity, long-term potentiation, and learning. Kv4.2 channel expression is down-regulated following hippocampal seizures and in epilepsy, suggesting A-type currents as therapeutic targets. In addition to pore-forming Kv4 subunits, modulatory auxiliary subunits called K+ channel-interacting proteins (KChIPs) modulate Kv4 expression and activity and are required to recapitulate native hippocampal A-type currents in heterologous expression systems. KChIP mRNAs contain multiple start sites and alternative exons that generate considerable N-terminal variation and functional diversity in shaping Kv4 currents. As members of the EF-hand domain-containing neuronal Ca2+ sensor protein family, KChIP auxiliary proteins may convey Ca2+ sensitivity upon Kv4 channels; however, to what degree intracellular Ca2+ regulates KChIP-Kv4.2 complexes is unclear. To answer this question, we expressed KChIP2 with Kv4.2 in HEK293T cells, and, with whole-cell patch-clamp electrophysiology, measured an approximate to 1.5-fold increase in Kv4.2 current density in the presence of elevated intracellular Ca2+. Intriguingly, the Ca2+ regulation of Kv4 current was specific to KChIP2b and KChIP2c splice isoforms that lack a putative polybasic domain that is present in longer KChIP2a1 and KChIP2a isoforms. Site-directed acidification of the basic residues within the polybasic motif of KChIP2a1 rescued Ca2+-mediated regulation of Kv4 current density. These results support divergent Ca2+ regulation of Kv4 channels mediated by alternative splicing of KChIP2 isoforms. They suggest that distinct KChIP-Kv4 interactions may differentially control excitability and function of hippocampal dendrites.	[Murphy, Jonathan G.] NIGMS, Bethesda, MD 20892 USA; [Murphy, Jonathan G.; Hoffman, Dax A.] NICHD, Sect Mol Neurophysiol, NIH, Rm 3C-905,Bldg 35,35 Lincoln Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hoffman, DA (corresponding author), NICHD, Sect Mol Neurophysiol, NIH, Rm 3C-905,Bldg 35,35 Lincoln Dr, Bethesda, MD 20892 USA.; Murphy, JG (corresponding author), NIGMS, NIH, Rm 3C-908,Bldg 35,35 Lincoln Dr, Bethesda, MD 20892 USA.	jonathan.murphy@nih.gov; hoffmand@mail.nih.gov	Murphy, Jonathan/AAD-6655-2019; Hoffman, Dax/E-5155-2011	Murphy, Jonathan/0000-0001-6485-5727; Hoffman, Dax/0000-0001-6999-2157	National Institutes of Health Intramural Funds [FI2 GM120004]; NIGMS [Z01 HD008755]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [FI2GM120004] Funding Source: NIH RePORTER	National Institutes of Health Intramural Funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Intramural Funds FI2 GM120004 from NIGMS (to J. G. M.) and Z01 HD008755 from NICHD (to D. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2018, CHANNELS, V12, P187, DOI 10.1080/19336950.2018.1491243; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Barnwell LFS, 2009, EPILEPSIA, V50, P1741, DOI 10.1111/j.1528-1167.2009.02086.x; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Chang LS, 2003, BIOCHEM BIOPH RES CO, V311, P258, DOI 10.1016/j.bbrc.2003.09.204; Chen CP, 2006, PROTEIN J, V25, P345, DOI 10.1007/s10930-006-9020-9; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gonzalez WG, 2014, J BIOL CHEM, V289, P32201, DOI 10.1074/jbc.M114.577528; Groen C, 2017, PFLUG ARCH EUR J PHY, V469, P1457, DOI 10.1007/s00424-017-2039-2; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jeffries O, 2012, J BIOL CHEM, V287, P1468, DOI 10.1074/jbc.M111.224840; Jerng HH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00082; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kunjilwar K, 2013, J NEUROCHEM, V126, P462, DOI 10.1111/jnc.12309; Lee L, 2009, PROTEIN PEPTIDE LETT, V16, P1081, DOI 10.2174/092986609789055368; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lin YL, 2004, BIOCHEM BIOPH RES CO, V321, P606, DOI 10.1016/j.bbrc.2004.07.006; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lockridge A, 2011, HIPPOCAMPUS, V21, P1152, DOI 10.1002/hipo.20877; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Marionneau C, 2009, CHANNELS, V3, P284; Matthews EA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00048; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Piazza M, 2017, BIOCHEMISTRY-US, V56, P944, DOI 10.1021/acs.biochem.6b01296; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Ramachandran PL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398495; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139332; Wang K, 2014, NEURON, V81, P379, DOI 10.1016/j.neuron.2013.11.004; Yao JJ, 2016, J BIOL CHEM, V291, P17369, DOI 10.1074/jbc.M115.708883	55	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3683	3695		10.1074/jbc.RA118.006549	http://dx.doi.org/10.1074/jbc.RA118.006549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622142	Green Published, hybrid			2022-12-26	WOS:000461853900030
J	Tirumuru, N; Wu, L				Tirumuru, Nagaraja; Wu, Li			HIV-1 envelope proteins up-regulate N-6-methyladenosine levels of cellular RNA independently of viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); infection; RNA methylation; gene expression; gene regulation; RNA modification; CD4+T-cells; HIV-1 envelope proteins; HIV-1 production; recombinant gp120; up-regulation	HUMAN-IMMUNODEFICIENCY-VIRUS; M(6)A METHYLTRANSFERASE; MONOCLONAL-ANTIBODIES; MESSENGER-RNAS; DC-SIGN; EXPRESSION; N6-METHYLADENOSINE; TYPE-1; CD4; IDENTIFICATION	N-6-methyladenosine (m(6)A) modification of HIV-1 RNA regulates viral replication and protein expression. The m(6)A modification is regulated by two groups of cellular proteins named writers and erasers that add or remove m(6)A, respectively. HIV-1 infection of CD4(+) T-cells increases m(6)A levels of cellular mRNA, but the underlying mechanism is unknown. Here, we show that HIV-1 infection of CD4(+) primary T-cells or Jurkat cells significantly increases m(6)A levels of cellular RNA independently of viral replication. Compared with HIV-1-infected CD4(+) T-cells, similar m(6)A up-regulation was detected in total RNA from HIV-1-infected cells treated with a reverse-transcriptase inhibitor or with heat-inactivated HIV-1. Compared with mock controls, significantly increased m(6)A levels were detected in total RNA from Jurkat cells infected by single-cycle HIV-1 pseudotyped with an HIV-1 envelope (Env) glycoprotein, but not with vesicular stomatitis virus glycoprotein G (VSV-G). Overexpression of HIV-1 Env in HEK293T cells did not affect m(6)A levels of cellular RNA, suggesting that de novo synthesis of Env is not required for m(6)A up-regulation. Interestingly, treatment of Jurkat cells with recombinant gp120 of HIV-1 Env significantly increased m(6)A levels of cellular RNA, which was reduced by a gp120-neutralizing antibody. Preincubation of Jurkat cells with a CD4 receptor-neutralizing antibody blocked HIV-1-induced up-regulation of m(6)A levels in cellular RNA. Moreover, HIV-1 infection or gp120 treatment did not alter the protein expression of m(6)A writers and erasers in cells. Our findings suggest that HIV-1 gp120 binding to the CD4 receptor is required for m(6)A up-regulation in cells.	[Tirumuru, Nagaraja; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA; [Tirumuru, Nagaraja; Wu, Li] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, L (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487	National Institutes of Health [GM128212, AI120209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM128212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM128212 and AI120209 (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Brocard M, 2017, J GEN VIROL, V98, P2207, DOI 10.1099/jgv.0.000910; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE3798, DOI 10.1073/pnas.1801213115; Chung NPY, 2010, J BIOL CHEM, V285, P2100, DOI 10.1074/jbc.M109.030619; Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116; CUMMINS LM, 1991, BLOOD, V77, P1111; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gelais CS, 2015, AIDS RES HUM RETROV, V31, P806, DOI [10.1089/aid.2014.0313, 10.1089/AID.2014.0313]; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188; HASHIMOTO S, 1976, J VIROL, V20, P425, DOI 10.1128/JVI.20.2.425-435.1976; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; Janas Alicia M, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2605s43; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Lu WX, 2018, J BIOL CHEM, V293, P12992, DOI 10.1074/jbc.RA118.004215; MCCALLUS DE, 1992, VIRAL IMMUNOL, V5, P163, DOI 10.1089/vim.1992.5.163; Melikyan GB, 2017, J BIOL CHEM, V292, P16511, DOI 10.1074/jbc.H117.791731; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Mishima E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143756; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; ORAVECZ T, 1993, AIDS RES HUM RETROV, V9, P945, DOI 10.1089/aid.1993.9.945; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Riquelme-Barrios S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2018.00576; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Santosuosso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018465; Tan B, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1983; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Wang CY, 2016, JOVE-J VIS EXP, DOI 10.3791/54672; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520	48	18	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3249	3260		10.1074/jbc.RA118.005608	http://dx.doi.org/10.1074/jbc.RA118.005608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30617182	Green Published, hybrid			2022-12-26	WOS:000464980100022
J	Chen, YT; Kuo, SC; Chao, PW; Chang, YY				Chen, Yung-Tai; Kuo, Shu-Chen; Chao, Pei-Wen; Chang, Yea-Yuan			Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study	PLOS ONE			English	Article							STATIN	Objectives Animal and ex vitro studies suggested lipid-lowering agents (LLAs) may be used as an adjunct to standard anti-tuberculosis (TB) treatment. No human study has been conducted to date. Using the Taiwan National Health Insurance Research Database (NHIRD), the current population-based cohort study sought to examine the association between use of LLAs and outcomes of patients with pulmonary TB receiving anti-TB treatment. Methods Using a NHIRD from 2003 to 2010, this population-based cohort study retrospectively examined the association between LLAs (statins or fibrates) and the outcomes of patients with pulmonary TB receiving anti-TB treatment. Results A total of 1452 adult patients newly diagnosed with pulmonary TB during the study period were identified and compared with 5808 matched patients. In the LAA cohort, 1258 received statin, and 295 received fibrate. Compared with patients who did not take LLA, patients who took oral LLAs had similar incidence of treatment completion at 9, 12, and 24 months. Conclusions Neither statins nor fibrates provide clinical benefit superior to that achieved with standard anti-tuberculosis treatment. Future clinical trials should investigate the effects of statins and fibrates on short-course standard anti-TB therapy.	[Chen, Yung-Tai] Taipei City Hosp, Heping Fuyou Branch, Dept Med, Taipei, Taiwan; [Chen, Yung-Tai; Chang, Yea-Yuan] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Kuo, Shu-Chen; Chang, Yea-Yuan] Taipei Vet Gen Hosp, Div Infect Dis, Dept Internal Med, Taipei, Taiwan; [Kuo, Shu-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Miaoli County, Taiwan; [Chao, Pei-Wen] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Chao, Pei-Wen] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chang, Yea-Yuan] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Chang, Yea-Yuan] Natl Yang Ming Univ Hosp, Div Infect Dis, Dept Internal Med, Yilan, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Yang Ming Chiao Tung University	Chang, YY (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan.; Chang, YY (corresponding author), Taipei Vet Gen Hosp, Div Infect Dis, Dept Internal Med, Taipei, Taiwan.; Chang, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Chang, YY (corresponding author), Natl Yang Ming Univ Hosp, Div Infect Dis, Dept Internal Med, Yilan, Taiwan.	15890@ymuh.ym.edu.tw	Kuo, Shu-Chen/U-6115-2019; chao, P/GSD-8001-2022	Kuo, Shu-Chen/0000-0002-6940-6450; 	National Health Research Institute [IV-106-PP-09]; Wan-Fang Hospital [106-swf-06]	National Health Research Institute(National Health Research Institutes - Taiwan); Wan-Fang Hospital	This work was supported by grants from the National Health Research Institute (IV-106-PP-09) (SCK) and Wan-Fang Hospital (106-swf-06) (PWC). The sponsors did not contribute to study design, the collection, analysis, or interpretation of data, writing of the report, or the decision to submit the article for publication.; The authors would like to thank the National Health Research Institute for making their database available. This work was supported by grants from the National Health Research Institute (IV-106-PP-09) (SCK) and Wan-Fang Hospital (106-swf-06) (PWC). The sponsors did not contribute to study design; the collection, analysis, or interpretation of data; writing of the report; or the decision to submit the article for publication.	Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dutta NK, 2016, J ANTIMICROB CHEMOTH, V71, P1570, DOI 10.1093/jac/dkw014; Kim SJ, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-42; Lai CC, 2016, THORAX, V71, P646, DOI 10.1136/thoraxjnl-2015-207052; Lee MY, 2015, INT J MOL SCI, V16, P11369, DOI 10.3390/ijms160511369; Liao KF, 2017, FRONT PHARMACOL, V8, P59, DOI [10.3389/fphar.2017.00059, DOI 10.3389/FPHAR.2017.00059]; Lobato LS, 2014, ANTIMICROB AGENTS CH, V58, P5766, DOI 10.1128/AAC.01826-13; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Reich-Slotky R, 2009, J BACTERIOL, V191, P5262, DOI 10.1128/JB.00175-09; Shih CJ, 2014, CIRCULATION, V130, P1684, DOI 10.1161/CIRCULATIONAHA.114.012717; Skerry C, 2014, J ANTIMICROB CHEMOTH, V69, P2453, DOI 10.1093/jac/dku166; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; WHO, TUBERCULOSIS	14	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210479	10.1371/journal.pone.0210479	http://dx.doi.org/10.1371/journal.pone.0210479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633771	Green Submitted, gold, Green Published			2022-12-26	WOS:000455485100024
J	Gamboa, M; Muranyi, D; Kanmori, S; Watanabe, K				Gamboa, Maribet; Muranyi, David; Kanmori, Shota; Watanabe, Kozo			Molecular phylogeny and diversification timing of the Nemouridae family (Insecta, Plecoptera) in the Japanese Archipelago	PLOS ONE			English	Article							OHOMOPTERUS GROUND BEETLES; STONEFLIES PLECOPTERA; SPECIES GROUP; DIVERSITY; EVOLUTION; CLOCK; GENUS; TREE; AGE; PHYLOGEOGRAPHY	The generation of the high species diversity of insects in Japan was profoundly influenced by the formation of the Japanese Archipelago. We explored the species diversification and biogeographical history of the Nemouridae Billberg, 1820 family in the Japanese Archipelago using mitochondrial DNA and nuclear DNA markers. We collected 49 species among four genera: Indonemoura Baumann, 1975; Protonemura Kempny, 1898; Amphinemura, Ris 1902 and Nemoura Latreille, 1796 in Japan, China, South Korea and North America. We estimated their divergence times-based on three molecular clock node calibrations-using Bayesian phylogeography approaches. Our results suggested that Japanese Archipelago formation events resulted in diversification events in the middle of the Cretaceous (<120 Ma), speciation in the Paleogene (<50 Ma) and intra-species diversification segregated into eastern and western Japan of the Fossa Magna region at late Neogene (20 Ma). The Indonemoura samples were genetically separated into two clades-that of Mainland China and that of Japan. The Japanese clade clustered with the Nemouridae species from North America, suggesting the possibility of a colonisation event prior to the formation of the Japanese Archipelago. We believe that our results enhanced the understanding both of the origin of the species and of local species distribution in the Japanese Archipelago.	[Gamboa, Maribet; Muranyi, David; Kanmori, Shota; Watanabe, Kozo] Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime, Japan; [Muranyi, David] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Dept Zool, Budapest, Hungary	Ehime University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Gamboa, M (corresponding author), Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime, Japan.	gamboa@cee.ehime-u.ac.jp	Gamboa, Maribet/AAT-7556-2020; Watanabe, Kozo/F-7388-2010	Gamboa, Maribet/0000-0003-3744-1339; Muranyi, David/0000-0002-3907-5590; Watanabe, Kozo/0000-0002-7062-595X	Japan Society for the Promotion of Science (JSPS) [13F03366, 17F17908, 15F15065]; JSPS International Research Fellowship [P13366, PU17908, P15065]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS International Research Fellowship	The Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/) supported this study under the grants: 13F03366, 17F17908, and 15F15065. The JSPS International Research Fellowship supported Maribet Gamboa (ID No. P13366, PU17908) and David Muranyi (ID No. P15065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Barba-Montoya J, 2017, MOL PHYLOGENET EVOL, V114, P386, DOI 10.1016/j.ympev.2017.07.005; Baumann RW, 1975, SMITHSON CONTR ZOOL, V211; Beaulieu JM, 2015, SYST BIOL, V64, P869, DOI 10.1093/sysbio/syv027; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boumans L, 2017, ECOL EVOL, V7, P1635, DOI 10.1002/ece3.2638; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Condamine FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19208; Condie K., 1997, PLATE TECTONIC CRUST; DeWalt R. E., 2018, PLECOPTERA SPECIES F; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ezard T, 2014, SPLITS SPECIES LIMIT; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Goodall-Copestake WP, 2012, HEREDITY, V109, P50, DOI 10.1038/hdy.2012.12; Grubbs SA, 2014, ZOOKEYS, P11, DOI 10.3897/zookeys.401.7299; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafson GT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08403-1; Hague MTJ, 2016, HEREDITY, V116, P92, DOI 10.1038/hdy.2015.76; Heath TA, 2014, P NATL ACAD SCI USA, V111, pE2957, DOI 10.1073/pnas.1319091111; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Kawai T., 2005, AQUATIC INSECTS JAPA; Konstantinov Alexander S., 2009, P107, DOI 10.1002/9781444308211.ch7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WH, 2017, ZOOTAXA, V4258, P60, DOI 10.11646/zootaxa.4258.1.4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu YS, 2009, PALEONTOL J+, V43, P183, DOI 10.1134/S0031030109020099; Marin J, 2018, MOL BIOL EVOL, V35, P2077, DOI 10.1093/molbev/msy103; McCulloch GA, 2016, MOL PHYLOGENET EVOL, V96, P150, DOI 10.1016/j.ympev.2015.10.028; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Muranyi D, 2014, ZOOTAXA, V3812, P1, DOI 10.11646/zootaxa.3812.1.1; Muranyi D, 2013, ZOOTAXA, V3694, P167, DOI 10.11646/zootaxa.3694.2.6; Ninomiya T, 2014, ISL ARC, V23, P206, DOI 10.1111/iar.12072; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; OTOFUJI YI, 1985, NATURE, V317, P603, DOI 10.1038/317603a0; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Rambaut A., 2009, FIGTREE V 1 3 1; Saito R, 2016, FRESHW SCI, V35, P712, DOI 10.1086/686564; Schoville SD, 2012, ANNU REV ECOL EVOL S, V43, P23, DOI 10.1146/annurev-ecolsys-110411-160248; Sekine K, 2013, BIOL J LINN SOC, V109, P181, DOI 10.1111/bij.12033; SHIMIZU T, 1994, AQUAT INSECT, V16, P213, DOI 10.1080/01650429409361558; Shimizu T, 1997, AQUAT INSECT, V19, P193, DOI 10.1080/01650429709361656; Shimizu T, 1998, AQUAT INSECT, V20, P203, DOI 10.1076/aqin.20.4.203.4469; Shimizu T., 2001, 21 CENTURY AQUATIC E, P11; Shimizu Takao, 1998, Species Diversity, V3, P133; Shimizu Takao, 1994, Japanese Journal of Entomology, V62, P619; Shimizu Takao, 1997, Japanese Journal of Systematic Entomology, V3, P77; Shimizu Takao, 1998, Japanese Journal of Systematic Entomology, V4, P227; Shimizu Takao, 1997, Japanese Journal of Entomology, V65, P793; Soares AER, 2012, BIOINFORM BIOL INSIG, V6, P129, DOI 10.4137/BBI.S9677; Sota T, 2008, PHILOS T R SOC B, V363, P3377, DOI 10.1098/rstb.2008.0111; Su ZH, 1996, J MOL EVOL, V43, P662, DOI 10.1007/BF02202114; Suzuki T, 2014, MOL PHYLOGENET EVOL, V72, P7, DOI 10.1016/j.ympev.2013.12.008; Taira A, 2001, ANNU REV EARTH PL SC, V29, P109, DOI 10.1146/annurev.earth.29.1.109; Teslenko VA, 2009, AQUAT INSECT, V31, P693, DOI 10.1080/01650420902812230; Tojo K., 2015, WONDERFUL MARVELOUS, P105; Tojo K, 2017, ENTOMOL SCI, V20, P357, DOI 10.1111/ens.12261; Tokuda M, 2010, BIOL J LINN SOC, V99, P570, DOI 10.1111/j.1095-8312.2010.01386.x; Tominaga O, 2000, J MOL EVOL, V50, P541, DOI 10.1007/s002390010057; van Tuinen M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00203; Verdone Chris J., 2017, Illiesia, V13, P30, DOI 10.25031/2017/13.03; Vitecek S, 2017, ARTHROPOD SYST PHYLO, V75, P497; Xiang QY, 2011, MOL PHYLOGENET EVOL, V59, P123, DOI 10.1016/j.ympev.2011.01.016; Yanai S, 2010, J GEOGR-TOKYO, V119, P1079, DOI 10.5026/jgeography.119.1079; Yang D, 2015, FAUNA SINICA, V58, P1; Yushuang L, 2011, PALAENTOLOGY, V54, P923; Zessin W., 2008, DTSCH ENTOMOL Z, V34, P1; Zhiltzova L. A., 2001, Russian Entomological Journal, V10, P125; Zhiltzova L.A., 2003, FAUNA RUSSIA NEIGHBO, V145, P1	78	13	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210269	10.1371/journal.pone.0210269	http://dx.doi.org/10.1371/journal.pone.0210269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633758	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000455485100015
J	Alomaim, H; Griffin, P; Swist, E; Plouffe, LJ; Vandeloo, M; Demonty, I; Kumar, A; Bertinato, J				Alomaim, Haya; Griffin, Philip; Swist, Eleonora; Plouffe, Louise J.; Vandeloo, Michelle; Demonty, Isabelle; Kumar, Ashok; Bertinato, Jesse			Dietary calcium affects body composition and lipid metabolism in rats	PLOS ONE			English	Article							SERUM-LIPIDS; CARDIOVASCULAR-DISEASE; ENERGY RESTRICTION; DAIRY-PRODUCTS; BLOOD-PRESSURE; OBESE ADULTS; WEIGHT-LOSS; FAT-CONTENT; SUPPLEMENTATION; CHOLESTEROL	Calcium (Ca) intakes may affect cardiovascular disease risk by altering body composition (body weight and fat) and serum lipid profile, but results have been inconsistent and the underlying mechanisms are not well understood. The effects of dietary Ca on body composition and lipid metabolism were examined in rats. Male Sprague-Dawley rats were fed high-fat, high-energy diets containing (g/kg) low (0.75Ca, 0.86 +/- 0.05; 2Ca, 2.26 +/- 0.02), normal (5Ca, 5.55 +/- 0.08) or high (10Ca, 11.03 +/- 0.17; 20Ca, 21.79 +/- 0.15) Ca for 10 weeks. Rats fed the lowest Ca diet (0.75Ca) had lower (p < 0.05) body weight and fat mass compared to other groups. Rats fed the high Ca diets had lower serum total and LDL cholesterol compared to rats fed normal or low Ca. Liver total cholesterol was lower in rats fed high compared to low Ca. In general, liver mRNA expression of genes involved in cholesterol uptake from the circulation (Ldlr), cholesterol synthesis (Hmgcr and Hmgcs1), fatty acid oxidation (Cpt2) and cholesterol esterification (Acat2) were higher in rats fed higher Ca. Apparent digestibility of total trans, saturated, monounsaturated and polyunsaturated fatty acids was lower in rats fed the high compared to the low Ca diets, with the largest effects seen on trans and saturated fatty acids. Fecal excretion of cholesterol and total bile acids was highest in rats fed the highest Ca diet (20Ca). The results suggest little effect of dietary Ca on body composition unless Ca intakes are very low. Decreased bile acid reabsorption and reduced absorption of neutral sterols and saturated and trans fatty acids may contribute to the better serum lipid profile in rats fed higher Ca.	[Alomaim, Haya; Griffin, Philip; Swist, Eleonora; Plouffe, Louise J.; Vandeloo, Michelle; Demonty, Isabelle; Bertinato, Jesse] Hlth Canada, Nutr Res Div, Bur Nutr Sci, Hlth Prod & Food Branch, Ottawa, ON, Canada; [Alomaim, Haya; Kumar, Ashok; Bertinato, Jesse] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Alomaim, Haya] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia	Health Canada; University of Ottawa; King Saud Bin Abdulaziz University for Health Sciences	Bertinato, J (corresponding author), Hlth Canada, Nutr Res Div, Bur Nutr Sci, Hlth Prod & Food Branch, Ottawa, ON, Canada.; Bertinato, J (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	jesse.bertinato@canada.ca			Bureau of Nutritional Sciences, Health Canada	Bureau of Nutritional Sciences, Health Canada	This research was funded by the Bureau of Nutritional Sciences, Health Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendsen NT, 2008, INT J OBESITY, V32, P1816, DOI 10.1038/ijo.2008.173; Bertinato J, 2016, J TRACE ELEM MED BIO, V38, P194, DOI 10.1016/j.jtemb.2016.02.005; Bertinato J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050253; Bertinato J, 2014, MAGNESIUM RES, V27, P35, DOI 10.1684/mrh.2014.0360; Bertinato J, 2014, EUR J NUTR, V53, P885, DOI 10.1007/s00394-013-0592-9; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bostick RM, 2000, ARCH FAM MED, V9, P31, DOI 10.1001/archfami.9.1.31; Brouwer IA, 2016, EFFECTS TRANSFATTY A; Canadian Community Health Survey, 2004, NUTR INT FOOD PROV R, V1; Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094; Chaput JP, 2009, OBESITY, V17, P1964, DOI 10.1038/oby.2009.116; Chung M, 2016, ANN INTERN MED, V165, P856, DOI 10.7326/M16-1165; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CZUBAYKO F, 1991, J LIPID RES, V32, P1861; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; DENKE MA, 1993, J NUTR, V123, P1047; DeRodas BZ, 1996, J DAIRY SCI, V79, P2121, DOI 10.3168/jds.S0022-0302(96)76586-4; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Ditscheid B, 2005, J NUTR, V135, P1678, DOI 10.1093/jn/135.7.1678; Felsenfeld AJ, 2015, CLIN KIDNEY J, V8, P180, DOI 10.1093/ckj/sfv011; GROOT PHE, 1980, EUR J PEDIATR, V135, P81, DOI 10.1007/BF00445899; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; He YH, 2011, J NUTR, V141, P1938, DOI 10.3945/jn.111.141762; Health Canada, 2012, DO CAN AD MEET THEIR, DOI [10.1016/j.jada.2011.02.014, DOI 10.1016/J.JADA.2011.02.014]; Heaney RP, 2012, ADV NUTR, V3, P763, DOI 10.3945/an.112.002899; Hsu HHT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-16; Jensen S. K., 2008, Lipid Technology, V20, P280, DOI 10.1002/lite.200800074; Jones KW, 2013, EUR J CLIN NUTR, V67, P371, DOI 10.1038/ejcn.2013.52; Kabrnova-Hlavata K, 2008, PHYSIOL RES, V57, P237, DOI 10.33549/physiolres.931057; Leong Xin-Fang, 2015, Biomed Res Int, V2015, P528757, DOI 10.1155/2015/528757; Lovejoy JC, 2001, AM J CLIN NUTR, V74, P90; Ma KY, 2011, MOL NUTR FOOD RES, V55, P247, DOI 10.1002/mnfr.201000161; Major GC, 2008, OBES REV, V9, P428, DOI 10.1111/j.1467-789X.2007.00465.x; Malekzadeh JM, 2007, PAKISTAN J NUTR, V6, P478; Mangano KM, 2011, J AM DIET ASSOC, V111, P687, DOI 10.1016/j.jada.2011.02.014; Marotte C, 2014, EUR J NUTR, V53, P769, DOI 10.1007/s00394-013-0581-z; MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459; Mensink RP, 2016, EFFECTS SATURATED FA, P1; Olatunji LA, 2008, CLIN HEMORHEOL MICRO, V38, P135; Onakpoya IJ, 2011, NUTR REV, V69, P335, DOI 10.1111/j.1753-4887.2011.00397.x; Palacios C, 2011, NUTRITION, V27, P520, DOI 10.1016/j.nut.2010.02.011; Papakonstantinou E, 2003, OBES RES, V11, P387, DOI 10.1038/oby.2003.52; Paradis S, 2005, PHYSIOL BEHAV, V85, P259, DOI 10.1016/j.physbeh.2005.03.026; Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353; Parikh SJ, 2003, AM J CLIN NUTR, V77, P281, DOI 10.1093/ajcn/77.2.281; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reid IR, 2010, AM J CLIN NUTR, V91, P131, DOI 10.3945/ajcn.2009.28097; Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720; Schrager S, 2005, J AM BOARD FAM PRACT, V18, P205, DOI 10.3122/jabfm.18.3.205; Sergeev IN, 2014, MOL NUTR FOOD RES, V58, P1342, DOI 10.1002/mnfr.201300503; Shahkhalili Y, 2001, AM J CLIN NUTR, V73, P246; Torres MRSG, 2013, NUTRITION, V29, P143, DOI 10.1016/j.nut.2012.05.012; Thomas AP, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-3; Tremblay A, 2011, J AM COLL NUTR, V30, p449S, DOI 10.1080/07315724.2011.10719989; Trowman R, 2006, BRIT J NUTR, V95, P1033, DOI 10.1079/BJN20051727; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Vaskonen T, 2002, BRIT J NUTR, V87, P239, DOI 10.1079/BJN2001508; Villarroel P, 2014, NUTR REV, V72, P627, DOI 10.1111/nure.12135; Vinarova L, 2016, FOOD FUNCT, V7, P151, DOI [10.1039/c5fo00856e, 10.1039/C5FO00856E]; Voznesenskaya A, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0035-0; Waldman T, 2015, AM J LIFESTYLE MED, V9, P298, DOI 10.1177/1559827613512593; Wennersberg MH, 2009, AM J CLIN NUTR, V90, P960, DOI 10.3945/ajcn.2009.27664; Yanovski JA, 2009, ANN INTERN MED, V150, P821, DOI 10.7326/0003-4819-150-12-200906160-00005; Zemel MB, 2004, AM J CLIN NUTR, V79, P907; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zhang QM, 2004, AM J PHYSIOL-REG I, V286, pR669, DOI 10.1152/ajpregu.00655.2003	72	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210760	10.1371/journal.pone.0210760	http://dx.doi.org/10.1371/journal.pone.0210760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629707	Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000126
J	Basulira, Y; Olet, SA; Alele, PE				Basulira, Yake; Olet, Susan A.; Alele, Paul Erasmus			Inappropriate usage of selected antimicrobials: Comparative residue proportions in rural and urban beef in Uganda	PLOS ONE			English	Article							ESCHERICHIA-COLI BACTERIA; FOOD ANIMALS; DRUG-USE; RESISTANCE; ANTIBIOTICS; PREVALENCE; CATTLE	Introduction In most developing countries like Uganda, antimicrobials including beta-lactams and tetracyclines are used indiscriminately in livestock. When livestock get sick and treatment is necessary, some producers and veterinarians use these drugs with minimal controls to prevent residues from occurring in the beef sent to markets. This study was done to determine the presence of drug residues above acceptable limits of two commonly used antimicrobials in Uganda's rural and urban beef. Methods A cross-sectional study was conducted of 134 cattle carcasses from eight different slaughter slabs over twelve weeks. This study entailed 81 samples of rural and 53 samples of urban origin. To enable detailed analysis these samples were categorized according to age (maturity), breed, and sex. For each of the 134 carcasses, three samples of liver, kidney and muscle were taken and homogeneously mixed into one sample, which was tested for beta-lactam and tetracycline drug residues. Results The results were statistically significant for beta-lactam levels (chi(2) = 22.10, df = 10, p = 0.0146) with average concentration (mu g/kg) of 2.93: 29.3 (rural: urban), though not for tetracycline levels (chi(2) = 3.594, df = 10, P = 0.9638) with average concentration (mu g/kg) of 5.028: 12.83 (rural: urban). Age (maturity) had significant effect at all values of antibiotic level (F-(1,F- 68) = 5.06, p = 0.0278). Age effect was extremely significant (F-(1,F- 68) = 15.51, p = 0.0002). Conclusion A significant difference existed in drug residue proportions of beta-lactam and tetracycline antimicrobials among Uganda's rural and urban beef. A significant difference also occured in drug residue proportions of these two commonly used antimicrobials related to age (maturity), but neither breed, nor sex, of Uganda's rural and urban beef.	[Basulira, Yake; Alele, Paul Erasmus] Mbarara Univ Sci & Technol, Dept Pharmacol & Therapeut, Fac Med, Mbarara, Uganda; [Olet, Susan A.] Aurora Res Inst, Dept Biostat, Milwaukee, WI USA	Mbarara University of Science & Technology	Alele, PE (corresponding author), Mbarara Univ Sci & Technol, Dept Pharmacol & Therapeut, Fac Med, Mbarara, Uganda.	paulalele@must.ac.ug		Alele, Paul E./0000-0002-9329-3441				Abdelgadir AE, 2011, SUDAN U KHARTOUM J V, V2, P71; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Azzouz A, 2011, J AGR FOOD CHEM, V59, P5125, DOI 10.1021/jf200364w; Azzouz A, 2011, TALANTA, V84, P820, DOI 10.1016/j.talanta.2011.02.016; Botsouglou NA, 2004, HDB FOOD ANAL; Caudell MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170328; CORPET DE, 1988, NEW ENGL J MED, V318, P1206; Holmes A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k259; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P3872, DOI 10.1128/AEM.71.7.3872-3881.2005; Jones GM, 2009, ON FARM TESTS DRUG R, P404; Kabir J, 2004, FOOD CONTROL, V15, P99, DOI 10.1016/S0956-7135(03)00020-3; Karimuribo Umoh ED, 2005, B ANIMAL HLTH PRODUC, V53, P234; Kish L, 1965, SURVEY SAMPLING; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; KuKanich B, 2005, JAVMA-J AM VET MED A, V227, P1574, DOI 10.2460/javma.2005.227.1574; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Love DC, 2011, ENVIRON HEALTH PERSP, V119, P279, DOI 10.1289/ehp.1002625; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mathers JJ, 2011, ENVIRON INT, V37, P991, DOI 10.1016/j.envint.2011.01.014; Mayuni I, 2013, JAPANESE J VET RES, V61, P13; Mensah Kwesi B, 2016, Ghana Med J, V50, P107, DOI 10.4314/gmj.v50i2.9; Ministry of Agriculture, AN IND FISH AGR HEAT; Nonga H. E., 2009, Pakistan Journal of Nutrition, V8, P203, DOI 10.3923/pjn.2009.203.207; NORCROSS MA, 1991, J AM VET MED ASSOC, V198, P819; Ocaido M., 2009, Livestock Research for Rural Development, V21, P155; Olatoye O. I., 2009, AFR J BIOMED RES, V12, P245; Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570; Porphyre V, 2013, TROPICAL ANIMAL HLTH, P445; Randox Laboratories Limited, 2013, ELISA MAN; Samandoulougou S., 2015, African Journal of Food Science, V9, P367; Sharma R, 2008, APPL ENVIRON MICROB, V74, P6178, DOI 10.1128/AEM.00704-08; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Teale CJ, 2002, J APPL MICROBIOL, V92, p85S, DOI 10.1046/j.1365-2672.92.5s1.20.x; Tunipssed SB, 2008, FOOD CONTAMINANTS RE; Uganda Investment Authority, AGR SECT BEEF; Ugandan Bureau of Statistics, 2017, STAT ABSTR; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; World Health Organization, 2015, WHA62015REC1 WORLD H	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209006	10.1371/journal.pone.0209006	http://dx.doi.org/10.1371/journal.pone.0209006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629586	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000020
J	Coetzer, A; Gwenhure, L; Makaya, P; Markotter, W; Nel, L				Coetzer, Andre; Gwenhure, Lambert; Makaya, Pious; Markotter, Wanda; Nel, Louis			Epidemiological aspects of the persistent transmission of rabies during an outbreak (2010-2017) in Harare, Zimbabwe	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MONGOOSE RABIES; VIRUS; AFRICA; CANID	Canine-mediated human rabies is endemic to the entire African continent, where the disease burden is often highest in rural communities of resource-limited countries. In this study, we analysed an animal rabies outbreak, which had persisted since 2010 in the predominantly metropolitan capital city of Zimbabwe, Harare. As rabies is considered to disproportionally affect rural communities, the persistence of urban rabies in this metropolitan setting is of interest. In order to gain an improved understanding of the epidemiology of the outbreak under investigation, we utilised both routine surveillance data that had been collected during the first eight years of the outbreak (2010-2017), as well as molecular epidemiological analyses relying on the Bayesian Markov Chain Monte Carlo methodology. This approach allowed us to characterize virus transmission by identifying specific suburbs within the city limits where persistent disease transmission took place, while also confirming that immunologically naive dogs were the most likely reservoir species in and around the city. In addition to gaining an improved local understanding of the outbreak, we are also able to infer that rabies was likely introduced to the city in 2010 when a rabid animal was moved from the north-east of Zimbabwe into Harare-resulting in an epizootic event. The work presented here not only showcased the value of combining conventional and molecular epidemiological data, but also highlighted the importance of maintaining rabies vaccination coverage and continued public awareness in urban areas where the risk appears to be low. By educating the general population on rabies and relying on owners to bring their companion animals to strategically placed vaccination points, the control and elimination of rabies from Harare may be feasible.	[Coetzer, Andre; Nel, Louis] Univ Pretoria, Dept Biochem Genet & Microbiol, Fac Nat & Agr Sci, Pretoria, Gauteng, South Africa; [Coetzer, Andre; Nel, Louis] Global Alliance Rabies Control SA NPC, Pretoria, Gauteng, South Africa; [Gwenhure, Lambert; Makaya, Pious] Cent Vet Res & Diagnost Lab, Dept Livestock & Vet Serv, Harare, Harare Metropol, Zimbabwe; [Markotter, Wanda] Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, Pretoria, Gauteng, South Africa	University of Pretoria; University of Pretoria	Nel, L (corresponding author), Univ Pretoria, Dept Biochem Genet & Microbiol, Fac Nat & Agr Sci, Pretoria, Gauteng, South Africa.; Nel, L (corresponding author), Global Alliance Rabies Control SA NPC, Pretoria, Gauteng, South Africa.	louis.nel@up.ac.za	Nel, Louis H/F-1001-2012	Nel, Louis H/0000-0001-8963-0153; Coetzer, Andre/0000-0003-0581-7207; Markotter, Wanda/0000-0002-7550-0080	World Animal Protection (WAP) [WAP/AF/IHC/GR/2016-01]; Centers for Disease Control and Prevention [1U2GGH001874-01]	World Animal Protection (WAP); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research is supported in part by grants from the World Animal Protection (WAP) (grant number: WAP/AF/IHC/GR/2016-01) and the Cooperative Agreement Number, (grant number: 1U2GGH001874-01) funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official position of the funding agencies.	Badrane H, 2001, J VIROL, V75, P3268, DOI 10.1128/JVI.75.7.3268-3276.2001; Banyard AC, 2013, ANTIVIR RES, V98, P357, DOI 10.1016/j.antiviral.2013.04.004; Bingham J, 1999, ONDERSTEPOORT J VET, V66, P1; Bingham J, 1999, ONDERSTEPOORT J VET, V66, P11; Bingham J., 1999, CONTROL RABIES JACKA; Bourhy H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005525; BROOKS R, 1990, VET REC, V127, P592; Brunker K, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev011; Butler JRA, 1998, ECOLOGY DOMESTIC DOG; Centers for Disease Control and Prevention (CDC), 2003, PROT POSTM DIAGN RAB; Chikwati E., 2016, THE HERALD; Coetzer A., 2014, CURRENT LAB TECHNIQU, V1st, P27; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis PL, 2007, ARCH VIROL, V152, P1251, DOI 10.1007/s00705-007-0962-9; Dean DJ, LAB TECHNIQUES RABIE; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edmonds C.R., 1922, DIS ANIMALS S AFRICA; Foggin CM, 1988, RABIES RABIES RELATE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hayman DTS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001001; Kgaladi Joe, 2013, Onderstepoort j. vet. res., V80, P1; KISSI B, 1995, VIROLOGY, V209, P526, DOI 10.1006/viro.1995.1285; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Madzima W.N., 1995, P 3 INT C SO E AFR R, P134; Mollentze N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3251; Vigilato MAN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0143; Nel L., 2009, MICROBE, V4, P61; Nel LH, 2007, CURR TOP MICROBIOL, V315, P161; Nel LH, 2005, VIRUS RES, V109, P165, DOI 10.1016/j.virusres.2004.12.003; Parliament of Zimbabwe, 2002, PUBL HLTH ACT; Parliament of Zimbabwe, 2001, AN HLTH ACT; Qiagen, 2017, CLC GEN WORKB; Rambaut A., 2007, FIGTREE; Sabeta CT, 2007, VIRUS RES, V129, P1, DOI 10.1016/j.virusres.2007.04.024; Sabeta CT, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.923; Sabeta CT, 2003, VIRUS RES, V91, P203, DOI 10.1016/S0168-1702(02)00272-1; SACRAMENTO D, 1991, MOL CELL PROBE, V5, P229, DOI 10.1016/0890-8508(91)90045-L; Salomao C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005787; Sinclair JM, 1914, REPORT DIRECTOR AGR; SWANEPOEL R, 1978, CENT AFR J MED, V24, P107; SWANEPOEL R, 1993, ONDERSTEPOORT J VET, V60, P325; Taylor LH, 2017, ACTA TROP, V165, P133, DOI 10.1016/j.actatropica.2015.12.007; The Gates Foundation, 2014, ASS RISKS DIG PAYM; TORDO N, 1993, ONDERSTEPOORT J VET, V60, P263; Van Zyl N, 2010, VIRUS RES, V150, P93, DOI 10.1016/j.virusres.2010.02.018; VONTEICHMAN BF, 1995, J GEN VIROL, V76, P73, DOI 10.1099/0022-1317-76-1-73; WHO, 2018, WHO TECH REP SER, V1012, P1; WHO, 2013, WHO TECH REP SER, V982, P1; World Health Organization, 2018, DIS OUTBR; Zimbabwe National Statistical Agency, 2012, ZIMB POP CENS 2012; Zulu GC, 2009, VIRUS RES, V140, P71, DOI 10.1016/j.virusres.2008.11.004	52	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210018	10.1371/journal.pone.0210018	http://dx.doi.org/10.1371/journal.pone.0210018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629634	gold, Green Submitted, Green Published			2022-12-26	WOS:000455483000041
J	da Silva, EF; Botsford, S; Dare-Shih, J; Hanna, MA; Porter, LA				da Silva, Elizabeth Fidalgo; Botsford, Sabrina; Dare-Shih, Jessica; Hanna, Miranda A.; Porter, Lisa A.			The Tuberin and Cyclin B1 complex functions as a novel G2/M sensor of serum conditions and Akt signaling	PLOS ONE			English	Article							GENE-PRODUCT; SCLEROSIS; PHOSPHORYLATION; TSC2; LOCALIZATION; HAMARTIN; GROWTH; IDENTIFICATION; PATHWAY; TARGET	A great deal of ground breaking work has determined that the Tuberin and Hamartin Complex function as a negative regulator of protein synthesis and cell cycle progression through G1/S. This is largely attributed to the GTPase activity of Tuberin that indirectly inhibits the mammalian target of rapamycin (mTOR). During times of ample nutrition Tuberin is inhibited by growth factor signaling, including direct phosphorylation by Akt/PKB, allowing for activation of mTOR and subsequent protein synthesis. It is well rationalized that maintaining homeostasis requires communication between cell growth (mTOR signaling) and cell division (cell cycle regulation), however how this occurs mechanistically has not been resolved. This work demonstrates that in the presence of high serum, and/or Akt signaling, direct binding between Tuberin and the G2/M cyclin, Cyclin B1, is stabilized and the rate of mitotic entry is decreased. Importantly, we show that this results in an increase in cell size. We propose that this represents a novel cell cycle checkpoint linking mitotic onset with the nutritional status of the cell to control cell growth.	[da Silva, Elizabeth Fidalgo; Botsford, Sabrina; Dare-Shih, Jessica; Hanna, Miranda A.; Porter, Lisa A.] Univ Windsor, Dept Biol Sci, Windsor, ON, Canada	University of Windsor	Porter, LA (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON, Canada.	lporter@uwindsor.ca	, Lisa/AAA-3185-2020	, Lisa/0000-0002-9234-1712; Fidalgo da Silva, Elizabeth/0000-0003-3540-9335	Natural Sciences and Engineering Council of Canada [312014-2009]; NSERC Undergraduate Student Research Assistance program (USRA); Southwestern Research Program (SWORP); Canadian Institutes of Health Research (CIHR) MSc Scholarship program	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Student Research Assistance program (USRA); Southwestern Research Program (SWORP); Canadian Institutes of Health Research (CIHR) MSc Scholarship program(Canadian Institutes of Health Research (CIHR))	This work is supported by an operating grant from the Natural Sciences and Engineering Council of Canada (#312014-2009 to LAP). Student scholarship support was received from the NSERC Undergraduate Student Research Assistance program (USRA), the Southwestern Research Program (SWORP) and the Canadian Institutes of Health Research (CIHR) MSc Scholarship program. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Astrinidis A, 2006, HUM MOL GENET, V15, P287, DOI 10.1093/hmg/ddi444; Astrinidis A, 2003, J BIOL CHEM, V278, P51372, DOI 10.1074/jbc.M303956200; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Catania MG, 2001, J NEUROPATH EXP NEUR, V60, P711, DOI 10.1093/jnen/60.7.711; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; da Silva EF, 2011, CELL CYCLE, V10, P3129, DOI 10.4161/cc.10.18.17296; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Fidalgo da Silva E, 2014, CYTOTECHNOLOGY; Govindarajan B, 2005, J BIOL CHEM, V280, P5870, DOI 10.1074/jbc.M411768200; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Pasumarthi KBS, 2000, CIRC RES, V86, P1069, DOI 10.1161/01.RES.86.10.1069; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210612	10.1371/journal.pone.0210612	http://dx.doi.org/10.1371/journal.pone.0210612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629673	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000117
J	Hashem, MM; Salama, MM; Mohammed, FF; Tohamy, AF; El Deeb, KS				Hashem, Mona M.; Salama, Maha M.; Mohammed, Faten F.; Tohamy, Adel F.; El Deeb, Kadriya S.			Metabolic profile and hepatoprotective effect of Aeschynomene elaphroxylon (Guill. & Perr.)	PLOS ONE			English	Article							CCL4-INDUCED LIVER-DAMAGE; ANTIOXIDANT ACTIVITIES; TRITERPENE SAPONINS; PHENOLIC CONTENTS; OXIDATIVE STRESS; EXTRACT; SERUM; MS; FLAVONOIDS; SEEDS	Liver diseases are life-threatening and need urgent medical treatments. Conventional treatment is expensive and toxic, so the urge for nutraceutical hepatoprotective agents is crucial. This study is considered the first metabolic profile of Aeschynomene elaphroxylon (Guill. & Perr.) extracts of; flowers, leaves & bark adopting UPLC-Orbitrap HRMS analysis to determine their bioactive metabolites, and it was designed to investigate the potential hepatoprotective activity of A. elaphroxylon flowers and bark extracts against CCl4-induced hepatic fibrosis in rats. Forty-nine compounds of various classes were detected in the three extracts, with triterpenoid saponins as the major detected metabolite. Flowers and bark extracts presented similar chemical profile while leaves extract was quite different. The antioxidant activities of the flowers, leaves & bark extracts were measured by in vitro assays as Fe+3 reducing antioxidant power and Oxygen radical absorbance capacity. It revealed that flowers and bark extracts had relatively high antioxidant activity as compared to leaves extract. Based on the metabolic profile and in vitro antioxidant activity, flowers and bark ethanolic extracts were chosen for alleviation of hepatotoxicity induced by CCl4 in rats. The hepato-protective activity was studied through measuring hepatotoxicity biomarkers in serum (ALT, AST, and Albumin). Liver tissues were examined histopathologically and their homogenates were used in determining the intracellular levels of oxidative stress biomarkers (MDA, GSH), inflammatory markers (TNF-alpha). Flowers and bark ethanolic extracts exerted a significant hepatoprotective effect through reduction in the activities of ALT, AST and Albumin, the tested extracts reduced oxidative stress by increasing GSH content and reducing the MDA level. Furthermore, the extracts decreased levels of pro-inflammatory TNF-alpha. Moreover, the present study revealed the potentiality of A. elaphroxylon in ameliorating the CCl4-induced hepatic fibrosis in rats. In this aspect, A. elaphroxylon can be used with other agents as a complementary drug.	[Hashem, Mona M.; Salama, Maha M.; El Deeb, Kadriya S.] Cairo Univ, Dept Pharmacognosy, Fac Pharm, Giza, Egypt; [Salama, Maha M.] British Univ Egypt, Dept Pharmacognosy, Fac Pharm, El Sherouk City, Egypt; [Mohammed, Faten F.] Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt; [Tohamy, Adel F.] Cairo Univ, Dept Toxicol & Forens Med, Fac Vet Med, Giza, Egypt; [Tohamy, Adel F.] Univ Vet Med Hannover, Inst Pharmacol Toxicol & Pharm, Hannover, Germany	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); British University in Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; University of Veterinary Medicine Hannover, Foundation	Hashem, MM (corresponding author), Cairo Univ, Dept Pharmacognosy, Fac Pharm, Giza, Egypt.	mona.hashem@pharma.cu.edu.eg	Mohammed, Faten/AHA-4407-2022; Afify, adel/AEY-4864-2022	Mohammed, Faten/0000-0003-0410-8118; Tohamy, Adel/0000-0001-7711-7432				Achika JI, 2016, BRIT J PHARM RES, V11, DOI 10.9734/BJPR/2016/23506; Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Alekhya C, 2013, INT J PHARM PHARM SC, V5, P386; [Anonymous], [No title captured]; Aruna C, 2012, INT J PHARM PHARM SC, V4, P1; Bharathi M. P., 2015, Journal of Pharmacy Research, V9, P21; Boll M, 2001, Z NATURFORSCH C, V56, P649; Burkill HM, 1994, USEFUL PLANTS W TROP, V2; Caamal-Fuentes E, 2013, NAT PROD COMMUN, V8, P1421; Caamal-Fuentes E, 2011, J ETHNOPHARMACOL, V135, P719, DOI 10.1016/j.jep.2011.04.004; Caamal-Fuentes EE, 2015, MOLECULES, V20, P13563, DOI 10.3390/molecules200813563; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Chiu YJ, 2018, J FOOD DRUG ANAL, V26, P369, DOI 10.1016/j.jfda.2017.04.007; Clichici S, 2015, J MED FOOD, V18, P290, DOI 10.1089/jmf.2013.0179; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Davis BD, 2004, J AM SOC MASS SPECTR, V15, P1287, DOI 10.1016/j.jasms.2004.06.003; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Dutta S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196411; ElSayed NH, 1997, ASIAN J CHEM, V9, P549; Ezejindu DN, 2013, INT J ENG SCI, V2, P54; Farag MA, 2015, ANAL BIOANAL CHEM, V407, P1937, DOI 10.1007/s00216-014-8432-1; Farag MA, 2013, PHYTOCHEMISTRY, V95, P177, DOI 10.1016/j.phytochem.2013.07.003; Ferreres F, 2004, J MASS SPECTROM, V39, P312, DOI 10.1002/jms.586; Ferreres F, 2012, FOOD CHEM, V134, P894, DOI 10.1016/j.foodchem.2012.02.201; Figueirinha A, 2008, FOOD CHEM, V110, P718, DOI 10.1016/j.foodchem.2008.02.045; Gu LW, 2003, J AGR FOOD CHEM, V51, P7513, DOI 10.1021/jf034815d; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harish R, 2006, FOOD CHEM, V95, P180, DOI 10.1016/j.foodchem.2004.11.049; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hong J, 2016, J MED FOOD, V19, P549, DOI 10.1089/jmf.2015.3604; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Hua YS, 2012, J CHROMATOGR SCI, V50, P213, DOI 10.1093/chromsci/bmr049; Ignoato MC, 2012, QUIM NOVA, V35, P2241, DOI 10.1590/S0100-40422012001100028; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JIANG Z, 1992, J HEPATOL, V16, P282, DOI 10.1016/S0168-8278(05)80658-0; Jin MC, 2007, J CHROMATOGR B, V846, P169, DOI 10.1016/j.jchromb.2006.08.043; KITAGAWA I, 1985, CHEM PHARM BULL, V33, P598; Koley TK, 2017, ARABIAN J CHEM; Li XC, 2009, MOLECULES, V14, P5349, DOI 10.3390/molecules14125349; Liang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105146; Maatta KR, 2003, J AGR FOOD CHEM, V51, P6736, DOI 10.1021/jf0347517; Mahmoodzadeh Y, 2017, TOXICOL REP, V4, P455, DOI 10.1016/j.toxrep.2017.08.003; Murakami T, 2001, CHEM PHARM BULL, V49, P73, DOI 10.1248/cpb.49.73; Pandae PT KaV, 2011, PHARMACOLOGYONLINE, V3, P297; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Pollier J, 2011, J NAT PROD, V74, P1462, DOI 10.1021/np200218r; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Radwan HA, 2015, RES J PHARM BIOL CHE, V6, P1061; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Rockenbach II, 2012, FOOD RES INT, V48, P848, DOI 10.1016/j.foodres.2012.07.001; Sadeghi H, 2016, AVICENNA J PHYTOMEDI, V6, P181; SHIRAIWA M, 1991, AGR BIOL CHEM TOKYO, V55, P911, DOI 10.1080/00021369.1991.10870686; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Xu Hui-Xian, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2187; Xu RA, 2012, CELL MOL IMMUNOL, V9, P296, DOI 10.1038/cmi.2011.53; Xu Y, 2018, CHIN J NAT MEDICINES, V16, P271, DOI 10.1016/S1875-5364(18)30057-8; Yang Yoon Mee, 2015, Curr Pathobiol Rep, V3, P253; Zhang W, 2009, MOLECULES, V14, P2959, DOI 10.3390/molecules14082959; Zhao HF, 2008, FOOD CHEM, V107, P296, DOI 10.1016/j.foodchem.2007.08.018; Zheng YF, 2015, MOLECULES, V20, P6273, DOI 10.3390/molecules20046273; Zhu LJ, 2016, PHARMACOGN MAG, V12, P302, DOI 10.4103/0973-1296.192203	65	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210576	10.1371/journal.pone.0210576	http://dx.doi.org/10.1371/journal.pone.0210576			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629685	Green Published, gold			2022-12-26	WOS:000455483000111
J	Htwe, KTZ; Dapat, C; Shobugawa, Y; Odagiri, T; Hibino, A; Kondo, H; Yagami, R; Saito, T; Takemae, N; Tamura, T; Watanabe, H; Kyaw, Y; Lin, N; Myint, YY; Tin, HH; Thein, W; Kyaw, LL; Soe, PE; Naito, M; Zaraket, H; Suzuki, H; Abe, T; Saito, R				Htwe, Khin Thu Zar; Dapat, Clyde; Shobugawa, Yugo; Odagiri, Takashi; Hibino, Akinobu; Kondo, Hiroki; Yagami, Ren; Saito, Takehiko; Takemae, Nobuhiro; Tamura, Tsutomu; Watanabe, Hisami; Kyaw, Yadanar; Lin, Nay; Myint, Yi Yi; Tin, Htay Htay; Thein, Win; Kyaw, Latt Latt; Soe, Pan Ei; Naito, Makoto; Zaraket, Hassan; Suzuki, Hiroshi; Abe, Takashi; Saito, Reiko			Phylogeographic analysis of human influenza A and B viruses in Myanmar, 2010-2015	PLOS ONE			English	Article							EPIDEMIOLOGIC DYNAMICS; GLOBAL CIRCULATION; INFERENCE; SOUTHERN	We investigated the circulation patterns of human influenza A and B viruses in Myanmar between 2010 and 2015 by analyzing full HA genes. Upper respiratory tract specimens were collected from patients with symptoms of influenza-like illness. A total of 2,860 respiratory samples were screened by influenza rapid diagnostic test, of which 1,577 (55.1%) and 810 (28.3%) were positive for influenza A and B, respectively. Of the 1,010 specimens that were positive for virus isolation, 370 (36.6%) were A(H1N1) pdm09, 327 (32.4%) were A(H3N2), 130 (12.9%) B(Victoria), and 183 (18.1%) were B(Yamagata) viruses. Our data showed that influenza epidemics mainly occurred during the rainy season in Myanmar. Our three study sites, Yangon, Pyinmana, and Pyin Oo Lwin had similar seasonality and circulating type and subtype of influenza in a given year. Moreover, viruses circulating in Myanmar during the study period were closely related genetically to those detected in Thailand, India, and China. Phylogeographic analysis showed that A(H1N1) pdm09 viruses in Myanmar originated from Europe and migrated to other countries via Japan. Similarly, A (H3N2) viruses in Myanmar originated from Europe, and disseminated to the various countries via Australia. In addition, Myanmar plays a key role in reseeding of influenza B viruses to Southeast Asia and East Asia as well as Europe and Africa. Thus, we concluded that influenza virus in Myanmar has a strong link to neighboring Asian countries, Europe and Oceania.	[Htwe, Khin Thu Zar; Shobugawa, Yugo; Odagiri, Takashi; Hibino, Akinobu; Kondo, Hiroki; Yagami, Ren; Saito, Reiko] Niigata Univ, Div Int Hlth, Grad Sch Med & Dent Sci, Chuo Ku, Asahimachi Dori, Niigata, Niigata, Japan; [Dapat, Clyde] Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi, Japan; [Saito, Takehiko; Takemae, Nobuhiro] Natl Agr & Food Res Org, Influenza & Prion Dis Res Ctr, NARO, 3-1-1 Kannondai, Tsukuba, Ibaraki, Japan; [Tamura, Tsutomu] Niigata Prefectural Inst Publ Hlth & Environm Sci, Nishi Ku, 314-1 Sowa, Niigata, Niigata, Japan; [Watanabe, Hisami] Niigata Univ, Infect Dis Res Ctr, Niigata Univ Myanmar, Grad Sch Med & Dent Sci, Niigata, Niigata, Japan; [Kyaw, Yadanar] Thingangyun Sanpya Hosp, Dept Resp Med, Yangon Div, Yangon, Myanmar; [Lin, Nay] Pyinmana Township Hosp, Clin Lab, Microbiol Sect, Pyinmana Township, Nay Pyi Taw, Myanmar; [Myint, Yi Yi] Yangon Gen Hosp, Yangon Div, Lanmadaw, Yangon, Myanmar; [Tin, Htay Htay; Thein, Win; Kyaw, Latt Latt; Soe, Pan Ei] Minist Hlth & Sports, Natl Hlth Lab, Yangon Div, Dagon, Yangon, Myanmar; [Naito, Makoto] Niigata Med Ctr Hosp, Dept Pathol, Nishi Ku, Niigata, Niigata, Japan; [Zaraket, Hassan] Amer Univ Beirut, Dept Expt Pathol Immunol & Microbiol, Fac Med, Beirut, Lebanon; [Zaraket, Hassan] Amer Univ Beirut, Ctr Infect Dis Res, Fac Med, Beirut, Lebanon; [Suzuki, Hiroshi] Niigata Seiryo Univ, Sch Nursing & Psychol, Chuo Ku, Suido Cho, Niigata, Niigata, Japan; [Abe, Takashi] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata, Niigata, Japan	Niigata University; Tohoku University; National Agriculture & Food Research Organization - Japan; Niigata University; American University of Beirut; American University of Beirut; Niigata University	Htwe, KTZ (corresponding author), Niigata Univ, Div Int Hlth, Grad Sch Med & Dent Sci, Chuo Ku, Asahimachi Dori, Niigata, Niigata, Japan.	ktzh@med.niigata-u.ac.jp	Dapat, Clyde/B-4196-2009; Saito, Takehiko/AFM-3038-2022	Dapat, Clyde/0000-0002-7616-4680; KONDO, HIROKI/0000-0002-8336-3995	International Development Strategy Program for Infectious Diseases Research (J-GRID) of AMED (Japan Medical Research and Development Organization) [15fm0108009h0001]; JSPS; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Health and Labor Sciences Research Grant, Ministry of Health, Labor and Welfare, Japan	International Development Strategy Program for Infectious Diseases Research (J-GRID) of AMED (Japan Medical Research and Development Organization); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grant, Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the International Development Strategy Program for Infectious Diseases Research (J-GRID) of AMED (Japan Medical Research and Development Organization) (15fm0108009h0001 to RS), JSPS Core-to-core Program, B to RS. Asia-Africa Science Platforms, and Kakenhi (Grants-in-Aid for Scientific Research), sourced from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Health and Labor Sciences Research Grant, Ministry of Health, Labor and Welfare, Japan.	Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Control CfD Prevention, 1982, CONCEPTS PROCEDURES; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dapat C, 2013, INFLUENZA OTHER RESP, V7, P766, DOI 10.1111/irv.12030; Dapat C, 2010, EMERG INFECT DIS, V16, P493, DOI 10.3201/eid1603.091321; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; Oliveira TFDS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0817-z; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, ROUGH GUIDE BEAST 1, DOI [10.1093/molbev/msw082, DOI 10.1093/MOLBEV/MSW082]; Geoghegan JL, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006780; Gong YN, 2019, J FORMOS MED ASSOC, V118, P116, DOI 10.1016/j.jfma.2018.01.019; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Lemey MSaGB P., PHYLOGEOGRAPHIC INFE; Le MQ, 2013, EMERG INFECT DIS, V19, P1756, DOI 10.3201/eid1911.130349; Manito ACB, 2017, VIRUS RES, V238, P69, DOI 10.1016/j.virusres.2017.06.002; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Shaw M, 2013, FIELDS VIROLOGY, V1; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Su YCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8952; Suzuki Y, RAPID SPECIFIC DETEC; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; who, WHO RECOMMENDATIONS; World Health Organization, 2011, MAN LAB DIAGN VIR SU	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210550	10.1371/journal.pone.0210550	http://dx.doi.org/10.1371/journal.pone.0210550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629691	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000107
J	MacDougall, L; Smolina, K; Otterstatter, M; Zhao, B; Chong, M; Godfrey, D; Mussavi-Rizi, A; Sutherland, J; Kuo, M; Kendall, P				MacDougall, Laura; Smolina, Kate; Otterstatter, Michael; Zhao, Bin; Chong, Mei; Godfrey, David; Mussavi-Rizi, Ali; Sutherland, Jenny; Kuo, Margot; Kendall, Perry			Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada	PLOS ONE			English	Article							OPIOID OVERDOSE; PUBLIC-HEALTH	Introduction British Columbia (BC), Canada declared a public health emergency in April 2016 for opioid overdose. Comprehensive data was needed to identify risk factors, inform interventions, and evaluate response actions. We describe the development of an overdose cohort, including linkage strategy, case definitions, and data governance model, and present the resulting characteristics, including data linkage yields and case overlap among data sources. Methods Overdose events from hospital admissions, physician visits, poison centre and ambulance calls, emergency department visits, and coroner's data were grouped into episodes if records were present in multiple sources. A minimum of five years of universal health care records (all prescription dispensations, fee-for-service physician billings, emergency department visits and hospitalizations) were appended for each individual. A 20% random sample of BC residents and a 1: 5 matched case-control set were generated. Consultation and prioritization ensured analysts worked to address questions to directly inform public health actions. Results 10,456 individuals suffered 14,292 overdoses from January 1, 2015 to Nov 30, 2016. Only 28% of overdose events were found in more than one dataset with the unique contribution of cases highest from ambulance records (32%). Compared with fatal overdoses, non-fatal events more often involved females, younger individuals (20 to 29 years) and those 60 or older. In 78% of illegal drug deaths, there was no associated ambulance response. In the year prior to first recorded overdose, 60% of individuals had at least one ED visit, 31% at least one hospital admission, 80% at least one physician visit, and 87% had filled at least one prescription in a community pharmacy. Conclusion While resource-intensive to establish, a linked cohort is useful for characterizing the full extent of the epidemic, defining sub-populations at risk, and patterns of contact with the health system. Overdose studies in other jurisdictions should consider the inclusion of multiple data sources.	[MacDougall, Laura; Smolina, Kate; Otterstatter, Michael; Zhao, Bin; Chong, Mei; Kuo, Margot] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Smolina, Kate; Otterstatter, Michael] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Godfrey, David] British Columbia Minist Hlth, Data Management & Stewardship Branch, Victoria, BC, Canada; [Mussavi-Rizi, Ali] Prov Hlth Serv Author, Performance Measurement & Reporting, Vancouver, BC, Canada; [Sutherland, Jenny; Kendall, Perry] British Columbia Minist Hlth, Off Prov Hlth Officer, Victoria, BC, Canada	University of British Columbia	MacDougall, L (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	laura.macdougall@canada.ca		Otterstatter, Michael/0000-0001-5489-014X				[Anonymous], 2018, ILL DRUG OV DEATHS B; [Anonymous], 2017, DRUG ALCOHOL REV; [Anonymous], 2017, COMMUNICATION; Bahorik AL, 2017, SUBST ABUS, V19, P1; Boscarino JA, 2016, SUBST ABUSE REHABIL, V7, P131, DOI 10.2147/SAR.S108302; Canadian Institute for Health Information, 2016, DAT QUAL DOC NAT AMB; Drug Analysis Service, 2017, DRUG SIT SUMM REP CA; European Monitoring Centre for Drugs and Drug Addiction, 2018, STAT B 2018 OV DEATH; Formica SW, 2018, INT J DRUG POLICY, V54, P43, DOI 10.1016/j.drugpo.2018.01.001; Gladstone EJ, 2016, INJURY PREV, V22, P288, DOI 10.1136/injuryprev-2015-041604; Janjua NZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150176; Leamon AW, 2017, ENHANCED EMERGENCY D; Office of the Provincial Health Officer of British Columbia, 2017, PREV PHARM OP ASS MO; Rasali D, 2016, PUBL HLTH ASS BRIT C; Rizi SAM, 2013, STUD HEALTH TECHNOL, V192, P861, DOI 10.3233/978-1-61499-289-9-861; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Wu LT, 2012, ANN EMERG MED, V60, P172, DOI 10.1016/j.annemergmed.2012.02.003	17	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210129	10.1371/journal.pone.0210129	http://dx.doi.org/10.1371/journal.pone.0210129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629607	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000052
J	Sandmann, J; Sichtermann, T; Muschenich, FS; Nasri, H; Heringer, S; Mpotsaris, A; Kramer, M; Wiesmann, M; Nikoubashman, O				Sandmann, Johanna; Sichtermann, Thorsten; Mueschenich, Franziska Sonja; Nasri, Hadi; Heringer, Sarah; Mpotsaris, Anastasios; Kramer, Martin; Wiesmann, Martin; Nikoubashman, Omid			Intra-arterial pulse wave analysis during thrombectomy for the assessment of collateral status - A feasibility study	PLOS ONE			English	Article							ISCHEMIC-STROKE; PREDICTOR; PRESSURE; MODEL	Purpose Knowledge of the collateralization of an occluded vessel is important for the risk-benefit analysis of difficult revascularization maneuvers during mechanical thrombectomy. If the territory behind a clot is well perfused, one could desist from performing a risky thrombectomy maneuver. The arterial pulse pressure curve may serve as an indicator for the collateralization of an occluded target vessel. We investigated the feasibility of arterial pulse measurements with a standard microcatheter. Methods We measured the intra-arterial blood pressure proximal and distal to the clot in 40 thrombectomy maneuvers in a porcine stroke model. We used a microcatheter (Trevo Pro 18, Stryker, Kalamazoo, CA, USA), a pressure transducer (MEMSCAP SP844), an AdInstruments Powerlab 16/35 workstation, and LabChart 8 Software (AdInstruments, Dunedin, New Zealand). Results Median arterial blood pressure proximal and distal to the clot was 96.0 mmHg (IQR, 23.8 mmHg) and 47.5 mmHg (IQR, 43.5 mmHg), respectively (p <.001). The median difference between systolic maximum and diastolic minimum proximal and distal to the clot decreased significantly from 1.8 mmHg (IQR, 3.6 mmHg) to 0.0 mmHg (IQR, 0.5 mmHg) (p <.001). There was loss of the curve in 26 of 40 cases and loss of pressure in 23 of 40 cases (p =.008). There was no significant correlation between vessel diameter and either loss of the pulse pressure curve (p =.20) or overall pressure loss (p =.31). Conclusion It is possible to measure the pulse pressure proximal and distal to the clot with a standard microcatheter used during mechanical thrombectomy.	[Sandmann, Johanna; Sichtermann, Thorsten; Mueschenich, Franziska Sonja; Nasri, Hadi; Heringer, Sarah; Mpotsaris, Anastasios; Wiesmann, Martin; Nikoubashman, Omid] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Univ Hosp, Aachen, Germany; [Kramer, Martin] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Giessen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Justus Liebig University Giessen	Sandmann, J (corresponding author), Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Univ Hosp, Aachen, Germany.	jsandmann@ukaachen.de	Wiesmann, Martin/GLU-1902-2022; Sichtermann, Thorsten/AAA-2045-2022; Mpotsaris, Anastasios/O-2247-2016	Sichtermann, Thorsten/0000-0002-9115-9548; Mpotsaris, Anastasios/0000-0002-1275-8164				Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326; Chueh JY, 2016, J NEUROINTERV SURG, V8, P197, DOI 10.1136/neurintsurg-2014-011491; Gounis MJ, 2013, STROKE, V44, pS7, DOI 10.1161/STROKEAHA.111.000692; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Gralla J, 2006, AM J NEURORADIOL, V27, P1357; Henkes H, 1999, BRIT J RADIOL, V72, P448, DOI 10.1259/bjr.72.857.10505007; Keulers A, 2019, J NEUROINTERV SURG, V11, P653, DOI 10.1136/neurintsurg-2018-014267; Kucinski T, 2003, NEURORADIOLOGY, V45, P11, DOI 10.1007/s00234-002-0881-0; Lenis G, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/9295029; Massari F, 2016, INTERV NEURORADIOL, V22, P325, DOI 10.1177/1591019916632369; Maus V, 2018, CLIN NEURORADIOL, V28, P327, DOI 10.1007/s00062-017-0566-z; Nikoubashman O, 2015, AM J NEURORADIOL, V36, P1162, DOI 10.3174/ajnr.A4240; Othman AE, 2016, J NEURORADIOLOGY, V43, P1, DOI 10.1016/j.neurad.2015.06.003; Robbie LA, 1997, THROMB HAEMOSTASIS, V77, P510; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Sorimachi T, 2005, J NEUROSURG, V102, P870, DOI 10.3171/jns.2005.102.5.0870; Sorimachi T, 2011, J NEUROINTERV SURG, V3, P43, DOI 10.1136/jnis.2010.003061; van der Born IMJ, 2012, AM J NEURORADIOL, V33, P353, DOI 10.3174/ajnr.A2944; Wiesmann M, 2017, J NEUROINTERV SURG, V9, P253, DOI 10.1136/neurintsurg-2016-012322	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210572	10.1371/journal.pone.0210572	http://dx.doi.org/10.1371/journal.pone.0210572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629721	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000110
J	Buchner, DL; Kitutu, FE; Cross, DE; Nakamoga, E; Awor, P				Buchner, Denise Lynn; Kitutu, Freddy Eric; Cross, Donall Eoin; Nakamoga, Esther; Awor, Phyllis			A cross-sectional study to identify the distribution and characteristics of licensed and unlicensed private drug shops in rural Eastern Uganda to inform an iCCM intervention to improve health outcomes for children under five years	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; PNEUMONIA; CARE; DIARRHEA; SERVICES; MALARIA; POOR	Introduction Malaria, pneumonia and diarrhea are leading causes of death in young children in Uganda. Between 50-60% of sick children receive treatment from the private sector, especially drug shops. There is an urgent need to improve quality of care and regulation of private drug shops in Uganda. This study was conducted to determine the distribution, the licensing status and characteristics of drug shops in four sub-districts of Kamuli district. Methods This study was part of a pre-post cross sectional study that examined the implementation of an integrated Community Case Management (iCCM) intervention for common childhood illness in rural private drug shops in Kamuli District in Eastern Uganda. This mapping exercise used a snowball sampling technique to identify licensed and unlicensed drug shops and collect information about their characteristics. Data were collected using a questionnaire. GPS data were collected for all drug shops. Analysis Quantitative data were analyzed using SPSS for descriptive statistics. Open ended questions were entered into NVivo 10 and analyzed using thematic analysis strategies. Results In total, 215 drug shops in 284 villages were located. Of these, 123 (57%) were open and consented to an interview. Only 12 (10%) drug shops were licensed, 93 (76%) were unlicensed, and the licensing status of 18 (15%) was unknown. Most respondents were the owner of the drug shop (88%); most drug sellers reported their qualification as nursing assistants (70%). Drug sellers reported licensing fees and costs of contracting an "in-charge" as barriers to licensing. Nearly all drug shops sold drugs for malaria (91%) and antibiotics (79%).	[Buchner, Denise Lynn] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Kitutu, Freddy Eric] Makerere Univ, Pharm Dept, Kampala, Uganda; [Kitutu, Freddy Eric] Upsala Univ, Dept Womans & Childrens Hlth, Uppsala, Sweden; [Cross, Donall Eoin] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Nakamoga, Esther; Awor, Phyllis] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of Calgary; Makerere University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Makerere University	Buchner, DL (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.	dlbuchne@ucalgary.ca	Kitutu, Freddy/AAM-8187-2020	Kitutu, Freddy/0000-0003-2277-9572; Cross, Donall Eoin/0000-0002-4974-951X	Grand Challenges Canada Stars in Global Health Round Six [0492-01-10]	Grand Challenges Canada Stars in Global Health Round Six	This work is supported by Grand Challenges Canada Stars in Global Health Round Six (#0492-01-10), http://www.grandchallenges.ca/programs/stars-in-global-health/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini A, 2012, TROP MED INT HEALTH, V17, P147, DOI 10.1111/j.1365-3156.2011.02904.x; Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; [Anonymous], 2006, POTENTIAL PRIVATE SE; Awor P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0798-9; Awor P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115440; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Bryce J, 2005, PROGRAMMATIC PATHWAY; Bryce J, 2005, IMPROVING QUALITY EF; Bryce J, 2005, 10 METHODOLOGICAL LE; Buchner D, 2015, BMJ OPEN, P5; Buchner D, 2011, STORIES ENDINGS ILLN; Buregyeya E, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1842-8; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Gyapong M.G., 2007, LESSONS LEARNED HOME; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; Kalyango JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-340; King C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011636; Kitutu F, 2017, MALARIA J, V16; Kitutu F, 2017, BMJ GLOBAL HLTH, P2; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Mamdani M, 2004, REPROD HEALTH MATTER, V12, P138, DOI 10.1016/S0968-8080(04)24135-0; Mayora C, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3343-z; Ministry of Health, 2015, STAT ABSTR; Ministry of Health (MOH), 2010, INT COMM CAS MAN CHI; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Nanyonjo A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0202-y; National Drug Authority, 2015, LIC REQ GUID; National Drug Authority, 2013, GUID EQ DISTR PHARM; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Rusk A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-263; Rutebemberwa E, 2009, MALARIA J, V8, P1; Rutebemberwa E, 2012, AM J TROP MED HYG, V87, P30, DOI 10.4269/ajtmh.2012.11-0732; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Thein S, 2017, MALARIA J, V16; Treleaven E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0747-7; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Ugandan Ministry of Health and USAID/ Uganda Health Supply Chain Program, 2016, SUPPL CHAIN SYST COM; USAID, 2015, GLOB FUND NEW FUND L; Victoria C, 2003, LANCET, V362; Wang LT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2454-7; WHO, 2005, INT MAN CHILDH ILLN; Wiysonge C, 2008, CAN WORKING PRIVATE; World Health Organization, 2013, WHO INFORMAL CONSULT; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209641	10.1371/journal.pone.0209641	http://dx.doi.org/10.1371/journal.pone.0209641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625187	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400050
J	Sumaye, R; Jansen, F; Berkvens, D; De Baets, B; Geubels, E; Thiry, E; Krit, M				Sumaye, Robert; Jansen, Famke; Berkvens, Dirk; De Baets, Bernard; Geubels, Eveline; Thiry, Etienne; Krit, Meryam			Rift Valley fever: An open-source transmission dynamics simulation model	PLOS ONE			English	Article							AEDES-AEGYPTI L.; VIRUS-INFECTION; SAUDI-ARABIA; SOUTH-AFRICA; RISK-FACTORS; OUTBREAK; PREVALENCE; SURVIVAL; DIPTERA; KENYA	Rift Valley fever (RVF) is one of the major viral zoonoses in Africa, affecting humans and several domestic animal species. The epidemics in eastern Africa occur in a 5-15 year cycle coinciding with abnormally high rainfall generally associated to the warm phase of the El Nino event. However, recently, evidence has been gathered of inter-epidemic transmission. An open-source, easily applicable, accessible and modifiable model was built to simulate the transmission dynamics of RVF. The model was calibrated using data collected in the Kilombero Valley in Tanzania with people and cattle as host species and AEdes mcintoshi, AE. aegypti and two Culex species as vectors. Simulations were run over a period of 27 years using standard parameter values derived from two previous studies in this region. Our model predicts low-level transmission of RVF, which is in line with epidemiological studies in this area. Emphasis in our simulation was put on both the dynamics and composition of vector populations in three ecological zones, in order to elucidate the respective roles played by different vector species: the model output did indicate the necessity of Culex involvement and also indicated that vertical transmission in AEdes mcintoshi may be underestimated. This model, being built with open-source software and with an easy-to-use interface, can be adapted by researchers and control program managers to their specific needs by plugging in new parameters relevant to their situation and locality.	[Sumaye, Robert; Geubels, Eveline] Ifakara Hlth Inst, Ifakara, Tanzania; [Sumaye, Robert; Jansen, Famke; Berkvens, Dirk; Krit, Meryam] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sumaye, Robert; Thiry, Etienne] Univ Liege, Fac Vet Sci, Liege, Belgium; [De Baets, Bernard] Univ Ghent, Fac Biosci Engn, Dept Data Anal & Math Modelling, Ghent, Belgium	Ifakara Health Institute; Institute of Tropical Medicine (ITM); University of Liege; Ghent University	Krit, M (corresponding author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	mkrit@itg.be		Sumaye, Robert/0000-0001-9734-3226	Robert Sumaye's PhD grant; Belgian Directorate-General for Development Cooperation (DGD)	Robert Sumaye's PhD grant; Belgian Directorate-General for Development Cooperation (DGD)	This work was supported by Robert Sumaye's PhD grant, obtained from the Belgian Directorate-General for Development Cooperation (DGD) within the Framework Agreement between DGD and ITM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuElyazeed R, 1996, B WORLD HEALTH ORGAN, V74, P155; Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671; Anderson EC, 1998, EPIDEMIOL INFECT, V121, P441, DOI 10.1017/S0950268898001289; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P17; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P169; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Anyangu AS, 2010, AM J TROP MED HYG, V83, P14, DOI 10.4269/ajtmh.2010.09-0293; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; Arsevska E, 2016, TRANSBOUND EMERG DIS, V63, P658, DOI 10.1111/tbed.12331; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bosworth A., 2016, New Microbes and New Infections, V9, P1, DOI 10.1016/j.nmni.2015.10.010; Canyon DV, 1999, J MED ENTOMOL, V36, P301, DOI 10.1093/jmedent/36.3.301; CDC, 2018, RVF FACTSHEET; Chevalier V, 2009, TRANSBOUND EMERG DIS, V56, P372, DOI 10.1111/j.1865-1682.2009.01083.x; Danzetta ML, 2016, PREV VET MED, V134, P197, DOI 10.1016/j.prevetmed.2016.09.007; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Davies FG, 2010, AM J TROP MED HYG, V83, P73, DOI 10.4269/ajtmh.2010.83s2a02; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; Di Nardo A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-92; Durand JP, 2003, EMERG INFECT DIS, V9, P751; Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806; Failloux Anna-Bella, 2017, Curr Trop Med Rep, V4, P27, DOI 10.1007/s40475-017-0101-y; Faull KJ, 2015, J VECTOR ECOL, V40, P292, DOI 10.1111/jvec.12167; Fischer EAJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-58; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; Gaff H, 2007, ELECTRON J DIFFER EQ, V115, P1, DOI DOI 10.1155/2012/138757; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gur S, 2017, TROP ANIM HEALTH PRO, V49, P1531, DOI 10.1007/s11250-017-1359-8; KITCHEN S. F., 1934, American Journal of Tropical Medicine, V14, P547; LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082; LaBeaud AD, 2011, AM J TROP MED HYG, V84, P641, DOI 10.4269/ajtmh.2011.10-0187; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; MCCLELLAND GAH, 1963, ANN TROP MED PARASIT, V57, P214, DOI 10.1080/00034983.1963.11686176; MCINTOSH BM, 1980, S AFR MED J, V58, P803; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Niu TC, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/138757; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Olive MM, 2012, J WILDLIFE DIS, V48, P241, DOI 10.7589/0090-3558-48.2.241; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; SMITHBURN KC, 1949, J IMMUNOL, V62, P213; Soti V, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-10; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Sumaye RD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003536; Swai ES, 2009, VECTOR-BORNE ZOONOT, V9, P579, DOI 10.1089/vbz.2008.0108; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tandon Neelam, 2000, Dengue Bulletin, V24, P117; Tchouassi DP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1473-x; Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136; WHITTLE RK, 1993, J AM MOSQUITO CONTR, V9, P72; WHO, 2016, RIFT VALL FEV CHIN; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2	57	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209929	10.1371/journal.pone.0209929	http://dx.doi.org/10.1371/journal.pone.0209929			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625221	Green Submitted, gold, Green Published			2022-12-26	WOS:000455359400064
J	Gallinari, MD; Cintra, LTA; Benetti, F; Rahal, V; Ervolino, E; Briso, ALF				Gallinari, Marjorie de Oliveira; Angelo Cintra, Luciano Tavares; Benetti, Francine; Rahal, Vanessa; Ervolino, Edilson; Fraga Briso, Andre Luiz			Pulp response of rats submitted to bleaching and the use of different anti-inflammatory drugs	PLOS ONE			English	Article							COLOR ALTERATION; SUBSTANCE-P; DENTAL-PULP; ACETAMINOPHEN; NEUROPEPTIDES; HOME	This study aimed to evaluate neuropeptide expression after bleaching treatment using histopathological and immunohistochemical analyses and the effects of hydrocortisone and acetaminophen on pulp inflammation, sine dental bleaching and inflammation first occur, and only then, the treatmentt. Sixty-three rats were divided into three groups (n = 21) according to the pain-relieving therapy used: I-control; II-topical application of Otosporin for 10 min after the bleaching treatment; Ill-oral administration of paracetamol 30 min before whitening and then every 12h. In all the study groups, placebo gel was applied to the left upper jaw (control) and a 35% H2O2-based whitening gel was applied to the right upper jaw for 45 min. Seven animals from each group were euthanized at different time points: 0h after treatment, 24h, and 48h. After euthanasia, the first molar on each side was analyzed by histology and immunohistochemistry to assess the degree of inflammation and verify the presence of the neuropeptides, substance P (SP) and calcitonin gene-related peptide (CGRP). The data were analyzed using the statistical nonparametric Kruskal-Wallis test followed by Dunn's test for individual comparisons. Extensive areas of necrosis were observed in the groups that received bleaching treatment only, whereas reduced damage were obtained in the group treated with Otosporin. The immunohistochemical analysis showed positive immuno-labeling in all groups, including the control, but this was stronger in the groups that received bleaching treatment. The best results were obtained in the group that received treatment with Otosporin. The use of Otosporin after dental bleaching minimized the side effects of this treatment.	[Gallinari, Marjorie de Oliveira; Angelo Cintra, Luciano Tavares; Benetti, Francine; Rahal, Vanessa; Fraga Briso, Andre Luiz] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Restorat Dent, Aracatuba, SP, Brazil; [Ervolino, Edilson] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Basic Sci, Aracatuba, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Briso, ALF (corresponding author), UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Restorat Dent, Aracatuba, SP, Brazil.	alfbriso@foa.unesp.br	Briso, Andre/AID-8946-2022; Gallinari, Marjorie/G-6093-2014; Benetti, Francine/N-2836-2013; Briso, André/AAQ-9746-2021; Cintra, Luciano/C-4936-2012; Briso, Andre/C-2792-2012	Briso, Andre/0000-0002-6126-1760; Gallinari, Marjorie/0000-0002-1804-9625; Benetti, Francine/0000-0002-5459-353X; Cintra, Luciano/0000-0003-2348-7846; ervolino, edilson/0000-0003-4859-0583	Sao Paulo Research Foundation (FAPESP) - Brazil [2015/01366-4, 2015/ 24090-4, 2015/21682-8]	Sao Paulo Research Foundation (FAPESP) - Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by research grants form Sao Paulo Research Foundation (FAPESP) - Brazil (#2015/01366-4, 2015/ 24090-4, and 2015/21682-8). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Almeida LCAG, 2015, CLIN ORAL INVEST, V19, P673, DOI 10.1007/s00784-014-1285-3; Cintra LTA, 2013, J ENDODONT, V39, P1576, DOI 10.1016/j.joen.2013.08.007; Basting RT, 2012, OPER DENT, V37, P464, DOI 10.2341/11-337-C; Benetti F, 2017, ARCH ORAL BIOL, V81, P103, DOI 10.1016/j.archoralbio.2017.04.013; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; Briso ALF, 2014, OPER DENT, V39, P166, DOI 10.2341/13-014-L; Briso ALF, 2010, LASER PHYS, V20, P2066, DOI 10.1134/S1054660X10210036; Caviedes-Bucheli J, 2006, INT ENDOD J, V39, P394, DOI 10.1111/j.1365-2591.2006.01093.x; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P773, DOI 10.1016/j.joen.2008.03.010; Cintra LTA, 2017, INT ENDOD J, V50, P790, DOI 10.1111/iej.12692; Cintra Luciano Tavares Angelo, 2016, Braz. Dent. J., V27, P169, DOI 10.1590/0103-6440201600329; Costa CAD, 2010, ORAL SURG ORAL MED O, V109, pE59, DOI 10.1016/j.tripleo.2009.12.002; de Almeida LCDG, 2012, INT J PERIODONT REST, V32, P303; Fracon RN, 2010, J APPL ORAL SCI, V18, P630, DOI 10.1590/S1678-77572010000600016; FRY A E, 1960, Oral Surg Oral Med Oral Pathol, V13, P594, DOI 10.1016/0030-4220(60)90491-6; Gallinari MO, 2018, NEW APPROACH DENT BL; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Holland R., 1991, REV ODONTOL UNESP, V20, P17; Kepler CK, 2013, SPINE, V38, pE1291, DOI 10.1097/BRS.0b013e3182a42bc2; LUYK NH, 1985, BRIT DENT J, V159, P12, DOI 10.1038/sj.bdj.4805630; Machado LS, 2016, INT J PERIODONT REST, V36, P251, DOI 10.11607/prd.2383; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Perdigao J, 2010, NW DENT, V89, P3; Perdigao Jorge, 2010, Northwest Dent, V89, P19; Roderjan Douglas Augusto, 2015, Braz. Dent. J., V26, P242, DOI 10.1590/0103-6440201302282; Silva Fabiane Bortoluci da, 2004, Braz. oral res., V18, P174, DOI 10.1590/S1806-83242004000200015; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Soares DG, 2014, J DENT, V42, P185, DOI 10.1016/j.jdent.2013.10.021; Souza V, 1996, REV ODONTOLOGICA UNE, V25, P181; Tay LY, 2009, J AM DENT ASSOC, V140, P1245, DOI 10.14219/jada.archive.2009.0047; Viola Thomas A, 2013, Gen Dent, V61, P14; Williams H A, 1992, Quintessence Int, V23, P673; Zhang Zhao, 2018, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V30, P369, DOI 10.3760/cma.j.issn.2095-4352.2018.04.017	34	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210338	10.1371/journal.pone.0210338	http://dx.doi.org/10.1371/journal.pone.0210338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620760	gold, Green Published, Green Submitted			2022-12-26	WOS:000455161300029
J	Hu, FZ; Krol, JE; Tsai, CHS; Eutsey, RA; Hiller, LN; Sen, B; Ahmed, A; Hillman, T; Buchinsky, FJ; Nistico, L; Dice, B; Longwell, M; Horsey, E; Ehrlich, GD				Hu, Fen Z.; Krol, Jaroslaw E.; Tsai, Chen Hsuan Sherry; Eutsey, Rory A.; Hiller, Luisa N.; Sen, Bhaswati; Ahmed, Azad; Hillman, Todd; Buchinsky, Farrel J.; Nistico, Laura; Dice, Bethany; Longwell, Mark; Horsey, Edward; Ehrlich, Garth D.			Deletion of genes involved in the ketogluconate metabolism, Entner-Doudoroff pathway, and glucose dehydrogenase increase local and invasive virulence phenotypes in Streptococcus pneumoniae	PLOS ONE			English	Article							FRUITING BODY MORPHOGENESIS; URONIC ACID METABOLISM; OTITIS-MEDIA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CARBOHYDRATE-METABOLISM; BACTERIAL BIOFILMS; BINDING-PROTEIN; ALPHA-ENOLASE; COMPETENCE; SURFACE	Streptococcus pneumoniae displays increased resistance to antibiotic therapy following bio-film formation. A genome-wide search revealed that SP 0320 and SP 0675 (respectively annotated as 5-keto-D-gluconate-5-reductase and glucose dehydrogenase) contain the highest degree of homology to CsgA of Myxococcus xanthus, a signaling factor that promotes cell aggregation and biofilm formation. Single and double SP 0320 and SP 0675 knockout mutants were created in strain BS72; however, no differences were observed in the biofilm-forming phenotypes of mutants compared to the wild type strain. Using the chin-chilla model of otitis media and invasive disease, all three mutants exhibited greatly increased virulence compared to the wild type strain (increased pus formation, tympanic membrane rupture, mortality rates). The SP 0320 gene is located in an operon with SP 0317, SP 0318 and SP 0319, which we bioinformatically annotated as being part of the Entner-Doudoroff pathway. Deletion of SP 0317 also resulted in increased mortality in chin-chillas; however, mutations in SP 0318 and SP 0319 did not alter the virulence of bacteria compared to the wild type strain. Complementing the SP 0317, SP 0320 and SP 0675 mutant strains reversed the virulence phenotype. We prepared recombinant SP 0317, SP 0318, SP 0320 and SP 0675 proteins and confirmed their functions. These data reveal that disruption of genes involved in the degradation of ketogluconate, the Entner-Doudoroff path-way, and glucose dehydrogenase significantly increase the virulence of bacteria in vivo; two hypothetical models involving virulence triggered by reduced in carbon-flux through the glycolytic pathways are presented.	[Hu, Fen Z.; Krol, Jaroslaw E.; Tsai, Chen Hsuan Sherry; Sen, Bhaswati; Ahmed, Azad; Ehrlich, Garth D.] Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA; [Hu, Fen Z.; Krol, Jaroslaw E.; Tsai, Chen Hsuan Sherry; Sen, Bhaswati; Ahmed, Azad] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Krol, Jaroslaw E.; Sen, Bhaswati; Ahmed, Azad; Ehrlich, Garth D.] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Adv Microbial Proc, Philadelphia, PA 19104 USA; [Eutsey, Rory A.; Hiller, Luisa N.; Ehrlich, Garth D.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Hillman, Todd; Buchinsky, Farrel J.; Nistico, Laura; Dice, Bethany; Longwell, Mark; Horsey, Edward; Ehrlich, Garth D.] Allegheny Hlth Network, Ctr Excellence Biofilm Res, Pittsburgh, PA 15212 USA	Drexel University; Drexel University; Drexel University; Drexel University; Carnegie Mellon University	Hu, FZ; Ehrlich, GD (corresponding author), Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.; Hu, FZ (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.; Hu, FZ; Ehrlich, GD (corresponding author), Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA.; Ehrlich, GD (corresponding author), Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Adv Microbial Proc, Philadelphia, PA 19104 USA.; Ehrlich, GD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.; Ehrlich, GD (corresponding author), Allegheny Hlth Network, Ctr Excellence Biofilm Res, Pittsburgh, PA 15212 USA.	fhu168168@gmail.com; GE33@drexel.edu	Buchinsky, Farrel/AAC-2080-2020; hiller, N. Luisa/A-3739-2016	Buchinsky, Farrel/0000-0002-2830-6023; hiller, N. Luisa/0000-0001-6572-1368; , Jaroslaw/0000-0002-2755-8739	National Institutes of Health [AI080935, DC02148, DC04173]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) Valid : Garth D Ehrlich AI080935; National Institutes of Health (NIH) Valid : Garth D Ehrlich DC02148; National Institutes of Health (NIH) Valid : Garth D Ehrlich DC04173.	Aul JJ, 1998, ANN OTO RHINOL LARYN, V107, P508; Avigad G, 1975, Methods Enzymol, V41, P142; Bakaletz LO, 2009, EXPERT REV VACCINES, V8, P1063, DOI 10.1586/ERV.09.63; Bausch C, 2004, J BACTERIOL, V186, P1388, DOI 10.1128/JB.186.5.1388-1397.2004; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; Chapuy-Regaud S, 2003, INFECT IMMUN, V71, P2615, DOI 10.1128/IAI.71.5.2615-2625.2003; CLAVERYS JP, 1995, GENE, V164, P123, DOI 10.1016/0378-1119(95)00485-O; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; CYNKIN MA, 1960, J BIOL CHEM, V235, P1576; Dagan R, 2001, J INFECT DIS, V183, P880, DOI 10.1086/319250; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Franza T, 2002, MOL PLANT MICROBE IN, V15, P1181, DOI 10.1094/MPMI.2002.15.11.1181; GIEBINK GS, 1981, REV INFECT DIS, V3, P342; GIEBINK GS, 1976, J INFECT DIS, V134, P595, DOI 10.1093/infdis/134.6.595; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Griffiths JS, 2002, BIOORGAN MED CHEM, V10, P545, DOI 10.1016/S0968-0896(01)00307-8; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Herbert D., 1971, METHODS MICROBIOLOGY, V5, P290, DOI [DOI 10.1016/S0580-9517(08)70641-X, 10.1007/978-3-030-30515-4_14]; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hiller NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028850; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hu FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047983; HUGOUVIEUXCOTTEPATTAT N, 1994, J BACTERIOL, V176, P2386, DOI 10.1128/JB.176.8.2386-2392.1994; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KIM SK, 1991, TRENDS GENET, V7, P361, DOI 10.1016/0168-9525(91)90256-P; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V; King SJ, 2004, MOL MICROBIOL, V54, P159, DOI 10.1111/j.1365-2958.2004.04252.x; KOVACHEVICH R, 1955, J BIOL CHEM, V213, P745; Kruse T, 2001, MOL MICROBIOL, V40, P156, DOI 10.1046/j.1365-2958.2001.02365.x; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; LIN ECC, 1996, ESCHERICHIA COLI SAL, P307; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Myers C, 2007, INT J ANTIMICROB AG, V30, pS24, DOI 10.1016/j.ijantimicag.2007.06.018; Nistico L, 2011, J CLIN MICROBIOL, V49, P1411, DOI 10.1128/JCM.00756-10; Ohshima T, 2007, PROTEIN EXPRES PURIF, V54, P73, DOI 10.1016/j.pep.2007.02.013; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; PORTALIER RC, 1974, MOL GEN GENET, V128, P301, DOI 10.1007/BF00268518; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; POUYSSEGJM, 1971, EUR J BIOCHEM, V21, P363, DOI DOI 10.1111/J.1432-1033.1971.TB01478.X; POUYSSEGUR J, 1974, J BACTERIOL, V117, P641, DOI 10.1128/JB.117.2.641-651.1974; POUYSSEGUR J, 1971, BIOCHIMIE, V53, P771, DOI 10.1016/S0300-9084(71)80118-9; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; ROBERTBAUDOUY JM, 1974, MOL GEN GENET, V131, P31, DOI 10.1007/BF00269385; Roos KL, 2000, SEMIN NEUROL, V20, P293, DOI 10.1055/s-2000-9393; Sa-Leao R, 2006, MICROBIOL-SGM, V152, P367, DOI 10.1099/mic.0.28596-0; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Shankarappa B, 1992, PCR Methods Appl, V1, P277; SHIMKETS LJ, 1990, J BACTERIOL, V172, P5299, DOI 10.1128/jb.172.9.5299-5306.1990; SMILEY JD, 1960, J BIOL CHEM, V235, P1571; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; Watanabe S, 2013, J INFECT DIS, V208, P1482, DOI 10.1093/infdis/jit353; Wu R, THE CRYSTAL STRUCTUR	72	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0209688	10.1371/journal.pone.0209688	http://dx.doi.org/10.1371/journal.pone.0209688			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620734	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300008
J	Santiago-Moreno, J; Bernal, B; Perez-Cerezales, S; Castano, C; Toledano-Diaz, A; Esteso, MC; Gutierrez-Adan, A; Lopez-Sebastian, A; Gil, MG; Woelders, H; Blesbois, E				Santiago-Moreno, Julian; Bernal, Berenice; Perez-Cerezales, Serafin; Castano, Cristina; Toledano-Diaz, Adolfo; Esteso, Milagros C.; Gutierrez-Adan, Alfonso; Lopez-Sebastian, Antonio; Gil, Maria G.; Woelders, Henri; Blesbois, Elisabeth			Seminal plasma amino acid profile in different breeds of chicken: Role of seminal plasma on sperm cryoresistance	PLOS ONE			English	Article							FREEZE-THAW DAMAGE; DENSITY-LIPOPROTEINS; FERTILIZING ABILITY; DOMESTIC-FOWL; VAS-DEFERENS; COLD-SHOCK; SEMEN; SPERMATOZOA; PROTEINS; DNA	Seminal plasma is a key biological fluid that modulates sperm function in the reproduction process. However, its role in sperm biotechnologies is scarce in poultry. The aims of the present study were to study the amino acids profile and total proteins of seminal plasma in 12 Spanish chicken breeds and to investigate the role of seminal plasma on cryoresistance of rooster sperm. To investigate the role of seminal plasma on cryoresistance, diluted pooled semen samples were cryopreserved in the presence and absence of seminal plasma. Glutamic acid was the most abundant free amino acid in seminal plasma, followed by alanine, serine, valine, and glycine. There was an influence of breed (P<0.05) on the percentage of viable sperm after freezing-thawing of samples with seminal plasma. Cluster analysis revealed that White Prat, Black Castellana, Blue Andaluza, Quail Castellana, and Red-Barred Vasca returned the best freezing-thawing response (good freezers). There was a positive correlation between seminal plasma concentrations of valine, isoleucine lysine, leucine and post thaw viability. The evaluation of fertilization capacity of frozen-thawed semen from the breeds White Prat ('good freezer') and Black-Red Andaluza ('bad freezer') showed that good freezer had higher fertility (20/68, 29.4%) compared to bad freezer breed (14/76, 18.4%), even if the difference was not significant (P = 0.08). The TUNEL assay revealed that freezing/thawing procedures in presence of seminal plasma provoked higher DNA fragmentation in most of the breeds, with a positive correlation between seminal alanine, valine, isoleucine, methionine, leucine, tyrosine, phenylalanine concentrations and DNA integrity. DNA fragmentation was lower in absence of seminal plasma and the breed effect on sperm viability was highly reduced. It is concluded that specific seminal plasma amino acids were associated with post-thaw percentage of viable sperm and DNA integrity. The removal of seminal plasma decreases the variability of the results and DNA fragmentation damages.	[Santiago-Moreno, Julian; Bernal, Berenice; Perez-Cerezales, Serafin; Castano, Cristina; Toledano-Diaz, Adolfo; Esteso, Milagros C.; Gutierrez-Adan, Alfonso; Lopez-Sebastian, Antonio] INIA, Dept Reprod Anim, Madrid, Spain; [Gil, Maria G.] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Woelders, Henri] Wageningen Univ & Res, Anim Breeding & Genom, Wageningen, Netherlands; [Blesbois, Elisabeth] Univ Francois Rabelais Haras Nationaux, CNRS, INRA, UMR Physiol Reprod & Comportements, Nouzilly, France	Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); INRAE	Santiago-Moreno, J (corresponding author), INIA, Dept Reprod Anim, Madrid, Spain.	moreno@inia.es	Juárez, Berenice Bernal/AAS-7598-2020; GARCIA-GIL, MARIA/Q-6585-2017; Gutierrez-Adan, Alfonso/A-1485-2014; SANTIAGO, JULIAN/K-5547-2017; Perez-Cerezales, Serafin/F-8494-2014	GARCIA-GIL, MARIA/0000-0003-2856-277X; Gutierrez-Adan, Alfonso/0000-0001-9893-9179; SANTIAGO, JULIAN/0000-0001-5551-8120; Perez-Cerezales, Serafin/0000-0003-2119-6228; Bernal Juarez, Berenice/0000-0001-9144-1554	European Union's Horizon 2020 Research and Innovation Programme [677353]	European Union's Horizon 2020 Research and Innovation Programme	The study reported here was part of a project that has received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No677353.	AHLUWALIA BS, 1966, J REPROD FERTIL, V12, P365, DOI 10.1530/jrf.0.0120365; AITKEN RJ, 1995, HUM REPROD, V10, P2061, DOI 10.1093/oxfordjournals.humrep.a136237; Al Ahmad MZA, 2008, REPROD DOMEST ANIM, V43, P429, DOI 10.1111/j.1439-0531.2007.00930.x; ALAGHBARI A, 1992, BIOL REPROD, V47, P1059, DOI 10.1095/biolreprod47.6.1059; Amidi F, 2016, CELL TISSUE BANK, V17, P745, DOI 10.1007/s10561-016-9566-5; ANCHORDOGUY T, 1988, BIOCHIM BIOPHYS ACTA, V946, P299, DOI 10.1016/0005-2736(88)90405-1; Atessahin A, 2008, SMALL RUMINANT RES, V77, P38, DOI 10.1016/j.smallrumres.2008.03.002; Ausio J, 2014, J STRUCT BIOL, V188, P142, DOI 10.1016/j.jsb.2014.09.004; BERGER T, 1985, J ANIM SCI, V60, P1295, DOI 10.2527/jas1985.6051295x; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; BLESBOIS E, 1990, J REPROD FERTIL, V90, P473, DOI 10.1530/jrf.0.0900473; BLESBOIS E, 1992, J REPROD FERTIL, V95, P263, DOI 10.1530/jrf.0.0950263; Bucak MN, 2010, CRYOBIOLOGY, V61, P248, DOI 10.1016/j.cryobiol.2010.09.001; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Caballero I, 2012, REPROD DOMEST ANIM, V47, P12, DOI 10.1111/j.1439-0531.2012.02028.x; Cabrita E, 2011, ANIM REPROD SCI, V125, P189, DOI 10.1016/j.anireprosci.2011.03.003; Campo J. L., 1982, P 2 WORLD C GEN APPL, P88; Campo JL, 1998, P 6 WORLD C GEN APPL, P155; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; Chalah T, 1998, THERIOGENOLOGY, V50, P487, DOI 10.1016/S0093-691X(98)00155-1; CHIVA M, 1987, FEBS LETT, V215, P237, DOI 10.1016/0014-5793(87)80153-9; CHU T M, 1974, Australian Journal of Plant Physiology, V1, P87; Coloma MA, 2010, THERIOGENOLOGY, V73, P900, DOI 10.1016/j.theriogenology.2009.11.014; Csapo J., 2008, Acta Universitatis Sapientiae - Alimentaria, V1, P5; Douard W, 2005, THERIOGENOLOGY, V63, P126, DOI 10.1016/j.theriogenology.2004.03.020; El-Sheshtawy R. I., 2008, Global Veterinaria, V2, P146; ELJACK MH, 1969, Q J EXP PHYSIOL CMS, V54, P332, DOI 10.1113/expphysiol.1969.sp002031; Farshad A, 2013, SMALL RUMINANT RES, V114, P258, DOI 10.1016/j.smallrumres.2013.07.007; Froman D, 2003, BIOL REPROD, V69, P248, DOI 10.1095/biolreprod.102.013482; Froman DP, 2005, BIOL REPROD, V72, P562, DOI 10.1095/biolreprod.104.035113; FUJIHARA N, 1992, WORLD POULTRY SCI J, V48, P39, DOI 10.1079/WPS19920005; GARCIA MA, 1987, CRYOBIOLOGY, V24, P446, DOI 10.1016/0011-2240(87)90048-4; Gliozzi TM, 2017, BRIT POULTRY SCI, V58, P578, DOI 10.1080/00071668.2017.1354355; Gliozzi TM, 2011, THERIOGENOLOGY, V75, P1613, DOI 10.1016/j.theriogenology.2011.01.001; Harkema W, 2004, THERIOGENOLOGY, V61, P215, DOI 10.1016/S0093-691X(03)00223-1; HEBER U, 1971, BIOCHIM BIOPHYS ACTA, V241, P578, DOI 10.1016/0005-2736(71)90056-3; KADURA SN, 1983, COMP BIOCHEM PHYS B, V74, P819, DOI 10.1016/0305-0491(83)90152-9; Khan RU, 2012, ANIM REPROD SCI, V135, P85, DOI 10.1016/j.anireprosci.2012.09.005; Khiabani AB, 2017, ANIM REPROD SCI, V184, P172, DOI 10.1016/j.anireprosci.2017.07.013; KRUUV J, 1992, CRYOBIOLOGY, V29, P291, DOI 10.1016/0011-2240(92)90028-Z; Kundu CN, 2001, CRYOBIOLOGY, V42, P21, DOI 10.1006/cryo.2001.2296; Labas V, 2015, J PROTEOMICS, V112, P313, DOI 10.1016/j.jprot.2014.07.024; LAKE PE, 1984, BRIT POULTRY SCI, V25, P145, DOI 10.1080/13632758408454852; LAKE PE, 1968, J REPROD FERTIL, V15, P139, DOI 10.1530/jrf.0.0150139; LAKE PE, 1959, BIOCHEM J, V71, P303, DOI 10.1042/bj0710303; LALONDE RJ, 1991, BIOCHIM BIOPHYS ACTA, V1079, P128, DOI 10.1016/0167-4838(91)90117-I; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Long JA, 2014, ANIMAL ANDROLOGY: THEORIES AND APPLICATIONS, P197, DOI 10.1079/9781780643168.0197; Lopez-Perez A, 2012, THERIOGENOLOGY, V77, P395, DOI 10.1016/j.theriogenology.2011.08.013; Mann T., 1981, MALE REPROD FUNCTION, P269; Marzoni M, 2013, ANIM REPROD SCI, V140, P216, DOI 10.1016/j.anireprosci.2013.06.009; Moce E, 2010, ANIM REPROD SCI, V122, P359, DOI 10.1016/j.anireprosci.2010.10.010; MOORE S, 1963, METHOD ENZYMOL, V6, P819, DOI 10.1016/0076-6879(63)06257-1; Ogretmen F, 2015, THERIOGENOLOGY, V83, P1548, DOI 10.1016/j.theriogenology.2015.02.001; Partyka A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7279341; Partyka A, 2010, THERIOGENOLOGY, V74, P1019, DOI 10.1016/j.theriogenology.2010.04.032; Perez-Pe R, 2001, THERIOGENOLOGY, V56, P425, DOI 10.1016/S0093-691X(01)00574-X; Renard P, 1996, CRYOBIOLOGY, V33, P311, DOI 10.1006/cryo.1996.0031; SANCHEZPARTIDA LG, 1992, REPROD FERT DEVELOP, V4, P113, DOI 10.1071/RD9920113; Santiago-Moreno J, 2012, REPROD DOMEST ANIM, V47, P578, DOI 10.1111/j.1439-0531.2011.01921.x; Santiago-Moreno J, 2011, POULTRY SCI, V90, P2047, DOI 10.3382/ps.2011-01355; Sieme H, 2015, REPROD DOMEST ANIM, V50, P20, DOI 10.1111/rda.12594; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Topraggaleh TR, 2014, ANDROLOGIA, V46, P777, DOI 10.1111/and.12148; Trimeche A, 1999, THERIOGENOLOGY, V52, P181, DOI 10.1016/S0093-691X(99)00120-X; WITHERS LA, 1979, PLANT PHYSIOL, V64, P675, DOI 10.1104/pp.64.5.675	66	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209910	10.1371/journal.pone.0209910	http://dx.doi.org/10.1371/journal.pone.0209910			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608977	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800031
J	Orue, B; Lopez, J; Moreno, G; Santiago, J; Soto, M; Murua, H				Orue, Blanca; Lopez, Jon; Moreno, Gala; Santiago, Josu; Soto, Maria; Murua, Hilario			Aggregation process of drifting fish aggregating devices (DFADs) in the Western Indian Ocean: Who arrives first, tuna or non-tuna species?	PLOS ONE			English	Article							PURSE-SEINE FISHERIES; TROPICAL TUNA; THUNNUS-OBESUS; ASSOCIATIVE BEHAVIOR; FLOATING OBJECTS; YELLOWFIN TUNA; PELAGIC FISH; FADS; VARIABILITY; PRODUCTIVITY	Floating objects drifting in the surface of tropical waters, also known as drifting fish aggregating devices (DFADs), attract hundreds of marine species, including tuna and non-tuna species. Industrial tropical purse seiners have been increasingly deploying artificial man-made DFADs equipped with satellite linked echo-sounder buoys, which provide fishers with information on the accurate geo-location of the object and rough estimates of the biomass aggregated underneath, to facilitate the catch of tuna. Although several hypotheses are under consideration to explain the aggregation and retention processes of pelagic species around DFADs, the reasons driving this associative behavior are uncertain. This study uses information from 962 echo-sounder buoys attached to virgin (i.e. newly deployed) DFADs deployed in the Western Indian Ocean between 2012 and 2015 by the Spanish fleet (42,322 days observations) to determine the first detection day of tuna and non-tuna species at DFAD and to model the aggregation processes of both species group using Generalize Additive Mixed Models. Moreover, different seasons, areas and depths of the DFAD under-water structure were considered in the analysis to account for potential spatio-temporal and structure differences. Results show that tuna species arrive at DFADs before non-tuna species (13.5 +/- 8.4 and 21.7 +/- 15.1 days, respectively), and provide evidence of the significant relationship between DFAD depth and detection time for tuna, suggesting faster tuna colonization in deeper objects. For non-tuna species, this relationship appeared to be not significant. The study also reveals both seasonal and spatial differences in the aggregation patterns for different species groups, suggesting that tuna and non-tuna species may have different aggregative behaviors depending on the spatio-temporal dynamic of DFADs. This work will contribute to the understanding of the fine and mesoscale ecology and behavior of target and non-target species around DFADs and will assist managers on the sustainability of exploited resources, helping to design spatio-temporal conservation management measures for tuna and non-tuna species.	[Orue, Blanca; Lopez, Jon; Santiago, Josu; Murua, Hilario] AZTI Tecnalia, Pasaia, Gipuzkoa, Spain; [Lopez, Jon] IATTC, La Jolla, CA USA; [Moreno, Gala] ISSF, Washington, DC USA; [Soto, Maria] Inst Espanol Oceanog, Madrid, Spain	AZTI; Spanish Institute of Oceanography	Orue, B (corresponding author), AZTI Tecnalia, Pasaia, Gipuzkoa, Spain.	borue@azti.es		Lopez, Jon/0000-0002-4172-4094; Orue, Blanca/0000-0002-6823-2292	AZTI Foundation	AZTI Foundation	The study was funded by PhD grant by the AZTI Foundation. The author who receives the funds was the main author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baez JC, 2017, IOTC2017WPTT19INFO5; Bard F-X, 1985, PECHE MARITIME   OCT, P655; Baske A, 2012, ESTIMATING USE DRIFT; BLOCK BA, 2001, TUNA PHYSL ECOLOGY E; Brill RW, 1999, MAR BIOL, V133, P395, DOI 10.1007/s002270050478; Capello M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36415; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Dagorn L, 1999, CAN J FISH AQUAT SCI, V56, P984, DOI 10.1139/cjfas-56-6-984; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; Dagorn L, 2012, FISH FISH, DOI [10.1111/faf.12007, DOI 10.1111/FAF.12007]; Dagorn L, 2000, AQUAT LIVING RESOUR, P13; Dagorn L, 2007, AQUAT LIVING RESOUR, V20, P307, DOI 10.1051/alr:2008001; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2012, CAN J FISH AQUAT SCI, V69, P1463, DOI 10.1139/F2012-089; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Davies TK, 2014, MAR POLICY, V45, P163, DOI 10.1016/j.marpol.2013.12.014; Dempster T, 2003, MAR ECOL PROG SER, V258, P213, DOI 10.3354/meps258213; DINNO A., 2017, PACKAGE DUNN TEST; Doray M, 2009, ICES J MAR SCI, V66, P1410, DOI 10.1093/icesjms/fsp039; Essington TE, 2002, ECOL APPL, V12, P724; Filmalter JD, 2011, B MAR SCI, V87, P325, DOI 10.5343/bms.2010.1057; Fonteneau A., 2000, PECHE THONIERE DISPO, V28, P15; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; FOOTE KG, 1980, J ACOUST SOC AM, V67, P2084, DOI 10.1121/1.384452; Forget FG, 2015, CAN J FISH AQUAT SCI, V72, P1398, DOI 10.1139/cjfas-2014-0458; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Fuller DW, 2015, FISH RES, V172, P57, DOI 10.1016/j.fishres.2015.06.024; Ghazali SM, 2013, FISH RES; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; GOODING RM, 1967, PAC SCI, V21, P486; Govinden R., 2010, IOTC2010WPTT25; Govinden R, 2013, AQUAT LIVING RESOUR, V26, P69, DOI 10.1051/alr/2012022; Hall M., 1992, P INT WORKSH EC FISH, P396; Hall M, 2016, SAC0703E IATTC; Hallier J-P, 1992, INT WORKSH EC FISH T; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Harley S, 2009, WCPFCTCC52009IP02; Hitchcock GL, 2000, DEEP-SEA RES PT II, V47, P1605, DOI 10.1016/S0967-0645(99)00156-3; HUNTER JR, 1967, US FISH WLD S FISH B, V66, P13; IATTC I-ATTC, 2008, WCPFCSC42008FTIP3; Ishibashi Y, 2009, AQUACULTURE, V293, P157, DOI 10.1016/j.aquaculture.2009.04.029; ISSF, 2017, 201702 ISSF; Itano D, 2003, 16 16 M STAND COMM T; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Josse E, 2000, AQUAT LIVING RESOUR, V13, P183, DOI 10.1016/S0990-7440(00)00051-6; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kawamura G., 1981, MEM KAGOSHIMA U RES, V1, P3; Le Gall JY, 2000, AQUAT LIVING RESOUR, V13, P181, DOI 10.1016/S0990-7440(00)01067-6; Lennert-Cody C, 2000, DEV PURSE SEINE FISH; Lennert-Cody CE, 2008, ICES J MAR SCI, V65, P970, DOI 10.1093/icesjms/fsn075; Leroy B, 2013, AQUAT LIVING RESOUR, V26, P49, DOI 10.1051/alr/2012033; Leroy B, 2009, REV-METHODS TECHNOL, V9, P161, DOI 10.1007/978-1-4020-9640-2_10; Longhurst A.R., 1987, ECOLOGY TROPICAL OCE; Lopez J, 2016, FISH B, V114; Lopez J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3075-3; Lopez J, 2014, FISH RES, V155, P127, DOI 10.1016/j.fishres.2014.02.033; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Macusi ED, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00188; Marsac F, 2008, OUTLOOK OCEAN CLIMAT; Marsac Francis, 2000, IFREMER Actes de Colloques, V28, P537; Matsumoto T, 2014, FISH RES, V157, P78, DOI 10.1016/j.fishres.2014.03.023; Maufroy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128023; Moreno G, 2016, FISH RES, V178, P122, DOI 10.1016/j.fishres.2015.09.021; Moreno G, 2015, SAC07INFC IATTC; Moreno G, 2007, AQUAT LIVING RESOUR, V20, P343, DOI 10.1051/alr:2008015; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Murua J, 2016, 201608 ISSF; Nickson A., 2015, ESTIMATING USE FADS; Parin N.V., 1999, PELAGIC FISH COMMUNI, V11, P447; Petit C, 2000, NEW SAMPLING DATA PR; Pitcher Tony J., 1993, Fish and Fisheries Series, V7, P363; R Development Core Team, 2017, R LANG ENV STAT COMP; Robert M, 2013, J EXP MAR BIOL ECOL, V440, P238, DOI 10.1016/j.jembe.2013.01.005; Romanov EV, 2002, FISH B-NOAA, V100, P90; Romanov Evgeny V., 2008, Western Indian Ocean Journal of Marine Science, V7, P163; ROUNTREE RA, 1989, B MAR SCI, V44, P960; Santiago J, 2017, IOTC2017WGFAD0113; Satoh K, 2008, WCPFCSC42008FTWP120; Schaefer KM, 2013, MAR BIOL, V160, P3005, DOI 10.1007/s00227-013-2290-9; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Scott GP, 2014, IPBPECHIC2013123 EUR; Soto M, 2016, IOTC2016WPDCS12INF04; Taquet M, 2007, AQUAT LIVING RESOUR, V20, P331, DOI 10.1051/alr:2008007; Taquet M, 2007, AQUAT LIVING RESOUR, V20, P323, DOI 10.1051/alr:2008008; Veldhuis MJW, 1997, DEEP-SEA RES PT I, V44, P425, DOI 10.1016/S0967-0637(96)00116-1; Weng JS, 2013, J APPL ICHTHYOL, V29, P990, DOI 10.1111/jai.12265; Wiebinga CJ, 1997, DEEP-SEA RES PT I, V44, P451, DOI 10.1016/S0967-0637(96)00115-X; Wiggert JD, 2006, DEEP-SEA RES PT II, V53, P644, DOI 10.1016/j.dsr2.2006.01.027; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	91	17	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210435	10.1371/journal.pone.0210435	http://dx.doi.org/10.1371/journal.pone.0210435			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645612	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200030
J	Wang, XL; Zhang, GH				Wang, Xiaoli; Zhang, Guohong			The influence of infiltration feedback on the characteristic of banded vegetation pattern on hillsides of semiarid area	PLOS ONE			English	Article							KLAUSMEIER MODEL; SPATIAL-PATTERN; SOIL; TRANSITION; STABILITY; CLIMATE	The formation and characteristics are two important topics in the study of vegetation pattern. In this paper, we focus on the influence of infiltration feedback of surface runoff on the formation and characteristics of banded vegetation pattern on hillsides of semiarid area. Firstly, it is shown that the infiltration feedback of surface runoff is an important formation mechanics of the banded vegetation pattern in semiarid area. Then it is found that the patterns formed within the reasonable parameter space are periodic both in space and time and the wave speed of the periodic vegetation stripes become larger with the increase of the infiltration feedback strength, while the wavelength is negatively correlated with the infiltration feedback strength. At last, it is shown that the mean productivity of grass pattern is lower than that of homogeneous steady state when the infiltration feedback is weak and it is larger than that with stronger infiltration feedback.	[Wang, Xiaoli; Zhang, Guohong] Southwest Univ, Sch Math & Stat, Chongqing 400700, Peoples R China	Southwest University - China	Zhang, GH (corresponding author), Southwest Univ, Sch Math & Stat, Chongqing 400700, Peoples R China.	zgh711@swu.edu.cn			National Natural Science Foundation of China [11701472, 11671327, 11871403, 11871060]; Fundamental Research Funds for the Central Universities [XDJK2017C055]; Foundation of Southwest University [SWU116069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Southwest University(Southwest University - China)	This work is supported by the National Natural Science Foundation of China (11701472, 11671327, 11871403, 11871060) (http://www.nsfc.gov.cn/), Fundamental Research Funds for the Central Universities (XDJK2017C055) and the Ph.D. Foundation of Southwest University (SWU116069).	Adams B, 2003, NONLINEARITY, V16, P1339, DOI 10.1088/0951-7715/16/4/309; Carteni F, 2012, J THEOR BIOL, V313, P153, DOI 10.1016/j.jtbi.2012.08.008; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; D'Odorico P, 2005, P NATL ACAD SCI USA, V102, P10819, DOI 10.1073/pnas.0502884102; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; Gilad E, 2007, J THEOR BIOL, V244, P680, DOI 10.1016/j.jtbi.2006.08.006; Isham V, 2005, P ROY SOC A-MATH PHY, V461, P4035, DOI 10.1098/rspa.2005.1568; Kealy BJ, 2012, B MATH BIOL, V74, P803, DOI 10.1007/s11538-011-9688-7; Kefi S, 2010, THEOR ECOL-NETH, V3, P257, DOI 10.1007/s12080-009-0067-z; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; Liu QX, 2008, J THEOR BIOL, V254, P350, DOI 10.1016/j.jtbi.2008.05.017; Marasco A, 2014, B MATH BIOL, V76, P2866, DOI 10.1007/s11538-014-0036-6; Marasco A, 2013, PROCEDIA ENVIRON SCI, V19, P139, DOI 10.1016/j.proenv.2013.06.016; Meron E, 2004, CHAOS SOLITON FRACT, V19, P367, DOI 10.1016/S0960-0779(03)00049-3; Murray J. D., 2001, MATH BIOL, V18; Peters DPC, 2006, J ARID ENVIRON, V65, P196, DOI 10.1016/j.jaridenv.2005.05.010; Qian Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032807; Qian Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036101; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rodriguez-Iturbe I, 1999, P ROY SOC A-MATH PHY, V455, P3789, DOI 10.1098/rspa.1999.0477; Scheffer M, 2005, GLOBAL CHANGE BIOL, V11, P1003, DOI 10.1111/j.1365-2486.2005.00962.x; Sherratt JA, 2005, J MATH BIOL, V51, P183, DOI 10.1007/s00285-005-0319-5; Sherratt JA, 2013, SIAM J APPL MATH, V73, P1347, DOI 10.1137/120899510; Sherratt JA, 2013, SIAM J APPL MATH, V73, P330, DOI 10.1137/120862648; Sherratt JA, 2013, PHYSICA D, V242, P30, DOI 10.1016/j.physd.2012.08.014; Sherratt JA, 2011, P ROY SOC A-MATH PHY, V467, P3272, DOI 10.1098/rspa.2011.0194; Sherratt JA, 2010, NONLINEARITY, V23, P2657, DOI 10.1088/0951-7715/23/10/016; Shnerb NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.038101; Sun GQ, 2013, NONLINEAR DYNAM, V73, P2207, DOI 10.1007/s11071-013-0935-3; Ursino N, 2005, ADV WATER RESOUR, V28, P956, DOI 10.1016/j.advwatres.2005.02.009; von Hardenberg J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198101; Wang XL, 2017, COMMUN NONLINEAR SCI, V42, P571, DOI 10.1016/j.cnsns.2016.06.008	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0205715	10.1371/journal.pone.0205715	http://dx.doi.org/10.1371/journal.pone.0205715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645597	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200003
J	Mamat, Z; Halik, U; Aishan, T; Aini, A				Mamat, Zulpiya; Halik, Umut; Aishan, Tayierjiang; Aini, Ayinuer			Ecological effect of the riparian ecosystem in the lower reaches of the Tarim River in northwest China	PLOS ONE			English	Article							CLIMATE-CHANGE; SERVICES; BASIN; BIODIVERSITY; VEGETATION	The riparian vegetation in the lower reaches of the Tarim River is an irreplaceable natural resource for its ecosystem, and also a guarantee for the transportation safety in this area. Here, we analyzed different plant influences on soil erosion and evaluate the main ecosystem service functions served by the riparian vegetation to study area. Results showed that the total amount of sand-fixation in the study area was 4.14x10(13) t and that Tamarix chinensis had a greater influence on wind speed and sediment transport than Populus euphratica, and the Tamarix chinensis can be used as suitable vegetation for wind erosion measures and provide scientific basis for the optimization of vegetation matching and reasonable allocation scheme for ecological construction in arid areas. The total ecosystem service value was calculated to be $11.03x10(11). Of the main ecosystem service functions, riparian vegetation primarily served as sand fixation. Results show that, this research was identical, and the construction of shelterbelt plays an important role in the promotion of wind and sand control measures. Finally, our findings highlights the need for further research on how vegetation function as windbreak and sand fixation.	[Mamat, Zulpiya; Aishan, Tayierjiang] Xinjiang Univ, Inst Arid Ecol & Environm, Urumqi, Peoples R China; [Halik, Umut; Aini, Ayinuer] Xinjiang Univ, Minist Educ, Key Lab Oasis Ecol, Urumqi, Peoples R China; [Halik, Umut; Aini, Ayinuer] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China	Xinjiang University; Xinjiang University; Xinjiang University	Halik, U (corresponding author), Xinjiang Univ, Minist Educ, Key Lab Oasis Ecol, Urumqi, Peoples R China.; Halik, U (corresponding author), Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China.	halik@xju.edu.cn	Halik, Ümüt/H-5150-2019	Halik, Ümüt/0000-0003-0533-8759	National Natural Science Foundation of China [U1703102, 31770750]; Natural Science Foundation of Xinjiang [2018D01C065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang	This study was supported by the National Natural Science Foundation of China (Nos. U1703102, 31770750) and the Natural Science Foundation of Xinjiang (No. 2018D01C065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, all data that necessary has been provided in the paper.r This study was supported by the National Natural Science Foundation of China (Nos. U1703102, 31770750) and the Natural Science Foundation of Xinjiang (No. 2018D01C065). We also express our extreme thanks to the reviewers' helpful comments and advice.	Betz F, 2015, AEOLIAN RES, V18, P23, DOI 10.1016/j.aeolia.2015.04.005; Brauman K A, 2007, ENV RESOURCES, V32; Capon SJ, 2013, ECOSYSTEMS, V16, P359, DOI 10.1007/s10021-013-9656-1; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chen WY, 2014, ENVIRON MANAGE, V54, P1; Chen X, 2013, CURR OPIN ENV SUST, V5, P116, DOI 10.1016/j.cosust.2012.12.005; [程皓 CHENG Hao], 2007, [中国沙漠, Journal of Desert Research], V27, P1022; China Council for International Cooperation on Environment and Development, 1997, RES NAT RES PRIC; Costanza R., 1997, NATURES SERVICES SOC, P49; Cyffka B, 2015, AEOLIAN RES, V18, P23; [董道瑞 Dong Daorui], 2013, [中国沙漠, Journal of Desert Research], V33, P724; [高君亮 Gao Junliang], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P41; [黄继红 Huang Jihong], 2014, [干旱区研究, Arid Zone Research], V31, P866; [黄粤 Huang Yue], 2013, [地理学报, Acta Geographica Sinica], V68, P1251; Liu SA, 2010, ECOL ECON, V69, P1387, DOI 10.1016/j.ecolecon.2010.03.010; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Mamat Z, 2013, ASIAN J CHEM, V25, P9034, DOI 10.14233/ajchem.2013.14978; OECD, 2017, OECD STAT LIB; Palomo I, 2014, REG ENVIRON CHANGE, V14, P237, DOI 10.1007/s10113-013-0488-5; [彭建 Peng Jian], 2005, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V41, P594; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Shao Y., 2008, PHYS MODELING WIND E; State Forestry Administration, 2008, SPEC ASS FOR EC SERV; Wu J S G, 2012, RES VALUE ASSESSMENT; Wu Y Y, 2001, E CHINA FOREST MANAG, V15, P42; Xie G. D., 2008, RESOURCES SCI, V38, P1152; [熊黑钢 XIONG HeiGang], 2006, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V20, P146; Yan H, 2014, ENVIRON EARTH SCI, V71, P4091, DOI 10.1007/s12665-013-2797-x; Yang L W, 2004, ECOLOGICAL SERVICE V; [杨丽雯 YANG LiWen], 2006, [生态学报, Acta Ecologica Sinica], V26, P681; Zhang YC, 2011, HYDROL PROCESS, V25, P3448, DOI 10.1002/hyp.8073; Zhao J, 2000, Ying Yong Sheng Tai Xue Bao, V11, P290; Zhu YH, 2016, ECOL ENG, V94, P629, DOI 10.1016/j.ecoleng.2016.06.107	33	9	9	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208462	10.1371/journal.pone.0208462	http://dx.doi.org/10.1371/journal.pone.0208462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629595	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000014
J	Richter, L; Schmid, D; Kanitz, EE; Zwazl, I; Pollabauer, E; Jasinska, J; Burgmann, H; Kundi, M; Wiedermann, U				Richter, Lukas; Schmid, Daniela; Kanitz, Elisabeth Eva; Zwazl, Ines; Poellabauer, Eva; Jasinska, Joanna; Burgmann, Heinz; Kundi, Michael; Wiedermann, Ursula			Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; IMPACT; BURDEN; PHID-CV10; INCREASE; YOUNGER; ENGLAND; QUEBEC	Background In February 2012 the ten-valent pneumococcal conjugate vaccine (PCV10) with a 2+1 doses schedule (3, 5, 12 or 14 months of age) without catch-up vaccination was introduced in Austria. We assessed direct and indirect vaccine effects on invasive pneumococcal disease (IPD) by a population-based intervention study. Methods The study period was divided into pre-(2009-2011) and post-period (2013-2017, February), regarding 2012 as transition year. Outcomes were defined as PCV10 ST-IPD, the PCV10-related ST 6A and 19A IPD and non-PCV10 excluding ST 6A-/19A-IPD (NVT-IPD). We used national surveillance data and compared average monthly incidence rate (IR) between pre- and post-period among <5, 5-49 and >= 50 years old. Additionally, for the 5-49 and >= 50 years old, and the 50-59 and >= 60 years old, we analyzed monthly incidence data of the pre-, post-period, and estimated trend and level changes by using a segmented time-series regression. Results The PCV-10 IPD was reduced by 58% (95% CI: 30%; 74%) and 67% (95% CI: 32%; 84%) among <5 and >= 50 years old; the reduction in >= 60 years was 71% (95% CI: 36%; 88%). There were no significant changes in the pre-post-rate or incidence trend of NVT-IPD in the <5 and >= 50 years old. ST-specific analyses revealed no ST 6A-and ST 19A IPD decline in any age-group, and a ST 8 IPD increase among >= 50 years old (IR ratio: 3.5; 95% CI: 1.7; 7.2). We found no vaccine effects among 5-49 years old. Conclusions Our study adds to the evidence on direct and indirect protection of a childhood PCV10 vaccine program. Elderlies seem to benefit the most. Findings did not support PCV 10 cross-protection, but indicate replacement at least for ST 8 among the >= 50 years old. Follow-up analyses of IPD surveillance data are needed to fully characterize the magnitude of serotype replacement and further vaccine-attributable IPD reduction with time.	[Richter, Lukas; Schmid, Daniela; Kanitz, Elisabeth Eva] Austrian Agcy Hlth & Food Safety, Dept Infect Dis Epidemiol, Vienna, Austria; [Zwazl, Ines; Poellabauer, Eva; Jasinska, Joanna; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Burgmann, Heinz] AKH, Gen Hosp, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Inst Environm Hlth, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Wiedermann, U (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at	Jasińska, Joanna/AAO-3161-2020	Jasińska, Joanna/0000-0002-0822-2084; Richter, Lukas/0000-0001-6982-6239; Wiedermann, Ursula/0000-0002-1302-3223	Pfizer AG	Pfizer AG	LR, DS, EK, MK, and HB did not receive any specific funding, their work was part of the national surveillance program of the Austrian Agency for health and Food Safety. UW, JJ, EP are employed by the medical university which received an investigator initiated grant from Pfizer AG for cooperation with children hospitals in Austria. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; [Anonymous], 2014, R LANG ENV STAT COMP; Avila-Aguero Maria L, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334555; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Camara J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175224; Cilloniz C, 2016, CURR OPIN INFECT DIS, V29, P187, DOI 10.1097/QCO.0000000000000246; Cohen O, 2017, PNEUMOCOCCAL CONJUGA; Davison AC, 2003, STAT SCI, V18, P141; De Wals P, 2014, VACCINE, V32, P1501, DOI 10.1016/j.vaccine.2013.11.028; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; European Medicines Agency, 2008, PREV 13 EPAR PROD IN; Ewald H, 2016, DTSCH ARZTEBL INT, V113, P139, DOI 10.3238/arztebl.2016.0139; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Feldman Charles, 2016, F1000Res, V5, P2320; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Habib M, 2014, JOVE-J VIS EXP, DOI 10.3791/51208; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hanquet G, 2017, ECCMID; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hausdorff WP, 2016, HUM VACC IMMUNOTHER, V12, P358, DOI 10.1080/21645515.2015.1118593; Htar MTT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1147-x; International Vaccine Access Center JHUBSoPH, 2017, EV BAS PNEUM CONJ VA; Isturiz R, 2017, EXPERT REV VACCINES, V16, P1007, DOI 10.1080/14760584.2017.1362339; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Lepoutre A, 2015, VACCINE, V33, P359, DOI 10.1016/j.vaccine.2014.11.011; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Madhi Shabir A., 2008, P95; Manly BFJ, 2011, J BIOPHARM STAT, V21, P1164, DOI 10.1080/10543406.2011.607748; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Myint TTH, 2013, ADV THER, V30, P127, DOI 10.1007/s12325-013-0007-6; Naucler P, 2017, CLIN INFECT DIS, V65, P1780, DOI 10.1093/cid/cix685; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Palmu AA, 2014, LANCET RESP MED, V2, P717, DOI 10.1016/S2213-2600(14)70139-0; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Paulke-Korinek M, 2014, EUR J PEDIATR, V173, P469, DOI 10.1007/s00431-013-2193-2; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Principi N, 2015, EXPERT REV VACCINES, V14, P1359, DOI 10.1586/14760584.2015.1075884; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Roos R, 2015, INVASIVE PNEUMOCOCCA; Steens A, 2015, EPIDEMICS-NETH, V11, P24, DOI 10.1016/j.epidem.2015.01.001; The National Institute for Health and Welfare, 2017, INC INV PNEUM DIS FI; Tsaban G, 2017, VACCINE, V35, P2882, DOI 10.1016/j.vaccine.2017.04.032; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; van der Linden M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0941-9; Verani JR, 2015, VACCINE, V33, P6145, DOI 10.1016/j.vaccine.2015.10.007; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; World Health Organization, 2017, EX SUMM SAGE OCT 201; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	58	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210081	10.1371/journal.pone.0210081	http://dx.doi.org/10.1371/journal.pone.0210081			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629620	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000048
J	Aburawi, EH; Al Hamad, S; Yasin, J; Almekhaini, LA; Souid, AK				Aburawi, Elhadi H.; Al Hamad, Sania; Yasin, Javed; Almekhaini, Lolowa A.; Souid, Abdul-Kader			Dyslipidemia, subclinical inflammation, hepatic cholestasis and endothelial dysfunction in schoolchildren with excess fat: A study from the United Arab Emirates	PLOS ONE			English	Article							ADHESION MOLECULES; CHILDHOOD OBESITY; PLASMA-PROTEIN; CHILDREN; ADIPONECTIN; ADOLESCENTS; DISEASE	Background The impact of obesity on cardiovascular health of young children is still to be fully illustrated. This study measured biomarkers for glycemic control, lipid metabolism, systemic inflammation, endothelial dysfunction, and hepatic cholestasis in schoolchildren. Its main purpose was to determine whether metabolic derangements could be detected in young children with excess fat. Method This cross-sectional study involved 967 children in the second, sixth, and tenth grades (median age, 7.3, 11.3, and 15.4 years, respectively). Using the International Obesity Task Force interpretation (IOTF) of body-mass-index (BMI), children were stratified as thin (<5th centiles), normal (5th to <85th centiles), overweight (85th to <95th centiles), obese (95th to <98th centiles), or extremely-obese (>= 98th centiles). Waist circumference was also measured. Several metabolic determinations were then used as surrogate biomarkers for cardiovascular risks. Results Prevalence of BMI >= 85th centile among the second graders was 13.1%, sixth graders 42.2%, and tenth graders 33.8%. BMI >= 85th centile was associated with a tendency for higher hemoglobin A(1c) (p >= 0.160) and higher blood glucose (p >= 0.197). For the second graders, BMI >= 85th centile was associated with higher high-sensitivity C-reactive protein (hs-CRP, p<0.001), higher tumor necrosis factor-alpha (TNF-alpha, p<0.001), higher interleukin-6 (IL-6, p<0.001), higher soluble intercellular cytoadhesive molecule-1 (sICAM-1), higher triglycerides (p <= 0.024), and lower high-density lipoprotein (HDL, p<0.001). Additionally, for the sixth and tenth graders, BMI >= 85th centile was associated with higher gamma-glutamyl transferase (GGT, p<0.001). In the sixth graders, BMI >= 85th centile was insignificantly changed with sICAM-1 or the soluble vascular cytoadhesive molecule-1 (sVCAM-1). Conclusions The studied children with excess fat had increased risks for developing systemic inflammation, dyslipidemia, endothelial dysfunction, cholestasis, and diabetes. These results suggest that metabolic biomarkers should be included in the routine assessment of children with an overweight problem.	[Aburawi, Elhadi H.; Al Hamad, Sania; Almekhaini, Lolowa A.; Souid, Abdul-Kader] UAE Univ, Dept Pediat, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Yasin, Javed] UAE Univ, Dept Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Aburawi, EH (corresponding author), UAE Univ, Dept Pediat, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.	e.aburawi@uaeu.ac.ae	PATHAN, JAVED YASIN/GOE-4396-2022	PATHAN, JAVED YASIN/0000-0002-5867-2833	CMHS (College of Medicine & Health Sciences), UAE University to EHA [31M257]	CMHS (College of Medicine & Health Sciences), UAE University to EHA	This work was supported by a research grant (31M257, 2016/2017) from the CMHS (College of Medicine & Health Sciences), UAE University to EHA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburawi EH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159808; AlBlooshi A, 2016, OBES SCI PRACT, V2, P196, DOI 10.1002/osp4.37; Allison DB, 2008, OBESITY, V16, P1161, DOI 10.1038/oby.2008.231; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P625, DOI 10.1001/jama.2016.9852; Byun Sung Hwan, 2014, Korean J Pediatr, V57, P533, DOI 10.3345/kjp.2014.57.12.533; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ebrahimi-Mamaeghani M, 2015, VASC HEALTH RISK MAN, V11, P55, DOI 10.2147/VHRM.S48753; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Kuczmarski RJ, 2000, HEALTH, V11, P1; Kumar S, 2017, MAYO CLIN PROC, V92, P251, DOI 10.1016/j.mayocp.2016.09.017; Kyle TK, 2016, ENDOCRIN METAB CLIN, V45, P511, DOI 10.1016/j.ecl.2016.04.004; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Nehus E, 2019, PEDIATR CLIN N AM, V66, P31, DOI 10.1016/j.pcl.2018.08.004; Nigro E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/658913; Okuda R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1455-z; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; da Fonseca ACP, 2017, J DIABETES COMPLICAT, V31, P1549, DOI 10.1016/j.jdiacomp.2017.04.026; Skrypnik D, 2016, BIOMED PHARMACOTHER, V80, P1, DOI 10.1016/j.biopha.2016.02.017; Skrypnik K, 2017, ACTA SCI POLON-TECHN, V16, P83, DOI 10.17306/J.AFS.2017.0442; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Szulinska M, 2018, POSTEP HIG MED DOSW, V72, P89, DOI 10.5604/01.3001.0011.5963; Szulinska M, 2017, FOOD NUTR RES, V61, DOI [10.1080/16546628.2017.1295525, 10.1080/16546628.2017]; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210316	10.1371/journal.pone.0210316	http://dx.doi.org/10.1371/journal.pone.0210316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625218	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400084
J	Hellerhoff, K; Birnbacher, L; Sztrokay-Gaul, A; Grandl, S; Auweter, S; Willner, M; Marschner, M; Mayr, D; Reiser, MF; Pfeiffer, F; Herzen, J				Hellerhoff, Karin; Birnbacher, Lorenz; Sztrokay-Gaul, Aniko; Grandl, Susanne; Auweter, Sigrid; Willner, Marian; Marschner, Mathias; Mayr, Doris; Reiser, Maximilian F.; Pfeiffer, Franz; Herzen, Julia			Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase-contrast CT at conventional X-ray sources: An experimental ex-vivo study	PLOS ONE			English	Article							DIGITAL BREAST TOMOSYNTHESIS; SYNCHROTRON-RADIATION; HIGH-RESOLUTION; MAMMOGRAPHY; TOMOGRAPHY; TISSUE; MARGINS; FEASIBILITY	Background The extent of intraductal carcinoma in situ (DCIS) is commonly underestimated due to the discontinuous growth and lack of microcalcifications. Specimen radiography has been established to reduce the rate of re-excision. However, the predictive value for margin assessment with conventional specimen radiography for DCIS is low. In this study we assessed the potential of grating-based phase-contrast computed tomography (GBPC-CT) at conventional X-ray sources for specimen tomography of DCIS containing samples. Materials and methods GBPC-CT was performed on four ex-vivo breast specimens containing DCIS and invasive carcinoma of non-specific type. Phase-contrast and absorption-based datasets were manually matched with corresponding histological slices as the standard of reference. Results Matching of CT images and histology was successful. GBPC-CT showed an improved soft tissue contrast compared to absorption-based images revealing more histological details in the same sections. Non-calcifying DCIS exceeding the invasive tumor could be correlated to areas of dilated bright ducts around the tumor. Conclusions GBPC-CT imaging at conventional X-ray sources offers improved depiction quality for the imaging of breast tissue samples compared to absorption-based imaging, allows the identification of diagnostically relevant tissue details, and provides full three-dimensional assessment of sample margins.	[Hellerhoff, Karin; Sztrokay-Gaul, Aniko; Grandl, Susanne; Auweter, Sigrid; Reiser, Maximilian F.] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Hellerhoff, Karin; Sztrokay-Gaul, Aniko; Grandl, Susanne] Rotkreuzklinikum Munchen, Abt Diagnost Radiol, Munich, Germany; [Birnbacher, Lorenz; Willner, Marian; Marschner, Mathias; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Chair Biomed Phys, Dept Phys, Garching, Germany; [Birnbacher, Lorenz; Willner, Marian; Marschner, Mathias; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Munich Sch BioEngn, Garching, Germany; [Mayr, Doris] Ludwig Maximilians Univ Hosp Munich, Inst Pathol, Munich, Germany; [Pfeiffer, Franz] Tech Univ Munich, Klinikum Rechts Isar, Inst Diagnost & Intervent Radiol, Munich, Germany	University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Birnbacher, L (corresponding author), Tech Univ Munich, Chair Biomed Phys, Dept Phys, Garching, Germany.; Birnbacher, L (corresponding author), Tech Univ Munich, Munich Sch BioEngn, Garching, Germany.	lorenz.birnbacher@ph.tum.de		Pfeiffer, Franz/0000-0001-6665-4363	European Research Council (ERC) [AdG 695045]; DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP) [EXC158]; DFG Gottfried Wilhelm Leibniz program; Karlsruhe Nano Micro Facility (KNMF), Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	European Research Council (ERC)(European Research Council (ERC)); DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); Karlsruhe Nano Micro Facility (KNMF), Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	This work was supported by the European Research Council (ERC, H2020, AdG 695045); DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP, EXC158); and DFG Gottfried Wilhelm Leibniz program to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge financial support through the European Research Council (ERC, H2020, AdG 695045), the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP, EXC158), and the DFG Gottfried Wilhelm Leibniz program. This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT).	Amer HA, 2017, EUR J RADIOL, V93, P258, DOI 10.1016/j.ejrad.2017.05.041; Auweter SD, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130606; Baran P, 2018, IEEE T MED IMAGING, V37, P2642, DOI 10.1109/TMI.2018.2845905; Birnbacher L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24022; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Butler-Henderson K, 2015, BREAST CANCER-TOKYO, V22, P641, DOI 10.1007/s12282-014-0531-5; Butler-Henderson K, 2014, BREAST, V23, P112, DOI 10.1016/j.breast.2014.01.002; Castelli E, 2011, RADIOLOGY, V259, P684, DOI 10.1148/radiol.11100745; Dreossi D, 2008, EUR J RADIOL, V68, pS58, DOI 10.1016/j.ejrad.2008.04.038; Edwards SB, 2016, BREAST J, V22, P303, DOI 10.1111/tbj.12573; Eggl E, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/68003; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Grandl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097101; Grandl S, 2013, Z MED PHYS, V23, P212, DOI 10.1016/j.zemedi.2013.02.005; Gromann LB, 2016, BIOMED OPT EXPRESS, V7, P381, DOI 10.1364/BOE.7.000381; Harness JK, 2014, ANN SURG ONCOL, V21, P3192, DOI 10.1245/s10434-014-3957-2; Hauser N, 2014, INVEST RADIOL, V49, P131, DOI 10.1097/RLI.0000000000000001; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Houssami N, 2014, J SURG ONCOL, V110, P2, DOI 10.1002/jso.23594; Jian WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124143; Keyrilainen J, 2005, EUR J RADIOL, V53, P226, DOI 10.1016/j.ejrad.2004.03.015; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Longo R, 2016, PHYS MED BIOL, V61, P1634, DOI 10.1088/0031-9155/61/4/1634; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Nesterets YI, 2015, J SYNCHROTRON RADIAT, V22, P1509, DOI 10.1107/S160057751501766X; Pani S, 2004, PHYS MED BIOL, V49, P1739, DOI 10.1088/0031-9155/49/9/011; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Rossler AC, 2017, ACAD RADIOL, V24, P184, DOI 10.1016/j.acra.2016.09.017; Scherer K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130776; Schmachtenberg C, 2012, ROFO-FORTSCHR RONTG, V184, P635, DOI 10.1055/s-0032-1312730; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Taba ST, 2018, AM J ROENTGENOL, V211, P133, DOI 10.2214/AJR.17.19179; Tanaka T, 2005, INVEST RADIOL, V40, P385, DOI 10.1097/01.rli.0000165575.43381.48; Topperwien M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42847; Van Zee KJ, 2015, ANN SURG, P1, DOI [10.1016/j.ejrad.2017.05.041, DOI 10.1016/J.EJRAD.2017.05.041]; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Zanette I, 2013, RSC ADV, V3, P19816, DOI 10.1039/c3ra41372a; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210291	10.1371/journal.pone.0210291	http://dx.doi.org/10.1371/journal.pone.0210291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625220	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400083
J	da Silva, AR; Silva, SA; dos Santos, LA; de Souza, DR; Araujo, GD; Dantas, JLL; Leite, ED; Dantas, ACVL				da Silva, Adielle Rodrigues; Silva, Simone Alves; dos Santos, Laurenice Araujo; de Souza, Deoclides Ricardo; Araujo, Gilmara de Melo; Loyola Dantas, Jorge Luiz; Leite, Elton da Silva; Vello Loyola Dantas, Ana Cristina			Characterization and performance of castor bean lineages and parents at the UFRB germplasm bank	PLOS ONE			English	Article							GENETIC-DIVERGENCE; POPULATION; FERTILIZATION; IMPROVEMENT; PLANT	The objective of this work was to characterize 203 lineages and five parents of Ricinus communis L. from the germplasm bank at the Federal University of Reconcavo da Bahia (UFRB), which was established by the Genetic Improvement and Biotechnology Program (NBIO) at the Center for Agrarian, Environmental and Biological Sciences. The study used 35 morpho-agronomic descriptors, proposed by the Ministry of Agriculture, Livestock and Supply, and 12 quantitative descriptors suggested by NBIO. The experiment was conducted in a randomized block design, composed of four blocks, in the experimental field at UFRB in 2014. The frequency and entropy level of the qualitative descriptors were estimated with the Renyi procedure, and an analysis of variance was used for the quantitative descriptors. The analyses were made with the statistical program R. Of the qualitative morpho-agronomic descriptors evaluated, 22.86% had a high level of entropy (above 1.0), and all 12 quantitative descriptors showed significant differences. This indicates genetic variability in the germ plasm bank and a satisfactory performance for most of the descriptors evaluated, as well as the possibility of direct and indirect use of the lineages and parents in genetic improvement programs of the species.	[da Silva, Adielle Rodrigues; Silva, Simone Alves; dos Santos, Laurenice Araujo; de Souza, Deoclides Ricardo; Araujo, Gilmara de Melo; Leite, Elton da Silva; Vello Loyola Dantas, Ana Cristina] Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Cruz das Almas, BA, Brazil; [Loyola Dantas, Jorge Luiz] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil	Universidade Federal do Reconcavo da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	da Silva, AR (corresponding author), Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Cruz das Almas, BA, Brazil.	adi.elle@hotmail.com	Silva, Simone Alves/AAK-7389-2021; do Nascimento Araújo Júnior, George/AAJ-5917-2021	Silva, Simone Alves/0000-0002-3017-6133; do Nascimento Araújo Júnior, George/0000-0001-9284-4160; Silva, Adielle/0000-0003-1419-3061	Petrobras Biocombustivel; National Petroleum, Natural Gas and Biofuels Agency (ANP); Federal University of Reconcavo da Bahia (UFRB); Coordination for the Improvement of Higher Education Personnel (CAPES); Petrobras Biocombustivel e a Agencia Nacional do PetrOleo, Gas Natural e Biocombustiveis (ANP); Universidade Federal do Reconcavo da Bahia (UFRB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Petrobras Biocombustivel(Petrobras); National Petroleum, Natural Gas and Biofuels Agency (ANP); Federal University of Reconcavo da Bahia (UFRB); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Petrobras Biocombustivel e a Agencia Nacional do PetrOleo, Gas Natural e Biocombustiveis (ANP); Universidade Federal do Reconcavo da Bahia (UFRB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Petrobras Biocombustivel and the National Petroleum, Natural Gas and Biofuels Agency (ANP), the Federal University of Reconcavo da Bahia (UFRB) and the Coordination for the Improvement of Higher Education Personnel (CAPES).; This work was supported by Petrobras Biocombustivel e a Agencia Nacional do PetrOleo, Gas Natural e Biocombustiveis (ANP), the Universidade Federal do Reconcavo da Bahia (UFRB) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Alves GD, 2015, REV CIENC AGRON, V46, P546, DOI 10.5935/1806-6690.20150037; Anjani K, 2010, IND CROP PROD, V31, P192, DOI 10.1016/j.indcrop.2009.10.005; [Anonymous], 2021, LEV UN; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2009, REGR AN SEM; Azevedo DMP, 2010, AGRONEGOCIO MAMONA B; Bahia HF, 2008, PESQUI AGROPECU BRAS, V43, P357, DOI 10.1590/S0100-204X2008000300010; Neto FVB, 2010, REV CIENC AGRON, V41, P294; da Silva MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183504; Silva MGD, 2012, REV CIENC AGRON, V43, P493, DOI 10.1590/S1806-66902012000300011; de Oliveira RS, 2013, REV CIENC AGRON, V44, P564, DOI 10.1590/S1806-66902013000300019; Souza AD, 2007, REV CIENC AGRON, V38, P422; EMBRAPA Empresa Brasileira de Pesquisa Agropecuaria, 1993, LEV DET SOL CTR NAC; Fernandes JD, 2015, REV CAATINGA, V28, P48; Menezes MAG, 2015, HOLOS, V31, P30, DOI 10.15628/holos.2015.2459; Milani M., 2008, CAMPINA GRANDE EMBRA; Moshkin V.A., 1986, CASTOR; Passos AR, 2010, PESQUI AGROPECU BRAS, V45, P709, DOI 10.1590/S0100-204X2010000700011; Pivetta LG, 2015, REV AGRIC NEOTROP, V2, P9; RAMALHO M. A. P., 2012, GENETICA AGROPECUARI; Rodrigues HCA, 2014, REV CIENCIAS AGROVET, V13, P247; SAMPAIO FILHO O. M., 2011, REV BRASILEIRA ED AM, V6, P28; Shankar VG, 2010, SABRAO J BREED GENET, V42, P57; SHIFRISS O, 1973, J HERED, V64, P351, DOI 10.1093/oxfordjournals.jhered.a108439; Silva SA, 2013, S RED REC GEN VEG NO, V25, P62; Singh AS, 2015, IND CROP PROD, V74, P55, DOI 10.1016/j.indcrop.2015.05.001; Soratto RP, 2011, PESQUI AGROPECU BRAS, V46, P245, DOI 10.1590/S0100-204X2011000300004; Varga F, 2017, IND CROP PROD, V109, P611, DOI 10.1016/j.indcrop.2017.09.018; Vieira E. A., 2008, Cientifica (Jaboticabal), V36, P56; ZORZENONI T. O., 2011, NUCLEUS, V8, P143, DOI [10.3738/nucleus.v8i2.572, DOI 10.3738/NUCLEUS.V8I2.572]	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209335	10.1371/journal.pone.0209335	http://dx.doi.org/10.1371/journal.pone.0209335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615633	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900019
J	Cheung, S; Schlegel, PN; Rosenwaks, Z; Palermo, GD				Cheung, Stephanie; Schlegel, Peter N.; Rosenwaks, Zev; Palermo, Gianpiero D.			Revisiting aneuploidy profile of surgically retrieved spermatozoa by whole exome sequencing molecular karyotype	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; CHILDREN BORN; TESTICULAR SPERM; DNA FRAGMENTATION; FOLLOW-UP; IN-VITRO; ICSI; MEN; OUTCOMES; FERTILIZATION	Previous studies, including our own, have reported that spermatozoa isolated from the testis have remarkably higher occurrence of aneuploidy once isolated from azoospermic men. This notion, however, did not translate into a lower pregnancy rate nor a greater proportion of miscarriages. Indeed, ICSI offspring generated from surgically retrieved gametes did not suffer from increased karyotypic aneuploidy than children generated from ejaculated specimens. In recent years, aneuploidy assessments on a larger number of cells and utilizing more chromosome probes have reported a progressive decrease in chromosomal aberrations in spermatozoa directly retrieved from the seminiferous tubules. In light of the availability of more accurate molecular genetic techniques, we have decided to challenge the notion that sampling epididymal and testicular tissues yields spermatozoa with higher incidence of aneuploidy than those retrieved in the ejaculate. In a retrospective manner, we have carried out an analysis by FISH with 9 chromosome probes on at least 1000 cells from the ejaculates of 87 consenting men and the specimens of 6 azoospermic men, while spermatozoa of fertile donors were used as control. Aneuploidy by FISH yielded 0.9% for the donor control but rose in the study group to 3.6% in the ejaculated, 1.2% for the epididymal, and 1.1% for testicular spermatozoa. There were no differences in autosomal or gonosomal disomies, nor nullisomies. In this group, once the specimens of these men were used for ICSI, ejaculated spermatozoa yielded a 22% clinical pregnancy rate that resulted in 62.5% pregnancy loss. The surgically retrieved specimens yielded a 50% clinical pregnancy rate that progressed to term. To confirm our findings, in a prospective analysis, DNA sequencing was carried out on the ejaculates and surgical samples of 22 men with various spermatogenic characteristics. In this comparison, the findings were similar with actually a higher incidence of aneuploidy in the ejaculated spermatozoa (n = 16) compared to those surgically retrieved (n = 6) (P<0.0001). For this group, the clinical pregnancy rate for the ejaculated specimens was 47.2% with 29.4% pregnancy loss, while the surgically retrieved yielded a 50% clinical pregnancy rate, all progressing to term. A subsequent prospective combined assessment on ejaculated and surgically retrieved spermatozoa by FISH and NGS was performed on non-azoospermic men with high DNA fragmentation in their ejaculate. The assessment by FISH evidenced 2.8% chromosomal defects in the ejaculated and 1.2% in testicular biopsies while by NGS became 8.4% and 1.3% (P = 0.02), respectively. Interestingly, we evidenced a pregnancy rate of 0% with ejaculated while 100% with the testicular spermatozoa in this latter group. This indicates that improved techniques for assessing sperm aneuploidy on a wider number of cells disproves earlier reports and corroborates the safe utilization of testicular spermatozoa with a positive impact on chances of pregnancy.	[Cheung, Stephanie; Rosenwaks, Zev; Palermo, Gianpiero D.] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Schlegel, Peter N.] Weill Cornell Med, Dept Urol, New York, NY USA	Cornell University; Cornell University	Palermo, GD (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	gdpalerm@med.cornell.edu		Palermo, Gianpiero D./0000-0001-8440-4560; Cheung, Stephanie/0000-0002-2092-7001				Bonduelle M, 1998, HUM REPROD, V13, P196, DOI 10.1093/humrep/13.suppl_1.196; Bonduelle M, 2002, HUM REPROD, V17, P2600, DOI 10.1093/humrep/17.10.2600; Bradley CK, 2016, ANDROLOGY-US, V4, P903, DOI 10.1111/andr.12215; Brezina PR, 2016, J ASSIST REPROD GEN, V33, P823, DOI 10.1007/s10815-016-0740-2; Colombero LT, 1999, FERTIL STERIL, V72, P90, DOI 10.1016/S0015-0282(99)00158-2; Cooper TG, 2010, WHO LABORATORY MANUA; De Palma A, 2005, HUM REPROD, V20, P2153, DOI 10.1093/humrep/dei036; Esteves SC, 2018, ASIAN J ANDROL, V20, P1, DOI 10.4103/aja.aja_7_17; Esteves SC, 2017, FERTIL STERIL, V108, P456, DOI 10.1016/j.fertnstert.2017.06.018; Esteves SC, 2015, FERTIL STERIL, V104, P1398, DOI 10.1016/j.fertnstert.2015.08.028; Fedder J, 2013, HUM REPROD, V28, P230, DOI 10.1093/humrep/des377; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; Greco E, 2005, HUM REPROD, V20, P226, DOI 10.1093/humrep/deh590; Guo YH, 2013, CHINESE MED J-PEKING, V126, P2129, DOI 10.3760/cma.j.issn.0366-6999.20122104; Halliday J, 2012, ASIAN J ANDROL, V14, P116, DOI 10.1038/aja.2011.71; Harton GL, 2012, ASIAN J ANDROL, V14, P32, DOI 10.1038/aja.2011.66; Hopps CV, 2003, HUM REPROD, V18, P1660, DOI 10.1093/humrep/deg348; Huang JYJ, 2014, METHODS MOL BIOL, V1154, P171, DOI 10.1007/978-1-4939-0659-8_8; Jozwiak EA, 2004, FERTIL STERIL, V82, P628, DOI 10.1016/j.fertnstert.2004.02.110; Kahraman S, 1996, HUM REPROD, V11, P1343; Kyono K, 2001, HUM REPROD, V16, P2347, DOI 10.1093/humrep/16.11.2347; Levron J, 2001, FERTIL STERIL, V76, P479, DOI 10.1016/S0015-0282(01)01957-4; Ludwig M, 2003, HUM REPROD, V18, P351, DOI 10.1093/humrep/deg048; Mazzilli R, 2017, FERTIL STERIL, V108, P961, DOI 10.1016/j.fertnstert.2017.08.033; McInnes B, 1998, HUM REPROD, V13, P2787, DOI 10.1093/humrep/13.10.2787; Mehta A, 2015, FERTIL STERIL, V104, P1382, DOI 10.1016/j.fertnstert.2015.08.008; Miyaoka R, 2013, CLINICS, V68, P111, DOI 10.6061/clinics/2013(Sup01)12; Nakamura Y, 2001, INT J UROL, V8, P49, DOI 10.1046/j.1442-2042.2001.00242.x; Neri QV, 2014, CELL CALCIUM, V55, P24, DOI 10.1016/j.ceca.2013.10.006; O'Neill CL, 2018, J ASSIST REPROD GEN, V35, P1911, DOI 10.1007/s10815-018-1270-x; Oppedisano L, 2002, HUM REPROD, V17, P710, DOI 10.1093/humrep/17.3.710; Pabuccu EG, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12609; Palermo GD, 1996, HUM REPROD, V11, P172; Palermo GD, 2002, HUM REPROD, V17, P570, DOI 10.1093/humrep/17.3.570; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; PALERMO GD, 1995, HUM REPROD, V10, P120, DOI 10.1093/humrep/10.suppl_1.120; Palermo GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113671; Pereira N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470819; Ramos-Ibeas P, 2013, REPRODUCTION, V146, P481, DOI 10.1530/REP-13-0145; Rodrigo L, 2011, FERTIL STERIL, V95, P1005, DOI 10.1016/j.fertnstert.2010.10.022; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Sutovsky P, 2001, HUM REPROD, V16, P250, DOI 10.1093/humrep/16.2.250; Tsai CC, 2011, FERTIL STERIL, V96, P567, DOI 10.1016/j.fertnstert.2011.06.080; Vozdova M, 2012, HUM REPROD, V27, P2233, DOI 10.1093/humrep/des115; Wells D, 2008, MOL HUM REPROD, V14, P703, DOI 10.1093/molehr/gan062; Wennerholm UB, 2000, HUM REPROD, V15, P1189, DOI 10.1093/humrep/15.5.1189; Woldringh GH, 2011, HUM REPROD, V26, P1759, DOI 10.1093/humrep/der136; Yilmaz LS, 2004, APPL ENVIRON MICROB, V70, P7126, DOI 10.1128/AEM.70.12.7126-7139.2004; Zheng HY, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0143-6	50	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210079	10.1371/journal.pone.0210079	http://dx.doi.org/10.1371/journal.pone.0210079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608972	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800042
J	Enshaeifar, S; Zoha, A; Skillman, S; Markides, A; Acton, ST; Elsaleh, T; Kenny, M; Rostill, H; Nilforooshan, R; Barnaghi, P				Enshaeifar, Shirin; Zoha, Ahmed; Skillman, Severin; Markides, Andreas; Acton, Sahr Thomas; Elsaleh, Tarek; Kenny, Mark; Rostill, Helen; Nilforooshan, Ramin; Barnaghi, Payam			Machine learning methods for detecting urinary tract infection and analysing daily living activities in people with dementia	PLOS ONE			English	Article							EARLY WARNING SCORE; HOSPITAL ADMISSIONS; VALIDATION; ACTIGRAPHY; PREVALENCE; OUTCOMES; REASONS; EVENTS	Dementia is a neurological and cognitive condition that affects millions of people around the world. At any given time in the United Kingdom, 1 in 4 hospital beds are occupied by a person with dementia, while about 22% of these hospital admissions are due to preventable causes. In this paper we discuss using Internet of Things (IoT) technologies and in-home sensory devices in combination with machine learning techniques to monitor health and well-being of people with dementia. This will allow us to provide more effective and preventative care and reduce preventable hospital admissions. One of the unique aspects of this work is combining environmental data with physiological data collected via low cost in-home sensory devices to extract actionable information regarding the health and well-being of people with dementia in their own home environment. We have worked with clinicians to design our machine learning algorithms where we focused on developing solutions for real-world settings. In our solutions, we avoid generating too many alerts/alarms to prevent increasing the monitoring and support workload. We have designed an algorithm to detect Urinary Tract Infections (UTI) which is one of the top five reasons of hospital admissions for people with dementia (around 9% of hospital admissions for people with dementia in the UK). To develop the UTI detection algorithm, we have used a Non-negative Matrix Factorisation (NMF) technique to extract latent factors from raw observation and use them for clustering and identifying the possible UTI cases. In addition, we have designed an algorithm for detecting changes in activity patterns to identify early symptoms of cognitive decline or health decline in order to provide personalised and preventative care services. For this purpose, we have used an Isolation Forest (iForest) technique to create a holistic view of the daily activity patterns. This paper describes the algorithms and discusses the evaluation of the work using a large set of real-world data collected from a trial with people with dementia and their caregivers.	[Enshaeifar, Shirin; Zoha, Ahmed; Skillman, Severin; Markides, Andreas; Acton, Sahr Thomas; Elsaleh, Tarek; Barnaghi, Payam] Univ Surrey, CVSSP, Dept Elect & Elect Engn, Guildford, Surrey, England; [Kenny, Mark; Rostill, Helen; Nilforooshan, Ramin] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England	University of Surrey	Barnaghi, P (corresponding author), Univ Surrey, CVSSP, Dept Elect & Elect Engn, Guildford, Surrey, England.	p.barnaghi@surrey.ac.uk	Zoha, Ahmed/ABB-8933-2020; Enshaeifar, Shirin/M-7783-2016; Elsaleh, Tarek/X-1141-2019; Elsaleh, Tarek/AAK-5803-2021; Barnaghi, Payam/ABE-9236-2020	Zoha, Ahmed/0000-0001-7497-9336; Enshaeifar, Shirin/0000-0001-6216-0622; Elsaleh, Tarek/0000-0002-9134-0232; Barnaghi, Payam/0000-0001-8591-9638; Nilforooshan, Ramin/0000-0001-9801-183X	Office of Life Sciences at Department of Health UK [TS/N009894/1]	Office of Life Sciences at Department of Health UK	This project is supported by a grant from the Office of Life Sciences at Department of Health UK, grant number (TS/N009894/1) (PB). More information can be found here: (https://www.gov.uk/government/organisations/office-for-lifesciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu S, 2002, INT J GERIATR PSYCH, V17, P422, DOI 10.1002/gps.624; Bernardes C, 2018, ARCH GERONTOL GERIAT, V77, P150, DOI 10.1016/j.archger.2018.05.006; Berry B., 2012, RULES TERMINOLOGY TE, VVolume 176, P2012; Caljouw MAA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-57; Carskadon MA, 2005, PRINCIPLES PRACTICE, P13, DOI DOI 10.1016/B0-72-160797-7/50009-4; Chernbumroong S, 2013, EXPERT SYST APPL, V40, P1662, DOI 10.1016/j.eswa.2012.09.004; Cook DJ, 2014, J INTELL INF SYST, V43, P503, DOI 10.1007/s10844-014-0341-4; Dawadi PN, 2013, TECHNOL HEALTH CARE, V21, P323, DOI 10.3233/THC-130734; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Demiris George, 2008, Technol Health Care, V16, P111; Enshaeifar S., 2018, IEEE T IND INFORM; Enshaeifar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195605; Enshaeifar S, 2018, IEEE INTERNET COMPUT, V22, P8, DOI 10.1109/MIC.2018.112102418; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gehrman P, 2002, J SLEEP RES, V11, P229, DOI 10.1046/j.1365-2869.2002.00306.x; Gerry S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019268; Hayes TL, 2010, IEEE ENG MED BIO, P2147, DOI 10.1109/IEMBS.2010.5628022; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; Ibrisimovic MA, 2017, IFMBE PROC, V62, P289, DOI 10.1007/978-981-10-4166-2_43; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Kim H, 2008, SIAM J MATRIX ANAL A, V30, P713, DOI 10.1137/07069239X; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Leibovici L, 2000, IEEE T KNOWL DATA EN, V12, P517, DOI 10.1109/69.868905; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Ligeza A., 2006, LOGICAL FDN RULE BAS, V11; Lymberopoulos D, 2011, UNIVERSAL ACCESS INF, V10, P125, DOI 10.1007/s10209-010-0197-5; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; McCurry SM, 2006, AM J GERIAT PSYCHIAT, V14, P112, DOI 10.1097/01.JGP.0000192499.25940.da; Meister L, 2013, ACAD EMERG MED, V20, P632, DOI 10.1111/acem.12171; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Mukadam N, 2011, INT PSYCHOGERIATR, V23, P344, DOI 10.1017/S1041610210001717; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647, DOI 10.1016/S0891-5520(05)70378-0; Nourhashemi F, 2001, ALZ DIS ASSOC DIS, V15, P21, DOI 10.1097/00002093-200101000-00003; ORRELL M, 1995, PSYCHOL MED, V25, P373, DOI 10.1017/S0033291700036278; Rantz M. J., 2011, 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services (Healthcom 2011), P142, DOI 10.1109/HEALTH.2011.6026731; Rao A, 2016, ARCH GERONTOL GERIAT, V66, P198, DOI 10.1016/j.archger.2016.06.008; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Sampson EL, 2014, BRIT J PSYCHIAT, V205, P189, DOI 10.1192/bjp.bp.113.130948; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Samy L, 2014, IEEE SENS J, V14, P2092, DOI 10.1109/JSEN.2013.2293917; Schmiemann G, 2010, DTSCH ARZTEBL INT, V107, P361, DOI 10.3238/arztebl.2010.0361; Skubic M, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2421499; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Smith L. J., 2003, MEASUREMENT SLEEP; Society A, 2018, COUNT COST CAR PEOPL; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Tamura Toshiyo, 2007, Open Med Inform J, V1, P1, DOI 10.2174/1874431100701010001; Toot S, 2013, J AM MED DIR ASSOC, V14, P463, DOI 10.1016/j.jamda.2013.01.011; Tuppin P, 2009, DEMENT GERIATR COGN, V28, P225, DOI 10.1159/000238394; Urwyler P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42084; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wang HY, 2010, IEEE INT C BIO BIO W, P405, DOI 10.1109/BIBMW.2010.5703836; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108	56	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209909	10.1371/journal.pone.0209909	http://dx.doi.org/10.1371/journal.pone.0209909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645599	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000455810200015
J	Ivanova, MM; Changsila, E; Iaonou, C; Goker-Alpan, O				Ivanova, Margarita M.; Changsila, Erk; Iaonou, Chidima; Goker-Alpan, Ozlem			Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; MAMMALIAN TARGET; GLUCOSYLCERAMIDE ACCUMULATION; RAPAMYCIN MTOR; CELLS; DEGRADATION; DYSFUNCTION; MOUSE; MANIFESTATIONS; REFORMATION	The major cellular clearance pathway for organelle and unwanted proteins is the autophagy-lysosome pathway (ALP). Lysosomes not only house proteolytic enzymes, but also traffic organelles, sense nutrients, and repair mitochondria. Mitophagy is initiated by damaged mitochondria, which is ultimately degraded by the ALP to compensate for ATP loss. While both systems are dynamic and respond to continuous cellular stressors, most studies are derived from animal models or cell based systems, which do not provide complete real time data about cellular processes involved in the progression of lysosomal storage diseases in patients. Gaucher and Fabry diseases are rare sphingolipid disorders due to the deficiency of the lysosomal enzymes; glucocerebrosidase and alpha-galactosidase A with resultant lysosomal dysfunction. Little is known about ALP pathology and mitochondrial function in patients with Gaucher and Fabry diseases, and the effects of enzyme replacement therapy (ERT). Studying blood mononuclear cells (PBMCs) from patients, we provide in vivo evidence, that regulation of ALP is defective. In PBMCs derived from Gaucher patients, we report a decreased number of autophagic vacuoles with increased cytoplasmic localization of LC3A/B, accompanied by lysosome accumulation. For both Gaucher and Fabry diseases, the level of the autophagy marker, Beclin1, was elevated and ubiquitin binding protein, SQSTM1/p62, was decreased. mTOR inhibition did not activate autophagy and led to ATP inhibition in PBMCs. Lysosomal abnormalities, independent of the type of the accumulated substrate suppress not only autophagy, but also mitochondrial function and mTOR signaling pathways. ERT partially restored ALP function, LC3-II accumulation and decreased LC3-I/LC3-II ratios. Levels of lysosomal (LAMP1), autophagy (LC3), and mitochondrial markers, (Tfam), normalized after ERT infusion. In conclusion, there is mTOR pathway dys-function in sphingolipidoses, as observed in both PBMCs derived from patients with Gaucher and Fabry diseases, which leads to impaired autophagy and mitochondrial stress. ERT partially improves ALP function.	[Ivanova, Margarita M.; Changsila, Erk; Iaonou, Chidima; Goker-Alpan, Ozlem] Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA 22030 USA		Ivanova, MM; Goker-Alpan, O (corresponding author), Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA 22030 USA.	mivanova@ldrtc.org; ogoker-alpan@ldrtc.org	Ivanova, Margarita/AAM-4510-2021	Ivanova, Margarita/0000-0002-6197-8606				Aflaki E, 2016, AGING CELL, V15, P77, DOI 10.1111/acel.12409; Awad O, 2015, HUM MOL GENET, V24, P5775, DOI 10.1093/hmg/ddv297; Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Baris HN, 2014, PEDIATR ENDOCR REV P, V12, P72; Bauerly KA, 2006, BBA-GEN SUBJECTS, V1760, P1741, DOI 10.1016/j.bbagen.2006.07.009; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Charrow J, 2015, AM J HEMATOL, V90, pS19, DOI 10.1002/ajh.24056; Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Collins Lucy M, 2017, F1000Res, V6, P1751, DOI 10.12688/f1000research.12090.1; Das AM, 2009, ADV CLIN CHEM, V49, P57, DOI 10.1016/S0065-2423(09)49003-6; de la Mata Mario, 2016, Diseases, V4, DOI 10.3390/diseases4040031; de la Mata M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10903; Du TT, 2015, AUTOPHAGY, V11, P1803, DOI 10.1080/15548627.2015.1086055; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Entingh AJ, 2001, ENDOCRINOLOGY, V142, P221, DOI 10.1210/en.142.1.221; Gegg ME, 2016, NEUROBIOL DIS, V90, P43, DOI 10.1016/j.nbd.2015.09.006; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Goker-Alpan O, 2011, MOL GENET METAB, V104, P438, DOI 10.1016/j.ymgme.2011.08.004; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hu YW, 2016, J CELL BIOCHEM, V117, P413, DOI 10.1002/jcb.25287; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kinghorn KJ, 2016, J NEUROSCI, V36, P11654, DOI 10.1523/JNEUROSCI.4527-15.2016; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Limgala RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168135; Lucke T, 2004, MOL GENET METAB, V82, P93, DOI 10.1016/j.ymgme.2004.01.011; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Magalhaes J, 2016, HUM MOL GENET, V25, P3432, DOI 10.1093/hmg/ddw185; Marchesan D, 2012, J INHERIT METAB DIS, V35, P1107, DOI 10.1007/s10545-012-9472-3; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mehta AB, 2009, INT J CLIN PHARM TH, V47, pS66; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Nelson MP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-20; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Osellame LD, 2014, BRIT J PHARMACOL, V171, P1958, DOI 10.1111/bph.12453; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pandey MK, 2017, NATURE, V543, P108, DOI 10.1038/nature21368; Pandey Manoj Kumar, 2013, Critical Reviews in Oncogenesis, V18, P197; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Perrot A, 2002, HERZ, V27, P699, DOI 10.1007/s00059-002-2429-9; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Plotegher N, 2017, TRENDS MOL MED, V23, P116, DOI 10.1016/j.molmed.2016.12.003; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Radde BN, 2015, BIOCHEM J, V465, P49, DOI 10.1042/BJ20131608; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rozenfeld P, 2017, MOL GENET METAB, V122, P19, DOI 10.1016/j.ymgme.2017.09.004; Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Slaats GG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29240-w; Squillaro T, 2017, J CELL PHYSIOL, V232, P3454, DOI 10.1002/jcp.25807; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Tatti M, 2012, HUM MOL GENET, V21, P5159, DOI 10.1093/hmg/dds367; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Welford RWD, 2018, HUM MOL GENET, V27, P3392, DOI 10.1093/hmg/ddy248; Wu YJ, 2018, MOL MED REP, V17, P8003, DOI 10.3892/mmr.2018.8831; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	80	33	34	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210617	10.1371/journal.pone.0210617	http://dx.doi.org/10.1371/journal.pone.0210617			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633777	Green Submitted, Green Published, gold			2022-12-26	WOS:000455485100033
J	Chicco, D; Rovelli, C				Chicco, Davide; Rovelli, Cristina			Computational prediction of diagnosis and feature selection on mesothelioma patient health records	PLOS ONE			English	Article							PROBABILISTIC NEURAL-NETWORK; MALIGNANT PLEURAL MESOTHELIOMA; LUNG-CANCER; CLASSIFICATION	Background Mesothelioma is a lung cancer that kills thousands of people worldwide annually, especially those with exposure to asbestos. Diagnosis of mesothelioma in patients often requires time-consuming imaging techniques and biopsies. Machine learning can provide for a more effective, cheaper, and faster patient diagnosis and feature selection from clinical data in patient records. Methods and findings We analyzed a dataset of health records of 324 patients having mesothelioma symptoms from Turkey. The patients had prior asbestos exposure and displayed symptoms consistent with mesothelioma. We compared probabilistic neural network, perceptron-based neural network, random forest, one rule, and decision tree classifiers to predict diagnosis of the patient records. We measured classifiers' performance through standard confusion matrix scores such as Matthews correlation coefficient (MCC). Random forest outperformed all models tried, obtaining MCC = +0.37 on the complete imbalanced dataset and MCC = +0.64 on the under-sampled balanced dataset. We then employed random forest feature selection to identify the two most relevant dataset traits associated with mesothelioma: lung side and platelet count. These two risk factors resulted so predictive, that decision tree focusing on them achieved the second top accuracy on the complete dataset diagnosis prediction (MCC = +0.28), outperforming all other methods and even decision tree itself applied to all features. Conclusions Our results show that machine learning can predict diagnoses of patients having mesothelioma symptoms with high accuracy, sensitivity, and specificity, in few minutes. Additionally, random forest can efficiently select the most important features of this clinical dataset (lung side and platelet count) in few seconds. The importance of pleural plaques in lung sides and blood platelets in mesothelioma diagnosis indicates that physicians should focus on these two features when reading records of patients with mesothelioma symptoms. Moreover, doctors can exploit our machinery to predict patient diagnosis when only lung side and platelet data are available.	[Chicco, Davide] Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Chicco, Davide] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Rovelli, Cristina] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; Peter Munk Cardiac Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Chicco, D (corresponding author), Peter Munk Cardiac Ctr, Toronto, ON, Canada.; Chicco, D (corresponding author), Princess Margaret Canc Ctr, Toronto, ON, Canada.	davidechicco@davidechicco.it	Chicco, Davide/C-7058-2017	Chicco, Davide/0000-0001-9655-7142	Peter Munk Cardiac Centre	Peter Munk Cardiac Centre(University of Toronto)	This project was supported by the Peter Munk Cardiac Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Khalid Amir Mahmoud Abdulla (the University of Melbourne) for his help in multiple programming tasks, Wail Ba-Alawi (Princess Margaret Cancer Centre) for his technical help, Christina Cumbaa (Krembil Research Institute) for his help in the review guidance, Crystal Kantores (Peter Munk Cardiac Centre) and Laura Aronoff (University of Toronto) for their help in the English proof-reading of the manuscript, and the University of California Irvine Machine Learning Repository for providing the mesothelioma dataset to the public. The authors especially thank Slava Epelman and the Peter Munk Cardiac Centre for having supported this publication. This paper is dedicated to all the patients having mesothelioma.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; American Cancer Society, 2017, MAL MES STAG; [Anonymous], 2018, WE HAVE TUNE NUMBER; Azar AT, 2013, NEURAL COMPUT APPL, V23, P1019, DOI 10.1007/s00521-012-1026-y; Bao FS, 2008, PROC INT C TOOLS ART, P482, DOI 10.1109/ICTAI.2008.99; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2004, RANDOM FORESTS GINI; Cai ZH, 2015, MOL BIOSYST, V11, P791, DOI 10.1039/c4mb00659c; Cancer Research UK, 2016, TYP MES; Cangelosi D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1194-3; Chicco D., 2014, P 5 ACM C BIOINF COM, P533; Chicco D, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0155-3; Chicco D, 2015, LECT N BIOINFORMAT, V8623, P19, DOI 10.1007/978-3-319-24462-4_2; Chicco D, 2015, IEEE ACM T COMPUT BI, V12, P837, DOI 10.1109/TCBB.2014.2382127; COATES A, 1993, J CLIN ONCOL, V11, P2050; Collobert R., 2002, TORCH MODULAR MACHIN; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Denisko D, 2018, P NATL ACAD SCI USA, V115, P1690, DOI 10.1073/pnas.1800256115; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dollinger M, 2002, EVERYONES GUIDE CANC; Er O, 2012, COMPUT ELECTR ENG, V38, P75, DOI 10.1016/j.compeleceng.2011.09.001; Fernandes K, 2018, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.154; Guan D, 2014, IETE TECH REV, V31, P190, DOI 10.1080/02564602.2014.906859; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Kao SC, 2013, CLIN LUNG CANCER, V14, P70, DOI 10.1016/j.cllc.2012.03.011; Kaur H., 2006, J COMPUT SCI-NETH, V2, P194, DOI [10.3844/jcssp.2006.194.200, DOI 10.3844/JCSSP.2006.194.200]; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; Koh H.C., 2011, J HEALTHCARE INFORM, V19, P65, DOI [DOI 10.0001/.1.92.3184, https://doi.org/10.0001/.1.92.3184]; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kraus OZ, 2016, BIOINFORMATICS, V32, P52, DOI 10.1093/bioinformatics/btw252; Kueffner R, 2018, BIORXIV; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li M, 2007, IEEE T SYST MAN CY A, V37, P1088, DOI 10.1109/TSMCA.2007.904745; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; Malignant Pleural Mesothelioma Staging, 2016, TNM CLASS MAL PLEUR; McDonald JC, 1996, EUR RESPIR J, V9, P1932, DOI 10.1183/09031936.96.09091932; MesotheliomaWeb, 2016, THROMB MES PAT; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pinoli P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S6-S4; Powers D. M, 2011, ARXIV201016061; Probst P, 2018, J MACH LEARN RES, V18; Ranganathan Priya, 2017, Perspect Clin Res, V8, P148, DOI 10.4103/picr.PICR_87_17; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Ruck D W, 1990, IEEE Trans Neural Netw, V1, P296, DOI 10.1109/72.80266; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Sanjeevi Madhu, 2017, DECISION TREES ALGOR; Sculley D, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P587; Shan YC, 2002, ANAL CHIM ACTA, V471, P77, DOI 10.1016/S0003-2670(02)00924-8; Shevchuk Y., 2015, NEUPY NEURAL NETWORK; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; Skocik M., 2016, BIORXIV; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Stolovitsky G, 2007, DREAM CHALLENGES; Therneau T. M., 1997, INTRO RECURSIVE PART; Thongkam J, 2008, IEEE IJCNN, P3062, DOI 10.1109/IJCNN.2008.4634231; University of California Irvine, 2016, MACH LEARN REP; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Vilar S, 2006, J MED CHEM, V49, P1118, DOI 10.1021/jm050932j; Ward MM, 2006, ARTHRIT RHEUM-ARTHR, V55, P74, DOI 10.1002/art.21695; Welton N.J., 2012, EVIDENCE SYNTHESIS D, V132; WHITWELL F, 1977, THORAX, V32, P377, DOI 10.1136/thx.32.4.377; WHITWELL F, 1971, THORAX, V26, P6, DOI 10.1136/thx.26.1.6; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yadav A, 2004, INDIAN J THORACIC CA, V20, P142, DOI [10.1007/s12055-004-0068-x, DOI 10.1007/S12055-004-0068-X]; YAZICIOGLU S, 1980, THORAX, V35, P564, DOI 10.1136/thx.35.8.564; Yen SJ, 2009, EXPERT SYST APPL, V36, P5718, DOI 10.1016/j.eswa.2008.06.108; Zhang ZH, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.32	75	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208737	10.1371/journal.pone.0208737	http://dx.doi.org/10.1371/journal.pone.0208737			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629589	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000018
J	Hu, X; Steimel, JP; Kapka-Kitzman, DM; Davis-Vogel, C; Richtman, NM; Mathis, JP; Nelson, ME; Lu, AL; Wu, GS				Hu, Xu; Steimel, Joseph P.; Kapka-Kitzman, Deirdre M.; Davis-Vogel, Courtney; Richtman, Nina M.; Mathis, John P.; Nelson, Mark E.; Lu, Albert L.; Wu, Gusui			Molecular characterization of the insecticidal activity of double-stranded RNA targeting the smooth septate junction of western corn rootworm (Diabrotica virgifera virgifera)	PLOS ONE			English	Article							COLEOPTERA; RESISTANCE	The western corn rootworm (WCR, Diabrotica virgifera virgifera) gene, dvssj1, is a putative homolog of the Drosophila melanogaster gene, snakeskin (ssk). This gene encodes a membrane protein associated with the smooth septate junction (SSJ) which is required for the proper barrier function of the epithelial lining of insect intestines. Disruption of DVSSJ integrity by RNAi technique has been shown previously to be an effective approach for corn rootworm control, by apparent suppression of production of DVSSJ1 protein leading to growth inhibition and mortality. To understand the mechanism that leads to the death of WCR larvae by dvssj1 double-stranded RNA, we examined the molecular characteristics associated with SSJ functions during larval development. Dvssj1 dsRNA diet feeding results in dose-dependent suppression of mRNA and protein; this impairs SSJ formation and barrier function of the midgut and results in larval mortality. These findings suggest that the malfunctioning of the SSJ complex in midgut triggered by dvssj1 silencing is the principal cause of WCR death. This study also illustrates that dvssj1 is a midgut-specific gene in WCR and its functions are consistent with biological functions described for ssk.	[Hu, Xu; Steimel, Joseph P.; Kapka-Kitzman, Deirdre M.; Davis-Vogel, Courtney; Richtman, Nina M.; Mathis, John P.; Nelson, Mark E.; Lu, Albert L.] DuPont Pioneer, Johnston, IA 50131 USA; [Wu, Gusui] DuPont Pioneer, Hayward, CA USA; [Wu, Gusui] Syngenta, Foster City, CA USA	DuPont; Pioneer Hi-Bred International, Inc.; Syngenta	Hu, X; Nelson, ME (corresponding author), DuPont Pioneer, Johnston, IA 50131 USA.	xu.hu@pioneer.com; MARK.E.NELSON@pioneer.com		Hu, Xu/0000-0002-1372-5399	DuPont Pioneer	DuPont Pioneer	Funding for this work was provided by DuPont Pioneer. The funder provided support in the form of salaries for XH, JPS, DMKK, NMR, CDV, JPM, MEN, ALL, and GW, as well as research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chien CH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126001; DOW JAT, 1986, ADV INSECT PHYSIOL, V19, P187; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 2017, ANN NY ACAD SCI, V1397, P17, DOI 10.1111/nyas.13366; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; GREEN LFB, 1980, TISSUE CELL, V12, P365, DOI 10.1016/0040-8166(80)90011-7; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hammack L, 2003, J ECON ENTOMOL, V96, P1153, DOI 10.1603/0022-0493-96.4.1153; HU X, 2017, International Patent Application NoWO, Patent No. [2017/218207, 2017218207]; Hu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep30542; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Izumi Y, 2016, J CELL SCI, V129, P1155, DOI 10.1242/jcs.180448; Izumi Y, 2014, SEMIN CELL DEV BIOL, V36, P186, DOI 10.1016/j.semcdb.2014.09.009; Izumi Y, 2012, J CELL SCI, V125, P4923, DOI 10.1242/jcs.112243; Katoch R, 2013, APPL BIOCHEM BIOTECH, V171, P847, DOI 10.1007/s12010-013-0399-4; King B, 2014, ARTHROPOD STRUCT DEV, V43, P605, DOI 10.1016/j.asd.2014.08.002; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Li H, 2015, J APPL ENTOMOL, V139, P432, DOI 10.1111/jen.12224; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101661; Narva KE, 2013, ADV BIOCHEM ENG BIOT, V136, P135, DOI 10.1007/10_2013_195; Niu XP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12638-3; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Yanagihashi Y, 2012, J CELL SCI, V125, P1980, DOI 10.1242/jcs.096800; Zhao JZ, 2016, J ECON ENTOMOL, V109, P1369, DOI 10.1093/jee/tow049	41	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210491	10.1371/journal.pone.0210491	http://dx.doi.org/10.1371/journal.pone.0210491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629687	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000096
J	Negiloni, K; Ramani, KK; Sudhir, RR				Negiloni, Kalpa; Ramani, Krishna Kumar; Sudhir, Rachapalle Reddi			Environmental factors in school classrooms: How they influence visual task demand on children	PLOS ONE			English	Article							LIGHT LEVELS; IMPACT; MYOPIA	Background The key visual factors in a classroom environment include the legibility, angle subtended at the eye, illumination, contrast, and colour of the visual task. The study evaluated the visual environmental factors in the school classrooms. Materials and methods The distance Visual Acuity (VA) demand was evaluated based on the size of visual task i.e. the smallest size of chalkboard writing and its viewing distance. The environmental factors which can have an effect on the visibility in classrooms such as illuminance on the chalkboard and at student's desk, chalkboard contrast, light sources and the student's perception of their classroom visual environment were measured. To quantify the distance VA demand and to compare with a standard high contrast VA chart measure, a validation of the measurements was performed by chalkboard simulation experiment. The "acuity reserve" to be included to the measured distance VA demand was evaluated. Results We included twenty-nine classrooms of eight schools. The median distance VA threshold demand was 0.28 logMAR(0.25,0.45). The median illuminance on front desk position and chalkboard contrast was 130 lux(92,208) and 40(36,50) respectively with 62% classrooms having low illumination (<150lux). The acuity reserve evaluated to be included to the distance VA demand was 0.13logMAR and 0.29 logMAR in classrooms with optimal and low chalkboard illumination respectively which was based on the results of the simulation experiment. The median distance VA demand including the acuity reserve was 0.09 logMAR (-0.03,0.23) [Snellen Equivalent: 20/25(20/19,20/34)]. Conclusion The study findings highlight the increased visual task demand in school classrooms and the need for appropriate seating arrangements in classrooms based on the visual acuity of children. The study emphasises regular audit of the classroom environment along with the school eye screening.	[Negiloni, Kalpa; Sudhir, Rachapalle Reddi] SankaraNethralaya, Unit Med Res Fdn, Madras, Tamil Nadu, India; [Negiloni, Kalpa] Shanmugha Arts Sci Technol & Res Acad SASTRA Univ, Thanjavur, India; [Negiloni, Kalpa; Ramani, Krishna Kumar] Elite Sch Optometry, Madras, Tamil Nadu, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Sudhir, RR (corresponding author), SankaraNethralaya, Unit Med Res Fdn, Madras, Tamil Nadu, India.	rrsudhir@gmail.com	Ramani, Krishna/AAF-6269-2019					[Anonymous], 2009, BRIGHT SCH LIGHT SUS; [Anonymous], 2004, 79421976 IS; Barrett P, 2015, BUILD ENVIRON, V89, P118, DOI 10.1016/j.buildenv.2015.02.013; Bureau of Indian Standards, 2010, NAT LIGHT COD 2010; Department of Education and Employment, BUILD B, V90; Gilavand A, 2016, INT J PEDIATR-MASSHA, V4, P1819; Hua WJ, 2015, OPHTHAL PHYSL OPT, V35, P252, DOI 10.1111/opo.12207; Meenakshi J., 2015, Asian Journal of Home Science, V10, P221, DOI 10.15740/HAS/AJHS/10.1/221-226; Mott MS, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012445585; Narayanasamy S, 2016, CLIN EXP OPTOM, V99, P233, DOI 10.1111/cxo.12365; Negiloni K, 2018, INDIAN J OPHTHALMOL, V66, P285, DOI [10.4103/ijo.IJO_772_17, 10.4103/ijo.IJO_1165_17]; Negiloni K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174983; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Ramamurthy D, 2015, CLIN EXP OPTOM, V98, P497, DOI 10.1111/cxo.12346; Samani S.A., 2012, INT J BUSINESS SOCIA, V3, P127; Zhou ZQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181772	16	2	2	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210299	10.1371/journal.pone.0210299	http://dx.doi.org/10.1371/journal.pone.0210299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629656	gold, Green Submitted, Green Published			2022-12-26	WOS:000455483000071
J	Rolim, FA; Langlois, T; Rodrigues, PFC; Bond, T; Motta, FS; Neves, LM; Gadig, OBF				Rolim, Fernanda A.; Langlois, Tim; Rodrigues, Pedro F. C.; Bond, Todd; Motta, Fabio S.; Neves, Leonardo M.; Gadig, Otto B. F.			Network of small no-take marine reserves reveals greater abundance and body size of fisheries target species	PLOS ONE			English	Article							REEF-FISH ASSEMBLAGES; UNDERWATER VIDEO STATIONS; STEREO-VIDEO; COMMUNITY STRUCTURE; ROCKY REEF; HABITAT COMPLEXITY; PROTECTED AREAS; FEEDING-BEHAVIOR; COASTAL ISLANDS; BIODIVERSITY	No-take marine reserves (NTRs), i. e. areas with total fishing restrictions, have been established worldwide aiming to promote biodiversity and ecosystem conservation. Brazil has 3.3% of its exclusive economic zone protected by 73 different NTRs, however, most of them currently lack scientific knowledge and understanding of their ecological role, particularly regarding rocky reefs in subtropical regions. In this context, this study aimed to contrast a network of NTRs with comparable fished sites across a coastal biogeographic gradient to investigate the effect of fishing and habitat variability on the abundance and body size of rocky reef fish. We used Baited Remote Underwater stereo-Video (stereo-BRUVs) and Diver Operated stereo-Video (stereo-DOVs) systems to simultaneously sample reef fish and habitat. Model selection and results identified habitat and biogeographic variables, such as distance from shore, as important predictor variables, explaining several aspects of the fish assemblage. The effect of protection was important in determining the abundance and body size of targeted species, in particular for epinephelids and carangids. Conversely, species richness was correlated with habitat complexity but not with protection status. This is the first study using these survey methods in the Southwestern Atlantic, demonstrating how a network of NTRs can provide benchmarks for biodiversity conservation and fisheries management.	[Rolim, Fernanda A.] Univ Estadual Paulista UNESP, Inst Biociencias, Campus Rio Claro, Rio Claro, SP, Brazil; [Rolim, Fernanda A.; Rodrigues, Pedro F. C.; Gadig, Otto B. F.] Univ Estadual Paulista UNESP, Lab Pesquisa Elasmobranquios, Inst Biociencias, Campus Litoral Paulista, Sao Vicente, SP, Brazil; [Langlois, Tim; Bond, Todd] UWA, UWA Oceans Inst, Perth, WA, Australia; [Langlois, Tim; Bond, Todd] UWA, Sch Biol Sci, Perth, WA, Australia; [Motta, Fabio S.] Univ Fed Sao Paulo UNIFESP, Lab Ecol & Conservacao Marinha, Inst Mar, Santos, SP, Brazil; [Neves, Leonardo M.] Univ Fed Rural Rio do Janeiro UFRRJ, Dept Ciencias Meio Ambiente, Campus Tres Rios, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Rolim, FA (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias, Campus Rio Claro, Rio Claro, SP, Brazil.; Rolim, FA (corresponding author), Univ Estadual Paulista UNESP, Lab Pesquisa Elasmobranquios, Inst Biociencias, Campus Litoral Paulista, Sao Vicente, SP, Brazil.	fernandarolim2@gmail.com	Neves, Leonardo/AAN-1167-2020; Motta, Fabio S./L-9006-2013; Bond, Todd/AAO-9083-2020; Neves, Leonardo M/C-7799-2013; Rolim, Fernanda Andreoli/U-4498-2019; Bond, Todd/V-9231-2019	Neves, Leonardo/0000-0002-0269-6588; Bond, Todd/0000-0001-6064-7015; Neves, Leonardo M/0000-0002-0269-6588; Rolim, Fernanda Andreoli/0000-0003-3761-3970; 	Boticario Foundation for Nature Protection [1043_20151]; National Council for Scientific and Technological Development (CNPq), Brazil [CNPq 141799/2016-1, CNPq 308430/2015-8]; Instituto Biopesca	Boticario Foundation for Nature Protection; National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Biopesca	This study was supported by the Boticario Foundation for Nature Protection (Otto B. F. Gadig, Project #1043_20151), and by the National Council for Scientific and Technological Development (CNPq), Brazil (PhD scholarship, Fernanda A. Rolim, CNPq 141799/2016-1; Research productivity grant, Otto B. F. Gadig, CNPq 308430/2015-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Chico Mendes Institute for Biodiversity Conservation (ICMBio) for the permits and field support, and also to the Universo Marinho Dive Company and the staff for sampling assistance and equipment. We are also thankful to Instituto Biopesca for all the funding management and Alfredo Carvalho Filho for the fish drawings.	Aburto-Oropeza O, 2001, MAR ECOL-P S Z N I, V22, P283, DOI 10.1046/j.1439-0485.2001.t01-1-01747.x; Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Althaus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141039; Anderson AB, 2014, MAR ECOL PROG SER, V514, P207, DOI 10.3354/meps11032; Anderson AB, 2018, MAR BIODIVERS, DOI [10.1007/s12526-017-0666-7, DOI 10.1007/S12526-017-0666-7]; [Anonymous], 2018, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.EN; Aued AW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198452; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barton K, 2018, MUMIN MULTIMODEL INF; BEGOSSI A, 1993, ECOL FOOD NUTR, V30, P51, DOI 10.1080/03670244.1993.9991322; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Bennett K, 2016, LIMNOL OCEANOGR-METH, V14, P874, DOI 10.1002/lom3.10141; Bonaldo RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170638; Bond T, 2018, MAR ENVIRON RES, V141, P53, DOI 10.1016/j.marenvres.2018.08.003; Burnham K P, 2003, MODEL SELECT MULTIMO; Cappo M., 2006, AUSTR SOC FISH BIOL, VVol. 1, P101, DOI DOI 10.1007/978-1-62703-724-2_1; Cappo Mike, 2011, Journal of the Royal Society of Western Australia, V94, P303; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carvalho-Filho A., PEIXES COSTA BRASILE; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Di Franco A, 2018, BIOL CONSERV, V221, P175, DOI 10.1016/j.biocon.2018.03.012; Dorman SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041538; Edgar GJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177216; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; EKLOV P, 1994, OECOLOGIA, V98, P344, DOI 10.1007/BF00324223; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; Ferreira CM, 2015, BRAZ J OCEANOGR, V63, P379, DOI 10.1590/S1679-87592015074706304; Ferreira CEL, 2001, ENVIRON BIOL FISH, V61, P353, DOI 10.1023/A:1011609617330; Ferreira CEL, 1998, J EXP MAR BIOL ECOL, V229, P241, DOI 10.1016/S0022-0981(98)00056-2; Fisher R, 2018, ECOL EVOL, V8, P6104, DOI 10.1002/ece3.4134; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Floeter SR, 2006, BIOL CONSERV, V128, P391, DOI 10.1016/j.biocon.2005.10.005; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Floeter SR, 2000, J FISH BIOL, V56, P1099, DOI 10.1111/j.1095-8649.2000.tb02126.x; Flournoy P.H., 2003, J INT WILDL LAW POL, V6, P137; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Freire KMF, 2010, FISH RES, V105, P57, DOI 10.1016/j.fishres.2010.02.008; Froese R, 2018, FISHBASE; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Gasparini Joao Luiz, 2003, Zootaxa, V384, P1; Gell F. R., 2002, FISHERY EFFECTS MARI, DOI 10.1016/s1386-5056(02)00038-2; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; Gibran FZ, 2012, NEOTROP ICHTHYOL, V10, P369, DOI 10.1590/S1679-62252012005000013; Giglio VJ, 2018, MAR POLICY, V96, P13, DOI 10.1016/j.marpol.2018.07.017; Goetze JS, 2015, J EXP MAR BIOL ECOL, V462, P74, DOI 10.1016/j.jembe.2014.10.004; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey E, 2001, FISH B-NOAA, V99, P63; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Hastie T., 1986, STAT SCI, V1, P297; Hauzy C, 2010, OECOLOGIA, V163, P625, DOI 10.1007/s00442-010-1585-5; Holmes TH, 2013, LIMNOL OCEANOGR-METH, V11, P337, DOI 10.4319/lom.2013.11.337; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; ICMBio, 2018, I CHIC MEND PROT NAT; Ilarri MI, 2017, MAR FRESHWATER RES, V68, P1303, DOI 10.1071/MF16071; Jennings S., 2009, MARINE FISHERIES ECO; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Krebs CJ, 1972, ECOLOGY EXPT ANAL DI; Langlois T., 2018, FIELD MANUALS MARINE, P82, DOI [DOI 10.11636/9781925297669, DOI 10.1177/0894318405277523]; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Langlois TJ, 2015, FISH RES, V161, P145, DOI 10.1016/j.fishres.2014.06.008; Langlois TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P886, DOI 10.1111/j.1466-8238.2011.00734.x; Langlois TJ, GLOBALARCHIVE ONLINE; Lecchini D, 2003, OCEANOL ACTA, V26, P537, DOI 10.1016/S0399-1784(03)00048-3; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Magris RA, 2018, SCIENCE, V360, P723, DOI 10.1126/science.aat6215; Malcolm HA, 2018, ESTUAR COAST SHELF S, V212, P118, DOI 10.1016/j.ecss.2018.07.003; Malcolm Hamish A., 2010, Marine Biodiversity, V40, P181, DOI 10.1007/s12526-010-0042-3; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Silvano RAM, 2006, BRAZ ARCH BIOL TECHN, V49, P623, DOI 10.1590/S1516-89132006000500012; McLaren BW, 2015, J EXP MAR BIOL ECOL, V471, P153, DOI 10.1016/j.jembe.2015.06.002; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Minte-Vera CV, 2008, MAR ECOL PROG SER, V367, P283, DOI 10.3354/meps07511; MMA, 2014, PORT MMA 445 17 DEZ; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Morais RA, 2017, J FISH BIOL, V91, P1642, DOI 10.1111/jfb.13482; Moura RL, P 9 INT COR REEF S B; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Neves LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166679; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Parsons DF, 2016, MAR ECOL PROG SER, V561, P155, DOI 10.3354/meps11927; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pinheiro HT, 2018, DIVERS DISTRIB, V24, P951, DOI 10.1111/ddi.12729; Pinheiro HT, 2013, J MAR BIOL ASSOC UK, V93, P1175, DOI 10.1017/S0025315412001749; Pinheiro Hudson Tercio, 2015, Check List, V11, P1615; Pinheiro HT, 2010, NAT CONSERVACAO, V8, P151, DOI 10.4322/natcon.00802008; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; R Core Team, 2018, R LANG ENV STAT COMP; Randall J.E., 1967, FOOD HABITS REEF FIS; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rolim FA, PEIXES RECIFE ROCHOS; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Santana-Garcon J, 2014, J EXP MAR BIOL ECOL, V460, P153, DOI 10.1016/j.jembe.2014.07.003; Sazima C, 2007, ENVIRON BIOL FISH, V80, P351, DOI 10.1007/s10641-006-9123-3; Schultz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096798; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; STJOHN J, 1990, MAR ECOL PROG SER, V64, P253, DOI 10.3354/meps064253; Teixeira-Neves TP, 2015, ENVIRON BIOL FISH, V98, P1645, DOI 10.1007/s10641-015-0390-8; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Tokeshi M, 2012, HYDROBIOLOGIA, V685, P27, DOI 10.1007/s10750-011-0832-z; Van Nguyen L, 2008, ENVIRON BIOL FISH, V82, P309, DOI 10.1007/s10641-007-9293-7; von Glasow R, 2013, AMBIO, V42, P13, DOI 10.1007/s13280-012-0343-9; Watson DL, 2009, MAR ECOL PROG SER, V384, P241, DOI 10.3354/meps08009; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; WHITELAW AW, 1991, AUST J MAR FRESH RES, V42, P369; Whitmarsh SK, 2017, REV FISH BIOL FISHER, V27, P53, DOI 10.1007/s11160-016-9450-1; Wickham H., 2018, TIDYVERSE DPLYR; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2012, MAR ENVIRON RES, V81, P1, DOI 10.1016/j.marenvres.2012.08.002; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S., 2017, GAMM4 GEN ADDITIVE M; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	126	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0204970	10.1371/journal.pone.0204970	http://dx.doi.org/10.1371/journal.pone.0204970			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629577	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000006
J	Lagerweij, GR; Moons, KGM; de Wit, GA; Koffijberg, H				Lagerweij, G. R.; Moons, K. G. M.; de Wit, G. A.; Koffijberg, H.			Interpretation of CVD risk predictions in clinical practice: Mission impossible?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; COHORT PROFILE; END-POINTS; PREVENTION; GUIDELINES; UPDATE; MODELS	Background Cardiovascular disease (CVD) risk prediction models are often used to identify individuals at high risk of CVD events. Providing preventive treatment to these individuals may then reduce the CVD burden at population level. However, different prediction models may predict different (sets of) CVD outcomes which may lead to variation in selection of high risk individuals. Here, it is investigated if the use of different prediction models may actually lead to different treatment recommendations in clinical practice. Method The exact definition of and the event types included in the predicted outcomes of four widely used CVD risk prediction models (ATP-III, Framingham (FRS), Pooled Cohort Equations (PCE) and SCORE) was determined according to ICD-10 codes. The models were applied to a Dutch population cohort (n = 18,137) to predict the 10-year CVD risks. Finally, treatment recommendations, based on predicted risks and the treatment threshold associated with each model, were investigated and compared across models. Results Due to the different definitions of predicted outcomes, the predicted risks varied widely, with an average 10-year CVD risk of 1.2% (ATP), 5.2% (FRS), 1.9% (PCE), and 0.7% (SCORE). Given the variation in predicted risks and recommended treatment thresholds, preventive drugs would be prescribed for 0.2%, 14.9%, 4.4%, and 2.0% of all individuals when using ATP, FRS, PCE and SCORE, respectively. Conclusion Widely used CVD prediction models vary substantially regarding their outcomes and associated absolute risk estimates. Consequently, absolute predicted 10-year risks from different prediction models cannot be compared directly. Furthermore, treatment decisions often depend on which prediction model is applied and its recommended risk threshold, introducing unwanted practice variation into risk-based preventive strategies for CVD.	[Lagerweij, G. R.; Moons, K. G. M.; de Wit, G. A.; Koffijberg, H.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Lagerweij, G. R.] Dutch Heart Inst, Utrecht, Netherlands; [de Wit, G. A.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Healthcare, Bilthoven, Netherlands; [Koffijberg, H.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, Enschede, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; University of Twente	Lagerweij, GR (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Lagerweij, GR (corresponding author), Dutch Heart Inst, Utrecht, Netherlands.	g.r.lagerweij@umcutrecht.nl		Lagerweij, Ghizelda/0000-0003-3286-2556; Koffijberg, Hendrik/0000-0002-1753-0652; de Wit, G. Ardine/0000-0002-1375-7657				Allan GM, 2013, CIRCULATION, V127, P1948, DOI 10.1161/CIRCULATIONAHA.112.000412; [Anonymous], 2014, LIPID MODIFICATION C; Beswick AD., 2008, SYSTEMATIC REV RISK; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Blokstra A., 2005, MONITORING OF RISK F; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Harrell FE, 2001, REGRESSION MODELING; Heeg BM, 2014, MED DECIS MAKING, V34, P300, DOI 10.1177/0272989X13517180; Jackson R, 2013, CIRCULATION, V127, P1929, DOI 10.1161/CIRCULATIONAHA.113.002650; Kent DM, 2012, JAMA-J AM MED ASSOC, V307, P1585, DOI 10.1001/jama.2012.469; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kip KE, 2008, J AM COLL CARDIOL, V51, P701, DOI 10.1016/j.jacc.2007.10.034; Members T.F., 2016, EUR J PREV CARDIOL, V2016, pNP1; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Nayor M, 2016, CIRCULATION, V133, P1795, DOI 10.1161/CIRCULATIONAHA.116.021407; Nederlands Huisartsen Genootschap, 2011, MULTIDISCIPLINAIRE R; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Usher-Smith JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008717; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209314	10.1371/journal.pone.0209314	http://dx.doi.org/10.1371/journal.pone.0209314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625177	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400035
J	Rokke, GB; Melo, TB; Muhlroth, A; Vadstein, O; Bones, AM; Hohmann-Marriott, MF				Rokke, Gunvor Bjerkelund; Melo, Thor Bernt; Muhlroth, Alice; Vadstein, Olav; Bones, Atle M.; Hohmann-Marriott, Martin F.			Unique photosynthetic electron transport tuning and excitation distribution in heterokont algae	PLOS ONE			English	Article							DIATOM PHAEODACTYLUM-TRICORNUTUM; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; XANTHOPHYLL CYCLE; REDOX STATE; NANNOCHLOROPSIS-GADITANA; PROTON GRADIENT; CORE COMPLEX; LIGHT; PHOTOPROTECTION	Heterokont algae are significant contributors to marine primary productivity. These algae have a photosynthetic machinery that shares many common features with that of Viridiplantae (green algae and land plants). Here we demonstrate, however, that the photosynthetic machinery of heterokont algae responds to light fundamentally differently than that of Viridiplantae. While exposure to high light leads to electron accumulation within the photosynthetic electron transport chain in Viridiplantae, this is not the case in heterokont algae. We use this insight to manipulate the photosynthetic electron transport chain and demonstrate that heterokont algae can dynamically distribute excitation energy between the two types of photosystems. We suggest that the reported electron transport and excitation distribution features are adaptations to the marine light environment.	[Rokke, Gunvor Bjerkelund; Vadstein, Olav; Hohmann-Marriott, Martin F.] Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway; [Melo, Thor Bernt] Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway; [Muhlroth, Alice; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Hohmann-Marriott, MF (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway.	martin.hohmann-marriott@ntnu.no	Bones, Atle M/C-6202-2014	Bones, Atle M/0000-0003-0544-7437; Hohmann-Marriott, Martin/0000-0002-2957-7052	Faculty of Natural Sciences at the Norwegian University of Science and Technology (NTNU)	Faculty of Natural Sciences at the Norwegian University of Science and Technology (NTNU)	The Faculty of Natural Sciences (https://www.ntnu.no/nv, priority programme NTNU Ocean) at the Norwegian University of Science and Technology (NTNU) founded the PhD position (G.B.R). Grant number is not available. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboresi A, 2017, NEW PHYTOL, V213, P714, DOI 10.1111/nph.14156; ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Belgio E, 2017, BBA-BIOENERGETICS, V1858, P56, DOI 10.1016/j.bbabio.2016.10.002; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; Bennoun P, 2001, BBA-BIOENERGETICS, V1506, P133, DOI 10.1016/S0005-2728(01)00190-6; Buchanan BB, 2016, ANNU REV PLANT BIOL, V67, P1, DOI 10.1146/annurev-arplant-043015-111949; Bukhov NG, 2003, BBA-BIOENERGETICS, V1604, P115, DOI 10.1016/S0005-2728(03)00042-2; Cao SN, 2013, FEBS LETT, V587, P1310, DOI 10.1016/j.febslet.2012.12.031; CARON L, 1987, PHOTOSYNTH RES, V11, P131, DOI 10.1007/BF00018271; Chukhutsina VU, 2017, BBA-BIOENERGETICS, V1858, P544, DOI 10.1016/j.bbabio.2017.05.003; Cruz S, 2011, J EXP BOT, V62, P509, DOI 10.1093/jxb/erq284; De-Luca R, 2018, ALGAL RES, V33, P430, DOI 10.1016/j.algal.2018.06.016; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Derks A, 2015, BBA-BIOENERGETICS, V1847, P468, DOI 10.1016/j.bbabio.2015.02.008; DINER B, 1973, BIOCHIM BIOPHYS ACTA, V305, P329, DOI 10.1016/0005-2728(73)90180-1; Duysens LMN, 1963, JAPANESE SOC PLANT P, P363; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Falkowski PG, 2004, MOL GLOBAL PHOTOSYNT, P287; FRANK K, 1995, PHOTOCHEM PHOTOBIOL, V61, P2, DOI 10.1111/j.1751-1097.1995.tb09237.x; Giovagnetti V, 2017, BBA-BIOENERGETICS, V1858, P218, DOI 10.1016/j.bbabio.2016.12.005; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HAGER A, 1970, ARCH MIKROBIOL, V73, P77, DOI 10.1007/BF00409954; Herbstova M, 2015, BBA-BIOENERGETICS, V1847, P534, DOI 10.1016/j.bbabio.2015.02.016; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Hohmann-Marriott MF, 2010, FEBS LETT, V584, P1021, DOI 10.1016/j.febslet.2010.01.052; Ikeda Y, 2008, BBA-BIOENERGETICS, V1777, P351, DOI 10.1016/j.bbabio.2008.01.011; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; Juhas M, 2012, J EXP BOT, V63, P3673, DOI 10.1093/jxb/ers049; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Kruger TPJ, 2017, P NATL ACAD SCI USA, V114, pE11063, DOI 10.1073/pnas.1714656115; Lamb JJ, 2018, PHOTOSYNTHETICA, V56, P105, DOI 10.1007/s11099-018-0791-y; Lamb J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132258; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Lepetit B, 2017, NEW PHYTOL, V214, P205, DOI 10.1111/nph.14337; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Litvin R, 2016, PHOTOSYNTH RES, V130, P137, DOI 10.1007/s11120-016-0234-1; Martinson TA, 1998, BBA-BIOENERGETICS, V1409, P72, DOI 10.1016/S0005-2728(98)00153-4; Meneghesso A, 2016, PHOTOSYNTH RES, V129, P291, DOI 10.1007/s11120-016-0297-z; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; MULLINEAUX CW, 1986, FEBS LETT, V205, P155, DOI 10.1016/0014-5793(86)80885-7; Nagao R, 2014, J PHYS CHEM B, V118, P5093, DOI 10.1021/jp502035y; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; OWENS TG, 1986, PLANT PHYSIOL, V80, P739, DOI 10.1104/pp.80.3.739; Papageorgiou G.C., 2004, CHLOROPHYLL FLUORESC; Rokke G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175184; Rousseaux CS, 2014, REMOTE SENS-BASEL, V6, P1, DOI 10.3390/rs6010001; SCHENCK H, 1957, J OPT SOC AM, V47, P653, DOI 10.1364/JOSA.47.000653; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; SCHREIBER U, 1974, BIOCHIM BIOPHYS ACTA, V368, P97, DOI 10.1016/0005-2728(74)90100-5; SCHREIBER U, 1995, AUST J PLANT PHYSIOL, V22, P209, DOI 10.1071/PP9950209; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P311, DOI 10.1093/oxfordjournals.pcp.a029543; WILHELM C, 1990, BIOCHIM BIOPHYS ACTA, V1016, P197, DOI 10.1016/0005-2728(90)90058-C; Yokono M, 2015, BBA-BIOENERGETICS, V1847, P1274, DOI 10.1016/j.bbabio.2015.07.006; You Y, 2010, APPL OPTICS, V49, P1041, DOI 10.1364/AO.49.001041	65	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209920	10.1371/journal.pone.0209920	http://dx.doi.org/10.1371/journal.pone.0209920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625205	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400063
J	Aki, T; Unuma, K; Noritake, K; Hirayama, N; Funakoshi, T; Uemura, K				Aki, Toshihiko; Unuma, Kana; Noritake, Kanako; Hirayama, Naho; Funakoshi, Takeshi; Uemura, Koichi			Formation of high molecular weight p62 by CORM-3	PLOS ONE			English	Article							CARBON-MONOXIDE; CO RELEASE; AUTOPHAGY; RUTHENIUM; LC3; COMPLEXES; CELLS	CORM-3 is a water-soluble carbon monoxide (CO)-releasing molecule developed for possible therapeutic use of CO. CORM-3 belongs to a group of metal carbonyl compounds that contain transition metals and carbonyls as the central scaffold and coordinated ligands, respectively. CORM-3 has been reported to be reactive with many proteins in eukaryotes including mammals. Among them, several extracellular proteins, such as lysozyme, as well as plasma albumin and fibronectin, have been shown to interact directly with CORM-3. p62 is an intracellular adaptor protein required for targeting ubiquitinated (Ub) proteins to lysosomal degradation through autophagy. p62 has been shown to undergo self-oligomerization via covalent crosslinking in response to treatment with verteporfin, a benzoporphyrin derivative used for photodynamic therapy. Here we show that CORM-3 also interacts directly with p62. When applied to mouse embryonic fibroblasts (MEFs) at a high concentration (1 mM), CORM-3 causes the formation of reduction-and detergent-resistant high molecular weight (HMW)-p62. HMW-p62 accumulates more in atg5-/-MEFs than in wild type (WT) MEFs, showing the elimination of HMW-p62 through autophagy. HMW-p62 is also generated in H9c2 rat cardiomyoblastoma as well as A549 human alveolar epithelial cells, suggesting that HMW-p62 formation is not specific to MEFs, but, rather, is a general event in mammalian cells. HMW-p62 formation by CORM-3 can be reproduced using purified p62 in vitro, demonstrating the direct interaction between CORM-3 and p62. These results show that p62 is a CORM-3-interactive intracellular protein.	[Aki, Toshihiko; Unuma, Kana; Noritake, Kanako; Hirayama, Naho; Funakoshi, Takeshi; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Bunkyo Ku, Tokyo, Japan.	aki.legm@tmd.ac.jp			MEXT KAKENHI [17H04147]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid from MEXT KAKENHI (grant number 17H04147 to T.A.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2018, TOXICOL IN VITRO, V50, P201, DOI 10.1016/j.tiv.2018.03.010; Cabrales P, 2007, RESUSCITATION, V72, P306, DOI 10.1016/j.resuscitation.2006.06.021; Carroll B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02746-z; Casini A, 2007, J BIOL INORG CHEM, V12, P1107, DOI 10.1007/s00775-007-0280-4; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chaves-Ferreira M, 2015, ANGEW CHEM INT EDIT, V54, P1172, DOI 10.1002/anie.201409344; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Donohue E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114964; Ferrandiz ML, 2008, ANN RHEUM DIS, V67, P1211, DOI 10.1136/ard.2007.082412; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Gomez H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135032; Hoetzel A, 2007, ANTIOXID REDOX SIGN, V9, P2013, DOI 10.1089/ars.2007.1762; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jung SS, 2015, AM J PHYSIOL-LUNG C, V308, pL1058, DOI 10.1152/ajplung.00400.2014; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Konstantinou EK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46581; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lin XL, 2013, DNA CELL BIOL, V32, P220, DOI 10.1089/dna.2012.1915; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakahira K, 2015, AM J PHYSIOL-LUNG C, V309, pL1387, DOI 10.1152/ajplung.00311.2015; Nobre LS, 2016, DALTON T, V45, P1455, DOI 10.1039/c5dt02238j; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Santos MFA, 2012, J INORG BIOCHEM, V117, P285, DOI 10.1016/j.jinorgbio.2012.06.018; Santos-Silva T, 2011, J AM CHEM SOC, V133, P1192, DOI 10.1021/ja108820s; Southam HM, 2018, REDOX BIOL, V18, P114, DOI 10.1016/j.redox.2018.06.008; Southam HM, 2017, ADV MICROB PHYSIOL, V71, P1, DOI 10.1016/bs.ampbs.2017.03.001; Wang PP, 2014, EUR J MED CHEM, V74, P199, DOI 10.1016/j.ejmech.2013.12.041; Zhou ZH, 2005, AM J PATHOL, V166, P27, DOI 10.1016/S0002-9440(10)62229-8	33	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210474	10.1371/journal.pone.0210474	http://dx.doi.org/10.1371/journal.pone.0210474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620762	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300037
J	Harasti, D; Davis, TR; Jordan, A; Erskine, L; Moltschaniwskyj, N				Harasti, David; Davis, Tom R.; Jordan, Alan; Erskine, Luke; Moltschaniwskyj, Natalie			Illegal recreational fishing causes a decline in a fishery targeted species (Snapper: Chrysophrys auratus) within a remote no-take marine protected area	PLOS ONE			English	Article							RESERVES; REEF; ENFORCEMENT; SIZE; POPULATIONS; PERCEPTIONS; ABUNDANCE; HABITAT; PARK; AGE	One role of Marine Protected Areas is to protect biodiversity; however, illegal fishing activity can reduce the effectiveness of protection. Quantifying illegal fishing effort within no-take MPAs is difficult and the impacts of illegal fishing on biodiversity are poorly understood. To provide an assessment of illegal fishing activity, a surveillance camera was deployed at the Seal Rocks no-take area within the Port Stephens-Great Lakes Marine Park from April 2017-March 2018. To assess impacts of illegal fishing activity in the no-take area, Baited Remote Underwater Video Systems (BRUVs) were used to quantify abundance and size of snapper Chrysophrys auratus from 2011-2017. BRUVs were also deployed at two nearby fished locations and two other no-take areas to allow comparison. Over 12 months of camera surveillance, a total of 108 recreational vessels were observed illegally fishing within the no-take area (avg 9.0 +/- 0.9 per month). The greatest number of vessels detected in a single month was 14 and the longest a vessel was observed fishing was similar to 6 hours. From 2011-2017, the abundance of C. auratus within the Seal Rocks no-take area significantly declined by 55%, whilst the abundance within the other fished areas and no-take areas did not significantly decline over the same period. Lengths of C. auratus in the Seal Rocks no-take area were significantly smaller in 2017 compared to 2013 which was driven by a decline in the number of legal sized fish over 30 cm. Based on mean number of illegal fishers per vessel recorded in the no-take area, and an allowable bag limit of 10 C. auratus per person, it is possible that more than 2,000 C. auratus are removed annually from this no-take area. There is a strong likelihood that illegal recreational fishing is causing a reduction on a fishery targeted species within a no-take MPA and measures need to be implemented to reduce the ongoing illegal fishing pressure.	[Harasti, David; Davis, Tom R.; Jordan, Alan; Erskine, Luke; Moltschaniwskyj, Natalie] NSW Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia	NSW Department of Primary Industries	Harasti, D (corresponding author), NSW Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia.	david.harasti@dpi.nsw.gov.au	Moltschaniwskyj, Natalie/AAB-7236-2019	Harasti, David/0000-0002-2851-9838; Moltschaniwskyj, Natalie/0000-0001-9709-9876				Advani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126098; Arias A, 2015, ECOL SOC, V20, DOI 10.5751/ES-07999-200419; Bergseth BJ, 2018, MAR POLICY, V89, P132, DOI 10.1016/j.marpol.2017.12.022; Bergseth BJ, 2017, FRONT ECOL ENVIRON, V15, P67, DOI 10.1002/fee.1457; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Byers JE, 2007, ECOL APPL, V17, P1851, DOI 10.1890/07-0067.1; Camaclang AE, 2016, CANADIAN J FISHERIES, V74, P894; Campbell SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050074; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Free CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143960; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Fulton CJ, 2016, ECOL INDIC, V70, P222, DOI 10.1016/j.ecolind.2016.06.032; Giakoumi S, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00223; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Haggarty DR, 2016, CAN J FISH AQUAT SCI, V73, P1587, DOI 10.1139/cjfas-2015-0205; Halpern BS, 2003, ECOL APPL, V13, pS117; Harasti D, 2013, J FISH BIOL, V83, P378, DOI 10.1111/jfb.12179; Harasti D, 2017, REGIONAL STUDIES IN, DOI [10.1126/science.aai9214, DOI 10.1126/SCIENCE.AAI9214]; Harasti D, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00208; Harasti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142454; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Kelaher BP, 2015, GLOB ECOL CONSERV, V3, P503, DOI 10.1016/j.gecco.2015.02.002; Keller K, 2016, FISH RES, V181, P84, DOI 10.1016/j.fishres.2016.03.025; Kuempel CD, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12433; Lancaster D, 2017, AQUAT CONSERV, V27, P804, DOI 10.1002/aqc.2736; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Malcolm HA, 2018, ESTUAR COAST SHELF S, V212, P118, DOI 10.1016/j.ecss.2018.07.003; Malcolm HA, 2016, AQUAT CONSERV, V26, P1090, DOI 10.1002/aqc.2600; Malcolm HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127616; Marra S, 2017, MEDITERR MAR SCI, V18, P406, DOI 10.12681/mms.2087; Martin CL, 2016, MAR POLICY, V73, P138, DOI 10.1016/j.marpol.2016.08.002; Miller KI, 2014, OCEAN COAST MANAGE, V96, P51, DOI 10.1016/j.ocecoaman.2014.05.003; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Pieraccini M, 2017, AQUAT CONSERV, V27, P177, DOI 10.1002/aqc.2632; Read AD, 2015, MAR POLICY, V60, P119, DOI 10.1016/j.marpol.2015.06.008; Read AD, 2011, J ENVIRON MANAGE, V92, P2558, DOI 10.1016/j.jenvman.2011.05.022; Rife AN, 2013, CONSERV LETT, V6, P200, DOI 10.1111/j.1755-263X.2012.00303.x; Sala E, 2018, ICES J MAR SCI, V75, P1166, DOI 10.1093/icesjms/fsx059; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Smallwood CB, 2012, N AM J FISH MANAGE, V32, P1265, DOI 10.1080/02755947.2012.728181; Smallwood CB, 2012, FISH RES, V125, P40, DOI 10.1016/j.fishres.2012.01.019; Sokal R.R., 1987, INTRO BIOSTATISTICS, V2nd; Voyer M, 2014, AQUAT CONSERV, V24, P441, DOI 10.1002/aqc.2363; Watson GJ, 2015, MAR POLICY, V52, P59, DOI 10.1016/j.marpol.2014.10.016; Williamson DH, 2015, PLOS ONE, V9; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Wood G, 2016, ECOL EVOL, V6, P6963, DOI 10.1002/ece3.2342	52	19	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0209926	10.1371/journal.pone.0209926	http://dx.doi.org/10.1371/journal.pone.0209926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG7HM	30620736	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300012
J	Cunha, ATM; Carvalho, JO; Guimaraes, ALS; Leme, LO; Caixeta, FM; Viana, JHM; Dode, MAN				Cunha, Andrielle T. M.; Carvalho, Jose O.; Guimaraes, Ana L. S.; Leme, Ligiane O.; Caixeta, Felippe M.; Viana, Joao H. M.; Dode, Margot A. N.			Bovine epididymal spermatozoa treatment for in vitro fertilization: Heparin accelerates fertilization and enables a reduction in coincubation time	PLOS ONE			English	Article							SPERM PREPARATION; SEMINAL PLASMA; CRYOPRESERVATION; PROTEINS; CENTRIFUGATION; CAPACITATION; PDC-109; QUALITY; BINDING; ABILITY	This study aimed to establish a protocol for in vitro embryo production using epididymal sperm (EP). Samples were obtained from ejaculated sperm (EJ) and the epididymis of 7 Gir bulls. First, the effect of heparin (+) on the viability, longevity (Experiment 1) and fertilization rates (Experiment 2) of the EP was evaluated. In experiment 2, a pool of EP and EJ sperm (n = 7) was coincubated with cumulus-oocyte complexes (COCs) for 0, 3, 6, 12 and 18 h, and the fertilization rate (FR) was evaluated. A third experiment was performed to test sperm treatments for IVP using the Percoll (P) or PureSperm (PS) gradients or a spTALP wash for sperm selection. Cleavage, blastocyst rate (BR) and embryo sex were evaluated. In experiment 4, embryos were produced using 6, 12, and 18 h of sperm-oocyte coincubation. The cleavage, BR, and total number and percentage of apoptotic cells were determined. Heparin affected EP viability, longevity and FR. After 6 h, 82% of the oocytes were fertilized in the EP+ group, a higher value (P<0.05) than that in the EJ (19%) and EP- (42%) groups. At 12 and 18 h, FR remained higher in the EP+ group, and a gradual increase in polyspermy was observed. The use of a P or PS gradient yielded a similar BR on D7 (54% and 52%), which was higher than the rate obtained using the washing method (37%). The embryos produced by EP and selected in a P or PS gradient resulted in a sex deviation in favor of male embryos (P>0.05). No differences (P>0.05) were observed among the groups that were coincubated for 6, 12 and 18 h with respect to embryo production, kinetics of development, total cell number and percentage of apoptotic cells. In conclusion, IVF time can be reduced to 6 h without affecting embryo production and quality. In addition, EP sperm selection can be performed by either a PS or P gradient.	[Cunha, Andrielle T. M.; Dode, Margot A. N.] Univ Brasilia, Inst Biol, Brasilia, DF, Brazil; [Carvalho, Jose O.; Leme, Ligiane O.] Univ Espirito Santo, Vet Med Dept, Alegre, Brazil; [Guimaraes, Ana L. S.; Caixeta, Felippe M.; Dode, Margot A. N.] Univ Brasilia, Sch Agr & Vet, Brasilia, DF, Brazil; [Viana, Joao H. M.; Dode, Margot A. N.] Embrapa Genet Resources & Biotechnol, Lab Anim Reprod, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Dode, MAN (corresponding author), Univ Brasilia, Inst Biol, Brasilia, DF, Brazil.; Dode, MAN (corresponding author), Univ Brasilia, Sch Agr & Vet, Brasilia, DF, Brazil.; Dode, MAN (corresponding author), Embrapa Genet Resources & Biotechnol, Lab Anim Reprod, Brasilia, DF, Brazil.	margot.dode@embrapa.br	Guimarães, Ana Luiza/ABG-2608-2020; dode, margot alves nunes/S-6524-2019; Dode, Margot/O-2486-2014; Viana, Joao Henrique Moreira/O-1635-2016; Carvalho, jose/U-5463-2019; Leme, Ligiane/P-3814-2019	Guimarães, Ana Luiza/0000-0002-6533-2490; dode, margot alves nunes/0000-0002-1096-0457; Dode, Margot/0000-0002-1096-0457; Viana, Joao Henrique Moreira/0000-0002-3742-2368; Carvalho, jose/0000-0003-0369-9649; Leme, Ligiane/0000-0003-4818-1202	Brazilian agriculture research company, Brazilian National Council for Scientific, University of Brasilia - UnB and Technological Development (CNPq)	Brazilian agriculture research company, Brazilian National Council for Scientific, University of Brasilia - UnB and Technological Development (CNPq)	This work was supported by Brazilian agriculture research company, Brazilian National Council for Scientific, University of Brasilia - UnB and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L-Y, 2017, J REPROD DEV; Arias ME, 2017, REPROD BIOL, V7; Boni R, 2012, ANIM REPROD, V9, P333; Buranaamnuay K, 2014, CHIANG MAI J SCI, V41, P1; Celeghini ECC, 2007, REPROD DOMEST ANIM, V42, P479, DOI 10.1111/j.1439-0531.2006.00810.x; Chaveiro A, 2015, IRAN J VET RES, V16, P188; CUMMINS JM, 1976, J EXP ZOOL, V197, P187, DOI 10.1002/jez.1401970204; Cunha ATM, 2016, CRYOBIOLOGY, V73, P348, DOI 10.1016/j.cryobiol.2016.09.170; de Sousa RV, 2017, THERIOGENOLOGY, V90, P25, DOI 10.1016/j.theriogenology.2016.11.003; De Vos A, 1997, HUM REPROD, V12, P1980, DOI 10.1093/humrep/12.9.1980; Demyda-Peyras S, 2013, REPROD FERTILITY DEV; Dode MAN, 2002, ANIM REPROD SCI, V69, P15, DOI 10.1016/S0378-4320(01)00148-8; Bertol MAF, 2016, THERIOGENOLOGY, V86, P1014, DOI 10.1016/j.theriogenology.2016.03.030; FRASER LR, 1976, J REPROD FERTIL, V48, P125, DOI 10.1530/jrf.0.0480125; Gwathmey TM, 2006, BIOL REPROD, V75, P501, DOI 10.1095/biolreprod.106.053306; Gwathmey TM, 2003, BIOL REPROD, V69, P809, DOI 10.1095/biolreprod.102.010827; Hallap T, 2006, THERIOGENOLOGY, V65, P1122, DOI 10.1016/j.theriogenology.2005.07.009; Holm P, 1998, THERIOGENOLOGY, V50, P1285, DOI 10.1016/S0093-691X(98)00227-1; Hossepian de Lima VFM, 2011, REV BRASILEIRA ZOOTE, V40; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; Kaabi M, 2003, THERIOGENOLOGY, V60, P1249, DOI 10.1016/S0093-691X(03)00139-0; Kadirvel G, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103879; Klinc P, 2007, REPROD DOMEST ANIM, V42, P63, DOI 10.1111/j.1439-0531.2006.00730.x; Krishnakumar S, 2011, THERIOGENOLOGY, V76, P252, DOI 10.1016/j.theriogenology.2011.02.001; Machado GM, 2009, THERIOGENOLOGY, V71, P1289, DOI 10.1016/j.theriogenology.2009.01.002; Martinez-Pastor F, 2006, THERIOGENOLOGY, V65, P471, DOI 10.1016/j.theriogenology.2005.05.045; Martinez-Pastor F, 2005, THERIOGENOLOGY, V63, P24, DOI 10.1016/j.theriogenology.2004.03.003; Martins CF, 2007, ANIM REPROD SCI, V101, P326, DOI 10.1016/j.anireprosci.2007.01.018; Martins CF, 2009, ANIM REPROD SCI, V116, P50, DOI 10.1016/j.anireprosci.2008.12.018; Matas C, 2010, THERIOGENOLOGY, V74, P1327, DOI 10.1016/j.theriogenology.2010.06.002; Mendes JOB, 2003, THERIOGENOLOGY, V60, P331, DOI 10.1016/S0093-691X(03)00029-3; Moura AA, 2006, J ANDROL, V27, P201, DOI 10.2164/jandrol.05089; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Parrish JJ, 2014, THERIOGENOLOGY, V81, P67, DOI 10.1016/j.theriogenology.2013.08.005; PAVLOK A, 1988, ANIM REPROD SCI, V16, P207, DOI 10.1016/0378-4320(88)90014-0; Rodriguez-Villamil P, 2016, THERIOGENOLOGY, V85, P540, DOI 10.1016/j.theriogenology.2015.09.044; Sepulveda B, 2017, INT J ANDROL, P1; Silva E, 2014, ANDROLOGY-US, V2, P763, DOI 10.1111/j.2047-2927.2014.00249.x; Stout MA, 2012, COMP EPIDIDYMAL EJAC; Therien I, 1998, BIOL REPROD, V59, P768, DOI 10.1095/biolreprod59.4.768; Vianna LL, 2014, CAN J ANIM SCI, V94, P35, DOI [10.4141/cjas2013-101, 10.4141/CJAS2013-101]	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209692	10.1371/journal.pone.0209692	http://dx.doi.org/10.1371/journal.pone.0209692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615639	gold, Green Submitted, Green Published			2022-12-26	WOS:000455045900026
J	Winslow, S; Scholz, A; Rappl, P; Brauss, TF; Mertens, C; Jung, M; Weigert, A; Brune, B; Schmid, T				Winslow, Sofia; Scholz, Anica; Rappl, Peter; Brauss, Thilo F.; Mertens, Christina; Jung, Michaela; Weigert, Andreas; Bruene, Bernhard; Schmid, Tobias			Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CANCER; GENE; CYTOCHROME-P450; EXPRESSION; RNA; 1A1; DIVERSITY	While aberrant cells are routinely recognized and removed by immune cells, tumors eventually escape innate immune responses. Infiltrating immune cells are even corrupted by the tumor to acquire a tumor-supporting phenotype. In line, tumor-associated macrophages are well-characterized to promote tumor progression and high levels of tumor-infiltrating macrophages are a poor prognostic marker in breast cancer. Here, we aimed to further decipher the influence of macrophages on breast tumor cells and determined global gene expression changes in three-dimensional tumor spheroids upon infiltration of macrophages. While various tumor-associated mRNAs were upregulated, expression of the cytochrome P450 family member CYP1A1 was markedly attenuated. Repression of CYP1A1 in tumor cells was elicited by a macrophage-shaped tumor microenvironment rather than by direct tumor cell-macrophage contacts. In line with changes in RNA expression profiles, macrophages enhanced proliferation of the tumor cells. Enhanced proliferation and macrophage presence further correlated with reduced CYP1A1 expression in patient tumors when compared with normal tissue. These findings are of interest in the context of combinatory therapeutic approaches involving cytotoxic and immune-modulatory compounds.	[Winslow, Sofia; Scholz, Anica; Rappl, Peter; Brauss, Thilo F.; Mertens, Christina; Jung, Michaela; Weigert, Andreas; Bruene, Bernhard; Schmid, Tobias] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Frankfurt, Germany	Goethe University Frankfurt	Schmid, T (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Frankfurt, Germany.	T.Schmid@biochem.uni-frankfurt.de	Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952; Schmid, Tobias/0000-0002-1952-5259; Mertens, Christina/0000-0002-0767-4759	Deutsche Forschungsgemeinschaft [SCHM2663/3]; Tegger Foundation; Thyssen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tegger Foundation; Thyssen Foundation	This study was supported by the Deutsche Forschungsgemeinschaft (SCHM2663/3, TS; http://www.dfg.de/) and scholarships by the Tegger Foundation (SW; http://teggerstiftelsen.se/) and the Thyssen Foundation (SW; http://www.fritz-thyssen-stiftung.de/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2018, CANC FACTS FIG 2018; Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Beccuti M, 2018, BIOINFORMATICS, V34, P871, DOI 10.1093/bioinformatics/btx674; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Brauss TF, 2017, MOL CARCINOGEN, V56, P2620, DOI 10.1002/mc.22706; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Henke N, 2016, ONCOTARGET, V7, P25915, DOI 10.18632/oncotarget.8297; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Lekas P, 2000, ARCH BIOCHEM BIOPHYS, V384, P311, DOI 10.1006/abbi.2000.2115; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mescher M, 2018, PHARMACOL THERAPEUT, V187, P71, DOI 10.1016/j.pharmthera.2018.02.012; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Milke L, 2013, CARCINOGENESIS, V34, P850, DOI 10.1093/carcin/bgs387; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ringleb J, 2018, J IMMUNOL, V200, P857, DOI 10.4049/jimmunol.1700609; Santes-Palacios R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5341081; Sergentanis TN, 2010, BREAST CANCER RES TR, V122, P459, DOI 10.1007/s10549-009-0694-5; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Winslow S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2864-2; Winslow S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0530-2; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhang WY, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4093285	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0209694	10.1371/journal.pone.0209694	http://dx.doi.org/10.1371/journal.pone.0209694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615637	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900027
J	Hsu, CP; Huang, CY; Wu, FY				Hsu, Chiao-Po; Huang, Chun-Yang; Wu, Fei-Yi			Relationship between the extent of aortic replacement and stent graft for acute DeBakey type I aortic dissection and outcomes: Results from a medical center in Taiwan	PLOS ONE			English	Article							TOTAL ARCH REPLACEMENT; FROZEN ELEPHANT TRUNK; ENDOVASCULAR TREATMENT; SURGICAL REPAIR; A DISSECTION; FALSE LUMEN; RISK; FATE; MORTALITY; SURGERY	Background Total arch replacement (TAR) and/or stent graft implantation has been proposed as the primary surgical treatment for acute DeBakey type I aortic dissection. However, the suggestion was based on excellent outcomes of high-volume or aortic centers. How about the real results in most places around the world? The purpose of this study was intended to compared in-hospital mortality, major complications, and aortic remodeling between TAR and/or stent graft implantation in a medical center of northern Taiwan. Methods Between January 2008 and August 2017, 156 patients with acute type I aortic dissection underwent surgery at our institution, including proximal aortic replacement only (Group I, n = 72), concomitant TAR (Group II, n = 23), concomitant TAR extended with stent grafting (Group III, n = 45), and proximal aortic replacement with descending aortic stent grafting (Group IV, n = 16). Results No significant differences were found in underlying disease and preoperative presentations, including operative risk among four groups. Overall in-hospital mortality was 22.4% (13 patients in Group I, 9 in Group II, 12 in Group III, and 1 in Group IV). New-onset stroke occurred in 15 patients postoperatively (3 patients [5.2%] in Group I, 3 [21.4%] in Group II, and 9 [26.5%] in Group III after excluding 36 patients with documented preoperative cerebrovascular accident or cerebral malperfusion). Root reconstruction and TAR were significantly associated with in-hospital mortality. TAR was significantly associated with surgery-related stroke. Compared to those in Group I, true lumen expansion and false lumen shrinkage during 1-year aortic remodeling were significantly higher in Groups III and IV. Both TAR and descending aorta stent grafting were significantly associated with decreased risk of patent false lumen. Conclusions Proximal aortic replacement remains the preferred surgical strategy for acute type I aortic dissection, with lower mortality and neurological complications. Proximal descending aorta stent grafting may benefit aortic remodeling, even without TAR.	[Hsu, Chiao-Po; Huang, Chun-Yang; Wu, Fei-Yi] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Hsu, Chiao-Po; Huang, Chun-Yang; Wu, Fei-Yi] Taipei Vet Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan; [Hsu, Chiao-Po] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Surg, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Hsu, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.; Hsu, CP (corresponding author), Taipei Vet Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan.; Hsu, CP (corresponding author), Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Surg, Taoyuan, Taiwan.	hsucp@vghtpe.gov.tw						Augoustides JGT, 2009, NAT CLIN PRACT CARD, V6, P140, DOI 10.1038/ncpcardio1417; Bonser RS, 2011, J AM COLL CARDIOL, V58, P2455, DOI 10.1016/j.jacc.2011.06.067; Borst H G, 1991, Semin Thorac Cardiovasc Surg, V3, P238; Conzelmann LO, 2016, EUR J CARDIO-THORAC, V49, pe44, DOI 10.1093/ejcts/ezv356; Czerny M, 2016, EUR J CARDIO-THORAC, V49, P1402, DOI 10.1093/ejcts/ezv354; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Fleck T, 2002, ANN THORAC SURG, V74, P761, DOI 10.1016/S0003-4975(02)03745-1; Flores J, 2006, J THORAC CARDIOV SUR, V131, P336, DOI 10.1016/j.jtcvs.2005.09.050; Galvin SD, 2016, ANN CARDIOTHORAC SUR, V5, P236, DOI 10.21037/acs.2016.05.11; Geirsson A, 2007, EUR J CARDIO-THORAC, V32, P255, DOI 10.1016/j.ejcts.2007.04.012; GUTHANER DF, 1979, RADIOLOGY, V133, P1; Halstead JC, 2007, J THORAC CARDIOV SUR, V133, P127, DOI 10.1016/j.jtcvs.2006.07.043; Kazui T, 2000, J THORAC CARDIOV SUR, V119, P558, DOI 10.1016/S0022-5223(00)70136-X; Kimura N, 2008, J THORAC CARDIOV SUR, V136, P1160, DOI 10.1016/j.jtcvs.2008.05.052; Mizuno T, 2002, EUR J CARDIO-THORAC, V22, P504, DOI 10.1016/S1010-7940(02)00429-3; Moon MR, 2001, ANN THORAC SURG, V72, P2003, DOI 10.1016/S0003-4975(01)03144-7; Moon MR, 2001, ANN THORAC SURG, V71, P1244, DOI 10.1016/S0003-4975(00)02610-2; Panos A, 2005, ANN THORAC SURG, V80, P1087, DOI 10.1016/j.athoracsur.2004.09.056; Parker JD, 2008, ANN THORAC SURG, V86, P1707, DOI 10.1016/j.athoracsur.2008.06.074; Poon SS, 2016, ANN CARDIOTHORAC SUR, V5, P156, DOI 10.21037/acs.2016.05.06; Preventza O, 2013, ANN CARDIOTHORAC SUR, V2, P649, DOI 10.3978/j.issn.2225-319X.2013.06.01; Smith HN, 2017, INTERACT CARDIOV TH, V24, P450, DOI 10.1093/icvts/ivw355; Spielvogel D, 2002, ANN THORAC SURG, V74, pS1810, DOI 10.1016/S0003-4975(02)04156-5; Spielvogel D, 2002, ANN THORAC SURG, V74, pS25; Takagi H, 2016, VASC ENDOVASC SURG, V50, P33, DOI 10.1177/1538574415624767; Tse KM, 2011, J BIOMECH, V44, P827, DOI 10.1016/j.jbiomech.2010.12.014; Uchida N, 2009, EUR J CARDIO-THORAC, V35, P83, DOI 10.1016/j.ejcts.2008.09.034; Yan Y, 2016, EUR J CARDIO-THORAC, V49, P1392, DOI 10.1093/ejcts/ezv351; Yeh TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001522; YUN KL, 1991, J THORAC CARDIOV SUR, V102, P355; Yun KL, 1991, J THORAC CARDIOVASC, V102	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0210022	10.1371/journal.pone.0210022	http://dx.doi.org/10.1371/journal.pone.0210022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608954	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800040
J	Ubby, I; Krueger, C; Rosato, R; Qian, W; Chang, J; Sabapathy, K				Ubby, Ifeoma; Krueger, Christian; Rosato, Roberto; Qian, Wei; Chang, Jenny; Sabapathy, Kanaga			Cancer therapeutic targeting using mutant-p53-specific siRNAs	ONCOGENE			English	Article							MUTANT P53; RNA INTERFERENCE; WILD-TYPE; GENE; MUTATIONS; TP53; GAIN; EXPRESSION; ABROGATION; GEFITINIB	Mutations in Tp53 compromise therapeutic response, due either to the dominant-negative effect over the functional wild-type allele; or as a result of the survival advantage conferred by mutant p53 to which cancer cells become addicted. Thus, targeting mutant p53 represents an effective therapeutic strategy to treat over half of all cancers. We have therefore generated a series of small-interfering-RNAs, capable of targeting four p53 hot-spot mutants which represent similar to 20% of all p53 mutations. These mutant-p53-specific siRNAs (MupSi) are highly specific in silencing the expression of the intended mutants without affecting wild-type p53. Functionally, these MupSis induce cell death by abrogating both the addiction to mutant p53 and the dominant-negative effect; and retard tumor growth in xenografts when administered in a therapeutic setting. These data together demonstrate the possibility of targeting mutant p53 specifically to improve clinical outcome.	[Ubby, Ifeoma; Krueger, Christian; Sabapathy, Kanaga] Natl Canc Ctr Singapore, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Rosato, Roberto; Qian, Wei; Chang, Jenny] Houston Methodist Canc Ctr, 6445 Main St, Houston, TX 77030 USA; [Sabapathy, Kanaga] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Sabapathy, Kanaga] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119228, Singapore; [Sabapathy, Kanaga] Inst Mol & Cellular Biol, Singapore 138673, Singapore	National Cancer Centre Singapore (NCCS); The Methodist Hospital System; The Methodist Hospital - Houston; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sabapathy, K (corresponding author), Natl Canc Ctr Singapore, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore.; Sabapathy, K (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore.; Sabapathy, K (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119228, Singapore.; Sabapathy, K (corresponding author), Inst Mol & Cellular Biol, Singapore 138673, Singapore.	cmrksb@nccs.com.sg			National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We thank the National Medical Research Council of Singapore for funding support to KS.	Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Allen EHA, 2013, INVEST OPHTH VIS SCI, V54, P494, DOI 10.1167/iovs.12-10528; Barata P, 2016, CANCER TREAT REV, V50, P35, DOI 10.1016/j.ctrv.2016.08.004; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Blagosklonny MV, 2005, CANCER RES, V65, P7386, DOI 10.1158/0008-5472.CAN-04-3433; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Dave B, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw292; Dave B, 2014, P NATL ACAD SCI USA, V111, P8838, DOI 10.1073/pnas.1320769111; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Donehower LA, 2014, HUM MUTAT, V35, P715, DOI 10.1002/humu.22507; Eiden AM, 2016, CLIN CANCER RES, V22, P277, DOI 10.1158/1078-0432.CCR-14-3239; Evans EK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao1690; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Hansen SA, 2016, DIS MODEL MECH, V9, P1139, DOI 10.1242/dmm.025767; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Hwang LA, 2018, CELL REP, V22, P299, DOI 10.1016/j.celrep.2017.11.112; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kim A, 2016, EXPERT OPIN DRUG DIS, V11, P907, DOI 10.1080/17460441.2016.1201057; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leachman SA, 2010, MOL THER, V18, P442, DOI 10.1038/mt.2009.273; Lee MK, 2008, J CELL SCI, V121, P1899, DOI 10.1242/jcs.022822; Lee MK, 2012, CANCER CELL, V22, P751, DOI 10.1016/j.ccr.2012.10.022; Liu Y, 2016, J INVEST DERMATOL, V136, P45, DOI 10.1038/JID.2015.375; Martinez LA, 2002, P NATL ACAD SCI USA, V99, P14849, DOI 10.1073/pnas.222406899; Merino Diana, 2014, Subcell Biochem, V85, P1, DOI 10.1007/978-94-017-9211-0_1; Montgomery Mary K, 2004, Methods Mol Biol, V265, P3; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Novelli F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.118; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Phang BH, 2015, P NATL ACAD SCI USA, V112, pE6349, DOI 10.1073/pnas.1510043112; Rasheed SAK, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0337-x; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Sabapathy K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00276; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Semczuk A, 2010, ONCOLOGY-BASEL, V78, P220, DOI 10.1159/000314353; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shrivastava Neeta, 2008, Biotechnol J, V3, P339, DOI 10.1002/biot.200700215; Solomon BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144559; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Trochet D, 2018, EMBO MOL MED, V10, P239, DOI 10.15252/emmm.201707988; Trochet D, 2015, CURR GENE THER, V15, P503, DOI 10.2174/1566523215666150812115730; Vikhanskaya F, 2007, NUCLEIC ACIDS RES, V35, P2093, DOI 10.1093/nar/gkm099; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	54	17	18	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3415	3427		10.1038/s41388-018-0652-y	http://dx.doi.org/10.1038/s41388-018-0652-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30643191	Green Published, hybrid			2022-12-26	WOS:000466610000007
J	Li, YF; Chu, JH; Feng, WT; Yang, MZ; Zhang, YH; Zhang, YQ; Qin, Y; Xu, J; Li, J; Vasilatos, SN; Fu, ZY; Huang, Y; Yin, YM				Li, Yongfei; Chu, Jiahui; Feng, Wanting; Yang, Mengzhu; Zhang, Yanhong; Zhang, Yanqiu; Qin, Ye; Xu, Juan; Li, Jun; Vasilatos, Shauna N.; Fu, Ziyi; Huang, Yi; Yin, Yongmei			EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties	FASEB JOURNAL			English	Article						breast cancer; CSC; trastuzumab resistance; CRISPR/Cas9	INITIATING CELLS; EXPRESSION; CHEMOTHERAPY; ACTIVATION; PROGNOSIS; FAMILY; MEMBER; GRADE; STAGE	Trastuzumab is a successful, rationally designed therapy that provides significant clinical benefit for human epidermal growth factor receptor-2 (HER2)-positive breast cancer patients. However, about half of individuals with HER2-positive breast cancer do not respond to trastuzumab treatment because of various resistance mechanisms, including but not limited to: 1) shedding of the HER2 extracellular domain, 2) steric hindrance (e.g., MUC4 and MUC1), 3) parallel pathway activation (this is the general mechanism cited in the quote above), 4) perturbation of downstream signaling events (e.g., PTEN loss or PIK3CA mutation), and 5) immunologic mechanisms (such as FcR polymorphisms). EPHA5, a receptor tyrosine kinase, has been demonstrated to act as an anticancer agent in several cancer cell types. In this study, deletion of EPHA5 can significantly increase the resistance of HER2-positive breast cancer patients to trastuzumab. To investigate how EPHA5 deficiency induces trastuzumab resistance, clustered regularly interspaced short palindromic repeat technology was used to create EPHA5-deficient variants of breast cancer cells. EPHA5 deficiency effectively increases breast cancer stem cell (BCSC)-like properties, including NANOG, CD133+, E-cadherin expression, and the CD44(+)/CD24(-/low) phenotype, concomitantly enhancing mammosphere-forming ability. EPHA5 deficiency also caused significant aggrandized tumor malignancy in trastuzumab-sensitive xenografts, coinciding with the up-regulation of BCSC-related markers and intracellular Notch1 and PTEN/AKT signaling pathway activation. These findings highlight that EPHA5 is a potential prognostic marker for the activity of Notch1 and better sensitivity to trastuzumab in HER2-positive breast cancer. Moreover, patients with HER2-positive breast cancers expressing high Notch1 activation and low EPHA5 expression could be the best candidates for anti-Notch1 therapy.	[Li, Yongfei; Chu, Jiahui; Feng, Wanting; Yang, Mengzhu; Zhang, Yanhong; Zhang, Yanqiu; Li, Jun; Fu, Ziyi; Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Juan; Fu, Ziyi] Nanjing Med Univ, Affiliated Obstet & Gynecol Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing, Jiangsu, Peoples R China; [Li, Yongfei; Qin, Ye; Vasilatos, Shauna N.; Huang, Yi] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Li, Yongfei] Nanjing Univ TCM, Affiliated Hosp, Jiangsu Prov Hosp Tradit Chinese Med TMC, Dept Breast Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing University of Chinese Medicine	Yin, YM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	ymyin@njmu.edu.cn	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X	National Natural Science Foundation of China [81172503, 81572603, 81302304, 81402139, 81570804]; Key Projects of Jiangsu Health Department [RC201153]; Second Level of 333 Project of Jiangsu Province [BRA2017534]; Third Level of 333 Project of Jiangsu Province [BRA2015470]; Project of Jiangsu Provincial Medical Talent [ZDRCA2016023]; Project of Jiangsu Provincial Medical Youth Talent [QNRC2016095]; General Project of Nanjing Health Bureau [YKK17179]; Project of Jiangsu Provincial Postgraduate Research and Practice Innovation [KYLX16_1116]; Project of Wu Jieping Medical Foundation [320.6750.17006]; Key Open Topics of Oncology Individualized Collaborative Innovation Center [JX21817902/008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Jiangsu Health Department; Second Level of 333 Project of Jiangsu Province; Third Level of 333 Project of Jiangsu Province; Project of Jiangsu Provincial Medical Talent; Project of Jiangsu Provincial Medical Youth Talent; General Project of Nanjing Health Bureau; Project of Jiangsu Provincial Postgraduate Research and Practice Innovation; Project of Wu Jieping Medical Foundation; Key Open Topics of Oncology Individualized Collaborative Innovation Center	This study was financially supported by the National Natural Science Foundation of China (Grants 81172503, 81572603, 81302304, 81402139, and 81570804), Key Projects of Jiangsu Health Department (Grant RC201153), the Second Level of 333 Project of Jiangsu Province (Grant BRA2017534), the Third Level of 333 Project of Jiangsu Province (Grant BRA2015470), the Project of Jiangsu Provincial Medical Talent (Grant ZDRCA2016023), the Project of Jiangsu Provincial Medical Youth Talent (Grant QNRC2016095), General Project of Nanjing Health Bureau (Grant YKK17179), the Project of Jiangsu Provincial Postgraduate Research and Practice Innovation (Grant KYLX16_1116), the Project of Wu Jieping Medical Foundation (Grant 320.6750.17006), and Key Open Topics of Oncology Individualized Collaborative Innovation Center (JX21817902/008). The authors declare no conflicts of interest.	Abarrategi A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3631764; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Boulbes DR, 2015, BREAST CANCER RES TR, V151, P501, DOI 10.1007/s10549-015-3414-3; Boyle ST, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0592-0; Burnett JP, 2017, CANCER LETT, V394, P52, DOI 10.1016/j.canlet.2017.02.023; Cameron D, 2017, LANCET, V389, P1195, DOI 10.1016/S0140-6736(16)32616-2; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Chen X, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0292-1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dhillon J, 2010, ONCOGENE, V29, P6294, DOI 10.1038/onc.2010.365; Ding KS, 2014, J BIOL CHEM, V289, P16057, DOI 10.1074/jbc.M113.529552; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Eisenstein M, 2015, NATURE, V527, pS110, DOI 10.1038/527S110a; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Fukushima K, 2006, AM J PHYSIOL-GASTR L, V291, pG812, DOI 10.1152/ajpgi.00250.2005; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Goltsov A, 2014, CELLS-BASEL, V3, P563, DOI 10.3390/cells3020563; Gu SD, 2017, HISTOL HISTOPATHOL, V32, P491, DOI 10.14670/HH-11-815; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Kabraji S, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0877-7; Kim H, 2014, J MATER CHEM A, V2, P33, DOI 10.1039/c3ta12522j; Kojima H, 2017, INT J ONCOL, V51, P49, DOI 10.3892/ijo.2017.4001; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Krusche B, 2016, ELIFE, V5, DOI 10.7554/eLife.14845; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Li SB, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1025-3; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mimoto R, 2017, ONCOGENE, V36, P1862, DOI 10.1038/onc.2016.349; O'Brien NA, 2014, CLIN CANCER RES, V20, P3507, DOI 10.1158/1078-0432.CCR-13-2769; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Pandya K, 2016, CLIN CANCER RES, V22, P175, DOI 10.1158/1078-0432.CCR-15-0179; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pradeep CR, 2012, ONCOGENE, V31, P3569, DOI 10.1038/onc.2011.547; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez CE, 2018, J CELL BIOCHEM, V119, P1381, DOI 10.1002/jcb.26298; Song KH, 2017, CANCER RES, V77, P5039, DOI 10.1158/0008-5472.CAN-17-0072; Staquicini FI, 2015, J BIOL CHEM, V290, P7345, DOI 10.1074/jbc.M114.630525; Wang XL, 2017, INT J EXP PATHOL, V98, P34, DOI 10.1111/iep.12219; Wong H, 2011, ONCOLOGIST, V16, P1535, DOI 10.1634/theoncologist.2011-0165; Zhang W, 2017, ONCOGENE, V36, P3890, DOI 10.1038/onc.2017.15; Zhong HH, 2016, CANCER RES, V76, P480, DOI 10.1158/0008-5472.CAN-15-0883; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	45	20	20	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4851	4865		10.1096/fj.201701561RRRR	http://dx.doi.org/10.1096/fj.201701561RRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30620624	Bronze			2022-12-26	WOS:000462888500018
J	Andres, SN; Li, ZMM; Erie, DA; Williams, RS				Andres, Sara N.; Li, Zimeng M.; Erie, Dorothy A.; Williams, R. Scott			Ctp1 protein-DNA filaments promote DNA bridging and DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; homologous recombination; atomic force microscopy (AFM); Schizosaccharomyces pombe; structural biology; chromosome damage; CtIP; Ctp1; DNA bridging; Sae2; DNA-binding protein	MRE11 COMPLEX; END RESECTION; CTIP; ENDONUCLEASE; NUCLEASE; SAE2; MRE11-RAD50-NBS1; BINDING	The Ctp1 protein in Schizosaccharomyces pombe is essential for DNA double-strand break (DSB) repair by homologous recombination. Fission yeast Ctp1 and its budding yeast (Sae2) and human (CtIP) homologs control Mre11-Rad50-Nbs1 nuclease complex activity and harbor DNA-binding and -bridging activities. However, the molecular basis for Ctp1-DNA transactions remains undefined. Here, we report atomic force microscopy (AFM) imaging of S. pombe Ctp1-DNA complexes revealing that Ctp1 polymerizes on dsDNA molecules and forms synaptic filaments that bridge two dsDNA strands. We observed that Ctp1 DNA filaments are typified by an average filament length of approximate to 180 bp of dsDNA and a Ctp1 tetramer footprint of approximate to 15 bp. Biochemical results characterizing Ctp1 variants with impaired DNA-binding or -bridging properties were consistent with Ctp1-mediated DNA bridging requiring the intact and correctly folded Ctp1 tetramer. Furthermore, mutations altering Ctp1 oligomerization and DNA bridging in vitro conferred cell sensitivity to DSB-producing agents. Together, these results support an important role for Ctp1-regulated DNA strand coordination required for DNA DSB repair in S. pombe.	[Andres, Sara N.; Williams, R. Scott] NIEHS, Genome Integr & Struct Biol Lab, Dept Hlth & Human Serv, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Li, Zimeng M.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27695 USA; [Erie, Dorothy A.] Univ N Carolina, Dept Chem, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Andres, Sara N.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 3T7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McMaster University	Williams, RS (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, Dept Hlth & Human Serv, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.; Erie, DA (corresponding author), Univ N Carolina, Dept Chem, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	derie@unc.edu; williamsrs@niehs.nih.gov	Williams, R Scott/A-6059-2015	Williams, R Scott/0000-0002-4610-8397; Andres, Sara/0000-0002-4795-2856	intramural research program of the National Institutes of Health; NIEHS, National Institutes of Health [1Z01ES102765]; NIGMS, National Institutes of Health [GM080294, GM109832]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480, R01GM109832, R35GM127151] Funding Source: NIH RePORTER	intramural research program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the intramural research program of the National Institutes of Health; NIEHS, National Institutes of Health, Grant 1Z01ES102765 (to R. S. W.); and NIGMS, National Institutes of Health, Grants GM080294 and GM109832 (to D. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand R, 2016, MOL CELL, V64, P940, DOI 10.1016/j.molcel.2016.10.017; Andres SN, 2017, DNA REPAIR, V56, P109, DOI 10.1016/j.dnarep.2017.06.013; Andres SN, 2015, NAT STRUCT MOL BIOL, V22, P158, DOI 10.1038/nsmb.2945; Andres SN, 2015, ENVIRON MOL MUTAGEN, V56, P1, DOI 10.1002/em.21892; Brouwer I, 2016, NATURE, V535, P566, DOI 10.1038/nature18643; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Davies OR, 2015, NAT STRUCT MOL BIOL, V22, P150, DOI 10.1038/nsmb.2937; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tournier S, 1997, YEAST, V13, P727, DOI 10.1002/(SICI)1097-0061(19970630)13:8<727::AID-YEA134>3.0.CO;2-W; Wang H., 2006, PROTEIN INTERACTIONS, P39; Wang WB, 2017, GENE DEV, V31, P2331, DOI 10.1101/gad.307900.117; Westmoreland JW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003420; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309; Zhu M, 2018, P NATL ACAD SCI USA, V115, P8793, DOI 10.1073/pnas.1808189115	40	15	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3312	3320		10.1074/jbc.RA118.006759	http://dx.doi.org/10.1074/jbc.RA118.006759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30626735	hybrid, Green Published			2022-12-26	WOS:000464980100028
J	Wu, H; Li, MJ; Guo, HJ; Zhou, H; Li, B; Xu, Q; Xu, CY; Yu, F; He, JH				Wu, Hai; Li, Minjun; Guo, Haojie; Zhou, Huan; Li, Bing; Xu, Qin; Xu, Chunyan; Yu, Feng; He, Jianhua			Crystal structure of the Vibrio cholerae VqmA-ligand-DNA complex provides insight into ligand-binding mechanisms relevant for drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; transcription promoter; protein-DNA interaction; protein structure; X-ray crystallography; DPO; ligand binding; Vibrio cholerae; virulence; VqmA	TO-CELL COMMUNICATION; LUXR-LUXI FAMILY; QUORUM; PROTEIN; EXPRESSION; REGULATOR; AUTOINDUCER; REPRESSION; FEATURES; DOMAIN	VqmA is a highly conserved transcriptional regulator of the quorum-sensing system of Vibrio cholerae, a major human pathogen that continues to imperil human health. VqmA represses biofilm formation and plays an important role in V. cholerae pathogenicity in the human host. Although VqmA's biological function is well understood, the molecular mechanisms by which its specific ligand (and effector), 3,5-dimethylpyrazine-2-ol (DPO), controls transcription of the target gene, vqmR, remain obscure. To elucidate the molecular mechanism of DPO binding, we used structural analyses and biochemical assays to study the V. cholerae VqmA-DPO-DNA complex. These analyses revealed that VqmA contains an N-terminal homodimer domain (PAS) and a C-terminal DNA-binding domain (DBD). We observed that VqmA directly binds to a DPO molecule via a compact hydrophobic pocket, consisting of a six-stranded antiparallel beta-sheet and several alpha-helices. We also found that the VqmA dimer interacts with the quasi-palindromic sequence of the vqmR promoter through its DBD. The results of the biochemical studies indicated that a water atom and VqmA residues Phe-67 and Lys-101 play a key role in effector recognition, which is also assisted by Tyr-36 and Phe-99. This is the first molecular level view of the VqmA dimer bound to DPO and DNA. The structure-function analyses presented here improve our understanding of the complex mechanisms in the transcriptional regulation of VqmA in Vibrio spp. and may inform the design of drugs to manage V. cholerae infections.	[Wu, Hai; Li, Minjun; Guo, Haojie; Zhou, Huan; Li, Bing; Xu, Qin; Xu, Chunyan; Yu, Feng; He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Wu, Hai; Guo, Haojie; Li, Bing; Xu, Qin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, F; He, JH (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China.	yufeng@sinap.ac.cn; hejianhua@sinap.ac.cn	zhou, huan/GYJ-4398-2022		National Natural Science Foundation [31570740, 81330076]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation Grants 31570740 and 81330076. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonova ES, 2011, FEMS MICROBIOL LETT, V322, P68, DOI 10.1111/j.1574-6968.2011.02328.x; Bardill JP, 2011, MOL MICROBIOL, V80, P1381, DOI 10.1111/j.1365-2958.2011.07655.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brudler R, 2000, BIOCHEMISTRY-US, V39, P13478, DOI 10.1021/bi0009946; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hurley A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006826; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kim BS, 2018, MBIO, V9, DOI 10.1128/mBio.02262-17; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Koh S, 2016, J BIOL CHEM, V291, P8575, DOI 10.1074/jbc.M116.718841; Liu Z, 2006, J BACTERIOL, V188, P2446, DOI 10.1128/JB.188.7.2446-2453.2006; Luscombe NM, 2000, GENOME BIOL, V1; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; Papenfort K, 2017, NAT CHEM BIOL, V13, DOI 10.1038/nchembio.2336; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Silpe J. E., 2019, CELL, V176, P1, DOI [10.1016/j.cell.2018.1010.1059, DOI 10.1016/J.CELL.2018.1010.1059]; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wysoczynski-Horita CL, 2018, MOL MICROBIOL, V108, P240, DOI 10.1111/mmi.13930; Xu C, 1997, J BIOL CHEM, V272, P15734, DOI 10.1074/jbc.272.25.15734; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	45	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2580	2592		10.1074/jbc.RA118.006082	http://dx.doi.org/10.1074/jbc.RA118.006082			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30610119	Green Published, hybrid			2022-12-26	WOS:000459601600001
J	Agerso, Y; Bjerre, K; Brockmann, E; Johansen, E; Nielsen, B; Siezen, R; Stuer-Lauridsen, B; Wels, M; Zeidan, AA				Agerso, Yvonne; Bjerre, Karin; Brockmann, Elke; Johansen, Eric; Nielsen, Bea; Siezen, Roland; Stuer-Lauridsen, Birgitte; Wels, Michiel; Zeidan, Ahmad A.			Putative antibiotic resistance genes present in extant Bacillus licheniformis and Bacillus paralicheniformis strains are probably intrinsic and part of the ancient resistome	PLOS ONE			English	Article							ERYTHROMYCIN ESTERASE; BACTERIAL-RESISTANCE; NUCLEOTIDE-SEQUENCE; SP NOV.; MACROLIDE; CHLORAMPHENICOL; AMINOGLYCOSIDES; IDENTIFICATION; DETERMINANT; MECHANISMS	Whole-genome sequencing and phenotypic testing of 104 strains of Bacillus licheniformis and Bacillus paralicheniformis from a variety of sources and time periods was used to characterize the genetic background and evolution of (putative) antimicrobial resistance mechanisms. Core proteins were identified in draft genomes and a phylogenetic analysis based on single amino acid polymorphisms allowed the species to be separated into two phylogenetically distinct clades with one outlier. Putative antimicrobial resistance genes were identified and mapped. A chromosomal ermD gene was found at the same location in all B. paralichenformis and in 27% of B. licheniformis genomes. Erythromycin resistance correlated very well with the presence of ermD. The putative streptomycin resistance genes, aph and aadK, were found in the chromosome of all strains as adjacent loci. Variations in amino acid sequence did not correlate with streptomycin susceptibility although the species were less susceptible than other Bacillus species. A putative chloramphenicol resistance gene (cat), encoding a novel chloramphenicol acetyltransferase protein was also found in the chromosome of all strains. Strains encoding a truncated CAT protein were sensitive to chloramphenicol. For all four resistance genes, the diversity and genetic context followed the overall phylogenetic relationship. No potentially mobile genetic elements were detected in their vicinity. Moreover, the genes were only distantly related to previously-described cat, aph, aad and erm genes present on mobile genetic elements or in other species. Thus, these genes are suggested to be intrinsic to B. licheniformis and B. paralicheniformis and part of their ancient resistomes. Since there is no evidence supporting horizontal transmission, these genes are not expected to add to the pool of antibiotic resistance elements considered to pose a risk to human or animal health. Whole-genome based phylogenetic and sequence analysis, combined with phenotypic testing, is proposed to be suitable for determining intrinsic resistance and evolutionary relationships.	[Agerso, Yvonne; Bjerre, Karin; Brockmann, Elke; Johansen, Eric; Nielsen, Bea; Stuer-Lauridsen, Birgitte; Zeidan, Ahmad A.] Chr Hansen AS, Horsholm, Denmark; [Siezen, Roland] Microbial Bioinformat, Ede, Netherlands; [Wels, Michiel] NIZO, Ede, Netherlands	Chr Hansen; NIZO Food Research	Agerso, Y (corresponding author), Chr Hansen AS, Horsholm, Denmark.	dkyvag@chr-hansen.com	Zeidan, Ahmad A./ABG-3139-2020	Zeidan, Ahmad A./0000-0001-9984-5625; Agerso, Yvonne/0000-0002-5560-8158; Johansen, Eric/0000-0003-2155-8866; Bjerre, Karin/0000-0001-6439-7877	Chr. Hansen A/S	Chr. Hansen A/S	This research was supported exclusively by internal funds at Chr. Hansen A/S.	Adimpong DB, 2012, APPL ENVIRON MICROB, V78, P7903, DOI 10.1128/AEM.00730-12; Agerso Y, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01108-18; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; [Anonymous], GEN REC SAF GRAS NOT; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; ARTHUR M, 1986, NUCLEIC ACIDS RES, V14, P4987, DOI 10.1093/nar/14.12.4987; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Devirgiliis C, 2011, GENES NUTR, V6, P275, DOI 10.1007/s12263-011-0226-x; Duc LH, 2003, VACCINE, V21, P4215, DOI 10.1016/S0264-410X(03)00492-4; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P3487, DOI 10.1099/ijsem.0.000441; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; European Commission, 2002, OP SCI COMM AN NUTR; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Gomez MJ, 2006, ANTIMICROB AGENTS CH, V50, P3562, DOI 10.1128/AAC.00579-06; GRYCZAN T, 1984, MOL GEN GENET, V194, P349, DOI 10.1007/BF00425543; GRYCZAN TJ, 1984, MOL GEN GENET, V194, P357, DOI 10.1007/BF00425544; HUE KK, 1992, J BACTERIOL, V174, P5860, DOI 10.1128/jb.174.18.5860-5868.1992; Ishihara H, 2002, CURR MICROBIOL, V45, P18, DOI 10.1007/s00284-001-0041-5; Johansen E, 2015, WOODHEAD PUBL FOOD S, V265, P227, DOI 10.1016/B978-1-78242-015-6.00010-4; KIM HS, 1993, J GEN MICROBIOL, V139, P601, DOI 10.1099/00221287-139-3-601; Kim SJ, 2015, INT J SYST EVOL MICR, V65, P3586, DOI 10.1099/ijsem.0.000462; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Krause KM, 2016, COLD SPRING HARB PER, V6; KWAK JH, 1991, J BACTERIOL, V173, P4725, DOI 10.1128/jb.173.15.4725-4735.1991; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; Lopes R, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2479-7; Madslien EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-230; Martinez JL, 2017, ANN NY ACAD SCI, V1388, P26, DOI 10.1111/nyas.13282; Mulder Nicola, 2007, V396, P59; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; OUNISSI H, 1985, GENE, V35, P271, DOI 10.1016/0378-1119(85)90005-8; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rachinger M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00525-13; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts MC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00040; Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823, DOI 10.1128/AAC.43.12.2823; RYCHEN G, 2018, EFSA J, V16, DOI [DOI 10.2903/J.EFSA.2018.5206, 10.2903/j.efsa.2018.5206]; Santiago-Rodriguez T.M., 2018, HUMAN MICROBIOME J, V10, P21, DOI [10.1016/j.humic.2018.07.001, DOI 10.1016/J.HUMIC.2018.07.001]; Santiago-Rodriguez TM, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110310; Santiago-Rodriguez TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138135; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; van Reenen CA, 2011, ARCH MICROBIOL, V193, P157, DOI 10.1007/s00203-010-0668-3; Vestergaard M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02018; Wilson DN, 2011, ANN NY ACAD SCI, V1241, P1, DOI 10.1111/j.1749-6632.2011.06192.x; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Wuitschick JD, 1999, J EUKARYOT MICROBIOL, V46, P239, DOI 10.1111/j.1550-7408.1999.tb05120.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhu QY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-717	63	20	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210363	10.1371/journal.pone.0210363	http://dx.doi.org/10.1371/journal.pone.0210363			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645638	gold, Green Submitted, Green Published			2022-12-26	WOS:000455810200025
J	Agnetta, D; Badalamenti, F; Colloca, F; D'Anna, G; Di Lorenzo, M; Fiorentino, F; Garofalo, G; Gristina, M; Labanchi, L; Patti, B; Pipitone, C; Solidoro, C; Libralato, S				Agnetta, Davide; Badalamenti, Fabio; Colloca, Francesco; D'Anna, Giovanni; Di Lorenzo, Manfredi; Fiorentino, Fabio; Garofalo, Germana; Gristina, Michele; Labanchi, Lucio; Patti, Bernardo; Pipitone, Carlo; Solidoro, Cosimo; Libralato, Simone			Benthic-pelagic coupling mediates interactions in Mediterranean mixed fisheries: An ecosystem modeling approach	PLOS ONE			English	Article							CENTRAL ADRIATIC SEA; WATER ROSE SHRIMP; PARAPENAEUS-LONGIROSTRIS; ENGRAULIS-ENCRASICOLUS; PHYSICAL FORCINGS; MARINE ECOSYSTEM; SICILIAN CHANNEL; GLOBAL ANALYSIS; STRAIT; NORTHERN	Benthic-pelagic coupling plays a pivotal role in aquatic ecosystems but the effects of fishery driven interactions on its functioning has been largely overlooked. Disentangling the benthic-pelagic links including effects of mixed fisheries, however, needs sketching a whole description of ecosystem interactions using quantitative tools. A holistic food web model has been here developed in order to understand the interplay between the benthic-pelagic coupling and mixed fisheries in a Mediterranean system such as the Strait of Sicily. The reconstruction of the food web required review and integration of a vast set of local and regional biological information from bacteria to large pelagic species that were aggregated into 72 functional groups. Fisheries were described by 18 fleet segments resulting from combination of fishing gears and fishing vessel size. The input-output analysis on the food web of energy pathways allowed identifying effects of biological and fishery components. Results showed that the structure of the Strait of Sicily food web is complex. Similarly to other Mediterranean areas, the food web of the Strait of Sicily encompasses 4.5 trophic levels (TLs) with the highest TLs reached by bluefin tuna, swordfish and large hake and largely impacted by bottom trawling and large longline. Importantly, benthic-pelagic coupling is affected by direct and indirect impacts among groups of species, fleets and fleets-species through the whole trophic spectrum of the food web. Moreover, functional groups able to move on large spatial scales or life history of which is spent between shelf and slope domains play a key role in linking subsystems together and mediate interactions in the Mediterranean mixed fisheries.	[Agnetta, Davide; Solidoro, Cosimo; Libralato, Simone] OGS OCE, Trieste, Italy; [Badalamenti, Fabio; D'Anna, Giovanni; Pipitone, Carlo] CNR, IAS, Castellammare Del Golfo, TP, Italy; [Badalamenti, Fabio] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Badalamenti, Fabio] SZN, Naples, Italy; [Colloca, Francesco; Di Lorenzo, Manfredi; Fiorentino, Fabio; Garofalo, Germana; Gristina, Michele] CNR, IRBIM, Mazara Del Vallo, TP, Italy; [Labanchi, Lucio] Mably Soc Cooperat, Salerno, Italy; [Patti, Bernardo] CNR, IAS, Campobello Di Mazara, TP, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Impatti Antropici Sostenibilita in Ambiente Marino (IAS-CNR); University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Risorse Biologiche Biotecnologie Marine (IRBIM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Impatti Antropici Sostenibilita in Ambiente Marino (IAS-CNR)	Agnetta, D (corresponding author), OGS OCE, Trieste, Italy.	dagnetta@inogs.it	Libralato, Simone/AAR-2198-2020; Fiorentino, Fabio/AAX-2883-2020; Patti, Bernardo/ABG-7214-2020; Pipitone, Carlo/B-7562-2015; BADALAMENTI, FABIO/B-8508-2015; D'ANNA, GIOVANNI/B-7995-2015	Libralato, Simone/0000-0001-8112-1274; Fiorentino, Fabio/0000-0002-6302-649X; Agnetta, Davide\\/0000-0002-3019-9095; Pipitone, Carlo/0000-0002-7632-1228; BADALAMENTI, FABIO/0000-0002-2395-454X; D'ANNA, GIOVANNI/0000-0002-8644-8222; solidoro, cosimo/0000-0003-2354-4302	Flagship Project RITMARE - The Italian Research for the Sea; Italian Ministry of Education, University and Research; Flagship Project RITMARE-The Italian Research for the Sea	Flagship Project RITMARE - The Italian Research for the Sea; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Flagship Project RITMARE-The Italian Research for the Sea	This work has been funded by the Flagship Project RITMARE - The Italian Research for the Sea -coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013 to DA.; This work has been funded by the Flagship Project RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013. Many thanks to Valentina Mosetti for precious help in drawing the pictogram.	Abid N, 2018, J MAR BIOL ASSOC UK, V98, P895, DOI 10.1017/S002531541700011X; Astraldi M, 2001, J PHYS OCEANOGR, V31, P3457, DOI 10.1175/1520-0485(2001)031<3457:DWDATS>2.0.CO;2; Basilone G, 2013, FISH OCEANOGR, V22, P309, DOI 10.1111/fog.12024; Baustian M., 2014, ECO DAS X S P, P25, DOI DOI 10.4319/ECODAS.2014.978-0-9845591-4-5.38; Beranger K, 2004, DEEP-SEA RES PT II, V51, P411, DOI 10.1016/j.dsr2.2003.08.004; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOLLENS SM, 1992, HYDROBIOLOGIA, V234, P33, DOI 10.1007/BF00010777; Castriota L, 2001, SCI COUNC M NAFO SCR, V9; Celic I, 2018, ICES J MAR SCI; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Civile D, 2015, GLOBAL PLANET CHANGE, V125, P36, DOI 10.1016/j.gloplacha.2014.12.003; Coll M, 2007, J MARINE SYST, V67, P119, DOI 10.1016/j.jmarsys.2006.10.002; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll M, 2009, MAR ECOL PROG SER, V381, P17, DOI 10.3354/meps07944; Consoli P, 2017, MAR BIOL RES, V13, P1084, DOI 10.1080/17451000.2017.1348010; Damalas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119330; de Juan S, 2007, MAR ECOL PROG SER, V334, P117; Di Lorenzo M, 2018, HYDROBIOLOGIA, V821, P235, DOI 10.1007/s10750-017-3389-7; Dunton KH, 2005, DEEP-SEA RES PT II, V52, P3462, DOI 10.1016/j.dsr2.2005.09.007; Eddy TD, 2017, FISH FISH, V18, P40, DOI 10.1111/faf.12165; Eigaard OR, 2017, ICES J MAR SCI, V74, P847, DOI 10.1093/icesjms/fsw194; FAO, 2016, STAT MED BLACK SEA F; Fiorentino F, 2013, MEDSUDMED TECH DOC, V32; Fiorentino F, 2013, FISH RES, V147, P290, DOI 10.1016/j.fishres.2013.06.001; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; Fortibuoni T, 2010, J CRUSTACEAN BIOL, V30, P167, DOI 10.1651/09-3167.1; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Garofalo G, 2007, HYDROBIOLOGIA, V580, P117, DOI 10.1007/s10750-006-0460-1; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; Garofalo G., 2007, BIOL MAR MEDITERR, V14, P250; Graf G, 1997, J MARINE SYST, V11, P269, DOI 10.1016/S0924-7963(96)00126-1; Griffiths JR, 2017, GLOBAL CHANGE BIOL, V23, P2179, DOI 10.1111/gcb.13642; Hiddink JG, 2017, P NATL ACAD SCI USA, V114, P8301, DOI 10.1073/pnas.1618858114; Howarth LM, 2018, MAR ECOL PROG SER, V602, P31, DOI 10.3354/meps12690; ICCAT, 2010, COLLECTIVE VOLUME SC; Jul-Larsen E., 2003, 4261 FAO; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Knittweiss L, 2013, MEDSUDMED TECH DOC, V28; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; Lauria V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08386-z; Lauzon-Guay JS, 2007, MAR ECOL PROG SER, V329, P191, DOI 10.3354/meps329191; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Lee JY, 2002, J SEA RES, V48, P287, DOI 10.1016/S1385-1101(02)00182-X; Levi D, 1997, ANAL TRAWIS DISCARD; Libralato S, 2016, VIE MILIEU, V66, P315; Libralato S., 2008, ENCY ECOLOGY, P3473; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Lopez S.D., 2013, THESIS; Madigan DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00654; Mangano MC, 2013, MAR ECOL PROG SER, V475, P101, DOI 10.3354/meps10115; Mannini A., 2015, Biologia Marina Mediterranea, V22, P1; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Mazzola S, 2006, AMECO SCI MARINE APP; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCormick MI, 1998, MAR BIOL, V132, P9, DOI 10.1007/s002270050367; Milisenda G, 2017, MEDITERR MAR SCI, V18, P53, DOI 10.12681/mms.1787; Milisenda G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094600; Moutopoulos DK, 2013, J MARINE SYST, V113, P13, DOI 10.1016/j.jmarsys.2012.12.002; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Petihakis G, 2007, ICES J MAR SCI, V64, P1627, DOI 10.1093/icesjms/fsm161; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinnegar JK, 2007, J EXP MAR BIOL ECOL, V352, P378, DOI 10.1016/j.jembe.2007.08.016; Piroddi C, 2015, MAR ECOL PROG SER, V533, P47, DOI 10.3354/meps11387; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Post DM, 2000, ECOLOGY, V81, P8, DOI 10.2307/177129; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Pusceddu A, 2014, P NATL ACAD SCI USA, V111, P8861, DOI 10.1073/pnas.1405454111; Raffaelli D, 2003, J EXP MAR BIOL ECOL, V285, P191, DOI 10.1016/S0022-0981(02)00527-0; Romano C, 2016, MAR ENVIRON RES, V122, P113, DOI 10.1016/j.marenvres.2016.10.002; Rossi S, 2013, OCEAN COAST MANAGE, V84, P77, DOI 10.1016/j.ocecoaman.2013.07.004; Sanchez-Hernandez J, 2017, ECOL EVOL, V7, P358, DOI 10.1002/ece3.2600; Sara G, 2007, J APPL ICHTHYOL, V23, P122, DOI 10.1111/j.1439-0426.2006.00829.x; Scarcella G, 2014, J SEA RES, V89, P12, DOI 10.1016/j.seares.2014.02.002; Sciberras M, 2018, FISH FISH, V19, P698, DOI 10.1111/faf.12283; Shannon L, 2014, MAR ECOL PROG SER, V512, P115, DOI 10.3354/meps10821; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Sinopoli M, 2012, SCI MAR, V76, P677, DOI 10.3989/scimar.03564.29A; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Tecchio S, 2015, PROG OCEANOGR, V135, P156, DOI 10.1016/j.pocean.2015.05.018; Tecchio S, 2013, DEEP-SEA RES PT I, V75, P1, DOI 10.1016/j.dsr.2013.01.003; Tilves U, 2018, MAR ECOL PROG SER, V591, P101, DOI 10.3354/meps12332; Torri M, 2018, PROG OCEANOGR, V162, P25, DOI 10.1016/j.pocean.2018.02.009; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Tsagarakis K, 2010, ESTUAR COAST SHELF S, V88, P233, DOI 10.1016/j.ecss.2010.04.007; ULANOWICZ R E, 1990, Coenoses, V5, P7; Walters C, 2007, ECOL MODEL, V209, P342, DOI 10.1016/j.ecolmodel.2007.06.025	93	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210659	10.1371/journal.pone.0210659	http://dx.doi.org/10.1371/journal.pone.0210659			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645620	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200042
J	Park, J; Choi, EK; Han, KD; Choi, YJ; Lee, E; Choe, W; Lee, SR; Cha, MJ; Lim, WH; Kang, J; Park, KW; Oh, S; Lip, GYH				Park, Jiesuck; Choi, Eue-Keun; Han, Kyung-Do; Choi, You-jung; Lee, Euijae; Choe, Wonseok; Lee, So-Ryoung; Cha, Myung-Jin; Lim, Woo-Hyun; Kang, Jeehoon; Park, Kyung Woo; Oh, Seil; Lip, Gregory Y. H.			Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study	PLOS ONE			English	Article							ANTAGONIST ORAL ANTICOAGULANTS; VITAMIN-K ANTAGONIST; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; SYNDROME AND/OR; ARTERY-DISEASE; RISK-FACTOR; MANAGEMENT; WARFARIN; STROKE	Background We investigated the recent 10-year trends in the number of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in relation to prescription patterns of antithrombotic therapy. Methods We analyzed the annual prevalence of PCI and patterns of antithrombotic therapy after PCI, including antiplatelets and oral anticoagulants (vitamin K antagonists and non-vitamin K antagonist oral anticoagulants [NOACs]), in patients with AF between 2006 and 2015 by using the Korean National Health Insurance Service database. Independent factors associated with triple therapy (oral anticoagulant plus dual antiplatelet) prescription were assessed using multivariable logistic regression analysis. Results The number of patients with AF undergoing PCI increased gradually from 2006 (n = 2,140) to 2015 (n = 3,631) (p(trend)<0.001). In 2006, only 22.7% of patients received triple therapy after PCI although 96.2% of them were indicated for anticoagulation (CHA(2)DS(2)-VASc score >= 2). The prescription rate of triple therapy increased to 38.3% in 2015 (p(trend)<0.001), which was mainly attributed to a recent increment of NOAC-based triple therapy from 2013 (17.5% in 2015). Previous ischemic stroke or systemic embolism, old age, hypertension, and congestive heart failure were significantly associated with a higher triple therapy prescription rate, whereas previous myocardial infarction, PCI, and peripheral arterial disease were associated with triple therapy underuse. Conclusions From 2006 to 2015, the number of patients with AF undergoing PCI and the prescription rate of triple therapy increased gradually with a recent increment of NOAC-based antithrombotic therapy from 2013. Previous myocardial infarction, peripheral artery disease, and PCI were associated with underuse of triple therapy.	[Park, Jiesuck; Choi, Eue-Keun; Choi, You-jung; Lee, Euijae; Choe, Wonseok; Cha, Myung-Jin; Kang, Jeehoon; Park, Kyung Woo; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, So-Ryoung] Soon Chun Hyang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lim, Woo-Hyun] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Thrombosis Res Unit, Aalborg, Denmark	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Soonchunhyang University; Seoul National University (SNU); Seoul National University Hospital; University of Birmingham; Aalborg University	Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	choiek17@snu.ac.kr	Park, Kyung Woo/AAX-3046-2020; Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014	Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Lim, Woo-Hyun/0000-0001-9298-8500	Seoul National University Hospital Research Fund [620172540]; Korea National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2014R1A1A2A16055218]; Korean Healthcare Technology R&D project - Ministry of Health Welfare [HI15C1200]; Biosense Webster [IIS368, IIS457]; Daiichi-Sankyo [06-2017-1370]; BMS/Pfizer [CV185-704]	Seoul National University Hospital Research Fund; Korea National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Korean Healthcare Technology R&D project - Ministry of Health Welfare; Biosense Webster; Daiichi-Sankyo(Daiichi Sankyo Company Limited); BMS/Pfizer(Pfizer)	This study was supported by a grant from the Seoul National University Hospital Research Fund (620172540) and the Korea National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2014R1A1A2A16055218). EKC specifically received grants from the Korean Healthcare Technology R&D project funded by the Ministry of Health & Welfare (HI15C1200), Biosense Webster (IIS368, IIS457), Daiichi-Sankyo (06-2017-1370), and BMS/Pfizer (CV185-704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angiolillo DJ, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004395; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Choi HI, 2017, JACC-CARDIOVASC INTE, V10, pE107, DOI 10.1016/j.jcin.2017.02.028; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; Fosbol EL, 2013, AM HEART J, V166, P864, DOI 10.1016/j.ahj.2013.08.005; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Gong XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186449; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; January C.T., 2014, J AM COLL CARDIOL, V64, pE1, DOI [DOI 10.1523/JNEUROSCI.2810-14.2015, DOI 10.1016/j.jacc.2014.03.022]; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lam DH, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0703-4; Lamberts M, 2013, J AM COLL CARDIOL, V62, P981, DOI 10.1016/j.jacc.2013.05.029; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495; Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039; Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lopes RD, 2018, AM HEART J, V200, P17, DOI 10.1016/j.ahj.2018.03.001; Ntaios G, 2017, INT J STROKE, V12, P589, DOI 10.1177/1747493017700663; Pastori D, 2018, INT J CARDIOL, V255, P69, DOI 10.1016/j.ijcard.2017.12.076; Rossini R, 2008, AM J CARDIOL, V102, P1618, DOI 10.1016/j.amjcard.2008.08.021; Rubboli A, 2009, J INTERV CARDIOL, V22, P390, DOI 10.1111/j.1540-8183.2009.00468.x; Schomig A, 2009, HEART, V95, P1280, DOI 10.1136/hrt.2008.160457; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Sutton NR, 2016, J AM COLL CARDIOL, V68, P895, DOI 10.1016/j.jacc.2016.05.085; Vranckx P, 2018, AM HEART J, V196, P105, DOI 10.1016/j.ahj.2017.10.009; Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947; Zulkifly H, 2017, AM J CARDIOL, V120, P1139, DOI 10.1016/j.amjcard.2017.06.058	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209593	10.1371/journal.pone.0209593	http://dx.doi.org/10.1371/journal.pone.0209593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645601	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200011
J	Li, Y; Wu, HD; Wang, JZ; Cui, LJ; Tian, DS; Wang, JS; Zhang, XD; Yan, L; Yan, ZP; Zhang, KR; Kang, XM; Song, B				Li, Yong; Wu, Haidong; Wang, Jinzhi; Cui, Lijuan; Tian, Dashuan; Wang, Jinsong; Zhang, Xiaodong; Yan, Liang; Yan, Zhongqing; Zhang, Kerou; Kang, Xiaoming; Song, Bing			Plant biomass and soil organic carbon are main factors influencing dry-season ecosystem carbon rates in the coastal zone of the Yellow River Delta	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; METHANE EMISSIONS; SALT-MARSH; POLYGONAL TUNDRA; CH4 EMISSIONS; RESPIRATION; WETLANDS; FLUXES; VEGETATION; SALINITY	Coastal wetlands are considered as a significant sink of global carbon due to their tremendous organic carbon storage. Coastal CO2 and CH4 flux rates play an important role in regulating atmospheric CO2 and CH4 concentrations. However, the relative contributions of vegetation, soil properties, and spatial structure on dry-season ecosystem carbon (C) rates (net ecosystem CO2 exchange, NEE; ecosystem respiration, ER; gross ecosystem productivity, GEP; and CH4) remain unclear at a regional scale. Here, we compared dry-season ecosystem C rates, plant, and soil properties across three vegetation types from 13 locations at a regional scale in the Yellow River Delta (YRD). The results showed that the Phragmites australis stand had the greatest NEE (-1365.4 mu mol m(-2) s(-1)), ER (660.2 mu mol m(-2) s(-1)), GEP (-2025.5 mu mol m(-2) s(-1)) and acted as a CH4 source (0.27 mu mol m(-2) s(-1)), whereas the Suaeda heteroptera and Tamarix chinensis stands uptook CH4 (-0.02 to -0.12 mu mol m(-2) s(-1)). Stepwise multiple regression analysis demonstrated that plant biomass was the main factor explaining all of the investigated carbon rates (GEP, ER, NEE, and CH4); while soil organic carbon was shown to be the most important for explaining the variability in the processes of carbon release to the atmosphere, i.e., ER and CH4. Variation partitioning results showed that vegetation and soil properties played equally important roles in shaping the pattern of C rates in the YRD. These results provide a better understanding of the link between ecosystem C rates and environmental drivers, and provide a framework to predict regional-scale ecosystem C fluxes under future climate change.	[Li, Yong; Wu, Haidong; Wang, Jinzhi; Cui, Lijuan; Zhang, Xiaodong; Yan, Liang; Yan, Zhongqing; Zhang, Kerou; Kang, Xiaoming] Chinese Acad Forestry, Inst Wetland Res, Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China; [Tian, Dashuan; Wang, Jinsong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Song, Bing] Ludong Univ, Sch Resources & Environm Engn, Yantai, Peoples R China	Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Ludong University	Kang, XM (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China.; Song, B (corresponding author), Ludong Univ, Sch Resources & Environm Engn, Yantai, Peoples R China.	xmkang@ucas.ac.cn; songbing@ldu.edu.cn	Li, Yong/A-4000-2013; Kang, Xiaoming/GLU-1610-2022; Wang, Jinsong/AAO-3115-2021	Li, Yong/0000-0001-9146-8044; Kang, Xiaoming/0000-0002-0528-1396; Wang, Jinsong/0000-0002-3425-7387; Yan, Liang/0000-0001-7315-5415	National Key Research and Development Program of China [2017YFC0506203]; National Natural Science Foundation of China [41403073, 31770511, 41701113, 41403102]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Key Research and Development Program of China (2017YFC0506203 to XK) and National Natural Science Foundation of China (41403073 to YL, 31770511 to XZ, 41701113 to LY, 41403102 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen CG, 2017, GLOBAL CHANGE BIOL, V23, P1128, DOI 10.1111/gcb.13469; Ardon M, 2018, BIOGEOCHEMISTRY, V140, P217, DOI 10.1007/s10533-018-0486-2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chang TC, 2003, ATMOS ENVIRON, V37, P4551, DOI 10.1016/S1352-2310(03)00588-0; Chen GC, 2010, SCI TOTAL ENVIRON, V408, P2761, DOI 10.1016/j.scitotenv.2010.03.007; Chen QF, 2018, ENVIRON POLLUT, V239, P289, DOI 10.1016/j.envpol.2018.04.043; Choi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111879; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Han GX, 2018, AGR FOREST METEOROL, V256, P292, DOI 10.1016/j.agrformet.2018.03.018; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacotot A, 2018, SCI TOTAL ENVIRON, V631-632, P334, DOI 10.1016/j.scitotenv.2018.03.006; Jin ZW, 2019, SCI TOTAL ENVIRON, V649, P1467, DOI 10.1016/j.scitotenv.2018.08.412; Jones SF, 2018, J GEOPHYS RES-BIOGEO, V123, P1976, DOI 10.1029/2017JG004369; Kang XM, 2018, REMOTE SENSING, V10, P20; Kelsey KC, 2016, J GEOPHYS RES-BIOGEO, V121, P2960, DOI 10.1002/2016JG003546; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Knoblauch C, 2015, J GEOPHYS RES-BIOGEO, V120, P2525, DOI 10.1002/2015JG003053; Kutzbach L, 2004, BIOGEOCHEMISTRY, V69, P341, DOI 10.1023/B:BIOG.0000031053.81520.db; Leps J, 2003, MULTIVARIATE ANAL EC; Li F, 2017, ECOLOGY, V98, P2851, DOI 10.1002/ecy.1975; Li H, 2018, BIOGEOCHEMISTRY, V137, P163, DOI 10.1007/s10533-017-0413-y; Li YJ, 2018, ESTUAR COAST SHELF S, V204, P202, DOI 10.1016/j.ecss.2018.03.008; Lu WZ, 2017, GLOBAL CHANGE BIOL, V23, P1180, DOI 10.1111/gcb.13424; Lu XL, 2018, J GEOPHYS RES-BIOGEO, V123, P1756, DOI [10.1029/2017jg004273, 10.1029/2017JG004273]; Martin RM, 2017, HYDROBIOLOGIA, V802, P71, DOI 10.1007/s10750-017-3240-1; Miao GF, 2017, AGR FOREST METEOROL, V247, P343, DOI 10.1016/j.agrformet.2017.08.022; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Nobrega S, 2008, ECOSYSTEMS, V11, P377, DOI 10.1007/s10021-008-9128-1; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Peng YF, 2017, GLOBAL CHANGE BIOL, V23, P5249, DOI 10.1111/gcb.13789; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Purvaja R, 2001, ENVIRON MANAGE, V27, P547, DOI 10.1007/s002670010169; R Core Team, 2018, R LANG ENV STAT COMP; Rey A, 2017, GEODERMA, V287, P135, DOI 10.1016/j.geoderma.2016.06.025; Riveros-Iregui DA, 2012, GLOBAL CHANGE BIOL, V18, P749, DOI 10.1111/j.1365-2486.2011.02556.x; Sachs T, 2010, GLOBAL CHANGE BIOL, V16, P3096, DOI 10.1111/j.1365-2486.2010.02232.x; Shao XX, 2017, PLOS ONE, V12, P13; Sho XX, 2017, ENVIRON PROG SUSTAIN, V36, P1301, DOI 10.1002/ep.12675; Singh R, 2017, ECOL ENG, V100, P291, DOI 10.1016/j.ecoleng.2017.01.002; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; Song HL, 2016, WETLANDS, V36, pS113, DOI 10.1007/s13157-014-0587-1; Tang YS, 2011, SOIL BIOL BIOCHEM, V43, P638, DOI 10.1016/j.soilbio.2010.11.035; von Fischer JC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001283; Wang JX, 2017, ATMOS ENVIRON, V167, P346, DOI 10.1016/j.atmosenv.2017.08.041; Welti N, 2017, BIOGEOCHEMISTRY, V132, P55, DOI 10.1007/s10533-016-0287-4; Wu HN, 2017, ENVIRON SCI POLLUT R, V24, P19795, DOI 10.1007/s11356-017-9602-4; Xiao LL, 2017, SCI TOTAL ENVIRON, V595, P337, DOI 10.1016/j.scitotenv.2017.03.279; Xu XW, 2014, ECOL ENG, V73, P469, DOI 10.1016/j.ecoleng.2014.09.087; Yang P, 2018, GEODERMA, V327, P138, DOI 10.1016/j.geoderma.2018.05.005	52	12	12	12	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210768	10.1371/journal.pone.0210768	http://dx.doi.org/10.1371/journal.pone.0210768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640931	Green Submitted, Green Published, gold			2022-12-26	WOS:000455808000047
J	Blondeau, JM; Fitch, SD				Blondeau, Joseph M.; Fitch, Shantelle D.			Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis	PLOS ONE			English	Article							INFECTIOUS-DISEASES-SOCIETY; SELECTION WINDOW HYPOTHESIS; LUNG-TISSUE CONCENTRATIONS; PROTEIN-BINDING; ANTIMICROBIAL SUSCEPTIBILITY; CEREBROSPINAL-FLUID; TRACT-INFECTION; UNITED-STATES; PHARMACOKINETICS; FLUOROQUINOLONES	Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis are prevalent bacterial causes of swine infections. Morbidity, mortality and positively impacting the financial burden of infection occurs with appropriate antimicrobial therapy. Increasing antimicrobial resistance complicates drug therapy and resistance prevention is now a necessity to optimize therapy and prolong drug life. Mutant bacterial cells are said to arise spontaneously in bacterial densities of 10(7)-10(9) or greater colony forming units/ml. Antibiotic drug concentration inhibiting growth of the least susceptible cell in these high density populations has been termed the mutant prevention concentration (MPC). In this study MPC and minimum inhibitory concentration (MIC) values of ceftiofur, enrofloxacin, florfenicol, tilmicosin and tulathromycin were determined against the swine pathogens A. pleuropneumoniae, P. multocida and S. suis. The following MIC90/MPC90 values (mg/L) for 67 A. pleuropneumoniae and 73 P. multocida strains respectively were as follows: A. pleuropneumoniae 0.031/0.5, <= 0.016/0.5, 0.5/2, 4/32, 2/32; P. multocida 0.004/0.25, 0.016/0.125, 0.5/0.5, 8/16, 0.5/1. For 33 S. suis strains, MIC90 values (mg/L) respectively were as follows: 1, 0.25, 4, >= 8 and >= 8. A total of 16 S. suis strains with MIC values of 0.063-0.5 mg/L to ceftiofur and 0.25-0.5 mg/L to enrofloxacin were tested by MPC; MPC values respectively were 0.5 and 1 mg/L respectively. MPC concentrations provide a dosing target which may serve to reduce amplification of bacterial subpopulations with reduced antimicrobial susceptibility. Drug potency based on MIC90 values was ceftiofur > enrofloxacin > florfenicol = tulathromycin > tilmicosin; based on MPC90 values was enrofloxacin > ceftiofur > tulathromycin > florfenicol >= tilmicosin.	[Blondeau, Joseph M.; Fitch, Shantelle D.] Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK, Canada; [Blondeau, Joseph M.; Fitch, Shantelle D.] Saskatchewan Hlth Author, Saskatoon, SK, Canada; [Blondeau, Joseph M.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Blondeau, Joseph M.] Univ Saskatchewan, Dept Pathol, Saskatoon, SK, Canada; [Blondeau, Joseph M.] Univ Saskatchewan, Dept Ophthalmol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Blondeau, JM (corresponding author), Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Saskatchewan Hlth Author, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Univ Saskatchewan, Dept Pathol, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Univ Saskatchewan, Dept Ophthalmol, Saskatoon, SK, Canada.	joseph.blondeau@saskhealthauthority.ca			Bayer Animal Health	Bayer Animal Health(Bayer AG)	This study was funded, in part, by an investigator initialized unrestricted research grant from Bayer Animal Health to JB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Deb Hills for excellent clerical assistance. This study was funded, in part, by an investigator initialized unrestricted research grant from Bayer Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Benchaoui HA, 2004, J VET PHARMACOL THER, V27, P203, DOI 10.1111/j.1365-2885.2004.00586.x; BINGEN E, 1990, EUR J CLIN MICROBIOL, V9, P278, DOI 10.1007/BF01968060; Blondeau JM, 2012, VET MICROBIOL, V160, P85, DOI 10.1016/j.vetmic.2012.05.006; Blondeau J M, 2004, J Chemother, V16 Suppl 3, P1; Blondeau JM, 2001, ANTIMICROB AGENTS CH, V45, P433, DOI 10.1128/AAC.45.2.433-438.2001; Blondeau JM, 2009, VET DERMATOL, V20, P383, DOI 10.1111/j.1365-3164.2009.00856.x; Bochev I., 2007, Bulgarian Journal of Veterinary Medicine, V10, P131; Burch DGS, 2010, THE PIG J, V63, P34; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT DISK; Croisier DE, 2004, ANTIMICROB AGENTS CH, V48, P1699, DOI 10.1128/AAC.48.5.1699-1707.2004; Cui JC, 2010, J ANTIBIOT, V63, P29, DOI 10.1038/ja.2009.111; Dagan R, 2001, J ANTIMICROB CHEMOTH, V47, P129, DOI 10.1093/jac/47.2.129; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Dorey L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177568; Dosen R., 2007, Biotechnology in Animal Husbandry, V23, P237; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Evans NA, 2005, VET THER, V6, P83; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; FELDMAN WE, 1976, J PEDIATR-US, V88, P549, DOI 10.1016/S0022-3476(76)80003-0; Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003; Firsov AA, 2014, INT J ANTIMICROB AG, V44, P301, DOI 10.1016/j.ijantimicag.2014.06.013; Firsov AA, 2006, J ANTIMICROB CHEMOTH, V58, P1185, DOI 10.1093/jac/dkl387; Frisch AW, 1942, J EXP MED, V76, P505, DOI 10.1084/jem.76.6.505; Hansen GT, 2005, J CHEMOTHERAPY, V17, P484, DOI 10.1179/joc.2005.17.5.484; Hedlin Peter, 2007, Eye Contact Lens, V33, P161, DOI 10.1097/01.icl.0000246872.73559.43; Hesje C, 2007, DETERMINATION MINIMU; Hesje CK, 2015, J ANTIMICROB CHEMOTH, V70, P494, DOI 10.1093/jac/dku389; Kamp EM, 1996, J VET DIAGN INVEST, V8, P304, DOI 10.1177/104063879600800305; Lei Z, 2018, FRONT PHARMACOL, V9, P1, DOI [10.3389/fphar.2018.00001, DOI 10.3389/FPHAR.2018.00001]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McVey DS, 2010, BACTERIAL ISOLATES L; Metzler K, 2013, J ANTIMICROB CHEMOTH, V68, P631, DOI 10.1093/jac/dks461; Nicolau David P., 2003, Journal of Infection and Chemotherapy, V9, P292, DOI 10.1007/s10156-003-0279-x; Nowakowski MA, 2004, VET THER, V5, P60; Portis E, 2013, J SWINE HEALTH PROD, V21, P30; Rapp RP, 1998, ANN PHARMACOTHER, V32, P785, DOI 10.1345/aph.17299; SALMON SA, 1995, J CLIN MICROBIOL, V33, P2435, DOI 10.1128/JCM.33.9.2435-2444.1995; SEBUNYA TNK, 1983, J AM VET MED ASSOC, V182, P1331; Shin SJ, 2005, VET MICROBIOL, V106, P73, DOI 10.1016/j.vetmic.2004.11.015; SINGHVI SM, 1978, CHEMOTHERAPY, V24, P121, DOI 10.1159/000237771; Smith HJ, 2003, J ANTIMICROB CHEMOTH, V51, P1323, DOI 10.1093/jac/dkg255; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Wetzstein HG, 2005, ANTIMICROB AGENTS CH, V49, P4166, DOI 10.1128/AAC.49.10.4166-4173.2005; Zbinden R., 2015, MANUAL CLIN MICROBIO, P652; Zeitlinger MA, 2004, J ANTIMICROB CHEMOTH, V54, P876, DOI 10.1093/jac/dkh443; Zeitlinger MA, 2011, ANTIMICROB AGENTS CH, V55, P3067, DOI 10.1128/AAC.01433-10; Zhou Q, 2017, FORESTS, V8, DOI 10.3390/f8080266; Zinner SH, 2003, J ANTIMICROB CHEMOTH, V52, P616, DOI 10.1093/jac/dkg401	49	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210154	10.1371/journal.pone.0210154	http://dx.doi.org/10.1371/journal.pone.0210154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629633	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000054
J	Hoset, KS; Husby, M				Hoset, Katrine S.; Husby, Magne			Are predation rates comparable between natural and artificial open-cup tree nests in boreal forest landscapes?	PLOS ONE			English	Article							SITE SELECTION; SONGBIRD NESTS; BIRD NESTS; QUAIL EGGS; SUCCESS; REAL; RISK; HABITAT; EDGE; FRAGMENTATION	Nest predation studies often use artificial nests to secure sample sizes and nest distribution patterns that allow empirically testing differences in predation rates between ecological units of interest. These studies rely on the assumption that natural and artificial nests experience similar or consistent relative predation rates across ecological gradients. As this assumption may depend on several factors (for example differences in predator community, nest construction, parental care patterns), it is important to test whether artificial nests provide adequate and comparable estimates of predation rates to natural nests. In this study, we compare predation rates of above-ground natural open-cup nests, artificial nests and natural nests with artificial eggs along a forest gradient from edge to interior (interior, transition zone and edge) and within two nest visibility classes (visible and concealed). Our aim was to determine whether nest structure affects comparability between nest types along these ecological gradients in boreal forests. Our results indicated important contributions of nest type, nest visibility and location along the forest edge-interior gradient, but no variable had strong significant effects on predation rates, except exposure time that showed lower predation rates at longer exposure times. Predation rates in visible and concealed nests remained similar for all nest types, but not along the forest edge-interior gradient. Here, artificial nests showed much lower predation rates than natural nests, whereas natural nests with artificial eggs tended to have higher predation rates than natural nests. We conclude that artificial nests in boreal forests represent an adequate measure of relative nest predation risk in open-cup natural nests along some ecological gradients, but results on predation rates along forest edge-interior gradients obtained from artificial nests should be interpreted with care.	[Hoset, Katrine S.; Husby, Magne] Nord Univ, Sect Sci, Levanger, Norway	Nord University	Hoset, KS (corresponding author), Nord Univ, Sect Sci, Levanger, Norway.	katrine.hoset@nord.no	Hoset, Katrine S./A-5090-2010	Hoset, Katrine S./0000-0002-1371-012X				ANDERSSON M, 1978, ANIM BEHAV, V26, P1207, DOI 10.1016/0003-3472(78)90110-0; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; [Anonymous], 2013, TEXTS STAT SCI SERIE; ARCESE P, 1992, ECOLOGY, V73, P805, DOI 10.2307/1940159; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Bayne EM, 1997, ECOGRAPHY, V20, P233, DOI 10.1111/j.1600-0587.1997.tb00366.x; Bures S, 1997, IBIS, V139, P173, DOI 10.1111/j.1474-919X.1997.tb04518.x; Burhans DE, 2002, J WILDLIFE MANAGE, V66, P240, DOI 10.2307/3802890; Burke DM, 2004, CONSERV BIOL, V18, P381, DOI 10.1111/j.1523-1739.2004.00014.x; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Collett R, 1911, NORGES PATTEDYR; Cox WA, 2012, AUK, V129, P147, DOI 10.1525/auk.2012.11169; Cresswell W, 1997, J AVIAN BIOL, V28, P296, DOI 10.2307/3676942; Davison WB, 2000, AUK, V117, P147, DOI 10.1642/0004-8038(2000)117[0147:PRORAA]2.0.CO;2; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Farnsworth GL, 1999, AUK, V116, P1075, DOI 10.2307/4089686; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Fontaine JJ, 2007, OIKOS, V116, P1887, DOI 10.1111/j.2007.0030-1299.16043.x; Gabry J., 2018, SHINYSTAN INTERACTIV; Goodrich B., 2018, RSTANARM BAYESIAN AP; Haegen WMV, 2002, CONDOR, V104, P496, DOI 10.1650/0010-5422(2002)104[0496:PORAAN]2.0.CO;2; Hartley MJ, 1998, CONSERV BIOL, V12, P465, DOI 10.1046/j.1523-1739.1998.96373.x; Haskell DG, 1995, AUK, V112, P767; Hogstad O, 2004, ARDEA, V92, P79; Hollander FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144098; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Hoset KS, 2018, ECOSCIENCE, V25, P199, DOI 10.1080/11956860.2018.1427309; Huhta E, 1998, ECOGRAPHY, V21, P464, DOI 10.1111/j.1600-0587.1998.tb00437.x; Huhta E., 2015, OLD GROWTH FORESTS C, P37; Husby M, 2019, ANIM BIOL, V69, P137, DOI 10.1163/15707563-20181058; Husby M, 2018, J ORNITHOL, V159, P975, DOI 10.1007/s10336-018-1563-y; Jokimaki J, 2000, CONDOR, V102, P838, DOI 10.1650/0010-5422(2000)102[0838:ANPAAO]2.0.CO;2; King DI, 1999, J FIELD ORNITHOL, V70, P257; Kurucz K, 2012, NORTH-WEST J ZOOL, V8, P362; Leech SM, 1997, BEHAV ECOL, V8, P644, DOI 10.1093/beheco/8.6.644; Ludwig M, 2012, ACTA OECOL, V45, P50, DOI 10.1016/j.actao.2012.08.008; Mainwaring MC, 2014, ECOL EVOL, V4, P3909, DOI 10.1002/ece3.1054; MAJOR RE, 1994, OIKOS, V69, P364, DOI 10.2307/3545849; Major RE, 1996, IBIS, V138, P298, DOI 10.1111/j.1474-919X.1996.tb04342.x; MAJOR RE, 1990, IBIS, V132, P608, DOI 10.1111/j.1474-919X.1990.tb00285.x; Martin JL, 2003, OIKOS, V102, P641, DOI 10.1034/j.1600-0706.2003.12040.x; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1988, P NATL ACAD SCI USA, V85, P2196, DOI 10.1073/pnas.85.7.2196; MARTIN TE, 1987, CONDOR, V89, P925, DOI 10.2307/1368547; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; Mezquida ET, 2003, WILSON BULL, V115, P270, DOI 10.1676/02-117; MOLLER AP, 1989, OIKOS, V56, P240, DOI 10.2307/3565342; Muth C, 2018, QUANT METH PSYCHOL, V14, P99, DOI 10.20982/tqmp.14.2.p099; Nams VO, 1997, OECOLOGIA, V110, P440, DOI 10.1007/s004420050179; NOUR N, 1993, ECOGRAPHY, V16, P111, DOI 10.1111/j.1600-0587.1993.tb00063.x; Ortega CP, 1998, J WILDLIFE MANAGE, V62, P925, DOI 10.2307/3802544; Part T, 2002, J AVIAN BIOL, V33, P39, DOI 10.1034/j.1600-048X.2002.330107.x; PATNODE KA, 1992, J FIELD ORNITHOL, V63, P77; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; R Core Team, 2018, R LANG ENV STAT COMP; Rangen SA, 2000, AUK, V117, P136, DOI 10.1642/0004-8038(2000)117[0136:VAOAOA]2.0.CO;2; Renfrew RB, 2003, AUK, V120, P371, DOI 10.1642/0004-8038(2003)120[0371:GPNPNP]2.0.CO;2; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; ROPER JJ, 1992, OIKOS, V65, P528, DOI 10.2307/3545570; Rotella JJ, 2000, AUK, V117, P92, DOI 10.1642/0004-8038(2000)117[0092:CNSEFO]2.0.CO;2; Schiegg K, 2007, IBIS, V149, P365, DOI 10.1111/j.1474-919X.2007.00654.x; Schultz M, 2017, INT J APPL EARTH OBS, V63, P206, DOI 10.1016/j.jag.2017.07.014; Seibold S, 2013, BASIC APPL ECOL, V14, P687, DOI 10.1016/j.baae.2013.09.003; Sloan SS, 1998, J WILDLIFE MANAGE, V62, P529, DOI 10.2307/3802326; Soderstrom B, 1998, OECOLOGIA, V117, P108, DOI 10.1007/s004420050638; STORAAS T, 1988, J WILDLIFE MANAGE, V52, P123, DOI 10.2307/3801071; Thompson FR, 2004, CONSERV BIOL, V18, P373, DOI 10.1111/j.1523-1739.2004.00167.x; Vander Lee BA, 1999, J WILDLIFE MANAGE, V63, P1299, DOI 10.2307/3802848; Villard MA, 2004, CONSERV BIOL, V18, P371, DOI 10.1111/j.1523-1739.2004.00485.x; Weidinger K, 2001, IBIS, V143, P632, DOI 10.1111/j.1474-919X.2001.tb04891.x; Weidinger K, 2009, IBIS, V151, P352, DOI 10.1111/j.1474-919X.2009.00907.x; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174; WILLEBRAND T, 1988, AUK, V105, P378, DOI 10.2307/4087508; Willson MF, 2001, CONSERV BIOL, V15, P447, DOI 10.1046/j.1523-1739.2001.015002447.x; Wilson GR, 1998, CONDOR, V100, P357, DOI 10.2307/1370277; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; YAHNER RH, 1992, WILSON BULL, V104, P162; YAHNER RH, 1989, J WILDLIFE MANAGE, V53, P21, DOI 10.2307/3801298; Zanette L, 2002, BIOL CONSERV, V103, P323, DOI 10.1016/S0006-3207(01)00143-4	80	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210151	10.1371/journal.pone.0210151	http://dx.doi.org/10.1371/journal.pone.0210151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625199	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400076
J	Kraamwinkel, N; Ekbrand, H; Davia, S; Daoud, A				Kraamwinkel, Nadine; Ekbrand, Hans; Davia, Stefania; Daoud, Adel			The influence of maternal agency on severe child undernutrition in conflict-ridden Nigeria: Modeling heterogeneous treatment effects with machine learning	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HEALTH EVIDENCE; ARMED CONFLICT; DEPRIVATION; EDUCATION; POVERTY; IMPACT; WATER	Nigeria is one of the fastest growing African economies, yet struggles with armed conflict, poverty, and morbidity. An area of high concern is how this situation affects vulnerable families and their children. A key pathway in improving the situation for children in times of conflict is to reinforce maternal agency, for instance, through education. However, the state of the art of research lacks a clear understanding of how many years of education is needed before children benefit. Due to mother's differing social context and ability, the effect of maternal education varies. We study the heterogeneous treatment effects of maternal agency, here operationalized as length of education, on severe child undernutrition in the context of armed conflict. We deploy a repeated cross-sectional study design, using the Nigeria 2008 and 2013 Demographic and Health Survey (DHS). The sample covers 25,917 children and their respective mothers. A key methodological challenge is to estimate this heterogeneity inductively. The causal inference literature proposes a machine learning approach, Bayesian Additive Regression Trees (BART), as a promising avenue to overcome this challenge. Based on BART-estimation of the Conditional Average Treatment Effect (CATE) this study confirms earlier findings in that maternal education decreases severe child undernutrition, but only when mothers acquire an education that lasts more than the country's compulsory 9 years; that is 10 years of education and higher. This protective effect remains even during the exposure of armed conflict.	[Kraamwinkel, Nadine; Ekbrand, Hans; Davia, Stefania] Univ Gothenburg, Dept Sociol & Work Sci, Gothenburg, Sweden; [Daoud, Adel] Harvard Univ, TH Chan Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA 02115 USA; [Daoud, Adel] Alan Turing Inst, London, England	University of Gothenburg; Harvard University; Harvard T.H. Chan School of Public Health	Daoud, A (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA 02115 USA.; Daoud, A (corresponding author), Alan Turing Inst, London, England.	adaoud@hsph.harvard.edu		Davia, Stefania/0000-0003-1765-9445; Kraamwinkel-Jha, Nadine/0000-0002-2277-6024	Wallenberg Foundation	Wallenberg Foundation(European Commission)	This research was funded by the Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akresh R, 2012, J DEV ECON, V99, P330, DOI 10.1016/j.jdeveco.2012.04.001; Bbaale E, 2014, AFR J ECON MANAG STU, V5, P52, DOI 10.1108/AJEMS-06-2012-0040; Caruso B, 2010, REV PANAM SALUD PUBL, V28, P429, DOI 10.1590/S1020-49892010001200004; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Daoud A, 2017, P NATL ACAD SCI USA, V114, P6492, DOI 10.1073/pnas.1617353114; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Dorie V., 2018, DBARTS DISCRETE BAYE; Ekbrand H., 2017, GLOBAL LIVING CONDIT; Ekbrand H, 2018, WORLD DEV, V108, P221, DOI 10.1016/j.worlddev.2018.01.028; Federal Government of Nigeria/ World Bank/ EU/ UN, 2013, NIG POSTD NEEDS ASS; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Goldson E, 1996, CHILD ABUSE NEGLECT, V20, P809, DOI 10.1016/0145-2134(96)00069-5; Gordon D., 2003, CHILD POVERTY DEV WO; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Makoka D, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0406-8; Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564; Morrow AL, 2005, J NUTR, V135, P1304, DOI 10.1093/jn/135.5.1304; Nandy S., 2012, HDB ANTHROPOMETRY PH, P127; Nandy S, 2016, SOC SCI MED, V149, P153, DOI 10.1016/j.socscimed.2015.11.036; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Ogwumike FO, 2018, CHILD ABUSE NEGLECT, V77, P13, DOI 10.1016/j.chiabu.2017.12.019; R Development Core Team, 2016, LANG ENV STAT COMP; RUBIN DB, 1978, ANN STAT, V6, P34, DOI 10.1214/aos/1176344064; Sharifa Begum, 2009, Bangladesh Development Studies, V32, P69; Sheffield J, 2014, B AM METEOROL SOC, V95, P861, DOI 10.1175/BAMS-D-12-00124.1; Smith-Greenaway E, 2016, SSM-POPUL HLTH, V2, P164, DOI 10.1016/j.ssmph.2016.02.001; Smits J, 2015, SOC INDIC RES, V122, P65, DOI 10.1007/s11205-014-0683-x; UN/ ISDR, 2009, DROUGHT RISK RED FRA, P1; UNICEF, 2017, LEV TRENDS CHILD MOR; UNOCHA, 2017, HUM NEEDS OV NIG; WHO, 2006, WHO CHILD GROWTH STA	36	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208937	10.1371/journal.pone.0208937	http://dx.doi.org/10.1371/journal.pone.0208937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG9VK	30625159	gold, Green Published, Green Submitted			2022-12-26	WOS:000455359400021
J	Chang, HW; Lin, YW; Lin, MH; Lan, YC; Wang, RY				Chang, Hsin-Wen; Lin, Ya-Wen; Lin, Ming-Hung; Lan, Yu-Ching; Wang, Ruey-Yun			Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus	PLOS ONE			English	Article							SERUM URIC-ACID; CARDIOMETABOLIC DISEASES; MENDELIAN RANDOMIZATION; INSULIN-RESISTANCE; GOUT; MANAGEMENT; CAUSAL; COMORBIDITIES; HYPERURICEMIA; PREVALENCE	Background Gout is independently associated with increased risk of type 2 diabetes mellitus (T2DM). Urate-lowering therapy (ULT) might be beneficial in lowering the risks of T2DM. Therefore, we conducted a nested case-control study to evaluate the associations between ULT and T2DM. Methods This study retrieved the data of 29,765 gout patients from the period of 1998-2010 by using data from Taiwan's National Health Insurance Research Database. Controls (n = 59,530) were matched at a 1:2 ratio by age, sex, and region. Multivariate Cox proportional hazards regression were performed to examine the dose-dependent relationship between ULT and T2DM. Results The adjusted Hazard ratio (HR) for the association of T2DM with allopurinol or benzbromarone exposure was 1.17 (95% confidence interval (CI) 1.07-1.28) and1.09 (95% CI 1.03-1.15), respectively. The HR for the cumulative allopurinol dose was 0.87 (95% CI 0.71-1.07) for patients with dose <= 1.3 mg/day and was 1.31 (95% CI 1.13-1.52) for those with a dose >15.2 mg/day. Similarly, the HR for the cumulative benzbromarone dose was 0.85 (95% CI 0.75-0.96) for patients with a dose <= 1.3 mg/day and 1.42 (95% CI 1.30-1.55) for patients with a dose>9.4 mg/day, respectively. Moreover, the average exposure dose of >100 mg/day for allopurinol and >100 mg/day for benzbromarone was associated with a 1.28-fold (95% CI 1.11-1.48) and 1.47-fold (95% CI 1.23-1.76) T2DM risk respectively. The HR for patients in aged >50 years group with cumulative dose <= 1.3 mg/day of allopurinol or benzbromarone had lower risk of T2DM (HR = 0.74, 95% CI 0.58-0.94 for allopurinol; HR = 0.79, 95% CI 0.69-0.90 for benzbromarone). Conclusion Gout patients with prolonged ULT and a high dose of ULT were associated with a significant increase in T2DM risk. Although gout patients with age greater than 50 years and a lower dose of ULT may be beneficial in lowering T2DM risk, further clinical studies need to be confirmed these associations.	[Chang, Hsin-Wen; Lin, Ya-Wen; Wang, Ruey-Yun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chang, Hsin-Wen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan; [Lin, Ming-Hung] China Med Univ, Sch Nursing, Coll Hlth Care, Taichung, Taiwan; [Lin, Ming-Hung] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Lan, Yu-Ching] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan	China Medical University Taiwan; Hsuan Chuang University; China Medical University Taiwan; China Medical University Taiwan	Wang, RY (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Lan, YC (corresponding author), China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan.	yclan@mail.cmu.edu.tw; rywang@mail.cmu.edu.tw	Lin, Ming Hung/ABH-4835-2020	Lin, Ming Hung/0000-0002-3128-7468				Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Dalbeth N, 2016, LANCET, V388, P2039, DOI 10.1016/S0140-6736(16)00346-9; Dalbeth N, 2015, NAT REV RHEUMATOL, V11, P506, DOI 10.1038/nrrheum.2015.94; De Vera MA, 2014, ARTHRIT CARE RES, V66, P1551, DOI 10.1002/acr.22336; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Dehlin M, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0614-2; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Johnson RJ, 2015, DIABETES, V64, P2720, DOI 10.2337/db15-0532; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kang E, 2017, J RHEUMATOL, V44, P380, DOI 10.3899/jrheum.160792; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Krishnan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050046; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Kuo CF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0522-8; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Kuwabara M, 2017, HYPERTENSION, V69, P1036, DOI [10.1161/HYPERTENSIONAHA.116.08998, 10.1161/hypertensionaha.116.08998]; Kuwabara M, 2017, AM J NEPHROL, V45, P330, DOI 10.1159/000464260; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Neogi T, 2006, J RHEUMATOL, V33, P104; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Ogino K, 2010, CIRC-HEART FAIL, V3, P73, DOI 10.1161/CIRCHEARTFAILURE.109.868604; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P356, DOI 10.1002/art.10511; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rees F, 2014, NAT REV RHEUMATOL, V10, P271, DOI 10.1038/nrrheum.2014.32; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Rho YH, 2005, J KOREAN MED SCI, V20, P1029, DOI 10.3346/jkms.2005.20.6.1029; Rho YH, 2016, ANN RHEUM DIS, V75, P91, DOI 10.1136/annrheumdis-2014-205827; Richette P, 2014, NAT REV RHEUMATOL, V10, P654, DOI 10.1038/nrrheum.2014.124; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Singh JA, 2011, CURR OPIN RHEUMATOL, V23, P192, DOI 10.1097/BOR.0b013e3283438e13; Sluijs I, 2015, DIABETES, V64, P3028, DOI 10.2337/db14-0742; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Takir M, 2015, J INVEST MED, V63, P924, DOI 10.1097/JIM.0000000000000242; YAMAMOTO T, 1991, ANN RHEUM DIS, V50, P631, DOI 10.1136/ard.50.9.631; Yang CY, 2015, JAMA INTERN MED, V175, P1550, DOI 10.1001/jamainternmed.2015.3536	42	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210085	10.1371/journal.pone.0210085	http://dx.doi.org/10.1371/journal.pone.0210085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615649	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900037
J	Macy, A; Sharma, S; Sparks, E; Goff, J; Heck, KL; Johnson, MW; Harper, P; Cebrian, J				Macy, Aaron; Sharma, Shailesh; Sparks, Eric; Goff, Josh; Heck, Kenneth L.; Johnson, Matthew W.; Harper, Patric; Cebrian, Just			Tropicalization of the barrier islands of the northern Gulf of Mexico: A comparison of herbivory and decomposition rates between smooth cordgrass (Spartina alterniflora) and black mangrove (Avicennia germinans)	PLOS ONE			English	Article							PLANT-GROWTH; SALT-MARSHES; CLIMATE; NITROGEN; PATTERNS; LEAF; PHOSPHORUS; TEMPERATE; RESPONSES; FORESTS	The expansion of black mangrove Avicennia germinans into historically smooth cordgrass Spartina alterniflora-dominated marshes with warming temperatures heralds the migration of the marsh-mangrove ecotone northward in the northern Gulf of Mexico. With this shift, A. germinans is expected to outcompete S. alterniflora where it is able to establish, offering another prevalent food source to first order consumers. In this study, we find A. germinans leaves to be preferable to chewing herbivores, but simultaneously, chewing herbivores cause more damage to S. alterniflora leaves. Despite higher nitrogen content, A. germinans leaves decomposed slower than S. alterniflora leaves, perhaps due to other leaf constituents or a different microbial community. Other studies have found the opposite in decomposition rates of the two species' leaf tissue. This study provides insights into basic trophic process, herbivory and decomposition, at the initial stages of black mangrove colonization into S. alterniflora salt marsh.	[Macy, Aaron; Sharma, Shailesh; Goff, Josh; Heck, Kenneth L.; Cebrian, Just] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Macy, Aaron; Sharma, Shailesh; Heck, Kenneth L.; Cebrian, Just] Univ S Alabama, Marine Sci Dept, Mobile, AL 36688 USA; [Sparks, Eric] Mississippi State Univ, Coastal Res & Extens Ctr, Biloxi, MS USA; [Sparks, Eric] Mississippi Alabama Sea Grant Consortium, Ocean Springs, MS USA; [Johnson, Matthew W.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA; [Harper, Patric] US Fish & Wildlife Serv, Grand Bay Coastal Resources Ctr, Northern Gulf Coastal Program, Moss Point, MS USA; [Sharma, Shailesh] CUNY Queens Coll, Queens, NY USA	Dauphin Island Sea Lab; University of South Alabama; Mississippi State University; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; City University of New York (CUNY) System	Macy, A (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.; Macy, A (corresponding author), Univ S Alabama, Marine Sci Dept, Mobile, AL 36688 USA.	amacy@disl.org	Sharma, Shailesh/I-2788-2019	Sharma, Shailesh/0000-0002-7918-4070	United States Fish and Wildlife Service [F11AC01390]; U.S. Department of Commerce's National Oceanic and Atmospheric Administration under NOAA [NA140AR4170098, MASGP-18-045]; Mississippi-Alabama Sea Grant Consortium	United States Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Department of Commerce's National Oceanic and Atmospheric Administration under NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Mississippi-Alabama Sea Grant Consortium	This project was funded by the United States Fish and Wildlife Service, grant #F11AC01390 to JC and KLH. Support was also provided by the U.S. Department of Commerce's National Oceanic and Atmospheric Administration under NOAA award NA140AR4170098 and the Mississippi-Alabama Sea Grant Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank D. Byron, T. Ferrero, R. Gamble, J. Hulsey, A. McDonald, B. Tuttle, and C. Wessel for their help in the field and lab. We thank J. Alberti for his statistical software advice. This publication (MASGP-18-045) was partially supported by the U.S. Department of Commerce's National Oceanic and Atmospheric Administration under NOAA Award NA14OAR4170098 and the Mississippi-Alabama Sea Grant Consortium. The views expressed herein do not necessarily reflect the views of any of these organizations.	Alleman LK, 2011, ESTUAR COAST, V34, P1068, DOI 10.1007/s12237-011-9404-8; ALONGI DM, 1987, OECOLOGIA, V71, P537, DOI 10.1007/BF00379293; Alongi DM, 2009, ENERGETICS MANGROVE, P129; Armitage AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125404; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barreto CR, 2018, WETLANDS, V38, P497, DOI 10.1007/s13157-018-0994-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V58, P147, DOI 10.1016/j.soilbio.2012.12.001; Burrows D., 2003, AVICENNIA MARINA RHI, P238; Cannicci S, 2008, AQUAT BOT, V89, P186, DOI 10.1016/j.aquabot.2008.01.009; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Devaney JL, 2017, ECOLOGY, V98, P2513, DOI 10.1002/ecy.1979; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; FARNSWORTH EJ, 1991, BIOTROPICA, V23, P555, DOI 10.2307/2388393; FILIP Z, 1989, SCI TOTAL ENVIRON, V83, P273, DOI 10.1016/0048-9697(89)90099-5; GALLAGHER JL, 1983, AM J BOT, V70, P212, DOI 10.2307/2443265; Guo H, 2017, ECOLOGY, V98, P762, DOI 10.1002/ecy.1698; HACKNEY CT, 1980, ECOLOGY, V61, P226, DOI 10.2307/1935178; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hobbie SE, 2000, ECOSYSTEMS, V3, P484, DOI 10.1007/s100210000042; Hunter A, 2015, WETLANDS, V35, P401, DOI 10.1007/s13157-014-0611-5; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Johnson MW, 2006, AQUAT BOT, V85, P103, DOI 10.1016/j.aquabot.2006.02.003; Kikuzawa K., 1995, CAN J BOT, V163, P158; Lewis RR, 2005, ECOL ENG, V24, P403, DOI 10.1016/j.ecoleng.2004.10.003; Massey FP, 2009, J ANIM ECOL, V78, P281, DOI 10.1111/j.1365-2656.2008.01472.x; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; MCKEE KL, 1995, OECOLOGIA, V101, P448, DOI 10.1007/BF00329423; Mendez-Alonzo R, 2008, BIOTROPICA, V40, P449, DOI 10.1111/j.1744-7429.2008.00397.x; Millar, 2012, BIOLOGY PLANT LITTER, V1, P105, DOI DOI 10.1016/B978-0-12-215001-2.50010-6; ONUF CP, 1977, ECOLOGY, V58, P514, DOI 10.2307/1939001; Osland MJ, 2017, ECOLOGY, V98, P125, DOI 10.1002/ecy.1625; Osland MJ, 2016, GLOBAL CHANGE BIOL, V22, P1, DOI 10.1111/gcb.13084; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Osland MJ, 2012, ECOSYSTEMS, V15, P848, DOI 10.1007/s10021-012-9551-1; PATRICK WH, 1976, ESTUAR COAST MAR SCI, V4, P59, DOI 10.1016/0302-3524(76)90006-2; Pennock JR, 2001, C N ANAL INSTRUMENTA; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; R Core Team, 2021, R LANGUAGE ENV STAT; REDDY KR, 1975, SOIL BIOL BIOCHEM, V7, P87, DOI 10.1016/0038-0717(75)90004-8; Rejmankova E, 2007, SOIL BIOL BIOCHEM, V39, P526, DOI 10.1016/j.soilbio.2006.08.022; Saur E, 1999, HYDROBIOLOGIA, V413, P89, DOI 10.1023/A:1003859331284; Scheffel Whitney A., 2013, Gulf of Mexico Science, V31, P79; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Sparks EL, 2015, ESTUAR COAST, V38, P988, DOI 10.1007/s12237-014-9858-6; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Suarez N, 2005, TREES-STRUCT FUNCT, V19, P721, DOI 10.1007/s00468-005-0001-y; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winter B., 2013, ARXIV, P1, DOI [10.48550/arXiv.1308.5499, DOI 10.48550/ARXIV.1308.5499]; Zhang J, 2014, J INTEGR AGR, V13, P648, DOI 10.1016/S2095-3119(13)60723-6; Zhang YH, 2012, ECOLOGY, V93, P588, DOI 10.1890/11-1302.1; Zuur Alain F., 2009, P1	58	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210144	10.1371/journal.pone.0210144	http://dx.doi.org/10.1371/journal.pone.0210144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615652	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900043
J	Domenici, G; Aurrekoetxea-Rodriguez, I; Simoes, BM; Rabano, M; Lee, SY; San Millan, J; Comaills, V; Oliemuller, E; Lopez-Ruiz, JA; Zabalza, I; Howard, BA; Kypta, RM; Vivanco, MD				Domenici, Giacomo; Aurrekoetxea-Rodriguez, Iskander; Simoes, Bruno M.; Rabano, Miriam; Lee, So Young; San Millan, Julia; Comaills, Valentine; Oliemuller, Erik; Lopez-Ruiz, Jose A.; Zabalza, Ignacio; Howard, Beatrice A.; Kypta, Robert M.; Vivanco, Maria d M.			A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells	ONCOGENE			English	Article							MAMMARY STEM; ALDEHYDE DEHYDROGENASE; TRANSCRIPTION FACTOR; WNT PATHWAY; SOX9; RESISTANCE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; ACTIVATION	Increased cancer stem cell content during development of resistance to tamoxifen in breast cancer is driven by multiple signals, including Sox2-dependent activation of Wnt signalling. Here, we show that Sox2 increases and estrogen reduces the expression of the transcription factor Sox9. Gain and loss of function assays indicate that Sox9 is implicated in the maintenance of human breast luminal progenitor cells. CRISPR/Cas knockout of Sox9 reduces growth of tamoxifen-resistant breast tumours in vivo. Mechanistically, Sox9 acts downstream of Sox2 to control luminal progenitor cell content and is required for expression of the cancer stem cell marker ALDH1A3 and Wnt signalling activity. Sox9 is elevated in breast cancer patients after endocrine therapy failure. This new regulatory axis highlights the relevance of SOX family transcription factors as potential therapeutic targets in breast cancer.	[Domenici, Giacomo; Aurrekoetxea-Rodriguez, Iskander; Simoes, Bruno M.; Rabano, Miriam; Lee, So Young; San Millan, Julia; Comaills, Valentine; Kypta, Robert M.; Vivanco, Maria d M.] CIC BioGUNE, Technol Pk Bizkaia, Derio 48160, Spain; [Oliemuller, Erik; Howard, Beatrice A.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Lopez-Ruiz, Jose A.] Radiodiagnost Serv PreteImagen, Bilbao, Spain; [Zabalza, Ignacio] Galdakao Usansolo Hosp, Dept Pathol, Galdakao, Spain; [Kypta, Robert M.] Imperial Coll London, Dept Surg & Canc, London, England	CIC bioGUNE; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Galdakao Hospital; Imperial College London	Vivanco, MD (corresponding author), CIC BioGUNE, Technol Pk Bizkaia, Derio 48160, Spain.	mdmvivanco@cicbiogune.es	Domenici, Giacomo/AAG-6224-2019; COMAILLS, VALENTINE/AAX-1697-2021; Simoes, Bruno/AAB-2582-2019; Vivanco, Maria/G-2393-2011; Kypta, Robert/F-7699-2011	COMAILLS, VALENTINE/0000-0001-8857-6976; Simoes, Bruno/0000-0003-1253-6657; Vivanco, Maria/0000-0002-9540-247X; Kypta, Robert/0000-0002-2389-310X; Oliemuller Garcia, Erik/0000-0002-4506-0504; Aurrekoetxea-Rodriguez, Iskander/0000-0001-5294-7798; Lee, So Young/0000-0003-3130-785X; Domenici, Giacomo/0000-0002-3947-5930	Spanish Ministry of Education and Science; Institute of Health Carlos III [PI14/01328]; Department of Education of the Government of the Autonomous Community of the Basque Country [PRE_2013_1_991]; Department of Health of the Government of the Autonomous Community of the Basque Country [2014111145]; Department of Industry, Tourism and Trade (Etortek) of the Government of the Autonomous Community of the Basque Country; Department of Innovation Technology of the Government of the Autonomous Community of the Basque Country; RED Nurcamein; Breast Cancer Now;  [SAF2017-84934-R];  [SAF2017-84092-R]	Spanish Ministry of Education and Science(Spanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III); Department of Education of the Government of the Autonomous Community of the Basque Country; Department of Health of the Government of the Autonomous Community of the Basque Country; Department of Industry, Tourism and Trade (Etortek) of the Government of the Autonomous Community of the Basque Country; Department of Innovation Technology of the Government of the Autonomous Community of the Basque Country; RED Nurcamein; Breast Cancer Now; ; 	We are grateful for the generosity of many women and patients that collaborated in this project. We thank the members of the laboratory for helpful discussions and Jessica Cellot for technical help. This work was supported by grants from the Spanish Ministry of Education and Science, the Institute of Health Carlos III (PI14/01328 to M.V.), the Departments of Education (PRE_2013_1_991 to G.D.) and Health (2014111145 to M.V.) of the Government of the Autonomous Community of the Basque Country, the Department of Industry, Tourism and Trade (Etortek) and Department of Innovation Technology of the Government of the Autonomous Community of the Basque Country (to R.K. and M.V.), the RED Nurcamein and SAF2017-84934-R (to M.V.) and SAF2017-84092-R (to R.K.). We thank Breast Cancer Now for funding this work as part of Programme Funding to the Breast Cancer Now Toby Robins Research Centre (to B.H.). We are particularly grateful for the generosity of ACAMBI and all its supporters (to M.V.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Arendt LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111442; Ashkenazi S, 2016, ONCOTARGET, V7, P30166, DOI 10.18632/oncotarget.7379; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Burdelski C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128525; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Canino C, 2015, ONCOTARGET, V6, P12637, DOI 10.18632/oncotarget.3703; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chang DR, 2013, P NATL ACAD SCI USA, V110, P18042, DOI 10.1073/pnas.1311760110; Chen MH, 2016, CLIN CANCER RES, V22, P4225, DOI 10.1158/1078-0432.CCR-15-1800; Cheng PF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0594-4; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dey N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-537; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gascoyne DM, 2003, CELL CYCLE, V2, P238, DOI 10.4161/cc.2.3.355; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gonzalez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083955; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Huang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10398; Iriondo O, 2015, ONCOTARGET, V6, P31721, DOI 10.18632/oncotarget.5564; Iriondo O, 2015, METHODS MOL BIOL, V1293, P63, DOI 10.1007/978-1-4939-2519-3_3; Jeselsohn R, 2017, P NATL ACAD SCI USA, V114, pE4482, DOI 10.1073/pnas.1620993114; Kang HM, 2016, CELL REP, V14, P861, DOI 10.1016/j.celrep.2015.12.071; KASTAN MB, 1990, BLOOD, V75, P1947; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Malhotra GK, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0047-4; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Martin-Martin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12595; Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Prevostel C, 2016, ONCOTARGET, V7, P82228, DOI 10.18632/oncotarget.10573; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Simoes BM, 2011, FUTURE ONCOL, V7, P995, DOI [10.2217/FON.11.80, 10.2217/fon.11.80]; Simoes BM, 2011, BREAST CANCER RES TR, V129, P23, DOI 10.1007/s10549-010-1169-4; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Vivanco MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001215; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wang HY, 2013, J BIOL CHEM, V288, P6478, DOI 10.1074/jbc.M112.419184; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Wu F, 2012, CELL SIGNAL, V24, P1989, DOI 10.1016/j.cellsig.2012.07.008; Zhou CH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-18	68	80	83	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3151	3169		10.1038/s41388-018-0656-7	http://dx.doi.org/10.1038/s41388-018-0656-7			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30622340	Green Published, hybrid			2022-12-26	WOS:000465557200004
J	Bass, MV; Nikitina, T; Norouzi, D; Zhurkin, VB; Grigoryev, SA				Bass, Mikhail V.; Nikitina, Tatiana; Norouzi, Davood; Zhurkin, Victor B.; Grigoryev, Sergei A.			Nucleosome spacing periodically modulates nucleosome chain folding and DNA topology in circular nucleosome arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin structure; DNA topology; nucleosome; histone; computer modeling; electron microscopy (EM); gene regulation; epigenetics; chromatin higher order structure; linker DNA; conformational simulation; epigenetic regulation	CHROMATIN FIBER; REPEAT LENGTH; ORGANIZATION; YEAST; VARIABILITY; DEPENDENCE; CHICKEN; EM	The length of linker DNA that separates nucleosomes is highly variable, but its mechanistic role in modulating chromatin structure and functions remains unknown. Here, we established an experimental system using circular arrays of positioned nucleosomes to investigate whether variations in nucleosome linker length could affect nucleosome folding, self-association, and interactions. We conducted EM, DNA topology, native electrophoretic assays, and Mg2+-dependent self-association assays to study intrinsic folding of linear and circular nucleosome arrays with linker DNA length of 36 bp and 41 bp (3.5 turns and 4 turns of DNA double helix, respectively). These experiments revealed that potential artifacts arising from open DNA ends and full DNA relaxation in the linear arrays do not significantly affect overall chromatin compaction and self-association. We observed that the 0.5 DNA helical turn difference between the two DNA linker lengths significantly affects DNA topology and nucleosome interactions. In particular, the 41-bp linkers promoted interactions between any two nucleosome beads separated by one bead as expected for a zigzag fiber, whereas the 36-bp linkers promoted interactions between two nucleosome beads separated by two other beads and also reduced negative superhelicity. Monte Carlo simulations accurately reproduce periodic modulations of chromatin compaction, DNA topology, and internucleosomal interactions with a 10-bp periodicity. We propose that the nucleosome spacing and associated chromatin structure modulations may play an important role in formation of different chromatin epigenetic states, thus suggesting implications for how chromatin accessibility to DNA-binding factors and the RNA transcription machinery is regulated.	[Bass, Mikhail V.; Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Bass, Mikhail V.] Lomonosov Moscow State Univ, Biol Fac, Dept Mol Biol, Moscow 119192, Russia; [Nikitina, Tatiana; Norouzi, Davood; Zhurkin, Victor B.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lomonosov Moscow State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grigoryev, SA (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Zhurkin, VB (corresponding author), NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zhurkin@nih.gov; sag17@psu.edu			National Science Foundation [1516999]; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010844] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant 1516999 (to S. A. G.) and Intramural Research Program of the National Cancer Institute, National Institutes of Health (to V. B. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldi S, 2018, NAT STRUCT MOL BIOL, V25, P894, DOI 10.1038/s41594-018-0110-0; BAUER WR, 1980, SCI AM, V243, P118; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Buckwalter JM, 2017, NUCLEIC ACIDS RES, V45, P9372, DOI 10.1093/nar/gkx562; Cai SJ, 2018, MOL BIOL CELL, V29, P2450, DOI 10.1091/mbc.E18-05-0331; Carruthers LM, 2000, METHOD ENZYMOL, V321, P66; Chereji RV, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1398-0; Collepardo-Guevara R, 2014, P NATL ACAD SCI USA, V111, P8061, DOI 10.1073/pnas.1315872111; COMPTON JL, 1976, P NATL ACAD SCI USA, V73, P4382, DOI 10.1073/pnas.73.12.4382; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Ekundayo B, 2017, J MOL BIOL, V429, P3031, DOI 10.1016/j.jmb.2017.09.002; Funke JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600974; Grigoryev SA, 2018, BIOPHYS J, V114, P2290, DOI 10.1016/j.bpj.2018.03.009; Grigoryev SA, 2016, P NATL ACAD SCI USA, V113, P1238, DOI 10.1073/pnas.1518280113; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kulaeva OI, 2012, MOL CELL BIOL, V32, P4892, DOI 10.1128/MCB.01127-12; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; LOHR D, 1986, J BIOL CHEM, V261, P9904; LOHR D, 1977, P NATL ACAD SCI USA, V74, P79, DOI 10.1073/pnas.74.1.79; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Nikitina T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700957; Nizovtseva EV, 2017, NUCLEIC ACIDS RES, V45, P3059, DOI 10.1093/nar/gkw1240; Norouzi D, 2018, BIOPHYS J, V115, P1644, DOI 10.1016/j.bpj.2018.06.032; Norouzi D, 2015, BIOPHYS J, V108, P2591, DOI 10.1016/j.bpj.2015.04.015; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Risca VI, 2017, NATURE, V541, P237, DOI 10.1038/nature20781; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SHURE M, 1977, NUCLEIC ACIDS RES, V4, P1183, DOI 10.1093/nar/4.5.1183; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vaughan RM, 2018, P NATL ACAD SCI USA, V115, P8775, DOI 10.1073/pnas.1806373115; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Voong LN, 2016, CELL, V167, P1555, DOI 10.1016/j.cell.2016.10.049; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Yan Y, 2018, NUCLEIC ACIDS RES, V46, P4417, DOI 10.1093/nar/gky153	54	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4233	4246		10.1074/jbc.RA118.006412	http://dx.doi.org/10.1074/jbc.RA118.006412			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30630950	Green Published, hybrid			2022-12-26	WOS:000461854400033
J	Engerud, H; Hope, K; Berg, HF; Fasmer, KE; Tangen, IL; Haldorsen, IS; Trovik, J; Krakstad, C				Engerud, Hilde; Hope, Kirsten; Berg, Hege Fredriksen; Fasmer, Kristine Eldevik; Tangen, Ingvild Loberg; Haldorsen, Ingfrid Salvesen; Trovik, Jone; Krakstad, Camilla			Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; LYMPH-NODE METASTASES; RISK; EXPRESSION; MIC-1; CURETTAGE; BIOMARKER; MEMBER; LEVEL	Objective Better biomarkers are needed in order to identify patients with endometrial carcinoma at risk of recurrence and who may profit from a more aggressive treatment regimen. Our objective was to explore the applicability of plasma growth differentiation factor 15 (GDF-15) as a marker for recurrent disease, as well as a marker for poor prognosis and lymph node metastases. Methods EDTA-blood samples were obtained from 235 patients with endometrial cancer before primary surgery. For 36 of these patients, matching blood samples were collected at time of recurrence. Blood samples were also collected from 78 patients with endometrial hyperplasia. Plasma GDF-15 was measured by an enzyme-linked immunosorbent assay (ELISA). Preoperative pelvic MRI scans for 141 patients were investigated in parallel for imaging variables. Results Preoperative plasma level of GDF-15 was significantly higher for patients who experienced recurrence (1780 ng/L; 95% CI; 518-9475 ng/L) than for patients who did not develop recurrent disease (1236 ng/L; 95% CI; 307-7030 ng/L) (p<0.001). Plasma levels of GDF-15 at recurrence (2818 ng/L, 95% CI 2088-3548 ng/L) were significantly higher than plasma levels of GDF-15 measured at time of primary diagnosis (1857 ng/L, 95% CI; 1317-2398 ng/L) (p = 0.001). High plasma level GDF-15 independently predicts recurrent disease (OR = 3.14; 95% CI 2.10-4.76) and lymph node metastases (OR = 2.64; 95% CI 1.52-4.61). Patients with high plasma level of GDF-15 had significantly larger tumor volume (p = 0.008). Conclusion Elevated plasma level of GDF-15 is associated with aggressive disease and lymph node metastasis in endometrial carcinoma. GDF-15 may be helpful in indicating recurrent disease.	[Engerud, Hilde; Berg, Hege Fredriksen; Tangen, Ingvild Loberg; Trovik, Jone; Krakstad, Camilla] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Engerud, Hilde; Hope, Kirsten; Berg, Hege Fredriksen; Tangen, Ingvild Loberg; Trovik, Jone; Krakstad, Camilla] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Fasmer, Kristine Eldevik; Haldorsen, Ingfrid Salvesen] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Fasmer, Kristine Eldevik; Haldorsen, Ingfrid Salvesen] Univ Bergen, Sect Radiol, Dept Clin Med, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Krakstad, C (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway.; Krakstad, C (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.	camilla.krakstad@med.uib.no	Berg, Hege/GWC-6893-2022; Krakstad, Camilla/AAB-5138-2020	Berg, Hege/0000-0002-1712-6609; Krakstad, Camilla/0000-0002-0174-8139	University of Bergen; Helse Vest; Norwegian Cancer Society [628837]; Research Council of Norway [239840]; Bergen Research Foundation	University of Bergen; Helse Vest; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Bergen Research Foundation	The study was supported by the University of Bergen, Helse Vest, the Norwegian Cancer Society (628837), the Research Council of Norway (239840), and Bergen Research Foundation. None of the funding sources were involved in collecting, analyzing or interpreting data, nor writing the article or deciding to submit for publication.	Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Baydar T, 2009, J CRIT CARE, V24, P318, DOI 10.1016/j.jcrc.2008.06.013; Berg A, 2017, ONCOTARGET, V8, P68530, DOI 10.18632/oncotarget.19708; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; de Wit NJW, 2005, BRIT J CANCER, V92, P2249, DOI 10.1038/sj.bjc.6602612; Haldorsen IS, 2013, EUR RADIOL, V23, P2916, DOI 10.1007/s00330-013-2901-3; Haldorsen IS, 2012, GYNECOL ONCOL, V126, P413, DOI 10.1016/j.ygyno.2012.05.009; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kempf T, 2007, EUR HEART J, V28, P2858, DOI 10.1093/eurheartj/ehm465; Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Knific T, 2018, J STEROID BIOCHEM, V178, P312, DOI 10.1016/j.jsbmb.2018.01.012; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Staff AC, 2011, CLIN CANCER RES, V17, P4825, DOI 10.1158/1078-0432.CCR-11-0715; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Sugulle M, 2009, HYPERTENSION, V54, P106, DOI 10.1161/HYPERTENSIONAHA.109.130583; Tangen IL, 2017, BRIT J CANCER, V117, P840, DOI 10.1038/bjc.2017.235; Tanner E, 2017, GYNECOL ONCOL, V147, P535, DOI 10.1016/j.ygyno.2017.10.020; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Trovik J, 2014, INT J GYNECOL CANCER, V24, P252, DOI 10.1097/IGC.0000000000000037; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210585	10.1371/journal.pone.0210585	http://dx.doi.org/10.1371/journal.pone.0210585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645608	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200037
J	Du, Y; Wolf, IK; Busch, MA; Knopf, H				Du, Yong; Wolf, Ingrid-Katharina; Busch, Markus A.; Knopf, Hildtraud			Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998	PLOS ONE			English	Article							RISK; ANTIDEPRESSANTS; DEMENTIA; OPIOIDS; MEDICATION; PEOPLE; DEATH; BENZODIAZEPINES; ANTIPSYCHOTICS; PRESCRIPTION	Background Use of psychotropic drugs is common among older adults. Population-based studies on the associations of psychotropic drug use with mortality are sparse. Objectives To investigate the associations between the use of specific psychotropic drug groups (opioids, antipsychotics, antidepressants and benzodiazepines) and all-cause mortality among community-dwelling older adults in Germany. Methods Participants of the German National Health Interview and Examination Survey 1998 were followed up for mortality from 1997 to 2011. Persons aged 60-79 years with complete data on psychotropic drug use at baseline and on mortality follow-up were considered as study population (N = 1,563). Associations between the use of opioids, antipsychotics, antidepressants and benzodiazepines and all-cause mortality were examined by Cox proportional hazards models adjusted for sociodemographics (sex, age, community size, region, socioeconomic status), life style (smoking, sports, risky alcohol drinking) and health conditions (obesity, disability, history of cardiovascular diseases, diabetes, hyperlipidemia, hypertension, any cancers, any mental disorders) at baseline. Results After a median follow-up of 11.4 years, 21, 18, 23 and 26 deaths were documented among those who used at baseline opioids (n = 39), antipsychotics (n = 30), antidepressants (n = 53) and benzodiazepines (n = 54) with an unadjusted mortality rate (MR) of 57.7, 59.1, 44.6 and 53.7 per 1000 person-years, respectively. Meanwhile, 400 deaths were documented among 1,406 nonusers of any of the above mentioned psychotropic drugs with a MR of 26.7 per 1000 person-years. The age and sex adjusted mortality rate ratios in comparison with nonusers were 2.20 (95% confidence intervals 1.42-3.41), 1.66(1.03-2.70), 1.56(1.062.28), and 1.57(1.07-2.31) for the use of opioids, antipsychotics, antidepressants and benzodiazepines, respectively. In the fully adjusted Cox models, use of opioids (hazardous ratio 2.04, 95% confidence intervals 1.07-3.89), antipsychotics (2.15, 1.11-4.15) and benzodiazepines (1.76, 1.09-2.82), but not antidepressants, were significantly associated with an increased risk of mortality. Conclusions Use of opioids, antipsychotics, benzodiazepines is significantly associated with an increased risk of all-cause mortality among community-dwelling older adults in Germany. Clinicians should be careful in prescribing these psychotropic drugs to older adults while patients already under psychotropic therapy should well balance the risks and benefits of drug use. Further studies with a larger sample size and information on specific indications for psychotropic drug use and mental comorbidities are required to confirm the findings of the present study.	[Du, Yong; Wolf, Ingrid-Katharina; Busch, Markus A.; Knopf, Hildtraud] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute	Du, Y (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	duy@rki.de		Du, Yong/0000-0001-8309-9293	Federal Ministry of Health; Robert Koch Institute	Federal Ministry of Health; Robert Koch Institute	This work was supported by the Federal Ministry of Health (https://www.bundesgesundheitsministerium.de) and the Robert Koch Institute (www.rki.de).The German Health Interview and Examination Survey for Adults 20082011 was funded by the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Bellach B M, 1998, Gesundheitswesen, V60 Suppl 2, pS59; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Carrasco-Garrido P, 2007, PHARMACOEPIDEM DR S, V16, P449, DOI 10.1002/pds.1344; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Coupland CAC, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15280; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Diez-Quevedo C, 2013, INT J CARDIOL, V167, P1217, DOI 10.1016/j.ijcard.2012.03.143; Du Y, 2008, PHARMACOPSYCHIATRY, V41, P242, DOI 10.1055/s-0028-1083791; Du Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182432; Du Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012182; Enache D, 2016, ACTA PSYCHIAT SCAND, V134, P430, DOI 10.1111/acps.12630; Fontanella CA, 2016, J CLIN PSYCHIAT, V77, pE661, DOI 10.4088/JCP.15m10271; Frandsen R, 2014, PARKINSONISM RELAT D, V20, P1124, DOI 10.1016/j.parkreldis.2014.07.012; Gisev N, 2011, CAN J PSYCHIAT, V56, P377, DOI 10.1177/070674371105600609; Gomes T, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3207; Hall WD, 2006, AUST NZ J PSYCHIAT, V40, P941, DOI 10.1111/j.1440-1614.2006.01917.x; Honkola J, 2012, EUR HEART J, V33, P745, DOI 10.1093/eurheartj/ehr368; Hulshof TA, 2015, J AM MED DIR ASSOC, V16, P817, DOI 10.1016/j.jamda.2015.03.015; Ilomaki J, 2013, DRUG ALCOHOL REV, V32, P218, DOI 10.1111/j.1465-3362.2012.00496.x; Jaussent I, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-212; Jennum P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010662; Jennum P, 2015, EUR NEUROPSYCHOPHARM, V25, P1906, DOI 10.1016/j.euroneuro.2015.08.014; Johnell K, 2017, INT J GERIATR PSYCH, V32, P414, DOI 10.1002/gps.4483; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Kripke DF, 2016, DRUG SAFETY, V39, P93, DOI 10.1007/s40264-015-0362-0; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Malekzadeh MM, 2013, AM J GASTROENTEROL, V108, P1757, DOI 10.1038/ajg.2013.336; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; Ndukwe HC, 2014, DRUG AGING, V31, P755, DOI 10.1007/s40266-014-0205-1; Neutel CI, 2015, EUR J CLIN PHARMACOL, V71, P637, DOI 10.1007/s00228-015-1841-z; Parsaik AK, 2016, AUST NZ J PSYCHIAT, V50, P520, DOI 10.1177/0004867415616695; Rahmati A, 2017, THORAX, V72, P1028, DOI 10.1136/thoraxjnl-2015-208251; Ralph SJ, 2018, J ALZHEIMERS DIS REP, V2, P1, DOI 10.3233/ADR-170042; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Rikala M, 2011, EUR J CLIN PHARMACOL, V67, P731, DOI 10.1007/s00228-011-0996-5; Ruths S, 2013, INT J GERIATR PSYCH, V28, P868, DOI 10.1002/gps.3902; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Schneider-Thoma J, 2018, LANCET PSYCHIAT, V5, P653, DOI 10.1016/S2215-0366(18)30177-9; Seth P, 2018, AM J TRANSPLANT, V18, P1556, DOI 10.1111/ajt.14905; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Tampi RR, 2016, THER ADV CHRONIC DIS, V7, P229, DOI 10.1177/2040622316658463; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Timour Q, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00076; Veien KT, 2011, INT J CARDIOL, V146, P64, DOI 10.1016/j.ijcard.2010.01.006; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996; Weisberg DF, 2015, JAIDS-J ACQ IMM DEF, V69, P223, DOI 10.1097/QAI.0000000000000591; Witchel HJ, 2003, J CLIN PSYCHOPHARM, V23, P58, DOI 10.1097/00004714-200302000-00010; Wolf IK, 2014, BUNDESGESUNDHEITSBLA, V57, P1331, DOI 10.1007/s00103-014-2053-x; Wolf IK, 2012, BUNDESGESUNDHEITSBLA, V55, P431, DOI 10.1007/s00103-012-1443-1; Wolf IK, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1254-x; Zhai YM, 2016, J ALZHEIMERS DIS, V52, P631, DOI 10.3233/JAD-151207; Zimmermann-Viehoff F, 2014, PSYCHOL MED, V44, P2975, DOI 10.1017/S003329171400066X; Zivin K, 2016, J CLIN PSYCHOPHARM, V36, P445, DOI 10.1097/JCP.0000000000000545	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210695	10.1371/journal.pone.0210695	http://dx.doi.org/10.1371/journal.pone.0210695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640945	gold, Green Published, Green Submitted			2022-12-26	WOS:000455808000039
J	Egea, LG; Jimenez-Ramos, R; Hernandez, I; Brun, FG				Egea, Luis G.; Jimenez-Ramos, Rocio; Hernandez, Ignacio; Brun, Fernando G.			Effect of In Situ short-term temperature increase on carbon metabolism and dissolved organic carbon (DOC) fluxes in a community dominated by the seagrass Cymodocea nodosa	PLOS ONE			English	Article							CLIMATE-CHANGE; POSIDONIA-OCEANICA; HEAT WAVES; ECOSYSTEM SERVICES; ZOSTERA-MARINA; MATTER; PRODUCTIVITY; REDUCTION; BALANCE; IMPACTS	Seagrasses form one of the most productive and threatened ecosystems worldwide because of global change and anthropogenic pressures. The frequency of extreme climatic events, such as heat waves, are expected to increase and may drive even more adverse effects than gradual warming. This study explores for the first time the effects of a sudden and temporary increase of temperature in situ on carbon metabolism and dissolved organic carbon (DOC) fluxes in a community dominated by a seagrass (Cymodocea nodosa) during two contrasting seasons (winter and summer). Results showed a positive correlation between temperature and seagrass production between seasons, while the experimental sudden and temporary increase in water temperature did not produce significant differences in carbon community metabolism and DOC fluxes in winter. In contrast, high temperature conditions in summer enhanced significantly the net community production and affected positively to DOC fluxes. Hence, this study indicates that a sudden and temporary increase in water temperature, which characterize marine heat waves, in temperate areas may enhance the autotrophic metabolism of seagrass communities and can yield an increase in the DOC released, in contrast to previous researches suggesting solely negative effects on seagrasses.	[Egea, Luis G.; Jimenez-Ramos, Rocio; Hernandez, Ignacio; Brun, Fernando G.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Puerto Real, Cadiz, Spain	Universidad de Cadiz	Egea, LG (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Puerto Real, Cadiz, Spain.	gonzalo.egea@uca.es	Brun, Fernando G. G/L-1346-2014; Jiménez-Ramos, Rocío/AAT-8081-2020; Hernandez, Ignacio/N-2942-2013; Egea, Luis G./AAT-7290-2020	Brun, Fernando G. G/0000-0002-6313-9531; Jiménez-Ramos, Rocío/0000-0003-1705-1149; Hernandez, Ignacio/0000-0002-8024-2813; Egea, Luis G./0000-0002-2233-3426	Junta de Andalucia Excellence Project [P12-RNM-3020]; Spanish national project [CTM2017-85365-R]; European Social Fund (ESF)	Junta de Andalucia Excellence Project(Junta de Andalucia); Spanish national project(Spanish Government); European Social Fund (ESF)(European Social Fund (ESF))	This work was supported by the Junta de Andalucia Excellence Project P12-RNM-3020 (PRODESCA) and by the Spanish national project CTM2017-85365-R (PAVAROTTI). LGE and RJ hold a contract as young researchers financed by the European Social Fund (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39930; Alcoverro T, 2000, MAR ECOL PROG SER, V194, P13, DOI 10.3354/meps194013; [Anonymous], 2013, LIMNOL OCEANOGR FLUI; [Anonymous], 2018, IPCC SR 1 5; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Arias-Ortiz A, 2018, NAT CLIM CHANGE, V8, P338, DOI 10.1038/s41558-018-0096-y; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barron C, 2004, LIMNOL OCEANOGR, V49, P1642, DOI 10.4319/lo.2004.49.5.1642; Barron C., 2014, FRONT MAR SCI, V1, P1; Barron C, 2009, MAR ECOL PROG SER, V374, P75, DOI 10.3354/meps07715; Beca-Carretero P, 2018, MAR ECOL PROG SER, V589, P59, DOI 10.3354/meps12439; Bragazza L, 2008, GLOBAL CHANGE BIOL, V14, P2688, DOI 10.1111/j.1365-2486.2008.01699.x; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2003, MAR ECOL PROG SER, V265, P85, DOI 10.3354/meps265085; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; Buapet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083804; Carruthers TJB, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P369, DOI 10.1016/B978-044450891-1/50020-7; Champenois W, 2012, LIMNOL OCEANOGR, V57, P347, DOI 10.4319/lo.2012.57.1.0347; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Cullen-Unsworth L, 2013, ENVIRONMENT, V55, P14, DOI 10.1080/00139157.2013.785864; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Boeck HJ, 2016, NEW PHYTOL, V209, P531, DOI 10.1111/nph.13601; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Dreesen FE, 2012, ENVIRON EXP BOT, V79, P21, DOI 10.1016/j.envexpbot.2012.01.005; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; DUARTE CM, 1989, MAR ECOL PROG SER, V51, P269, DOI 10.3354/meps051269; Egea LG, 2018, MAR POLLUT BULL, V134, P14, DOI 10.1016/j.marpolbul.2018.02.029; Egea LG, 2017, THESIS; Egea LG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192402; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Ferguson AJP, 2017, ESTUAR COAST SHELF S, V187, P216, DOI 10.1016/j.ecss.2017.01.005; Field C.B., 2012, MANAGING RISKS EXTRE, P555; Field C.B., 2014, CLIMATE CHANGE 2014, P1132; Fraser MW, 2014, J ECOL, V102, P1528, DOI 10.1111/1365-2745.12300; Frolicher TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03163-6; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garthwin RG, 2014, MAR POLLUT BULL, V83, P475, DOI 10.1016/j.marpolbul.2013.08.010; Gonzalez-Ortiz V, 2014, ESTUAR COAST SHELF S, V139, P20, DOI 10.1016/j.ecss.2013.12.015; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hegerl GC, 2011, NAT GEOSCI, V4, P142, DOI 10.1038/ngeo1090; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hopkinson CS, 1999, ESTUARIES, V22, P863, DOI 10.2307/1353067; Invers O, 1997, AQUAT BOT, V59, P185, DOI 10.1016/S0304-3770(97)00072-7; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jimenez-Arias JL, 2016, HOLOCENE, V26, P1355, DOI 10.1177/0959683616640046; Jimenez-Ramos R, 2017, J EXP MAR BIOL ECOL, V497, P41, DOI 10.1016/j.jembe.2017.09.008; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Macreadie PI, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10040115; Malinverno A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17861; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Marchand FL, 2006, NEW PHYTOL, V170, P291, DOI 10.1111/j.1469-8137.2006.01659.x; Mateo MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P159; McGregor P, 2015, 1142 WMO, V1142, P96; Mckay G, 2017, ENVIRON SCI TECHNOL, V51, P5404, DOI 10.1021/acs.est.6b06372; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moore KA, 2014, ESTUAR COAST, V37, pS20, DOI 10.1007/s12237-013-9667-3; Moreno-Marin F, 2018, LIMNOL OCEANOGR, V63, P1528, DOI 10.1002/lno.10789; Morris EP, 2009, MAR ECOL PROG SER, V390, P117, DOI 10.3354/meps08184; Navarro N, 2004, AQUAT MICROB ECOL, V37, P47, DOI 10.3354/ame037047; Olive I, 2016, ESTUAR COAST, V39, P138, DOI 10.1007/s12237-015-9973-z; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; PAI SC, 1993, MAR CHEM, V41, P343, DOI 10.1016/0304-4203(93)90266-Q; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEREZ M, 1992, AQUAT BOT, V43, P51, DOI 10.1016/0304-3770(92)90013-9; Perkins-Kirkpatrick SE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12520-2; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Robinson KIM, 1987, EFFECTS THERMAL POWE, V7, P1; Roland F, 1999, LIMNOL OCEANOGR, V44, P1148, DOI 10.4319/lo.1999.44.4.1148; Romera-Castillo C, 2011, APPL ENVIRON MICROB, V77, P7490, DOI 10.1128/AEM.00200-11; Royer PD, 2011, J ECOL, V99, P714, DOI 10.1111/j.1365-2745.2011.01804.x; Ruiz-Frau A, 2017, OCEAN COAST MANAGE, V149, P107, DOI 10.1016/j.ocecoaman.2017.10.004; Schrameyer V, 2018, MAR ENVIRON RES, V136, P38, DOI 10.1016/j.marenvres.2018.02.008; Seddon S, 2000, AQUAT BOT, V66, P297, DOI 10.1016/S0304-3770(99)00080-7; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Thomson JA, 2015, GLOBAL CHANGE BIOL, V21, P1463, DOI 10.1111/gcb.12694; Thorhaug A, 2017, SCI TOTAL ENVIRON, P605; Thorhaugh A., 1984, BIOSPHERE PROBLEM SO, P407; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P169, DOI 10.1016/S0022-0981(00)00196-9; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vergara JJ, 2012, ESTUAR COAST SHELF S, V112, P255, DOI 10.1016/j.ecss.2012.07.031; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Yuan WP, 2016, SCI REP-UK, V6, DOI 10.1038/srep18813; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100; Ziegler S, 1998, MAR ECOL PROG SER, V173, P1, DOI 10.3354/meps173001; ZIMMERMAN RC, 1989, J EXP MAR BIOL ECOL, V130, P93, DOI 10.1016/0022-0981(89)90197-4	95	18	18	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210386	10.1371/journal.pone.0210386	http://dx.doi.org/10.1371/journal.pone.0210386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640926	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000025
J	Behme, D; Tsogkas, I; Colla, R; Gera, RG; Schregel, K; Hesse, AC; Maier, IL; Liman, J; Liebeskind, DS; Psychogios, MN				Behme, Daniel; Tsogkas, Ioannis; Colla, Ruben; Gera, Roland G.; Schregel, Katharina; Hesse, Amelie C.; Maier, Ilko L.; Liman, Jan; Liebeskind, David S.; Psychogios, Marios-Nikos			Validation of the extended thrombolysis in cerebral infarction score in a real world cohort	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; REPERFUSION; RECANALIZATION; THROMBECTOMY; 2B	Background A thrombolysis in cerebral infarction (TICI) score of 2b is defined as a good recanalization result although the reperfusion may only cover 50% of the affected territory. An additional mTICI2c category was introduced to further differentiate between mTICI scores. Despite the new mTICI2c category, mTICI2b still covers a range of 50-90% reperfusion which might be too imprecise to predict neurological improvement after therapy. Aim To compare the 7-point "expanded TICI" (eTICI) scale with the traditional mTICI in regard to predict functional independence at 90 days. Methods Retrospective review of 225 patients with large artery occlusion. Angiograms were graded by 2 readers according the 7-point eTICI score (0% = eTICI0; reduced clot = eTICI1; 1-49% = eTICI2a, 50-66% = eTICI2b50; 67-89% = eTICI2b67, 90-99% = eTICI2c and complete reperfusion = eTICI3) and the conventional mTICI score. The ability of e-and mTICI to predict favorable outcome at 90days was compared. Results Given the ROC analysis eTICI was the better predictor of favorable outcome (p-value 0.047). Additionally, eTICI scores 2b50, 2b67 and 2c (former mTICI2b) were significantly superior at predicting the probability of a favorable outcome at 90 days after endovascular therapy with a p-value of 0.033 (probabilities of 17% for mTICI2b50, 24% for mTICI2b67 and 54% for mTICI2c vs. 36% for mTICI2b). Conclusions The 7-point eTICI allows for a more accurate outcome prediction compared to the mTICI score because it refines the broad range of former mTICI2b results.	[Behme, Daniel; Tsogkas, Ioannis; Colla, Ruben; Schregel, Katharina; Hesse, Amelie C.; Psychogios, Marios-Nikos] Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany; [Gera, Roland G.] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Maier, Ilko L.; Liman, Jan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Liebeskind, David S.] UCLA, Dept Neurol, Neurovasc Imaging Res Core, Los Angeles, CA 90024 USA; [Liebeskind, David S.] UCLA, Dept Neurol, Stroke Ctr, Los Angeles, CA 90024 USA	University of Gottingen; University of Gottingen; University of Gottingen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Psychogios, MN (corresponding author), Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany.	m.psychogios@med.uni-goettingen.de	Behme, Daniel/H-4551-2019	Gera, Roland Gerard/0000-0001-8896-3749				Almekhlafi MA, 2014, INTERV NEURORADIOL, V20, P21, DOI 10.15274/INR-2014-10004; Behme D, 2016, J NEUROINTERV SURG, V8, P8, DOI 10.1136/neurintsurg-2014-011446; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gobin YP, 2004, STROKE, V35, P2848, DOI 10.1161/01.STR.0000147718.12954.60; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jayaraman MV, 2013, AM J NEURORADIOL, V34, P135, DOI 10.3174/ajnr.A3278; Jung C, 2016, AM J NEURORADIOL, V37, P285, DOI 10.3174/ajnr.A4529; Kaesmacher J, 2018, EUR RADIOL, V28, P274, DOI 10.1007/s00330-017-4928-3; Kleine JF, 2017, J NEUROINTERV SURG, V9, P117, DOI 10.1136/neurintsurg-2015-012218; Kowoll A, 2016, J NEUROINTERV SURG, V8, P230, DOI 10.1136/neurintsurg-2014-011520; Leyhe JR, 2017, J NEUROINTERV SURG, V9, P1253, DOI 10.1136/neurintsurg-2016-012866; Liebeskind DS, 2019, J NEUROINTERV SURG, V11, P433, DOI 10.1136/neurintsurg-2018-014127; Maus V, 2019, CLIN NEURORADIOL, V29, P669, DOI 10.1007/s00062-018-0702-4; Maus V, 2018, CLIN NEURORADIOL, V28, P327, DOI 10.1007/s00062-017-0566-z; Psychogios MN, 2017, STROKE, V48, P3152, DOI 10.1161/STROKEAHA.117.018077; Rozeman AD, 2016, J STROKE CEREBROVASC, V25, P115, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.002; Sanossian N, 2017, STROKE, V48, P1389, DOI 10.1161/STROKEAHA.117.014745; Tung EL, 2017, STROKE, V48, P2488, DOI 10.1161/STROKEAHA.117.017182; Volny O, 2017, J STROKE CEREBROVASC, V26, P992, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.008; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	20	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210334	10.1371/journal.pone.0210334	http://dx.doi.org/10.1371/journal.pone.0210334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629664	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000075
J	Ijichi, T; Nakazawa, G; Torii, S; Nagamatsu, H; Yoshikawa, A; Souba, J; Isobe, A; Hagiwara, H; Ikari, Y				Ijichi, Takeshi; Nakazawa, Gaku; Torii, Sho; Nagamatsu, Hirofumi; Yoshikawa, Ayako; Souba, Junko; Isobe, Atsushi; Hagiwara, Hitomi; Ikari, Yuji			Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery	PLOS ONE			English	Article							BARE-METAL; EX-VIVO; SIROLIMUS; RESTENOSIS; COATINGS; THROMBOGENICITY; THROMBOSIS; PERMANENT; PATHOLOGY; RESPONSES	Current drug-eluting stents have abluminal polymer coating; however, thrombus formation in these compared with that in uniformly coated stents remains controversial. We evaluated thrombus formation and early endothelialization after using abluminal biodegradable polymer- coated sirolimus-(BP-SES), and everolimus-eluting stents (BP-EES) versus a durable polymer-coated everolimus-eluting stent (DP-EES) in an in vivo setting. BP-SES, BP-EES, and DP-EES (n = 6 each) were implanted in coronary arteries of 12 mini-pigs that were then sacrificed after 7 and 10 days. Stents were stained with hematoxylin and eosin, and a combined Verhoeff and Masson trichrome stain. Areas of fibrin deposition were digitally detected and measured with off-line morphometric software. Stents were investigated for re-endothelialization by transmission electron microscopy. At 7 days, histological analysis revealed the lowest area of fibrin deposition in BP-SES (BP-SES vs. BP-EES vs. DP-EES; 0.10 +/- 0.06 mm(2) vs. 0.15 +/- 0.07 mm(2) vs. 0.19 +/- 0.06 mm(2), p = 0.0004). At 10 days, the area of fibrin deposition was significantly greater in DP-EES (0.13 +/- 0.04 mm(2) vs. 0.14 +/- 0.05 mm(2) vs. 0.19 +/- 0.08 mm(2), p = 0.007). Endothelial cells in BP-SES demonstrated a significantly greater number of tight junctions than those in DP-EES according to by transmission electron microscopy for both days (p< 0.05). Various parameters, including an inflammatory reaction and neointimal formation, were comparable among the groups at 7 and 10 days. An abluminal biodegradable polymer-coated SES showed the least fibrin deposition and greatest endothelial cell recovery at an early stage following implantation in the coronary arteries of mini-pigs.	[Ijichi, Takeshi; Nakazawa, Gaku; Torii, Sho; Nagamatsu, Hirofumi; Yoshikawa, Ayako; Ikari, Yuji] Tokai Univ, Dept Cardiol, Sch Med, Hiratsuka, Kanagawa, Japan; [Souba, Junko; Isobe, Atsushi; Hagiwara, Hitomi] TERUMO Corp Evaluat Ctr, Nakai, Kanagawa, Japan	Tokai University; Terumo Corporation	Nakazawa, G (corresponding author), Tokai Univ, Dept Cardiol, Sch Med, Hiratsuka, Kanagawa, Japan.	gnakazawa@tokai-u.jp			TERUMO Corporation	TERUMO Corporation	This study was all supported by TERUMO Corporation. There was no additional external funding received for this study. The funder provided support in the form of salaries or research grants for authors GN, JS, AI, HH and YI.	Granada JF, 2010, CIRC-CARDIOVASC INTE, V3, P257, DOI 10.1161/CIRCINTERVENTIONS.109.919936; Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Koppara T, 2016, EUROINTERVENTION, V11, P1020, DOI 10.4244/EIJY14M10_08; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Lee DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183079; Longo G, 2015, MINERVA CARDIOANGIOL, V63, P193; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Nakano M, 2014, J AM COLL CARDIOL, V63, P2510, DOI 10.1016/j.jacc.2014.02.607; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Otsuka F, 2015, JACC-CARDIOVASC INTE, V8, P1248, DOI 10.1016/j.jcin.2015.03.029; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Saito N, 2016, MED DEVICES-EVID RES, V9, P33, DOI 10.2147/MDER.S102094; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974; Seifert PS, 2007, CARDIOVASC REVASCULA, V8, P251, DOI 10.1016/j.carrev.2007.08.002; Steigerwald K, 2012, EUROINTERVENTION, V8, P752, DOI 10.4244/EIJV8I6A115; Stojkovic S, 2015, FUND CLIN PHARMACOL, V29, P95, DOI 10.1111/fcp.12092; Tada T, 2014, INT J CARDIOVAS IMAG, V30, P495, DOI 10.1007/s10554-014-0376-1; van Beusekom HMM, 1998, J AM COLL CARDIOL, V32, P1109, DOI 10.1016/S0735-1097(98)00348-9; Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133; Wilson GJ, 2015, CATHETER CARDIO INTE, V86, pE247, DOI 10.1002/ccd.25993; Wilson GJ, 2012, EUROINTERVENTION, V8, P250, DOI 10.4244/EIJV8I2A39	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209841	10.1371/journal.pone.0209841	http://dx.doi.org/10.1371/journal.pone.0209841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629613	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000035
J	Bolanos, LM; Rosenblueth, M; de Lara, AM; Migueles-Lozano, A; Gil-Aguillon, C; Mateo-Estrada, V; Gonzalez-Serrano, F; Santibanez-Lopez, CE; Garcia-Santibanez, T; Martinez-Romero, E				Bolanos, Luis M.; Rosenblueth, Monica; Manrique de Lara, Amaranta; Migueles-Lozano, Anali; Gil-Aguillon, Citlali; Mateo-Estrada, Valeria; Gonzalez-Serrano, Francisco; Santibanez-Lopez, Carlos E.; Garcia-Santibanez, Tonalli; Martinez-Romero, Esperanza			Cophylogenetic analysis suggests cospeciation between the Scorpion Mycoplasma Clade symbionts and their hosts	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; BACTERIAL ENDOSYMBIONT; INSECTS HEMIPTERA; GUT; DIVERSITY; WOLBACHIA; APHIDS; AMPLIFICATION; TRANSMISSION; RESISTANCE	Scorpions are predator arachnids of ancient origin and worldwide distribution. Two scorpion species, Vaejovis smithi and Centruroides limpidus, were found to harbor two different Mollicutes phylotypes: a Scorpion Mycoplasma Clade (SMC) and Scorpion Group 1 (SG1). Here we investigated, using a targeted gene sequencing strategy, whether these Mollicutes were present in 23 scorpion morphospecies belonging to the Vaejovidae, Carboctonidae, Euscorpiidae, Diplocentridae, and Buthidae families. Our results revealed that SMC is found in a species-specific association with Vaejovidae and Buthidae, whereas SG1 is uniquely found in Vaejovidae. SMC and SG1 co-occur only in Vaejovis smithi where 43% of the individuals host both phylotypes. A phylogenetic analysis of Mollicutes 16S rRNA showed that SMC and SG1 constitute well-delineated phylotypes. Additionally, we found that SMC and scorpion phylogenies are significantly congruent, supporting the observation that a cospeciation process may have occurred. This study highlights the phylogenetic diversity of the scorpion associated Mollicutes through different species revealing a possible cospeciation pattern.	[Bolanos, Luis M.; Rosenblueth, Monica; Manrique de Lara, Amaranta; Migueles-Lozano, Anali; Gil-Aguillon, Citlali; Mateo-Estrada, Valeria; Gonzalez-Serrano, Francisco; Garcia-Santibanez, Tonalli; Martinez-Romero, Esperanza] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Lab Ecol Genom, Cuernavaca, Morelos, Mexico; [Santibanez-Lopez, Carlos E.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca, Morelos, Mexico; [Bolanos, Luis M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Santibanez-Lopez, Carlos E.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Oregon State University; University of Wisconsin System; University of Wisconsin Madison	Bolanos, LM (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Lab Ecol Genom, Cuernavaca, Morelos, Mexico.; Bolanos, LM (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	lbolanos@lcg.unam.mx	Bolaños, Luis/J-2138-2019	Bolaños, Luis/0000-0002-0832-016X; Gonzalez-Serrano, Francisco/0000-0002-7740-3727; martinez-romero, esperanza/0000-0002-2295-2606; Manrique de Lara, Amaranta/0000-0002-1531-8770	CONACyT [253116, 580519]; Universidad Nacional Autonoma de Mexico PAPIIT (UNAM) [IN207718]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico PAPIIT (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This research was supported by CONACyT Basic Science grant 253116 to EMR and Universidad Nacional Autonoma de Mexico PAPIIT (UNAM) IN207718 to EMR. TGS is a doctoral student from the graduate program in Biomedical Sciences UNAM and received a fellowship (number 580519) from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053084; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; Baradaran M, 2011, AFR J BIOTECHNOL, V10, P19802, DOI 10.5897/AJB11.2453; Baumann L, 2005, CURR MICROBIOL, V50, P84, DOI 10.1007/s00284-004-4437-x; Bhat AH, 2019, J HELMINTHOL, V93, P81, DOI 10.1017/S0022149X17001171; Bolanos LM, 2016, ENVIRON MICROBIOL, V18, P1364, DOI 10.1111/1462-2920.12939; Bolanos LM, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu008; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; Bryson RW, 2014, MOL ECOL RESOUR, V14, P789, DOI 10.1111/1755-0998.12220; Ceja-Navarro JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8618; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001; Duron O, 2016, ENV MICROBIOL REP, V8, P715, DOI 10.1111/1758-2229.12432; Ebert D, 2013, ANNU REV ECOL EVOL S, V44, P623, DOI 10.1146/annurev-ecolsys-032513-100555; Elmnasri K, 2018, J BASIC MICROB, V58, P827, DOI 10.1002/jobm.201800144; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenn K, 2004, TRENDS ECOL EVOL, V19, P163, DOI 10.1016/j.tree.2004.01.002; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraune S, 2008, ENVIRON MICROBIOL, V10, P2497, DOI 10.1111/j.1462-2920.2008.01672.x; Gasparich GE, 2010, BIOLOGICALS, V38, P193, DOI 10.1016/j.biologicals.2009.11.007; Goto S, 2006, APPL ENVIRON MICROB, V72, P4805, DOI 10.1128/AEM.00416-06; Gruwell ME, 2007, MOL PHYLOGENET EVOL, V44, P267, DOI 10.1016/j.ympev.2007.01.014; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Hall AAG, 2016, ENVIRON MICROBIOL, V18, P2591, DOI 10.1111/1462-2920.13351; He LS, 2017, APPL ENVIRON MICROB; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Huang QY, 2008, ENTOMOL EXP APPL, V129, P210, DOI 10.1111/j.1570-7458.2008.00764.x; Itoh H, 2014, APPL ENVIRON MICROB, V80, P5974, DOI 10.1128/AEM.01087-14; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Katoh K., 2017, BRIEF BIOINFORM, DOI [10.1093/bib/bbx108, doi.org/10.1093/bib/bbx108, DOI 10.1093/BIB/BBX108]; Kellner RLL, 1996, OECOLOGIA, V107, P293, DOI 10.1007/BF00328445; Kikuchi Y, 2008, DIVERSITY BACTERIAL; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Leclercq S, 2014, GENOME BIOL EVOL, V6, P407, DOI 10.1093/gbe/evu020; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lopez CE, 2009, REV MEX BIODIVERS, V80; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; Mateos M, 2016, ECOL EVOL, V6, P2679, DOI 10.1002/ece3.2085; Morales-Jimenez J, 2013, MICROB ECOL, V66, P200, DOI 10.1007/s00248-013-0206-3; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Naumann M, 2010, ISME J, V4, P862, DOI 10.1038/ismej.2010.21; Nishiguchi MK, 1998, APPL ENVIRON MICROB, V64, P3209; Nishiwaki H, 2007, APPL ENVIRON MICROB, V73, P3404, DOI 10.1128/AEM.00021-07; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Oksanen J., 2015, VEGAN COMMUNITY ECOL; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Polis GA, 1990, BIOL SCORPIONS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prendini Lorenzo, 2001, P113; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Razin S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P836, DOI 10.1007/0-387-30744-3_29; Razin Shmuel, 1992, P3; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; Rehm P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-19; Rosenblueth M, 2012, J EVOLUTION BIOL, V25, P2357, DOI 10.1111/j.1420-9101.2012.02611.x; Rychlik Wojciech, 2007, V402, P35; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Salem H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1838; Santibanez-Lopez CE, 2017, INVERTEBR SYST, V31, P233, DOI [10.1071/is16078, 10.1071/IS16078]; Santibanez-Lopez CE, 2016, TOXINS, V8, DOI 10.3390/toxins8010002; Schramm A, 2003, ENVIRON MICROBIOL, V5, P804, DOI 10.1046/j.1462-2920.2003.00474.x; Sharma PP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2953; Sharma PP, 2018, MOL PHYLOGENET EVOL, V122, P37, DOI 10.1016/j.ympev.2018.01.003; Sharon G, 2012, P NATL ACAD SCI USA, V109, P8618; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suesdek-Rocha Lincoln, 2007, Revista Iberica de Aracnologia, V14, P183; Sylvain FE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05662-w; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urban JM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-87; de Leon AVP, 2017, GENOME BIOL EVOL, V9, P2237, DOI 10.1093/gbe/evx156; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Wang Y, 2016, ENVIRON MICROBIOL, V18, P2646, DOI 10.1111/1462-2920.13411; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Whitcomb RF, 1983, METHODS MYCOPLASMOLO, P147; Xie J, 2014, HEREDITY, V112, P399, DOI 10.1038/hdy.2013.118; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Yamashita T, 2018, PREPRINT; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	97	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209588	10.1371/journal.pone.0209588	http://dx.doi.org/10.1371/journal.pone.0209588			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625167	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400046
J	Ribeiro, MM; Roque, N; Ribeiro, S; Gavinhos, C; Castanheira, I; Quinta-Nova, L; Albuquerque, T; Gerassis, S				Ribeiro, Maria Margarida; Roque, Natalia; Ribeiro, Silvia; Gavinhos, Catarina; Castanheira, Isabel; Quinta-Nova, Luis; Albuquerque, Teresa; Gerassis, Saki			Bioclimatic modeling in the Last Glacial Maximum, Mid-Holocene and facing future climatic changes in the strawberry tree (Arbutus unedo L.)	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; RESPONSES; VARIABILITY; ADAPTATION; PLASTICITY; PREDICTION; DIVERSITY; EVOLUTION; DYNAMICS; HOLOCENE	Increasing forest wildfires in Portugal remain a growing concern since forests in the Mediterranean region are vulnerable to recent global warming and reduction of precipitation. Therefore, a long-term negative effect is expected on the vegetation, with increasing drought and areas burnt by fires. The strawberry tree (Arbutus unedo L.) is particularly used in Portugal to produce a spirit by processing its fruits and is the main income for forestry owners. Other applications are possible due to the fruit and leaves' anti-oxidant properties and bioactive compounds production, with a potential for clinical and food uses. It is a sclerophyllous plant, dry-adapted and fire resistant, enduring the Mediterranean climate, and recently considered as a possibility for afforestation, to intensify forest discontinuity where pines and eucalypts monoculture dominate the region. To improve our knowledge about the species' spatial distribution we used 318 plots (the centroid of a 1 km(2) square grid) measuring the species presence and nine environmental attributes. The seven bioclimatic variables most impacting on the species distribution and two topographic features, slope and altitude, were used. The past, current and future climate data were obtained through WorldClim. Finally, the vulnerability of the strawberry tree to the effects of global climate change was examined in the face of two emission scenarios (RCP 4.5 and 8.5), to predict distribution changes in the years 2050 and 2070, using a species distribution models (MaxEnt). The reduction of suitable habitat for this species is significant in the southern regions, considering the future scenarios of global warming. Central and northern mountainous regions are putative predicted refuges for this species. Forest policy and management should reflect the impact of climate change on the usable areas for forestry, particularly considering species adapted to the Mediterranean regions and wildfires, such as the strawberry tree. The distribution of the species in the Last Glacial Maximum (LGM) and Mid-Holocene (MH) agrees with previous genetic and paleontological studies in the region, which support putative refuges for the species. Two in the southern and coastal-central regions, since the LGM, and one in the east-central mountainous region, considered as cryptic refugia.	[Ribeiro, Maria Margarida; Roque, Natalia; Gavinhos, Catarina; Castanheira, Isabel; Quinta-Nova, Luis] Escola Super Agr, Inst Politecn Castelo Branco, Dept Recursos Nat & Desenvolvimento Sustentavel, Castelo Branco, Portugal; [Ribeiro, Maria Margarida; Albuquerque, Teresa] Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal; [Ribeiro, Maria Margarida] Ctr Biotecnol Plantas Beira Interior, Castelo Branco, Portugal; [Ribeiro, Maria Margarida; Castanheira, Isabel; Quinta-Nova, Luis] Inst Politecn Castelo Branco, Ctr Recursos Nat Ambiente & Soc CERNAS, Castelo Branco, Portugal; [Ribeiro, Silvia] Univ Lisbon, Inst Super Agron, Ctr Invest & Agron Alimentos & Ambiente Paisagem, Lisbon, Portugal; [Albuquerque, Teresa] Escola Super Tecnol, Inst Politecn Castelo Branco, Castelo Branco, Portugal; Vigo Univ, Dept Nat Resources & Environm Engn, Vigo, Spain	Polytechnic Institute of Castelo Branco; Universidade de Lisboa; Forest Research Centre; Polytechnic Institute of Castelo Branco; Universidade de Lisboa; Polytechnic Institute of Castelo Branco; Universidade de Vigo	Ribeiro, MM (corresponding author), Escola Super Agr, Inst Politecn Castelo Branco, Dept Recursos Nat & Desenvolvimento Sustentavel, Castelo Branco, Portugal.; Ribeiro, MM (corresponding author), Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal.; Ribeiro, MM (corresponding author), Ctr Biotecnol Plantas Beira Interior, Castelo Branco, Portugal.; Ribeiro, MM (corresponding author), Inst Politecn Castelo Branco, Ctr Recursos Nat Ambiente & Soc CERNAS, Castelo Branco, Portugal.	mataide@ipcb.pt	Ribeiro, Maria Margarida/O-7373-2019; Quinta-Nova, Luís/O-2888-2014; Albuquerque, Maria Teresa Durães/B-1536-2013; Roque, Natália Martins/AAB-4276-2021; Ribeiro, Maria Margarida/M-4235-2013; Gerassis, Saki/E-8767-2019	Ribeiro, Maria Margarida/0000-0003-4684-1262; Quinta-Nova, Luís/0000-0002-8464-7527; Albuquerque, Maria Teresa Durães/0000-0002-8782-6133; Roque, Natália Martins/0000-0001-8859-4365; Ribeiro, Maria Margarida/0000-0003-4684-1262; Castanheira, Isabel/0000-0002-9174-2039; Gavinhos, Catarina/0000-0002-6011-5016; Ribeiro, Silvia/0000-0002-3297-178X; Gerassis Davite, Saki/0000-0002-9249-6407	Fundacao para a Ciencia e Tecnologia (Portugal) (FCT) [UID/AGR/00239/2013, SFRH/BSAB/113895/2015]; FCT [UID/AGR/00239/2013, SFRH/BSAB/127907/2016, UID/AGR/04129/2013, UID/AMB/00681/2013]; Fundação para a Ciência e a Tecnologia [UID/AGR/00239/2013, UID/AGR/04129/2013, UID/AMB/00681/2013] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal) (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Fundacao para a Ciencia e Tecnologia (Portugal) (FCT) funded MMR's work with the grants UID/AGR/00239/2013 and SFRH/BSAB/113895/2015. TA was funded with the FCT grants UID/AGR/00239/2013 and SFRH/BSAB/127907/2016. SR acknowledges the UID/AGR/04129/2013 grant by FCT. FCT grant UID/AMB/00681/2013 additionally funded MMR, IC and LQN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Alvarado-Serrano DF, 2014, MOL ECOL RESOUR, V14, P233, DOI 10.1111/1755-0998.12184; [Anonymous], 2000, NON TRADITIONAL REF; Atkins KE, 2010, J THEOR BIOL, V266, P449, DOI 10.1016/j.jtbi.2010.07.014; Bosso L, 2016, PHYTOPATHOL MEDITERR, V55, P62, DOI 10.14601/Phytopathol_Mediterr-16429; Burrough P.A., 1998, PRINCIPLES GEOGRAPHI; Carrion JS, 2010, REV PALAEOBOT PALYNO, V162, P458, DOI 10.1016/j.revpalbo.2009.12.007; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Conrady S., 2015, BAYESIAN NETWORKS BA; Costa JC, 2012, GLOBAL GEOBOTANY, DOI [DOI 10.5616/GG120001, 10]; Danielson J. J., 2011, GLOBAL MULTIRESOLUTI, DOI 10.3133/ofr20111073; Dury M, 2011, IFOREST, V4, P82, DOI 10.3832/ifor0572-004; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Figueiral I, 2002, QUATERNARY SCI REV, V21, P549, DOI 10.1016/S0277-3791(01)00022-1; FIGUEIRAL I, 1995, REV PALAEOBOT PALYNO, V89, P441, DOI 10.1016/0034-6667(95)00013-3; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Guiot J, 2016, SCIENCE, V354, P465, DOI 10.1126/science.aah5015; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Lascoux M, 2004, PHILOS T ROY SOC B, V359, P197, DOI 10.1098/rstb.2003.1390; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lopez-Merino L, 2012, GLOBAL PLANET CHANGE, V92-93, P58, DOI 10.1016/j.gloplacha.2012.04.003; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; MESLEARD F, 1989, OECOLOGIA, V80, P127, DOI 10.1007/BF00789941; Monteiro P. D., 2013, ARKEOGAZTE, V3, P51; Monteiro-Henriques T, 2016, INT J CLIMATOL, V36, P400, DOI 10.1002/joc.4357; Nagel LM, 2017, J FOREST, V115, P167, DOI 10.5849/jof.16-039; Oliveira SLJ, 2012, INT J WILDLAND FIRE, V21, P48, DOI 10.1071/WF10131; Ormsby T., 2010, GETTING KNOW ARCGIS; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pedro J.G., 1994, PORTUGAL ATLAS AMBIE; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Petit RJ, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P23, DOI 10.1007/1-4020-4904-8_2; Phillips S.J., MAXENT SOFTWARE MODE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Queiroz PF, 2011, RELATORIO FINAL PROJ; Reboredo F, 2014, WORLD FORESTS, V19, P1, DOI 10.1007/978-3-319-08455-8_1; Ribeiro MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175239; Rodriguez-Sanchez F, 2010, REV PALAEOBOT PALYNO, V162, P507, DOI 10.1016/j.revpalbo.2010.03.008; Santiso X, 2015, THESIS; Santiso X, 2017, J PLANT ECOL, V10, P869, DOI 10.1093/jpe/rtw095; Santiso X, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw003; Santiso X, 2015, TREE PHYSIOL, V35, P1118, DOI 10.1093/treephys/tpv081; Santos FD, 2006, 2 SIAM; SEALY JR, 1949, J ECOL, V37, P365, DOI 10.2307/2256613; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Takrouni MM, 2012, SCI HORTIC-AMSTERDAM, V146, P92, DOI 10.1016/j.scienta.2012.08.005; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Torres JA, 2002, PLANT ECOL, V160, P207, DOI 10.1023/A:1015864821706; Urbani F, 2017, B INSECTOL, V70, P189; Valiente-Banuet A, 2006, P NATL ACAD SCI USA, V103, P16812, DOI 10.1073/pnas.0604933103; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; VANDERKNAAP WO, 1995, REV PALAEOBOT PALYNO, V89, P153, DOI 10.1016/0034-6667(95)00048-0; Wu HB, 2007, CLIM DYNAM, V29, P211, DOI 10.1007/s00382-007-0231-3	60	17	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210062	10.1371/journal.pone.0210062	http://dx.doi.org/10.1371/journal.pone.0210062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625214	Green Published, Green Submitted, gold			2022-12-26	WOS:000455359400071
J	van Kuppevelt, D; Heywood, J; Hamer, M; Sabia, S; Fitzsimons, E; van Hees, V				van Kuppevelt, Dafne; Heywood, Joe; Hamer, Mark; Sabia, Severine; Fitzsimons, Emla; van Hees, Vincent			Segmenting accelerometer data from daily life with unsupervised machine learning	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY RECOGNITION; ENERGY-EXPENDITURE; DIETARY PATTERNS; WRIST	Purpose Accelerometers are increasingly used to obtain valuable descriptors of physical activity for health research. The cut-points approach to segment accelerometer data is widely used in physical activity research but requires resource expensive calibration studies and does not make it easy to explore the information that can be gained for a variety of raw data metrics. To address these limitations, we present a data-driven approach for segmenting and clustering the accelerometer data using unsupervised machine learning. Methods The data used came from five hundred fourteen-year-old participants from the Millennium cohort study who wore an accelerometer (GENEActiv) on their wrist on one weekday and one weekend day. A Hidden Semi-Markov Model (HSMM), configured to identify a maximum of ten behavioral states from five second averaged acceleration with and without addition of x, y, and z-angles, was used for segmenting and clustering of the data. A cut-points approach was used as comparison. Results Time spent in behavioral states with or without angle metrics constituted eight and five principal components to reach 95% explained variance, respectively; in comparison four components were identified with the cut-points approach. In the HSMM with acceleration and angle as input, the distributions for acceleration in the states showed similar groupings as the cut-points categories, while more variety was seen in the distribution of angles. Conclusion Our unsupervised classification approach learns a construct of human behavior based on the data it observes, without the need for resource expensive calibration studies, has the ability to combine multiple data metrics, and offers a higher dimensional description of physical behavior. States are interpretable from the distributions of observations and by their duration.	[van Kuppevelt, Dafne; van Hees, Vincent] Netherlands eSci Ctr, Amsterdam, Netherlands; [Heywood, Joe; Fitzsimons, Emla] UCL Inst Educ, Ctr Longitudinal Studies, London, England; [Hamer, Mark] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Sabia, Severine] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Paris, France; [Sabia, Severine] UCL, Dept Epidemiol & Publ Hlth, London, England; [Fitzsimons, Emla] Inst Fiscal Studies, London, England	University of London; University College London; UCL Institute of Education; Loughborough University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; University of London; London School Economics & Political Science	Fitzsimons, E (corresponding author), UCL Inst Educ, Ctr Longitudinal Studies, London, England.; Fitzsimons, E (corresponding author), Inst Fiscal Studies, London, England.	e.fitzsimons@ucl.ac.uk	Sabia, Séverine/G-2966-2017; Hamer, Mark/C-1602-2008; Hamer, Mark/AAJ-6814-2021	Sabia, Séverine/0000-0003-3109-9720; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; van Hees, Vincent/0000-0003-0182-9008	Economic and Social Research Council (ESRC) [ES/K005987/1]; Department for Education; Department of Health, Ministry of Justice, Home Office; Department for Transport; Department of Work and Pensions, Welsh Government; Department for Employment and Learning (Northern Ireland); SURFsara (the collaborative ICT organization for Dutch education and research); ESRC [ES/M001660/1, ES/K005987/1] Funding Source: UKRI; MRC [MR/R024227/1, MR/K013351/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department for Education; Department of Health, Ministry of Justice, Home Office; Department for Transport; Department of Work and Pensions, Welsh Government; Department for Employment and Learning (Northern Ireland); SURFsara (the collaborative ICT organization for Dutch education and research); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The sixth sweep of the Millennium Cohort Study was core-funded by the Economic and Social Research Council (ESRC), grant number ES/K005987/1, and co-funded by the following consortium of government departments: Department for Education, Department of Health, Ministry of Justice, Home Office, Department for Transport, Department of Work and Pensions, Welsh Government and Department for Employment and Learning (Northern Ireland). SURFsara (the collaborative ICT organization for Dutch education and research, https://www.surf.nl/en/about-surf/subsidiaries/surfsara/) funded compute resources for the experiments in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakrania K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164045; Bellettiere J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180119; Brandes M, 2012, MED SCI SPORT EXER, V44, P2235, DOI 10.1249/MSS.0b013e318260402b; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chatzitheochari S, 2015, MEASURING YOUNG PEOP; Diaz KM, 2017, J SPORTS SCI, P1; Duong TV, 2005, PROC CVPR IEEE, P838; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Freedson PS, 2011, J APPL PHYSIOL, V111, P1804, DOI 10.1152/japplphysiol.00309.2011; Fung TT, 2005, INT J CANCER, V116, P116, DOI 10.1002/ijc.20999; Guinhouya CB, 2007, BEHAV RES METHODS, V39, P682, DOI 10.3758/BF03193040; Hildebrand M, 2016, SCANDINAVIAN J MED S; Hildebrand M, 2014, MED SCI SPORTS EXERC, V1; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Ipsos MORI CLS, 2017, MILL COH STUD 6 SWEE, V2017; Ipsos MORI CLS, 2016, MILL COH STUD 6 SWEE; Johnson MJ, 2013, J MACH LEARN RES, V14, P673; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118078; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lin JF-S, 2011, WORKSH ROB NEUR REH, P33; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d; McGarty AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164928; Menai M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45772; Phillips LRS, JOURNAL OF SCIENCE A; Pober DM, 2006, MED SCI SPORT EXER, V38, P1626, DOI 10.1249/01.mss.0000227542.43669.45; Rosenberg D, 2017, MED SCI SPORTS EXERC, V49; Rowlands AV, 2017, J SCI MED SPORT, V20, P368, DOI 10.1016/j.jsams.2016.04.013; Rowlands AV, 2016, MED SCI SPORT EXER, V48, P748, DOI 10.1249/MSS.0000000000000813; Rowlands AV, 2013, MED SCI SPORTS EXERC, DOI 10.1249/MSS.0000000000000224; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Saint-Maurice PF, 2018, J AM HEART ASS, V7; Vaha-Ypya H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134813; van Hees V, 2017, MILLENNIUMCOHORT ACC; van Hees V, 2017, R PACKAGE GGIR; van Hees VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142533; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; van Hees VT, 2013, J APPL PHYSIOL, V114, P1042, DOI 10.1152/japplphysiol.00984.2012; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; van Kasteren TLM, 2010, J AMB INTEL SMART EN, V2, P311, DOI 10.3233/AIS-2010-0070; van Kuppevelt D, 2017, HSMM4ACC; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; Veltink P H, 1996, IEEE Trans Rehabil Eng, V4, P375, DOI 10.1109/86.547939; Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142; Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011	47	19	19	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208692	10.1371/journal.pone.0208692	http://dx.doi.org/10.1371/journal.pone.0208692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625153	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400016
J	Ding, WC; Li, ST; He, P; Huang, SM				Ding, Wencheng; Li, Shutian; He, Ping; Huang, Shaomin			Contribution and fate of maize residue-N-15 and urea-N-15 as affected by N fertilization regime	PLOS ONE			English	Article							NITROGEN USE EFFICIENCIES; CONSERVATION AGRICULTURE; PLANT RESIDUES; INORGANIC N; NORTH CHINA; SOIL; RICE; CROP; RECOVERY; TILLAGE	Increasing amounts of crop residues are being returned to croplands. Understanding nitrogen (N) availability in crop residues under various N fertilization regimes is important in optimizing N management. Pot experiments were conducted to investigate the contribution, fate and residual effects of urea and maize residue-N using a N-15 isotope technique. Four N regimes were tested: three basal-topdressing ratios of N applied as urea (100-0, 75-25, 50-50) and one basal application of 75% N as urea and 25% N as manure (75U+25M). An average of 31.4% wheat N uptake was derived from urea, 9.2% from maize residue, and 59.5% from the soil in the first season. During the growing stages of wheat, maize residue contributed 0.3-4.8% and 3.1-13.2% to soil mineral and microbial biomass N, respectively, and those originated from urea was 1.0-4.2% and 4.6-16.8%, respectively. Regarding the fate of urea and residue-N after the first season, 35.9% and 16.9% of urea-N-15 and residue -N-15 were recovered by wheat, 28.1% and 46.9% remained in the soil, and 36.0% and 36.2% were lost. The contribution of urea to crop N uptake and N recovery efficiency increased, while that of residue-N decreased with increasing proportion of topdressing N. Substituting 25% mineral N with manure decreased the urea-N-15 loss without negative effects on crop dry matter and N uptake. Residual urea-N-15 and maize residue-N-15 from the previous season contributed 3.9% and 3.0% to summer maize N uptake. Additionally, 29.3% of residue-N-15 remained in the soil after the second season, while only 18.6% of urea-N-15 remained. Our study suggests that fertilizer and crop residue are actively involved in soil N transformation and plant N nutrition, emphasizing the capacities of organic residues to sustainably supply nutrients. Considering the utilization of both N fertilizer and maize residue, we may suggest a 75-25 split in N fertilizer application, but more appropriate options need to be further assessed under different cropping systems.	[Ding, Wencheng; Li, Shutian; He, Ping] Chinese Acad Agr Sci CAAS, Inst Agr Resources & Reg Planning, Minist Agr Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China; [Li, Shutian; He, Ping] IPNI, China Program, CAAS IPNI Joint Lab Plant Nutr Innovat Res, Beijing, Peoples R China; [Huang, Shaomin] Henan Acad Agr Sci, Inst Plant Nutr & Resource Environm, Zhengzhou, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences	Li, ST (corresponding author), Chinese Acad Agr Sci CAAS, Inst Agr Resources & Reg Planning, Minist Agr Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China.	lishutian@caas.cn		Wencheng, Ding/0000-0002-6877-1157	China "973" Project [20130127406]; National Natural Science of Foundation [31372135]; National Key Research & Development Plan [2016YFD0200103]	China "973" Project(National Basic Research Program of China); National Natural Science of Foundation; National Key Research & Development Plan	The study design was supported by China "973" Project (20130127406) and National Natural Science of Foundation (31372135). The experimental analysis and decision to publish were supported by the National Key Research & Development Plan (2016YFD0200103).	Ai C., 2015, BIOL FERT SOILS, V51, P465, DOI [10.1007/s00374-015-0994-3, DOI 10.1007/s00374-015-0994-3]; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Al-Kaisi MM, 2017, AGRON J, V109, P2415, DOI 10.2134/agronj2016.11.0633; Aulakh MS, 2017, NUTR CYCL AGROECOSYS, V107, P79, DOI 10.1007/s10705-016-9816-8; AZAM F, 1993, SOIL BIOL BIOCHEM, V25, P1787, DOI 10.1016/0038-0717(93)90184-D; Bijay-Singh, 2001, NUTR CYCL AGROECOSYS, V59, P227, DOI 10.1023/A:1014410203975; Bird JA, 2001, SOIL SCI SOC AM J, V65, P1143, DOI 10.2136/sssaj2001.6541143x; Burgess MS, 2002, SOIL SCI SOC AM J, V66, P1350, DOI 10.2136/sssaj2002.1350; Cao YS, 2015, AGR ECOSYST ENVIRON, V202, P1, DOI 10.1016/j.agee.2015.01.001; Chen Y, 2010, PEDOSPHERE, V20, P198, DOI 10.1016/S1002-0160(10)60007-0; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; da Silva EC, 2016, PESQUI AGROPECU BRAS, V51, P728, DOI 10.1590/S0100-204X2016000600004; Dambreville C, 2008, AGR ECOSYST ENVIRON, V123, P201, DOI 10.1016/j.agee.2007.06.001; Ding XL, 2011, SOIL BIOL BIOCHEM, V43, P1968, DOI 10.1016/j.soilbio.2011.06.012; Dourado Neto D, 2010, SOIL SCI SOC AM J, V74, P139, DOI 10.2136/sssaj2009.0192; Gao N, 2017, SCI HORTIC-AMSTERDAM, V215, P117, DOI 10.1016/j.scienta.2016.12.011; Ghoneim A. M., 2008, World Applied Sciences Journal, V3, P869; Goloran JB, 2015, EUR J SOIL SCI, V66, P942, DOI 10.1111/ejss.12274; Goloran JB, 2015, ECOL ENG, V74, P68, DOI 10.1016/j.ecoleng.2014.09.118; Guggenberger G, 1999, SOIL SCI SOC AM J, V63, P1188, DOI 10.2136/sssaj1999.6351188x; Hillin CK, 2003, B ENVIRON CONTAM TOX, V70, P674, DOI 10.1007/s00128-003-0037-x; Hu GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133437; Huang S, 2013, FIELD CROP RES, V154, P188, DOI 10.1016/j.fcr.2013.08.013; Ismaili K, 2015, EUR J AGRON, V64, P1, DOI 10.1016/j.eja.2014.12.005; Jing Q, 2007, EUR J AGRON, V26, P166, DOI 10.1016/j.eja.2006.09.005; Ju XT, 2017, J INTEGR AGR, V16, P2848, DOI [10.1016/s2095-3119(17)61743-x, 10.1016/S2095-3119(17)61743-X]; Kampradit W, 2009, FIELD CROP RES, V110, P130, DOI 10.1016/j.fcr.2008.07.011; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Karaman MR, 2013, ISOT ENVIRON HEALT S, V49, P243, DOI 10.1080/10256016.2013.759954; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P1, DOI 10.1016/j.soilbio.2009.08.020; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Li ShuTian, 2016, Better Crops with Plant Food, V100, P4; Li XX, 2007, AGR WATER MANAGE, V89, P137, DOI 10.1016/j.agwat.2006.12.012; Lu CY, 2008, COMMUN SOIL SCI PLAN, V39, P707, DOI 10.1080/00103620701879307; Lu CY, 2010, J SOIL SCI PLANT NUT, V10, P443, DOI 10.4067/S0718-95162010000200005; Luo LG, 2004, COMPOST SCI UTIL, V12, P18; Mubarak AR, 2003, COMMUN SOIL SCI PLAN, V34, P2375, DOI 10.1081/CSS-120024774; Murphy RP, 2016, APPL SOIL ECOL, V103, P110, DOI 10.1016/j.apsoil.2016.03.014; Ngoran K, 1998, BIOL FERT SOILS, V28, P95, DOI 10.1007/s003740050468; Olsen SR, 1982, AGRON MONGR PART 2, V9; PALM CA, 1991, SOIL BIOL BIOCHEM, V23, P83, DOI 10.1016/0038-0717(91)90166-H; Qiu SJ, 2012, BIOL FERT SOILS, V48, P161, DOI 10.1007/s00374-011-0613-x; SCHOMBERG HH, 1994, SOIL SCI SOC AM J, V58, P372, DOI 10.2136/sssaj1994.03615995005800020019x; Scopel E, 2013, AGRON SUSTAIN DEV, V33, P113, DOI 10.1007/s13593-012-0106-9; [单鹤翔 Shan Hexiang], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P35; Shindo H, 2005, SOIL BIOL BIOCHEM, V37, P425, DOI 10.1016/j.soilbio.2004.07.027; [宋大利 Song Dali], 2018, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V24, P1; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TOOR GS, 1991, BIORESOURCE TECHNOL, V37, P189, DOI 10.1016/0960-8524(91)90210-B; Ueno H, 2001, SOIL SCI PLANT NUTR, V47, P747, DOI 10.1080/00380768.2001.10408439; Vanlauwe B, 1996, PLANT SOIL, V183, P221, DOI 10.1007/BF00011437; Verhulst N, 2010, ADV SOIL SCI-SER, P137; Wang XB, 2015, APPL SOIL ECOL, V96, P265, DOI 10.1016/j.apsoil.2015.08.018; Williams PH, 2000, NUTR CYCL AGROECOSYS, V56, P117, DOI 10.1023/A:1009803008544; Yan D-Z, 2012, CHINESE J SOIL SCI, V43, P631; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhang JB, 2012, EUR J SOIL SCI, V63, P75, DOI 10.1111/j.1365-2389.2011.01410.x; Zhang QW, 2012, AGR ECOSYST ENVIRON, V158, P118, DOI 10.1016/j.agee.2012.06.003; [庄振东 Zhuang Zhendong], 2016, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V22, P1232	59	15	16	11	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210176	10.1371/journal.pone.0210176	http://dx.doi.org/10.1371/journal.pone.0210176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620761	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300018
J	Lehman, RR; Archer, KJ				Lehman, Rebecca R.; Archer, Kellie J.			Penalized negative binomial models for modeling an overdispersed count outcome with a high-dimensional predictor space: Application predicting micronuclei frequency	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; SISTER-CHROMATID EXCHANGES; GENE-EXPRESSION DETECTION; COX REGRESSION-ANALYSIS; BREAST-CANCER PATIENTS; CHROMOSOME-ABERRATIONS; SURVIVAL PREDICTION; ORDINAL REGRESSION; NUCLEAR ANOMALIES; PATH ALGORITHM	Chromosomal aberrations, such as micronuclei (MN), have served as biomarkers of genotoxic exposure and cancer risk. Guidelines for the process of scoring MN have been presented by the HUman MicroNucleus (HUMN) project. However, these guidelines were developed for assay performance but do not address how to statistically analyze the data generated by the assay. This has led to the application of various statistical methods that may render different interpretations and conclusions. By combining MN with data from other high-throughput genomic technologies such as gene expression microarray data, we may elucidate molecular features involved in micronucleation. Traditional methods that can model discrete (synonymously, count) data, such as MN frequency, require that the number of explanatory variables (P) is less than the number of samples (N). Due to this limitation, penalized models have been developed to enable model fitting for such over-parameterized datasets. Because penalized models in the discrete response setting are lacking, particularly when the count outcome is over-dispersed, herein we present our penalized negative binomial regression model that can be fit when P > N. Using simulation studies we demonstrate the performance of our method in comparison to commonly used penalized Poisson models when the outcome is over-dispersed and applied it to MN frequency and gene expression data collected as part of the Norwegian Mother and Child Cohort Study. Our countgmifs R package is available for download from the Comprehensive R Archive Network and can be applied to datasets having a discrete outcome that is either Poisson or negative binomial distributed and a high-dimensional covariate space.	[Lehman, Rebecca R.] United Network Organ Sharing, Richmond, VA USA; [Archer, Kellie J.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA	United Network for Organ Sharing; University System of Ohio; Ohio State University	Archer, KJ (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA.	archer.43@osu.edu		Archer, Kellie/0000-0003-1555-5781	National Library of Medicine; National Institutes of Health [R01 LM011169]; National Institute of Environmental Health Sciences [T32 ES007334]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007334] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Research reported in this publication was supported by the National Library of Medicine (https://www.nim.nih.gov) of the National Institutes of Health under Award Number R01 LM011169 & the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov) under Award Number T32 ES007334. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archer KJ, 2012, STAT MED, V31, P1464, DOI 10.1002/sim.4484; Archer KJ, 2014, CANCER INFORM, V13, P187, DOI 10.4137/CIN.S20806; Archer KJ, 2014, NEW FRONTIERS MULTID, P111; Aristei C, 2009, CANCER GENET CYTOGEN, V192, P24, DOI 10.1016/j.cancergencyto.2009.02.019; BANERJEE M, 2013, SCI REP UK, V3; Battershill JM, 2008, MUTAGENESIS, V23, P423, DOI 10.1093/mutage/gen040; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Cardinale F, 2012, BRIT J CANCER, V106, P780, DOI 10.1038/bjc.2011.567; Celik DA, 2013, J BREAST CANCER, V16, P285, DOI 10.4048/jbc.2013.16.3.285; Ceppi M, 2010, MUTAT RES-REV MUTAT, V705, P11, DOI 10.1016/j.mrrev.2009.11.001; Decordier I, 2009, MUTAGENESIS, V24, P85, DOI 10.1093/mutage/gen057; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; El-Zein RA, 2008, CANCER EPIDEM BIOMAR, V17, P1111, DOI 10.1158/1055-9965.EPI-07-2827; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Ferber K, 2015, CANCER INFORM, V14, P37, DOI 10.4137/CIN.S17275; Fischer WH, 2001, MUTAGENESIS, V16, P209, DOI 10.1093/mutage/16.3.209; Flores-Garcia A, 2014, J BUON, V19, P895; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gandhi G, 2005, TOXICOL MECH METHOD, V15, P219, DOI 10.1080/15376520590945649; Gentry AE, 2015, CANCER INFORM, V14, P201, DOI 10.4137/CIN.S17277; Ghandhi SA, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-206; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Groll A, 2014, STAT COMPUT, V24, P137, DOI 10.1007/s11222-012-9359-z; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; Gutierrez S, 1999, EUR J NUCL MED, V26, P1589, DOI 10.1007/s002590050499; Hastie T, 2007, ELECTRON J STAT, V1, P1, DOI 10.1214/07-EJS004; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Hemalatha A, 2014, J CANCER RES THER, V10, P309, DOI 10.4103/0973-1482.136588; Hilbe JM, 2011, NEGATIVE BINOMIAL RE, DOI [10.1186/1748-717X-9-206, DOI 10.1186/1748-717X-9-206]; Hochstenbach K, 2012, CANCER EPIDEM BIOMAR, V21, P1756, DOI 10.1158/1055-9965.EPI-12-0304; Holland N, 2008, MUTAT RES-REV MUTAT, V659, P93, DOI 10.1016/j.mrrev.2008.03.007; Hond E D, 2015, ENV HLTH PERSPECT, V123, P255, DOI DOI 10.1289/EHP; Hou JY, 2015, STAT APPL GENET MOL, V14, P93, DOI 10.1515/sagmb-2014-0004; Karahalil B, 1999, MUTAT RES-GEN TOX EN, V442, P29, DOI 10.1016/S1383-5718(99)00055-8; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kirsch-Volders M, 2011, MUTAGENESIS, V26, P177, DOI 10.1093/mutage/geq068; Lee SJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02783; Li HZ, 2004, BIOINFORMATICS, V20, P208, DOI 10.1093/bioinformatics/bth900; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Makowski M, 2015, CANCER INFORM, V14, P97, DOI 10.4137/CIN.S17278; Mandal BN, 2016, COMPUT STAT DATA AN, V101, P289, DOI 10.1016/j.csda.2016.03.009; Merlo DF, 2007, TOXICOL LETT, V172, P60, DOI 10.1016/j.toxlet.2007.05.016; Minozzo R, 2004, MUTAT RES-GEN TOX EN, V565, P53, DOI 10.1016/j.mrgentox.2004.09.003; Moretti M, 2015, INT ARCH OCC ENV HEA, V88, P683, DOI 10.1007/s00420-014-0993-y; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Payne EH, 2017, STAT METHODS MED RES, V26, P1802, DOI 10.1177/0962280215588569; Pedersen M, 2006, MUTAT RES-GEN TOX EN, V608, P112, DOI 10.1016/j.mrgentox.2006.02.013; Ramirez Andrea, 2002, Genetics and Molecular Research, V1, P246; Cassel APR, 2014, GENET MOL BIOL, V37, P360, DOI [10.1590/S1415-47572014005000010, 10.1590/S1415-47572014000300007]; Sagari SG, 2014, J CLIN DIAGN RES, V8, pZC15, DOI 10.7860/JCDR/2014/9059.5240; Samanta S, 2011, CYTOPATHOLOGY, V22, P111, DOI 10.1111/j.1365-2303.2010.00773.x; Santos RA, 2010, CLIN EXP MED, V10, P87, DOI 10.1007/s10238-009-0079-4; Schelldorfer J, 2014, J COMPUT GRAPH STAT, V23, P460, DOI 10.1080/10618600.2013.773239; Schelldorfer J, 2011, SCAND J STAT, V38, P197, DOI 10.1111/j.1467-9469.2011.00740.x; Schimek MG, 2004, METHOD INFORM MED, V43, P439; Schumacher M, 2007, BIOINFORMATICS, V23, P1768, DOI 10.1093/bioinformatics/btm232; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Surowy H, 2011, MUTAGENESIS, V26, P111, DOI 10.1093/mutage/geq059; Thomas P, 2009, NAT PROTOC, V4, P825, DOI 10.1038/nprot.2009.53; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TOLBERT PE, 1992, MUTAT RES, V271, P69, DOI 10.1016/0165-1161(92)90033-I; Tucker JD, 1996, MUTAT RES-REV GENET, V365, P147, DOI 10.1016/S0165-1110(96)90018-4; Varga D, 2006, MUTAGENESIS, V21, P313, DOI 10.1093/mutage/gel035; Wang W, 2015, J BIOL CHEM, V290, P13372, DOI 10.1074/jbc.M115.643767; WARNER ML, 1994, CANCER EPIDEM BIOMAR, V3, P583; Wu BL, 2006, BIOINFORMATICS, V22, P472, DOI 10.1093/bioinformatics/bti827; Wu BL, 2005, BIOINFORMATICS, V21, P1565, DOI 10.1093/bioinformatics/bti217; Yang HY, 2014, ASIAN PAC J CANCER P, V15, P6955, DOI 10.7314/APJCP.2014.15.16.6955; Zeller J, 2011, MUTAGENESIS, V26, P555, DOI 10.1093/mutage/ger016; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	79	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0209923	10.1371/journal.pone.0209923	http://dx.doi.org/10.1371/journal.pone.0209923			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620740	gold, Green Submitted, Green Published			2022-12-26	WOS:000455161300011
J	Alipour, H; Bai, GH; Zhang, GR; Bihamta, MR; Mohammadi, V; Peyghambari, SA				Alipour, Hadi; Bai, Guihua; Zhang, Guorong; Bihamta, Mohammad Reza; Mohammadi, Valiollah; Peyghambari, Seyed Ali			Imputation accuracy of wheat genotyping-by-sequencing (GBS) data using barley and wheat genome references	PLOS ONE			English	Article							HEXAPLOID WHEAT; MARKER IMPUTATION; POLYPLOID WHEAT; POLYMORPHISM; SELECTION; ASSOCIATION; DIVERSITY; DISCOVERY; LANDRACES; IMPACT	Genotyping-by-sequencing (GBS) provides high SNP coverage and has recently emerged as a popular technology for genetic and breeding applications in bread wheat (Triticum aestivum L.) and many other plant species. Although GBS can discover millions of SNPs, a high rate of missing data is a major concern for many applications. Accurate imputation of those missing data can significantly improve the utility of GBS data. This study compared imputation accuracies among four genome references including three wheat references (Chinese Spring survey sequence, W7984, and IWGSC RefSeq v1.0) and one barley reference genome by comparing imputed data derived from low-depth sequencing to actual data from high-depth sequencing. After imputation, the average number of imputed data points was the highest in the B genome (similar to 48.99%). The D genome had the lowest imputed data points (similar to 15.02%) but the highest imputation accuracy. Among the four reference genomes, IWGSC RefSeq v1.0 reference provided the most imputed data points, but the lowest imputation accuracy for the SNPs with < 10% minor allele frequency (MAF). The W7984 reference, however, provided the highest imputation accuracy for the SNPs with < 10% MAF.	[Alipour, Hadi; Zhang, Guorong] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Alipour, Hadi] Urmia Univ, Dept Plant Breeding & Biotechnol, Fac Agr, Orumiyeh, Iran; [Bai, Guihua] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA; [Bihamta, Mohammad Reza; Mohammadi, Valiollah; Peyghambari, Seyed Ali] Univ Tehran, Dept Agron & Plant Breeding, Fac Agr, Karaj, Iran	Kansas State University; Urmia University; United States Department of Agriculture (USDA); University of Tehran	Zhang, GR (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	gzhang@ksu.edu	Alipour, Hadi/E-3780-2019	Alipour, Hadi/0000-0003-0086-002X; Mohammadi, Valiollah/0000-0001-6487-0740	US Wheat and Barley Scab Initiative; National Research Initiative Competitive from the National Institute of Food and Agriculture, U.S. Department of Agriculture [2017-67007-25939, 2017-67007-25929]	US Wheat and Barley Scab Initiative(United States Department of Agriculture (USDA)); National Research Initiative Competitive from the National Institute of Food and Agriculture, U.S. Department of Agriculture	This project is partly funded by US Wheat and Barley Scab Initiative and the National Research Initiative Competitive Grants 2017-67007-25939 to GB and 2017-67007-25929 to GB from the National Institute of Food and Agriculture, U.S. Department of Agriculture. Funders had no role in the study design, data collection and analysis, decision to publication, or manuscript preparation.	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Alipour H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01293; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Batley J., 2007, Association mapping in plants, P95, DOI 10.1007/978-0-387-36011-9_6; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Berkman PJ, 2013, PLANT BIOTECHNOL J, V11, P564, DOI 10.1111/pbi.12044; Bernardo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143890; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chan AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160733; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Cui F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04028-6; Cupples L.A., 2007, FRAMINGHAM HEART STU; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Druet T, 2014, HEREDITY, V112, P39, DOI 10.1038/hdy.2013.13; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Edae EA, 2015, G3-GENES GENOM GENET, V5, P2547, DOI 10.1534/g3.115.020362; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAO, 2009, FOOD AGR ORG UN HIGH; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; He Sang, 2015, BMC Genomics, V16, P168, DOI 10.1186/s12864-015-1366-y; Huang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102448; Hussain W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16006-z; International Wheat Genome Sequencing C, 2014, SCIENCE, V345, DOI 10.1126/science.1251780; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kono TJY, 2016, MOL BIOL EVOL, V33, P2307, DOI 10.1093/molbev/msw102; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Lai K., 2015, THESIS; Lai KT, 2015, PLANT BIOTECHNOL J, V13, P97, DOI 10.1111/pbi.12240; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lorenc Michal T, 2012, Biology (Basel), V1, P370, DOI 10.3390/biology1020370; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Manickavelu A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0320-5; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Meuwissen TH, 2010, GENETICS; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rimbert H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186329; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P988, DOI 10.1093/molbev/msg113; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sato K, 2009, HEREDITY, V103, P110, DOI 10.1038/hdy.2009.57; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Talbert LE, 1998, GENOME, V41, P402, DOI 10.1139/gen-41-3-402; Thomson M. J., 2014, Plant Breeding and Biotechnology, V2, P195, DOI 10.9787/PBB.2014.2.3.195; Torkamaneh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131533; Turuspekov Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0686-z; Verma S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17512; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y., 2016, SPRINGER SCI REV, V4, P79, DOI [DOI 10.1007/S40362-017-0041-X, 10.1007/s40362-017-0041-x]; Whalen A, 2017, BIORXIV2017227157; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501	68	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0208614	10.1371/journal.pone.0208614	http://dx.doi.org/10.1371/journal.pone.0208614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615624	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900010
J	Piubelli, C; Soleymanpoor, H; Giorli, G; Formenti, F; Buonfrate, D; Bisoffi, Z; Perandin, F				Piubelli, Chiara; Soleymanpoor, Hossein; Giorli, Giovanni; Formenti, Fabio; Buonfrate, Dora; Bisoffi, Zeno; Perandin, Francesca			Blastocystis prevalence and subtypes in autochthonous and immigrant patients in a referral centre for parasitic infections in Italy	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; PCR; IDENTIFICATION; URTICARIA	In this study we characterized the presence and subtype (ST1-ST4) of Blastocystis in patients attended at a referral center for tropical diseases in Northern Italy. We also, evaluated the organism's association with other intestinal parasites. Parasite screening was performed on 756 patients, from different geographical origins (namely, Italians, Africans, South Americans, Asian and non-Italian Europeans) in which Italians represented the largest group. Blastocystis was seen to be the most prevalent parasite in the study. Subtype 3 and 1 were the most frequently found in the Italians and Africans. Our data confirmed previous studies performed in Italy, in which ST3 proved to be the most prevalent subtype, but we highlighted also a high frequency of mixed subtypes, which were probably underestimated in former analyses. Interestingly, the mixed subtypes group was the most prevalent in all the analysed geographical areas. About half of our cases showed other co-infecting parasites and the most frequent was Dientamoeba fragilis. Our study confirms that, in Blastocystis infection, multiple subtypes and co-infecting parasites are very frequently present, in particular Dientamoeba fragilis.	[Piubelli, Chiara; Soleymanpoor, Hossein; Giorli, Giovanni; Formenti, Fabio; Buonfrate, Dora; Bisoffi, Zeno; Perandin, Francesca] IRCCS Sacro Cuore Don Calabria Hosp, Dept Infect & Trop Dis, Negrar, Vr, Italy; [Soleymanpoor, Hossein] Univ Politecn Marche, Inst Infect Dis & Publ Hlth, Ancona, Italy	IRCCS Sacro Cuore Don Calabria; Marche Polytechnic University	Piubelli, C (corresponding author), IRCCS Sacro Cuore Don Calabria Hosp, Dept Infect & Trop Dis, Negrar, Vr, Italy.	chiara.piubelli@sacrocuore.it	Buonfrate, Dora/N-2965-2016; Formenti, Fabio/Y-7446-2018; Piubelli, Chiara/AAM-7183-2021; Piubelli, Chiara/J-7881-2016; Buonfrate, Dora/ABG-7386-2020; Bisoffi, Zeno/B-6438-2013	Buonfrate, Dora/0000-0003-0108-6822; Piubelli, Chiara/0000-0002-5739-3795; Piubelli, Chiara/0000-0002-5739-3795; Buonfrate, Dora/0000-0003-0108-6822; Bisoffi, Zeno/0000-0001-9530-8742; Formenti, Fabio/0000-0003-3203-0872				Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Bart A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-389; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; Ramirez JD, 2016, INFECT GENET EVOL, V41, P32, DOI 10.1016/j.meegid.2016.03.017; Formenti F, 2015, Bull Soc Pathol Exot, V108, P171, DOI 10.1007/s13149-015-0434-5; Forsell J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1637-8; Kaneda Yoshimasa, 2000, Tokai Journal of Experimental and Clinical Medicine, V25, P51; Kolkhir P, 2016, ALLERGY, V71, P308, DOI 10.1111/all.12818; Lee IL, 2012, PARASITOL RES, V110, P1553, DOI 10.1007/s00436-011-2665-0; Lepczynska M, 2016, INT J DERMATOL, V55, P259, DOI 10.1111/ijd.13064; Li LH, 2007, PARASITOL INT, V56, P281, DOI 10.1016/j.parint.2007.06.001; Mattiucci S, 2016, EPIDEMIOL INFECT, V144, P635, DOI 10.1017/S0950268815001697; Meloni D, 2011, PARASITOL RES, V109, P613, DOI 10.1007/s00436-011-2294-7; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Roberts T, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-17; Scanlan PD, 2015, APPL ENVIRON MICROB, V81, P4071, DOI 10.1128/AEM.00520-15; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Sekar U, 2015, JMR, V1, P33; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2016, PARASITOL INT, V65, P763, DOI 10.1016/j.parint.2016.05.015; Stensvold CR, 2013, J CLIN MICROBIOL, V51, P190, DOI 10.1128/JCM.02541-12; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Verweij JJ, 2007, MOL CELL PROBE, V21, P400, DOI 10.1016/j.mcp.2007.05.006	24	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210171	10.1371/journal.pone.0210171	http://dx.doi.org/10.1371/journal.pone.0210171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615638	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900048
J	Wang, LN; Yu, T; Li, W; Li, MM; Zuo, QF; Zou, QM; Xiao, B				Wang, Lina; Yu, Ting; Li, Wei; Li, Mengmeng; Zuo, Qianfei; Zou, Quanming; Xiao, Bin			The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3	ONCOGENE			English	Article							PRL-3 PROMOTES; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; SPLICING FACTOR; UP-REGULATION; METASTASIS; KIAA1199; PROTEIN; EXPRESSION; INVASION	Gastric cancer (GC) is the second leading cause of death among patients with cancer in China. The primary reason of GC treatment failure is metastasis. Therefore, identifying metastatic biomarkers and clarifying the regulatory mechanisms involved in the GC metastatic process are important. Here, we found that KIAA1199, a cell migration-inducing protein, was significantly overexpressed in GC and correlated with lymph node metastasis and poorer patient survival. Additionally, the introduction of KIAA1199 dramatically promoted GC cell proliferation and migration in vitro and in vivo, and the inhibition of KIAA1199 suppressed GC cell growth and migration and induced GC cell apoptosis. Cell migration is a functional consequence of the epithelial-mesenchymal transition (EMT). In this study, we found that KIAA1199 inhibition or overexpression regulated the expression of E-cadherin and N-cadherin through KIAA1199 binding to WW domain binding protein 11 (WBP11) and protein tyrosine phosphatase type IVA, member 3 (PTP4A3) and through the subsequent activation of the FGFR4/Wnt/beta-catenin and EGFR signaling pathways. More importantly, ectopic expression of WBP11 or PTP4A3 blocked the stimulatory effects of KIAA1199 on GC cell proliferation and migration. Meanwhile, we illustrated that KIAA1199 was a target gene of miR-29c-3p and that miR-29c-3p overexpression led to decreased migration of GC cells in vitro and in vivo by suppressing the expression of KIAA1199 and several key proteins in the Wnt/beta-catenin and EGFR signaling pathways (e.g., WBP11, FGFR4, and PTP4A3). Taken together, these data demonstrate that KIAA1199 promotes GC metastasis by activating EMT-related signaling pathways and that miR-29c-3p regulates GC cell migration in vitro and in vivo by regulating KIAA1199 expression and activating the FGFR4/Wnt/beta-catenin and EGFR signaling pathways. These findings provide a new understanding of GC development and progression and may provide novel therapeutic strategies for GC.	[Wang, Lina; Yu, Ting; Li, Mengmeng; Zuo, Qianfei; Zou, Quanming; Xiao, Bin] Third Mil Med Univ, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Coll Pharm, Chongqing 400038, Peoples R China; [Li, Wei] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Zuo, QF; Zou, QM; Xiao, B (corresponding author), Third Mil Med Univ, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Coll Pharm, Chongqing 400038, Peoples R China.	zqfzqma@163.com; qmzoutmmu@yeah.net; binxiaotmmu@163.com			Chongqing Youth Science and Technology Talent Training Project [cstc2014kjrc-qnrc10008]; National Science Foundation of China (NSFC) [81872392]	Chongqing Youth Science and Technology Talent Training Project; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Chongqing Youth Science and Technology Talent Training Project (cstc2014kjrc-qnrc10008) and National Science Foundation of China (NSFC) (81872392).	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng XB, 2016, ONCOTARGET, V7, P4829, DOI 10.18632/oncotarget.6617; Da N, 2009, WORLD J GASTROENTERO, V15, P1499, DOI 10.3748/wjg.15.1499; Diepenbruck M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01197-w; Dong Q, 2016, J ORAL PATHOL MED, V45, P111, DOI 10.1111/jop.12331; Evensen NA, 2015, ONCOTARGET, V6, P20723, DOI 10.18632/oncotarget.3978; Evensen NA, 2013, JNCI-J NATL CANCER I, V105, P1402, DOI 10.1093/jnci/djt224; Guo K, 2004, CANCER BIOL THER, V3, P945, DOI 10.4161/cbt.3.10.1111; Han TS, 2015, GUT, V64, P203, DOI 10.1136/gutjnl-2013-306640; He X, 2005, CELL, V120, P156, DOI 10.1016/j.cell.2005.01.006; Iwasaki Y, 2014, DEVELOPMENT, V141, P3740, DOI 10.1242/dev.106658; Jia SQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175058; Ju JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00988-5; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kohi S, 2017, ONCOTARGET, V8, P17156, DOI 10.18632/oncotarget.15052; Li BS, 2015, ONCOGENE, V34, P2556, DOI 10.1038/onc.2014.214; Li L, 2017, J CANCER, V8, P2238, DOI 10.7150/jca.19295; Liu R, 2013, CANCER RES, V73, P5926, DOI 10.1158/0008-5472.CAN-12-4718; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Mitra R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01781-0; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Natsuizaka M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01500-9; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Rizzolio S, 2018, CANCER RES, V78, P1058, DOI 10.1158/0008-5472.CAN-17-2020; Ruedel A, 2015, INT J CLIN EXP PATHO, V8, P4953; Shostak K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6232; Thrumurthy SG, 2015, NAT REV CLIN ONCOL, V12, P676, DOI 10.1038/nrclinonc.2015.132; Tiwari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069473; Wang YX, 2015, CANCER RES, V75, P1332, DOI 10.1158/0008-5472.CAN-14-0787; Wrighton KH, 2015, NAT REV MOL CELL BIO, V16, P518, DOI 10.1038/nrm4045; Xiong JB, 2016, ONCOL REP, V36, P1819, DOI 10.3892/or.2016.5030; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Ye GD, 2016, GASTROENTEROLOGY, V150, P659, DOI 10.1053/j.gastro.2015.11.041; Ye YW, 2011, CANCER-AM CANCER SOC, V117, P5304, DOI 10.1002/cncr.26207; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Yu BQ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3096-9; Yu T, 2018, CANCER SCI, V109, P1393, DOI 10.1111/cas.13583; Zaravinos A., 2015, J ONCOL, V2015, DOI DOI 10.1155/2015/865816; Zhang DJ, 2017, INT J CANCER, V140, P2298, DOI 10.1002/ijc.30656; Zhang YS, 2014, ONCOL REP, V31, P1503, DOI 10.3892/or.2014.3038; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.573	52	45	46	5	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3134	3150		10.1038/s41388-018-0642-0	http://dx.doi.org/10.1038/s41388-018-0642-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30626935				2022-12-26	WOS:000465557200003
J	Jing, Y; Zhang, Y; Zhu, H; Zhang, K; Cai, MC; Ma, PF; Shen, PY; Zhang, ZF; Shao, MH; Wang, J; Yu, MH; Yin, X; Zhang, MY; Hu, Y; Chen, DN; Di, W; Wang, XJ; Zhuang, GL				Jing, Ying; Zhang, Yi; Zhu, Hui; Zhang, Ke; Cai, Mei-Chun; Ma, Pengfei; Shen, Peiye; Zhang, Zhenfeng; Shao, Minghui; Wang, Jing; Yu, Minhua; Yin, Xia; Zhang, Meiying; Hu, Yuan; Chen, Danni; Di, Wen; Wang, Xiaojie; Zhuang, Guanglei			Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer	ONCOGENE			English	Article							UPDATED RESOURCE; ALIGNMENT; QUANTIFICATION; HETEROGENEITY; CARBOPLATIN; MECHANISMS; BORTEZOMIB; LANDSCAPE; CARCINOMA; ONCOLOGY	Comprehensive molecular characterization of myriad somatic alterations and aberrant gene expressions at personal level is key to precision cancer therapy, yet limited by current short-read sequencing technology, individualized catalog of complete genomic and transcriptomic features is thus far elusive. Here, we integrated second- and third-generation sequencing platforms to generate a multidimensional dataset on a patient affected by metastatic epithelial ovarian cancer. Whole-genome and hybrid transcriptome dissection captured global genetic and transcriptional variants at previously unparalleled resolution. Particularly, single-molecule mRNA sequencing identified a vast array of unannotated transcripts, novel long noncoding RNAs and gene chimeras, permitting accurate determination of transcription start, splice, polyadenylation and fusion sites. Phylogenetic and enrichment inference of isoform-level measurements implicated early functional divergence and cytosolic proteostatic stress in shaping ovarian tumorigenesis. A complementary imaging-based high-throughput drug screen was performed and subsequently validated, which consistently pinpointed proteasome inhibitors as an effective therapeutic regime by inducing protein aggregates in ovarian cancer cells. Therefore, our study suggests that clinical application of the emerging long-read full-length analysis for improving molecular diagnostics is feasible and informative. An in-depth understanding of the tumor transcriptome complexity allowed by leveraging the hybrid sequencing approach lays the basis to reveal novel and valid therapeutic vulnerabilities in advanced ovarian malignancies.	[Jing, Ying; Zhang, Yi; Ma, Pengfei; Shen, Peiye; Yu, Minhua; Yin, Xia; Zhang, Meiying; Hu, Yuan; Di, Wen; Zhuang, Guanglei] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Dept Obstet & Gynecol, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China; [Jing, Ying; Zhang, Yi; Yu, Minhua; Yin, Xia; Zhang, Meiying; Hu, Yuan; Di, Wen; Zhuang, Guanglei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Zhu, Hui] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Anesthesiol, Shanghai, Peoples R China; [Zhang, Ke] Rizhao Peoples Hosp, Dept Oncol, Rizhao, Shandong, Peoples R China; [Cai, Mei-Chun; Zhang, Zhenfeng] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China; [Shao, Minghui; Wang, Jing] Novogene Bioinformat Technol Co Ltd, Beijing, Peoples R China; [Chen, Danni; Wang, Xiaojie] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhuang, GL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Dept Obstet & Gynecol, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China.; Zhuang, GL (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China.; Wang, XJ (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China.	wangxiaojie2008@hotmail.com; zhuangguanglei@gmail.com	Zhang, Yi/ABE-2574-2020	Zhuang, Guanglei/0000-0001-8141-5096	National Natural Science Foundation of China [81472537, 81672714, 81502597, 81472426]; State Key Laboratory of Oncogenes and Related Genes [SB17-06]; Shanghai Jiao Tong University School of Medicine [DLY201505, YG2016MS51]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20161313]; Shanghai Institutions of Higher Learning (Eastern Scholar); Shanghai Rising-Star Program [16QA1403600]; Shanghai Municipal Commission of Health and Family Planning [2013ZYJB0202, 15GWZK0701, 20174Y0189, 20174Y0043]; Shanghai Key Laboratory of Gynecologic Oncology [FKZL-2017-01]; Science and Technology Commission of Shanghai Municipality [16140904401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncogenes and Related Genes; Shanghai Jiao Tong University School of Medicine; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Shanghai Institutions of Higher Learning (Eastern Scholar); Shanghai Rising-Star Program; Shanghai Municipal Commission of Health and Family Planning; Shanghai Key Laboratory of Gynecologic Oncology; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (81472537 and 81672714 to GZ; 81502597 to YJ; 81472426 to WD), the Grants from the State Key Laboratory of Oncogenes and Related Genes (SB17-06 to M-CC), the grants from Shanghai Jiao Tong University School of Medicine (DLY201505 to WD; YG2016MS51 to XY), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20161313 to GZ), the Shanghai Institutions of Higher Learning (Eastern Scholar to GZ), Shanghai Rising-Star Program (16QA1403600 to GZ), Shanghai Municipal Commission of Health and Family Planning (2013ZYJB0202 and 15GWZK0701 to WD; 20174Y0189 to YJ; 20174Y0043 to M-CC), the grant from Shanghai Key Laboratory of Gynecologic Oncology (FKZL-2017-01 to YJ), and the grant from Science and Technology Commission of Shanghai Municipality (16140904401 to XY).	Abdel-Ghany SE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11706; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chatterjee S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091978; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Choi YJ, 2017, J PATHOL, V241, P57, DOI 10.1002/path.4819; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cieslik M, 2018, NAT REV GENET, V19, P93, DOI 10.1038/nrg.2017.96; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cui TY, 2018, NUCLEIC ACIDS RES, V46, pD371, DOI 10.1093/nar/gkx1025; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Faoro R, 2018, P NATL ACAD SCI USA, V115, P1204, DOI 10.1073/pnas.1717282115; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fulda S, 2012, EMBO MOL MED, V4, P545, DOI 10.1002/emmm.201100707; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Hoogstraat M, 2014, GENOME RES, V24, P200, DOI 10.1101/gr.161026.113; Jandial DA, 2017, GYNECOL ONCOL, V145, P236, DOI 10.1016/j.ygyno.2017.03.013; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kuang Z, 2017, GENOME RES, V27, P145, DOI 10.1101/gr.208041.116; Kumar SK, 2017, J NATL COMPR CANC NE, V15, P709, DOI 10.6004/jnccn.2017.0080; Kumar-Sinha C, 2018, NAT BIOTECHNOL, V36, P46, DOI 10.1038/nbt.4017; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2016, DEV CELL, V39, P508, DOI 10.1016/j.devcel.2016.10.012; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1007/s12079-011-0121-7, 10.1038/nrclinonc.2016.206]; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Mills Kathryn, 2017, F1000Res, V6, P84, DOI 10.12688/f1000research.9977.1; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Ramirez PT, 2008, GYNECOL ONCOL, V108, P68, DOI 10.1016/j.ygyno.2007.08.071; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Schram AM, 2017, NAT REV CLIN ONCOL, V14, P735, DOI 10.1038/nrclinonc.2017.127; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Trincado JL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1417-1; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Vilasi S, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00099; Wang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11708; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YK, 2017, NAT GENET, V49, P856, DOI 10.1038/ng.3849; Weirather JL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv562; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yi Y, 2017, NUCLEIC ACIDS RES, V45, pD115, DOI 10.1093/nar/gkw1052; Yin X, 2017, CANCER RES, V77, P6551, DOI 10.1158/0008-5472.CAN-17-1461; Zhang T, 2017, NUCLEIC ACIDS RES, V45, pD135, DOI 10.1093/nar/gkw728; Zhang ZF, 2017, MOL CANCER THER, V16, P1739, DOI 10.1158/1535-7163.MCT-17-0078; Zhang ZF, 2016, THERANOSTICS, V6, P219, DOI 10.7150/thno.13178	83	2	3	5	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2019	38	16					3047	3060		10.1038/s41388-018-0644-y	http://dx.doi.org/10.1038/s41388-018-0644-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU3IV	30617306				2022-12-26	WOS:000465167600013
J	Goes, ESD; Goes, MD; de Castro, PL; de Lara, JAF; Vital, ACP; Ribeiro, RP				dos Reis Goes, Elenice Souza; Goes, Marcio Douglas; de Castro, Pedro Luiz; Ferreira de lara, Jorge Antonio; Pelaes Vital, Ana Carolina; Ribeiro, Ricardo Pereira			Imbalance of the redox system and quality of tilapia fillets subjected to pre-slaughter stress	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MEAT TENDERNESS; FLESH QUALITY; IN-VITRO; MUSCLE; EXPRESSION; OXIDATION; TRANSPORTATION; INDICATORS; CONSUMERS	The objective of this study was to evaluate the effect of oxidative stress on the instrumental and sensory quality of Nile tilapia fillets. The experiment was conducted in a 2x2 factorial arrangement, evaluating densities (60 and 300 kg m(-3)) and depuration times (1 and 24 hours) in a total of four treatments. The serum levels of cortisol and gene expression levels of catalase (CAT), glutathione peroxidase (GPx) and 70 kDa heat shock protein (HSP70) as well as the pH, color, tenderness, water-holding capacity and sensory analysis of the fillets were evaluated. High density (300 kg m(-3)) resulted in higher mean cortisol levels, lower expression of CAT and GPx enzymes as well as higher expression of HSP70. Fish under this treatment also exhibited fillets with greater tenderness, higher lightness, lower redness and lower sensory acceptance. The longer depuration time (24 hours) resulted in lower expression of the CAT and GPx enzymes and fillets with higher lightness. The water-holding capacity was not affected by the different treatments. Therefore, low density and longer depuration times are recommended for decreased stress and improved quality of fillets.	[dos Reis Goes, Elenice Souza] Fed Univ Grande Dourados, Sch Agr Sci, Dourados, MG, Brazil; [Goes, Marcio Douglas] State Univ Western Parana, Anim Sci Postgrad Program, Marechal Candido Rodondo, Parana, Brazil; [de Castro, Pedro Luiz] Univ Estadual Maringa, Anim Sci Postgrad Program, Maringa, Parana, Brazil; [Ferreira de lara, Jorge Antonio] EMBRAPA Pantanal, Brazilian Agr Res Corp, Corumba, MG, Brazil; [Pelaes Vital, Ana Carolina] Univ Estadual Maringa, Food Sci Postgrad Program, Maringa, Parana, Brazil; [Ribeiro, Ricardo Pereira] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Maringa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Maringa; Universidade Estadual de Maringa	Goes, ESD (corresponding author), Fed Univ Grande Dourados, Sch Agr Sci, Dourados, MG, Brazil.	elenicesreis@yahoo.com.br	Vital, Ana Carolina/AAE-1715-2022; Souza dos Reis Goes, Elenice/HHS-6947-2022; de Castro, Pedro Luiz/AAM-2517-2020	Souza dos Reis Goes, Elenice/0000-0003-2437-4800; de Castro, Pedro Luiz/0000-0001-7351-6938; Vital, Ana Carolina/0000-0002-6033-6898	CNPq National Research Council [150657/2015-3]; Federal University of Grande Dourados	CNPq National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Grande Dourados	This work was supported and financed by the CNPq National Research Council (150657/2015-3) and the Federal University of Grande Dourados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Bjarnadottir SG, 2012, J ANIM SCI, V90, P2035, DOI 10.2527/jas.2011-4721; Carvalho ME, 2014, MEAT SCI, V96, P1318, DOI 10.1016/j.meatsci.2013.11.014; Carvalho RH, 2017, FOOD CHEM, V215, P129, DOI 10.1016/j.foodchem.2016.07.182; Chen T, 2010, MEAT SCI, V84, P143, DOI 10.1016/j.meatsci.2009.08.039; Coble DJ, 2011, POULTRY SCI, V90, P1659, DOI 10.3382/ps.2010-01279; Contreras-Guzman E., 1994, BIOQUIMICA PESCADOS; D'Alessandro A, 2013, J PROTEOMICS, V78, P558, DOI 10.1016/j.jprot.2012.10.023; D'Alessandro A, 2012, J PROTEOMICS, V75, P4360, DOI 10.1016/j.jprot.2012.02.013; Daun C, 2004, FOOD CHEM, V85, P295, DOI 10.1016/j.foodchem.2003.07.009; Delles RM, 2014, POULTRY SCI, V93, P1561, DOI 10.3382/ps.2013-03682; Digre H, 2010, AQUAC RES, V41, P1190, DOI 10.1111/j.1365-2109.2009.02406.x; Goes ESD, 2018, SCI AGR, V75, P321, DOI [10.1590/1678-992X-2016-0387, 10.1590/1678-992x-2016-0387]; Erikson U, 2011, J FOOD SCI, V76, pS251, DOI 10.1111/j.1750-3841.2011.02141.x; Estevez M, 2015, POULTRY SCI, V94, P1368, DOI 10.3382/ps/pev094; Furnols MFI, 2008, MEAT SCI, V80, P1013, DOI 10.1016/j.meatsci.2008.04.018; Guillemin N. P., 2012, International Journal of Biology, V4, P26, DOI 10.5539/ijb.v4n2p26; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; Hultmann L, 2012, FOOD CHEM, V134, P1399, DOI 10.1016/j.foodchem.2012.03.038; Iwama George K., 2006, P319; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kristoffersen S, 2006, INT J FOOD SCI TECH, V41, P861, DOI 10.1111/j.1365-2621.2005.01149.x; Lakshmanan R, 2007, LWT-FOOD SCI TECHNOL, V40, P544, DOI 10.1016/j.lwt.2005.12.003; Lefevre F, 2016, AQUACULTURE, V464, P654, DOI 10.1016/j.aquaculture.2016.07.039; Lomiwes D, 2014, MEAT SCI, V96, P26, DOI 10.1016/j.meatsci.2013.06.008; LOWE TE, 1993, J FOOD SCI, V58, P770, DOI 10.1111/j.1365-2621.1993.tb09355.x; MACFIE HJH, 1990, NUTR REV, V48, P87, DOI [10.1111/j.1745-459X.1989.tb00463.x, 10.1111/j.1753-4887.1990.tb02910.x]; Mercier Y, 2004, MEAT SCI, V66, P467, DOI 10.1016/S0309-1740(03)00135-9; Ouali A, 2006, MEAT SCI, V74, P44, DOI 10.1016/j.meatsci.2006.05.010; Picard B., 2012, Animal Frontiers, V2, P18, DOI 10.2527/af.2012-0058; Poli BM, 2009, ITAL J ANIM SCI, V8, P139; Rahmanifarah K., 2011, J FISH AQUAT SCI, V11, P139, DOI [10.4194/trjfas.20110118, DOI 10.4194/TRJFAS.2011.0118]; Robb DHF, 2000, AQUACULTURE, V182, P261, DOI 10.1016/S0044-8486(99)00273-2; Santos GA, 2010, AQUACULTURE, V299, P73, DOI 10.1016/j.aquaculture.2009.11.018; Sentandreu MA, 2002, TRENDS FOOD SCI TECH, V13, P400, DOI 10.1016/S0924-2244(02)00188-7; Skjervold PO, 2001, AQUACULTURE, V192, P265, DOI 10.1016/S0044-8486(00)00447-6; Stien LH, 2005, AQUAC RES, V36, P1197, DOI 10.1111/j.1365-2109.2005.01339.x; Sveinsdottir K, 2010, J SENS STUD, V25, P280, DOI 10.1111/j.1745-459X.2009.00257.x; Terevinto A, 2010, MEAT SCI, V84, P706, DOI 10.1016/j.meatsci.2009.11.007; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yu JM, 2009, MEAT SCI, V83, P474, DOI 10.1016/j.meatsci.2009.06.028	45	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210742	10.1371/journal.pone.0210742	http://dx.doi.org/10.1371/journal.pone.0210742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645627	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200050
J	Hynninen, Y; Linna, M; Vilkkumaa, E				Hynninen, Yrjana; Linna, Miika; Vilkkumaa, Eeva			Value of genetic testing in the prevention of coronary heart disease events	PLOS ONE			English	Article							COST-EFFECTIVENESS; CARDIOVASCULAR-DISEASE; RISK SCORE; PREDICTION	Background The health economic evidence about the value and optimal targeting of genetic testing in the prevention of coronary heart disease (CHD) events has remained limited and ambiguous. The objective of this study is to optimize the population-level use and targeting of genetic testing alongside traditional risk factors in the prevention of CHD events and, thereby, to assess the cost-benefit of genetic testing. Methods and findings We compare several strategies for using traditional and genetic testing in the prevention of CHD through statin therapy. The targeting of tests to different patient segments within these strategies is optimized by using a decision-analytic model, in which a patient's estimated risk of CHD is updated based on test results using Bayesian methods. We adopt the perspective of healthcare sector. The data for the model is exceptionally wide and combined from national healthcare registers, the Finnish Institute for Molecular Medicine, and published literature. Our results suggest that targeting genetic testing in an optimal way to those patients about which traditional risk factors do not provide sufficiently accurate information results in the highest expected net benefit. In particular, compared to the use of traditional risk factors only, the optimal use of genetic testing would decrease the expected costs of an average patient aged 45 years or more by 2.54(sic) in a 10-year follow-up period while maintaining the level of the expected health outcome. Thus, genetic testing is found to be a part of a cost-beneficial testing strategy alongside traditional risk factors. This conclusion is robust to reasonable changes in model inputs. Conclusions If targeted optimally, the use of genetic testing alongside traditional risk factors is cost-beneficial in the prevention of CHD.	[Hynninen, Yrjana] Aalto Univ, Sch Sci, Dept Math & Syst Anal, Espoo, Finland; [Linna, Miika] Aalto Univ, Inst Healthcare Engn Management & Architecture, Sch Sci, Dept Ind Engn & Management, Espoo, Finland; [Vilkkumaa, Eeva] Aalto Univ, Sch Business, Dept Informat & Serv Management, Helsinki, Finland	Aalto University; Aalto University; Aalto University	Hynninen, Y (corresponding author), Aalto Univ, Sch Sci, Dept Math & Syst Anal, Espoo, Finland.	yrjana.hynninen@gmail.com		Hynninen, Yrjana/0000-0001-9224-7171; Vilkkumaa, Eeva/0000-0002-4217-8697	Aalto University; SalWe Research Program for GET IT DONE (Tekes - the Finnish Funding Agency for Technology and Innovation) [534/14]; Academy of Finland; PVN project of the Strategic Research Council of the Academy of Finland [293446]	Aalto University; SalWe Research Program for GET IT DONE (Tekes - the Finnish Funding Agency for Technology and Innovation); Academy of Finland(Academy of Finland); PVN project of the Strategic Research Council of the Academy of Finland	Financial support for this study was provided in part by a contract with Aalto University (YH, ML, EV), in part by a grant from the SalWe Research Program for GET IT DONE (Tekes - the Finnish Funding Agency for Technology and Innovation grant 534/14; https://www.tekes.fi/) (ML), and in part by a grant from the Academy of Finland's IMPRO project (https://www.stnimpro.fi/) (ML). This research has been partly supported by the PVN project, funding decision 293446 of the Strategic Research Council of the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio E, 2015, ATHEROSCLEROSIS, V239, P240, DOI 10.1016/j.atherosclerosis.2014.12.059; Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Borodulin K, 2013, STATISTICS; BORODULIN K, 2016, KANSALLINEN FINRISKI, V1, P2013; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Casas JP, 2006, ANN HUM GENET, V70, P145, DOI 10.1111/j.1469-1809.2005.00241.x; Drummond MF, 2005, JOHN; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GENERISK R, 2016, AUG, V10; Gold MR, 1996, COST EFFECTIVENESS I; *GOV COMM DEP, GOVERNMENT AGREES GE, P2017; Grosse SD, 2008, GENET MED, V10, P648, DOI 10.1097GIM.0b013e3181837217; Hujanen T, 2008, DD; HUJANEN T, 2008, TERVEYDENHUOLLON YKS, P2006; Hutchins R, 2015, CIRC-CARDIOVASC QUAL, V8, P155, DOI 10.1161/CIRCOUTCOMES.114.001240; Ingles J, 2014, TRENDS CARDIOVAS MED, V24, P217, DOI 10.1016/j.tcm.2014.05.009; INOUYE M, 2018, MJ, V500; Inouye M, 2018, HEALTH CARE PRICE IN; Jarmul J, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004171; KAPIAINEN S, 2016, TERVEYDEN JA HYVINVO, V1, P1; Kattainen E, 2005, INT J TECHNOL ASSESS, V21, P172, DOI 10.1017/S0266462305050233; KATTAINEN E, 2004, A LONGITUDINAL RESEA; Kattainen E, 2005, THL RAPORTTI 68 2012, V2, P172; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kiviniemi V, 2011, EUR J CLIN PHARMACOL, V67, P971, DOI 10.1007/s00228-011-1037-0; Mushlin AI, 2001, LANCET, V358, P1353, DOI 10.1016/S0140-6736(01)06417-0; *NAT I HLTH WELF, 2016, NATIONAL CARDIOVASCU, V3; National Institute for Health and Welfare, FFF; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Palomaki GE, 2010, GENET MED, V12, P772, DOI 10.1097/GIM.0b013e3181f8728d; Peura P, 2008, CURR MED RES OPIN, V24, P1823, DOI 10.1185/03007990802144705; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Ruas J., 2018, DD; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Statistics Finland, 2017, PRESS; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Tikkanen E, 2013, ARTERIOSCL THROM VAS, V33, P2261, DOI 10.1161/ATVBAHA.112.301120; Vartiainen E., 2007, FIN MED J, V48, P4507; WHO, 2013, ORGANIZATION; WHO, 2016, CARDIOVASCULAR DISEA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wordsworth S, 2010, EUR HEART J, V31, P926, DOI 10.1093/eurheartj/ehq067; *WORK SET FINN MED, 2016, CURRENT CARE GUIDELI, V2, P2014	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210010	10.1371/journal.pone.0210010	http://dx.doi.org/10.1371/journal.pone.0210010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645616	Green Published, gold			2022-12-26	WOS:000455810200016
J	Sartor, ITS; Recamonde-Mendoza, M; Ashton-Prolla, P				Sauthier Sartor, Ivaine Tais; Recamonde-Mendoza, Mariana; Ashton-Prolla, Patricia			TULP3: A potential biomarker in colorectal cancer?	PLOS ONE			English	Article							GENE-EXPRESSION; LYMPHATIC INVASION; CARCINOMA; COLON; POLYPS; CELLS; WNT	Colorectal cancer (CRC) is the second most common cancer in women and the third most common cancer in men globally. The identification of differentially expressed genes associated to patient's clinical data may represent a useful approach to find important genes in CRC carcinogenesis. Previously, the TULP3 transcription factor was identified as a possible prognostic biomarker in pancreatic ductal adenocarcinoma. Considering that pancreatic and colorectal tissues have the same embryonic origin, we investigated the profile of TULP3 expression in CRC hypothesizing that it may have a role in its development. We comparatively analysed TULP3 gene expression in CRC and normal adjacent colonic tissue and assessed association of expression profiles with survival and clinicopathological information, using publicly available datasets. TULP3 expression levels were increased in CRC when compared to the adjacent non-tumoral tissue. In addition, higher TULP3 gene expression was associated to lymphatic and vascular invasion in colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ), respectively. In summary, our results point to a possible role of TULP3 as a diagnostic and prognostic biomarker in CRC. Additional studies are necessary to confirm these preliminary findings.	[Sauthier Sartor, Ivaine Tais; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, PPGBM, Porto Alegre, RS, Brazil; [Sauthier Sartor, Ivaine Tais; Ashton-Prolla, Patricia] HCPA, SPE, LMG, Porto Alegre, RS, Brazil; [Recamonde-Mendoza, Mariana] Univ Fed Rio Grande do Sul, INF, Inst Informat, Dept Informat Aplicada, Porto Alegre, RS, Brazil; [Recamonde-Mendoza, Mariana] Hosp Clin Porto Alegre, Serv Pesquisa Expt, Nucleo Bioinformat, Porto Alegre, RS, Brazil; [Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, DEGEN, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Sartor, ITS (corresponding author), Univ Fed Rio Grande do Sul, PPGBM, Porto Alegre, RS, Brazil.; Sartor, ITS (corresponding author), HCPA, SPE, LMG, Porto Alegre, RS, Brazil.	ivaine.sauthier@gmail.com	Sartor, Ivaine/AAR-1856-2021; Ashton-Prolla, Patricia/T-3515-2019; Recamonde Mendoza, Mariana/F-6818-2015; Ashton-Prolla, Patricia/H-2927-2012	Sartor, Ivaine/0000-0002-8775-6622; Recamonde Mendoza, Mariana/0000-0003-2800-1032; 	Fundo de Incentivo a Pesquisa, Hospital de Clinicas de Porto Alegre [FIPE-HCPA 16-0032]; FAPERGS [16/2551-0000520-6]; I. T.S.S scholarship [140045/2015-5, 307826/2017-1]; P.A-P CNPq scholarship [140045/2015-5, 307826/2017-1]	Fundo de Incentivo a Pesquisa, Hospital de Clinicas de Porto Alegre; FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); I. T.S.S scholarship; P.A-P CNPq scholarship	This study was supported in part by grants from Fundo de Incentivo a Pesquisa, Hospital de Clinicas de Porto Alegre (FIPE-HCPA 16-0032), FAPERGS (16/2551-0000520-6), and I. T.S.S. and P.A-P CNPq scholarships (140045/2015-5 and 307826/2017-1).	Alhopuro P, 2012, INT J CANCER, V130, P1558, DOI 10.1002/ijc.26167; Aran D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01027-z; Assumpcao PP, 2016, GASTRIC CANCER, V19, P1024, DOI [10.1007/s10120-015-0539-3, DOI 10.1007/S10120-015-0539-3]; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Cameron DA, 2009, DEV DYNAM, V238, P1140, DOI 10.1002/dvdy.21926; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Costa NR, 2018, LIFE SCI, V199, P188, DOI 10.1016/j.lfs.2018.02.025; COVERLIZZA S, 1989, CANCER-AM CANCER SOC, V64, P1937, DOI 10.1002/1097-0142(19891101)64:9<1937::AID-CNCR2820640929>3.0.CO;2-X; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fausett SR, 2012, WIRES DEV BIOL, V1, P184, DOI 10.1002/wdev.12; Fujii T, 2014, ANTICANCER RES, V34, P3147; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GLOBOCAN, 2018, EST CANC INC MORT PR; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Han T, 2018, BIOMED PHARMACOTHER, V103, P1369, DOI 10.1016/j.biopha.2018.04.190; Harris EI, 2008, AM J SURG PATHOL, V32, P1816, DOI 10.1097/PAS.0b013e3181816083; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Jennings RE, 2015, DEVELOPMENT, V142, P3126, DOI 10.1242/dev.120063; Kim TH, 2016, DEVELOPMENT, V143, P554, DOI 10.1242/dev.124891; Koumarianou A, 2014, ANTICANCER RES, V34, P4949; Li CS, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0158-7; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; MULLER S, 1989, GUT, V30, P1385, DOI 10.1136/gut.30.10.1385; Nakagawa N, 2017, GENE DEV, V31, P1679, DOI 10.1101/gad.302679.117; NIVATVONGS S, 1991, DIS COLON RECTUM, V34, P323, DOI 10.1007/BF02050592; Norman RX, 2009, HUM MOL GENET, V18, P1740, DOI 10.1093/hmg/ddp113; Ouchi K, 1996, CANCER, V78, P2313, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2313::AID-CNCR7>3.0.CO;2-N; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Qian XH, 2016, ONCOTARGET, V7, P55377, DOI 10.18632/oncotarget.10553; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Sanz-Pamplona R, 2011, CLIN CANCER RES, V17, P7303, DOI 10.1158/1078-0432.CCR-11-1570; Sartor ITS, 2014, MOL BIOSYST, V10, P1461, DOI 10.1039/c3mb70590k; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Therneau T, 2013, MODELING SURVIVAL DA; Tsukamoto S, 2011, CLIN CANCER RES, V17, P2444, DOI 10.1158/1078-0432.CCR-10-2884; Umbreit C, 2014, ANTICANCER RES, V34, P7061; Xing YW, 2018, ONCOL REP, V39, P2365, DOI 10.3892/or.2018.6324; Yoshida N, 2015, ANTICANCER RES, V35, P4403	40	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210762	10.1371/journal.pone.0210762	http://dx.doi.org/10.1371/journal.pone.0210762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640939	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000046
J	Ocana, GJ; Sims, EK; Watkins, RA; Ragg, S; Mather, KJ; Oram, RA; Mirmira, RG; DiMeglio, LA; Blum, JS; Evans-Molina, C				Ocana, Gail J.; Sims, Emily K.; Watkins, Renecia A.; Ragg, Susanne; Mather, Kieren J.; Oram, Richard A.; Mirmira, Raghavendra G.; DiMeglio, Linda A.; Blum, Janice S.; Evans-Molina, Carmella			Analysis of serum Hsp90 as a potential biomarker of beta cell autoimmunity in type 1 diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; C-PEPTIDE; PROGRESSION; AUTOANTIBODIES; INFLAMMATION; PREDICTION; ONSET	Heat shock protein 90 (Hsp90) is a protein chaperone that is upregulated and released from pancreatic beta cells under pro-inflammatory conditions. We hypothesized that serum Hsp90 may have utility as a biomarker of type 1 diabetes risk and exhibit elevations before the onset of clinically significant hyperglycemia. To this end, total levels of the alpha cytoplasmic isoform of Hsp90 were assayed in autoantibody-positive progressors to type 1 diabetes using banked serum samples from the TrialNet Pathway to Prevention Cohort that had been collected 12 months prior to diabetes onset, with comparison to age, sex, and BMI-category matched autoantibody-positive nonprogressors and healthy controls. Hsp90 levels were higher in autoantibody-positive progressors and nonprogressors. 18 years of age compared to matched healthy controls. However, Hsp90 levels were not different between progressors and nonprogressors in any age group. Hsp90 was positively correlated with age in control subjects, but this correlation was absent in autoantibody positive individuals. In aggregate these data indicate that elevated Hsp90 levels are present in youth with beta cell autoimmunity, but are not able to distinguish youth or adult type 1 diabetes progressors from nonprogressors in samples collected 12 months prior to diabetes development.	[Ocana, Gail J.; Blum, Janice S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Sims, Emily K.; Mirmira, Raghavendra G.; DiMeglio, Linda A.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Sims, Emily K.; Mirmira, Raghavendra G.; DiMeglio, Linda A.; Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Watkins, Renecia A.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Ragg, Susanne] Univ Florida, Dept Pediat, Coll Med Jacksonville, Jacksonville, FL USA; [Mather, Kieren J.; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Oram, Richard A.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Oram, Richard A.] Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England; [Evans-Molina, Carmella] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington; University of Exeter; University of Exeter; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Evans-Molina, C (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.; Evans-Molina, C (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.; Evans-Molina, C (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.; Evans-Molina, C (corresponding author), Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.	cevansmo@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020; Mather, Kieren/ABE-4117-2020; DiMeglio, Linda A./F-9277-2019	Mirmira, Raghavendra G/0000-0002-5013-6075; DiMeglio, Linda A./0000-0002-8033-6078; Oram, Richard/0000-0003-3581-8980	NIH [R01 DK093954, UC4 DK 104166, K08DK103983, U01DK107014]; VA Merit Award [I01BX001733]; Diabetes Research Center [P30 DK097512]; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085509]; JDRF; JDRF Strategic Research Agreement; Diabetes UK Harry Keen Fellowship [16/0005529]; Type 1 Diabetes TrialNet Study Group;  [U01 DK103180];  [U01 DK103153];  [U01 DK085476];  [U01 DK103266];  [U01 DK106984];  [U01 DK106994];  [U01 DK107013];  [U01 DK107014];  [UC4 DK106993];  [U01 DK103282]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085476, U01DK106984, U01DK061034, U01DK085465, U01DK103153, U01DK061042, U01DK061010, U01DK103266, U01DK085509, K08DK103983, U01DK103180, U01DK085461, P30DK097512, U01DK103282, R01DK060581, U01DK085499, U01DK061058, R01DK093954, U01DK085466, U01DK107014, U01DK107013, U01DK106994] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Diabetes Research Center; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); JDRF(Juvenile Diabetes Research Foundation); JDRF Strategic Research Agreement; Diabetes UK Harry Keen Fellowship(Diabetes UK); Type 1 Diabetes TrialNet Study Group; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants R01 DK093954 (to C.E.M) and UC4 DK 104166 (to C.E.M. and R.G.M.), K08DK103983 (to E.K.S.), and U01DK107014 (to L.A.D.), VA Merit Award I01BX001733 (to C.E.M.), a JDRF Strategic Research Agreement (C.E.M., L.A.D., J.B.), and gifts from the Sigma Beta Sorority (to C.E.M), the Ball Brothers Foundation, the George and Frances Ball Foundation, and the Holiday Management Foundation (to C.E-M. and R.G.M.). RAO is supported by a Diabetes UK Harry Keen Fellowship (16/0005529). This work utilized core services provided by the Diabetes Research Center grant P30 DK097512 (to Indiana University School of Medicine). Our analysis involved material and data provided by the Type 1 Diabetes TrialNet Study Group. The Type 1 Diabetes TrialNet Study Group is a clinical trial network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, through cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK085476, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK106993, and the JDRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge Lynette Guindon for her expert technical assistance. We also wish to thank TrialNet study participants and acknowledge the support of the Type 1 Diabetes TrialNet Study Group.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z; Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Krzywinski M, 2014, NAT METHODS, V11, P467, DOI 10.1038/nmeth.2937; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Mahon JL, 2009, PEDIATR DIABETES, V10, P97, DOI 10.1111/j.1399-5448.2008.00464.x; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Ocana GJ, 2017, IMMUNOLOGY, V151, P198, DOI 10.1111/imm.12723; Qin HY, 2003, J AUTOIMMUN, V20, P237, DOI 10.1016/S0896-8411(03)00035-0; Ripley BJM, 2001, J AUTOIMMUN, V17, P341, DOI 10.1006/jaut.2001.0549; Soleimanpour SA, 2013, TRENDS ENDOCRIN MET, V24, P324, DOI 10.1016/j.tem.2013.03.005; Sosenko JM, 2010, DIABETES, V59, P2386, DOI 10.2337/db10-0534; Sosenko JM, 2010, DIABETES CARE, V33, P620, DOI 10.2337/dc09-1770; Steck AK, 2015, DIABETES CARE, V38, P808, DOI 10.2337/dc14-2426; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tukaj S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070496; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; Watkins RA, 2014, TRANSL RES, V164, P110, DOI 10.1016/j.trsl.2014.02.004	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208456	10.1371/journal.pone.0208456	http://dx.doi.org/10.1371/journal.pone.0208456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629603	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000013
J	Perslev, K; Msemo, OA; Minja, DTR; Moller, SL; Theander, TG; Lusingu, JPA; Bygbjerg, IC; Nielsen, BB; Schmiegelow, C				Perslev, K.; Msemo, O. A.; Minja, D. T. R.; Moller, S. L.; Theander, T. G.; Lusingu, J. P. A.; Bygbjerg, I. C.; Nielsen, B. B.; Schmiegelow, C.			Marked reduction in fertility among African women with urogenital infections: A prospective cohort study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; INFERTILITY CARE; REPRODUCTIVE TECHNOLOGIES; ASSOCIATION; ACCESS; AGE; CONSEQUENCES; PREVALENCE; MANAGEMENT; PREGNANCY	Background There is paucity of data on risk factors for reduced fertility in low-income countries. Objective To investigate factors associated with fertility among women in rural north eastern Tanzania. Subjects and methods A cohort of 1248 non-pregnant women was followed with urine pregnancy testing every third month or more regularly if they reported a missed menstrual period. Pregnancy was confirmed with trans-abdominal ultrasound. Information regarding general health, socioeconomic status and obstetric-gynaecological history was collected. Factors associated with conceiving within 180 days were identified using multivariate logistic regression analyses. Results Among the 1248 women, 736 were followed for 180 days and 209 of these had an ultra-sound confirmed pregnancy. During the follow-up period, 169/736 women were diagnosed with urogenital infections, including suspected sexually transmitted or reproductive tract infections, urinary tract infection, and vaginal candidiasis. Urogenital infections were significantly associated with reduced odds of conceiving within 180 days (adjusted OR (AOR) 00.21, 95% CI 0.11-0.36). Being above 30 years of age was also negatively associated with odds of conceiving (AOR 0.45, 95% CI 0.26-0.77). In contrast, women who recently stopped using hormonal contraceptives (AOR 2.86, 95% CI 1.45-5.70) and women with low socioeconomic status (AOR 1.56, 95% CI 1.04-2.33) were significantly more likely to become pregnant within 180 days. Conclusion Urogenital infection seems to be a major health factor associated with reduced chances of conceiving. Considering the availability of effective treatment options for these diseases, public health authorities should increase awareness of diagnostic tools in settings with limited resources in order to improve fertility.	[Perslev, K.; Theander, T. G.; Lusingu, J. P. A.; Schmiegelow, C.] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Msemo, O. A.; Minja, D. T. R.; Lusingu, J. P. A.] Natl Inst Med Res, Korogwe, Tanga, Tanzania; [Moller, S. L.; Bygbjerg, I. C.] Univ Copenhagen, Dept Publ Hlth, Div Global Hlth, Copenhagen, Denmark; [Nielsen, B. B.] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Perslev, K (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	kperslev@hotmail.com	Lusingu, John P. A./GSJ-3228-2022; Theander, Thor G./F-6714-2015	Lusingu, John P. A./0000-0002-9407-0602; perslev, kathrine/0000-0001-5201-8171; shmiegelow, christentze/0000-0002-9360-9741; Theander, Thor G./0000-0002-3509-7514; ABDUL, OMARI/0000-0002-7728-0149; Bygbjerg, Ib/0000-0001-9100-2754	Danish Council for Strategic Research [1309-00003B]; Lundbeck Foundation [R209-2015-3580]; Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Fonden; NIMR-Tanga Center, Joint Malaria Programme	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Fonden; NIMR-Tanga Center, Joint Malaria Programme	This study received funding from the Danish Council for Strategic Research (http://ufm.dk/en/research-and-innovation/councils-andcommissions/formercouncilsandcommissions/the-danish-council-for-strategicresearch) with grant number 1309-00003B received by ICB. The funders had no role in study design, data collection and analysis or preparation of this manuscript. Christentze Schmiegelow was also funded by the Lundbeck Foundation [R209-2015-3580] and Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Fonden.; Locally this project was made possible by the help and support from the NIMR-Tanga Center, Joint Malaria Programme, and the administration at Korogwe District hospital. We are grateful to all study participants and the project team in Tanzania including all nurses, fieldworkers, drivers, clinicians, laboratory technicians, data entry clerks, administration, and research assistants, for the hard work and unprecedented commitment on this study.	Adegbola O, 2013, NIGERIA AFR HLTH SCI, V13, P1126, DOI DOI 10.4314/AHS.V13I4.37; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arroyo-Johnson C, 2016, GASTROENTEROL CLIN N, V45, P571, DOI 10.1016/j.gtc.2016.07.012; Asemota OA, 2015, SEMIN REPROD MED, V33, P17, DOI 10.1055/s-0034-1395274; Augood C, 1998, HUM REPROD, V13, P1532, DOI 10.1093/humrep/13.6.1532; Ayele DG, 2015, AFR HEALTH SCI, V15, P546, DOI 10.4314/ahs.v15i2.29; Bahamondes L, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-87; Basso O, 1997, HUM REPROD, V12, P1448, DOI 10.1093/humrep/12.7.1448; Best D, 2015, HORM MOL BIOL CLIN I, V24, P5, DOI 10.1515/hmbci-2015-0023; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Borghtb MV WC, 2018, CLIN BIOCH; Bygbjerg I, FOETAL EXPOSURE EPID; CATES W, 1985, LANCET, V2, P596; Crawford NM, 2015, OBSTET GYN CLIN N AM, V42, P15, DOI 10.1016/j.ogc.2014.09.005; Darwish O A, 1979, Egypt Popul Fam Plann Rev, V13, P1; Department of Reproductive Health and Research World Health Organization, 2011, UNS AB GLOB REG EST; Ericksen K, 1996, SOC SCI MED, V42, P209, DOI 10.1016/0277-9536(95)00087-9; Famurewa O, 2013, AFR HEALTH SCI, V13, P441, DOI 10.4314/ahs.v13i2.34; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P570, DOI 10.1097/OLQ.0b013e3181a866b8; Gottlieb SL, 2013, INT J GYNECOL OBSTET, V123, P183, DOI 10.1016/j.ijgo.2013.09.013; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hollos M, 2014, HUM FERTIL, V17, P188, DOI 10.3109/14647273.2014.936052; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Kucera R, 2016, GYNECOL ENDOCRINOL, V32, P383, DOI 10.3109/09513590.2015.1121981; Li YQ, 2014, GYNECOL OBSTET INVES, V77, P19, DOI 10.1159/000355112; Manoni F, 2012, CLIN CHEM LAB MED, V50, P679, DOI [10.1515/cclm.2011.823, 10.1515/CCLM.2011.823]; Mascarenhas MN, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-17; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Mikkelsen EM, 2016, BMJ-BRIT MED J, V354, pi4262; Msuya S E, 2002, East Afr Med J, V79, P16; Nachtigall RD, 2006, FERTIL STERIL, V85, P871, DOI 10.1016/j.fertnstert.2005.08.066; Ombelet W, 2011, FACTS VIEWS VIS OBGY, V3, P257; Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Patry-Parisien J, 2012, HEALTH REP, V23, P53; Polis CB, 2017, HUM REPROD, V32, P1064, DOI 10.1093/humrep/dex025; Rouchou B, 2013, PERSPECT PUBLIC HEAL, V133, P174, DOI 10.1177/1757913912472415; Tann CJ, 2006, SEX TRANSM INFECT, V82, P285, DOI 10.1136/sti.2005.014845; Van Balen F, 2008, HUM REPROD, P25, DOI 10.1093/humrep/den141; Vitale SG, 2015, CURR OPIN OBSTET GYN, V27, P432, DOI 10.1097/GCO.0000000000000220; WHO, POINT CAR DIAGN TEST; World Health Organization, INF DEF TERM; World Health Organization, REPR HLTH; World Health Organization (WHO), 2004, DEM HLTH SURV DHS CO, V9	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210421	10.1371/journal.pone.0210421	http://dx.doi.org/10.1371/journal.pone.0210421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629655	Green Published, gold			2022-12-26	WOS:000455483000086
J	Severnini, E				Severnini, Edson			The unintended impact of ecosystem preservation on greenhouse gas emissions: Evidence from environmental constraints on hydropower development in the United States	PLOS ONE			English	Article							HYDROELECTRIC RESERVOIRS; POWER; IDENTIFICATION; ECONOMICS; RIVER; COST; COAL	Many countries have passed environmental laws aiming at preserving natural ecosystems, such as the Endangered Species Act of 1973 in the United States. Although those regulations seem to have improved preservation, they may have had unintended consequences in energy production. Here we show that while environmental constraints on hydropower may have preserved the wilderness and wildlife by restricting the development of hydroelectric projects, they led to more greenhouse gas emissions. Environmental regulations gave rise to a replacement of hydropower, which is a renewable, relatively low-emitting source of energy, with conventional fossil-fuel power, which is highly polluting. Our estimates indicate that, on average, each megawatt of fossil fuel power-generating capacity added to the grid because of environmental constraints on hydropower development led to an increase in annual carbon dioxide emissions of about 1,400 tons. Environmental regulations focusing only on the preservation of ecosystems appear to have encouraged electric utilities to substitute dirtier fuels for hydropower in electricity generation.	[Severnini, Edson] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Severnini, Edson] IZA, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Severnini, E (corresponding author), Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA.; Severnini, E (corresponding author), IZA, Pittsburgh, PA 15213 USA.	edsons@andrew.cmu.edu		Severnini, Edson/0000-0002-0166-4250				[Anonymous], 2003, 9844 NBER; Atack J., 2016, HIST GEOGRAPHIC INFO; Banzhaf S, 2008, AM ECON REV, V98, P843, DOI 10.1257/aer.98.3.843; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Baum-Snow N, 2007, Q J ECON, V122, P775, DOI 10.1162/qjec.122.2.775; Borenstein S, 2012, J ECON PERSPECT, V26, P67, DOI 10.1257/jep.26.1.67; Brown GM, 1998, J ECON PERSPECT, V12, P3, DOI 10.1257/jep.12.3.3; CALZONETTI FJ, 1980, ENERG POLICY, V8, P138, DOI 10.1016/0301-4215(80)90006-3; Casey JA, 2018, AM J EPIDEMIOL, V187, P1586, DOI 10.1093/aje/kwy110; Casey JA, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0388-8; Cirillo R.R., 1977, EVALUATION REGIONAL; Conner A.M., 1998, US HYDROPOWER RESOUR; Davis LW, 2011, REV ECON STAT, V93, P1391, DOI 10.1162/REST_a_00119; de Faria FAM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124019; Deemer BR, 2016, BIOSCIENCE, V66, P949, DOI 10.1093/biosci/biw117; Demarty M, ENERGY POLICY, V39, P4197; Diamond R, 2016, AM ECON REV, V106, P479, DOI 10.1257/aer.20131706; Edwards BK, 1999, LAND ECON, V75, P267, DOI 10.2307/3147010; Emissions and Generation Resource Integrated Database (eGRID), 2014, EGRID2014; Fairley P, 2017, NATURE, V551, pS150, DOI 10.1038/d41586-017-07511-2; Fearnside PM, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/1/011002; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Fowlie ML, 2009, AM ECON J-ECON POLIC, V1, P72, DOI 10.1257/pol.1.2.72; Giles J, 2006, NATURE, V444, P524, DOI 10.1038/444524a; Greenstone M, 2010, J POLIT ECON, V118, P536, DOI 10.1086/653714; HAMILTON MS, 1979, NAT RESOUR J, V19, P75; Harpman DA, 1999, LAND ECON, V75, P390, DOI 10.2307/3147185; Hu YA, 2013, NAT CLIM CHANGE, V3, P708, DOI 10.1038/NCLIMATE1831; Huppert DD, 1999, CONTEMP ECON POLICY, V17, P476, DOI 10.1111/j.1465-7287.1999.tb00698.x; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; INL, 1998, US HYDR RES ASS; Kosnik L, 2010, LAND ECON, V86, P444, DOI 10.3368/le.86.3.444; Kotchen MJ, 2006, LAND ECON, V82, P384, DOI 10.3368/le.82.3.384; Mas-Colell A., 1995, MICROECONOMIC THEORY; Mendelsohn R, 2009, ANNU REV ENV RESOUR, V34, P325, DOI [10.1146/annurev-environ-011509-135201, 10.1146/annurev.environ.011509-135201]; Michaels G, 2008, REV ECON STAT, V90, P683, DOI 10.1162/rest.90.4.683; Pociask S, 2011, PROGR DENIED STUDY P; Rasanen TA, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa817; Rhodes JD, 2017, ENERG POLICY, V102, P491, DOI 10.1016/j.enpol.2016.12.025; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Severnini E, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.51; Shilling F, 1997, SCIENCE, V276, P1662, DOI 10.1126/science.276.5319.1662; Sovacool BK, 2009, ENERG POLICY, V37, P2241, DOI 10.1016/j.enpol.2009.02.011; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Stokstad E, 2005, SCIENCE, V309, P2150, DOI 10.1126/science.309.5744.2150; Sutton A, 2004, GEOGRAPHY, V89, P111; Tarlock AD, 1972, SOUTH CALIF LAW REV, V45, P502; The Energy Policy Staff, 1968, CONS AFF STEAM POW P; U. S. Department of Energy, 1995, DOEEIS0170 BONN POW; U. S. Department of the Interior, 1995, OP GLEN CAN DAM FIN; U. S. Environmental Protection Agency (EPA), 430R18003 US EPA; Ulibarri N, 2018, J ENVIRON PLANN MAN, V61, P617, DOI 10.1080/09640568.2017.1327845; Union of Concerned Scientists (UCS), ENV IMP WIND POW; Upton J., 2014, SOLAR FARMS THREATEN; Wehrli B, 2011, NAT GEOSCI, V4, P585, DOI 10.1038/ngeo1226; Willis CKR, 2010, ENERG POLICY, V38, P2067, DOI 10.1016/j.enpol.2009.08.034; Yang MZ, 2018, J ENVIRON ECON MANAG, V90, P269, DOI 10.1016/j.jeem.2018.05.005	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210483	10.1371/journal.pone.0210483	http://dx.doi.org/10.1371/journal.pone.0210483			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629678	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000095
J	Xu, CY; Huang, Q; Ge, XH; Li, ZY				Xu, Chuanyuan; Huang, Qian; Ge, Xianhong; Li, Zaiyun			Phenotypic, cytogenetic, and molecular marker analysis of Brassica napus introgressants derived from an intergeneric hybridization with Orychophragmus	PLOS ONE			English	Article							INTERTRIBAL PARTIAL HYBRIDS; CHROMOSOME ELIMINATION; DOSAGE COMPENSATION; HEXAPLOID OAT; C-GENOME; GENE; WHEAT; RAPA; CROSSES; VIOLACEUS	Aneuploids of a single species that have lost or gained different chromosomes are useful for genomic analysis. The polyploid nature of many crops including oilseed rape (Brassica napus) allows these plants to tolerate the loss of individual chromosomes from homologous pairs, thus facilitating the development of aneuploid lines. Here, we selected 39 lines from advanced generations of an intergeneric hybridization between Brassica rapa and Orychophragmus violaceus with accidental pollination by B. napus. The lines showed a wide spectrum of phenotypic variations, with some traits specific to O. violaceus. Most lines had the same chromosome number (2n = 38) as B. napus. However, we also identified B. napus nulli-tetrasomics with 22 A-genome and 16 C-genome chromosomes and lines with the typical B. napus complement of 20 A-genome and 18 C-genome chromosomes, as revealed by FISH analysis using a C-genome specific probe. Other lines had 2n = 37 or 39 chromosomes, with variable numbers of A- or C-genome chromosomes. The formation of quadrivalents by four A-genome chromosomes with similar shapes suggests that they were derived from the same chromosome. The frequent homoeologous pairing between chromosomes of the A and C genomes points to their non-diploidized meiotic behavior. Sequence-related amplified polymorphism (SRAP) analysis revealed substantial genomic changes of the lines compared to B. rapa associated with O. violaceus specific DNA bands, but only a few genes were identified in these bands by DNA sequencing. These novel B. napus aneuploids and introgressants represent unique tools for studies of Brassica genetics and for Brassica breeding projects.	[Xu, Chuanyuan; Huang, Qian; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Xu, Chuanyuan] North China Univ Sci & Technol, Coll Life Sci, Tangshan, Hebei, Peoples R China; [Huang, Qian] CAAS, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crops Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; North China University of Science & Technology; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Ge, XH (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	gexianhong@mail.hzau.edu.cn			National Key Research and Development Program of China [2016YFD0100202]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China to XH (grant no. 2016YFD0100202, http://service.most.gov.cn/2015tztg_all/20160622/1104.html).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAGONCILLO C, 1978, P NATL ACAD SCI USA, V75, P1446, DOI 10.1073/pnas.75.3.1446; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Boyd LA, 2006, PLANT PATHOL, V55, P475, DOI 10.1111/j.1365-3059.2006.01402.x; Chen HF, 2007, PLANT CELL REP, V26, P1791, DOI 10.1007/s00299-007-0392-x; Cheng BF, 2001, GENOME, V44, P738, DOI 10.1139/gen-44-4-738; CHENG BF, 1994, GENOME, V37, P584, DOI 10.1139/g94-083; Cheng DW, 2002, GENOME, V45, P100, DOI 10.1139/g01-135; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du XZ, 2008, PLANT CELL REP, V27, P261, DOI 10.1007/s00299-007-0452-2; FAN ZG, 1985, CAN J GENET CYTOL, V27, P683, DOI 10.1139/g85-102; Faure N, 2002, THEOR APPL GENET, V104, P652, DOI 10.1007/s001220100746; GALILI G, 1986, P NATL ACAD SCI USA, V83, P6524, DOI 10.1073/pnas.83.17.6524; Garg M, 2007, THEOR APPL GENET, V114, P1141, DOI 10.1007/s00122-007-0506-4; Grant G, 2010, LEARNING DISABILITY, P43; Heneen WK, 2012, ANN BOT-LONDON, V109, P1227, DOI 10.1093/aob/mcs052; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; Hua YW, 2006, PLANT BREEDING, V125, P144, DOI 10.1111/j.1439-0523.2006.01200.x; Huettel B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000226; Khush G, 1973, CYTOGENETICS ANEUPLO; Kianian SF, 1997, GENOME, V40, P386, DOI 10.1139/g97-052; Leflon M, 2010, PLANT CELL, V22, P2253, DOI 10.1105/tpc.110.075986; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li Z, 1999, THEOR APPL GENET, V99, P694, DOI 10.1007/s001220051286; Li Z, 1998, THEOR APPL GENET, V96, P251, DOI 10.1007/s001220050734; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Li ZY, 2007, PLANT CELL REP, V26, P701, DOI 10.1007/s00299-006-0290-7; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu M, 2007, GENOME, V50, P985, DOI 10.1139/G07-071; Makarevitch I, 2010, PLANT PHYSIOL, V152, P927, DOI 10.1104/pp.109.150466; Makarevitch I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-7; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Schwarzacher T, 2000, PRACTICAL SITU HYBRI, P35; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; Thorneycroft D, 2003, PLANT BIOTECHNOL J, V1, P259, DOI 10.1046/j.1467-7652.2003.00025.x; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; WILLS AB, 1966, CARYOLOGIA, V19, P103, DOI 10.1080/00087114.1966.10796209; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Xu CY, 2007, J GENET, V86, P249, DOI 10.1007/s12041-007-0032-9; Zhang A, 2010, PLANT PHYSIOL, V175, P828; Zhu B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00377; Zhu B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00763; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	50	3	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210518	10.1371/journal.pone.0210518	http://dx.doi.org/10.1371/journal.pone.0210518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629679	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000099
J	Yang, ZG; Zhou, JY; Wei, BH; Cheng, YX; Zhang, L; Zhen, XM				Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin			Comparative transcriptome analysis reveals osmotic-regulated genes in the gill of Chinese mitten crab (Eriocheir sinensis)	PLOS ONE			English	Article							LONG-TERM EXPOSURE; POSTERIOR GILLS; H+-ATPASE; SALINITY; OSMOREGULATION; DOPAMINE; DECAPODA; NA+,K+-ATPASE; TEMPERATURE; AMERICANUS	Salinity is one of the most important abiotic factors directly affecting the reproduction, molting, growth, immune, physiological and metabolic activities of Chinese mitten crab (Eriocheir sinensis). This species has strong osmoregulatory capacity and can maintain stringent internal homeostasis. However, the mechanisms conferring tolerance to salinity fluctuations are not well understood. To reveal the genes and pathways involved in osmoregulation, adult male crabs (body weight = 110 +/- 5 g) were acclimated for 144 h in freshwater (FW, 0 ppt) or seawater (SW, 25 ppt). Changes in the transcriptome of crab gills were then analysed by RNA-Seq, and 174,903 unigenes were obtained. Comparison of genes between FW-SW-acclimated groups identified 932 genes that were significantly differentially expressed in the gill, comprising 433 and 499 up- and downregulated transcripts. Gene Ontology functional enrichment analysis revealed that important biological processes related to salt stress were significantly enriched, including energy metabolism, ion transport, signal transduction and antioxidant activity. Kyoto Encyclopaedia of Genes and Genomes enrichment analysis mapped the differentially expressed genes to 241 specific metabolic pathways, and pathways related to energy metabolism, oxidative phosphorylation and the tricarboxylic acid (TCA)/citrate cycle were significantly enriched. Salinity stress altered the expression of many enzymes involved in energy metabolism, ion transport, signal transduction and antioxidant pathways, including citrate synthase (CS), Na+/K+-ATPase (NKA), Na+-K+-2Cl cotran-sporter-1 (NKCC1), dopamine receptor D1 (DRD1), synaptic binding protein 1 (STXBP1), Cu2+/Zn2+ superoxide dismutase (SOD1) and glutathione S-transferase (GST). Additionally, the obtained transcriptomic sequencing data provided a useful resource for identification of novel genes, and further physiological analysis of Chinese mitten crab.	[Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China; [Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin] Shanghai Ocean Univ, Minist Agr, CREEFN, Shanghai, Peoples R China; [Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University	Yang, ZG; Cheng, YX (corresponding author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China.; Yang, ZG; Cheng, YX (corresponding author), Shanghai Ocean Univ, Minist Agr, CREEFN, Shanghai, Peoples R China.; Yang, ZG; Cheng, YX (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.	zgyang@shou.edu.cn; chengyongxucrablab6@hotmail.com	Wei, Banghong/AAT-5451-2020		National Natural Science Foundation of China [31472287]; China Agriculture Research System-48	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System-48	National Natural Science Foundation of China [grant number 31472287] and the China Agriculture Research System-48 are all the funding of support received during this study; there is no additional external funding received for this study.	Mejia SA, 2018, EUR J PHARMACOL, V818, P499, DOI 10.1016/j.ejphar.2017.10.048; ANGER K, 1991, MAR ECOL PROG SER, V72, P103, DOI 10.3354/meps072103; BARRA JA, 1983, TISSUE CELL, V15, P583, DOI 10.1016/0040-8166(83)90009-5; Belli NM, 2009, COMP BIOCHEM PHYS A, V152, P431, DOI 10.1016/j.cbpa.2008.11.017; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Castilho PC, 2001, J EXP MAR BIOL ECOL, V256, P215, DOI 10.1016/S0022-0981(00)00315-4; CHARMANTIER G, 1988, BIOL BULL-US, V175, P102, DOI 10.2307/1541897; Chen GH, 2007, NEUROBIOL AGING, V28, P611, DOI 10.1016/j.neurobiolaging.2006.03.001; Chen JC, 1997, COMP BIOCHEM PHYS A, V117, P239, DOI 10.1016/S0300-9629(96)00237-X; Cheng YX, 2008, REV FISH SCI, V16, P377, DOI 10.1080/10641260701681698; Cutler CP, 2002, BBA-BIOMEMBRANES, V1566, P92, DOI 10.1016/S0005-2736(02)00596-5; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; DALLA VIA GJ, 1987, COMP BIOCHEM PHYS A, V88, P299; Dittel AI, 2009, J EXP MAR BIOL ECOL, V374, P79, DOI 10.1016/j.jembe.2009.04.012; Evans David H., 2010, J EXPT ZOOLOGY A, V293, P336, DOI [10.1002/jez.1857, DOI 10.1002/JEZ.1857]; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; GILLES R, 1988, COMP BIOCHEM PHYS A, V90, P201, DOI 10.1016/0300-9629(88)91028-6; Holt MEV, 2006, CELL BIOCHEM BIOPHYS, V45, P1, DOI 10.1385/CBB:45:1:1; Jia XiaoYan, 2012, Journal of Fisheries of China, V36, P91; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kultz D, 2007, J EXP BIOL, V210, P1593, DOI 10.1242/jeb.000141; KUTTY MN, 1971, MAR BIOL, V11, P125; LA H, 2008, J BIOL CHEM, V283, P36441; Leguen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139938; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Liu SS, 2017, FISH SHELLFISH IMMUN, V60, P545, DOI 10.1016/j.fsi.2016.07.033; Liu Y, 2007, AQUACULTURE, V265, P351, DOI 10.1016/j.aquaculture.2007.02.010; Long XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179036; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; Mendonca NN, 2007, COMP BIOCHEM PHYS A, V146, P534, DOI 10.1016/j.cbpa.2006.01.019; Mo JL, 2003, J CRUSTACEAN BIOL, V23, P505; Onken H, 1999, COMP BIOCHEM PHYS A, V123, P377, DOI 10.1016/S1095-6433(99)00078-1; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; PEQUEUX A, 1984, MAR BIOL LETT, V5, P35; Rathmayer M, 2001, J COMP PHYSIOL B, V171, P271, DOI 10.1007/s003600100173; RIESTENPATT S, 1995, COMP BIOCHEM PHYS A, V110, P235, DOI 10.1016/0300-9629(94)00169-T; Roast SD, 2002, MAR ENVIRON RES, V53, P453, DOI 10.1016/S0141-1136(02)00090-9; Rudneva II, 1997, COMP BIOCHEM PHYS C, V118, P255, DOI 10.1016/S0742-8413(97)00111-4; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Schnarrenberger C, 2010, FEBS J, V269, P868, DOI [10.1046/j.0014-2956.2001, DOI 10.1046/J.0014-2956.2001]; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; STRANGE PG, 1991, TRENDS PHARMACOL SCI, V12, P48, DOI 10.1016/0165-6147(91)90494-D; Sui LY, 2009, MAR BIOL, V156, P1573, DOI 10.1007/s00227-009-1193-2; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Wang RF, 2012, CRUSTACEANA, V85, P1431, DOI 10.1163/15685403-00003125; Yang Y, 2001, J BIOL CHEM, V276, P19220, DOI 10.1074/jbc.M100551200; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yip YY, 2014, J BIOL CHEM, V289, P2157, DOI 10.1074/jbc.M113.470682; Zhang DZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203280; Zhang TL, 2001, J FRESHWATER ECOL, V16, P633, DOI 10.1080/02705060.2001.9663855; Zhang XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173238	57	21	22	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210469	10.1371/journal.pone.0210469	http://dx.doi.org/10.1371/journal.pone.0210469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629688	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000094
J	Zhu, LY; Fu, CZ; Liu, H; Zhao, DD; Su, L; Rehman, H; Ji, SC				Zhu, Lingyu; Fu, Chenzhao; Liu, Hao; Zhao, Dandan; Su, Lei; Rehman, Habibur; Ji, Shengchang			A decoupled circuital model methodology for calculating DC currents in AC grids induced by HVDC grounding current	PLOS ONE			English	Article							POWER-SYSTEM; TRANSFORMER; SIMULATION; SOIL	Large currents are injected into the earth from grounding poles of HVDC systems under monopole ground return mode. The currents change the earth surface potential and result in DC currents in AC systems. This paper proposes a computationally efficient decoupled circuital calculation method for assessing the unwanted DC currents in AC grids. Firstly, the earth resistive network is acquired by simulating the DC grounding current distribution using Finite Element Method (FEM). Secondly, the earth resistive network and AC grid are combined to develop a decoupled circuital model of the overall system. The acquired model is used to calculate the DC currents in AC grids by solving a set of linear equations. The proposed method is computationally more efficient as compared to field-circuit coupled methods. In addition, its accuracy is proved by showing a close agreement between our results and field-circuit coupled model as well as the actual measurements. Finally, in Shanghai area power grid the DC currents are calculated using the proposed technique. Based on these calculations, remedial measures for reducing the DC currents in AC grid are suggested. Our research results indicate that DC currents in AC systems can be reduced by operating the two HVDC projects with opposite polarities.	[Zhu, Lingyu; Ji, Shengchang] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China; [Fu, Chenzhao; Zhao, Dandan; Su, Lei] Shanghai Elect Power Co, Elect Power Res Inst, Shanghai, Peoples R China; [Liu, Hao] State Grid Chengdu Power Supply Co, Chengdu, Sichuan, Peoples R China; [Rehman, Habibur] Amer Univ Sharjah, Sharjah, U Arab Emirates	Xi'an Jiaotong University; Shanghai Electric; American University of Sharjah	Zhu, LY (corresponding author), Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China.	zhuly1026@xjtu.edu.cn	Zhu, Lingyu/AAE-6230-2019; Zhu, Lingyu/A-8077-2013; Rehman, Habibur/AAJ-6402-2021	Zhu, Lingyu/0000-0002-0379-4059; Zhu, Lingyu/0000-0002-0379-4059; Rehman, Habibur/0000-0002-8251-654X				Chou CJ, 2012, IEEE T IND APPL, V48, P1639, DOI 10.1109/TIA.2012.2209622; Etemadi AH, 2014, IEEE T POWER SYST, V29, P2753, DOI 10.1109/TPWRS.2014.2309004; Guihua Mei, 2010, Journal of Electromagnetic Analysis and Applications, V2, P418, DOI 10.4236/jemaa.2010.27054; Hao Z, 2009, ELECT POWER AUTOMATI, P610; He J.-H., 2017, NONLINEAR SCI LETT A, V8, P121; He JL, 2012, IEEE T POWER DELIVER, V27, P1835, DOI 10.1109/TPWRD.2012.2205409; KOVARSKY D, 1988, IEEE T POWER DELIVER, V3, P1204, DOI 10.1109/61.193904; LAGACE PJ, 1988, IEEE T POWER DELIVER, V3, P1573, DOI 10.1109/61.193957; Li XP, 2010, IEEE T POWER DELIVER, V25, P2504, DOI 10.1109/TPWRD.2010.2052837; Liu Qu, 2007, Proceedings of the CSEE, V27, P8; Lu Jiming, 2006, High Voltage Engineering, V32, P55; Marti L, 2014, IEEE T POWER DELIVER, V29, P1886, DOI 10.1109/TPWRD.2014.2317851; Marti L, 2013, IEEE T POWER DELIVER, V28, P1280, DOI 10.1109/TPWRD.2012.2219885; Overbye TJ, 2013, IEEE T POWER SYST, V28, P4821, DOI 10.1109/TPWRS.2013.2274624; Pan ZH, 2016, IEEE T POWER DELIVER, V31, P103, DOI 10.1109/TPWRD.2015.2438853; Pan ZH, 2016, IEEE T POWER DELIVER, V31, P165, DOI 10.1109/TPWRD.2015.2445913; Pan Zhuohong, 2011, Automation of Electric Power Systems, V35, P110; Rezaei-Zare A, 2015, IEEE T POWER DELIVER, V30, P316, DOI 10.1109/TPWRD.2014.2347934; Villas JET, 2003, IEEE T POWER DELIVER, V18, P867, DOI 10.1109/TPWRD.2003.809741; Wang Faming, 2012, High Voltage Engineering, V38, P3054, DOI 10.3969/j.issn.1003-6520.2012.11.038; Zeng R, 2011, IEEE T POWER DELIVER, V26, P2785, DOI 10.1109/TPWRD.2011.2161345; Zhang B, 2006, IEEE T MAGN, V42, P703, DOI 10.1109/TMAG.2006.871460; Zhang B, 2008, IEEE T POWER DELIVER, V23, P960, DOI 10.1109/TPWRD.2007.908748; Zhao Wanjun, 2004, HIGH VOLTAGE DIRECT; Zheng K, 2013, IEEE T POWER DELIVER, V28, P442, DOI 10.1109/TPWRD.2012.2226248; Zhu H, 2015, IEEE T POWER SYST, V30, P2081, DOI 10.1109/TPWRS.2014.2357213	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209548	10.1371/journal.pone.0209548	http://dx.doi.org/10.1371/journal.pone.0209548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629629	Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000027
J	Chiu, HC; Hsieh, HM; Wan, CL; Tsai, HL; Wang, JY				Chiu, Herng-Chia; Hsieh, Hui-Min; Wan, Chi-Lin; Tsai, Hsiang-Lin; Wang, Jaw-Yuan			Cost-effectiveness of mini-laparotomy in patients with colorectal cancers: A propensity scoring matching approach	PLOS ONE			English	Article							RECTAL-CANCER; EORTC QLQ-C30; MINILAPAROTOMY APPROACH; ROBOTIC SURGERY; RESECTION; OUTCOMES; COLON; COLECTOMY; RISK	Objective Surgical technique process innovations are expected to generally incur no additional cost but gain better quality. Whether a mini-laparotomy surgery (MLS) in the treatment of colorectal cancer (CRC) is more cost effective than conventional open surgery had not been well examined. The objective of this study was to apply cost-effectiveness approaches to investigate the cost effectiveness of adopting MLS compared with open surgery 1 year following resection in CRC patients. Research design A prospective non-randomized cohort study design Setting An academic medical center Participants A total of 224 patients who received elective MLS and 339 who received conventional surgery; after propensity score matching, 212 pairs were included for analysis. Intervention None Main outcome measures Cost measures were hospital-index cost and outpatient and inpatient costs within 1 year after discharge. Effectiveness measures were life-years (LYs) gained and quality-adjusted life-year (QALYs) gained. Statistical methods We calculated incremental costs and effectiveness by differences in these values between MLS and conventional surgery using adjusted predicted estimates. Results MLS patients had lower rates of blood transfusions, less complication, and shorter post-surgical lengths of stay and more medical cost savings. One-year overall medical costs for MLS patients were TWD 748,269 (USD 24,942) per QALY gained, significant lower than for the comparison group (p-value = 0.045). Conclusion Our findings supported that the less invasive surgical process through MLS not only saved medical costs, but also increased QALYs for surgical treatment in CRC patients.	[Chiu, Herng-Chia] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chiu, Herng-Chia; Wan, Chi-Lin] Changhua Christian Hosp, Res Educ & Epidemiol Ctr, Changhua, Taiwan; [Chiu, Herng-Chia] Tsinghua Univ, Inst Hosp Management, Beijing, Peoples R China; [Chiu, Herng-Chia] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Hsieh, Hui-Min] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Hsieh, Hui-Min] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Hsieh, Hui-Min] Kaohsiung Med Univ Hosp, Dept Community Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Gen Surg Med, Dept Surg, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan	Kaohsiung Medical University; Changhua Christian Hospital; Tsinghua University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wang, JY (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net	Wang, Jaw-Yuan/Q-1275-2019; Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621	Ministry of Science and Technology [MOST107-2321-B-037-003, MOST107-2314-B-037-116, MOST107-2314-B-037-022-MY2, MOST107-2314-B-037-023-MY2]; Ministry of Health and Welfare (Health and welfare surcharge of tobacco products) [MOHW106-TDU-B-212-113006, MOHW107-TDU-B-212-123006, MOHW107-TDU-B-212-114026B]; Kaohsiung Medical University Hospital [KMUH106-6R32, KMUH1066M28, KMUH106-6M29, KMUH106-6M30, KMUH106-6M31, KMUHS10701, KMUHS10710]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH104-023]; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan, R.O. C.; Kaohsiung Medical University [KMU-S105011, KMU-PT10616]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare (Health and welfare surcharge of tobacco products); Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan, R.O. C.; Kaohsiung Medical University	This work was supported by grants through funding from the Ministry of Science and Technology (MOST107-2321-B-037-003, MOST107-2314-B-037-116, MOST107-2314-B-037-022-MY2, MOST107-2314-B-037-023-MY2) and the Ministry of Health and Welfare (MOHW106-TDU-B-212-113006, MOHW107-TDU-B-212-123006, MOHW107-TDU-B-212-114026B funded by Health and welfare surcharge of tobacco products), and the Kaohsiung Medical University Hospital (KMUH106-6R32, KMUH1066M28, KMUH106-6M29, KMUH106-6M30, KMUH106-6M31, KMUHS10701, KMUHS10710), and the Kaohsiung Municipal Ta-Tung Hospital (KMTTH104-023). In addition, this study was supported by the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan, R.O. C.; and Grant by the Kaohsiung Medical University (KMU-S105011, KMU-PT10616).	Akhondi-Meybodi M, 2016, ARAB J GASTROENTEROL, V17, P127, DOI 10.1016/j.ajg.2016.06.001; Arnold DT, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-014-0196-y; Arnold M, 2015, EUR J CANCER, V51, P1164, DOI 10.1016/j.ejca.2013.09.002; Baek SJ, 2012, WORLD J SURG, V36, P2722, DOI 10.1007/s00268-012-1728-4; Chen CF, 2018, J MINIM ACCESS SURG, V14, P321, DOI 10.4103/jmas.JMAS_155_17; Chiu HC, 2017, JOURNAL OF INTERNATI; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Drummond MF, 1987, METHODS FOR THE ECON; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ferretti S, 2015, WORLD J SURG, V39, P2052, DOI 10.1007/s00268-015-3034-4; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Furstenberg S, 1998, DIS COLON RECTUM, V41, P997, DOI 10.1007/BF02237389; Gold MR, 1996, COST EFFECTIVENESS I; Gray NM, 2014, SUPPORT CARE CANCER, V22, P307, DOI 10.1007/s00520-013-1963-8; Hsieh HM, 2015, MED CARE, V53, P106, DOI 10.1097/MLR.0000000000000264; Ishikawa M, 2007, HEPATO-GASTROENTEROL, V54, P1970; Jensen CC, 2012, DIS COLON RECTUM, V55, P1017, DOI 10.1097/DCR.0b013e3182656898; Jordan J, 2014, CLINICOECONOMIC OUTC, V6, P415, DOI 10.2147/CEOR.S66247; Kang J, 2013, ANN SURG, V257, P95, DOI 10.1097/SLA.0b013e3182686bbd; Kim CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000823; Kontodimopoulos N, 2009, VALUE HEALTH, V12, P1151, DOI 10.1111/j.1524-4733.2009.00569.x; Kuo CF, 2012, SCAND J RHEUMATOL, V41, P44, DOI 10.3109/03009742.2011.618145; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Magaji Bello Arkilla, 2015, Asian Pac J Cancer Prev, V16, P8107; May AM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012187; Moon SY, 2016, CANC MED; Nakagoe T, 2001, BRIT J SURG, V88, P831, DOI 10.1046/j.1365-2168.2001.01765.x; Nakagoe T, 2001, EUR J SURG, V167, P705, DOI 10.1080/11024150152619372; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Pandya A, 2015, JAMA-J AM MED ASSOC, V314, P142, DOI 10.1001/jama.2015.6822; Parisi A, 2014, INT J SURG, V12, P1456, DOI 10.1016/j.ijsu.2014.11.012; Rinaldi L, 2017, DIGEST LIVER DIS, V49, P84, DOI 10.1016/j.dld.2016.06.039; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Shih CL, 2013, VALUE HEALTH, V16, P848, DOI 10.1016/j.jval.2013.05.004; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sulu B, 2014, TECH COLOPROCTOL, V18, P835, DOI 10.1007/s10151-014-1147-7; Tam MS, 2016, SURG ENDOSC, V30, P455, DOI 10.1007/s00464-015-4218-6; Tang FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164971; TCRTF, 2013, CANCER INCIDENCE AND; Tsai HL, 2012, HEPATO-GASTROENTEROL, V59, P2132, DOI 10.5754/hge11953; van Roekel Eline H, 2016, Prev Med Rep, V4, P262, DOI 10.1016/j.pmedr.2016.06.022; Wan C, 2008, ANN ONCOL, V19, P2053, DOI 10.1093/annonc/mdn417; Wang XD, 2012, WORLD J GASTROENTERO, V18, P5289, DOI 10.3748/wjg.v18.i37.5289; Weintraub WS, 2009, CIRC-CARDIOVASC QUAL, V2, P55, DOI 10.1161/CIRCOUTCOMES.108.812321; Welfare MoHa, 2016, 2015 STATISTICS OF C; Yu KH, 2013, ARTHRIT CARE RES, V65, P244, DOI 10.1002/acr.21820; Zhou T, 2014, J GASTROINTEST ONCOL, V5, P36, DOI 10.3978/j.issn.2078-6891.2013.052	47	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209970	10.1371/journal.pone.0209970	http://dx.doi.org/10.1371/journal.pone.0209970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625209	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400068
J	Perniciaro, S; Imohl, M; Fitzner, C; van der Linden, M				Perniciaro, Stephanie; Imoehl, Matthias; Fitzner, Christina; van der Linden, Mark			Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; MENINGITIS; RESISTANCE; IMPACT; PCV13	Overview The protective effect of infant pneumococcal conjugate vaccine (PCV) recommendation can be seen in Germany as a whole and in smaller regional groups. Comparisons between population-normalized geographic regions of Germany show different serotype distributions after program implementation, particularly in non-vaccine serotypes. The prior distinct differences in serotype distribution in children between the former East and former West German federal states have vanished. Children under six remain a vulnerable group, but the occurrence of vaccine-type (VT) invasive pneumococcal disease (IPD) in children correctly vaccinated (using a three-dose primary series plus one booster dose) with PCV13 was low (9 out of 374 cases, 2.4%). However, only 18.4% of children in Germany with IPD were correctly vaccinated with PCV13 according to the recommended schedule. Continued surveillance and better schedule adherence are essential to definitively establish the most effective PCV administration schedule. Vaccination effects For all PCV products used in Germany (PCV7, PCV10, and PCV13), vaccination status was the most common statistically significant predictor of infection with a particular serotype: Unvaccinated children old enough to have received at least one dose of vaccine in the PCV7 group had significantly higher odds (OR: 6.84, 95% CI: 2.66-22.06, adjusted for per capita income and residence in the northeastern federal states) of contracting VT IPD. In the PCV10 group, VT IPD had an OR of 4.52 (95% CI: 1.60-15.62, adjusted for year of infection, median household size, and residence in the southern federal states) in unvaccinated children, and in the PCV13 group, unvaccinated children continued to have higher odds (OR: 6.21, 95% CI: 3.45-11.36, adjusted for year of infection, age of child, per capita income, residence in the southern federal states, and percentage of children using public daycare) of getting vaccine-type IPD. Being unvaccinated was the most frequent significant indicator for infection with vaccine-type serotypes for each analysis group, while geographic groupings showed more limited potential to predict serotype of infection in early childhood IPD in Germany.	[Perniciaro, Stephanie; Imoehl, Matthias; van der Linden, Mark] Univ Hosp RWTH Aachen, Dept Med Microbiol, German Natl Reference Ctr Streptococci, Aachen, Germany; [Fitzner, Christina] Univ Hosp RWTH Aachen, Dept Med Stat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Perniciaro, S (corresponding author), Univ Hosp RWTH Aachen, Dept Med Microbiol, German Natl Reference Ctr Streptococci, Aachen, Germany.	sperniciaro@ukaachen.de	Perniciaro, Stephanie R/J-3669-2017; Imöhl, Matthias/P-5014-2014; van der Linden, Mark/B-9305-2009	Perniciaro, Stephanie R/0000-0002-3146-2182; Imöhl, Matthias/0000-0002-8372-0251; van der Linden, Mark/0000-0002-6574-4313	Robert Koch Institute; Pfizer Deutschland GmbH	Robert Koch Institute; Pfizer Deutschland GmbH	The authors would also like to thank the Robert Koch Institute and Pfizer Deutschland GmbH for their financial support of IPD surveillance in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Destatis, the German Federal Statistical Office, for collecting and providing the population data and for use of the GENESIS online database. We would also like to thank the Robert Koch Institute and Pfizer Deutschland GmbH for their financial support of IPD surveillance in Germany.	Alari A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0755-7; Alderson MR, 2016, VACCINE, V34, P2959, DOI 10.1016/j.vaccine.2016.03.107; Amrine-Madsen H, 2008, ANTIMICROB AGENTS CH, V52, P3216, DOI 10.1128/AAC.00358-08; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2017, SUMM WHO POS PAP REC; Azevedo J, 2016, J MED MICROBIOL, V65, P1164, DOI 10.1099/jmm.0.000346; Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Ben-Shimol S, 2016, VACCINE, V34, P4543, DOI 10.1016/j.vaccine.2016.07.038; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Camilli R, 2017, VACCINE, V35, P4587, DOI 10.1016/j.vaccine.2017.07.010; Cho EY, 2016, J KOREAN MED SCI, V31, P1082, DOI 10.3346/jkms.2016.31.7.1082; Cho YC, 2017, PEDIATR INFECT DIS J, V36, pE334, DOI [10.1097/INF.0000000000001664, 10.1097/inf.0000000000001664]; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; Deng XD, 2015, PEDIATR INFECT DIS J, V34, P594, DOI 10.1097/INF.0000000000000697; Gabarrot GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112337; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hawkins P, 2017, INT J MED MICROBIOL, V307, P415, DOI 10.1016/j.ijmm.2017.07.008; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Kawaguchiya M., 2016, New Microbes and New Infections, V9, P66, DOI 10.1016/j.nmni.2015.11.001; LEPOUTRE A, 2008, EURO SURVEILL, V13; Link-Gelles R, 2016, SSM-POPUL HLTH, V2, P587, DOI 10.1016/j.ssmph.2016.08.005; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Robert Koch Institut, 2001, EPIDEMIOLOGISCHES B, V28; Robert Koch Institut, 2015, EPIDEMIOL B, P377; Siedler A, 2005, PEDIATR INFECT DIS J, V24, P1114, DOI 10.1097/01.inf.0000189985.96561.81; Singh J, 2017, VACCINE, V35, P4501, DOI 10.1016/j.vaccine.2017.06.079; Standige Impfkommission (STIKO), 2006, EPIDEMIOL B, P255; Tam PYI, 2017, VACCINE, V35, P1817, DOI 10.1016/j.vaccine.2017.02.045; Tothpal A, 2015, EUR J PEDIATR, V174, P373, DOI 10.1007/s00431-014-2408-1; van der Linden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161257; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weinberger R, 2016, VACCINE, V34, P2062, DOI 10.1016/j.vaccine.2016.02.043; Weiss S, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21057; World Health Organization, 2008, EST HIB PNEUM DEATHS; Yildirim I, 2017, VACCINE, V35, P4002, DOI 10.1016/j.vaccine.2017.05.077; Zhang XY, 2017, VACCINE, V35, P4119, DOI 10.1016/j.vaccine.2017.06.046	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0210278	10.1371/journal.pone.0210278	http://dx.doi.org/10.1371/journal.pone.0210278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625215	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400082
J	Shaffer, JA; Roth, CL; Mushet, DM				Shaffer, Jill A.; Roth, Cali L.; Mushet, David M.			Modeling effects of crop production, energy development and conservation-grassland loss on avian habitat	PLOS ONE			English	Article							LAND-USE CHANGE; GAS DEVELOPMENT; PRAIRIE; BIRDS; SONGBIRDS; DENSITY; POPULATIONS; CONVERSION; LANDSCAPE; PATTERNS	Birds are essential components of most ecosystems and provide many services valued by society. However, many populations have undergone striking declines as their habitats have been lost or degraded by human activities. Terrestrial grasslands are vital habitat for birds in the North American Prairie Pothole Region (PPR), but grassland conversion and fragmentation from agriculture and energy-production activities have destroyed or degraded millions of hectares. Conservation grasslands can provide alternate habitat. In the United States, the Conservation Reserve Program (CRP) is the largest program maintaining conservation grasslands on agricultural lands, but conservation grasslands in the PPR have declined by over 1 million ha since the program's zenith in 2007. We used an ecosystem-services model (InVEST) parameterized for the PPR to quantify grassland-bird habitat remaining in 2014 and to assess the degradation status of the remaining grassland-bird habitat as influenced by crop and energy (i.e., oil, natural gas, and wind) production. We compared our resultant habitat-quality ratings to grassland-bird abundance data from the North American Breeding Bird Survey to confirm that ratings were related to grassland-bird abundance. Of the grassland-bird habitat remaining in 2014, about 19% was degraded by crop production that occurred within 0.1 km of grassland habitats, whereas energy production degraded an additional 16%. We further quantified the changes in availability of grassland-bird habitat under various land-cover scenarios representing incremental losses (10%, 25%, 50%, 75%, and 100%) of CRP grasslands from 2014 levels. Our model identified 1 million ha (9%) of remaining grassland-bird habitat in the PPR that would be lost or degraded if all CRP conservation grasslands were returned to crop production. Grassland regions world-wide face similar challenges in maintaining avian habitat in the face of increasing commodity and energy production to sate the food and energy needs of a growing world population. Identifying ways to model the impacts of the tradeoff between food and energy production and wildlife production is an important step in creating solutions.	[Shaffer, Jill A.; Mushet, David M.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Roth, Cali L.] US Geol Survey, Western Ecol Res Ctr, Dixon Field Stn, Dixon, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Shaffer, JA (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.	jshaffer@usgs.gov			USDA's Natural Resources Conservation Service through their Conservation Effects Assessment Project (CEAP-Wetlands); Farm Service Agency	USDA's Natural Resources Conservation Service through their Conservation Effects Assessment Project (CEAP-Wetlands); Farm Service Agency	Financial support for this effort came from the USDA's Natural Resources Conservation Service through their Conservation Effects Assessment Project (CEAP-Wetlands) and the Farm Service Agency's Economics and Policy Analysis Staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this effort came from the USDA's Natural Resources Conservation Service through their Conservation Effects Assessment Project (CEAP-Wetlands) and the Farm Service Agency's Economics and Policy Analysis Staff. Deb Buhl provided advice in statistical modeling, Neal Niemuth in modeling BBS data, Lawrence Igl in grassland-bird threats, Clint Otto and Max Post van der Burg in theoretical considerations, and Skip Hyberg in CRP information. Eric Lonsdorf and three anonymous reviewers provided critical reviews of an earlier draft of this manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. All data used in support of this manuscript are publicly available through USGS at https://doi.org/10.5066/F72J69RM.	Allen A.W., 2012, 20125066 US GEOL SUR; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Askins Robert A., 1993, Current Ornithology, V11, P1; BEST L B, 1986, Wildlife Society Bulletin, V14, P308; Beyersbergen G. W., 2004, NO PRAIRIE PARKLAND; Bogard HJK, 2014, J WILDLIFE MANAGE, V78, P471, DOI 10.1002/jwmg.684; Brown S, 2001, US SHOREBIRD CONSERV; Bystrak D., 1981, Studies in Avian Biology, P34; Claassen R., 2011, ERR120 USDA EC RES S; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Doherty KE, 2013, WILDLIFE SOC B, V37, P546, DOI 10.1002/wsb.284; Euliss NH, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P471; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Fritzell E.K., 1989, P268; Gage Anne M., 2016, Great Plains Research, V26, P107; Grant TA, 2004, WILDLIFE SOC B, V32, P807, DOI 10.2193/0091-7648(2004)032[0807:TASIIN]2.0.CO;2; Haire SL, 2000, LANDSCAPE URBAN PLAN, V48, P65, DOI 10.1016/S0169-2046(00)00044-X; Haufler J.B., 2005, FISH WILDLIFE BENEFI; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; Higgins KF, 2002, WATERBIRDS, V25, P42; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hohman, 2000, COMPREHENSIVE REV FA; International Energy Agency, 2016, WORLD EN OUTL 2016; Kantrud H. A., 1989, PRAIRIE BASIN WETLAN; Knopf Fritz L., 1994, Studies in Avian Biology, V15, P247; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; Larson D.L., 1998, STATUS TRENDS NATION, V2, P450; Leitch J. A., 1989, Northern prairie wetlands., P3; Ludlow SM, 2015, CONDOR, V117, P64, DOI 10.1650/CONDOR-14-79.1; McLaughlin ME, 2014, J FIELD ORNITHOL, V85, P258, DOI 10.1111/jofo.12066; MEA (Millenium Ecosystem Assessment), 2003, ECOSYSTEMS HUMAN WEL; Morefield PE, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094005; Mushet DM, 2014, BIOL CONSERV, V174, P93, DOI 10.1016/j.biocon.2014.04.001; Nelson E, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P229; Niemuth ND, 2017, CONDOR, V119, P506, DOI 10.1650/CONDOR-17-14.1; Northern Great Plains Floristic Quality Assessment Panel (NGPFQAP), 2001, USGSBRDITR20010001; Otto CRV, 2016, P NATL ACAD SCI USA, V113, P10430, DOI 10.1073/pnas.1603481113; R Core Team, 2021, R LANGUAGE ENV STAT; Rashford BS, 2011, CONSERV BIOL, V25, P276, DOI 10.1111/j.1523-1739.2010.01618.x; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; Riffell S, 2008, ENVIRON MONIT ASSESS, V146, P309, DOI 10.1007/s10661-007-0082-8; Rodgers JA, 2017, J WILDLIFE MANAGE, V81, P406, DOI 10.1002/jwmg.21210; Rosenberg K. V., 2016, PARTNERS FLIGHT LAND; Sauer John R., 2013, North American Fauna, V79, P2, DOI 10.3996/nafa.79.0001; Sekercioglu C. H., 2016, WHY BIRDS MATTER AVI; Shaffer JA, 2016, CONSERV BIOL, V30, P59, DOI 10.1111/cobi.12569; Sharp R., 2014, INVEST 3 1 1 USERS G; Sliwinski MS, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00534-070206; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Swengel AB, 1998, STATUS TRENDS NATION, V2; Tack JD, 2017, J ENVIRON MANAGE, V198, P163, DOI 10.1016/j.jenvman.2017.04.044; Thompson SJ, 2015, BIOL CONSERV, V192, P82, DOI 10.1016/j.biocon.2015.08.040; Uden DR, 2015, GCB BIOENERGY, V7, P717, DOI 10.1111/gcbb.12157; United States Department of Agriculture (USDA), 2016, CRP CONTR SUMM STAT; United States Department of Energy (USDOE), 2016, DOEGO102164885; United States Energy Information Administration (USEIA), 2015, US CRUD OIL PROD 202; US Fish and Wildlife Service (USFWS), 2008, BIRDS CONS CONC; USEPA, 2013, LEV 3 4 EC CONT US; van der Valk A.G., 2005, P393; Veech JA, 2006, CONSERV BIOL, V20, P1422, DOI 10.1111/j.1523-1739.2006.00487.x; Villard MA, 2002, ECOL APPL, V12, P319, DOI 10.1890/1051-0761(2002)012[0319:HFMCIO]2.0.CO;2; WE Energies, 2018, DEV CONSTR WIND EN; White C.A., 1983, HIST RECTANGULAR SUR; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	66	17	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0198382	10.1371/journal.pone.0198382	http://dx.doi.org/10.1371/journal.pone.0198382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625148	Green Submitted, Green Published, gold			2022-12-26	WOS:000455359400002
J	Tan, BY; Leong, AZ; Leow, AS; Ngiam, NJ; Ng, BS; Sharma, M; Yeo, LL; Seow, PA; Hong, CS; Chee, YH; Chen, JT; Du, ZD; Wong, LY; Batra, A; Sarkar, N; Teoh, HL; Ho, RC; Sharma, VK				Tan, Benjamin Y.; Leong, Adriel Z.; Leow, Aloysius S.; Ngiam, Nicholas J.; Ng, Bridget S.; Sharma, Manasi; Yeo, Leonard L.; Seow, Philip A.; Hong, Chiew S.; Chee, Young H.; Chen, Jintao; Du, Zhengdao; Wong, Lily Y.; Batra, Amit; Sarkar, Nabin; Teoh, Hock-Luen; Ho, Roger C.; Sharma, Vijay K.			Psychosomatic symptoms during South East Asian haze crisis are related to changes in cerebral hemodynamics	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; TRANSCRANIAL DOPPLER; EXPOSURE; REACTIVITY; PRESSURE	Objectives Forest fires in South Asia lead to widespread haze, where many healthy individuals develop psychosomatic symptoms. We investigated the effects of haze exposure on cerebral hemodynamics and new symptoms. We hypothesised that vasoactive substances present in the haze, would lead to vasodilation of cerebral vasculature, thereby altering cerebral hemodynamics, which in turn may account for new psychosomatic symptoms. Methods Seventy-four healthy volunteers were recruited, and serial transcranial Doppler (TCD) ultrasonography was performed to record blood flow parameters of bilateral middle cerebral arteries (MCA). The first TCD was performed in an air-conditioned environment. It was repeated outdoors after the participants spent 30-minutes in the haze environment. The prevailing level of pollutant standards index (PSI) was recorded. Appropriate statistical analyses were performed to compare cerebral hemodynamics at baseline and after haze exposure in all participants. Subgroup analyses were then employed to compare the findings between symptomatic and asymptomatic participants. Results Study participants' median age was 30 years (IQR 26-34), and new psychosomatic symptoms were reported by 35 (47.3%). There was a modest but significant decrease in pulsatility index (PI) and resistivity index (RI) in the left MCA after haze exposure (PI: p = 0.026; RI: p = 0.021). When compared to baseline parameters, haze exposure resulted in significantly lower mean PI (p = 0.001) and RI (p = 0.001) in symptomatic patients, but this difference was not present in asymptomatic patients (PI: p = 0.919; RI: p = 0.970). Conclusion Haze causes significant alterations in cerebral hemodynamics in susceptible individuals, probably responsible for various psychosomatic symptoms. The prognostic implications and health effects of haze require evaluation in a larger study.	[Tan, Benjamin Y.; Leong, Adriel Z.; Ngiam, Nicholas J.; Sharma, Manasi; Yeo, Leonard L.; Seow, Philip A.; Hong, Chiew S.; Chee, Young H.; Chen, Jintao; Du, Zhengdao; Wong, Lily Y.; Batra, Amit; Sarkar, Nabin; Teoh, Hock-Luen; Sharma, Vijay K.] Natl Univ Hlth Syst, Div Neurol, Dept Med, Singapore, Singapore; [Leow, Aloysius S.; Ng, Bridget S.; Ho, Roger C.; Sharma, Vijay K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Ho, Roger C.] Natl Univ Hlth Syst, Dept Psychol Med, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Tan, BY (corresponding author), Natl Univ Hlth Syst, Div Neurol, Dept Med, Singapore, Singapore.	benjamin_yq_tan@nuhs.edu.sg	yeo, leonard/AAA-8258-2020; Du, Zhengdao Hideyoshi/AAY-2633-2021; Ho, Roger/ABD-8859-2021; sharma, Vijay/T-5286-2019; Ho, Roger C./ABD-9061-2021	yeo, leonard/0000-0002-4249-0402; Du, Zhengdao Hideyoshi/0000-0002-8725-2475; sharma, Vijay/0000-0002-8976-5696; Ho, Roger C./0000-0001-9629-4493; /0000-0002-4763-6984; Ngiam, Nicholas/0000-0002-3339-7281; WONG, LILY/0000-0002-6772-9053; Tan, Benjamin YQ/0000-0003-1824-9077				Agency NE, 2017, NON TRADITIONAL REF; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Auchincloss AH, 2008, ENVIRON HEALTH PERSP, V116, P486, DOI 10.1289/ehp.10899; Awang M B, 2000, Respirology, V5, P183, DOI 10.1046/j.1440-1843.2000.00248.x; Barrett KE, 2009, GANONGS REV MED PHYS, P23; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Gosling R, 1974, ROLE MEASUREMENT PER; Goswami K, 2012, FOREST POLICY ECON, V15, P146, DOI 10.1016/j.forpol.2011.11.005; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Ho RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-81; Lavi S, 2006, AM J PHYSIOL-HEART C, V291, pH1856, DOI 10.1152/ajpheart.00014.2006; Long WQ, 1998, CHEST, V113, P351, DOI 10.1378/chest.113.2.351; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Moreno J, 2000, NEUROSURG FOCUS, V8, P1; O'Callaghan J, 2013, NON TRADITIONAL REF; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Ostermann K, 2001, FOREST FIRES REGIONA, P2; Ouah E, 2001, J ENVIRON MANAGE, V63, P181, DOI 10.1006/jema.2001.0475; Pinto J, 1998, EPA600R98071 NAT CTR; Pourcelot L, 1973, DIAGNOSTIC ULTRASOUN, P141; Ramakreshnan L, 2018, ENVIRON SCI POLLUT R, V25, P2096, DOI 10.1007/s11356-017-0860-y; Robertson AD, 2013, CEREBROVASCULAR HEMO; Rockman CB, 2001, ANN VASC SURG, V15, P557, DOI 10.1007/s10016-001-0029-4; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Sharma AK, 2016, ANN INDIAN ACAD NEUR, V19, P102, DOI 10.4103/0972-2327.173407; Tacconi L, 2003, CIFOR OCCASIONAL PAP; Tan WC, 2000, AM J RESP CRIT CARE, V161, P1213, DOI 10.1164/ajrccm.161.4.9904084; Ursino M, 1998, J NEUROSURG, V89, P255, DOI 10.3171/jns.1998.89.2.0255; Valentic D, 2010, COLLEGIUM ANTROPOL, V34, P113; Wellenius GA, 2013, STROKE, V44, P1533, DOI 10.1161/STROKEAHA.111.000395; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; White RP, 1999, J CEREBR BLOOD F MET, V19, P673, DOI 10.1097/00004647-199906000-00011	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0208724	10.1371/journal.pone.0208724	http://dx.doi.org/10.1371/journal.pone.0208724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG5UW	30615620	gold, Green Submitted, Green Published			2022-12-26	WOS:000455045900012
J	Zhu, JL; Huang, G; Hua, XH; Li, Y; Yan, HY; Che, X; Tian, ZX; Liufu, HT; Huang, C; Li, JX; Xu, JH; Dai, W; Huang, HS; Huang, CS				Zhu, Junlan; Huang, Grace; Hua, Xiaohui; Li, Yang; Yan, Huiying; Che, Xun; Tian, Zhongxian; Liufu, Huating; Huang, Chao; Li, Jingxia; Xu, Jiheng; Dai, Wei; Huang, Haishan; Huang, Chuanshu			CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells	ONCOGENE			English	Article							MALIGNANT-TRANSFORMATION; DOWN-REGULATION; AUTOPHAGY; PROTEINS; USP28; OVEREXPRESSION; MAINTENANCE; INHIBITOR; 5-HYDROXYMETHYLCYTOSINE; PROLIFERATION	Over half a million US residents are suffering with bladder cancer (BC), which costs a total $4 billion in treatment annually. Although recent studies report that autophagy-related gene 7 (ATG7) is overexpressed in BCs, the regulatory effects of ATG7 on cancer stem-like phenotypes and invasion have not been explored yet. Current studies demonstrated that the deficiency of ATG7 by its shRNA dramatically reduced sphere formation and invasion in vitro, as well as lung metastasis in vivo in human invasive BC cells. Further studies indicated that the knockdown of ATG7 attenuated the expression of CD44 standard (CD44s), while ectopic introduction of CD44s, was capable of completely restoring sphere formation, invasion, and lung metastasis in T24T(shATG7) cells. Mechanistic studies revealed that ATG7 overexpression stabilized CD44s proteins accompanied with upregulating USP28 proteins. Upregulated USP28 was able to bind to CD44s and remove the ubiquitin group from CD44s' protein, resulting in the stabilization of CD44s protein. Moreover, ATG7 inhibition stabilized AUF1 protein and thereby reduced tet1 mRNA stability and expression, which was able to demethylate usp28 promoter, reduced USP28 expression, finally promoting CD44s degradation. In addition, CD44s was defined to inhibit degradation of RhoGDI beta, which in turn promotes BC invasion. Our results demonstrate that CD44s is a key ATG7 downstream regulator of the sphere formation, invasion, and lung metastasis of BCs, providing significant insight into understanding the BC invasions, metastasis, and stem-like properties.	[Zhu, Junlan; Huang, Grace; Hua, Xiaohui; Li, Yang; Yan, Huiying; Che, Xun; Tian, Zhongxian; Liufu, Huating; Huang, Chao; Li, Jingxia; Xu, Jiheng; Dai, Wei; Huang, Haishan; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, New York, NY 10010 USA	New York University	Huang, HS; Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, New York, NY 10010 USA.	haishan_333@163.com; Chuanshu.huang@nyulangone.org	Xu, Jiheng/AAV-5732-2020	Xu, Jiheng/0000-0002-3538-3174; Dai, Wei/0000-0003-0169-8327; Huang, Chuanshu/0000-0003-4133-5096	NIH/NCI [CA177665, CA165980, CA217923]; NIH/NIEHS [ES000260]; NATIONAL CANCER INSTITUTE [P01CA165980, R01CA217923, R01CA177665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Martin Eilers from the Institute of Molecular Biology and Tumor Research, Marburg, Germany, and Dr. James M. Angelastro from the Department of Molecular Biosciences, University of California at Davis for their generous gifts of the Flagtagged USP28 plasmid, the pcDNA3.1/NT-GFP-CD133, and pcDNA3.1/NT-GFP plasmids. We also thank Ms. Nedda Tichi for her critical reading of the manuscript. This work was partially supported by grants from NIH/NCI CA177665, CA165980, CA217923, and NIH/NIEHS ES000260.	Bartakova A., 2017, J OBSTET GYNAECOL, P1; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Ceriani M, 2015, EXP CELL RES, V333, P49, DOI 10.1016/j.yexcr.2015.01.019; Chan KS, 2010, CURR OPIN UROL, V20, P393, DOI 10.1097/MOU.0b013e32833cc9df; Chandrasekar T, 2016, INVESTIG CLIN UROL, V57, pS89, DOI 10.4111/icu.2016.57.S1.S89; Chen Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.142; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Cho Y, 2015, ONCOTARGET, V6, P8709, DOI 10.18632/oncotarget.3325; Ciesielski P, 2015, POSTEP HIG MED DOSW, V69, P1371; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Dickstein RJ, 2012, CANCER BIOL THER, V13, P1325, DOI 10.4161/cbt.21793; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Gomez-Puerto MC, 2016, STEM CELLS, V34, P1651, DOI 10.1002/stem.2347; Gong C, 2012, AUTOPHAGY, V8, P1853, DOI 10.4161/auto.21996; Good CR, 2017, NUCLEIC ACIDS RES, V45, P8269, DOI 10.1093/nar/gkx435; Guo GY, 2014, TUMOR BIOL, V35, P4017, DOI 10.1007/s13277-013-1525-1; Han X, 2017, CELL BIOL INT, V41, P405, DOI 10.1002/cbin.10734; Hofner T, 2014, UROL ONCOL-SEMIN ORI, V32, P678, DOI 10.1016/j.urolonc.2014.01.001; Hua XH, 2018, CANCER LETT, V436, P38, DOI 10.1016/j.canlet.2018.08.013; Huang HS, 2016, AUTOPHAGY, V12, P1687, DOI 10.1080/15548627.2016.1196313; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kobayashi K, 2016, ONCOL REP, V36, P2852, DOI 10.3892/or.2016.5061; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li XZ, 2012, ANN SURG ONCOL, V19, P145, DOI 10.1245/s10434-011-1944-4; Liang YG, 2016, AUTOPHAGY, V12, P1229, DOI 10.1080/15548627.2016.1179403; Lin CJ, 2013, INT J ONCOL, V42, P993, DOI 10.3892/ijo.2013.1791; Lin YC, 2016, J UROLOGY, V195, P1126, DOI 10.1016/j.juro.2015.10.128; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mandelbaum J., 2015, AUTOPHAGY; Mani J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1239-4; Maycotte P, 2015, MOL CANCER RES, V13, P651, DOI 10.1158/1541-7786.MCR-14-0487; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishino M, 2017, J CANCER, V8, P1774, DOI 10.7150/jca.19732; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pei YF, 2016, ONCOTARGET, V7, P31322, DOI 10.18632/oncotarget.8900; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Quail DF, 2012, CURR STEM CELL RES T, V7, P197; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0208-z; Warrick JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep38531; Whelan KA, 2017, ONCOGENE, V36, P4843, DOI 10.1038/onc.2017.102; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Yang F, 2014, DNA CELL BIOL, V33, P781, DOI 10.1089/dna.2014.2545; Yi B, 2015, ONCOL REP, V33, P1201, DOI 10.3892/or.2015.3707; Yin XT, 2016, ADV EXP MED BIOL, V945, P275, DOI 10.1007/978-3-319-43624-1_12; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu G, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0115-4; Zavros Y, 2017, CELL MOL GASTROENTER, V4, P55, DOI 10.1016/j.jcmgh.2017.03.003; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhou C, 2017, ONCOGENE, V36, P3878, DOI 10.1038/onc.2017.14; Zhou FF, 2017, EMBO J, V36, P1623, DOI 10.15252/embj.201695372; Zhu JL, 2017, NEOPLASIA, V19, P672, DOI 10.1016/j.neo.2017.06.002; Zhu JL, 2017, MOL THER-NUCL ACIDS, V7, P299, DOI 10.1016/j.omtn.2017.04.012; Zhu JL, 2014, CANCER PREV RES, V7, P1270, DOI 10.1158/1940-6207.CAPR-14-0233	70	25	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3301	3315		10.1038/s41388-018-0664-7	http://dx.doi.org/10.1038/s41388-018-0664-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30635654	Green Accepted			2022-12-26	WOS:000465557200014
J	Chauhan, AS; Kumar, M; Chaudhary, S; Dhiman, A; Patidar, A; Jakhar, P; Jaswal, P; Sharma, K; Sheokand, N; Malhotra, H; Raje, CI; Raje, M				Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Dhiman, Asmita; Patidar, Anil; Jakhar, Priyanka; Jaswal, Pallavi; Sharma, Kapil; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Chaaya Iyengar; Raje, Manoj			Trafficking of a multifunctional protein by endosomal microautophagy: linking two independent unconventional secretory pathways	FASEB JOURNAL			English	Article						GAPDH; lysosomal exocytosis; exosomal exocytosis; nonclassical protein secretion; misfolded protein aggregate	CHAPERONE-MEDIATED AUTOPHAGY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; LYSOSOMAL EXOCYTOSIS; FUNCTIONAL DIVERSITY; ALZHEIMERS-DISEASE; MEMBRANE-PROTEINS; EXOSOME RELEASE; BIOGENESIS; PHOSPHATIDYLSERINE; TRANSFERRIN	During physiologic stresses, like micronutrient starvation, infection, and cancer, the cytosolic moonlighting protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is trafficked to the plasma membrane (PM) and extracellular milieu (ECM). Our work demonstrates that GAPDH mobilized to the PM, and the ECM does not utilize the classic endoplasmic reticulum-Golgi route of secretion; instead, it is first selectively translocated into early and late endosomes from the cytosol via microautophagy. GAPDH recruited to this common entry point is subsequently delivered into multivesicular bodies, leading to its membrane trafficking through secretion via exosomes and secretory lysosomes. We present evidence that both pathways of GAPDH membrane trafficking are up-regulated upon iron starvation, potentially by mobilization of intracellular calcium. These pathways also play a role in clearance of misfolded intracellular polypeptide aggregates. Our findings suggest that cells build in redundancy for vital cellular pathways to maintain micronutrient homeostasis and prevent buildup of toxic intracellular misfolded protein refuse.	[Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Dhiman, Asmita; Patidar, Anil; Jakhar, Priyanka; Jaswal, Pallavi; Sharma, Kapil; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Manoj] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Raje, Chaaya Iyengar] Natl Inst Pharmaceut Educ & Res, Mohali, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Raje, M (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	manoj@imtech.res.in	Malik, Navdeep/V-9125-2019; Malik, Navdeep/AAU-3303-2020; Chauhan, Anoop/GYD-7325-2022; Raje, Chaaya Iyengar/AAU-2651-2021	Malik, Navdeep/0000-0003-1113-2562; Chauhan, Anoop/0000-0001-8722-2404; KUMAR, MANOJ/0000-0001-6934-2103; , Asmita/0000-0002-6415-6819; Chaudhary, Surbhi/0000-0002-7457-7166; Iyengar, Chaaya/0000-0003-4434-0536	India's Department of Biotechnology; Council of Scientific and Industrial Research; University Grants Commission; Department of Biotechnology; Department of Science and Technology of the Government of India	India's Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Department of Biotechnology; Department of Science and Technology of the Government of India(Department of Science & Technology (India))	Anil Theophilus, Randeep Sharma, and Dr. Subash Pawar (all from the Institute of Microbial Technology) are acknowledged for technical assistance. A.S.C., A.P., and A.D. received fellowships from India's Department of Biotechnology. N.S., P. Jakhar, P. Jaswal, and K.S. received fellowships from the Council of Scientific and Industrial Research, and H.M. and S.C. received fellowships from the University Grants Commission. Financial assistance from the Department of Biotechnology and the Department of Science and Technology of the Government of India is acknowledged. This article is Institute of Microbial Technology (IMTECH) Communication 029/2014. The authors declare no conflicts of interest.	ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Appelqvist H, 2013, J CELL SCI, V126, P5578, DOI 10.1242/jcs.130633; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Boradia VM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5730; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Chauhan AS, 2017, FASEB J, V31, P2638, DOI 10.1096/fj.201600982R; CHAUHAN AS, 2015, SCI REP UK, V5; Chen JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077023; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Cortez LM, 2010, FEBS LETT, V584, P625, DOI 10.1016/j.febslet.2009.12.012; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Gonzalez AE, 2017, FASEB J, V31, P2446, DOI 10.1096/fj.201600713R; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hwang S, 2015, FASEB J, V29; Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; Kaneda M, 1997, J BIOCHEM-TOKYO, V122, P1233; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Malhotra H, 2016, J BIOMED NANOTECHNOL, V12, P1101, DOI 10.1166/jbn.2016.2229; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mazzola JL, 2001, J NEUROCHEM, V76, P442, DOI 10.1046/j.1471-4159.2001.00033.x; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Miura N, 2012, EUKARYOT CELL, V11, P1075, DOI 10.1128/EC.00075-12; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Mukherjee A, 2016, AUTOPHAGY, V12, P1984, DOI 10.1080/15548627.2016.1208887; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Rawat P, 2012, BIOCHEM CELL BIOL, V90, P329, DOI [10.1139/O11-058, 10.1139/o11-058]; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Seidler N. W., 2012, GAPDH BIOLOGICAL PRO, V985; Sheokand N, 2016, J CELL SCI, V129, P843, DOI 10.1242/jcs.180356; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Shibuya A, 2002, HEPATOL RES, V22, P174, DOI 10.1016/S1386-6346(01)00134-6; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2014, INT J BIOCHEM CELL B, V57, P20, DOI 10.1016/j.biocel.2014.09.026; Sirover MA, 2013, OXID STRESS APPL BAS, P25, DOI 10.1007/978-1-62703-598-9_4; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Stolp ZD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068835; Takenouchi T, 2015, IMMUNOL LETT, V167, P116, DOI 10.1016/j.imlet.2015.08.002; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Tisdale EJ, 2016, EXP CELL RES, V349, P310, DOI 10.1016/j.yexcr.2016.10.025; Uytterhoeven V, 2015, NEURON, V88, P735, DOI 10.1016/j.neuron.2015.10.012; van Leeuwen W, 2018, J CELL BIOL, V217, P2261, DOI 10.1083/jcb.201802003; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Xu P, 2013, J CELL BIOL, V202, P875, DOI 10.1083/jcb.201305094; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	77	13	13	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5626	5640		10.1096/fj.201802102R	http://dx.doi.org/10.1096/fj.201802102R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30640524	Bronze			2022-12-26	WOS:000462888500079
J	Hu, RK; Huang, WL; Liu, JF; Jin, MM; Wu, Y; Li, JY; Wang, JY; Yu, ZH; Wang, H; Cao, Y				Hu, Ruikun; Huang, Weilai; Liu, Jiangfang; Jin, Miaomiao; Wu, Yue; Li, Jingyu; Wang, Jingyi; Yu, Zehao; Wang, Hong; Cao, Ying			Mutagenesis of putative ciliary genes with the CRISPR/Cas9 system in zebrafish identifies genes required for retinal development	FASEB JOURNAL			English	Article						cilium; retina; genetic screen	CILIOPATHY PROTEIN; TRANSPORT; COMPLEX; GENOME; PHOTORECEPTORS; DISSECTION; MEMBRANES; INTERACTS; SURVIVAL; DISEASE	Cilia are conserved microtubule-based organelles that function as mechanical and chemical sensors in various cell types. By bioinformatic, genomic, and proteomic studies, more than 2000 proteins have been identified as cilium-associated proteins or putative ciliary proteins; these proteins are referred to as the ciliary proteome or the ciliome. However, little is known about the function of these numerous putative ciliary proteins in cilia. To identify the possible new functional proteins or pathways in cilia, we carried out a small-scale genetic screen targeting 54 putative ciliary genes by using the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system. We successfully constructed 54 zebrafish mutants, and 8 of them displayed microphthalmias. Three of these 8 genes encode proteins for protein transport, suggesting the important roles of protein transport in retinal development. In situ hybridization revealed that all these genes are expressed in zebrafish eyes. Furthermore, polo-like kinase 1 was required for ciliogenesis in neural tube. We uncovered the potential function of the ciliary genes for the retinal development of zebrafish.	[Hu, Ruikun; Huang, Weilai; Liu, Jiangfang; Jin, Miaomiao; Wu, Yue; Li, Jingyu; Wang, Jingyi; Yu, Zehao; Wang, Hong; Cao, Ying] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Life Sci & Technol, Clin & Translat Res Ctr, 1239 Siping Rd,Med Bldg 1315, Shanghai 200092, Peoples R China	Tongji University	Cao, Y (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Life Sci & Technol, Clin & Translat Res Ctr, 1239 Siping Rd,Med Bldg 1315, Shanghai 200092, Peoples R China.	yingcao@tongji.edu.cn	Li, Jing/GYU-5036-2022; WANG, JINGYI/GSJ-1241-2022; Li, Jingyu/GSD-1924-2022; wang, jing/GVT-8700-2022	Wu, Yue/0000-0002-2337-0923; yu, zehao/0000-0002-7290-8005	National Key Research and Development Program of China [2017YFA0104600]; National Natural Science Foundation of China [31771597, 31571515]; National Basic Research Program of China (973 Program) [2012CB966601, 2013CB945300]; Ministry of Science and Technology of China [2011DFB30010]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The authors thank the members of the Y.C. Laboratory for helpful discussions. This project was supported by National Key Research and Development Program of China Grant 2017YFA0104600, National Natural Science Foundation of China Grants 31771597 and 31571515, National Basic Research Program of China (973 Program) Grants 2012CB966601 and 2013CB945300, and Ministry of Science and Technology of China Grant 2011DFB30010. The authors declare no conflicts of interest.	Attanasio M, 2015, CURR OPIN NEPHROL HY, V24, P366, DOI 10.1097/MNH.0000000000000134; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; DERETIC D, 1995, J CELL SCI, V108, P215; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dona M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005574; Dutta N, 2016, BIOL OPEN, V5, P1283, DOI 10.1242/bio.020461; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Gerth-Kahlert C, 2018, KLIN MONATSBL AUGENH, V235, P264, DOI 10.1055/a-0573-9199; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22281; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hsu Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007057; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Juan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04284-8; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Lin CY, 2015, INT J DEV BIOL, V59, P435, DOI 10.1387/ijdb.150310ht; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nielsen BS, 2015, J CELL SCI, V128, P3543, DOI 10.1242/jcs.173559; Niu XB, 2014, J BIOL CHEM, V289, P11971, DOI 10.1074/jbc.M114.547190; Pujic Z, 2004, SEMIN CELL DEV BIOL, V15, P105, DOI 10.1016/j.semcdb.2003.09.008; Rao KN, 2016, HUM MOL GENET, V25, P4533, DOI 10.1093/hmg/ddw281; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Song P, 2016, INVEST OPHTH VIS SCI, V57, P4517, DOI 10.1167/iovs.16-19898; Sorrells S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002922; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; West MA, 2000, ADV INT ST, V5, P1; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wu Q, 2015, FASEB J, V29, P4989, DOI 10.1096/fj.15-273409; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; Yin J, 2012, INVEST OPHTH VIS SCI, V53, P4943, DOI 10.1167/iovs.12-9511	50	5	5	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5248	5256		10.1096/fj.201802140R	http://dx.doi.org/10.1096/fj.201802140R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624971				2022-12-26	WOS:000462888500050
J	Kotil, S; Jakobsson, E				Kotil, Seyfullah; Jakobsson, Eric			Rationally designing antisense therapy to keep up with evolving bacterial resistance	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISMS; ESCHERICHIA-COLI; PEPTIDE; MUTATIONS; OLIGOMERS; SYSTEMS; VALIDATION; CONJUGATE	Antisense molecules used as antibiotics offer the potential to keep up with acquired resistance, by redesigning the sequence of an antisense. Once bacteria acquire resistance by mutating the targeted sequence, new antisense can readily be designed by using sequence information of a target gene. However, antisense molecules require additional delivery vehicles to get into bacteria and be protected from degradation. Based on progress in the last few years it appears that, while redesigning or finding new delivery vehicle will be more difficult than redesigning the antisense cargo, it will perhaps be less difficult than finding new conventional small molecule antibiotics. In this study we propose a protocol that maximizes the combined advantages of engineered delivery vehicle and antisense cargo by decreasing the immediate growth advantage to the pathogen of mutating the entry mechanisms and increasing the advantage to the pathogen of antisense target mutations. Using this protocol, we show by computer simulation an appropriately designed antisense therapy can potentially be effective many times longer than conventional antibiotics before succumbing to resistance. While the simulations describe an in-vitro situation, based on comparison with other in-vitro studies on acquired resistance we believe the advantages of the combination antisense strategy have the potential to provide much more sustainability in vivo than conventional antibiotic therapy.	[Kotil, Seyfullah; Jakobsson, Eric] Univ Illinois, Program Biophys & Computat Biol, Urbana, IL 61801 USA; [Kotil, Seyfullah; Jakobsson, Eric] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jakobsson, Eric] Univ Illlinois Urbana Champaign, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Kotil, Seyfullah] Univ Wisconsin Madison, Wisconsin Inst Discovery, Madison, WI USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison	Jakobsson, E (corresponding author), Univ Illinois, Program Biophys & Computat Biol, Urbana, IL 61801 USA.; Jakobsson, E (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.; Jakobsson, E (corresponding author), Univ Illlinois Urbana Champaign, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jake@illinois.edu			National Institute of General Medical Sciences [R01GM098736]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant #R01GM098736 from the National Institute of General Medical Sciences nigms.nih.gov to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11660; Bergmann R, 2014, ANTIMICROBIAL AGENTS; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Figliuzzi M, 2016, MOL BIOL EVOL, V33, P268, DOI 10.1093/molbev/msv211; Geller BL, 2014, THER DELIV, V5, P243, DOI [10.4155/tde.13.145, 10.4155/TDE.13.145]; Geller BL, 2013, J INFECT DIS, V208, P1553, DOI 10.1093/infdis/jit460; Gerth ML, 2012, ENVIRON MICROBIOL, V14, P1929, DOI 10.1111/j.1462-2920.2011.02691.x; Ghosal A, 2013, ACS CHEM BIOL, V8, P360, DOI 10.1021/cb300434e; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gleave ME, 2005, NAT REV CANCER, V5, P468, DOI 10.1038/nrc1631; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663; Hoynes-O'Connor A, 2017, BIOTECHNOL BIOENG, V114, P1626, DOI 10.1002/bit.26279; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Kalhapure RS, 2015, J PHARM SCI-US, V104, P872, DOI 10.1002/jps.24298; Kieldsen KR, 2009, BIOTECHNOL BIOENG, V102, P583, DOI 10.1002/bit.22067; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Mann JK, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003776; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Meng J, 2015, J ANTIBIOT, V68, P158, DOI 10.1038/ja.2014.132; Morse TO, 2010, ENVIRON SCI TECHNOL, V44, P3293, DOI 10.1021/es901404a; Nayak DD, 2016, CURR BIOL, V26, P1416, DOI 10.1016/j.cub.2016.04.029; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Nurjadi D, 2014, J ANTIMICROB CHEMOTH, V69, P2361, DOI 10.1093/jac/dku174; Okumus B, 2014, CURR OPIN BIOTECH, V25, P30, DOI 10.1016/j.copbio.2013.08.016; Podnecky NL, 2013, ANTIMICROBIAL AGENTS; Puckett SE, 2012, ANTIMICROBIAL AGENTS; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Sawyer AJ, 2013, INT J PHARMACEUT, V453, P651, DOI 10.1016/j.ijpharm.2013.05.041; Schaberle TF, 2014, TRENDS MICROBIOL, V22, P165, DOI 10.1016/j.tim.2013.12.007; Stoer J., 2013, INTRO NUMERICAL ANAL; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Ventola C Lee, 2015, P T, V40, P344; Wesolowski D, 2011, P NATL ACAD SCI; Wesolowski D, 2013, P NATL ACAD SCI USA, V110, P8686, DOI 10.1073/pnas.1306911110; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	57	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209894	10.1371/journal.pone.0209894	http://dx.doi.org/10.1371/journal.pone.0209894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645595	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200014
J	Oyetunde, T; Liu, D; Martin, HG; Tang, YJJ				Oyetunde, Tolutola; Liu, Di; Garcia Martin, Hector; Tang, Yinjie J.			Machine learning framework for assessment of microbial factory performance	PLOS ONE			English	Article							SYNTHETIC BIOLOGY	Metabolic models can estimate intrinsic product yields for microbial factories, but such frameworks struggle to predict cell performance (including product titer or rate) under suboptimal metabolism and complex bioprocess conditions. On the other hand, machine learning, complementary to metabolic modeling necessitates large amounts of data. Building such a database for metabolic engineering designs requires significant manpower and is prone to human errors and bias. We propose an approach to integrate data-driven methods with genome scale metabolic model for assessment of microbial bio-production (yield, titer and rate). Using engineered E. coli as an example, we manually extracted and curated a data set comprising about 1200 experimentally realized cell factories from similar to 100 papers. We furthermore augmented the key design features (e.g., genetic modifications and bioprocess variables) extracted from literature with additional features derived from running the genome-scale metabolic model iML1515 simulations with constraints that match the experimental data. Then, data augmentation and ensemble learning (e.g., support vector machines, gradient boosted trees, and neural networks in a stacked regressor model) are employed to alleviate the challenges of sparse, non-standardized, and incomplete data sets, while multiple correspondence analysis/principal component analysis are used to rank influential factors on bio-production. The hybrid framework demonstrates a reasonably high cross-validation accuracy for prediction of E. coli factory performance metrics under presumed bioprocess and pathway conditions (Pearson correlation coefficients between 0.8 and 0.93 on new data not seen by the model).	[Oyetunde, Tolutola; Liu, Di; Tang, Yinjie J.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Garcia Martin, Hector] DOE Joint BioEnergy Inst, Emeryville, CA USA; [Garcia Martin, Hector] DOE Agile BioFoundry, Emeryville, CA USA; [Garcia Martin, Hector] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Garcia Martin, Hector] Basque Ctr Appl Math, Bilbao, Spain; [Liu, Di] Sandia Natl Labs, Livermore, CA USA	Washington University (WUSTL); United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Basque Center for Applied Mathematics (BCAM); United States Department of Energy (DOE); Sandia National Laboratories	Tang, YJJ (corresponding author), Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.	yinjie.tang@seas.wustl.edu	Tang, Yinjie/AAI-5584-2020; Garcia Martin, Hector/B-5357-2009	Garcia Martin, Hector/0000-0002-4556-9685; Oyetunde, Tolutola/0000-0002-3875-8613	Department of Energy [DESC0018324]; National Science Foundation [MCB 1616619]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by a Department of Energy grant (DESC0018324) and a National Science Foundation grant (MCB 1616619) to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by an NSF grant (MCB 1616619) and a DOE grant (DESC0018324) to YT. Authors thank Jeffery Czajka for useful discussions.	Abdi Herve, 2007, ENCYCL MEASUR STATIS, V2, P651; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Arkin AP, 2018, NAT BIOTECHNOL, V36, P566, DOI 10.1038/nbt.4163; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chollet F., 2015, KERAS DEEP LEARNING; Chuang KV, 2018, SCIENCE, V362, DOI 10.1126/science.aat8603; Colletti PF, 2011, BIOTECHNOL BIOENG, V108, P893, DOI 10.1002/bit.22996; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Long MR, 2015, CURR OPIN BIOTECH, V34, P135, DOI 10.1016/j.copbio.2014.12.019; Maarleveld TR, 2014, PLANT PHYSIOL, P113; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003989; Monk JM, 2017, NAT BIOTECHNOL, V35, P904, DOI 10.1038/nbt.3956; Morell WC, 2017, ACS SYNTH BIOL, V6, P2248, DOI 10.1021/acssynbio.7b00204; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Smith L. I., 2002, TUTORIAL PRINCIPAL C; Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11; Winkler James D, 2015, Metab Eng Commun, V2, P30, DOI 10.1016/j.meteno.2015.06.003; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; Wu SG, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0219-3; Wu SG, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004838; Wu SG, 2016, CHEMBIOENG REV, V3, P45, DOI 10.1002/cben.201500024; Zhang ZD, 2015, NUCLEIC ACIDS RES, V43, pD549, DOI 10.1093/nar/gku1137	26	20	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210558	10.1371/journal.pone.0210558	http://dx.doi.org/10.1371/journal.pone.0210558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645629	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000455810200034
J	Cava, JA; Perlut, NG; Travis, SE				Cava, Jenna A.; Perlut, Noah G.; Travis, Steven E.			Heritability and evolvability of morphological traits of Savannah sparrows (Passerculus sandwichensis) breeding in agricultural grasslands	PLOS ONE			English	Article							NATURAL-POPULATIONS; MICROSATELLITE LOCI; NATAL PHILOPATRY; PATERNITY; SELECTION; BIRD; CONSERVATION; SONGBIRDS	Heritability and evolvability estimates of adult traits from free-living bird populations can be used to gauge the ability of populations to respond to selection, but are rare due to difficulties in gathering detailed pedigree information. The capacity to respond to selection is particularly important for species occupying managed habitats such as agricultural grasslands because of the potential for humans to accidentally influence traits. We calculated heritability and evolvability of six morphological traits in a population of Savannah Sparrows (Passerculus sandwichensis) breeding in a large agricultural landscape. We used microsatellite analysis to determine a genetic pedigree, revealing a high level of extra-pair paternity (63%) within a relatively philopatric population. For the entire population, heritabilities varied from low to high (bill width: 0.160 +/- 0.182 to tarsus length: 0.651 +/- 0.155), while evolvabilities were low across all traits (wing length: 0.035 +/- 0.013 to body mass: 0.066 +/- 0.106). Our results indicate that any directional selection from agricultural management practices will produce negligible changes in basic morphometrics of Savannah sparrow populations occupying the Champlain Valley of Vermont, USA.	[Cava, Jenna A.] Univ New England, Dept Biol, Biddeford, ME USA; [Perlut, Noah G.; Travis, Steven E.] Univ New England, Dept Environm Studies, Biddeford, ME 04005 USA	University of New England - Maine; University of New England - Maine	Perlut, NG (corresponding author), Univ New England, Dept Environm Studies, Biddeford, ME 04005 USA.	nperlut@une.edu			Toyota TogetherGreen, Toyota; National Audubon; Nuttall Ornithological Club; 'Interface: a Systemic PARTnership Aimed at Connecting University and School (SPARTACUS)' National Science Foundation DGE Award [0841361]	Toyota TogetherGreen, Toyota; National Audubon; Nuttall Ornithological Club; 'Interface: a Systemic PARTnership Aimed at Connecting University and School (SPARTACUS)' National Science Foundation DGE Award	This work was supported by D. Galipeau, private donation (NGP); Toyota TogetherGreen, Toyota and National Audubon, https://www.toyotaglobal.com/sustainability/social_contribution/environment/overseas/togethergreen/ (NGP); Nuttall Ornithological Club, https://www.nuttallclub.org/ (JC); 'Interface: a Systemic PARTnership Aimed at Connecting University and School (SPARTACUS)' National Science Foundation DGE Award (number 0841361) (JC).	Akesson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001739; Cava JA, 2016, ANIM BEHAV, V118, P39, DOI 10.1016/j.anbehav.2016.05.006; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Ibanez-Alamo JD, 2010, BIOL J LINN SOC, V101, P759, DOI 10.1111/j.1095-8312.2010.01543.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Fajardo N, 2009, AUK, V126, P310, DOI 10.1525/auk.2009.07097; Falconer D. S., 1996, INTRO QUANTITATIVE G; Freeman-Gallant CR, 2005, EVOLUTION, V59, P422, DOI 10.1111/j.0014-3820.2005.tb01000.x; Garcia-Gonzalez F, 2012, EVOLUTION, V66, P2341, DOI 10.1111/j.1558-5646.2011.01565.x; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; HANOTTE O, 1994, MOL ECOL, V3, P529, DOI 10.1111/j.1365-294X.1994.tb00133.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; HOULE D, 1992, GENETICS, V130, P195; Jeffery KJ, 2001, MOL ECOL NOTES, V1, P11, DOI 10.1046/j.1471-8278.2000.00005.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Kim SY, 2013, HEREDITY, V111, P139, DOI 10.1038/hdy.2013.29; Kinnard TB, 2009, AUK, V126, P884, DOI 10.1525/auk.2009.08119; Kruuk LEB, 2001, AM NAT, V158, P557, DOI 10.1086/323585; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Meyer K., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Morrissey MB, 2007, J EVOLUTION BIOL, V20, P2309, DOI 10.1111/j.1420-9101.2007.01412.x; [NASS] National Agricultural Statistics Service, 2010, CENS AGR; Perlut NG, 2008, ECOLOGY, V89, P1941, DOI 10.1890/07-0900.1; Perlut NG, 2008, MOL ECOL, V17, P1248, DOI 10.1111/j.1365-294X.2008.03695.x; Perlut NG, 2006, ECOL APPL, V16, P2235, DOI 10.1890/1051-0761(2006)016[2235:GSIADM]2.0.CO;2; Perlut NG, 2011, J WILDLIFE MANAGE, V75, P1657, DOI 10.1002/jwmg.199; Perlut NG, 2008, BIOL CONSERV, V141, P3139, DOI 10.1016/j.biocon.2008.09.011; Postma E, 2014, QUANTITATIVE GENETICS IN THE WILD, P16; Rodewald P. G., 2008, BIRDS N AM; Saunders SP, 2014, BIOL CONSERV, V177, P26, DOI 10.1016/j.biocon.2014.06.005; Temple M, 2000, THESIS; Teplitsky C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090444; Teplitsky C, 2009, EVOLUTION, V63, P716, DOI 10.1111/j.1558-5646.2008.00581.x; Urlich SC, 2015, NEW ZEAL J ECOL, V39, P133; WEATHERHEAD PJ, 1994, BEHAV ECOL, V5, P426, DOI 10.1093/beheco/5.4.426; Wheelwright NT, 2014, EVOLUTION, V68, P3325, DOI 10.1111/evo.12499; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x	40	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210472	10.1371/journal.pone.0210472	http://dx.doi.org/10.1371/journal.pone.0210472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640933	gold, Green Published, Green Submitted			2022-12-26	WOS:000455808000032
J	Batres, C; Kramer, SS; DeAngelis, CG; Russell, R				Batres, Carlota; Kramer, Sarah S.; DeAngelis, Caroline G.; Russell, Richard			Examining the 'cosmetics placebo effect'	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; BEAUTY; MAKEUP	Previous studies have found a positive effect of cosmetics on certain behavioral measures, such as the tip given to waitresses by male patrons. These studies have employed confederates who usually wear cosmetics. We therefore sought to examine whether the positive effect found in these studies could, in part, be explained by a change in behavior. In order to test the possibility of a 'cosmetics placebo effect', we employed a confederate to solicit donations from passersby. On some days our confederate would not have any cosmetics applied to her face (i.e., no cosmetics condition), on some days cosmetics were pretended to be applied to her face (i.e., placebo cosmetics condition), and on other days cosmetics were actually applied to her face (i.e., cosmetics condition). In line with previous research, we found that across conditions men donated significantly more than women to our female solicitor, providing support for the 'showoff hypothesis', in which male generosity serves as a mating tactic. When investigating men's donations in more detail, we found that the highest percentage of donations came in the cosmetics condition, followed by the placebo cosmetics condition, and then by no cosmetics condition. The effect of condition on donation rates, however, was not statistically significant. Our study was limited to one solicitor and one dependent variable (i.e., percentage of people approached who donated) and therefore future research would benefit from using more confederates as well as examining other behavioral measures. Given the influence of cosmetics use on so many real-world outcomes, we believe that further exploration into a possible 'cosmetics placebo effect' would be valuable.	[Batres, Carlota; Kramer, Sarah S.; DeAngelis, Caroline G.; Russell, Richard] Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA; [Batres, Carlota] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA	Gettysburg College; Franklin & Marshall College	Batres, C (corresponding author), Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA.; Batres, C (corresponding author), Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA.	cbatres@fandm.edu	; Batres, Carlota/J-2294-2015	Russell, Richard/0000-0002-4007-8596; Batres, Carlota/0000-0002-3833-7667				[Anonymous], 1980, ADV CONSUMER RES; Batres C, 2018, PERS INDIV DIFFER, V122, P148, DOI 10.1016/j.paid.2017.10.023; BROCKNER J, 1984, J CONSUM RES, V11, P611, DOI 10.1086/208997; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; CASH TF, 1982, INT J COSMETIC SCI, V4, P1, DOI 10.1111/j.1467-2494.1982.tb00295.x; COX CL, 1986, SEX ROLES, V14, P51, DOI 10.1007/BF00287847; DERMER M, 1975, J PERS SOC PSYCHOL, V31, P1168, DOI 10.1037/h0077085; FRASER C, 1988, J CONSUM RES, V15, P284, DOI 10.1086/209166; GRAHAM JA, 1981, INT J COSMETIC SCI, V3, P199, DOI 10.1111/j.1467-2494.1981.tb00283.x; Gueguen N, 2008, N AM J PSYCHOL, V10, P221; Gueguen N, 2011, J COSMET SCI, V62, P283; HAMID PN, 1972, J SOC PSYCHOL, V86, P279, DOI 10.1080/00224545.1972.9918629; HAWKES K, 1991, ETHOL SOCIOBIOL, V12, P29, DOI 10.1016/0162-3095(91)90011-E; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Iredale W, 2008, EVOL PSYCHOL-US, V6, P386, DOI 10.1177/147470490800600302; Jacob C, 2010, INT J HOSP MANAG, V29, P188, DOI 10.1016/j.ijhm.2009.04.003; Jones AL, 2015, EVOL PSYCHOL-US, V13, P210, DOI 10.1177/147470491501300113; Jonesu AL, 2015, PERCEPTION, V44, P79, DOI 10.1068/p7904; Landry CE, 2006, Q J ECON, V121, P747, DOI 10.1162/qjec.2006.121.2.747; Mileva VR, 2016, PERCEPTION, V45, P1166, DOI 10.1177/0301006616652053; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Osborn DR, 1996, J APPL SOC PSYCHOL, V26, P31, DOI 10.1111/j.1559-1816.1996.tb01837.x; Panesar P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154202	23	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210238	10.1371/journal.pone.0210238	http://dx.doi.org/10.1371/journal.pone.0210238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629657	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000064
J	Domizi, P; Malizia, F; Chazarreta-Cifre, L; Diacovich, L; Banchio, C				Domizi, Pablo; Malizia, Florencia; Chazarreta-Cifre, Lorena; Diacovich, Lautaro; Banchio, Claudia			KDM2B regulates choline kinase expression and neuronal differentiation of neuroblastoma cells	PLOS ONE			English	Article							PHOSPHOLIPID BIOSYNTHESIS; CPG ISLANDS; PHOSPHATIDYLCHOLINE; PROLIFERATION; MECHANISMS; PATHWAY; COMPLEX; ASSAY	The process of neuronal differentiation is associated with neurite elongation and membrane biogenesis, and phosphatidylcholine (PtdCho) is the major membrane phospholipid in mammalian cells. During neuroblast differentiation, the transcription of two genes involved in PtdCho biosynthesis are stimulated: Chka gene for choline kinase (CK) alpha isoform and Pcyt1a gene for CTP:phosphocholine cytidylyltransferase (CCT) alpha isoform. Here we show that CK alpha is essential for neuronal differentiation. In addition, we demonstrated that KDM2B regulates CK alpha expression and, as a consequence, neuronal differentiation. This factor is up-regulated in the course of the neuroblasts proliferative and undifferentiated state and down-regulated during differentiation induced by retinoic acid (RA). During proliferation, KDM2B binds to the Box2 located in the Chka promoter repressing its transcription. Interestingly, KDM2B knockdown enhances the levels of CK alpha expression in neuroblast cells and induces neuronal differentiation even in the absence of RA. These results suggest that KDM2B is required for the appropriate regulation of CK alpha during neuronal differentiation and to the maintaining of the undifferentiated stage of neuroblast cells.	[Domizi, Pablo; Malizia, Florencia; Chazarreta-Cifre, Lorena; Diacovich, Lautaro; Banchio, Claudia] Univ Nacl Rosario, Predio CONICET, Inst Biol Mol & Celular Rosario, IBR,CONICET,Ocampo & Esmeralda, Rosario, Santa Fe, Argentina; [Domizi, Pablo; Malizia, Florencia; Chazarreta-Cifre, Lorena; Diacovich, Lautaro; Banchio, Claudia] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario	Banchio, C (corresponding author), Univ Nacl Rosario, Predio CONICET, Inst Biol Mol & Celular Rosario, IBR,CONICET,Ocampo & Esmeralda, Rosario, Santa Fe, Argentina.	banchio@ibr-conicet.gov.ar		Banchio, Claudia/0000-0002-5234-7212; Diacovich, Lautaro/0000-0002-3339-0100; Domizi, Pablo/0000-0003-2903-0337	Fondo para la Investigacion Cientifica y Tecnologica [PICT2013]	Fondo para la Investigacion Cientifica y Tecnologica	This study was supported by Fondo para la Investigacion Cientifica y Tecnologica, grant number PICT2013 to CB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Domizi P, 2014, BBA-MOL CELL BIOL L, V1841, P544, DOI 10.1016/j.bbalip.2014.01.007; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Galbiati A, 2017, ONCOTARGET, V8, P37091, DOI 10.18632/oncotarget.16181; Guimier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101990; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Inagaki T, 2015, J BIOL CHEM, V290, P4163, DOI 10.1074/jbc.M114.626929; INFANTE JP, 1977, BIOCHEM J, V167, P847, DOI 10.1042/bj1670847; Jansen SM, 2001, J BIOL CHEM, V276, P18722, DOI 10.1074/jbc.M101817200; KNIPPER M, 1989, NEUROCHEM INT, V14, P211, DOI 10.1016/0197-0186(89)90124-1; Kuang Y, 2017, ONCOTARGETS THER, V10, P3131, DOI 10.2147/OTT.S134784; Lochmann TL, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4680; Marcucci H, 2010, J BIOL CHEM, V285, P25382, DOI 10.1074/jbc.M110.139477; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paoletti L, 2016, MOL NEUROBIOL, V53, P6316, DOI 10.1007/s12035-015-9528-0; Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Zhao ER, 2017, CELL SIGNAL, V36, P222, DOI 10.1016/j.cellsig.2017.05.011; Zhao XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0066-8	29	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210207	10.1371/journal.pone.0210207	http://dx.doi.org/10.1371/journal.pone.0210207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629659	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000061
J	Handa, S; Shaw, KL; Ghosh, P				Handa, Sumit; Shaw, Kharissa L.; Ghosh, Partho			Crystal structure of a Thermus aquaticus diversity-generating retroelement variable protein	PLOS ONE			English	Article							DISPLAY SCAFFOLDS; LECTIN FOLD; EVOLUTION	Diversity-generating retroelements (DGRs) are widely distributed in bacteria, archaea, and microbial viruses, and bring about unparalleled levels of sequence variation in target proteins. While DGR variable proteins share low sequence identity, the structures of several such proteins have revealed the C-type lectin (CLec)-fold as a conserved scaffold for accommodating massive sequence variation. This conservation has led to the suggestion that the CLec-fold may be useful in molecular surface display applications. Thermostability is an attractive feature in such applications, and thus we studied the variable protein of a DGR encoded by a prophage of the thermophile Thermus aquaticus. We report here the 2.8 A resolution crystal structure of the variable protein from the T. aquaticus DGR, called TaqVP, and confirm that it has a CLec-fold. Remarkably, its variable region is nearly identical in structure to those of several other CLec-fold DGR variable proteins despite low sequence identity among these. TaqVP was found to be thermostable, which appears to be a property shared by several CLec-fold DGR variable proteins. These results provide impetus for the pursuit of the DGR variable protein CLec-fold in molecular display applications.	[Handa, Sumit; Shaw, Kharissa L.; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu		Shaw, Kharissa/0000-0002-4029-4088; Ghosh, Partho/0000-0003-0254-5218	National Institutes of Health [R01 AI096838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (https://www.nih.gov) R01 AI096838 (P.G.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Arambula D, 2013, P NATL ACAD SCI USA, V110, P8212, DOI 10.1073/pnas.1301366110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Brumm PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138674; Carugo O, 2008, PROTEIN SCI, V17, P2187, DOI 10.1110/ps.037762.108; Castelle CJ, 2018, CELL, V172, P1181, DOI 10.1016/j.cell.2018.02.016; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guo H, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0029-2014; Handa S, 2018, NUCLEIC ACIDS RES, V46, P9711, DOI 10.1093/nar/gky620; Handa S, 2016, BMC STRUCT BIOL, V16, DOI 10.1186/s12900-016-0064-6; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; KUWAJIMA K, 1991, BIOCHEMISTRY-US, V30, P7693, DOI 10.1021/bi00245a005; Le Coq J, 2011, P NATL ACAD SCI USA, V108, P14649, DOI 10.1073/pnas.1105613108; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Miller JL, 2008, PLOS BIOL, V6, P1195, DOI 10.1371/journal.pbio.0060131; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nimkulrat S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00852; Nuttall SD, 2008, CURR OPIN PHARMACOL, V8, P609, DOI 10.1016/j.coph.2008.06.007; Paul BG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.45; Paul BG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7585; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu L, 2018, NUCLEIC ACIDS RES, V46, P11, DOI 10.1093/nar/gkx1150; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Ye YZ, 2014, INT J MOL SCI, V15, P14234, DOI 10.3390/ijms150814234; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0205618	10.1371/journal.pone.0205618	http://dx.doi.org/10.1371/journal.pone.0205618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629599	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000007
J	Mitsuya, K; Nakasu, Y; Hayashi, N; Deguchi, S; Takahashi, T; Murakami, H; Naito, T; Kenmotsu, H; Ono, A; Wakuda, K; Harada, H				Mitsuya, Koichi; Nakasu, Yoko; Hayashi, Nakamasa; Deguchi, Shoichi; Takahashi, Toshiaki; Murakami, Haruyasu; Naito, Tateaki; Kenmotsu, Hirotsugu; Ono, Akira; Wakuda, Kazushige; Harada, Hideyuki			Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study	PLOS ONE			English	Article							NEOPLASTIC MENINGITIS; INTRATHECAL CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; LUMBOPERITONEAL SHUNT; CANCER PATIENTS; CARCINOMATOSIS; SURVIVAL; DISEASE; BRAIN; METHOTREXATE	Purpose Management of leptomeningeal metastasis-related hydrocephalus (LM-H) is particularly challenging regarding the control of severe headache, nausea, and vomiting due to intracranial hypertension. To investigate the improvements of performance status and outcome with cerebrospinal fluid (CSF) shunt surgery for LM-H in patients with lung adenocarcinoma. Methods Data on patients with leptomeningeal metastasis-related hydrocephalus from lung adenocarcinoma diagnosed by MR imaging and/or cytological examination were retrospectively analyzed. Between August 2008 and July 2017, the authors reviewed 31 patients requiring CSF shunt, who underwent ventriculo-peritoneal or lumbo-peritoneal shunt. Results The patients consisted of 11 men and 20 women with a median age of 59 years. Twenty-six patients received EGFR-tyrosine kinase inhibitors (TKIs). CSF shunt surgery yielded rapid improvement in the performance status of 90.3% of patients. Median overall survival from the diagnosis of LM in patients with ECOG performance status less than 2 was 7.7 months, and this was significantly longer than those in patients with PS 3 or 4 (4.4 or 1.5 months; p<0.001). Multivariate analysis by Cox regression revealed survival differences according to PS at diagnosis of LM [PS 1-3 vs. PS4, hazard ratio (HR) 0.201, p = 0.034], controlled extra-cranial disease (HR 0.248, p = 0.005), and post-shunt EGFR-TKI for LM treatment (HR 0.193, p = 0.008). Postoperative symptomatic peritoneal carcinomatosis was observed in one patient (3.2%). Conclusion CSF shunting may be a safe and effective strategy in patients with LM-H from lung adenocarcinoma. A prospective study is needed to establish the effectiveness and safety of palliative CSF shunt for LM-H.	[Mitsuya, Koichi; Nakasu, Yoko; Hayashi, Nakamasa; Deguchi, Shoichi] Shizuoka Canc Ctr, Div Neurosurg, Shizuoka, Japan; [Takahashi, Toshiaki; Murakami, Haruyasu; Naito, Tateaki; Kenmotsu, Hirotsugu; Ono, Akira; Wakuda, Kazushige] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Harada, Hideyuki] Shizuoka Canc Ctr, Div Radiat Oncol, Shizuoka, Japan	Shizuoka Cancer Center; Shizuoka Cancer Center; Shizuoka Cancer Center	Mitsuya, K (corresponding author), Shizuoka Canc Ctr, Div Neurosurg, Shizuoka, Japan.	k.mitsuya@scchr.jp	Naito, Tateaki/K-4703-2019	Naito, Tateaki/0000-0003-4047-2929; Mitsuya, Koichi/0000-0001-8956-5427				Aparicio A, 2002, CURR NEUROL NEUROSCI, V2, P325; BERGER MS, 1991, J NEUROSURG, V74, P872, DOI 10.3171/jns.1991.74.6.0872; Bruna J, 2009, CANCER-AM CANCER SOC, V115, P381, DOI 10.1002/cncr.24041; Chamberlain MC, 2009, SEMIN ONCOL, V36, pS35, DOI 10.1053/j.seminoncol.2009.05.005; Chamberlain MC, 1997, ARCH NEUROL-CHICAGO, V54, P1364, DOI 10.1001/archneur.1997.00550230037013; Chamberlain MC, 1998, ARCH NEUROL-CHICAGO, V55, P506, DOI 10.1001/archneur.55.4.506; Chuang TY, 2008, J FORMOS MED ASSOC, V107, P851, DOI 10.1016/S0929-6646(08)60201-6; DeAngelis LM, 2005, CANCER INVEST, V23, P145, DOI 10.1081/CNV-200050458; Demopoulos Alexis, 2004, Curr Neurol Neurosci Rep, V4, P196, DOI 10.1007/s11910-004-0039-z; Glantz MJ, 1999, CLIN CANCER RES, V5, P3394; Gong L, 2015, LUNG CANCER, V89, P268, DOI 10.1016/j.lungcan.2015.06.001; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Herrlinger U, 2004, J NEUROL SCI, V223, P167, DOI 10.1016/j.jns.2004.05.008; Jung TY, 2014, CLIN NEUROL NEUROSUR, V119, P80, DOI 10.1016/j.clineuro.2014.01.023; Kim DY, 2003, JPN J CLIN ONCOL, V33, P608, DOI 10.1093/jjco/hyg118; Le Rhun Emilie, 2013, Surg Neurol Int, V4, pS265, DOI 10.4103/2152-7806.111304; Lee SJ, 2013, J THORAC ONCOL, V8, P185, DOI 10.1097/JTO.0b013e3182773f21; Li YS, 2016, J THORAC ONCOL, V11, P1962, DOI 10.1016/j.jtho.2016.06.029; Lin N, 2011, J NEUROSURG, V115, P730, DOI 10.3171/2011.5.JNS101768; Masuda T, 2011, CANCER CHEMOTH PHARM, V67, P1465, DOI 10.1007/s00280-011-1555-6; Melisko ME, 2009, NAT CLIN PRACT ONCOL, V6, P25, DOI 10.1038/ncponc1243; Morris PG, 2012, J THORAC ONCOL, V7, P382, DOI 10.1097/JTO.0b013e3182398e4f; Omuro AMP, 2005, CANCER-AM CANCER SOC, V103, P2344, DOI 10.1002/cncr.21033; Omuro AMP, 2005, NEUROLOGY, V64, P1625, DOI 10.1212/01.WNL.0000160396.69050.DC; Palma JA, 2013, CLIN NEUROL NEUROSUR, V115, P19, DOI 10.1016/j.clineuro.2012.03.048; Park JH, 2012, LUNG CANCER, V76, P387, DOI 10.1016/j.lungcan.2011.11.022; Tailliberta S, 2006, CURR OPIN ONCOL, V18, P637, DOI 10.1097/01.cco.0000245323.19411.d7; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7; Yamashiro S, 2017, PALLIATIVE MED, V31, P93, DOI 10.1177/0269216316649128; Yi HG, 2009, LUNG CANCER, V65, P80, DOI 10.1016/j.lungcan.2008.10.016; Zhang XH, 2015, MED HYPOTHESES, V84, P506, DOI 10.1016/j.mehy.2015.02.009	31	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210074	10.1371/journal.pone.0210074	http://dx.doi.org/10.1371/journal.pone.0210074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629621	Green Published, Green Submitted, gold			2022-12-26	WOS:000455483000047
J	Patrignani, F; Siroli, L; Parolin, C; Serrazanetti, DI; Vitali, B; Lanciotti, R				Patrignani, Francesca; Siroli, Lorenzo; Parolin, Carola; Serrazanetti, Diana I.; Vitali, Beatrice; Lanciotti, Rosalba			Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections	PLOS ONE			English	Article							HIGH-PRESSURE HOMOGENIZATION; FUNCTIONAL FOODS; DOUBLE-BLIND; BACTERIAL VAGINOSIS; CRESCENZA CHEESE; FERMENTED MILKS; WOMEN; MICROBIOTA; HEALTH; ADVANCEMENTS	This research is aimed to evaluate the suitability of Squacquerone cheese to support the viability of Lactobacillus crispatus BC4, a vaginal strain endowed with a strong antimicrobial activity against urogenital pathogens and foodborne microorganisms, in order to recommend a gender food for woman wellbeing. The viability of L. crispatus BC4, used as adjunct culture, was evaluated during the refrigerated storage of Squacquerone cheese, as well as when the cheese was subjected to simulated stomach-duodenum passage tested by the patented Simulator of the Human Intestinal Microbial Ecosystem (SHIME). Moreover, the effects of L. crispatus BC4 addition were evaluated on product hydrolytic patterns, in terms of proteolysis, lipolysis and volatile molecule profiles. The data showed that L. crispatus BC4 maintained high viability, also in presence of physiological stress conditions, until the end of the refrigerated storage. Moreover, the inclusion of L. crispatus BC4 gave rise to cheese product with higher score of overall acceptability when compared to control cheese. In addition, the survival of L. crispatus BC4, carried in test cheese, in gastro intestinal conditions was confirmed by SHIME. The results showed that the vaginal Lactobacillus strain was more affected by the low pH of the stomach, simulated by the SHIME reactor, rather than to bile salts and pancreatic juices. Although only in vivo trials will be able to confirm the functionality of the cheese in the vaginal environment, these data represent a first step towards the employment of the Squacquerone cheese as probiotic food able to promote the woman's health by preventing gynaecological infections.	[Patrignani, Francesca; Siroli, Lorenzo; Serrazanetti, Diana I.; Lanciotti, Rosalba] Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci, Cesena, Italy; [Parolin, Carola; Vitali, Beatrice] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of Bologna; University of Bologna	Patrignani, F (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci, Cesena, Italy.	francesca.patrignani@unibo.it	SIROLI, LORENZO/K-4396-2015; parolin, carola/C-1144-2013; Patrignani, Francesca/K-4333-2015	SIROLI, LORENZO/0000-0002-2439-242X; parolin, carola/0000-0003-1536-9276; Patrignani, Francesca/0000-0002-6688-2638	GRANT ALMAIDEA 2017 by University of Bologna	GRANT ALMAIDEA 2017 by University of Bologna	This work was funded by GRANT ALMAIDEA 2017 given by University of Bologna. Grant recipient: Francesca Patrignani.	Barrons R, 2008, CLIN THER, V30, P453, DOI 10.1016/j.clinthera.2008.03.013; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Becker A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00687; Bohbot JM, 2018, J GYNECOL OBSTET HUM, V47, P81, DOI 10.1016/j.jogoh.2017.11.005; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Borges S, 2014, ARCH GYNECOL OBSTET, V289, P479, DOI 10.1007/s00404-013-3064-9; Burns P, 2008, J DAIRY SCI, V91, P500, DOI 10.3168/jds.2007-0516; Burns PG, 2015, J FUNCT FOODS, V13, P126, DOI 10.1016/j.jff.2014.12.037; da Silva BV, 2016, TRENDS FOOD SCI TECH, V50, P144, DOI 10.1016/j.tifs.2015.12.007; Dahiya DK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00563; das Neves J, 2008, DRUGS, V68, P1787, DOI 10.2165/00003495-200868130-00002; De Angelis M, 2006, RES MICROBIOL, V157, P792, DOI 10.1016/j.resmic.2006.05.003; Dols JAM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.012; Farhangi MA, 2018, CLIN NUTR, V37, P1216, DOI 10.1016/j.clnu.2017.06.005; Foschi C, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00502; Gallardo-Escamilla FJ, 2007, INT DAIRY J, V17, P308, DOI 10.1016/j.idairyj.2006.04.009; Gilbert SF, 2012, Q REV BIOL, V87, P325, DOI 10.1086/668166; Gobbetti M, 1998, J DAIRY SCI, V81, P37, DOI 10.3168/jds.S0022-0302(98)75548-1; Govender M, 2014, AAPS PHARMSCITECH, V15, P29, DOI 10.1208/s12249-013-0027-1; Han C, 2015, ARCH GYNECOL OBSTET, V291, P251, DOI 10.1007/s00404-014-3525-9; Heczko PB, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0246-6; Hossain MI, 2017, FOOD RES INT, V100, P63, DOI 10.1016/j.foodres.2017.07.077; Kimoto-Nira H, 2014, J DAIRY SCI, V97, P5898, DOI 10.3168/jds.2014-7980; Korzen-Bohr S, 2006, APPETITE, V46, P152, DOI 10.1016/j.appet.2005.11.003; Koutina G, 2018, INT DAIRY J, V77, P10, DOI 10.1016/j.idairyj.2017.09.001; KUCHROO CN, 1982, MILCHWISSENSCHAFT, V37, P331; Lindsay KL, 2014, AM J CLIN NUTR, V99, P1432, DOI 10.3945/ajcn.113.079723; Mackie A., 2015, IMPACT FOOD BIOACTIV, P13, DOI [10.1007/978-3-319-16104-4_2, DOI 10.1007/978-3-319-16104-4_2]; Macklaim Jean M., 2015, Microbial Ecology in Health and Disease, V26, P27799, DOI 10.3402/mehd.v26.27799; Marino M, 2011, MOL ASPECTS MED, V32, P1, DOI 10.1016/j.mam.2011.02.001; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Nagpal R, 2012, FEMS MICROBIOL LETT, V334, P1, DOI 10.1111/j.1574-6968.2012.02593.x; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; Parolin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131220; Patrignani F, 2007, J DAIRY SCI, V90, P4513, DOI 10.3168/jds.2007-0373; Patrignani F, 2016, INT J DAIRY TECHNOL, V69, P262, DOI 10.1111/1471-0307.12251; Prakash S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/981214; Rajoka MSR, 2017, FOOD SCI HUM WELL, V6, P121, DOI 10.1016/j.fshw.2017.07.003; Reid G, 2001, FEMS IMMUNOL MED MIC, V30, P49, DOI 10.1111/j.1574-695X.2001.tb01549.x; Rizzo A, 2015, INT J MED MICROBIOL, V305, P815, DOI 10.1016/j.ijmm.2015.07.005; Rizzo A, 2013, IMMUNOL LETT, V156, P102, DOI 10.1016/j.imlet.2013.08.013; Sanz Y, 2011, AM J CLIN NUTR, V94, p2000S, DOI 10.3945/ajcn.110.001172; Domingo JJS, 2017, GASTROENT HEPAT-BARC, V40, P417, DOI 10.1016/j.gastrohep.2016.12.003; Siro I, 2008, APPETITE, V51, P456, DOI 10.1016/j.appet.2008.05.060; Siroli L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00166; Strus M, 2012, EUR J OBSTET GYN R B, V163, P210, DOI 10.1016/j.ejogrb.2012.05.001; Tachedjian G, 2017, RES MICROBIOL, V168, P782, DOI 10.1016/j.resmic.2017.04.001; Tan YL, 2016, J MICROBIOL METH, V130, P123, DOI 10.1016/j.mimet.2016.09.011; Tanaka M, 2017, ALLERGOL INT, V66, P515, DOI 10.1016/j.alit.2017.07.010; Tofalo R, 2015, FOOD CHEM, V175, P121, DOI 10.1016/j.foodchem.2014.11.088; Tripathi MK, 2014, J FUNCT FOODS, V9, P225, DOI 10.1016/j.jff.2014.04.030; Van Biervliet S, 2017, CLIN NUTR ESPEN, V18, P37, DOI 10.1016/j.clnesp.2017.01.007; Vannini L, 2008, INT J FOOD MICROBIOL, V128, P329, DOI 10.1016/j.ijfoodmicro.2008.09.018; Vazquez-Fresno R, 2014, PHARMACOL RES, V87, P160, DOI 10.1016/j.phrs.2014.05.010; Vinderola G, 2011, INT J DAIRY TECHNOL, V64, P269, DOI 10.1111/j.1471-0307.2010.00659.x; Vitali B, 2016, CARBOHYD POLYM, V136, P1161, DOI 10.1016/j.carbpol.2015.10.035; Vitali B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-236; von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001; Vujic G, 2013, EUR J OBSTET GYN R B, V168, P75, DOI 10.1016/j.ejogrb.2012.12.031; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Yadav R, 2018, CRIT REV FOOD SCI, V58, P1735, DOI 10.1080/10408398.2016.1274877; Yadav R, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02116; Yadav R, 2017, CRIT REV FOOD SCI, V57, P3233, DOI 10.1080/10408398.2015.1108957; Younes JA, 2018, TRENDS MICROBIOL, V26, P16, DOI 10.1016/j.tim.2017.07.008	64	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0208906	10.1371/journal.pone.0208906	http://dx.doi.org/10.1371/journal.pone.0208906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625157	Green Published, gold, Green Submitted			2022-12-26	WOS:000455359400020
J	Pascarella, G; Capasso, A; Nardone, A; Triassi, M; Pignata, S; Arenare, L; Ascierto, P; Curvietto, M; Maiolino, P; D'Aniello, R; Montanino, A; Laudato, F; De Feo, G; Botti, G; Perrone, F; Petrillo, A; Cavalcanti, E; Lastoria, S; Maurea, N; Morabito, A				Pascarella, Giacomo; Capasso, Arturo; Nardone, Antonio; Triassi, Maria; Pignata, Sandro; Arenare, Laura; Ascierto, Paolo; Curvietto, Marcello; Maiolino, Piera; D'Aniello, Roberta; Montanino, Agnese; Laudato, Francesca; De Feo, Gianfranco; Botti, Gerardo; Perrone, Francesco; Petrillo, Antonella; Cavalcanti, Ernesta; Lastoria, Secondo; Maurea, Nicola; Morabito, Alessandro			Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology	PLOS ONE			English	Article								Aim The aim of the present study was to assess the estimated "per patient" total cost for a single Oncologic Italian Cancer Center pairticipating in a multicenter clinical trial with new anticancer biological agents using the activity-based costing (ABC) methodology. Methodology Nine randomized phase 3 clinical trials employing biological agents at the National Cancer Institute of Napoli, Italy, were analyzed to indentify "per patient" costs of each trial, according to the ABC methodology. The average consumption of resources for a patient completing the entire planned treatment was estimated for each trial. Through interviews of the personnel (doctors, nurses and technicians) and by analyses of the clinical trials protocols, the main activities of the 9 clinical trials were identified and, for each trial, the complete health care pathway of the patients and the treatment programmes were minutely reconstructed. Drug costs were not included because provided by Sponsors. Principal findings The average costs of the pre-study, treatment, monitoring, follow-up, audit, and administrative activities accounted for 2.357, 4.783, 700, 372, 1.263, and 9 Euro, respectively. The average total cost estimated for all "per patient" activities, including overhead costs, was 11.379 Euro. Staff costs accounted for (sic)5.988, while costs of diagnostic test accounted for 3.494 Euro. Clinical trials with immunotherapeutic drugs accounted for higher costs (+601 Euro as oncological staff costs, +1.318 Euro as intermediate services cost and +384 Euro as overheads). Conclusions The average total cost estimated for all "per patient" activities of a clinical trial with new anticancer biological agents was 11.379 Euro using the ABC methodology.	[Pascarella, Giacomo; De Feo, Gianfranco; Botti, Gerardo] IRCCS, Ist Nazl Tumori Fdn G Pascale, Sci Directorate, Naples, Italy; [Capasso, Arturo] Univ Sannio, Dipartimento Diritto Econ Management & Metodi Qua, Benevento, Italy; [Nardone, Antonio; Triassi, Maria] Univ Federico II, Dipartimento Sanita Pubbl, Naples, Italy; [Pignata, Sandro; Arenare, Laura] IRCCS, Ist Nazl Tumori Fdn G Pascale, Dipartimento Oncol Uroginecol, Naples, Italy; [Ascierto, Paolo; Curvietto, Marcello] IRCCS, Ist Nazl Tumori Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Naples, Italy; [Maiolino, Piera; D'Aniello, Roberta] IRCCS, Ist Nazl Tumori Fdn G Pascale, Hosp Pharm, Naples, Italy; [Montanino, Agnese; Laudato, Francesca; Morabito, Alessandro] IRCCS, Ist Nazl Tumori Fdn G Pascale, Thorac Med Oncol, Naples, Italy; [Perrone, Francesco] IRCCS, Ist Nazl Tumori Fdn G Pascale, Clin Trials Unit, Naples, Italy; [Petrillo, Antonella] IRCCS, Ist Nazl Tumori Fdn G Pascale, Radiol Unit, Naples, Italy; [Cavalcanti, Ernesta] IRCCS, Ist Nazl Tumori Fdn G Pascale, Lab Med Unit, Naples, Italy; [Lastoria, Secondo] IRCCS, Ist Nazl Tumori Fdn G Pascale, Nucl Med Unit, Naples, Italy; [Maurea, Nicola] IRCCS, Ist Nazl Tumori Fdn G Pascale, Div Cardiol, Naples, Italy	IRCCS Fondazione Pascale; University of Sannio; University of Naples Federico II; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Morabito, A (corresponding author), IRCCS, Ist Nazl Tumori Fdn G Pascale, Thorac Med Oncol, Naples, Italy.	a.morabito@istitutotumori.na.it	Pascarella, Giacomo/AAA-2674-2020; Perrone, Francesco/AAB-8283-2022; Ascierto, Paolo A/J-9106-2016; arenare, laura/AAB-5927-2022; Maurea, Nicola/AAC-2341-2022; CURVIETTO, MARCELLO/AAA-1375-2020; Montanino, Agnese/AAB-7030-2022; lastoria, secondo/J-9607-2018	Pascarella, Giacomo/0000-0002-6458-6106; Perrone, Francesco/0000-0002-9738-0526; Ascierto, Paolo A/0000-0002-8322-475X; CURVIETTO, MARCELLO/0000-0003-0734-1863; Arenare, Laura/0000-0001-7100-4517; Maurea, Nicola/0000-0003-3704-0092; lastoria, secondo/0000-0002-6649-9903; Melucci, Maria Teresa/0000-0002-1677-3345; pignata, sandro/0000-0002-8836-2633; Botti, Gerardo/0000-0002-6287-733X	Associazione Italiana per la Ricerca sul Cancro (AIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The Thoraco-Pulmonary Medical Oncology is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC). The authors would like to thank Dr. Francesca D'Ambrosio of the Istituto Nazionale Tumori-IRCCS-"Fondazione G.Pascale", Napoli Italy for her help in the submission process and Dr. Maria Gabriella Malzone for her contribution in revising the paper for language.	Chan Y C, 1993, Health Care Manage Rev, V18, P71; Emanuel EJ, 2003, J CLIN ONCOL, V21, P4145, DOI 10.1200/JCO.2003.08.156; Grandlich Cheryl, 2004, AORN J, V79, P189, DOI 10.1016/S0001-2092(06)61152-6; Horngren CT, 2001, MANAGEMENT ACCOUNTIN; Institute of Medicine, 2008, IMPR QUAL CANC CLIN; Jan E, 2001, ACTIVITY BASED COST; Jones B., 2015, J CLIN TRIALS, V5, P216; Lievens Y, 2003, INT J RADIAT ONCOL, V57, P522, DOI 10.1016/S0360-3016(03)00579-0; Ridderstolpe L, 2002, J MED SYST, V26, P309, DOI 10.1023/A:1015816703951; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Speich B, 2018, J CLIN EPIDEMIOL, V96, P73, DOI 10.1016/j.jclinepi.2017.12.022; Udpa S, 1996, HEALTH CARE MANAGE R, V21, P83, DOI 10.1097/00004010-199622000-00009	12	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210330	10.1371/journal.pone.0210330	http://dx.doi.org/10.1371/journal.pone.0210330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620767	gold, Green Submitted, Green Published			2022-12-26	WOS:000455161300028
J	Brandt, C; McFie, PJ; Vu, H; Chumala, P; Katselis, GS; Stone, SJ				Brandt, Curtis; McFie, Pamela J.; Vu, Huyen; Chumala, Paulos; Katselis, George S.; Stone, Scot J.			Identification of calnexin as a diacyiglycerol acyltransferase-2 interacting protein	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DIACYLGLYCEROL ACYLTRANSFERASE-2; TRIACYLGLYCEROL SYNTHESIS; QUALITY-CONTROL; LIPID DROPLETS; ACYL-COA; DGAT2; MEMBRANE; MITOCHONDRIA; COMPLEX	Triacylglycerol synthesis is catalyzed by acyl CoA:diacylglycerol acyltransferase-2 (DGAT2). DGAT2 is an integral membrane protein that is localized to the endoplasmic reticulum and interacts with lipid droplets. Using Biold, a method to detect proximal and interacting proteins, we identified calnexin as a DGAT2-interacting protein. Co-immunoprecipitation and proximity ligation assays confirmed this finding. We found that calnexin-deficient mouse embryonic fibroblasts had reduced intracellular triacylglycerol levels and fewer large lipid droplets (>1.0 mu m(2) area). Despite the alterations in triacylglycerol metabolism, in vitro DGAT2 activity, localization and protein stability were not affected by the absence of calnexin.	[Brandt, Curtis; McFie, Pamela J.; Vu, Huyen; Stone, Scot J.] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada; [Chumala, Paulos; Katselis, George S.] Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada; [Chumala, Paulos; Katselis, George S.] Univ Saskatchewan, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Stone, SJ (corresponding author), Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada.	scot.stone@usask.ca			Canadian Institutes of Health Research [123385]; Canada Foundation for Innovation; Heart and Stroke Foundation of Saskatchewan; College of Medicine James Regan Cardiology PhD Scholarship (University of Saskatchewan); John Spencer Middleton & Jack Spencer Gordon Middleton Bursary	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation of Saskatchewan; College of Medicine James Regan Cardiology PhD Scholarship (University of Saskatchewan); John Spencer Middleton & Jack Spencer Gordon Middleton Bursary	This work was supported by the Canadian Institutes of Health Research (FRN#123385) and the Canada Foundation for Innovation. CB was supported by funding from the Heart and Stroke Foundation of Saskatchewan, the College of Medicine James Regan Cardiology PhD Scholarship (University of Saskatchewan), and John Spencer Middleton & Jack Spencer Gordon Middleton Bursary. The funding sources had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Canadian Institutes of Health Research (FRN#123385) and the Canada Foundation for Innovation (SJS). CB was supported by funding from the Heart and Stroke Foundation of Saskatchewan, College of Medicine James Regan Cardiology PhD Scholarship, and John Spencer Middleton & Jack Spencer Gordon Middleton Bursary. The authors thank Brooke Thompson for her assistance with mass spectrometry sample preparation.	Aitchison AJ, 2015, MOL BIOL CELL, V26, P2927, DOI 10.1091/mbc.E15-03-0159; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bogdanovic E, 2015, J CELL MOL MED, V19, P82, DOI 10.1111/jcmm.12384; Brandt C, 2016, BIOCH J; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Choi K, 2014, FEBS J, V281, P3048, DOI 10.1111/febs.12841; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Dow RL, 2011, ACS MED CHEM LETT, V2, P407, DOI 10.1021/ml200051p; Dudek E, 2015, BIOCHEM BIOPH RES CO, V468, P889, DOI 10.1016/j.bbrc.2015.11.052; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Gardner TG, 2000, ARCH BIOCHEM BIOPHYS, V378, P182, DOI 10.1006/abbi.2000.1804; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; Jung J, 2017, BIOCHEM BIOPH RES CO, V493, P202, DOI 10.1016/j.bbrc.2017.09.046; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Lee D, 2015, J BIOL CHEM, V290, P5725, DOI 10.1074/jbc.M114.635474; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2014, BBA-MOL CELL BIOL L, V1841, P1318, DOI 10.1016/j.bbalip.2014.06.004; McFie PJ, 2011, J LIPID RES, V52, P1760, DOI 10.1194/jlr.D016626; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Myhill N, 2008, MOL BIOL CELL; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wang Q, 2015, MOLECULES, V20, P13689, DOI 10.3390/molecules200813689; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Ye F, 2011, J CELL BIOCHEM, V112, P3002, DOI 10.1002/jcb.23223	47	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210396	10.1371/journal.pone.0210396	http://dx.doi.org/10.1371/journal.pone.0210396			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615684	gold, Green Published, Green Submitted			2022-12-26	WOS:000455045900072
J	Sahlin, E; Green, A; Gustavsson, P; Lieden, A; Nordenskjold, M; Papadogiannakis, N; Pettersson, K; Nilsson, D; Jonasson, J; Iwarsson, E				Sahlin, Ellika; Green, Anna; Gustavsson, Peter; Lieden, Agne; Nordenskjold, Magnus; Papadogiannakis, Nikos; Pettersson, Karin; Nilsson, Daniel; Jonasson, Jon; Iwarsson, Erik			Identification of putative pathogenic single nucleotide variants (SNVs) in genes associated with heart disease in 290 cases of stillbirth	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; MUTATIONS; PREVALENCE; GENETICS	The incidence of stillbirth in Sweden has essentially remained constant since the 1980's, and despite thorough investigation, many cases remain unexplained. It has been suggested that a proportion of stillbirth cases is caused by heart disease, mainly channelopathies. The aim of this study was to analyze DNA from 290 stillbirth cases without chromosomal abnormalities for pathogenic single nucleotide variants (SNVs) in 70 genes associated with cardiac channelopathies and cardiomyopathies. The HaloPlex Target Enrichment System (Agilent Technologies) was utilized to prepare sequencing libraries which were sequenced on the Illumina NextSeq platform. We found that 12.1% of the 290 investigated stillbirth cases had one (n = 31) or two (n = 4) variants with evidence supporting pathogenicity, i.e. loss-of-function variants (nonsense, frameshift, splice site substitutions), evidence from functional studies, or previous identification of the variants in affected individuals. Regarding identified putative pathogenic variants in genes associated with channelopathies, the prevalence was significantly higher in the stillbirth cohort (n = 23, 7.93%) than the corresponding prevalence of the same variants in the non-Finnish European population of the Exome Aggregation Consortium (2.70%, p<0.001) and SweGen, (2.30%, p<0.001). Our results give further support to the hypothesis that cardiac channelopathies might contribute to stillbirth. Screening for pathogenic SNVs in genes associated with heart disease might be a valuable complement for stillbirth cases where today's conventional investigation does not reveal the underlying cause of fetal demise.	[Sahlin, Ellika; Gustavsson, Peter; Lieden, Agne; Nordenskjold, Magnus; Nilsson, Daniel; Iwarsson, Erik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Sahlin, Ellika; Green, Anna; Gustavsson, Peter; Lieden, Agne; Nordenskjold, Magnus; Nilsson, Daniel; Iwarsson, Erik] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Sahlin, Ellika; Green, Anna; Gustavsson, Peter; Lieden, Agne; Nordenskjold, Magnus; Nilsson, Daniel; Iwarsson, Erik] Karolinska Univ Hosp, Stockholm, Sweden; [Green, Anna; Jonasson, Jon] Linkoping Univ, Dept Clin Pathol & Clin Genet, Linkoping, Sweden; [Green, Anna; Jonasson, Jon] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Papadogiannakis, Nikos] Karolinska Univ Hosp, Ctr Perinatal Pathol, Stockholm, Sweden; [Papadogiannakis, Nikos] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden; [Pettersson, Karin] Karolinska Univ Hosp, Dept Obstet & Gynecol, Huddinge, Sweden; [Papadogiannakis, Nikos; Pettersson, Karin] Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sahlin, E (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Sahlin, E (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.; Sahlin, E (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	ellika.sahlin@ki.se	Nilsson, Daniel/B-8365-2009	Nilsson, Daniel/0000-0001-5831-385X; Nordenskjold, Magnus/0000-0002-4974-425X	FORSS, Forskningsradet i sydostra Sverige (the Medical Research Council of Southeast Sweden) [FORSS-307961]; Stockholms Ians landsting (Stockholm County Council) [SLL20160339]	FORSS, Forskningsradet i sydostra Sverige (the Medical Research Council of Southeast Sweden); Stockholms Ians landsting (Stockholm County Council)	This research was supported by FORSS, Forskningsradet i sydostra Sverige (the Medical Research Council of Southeast Sweden, http.//www.fou.nu/is/forss), grant FORSS-307961 (A.G.), and a grant from the Stockholms Ians landsting (Stockholm County Council, https//www.sll/se/), grant SLL20160339 (E.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2016, SWEGEN WHOLE GENOME, DOI [10.1101/081505, DOI 10.1101/081505]; Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; [Anonymous], TYPE 4 PILLI ACIDITH, DOI DOI 10.1038/EJHG.2012.283; [Anonymous], 2015, GRAVIDITETER FORLOSS; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Brion M, 2012, FORENSIC SCI INT, V219, P278, DOI 10.1016/j.forsciint.2012.01.018; Crotti L, 2013, JAMA-J AM MED ASSOC, V309, P1473, DOI 10.1001/jama.2013.3219; Dettmeyer RB, 2010, FORENSIC SCI INT, V194, pE21, DOI 10.1016/j.forsciint.2009.10.010; Green A, 2015, J MOL DIAGN, V17, P31, DOI 10.1016/j.jmoldx.2014.09.006; Hertz CL, 2016, EUR J HUM GENET, V24, P817, DOI 10.1038/ejhg.2015.198; Hosseini SM, 2018, CIRCULATION, V138, P1195, DOI 10.1161/CIRCULATIONAHA.118.035070; Ishikawa S, 2013, FETAL DIAGN THER, V33, P1, DOI 10.1159/000339150; Kim June-Bum, 2014, Korean J Pediatr, V57, P1, DOI 10.3345/kjp.2014.57.1.1; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lamont K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3080; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV13033997V1QBIOG; Petersson K, 2002, ACTA OBSTET GYN SCAN, V81, P284; Reddy UM, 2012, NEW ENGL J MED, V367, P2185, DOI 10.1056/NEJMoa1201569; Refsgaard L, 2012, EUR J HUM GENET, V20, P905, DOI 10.1038/ejhg.2012.23; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sahlin E, 2014, FETAL DIAGN THER, V36, P326, DOI 10.1159/000361017; Sarquella-Brugada G, 2016, INT J LEGAL MED, V130, P415, DOI 10.1007/s00414-016-1330-7; Sisakian H, 2014, WORLD J CARDIOL, V6, P478, DOI 10.4330/wjc.v6.i6.478; Tfelt-Hansen J, 2011, CARDIOLOGY, V119, P21, DOI 10.1159/000329047; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; Van Norstrand DW, 2009, HEART RHYTHM, V6, P272, DOI 10.1016/j.hrthm.2008.07.028; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Wapner RJ, 2010, CLIN OBSTET GYNECOL, V53, P628, DOI 10.1097/GRF.0b013e3181ee2793; Whiffin N, 2016, USING HIGH RESOLUTIO, DOI [10.1101/073114, DOI 10.1101/073114]	31	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210017	10.1371/journal.pone.0210017	http://dx.doi.org/10.1371/journal.pone.0210017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615648	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900034
J	Wu, YZ; Chan, KYY; Leung, KT; Lam, HS; Tam, YH; Lee, KH; Li, K; Ng, PC				Wu, Yu Zheng; Chan, Kathy Yuen Yee; Leung, Kam Tong; Lam, Hugh Simon; Tam, Yuk Him; Lee, Kim Hung; Li, Karen; Ng, Pak Cheung			Dysregulation of miR-431 and target gene FOXA1 in intestinal tissues of infants with necrotizing enterocolitis	FASEB JOURNAL			English	Article						Forkhead protein; microRNA; proinflammation; enterocyte	HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; MIRNA EXPRESSION; MICRORNAS; CANCER; REGULATORS; INVASION; DISEASE; MODELS	The level of microRNA (miR)-431 was found to be markedly up-regulated in intestinal tissue of necrotizing enterocolitis (NEC). The objective of this study was to identify the target gene of miR-431 and to investigate the role of the miR-431-FOXA1 axis in the pathophysiology of NEC. The target gene of miR-431 was identified by in silico target prediction bioinformatics, luciferase assay, and Western blotting. Effects of miR-431 on downstream expression signals, cell proliferation, and apoptosis were investigated by overexpression in Caco-2 cells upon stimulation by LPS or lipoteichoic acid (LTA). FOXA1 was identified as the target gene of miR-431. Overexpression of miR-431 in Caco-2 cells significantly inhibited FOXA1, ESRRG, and HNF4A and activated IL-6, LGR5, NFKB2, PLA2G2A, PRKCZ, and TNF. IL-8 and -10 were enhanced when costimulated with LPS or LTA. These potential downstream genes were also significantly dysregulated in primary NEC tissues compared with surgical-control tissues. Overexpression of miR-431 significantly decreased proliferation and increased apoptosis of Caco-2 cells. A proposed network of miR-431-FOXA1 interaction with LPS and LTA receptors demonstrates dysregulation of transcription factors, inflammatory mediators, epithelium tight junction regulators, and cell proliferation and apoptosis signals. The miR-431-FOXA1 axis could in part be responsible for the intensification of the inflammatory response in NEC tissues and contribute to the proinflammatory pathophysiology.	[Wu, Yu Zheng; Chan, Kathy Yuen Yee; Leung, Kam Tong; Lam, Hugh Simon; Li, Karen; Ng, Pak Cheung] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Dept Paediat, Level 6-F,Lui Che Woo Clin Sci Bldg, Hong Kong, Peoples R China; [Tam, Yuk Him; Lee, Kim Hung] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Dept Surg, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ng, PC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Dept Paediat, Level 6-F,Lui Che Woo Clin Sci Bldg, Hong Kong, Peoples R China.	pakcheungng@cuhk.edu.hk	Wu, Yuzheng/HHN-8865-2022; Lam, Hugh Simon/G-8373-2015; Leung, Kam Tong/I-8569-2017; Chan, Kathy/AAE-8538-2021	Lam, Hugh Simon/0000-0001-9912-0544; Leung, Kam Tong/0000-0002-7695-2513; Chan, Kathy/0000-0002-6501-9592	Hong Kong Special Administrative Region Health and Medical Research Fund Project [02130566]	Hong Kong Special Administrative Region Health and Medical Research Fund Project	This study was supported by the Hong Kong Special Administrative Region Health and Medical Research Fund Project 02130566. The authors declare no conflicts of interest.	Ares GJ, 2018, SEMIN PEDIATR SURG, V27, P29, DOI 10.1053/j.sempedsurg.2017.11.006; Chan KYY, 2014, ANN SURG, V260, P1128, DOI 10.1097/SLA.0000000000000374; Coggins SA, 2015, CLIN PERINATOL, V42, P133, DOI 10.1016/j.clp.2014.10.012; Dou CW, 2015, ONCOTARGET, V6, P13216, DOI 10.18632/oncotarget.3916; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Gupta A, 2016, EARLY HUM DEV, V97, P17, DOI 10.1016/j.earlhumdev.2016.03.008; Han XR, 2018, J CELL PHYSIOL, V233, P5895, DOI 10.1002/jcp.26394; Heida FH, 2017, J PERINATOL, V37, P67, DOI 10.1038/jp.2016.165; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Lee KP, 2015, GENE DEV, V29, P1605, DOI 10.1101/gad.263574.115; Lim JC, 2015, PEDIATR SURG INT, V31, P509, DOI 10.1007/s00383-015-3697-9; Lorenzen JM, 2015, J PHYSIOL-LONDON, V593, P1777, DOI 10.1113/JP270318; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ng PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135737; O'Sullivan F, 2017, WORLD J GASTROENTERO, V23, P7369, DOI 10.3748/wjg.v23.i41.7369; Papillon Stephanie, 2013, Adv Pediatr, V60, P263, DOI 10.1016/j.yapd.2013.04.011; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Patel RM, 2015, PEDIATR RES, V78, P232, DOI 10.1038/pr.2015.97; Ross SP, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00087; Roy I, 2014, GUT, V63, P1202, DOI 10.1136/gutjnl-2013-305886; Roy SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201172; Schmidt MF, 2014, TRENDS BIOTECHNOL, V32, P578, DOI 10.1016/j.tibtech.2014.09.002; Schultz NA, 2012, WORLD J SURG, V36, P2699, DOI 10.1007/s00268-012-1705-y; Sharma R, 2006, J PERINATOL, V26, P342, DOI 10.1038/sj.jp.7211510; Tu HH, 2015, ONCOTARGETS THER, V8, P2227, DOI 10.2147/OTT.S87976; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Ree MH, 2016, ALIMENT PHARM THER, V43, P102, DOI 10.1111/apt.13432; van der Sluis M, 2008, BIOCHEM BIOPH RES CO, V369, P1108, DOI 10.1016/j.bbrc.2008.02.158; Veenstra M, 2014, SURGERY, V156, P578, DOI 10.1016/j.surg.2014.04.031; Wang D, 2018, ACTA PHARMACOL SIN, V39, P124, DOI 10.1038/aps.2017.89; Wu RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8713; Xu XM, 2016, WORLD J GASTROENTERO, V22, P2206, DOI 10.3748/wjg.v22.i7.2206; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059; Yu Q, 2018, ONCOL LETT, V15, P8088, DOI 10.3892/ol.2018.8347; Zhu X, 2016, ONCOTARGET, V7, P13139, DOI 10.18632/oncotarget.7545	41	20	24	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5143	5152		10.1096/fj.201801470R	http://dx.doi.org/10.1096/fj.201801470R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30624964	Bronze			2022-12-26	WOS:000462888500042
J	Hollnagel, JO; Elzoheiry, S; Gorgas, K; Kins, S; Beretta, CA; Kirsch, J; Kuhse, J; Kann, O; Kiss, E				Hollnagel, Jan-Oliver; Elzoheiry, Shehabeldin; Gorgas, Karin; Kins, Stefan; Beretta, Carlo Antonio; Kirsch, Joachim; Kuhse, Jochen; Kann, Oliver; Kiss, Eva			Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis	PLOS ONE			English	Article							PARVALBUMIN-IMMUNOREACTIVE NEURONS; GAMMA-OSCILLATIONS; SYNAPTIC PLASTICITY; PRESYNAPTIC BOUTONS; ENTORHINAL CORTEX; PROTEIN GEPHYRIN; DENTATE GYRUS; CALRETININ; BETA; INTERNEURONS	Several lines of evidence imply changes in inhibitory interneuron connectivity and subsequent alterations in oscillatory network activities in the pathogenesis of Alzheimer's Disease (AD). Recently, we provided evidence for an increased immunoreactivity of both the postsynaptic scaffold protein gephyrin and the GABA(A) receptor gamma 2-subunit in the hippocampus of young (1 and 3 months of age), APPPS1 mice. These mice represent a well-established model of cerebral amyloidosis, which is a hallmark of human AD. In this study, we demonstrate a robust increase of parvalbumin immunoreactivity and accentuated projections of parvalbumin positive (PV+) interneurons, which target perisomatic regions of pyramidal cells within the hippocampal subregions CA1 and CA3 of 3-month-old APPPS1 mice. Colocalisation studies confirmed a significant increase in the density of PV+ projections labeled with antibodies against a presynaptic (vesicular GABA transporter) and a postsynaptic marker (gephyrin) of inhibitory synapses within the pyramidal cell layer of CA1 and CA3. As perisomatic inhibition by PV+-interneurons is crucial for the generation of hippocampal network oscillations involved in spatial processing, learning and memory formation we investigated the impact of the putative enhanced perisomatic inhibition on two types of fast neuronal network oscillations in acute hippocampal slices: 1. spontaneously occurring sharp wave-ripple complexes (SPW-R), and 2. cholinergic gamma-oscillations. Interestingly, both network patterns were generally preserved in APPPS1 mice similar to WT mice. However, the comparison of simultaneous CA3 and CA1 recordings revealed that the incidence and amplitude of SPW-Rs were significantly lower in CA1 vs CA3 in APPPS1 slices, whereas the power of gamma-oscillations was significantly higher in CA3 vs CA1 in WT-slices indicating an impaired communication between the CA3 and CA1 network activities in APPPS1 mice. Taken together, our data demonstrate an increased GABAergic synaptic output of PV+ interneurons impinging on pyramidal cells of CA1 and CA3, which might limit the coordinated cross-talk between these two hippocampal areas in young APPPS1 mice and mediate long-term changes in synaptic inhibition during progression of amyloidosis.	[Hollnagel, Jan-Oliver; Elzoheiry, Shehabeldin; Kann, Oliver] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Gorgas, Karin; Kirsch, Joachim; Kuhse, Jochen; Kiss, Eva] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Kins, Stefan] Univ Kaiserslautern, Dept Human Biol & Human Genet, Kaiserslautern, Germany; [Beretta, Carlo Antonio] Heidelberg Univ, CellNetworks Math Clin Core Facil, Heidelberg, Germany; [Kiss, Eva] Univ Med & Pharm Targu Mures, Dept Cellular & Mol Biol, Targu Mures, Romania	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Kaiserslautern; Ruprecht Karls University Heidelberg; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Kuhse, J; Kiss, E (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.; Kiss, E (corresponding author), Univ Med & Pharm Targu Mures, Dept Cellular & Mol Biol, Targu Mures, Romania.	jochen.kuhse@urz.uni-heidelberg.de; kiss@ana.uni-heidelberg.de	Kann, Oliver/M-4302-2019; Kuhse, Jochen/T-3864-2019	Kann, Oliver/0000-0003-4365-8067; , Eva/0000-0003-4052-2797; hollnagel, jan-oliver/0000-0002-4060-0022	Romanian Ministry of Research and Innovation CNCS- UEFISCDI within PNCDI III [PN-III-P4-ID-PCE-2016-0052]; Alzheimer Forschung Initiative e.V. (AFI) [17024]	Romanian Ministry of Research and Innovation CNCS- UEFISCDI within PNCDI III; Alzheimer Forschung Initiative e.V. (AFI)	This work was supported by a grant of Romanian Ministry of Research and Innovation CNCS- UEFISCDI (PN-III-P4-ID-PCE-2016-0052, within PNCDI III) to E.K. and was supported by a grant of the Alzheimer Forschung Initiative e.V. (AFI) (Project number: 17024) to J. Kuhse; E.K; S.K. URLs of funders: http://uefiscdi.gov.ro, https:// www.alzheimer-forschung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant of Romanian Ministry of Research and Innovation CNCS- UEFISCDI (PN-III-P4-ID-PCE-2016-0052, within PNCDI III) to E.K and a grant of the Alzheimer Forschung Initiative e.V. (AFI) (Project number: 17024) to J. Kuhse, E. K. and S.K.	Albuquerque MS, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/Thagi.2015.00030, 10.3389/fnagi.2015.00030]; Arendt T, 1997, J NEUROSCI, V17, P516; Auffret A, 2009, J NEUROSCI, V29, P10144, DOI 10.1523/JNEUROSCI.1856-09.2009; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Battaglia S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0203-17.2017; Bell KFS, 2003, NEUROSCI LETT, V353, P143, DOI 10.1016/j.neulet.2003.09.027; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Brady DR, 1997, NEUROSCIENCE, V80, P1113, DOI 10.1016/S0306-4522(97)00068-7; BRION JP, 1994, ACTA NEUROPATHOL, V88, P33, DOI 10.1007/BF00294357; Brown JA, 2015, MOL PSYCHIATR, V20, P1499, DOI 10.1038/mp.2014.192; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, ANNU REV NEUROSCI, V35, P203; Caliskan G, 2016, CEREB CORTEX, V26, P2325, DOI 10.1093/cercor/bhw001; Canas PM, 2014, NEUROPHARMACOLOGY, V76, P51, DOI 10.1016/j.neuropharm.2013.08.026; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen M, 2017, ELIFE, V6, DOI 10.7554/eLife.20142; Chevaleyre V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00093; Chong SA, 2011, NEUROBIOL DIS, V44, P284, DOI 10.1016/j.nbd.2011.07.006; da Silva SV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11915; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Driver JE, 2007, EUR J NEUROSCI, V26, P1280, DOI 10.1111/j.1460-9568.2007.05705.x; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; FLOOD DG, 1990, PROG BRAIN RES, V83, P435; Flores CE, 2015, P NATL ACAD SCI USA, V112, pE65, DOI 10.1073/pnas.1411170112; FONSECA M, 1993, NEUROSCIENCE, V55, P1107, DOI 10.1016/0306-4522(93)90324-9; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Hengen KB, 2016, CELL, V165, P180, DOI 10.1016/j.cell.2016.01.046; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; HOF PR, 1991, J NEUROPATH EXP NEUR, V50, P451, DOI 10.1097/00005072-199107000-00006; HOF PR, 1993, NEUROSCI LETT, V152, P145, DOI 10.1016/0304-3940(93)90504-E; Hollnagel JO, 2015, NEUROSCIENCE, V284, P459, DOI 10.1016/j.neuroscience.2014.10.016; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hu L, 2003, NEUROSCIENCE, V121, P421, DOI 10.1016/S0306-4522(03)00394-4; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; Kiss E, 2016, AM J PATHOL, V186, P2279, DOI 10.1016/j.ajpath.2016.05.013; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klein AS, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00083; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; LEUNG LWS, 1982, ELECTROEN CLIN NEURO, V54, P203, DOI 10.1016/0013-4694(82)90162-6; Li YF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00031; Lietzau G, 2017, PSYCHONEUROENDOCRINO, V82, P46, DOI 10.1016/j.psyneuen.2017.04.012; Machado NJ, 2017, MOL NEUROBIOL, V54, P1552, DOI 10.1007/s12035-016-9774-9; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; Mikkonen M, 1999, NEUROSCIENCE, V92, P515, DOI 10.1016/S0306-4522(99)00047-0; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; PIKE CJ, 1994, NEUROSCIENCE, V63, P517, DOI 10.1016/0306-4522(94)90547-9; Popovic M, 2008, NEUROSCIENCE, V155, P182, DOI 10.1016/j.neuroscience.2008.05.023; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roumis DK, 2015, CURR OPIN NEUROBIOL, V35, P6, DOI 10.1016/j.conb.2015.05.001; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Schlingloff D, 2014, J NEUROSCI, V34, P11385, DOI 10.1523/JNEUROSCI.0867-14.2014; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Simburger E, 2000, CEREB CORTEX, V10, P422, DOI 10.1093/cercor/10.4.422; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Solodkin A, 1996, J NEUROSCI, V16, P3311; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; SU JH, 1993, BRAIN RES, V625, P228, DOI 10.1016/0006-8993(93)91063-X; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Teter B, 2002, J NEUROSCI RES, V70, P402, DOI 10.1002/jnr.10441; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Verdaguer E, 2015, EXP GERONTOL, V69, P176, DOI 10.1016/j.exger.2015.06.013; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang Y., 2017, J ALZHEIMERS DIS PAR, V7; Witton J, 2016, J PHYSIOL-LONDON, V594, P4615, DOI 10.1113/jphysiol.2014.282889; Zott B, 2018, ANNU REV NEUROSCI, V41, P277, DOI 10.1146/annurev-neuro-080317-061725	89	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209228	10.1371/journal.pone.0209228	http://dx.doi.org/10.1371/journal.pone.0209228			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645585	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200008
J	Kalembo, FW; Kendall, GE; Ali, M; Chimwaza, AF				Kalembo, Fatch Welcome; Kendall, Garth E.; Ali, Mohammed; Chimwaza, Angela F.			Socio-demographic, clinical, and psychosocial factors associated with primary caregivers' decisions regarding HIV disclosure to their child aged between 6 and 12 years living with HIV in Malawi	PLOS ONE			English	Article							INFECTED CHILDREN; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; LIFE EXPECTANCY; SOCIAL SUPPORT; FAMILY SCALE; DIAGNOSIS; IMPACT; ADOLESCENTS; FOUNDATION	The World Health Organisation (WHO) recommends that children living with HIV should be informed about their HIV status within the ages of 6 to 12 years using age-appropriate resources. The aim of this study was to assess the socio-demographic, clinical and psycho-social factors associated with primary caregivers' decisions to disclose HIV to children living with HIV aged 6 to 12 years in Malawi. A cross-sectional study of 429 primary caregivers of children living with HIV were systematically recruited from all regions of the country. Information on HIV disclosure, family and child socio-demographic characteristics, child clinical characteristics, and child and family psychosocial characteristics was collected using validated instruments. Logistic regression was used to analyse data. The prevalence of non-disclosure of HIV status to children was 64 per cent. Concerns about the child's inability to cope with the news (29%), a lack of knowledge on how to disclose HIV status (19%), and fear of stigma and discrimination (17%) were the main reasons for non-disclosure. On multivariate analysis, the odds of non-disclosure were higher among primary caregivers who were farmers (aOR 3.0; 95% CI: 1.1-8.4), in younger children (6-8 years) (aOR 4.1; 95% CI: 2.3-7.4), in children who were in WHO HIV clinical stage one (aOR 3.8; 95% CI: 1.4-10.2), and in children who were not asking why they were taking ARVs (aOR 2.9; 95% CI: 1.8-4.8). On the other hand, nondisclosure of HIV status was less likely in underweight children (aOR 0.6; 95% CI: 0.3-0.9). Many children living with HIV in Malawi are unaware of their HIV status. Non-disclosure is associated with a number of clinical and demographic characteristics. The findings highlight the need to provide guidance and support to primary caregivers to help them to effectively disclose HIV status to their children.	[Kalembo, Fatch Welcome; Kendall, Garth E.; Ali, Mohammed] Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia; [Kalembo, Fatch Welcome] Mzuzu Univ, Fac Hlth Sci, Mzuzu, Malawi; [Chimwaza, Angela F.] Univ Malawi, Kamuzu Coll Nursing, Blantyre, Malawi	Curtin University; University of Malawi	Kalembo, FW (corresponding author), Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia.; Kalembo, FW (corresponding author), Mzuzu Univ, Fac Hlth Sci, Mzuzu, Malawi.	kalembofatch@yahoo.com		Kalembo, Fatch W./0000-0003-3032-3495				Amare Alemu, 2013, Journal of AIDS and Clinical Research, V4, P253; American Academy Paediatrics, 1999, J AM ACAD PEDIAT, V103, P164; Anderson M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-22; [Anonymous], 2011, MAL DEM HLTH SURV; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Binagwaho A., 2012, RWANDA MED J, V69, P9; Brewer Devon D, 2012, F1000Res, V1, P1, DOI 10.12688/f1000research.1-1.v1; Demmer C, 2011, AIDS CARE, V23, P873, DOI 10.1080/09540121.2010.542123; Doku Paul Narh, 2009, Int J Ment Health Syst, V3, P26, DOI 10.1186/1752-4458-3-26; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Dunst C., 1988, ENABLING EMPOWERING; DUNST CJ, 1986, AM J MENT DEF, V90, P403; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Fry K., 2014, MEASURING EQUITY NAT; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R., SCORING STRENGTHS DI; Government of Malawi, 2016, MAL POP BAS HIV IMP; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Heeren GA, 2012, VULNERABLE CHILD YOU, V7, P47, DOI 10.1080/17450128.2012.656733; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Kajubi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147119; Kajubi P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19012; Kiwanuka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093276; Kuczmarski RJ, 2000, HEALTH, V11, P1; Madiba S., 2016, NURSING RES PRACTICE, V2016; Madiba S, 2016, NURS RES PRACT, V2016, DOI 10.1155/2016/9637587; Madiba S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/402403; Madiba S, 2015, PEERJ, V3, DOI 10.7717/peerj.893; Mahloko JM, 2012, AFR J ODI DISTR S AF, V4, P1, DOI [10.4102/phcfm.v4i1.345, DOI 10.4102/PHCFM.V4I1.345]; Malawi National Statistical Office Integrated Household Survey, 2010, HOUS SOC CHAR REP; Mandalazi P, 2014, MALAWI MED J, V26, P101; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; Mccleary-Sills J, 2013, J HIV-AIDS SOC SERV, V12, P49, DOI 10.1080/15381501.2012.749818; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Mutevedzi PC, 2014, TROP MED INT HEALTH, V19, P1015, DOI 10.1111/tmi.12344; Namasopo-Oleja MS, 2015, AFR HEALTH SCI, V15, P344, DOI 10.4314/ahs.v15i2.6; Namukwaya S, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00343; Nsanzimana S, 2015, LANCET GLOB HEALTH, V3, pE169, DOI 10.1016/S2214-109X(14)70364-X; Nyando MC, 2014, EXPERIENCES CAREGIVE; Nzota MS, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0399-3; O'Malley G, 2014, J ACQ IMMUN DEF SYND, V68, pe1, DOI DOI 10.1097/QAI; Oddy WH, 2010, J PEDIATR-US, V156, P568, DOI 10.1016/j.jpeds.2009.10.020; Odiachi A, 2017, VULNERABLE CHILD YOU, V12, P58, DOI 10.1080/17450128.2016.1247220; Odiachi A, 2016, AIDS CARE, V28, P1046, DOI 10.1080/09540121.2016.1147018; Pindani M, 2014, WORLD J AIDS, V2014, DOI [10.4236/wja.2014.43039, DOI 10.4236/WJA.2014.43039]; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; Sharer M, 2016, AIDS CARE, V28, P110, DOI 10.1080/09540121.2016.1178942; Sheeran T, 1997, J PEDIATR PSYCHOL, V22, P197; Sirikum C, 2014, AIDS CARE, V26, P1144, DOI 10.1080/09540121.2014.894614; Skeen S, 2014, CHILD YOUTH SERV REV, V45, P90, DOI 10.1016/j.childyouth.2014.03.041; SPINETTA JJ, 1975, PEDIATRICS, V56, P1034; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; STEIN REK, 1980, MED CARE, V18, P465, DOI 10.1097/00005650-198004000-00010; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; TENNANT C, 1976, AUST NZ J PSYCHIAT, V10, P27, DOI 10.3109/00048677609159482; TENNANT C, 1979, PSYCHOL MED, V9, P525, DOI 10.1017/S0033291700032086; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Turissini ML, 2013, J PEDIATR INFECT DIS, V2, P136, DOI 10.1093/jpids/pit024; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2014, BEG END AIDS EP; United Nations programme for HIV/ AIDS Malawi, 2016, HIV EST; Vaz L, 2008, AIDS CARE, V20, P842, DOI 10.1080/09540120701742276; Vaz LME, 2011, J DEV BEHAV PEDIATR, V32, P307, DOI 10.1097/DBP.0b013e31820f7a47; Vreeman RC, 2015, AIDS CARE, V27, P6, DOI 10.1080/09540121.2015.1026307; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2014, PROC TRANSL AD INSTR	76	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210781	10.1371/journal.pone.0210781	http://dx.doi.org/10.1371/journal.pone.0210781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645639	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200053
J	Jansen, P; Scheer, C; Zayed, K				Jansen, Petra; Scheer, Clara; Zayed, Kashef			Motor ability and working memory in Omani and German primary school-aged children	PLOS ONE			English	Article							6-YEAR-OLD CHILDREN; GENDER-DIFFERENCES; COORDINATION; PERFORMANCE; ATTENTION; CULTURE; FITNESS; EXPERT	This study investigated the motor ability and working memory performance of Omani and German primary school-aged children. One hundred eighty-five children from public schools participated in a gross motor test that integrated whole body coordination, three different ball tasks, and a 20-meter run. Furthermore, they completed four working memory tests (the Digit-Span Test forward and backwards and the Corsi Block-Tapping Test forward and backwards). Two MANOVAS with the different motor and working memory tests and one univariate analysis of the general motor ability with the between-subject factors group and gender were conducted. Additionally, correlations between motor ability and working memory scores were executed. German children outperformed Omani children in the overall measurement of motor ability, (p = .01) and all aspects of working memory, (all p<.015). There were no correlations between motor and cognitive variables, when analyzing the results for the Omani and German children separately. These findings may be a result of different educational styles or socioeconomic status and must be investigated in more detail.	[Jansen, Petra; Scheer, Clara] Univ Regensburg, Fac Psychol Pedag & Sport Sci, Regensburg, Germany; [Zayed, Kashef] Sultan Qaboos Univ, Dept Phys Educ, Muscat, Oman	University of Regensburg; Sultan Qaboos University	Jansen, P (corresponding author), Univ Regensburg, Fac Psychol Pedag & Sport Sci, Regensburg, Germany.	petra.jansen@ur.de		Jansen, Petra/0000-0002-0973-2158; Zayed, Kashef/0000-0001-6440-4643	Deanship of Research at Sultan Qaboos University [IG/EDU/PHED/17/02]	Deanship of Research at Sultan Qaboos University	The study was approved and funded by the Deanship of Research at Sultan Qaboos University, IG/EDU/PHED/17/02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2008, J LEARN DISABIL-US, V41, P251, DOI 10.1177/0022219408315815; Amer T, 2017, BRIT J PSYCHOL, V108, P244, DOI 10.1111/bjop.12194; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bardid F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00964; Bos K, 2002, GESUNDHEITSWESEN, V64, pS80; Castelli DM, 2014, MONOGR SOC RES CHILD, V79, P119, DOI 10.1111/mono.12133; Chow SMK, 2001, AM J OCCUP THER, V55, P55, DOI 10.5014/ajot.55.1.55; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Corsi P., 1972, THESIS; de Abreu PMJE, 2014, MEMORY, V22, P323, DOI 10.1080/09658211.2013.781186; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Guida A, 2018, COGNITION, V175, P96, DOI 10.1016/j.cognition.2018.02.013; Hill AC, 2014, BIOL PSYCHOL, V102, P18, DOI 10.1016/j.biopsycho.2014.06.008; Hsieh SS, 2017, MED SCI SPORT EXER, V49, P2537, DOI 10.1249/MSS.0000000000001399; Huttermann S, 2014, PHYSIOL BEHAV, V131, P87, DOI 10.1016/j.physbeh.2014.04.020; Islam M Mazharul, 2015, Oman Med J, V30, P241, DOI 10.5001/omj.2015.50; Jansen P, 2018, J GENET PSYCHOL, P1; Jansen P, 2016, LEARN INDIVID DIFFER, V51, P284, DOI 10.1016/j.lindif.2016.08.033; Kahan D, 2015, CLIN OBES, V5, P87, DOI 10.1111/cob.12089; Kahan David, 2015, Prev Med Rep, V2, P71, DOI 10.1016/j.pmedr.2014.12.007; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Kokstejn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176556; Lehmann J, 2014, EUR J DEV PSYCHOL, V11, P560, DOI 10.1080/17405629.2014.888995; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Petermann F., 2010, HAWIK 4 HAMBURG WECH; Piek JP, 2004, ARCH CLIN NEUROPSYCH, V19, P1063, DOI 10.1016/j.acn.2003.12.007; R?thlisberger M., 2013, J ED DEV PSYCHOL, V3, P153, DOI [DOI 10.5539/JEDP.V3N2P153, 10.5539/jedp.v3n2p153]; Raine LB, 2018, J COGNITIVE ENHANCEM, P1; Rigoli D, 2012, ARCH CLIN NEUROPSYCH, V27, P766, DOI 10.1093/arclin/acs061; Roth A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7231818; Samuel RD, 2017, J HUM KINET, V57, P85, DOI 10.1515/hukin-2017-0050; Sjowall D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01342; van der Fels IMJ, 2015, J SCI MED SPORT, V18, P697, DOI 10.1016/j.jsams.2014.09.007; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Voyer D, 2017, PSYCHON B REV, V24, P307, DOI 10.3758/s13423-016-1085-7; Wassenberg R, 2005, CHILD DEV, V76, P1092, DOI 10.1111/j.1467-8624.2005.00899.x; Zayed K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02477	41	2	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209848	10.1371/journal.pone.0209848	http://dx.doi.org/10.1371/journal.pone.0209848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640912	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000015
J	Flores, RMO; Distel, JS; Aguilera, MO; Beron, W				Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Beron, Walter			The role of microtubules and the dynein/dynactin motor complex of host cells in the biogenesis of the Coxiella burnetii-containing vacuole	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; EFFECTOR PROTEIN; ALPHA-TUBULIN; RAB7 EFFECTOR; DYNEIN; ACETYLATION; TRANSPORT; TRAFFICKING; RECRUITMENT; INHIBITION	Microtubules (Mts) are dynamic cytoskeleton structures that play a key role in vesicular transport. The Mts-mediated transport depends on motor proteins named kinesins and the dynein/dynactin motor complex. The Rab7 adapter protein FYCO1 controls the anterograde transport of the endocytic compartments through the interaction with the kinesin KIF5. Rab7 and its partner RILP induce the recruitment of dynein/dynactin to late endosomes regulating its retrograde transport to the perinuclear area to fuse with lysosomes. The late endosomal-lysosomal fusion is regulated by the HOPS complex through its interaction with RILP and the GTPase Arl8. Coxiella burnetii (Cb), the causative agent of Q fever, is an obligate intracellular pathogen, which generates a large compartment with autophagolysosomal characteristics named Cb-containing vacuole (CCV). The CCV forms through homotypic fusion between small non-replicative CCVs (nrCCV) and through heterotypic fusion with other compartments, such as endosomes and lysosomes. In this work, we characterise the role of Mts, motor proteins, RILP/Rab7 and Arl8 on the CCV biogenesis. The formation of the CCV was affected when either the dynamics and/or the acetylation state of Mts were modified. Similarly, the overexpression of the dynactin subunit non-functional mutants p150(Glued) and RILP led to the formation of small nrCCVs. This phenomenon is not observed in cells overexpressing WT proteins, the motor KIF5 or its interacting protein FYCO1. The formation of the CCV was normal in infected cells that overexpressed Arl8 alone or together with hVps41 (a HOPS subunit) or in cells co-overexpressing hVps41 and RILP. The dominant negative mutant of Arl8 and the non-functional hVps41 inhibited the formation of the CCV. When the formation of CCV was affected, the bacterial multiplication diminished. Our results suggest that nrCCVs recruit the molecular machinery that regulate the Mts-dependent retrograde transport, Rab7/RILP and the dynein/dynactin system, as well as the tethering processes such as HOPS complex and Arl8 to finally originate the CCV where C. burnetii multiplies.	[Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Beron, Walter] Univ Nacl Cuyo, Fac Ciencias Med, CONICET, Inst Histol & Embriol, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Beron, W (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, CONICET, Inst Histol & Embriol, Mendoza, Argentina.	wberon@fcm.uncu.edu.ar	Ortiz Flores, Rodolfo Matias/ABA-5380-2021	Ortiz Flores, Rodolfo Matias/0000-0003-4509-0161; Beron, Walter/0000-0001-9654-5467; Distel, Jesus Sebastian/0000-0003-4589-5314	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) [PICT-2012-2425]; SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2016-2017), Universidad Nacional de Cuyo	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica)(ANPCyT); SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2016-2017), Universidad Nacional de Cuyo	This work was supported by grants from ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) (PICT-2012-2425) and SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2016-2017), Universidad Nacional de Cuyo, to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Aguilar A, 2014, MOL BIOL CELL, V25, P1854, DOI 10.1091/mbc.E13-10-0609; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bhuwania R, 2014, EUR J CELL BIOL, V93, P424, DOI 10.1016/j.ejcb.2014.07.006; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Bouwman LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054759; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Clausen JD, 1997, MOL MICROBIOL, V25, P441, DOI 10.1046/j.1365-2958.1997.4591832.x; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dumont A, 2010, TRAFFIC, V11, P899, DOI 10.1111/j.1600-0854.2010.01069.x; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Guardia CM, 2016, CELL REP, V17, P1950, DOI 10.1016/j.celrep.2016.10.062; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; HECHEMY KE, 1993, INFECT IMMUN, V61, P4485, DOI 10.1128/IAI.61.10.4485-4488.1993; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Howe D, 2003, ANN NY ACAD SCI, V990, P556, DOI 10.1111/j.1749-6632.2003.tb07426.x; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huynh KK, 2010, J INNATE IMMUN, V2, P522, DOI 10.1159/000319864; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kaniuk NA, 2011, CELL MICROBIOL, V13, P1812, DOI 10.1111/j.1462-5822.2011.01663.x; Khatter Divya, 2015, Cell Logist, V5, pe1086501; Khatter D, 2015, J CELL SCI, V128, P1746, DOI 10.1242/jcs.162651; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Lin XS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07282; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Magiera MM, 2014, CURR BIOL, V24, pR351, DOI 10.1016/j.cub.2014.03.032; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Meyer DH, 1999, INFECT IMMUN, V67, P6518; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Personnic N, 2016, TRENDS MICROBIOL, V24, P450, DOI 10.1016/j.tim.2016.02.003; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; PRESTON RA, 1992, GENETICS, V131, P551; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Rajashekar R, 2011, EUR J CELL BIOL, V90, P897, DOI 10.1016/j.ejcb.2011.05.008; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Richards TS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-185; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sadoul K, 2016, BIOCHEM J, V473, P1859, DOI 10.1042/BCJ20160172; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shaaban KA, 2014, J ANTIBIOT, V67, P223, DOI 10.1038/ja.2013.113; Sherwood RK, 2013, CELL HOST MICROBE, V14, P256, DOI 10.1016/j.chom.2013.08.010; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Taylor P, 2014, PATIENTS ACTIVE TUBE, P37, DOI [10.4161/15548627.2014.981791, DOI 10.4161/15548627.2014.981791]; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; van der Kant R, 2015, J BIOL CHEM, V290, P30280, DOI 10.1074/jbc.M115.688440; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; VERAS PST, 1995, INFECT IMMUN, V63, P3502, DOI 10.1128/IAI.63.9.3502-3506.1995; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wang JA, 2008, INT J MED MICROBIOL, V298, P209, DOI 10.1016/j.ijmm.2007.05.004; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	104	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209820	10.1371/journal.pone.0209820	http://dx.doi.org/10.1371/journal.pone.0209820			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640917	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000013
J	Rando, A; de la Torre, M; Martinez-Muriana, A; Zaragoza, P; Musaro, A; Hernandez, S; Navarro, X; Toivonen, JM; Osta, R				Rando, Amaya; de la Torre, Miriam; Martinez-Muriana, Anna; Zaragoza, Pilar; Musaro, Antonio; Hernandez, Sara; Navarro, Xavier; Toivonen, Janne M.; Osta, Rosario			Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION; STEM-CELLS; MICE; PROLIFERATION; LEVEL	Amyotrophic lateral sclerosis (ALS) is a lethal motor neuron disease with no cure. Currently there are only two ALS drugs approved by the FDA, both with a limited therapeutic effect. In the search for drug candidates for ALS, we studied the effect of known stem cell mobilizing agents (treatment) and antimetabolite 5-fluorouracil (5-FU) (anti-treatment) in SOD1G93A model of ALS. Surprisingly, we found that anti-cancer drug 5-FU increases lifespan, delays the disease onset and improves motor performance in ALS mice. Although we were not able to demonstrate the mechanistic basis of the beneficial 5-FU action in ALS mice, our findings suggest that 5-FU or similar drugs are possible drug candidates for the treatment of motor neuron diseases through drug repurposing.	[Rando, Amaya; de la Torre, Miriam; Zaragoza, Pilar; Toivonen, Janne M.; Osta, Rosario] Univ Zaragoza, Fac Vet, Dept Anat Embriol & Genet Anim, LAGENBIO, Zaragoza, Spain; [Rando, Amaya; de la Torre, Miriam; Zaragoza, Pilar; Toivonen, Janne M.; Osta, Rosario] Univ Zaragoza CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain; [Rando, Amaya; de la Torre, Miriam; Zaragoza, Pilar; Toivonen, Janne M.; Osta, Rosario] CIBA, Inst Invest Sanitaria Aragon, Zaragoza, Spain; [Martinez-Muriana, Anna; Navarro, Xavier] Univ Autonoma Barcelona, Inst Neurosci, Bellaterra, Spain; [Martinez-Muriana, Anna; Navarro, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Bellaterra, Spain; [Martinez-Muriana, Anna; Navarro, Xavier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain; [Musaro, Antonio] Sapienza Univ Rome, Ist Pasteur Italia, Fdn Cenci Bolognetti, DAHFMO Unit Histol & Med Embryol, Rome, Italy; [Musaro, Antonio] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Hernandez, Sara] Univ Lleida IRBLLEIDA, Fac Med, Grp Patol Neuromuscular Expt, Dept Med Expt, Lleida, Catalonia, Spain	University of Zaragoza; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Universitat de Lleida	Toivonen, JM; Osta, R (corresponding author), Univ Zaragoza, Fac Vet, Dept Anat Embriol & Genet Anim, LAGENBIO, Zaragoza, Spain.; Toivonen, JM; Osta, R (corresponding author), Univ Zaragoza CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain.; Toivonen, JM; Osta, R (corresponding author), CIBA, Inst Invest Sanitaria Aragon, Zaragoza, Spain.	toivonen@unizar.es; osta@unizar.es	Osta, Rosario/R-5410-2019; Musarò, Antonio/K-9598-2016; Hernandez, Sara/N-4017-2014; zaragoza, pilar/AAN-9479-2021; Toivonen, Janne M./E-5691-2011; Hernández, Sara/HHN-5230-2022; Musaro, Antonio/P-2953-2019; Navarro, Xavier/C-9577-2011	Musarò, Antonio/0000-0002-2944-9739; Hernandez, Sara/0000-0002-6451-724X; Toivonen, Janne M./0000-0002-7243-1737; Musaro, Antonio/0000-0002-2944-9739; Navarro, Xavier/0000-0001-9849-902X; Osta, Rosario/0000-0001-5687-6704	Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI14/00947, PI17/00949]; Asociacion Adelante de La Roda, Plataforma Afectados por la ELA, Asociacion Juntos Venceremos ELA, AVPA Zaragoza; Instituto de Salud Carlos III of Spain [RD12/0019/0011, RD16/0011/0035, CB06/05/1105]; Fondazione Roma; Agenzia Spaziale Italiana	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union; Asociacion Adelante de La Roda, Plataforma Afectados por la ELA, Asociacion Juntos Venceremos ELA, AVPA Zaragoza; Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); Fondazione Roma(Fondazione RomaEuropean Commission); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was funded by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union (Grants PI14/00947 and PI17/00949), Asociacion Adelante de La Roda, Plataforma Afectados por la ELA, Asociacion Juntos Venceremos ELA, AVPA Zaragoza (RO), TERCEL (RD12/0019/0011 and RD16/0011/0035) and CIBERNED (CB06/05/1105) funds from the Instituto de Salud Carlos III of Spain (XN), and Fondazione Roma and Agenzia Spaziale Italiana (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey D, 2014, AMYOTROPHIC LATERAL, V14, P1; Amante DJ, 2010, AMYOTROPH LATERAL SC, V11, P520, DOI 10.3109/17482968.2010.491867; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Bucchia M, 2015, CLIN THER, V37, P668, DOI 10.1016/j.clinthera.2014.12.020; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; CHENAILLE PJ, 1990, BLOOD, V76, P508; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Ghoshal K, 1997, BIOCHEM PHARMACOL, V53, P1569, DOI 10.1016/S0006-2952(97)00040-3; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014; Hardiman O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.71; Henriques A, 2011, MOL THER, V19, P284, DOI 10.1038/mt.2010.271; Leitner M, GUIDELINES PRECLINIC; Levin J, 2001, BLOOD, V98, P1019, DOI 10.1182/blood.V98.4.1019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mancuso R, 2012, NEUROTHERAPEUTICS, V9, P814, DOI 10.1007/s13311-012-0140-y; Manzano R, 2011, BIOCHEM BIOPH RES CO, V407, P758, DOI 10.1016/j.bbrc.2011.03.096; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Mojardin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078172; Moreno-Igoa M, 2010, J MOL MED, V88, P297, DOI 10.1007/s00109-009-0556-y; Numazawa S, 2011, BASIC CLIN PHARMACOL, V108, P40, DOI 10.1111/j.1742-7843.2010.00621.x; Olivan S, 2014, EXP ANIM; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Petrov D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00068; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Pokrishevsky E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184384; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Pollari E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00131; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; QUESNIAUX VFJ, 1993, BLOOD, V81, P1497; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rando A, 2017, NEURODEGENER DIS, V17, P1, DOI 10.1159/000446113; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Udelnow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020143	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210752	10.1371/journal.pone.0210752	http://dx.doi.org/10.1371/journal.pone.0210752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640943	Green Published, gold, Green Submitted			2022-12-26	WOS:000455808000045
J	Tissier, ML; Bousquet, CAH; Fleitz, J; Habold, C; Petit, O; Handrich, Y				Tissier, Mathilde L.; Bousquet, Christophe A. H.; Fleitz, Julie; Habold, Caroline; Petit, Odile; Handrich, Yves			Captive-reared European hamsters follow an offensive strategy during risk-assessment	PLOS ONE			English	Article							ANTI-PREDATION DEVICE; CRICETUS-CRICETUS; SMALL MAMMALS; BEHAVIOR; ODORS; FACILITATE; DEFENSE; SECURE; TESTS	Understanding whether captive-reared animals destined to reintroduction are still able to discriminate predators has important implications for conservation biology. The endangered European hamster benefits from conservation programs throughout Europe, in which several thousand individuals are released into the wild every year. Despite this, the anti-predator strategy of hamsters and their ability to maintain predator discrimination in captivity remain to be investigated. Here, we explore the predator discrimination behaviour of captive-reared European hamsters and their response to different predation cues. When first exposed to the urine of cats and goats in a Y-maze test, hamsters spent more time close to the cat scent rather than to the goat scent. In a second experiment, during which hamsters were exposed to a non-mobile European ferret (inside a cage), hamsters significantly increased the time spent close to the ferret's cage and displayed aggressive behaviour towards the ferret. Furthermore, they did not take refuge inside an anti-predation tube (APT), a device designed to upgrade wildlife underpasses and reconnect wild hamster populations. Finally, when exposed to a mobile ferret (but without physical contact), hamsters displayed mobbing and aggressive behaviours towards the ferret, before taking refuge inside the APT. Taken together, our results show that captive-reared hamsters are still able to detect and react to predation cues, but that they initially adopt an offensive strategy (grunting, spitting, mobbing) during the risk-assessment phase. After risk assessment, however, hamsters used the APT as a refuge. Our study provides important insights into the anti-predator behaviour of hamsters. Testing the efficacy of the APT, a device that will allow upgrading wildlife underpasses for the hamster and other rodents, is also of great importance and is instrumental in conservation efforts for these species.	[Tissier, Mathilde L.; Bousquet, Christophe A. H.; Fleitz, Julie; Habold, Caroline; Petit, Odile; Handrich, Yves] Univ Strasbourg, CNRS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tissier, ML; Bousquet, CAH (corresponding author), Univ Strasbourg, CNRS, Strasbourg, France.	mathilde.tissier@hotmail.com; chr_bousquet@protonmail.com	Bousquet, Christophe Alexandre Henri/AAP-4891-2020; Handrich, Yves/AAD-6472-2022	Bousquet, Christophe Alexandre Henri/0000-0003-1650-8004; 	European Commission [LIFE12 BIO/FR/000979]; LIFE + Biodiversity grant [LIFE12 BIO/FR/000979]; Ministere de l'Ecologie, du Developpement Durable et de l'Energie	European Commission(European CommissionEuropean Commission Joint Research Centre); LIFE + Biodiversity grant; Ministere de l'Ecologie, du Developpement Durable et de l'Energie	This work was supported by the European Commission (http://ec.europa.eu/environment/life/themes/biodiversity.htm), grant number: LIFE12 BIO/FR/000979. The funders did not participate in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.; We are grateful to Pierre Uhlrich for building the Y-maze. We are also grateful to the veterinarians that collected cat urine, namely Dr. Vigneron and Dr. Capber. Many thanks to Andre Gross for giving us access to his goats to collect urine used in the Y-maze test, and to Stephanie Cornejo and Caroline Croguennec that helped with data collection during the first experiment. We are also thankful to Christopher Turbill and Manfred Enstipp for their advice on this manuscript. Finally, we would like to thank anonymous reviewers that helped improving the quality of this paper. Authors have no competing interest to declare. This work was supported by the LIFE + Biodiversity grant No LIFE12 BIO/FR/000979 and the Ministere de l'Ecologie, du Developpement Durable et de l'Energie. The funders did not participate in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; APFELBACH R, BEHAV; Banks Peter B., 2003, Australian Zoologist, V32, P406; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BLANCHARD RJ, 1990, NEUROSCI BIOBEHAV R, V14, P463, DOI 10.1016/S0149-7634(05)80069-7; Blumstein DT, 2006, ANIM CONSERV, V9, P274, DOI 10.1111/j.1469-1795.2006.00033.x; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Carlson NV, 2017, ANIM BEHAV, V128, P79, DOI 10.1016/j.anbehav.2017.04.006; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; De Franceschi G, 2016, CURR BIOL, V26, P2150, DOI 10.1016/j.cub.2016.06.006; DEMEYRIER V, 2016, HABITATS URBANISES D; Eibl-Eibesfeldt I., 1954, Zeitschrift fuer Tierpsychologie, V10, P204; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Fenyk-Melody J, 2012, AM COLL LAB, P923, DOI 10.1016/B978-0-12-380920-9.00036-5; Franceschini C, 2007, GEN COMP ENDOCR, V152, P14, DOI 10.1016/j.ygcen.2007.02.008; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; Graw B, 2007, ANIM BEHAV, V74, P507, DOI 10.1016/j.anbehav.2006.11.021; Haye M. J. J. la, 2010, Aspects of Applied Biology, P117; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; J CUB, DD; J CUB, 2016, SD, V6, P6; J CUB, 2015, SD, V146, P57; JUMEAU J, ANALYSE EXPERIMENTAL; Kayser A, 2003, ACTA THERIOL, V48, P47, DOI 10.1007/BF03194265; KLEIMAN DG, 1973, BEHAVIOUR, P48; Kramer DL, 1997, ANIM BEHAV, V54, P289, DOI 10.1006/anbe.1996.0360; La Haye M.J.J., 2010, ACTA THERIOL WARSZ, V100, P117; Lenth R, 2018, SF; LENTH R, 2018, R PACKAGE VERSION 1, V2, P1; McPhee ME, 2010, ETHOLOGY, V116, P517, DOI 10.1111/j.1439-0310.2010.01766.x; McPhee ME, 2009, J ETHOL, V27, P137, DOI 10.1007/s10164-008-0099-7; Monclus R, 2005, ANIM BEHAV, V70, P753, DOI 10.1016/j.anbehav.2004.12.019; Nechay G., 1977, EPPO Bulletin, V7, P255, DOI 10.1111/j.1365-2338.1977.tb02727.x; RE P, 2007, BIOL REV, V82, P291; REZNIKSCHULLER H, 1974, Z VERSUCHSTIERKD, V16, P48; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; SINGMANN H, INTERNET, P20; SIUTZ C, 2005, 13 M INT HAMST WORKG, P13; Siutz C, 2005, SF; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Spencer R.-J., 2005, Austral Ecology, V30, P868, DOI 10.1111/j.1442-9993.2005.01530.x; Surov A, 2016, ENDANGER SPECIES RES, V31, P119, DOI 10.3354/esr00749; Tissier ML, 2018, ECOL ENG, V125, P106, DOI 10.1016/j.ecoleng.2018.10.013; Tissier ML, 2016, ECOL ENG, V95, P738, DOI 10.1016/j.ecoleng.2016.07.012; Tissier ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep25531; VOHRALIK V, 1974, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V38, P228; Vohralik V, 1974, DER ZOOL GARTEN, V38, P228; Ward JF, 1996, PHYSIOL BEHAV, V60, P1469, DOI 10.1016/S0031-9384(96)00245-4; WEINHOLD U, 2008, CONVENTION ON THE CO, P1758; WICKHAM H, 2009, NEW YORK, P2; Williams JL, 1999, PSYCHOL REC, V49, P493; Zhang JX, 2008, J ETHOL, V26, P279, DOI 10.1007/s10164-007-0060-1	56	1	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210158	10.1371/journal.pone.0210158	http://dx.doi.org/10.1371/journal.pone.0210158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640936	gold, Green Published, Green Submitted			2022-12-26	WOS:000455808000020
J	Montano-Campaz, ML; Gomes-Dias, L; Restrepo, BET; Garcia-Merchan, CH				Leoncio Montano-Campaz, Milton; Gomes-Dias, Lucimar; Toro Restrepo, Beatriz Edilma; Hugo Garcia-Merchan, Victor			Incidence of deformities and variation in shape of mentum and wing of Chironomus columbiensis (Diptera, Chironomidae) as tools to assess aquatic contamination	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; LARVAE DIPTERA; MORPHOLOGICAL DEFORMITIES; GEOMETRIC MORPHOMETRICS; MOUTHPART DEFORMITIES; EVOLUTION; TOXICITY; PATTERNS; EXPOSURE; STREAMS	Constantly, aquatic ecosystems are under pressure by complex mixtures of contaminants whose effects are not always easy to evaluate. Due to this, organisms are sought in which early warning signs may be detected upon the presence of potentially toxic xenobiotic substances. Thereby, the study evaluated the incidence of deformities and other morphometric variations in the mentum and wing of Chironomus columbiensis exposed to water from some of the Colombian Andes affected by mining, agriculture, and cattle raising. Populations of C. columbiensis were subjected throughout their life cycle (24 days) for two generations (F-1 and F-2). Five treatments were carried out in controlled laboratory conditions (water from the site without impact, site of mining mercury, mining mercury + cyanide, cattle raising, and agriculture) and the respective control (reconstituted water). Thereafter, the percentage of deformities in the mentum was calculated, and for the morphometric analysis 29 landmarks were digitized for the mentum and 12 for the wing. As a result, four types of deformities were registered in the C. columbiensis mentum, like absence of teeth, increased number of teeth, fusion and space between teeth, none of them detected in the individuals from the control. Additionally, the highest incidence of deformity in F-1 occurred in the treatment of mining mercury, while for F-2 this took place in the treatments of mining mercury + cyanide, cattle raising and agriculture. Differences were also found with respect to the morphometric variations of the mentum and wing of C. columbiensis among the control and the treatments with water from the creeks intervened. The treatments of mining mercury + cyanide and agriculture had the highest morphological variation in the mentum and wing of C. columbiensis. The results suggest that the anthropogenic impacts evaluated generate alterations in the oral apparatus of the larval state of C. columbiensis and in the adult state provoke alterations in the wing shape (increased width and reduced basal area). These deformities may be related to multiple stress factors, among them the xeno-biotics metabolized by the organisms under conditions of environmental contamination.	[Leoncio Montano-Campaz, Milton; Gomes-Dias, Lucimar; Toro Restrepo, Beatriz Edilma] Univ Caldas, Grp Invest BIONAT Biodiversidad & Recursos Nat, Fac Ciencias Exactas & Nat, Dept Ciencias Biol, Manizales, Colombia; [Hugo Garcia-Merchan, Victor] Univ Quindio, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Quindio, Colombia	Universidad de Caldas; Universidad del Quindio	Garcia-Merchan, CH (corresponding author), Univ Quindio, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Quindio, Colombia.	victorhgarcia@uniquindio.edu.co		Montano Campaz, Milton Leoncio/0000-0002-9470-9840	University of Caldas	University of Caldas	The University of Caldas financed the research and the University of Quindio the translation of the document.	Adams CA, 2004, J BIOL CHEM, V279, P1376, DOI 10.1074/jbc.M307867200; [Anonymous], PRINCIPLES SERVICES; Arambourou H, 2014, SCI TOTAL ENVIRON, V484, P92, DOI 10.1016/j.scitotenv.2014.03.010; Arambourou H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048844; Benitez HA, 2013, NEOTROP ENTOMOL, V42, P164, DOI 10.1007/s13744-012-0107-z; Bispo P. C., 2006, Braz. J. Biol., V66, P611, DOI 10.1590/S1519-69842006000400005; Bonada N, 2007, HYDROBIOLOGIA, V589, P91, DOI 10.1007/s10750-007-0723-5; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Campero M, 2008, FUNCT ECOL, V22, P271, DOI 10.1111/j.1365-2435.2007.01381.x; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Chara J., 2003, MANUAL EVALUACION BI; Chara-Serna AM, 2015, FRESHW SCI, V34, P727, DOI 10.1086/681094; Clarke GM, 1998, HEREDITY, V80, P562, DOI 10.1046/j.1365-2540.1998.00294.x; Conroy PT, 1996, ENVIRON TOXICOL CHEM, V15, P1245, DOI 10.1002/etc.5620150733; de Bisthoven LJ, 1998, FRESHWATER BIOL, V39, P179, DOI 10.1046/j.1365-2427.1998.00265.x; Di Veroli A, 2012, ENVIRON POLLUT, V166, P212, DOI 10.1016/j.envpol.2012.03.029; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; GARCIABELLIDO A, 1992, ANNU REV GENET, V26, P277, DOI 10.1146/annurev.ge.26.120192.001425; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Groenendijk D, 1998, ENVIRON TOXICOL CHEM, V17, P1999, DOI [10.1002/etc.5620171016, 10.1897/1551-5028(1998)017&lt;1999:FAAMGI&gt;2.3.CO;2]; HARE L, 1976, CAN J ZOOL, V54, P2129, DOI 10.1139/z76-246; Hoffman DJ., 2002, HDB ECOTOXICOLOGY; Hoffmann AA, 2005, AUST J ENTOMOL, V44, P233, DOI 10.1111/j.1440-6055.2005.00469.x; Hudson LA, 1996, CAN J FISH AQUAT SCI, V53, P297, DOI 10.1139/cjfas-53-2-297; Iannacone J, 2007, AGR TEC, V67, P126; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1255, DOI 10.1098/rspb.1998.0427; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; Lal R., 1998, AGR ECOSYST ENVIRON, V24, P101; Leah Zelditch Miriam, 2012, GEOMETRIC MORPHOMETR; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P265, DOI 10.2307/1467461; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; Marin E., 2005, TERRA LATINOAM, V25, P297; Martinez EA, 2004, ARCH ENVIRON CON TOX, V47, P193, DOI 10.1007/s00244-004-3116-z; Martinez S, 2002, NUTR HOSP, V17; MAYER FL, 1988, AMBIO, V17, P367; Meregalli V, 2001, APPL PHYS A-MATER, V72, P143, DOI 10.1007/s003390100789; Miserendino ML, 2012, SCI TOTAL ENVIRON, V424, P202, DOI 10.1016/j.scitotenv.2012.02.054; Moore M, 1987, PHILOS T R SOC B, V316, P209; Mozeto A, 2008, ECOTOXICOLOGIA AQUAT, V2, P15; Odume ON, 2016, ECOL INDIC, V67, P391, DOI 10.1016/j.ecolind.2016.03.001; OECD, 2004, SED WAT CHIR TOX TES; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; Piggott JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049873; PINDER LCV, 1983, ENTOMOL SCAND, P7; Pither J, 2000, CAN J ZOOL, V78, P1740, DOI 10.1139/cjz-78-10-1740; Pitt RE, 2002, HDB ECOTOXICOLOGY, P575; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Salmelin J, 2015, ENVIRON TOXICOL CHEM, V34, P1891, DOI 10.1002/etc.3010; Sanin D, 2008, REV ACAD COLOMBIANA, V32, P331; WARWICK WF, 1988, CAN J FISH AQUAT SCI, V45, P1123, DOI 10.1139/f88-136; WIEDERHOLM T, 1984, HYDROBIOLOGIA, V109, P243, DOI 10.1007/BF00007742; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x; Zorrilla Domenichi M., 2012, THESIS	64	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210348	10.1371/journal.pone.0210348	http://dx.doi.org/10.1371/journal.pone.0210348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629652	gold, Green Published, Green Submitted			2022-12-26	WOS:000455483000077
J	Rajasingham, R; Meya, DB; Greene, GS; Jordan, A; Nakawuka, M; Chiller, TM; Boulware, DR; Larson, BA				Rajasingham, Radha; Meya, David B.; Greene, Gregory S.; Jordan, Alexander; Nakawuka, Mina; Chiller, Tom M.; Boulware, David R.; Larson, Bruce A.			Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MENINGITIS; IMMUNODEFICIENCY; START	Background Cryptococcal meningitis accounts for 15% of AIDS-related mortality. Cryptococcal antigen (CrAg) is detected in blood weeks before onset of meningitis, and CrAg positivity is an independent predictor of meningitis and death. CrAg screening for patients with advanced HIV and preemptive treatment is recommended by the World Health Organization, though implementation remains limited. Our objective was to evaluate costs and mortality reduction (lives saved) from a national CrAg screening program across Uganda. Methods We created a decision analytic model to evaluate CrAg screening. CrAg screening was considered for those with a CD4<100 cells/mu L per national and international guidelines, and in the context of a national HIV test-and-treat program where CD4 testing was not available. Costs (2016 USD) were estimated for screening, preemptive therapy, hospitalization, and maintenance therapy. Parameter assumptions were based on large prospective CrAg screening studies in Uganda, and clinical trials from sub Saharan Africa. CrAg positive (CrAg+) persons could be: (a) asymptomatic and thus eligible for preemptive treatment with fluconazole; or (b) symptomatic with meningitis with hospitalization. Results In the base case model for 1 million persons with a CD4 test annually, 128,000 with a CD4<100 cells/mu L were screened, and 8,233 were asymptomatic CrAg+ and received preemptive therapy. Compared to no screening and treatment, CrAg screening and treatment in the base case cost $3,356,724 compared to doing nothing, and saved 7,320 lives, for a cost of $ 459 per life saved, with the $ 3.3 million in cost savings derived from fewer patients developing fulminant meningitis. In the scenario of a national HIV test-and-treat program, of 1 million HIV-infected persons, 800,000 persons were screened, of whom 640,000 returned to clinic, and 8,233 were incident CrAg positive (CrAg prevalence 1.4%). The total cost of a CrAg screening and treatment program was $4.16 million dollars, with 2,180 known deaths. Conversely, without CrAg screening, the cost of treating meningitis was $3.09 million dollars with 3,806 deaths. Thus, despite the very low CrAg prevalence of 1.4% in the general HIV-infected population, and inadequate retention-in-care, CrAg screening averted 43% of deaths from cryptococcal meningitis at a cost of $662 per death averted. Conclusion CrAg screening and treatment programs are cost-saving and lifesaving, assuming preemptive treatment is 77% effective in preventing death, and could be adopted and implemented by ministries of health to reduce mortality in those with advanced HIV disease. Even within HIV test-and-treat programs where CD4 testing is not performed, and CrAg prevalence is only 1.4%, CrAg screening is cost-effective.	[Rajasingham, Radha; Boulware, David R.] Univ Minnesota, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA; [Meya, David B.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Greene, Gregory S.; Jordan, Alexander; Chiller, Tom M.] CDC, Mycot Dis Branch, Atlanta, GA 30333 USA; [Nakawuka, Mina] Minist Hlth, AIDS Control Program, Kampala, Uganda; [Larson, Bruce A.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; Centers for Disease Control & Prevention - USA; Boston University	Rajasingham, R (corresponding author), Univ Minnesota, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA.	radha@umn.edu	Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Meya, David/AAO-2796-2020	Boulware, David R/0000-0002-4715-0060; Jordan, Alexander/0000-0002-7834-866X; , David/0000-0002-8854-0321; Larson, Bruce/0000-0002-9322-2387	National Institute of Allergy and Infectious diseases [K23AI138851]; CDC foundation; Pfizer Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI138851] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer Inc(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RR is supported by the National Institute of Allergy and Infectious diseases (K23AI138851). BL is supported by the CDC foundation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. The source of this information is the Global Cryptococcal Antigen Screening Initiative, a project of the CDC Foundation funded by a grant from Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Beyene T, 2017, CLIN INFECT DIS, V65, P2126, DOI 10.1093/cid/cix613; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Larson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158986; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Merry M, 2016, CLIN INFECT DIS, V62, P1564, DOI 10.1093/cid/ciw151; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mfinanga S, 2015, LANCET; Morawski B, 2016, PRE ART CRYPTOCOCCAL; Nalintya E MD, 2018, PROSPECTIVE EVALUATI; Nalintya E, 2018, JAIDS-J ACQ IMM DEF, V78, P231, DOI 10.1097/QAI.0000000000001669; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Rhein J, 2018, HIGH MORTALITY ASS U; Siedner MJ, 2014, TRENDS CD4 COUNT PRE; Wake RM, 2018, CLIN INFECT DIS, V66, P686, DOI 10.1093/cid/cix872; World Health Organization, 2017, GUID MAN ADV HIV DIS; World Health Organization, 2018, GUID DIAGN PREV MAN	21	27	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210105	10.1371/journal.pone.0210105	http://dx.doi.org/10.1371/journal.pone.0210105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629619	Green Published, gold, Green Submitted			2022-12-26	WOS:000455483000050
J	Gariboldi, MI; Butler, R; Best, SM; Cameron, RE				Gariboldi, Maria Isabella; Butler, Richard; Best, Serena M.; Cameron, Ruth E.			Engineering vasculature: Architectural effects on microcapillary-like structure self-assembly	PLOS ONE			English	Article							VASCULARIZATION; SCAFFOLDS; CELLS; COCULTURES; GROWTH; BONE	One of the greatest obstacles to clinical translation of bone tissue engineering is the inability to effectively and efficiently vascularize scaffolds. The goal of this work was to explore systematically whether architecture, at a scale of hundreds of microns, can be used to direct the growth of microcapillary-like structures into the core of scaffolds. Biphasic bioceramic patterned architectures were produced using silicone molds of 3D printed parts. Grooves and ridges were designed to have widths of 330 pm and 660 pm, with periodicities respectively of 1240 pm and 630 pm. Groove depth was varied between 150 pm and 585 pm. Co-cultures of human dermal microvascular endothelial cells (HDMECs) and human osteoblasts (hOBs) were used to grow microcapillary-like structures on substrates. Bioceramic architecture was found to significantly affect microcapillary-like structure location and orientation. Microcapillary-like structures were found to form predominantly in grooves or between convexities. For all patterned samples, the CD31 (endothelial cell marker) signal was at least 2.5 times higher along grooves versus perpendicular to grooves. In addition, the average signal was at least two times higher within grooves than outside grooves for all samples. Grooves with a width of 330 pm and a depth of 300 pm resulted in the formation of individual, highly aligned microcapillary-like structures with lengths around 5 mm. Extensive literature has focused on the role of nano-and micro-topography (on the scale below tens of microns) on cellular response. However, the idea that architecture at a scale much larger than a cell could be used to modulate angiogenesis has not been systematically investigated. This work shows the crucial influence of architecture on microcapillary-like structure self-assembly at the scale of hundreds of microns. Elucidating the precise correspondence between architecture and microcapillary-like structure organization will ultimately allow the engineering of microvasculature by tuning local scaffold design to achieve desirable microvessel properties.	[Gariboldi, Maria Isabella; Best, Serena M.; Cameron, Ruth E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge Ctr Med Mat, Cambridge, England; [Butler, Richard] Univ Cambridge, Gurdon Inst, Imaging Facil, Cambridge, England	University of Cambridge; University of Cambridge	Gariboldi, MI (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Cambridge Ctr Med Mat, Cambridge, England.	mig29@cam.ac.uk		Butler, Richard/0000-0002-3885-1332; Cameron, Ruth/0000-0003-1573-4923; Gariboldi, Maria Isabella/0000-0003-2020-6885	Gates Cambridge Trust; Geistlich Pharma AG; Engineering and Physical Sciences Research Council (EPSRC) [EP/N019938/1]; EPSRC [EP/N019938/1] Funding Source: UKRI	Gates Cambridge Trust; Geistlich Pharma AG; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.I.G. gratefully acknowledges the financial support of the Gates Cambridge Trust and Geistlich Pharma AG. S.M.B. and R.E.C. are funded by the Engineering and Physical Sciences Research Council (EPSRC) Established Career Fellowship Grant No. EP/N019938/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth JC, 2015, ADV HEALTHC MATER, V4, P1317, DOI 10.1002/adhm.201500197; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111; Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gamsjager E, 2013, ACTA BIOMATER, V9, P5531, DOI 10.1016/j.actbio.2012.10.020; Guyot Y, 2014, BIOMECH MODEL MECHAN, V13, P1361, DOI 10.1007/s10237-014-0577-5; Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020; Jeong CG, 2010, J BIOMED MATER RES B, V93B, P141, DOI 10.1002/jbm.b.31568; Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009; Li YB, 2009, J BIOMED MATER RES B, V89B, P508, DOI 10.1002/jbm.b.31242; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Poldervaart MT, 2014, J CONTROL RELEASE, V184, P58, DOI 10.1016/j.jconrel.2014.04.007; Ripamonti U, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01084; Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Scarano A, 2014, ODONTOLOGY, V102, P259, DOI 10.1007/s10266-013-0116-3; Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010; Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098	22	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210390	10.1371/journal.pone.0210390	http://dx.doi.org/10.1371/journal.pone.0210390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620757	Green Published, gold, Green Submitted			2022-12-26	WOS:000455161300031
J	Cordero-Maldonado, ML; Perathoner, S; van der Kolk, KJ; Boland, R; Heins-Marroquin, U; Spaink, HP; Meijer, AH; Crawford, AD; de Sonneville, J				Cordero-Maldonado, Maria Lorena; Perathoner, Simon; van der Kolk, Kees-Jan; Boland, Ralf; Heins-Marroquin, Ursula; Spaink, Herman P.; Meijer, Annemarie H.; Crawford, Alexander D.; de Sonneville, Jan			Deep learning image recognition enables efficient genome editing in zebrafish by automated injections	PLOS ONE			English	Article							CRISPR/CAS9; EXPRESSION; PARTICLES; NEURONS; AXIS	One of the most popular techniques in zebrafish research is microinjection. This is a rapid and efficient way to genetically manipulate early developing embryos, and to introduce microbes, chemical compounds, nanoparticles or tracers at larval stages. Here we demonstrate the development of a machine learning software that allows for microinjection at a trained target site in zebrafish eggs at unprecedented speed. The software is based on the open-source deep-learning library Inception v3. In a first step, the software distinguishes wells containing embryos at one-cell stage from wells to be skipped with an accuracy of 93%. A second step was developed to pinpoint the injection site. Deep learning allows to predict this location on average within 42 pm to manually annotated sites. Using a Graphics Processing Unit (GPU), both steps together take less than 100 milliseconds. We first tested our system by injecting a morpholino into the middle of the yolk and found that the automated injection efficiency is as efficient as manual injection (similar to 80%). Next, we tested both CRISPR/Cas9 and DNA construct injections into the zygote and obtained a comparable efficiency to that of an experienced experimentalist. Combined with a higher throughput, this results in a higher yield. Hence, the automated injection of CRISPR/Cas9 will allow high throughput applications to knock out and knock in relevant genes to study their mechanisms or pathways of interest in diverse areas of biomedical research.	[Cordero-Maldonado, Maria Lorena; Perathoner, Simon; Heins-Marroquin, Ursula; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Belvaux, Luxembourg; [van der Kolk, Kees-Jan; de Sonneville, Jan] Life Sci Methods BV, Leiden, Netherlands; [Boland, Ralf; Spaink, Herman P.; Meijer, Annemarie H.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Perathoner, Simon] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Crawford, Alexander D.] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway	University of Luxembourg; Leiden University; Leiden University - Excl LUMC; Max Planck Society; Norwegian University of Life Sciences	Cordero-Maldonado, ML (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Belvaux, Luxembourg.; de Sonneville, J (corresponding author), Life Sci Methods BV, Leiden, Netherlands.	marialorena.corderomaldonado@uni.lu; jan@lifesciencemethods.com	Spaink, Herman P./S-3586-2017; Meijer, Annemarie/W-3726-2019	Spaink, Herman P./0000-0003-4128-9501; Perathoner, Simon/0000-0003-4779-7259; Meijer, Annemarie H./0000-0002-1325-0725; de Sonneville, Jan/0000-0002-6399-7042; Boland, Ralf/0000-0002-1463-5977	Netherlands Organisation for Scientific Research (NWO) Domain Applied and Engineering Sciences [13259]; Atoz Foundation	Netherlands Organisation for Scientific Research (NWO) Domain Applied and Engineering Sciences(Netherlands Organization for Scientific Research (NWO)); Atoz Foundation	RB, AHM and HPS were supported by the Netherlands Organisation for Scientific Research (NWO) Domain Applied and Engineering Sciences (TTW project 13259). UHM was supported by Atoz Foundation and Mr. Norbert Becker. The funders provided support in the form of salary for two authors [NWO for RB and Atoz Foundation and Mr. Norbert Becker for UHM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two authors [KJvdK and JdS] are employed by the company Life Science Methods and both authors participated in the development of the study and in the preparation of the manuscript. The other authors [MLCM, SP, and ADC] received no specific funding for this work. The specific roles of all the authors are articulated in the "author contributions" section.	Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Braunbeck T, 2005, ALTEX-ALTERN TIEREXP, V22, P87; Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779; Chen L, 2017, FRONTIERS NEUROSCIEN, V11, P1, DOI [10.3389/fnins.2017.00001, DOI 10.3389/FNINS.2017.00001]; Clark KJ, 2011, ZEBRAFISH, V8, P147, DOI 10.1089/zeb.2011.9993; Craig MP, 2012, ZEBRAFISH, V9, P108, DOI 10.1089/zeb.2012.0740; Dooley CM, 2012, PIGM CELL MELANOMA R, V26, P205, DOI DOI 10.1111/PCMR; Dove A, 2003, NAT BIOTECHNOL, V21, P859, DOI 10.1038/nbt0803-859; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Haque E, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070561; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang WY, 2014, METHODS, V69, P76, DOI 10.1016/j.ymeth.2014.04.009; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung DW, 2012, MOL BIOSYST, V8, P1930, DOI 10.1039/c2mb05501e; Kaethner RJ, 1997, J NEUROBIOL, V32, P627, DOI 10.1002/(SICI)1097-4695(19970605)32:6<627::AID-NEU7>3.0.CO;2-1; Kim CH, 1997, NEUROSCI LETT, V239, P113, DOI 10.1016/S0304-3940(97)00908-7; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Kingma DP., 2014, ADAM METHOD STOCHAST; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lieschke G., 2008, ZEBRAFISH METHODS PR; LIN S, 1992, P NATL ACAD SCI USA, V89, P4519, DOI 10.1073/pnas.89.10.4519; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Rosen JN, 2009, J VISUALIZED EXPT JO; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Spaink HP, 2013, METHODS, V62, P246, DOI 10.1016/j.ymeth.2013.06.002; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Ungar A.A., 2010, BARYCENTRIC CALCULUS; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; VANASSELT E, 1991, NEUROSCIENCE, V43, P611, DOI 10.1016/0306-4522(91)90320-N; Veneman WJ, 2017, AQUAT TOXICOL, V190, P112, DOI 10.1016/j.aquatox.2017.06.014; Wang WH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000862; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE	49	15	15	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0202377	10.1371/journal.pone.0202377	http://dx.doi.org/10.1371/journal.pone.0202377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615627	Green Published, Green Submitted, gold			2022-12-26	WOS:000455045900003
J	Peverill, RE				Peverill, Roger E.			Aging and the relationships between long-axis systolic and early diastolic excursion, isovolumic relaxation time and left ventricular length-Implications for the interpretation of aging effects on e '	PLOS ONE			English	Article							DOPPLER MEASURES; ECHOCARDIOGRAPHIC-ASSESSMENT; PLANE DISPLACEMENT; HEALTHY-SUBJECTS; REFERENCE VALUES; FILLING PATTERN; AGE; CONTRACTION; PARAMETERS; DYSFUNCTION	Background Both the left ventricular (LV) long-axis peak early diastolic lengthening velocity (e') and long axis early diastolic excursion (EDExc) decrease with age, but the mechanisms underlying these decreases are not fully understood. The aim of this study was to investigate the relative contributions to aging-related decreases in e'and EDExc from LV long-axis systolic excursion (SExc), isovolumic relaxation time (IVRT, as a measure of the speed of relaxation) and LV end-diastolic length (LVEDL). Methods The study group was 50 healthy adult subjects of ages 17-75 years with a normal LV ejection fraction. SExc, EDExc, e'and IVRT were measured from pulsed wave tissue Doppler signals acquired from the septal and lateral walls. Multivariate modelling was performed to identify independent predictors of EDExc and e'which were consistent for the septal and lateral walls. Results EDExc decreased with age and the major determinant of EDExc was SExc, which also decreased with age. There was also a decrease of e'with age, and the major determinant of e'was EDExc. IVRT decreased with age and on univariate analysis was not only inversely correlated with EDExc and e', but also with SExc. IVRT was only a minor contributor to models of EDExc which included SExc, and was an inconsistent contributor to models of e'which included EDExc. LVEDL decreased with age independent of sex and body size, and was positively correlated with SExc, EDExc and e'. Conclusion Major mechanisms underlying the decrease in e'seen during aging are the concomitant decreases in long-axis contraction and early diastolic excursion, which are in turn related in part to long-axis remodelling of the left ventricle. After adjusting for the extent of systolic and early diastolic excursion, slowing of relaxation, as reflected in prolongation of the IVRT, makes no more than a minor contribution to aging-related decreases in EDExc and e'.	[Peverill, Roger E.] Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia; [Peverill, Roger E.] Monash Univ, Dept Med, Sch Clin Sci, Monash Hlth, Clayton, Vic, Australia; [Peverill, Roger E.] Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia.; Peverill, RE (corresponding author), Monash Univ, Dept Med, Sch Clin Sci, Monash Hlth, Clayton, Vic, Australia.; Peverill, RE (corresponding author), Monash Hlth, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				ALAM M, 1992, AM J CARDIOL, V69, P565, DOI 10.1016/0002-9149(92)91009-S; Alam M, 1999, J AM SOC ECHOCARDIOG, V12, P618, DOI 10.1053/je.1999.v12.a99246; ARORA RR, 1987, J AM COLL CARDIOL, V9, P1255, DOI 10.1016/S0735-1097(87)80464-3; BONOW RO, 1988, J AM COLL CARDIOL, V11, P50, DOI 10.1016/0735-1097(88)90166-0; BONOW RO, 1983, AM J CARDIOL, V51, P1386, DOI 10.1016/0002-9149(83)90317-X; BOUDOULAS H, 1981, CHEST, V80, P613, DOI 10.1378/chest.80.5.613; BRUTSAERT DL, 1987, J AM COLL CARDIOL, V9, P341, DOI 10.1016/S0735-1097(87)80387-X; Carrick-Ranson G, 2012, AM J PHYSIOL-HEART C, V303, P315, DOI 10.1152/ajpheart.00142.2012; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; DOWNES TR, 1989, AM J CARDIOL, V64, P523, DOI 10.1016/0002-9149(89)90433-5; Duncan AM, 2001, HEART, V86, P397, DOI 10.1136/heart.86.4.397; GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273; Gibson DG, 2003, HEART, V89, P231, DOI 10.1136/heart.89.2.231; GILBERT JC, 1989, CIRC RES, V64, P827, DOI 10.1161/01.RES.64.5.827; HANRATH P, 1980, AM J CARDIOL, V45, P15, DOI 10.1016/0002-9149(80)90214-3; HARRISON TR, 1964, AM HEART J, V67, P189, DOI 10.1016/0002-8703(64)90370-9; Hees PS, 2002, AM J CARDIOL, V90, P1231, DOI 10.1016/S0002-9149(02)02840-0; Hees PS, 2004, AM J PHYSIOL-HEART C, V286, pH782, DOI 10.1152/ajpheart.01092.2002; Henein M, 2002, EUR HEART J, V23, P162, DOI 10.1053/euhj.2001.3032; HIROTA Y, 1980, CIRCULATION, V62, P756, DOI 10.1161/01.CIR.62.4.756; HOGLUND C, 1988, ACTA MED SCAND, V224, P557; Jarnert C, 2000, EUR J HEART FAIL, V2, P151, DOI 10.1016/S1388-9842(00)00075-1; JONES CJH, 1990, BRIT HEART J, V63, P215; Kaku K, 2011, J AM SOC ECHOCARDIOG, V24, P541, DOI 10.1016/j.echo.2011.01.011; Kim HK, 2010, CLIN CARDIOL, V33, pE24, DOI 10.1002/clc.20477; LAKATTA EG, 1975, J CLIN INVEST, V55, P61, DOI 10.1172/JCI107918; LAKATTA EG, 1982, AM J PHYSIOL, V242, pH927, DOI 10.1152/ajpheart.1982.242.6.H927; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; MANTERO A, 1995, EUR HEART J, V16, P94, DOI 10.1093/eurheartj/16.1.94; MERILLON JP, 1982, EUR HEART J, V3, P95, DOI 10.1093/eurheartj/3.suppl_A.95; MILLER TR, 1986, AM J CARDIOL, V58, P531, DOI 10.1016/0002-9149(86)90028-7; MIYATAKE K, 1984, AM J CARDIOL, V53, P586, DOI 10.1016/0002-9149(84)90035-3; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Mureddu GF, 1997, HYPERTENSION, V29, P544, DOI 10.1161/01.HYP.29.2.544; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; Nikitin NP, 2005, AGE AGEING, V34, P343, DOI 10.1093/ageing/afi043; Oki T, 1997, AM J CARDIOL, V79, P921, DOI 10.1016/S0002-9149(97)00015-5; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Ommen SR, 2000, CIRCULATION, V102, P1788; Opdahl A, 2009, CIRCULATION, V119, P2578, DOI 10.1161/CIRCULATIONAHA.108.791681; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Peverill RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173383; Peverill RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158302; Popovic ZB, 2011, EUR J ECHOCARDIOGR, V12, P818, DOI 10.1093/ejechocard/jer146; Prasad A, 2005, CIRCULATION, V111, P1499, DOI 10.1161/01.CIR.0000159353.31271.F2; Prasad A, 2007, AM J CARDIOL, V99, P1629, DOI 10.1016/j.amjcard.2007.01.050; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; Sengupta PP, 2006, J AM COLL CARDIOL, V47, P163, DOI 10.1016/j.jacc.2005.08.073; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Stoylen A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000465; Svealv BG, 2006, EUR J ECHOCARDIOGR, V7, P298, DOI 10.1016/j.euje.2005.06.008; THOMAS JD, 1992, AM HEART J, V124, P1305, DOI 10.1016/0002-8703(92)90416-S; Tokushima T, 2001, Am J Geriatr Cardiol, V10, P20, DOI 10.1111/j.1076-7460.2001.90851.x; Wandt B, 1998, J AM SOC ECHOCARDIOG, V11, P857, DOI 10.1016/S0894-7317(98)70005-7; WEISFELDT ML, 1971, AM J PHYSIOL, V220, P1921, DOI 10.1152/ajplegacy.1971.220.6.1921; WILLEMS JL, 1970, CIRCULATION, V42, P37, DOI 10.1161/01.CIR.42.1.37; Wolsk E, 2017, JACC-HEART FAIL, V5, P337, DOI 10.1016/j.jchf.2016.10.012; Yamakado T, 1997, CIRCULATION, V95, P917; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Zamfirescu N R, 1982, Physiologie, V19, P73	63	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0210277	10.1371/journal.pone.0210277	http://dx.doi.org/10.1371/journal.pone.0210277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30615676	Green Published, gold, Green Submitted			2022-12-26	WOS:000455045900057
J	Kosman, DJ				Kosman, Daniel J.			Energy metabolism, oxygen flux, and iron in bacteria: The Mossbauer report	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Iron is the most common transition metal cofactor across biological systems. As the earth transitioned from an anaerobic to aerobic environment, cellular mechanisms evolved to protect against iron-mediated oxidative damage, but the molecular details of these protective strategies remain unclear. In this report, the Lindahl group has combined spectroscopic, biochemical, and genetic approaches to inventory iron in Escherichia coli as a function of bacterial oxygen metabolism. Their results suggest that ferrous iron functions as an oxygen sink that is modulated by a respiratory shield of electron flux in the bacterial plasma membrane.	[Kosman, Daniel J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), Jacobs Sch Med & Biomed Sci, Dept Biochem, Suite 4102,955 Main St, Buffalo, NY 14203 USA.	camkos@buffalo.edu		Kosman, Daniel/0000-0003-3570-7682	National Institute of Neurologic Diseases and Stroke of the Department of Health and Human Services [RO1NS102337]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102337] Funding Source: NIH RePORTER	National Institute of Neurologic Diseases and Stroke of the Department of Health and Human Services; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research in the Kosman Lab is supported by Grant RO1NS102337 from the National Institute of Neurologic Diseases and Stroke of the Department of Health and Human Services (to D.J.K.). The author declares that he has no conflicts of interest with the contents of this article. The content of this article is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; Jhurry ND, 2012, BIOCHEMISTRY-US, V51, P5276, DOI 10.1021/bi300382d; Kosman DJ, 2013, COORDIN CHEM REV, V257, P210, DOI 10.1016/j.ccr.2012.06.030; Lopez-Torrejon G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11426; Lv HH, 2018, METALLOMICS, V10, P899, DOI 10.1039/c8mt00048d; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Wofford JD, 2019, J BIOL CHEM, V294, P50, DOI 10.1074/jbc.RA118.005233	9	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					63	64		10.1074/jbc.H118.006703	http://dx.doi.org/10.1074/jbc.H118.006703			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30610120	hybrid, Green Published			2022-12-26	WOS:000455105500007
J	Tumendelger, A; Alshboul, Z; Lorke, A				Tumendelger, Azzaya; Alshboul, Zeyad; Lorke, Andreas			Methane and nitrous oxide emission from different treatment units of municipal wastewater treatment plants in Southwest Germany	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; SITE PREFERENCE; N2O PRODUCTION; MARINE; DENITRIFICATION; FRACTIONATION; ISOTOPOMERS; RIVER	We measured the atmospheric emission rates of methane (CH4) and nitrous oxide (N2O) in two wastewater treatment plants in Southwest Germany, which apply different treatment technologies. Dissolved gas concentrations and fluxes were measured during all processing steps as well as in the discharge receiving streams. N2O isotopocule analysis revealed that NH2OH oxidation during nitrification contributed 86-96% of the N2O production in the nitrification tank, whereas microbial denitrification was the main production pathway in the denitrification tank in a conventional activated sludge (CAS) system. During wastewater treatment using a modified Ludzack-Ettinger system (MLE) with energy recovery, N2O was predominantly produced by the NO2- reduction by nitrifier-denitrification process. For both systems, N2O emissions were low, with emission factors of 0.008% and 0.001% for the MLE and the CAS system, respectively. In the effluent-receiving streams, bacterial denitrification and nitrification contributed nearly equally to N2O production. The CH4 emission from the MLE system was estimated as 118.1 g-C d(-1), which corresponds to an emission factor of 0.004%, and was three times lower than the emission from the CAS system with 0.01%.	[Tumendelger, Azzaya] Mongolian Acad Sci, Inst Chem & Chem Technol, Ulaanbaatar, Mongolia; [Tumendelger, Azzaya; Alshboul, Zeyad; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Alshboul, Zeyad] Appl Sci Univ, Fac Engn, Civil Engn Dept, Amman, Jordan	Mongolian Academy of Sciences; University of Koblenz & Landau; Applied Science University - Jordan	Tumendelger, A (corresponding author), Mongolian Acad Sci, Inst Chem & Chem Technol, Ulaanbaatar, Mongolia.; Tumendelger, A (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	azzayat@mas.ac.mn	Tumendelger, Azzaya/AAX-8033-2020; Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817; Alshboul, Zeyad/0000-0002-9445-3347; Tumendelger, Azzaya/0000-0003-0778-7216	Deutscher Akademischer Austauschdienst (DE) (DAAD) [91601045]; German Research Foundation (DFG) [LO1150/11-1]; Applied Science University [2/2017]	Deutscher Akademischer Austauschdienst (DE) (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); Applied Science University	This study was supported by Deutscher Akademischer Austauschdienst (DE) (DAAD, no.: 91601045) to Dr. Azzaya Tumendelger and Dr. Zeyad Alshboul; German Research Foundation (DFG, grant no.: LO1150/11-1) to prof. Dr. Andreas Lorke and Dr. Azzaya Tumendelger; Applied Science University 2/2017 to Dr. Zeyad Alshboul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshboul Z, 2016, ENVIRON SCI TECHNOL, V50, P5555, DOI 10.1021/acs.est.5b04923; Baulch HM, 2011, ENVIRON SCI TECHNOL, V45, P4682, DOI 10.1021/es104116a; Beaulieu JJ, 2010, ENVIRON SCI TECHNOL, V44, P7527, DOI 10.1021/es1016735; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; CZEPIEL P, 1995, ENVIRON SCI TECHNOL, V29, P2352, DOI 10.1021/es00009a030; CZEPIEL PM, 1993, ENVIRON SCI TECHNOL, V27, P2472, DOI 10.1021/es00048a025; Daelman MRJ, 2013, WATER SCI TECHNOL, V67, P2350, DOI 10.2166/wst.2013.109; Daelman MRJ, 2015, SCI TOTAL ENVIRON, V536, P1, DOI 10.1016/j.scitotenv.2015.06.122; Daelman MRJ, 2012, WATER RES, V46, P3657, DOI 10.1016/j.watres.2012.04.024; Frame CH, 2010, BIOGEOSCIENCES, V7, P2695, DOI 10.5194/bg-7-2695-2010; Goldenfum J.A., 2011, GHG MEASUREMENT GUID; Guisasola A, 2008, WATER RES, V42, P1421, DOI 10.1016/j.watres.2007.10.014; Holmes RM, 1998, MAR CHEM, V60, P235, DOI 10.1016/S0304-4203(97)00099-6; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; Kwok CEY, 2015, ATMOS MEAS TECH, V8, P2853, DOI 10.5194/amt-8-2853-2015; Law Y, 2012, WATER RES, V46, P3409, DOI 10.1016/j.watres.2012.03.043; Lorke A, 2015, BIOGEOSCIENCES, V12, P7013, DOI 10.5194/bg-12-7013-2015; Mampaey KE, 2015, ENVIRON TECHNOL, V36, P1680, DOI 10.1080/09593330.2015.1005029; Pinakoulaki E, 2002, J BIOL CHEM, V277, P23407, DOI 10.1074/jbc.M201913200; Rathnayake RMLD, 2013, WATER RES, V47, P7078, DOI 10.1016/j.watres.2013.07.055; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Samarkin VA, 2010, NAT GEOSCI, V3, P341, DOI 10.1038/NGEO847; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Stieglmeier M, 2014, ISME J, V8, P1135, DOI 10.1038/ismej.2013.220; SUMER E, 1995, EXPERIENTIA, V51, P419, DOI 10.1007/BF01928908; Sutka RL, 2003, RAPID COMMUN MASS SP, V17, P738, DOI 10.1002/RCM.968; Sutka RL, 2004, RAPID COMMUN MASS SP, V18, P1411, DOI 10.1002/rcm.1482; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Sutka RL, 2008, RAPID COMMUN MASS SP, V22, P3989, DOI 10.1002/rcm.3820; Toyoda S, 1999, ANAL CHEM, V71, P4711, DOI 10.1021/ac9904563; Toyoda S, 2005, SOIL BIOL BIOCHEM, V37, P1535, DOI 10.1016/j.soilbio.2005.01.009; Toyoda S, 2017, MASS SPECTROM REV, V36, P135, DOI 10.1002/mas.21459; Toyoda S, 2011, ENVIRON SCI TECHNOL, V45, P917, DOI 10.1021/es102985u; Toyoda S, 2009, RAPID COMMUN MASS SP, V23, P809, DOI 10.1002/rcm.3945; Tumendelger A, 2016, GEOCHEM J, V50, P105, DOI 10.2343/geochemj.2.0390; Tumendelger A, 2014, RAPID COMMUN MASS SP, V28, P1883, DOI 10.1002/rcm.6973; Turner PA, 2016, GEOPHYS RES LETT, V43, P4400, DOI 10.1002/2016GL068710; Venkiteswaran JJ, 2014, ENVIRON SCI TECHNOL, V48, P1566, DOI 10.1021/es500069j; VONSCHULTHESS R, 1995, WATER RES, V29, P215, DOI 10.1016/0043-1354(94)E0108-I; Wang JH, 2011, BIORESOURCE TECHNOL, V102, P5479, DOI 10.1016/j.biortech.2010.10.090; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Yin ZX, 2018, ARCHAEA, V2018, DOI 10.1155/2018/8429145; Yoshida H, 2014, WATER RES, V61, P108, DOI 10.1016/j.watres.2014.05.014; Yoshida N, 2000, NATURE, V405, P330, DOI 10.1038/35012558	47	19	19	11	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209763	10.1371/journal.pone.0209763	http://dx.doi.org/10.1371/journal.pone.0209763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608974	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800026
J	Parzych, K; Saavedra-Garcia, P; Valbuena, GN; Al-Sadah, HA; Robinson, ME; Penfold, L; Kuzeva, DM; Ruiz-Tellez, A; Loaiza, S; Holzmann, V; Caputo, V; Johnson, DC; Kaiser, MF; Karadimitris, A; Lam, EWF; Chevet, E; Feldhahn, N; Keun, HC; Auner, HW				Parzych, Katarzyna; Saavedra-Garcia, Paula; Valbuena, Gabriel N.; Al-Sadah, Hibah A.; Robinson, Mark E.; Penfold, Lucy; Kuzeva, Desislava M.; Ruiz-Tellez, Angie; Loaiza, Sandra; Holzmann, Viktoria; Caputo, Valentina; Johnson, David C.; Kaiser, Martin F.; Karadimitris, Anastasios; Lam, Eric W-F; Chevet, Eric; Feldhahn, Niklas; Keun, Hector C.; Auner, Holger W.			The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation	ONCOGENE			English	Article							VALOSIN-CONTAINING PROTEIN; AMINO-ACID DEPRIVATION; AAA-ATPASE CDC48/P97; ELEVATED EXPRESSION; EIF2-ALPHA KINASE; INDUCED AUTOPHAGY; P97; STRESS; ER; DEGRADATION	VCP/p97 regulates numerous cellular functions by mediating protein degradation through its segregase activity. Its key role in governing protein homoeostasis has made VCP/p97 an appealing anticancer drug target. Here, we provide evidence that VCP/p97 acts as a regulator of cellular metabolism. We found that VCP/p97 was tied to multiple metabolic processes on the gene expression level in a diverse range of cancer cell lines and in patient-derived multiple myeloma cells. Cellular VCP/p97 dependency to maintain proteostasis was increased under conditions of glucose and glutamine limitation in a range of cancer cell lines from different tissues. Moreover, glutamine depletion led to increased VCP/p97 expression, whereas VCP/p97 inhibition perturbed metabolic processes and intracellular amino acid turnover. GCN2, an amino acid-sensing kinase, attenuated stress signalling and cell death triggered by VCP/p97 inhibition and nutrient shortages and modulated ERK activation, autophagy, and glycolytic metabolite turnover. Together, our data point to an interconnected role of VCP/p97 and GCN2 in maintaining cancer cell metabolic and protein homoeostasis.	[Parzych, Katarzyna; Saavedra-Garcia, Paula; Al-Sadah, Hibah A.; Penfold, Lucy; Kuzeva, Desislava M.; Ruiz-Tellez, Angie; Loaiza, Sandra; Holzmann, Viktoria; Auner, Holger W.] Imperial Coll London, Canc Cell Prot Metab Grp, Dept Med, Ctr Haematol, London, England; [Valbuena, Gabriel N.; Lam, Eric W-F; Keun, Hector C.] Imperial Coll London, Hammersmith Hosp, Div Canc, Dept Surg & Canc, London, England; [Robinson, Mark E.; Caputo, Valentina; Karadimitris, Anastasios; Feldhahn, Niklas] Imperial Coll London, Dept Med, Ctr Haematol, London, England; [Johnson, David C.; Kaiser, Martin F.] Inst Canc Res, Div Mol Pathfol, Sutton, Surrey, England; [Chevet, Eric] Univ Rennes 1, INSERM, U1242, Chem,Oncogenesis,Stress,Signaling, Rennes, France; [Chevet, Eric] Ctr Lutte Canc Eugene Marquis Rennes, Rennes, France	Imperial College London; Imperial College London; Imperial College London; University of London; Institute of Cancer Research - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Auner, HW (corresponding author), Imperial Coll London, Canc Cell Prot Metab Grp, Dept Med, Ctr Haematol, London, England.	holger.auner04@imperial.ac.uk	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; Holzmann, Viktoria/0000-0001-5168-1289; Kaiser, Martin/0000-0002-3677-4804; Auner, Holger/0000-0003-4040-0642; Penfold, Lucy/0000-0003-0642-4165; Saavedra, Paula/0000-0002-9907-475X; Robinson, Mark/0000-0003-2363-6047; Valbuena, Gabriel/0000-0001-6825-7214; Kuzeva, Desislava/0000-0002-7616-3012	Cancer Research UK Clinician Scientist Fellowship [C41494/A15448]; British Society for Haematology Early Stage Research Start-up Grant; Imperial College London National Institute of Health Research-Biomedical Research Centre (NIHR-BRC); Imperial College London Cancer Research UK Centre; Imperial College Healthcare Charity 'Dorothy Cave Legacy Fund'; Cancer Research UK [A22544]; Saudi Arabian Cultural Bureau in the UK; MRC [MR/N012097/1] Funding Source: UKRI	Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); British Society for Haematology Early Stage Research Start-up Grant; Imperial College London National Institute of Health Research-Biomedical Research Centre (NIHR-BRC); Imperial College London Cancer Research UK Centre; Imperial College Healthcare Charity 'Dorothy Cave Legacy Fund'; Cancer Research UK(Cancer Research UK); Saudi Arabian Cultural Bureau in the UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Cancer Research UK Clinician Scientist Fellowship (C41494/A15448) and a British Society for Haematology Early Stage Research Start-up Grant to HWA. The work was also supported by grants from the Imperial College London National Institute of Health Research-Biomedical Research Centre (NIHR-BRC), the Imperial College London Cancer Research UK Centre, and the Imperial College Healthcare Charity 'Dorothy Cave Legacy Fund' to HWA. HCK acknowledges support by Cancer Research UK (A22544) and the Imperial College London Cancer Research UK Centre. HAAS was supported by an award from the Saudi Arabian Cultural Bureau in the UK. The authors also acknowledge the excellent technical flow cytometry support provided by Miss Carme Ripoll Fiol.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Behrends V, 2011, ANAL BIOCHEM, V415, P206, DOI 10.1016/j.ab.2011.04.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Dickens NJ, 2010, CLIN CANCER RES, V16, P1856, DOI 10.1158/1078-0432.CCR-09-2831; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Ishimura R, 2016, ELIFE, V5, DOI 10.7554/eLife.14295; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Le Moigne R, 2017, MOL CANCER THER, V16, P2375, DOI 10.1158/1535-7163.MCT-17-0233; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Martin R, 2013, J CELL SCI, V126, P3010, DOI 10.1242/jcs.118067; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; NEUMAN RE, 1956, SCIENCE, V124, P124, DOI 10.1126/science.124.3212.124; Pan M, 2016, NAT CELL BIOL, V18, P1090, DOI 10.1038/ncb3410; Parzych K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.373; PASIEKA AE, 1959, NATURE, V183, P1201, DOI 10.1038/1831201a0; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Saito Y, 2015, CELL STEM CELL, V17, P585, DOI 10.1016/j.stem.2015.08.019; Sasagawa Y, 2012, J STRUCT BIOL, V179, P104, DOI 10.1016/j.jsb.2012.06.009; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Shin S, 2015, MOL CELL, V59, P382, DOI 10.1016/j.molcel.2015.06.020; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Nguyen TV, 2017, P NATL ACAD SCI USA, V114, P3565, DOI 10.1073/pnas.1700949114; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vlahakis A, 2014, P NATL ACAD SCI USA, V111, P10586, DOI 10.1073/pnas.1406305111; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wang YG, 2013, NEOPLASIA, V15, P989, DOI 10.1593/neo.13262; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wengrod J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0899; Wilson GJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE283, DOI 10.1152/ajpendo.00361.2014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	86	24	25	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2019	38	17					3216	3231		10.1038/s41388-018-0651-z	http://dx.doi.org/10.1038/s41388-018-0651-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HU8RI	30626938	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000465557200008
J	Alpizar, P; Rodriguez-Herrera, B; Jung, K				Alpizar, Priscilla; Rodriguez-Herrera, Bernal; Jung, Kirsten			The effect of local land use on aerial insectivorous bats (Chiroptera) within the two dominating crop types in the Northern-Caribbean lowlands of Costa Rica	PLOS ONE			English	Article							SHADE CACAO PLANTATIONS; SOUTHERN BAHIA; BIODIVERSITY; HABITAT; FOREST; IDENTIFICATION; ECHOLOCATION; INTENSIFICATION; CONSERVATION; DIVERSITY	Land transformation into agricultural areas and the intensification of management practices represent two of the most devastating threats to biodiversity worldwide. Within this study, we investigated the effect of intensively managed agroecosystems on bat activity and species composition within two focal areas differing in landscape structure. We sampled bats via acoustic monitoring and insects with flight interception traps in banana and pineapple monoculture plantations and two nearby protected forested areas within the area of Sarapiqui, Costa Rica. Our results revealed that general occurrence and feeding activity of bats was higher above plantations compared to forested areas. We also recorded higher species richness at recording sites in plantations. This trend was especially strong within a fragmented landscape, with only four species recorded in forests, but 12 above pineapple plantations. Several bat species, however, occurred only once or twice above plantations, and forest specialist species such as Centronycteris centralis, Myotis riparius and Pteronotus mesoamericanus were only recorded at forest sites. Our results indicated, that mostly mobile open space and edge foraging bat species can use plantations as potential foraging habitat and might even take advantage of temporal insect outbreaks. However, forests are vital refugia for several species, including slower flying forest specialists, and thus a prerequisite to safeguard bat diversity within agricultural dominated landscapes.	[Alpizar, Priscilla; Rodriguez-Herrera, Bernal] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Alpizar, Priscilla; Jung, Kirsten] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Baden Wurttemberg, Germany	Universidad Costa Rica; Ulm University	Alpizar, P (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.; Alpizar, P (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Baden Wurttemberg, Germany.	priscilla.alpizar-alpizar@uni-ulm.de			Bat Conservation International; University of Costa Rica; German Academic Exchange Program (DAAD); Spanish Agency of International Cooperation and Development [D/027406/09, D/033858/10, A1/039089/11]	Bat Conservation International; University of Costa Rica; German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Agency of International Cooperation and Development	This work was supported by Bat Conservation International (BCI Student Research Scholarship 2012), University of Costa Rica, the German Academic Exchange Program (DAAD), and the Spanish Agency of International Cooperation and Development (funding projects D/027406/09, D/033858/10, and A1/039089/11 for the Universidad de Las Palmas de Gran Canaria and Universidad de Costa Rica).	Alpizar Priscilla, 2012, Revista Biodiversidad Neotropical, V2, P138; Bader E, 2015, BIOL CONSERV, V186, P97, DOI 10.1016/j.biocon.2015.02.028; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellamy AS, 2013, AMBIO, V42, P334, DOI 10.1007/s13280-012-0341-y; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brose U, 2004, OIKOS, V105, P292, DOI 10.1111/j.0030-1299.2004.12884.x; CEBALLOS G, 1988, Mammalian Species, P1, DOI 10.2307/3504140; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Estrada-Villegas S, 2012, ECOLOGY, V93, P1183, DOI 10.1890/11-0275.1; Estrada-Villegas S, 2010, BIOL CONSERV, V143, P597, DOI 10.1016/j.biocon.2009.11.009; FAO, 2011, STAT WORLDS LAND WAT, DOI DOI 10.1007/978-3-319-92049-8_31; Faria D, 2006, BIODIVERS CONSERV, V15, P587, DOI 10.1007/s10531-005-2089-1; Faria D, 2007, BIODIVERS CONSERV, V16, P291, DOI 10.1007/s10531-005-8346-5; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Freudmann A, 2015, BIODIVERS CONSERV, V24, P3583, DOI 10.1007/s10531-015-1021-6; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Gotelli NJ, 2006, ECOSIM NULL MODELS S; Heer K, 2015, J MAMMAL, V96, P720, DOI 10.1093/jmammal/gyv068; Heim O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134443; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085279; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kerr JT, 2002, BIODIVERS CONSERV, V11, P695, DOI 10.1023/A:1015500513603; Kingston T, 2010, BIODIVERS CONSERV, V19, P471, DOI 10.1007/s10531-008-9458-5; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; LaVal RK, 2002, MURCIELAGOS COSTA RI; Lentini PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048201; McDade Lucinda A., 1994, P6; Meynard CN, 2014, BIODIVERS CONSERV, V23, P1949, DOI 10.1007/s10531-014-0697-3; Mone Shamika, 2014, Journal of Threatened Taxa, V6, P6186, DOI 10.11609/JoTT.o3778.6186-94; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Ruiz AT, 2017, 8 INT C PATT REC SUS, DOI [10.1049/cp.2017.0130, DOI 10.1049/CP.2017.0130]; Ruiz AT, 23 IB C PATT REC MAD; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SEPSA, 2012, B EST AGR; SINAC (Sistema Nacional de areas de Conservacion), 2012, SINAC NUM INF AN EST; Solano J., 1996, ASPECTOS FISIOGRAFIC; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Treitler JT, 2016, ECOL EVOL, V6, P4289, DOI 10.1002/ece3.2160; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Williams-Guillen Kimberly, 2016, P151	59	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210364	10.1371/journal.pone.0210364	http://dx.doi.org/10.1371/journal.pone.0210364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645621	Green Submitted, gold, Green Published			2022-12-26	WOS:000455810200026
J	Ke, CJ; Guan, WX; Bu, SH; Li, XX; Deng, Y; Wei, ZN; Wu, WR; Zheng, Y				Ke, Changjiao; Guan, Wenxiang; Bu, Suhong; Li, Xiaoxu; Deng, Yun; Wei, Zhinan; Wu, Weiren; Zheng, Yan			Determination of absorption dose in chemical mutagenesis in plants	PLOS ONE			English	Article							EFFICIENCY; SULFONATE	Chemical mutagenesis is a useful tool for inducing mutations in plants. Seeds are often used as the material for chemical mutagenesis. The biological effect of a chemical mutagen on seeds is determined by absorption dose (the product of mutagen concentration and acting time, which starts after the mutagen is absorbed by the seeds). In practice, however, the concept of exposure dose (the product of mutagen concentration and treating time) is usually used instead because the time for absorbing mutagen is unknown. In this study, we conducted an experiment using ethyl methane sulphonate (EMS) to treat cauliflower seeds, in which five EMS concentrations (0%, 0.5%, 1.0%, 1.5% and 2.0%), three treating time lengths (4 h, 6 h and 8 h) and two pretreatments (non-presoaking and presoaking of seeds for 2 h) were set. We obtained a well-fitted nonlinear regression model for the relationship between seedling survival rate and the EMS treatment, and its marginal models for the two pretreatments. Based on the models, we determined the EMS absorption doses under the two different pretreatments and identified their 50% lethality dose (LD50). We found that presoaking could delay EMS absorption and therefore reduce the injury caused by EMS within a given treating time, but could hardly change the biological effect of EMS after it is absorbed. The conclusions about absorption dose and presoaking effect obtained in this study might be generally applicable to plant chemical mutagenesis in principle.	[Ke, Changjiao; Guan, Wenxiang; Bu, Suhong; Wu, Weiren; Zheng, Yan] Fujian Agr & Forestry Univ, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China; [Ke, Changjiao; Guan, Wenxiang; Bu, Suhong; Wu, Weiren; Zheng, Yan] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China; [Li, Xiaoxu; Deng, Yun; Wei, Zhinan; Zheng, Yan] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wu, WR; Zheng, Y (corresponding author), Fujian Agr & Forestry Univ, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China.; Wu, WR; Zheng, Y (corresponding author), Fujian Agr & Forestry Univ, Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China.; Zheng, Y (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wuwr@fafu.edu.cn; swallow1318@126.com			Natural Science Foundation of Fujian Province (CN) [2017J01424]	Natural Science Foundation of Fujian Province (CN)	Funding was provided by the Natural Science Foundation of Fujian Province (CN), grant #2017J01424, to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Dhanavel D, 2008, AFR J BIOTECHNOL, V7, P4116; Feng HY, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P107, DOI 10.1079/9781780640853.0107; Hohmann U, 2005, PLANT BREEDING, V124, P317, DOI 10.1111/j.1439-0523.2005.01126.x; Jander G, 2003, PLANT PHYSIOL, V131, P139, DOI 10.1104/pp.102.010397; Khan S, 2009, ENV WE INT J SCI TEC, V4, P1; Kodym A, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P169, DOI 10.1079/9781780640853.0169; Lee DK, 2017, APPL BIOL CHEM, V60, P241, DOI 10.1007/s13765-017-0273-0; Leitao JM, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P135, DOI 10.1079/9781780640853.0135; Rajarajeswari P., 2017, INT J FUZZY LOGIC SY, V7, P1; Rajib Roychowdhury, 2011, Current Botany, V2, P19; Talebi A. B., 2012, American Journal of Plant Sciences, V3, P1661, DOI 10.4236/ajps.2012.312202; Wani Aijaz A., 2009, Asian Journal of Plant Sciences, V8, P318	13	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210596	10.1371/journal.pone.0210596	http://dx.doi.org/10.1371/journal.pone.0210596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640941	Green Published, Green Submitted, gold			2022-12-26	WOS:000455808000034
J	Spiteri, J; James, J; Belot, M				Spiteri, Jonathan; James, Jonathan; Belot, Michele			A computer-based incentivized food basket choice tool: Presentation and evaluation	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY-INTAKE; FREQUENCY QUESTIONNAIRES; PHYSICAL-ACTIVITY; RANDOMIZED-RESPONSE; NATIONAL-HEALTH; ENERGY-INTAKE; NUTRITION; RECALL; VALIDITY	Objective To develop and evaluate a low-cost computer-based tool to elicit dietary choices in an incentive compatible manner, which can be used on-line or as part of a laboratory study. Methods The study was conducted with around 255 adults. Respondents were asked to allocate a fixed monetary budget across a choice of around a hundred grocery items with the prospect of receiving these items with some probability delivered to their home by a real supermarket. The tool covers a broad range of food items, allows inference of macro-nutrients and calories, and allows the researcher to fix the choice set participants can choose from. We compare the information derived from our incentivized tool, and compare it to alternative low-cost ways of measuring dietary intake, namely the food frequency questionnaire and a one-shot version of the 24-hour dietary recall, which are both based on self-reports. We compare the calorie intake indicators derived from each tool with a number of biometric measures for each subject, namely weight, body-mass-index (BMI) and waist size. Results The results show that the dietary information collected is only weakly correlated across the three methods. We find that only the calorie intake measure from our incentivized tool is positively and significantly related to each of the biometric indicators. Specifically, a 10% increase in calorie intake is associated with a 1.5% increase in BMI. By contrast, we find no significant correlations for either of the two measures based on self-reports. Conclusion The computer-based tool is a promising new, low-cost measure of dietary choices, particularly in one-shot situations where such behaviours are only observed once, whereas other tools like 24-hour dietary recalls and food frequency questionnaires may be more suited when they are administered repeatedly. The tool may be useful for research conducted with limited time and budget.	[Spiteri, Jonathan] Univ Malta, Fac Econ Management & Accountancy, Msida, Malta; [James, Jonathan] Univ Bath, Dept Econ, Bath, Avon, England; [Belot, Michele] European Univ Inst, Dept Econ, Florence, Italy	University of Malta; University of Bath; European University Institute	James, J (corresponding author), Univ Bath, Dept Econ, Bath, Avon, England.	J.James@bath.ac.uk		James, Jonathan/0000-0002-8206-1637	NUDGE-IT [607310]	NUDGE-IT	This work was supported by NUDGE-IT, Project ID: 607310, Funded under: FP7-KBBE (https://cordis.europa.eu/project/rcn/111139_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz W, 1998, AM J AGR ECON, V80, P64, DOI 10.2307/3180269; Alfnes F, 2006, AM J AGR ECON, V88, P1050, DOI 10.1111/j.1467-8276.2006.00915.x; Arab L, 2011, AM J EPIDEMIOL, V174, P1256, DOI 10.1093/aje/kwr224; Atkin LM, 2000, AM J CLIN NUTR, V72, P15; Baranowski T, 2012, J ACAD NUTR DIET, V112, P527, DOI 10.1016/j.jada.2011.10.002; Barrios P, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0150-2; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Belot M, WHAT YOU DONT UNPUB; Berg JE, 2010, GAME ECON BEHAV, V68, P443, DOI 10.1016/j.geb.2009.07.008; Bertrand M, 2001, AM ECON REV, V91, P67, DOI 10.1257/aer.91.2.67; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Bingham SA, 2002, PUBLIC HEALTH NUTR, V5, P821, DOI 10.1079/PHN2002368; Bingham SA, 2001, AM J CLIN NUTR, V74, P188; BLOCK G, 1982, AM J EPIDEMIOL, V115, P492, DOI 10.1093/oxfordjournals.aje.a113331; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5; Burger R, 2010, WORLD DEV, V38, P1263, DOI 10.1016/j.worlddev.2009.12.018; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Carlsson F, 2007, AM J AGR ECON, V89, P152, DOI 10.1111/j.1467-8276.2007.00969.x; Chang JB, 2009, AM J AGR ECON, V91, P518, DOI 10.1111/j.1467-8276.2008.01242.x; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Cubitt R. P., 1998, Experimental Economics, V1, P115, DOI 10.1023/A:1026435508449; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Daniel Z, 131 CHE; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Demarque C, 2015, J ENVIRON PSYCHOL, V43, P166, DOI 10.1016/j.jenvp.2015.06.008; Diener A, 1998, HEALTH ECON, V7, P313, DOI 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.3.CO;2-2; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; George SM, 2012, PUBLIC HEALTH NUTR, V15, P1000, DOI 10.1017/S1368980011003272; Graham DJ, 2011, J AM DIET ASSOC, V111, P1704, DOI 10.1016/j.jada.2011.08.005; Griffith R, 2015, OXFORD REV ECON POL, V31, P116, DOI 10.1093/oxrep/grv004; Griffith R, 2010, FISC STUD, V31, P481, DOI 10.1111/j.1475-5890.2010.00122.x; Griffith R, 2009, FISC STUD, V30, P339, DOI 10.1111/j.1475-5890.2009.00099.x; Guo X, 2004, EUR J CLIN NUTR, V58, P1580, DOI 10.1038/sj.ejcn.1601989; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Harper H, 2016, COUNTING CALORIES RE; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Johnson RK, 2002, OBES RES, V10, p63S, DOI 10.1038/oby.2002.192; KOLLAT DT, 1967, J MARKETING RES, V4, P21, DOI 10.2307/3150160; Kozup JC, 2003, J MARKETING, V67, P19, DOI 10.1509/jmkg.67.2.19.18608; Kristal AK, 1992, P 17 NAT NUTR DAT C, P110; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Loomis J.B., 2009, J AGRIC APPL ECON, V41, P698, DOI DOI 10.1017/S1074070800003163; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Lynch JG, 2006, J PUBLIC POLICY MARK, V25, P67, DOI 10.1509/jppm.25.1.67; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x; McFerran B, 2010, J CONSUM RES, V36, P915, DOI 10.1086/644611; Mulligan AA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004503; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2007, J LAW MED ETHICS, V35, P35, DOI 10.1111/j.1748-720X.2007.00112.x; Newby PK, 2003, ARCH PEDIAT ADOL MED, V157, P759, DOI 10.1001/archpedi.157.8.759; Office of National Statistics, 2018, FAM SPEND UK FIN YEA; Panzone LA, J ENV EC MANAGEMENT; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; RAGHAVARAO D, 1979, J ROY STAT SOC B MET, V41, P40; Resnicow K, 2000, AM J EPIDEMIOL, V152, P1072, DOI 10.1093/aje/152.11.1072; Romieu I, 2004, PEDIATR PULM, V38, P31, DOI 10.1002/ppul.20042; Shang Lei, 2015, Prev Med Rep, V2, P265, DOI 10.1016/j.pmedr.2015.04.003; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Smith C, 2006, AM J HUM BIOL, V18, P706, DOI 10.1002/ajhb.20475; STARMER C, 1991, AM ECON REV, V81, P971; STERN H, 1962, J MARKETING, V26, P59, DOI 10.2307/1248439; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Thomas M, 2011, J CONSUM RES, V38, P126, DOI 10.1086/657331; Thompson FE, 2005, J AM DIET ASSOC, V105, P352, DOI 10.1016/j.jada.2004.12.032; Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642; Trost SG, 2003, INT J OBESITY, V27, P834, DOI 10.1038/sj.ijo.0802311; Umbach P., 2005, NEW DIRECTIONS I RES, V127, P73, DOI DOI 10.1002/ir.156; Wansink B, 2009, AM ECON REV, V99, P165, DOI 10.1257/aer.99.2.165; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Wisdom J, 2010, AM ECON J-APPL ECON, V2, P164, DOI 10.1257/app.2.2.164; Zhou X, 2015, NUTRIENTS, V7, P5396, DOI 10.3390/nu7075228	77	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210061	10.1371/journal.pone.0210061	http://dx.doi.org/10.1371/journal.pone.0210061			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629643	Green Submitted, Green Published, gold			2022-12-26	WOS:000455483000044
J	Sultana, M; Sarker, AR; Sheikh, N; Akram, R; Ali, N; Mahumud, RA; Alam, NH				Sultana, Marufa; Sarker, Abdur Razzaque; Sheikh, Nurnabi; Akram, Raisul; Ali, Nausad; Mahumud, Rashidul Alam; Alam, Nur Haque			Prevalence, determinants and health care-seeking behavior of childhood acute respiratory tract infections in Bangladesh	PLOS ONE			English	Article							CHILDREN; PNEUMONIA; EPIDEMIOLOGY; ILLNESS; URBAN	Background Acute respiratory infections (ARIs) are one of the leading causes of child mortality worldwide and contribute significant health burden for developing nations such as Bangladesh. Seeking care and prompt management is crucial to reduce disease severity and to prevent associated morbidity and mortality. Objective This study investigated the prevalence and care-seeking behaviors among under-five children in Bangladesh and identified factors associated with ARI prevalence and subsequent care-seeking behaviors. Method The present study analyzed cross-sectional data from the 2014 Bangladesh Demographic Health Survey. Bivariate analysis was performed to estimate the prevalence of ARIs and associated care-seeking. Logistic regression analysis was used to determine the influencing socio-economic and demographic predictors. A p-value of <0.05 was considered as the level of significance. Result Among 6,566 under-five children, 5.42% had experienced ARI symptoms, care being sought for 90% of affected children. Prevalence was significantly higher among children < 2 years old, and among males. Children from poorer and the poorest quintiles of households were 2.40 (95% CI = 1.12, 5.15) and 2.36 (95% CI = 1.06, 5.24) times more likely to suffer from ARIs compared to the wealthiest group. Seeking care was significantly higher among female children (AOR = 2.19, 95% CI = 0.94, 5.12). The likelihood of seeking care was less for children belonging to the poorest quintile compared to the richest (AOR = 0.03, 95% CI = 0.01, 0.55). Seeking care from untrained providers was 3.74 more likely among rural residents compared to urban (RRR = 3.74, 95% CI = 1.10, 12.77). Conclusion ARIs continue to contribute high disease burden among under-five children in Bangladesh lacking of appropriate care-seeking behavior. Various factors, such as age and sex of the children, wealth index, the education of the mother, and household lifestyle factors were significantly associated with ARI prevalence and care-seeking behaviors. In addition to publicprivate actions to increase service accessibility for poorer households, equitable and efficient service distribution and interventions targeting households with low socio-economic status and lower education level, are recommended.	[Sultana, Marufa; Alam, Nur Haque] Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sultana, Marufa] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia; [Sarker, Abdur Razzaque; Sheikh, Nurnabi; Akram, Raisul; Ali, Nausad] Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Sarker, Abdur Razzaque] Univ Strathclyde, Glasgow, Lanark, Scotland; [Mahumud, Rashidul Alam] Univ Southern Queensland, Toowoomba, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Deakin University; International Centre for Diarrhoeal Disease Research (ICDDR); University of Strathclyde; University of Southern Queensland	Sultana, M (corresponding author), Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Sultana, M (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia.	marufa@icddrb.org	Mahumud, Rashidul Alam/O-2477-2018	Mahumud, Rashidul Alam/0000-0001-9788-1868; Sheikh, Nurnabi/0000-0002-5185-9996				Abdulkadir MB, 2016, S AFR J CHILD HEALTH, V10, P92, DOI [10.7196/sajch.2016.v10i1.1076, 10.7196/SAJCH.2016.v10i1.1076]; Abdulkadir Mohammed B, 2015, Oman Med J, V30, P331, DOI 10.5001/omj.2015.68; Adesanya OA, 2016, BMC PUBLIC HEALTH, V16, P1, DOI [10.1186/s12889-015-2639-8, DOI 10.1186/S12889-015-2639-8]; Akram R, 2018, FOOD NUTR BULL, V39, P521, DOI 10.1177/0379572118794770; Althouse BM, 2018, INT J INFECT DIS, V75, P18, DOI 10.1016/j.ijid.2018.08.001; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; [Anonymous], 2013, MEAS DHS ICF INT DEM; Astale T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142553; Azad K., 2009, J SCI RES, V1, P72, DOI 10.3329/jsr.v1i1.1055; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; BBS, 2013, HLTH MORB STAT SURV; Erling V, 1999, J PUBLIC HEALTH MED, V21, P331, DOI 10.1093/pubmed/21.3.331; Goldman N, 2000, TROP MED INT HEALTH, V5, P145, DOI 10.1046/j.1365-3156.2000.00527.x; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Hamed A, 2017, WORLD J UROL, V35, P459, DOI 10.1007/s00345-016-1879-2; Hemila H, 2008, RESP MED, V102, P625, DOI 10.1016/j.rmed.2007.12.011; International Vaccine Access Center (IVAC), 2015, JOHNS HOPKINS BLOOMB, P1; Islam A., 2014, AM J HLTH RES, V6, P366, DOI [10.11648/j.ajhr.20140206.18, DOI 10.11648/J.AJHR.20140206.18]; Islam F, 2013, J GLOB INFECT DIS, V5, P8, DOI 10.4103/0974-777X.107167; Kabir AL, 2016, J RESP MED RES TREAT, V11, DOI [10.5171/2016.183615, DOI 10.5171/2016.183615]; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kante AM, 2015, BMC PUBLIC HLTH, V15, P1, DOI [10.1186/1471-2458-15-1, DOI 10.1186/1471-2458-15-1]; Kanungo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125865; Khera R, 2014, ARCH DIS CHILD, V99, P369, DOI 10.1136/archdischild-2013-303889; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kilabuko James H, 2007, Int J Environ Res Public Health, V4, P283, DOI 10.3390/ijerph200704040003; Mahumud Rashidul Alam, 2017, J Prev Med Public Health, V50, P91, DOI 10.3961/jpmph.16.089; Pinzon-Rondon AM, 2016, PAEDIATR INT CHILD H, V36, P84, DOI 10.1179/2046905515Y.0000000021; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; Ndugwa RP, 2008, J CHILD HEALTH CARE, V12, P314, DOI 10.1177/1367493508096206; NIPORT, 2015, BANGL URB HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; Pal Ranabir, 2009, Indian J Community Med, V34, P310, DOI 10.4103/0970-0218.58389; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Rutstein S. O., 2004, DHS WEALTH INDEX; Sadruddin S, 2012, AM J TROP MED HYG, V87, P137, DOI 10.4269/ajtmh.2012.12-0242; Sahoo AK, 2014, J HEALTH MANAG, V16, P397, DOI 10.1177/0972063414539614; Sanbata H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1122; Sarker AR, 2018, PUBLIC HEALTH, V157, P94, DOI 10.1016/j.puhe.2018.01.010; Sarker Abdur Razzaque, 2016, Glob Pediatr Health, V3, p2333794X16680901, DOI 10.1177/2333794X16680901; Sarker AR, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000052; Scott JAG, 2008, B WORLD HEALTH ORGAN, V86, P494, DOI 10.2471/BLT.08.052753; Seam MOR, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6010006; Selvaraj Kalaiselvi, 2014, J Nat Sci Biol Med, V5, P15, DOI 10.4103/0976-9668.127275; Shibata T, 2014, INT J ENV RES PUB HE, V11, P12190, DOI 10.3390/ijerph111212190; Sreeramareddy CT., 2006, BMC INT HEALTH HUM R, V6, P1; Sultana NK, 2013, J PEDIATR-US, V163, pS73, DOI 10.1016/j.jpeds.2013.03.033; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; UNICEF, 2022, DEM WSPOLCZ DZIETN; Vlassoff C, 2007, J HEALTH POPUL NUTR, V25, P47; Walke Sneha P, 2014, Int Sch Res Notices, V2014, P165152, DOI 10.1155/2014/165152; Walke SP, 2014, INT SCH RES NOTICES, V2014, P6; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization (WHO), 2013, PNEUM FACTSH	59	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210433	10.1371/journal.pone.0210433	http://dx.doi.org/10.1371/journal.pone.0210433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629689	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000455483000090
J	Castel, B; Tomlinson, L; Locci, F; Yang, Y; Jones, JDG				Castel, Baptiste; Tomlinson, Laurence; Locci, Federica; Yang, Ying; Jones, Jonathan D. G.			Optimization of T-DNA architecture for Cas9-mediated mutagenesis in Arabidopsis	PLOS ONE			English	Article							TARGETED MUTAGENESIS; GENE-EXPRESSION; HIGH-EFFICIENCY; GENOME; CAS9; CRISPR/CAS9; PROMOTER; RECOMBINATION; SPECIFICITY; NUCLEASES	Bacterial CRISPR systems have been widely adopted to create operator-specified site-specific nucleases. Such nuclease action commonly results in loss-of-function alleles, facilitating functional analysis of genes and gene families We conducted a systematic comparison of components and T-DNA architectures for CRISPR-mediated gene editing in Arabidopsis, testing multiple promoters, terminators, sgRNA backbones and Cas9 alleles. We identified a T-DNA architecture that usually results in stable (i.e. homozygous) mutations in the first generation after transformation. Notably, the transcription of sgRNA and Cas9 in head-to-head divergent orientation usually resulted in highly active lines. Our Arabidopsis data may prove useful for optimization of CRISPR methods in other plants.	[Castel, Baptiste; Tomlinson, Laurence; Locci, Federica; Yang, Ying; Jones, Jonathan D. G.] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England; [Locci, Federica] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Yang, Ying] Univ Lincoln, Beadle Ctr, Ctr Plant Sci Innovat, Lincoln, NE USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Sapienza University Rome	Jones, JDG (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	jonathan.jones@tsl.ac.uk	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Castel, Baptiste/0000-0002-2722-0228	Gatsby Charitable Foundation at The Sainsbury Laboratory, Norwich; Bill and Melinda Gates Foundation (Grand Challenges Exploration) [OPP1060026]; Sapienza University of Rome; Gatsby Charitable Foundation at The Sainsbury Laboratory; BBSRC [BB/M003809/1, BBS/E/J/000PR9797, BB/L014130/1, BB/K003550/1] Funding Source: UKRI	Gatsby Charitable Foundation at The Sainsbury Laboratory, Norwich; Bill and Melinda Gates Foundation (Grand Challenges Exploration); Sapienza University of Rome; Gatsby Charitable Foundation at The Sainsbury Laboratory; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Gatsby Charitable Foundation at The Sainsbury Laboratory, Norwich, and the Bill and Melinda Gates Foundation (Grand Challenges Exploration, grant agreement OPP1060026). Federica Locci was supported by the "Funding of joint research projects for the PhD students' mobility abroad" from Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Gatsby Charitable Foundation at The Sainsbury Laboratory and the Bill and Melinda Gates Foundation (Grand Challenges Exploration, grant agreement OPP1060026). Federica LOCCI was supported by the "Funding of joint research projects for the PhD students' mobility abroad" from Sapienza University of Rome. We thank Dr Sylvestre Marillonnet for help refining Golden Gate cloning vectors.	Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Eid A, 2016, PLANT CELL REP, V35, P1555, DOI 10.1007/s00299-016-2000-4; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gisler B, 2002, PLANT J, V32, P277, DOI 10.1046/j.1365-313X.2002.01421.x; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hayut SF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15605; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; LeBlanc C, 2018, PLANT J, V93, P377, DOI [10.1111/tpj.13782, 10.1111/tpj.13828]; Li X, 2007, J INTEGR PLANT BIOL, V49, P222, DOI 10.1111/j.1744-7909.2007.00393.x; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2018, NAT PROTOC, V13, P413, DOI 10.1038/nprot.2017.145; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2016.12.038, 10.1016/j.cell.2017.02.018]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Morineau C, 2017, PLANT BIOTECHNOL J, V15, P729, DOI 10.1111/pbi.12671; Nagaya S, 2010, PLANT CELL PHYSIOL, V51, P328, DOI 10.1093/pcp/pcp188; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; PERALTA EG, 1986, EMBO J, V5, P1137, DOI 10.1002/j.1460-2075.1986.tb04338.x; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Sunilkumar G, 2002, PLANT MOL BIOL, V50, P463, DOI 10.1023/A:1019832123444; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsutsui H, 2017, PLANT CELL PHYSIOL, V58, P46, DOI 10.1093/pcp/pcw191; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu R, 2018, BIOMED CENTRAL, V14, P65, DOI [10.1186/s13007-018-0330-7, DOI 10.1186/S13007-018-0330-7]; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004	49	49	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0204778	10.1371/journal.pone.0204778	http://dx.doi.org/10.1371/journal.pone.0204778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625150	Green Submitted, gold, Green Published			2022-12-26	WOS:000455359400006
J	Voss, M; Antar, MSM; Zalmout, IS; Gingerich, PD				Voss, Manja; Antar, Mohammed Sameh M.; Zalmout, Iyad S.; Gingerich, Philip D.			Stomach contents of the archaeocete Basilosaurus isis: Apex predator in oceans of the late Eocene	PLOS ONE			English	Article							SHARK CARCHAROCLES-MEGALODON; KILLER WHALES; LATE MIOCENE; SPERM-WHALE; DEEP-SEA; CETACEA; CARCASSES; MAMMALIA; HITAN; FALLS	Apex predators live at the top of an ecological pyramid, preying on animals in the pyramid below and normally immune from predation themselves. Apex predators are often, but not always, the largest animals of their kind. The living killer whale Orcinus orca is an apex predator in modern world oceans. Here we focus on an earlier apex predator, the late Eocene archaeocete Basilosaurus isis from Wadi Al Hitan in Egypt, and show from stomach contents that it fed on smaller whales (juvenile Dorudon atrox) and large fishes (Pycnodus mokattamensis). Our observations, the first direct evidence of diet in Basilosaurus isis, confirm a predator-prey relationship of the two most frequently found fossil whales in Wadi Al-Hitan, B. isis and D. atrox. This extends our understanding of their paleoecology. Late Eocene Basilosaurus isis, late Miocene Livyatan melvillei, and modern Orcinus orca are three marine apex predators known from relatively short intervals of time. Little is known about whales as apex predators through much of the Cenozoic era, and whales as apex predators deserve more attention than they have received.	[Voss, Manja] Leibniz Inst Evolut & Biodivers Sci, Museum Naturkunde Berlin, Berlin, Germany; [Antar, Mohammed Sameh M.] Egyptian Environm Affairs Agcy, Nat Conservat Sect, Dept Geol & Paleontol, Cairo, Egypt; [Zalmout, Iyad S.; Gingerich, Philip D.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Michigan System; University of Michigan	Voss, M (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Naturkunde Berlin, Berlin, Germany.	manja.voss@mfn.berlin	Gingerich, Philip D/A-6903-2008	Gingerich, Philip D/0000-0002-1550-2674; ZALMOUT, IYAD/0000-0003-1874-801X	U.S. National Science Foundation [EAR-0920972]; Innovationsfonds of the Museum fur Naturkunde Berlin	U.S. National Science Foundation(National Science Foundation (NSF)); Innovationsfonds of the Museum fur Naturkunde Berlin	Field work was supported by U.S. National Science Foundation grant EAR-0920972 to PDG. MV was supported with a travel grant by the Innovationsfonds of the Museum fur Naturkunde Berlin to finalize this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank G. Bianucci, O. Lambert, and M. Uhen for helpful reviews of the manuscript, which significantly improved the quality of the present paper. C. Meloro is acknowledged for his valuable editorial support. Finally, we are grateful to the park rangers and staff of the Wadi Al-Rayan Protected Area for their able and tireless assistance; and the Egyptian Environmental Affairs Agency for encouraging and supporting our field studies.	ALLISON PA, 1991, PALEOBIOLOGY, V17, P78, DOI 10.1017/S0094837300010368; Antar MSM, 2010, SOC VERT PAL ANN M P, P54; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Brochu Christopher A., 2000, Contributions from the Museum of Paleontology University of Michigan, V30, P251; BRODIE PF, 1969, AM MIDL NAT, V82, P312, DOI 10.2307/2423849; Buffrenil Vd, 1986, CAN J ZOOL, V64, P1750, DOI [10.1139/z86-264, DOI 10.1139/Z86-264]; Cherney MD, 2011, SOC VERT PAL ANN M P, P87; Collareta A, 2017, PALAEOGEOGR PALAEOCL, V469, P84, DOI 10.1016/j.palaeo.2017.01.001; Collareta A, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1319-y; Cozzi B, 2017, ANATOMY OF DOLPHINS: INSIGHTS INTO BODY STRUCTURE AND FUNCTION, pXV; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; de Ricqles Armand, 2001, P289; Diedrich C. G., 2013, NAT SCI, V5, P1203; El-Sayed SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172409; Eschricht D. F., 1866, RECENT MEMOIRS CETAC, P151; Fahlke JM, 2012, PALAEONTOL ELECTRON, V15; Fallows C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060797; Ferguson SH, 2012, POPUL ECOL, V54, P31, DOI 10.1007/s10144-011-0284-3; Fierstine HL, 2009, J VERTEBR PALEONTOL, V29, P589, DOI 10.1671/039.029.0207; Fourtau R., 1897, B SOC GEOL FRANCE, V25, P208; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Gingerich Philip D., 1996, Contributions from the Museum of Paleontology University of Michigan, V29, P359; Gingerichi Philip D., 2007, Contributions from the Museum of Paleontology University of Michigan, V31, P363; Gingrich Phillip D., 2011, Egyptian Journal of Paleontology, V11, P171; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Gray JE, 1870, P ZOOL SOC LOND, P70; Hardenbol J., 1998, MESOZOIC CENOZOIC SE, V60, P3; HARRISON RJ, 1970, J ZOOL, V160, P377; Higdon JW, 2012, MAR MAMMAL SCI, V28, pE93, DOI 10.1111/j.1748-7692.2011.00489.x; Houssaye A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118409; Hunter J, 1787, PHILOS T ROY SOC LON, V77, P371, DOI DOI 10.1098/RSTL.1787.0038; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Jones EG, 1998, P ROY SOC B-BIOL SCI, V265, P1119, DOI 10.1098/rspb.1998.0407; Kellogg AR., 1936, CARNEGIE I WASHINGTO, V482, P1; Kiel S, 2008, PALAEOGEOGR PALAEOCL, V267, P161, DOI 10.1016/j.palaeo.2008.06.016; Kriwet Juergen, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P139; Kriwet Juergen, 2005, Zitteliana Reihe A, V45, P135; Lambert O, 2017, ZOOL J LINN SOC-LOND, V179, P404, DOI 10.1111/zoj.12456; Lambert O, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1530; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Licht Martin, 2009, Studia Geologica Salmanticensia, V45, P139; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Nursall J. Ralph, 1996, P115; Peters SE, 2009, PALAIOS, V24, P290, DOI 10.2110/palo.2008.p08-080r; Pimiento C, 2015, PALEOBIOLOGY, V41, P479, DOI 10.1017/pab.2015.16; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Pitman Robert L., 2003, Aquatic Mammals, V29, P321, DOI 10.1578/01675420360736488; Pitman RL, 2015, MAR MAMMAL SCI, V31, P629, DOI 10.1111/mms.12182; Poyato-Ariza Francisco Jose, 2002, Geodiversitas, V24, P139; Priem F., 1897, B SOC GEOLOGIQUE FRA, V25, P212; Pyenson ND, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0186; Sch?fer W., 1962, AKTUO PALAONTOLOGIE; Schafer W., 1972, ECOLOGY PALAEOECOLOG; SLIJPER EJ, 1979, WHALES; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Strougo Amin, 2013, Contributions from the Museum of Paleontology University of Michigan, V32, P111; Swift CC., 1996, PALEONTOLOGICAL SOC, V8, P380; TARPLEY RJ, 1987, AM J ANAT, V180, P295, DOI 10.1002/aja.1001800310; Tripp E., 2013, MARINE SCI TODAY; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Underwood CJ, 2011, P GEOLOGIST ASSOC, V122, P47, DOI 10.1016/j.pgeola.2010.09.004; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Visser IN, 2010, AQUAT MAMM, V36, P195, DOI 10.1578/AM.36.2.2010.195; Wellard R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166670; Whitehead H, 2005, BIOL LETTERS, V1, P415, DOI 10.1098/rsbl.2005.0348; Wings O., 2004, THESIS; Wood Roger Conant, 1996, Chelonian Conservation and Biology, V2, P266; Wottke M., 1983, Senckenbergiana Lethaea, V64, P529; Wuttke Michael, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P1, DOI 10.1007/s12549-012-0070-z; Zalmout IS, 2000, J VERTEBR PALEONTOL, V20, P201, DOI 10.1671/0272-4634(2000)020[0201:PBICFT]2.0.CO;2; Zalmout IS, 2011, GEOLOGICAL SOC AM AB, V43, P264; Zalmout Iyad S., 2012, Museum of Paleontology Papers on Paleontology, V37, P1; Zouhri S, 2014, CR PALEVOL, V13, P599, DOI 10.1016/j.crpv.2014.04.002	73	12	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2019	14	1							e0209021	10.1371/journal.pone.0209021	http://dx.doi.org/10.1371/journal.pone.0209021			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG9VK	30625131	Green Submitted, gold, Green Published			2022-12-26	WOS:000455359400023
J	Choi, IA; Lee, JS; Song, YW; Lee, EY				Choi, In Ah; Lee, Jeong Seok; Song, Yeong Wook; Lee, Eun Young			Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study	PLOS ONE			English	Article							COHORT	Background We investigated the mortality and disability rate, as well as the healthcare expenditure, for patients with newly diagnosed seropositive rheumatoid arthritis (RA) who were followed-up for up to 10 years, compared to the general population in Korea. Methods We conducted a nationwide population-based study using a National Health Insurance Service-National Sample Cohort of the Korean population, consisting of 1 million individuals who submitted medical care claims between 2002 and 2013. RA was identified using as the International Classification of Diseases code M05 (seropositive RA), with prescription of any disease-modifying anti-rheumatic drug (DMARD). Our analysis was based on the data of 1655 patients with incident seropositive RA and 8275 non-RA controls. The controls were matched to the RA cohort by sex, age at the time of diagnosis, duration of follow-up, geographic region, type of social security, and household income. Results The most commonly used conventional synthetic DMARDs were hydroxychloroquine (71.30%) and methotrexate (69.5%), with adalimumab being the most commonly used biologic DMARD (2.54%). The mortality rate was significantly higher in the RA than the control group (incidence rate ratio [IRR] 1.29, 95% confidence interval [CI] 1.02-1.64) in the first 10 years after diagnosis. Specifically, mortality due to infectious diseases (IRR 4.41, 95% CI 1.60-12.17) and pneumonia (IRR 3.92, 95% CI 1.46-10.53) was significantly higher in the RA than control group. The disability rate was higher in the RA than control group over the first 10 years of the disease (IRR 2.27, 95% CI 1.77-2.92), which was attributed to a higher incidence of physical disability (IRR 3.81, 95% CI 2.81-5.15). Annual health expenditure was greater for the RA than the control group. Conclusions Therefore, the rate of mortality and disability, as well as healthcare expenditure, are higher for patients with RA over the first 10 years of the disease onset, than the general population of Korea. The use of claim data has limited the quality of information and there is a limit to the observation period, and we expect the prospective national-wide multicenter cohort for longer period to overcome these limitations.	[Choi, In Ah] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Cheongju, South Korea; [Lee, Jeong Seok; Song, Yeong Wook; Lee, Eun Young] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Jeong Seok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea	Chungbuk National University; Chungbuk National University Hospital; Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Lee, EY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	elee@snu.ac.kr		Choi, In Ah/0000-0003-4662-4065	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277 to EYL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek A, 2018, RHEUMATOLOGY, V57, P977, DOI 10.1093/rheumatology/key013; Abhishek A, 2017, RHEUMATOLOGY, V56, P736, DOI 10.1093/rheumatology/kew468; Barra L, 2014, J RHEUMATOL, V41, P2361, DOI 10.3899/jrheum.140082; Cho SK, 2013, RHEUMATOL INT, V33, P2985, DOI 10.1007/s00296-013-2833-x; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Dadoun S, 2013, JOINT BONE SPINE, V80, P29, DOI 10.1016/j.jbspin.2012.02.005; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; HAWLEY DJ, 1991, J RHEUMATOL, V18, P1552; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kim HY, 2016, NAT REV RHEUMATOL, V12, P183, DOI 10.1038/nrrheum.2015.165; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Kim YJ, 2012, J RHEUMATOL, V39, P226, DOI 10.3899/jrheum.110704; Lee JH, 2014, J KOREAN MED SCI, V29, P1082, DOI 10.3346/jkms.2014.29.8.1082; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee TJ, 2012, VALUE HEALTH, V15, pS43, DOI 10.1016/j.jval.2011.11.020; Orlewska E, 2011, MED SCI MONITOR, V17, pSR1, DOI 10.12659/MSM.881697; Sokka T, 2009, ANN RHEUM DIS, V68, P1666, DOI 10.1136/ard.2009.109983; Sung YK, 2012, SEMIN ARTHRITIS RHEU, V41, P745, DOI 10.1016/j.semarthrit.2011.09.007; Won S, 2018, RHEUMATOL INT, V38, P649, DOI 10.1007/s00296-017-3925-9	21	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210471	10.1371/journal.pone.0210471	http://dx.doi.org/10.1371/journal.pone.0210471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620765	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300036
J	Fokialakis, N; Alexi, X; Aligiannis, N; Boulaka, A; Meligova, AK; Lambrinidis, G; Kalpoutzakis, E; Pratsinis, H; Cheilari, A; Mitsiou, DJ; Mitakou, S; Alexis, MN				Fokialakis, Nikolas; Alexi, Xanthippi; Aligiannis, Nektarios; Boulaka, Athina; Meligova, Aggeliki K.; Lambrinidis, George; Kalpoutzakis, Eleftherios; Pratsinis, Harris; Cheilari, Antigoni; Mitsiou, Dimitra J.; Mitakou, Sofia; Alexis, Michael N.			Biological evaluation of isoflavonoids from Genista halacsyi using estrogen-target cells: Activities of glucosides compared to aglycones	PLOS ONE			English	Article							RECEPTOR-BETA; OSTEOCLASTIC DIFFERENTIATION; FLAVONOID GLYCOSIDES; GENE-EXPRESSION; PHYTOESTROGENS; BINDING; PLASMA; ABSORPTION; ALPHA; PHARMACOKINETICS	The purpose of this study was to evaluate the response of estrogen target cells to a series of isoflavone glucosides and aglycones from Genista halacsyi Heldr. The methanolic extract of aerial parts of this plant was processed using fast centrifugal partition chromatography, resulting in isolation of four archetypal isoflavones (genistein, daidzein, isoprunetin, 8-C-beta-D-glucopyranosyl-genistein) and ten derivatives thereof. 7-O-beta-D-glucopyranosyl-genistein and 7,4'-di-O-beta-D-glucopyranosyl-genistein were among the most abundant constituents of the isolate. All fourteen, except genistein, displayed low binding affinity for estrogen receptors (ER). Models of binding to ER alpha could account for the low binding affinity of monoglucosides. Genistein and its glucosides displayed full efficacy in inducing alkaline phosphatase (AIkP) in Ishikawa cells, proliferation of MCF-7 cells and ER-dependent gene expression in reporter cells at low concentrations (around 0.3 mu M). IC1182,780 fully antagonized these effects. The AIkP-inducing efficacy of the fourteen isoflavonoids was more strongly correlated with their transcriptional efficacy through ER alpha. O-monoglucosides displayed higher area under the dose-response curve (AUC) of AIkP response relative to the AUC of ER alpha-transcriptional response compared to the respective aglycones. In addition, 7-O-beta-D-glucopyranosyl-genistein and 7,4-di-O-beta-D-glucopyranosyl-genistein displayed estradiol-like efficacy in promoting differentiation of MC3T3-E1 cells to osteoblasts, while genistein was not convincingly effective in this respect. Moreover, 7,4-di-O-beta-D-glucopyranosyl-genistein suppressed lipopolysaccharide-induced tumor necrosis factor mRNA expression in RAW 264.7 cells, while 7-O-beta-D-glucopyranosyl-genistein was not convincingly effective and genistein was ineffective. However, genistein and its O-glucosides were ineffective in inhibiting differentiation of RAW 264.7 cells to osteoclasts and in protecting glutamate-challenged HT22 hippocampal neurons from oxidative stress-induced cell death. These findings suggest that 7-O-beta-D-glucopyranosyl-genistein and 7,4-di-O-beta-D-glucopyranosyl-genistein display higher estrogen-like and/or anti-inflammatory activity compared to the aglycone. The possibility of using preparations rich in O-beta-D-glucopyranosides of genistein to substitute for low-dose estrogen in formulations for menopausal symptoms is discussed.	[Fokialakis, Nikolas; Aligiannis, Nektarios; Kalpoutzakis, Eleftherios; Cheilari, Antigoni; Mitakou, Sofia] Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens, Greece; [Alexi, Xanthippi; Boulaka, Athina; Meligova, Aggeliki K.; Mitsiou, Dimitra J.; Alexis, Michael N.] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Mol Endocrinol Program, Athens, Greece; [Lambrinidis, George] Univ Athens, Fac Pharm, Div Pharmaceut Chem, Athens, Greece; [Pratsinis, Harris] NCSR Demokritos, Inst Biosci & Applicat, Lab Cell Proliferat & Ageing, Athens, Greece	National & Kapodistrian University of Athens; National Hellenic Research Foundation; National & Kapodistrian University of Athens; National Centre of Scientific Research "Demokritos"	Fokialakis, N (corresponding author), Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens, Greece.; Alexis, MN (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Mol Endocrinol Program, Athens, Greece.	fokialakis@pharm.uoa.gr; mnalexis@eie.gr	Pratsinis, Harris/G-9861-2013; Fokialakis, Nikolas/AAD-1498-2020; Cheilari, Antigoni/A-7149-2019; Alexis, Michael N./AFM-1847-2022; Lambrinidis, George/AAD-2196-2020; Mitsiou, Dimitra/AEG-6575-2022	Pratsinis, Harris/0000-0001-7550-1975; Fokialakis, Nikolas/0000-0001-7028-1870; Cheilari, Antigoni/0000-0002-6180-821X; Alexis, Michael N./0000-0002-4243-7628; Lambrinidis, George/0000-0002-2820-9338; Mitsiou, Dimitra/0000-0001-8521-4216; ALIGIANNIS, NEKTARIOS/0000-0002-3335-8135	Thales 2011 project (European Social Fund) [MIS 375617]; Thales 2011 project (National Resources) [MIS 375617]	Thales 2011 project (European Social Fund); Thales 2011 project (National Resources)	This work was supported by Thales 2011 project MIS 375617 (SERMENCO; co-funded by the European Social Fund and National Resources) to SM and MNA.	Alexi X, 2009, J STEROID BIOCHEM, V117, P159, DOI 10.1016/j.jsbmb.2009.09.006; Amer DAM, 2012, J CELL PHYSIOL, V227, P3434, DOI 10.1002/jcp.24044; Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; Barnes S, 2011, FOOD FUNCT, V2, P235, DOI 10.1039/c1fo10025d; Bedell S, 2014, J STEROID BIOCHEM, V139, P225, DOI 10.1016/j.jsbmb.2012.12.004; Biasutto L, 2007, J MED CHEM, V50, P241, DOI 10.1021/jm060912x; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; CHANG YC, 1994, J AGR FOOD CHEM, V42, P1869, DOI 10.1021/jf00045a007; Chanteranne B, 2008, CLIN INTERV AGING, V3, P711; Chiang SS, 2013, APPL MICROBIOL BIOT, V97, P1489, DOI 10.1007/s00253-012-4675-y; Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182, DOI 10.1290/0510075.1; Deecher DC, 2005, J CELL BIOCHEM, V95, P302, DOI 10.1002/jcb.20413; Dietz BM, 2016, PHARMACOL REV, V68, P1026, DOI 10.1124/pr.115.010843; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; Fokialakis N, 2004, CHEM BIOL, V11, P397, DOI 10.1016/j.chembiol.2004.02.014; Fokialakis N, 2012, BIOORGAN MED CHEM, V20, P2962, DOI 10.1016/j.bmc.2012.03.012; Ghazanfarpour M, 2015, J OBSTET GYNAECOL, V35, P783, DOI 10.3109/01443615.2015.1011104; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gritzapis AD, 2003, BREAST CANCER RES TR, V80, P1, DOI 10.1023/A:1024462416640; Halabalaki M, 2006, PLANTA MED, V72, P488, DOI 10.1055/s-2005-916261; Harborne J. B., 1994, PHYTOCHEMICAL DICT L, P313; HARBORNE JB, 1999, HDB NATURAL FLAVONOI, V2, P1; He X, 2010, BIOCHEM BIOPH RES CO, V401, P356, DOI 10.1016/j.bbrc.2010.09.053; Hosoda K, 2008, DRUG METAB DISPOS, V36, P1485, DOI 10.1124/dmd.108.021006; Huang SG, 2012, ASSAY DRUG DEV TECHN, V10, P88, DOI 10.1089/adt.2011.0388; Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695; Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101; Jiang QA, 2010, J MED CHEM, V53, P6153, DOI 10.1021/jm100610w; Jiang Y, 2013, FASEB J, V27, P4406, DOI 10.1096/fj.13-234617; Jimenez M, 1999, J AGR FOOD CHEM, V47, P56, DOI 10.1021/jf9805653; Jin JS, 2008, BIOL PHARM BULL, V31, P1621, DOI 10.1248/bpb.31.1621; Jung ME, 2005, J NEUROCHEM, V95, P745, DOI 10.1111/j.1471-4159.2005.03424.x; JURD L, 1972, PHYTOCHEMISTRY, V11, P2535, DOI 10.1016/S0031-9422(00)88532-5; Kang JS, 2005, BIOCHEM PHARMACOL, V71, P136, DOI 10.1016/j.bcp.2005.10.009; Kanno S, 2004, TOXICOLOGY, V196, P137, DOI 10.1016/j.tox.2003.12.002; Katsanou ES, 2007, J STEROID BIOCHEM, V104, P228, DOI 10.1016/j.jsbmb.2007.03.028; Kim JL, 2012, J CELL BIOCHEM, V113, P247, DOI 10.1002/jcb.23351; KINJO JE, 1987, CHEM PHARM BULL, V35, P4846; Kottra G, 2007, J PHARMACOL EXP THER, V322, P829, DOI 10.1124/jpet.107.124040; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lambrinidis G, 2006, ENVIRON CHEM LETT, V4, P159, DOI 10.1007/s10311-006-0065-y; Lee SH, 2014, INT J MOL SCI, V15, P10605, DOI 10.3390/ijms150610605; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; MARKIEWICZ L, 1993, J STEROID BIOCHEM, V45, P399, DOI 10.1016/0960-0760(93)90009-L; Marston A, 2006, J CHROMATOGR A, V1112, P181, DOI 10.1016/j.chroma.2005.10.018; Maubach J, 2003, J CHROMATOGR B, V784, P137, DOI 10.1016/S1570-0232(02)00789-4; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123; Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Panagiotidou E, 2014, J ENDOCRINOL, V220, P207, DOI 10.1530/JOE-13-0416; Pardo C, 2004, PLANT SYST EVOL, V244, P93, DOI 10.1007/s00606-003-0091-1; Park K, 2014, INT J MOL MED, V33, P178, DOI 10.3892/ijmm.2013.1557; Pfitscher A, 2008, J STEROID BIOCHEM, V112, P87, DOI 10.1016/j.jsbmb.2008.08.007; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Thai QD, 2016, PHYTOCHEMISTRY, V130, P170, DOI 10.1016/j.phytochem.2016.04.006; Rahn DD, 2014, OBSTET GYNECOL, V124, P1147, DOI 10.1097/AOG.0000000000000526; Richelle M, 2002, J NUTR, V132, P2587, DOI 10.1093/jn/132.9.2587; Rufer CE, 2008, AM J CLIN NUTR, V87, P1314, DOI 10.1093/ajcn/87.5.1314; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447, DOI 10.1093/ajcn/76.2.447; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Skretas G, 2007, J AM CHEM SOC, V129, P8443, DOI 10.1021/ja067754j; Soukup ST, 2014, ANAL BIOANAL CHEM, V406, P6007, DOI 10.1007/s00216-014-8034-y; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236; Sucontphunt A, 2011, J NAT MED-TOKYO, V65, P1, DOI 10.1007/s11418-010-0442-5; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tchourrachoua J, 2016, J STEROID BIOCHEM, V158, P138, DOI 10.1016/j.jsbmb.2015.12.015; THERON EJ, 1994, IN VITRO CELL DEV-AN, V30A, P115, DOI 10.1007/BF02631403; Villalonga-Barber C, 2011, BIOORGAN MED CHEM, V19, P339, DOI 10.1016/j.bmc.2010.11.018; WATANABE K, 1993, CHEM PHARM BULL, V41, P394, DOI 10.1248/cpb.41.394; WENKERT E, 1977, PHYTOCHEMISTRY, V16, P1811, DOI 10.1016/0031-9422(71)85095-1; Zhang DW, 2012, BIOCHIMIE, V94, P2514, DOI 10.1016/j.biochi.2012.06.033	79	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2019	14	1							e0210247	10.1371/journal.pone.0210247	http://dx.doi.org/10.1371/journal.pone.0210247			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG7HM	30620769	Green Published, Green Submitted, gold			2022-12-26	WOS:000455161300025
J	Garcia, D; Harbaoui, B; van de Hoef, TP; Meuwissen, M; Nijjer, SS; Echavarria-Pinto, M; Davies, JE; Piek, JJ; Lantelme, P				Garcia, Damien; Harbaoui, Brahim; van de Hoef, Tim P.; Meuwissen, Martijn; Nijjer, Sukhjinder S.; Echavarria-Pinto, Mauro; Davies, Justin E.; Piek, Jan J.; Lantelme, Pierre			Relationship between FFR, CFR and coronary microvascular resistance - Practical implications for FFR-guided percutaneous coronary intervention	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; MICROCIRCULATORY RESISTANCE; VELOCITY RESERVE; PROGNOSTIC VALUE; FLUID-DYNAMICS; PRESSURE-DROP; DISCORDANCE; STENOSES; INDEX	Objective The aim was threefold: 1) expound the independent physiological parameters that drive FFR, 2) elucidate contradictory conclusions between fractional flow reserve (FFR) and coronary flow reserve (CFR), and 3) highlight the need of both FFR and CFR in clinical decision making. Simple explicit theoretical models were supported by coronary data analyzed retrospectively. Methodology FFR was expressed as a function of pressure loss coefficient, aortic pressure and hyperemic coronary microvascular resistance. The FFR-CFR relationship was also demonstrated mathematically and was shown to be exclusively dependent upon the coronary microvascular resistances. The equations were validated in a first series of 199 lesions whose pressures and distal velocities were monitored. A second dataset of 75 lesions with pre- and post-PCI measures of FFR and CFR was also analyzed to investigate the clinical impact of our hemodynamic reasoning. Results Hyperemic coronary microvascular resistance and pressure loss coefficient had comparable impacts (45% and 49%) on FFR. There was a good concordance (y= 0.96 x - 0.02, r(2) = 0.97) between measured CFR and CFR predicted by FFR and coronary resistances. In patients with CFR < 2 and CFR/FFR >= 2, post-PCI CFR was significantly >2 (p < 0.001), whereas it was not (p = 0.94) in patients with CFR < 2 and CFR/FFR < 2. Conclusion The FFR behavior and FFR-CFR relationship are predictable from basic hemodynamics. Conflicting conclusions between FFR and CFR are explained from coronary vascular resistances. As confirmed by our results, FFR and CFR are complementary; they could jointly contribute to better PCI guidance through the CFR-to-FFR ratio in patients with coronary artery disease.	[Garcia, Damien; Harbaoui, Brahim; Lantelme, Pierre] Univ Lyon 1, INSA Lyon, INSERM U1206, CREATIS, Villeurbanne, France; [Harbaoui, Brahim; Lantelme, Pierre] Hosp Civils Lyon, Hop Croix Rousse, Dept Cardiol, Lyon, France; [van de Hoef, Tim P.; Echavarria-Pinto, Mauro; Piek, Jan J.] Univ Amsterdam, Acad Med Ctr, AMC Heart Ctr, Amsterdam, Netherlands; [van de Hoef, Tim P.; Davies, Justin E.] Tergooi Hosp, Dept Cardiol, Blaricum, Netherlands; [Meuwissen, Martijn] Amphia Hosp, Dept Cardiol, Breda, Netherlands; [Nijjer, Sukhjinder S.] Imperial Coll London, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; University of Amsterdam; Academic Medical Center Amsterdam; Tergooi Blaricum; Amphia Hospital; Imperial College London	Garcia, D (corresponding author), Univ Lyon 1, INSA Lyon, INSERM U1206, CREATIS, Villeurbanne, France.	garcia.damien@gmail.com	Garcia, Damien/E-2206-2011; Meuwissen, martijn/GWV-1891-2022; Lantelme, Pierre/G-2708-2019; Harbaoui, Brahim/AAA-4986-2019	Garcia, Damien/0000-0002-8552-1475; Piek, Jan/0000-0001-8666-7129; Nijjer, Sukhjinder/0000-0001-9146-1037	Medical Research Council [G1100443] Funding Source: Medline; MRC [G1100443] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bax M, 2006, AM J CARDIOL, V97, P1131, DOI 10.1016/j.amjcard.2005.11.026; De Bruyne B, 2008, HEART, V94, P949, DOI 10.1136/hrt.2007.122838; Fearon WF, 2013, CIRCULATION, V127, P2436, DOI 10.1161/CIRCULATIONAHA.112.000298; Ferrari M, 1999, J AM COLL CARDIOL, V33, P82, DOI 10.1016/S0735-1097(98)00552-X; GOULD KL, 1990, J AM COLL CARDIOL, V15, P459, DOI 10.1016/S0735-1097(10)80078-6; Govindaraju K, 2016, COMPUT METHOD BIOMEC, V19, P1541, DOI 10.1080/10255842.2016.1170119; Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P193, DOI 10.1016/j.jcmg.2011.09.020; Kolli KK, 2016, CATHETER CARDIO INTE, V87, P273, DOI 10.1002/ccd.26063; Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053; Liu Z, 2016, INT J CARDIOL, V219, P56, DOI 10.1016/j.ijcard.2016.05.032; MARCUS ML, 1983, AM J MED, V75, P62, DOI 10.1016/0002-9343(83)90120-1; MATES RE, 1978, CIRC RES, V42, P152, DOI 10.1161/01.RES.42.1.152; Meuwissen M, 2001, CIRCULATION, V103, P184; Meuwissen M., 2009, INTERV CARDIOL, V1, P237, DOI [10.2217/ica.09.33, DOI 10.2217/ICA.09.33]; Meuwissen M, 2008, CATHETER CARDIO INTE, V71, P291, DOI 10.1002/ccd.21331; Morris Paul D, 2017, JACC Basic Transl Sci, V2, P434, DOI 10.1016/j.jacbts.2017.04.003; Naya M, 2014, J NUCL MED, V55, P248, DOI 10.2967/jnumed.113.121442; Ng MKC, 2012, CIRC-CARDIOVASC INTE, V5, P515, DOI 10.1161/CIRCINTERVENTIONS.112.969048; Nijjer SS, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001715; ROSSEN JD, 1993, J AM COLL CARDIOL, V21, P343, DOI 10.1016/0735-1097(93)90673-O; Siebes M, 2002, AM J PHYSIOL-HEART C, V283, pH1462, DOI 10.1152/ajpheart.00165.2002; Sonin AA, 2004, P NATL ACAD SCI USA, V101, P8525, DOI 10.1073/pnas.0402931101; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van de Hoef TP, 2014, CIRC-CARDIOVASC INTE, V7, P301, DOI 10.1161/CIRCINTERVENTIONS.113.001049; van de Hoef TP, 2014, HEART, V100, P951, DOI 10.1136/heartjnl-2013-305124; Verdier-Watts F, 2015, EUROINTERVENTION, V11, P416, DOI 10.4244/EIJV11I4A82; Wijntjens GW, 2015, INTERV CARDIOL, V7, P401, DOI [10.2217/ica.15.24, DOI 10.2217/ICA.15.24]; YOUNG DF, 1975, CIRC RES, V36, P735, DOI 10.1161/01.RES.36.6.735	29	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2019	14	1							e0208612	10.1371/journal.pone.0208612	http://dx.doi.org/10.1371/journal.pone.0208612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG5UW	30616240	Green Submitted, Green Published, gold			2022-12-26	WOS:000455045900009
